Citrus Sinensis ID: 001768
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 1016 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGG8 | 1038 | Probable LRR receptor-lik | yes | no | 0.974 | 0.953 | 0.653 | 0.0 | |
| C0LGG9 | 1035 | Probable LRR receptor-lik | yes | no | 0.991 | 0.972 | 0.637 | 0.0 | |
| C0LGE0 | 1014 | Probable LRR receptor-lik | no | no | 0.912 | 0.914 | 0.550 | 0.0 | |
| C0LGN2 | 1020 | Probable leucine-rich rep | no | no | 0.952 | 0.949 | 0.498 | 0.0 | |
| C0LGG7 | 953 | Probable LRR receptor-lik | no | no | 0.851 | 0.907 | 0.518 | 0.0 | |
| Q9FXF2 | 1021 | Probable LRR receptor-lik | no | no | 0.929 | 0.924 | 0.453 | 0.0 | |
| Q9ASQ6 | 1019 | Probable LRR receptor-lik | no | no | 0.965 | 0.962 | 0.444 | 0.0 | |
| C0LGH3 | 1033 | Probable LRR receptor-lik | no | no | 0.883 | 0.869 | 0.438 | 0.0 | |
| C0LGH2 | 1032 | Probable LRR receptor-lik | no | no | 0.884 | 0.871 | 0.427 | 0.0 | |
| Q9ZP16 | 667 | Cysteine-rich receptor-li | no | no | 0.336 | 0.512 | 0.453 | 3e-79 |
| >sp|C0LGG8|Y5343_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53430 OS=Arabidopsis thaliana GN=At1g53430 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 1341 bits (3470), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 659/1008 (65%), Positives = 808/1008 (80%), Gaps = 18/1008 (1%)
Query: 1 MGKIVS----VFVVLGFLVLNCFANFGSHAQRLPDDEVQTLQSIFRKLNFRNGQVNQTSC 56
MG I S V+V+L L+ C NFGS+AQ LP+DEVQTL++IFRKL + + +TSC
Sbjct: 1 MGFIFSTEKVVYVLL--LIFVCLENFGSNAQLLPEDEVQTLRTIFRKLQNQTVNIERTSC 58
Query: 57 TEGSWNVTID---DSNGSNFTCDCTYSNNTVCHVTVILLKGFNLAGVIPEEFGNLTFLQE 113
++ +WN ++ +S SN TCDCT++ ++VC VT I LK F+L G+ P EFGNLT L+E
Sbjct: 59 SDQNWNFVVESASNSPTSNITCDCTFNASSVCRVTNIQLKSFSLPGIFPPEFGNLTRLRE 118
Query: 114 VDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGDISTLEELVLEDNQLVGPL 173
+DLSRN+ NG++P + +++ L L ++GNRLSG P ++GDI+TL ++ LE N GPL
Sbjct: 119 IDLSRNFLNGTIPTTLSQIP-LEILSVIGNRLSGPFPPQLGDITTLTDVNLETNLFTGPL 177
Query: 174 PENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDR 233
P NLGNL+SL+ +LLS+NNFTG IPES NLKNLTEFRIDG++L+G+IP+FIGNWT L+R
Sbjct: 178 PRNLGNLRSLKELLLSANNFTGQIPESLSNLKNLTEFRIDGNSLSGKIPDFIGNWTLLER 237
Query: 234 LDLQGTSLEGPIPSTISQLKNLTELRISDLKGSSS-SFPNLQDMKKMERLILRNCLITGR 292
LDLQGTS+EGPIP +IS L NLTELRI+DL+G ++ SFP+L+++ KM+RL+LRNCLI G
Sbjct: 238 LDLQGTSMEGPIPPSISNLTNLTELRITDLRGQAAFSFPDLRNLMKMKRLVLRNCLIRGP 297
Query: 293 IPEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGTLPDWILTSEKNL 352
IPEYI M++LK LDLS N LTG +P +NL +++FL NNSL+G +P +I+ S++NL
Sbjct: 298 IPEYIGSMSELKTLDLSSNMLTGVIPDTFRNLDAFNFMFLNNNSLTGPVPQFIINSKENL 357
Query: 353 DLSYNNFTESSPATCRESRVNILSSFSSTGSNSVSWCLKKDLPCPKEAKHYSLFINCGGS 412
DLS NNFT+ +C + VN++SS+ S NSV WCL++ LPCP++AK SLFINCGGS
Sbjct: 358 DLSDNNFTQPPTLSCNQLDVNLISSYPSVTDNSVQWCLREGLPCPEDAKQSSLFINCGGS 417
Query: 413 PTEFEENDYEEDLNTQGPSNFGIVSDRWAYSSTGVYVGNESSKYLAANQYGL-NVSGAEY 471
+ ++ Y +DLN++G S F VS+RW YSS+GV++G E + YLA +++ L N S EY
Sbjct: 418 RLKIGKDTYTDDLNSRGQSTFSSVSERWGYSSSGVWLGKEDAGYLATDRFNLINGSTPEY 477
Query: 472 YKTARLAPQSLKYYGLCMLKGSYTVKLHFAEIMFTNDQTYKSLGKRMFDVSIQGKQVLKD 531
YKTARL+PQSLKYYGLC+ +GSY ++LHFAEIMF+NDQT+ SLG+R+FD+ +QG + +D
Sbjct: 478 YKTARLSPQSLKYYGLCLRRGSYKLQLHFAEIMFSNDQTFNSLGRRIFDIYVQGNLLERD 537
Query: 532 FDIMEEAGGVGIGITREFKDVSVNGSTMEIHLYWAGKGTNAIPYRGVYGPLISAITVTPN 591
F+I E AGGVG R+ V VNGST+EIHL W GKGTN IP RGVYGPLISAIT+TPN
Sbjct: 538 FNIAERAGGVGKPFIRQIDGVQVNGSTLEIHLQWTGKGTNVIPTRGVYGPLISAITITPN 597
Query: 592 FEVDTGGGLSAGAIVGIVAGSCAVVIILLFILWRL-GYLGGKNV-EDKELRGLDLQTGYF 649
F+VDTG LS GA+ GIV +CAV +L+ ++ RL GYLGGK V E++ELRGLDLQTG F
Sbjct: 598 FKVDTGKPLSNGAVAGIVIAACAVFGLLVLVILRLTGYLGGKEVDENEELRGLDLQTGSF 657
Query: 650 TLRQIKAATNNFDAANKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGNREFVNEIGMI 709
TL+QIK ATNNFD NKIGEGGFGPVYKG L+DG IAVKQLSSKSKQGNREFV EIGMI
Sbjct: 658 TLKQIKRATNNFDPENKIGEGGFGPVYKGVLADGMTIAVKQLSSKSKQGNREFVTEIGMI 717
Query: 710 SALQHQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIA 769
SALQH NLVKLYGCCIEG +LLLVYEYLENNSLARALFG E Q L+LDW+TR +IC IA
Sbjct: 718 SALQHPNLVKLYGCCIEGKELLLVYEYLENNSLARALFGTEKQRLHLDWSTRNKICIGIA 777
Query: 770 RGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGY 829
+GLAYLHEESRLKIVHRDIKATNVLLD LNAKISDFGLAKL++DENTHISTRIAGT+GY
Sbjct: 778 KGLAYLHEESRLKIVHRDIKATNVLLDLSLNAKISDFGLAKLNDDENTHISTRIAGTIGY 837
Query: 830 MAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLE 889
MAPEYAMRGYLTDKADVYSFG+V LEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQG+LLE
Sbjct: 838 MAPEYAMRGYLTDKADVYSFGVVCLEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGSLLE 897
Query: 890 LVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTAVQAPIIRRNSD- 948
LVDP LG++FSKKEAM MLNIALLCTNPSPTLRP MSS VSMLEGK VQ P+++R +D
Sbjct: 898 LVDPDLGTSFSKKEAMRMLNIALLCTNPSPTLRPPMSSVVSMLEGKIKVQPPLVKREADP 957
Query: 949 --SQDARFRAFEILSQDSQTHVSTLSQESEMQ-RTMSIDAPWTDSSVS 993
S RF+A E+LSQDS++ VST ++ E + S+D PW DSS S
Sbjct: 958 SGSAAMRFKALELLSQDSESQVSTYARNREQDISSSSMDGPWVDSSFS 1005
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|C0LGG9|Y5344_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53440 OS=Arabidopsis thaliana GN=At1g53440 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 1327 bits (3435), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 653/1025 (63%), Positives = 802/1025 (78%), Gaps = 18/1025 (1%)
Query: 1 MGKIVSVFVVLGFLVLNCFANFGSHAQRLPDDEVQTLQSIFRKLNFRNGQVNQTSCTEGS 60
MG S L ++ C FGS+AQ LP+DEVQTL++IFRKL + + +TSC +
Sbjct: 1 MGFFFSTRKGLLLIIFICLDIFGSNAQLLPEDEVQTLRTIFRKLQNQTVNIERTSCLDRK 60
Query: 61 WNVTIDDSNG---SNFTCDCTYSNNTVCHVTVILLKGFNLAGVIPEEFGNLTFLQEVDLS 117
WN + ++ SN TCDCT++ ++VC VT I L+GFNL G+IP EFGNLT L E+DL
Sbjct: 61 WNFVAESTSKLPTSNITCDCTFNASSVCRVTNIQLRGFNLRGIIPPEFGNLTRLTEIDLV 120
Query: 118 RNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGDISTLEELVLEDNQLVGPLPENL 177
N+ +G++P + +++ L L + GNRLSG P ++G I+TL ++++E N G LP NL
Sbjct: 121 LNFLSGTIPTTLSQIP-LEILAVTGNRLSGPFPPQLGQITTLTDVIMESNLFTGQLPPNL 179
Query: 178 GNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQ 237
GNL+SL+R+L+SSNN TG IPES NLKNLT FRIDG++L+G+IP+FIGNWT+L RLDLQ
Sbjct: 180 GNLRSLKRLLISSNNITGRIPESLSNLKNLTNFRIDGNSLSGKIPDFIGNWTRLVRLDLQ 239
Query: 238 GTSLEGPIPSTISQLKNLTELRISDLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYI 297
GTS+EGPIP++IS LKNLTELRI+DL+G +S FP+LQ+M MERL+LRNCLI IPEYI
Sbjct: 240 GTSMEGPIPASISNLKNLTELRITDLRGPTSPFPDLQNMTNMERLVLRNCLIREPIPEYI 299
Query: 298 -EDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGTLPDWILTSEKNLDLSY 356
MT LK+LDLS N L G +P ++L ++++L NNSL+G +P +IL S++N+DLSY
Sbjct: 300 GTSMTMLKLLDLSSNMLNGTIPDTFRSLNAFNFMYLNNNSLTGPVPQFILDSKQNIDLSY 359
Query: 357 NNFTESSPATCRESRVNILSSFSSTGSNSVSWCLKKDLPCPKEAKHYSLFINCGGSPTEF 416
NNFT+ +C + VN++SS+ S +NSV WCL+KDLPCP +A H SLFINCGG+ +
Sbjct: 360 NNFTQPPTLSCNQLDVNLISSYPSVTNNSVQWCLRKDLPCPGDAHHSSLFINCGGNRLKV 419
Query: 417 EENDYEEDLNTQGPSNFGIVSDRWAYSSTGVYVGNESSKYLAANQYGL-NVSGAEYYKTA 475
++++Y +DLN +G S F VS+RW YSS+G ++GN+ + YLA + + L N S EYYKTA
Sbjct: 420 DKDEYADDLNKRGASTFSSVSERWGYSSSGAWLGNDGATYLATDTFNLINESTPEYYKTA 479
Query: 476 RLAPQSLKYYGLCMLKGSYTVKLHFAEIMFTNDQTYKSLGKRMFDVSIQGKQVLKDFDIM 535
RLA QSLKYYGLCM +GSY V+L+FAEIMF+NDQTY SLG+R+FD+ +QG + +DF+I
Sbjct: 480 RLASQSLKYYGLCMRRGSYKVQLYFAEIMFSNDQTYSSLGRRLFDIYVQGILLERDFNIA 539
Query: 536 EEAGGVGIGITREFKDVSVNGSTMEIHLYWAGKGTNAIPYRGVYGPLISAITVTPNFEVD 595
+ AGGVG R+ +V VNGST+EIHL W GKGTN IP RGVYGPLISAITVTPNF+VD
Sbjct: 540 QRAGGVGKPFLRQVDEVQVNGSTLEIHLKWTGKGTNVIPTRGVYGPLISAITVTPNFKVD 599
Query: 596 TGGGLSAGAIVGIVAGSCAVVIILLFILWRL-GYLGGKNV-EDKELRGLDLQTGYFTLRQ 653
TG LS G + GIV +C +L+ ++ RL GYLGGK V E++ELRGLDLQTG FTL+Q
Sbjct: 600 TGKPLSNGVVAGIVIAACVAFGLLVLVILRLTGYLGGKEVDENEELRGLDLQTGSFTLKQ 659
Query: 654 IKAATNNFDAANKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQ 713
IK ATNNFD NKIGEGGFGPVYKG L+DG IAVKQLSSKSKQGNREFV EIGMISALQ
Sbjct: 660 IKRATNNFDPENKIGEGGFGPVYKGVLADGMTIAVKQLSSKSKQGNREFVTEIGMISALQ 719
Query: 714 HQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLA 773
H NLVKLYGCCIEG +LLLVYEYLENNSLARALFG E Q L+LDW+TR ++C IA+GLA
Sbjct: 720 HPNLVKLYGCCIEGKELLLVYEYLENNSLARALFGTEKQRLHLDWSTRNKVCIGIAKGLA 779
Query: 774 YLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPE 833
YLHEESRLKIVHRDIKATNVLLD LNAKISDFGLAKLDE+ENTHISTRIAGT+GYMAPE
Sbjct: 780 YLHEESRLKIVHRDIKATNVLLDLSLNAKISDFGLAKLDEEENTHISTRIAGTIGYMAPE 839
Query: 834 YAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDP 893
YAMRGYLTDKADVYSFG+V LEIVSGKSNTNYRPKEEF+YLLDWAYVLQEQG+LLELVDP
Sbjct: 840 YAMRGYLTDKADVYSFGVVCLEIVSGKSNTNYRPKEEFIYLLDWAYVLQEQGSLLELVDP 899
Query: 894 SLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTAVQAPIIRRNSD---SQ 950
LG++FSKKEAM MLNIALLCTNPSPTLRP MSS VSML+GK VQ P+++R +D S
Sbjct: 900 DLGTSFSKKEAMRMLNIALLCTNPSPTLRPPMSSVVSMLQGKIKVQPPLVKREADPSGSA 959
Query: 951 DARFRAFEILSQDSQTHVSTLSQESEMQRTMSIDAPWTDSSVSVQIPDETREHSSSSLLL 1010
RF+A E LSQDS++ VST ++ E + + S+D PW DSS S D +++ SLL
Sbjct: 960 AMRFKALEHLSQDSESQVSTYTRNKEHKSSSSMDGPWVDSSFS----DPSKD---VSLLQ 1012
Query: 1011 QNENN 1015
Q E N
Sbjct: 1013 QEEGN 1017
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGE0|Y1765_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g07650 OS=Arabidopsis thaliana GN=At1g07650 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 981 bits (2535), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 528/959 (55%), Positives = 685/959 (71%), Gaps = 32/959 (3%)
Query: 5 VSVFVVLGFLVLNCFANFGSHAQRLPDDEVQTLQSIFRKLNFRNGQVNQTSCT-EGSWNV 63
+ +VL L+ + F S +L + EV+ L+ I +KL ++ N+ C+ EG+W V
Sbjct: 7 IYFIIVLFTLIFHGRLGF-SDNNKLHEAEVRALKEIGKKLGKKDWDFNKDPCSGEGTWIV 65
Query: 64 TIDDSNG--SNFTCDCTY-SNNTVCHVTVILLKGFNLAGVIPEEFGNLTFLQEVDLSRNY 120
T + G SN TCDC++ N+ CHV I LK NL G++P EF L L+ +DLSRN
Sbjct: 66 TTYTTKGFESNITCDCSFLPQNSSCHVIRIALKSQNLTGIVPPEFSKLRHLKVLDLSRNS 125
Query: 121 FNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGDISTLEELVLEDNQLVGPLPENLGNL 180
GS+PK +A ++ L L +GNRLSG P + ++ L L LE NQ GP+P ++G L
Sbjct: 126 LTGSIPKEWASMR-LEDLSFMGNRLSGPFPKVLTRLTMLRNLSLEGNQFSGPIPPDIGQL 184
Query: 181 KSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTS 240
L ++ L SN FTG + E G LKNLT+ RI +N TG IP+FI NWT++ +L + G
Sbjct: 185 VHLEKLHLPSNAFTGPLTEKLGLLKNLTDMRISDNNFTGPIPDFISNWTRILKLQMHGCG 244
Query: 241 LEGPIPSTISQLKNLTELRISDLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDM 300
L+GPIPS+IS L +LT+LRISDL G SSFP L++++ ++ LILR C I G IP+YI D+
Sbjct: 245 LDGPIPSSISSLTSLTDLRISDLGGKPSSFPPLKNLESIKTLILRKCKIIGPIPKYIGDL 304
Query: 301 TDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGTLPDWILTSEKNLDLSYNNFT 360
LK LDLSFN L+G +P +N+KK D+I+LT N L+G +P++ + KN+D+S+NNFT
Sbjct: 305 KKLKTLDLSFNLLSGEIPSSFENMKKADFIYLTGNKLTGGVPNYFVERNKNVDVSFNNFT 364
Query: 361 ESS--PA-TCRESRVNILSSFS-STGSNSVSWCLKKDLPC--PKEAKHYSLFINCGGSPT 414
+ S P+ C N++ SF+ S+ S C + +PC PK Y L+INCGG
Sbjct: 365 DESSIPSHDCNRVTSNLVESFALGNKSHKGSTCFLQRMPCVHPKRYHLYKLYINCGGGEV 424
Query: 415 EFE-ENDYEEDLNTQGPSNFGI-VSDRWAYSSTGVYVGNE--SSKYLAANQYGLNVSGAE 470
+ + E Y+ D +G S + + + RWA SSTG ++ N+ + +Y N L+V+ +
Sbjct: 425 KVDKEITYQADDEPKGASMYVLGANKRWALSSTGNFMDNDDDADEYTVQNTSRLSVNASS 484
Query: 471 ----YYKTARLAPQSLKYYGLCMLKGSYTVKLHFAEIMFTNDQTYKSLGKRMFDVSIQGK 526
Y+TAR++P SL YYG+C+ G+YTV LHFAEI+FT+D T SLGKR+FD+ +Q +
Sbjct: 485 PSFGLYRTARVSPLSLTYYGICLGNGNYTVNLHFAEIIFTDDNTLYSLGKRLFDIYVQDQ 544
Query: 527 QVLKDFDIMEEAGGVGIGITREFKDVSVNGSTMEIHLYWAGKGTNAIPYRGVYGPLISAI 586
V+K+F+I E A G G I + F V+V T++I L WAGKGT IP RGVYGP+ISAI
Sbjct: 545 LVIKNFNIQEAARGSGKPIIKSFL-VNVTDHTLKIGLRWAGKGTTGIPIRGVYGPMISAI 603
Query: 587 TVTPNFE----VDTGGGLSAGAIVGI-VAGSCAVVIILLFILWRLGYLGGKNVEDKELRG 641
+V PNF+ DT + VG+ VA + ++ I++ + W+ KN DKELRG
Sbjct: 604 SVEPNFKPPVYYDTKDIILK---VGVPVAAATLLLFIIVGVFWK--KRRDKNDIDKELRG 658
Query: 642 LDLQTGYFTLRQIKAATNNFDAANKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGNRE 701
LDLQTG FTLRQIKAAT+NFD KIGEGGFG VYKG LS+G +IAVKQLS+KS+QGNRE
Sbjct: 659 LDLQTGTFTLRQIKAATDNFDVTRKIGEGGFGSVYKGELSEGKLIAVKQLSAKSRQGNRE 718
Query: 702 FVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGK-EGQCLNLDWAT 760
FVNEIGMISALQH NLVKLYGCC+EGNQL+LVYEYLENN L+RALFGK E L LDW+T
Sbjct: 719 FVNEIGMISALQHPNLVKLYGCCVEGNQLILVYEYLENNCLSRALFGKDESSRLKLDWST 778
Query: 761 RKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHIS 820
RK+I IA+GL +LHEESR+KIVHRDIKA+NVLLDKDLNAKISDFGLAKL++D NTHIS
Sbjct: 779 RKKIFLGIAKGLTFLHEESRIKIVHRDIKASNVLLDKDLNAKISDFGLAKLNDDGNTHIS 838
Query: 821 TRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYV 880
TRIAGT+GYMAPEYAMRGYLT+KADVYSFG+VALEIVSGKSNTN+RP E+FVYLLDWAYV
Sbjct: 839 TRIAGTIGYMAPEYAMRGYLTEKADVYSFGVVALEIVSGKSNTNFRPTEDFVYLLDWAYV 898
Query: 881 LQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTAVQ 939
LQE+G+LLELVDP+L S++S++EAM MLN+AL+CTN SPTLRPTMS VS++EGKTA+Q
Sbjct: 899 LQERGSLLELVDPTLASDYSEEEAMLMLNVALMCTNASPTLRPTMSQVVSLIEGKTAMQ 957
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGN2|Y3148_ARATH Probable leucine-rich repeat receptor-like serine/threonine-protein kinase At3g14840 OS=Arabidopsis thaliana GN=LRR-RLK PE=1 SV=1 | Back alignment and function description |
|---|
Score = 937 bits (2421), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 504/1011 (49%), Positives = 670/1011 (66%), Gaps = 43/1011 (4%)
Query: 7 VFVVLGFLVLNCFANFGSHAQRLPDDEVQTLQSIFRKLNFRNGQVNQTSC----TEGSW- 61
+F + L F++F S A LP +EV LQS+ L N + C +EG W
Sbjct: 8 LFTYYFIVSLILFSDFVSSAT-LPKEEVDALQSVATALKKSNWNFSVDPCDETLSEGGWR 66
Query: 62 NVTIDDSNGSNFTCDCTYSNNTVCHVTVILLKGFNLAGVIPEEFGNLTFLQEVDLSRNYF 121
N TC+C+ + +CHVT I+LK +L G +P + L FLQE+DL+RNY
Sbjct: 67 NPNAAKGFEDAVTCNCS---SVICHVTNIVLKAQDLQGSLPTDLSGLPFLQELDLTRNYL 123
Query: 122 NGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGDISTLEELVLEDNQLVGPLPENLGNLK 181
NGS+P + +L + +LGNR+SGSIP E+G+++TL LVLE NQL G +P LGNL
Sbjct: 124 NGSIPPEWGA-SSLLNISLLGNRISGSIPKELGNLTTLSGLVLEYNQLSGKIPPELGNLP 182
Query: 182 SLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSL 241
+L+R+LLSSNN +G IP ++ L LT+ RI + TG IP+FI NW L++L +Q + L
Sbjct: 183 NLKRLLLSSNNLSGEIPSTFAKLTTLTDLRISDNQFTGAIPDFIQNWKGLEKLVIQASGL 242
Query: 242 EGPIPSTISQLKNLTELRISDLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDMT 301
GPIPS I L LT+LRI+DL G S FP L++M M+ LILRNC +TG +P Y+
Sbjct: 243 VGPIPSAIGLLGTLTDLRITDLSGPESPFPPLRNMTSMKYLILRNCNLTGDLPAYLGQNR 302
Query: 302 DLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGTLPDWILTSEKNLDLSYNNFTE 361
LK LDLSFN+L+GP+P L +D+I+ T+N L+G +P W++ +D++YNNF++
Sbjct: 303 KLKNLDLSFNKLSGPIPATYSGLSDVDFIYFTSNMLNGQVPSWMVDQGDTIDITYNNFSK 362
Query: 362 SSPATCRESRVNILSSFSSTGSNSVS--WCLKKDLPCPKEAKHYSLFINCGGSPTEFEEN 419
C++ VN SS S +N+ S CL K CPK Y L INCGG+ E N
Sbjct: 363 DKTEECQQKSVNTFSSTSPLVANNSSNVSCLSK-YTCPK--TFYGLHINCGGN--EITSN 417
Query: 420 DYEEDLNTQGPSNFGIVSDRWAYSSTGVYV-----GNESSKYLAANQYGLNVSGAEY--Y 472
+ + D +T + + W S+TG ++ N SK+ +++ + S ++ Y
Sbjct: 418 ETKYDADTWDTPGYYDSKNGWVSSNTGNFLDDDRTNNGKSKWSNSSELKITNSSIDFRLY 477
Query: 473 KTARLAPQSLKYYGLCMLKGSYTVKLHFAEIMFTNDQTYKSLGKRMFDVSIQGKQVLKDF 532
ARL+ SL Y LC+ KG+YTV LHFAEIMF Y +LG+R FD+ +QGK+ +KDF
Sbjct: 478 TQARLSAISLTYQALCLGKGNYTVNLHFAEIMFNEKNMYSNLGRRYFDIYVQGKREVKDF 537
Query: 533 DIMEEAGGVGIGITREFKDVSVNGSTMEIHLYWAGKGTNAIPYRGVYGPLISAITVTPNF 592
+I++EA GVG + ++F + NG +EI L WAGKGT AIP RGVYGPLISA++V P+F
Sbjct: 538 NIVDEAKGVGKAVVKKFPVMVTNGK-LEIRLQWAGKGTQAIPVRGVYGPLISAVSVDPDF 596
Query: 593 -------EVDTGGGLSAGAIVGIVAGSCAVVIILLFILWRLGYLGGKNVEDKELRGLDLQ 645
GG + ++A + +V+++ ILW G L K+ +K+ + LD Q
Sbjct: 597 IPPKEPGTGTGGGSSVGTVVGSVIASTVFLVLLIGGILWWRGCLRPKSQMEKDFKNLDFQ 656
Query: 646 TGYFTLRQIKAATNNFDAANKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGNREFVNE 705
F+LRQIK AT+NFD ANKIGEGGFGPV+KG ++DG VIAVKQLS+KSKQGNREF+NE
Sbjct: 657 ISSFSLRQIKVATDNFDPANKIGEGGFGPVHKGIMTDGTVIAVKQLSAKSKQGNREFLNE 716
Query: 706 IGMISALQHQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRIC 765
I MISALQH +LVKLYGCC+EG+QLLLVYEYLENNSLARALFG + + L+W R++IC
Sbjct: 717 IAMISALQHPHLVKLYGCCVEGDQLLLVYEYLENNSLARALFGPQETQIPLNWPMRQKIC 776
Query: 766 SDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAG 825
IARGLAYLHEESRLKIVHRDIKATNVLLDK+LN KISDFGLAKLDE+ENTHISTR+AG
Sbjct: 777 VGIARGLAYLHEESRLKIVHRDIKATNVLLDKELNPKISDFGLAKLDEEENTHISTRVAG 836
Query: 826 TVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQG 885
T GYMAPEYAMRG+LTDKADVYSFG+VALEIV GKSNT+ R K + YLLDW +VL+EQ
Sbjct: 837 TYGYMAPEYAMRGHLTDKADVYSFGVVALEIVHGKSNTSSRSKADTFYLLDWVHVLREQN 896
Query: 886 NLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTAVQAPIIRR 945
LLE+VDP LG++++K+EA+ M+ I +LCT+P+P RP+MS+ VSMLEG + V +
Sbjct: 897 TLLEVVDPRLGTDYNKQEALMMIQIGMLCTSPAPGDRPSMSTVVSMLEGHSTVNVEKLLE 956
Query: 946 ---NSDSQDARFRAFEILSQDSQTHVSTLSQESEMQRTMSIDAPWTDSSVS 993
N++ + RA + H +T+ +E T + D P+T SS S
Sbjct: 957 ASVNNEKDEESVRAM-------KRHYATIGEEEITNTTTT-DGPFTSSSTS 999
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGG7|Y1534_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53420 OS=Arabidopsis thaliana GN=At1g53420 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 885 bits (2286), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 466/899 (51%), Positives = 605/899 (67%), Gaps = 34/899 (3%)
Query: 92 LKGFNLAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPL 151
LK NL G +P+E L LQE+DLSRNY NGS+P + L L + +LGNRL+G IP
Sbjct: 70 LKRENLQGSLPKELVGLPLLQEIDLSRNYLNGSIPPEWGVLP-LVNIWLLGNRLTGPIPK 128
Query: 152 EIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFR 211
E G+I+TL LVLE NQL G LP LGNL ++++++LSSNNF G IP ++ L L +FR
Sbjct: 129 EFGNITTLTSLVLEANQLSGELPLELGNLPNIQQMILSSNNFNGEIPSTFAKLTTLRDFR 188
Query: 212 IDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISDLKGSSSSFP 271
+ + L+G IP+FI WTKL+RL +Q + L GPIP I+ L L +LRISDL G S FP
Sbjct: 189 VSDNQLSGTIPDFIQKWTKLERLFIQASGLVGPIPIAIASLVELKDLRISDLNGPESPFP 248
Query: 272 NLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIF 331
L+++KKME LILRNC +TG +P+Y+ +T K LDLSFN+L+G +P NL+ YI+
Sbjct: 249 QLRNIKKMETLILRNCNLTGDLPDYLGKITSFKFLDLSFNKLSGAIPNTYINLRDGGYIY 308
Query: 332 LTNNSLSGTLPDWILTSEKNLDLSYNNFT-ESSPATCRESRVNILSSFSSTGSNSVSWCL 390
T N L+G++PDW++ +DLSYNNF+ + + A C+ + N+LS C+
Sbjct: 309 FTGNMLNGSVPDWMVNKGYKIDLSYNNFSVDPTNAVCKYN--NVLS------------CM 354
Query: 391 KKDLPCPKEAKHYSLFINCGGSPTEFEENDYEEDLNTQGPSNFGIVSDRWAYSSTGVYVG 450
+ + CPK +L INCGG YE D + S + + W ++ GV+V
Sbjct: 355 R-NYQCPKTFN--ALHINCGGDEMSINGTIYESDKYDRLESWYE-SRNGWFSNNVGVFVD 410
Query: 451 NESSK---YLAANQYGLNVSGAEYYKTARLAPQSLKYYGLCMLKGSYTVKLHFAEIMFTN 507
++ + +N LNV Y AR++ SL YY LC+ G+Y V LHFAEIMF
Sbjct: 411 DKHVPERVTIESNSSELNVVDFGLYTQARISAISLTYYALCLENGNYNVNLHFAEIMFNG 470
Query: 508 DQTYKSLGKRMFDVSIQGKQVLKDFDIMEEAGGVGIGITREFKDVSVNGSTMEIHLYWAG 567
+ Y+SLG+R FD+ IQ K +KDF+I +EA VG + + F V + +EI LYWAG
Sbjct: 471 NNNYQSLGRRFFDIYIQRKLEVKDFNIAKEAKDVGNVVIKTFP-VEIKDGKLEIRLYWAG 529
Query: 568 KGTNAIPYRGVYGPLISAITVTPNFEVDTGGGLSAGAIVGIVAGSCAVVIILLF-ILWRL 626
+GT IP VYGPLISAI+V + G+S G + +V ++ L+F LW+
Sbjct: 530 RGTTVIPKERVYGPLISAISVDSSVNPSPRNGMSTGTLHTLVVILSIFIVFLVFGTLWKK 589
Query: 627 GYLGGKNVEDKELRGLDLQTGYFTLRQIKAATNNFDAANKIGEGGFGPVYKGTLSDGAVI 686
GYL K+ +K+ + L+L F+LRQIK ATNNFD+AN+IGEGGFGPVYKG L DG +I
Sbjct: 590 GYLRSKSQMEKDFKSLELMIASFSLRQIKIATNNFDSANRIGEGGFGPVYKGKLFDGTII 649
Query: 687 AVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYLENNSLARAL 746
AVKQLS+ SKQGNREF+NEIGMISAL H NLVKLYGCC+EG QLLLVYE++ENNSLARAL
Sbjct: 650 AVKQLSTGSKQGNREFLNEIGMISALHHPNLVKLYGCCVEGGQLLLVYEFVENNSLARAL 709
Query: 747 FGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDF 806
FG + L LDW TR++IC +ARGLAYLHEESRLKIVHRDIKATNVLLDK LN KISDF
Sbjct: 710 FGPQETQLRLDWPTRRKICIGVARGLAYLHEESRLKIVHRDIKATNVLLDKQLNPKISDF 769
Query: 807 GLAKLDEDENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYR 866
GLAKLDE+++THISTRIAGT GYMAPEYAMRG+LTDKADVYSFGIVALEIV G+SN R
Sbjct: 770 GLAKLDEEDSTHISTRIAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVHGRSNKIER 829
Query: 867 PKEEFVYLLDWAYVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMS 926
K YL+DW VL+E+ NLLELVDP LGS ++++EAMTM+ IA++CT+ P RP+MS
Sbjct: 830 SKNNTFYLIDWVEVLREKNNLLELVDPRLGSEYNREEAMTMIQIAIMCTSSEPCERPSMS 889
Query: 927 SAVSMLEGKTAVQAPIIRRNSDSQDARF--------RAFEILSQDSQTHVST-LSQESE 976
V MLEGK V+ + S ++ + + +E++ Q+ T +S +S SE
Sbjct: 890 EVVKMLEGKKMVEVEKLEEASVHRETKRLENMNTMKKYYEMIGQEISTSMSMIMSDRSE 948
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FXF2|RKF1_ARATH Probable LRR receptor-like serine/threonine-protein kinase RFK1 OS=Arabidopsis thaliana GN=RKF1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 813 bits (2101), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 448/987 (45%), Positives = 624/987 (63%), Gaps = 43/987 (4%)
Query: 6 SVFVVLGFLVLNCFANFGSHAQRLPDDEVQTLQSI-------FRKLNFRNGQVNQTSCTE 58
SVF ++ CF + +A +LP EV LQ I F K + N ++ TE
Sbjct: 25 SVFAII------CFKFYSVNAIKLPQQEVDALQQIATTLGSKFWKFDAENCKIEMVGLTE 78
Query: 59 GSWNVTIDDSNGSNFTCDCTYSNNTVCHVTVILLKGFNLAGVIPEEFGNLTFLQEVDLSR 118
T + C+C+ +N+T CHV K NL G +P+ L +L+E+DL+
Sbjct: 79 -----TPPPTAKQEIECECSPTNDTDCHVVKFAFKDHNLPGTLPQ-IVKLPYLREIDLAY 132
Query: 119 NYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGDISTLEELVLEDNQLVGPLPENLG 178
NY NG+LP+ +A NLT + +L NRLSG IP E G+ S+L L LE N G +P+ LG
Sbjct: 133 NYINGTLPREWAS-SNLTFISLLVNRLSGEIPKEFGN-SSLTYLDLESNAFSGTIPQELG 190
Query: 179 NLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQG 238
NL L+++LLSSN TG++P S L+N+T+FRI+ L+G IP++I NW +L+RL++
Sbjct: 191 NLVHLKKLLLSSNKLTGTLPASLARLQNMTDFRINDLQLSGTIPSYIQNWKQLERLEMIA 250
Query: 239 TSLEGPIPSTISQLKNLTELRISDLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYIE 298
+ L GPIPS IS L NL LRISD++G FP+L+++ + ++IL+NC I+G+IP Y+
Sbjct: 251 SGLTGPIPSVISVLSNLVNLRISDIRGPVQPFPSLKNVTGLTKIILKNCNISGQIPTYLS 310
Query: 299 DMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGTLPDWILTSEKNLDLSYNN 358
+ +L+ LDLSFN+L G +P Q + + +I L N L G PD +L +DLSYNN
Sbjct: 311 HLKELETLDLSFNKLVGGIPSFAQ-AENLRFIILAGNMLEGDAPDELLRDGITVDLSYNN 369
Query: 359 FTESSPAT--CRES---RVNILSSFSSTGSNSVSWCLKKDLPCPKEAKHYSLFINCGGSP 413
SP + CR + +N+ S S+ S+ C+K D CP+ + L +NCGGS
Sbjct: 370 LKWQSPESRACRPNMNLNLNLFQSTSTKKSSKFLPCIK-DFKCPRYSS--CLHVNCGGSD 426
Query: 414 TEFEEND----YEEDLNTQG-PSNFGIVSD-RWAYSSTGVYVGNESSKYLAANQYGLNVS 467
+E YE D N +G + + + D W +SSTG ++ + + + + +
Sbjct: 427 MYVKEKKTKELYEGDGNVEGGAAKYFLKPDANWGFSSTGDFMDDNNFQNTRFTMFVPASN 486
Query: 468 GAEYYKTARLAPQSLKYYGLCMLKGSYTVKLHFAEIMFTNDQTYKSLGKRMFDVSIQGKQ 527
++ YK+AR+AP SL Y+ C+ G+YT+ L FAEI FTND+ Y LG+R+FD+ IQ K
Sbjct: 487 QSDLYKSARIAPVSLTYFHACLENGNYTINLDFAEIRFTNDENYNRLGRRLFDIYIQEKL 546
Query: 528 VLKDFDIMEEAGGVGIGITREFKDVSVNGSTMEIHLYWAGKGTNAIPYRGVYGPLISAIT 587
V KDF+IM+EA G I + V + I L WAGKGT IP RGVYGP+ISAI+
Sbjct: 547 VAKDFNIMDEAKGAQTPIIKPLT-AYVTNHFLTIRLSWAGKGTTRIPTRGVYGPIISAIS 605
Query: 588 VTPNFEV--DTGGGLSAGAIVGIVAGSCAVVIILLFILWRLGYLGGKNVEDKELRGLDLQ 645
+ + + G+S GA + I G+ ++I +L LW G L + K+ +L
Sbjct: 606 IVSDSKPCERPKTGMSPGAYIAIGIGAPCLIIFILGFLWICGCLPRCGRQRKDPYEEELP 665
Query: 646 TGYFTLRQIKAATNNFDAANKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGNREFVNE 705
+G FTLRQIK AT++F+ NKIGEGGFG V+KG L+DG V+AVKQLSSKS+QGNREF+NE
Sbjct: 666 SGTFTLRQIKFATDDFNPTNKIGEGGFGAVFKGVLADGRVVAVKQLSSKSRQGNREFLNE 725
Query: 706 IGMISALQHQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRIC 765
IG IS LQH NLVKL+G C+E QLLL YEY+ENNSL+ ALF + + + +DW TR +IC
Sbjct: 726 IGAISCLQHPNLVKLHGFCVERAQLLLAYEYMENNSLSSALFSPKHKQIPMDWPTRFKIC 785
Query: 766 SDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAG 825
IA+GLA+LHEES LK VHRDIKATN+LLDKDL KISDFGLA+LDE+E THIST++AG
Sbjct: 786 CGIAKGLAFLHEESPLKFVHRDIKATNILLDKDLTPKISDFGLARLDEEEKTHISTKVAG 845
Query: 826 TVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQG 885
T+GYMAPEYA+ GYLT KADVYSFG++ LEIV+G +N+N+ + V LL++A E G
Sbjct: 846 TIGYMAPEYALWGYLTFKADVYSFGVLVLEIVAGITNSNFMGAGDSVCLLEFANECVESG 905
Query: 886 NLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTAV--QAPII 943
+L+++VD L +KEA ++ +AL+C++ SPT RP MS V+MLEG V P +
Sbjct: 906 HLMQVVDERLRPEVDRKEAEAVIKVALVCSSASPTDRPLMSEVVAMLEGLYPVPESTPGV 965
Query: 944 RRNSDSQDARFRAFEILSQDSQTHVST 970
RN+ D RF+AF+ L + + + T
Sbjct: 966 SRNAG--DIRFKAFKDLRRGMENNSKT 990
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ASQ6|Y1972_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g29720 OS=Arabidopsis thaliana GN=RFK1 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 774 bits (1999), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 465/1046 (44%), Positives = 637/1046 (60%), Gaps = 65/1046 (6%)
Query: 1 MGKIVSVFVVLGFLVLNCFANFGSHAQ--RLPDDEVQTLQSI-----FRKLNFRNGQVNQ 53
M I+ F + ++L+ N + A L DE+ L+ I ++LN R+ +
Sbjct: 1 MSIILWSFFLFFTIILSSLTNITTLASFSSLHADELNALKEIATTLGIKRLNLRD----E 56
Query: 54 TSCTEGSW----------NVTIDDSNGSNFTCDCTYSNNTVCHVTVILLKGFNLAGVIPE 103
C+ + N+ I+++ G CDC+++NNT+C +T + LK +L G +P
Sbjct: 57 DPCSSKTLKIIQEVDFVPNLDINNTIG----CDCSFNNNTICRITELALKTMSLRGKLPP 112
Query: 104 EFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGDISTLEELV 163
E L +L+ ++L RNY +G++P +A++ LT + + N LSG++P + + L L
Sbjct: 113 ELTKLPYLKSIELCRNYLSGTIPMEWAKMAYLTSISVCANNLSGNLPAGLQNFKNLTFLG 172
Query: 164 LEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIPN 223
+E NQ GP+P+ LGNL SL + L+SN FTG +P + L NL RI +N TG IP
Sbjct: 173 VEGNQFSGPIPDELGNLTSLTGLELASNKFTGILPGTLARLVNLERVRICDNNFTGIIPA 232
Query: 224 FIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISDLKGSSSSFPNLQDMKKMERLI 283
+IGNWT+L +L L + L GPIP + +L+NL EL +SD G S FPNL K ++RLI
Sbjct: 233 YIGNWTRLQKLHLYASGLTGPIPDAVVRLENLLELSLSDTTGIKS-FPNLSS-KGLKRLI 290
Query: 284 LRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGTLPD 343
LRN ++G IP YI ++TDLKILDLSFN+L G V G+ QN K I+LT N LSG +
Sbjct: 291 LRNVGLSGPIPSYIWNLTDLKILDLSFNKLNGIVQGV-QNPPK--NIYLTGNLLSGNIES 347
Query: 344 W-ILTSEKNLDLSYNNFTESSPATCRE-SRVNIL-SSFSSTGSNSVSWCLKKDLPCPKEA 400
+L S+ +DLSYNNF+ SS +C++ S +N SS+S + C P
Sbjct: 348 GGLLNSQSYIDLSYNNFSWSS--SCQKGSTINTYQSSYSKNNLTGLPPC-----AVPANC 400
Query: 401 KHYSLF--INCGGSPTEFEEN----DYEEDLNTQGPSNFGIVSDRWAYSSTGVYVGNESS 454
K Y F INCGG + Y+ D + Q + D W S+TG + + S
Sbjct: 401 KKYQRFLHINCGGEEVSIRNSLGKITYQTDNSRQTNAASNQQFDYWGVSNTGDFTDDNSD 460
Query: 455 --KYLAANQYGLNVSGAEYYKTARLAPQSLKYYGLCMLKGSYTVKLHFAEIMFTNDQTYK 512
+Y + L+ + YKTAR + SL YY C+ G+Y VKLHF EI F++ + Y
Sbjct: 461 HDEYYTSTNLTLSGDYPDLYKTARRSALSLVYYAFCLENGNYNVKLHFMEIQFSDKEVYS 520
Query: 513 SLGKRMFDVSIQGKQVLKDFDIMEEAGGVGIGITREFKDVSVNGSTMEIHLYWAGKGTNA 572
LG+R+FDV +QGK L+DF+I +EA G + +E + +V +EI LYWAGKGT
Sbjct: 521 RLGRRIFDVYVQGKLFLRDFNINKEANGNMKPVIKEI-NATVTNHMLEIRLYWAGKGTTL 579
Query: 573 IPYRGVYGPLISAITVTPNFEV-----DTGGGLSAGAIVGIVAGSCAVVIILLFILWRLG 627
IP RG YGPLISAI++ + E T + I+G +V++ + I R
Sbjct: 580 IPKRGNYGPLISAISLCHSQEPLCGVEKTKHHIKYPLILGASGALVTIVLLAVGIYARGI 639
Query: 628 YLGGKNVEDKELRGLDLQTGYFTLRQIKAATNNFDAANKIGEGGFGPVYKGTLSDGAVIA 687
Y N +++LR LQT F+ RQ++ ATNNFD ANK+GEGGFG V+KG LSDG +IA
Sbjct: 640 YRRDNNRRERDLRAQGLQTVCFSWRQLQTATNNFDQANKLGEGGFGSVFKGELSDGTIIA 699
Query: 688 VKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYLENNSLARALF 747
VKQLSSKS QGNREFVNEIGMIS L H NLVKLYGCC+E +QLLLVYEY+ENNSLA ALF
Sbjct: 700 VKQLSSKSSQGNREFVNEIGMISGLNHPNLVKLYGCCVERDQLLLVYEYMENNSLALALF 759
Query: 748 GKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFG 807
G+ L LDWA R++IC IARGL +LH+ S +++VHRDIK TNVLLD DLNAKISDFG
Sbjct: 760 GQNS--LKLDWAARQKICVGIARGLEFLHDGSAMRMVHRDIKTTNVLLDTDLNAKISDFG 817
Query: 808 LAKLDEDENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRP 867
LA+L E E+THIST++AGT+GYMAPEYA+ G LT+KADVYSFG+VA+EIVSGKSNT +
Sbjct: 818 LARLHEAEHTHISTKVAGTIGYMAPEYALWGQLTEKADVYSFGVVAMEIVSGKSNTKQQG 877
Query: 868 KEEFVYLLDWAYVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSS 927
+ V L++WA LQ+ G++LE+VD L F++ EA+ M+ +AL+CTN SP+LRPTMS
Sbjct: 878 NADSVSLINWALTLQQTGDILEIVDRMLEGEFNRSEAVRMIKVALVCTNSSPSLRPTMSE 937
Query: 928 AVSMLEGKTAVQAPIIRRNSDSQDARFRAFEILSQDSQTHVSTLSQESEMQRTMSIDAPW 987
AV MLEG+ + + D +D TH S+ + Q T ++ +
Sbjct: 938 AVKMLEGEIEITQVMSDPGIYGHDWSISKL----RDIDTHSSSSTSGVTDQTTTTMKSSV 993
Query: 988 TDSSVSVQIPD-----ETREHSSSSL 1008
+ + P+ T E+SSSSL
Sbjct: 994 SGCDLYPLYPESMILNSTVENSSSSL 1019
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGH3|Y5614_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g56140 OS=Arabidopsis thaliana GN=At1g56140 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 745 bits (1923), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 411/938 (43%), Positives = 594/938 (63%), Gaps = 40/938 (4%)
Query: 32 DEVQTLQSIFRKLNFRNGQ---VNQTSCTEGSWNVTIDDSNGSN---FTCDCTYSNNTVC 85
DE L SIF R + ++ C+ + + ++ DSN + CDC++ N+T+C
Sbjct: 39 DEALALNSIFAAWRIRAPREWNISGELCSGAAIDASVLDSNPAYNPLIKCDCSFENSTIC 98
Query: 86 HVTVILLKGFNLAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRL 145
+T I + + G IP++ L +L ++L +N GSLP + L + + N L
Sbjct: 99 RITNIKVYAMEVVGSIPQQLWTLEYLTNLNLGQNVLTGSLPPALGNLTRMRWMTFGINAL 158
Query: 146 SGSIPLEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLK 205
SG IP EIG ++ L L + N G +P+ +G L++I + S+ +G +P S+ NL
Sbjct: 159 SGPIPKEIGLLTDLRLLSISSNNFSGSIPDEIGRCTKLQQIYIDSSGLSGGLPVSFANLV 218
Query: 206 NLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISDLKG 265
L + I LTG+IP+FIG+WTKL L + GT L GPIP++ S L +LTELR+ D+
Sbjct: 219 ELEQAWIADMELTGQIPDFIGDWTKLTTLRILGTGLSGPIPASFSNLTSLTELRLGDISN 278
Query: 266 SSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLK 325
+SS ++DMK + L+LRN +TG IP I + + L+ LDLSFN+L G +P L NL+
Sbjct: 279 GNSSLEFIKDMKSLSILVLRNNNLTGTIPSNIGEYSSLRQLDLSFNKLHGTIPASLFNLR 338
Query: 326 KIDYIFLTNNSLSGTLPDWILTSEKNLDLSYNNFTESSP---ATCRESRVNILSSFSSTG 382
++ ++FL NN+L+G+LP S N+D+SYN+ + S P + + + ++F+ G
Sbjct: 339 QLTHLFLGNNTLNGSLPTQKGQSLSNVDVSYNDLSGSLPSWVSLPNLNLNLVANNFTLEG 398
Query: 383 SNSVSW----CLKKDLPCPKEAKHYSLF-INCGG----SPTE--FEENDYEEDLNTQGPS 431
++ CL+K+ PC + YS F INCGG S TE FE D EDL GP+
Sbjct: 399 LDNRVLSGLNCLQKNFPCNRGKGIYSDFSINCGGPEIRSVTEAVFERED--EDL---GPA 453
Query: 432 NFGI-VSDRWAYSSTGVYVGNESSKYLAANQYG-LNVSGAEYYKTARLAPQSLKYYGLCM 489
+F + RWA SS G++ G+ ++ Y++ +Q +N +E +++ARL+ SL+YYGL +
Sbjct: 454 SFVVSAGQRWAASSVGLFAGSSNNIYISTSQSQFVNTLDSELFQSARLSASSLRYYGLGL 513
Query: 490 LKGSYTVKLHFAEIMF--TNDQTYKSLGKRMFDVSIQGKQVLKDFDIMEEAGGVGI-GIT 546
G YTV L FAEI + T++ LG+R FD+ +QG+ V KDFD+ AG + +
Sbjct: 514 ENGGYTVTLQFAEIQILGSTSNTWRGLGRRRFDIYVQGRLVEKDFDVRRTAGDSTVRAVQ 573
Query: 547 REFKDVSVNGSTMEIHLYWAGKGTNAIPYRGVYGPLISAITVTPNFEVDTG------GGL 600
RE+K +V+ + +EIHL+WAGKGT IP +G YGPLISA+ TP+F G G
Sbjct: 574 REYK-ANVSQNHLEIHLFWAGKGTCCIPIQGAYGPLISAVGATPDFTPTVGNRPPSKGKS 632
Query: 601 SAGAIVGIVAGSCAVVIILLFILWRLGYLGGKNVEDKELRGLDLQTGYFTLRQIKAATNN 660
G IVG++ G + II +++ + + +D+E+ +D++ FT ++K+AT +
Sbjct: 633 MTGTIVGVIVGVGLLSIISGVVIFIIRKRRKRYTDDEEILSMDVKPYTFTYSELKSATQD 692
Query: 661 FDAANKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKL 720
FD +NK+GEGGFGPVYKG L+DG +AVK LS S+QG +FV EI ISA+QH+NLVKL
Sbjct: 693 FDPSNKLGEGGFGPVYKGKLNDGREVAVKLLSVGSRQGKGQFVAEIVAISAVQHRNLVKL 752
Query: 721 YGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESR 780
YGCC EG LLVYEYL N SL +ALFG+ + L+LDW+TR IC +ARGL YLHEE+R
Sbjct: 753 YGCCYEGEHRLLVYEYLPNGSLDQALFGE--KTLHLDWSTRYEICLGVARGLVYLHEEAR 810
Query: 781 LKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRGYL 840
L+IVHRD+KA+N+LLD L K+SDFGLAKL +D+ THISTR+AGT+GY+APEYAMRG+L
Sbjct: 811 LRIVHRDVKASNILLDSKLVPKVSDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHL 870
Query: 841 TDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGSNFS 900
T+K DVY+FG+VALE+VSG+ N++ ++E YLL+WA+ L E+G +EL+D L + F+
Sbjct: 871 TEKTDVYAFGVVALELVSGRPNSDENLEDEKRYLLEWAWNLHEKGREVELIDHQL-TEFN 929
Query: 901 KKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTAV 938
+E M+ IALLCT S LRP MS V+ML G V
Sbjct: 930 MEEGKRMIGIALLCTQTSHALRPPMSRVVAMLSGDVEV 967
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGH2|Y1561_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g56130 OS=Arabidopsis thaliana GN=At1g56130 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 744 bits (1922), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 401/937 (42%), Positives = 592/937 (63%), Gaps = 38/937 (4%)
Query: 32 DEVQTLQSIFRKLNF---RNGQVNQTSCTEGSWNVTIDDSNGSN---FTCDCTYSNNTVC 85
DE + L SIF R ++ C+ + + ++ DSN + CDC++ N+T+C
Sbjct: 40 DEARALNSIFAAWKIQAPREWNISGELCSGAAIDASVLDSNPAYNPLIKCDCSFQNSTIC 99
Query: 86 HVTVILLKGFNLAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRL 145
+T I + ++ G IP E LT+L ++L +N GSLP + L + + N L
Sbjct: 100 RITNIKVYAIDVVGPIPPELWTLTYLTNLNLGQNVLTGSLPPAIGNLTRMQWMTFGINAL 159
Query: 146 SGSIPLEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLK 205
SG +P EIG ++ L L + N G +P+ +G L+++ + S+ +G IP S+ NL
Sbjct: 160 SGPVPKEIGLLTDLRLLGISSNNFSGSIPDEIGRCTKLQQMYIDSSGLSGRIPLSFANLV 219
Query: 206 NLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISDLKG 265
L + I +T +IP+FIG+WTKL L + GT L GPIPS+ S L +LTELR+ D+
Sbjct: 220 QLEQAWIADLEVTDQIPDFIGDWTKLTTLRIIGTGLSGPIPSSFSNLTSLTELRLGDISS 279
Query: 266 SSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLK 325
SSS ++DMK + L+LRN +TG IP I + + L+ +DLSFN+L GP+P L NL
Sbjct: 280 GSSSLDFIKDMKSLSVLVLRNNNLTGTIPSTIGEHSSLRQVDLSFNKLHGPIPASLFNLS 339
Query: 326 KIDYIFLTNNSLSGTLPDWILTSEKNLDLSYNNFTESSPA--TCRESRVNILS-SFSSTG 382
++ ++FL NN+L+G+ P S +N+D+SYN+ + S P+ + ++N+++ +F+ G
Sbjct: 340 QLTHLFLGNNTLNGSFPTQKTQSLRNVDVSYNDLSGSLPSWVSLPSLKLNLVANNFTLEG 399
Query: 383 SNSVSW----CLKKDLPCPKEAKHYSLF-INCGGSPTE------FEENDYEEDLNTQGPS 431
++ CL+K+ PC + YS F INCGG FE D ED GP+
Sbjct: 400 LDNRVLPGLNCLQKNFPCNRGKGIYSDFSINCGGPEKRSVTGALFERED--EDF---GPA 454
Query: 432 NFGI-VSDRWAYSSTGVYVGNESSKYLAANQYG-LNVSGAEYYKTARLAPQSLKYYGLCM 489
+F + RWA SS G++ G+ ++ Y+A +Q +N +E +++ARL+ S++YYGL +
Sbjct: 455 SFFVSAGQRWAASSVGLFAGSSNNIYIATSQSQFVNTLDSELFQSARLSASSVRYYGLGL 514
Query: 490 LKGSYTVKLHFAEIMF--TNDQTYKSLGKRMFDVSIQGKQVLKDFDIMEEAGGVGIGITR 547
G YTV L FAEI + T+K LG+R FD+ +QG+ V KDFD+ AG + +
Sbjct: 515 ENGGYTVTLQFAEIQILGSTSTTWKGLGRRRFDIYVQGRLVEKDFDVRRTAGDSTVRAVQ 574
Query: 548 EFKDVSVNGSTMEIHLYWAGKGTNAIPYRGVYGPLISAITVTPNF------EVDTGGGLS 601
+V+ + +E+HL+WAGKGT IP +G YGPLISA++ TP+F + + G
Sbjct: 575 RVYKANVSENHLEVHLFWAGKGTCCIPIQGAYGPLISAVSATPDFTPTVANKPPSKGKNR 634
Query: 602 AGAIVGIVAGSCAVVIILLFILWRLGYLGGKNVEDKELRGLDLQTGYFTLRQIKAATNNF 661
G IVG++ G + I+ +++ + + +D+EL G+D++ FT ++K+AT +F
Sbjct: 635 TGTIVGVIVGVGLLSILAGVVMFTIRKRRKRYTDDEELLGMDVKPYIFTYSELKSATQDF 694
Query: 662 DAANKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLY 721
D +NK+GEGGFGPVYKG L+DG V+AVK LS S+QG +FV EI IS++ H+NLVKLY
Sbjct: 695 DPSNKLGEGGFGPVYKGNLNDGRVVAVKLLSVGSRQGKGQFVAEIVAISSVLHRNLVKLY 754
Query: 722 GCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRL 781
GCC EG +LVYEYL N SL +ALFG + L+LDW+TR IC +ARGL YLHEE+ +
Sbjct: 755 GCCFEGEHRMLVYEYLPNGSLDQALFGD--KTLHLDWSTRYEICLGVARGLVYLHEEASV 812
Query: 782 KIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRGYLT 841
+IVHRD+KA+N+LLD L +ISDFGLAKL +D+ THISTR+AGT+GY+APEYAMRG+LT
Sbjct: 813 RIVHRDVKASNILLDSRLVPQISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLT 872
Query: 842 DKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGSNFSK 901
+K DVY+FG+VALE+VSG+ N++ +EE YLL+WA+ L E+ +EL+D L ++F+
Sbjct: 873 EKTDVYAFGVVALELVSGRPNSDENLEEEKKYLLEWAWNLHEKSRDIELIDDKL-TDFNM 931
Query: 902 KEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTAV 938
+EA M+ IALLCT S LRP MS V+ML G +
Sbjct: 932 EEAKRMIGIALLCTQTSHALRPPMSRVVAMLSGDVEI 968
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZP16|CRK11_ARATH Cysteine-rich receptor-like protein kinase 11 OS=Arabidopsis thaliana GN=CRK11 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 297 bits (760), Expect = 3e-79, Method: Compositional matrix adjust.
Identities = 161/355 (45%), Positives = 225/355 (63%), Gaps = 13/355 (3%)
Query: 599 GLSAGAIVGIVAGSCAVVIILL---FILWRL--GYLGGKNVEDKELRGLDLQTGYFTLRQ 653
G+SAG +V I + ++ILL F+L+R Y K + ++ D + + +
Sbjct: 285 GISAGVVVAITVPTVIAILILLVLGFVLFRRRKSYQRTKTESESDISTTD--SLVYDFKT 342
Query: 654 IKAATNNFDAANKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQ 713
I+AATN F +NK+GEGGFG VYKG LS+G +AVK+LS KS QG REF NE +++ LQ
Sbjct: 343 IEAATNKFSTSNKLGEGGFGAVYKGKLSNGTDVAVKRLSKKSGQGTREFRNEAVLVTKLQ 402
Query: 714 HQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLA 773
H+NLV+L G C+E + +L+YE++ N SL LF E Q LDW R +I IARG+
Sbjct: 403 HRNLVRLLGFCLEREEQILIYEFVHNKSLDYFLFDPEKQS-QLDWTRRYKIIGGIARGIL 461
Query: 774 YLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHIST-RIAGTVGYMAP 832
YLH++SRLKI+HRD+KA+N+LLD D+N KI+DFGLA + E T +T RIAGT YM+P
Sbjct: 462 YLHQDSRLKIIHRDLKASNILLDADMNPKIADFGLATIFGVEQTQGNTNRIAGTYAYMSP 521
Query: 833 EYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVY---LLDWAYVLQEQGNLLE 889
EYAM G + K+D+YSFG++ LEI+SGK N+ +E L+ +A L + LE
Sbjct: 522 EYAMHGQYSMKSDIYSFGVLVLEIISGKKNSGVYQMDETSTAGNLVTYASRLWRNKSPLE 581
Query: 890 LVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTAVQAPIIR 944
LVDP+ G N+ E ++IALLC +P RP +S+ + ML T + P+ R
Sbjct: 582 LVDPTFGRNYQSNEVTRCIHIALLCVQENPEDRPMLSTIILMLTSNT-ITLPVPR 635
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1016 | ||||||
| 302142859 | 1181 | unnamed protein product [Vitis vinifera] | 0.960 | 0.826 | 0.722 | 0.0 | |
| 224114756 | 1015 | predicted protein [Populus trichocarpa] | 0.984 | 0.985 | 0.684 | 0.0 | |
| 357451971 | 1011 | Receptor-like serine/threonine kinase [M | 0.974 | 0.979 | 0.689 | 0.0 | |
| 225461770 | 1023 | PREDICTED: probable LRR receptor-like se | 0.968 | 0.961 | 0.706 | 0.0 | |
| 302142847 | 1021 | unnamed protein product [Vitis vinifera] | 0.968 | 0.963 | 0.707 | 0.0 | |
| 449439065 | 1030 | PREDICTED: probable LRR receptor-like se | 0.974 | 0.961 | 0.685 | 0.0 | |
| 225461763 | 1020 | PREDICTED: probable LRR receptor-like se | 0.977 | 0.973 | 0.679 | 0.0 | |
| 449522496 | 993 | PREDICTED: probable LRR receptor-like se | 0.958 | 0.980 | 0.688 | 0.0 | |
| 264664531 | 1038 | RecName: Full=Probable LRR receptor-like | 0.974 | 0.953 | 0.653 | 0.0 | |
| 297847742 | 1037 | leucine-rich repeat family protein [Arab | 0.974 | 0.954 | 0.652 | 0.0 |
| >gi|302142859|emb|CBI20154.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1406 bits (3639), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 712/986 (72%), Positives = 821/986 (83%), Gaps = 10/986 (1%)
Query: 26 AQRLPDDEVQTLQSIFRKLNFRNGQVNQTSCTEGSWNVTIDDSNGSNFTCDCTYSNNTVC 85
AQ LP+DEVQTL++I +LN R ++QTSC G +NV SN TCDCT+ N+TVC
Sbjct: 195 AQLLPEDEVQTLETIATRLNNRYWNISQTSCG-GGFNVNFTSDYFSNVTCDCTFENSTVC 253
Query: 86 HVTVILLKGFNLAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRL 145
HVT I LKG NL G++P+EFGNLT+LQE+DL+RNY NGS+P S A++ L L LGNRL
Sbjct: 254 HVTNIQLKGLNLTGIMPDEFGNLTYLQEIDLTRNYLNGSIPTSLAQIP-LVTLSALGNRL 312
Query: 146 SGSIPLEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLK 205
SGSIP EIGDI+TLEELVLEDNQL G LPENLGNL SL R+LL++NNFTG+IPE++GNLK
Sbjct: 313 SGSIPKEIGDIATLEELVLEDNQLEGSLPENLGNLSSLSRLLLTANNFTGTIPETFGNLK 372
Query: 206 NLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISDLKG 265
NLT+ R+DG+ +G+IP+FIGNWT+LDRLD+QGTS++GPIPSTIS L NLT+LRI+DL G
Sbjct: 373 NLTDVRLDGNAFSGKIPDFIGNWTQLDRLDMQGTSMDGPIPSTISLLTNLTQLRIADLNG 432
Query: 266 SSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLK 325
SS +FPNLQ++ KME L+LRNC IT IP+YI M LK LDLSFN+L+G V +L
Sbjct: 433 SSMAFPNLQNLTKMEELVLRNCSITDSIPDYIGKMASLKTLDLSFNRLSGQVSDTW-SLS 491
Query: 326 KIDYIFLTNNSLSGTLPDWILTSEKNLDLSYNNFT-ESSPATCRESRVNILSSFSSTGSN 384
+++Y+FLTNNSLSGTLP WI S + D+SYNNFT SS C++ VN++SSFSS+ SN
Sbjct: 492 QLEYLFLTNNSLSGTLPSWISDSNQKFDVSYNNFTGPSSLTVCQQRAVNLVSSFSSSDSN 551
Query: 385 SVSWCLKKDLPCPKEAKHYSLFINCGGSPTEFEENDYEEDLNTQGPSNFGIVSDRWAYSS 444
SV WCLKK LPCP AKHYSLFINCGGS +E NDYE DL+ G S+F S++W YSS
Sbjct: 552 SVLWCLKKGLPCPGNAKHYSLFINCGGSEINYEGNDYERDLDGSGASHFSDYSEKWGYSS 611
Query: 445 TGVYVGNESSKYLAANQYGLNVSGAEYYKTARLAPQSLKYYGLCMLKGSYTVKLHFAEIM 504
TGV+ N+ + Y+A N + LN++G EY +TAR +P SLKYYGLCM KGSY V+LHFAEIM
Sbjct: 612 TGVFTNNDDAAYVATNTFSLNITGPEYLQTARTSPISLKYYGLCMRKGSYRVQLHFAEIM 671
Query: 505 FTNDQTYKSLGKRMFDVSIQGKQVLKDFDIMEEAGGVGIGITREFKDVSVNGSTMEIHLY 564
F++D+T+ SLGKR+FDVSIQG VLKDF+I+EEA GVG IT++F + SVNGST+EIHLY
Sbjct: 672 FSDDETFSSLGKRIFDVSIQGVTVLKDFNIVEEAKGVGKAITKDF-ETSVNGSTLEIHLY 730
Query: 565 WAGKGTNAIPYRGVYGPLISAITVTPNFEVDTGGGLSAGAIVGIVAGSCAVVIILLFILW 624
WAGKGTNAIP RGVYGPLISAITVTPNF+V TG LSAGAI GIV S A V+++L +L
Sbjct: 731 WAGKGTNAIPSRGVYGPLISAITVTPNFDVSTG--LSAGAIAGIVIASIAAVVLILIVLR 788
Query: 625 RLGYLGGKNVEDKELRGLDLQTGYFTLRQIKAATNNFDAANKIGEGGFGPVYKGTLSDGA 684
GYLGGK+ EDKEL+ L LQTGYF+LRQIKAATNNFD ANKIGEGGFGPVYKG L DG+
Sbjct: 789 LTGYLGGKDQEDKELQALKLQTGYFSLRQIKAATNNFDPANKIGEGGFGPVYKGVLPDGS 848
Query: 685 VIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYLENNSLAR 744
VIAVKQLSSKSKQGNREFVNEIGMISALQH NLVKLYG CIEGNQLLL+YEYLENN LAR
Sbjct: 849 VIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGWCIEGNQLLLIYEYLENNCLAR 908
Query: 745 ALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKIS 804
ALFG+ Q LNLDW TR +IC IARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKIS
Sbjct: 909 ALFGRIEQRLNLDWPTRNKICLGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKIS 968
Query: 805 DFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTN 864
DFGLAKLDE+ENTHISTRIAGT+GYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTN
Sbjct: 969 DFGLAKLDEEENTHISTRIAGTIGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTN 1028
Query: 865 YRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPT 924
YRPKEEFVYLLDWAYVLQEQ NLLELVDPSLGS +SK+EA MLN+ALLC NPSPTLRP+
Sbjct: 1029 YRPKEEFVYLLDWAYVLQEQENLLELVDPSLGSKYSKEEAQRMLNLALLCANPSPTLRPS 1088
Query: 925 MSSAVSMLEGKTAVQAPIIRR---NSDSQDARFRAFEILSQDSQTHVSTLSQESEMQRTM 981
MSS VSMLEGKTAVQ P+I+R NS + D RF+AFE LSQDSQT+VS SQ S+MQR+M
Sbjct: 1089 MSSVVSMLEGKTAVQVPLIKRSSMNSMNLDMRFKAFEKLSQDSQTYVSERSQGSQMQRSM 1148
Query: 982 SIDAPWTDSSVSVQIPDETREHSSSS 1007
S+D PW SSVS D+TREHSSSS
Sbjct: 1149 SMDGPWFGSSVSFPDKDKTREHSSSS 1174
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224114756|ref|XP_002316847.1| predicted protein [Populus trichocarpa] gi|222859912|gb|EEE97459.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1404 bits (3633), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 690/1008 (68%), Positives = 829/1008 (82%), Gaps = 8/1008 (0%)
Query: 1 MGKIVSVFVVLGFLVLNCFA--NFGSHAQ---RLPDDEVQTLQSIFRKLNFRNGQVNQTS 55
+ K VSVFV LG ++LNCF+ FGSHAQ LP+DEVQ L++I KL N +++TS
Sbjct: 7 LSKNVSVFV-LGLVLLNCFSVDKFGSHAQVAPLLPEDEVQILKTISSKLQNSNWTIDRTS 65
Query: 56 CTEGSWNVTI--DDSNGSNFTCDCTYSNNTVCHVTVILLKGFNLAGVIPEEFGNLTFLQE 113
C WN+TI D S TCDCT++++TVCHV + +KGFNL GV P EF NLT L+E
Sbjct: 66 CGSAQWNLTIVGGDKIQSQVTCDCTFNSSTVCHVISLYMKGFNLTGVFPSEFRNLTHLRE 125
Query: 114 VDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGDISTLEELVLEDNQLVGPL 173
+DL+RNY NGS+P S A L NL L +L NR++GSIP E G ++TLE LVLEDN L G L
Sbjct: 126 IDLTRNYINGSIPASLAELPNLQTLSLLANRITGSIPREFGSMATLESLVLEDNLLGGSL 185
Query: 174 PENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDR 233
+LGNL+SL+R+LLS+NNFTG+IP+++GNLKNLT+FRIDGS L+G+IPNFIGNWT ++R
Sbjct: 186 HPDLGNLRSLKRLLLSANNFTGTIPDTFGNLKNLTDFRIDGSELSGKIPNFIGNWTNIER 245
Query: 234 LDLQGTSLEGPIPSTISQLKNLTELRISDLKGSSSSFPNLQDMKKMERLILRNCLITGRI 293
LDLQGTS+EGPIPSTIS LK L ELRISDL GSSS+FP+L+DMK M LILR+C + G I
Sbjct: 246 LDLQGTSMEGPIPSTISLLKKLEELRISDLNGSSSTFPDLKDMKNMTTLILRSCSLNGTI 305
Query: 294 PEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGTLPDWILTSEKNLD 353
PEYI DM L LDLSFN+ TG +P L++L K+ ++FL NN L+G +P WIL S+ LD
Sbjct: 306 PEYIGDMASLDTLDLSFNKFTGQIPVSLESLAKLRFMFLNNNLLTGEVPGWILNSKNELD 365
Query: 354 LSYNNFTESSPATCRESRVNILSSFSSTGSNSVSWCLKKDLPCPKEAKHYSLFINCGGSP 413
LSYNNFT S+ ++C++ VN++SS +TG+N++SWCL KDL C ++ +H+SLFINCGG+
Sbjct: 366 LSYNNFTGSTQSSCQQLSVNLVSSHVTTGNNTISWCLNKDLVCSRKPEHHSLFINCGGNS 425
Query: 414 TEFEENDYEEDLNTQGPSNFGIVSDRWAYSSTGVYVGNESSKYLAANQYGLNVSGAEYYK 473
+N+YEED + G + F +S+RW YSSTG Y+ N+ + Y A N +GLNV+G +Y+
Sbjct: 426 MTVGDNEYEEDATSGGAAEFVSLSERWGYSSTGTYMNNDGAGYKAQNSFGLNVTGEGFYQ 485
Query: 474 TARLAPQSLKYYGLCMLKGSYTVKLHFAEIMFTNDQTYKSLGKRMFDVSIQGKQVLKDFD 533
TARLAPQSLKYY LCM GSY VKLHFAEIM++ND T+ SLG+R+FD+SIQG+ V KDF+
Sbjct: 486 TARLAPQSLKYYALCMRAGSYKVKLHFAEIMYSNDSTFSSLGRRIFDISIQGEVVRKDFN 545
Query: 534 IMEEAGGVGIGITREFKDVSVNGSTMEIHLYWAGKGTNAIPYRGVYGPLISAITVTPNFE 593
IME+AGGVGIGI EF + VNGST+EI LYW+GKGT A+P RGVYGPLISAITVTPNF+
Sbjct: 546 IMEKAGGVGIGIAEEFDSIIVNGSTLEIDLYWSGKGTTAVPDRGVYGPLISAITVTPNFK 605
Query: 594 VDTGGGLSAGAIVGIVAGSCAVVIILLFILWRLGYLGGKNVEDKELRGLDLQTGYFTLRQ 653
VD G GLS GAI+GIVA SC + + L +LWR GYLGGK EDK+LR LDLQTGYF+LRQ
Sbjct: 606 VDNGDGLSVGAIIGIVAASCVLAALALLVLWRKGYLGGKYHEDKDLRALDLQTGYFSLRQ 665
Query: 654 IKAATNNFDAANKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQ 713
IK ATNNFD ANKIGEGGFGPVYKG LSDG +IAVKQLSSKSKQGNREFVNEIGMISALQ
Sbjct: 666 IKNATNNFDPANKIGEGGFGPVYKGVLSDGTIIAVKQLSSKSKQGNREFVNEIGMISALQ 725
Query: 714 HQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLA 773
H +LVKLYGCCIEGNQLL+VYEYLENNSLARALFG++ + +DW TRK+I IA+GLA
Sbjct: 726 HPHLVKLYGCCIEGNQLLVVYEYLENNSLARALFGRDEHQIKMDWQTRKKILLGIAKGLA 785
Query: 774 YLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPE 833
YLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDE+ENTHISTRIAGT+GYMAPE
Sbjct: 786 YLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEEENTHISTRIAGTIGYMAPE 845
Query: 834 YAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDP 893
YAMRGYLTDKADVYSFG+V LEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDP
Sbjct: 846 YAMRGYLTDKADVYSFGVVVLEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDP 905
Query: 894 SLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTAVQAPIIRRNSDSQDAR 953
+LGSN+S++EAM MLN+ALLCTNPSP+LRP MSSAVSM+EG+ VQAPI++R + +++AR
Sbjct: 906 NLGSNYSEEEAMRMLNLALLCTNPSPSLRPLMSSAVSMIEGQIPVQAPIVKRGTMNEEAR 965
Query: 954 FRAFEILSQDSQTHVSTLSQESEMQRTMSIDAPWTDSSVSVQIPDETR 1001
F+AFE+LSQDSQ HVS SQ S +Q+++S+D PW DS +S Q DETR
Sbjct: 966 FKAFELLSQDSQAHVSNTSQSSLVQKSISMDGPWMDSEISTQTMDETR 1013
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357451971|ref|XP_003596262.1| Receptor-like serine/threonine kinase [Medicago truncatula] gi|355485310|gb|AES66513.1| Receptor-like serine/threonine kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 1400 bits (3624), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 692/1004 (68%), Positives = 838/1004 (83%), Gaps = 14/1004 (1%)
Query: 3 KIVSVFVVLGFLVLNCFANFGSHAQRLPDDEVQTLQSIFRKLNFRNGQVNQTSCTEGSW- 61
K VS+ L FL NCF+ FGS+AQ LP DEV+ LQ+I K+N N +V SC G
Sbjct: 7 KHVSMLFFL-FLAFNCFSMFGSNAQSLPQDEVKLLQTISDKVNNLNWKVTNRSCNSGDKG 65
Query: 62 ---NVTIDDSNGSNFTCDCTYSNNTVCHVTVILLKGFNLAGVIPEEFGNLTFLQEVDLSR 118
+ ++D N TCDC+++++TVCHVT+I LKG N++G+ P EFGNLT L+ +DL+R
Sbjct: 66 FGNEIIVEDQIVRNVTCDCSFNSSTVCHVTMIFLKGLNISGIFPSEFGNLTHLKTLDLTR 125
Query: 119 NYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGDISTLEELVLEDNQLVGPLPENLG 178
NY NGS+PKS L +L L +LGNRLSG IP EIGDISTL+E+ +EDNQL G LP NLG
Sbjct: 126 NYINGSIPKSLGGLSSLVTLSLLGNRLSGPIPSEIGDISTLQEMNVEDNQLEGNLPPNLG 185
Query: 179 NLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQG 238
NLK+L++++LS+NNFTG+IPE++GNLKNLT FRIDGS+L+G+IP+FIGNWTKL+RLDLQG
Sbjct: 186 NLKNLQKLMLSANNFTGTIPEAFGNLKNLTNFRIDGSSLSGKIPSFIGNWTKLERLDLQG 245
Query: 239 TSLEGPIPSTISQLKNLTELRISDLKGSSS-SFPNLQDMKKMERLILRNCLITGRIPEYI 297
TSLEGPIP +S LKNL ELRISDLKG+++ +FP+L+D+K+M+RL LRNCLITG IP+YI
Sbjct: 246 TSLEGPIPPAVSVLKNLKELRISDLKGNTTMTFPDLKDLKRMQRLELRNCLITGPIPDYI 305
Query: 298 EDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGTLPDWILTSEKNLDLSYN 357
++ +LK +DLS N+LTGP+PG L++L+ I+++FLTNNSL+GT+P WIL++++N DLS+N
Sbjct: 306 GELENLKTIDLSSNRLTGPIPGSLEDLESINFVFLTNNSLNGTIPGWILSNKQNFDLSFN 365
Query: 358 NFTESSPATCRESRVNILSSFSSTGSNSVSWCLKKDLPCPKEAKHYSLFINCGGSPTEFE 417
NFTESS C+ VN+ SS S + + ++S CLK++LPC + +++SLFINCGG TEF+
Sbjct: 366 NFTESSAPDCQILDVNLASSVSPSANTTLS-CLKRNLPCSGKPRYHSLFINCGGPATEFD 424
Query: 418 ENDYEEDLNTQGPSNF-GIVSDRWAYSSTGVYVGNESSKYLAANQYGLNVS-GAEYYKTA 475
+N+YE D + +G SNF VS +WAYSSTGV++GNE + Y+A N + LN++ G+EYY+TA
Sbjct: 425 DNEYEADDHLRGISNFVPSVSGKWAYSSTGVFLGNEKADYVARNVFSLNINNGSEYYQTA 484
Query: 476 RLAPQSLKYYGLCMLKGSYTVKLHFAEIMFTNDQTYKSLGKRMFDVSIQGKQVLKDFDIM 535
R+AP SLKY+G CMLKG+Y VKLHFAEIMF++DQ + SLG+R+FDVS+QG + LKDF+IM
Sbjct: 485 RIAPISLKYFGFCMLKGNYNVKLHFAEIMFSDDQKFSSLGRRIFDVSVQGHKYLKDFNIM 544
Query: 536 EEAGGVGIGITREFKDVSVNGSTMEIHLYWAGKGTNAIPYRGVYGPLISAITVTPNFEVD 595
EEAGGVG GITR+F +V VN ST+EIHL WAGKGTNAIP RGVYGPLISAITVTPNF++
Sbjct: 545 EEAGGVGKGITRDF-NVDVNDSTLEIHLSWAGKGTNAIPMRGVYGPLISAITVTPNFKIP 603
Query: 596 TGGGLSAGAIVGIVAGSCAVVIILLFILWRLGYLGGKNVEDKELRGLDLQTGYFTLRQIK 655
+ G LSAGAI GIV GS A V+++LF+LW++GYL GK+ DKEL L+L+TGY++LRQIK
Sbjct: 604 SNG-LSAGAIAGIVIGSLAFVMLILFVLWKMGYLCGKDQTDKEL--LELKTGYYSLRQIK 660
Query: 656 AATNNFDAANKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQ 715
ATNNFD NKIGEGGFGPVYKG LSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQH
Sbjct: 661 VATNNFDPKNKIGEGGFGPVYKGVLSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHP 720
Query: 716 NLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYL 775
NLVKLYGCCIEGNQLLLVYEY+ENNSLARALFGK Q LNLDW TR +IC IARGLAYL
Sbjct: 721 NLVKLYGCCIEGNQLLLVYEYMENNSLARALFGKPEQRLNLDWRTRMKICVGIARGLAYL 780
Query: 776 HEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYA 835
HEESRLKIVHRDIKATNVLLDK+LNAKISDFGLAKLDE+ENTHISTRIAGT+GYMAPEYA
Sbjct: 781 HEESRLKIVHRDIKATNVLLDKNLNAKISDFGLAKLDEEENTHISTRIAGTIGYMAPEYA 840
Query: 836 MRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSL 895
MRGYLTDKADVYSFG+VALEIVSG SNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDP+L
Sbjct: 841 MRGYLTDKADVYSFGVVALEIVSGMSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPTL 900
Query: 896 GSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTAVQAPIIRRNSDSQDARFR 955
GS +S +EAM ML +ALLCTNPSPTLRP MSS VSMLEG T +QAPII+R+ + ARF+
Sbjct: 901 GSKYSSEEAMRMLQLALLCTNPSPTLRPPMSSVVSMLEGNTPIQAPIIKRSDSTAGARFK 960
Query: 956 AFEILSQDSQTHVSTLSQESEMQRTMSIDAPWTDSSVSVQIPDE 999
AFE+LSQDSQT ST Q+S R S+D PW DSS+S DE
Sbjct: 961 AFELLSQDSQT-TSTFLQDSRELRGKSMDGPWVDSSISYPSKDE 1003
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225461770|ref|XP_002283521.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g53430-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1390 bits (3599), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 704/997 (70%), Positives = 835/997 (83%), Gaps = 13/997 (1%)
Query: 22 FGSHAQRLPDDEVQTLQSIFRKLNFRNG------QVNQTSCTEG-SWNVTIDDSNGSNFT 74
F SHAQ +P+DEV+ L +I KLN V+Q+SC EG +NV I S T
Sbjct: 20 FTSHAQDIPEDEVKALNTISSKLNISAKLNNSYWSVSQSSCREGRDFNVNITSEIRSLVT 79
Query: 75 CDCTYSNNTVCHVTVILLKGFNLAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQN 134
C+CT+ N+TVCHVT I LKG NL GV+P EFG+L +LQE+DL+RNYFNGS+P SF+RL
Sbjct: 80 CNCTFVNSTVCHVTNIQLKGLNLTGVLPAEFGSLKYLQELDLTRNYFNGSIPTSFSRLP- 138
Query: 135 LTKLLILGNRLSGSIPLEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFT 194
L L +LGNRLSGSIP EIG I+TLEEL+LEDNQL GPL ENLGNL LRR+LLS NNFT
Sbjct: 139 LVNLSLLGNRLSGSIPKEIGGIATLEELILEDNQLEGPLNENLGNLGRLRRLLLSGNNFT 198
Query: 195 GSIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKN 254
G+IP+++ NLKNLT+FRIDG+NL G+IP+ IGNWTKLD+L LQGTS+EGPIPSTISQLKN
Sbjct: 199 GTIPQNFRNLKNLTDFRIDGNNLFGKIPDLIGNWTKLDKLFLQGTSMEGPIPSTISQLKN 258
Query: 255 LTELRISDLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLT 314
LTEL IS+L G+S SFP+LQDMK M RL LR+CLITG+IP Y+ +M LKILDLSFN+LT
Sbjct: 259 LTELMISNLNGASMSFPDLQDMKNMTRLALRDCLITGQIPPYLGEMKKLKILDLSFNRLT 318
Query: 315 GPVPGILQNLKKIDYIFLTNNSLSGTLPDWILTSEKNLDLSYNNFTESSPATCRESRVNI 374
G +P LQ+L IDY+FL +N LSG +P IL ++N+DLSYNNFT S P+TC+++ V+
Sbjct: 319 GQIPESLQSLDSIDYMFLNDNLLSGEVPRGILNWKENVDLSYNNFTGSPPSTCQQNDVSF 378
Query: 375 LSSFSSTGSNSVSWCLKKDLPCPKEAKHYSLFINCGGSPTEFEENDYEEDLNTQGPSNF- 433
+SS+SS+ S++V WCLKKDLPCP++ +++S FINCGG FE N+Y++D++ +G S+F
Sbjct: 379 VSSYSSSKSSTVQWCLKKDLPCPEKPRYHSFFINCGGGKMSFEGNEYDKDVDGRGASHFL 438
Query: 434 GIVSDRWAYSSTGVYVGNESSKYLAANQYGLNVSGAEYYKTARLAPQSLKYYGLCMLKGS 493
+RWAYSSTGV+ E + YLA N L + G E+Y+TAR+AP SLKYYGLC+ KGS
Sbjct: 439 ADYLERWAYSSTGVF-SKEDTAYLA-NNTSLKIIGPEFYQTARVAPNSLKYYGLCLQKGS 496
Query: 494 YTVKLHFAEIMFTNDQTYKSLGKRMFDVSIQGKQVLKDFDIMEEAGGVGIGITREFKDVS 553
Y V+LHFAEIMFTNDQT+ SLGKR+FDVSIQG VLKDF+IMEEA G G GI ++F DV
Sbjct: 497 YKVRLHFAEIMFTNDQTFSSLGKRIFDVSIQGNVVLKDFNIMEEAKGAGKGIYKDFDDVL 556
Query: 554 VNGSTMEIHLYWAGKGTNAIPYRGVYGPLISAITVTPNFEVDTGGGLSAGAIVGIVAGSC 613
VNGST+EIHLYW+GKGT +IP RGVYGPLISAI VTPNF D GLS GAI+GIV SC
Sbjct: 557 VNGSTLEIHLYWSGKGTKSIPVRGVYGPLISAIAVTPNF--DPNAGLSVGAIIGIVMASC 614
Query: 614 AVVIILLFILWRLGYLGGKNVEDKELRGLDLQTGYFTLRQIKAATNNFDAANKIGEGGFG 673
V+ +L +LW GYLGGK++EDKELR L+LQTGYF+LRQIKAATNNFD+ANKIGEGGFG
Sbjct: 615 VVLAFILALLWTKGYLGGKDLEDKELRALELQTGYFSLRQIKAATNNFDSANKIGEGGFG 674
Query: 674 PVYKGTLSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLV 733
PVYKG LSDG++IAVKQLSSKSKQGNREFVNEIGMISALQH NLV+LYGCCIEGNQLLL+
Sbjct: 675 PVYKGVLSDGSIIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVRLYGCCIEGNQLLLI 734
Query: 734 YEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNV 793
YEY+ENNSLARALFG+E L+LDW TRK+IC IARGLAYLHEESRLKIVHRDIKATNV
Sbjct: 735 YEYMENNSLARALFGREEHRLHLDWPTRKKICLGIARGLAYLHEESRLKIVHRDIKATNV 794
Query: 794 LLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVA 853
LLDKDL+AKISDFGLAKLDE+ENTHISTRIAGT+GYMAPEYAMRGYLTDKADVYSFG+VA
Sbjct: 795 LLDKDLSAKISDFGLAKLDEEENTHISTRIAGTIGYMAPEYAMRGYLTDKADVYSFGVVA 854
Query: 854 LEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALL 913
LEIVSGKSNTNYRPKEEFVYLLDWAYVL EQGN+LELVDP LGSN+S++EA MLN++LL
Sbjct: 855 LEIVSGKSNTNYRPKEEFVYLLDWAYVLHEQGNILELVDPILGSNYSEEEAAKMLNLSLL 914
Query: 914 CTNPSPTLRPTMSSAVSMLEGKTAVQAPIIRRNSDSQDARFRAFEILSQDSQTHVSTLSQ 973
CTNPSPTLRP+MSS VSMLEGK AVQAPI++++S +QD RF+AFE LSQDSQ+HVS SQ
Sbjct: 915 CTNPSPTLRPSMSSVVSMLEGKIAVQAPIVKKSSMNQDMRFKAFEKLSQDSQSHVSAFSQ 974
Query: 974 ESEMQRTMSIDAPWTDSSVSVQIPDETREHSSSSLLL 1010
ES++Q ++S++ PW DSSVS+ ++TR+HSSSS LL
Sbjct: 975 ESQVQGSISMNGPWIDSSVSLTSREDTRDHSSSSKLL 1011
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|302142847|emb|CBI20142.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1384 bits (3583), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 704/995 (70%), Positives = 835/995 (83%), Gaps = 11/995 (1%)
Query: 22 FGSHAQRLPDDE-VQTLQS---IFRKLNFRNGQVNQTSCTEG-SWNVTIDDSNGSNFTCD 76
F SHAQ +P+DE + T+ S I KLN V+Q+SC EG +NV I S TC+
Sbjct: 20 FTSHAQDIPEDEALNTISSKLNISAKLNNSYWSVSQSSCREGRDFNVNITSEIRSLVTCN 79
Query: 77 CTYSNNTVCHVTVILLKGFNLAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLT 136
CT+ N+TVCHVT I LKG NL GV+P EFG+L +LQE+DL+RNYFNGS+P SF+RL L
Sbjct: 80 CTFVNSTVCHVTNIQLKGLNLTGVLPAEFGSLKYLQELDLTRNYFNGSIPTSFSRLP-LV 138
Query: 137 KLLILGNRLSGSIPLEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGS 196
L +LGNRLSGSIP EIG I+TLEEL+LEDNQL GPL ENLGNL LRR+LLS NNFTG+
Sbjct: 139 NLSLLGNRLSGSIPKEIGGIATLEELILEDNQLEGPLNENLGNLGRLRRLLLSGNNFTGT 198
Query: 197 IPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLT 256
IP+++ NLKNLT+FRIDG+NL G+IP+ IGNWTKLD+L LQGTS+EGPIPSTISQLKNLT
Sbjct: 199 IPQNFRNLKNLTDFRIDGNNLFGKIPDLIGNWTKLDKLFLQGTSMEGPIPSTISQLKNLT 258
Query: 257 ELRISDLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGP 316
EL IS+L G+S SFP+LQDMK M RL LR+CLITG+IP Y+ +M LKILDLSFN+LTG
Sbjct: 259 ELMISNLNGASMSFPDLQDMKNMTRLALRDCLITGQIPPYLGEMKKLKILDLSFNRLTGQ 318
Query: 317 VPGILQNLKKIDYIFLTNNSLSGTLPDWILTSEKNLDLSYNNFTESSPATCRESRVNILS 376
+P LQ+L IDY+FL +N LSG +P IL ++N+DLSYNNFT S P+TC+++ V+ +S
Sbjct: 319 IPESLQSLDSIDYMFLNDNLLSGEVPRGILNWKENVDLSYNNFTGSPPSTCQQNDVSFVS 378
Query: 377 SFSSTGSNSVSWCLKKDLPCPKEAKHYSLFINCGGSPTEFEENDYEEDLNTQGPSNF-GI 435
S+SS+ S++V WCLKKDLPCP++ +++S FINCGG FE N+Y++D++ +G S+F
Sbjct: 379 SYSSSKSSTVQWCLKKDLPCPEKPRYHSFFINCGGGKMSFEGNEYDKDVDGRGASHFLAD 438
Query: 436 VSDRWAYSSTGVYVGNESSKYLAANQYGLNVSGAEYYKTARLAPQSLKYYGLCMLKGSYT 495
+RWAYSSTGV+ E + YLA N L + G E+Y+TAR+AP SLKYYGLC+ KGSY
Sbjct: 439 YLERWAYSSTGVF-SKEDTAYLA-NNTSLKIIGPEFYQTARVAPNSLKYYGLCLQKGSYK 496
Query: 496 VKLHFAEIMFTNDQTYKSLGKRMFDVSIQGKQVLKDFDIMEEAGGVGIGITREFKDVSVN 555
V+LHFAEIMFTNDQT+ SLGKR+FDVSIQG VLKDF+IMEEA G G GI ++F DV VN
Sbjct: 497 VRLHFAEIMFTNDQTFSSLGKRIFDVSIQGNVVLKDFNIMEEAKGAGKGIYKDFDDVLVN 556
Query: 556 GSTMEIHLYWAGKGTNAIPYRGVYGPLISAITVTPNFEVDTGGGLSAGAIVGIVAGSCAV 615
GST+EIHLYW+GKGT +IP RGVYGPLISAI VTPNF D GLS GAI+GIV SC V
Sbjct: 557 GSTLEIHLYWSGKGTKSIPVRGVYGPLISAIAVTPNF--DPNAGLSVGAIIGIVMASCVV 614
Query: 616 VIILLFILWRLGYLGGKNVEDKELRGLDLQTGYFTLRQIKAATNNFDAANKIGEGGFGPV 675
+ +L +LW GYLGGK++EDKELR L+LQTGYF+LRQIKAATNNFD+ANKIGEGGFGPV
Sbjct: 615 LAFILALLWTKGYLGGKDLEDKELRALELQTGYFSLRQIKAATNNFDSANKIGEGGFGPV 674
Query: 676 YKGTLSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYE 735
YKG LSDG++IAVKQLSSKSKQGNREFVNEIGMISALQH NLV+LYGCCIEGNQLLL+YE
Sbjct: 675 YKGVLSDGSIIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVRLYGCCIEGNQLLLIYE 734
Query: 736 YLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLL 795
Y+ENNSLARALFG+E L+LDW TRK+IC IARGLAYLHEESRLKIVHRDIKATNVLL
Sbjct: 735 YMENNSLARALFGREEHRLHLDWPTRKKICLGIARGLAYLHEESRLKIVHRDIKATNVLL 794
Query: 796 DKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALE 855
DKDL+AKISDFGLAKLDE+ENTHISTRIAGT+GYMAPEYAMRGYLTDKADVYSFG+VALE
Sbjct: 795 DKDLSAKISDFGLAKLDEEENTHISTRIAGTIGYMAPEYAMRGYLTDKADVYSFGVVALE 854
Query: 856 IVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCT 915
IVSGKSNTNYRPKEEFVYLLDWAYVL EQGN+LELVDP LGSN+S++EA MLN++LLCT
Sbjct: 855 IVSGKSNTNYRPKEEFVYLLDWAYVLHEQGNILELVDPILGSNYSEEEAAKMLNLSLLCT 914
Query: 916 NPSPTLRPTMSSAVSMLEGKTAVQAPIIRRNSDSQDARFRAFEILSQDSQTHVSTLSQES 975
NPSPTLRP+MSS VSMLEGK AVQAPI++++S +QD RF+AFE LSQDSQ+HVS SQES
Sbjct: 915 NPSPTLRPSMSSVVSMLEGKIAVQAPIVKKSSMNQDMRFKAFEKLSQDSQSHVSAFSQES 974
Query: 976 EMQRTMSIDAPWTDSSVSVQIPDETREHSSSSLLL 1010
++Q ++S++ PW DSSVS+ ++TR+HSSSS LL
Sbjct: 975 QVQGSISMNGPWIDSSVSLTSREDTRDHSSSSKLL 1009
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449439065|ref|XP_004137308.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g53430-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1370 bits (3546), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 688/1003 (68%), Positives = 816/1003 (81%), Gaps = 13/1003 (1%)
Query: 19 FANFGSHAQRLPDDEVQTLQSIFRKLNFRNGQVNQTSCTEG---SWNVTIDDSNGSNFTC 75
F FGS AQ LP+ EV+TLQ+I KL + V ++SC G S + N +C
Sbjct: 22 FQAFGSDAQLLPESEVKTLQTISSKLENLSWNVTRSSCIRGEGFSNQAFQGNQILRNISC 81
Query: 76 DCTYSNNTVCHVTVILLKGFNLAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNL 135
+CT +T+CHVT++LLKG NL G P EFGNLT LQE+DL+RN+ NG LP S A L
Sbjct: 82 NCT---STLCHVTIVLLKGLNLTGTFPAEFGNLTHLQELDLTRNHINGQLPSSLANAP-L 137
Query: 136 TKLLILGNRLSGSIPLEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTG 195
KL +LGNRL+GSIP EIG+I TLEEL+LEDNQL G LP +LGNL SLRR+LLS+NNFTG
Sbjct: 138 VKLSLLGNRLNGSIPKEIGEIGTLEELILEDNQLTGSLPASLGNLNSLRRLLLSANNFTG 197
Query: 196 SIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNL 255
IP+S+G L NL +FR+DG+ L+G+IP FIGNW LDRLD+QGTS+E PIPSTISQLKNL
Sbjct: 198 KIPDSFGKLTNLVDFRVDGNGLSGKIPEFIGNWINLDRLDMQGTSMENPIPSTISQLKNL 257
Query: 256 TELRISDLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTG 315
T+LRISDLKGS SFPNL DM M+ L+LRNCLI G IPEYI +M L LDLSFN L G
Sbjct: 258 TQLRISDLKGSFISFPNLTDMINMKELVLRNCLINGSIPEYIGEMNKLSTLDLSFNHLNG 317
Query: 316 PVPGILQNL--KKIDYIFLTNNSLSGTLPDWILTSEKNLDLSYNNFTESSPATCRESRVN 373
+P QNL +KID++FLTNNSLSG +P WIL+S+KN+DLSYNNF+ S+ A+C++S VN
Sbjct: 318 DIPETFQNLMKRKIDFMFLTNNSLSGEVPGWILSSKKNIDLSYNNFSGSTLASCQQSPVN 377
Query: 374 ILSSFSSTGSNSVSWCLKKDLPCPKEAKHYSLFINCGGSPTEFEENDYEEDLNTQGPSNF 433
+++S+ ++ V WCLKKDLPC +A+++SLFINCGG+ + +DYEEDL T+G SNF
Sbjct: 378 LIASYPPATNHQVPWCLKKDLPCSGKAEYHSLFINCGGTRVTADGHDYEEDLTTEGKSNF 437
Query: 434 GIVSDRWAYSSTGVYVGNESSKYLAANQYGLNVSGAEYYKTARLAPQSLKYYGLCMLKGS 493
VS++WAYSSTGV++G+E++ YLA N++GLNVSG YY+ ARL+P SLKYYGLC+ GS
Sbjct: 438 FSVSEKWAYSSTGVFLGDENADYLATNKFGLNVSGPRYYQNARLSPLSLKYYGLCLRSGS 497
Query: 494 YTVKLHFAEIMFTNDQTYKSLGKRMFDVSIQGKQVLKDFDIMEEAGGVGIGITREFKDVS 553
Y VKLHFAEIM++NDQT+ SLGKR+FD+SIQGK V KDF+I++ AGGVG T E K+V
Sbjct: 498 YNVKLHFAEIMYSNDQTFSSLGKRIFDISIQGKLVKKDFNIVDAAGGVGKNFTVEDKNVL 557
Query: 554 VNGSTMEIHLYWAGKGTNAIPYRGVYGPLISAITVTPNFEVDTGGGLSAGAIVGIVAGSC 613
VNGST+EI+LYWAGKGT A+P RGVYGPLISAITVTPNF+++ GG LS+GA+ GI+ S
Sbjct: 558 VNGSTLEINLYWAGKGTTAVPDRGVYGPLISAITVTPNFKINEGG-LSSGALAGIIVSSF 616
Query: 614 AVVIILLFI-LWRLGYLGGKNVEDKELRGLDLQTGYFTLRQIKAATNNFDAANKIGEGGF 672
VVIIL+ + LW GY+ K EL G+DLQTG+FTL+QIKAATNNFD +KIGEGGF
Sbjct: 617 LVVIILVLVFLWMTGYICKKEDLANELSGIDLQTGHFTLKQIKAATNNFDPKSKIGEGGF 676
Query: 673 GPVYKGTLSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLL 732
GPVYKG LSDGA+IAVKQLSSKSKQG+REFV EIGMISALQH NLVKLYGCC+EGNQLLL
Sbjct: 677 GPVYKGVLSDGALIAVKQLSSKSKQGSREFVTEIGMISALQHPNLVKLYGCCVEGNQLLL 736
Query: 733 VYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATN 792
VYEY+ENNSLARALFG+E Q L+LDW TRK+IC +IARGLAYLHEESRLKIVHRDIKATN
Sbjct: 737 VYEYMENNSLARALFGREEQRLHLDWRTRKKICLEIARGLAYLHEESRLKIVHRDIKATN 796
Query: 793 VLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIV 852
VLLDKDLNAKISDFGLAKLDE+ENTHISTRIAGT+GYMAPEYAMRGYLTDKADVYSFGIV
Sbjct: 797 VLLDKDLNAKISDFGLAKLDEEENTHISTRIAGTIGYMAPEYAMRGYLTDKADVYSFGIV 856
Query: 853 ALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIAL 912
ALEIVSGKSNTNYRPKEEFVYLLDWAYVL+EQGNLLEL DP LGSN+S +EAM MLN+AL
Sbjct: 857 ALEIVSGKSNTNYRPKEEFVYLLDWAYVLEEQGNLLELADPDLGSNYSSEEAMRMLNVAL 916
Query: 913 LCTNPSPTLRPTMSSAVSMLEGKTAVQAPIIRRNSDSQDARFRAFEILSQDSQTHV--ST 970
LCTNPSPTLRPTMSS VSMLEGK AVQAPII+R S QD RFRAFE LS DS++ + ST
Sbjct: 917 LCTNPSPTLRPTMSSVVSMLEGKIAVQAPIIKRTSSGQDPRFRAFEKLSHDSRSQISSST 976
Query: 971 LSQESEMQRTMSIDAPWTDSSVSVQIPDETREHSSSSLLLQNE 1013
+S ++E Q++M +D P DSSV++ HS+SS L+N
Sbjct: 977 VSLDAEPQKSMLMDGPCPDSSVTIDTNGNNHYHSASSDPLENH 1019
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225461763|ref|XP_002283477.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g53440-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1367 bits (3537), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 683/1005 (67%), Positives = 822/1005 (81%), Gaps = 12/1005 (1%)
Query: 18 CFANFGSHAQRLPDDEVQTLQSIFRKLNFRNGQVNQTSCTEGSWNVTIDDSNGSNFTCDC 77
CFA F SHAQ +P+DEVQTL++IF KLN++ ++QTSC+ G +N TIDD++ SN C+C
Sbjct: 16 CFAEFTSHAQLIPEDEVQTLRTIFTKLNYKYWNISQTSCS-GGFNRTIDDNSYSNVACNC 74
Query: 78 TYSNNTVCHVTVILLKGFNLAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTK 137
T++ VCHVT I LKG +L G +P+EFGNL++LQE+DLSRNY NGS+P S RL +LT
Sbjct: 75 TFNKGNVCHVTNIQLKGLDLDGTLPDEFGNLSYLQELDLSRNYINGSIPTSLGRL-SLTI 133
Query: 138 LLILGNRLSGSIPLEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSI 197
L ++GNR+SGSIP I +ISTLEELVLE NQL LP +LG L LRR++LS+NNFTG+I
Sbjct: 134 LALVGNRISGSIPEVISNISTLEELVLEANQLGEHLPPSLGKLSHLRRLVLSANNFTGTI 193
Query: 198 PESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTE 257
PE++ NLKNLT+FRIDG+NL+G+IP++IGNWTKL++L LQGTS++GPIPS ISQLKNLTE
Sbjct: 194 PENFHNLKNLTDFRIDGNNLSGKIPDWIGNWTKLEKLYLQGTSMDGPIPSIISQLKNLTE 253
Query: 258 LRISDLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPV 317
L ISDL G +SFPNL+DM K++ L++RNC ITG IPE I ++ LK+LDLSFN+L+G +
Sbjct: 254 LLISDLSGPITSFPNLKDMNKLKTLVMRNCSITGEIPEDIGNIESLKLLDLSFNRLSGTI 313
Query: 318 PGILQNLKKI----DYIFLTNNSLSGTLPDWILT-SEKNLDLSYNNFTESSPATCRESRV 372
P + KK+ D++FLTNNSL+G +P WI + +E +DLSYNNFT +C+ +V
Sbjct: 314 PKSFKQEKKVKTKLDFMFLTNNSLTGEVPSWIRSDTENKIDLSYNNFTGPRLDSCKH-QV 372
Query: 373 NILSSFSSTGSNSVSWCLKKDLPCPKEAKHYSLFINCGGSPTEFEENDYEEDLNTQGPSN 432
N++SS++S+ N WCL+KDLPC ++AK+YSL+INCGG T F+ YE+D N +G S
Sbjct: 373 NLVSSYASSARNMTPWCLQKDLPCSRKAKYYSLYINCGGEETTFKGKTYEKDNNVEGASQ 432
Query: 433 FGIVS-DRWAYSSTGVYVGNESSKYLAANQYGLNVSGAEYYKTARLAPQSLKYYGLCMLK 491
F S D+WAYSSTGV++GN +LA N+ LN AE Y+TARLAP SLKYYGLC+ K
Sbjct: 433 FFTDSLDKWAYSSTGVFIGNRHGSHLAKNESALNSKDAEIYQTARLAPISLKYYGLCLQK 492
Query: 492 GSYTVKLHFAEIMFTNDQTYKSLGKRMFDVSIQGKQVLKDFDIMEEAGGVGIGITREFKD 551
G+Y V+L+FAEIMF +QT+ S GKR+FDVSIQG VLKDF+IMEEA G G GI ++F D
Sbjct: 493 GNYKVRLYFAEIMFFTNQTFGSPGKRLFDVSIQGNVVLKDFNIMEEAKGAGKGIYKDF-D 551
Query: 552 VSVNGSTMEIHLYWAGKGTNAIPYRGVYGPLISAITVTPNFEVDTGGGLSAGAIVGIVAG 611
SV+GST+EIHLYW GKGTN+IP GVYGPLISAI VTP F + G LS G I+GIV
Sbjct: 552 ASVDGSTLEIHLYWTGKGTNSIPDEGVYGPLISAIAVTPKFNPNPG--LSVGGIIGIVIP 609
Query: 612 SCAVVIILLFILWRLGYLGGKNVEDKELRGLDLQTGYFTLRQIKAATNNFDAANKIGEGG 671
SC V+I++L +L GYLGGK++ED+ELR L +QTGYF+LRQIKAATNNFD+ANKIGEGG
Sbjct: 610 SCVVLILILVLLRMKGYLGGKDLEDRELRELGMQTGYFSLRQIKAATNNFDSANKIGEGG 669
Query: 672 FGPVYKGTLSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLL 731
FGPVYKG LSDG+V AVKQLSSKSKQGNREFVNEIGMISALQH NLVKLYGCCIEGNQLL
Sbjct: 670 FGPVYKGVLSDGSVSAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLL 729
Query: 732 LVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKAT 791
L+YEYLENNSLARALFG + Q LNLDW TRK+IC IARGLAYLHEESRLKIVHRDIKAT
Sbjct: 730 LIYEYLENNSLARALFGSDEQRLNLDWPTRKKICLGIARGLAYLHEESRLKIVHRDIKAT 789
Query: 792 NVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGI 851
NVLLDK+LNAKISDFGLAKLDEDENTHISTRIAGT+GYMAPEYA RGYLTDKADVYSFGI
Sbjct: 790 NVLLDKNLNAKISDFGLAKLDEDENTHISTRIAGTIGYMAPEYATRGYLTDKADVYSFGI 849
Query: 852 VALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIA 911
VALEIVSGKSNTNYRPKEEFVYLLDWAYVL EQGNLLELVDPSLGSN+S++E M MLN+A
Sbjct: 850 VALEIVSGKSNTNYRPKEEFVYLLDWAYVLHEQGNLLELVDPSLGSNYSEEEVMRMLNLA 909
Query: 912 LLCTNPSPTLRPTMSSAVSMLEGKTAVQAPIIRRNSDSQDARFRAFEILSQDSQTHVSTL 971
LLCTN SPTLRP MSS VSML+GK AVQAP I+ +S + D RF+AFE LS DSQ+HVS
Sbjct: 910 LLCTNQSPTLRPPMSSVVSMLDGKIAVQAPTIKHDSMNPDMRFKAFEKLSLDSQSHVSAF 969
Query: 972 SQESEMQRTMSIDAPWTDSSVSVQIPDETREHSSSSLLLQNENNL 1016
S +S++Q ++S+D PW DSS+S+ +ETR+ SSSS LL +L
Sbjct: 970 SVDSQVQGSISLDGPWIDSSISLHSREETRDFSSSSKLLTGHQDL 1014
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449522496|ref|XP_004168262.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g53430-like, partial [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1345 bits (3480), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 680/987 (68%), Positives = 805/987 (81%), Gaps = 13/987 (1%)
Query: 35 QTLQSIFRKLNFRNGQVNQTSCTEG---SWNVTIDDSNGSNFTCDCTYSNNTVCHVTVIL 91
+TLQ+I KL + V ++SC G S + N +C+CT +T+CHVT++L
Sbjct: 1 KTLQTISSKLENLSWNVTRSSCIRGEGFSNQAFQGNQILRNISCNCT---STLCHVTIVL 57
Query: 92 LKGFNLAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPL 151
LKG NL G P EFGNLT LQE+DL+RN+ NG LP S A L KL +LGNRL+GSIP
Sbjct: 58 LKGLNLTGTFPAEFGNLTHLQELDLTRNHINGQLPSSLANAP-LVKLSLLGNRLNGSIPK 116
Query: 152 EIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFR 211
EIG+I TLEEL+LEDNQL G LP +LGNL SLRR+LLS+NNFTG IP+S+G L NL +FR
Sbjct: 117 EIGEIGTLEELILEDNQLTGSLPASLGNLNSLRRLLLSANNFTGKIPDSFGKLTNLVDFR 176
Query: 212 IDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISDLKGSSSSFP 271
+DG+ L+G+IP FIGNW LDRLD+QGTS+E PIPSTISQLKNLT+LRISDLKGS SFP
Sbjct: 177 VDGNGLSGKIPEFIGNWINLDRLDMQGTSMENPIPSTISQLKNLTQLRISDLKGSFISFP 236
Query: 272 NLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNL--KKIDY 329
NL DM M+ L+LRNCLI G IPEYI +M L LDLSFN L G +P QNL +KID+
Sbjct: 237 NLTDMINMKELVLRNCLINGSIPEYIGEMNKLSTLDLSFNHLNGDIPETFQNLMKRKIDF 296
Query: 330 IFLTNNSLSGTLPDWILTSEKNLDLSYNNFTESSPATCRESRVNILSSFSSTGSNSVSWC 389
+FLTNNSLSG +P WIL+S+KN+DLSYNNF+ S+ A+C++S VN+++S+ ++ V WC
Sbjct: 297 MFLTNNSLSGEVPGWILSSKKNIDLSYNNFSGSTLASCQQSPVNLIASYPPATNHQVPWC 356
Query: 390 LKKDLPCPKEAKHYSLFINCGGSPTEFEENDYEEDLNTQGPSNFGIVSDRWAYSSTGVYV 449
LKKDLPC +A+++SLFINCGG+ + +DYEEDL T+G SNF VS++WAYSSTGV++
Sbjct: 357 LKKDLPCSGKAEYHSLFINCGGTRVTADGHDYEEDLTTEGKSNFFSVSEKWAYSSTGVFL 416
Query: 450 GNESSKYLAANQYGLNVSGAEYYKTARLAPQSLKYYGLCMLKGSYTVKLHFAEIMFTNDQ 509
G+E++ YLA N++GLNVSG YY+ ARL+P SLKYYGLC+ GSY VKLHFAEIM++NDQ
Sbjct: 417 GDENADYLATNKFGLNVSGPRYYQNARLSPLSLKYYGLCLRSGSYNVKLHFAEIMYSNDQ 476
Query: 510 TYKSLGKRMFDVSIQGKQVLKDFDIMEEAGGVGIGITREFKDVSVNGSTMEIHLYWAGKG 569
T+ SLGKR+FD+SIQGK V KDF+I+E AGGVG T E K+V VNGST+EI+LYWAGKG
Sbjct: 477 TFSSLGKRIFDISIQGKLVKKDFNIVEAAGGVGKNFTVEDKNVLVNGSTLEINLYWAGKG 536
Query: 570 TNAIPYRGVYGPLISAITVTPNFEVDTGGGLSAGAIVGIVAGSCAVVIILLF-ILWRLGY 628
T A+P RGVYGPLISAITVTPNF+++ GG LS+GA+ GI+ SC VVIIL+ LW GY
Sbjct: 537 TTAVPDRGVYGPLISAITVTPNFKINEGG-LSSGALAGIIVSSCVVVIILVLVFLWMTGY 595
Query: 629 LGGKNVEDKELRGLDLQTGYFTLRQIKAATNNFDAANKIGEGGFGPVYKGTLSDGAVIAV 688
+ K EL G+DLQTG+FTL+QIKAATNNFD +KIGEGGFGPVYKG LSDGA+IAV
Sbjct: 596 ICKKEDLANELSGIDLQTGHFTLKQIKAATNNFDPKSKIGEGGFGPVYKGVLSDGALIAV 655
Query: 689 KQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFG 748
KQLSSKSKQG+REFV EIGMISALQH NLVKLYGCC+EGNQLLLVYEY+ENNSLARALFG
Sbjct: 656 KQLSSKSKQGSREFVTEIGMISALQHPNLVKLYGCCVEGNQLLLVYEYMENNSLARALFG 715
Query: 749 KEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGL 808
+E Q L+LDW TRK+IC +IARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGL
Sbjct: 716 REEQRLHLDWRTRKKICLEIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGL 775
Query: 809 AKLDEDENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPK 868
AKLDE+ENTHISTRIAGT+GYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPK
Sbjct: 776 AKLDEEENTHISTRIAGTIGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPK 835
Query: 869 EEFVYLLDWAYVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSA 928
EEFVYLLDWAYVL+EQGNLLEL DP LGSN+S +EAM MLN+ALLCTNPSPTLRPTMSS
Sbjct: 836 EEFVYLLDWAYVLEEQGNLLELADPDLGSNYSSEEAMRMLNVALLCTNPSPTLRPTMSSV 895
Query: 929 VSMLEGKTAVQAPIIRRNSDSQDARFRAFEILSQDSQTHV--STLSQESEMQRTMSIDAP 986
VSMLEGK AVQAPII+R S QD RFRAFE LS DS++ + ST+S ++E Q++M +D P
Sbjct: 896 VSMLEGKIAVQAPIIKRTSSGQDPRFRAFEKLSHDSRSQISSSTVSLDAEPQKSMLMDGP 955
Query: 987 WTDSSVSVQIPDETREHSSSSLLLQNE 1013
DSSV++ HS+SS L+N
Sbjct: 956 CPDSSVTIDTNGNNHYHSASSDPLENH 982
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|264664531|sp|C0LGG8.1|Y5343_ARATH RecName: Full=Probable LRR receptor-like serine/threonine-protein kinase At1g53430; Flags: Precursor gi|224589438|gb|ACN59253.1| leucine-rich repeat receptor-like protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1341 bits (3470), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 659/1008 (65%), Positives = 808/1008 (80%), Gaps = 18/1008 (1%)
Query: 1 MGKIVS----VFVVLGFLVLNCFANFGSHAQRLPDDEVQTLQSIFRKLNFRNGQVNQTSC 56
MG I S V+V+L L+ C NFGS+AQ LP+DEVQTL++IFRKL + + +TSC
Sbjct: 1 MGFIFSTEKVVYVLL--LIFVCLENFGSNAQLLPEDEVQTLRTIFRKLQNQTVNIERTSC 58
Query: 57 TEGSWNVTID---DSNGSNFTCDCTYSNNTVCHVTVILLKGFNLAGVIPEEFGNLTFLQE 113
++ +WN ++ +S SN TCDCT++ ++VC VT I LK F+L G+ P EFGNLT L+E
Sbjct: 59 SDQNWNFVVESASNSPTSNITCDCTFNASSVCRVTNIQLKSFSLPGIFPPEFGNLTRLRE 118
Query: 114 VDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGDISTLEELVLEDNQLVGPL 173
+DLSRN+ NG++P + +++ L L ++GNRLSG P ++GDI+TL ++ LE N GPL
Sbjct: 119 IDLSRNFLNGTIPTTLSQIP-LEILSVIGNRLSGPFPPQLGDITTLTDVNLETNLFTGPL 177
Query: 174 PENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDR 233
P NLGNL+SL+ +LLS+NNFTG IPES NLKNLTEFRIDG++L+G+IP+FIGNWT L+R
Sbjct: 178 PRNLGNLRSLKELLLSANNFTGQIPESLSNLKNLTEFRIDGNSLSGKIPDFIGNWTLLER 237
Query: 234 LDLQGTSLEGPIPSTISQLKNLTELRISDLKGSSS-SFPNLQDMKKMERLILRNCLITGR 292
LDLQGTS+EGPIP +IS L NLTELRI+DL+G ++ SFP+L+++ KM+RL+LRNCLI G
Sbjct: 238 LDLQGTSMEGPIPPSISNLTNLTELRITDLRGQAAFSFPDLRNLMKMKRLVLRNCLIRGP 297
Query: 293 IPEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGTLPDWILTSEKNL 352
IPEYI M++LK LDLS N LTG +P +NL +++FL NNSL+G +P +I+ S++NL
Sbjct: 298 IPEYIGSMSELKTLDLSSNMLTGVIPDTFRNLDAFNFMFLNNNSLTGPVPQFIINSKENL 357
Query: 353 DLSYNNFTESSPATCRESRVNILSSFSSTGSNSVSWCLKKDLPCPKEAKHYSLFINCGGS 412
DLS NNFT+ +C + VN++SS+ S NSV WCL++ LPCP++AK SLFINCGGS
Sbjct: 358 DLSDNNFTQPPTLSCNQLDVNLISSYPSVTDNSVQWCLREGLPCPEDAKQSSLFINCGGS 417
Query: 413 PTEFEENDYEEDLNTQGPSNFGIVSDRWAYSSTGVYVGNESSKYLAANQYGL-NVSGAEY 471
+ ++ Y +DLN++G S F VS+RW YSS+GV++G E + YLA +++ L N S EY
Sbjct: 418 RLKIGKDTYTDDLNSRGQSTFSSVSERWGYSSSGVWLGKEDAGYLATDRFNLINGSTPEY 477
Query: 472 YKTARLAPQSLKYYGLCMLKGSYTVKLHFAEIMFTNDQTYKSLGKRMFDVSIQGKQVLKD 531
YKTARL+PQSLKYYGLC+ +GSY ++LHFAEIMF+NDQT+ SLG+R+FD+ +QG + +D
Sbjct: 478 YKTARLSPQSLKYYGLCLRRGSYKLQLHFAEIMFSNDQTFNSLGRRIFDIYVQGNLLERD 537
Query: 532 FDIMEEAGGVGIGITREFKDVSVNGSTMEIHLYWAGKGTNAIPYRGVYGPLISAITVTPN 591
F+I E AGGVG R+ V VNGST+EIHL W GKGTN IP RGVYGPLISAIT+TPN
Sbjct: 538 FNIAERAGGVGKPFIRQIDGVQVNGSTLEIHLQWTGKGTNVIPTRGVYGPLISAITITPN 597
Query: 592 FEVDTGGGLSAGAIVGIVAGSCAVVIILLFILWRL-GYLGGKNV-EDKELRGLDLQTGYF 649
F+VDTG LS GA+ GIV +CAV +L+ ++ RL GYLGGK V E++ELRGLDLQTG F
Sbjct: 598 FKVDTGKPLSNGAVAGIVIAACAVFGLLVLVILRLTGYLGGKEVDENEELRGLDLQTGSF 657
Query: 650 TLRQIKAATNNFDAANKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGNREFVNEIGMI 709
TL+QIK ATNNFD NKIGEGGFGPVYKG L+DG IAVKQLSSKSKQGNREFV EIGMI
Sbjct: 658 TLKQIKRATNNFDPENKIGEGGFGPVYKGVLADGMTIAVKQLSSKSKQGNREFVTEIGMI 717
Query: 710 SALQHQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIA 769
SALQH NLVKLYGCCIEG +LLLVYEYLENNSLARALFG E Q L+LDW+TR +IC IA
Sbjct: 718 SALQHPNLVKLYGCCIEGKELLLVYEYLENNSLARALFGTEKQRLHLDWSTRNKICIGIA 777
Query: 770 RGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGY 829
+GLAYLHEESRLKIVHRDIKATNVLLD LNAKISDFGLAKL++DENTHISTRIAGT+GY
Sbjct: 778 KGLAYLHEESRLKIVHRDIKATNVLLDLSLNAKISDFGLAKLNDDENTHISTRIAGTIGY 837
Query: 830 MAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLE 889
MAPEYAMRGYLTDKADVYSFG+V LEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQG+LLE
Sbjct: 838 MAPEYAMRGYLTDKADVYSFGVVCLEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGSLLE 897
Query: 890 LVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTAVQAPIIRRNSD- 948
LVDP LG++FSKKEAM MLNIALLCTNPSPTLRP MSS VSMLEGK VQ P+++R +D
Sbjct: 898 LVDPDLGTSFSKKEAMRMLNIALLCTNPSPTLRPPMSSVVSMLEGKIKVQPPLVKREADP 957
Query: 949 --SQDARFRAFEILSQDSQTHVSTLSQESEMQ-RTMSIDAPWTDSSVS 993
S RF+A E+LSQDS++ VST ++ E + S+D PW DSS S
Sbjct: 958 SGSAAMRFKALELLSQDSESQVSTYARNREQDISSSSMDGPWVDSSFS 1005
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297847742|ref|XP_002891752.1| leucine-rich repeat family protein [Arabidopsis lyrata subsp. lyrata] gi|297337594|gb|EFH68011.1| leucine-rich repeat family protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 1341 bits (3470), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 657/1007 (65%), Positives = 801/1007 (79%), Gaps = 17/1007 (1%)
Query: 1 MGKIVS----VFVVLGFLVLNCFANFGSHAQRLPDDEVQTLQSIFRKLNFRNGQVNQTSC 56
MG I S V+V+L L+ C NFGS+AQ LPDDEVQTL++IFRKL + + +TSC
Sbjct: 1 MGFIFSTKEVVYVLL--LIFICLENFGSNAQLLPDDEVQTLRTIFRKLQNQTVNIERTSC 58
Query: 57 TEGSWNVTIDDSNG---SNFTCDCTYSNNTVCHVTVILLKGFNLAGVIPEEFGNLTFLQE 113
T+ +WN S SN TCDCT++ ++VC VT I L+GFNL G+IP EFGNLT L E
Sbjct: 59 TDENWNFVAGSSPNAVTSNITCDCTFNASSVCRVTNIQLRGFNLRGIIPPEFGNLTRLTE 118
Query: 114 VDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGDISTLEELVLEDNQLVGPL 173
+DL N+ +G++P + +++ L L + GNRLSG P ++G+I+TL ++V+E N G L
Sbjct: 119 IDLMLNFLSGTIPTTLSQIP-LEILAVTGNRLSGPFPPQLGEITTLTDVVMETNLFTGQL 177
Query: 174 PENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDR 233
P NLGNL+SL+R+L+SSNN TG IPES NLKNLT+FRIDG++LTG+IP+FIGNWT+L R
Sbjct: 178 PSNLGNLRSLKRLLISSNNITGRIPESLSNLKNLTDFRIDGNSLTGKIPDFIGNWTRLVR 237
Query: 234 LDLQGTSLEGPIPSTISQLKNLTELRISDLKGSSSSFPNLQDMKKMERLILRNCLITGRI 293
LDLQGTS+EGPIP++IS LKNLT+LR++DL+G +S FP+LQ+M MERL+LRNCLI I
Sbjct: 238 LDLQGTSMEGPIPASISNLKNLTQLRVTDLRGPTSPFPDLQNMTNMERLVLRNCLIREPI 297
Query: 294 PEYI-EDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGTLPDWILTSEKNL 352
PEYI M+ LK+LDLS N L G +P ++L ++++L NNSL+G +P +I+ S++N+
Sbjct: 298 PEYIGTSMSMLKLLDLSSNMLNGTIPDTFRSLTAFNFMYLNNNSLTGPVPQFIINSKENI 357
Query: 353 DLSYNNFTESSPATCRESRVNILSSFSSTGSNSVSWCLKKDLPCPKEAKHYSLFINCGGS 412
DLS NNFT+ +C + VN++SS+ S NSV WCL+KDLPCP +A H SLFINCGG+
Sbjct: 358 DLSDNNFTQPPTLSCNQLDVNLISSYPSVTDNSVQWCLRKDLPCPGDAHHSSLFINCGGN 417
Query: 413 PTEFEENDYEEDLNTQGPSNFGIVSDRWAYSSTGVYVGNESSKYLAANQYGL-NVSGAEY 471
+ ++++Y +DLN +G S F VS+RW YSS+G ++GN+S+ YLA + + L N S EY
Sbjct: 418 RLKVDKDEYADDLNKRGASTFSSVSERWGYSSSGAWLGNDSAPYLATDTFNLINESTPEY 477
Query: 472 YKTARLAPQSLKYYGLCMLKGSYTVKLHFAEIMFTNDQTYKSLGKRMFDVSIQGKQVLKD 531
YKTARLA QSLKYYGLCM +GSY V+LHFAEIMF+NDQTY SLG+R+FD+ +QG + +D
Sbjct: 478 YKTARLASQSLKYYGLCMRRGSYKVQLHFAEIMFSNDQTYSSLGQRVFDIYVQGILLERD 537
Query: 532 FDIMEEAGGVGIGITREFKDVSVNGSTMEIHLYWAGKGTNAIPYRGVYGPLISAITVTPN 591
F+I E AGGVG R+ DV VNGST+EIHL W GKGTN IP RGVYGPLISAIT+TPN
Sbjct: 538 FNIAERAGGVGKPFLRQIDDVQVNGSTLEIHLKWLGKGTNVIPTRGVYGPLISAITITPN 597
Query: 592 FEVDTGGGLSAGAIVGIVAGSCAVV-IILLFILWRLGYLGGKNV-EDKELRGLDLQTGYF 649
F+VDTG LS A+ GIV +CA +++L ILW GYLGGK V E++ELRGLDLQTG F
Sbjct: 598 FKVDTGKPLSNKAVAGIVIAACAAFGLLVLVILWLTGYLGGKEVDENEELRGLDLQTGSF 657
Query: 650 TLRQIKAATNNFDAANKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGNREFVNEIGMI 709
TL+QIK ATNNFD NKIGEGGFGPVYKG L+DG IAVKQLSSKSKQGNREFV EIGMI
Sbjct: 658 TLKQIKRATNNFDPENKIGEGGFGPVYKGVLADGMTIAVKQLSSKSKQGNREFVTEIGMI 717
Query: 710 SALQHQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIA 769
SALQH NLVKLYGCCIEG +LLLVYEYLENNSLARALFG E Q L+LDW+TR +IC IA
Sbjct: 718 SALQHPNLVKLYGCCIEGKELLLVYEYLENNSLARALFGTEKQRLHLDWSTRNKICLGIA 777
Query: 770 RGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGY 829
+GLAYLHEESRLKIVHRDIKATNVLLD+ LNAKISDFGLAKLDE+ENTHISTRIAGT+GY
Sbjct: 778 KGLAYLHEESRLKIVHRDIKATNVLLDQSLNAKISDFGLAKLDEEENTHISTRIAGTIGY 837
Query: 830 MAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLE 889
MAPEYAMRGYLTDKADVYSFG+V LEIVSGKSNTNYRPKEEF+YLLDWAYVLQEQG+LLE
Sbjct: 838 MAPEYAMRGYLTDKADVYSFGVVCLEIVSGKSNTNYRPKEEFIYLLDWAYVLQEQGSLLE 897
Query: 890 LVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTAVQAPIIRRNSD- 948
L+DP LG++FSKKEAM MLNIALLCTNPSPTLRP MSS V MLEGK VQ P+++R +D
Sbjct: 898 LMDPDLGTSFSKKEAMRMLNIALLCTNPSPTLRPPMSSVVRMLEGKIKVQPPLVKREADP 957
Query: 949 --SQDARFRAFEILSQDSQTHVSTLSQESEMQRTMSIDAPWTDSSVS 993
S RF+AFE+LSQDS++ VST + E + + S+D PW DSS S
Sbjct: 958 SGSAAMRFKAFELLSQDSESQVSTHTSNREHKSSSSMDGPWVDSSFS 1004
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1016 | ||||||
| TAIR|locus:2203718 | 1035 | AT1G53440 [Arabidopsis thalian | 0.955 | 0.938 | 0.646 | 0.0 | |
| TAIR|locus:2009630 | 953 | AT1G53420 [Arabidopsis thalian | 0.851 | 0.907 | 0.518 | 5.7e-233 | |
| TAIR|locus:2203847 | 1021 | RKF1 "receptor-like kinase in | 0.919 | 0.914 | 0.453 | 3.4e-212 | |
| TAIR|locus:2019317 | 969 | AT1G29730 [Arabidopsis thalian | 0.338 | 0.355 | 0.616 | 1.8e-209 | |
| TAIR|locus:2019367 | 1078 | AT1G29740 [Arabidopsis thalian | 0.895 | 0.844 | 0.460 | 1.4e-208 | |
| TAIR|locus:2205250 | 1032 | AT1G56130 [Arabidopsis thalian | 0.817 | 0.805 | 0.415 | 5e-163 | |
| TAIR|locus:2205260 | 1047 | AT1G56120 [Arabidopsis thalian | 0.819 | 0.795 | 0.401 | 1e-155 | |
| TAIR|locus:2020417 | 1101 | AT1G17230 [Arabidopsis thalian | 0.296 | 0.273 | 0.394 | 3.9e-88 | |
| TAIR|locus:2182870 | 1192 | EMS1 "EXCESS MICROSPOROCYTES1" | 0.278 | 0.237 | 0.443 | 2.2e-87 | |
| TAIR|locus:2017923 | 390 | AT1G16670 [Arabidopsis thalian | 0.341 | 0.889 | 0.494 | 1.1e-85 |
| TAIR|locus:2203718 AT1G53440 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 3308 (1169.5 bits), Expect = 0., P = 0.
Identities = 635/982 (64%), Positives = 777/982 (79%)
Query: 22 FGSHAQRLPDDEVQTLQSIFRKLNFRNGQVNQTSCTEGSWNVTIDDSNG---SNFTCDCT 78
FGS+AQ LP+DEVQTL++IFRKL + + +TSC + WN + ++ SN TCDCT
Sbjct: 22 FGSNAQLLPEDEVQTLRTIFRKLQNQTVNIERTSCLDRKWNFVAESTSKLPTSNITCDCT 81
Query: 79 YSNNTVCHVTVILLKGFNLAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKL 138
++ ++VC VT I L+GFNL G+IP EFGNLT L E+DL N+ +G++P + +++ L L
Sbjct: 82 FNASSVCRVTNIQLRGFNLRGIIPPEFGNLTRLTEIDLVLNFLSGTIPTTLSQIP-LEIL 140
Query: 139 LILGNRLSGSIPLEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIP 198
+ GNRLSG P ++G I+TL ++++E N G LP NLGNL+SL+R+L+SSNN TG IP
Sbjct: 141 AVTGNRLSGPFPPQLGQITTLTDVIMESNLFTGQLPPNLGNLRSLKRLLISSNNITGRIP 200
Query: 199 ESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTEL 258
ES NLKNLT FRIDG++L+G+IP+FIGNWT+L RLDLQGTS+EGPIP++IS LKNLTEL
Sbjct: 201 ESLSNLKNLTNFRIDGNSLSGKIPDFIGNWTRLVRLDLQGTSMEGPIPASISNLKNLTEL 260
Query: 259 RISDLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYI-EDMTDLKILDLSFNQLTGPV 317
RI+DL+G +S FP+LQ+M MERL+LRNCLI IPEYI MT LK+LDLS N L G +
Sbjct: 261 RITDLRGPTSPFPDLQNMTNMERLVLRNCLIREPIPEYIGTSMTMLKLLDLSSNMLNGTI 320
Query: 318 PGILQNLKKIDYIFLTNNSLSGTLPDWILTSEKNLDLSYNNFTESSPATCRESRVNILXX 377
P ++L ++++L NNSL+G +P +IL S++N+DLSYNNFT+ +C + VN++
Sbjct: 321 PDTFRSLNAFNFMYLNNNSLTGPVPQFILDSKQNIDLSYNNFTQPPTLSCNQLDVNLISS 380
Query: 378 XXXXXXXXXXWCLKKDLPCPKEAKHYSLFINCGGSPTEFEENDYEEDLNTQGPSNFGIVS 437
WCL+KDLPCP +A H SLFINCGG+ + ++++Y +DLN +G S F VS
Sbjct: 381 YPSVTNNSVQWCLRKDLPCPGDAHHSSLFINCGGNRLKVDKDEYADDLNKRGASTFSSVS 440
Query: 438 DRWAYSSTGVYVGNESSKYLAANQYGL-NVSGAEYYKTARLAPQSLKYYGLCMLKGSYTV 496
+RW YSS+G ++GN+ + YLA + + L N S EYYKTARLA QSLKYYGLCM +GSY V
Sbjct: 441 ERWGYSSSGAWLGNDGATYLATDTFNLINESTPEYYKTARLASQSLKYYGLCMRRGSYKV 500
Query: 497 KLHFAEIMFTNDQTYKSLGKRMFDVSIQGKQVLKDFDIMEEAGGVGIGITREFKDVSVNG 556
+L+FAEIMF+NDQTY SLG+R+FD+ +QG + +DF+I + AGGVG R+ +V VNG
Sbjct: 501 QLYFAEIMFSNDQTYSSLGRRLFDIYVQGILLERDFNIAQRAGGVGKPFLRQVDEVQVNG 560
Query: 557 STMEIHLYWAGKGTNAIPYRGVYGPLISAITVTPNFEVDTGGGLSAGAIVGIVAGSCAVV 616
ST+EIHL W GKGTN IP RGVYGPLISAITVTPNF+VDTG LS G + GIV +C
Sbjct: 561 STLEIHLKWTGKGTNVIPTRGVYGPLISAITVTPNFKVDTGKPLSNGVVAGIVIAACVAF 620
Query: 617 IILLFILWRL-GYLGGKNV-EDKELRGLDLQTGYFTLRQIKAATNNFDAANKIGEGGFGP 674
+L+ ++ RL GYLGGK V E++ELRGLDLQTG FTL+QIK ATNNFD NKIGEGGFGP
Sbjct: 621 GLLVLVILRLTGYLGGKEVDENEELRGLDLQTGSFTLKQIKRATNNFDPENKIGEGGFGP 680
Query: 675 VYKGTLSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVY 734
VYKG L+DG IAVKQLSSKSKQGNREFV EIGMISALQH NLVKLYGCCIEG +LLLVY
Sbjct: 681 VYKGVLADGMTIAVKQLSSKSKQGNREFVTEIGMISALQHPNLVKLYGCCIEGKELLLVY 740
Query: 735 EYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVL 794
EYLENNSLARALFG E Q L+LDW+TR ++C IA+GLAYLHEESRLKIVHRDIKATNVL
Sbjct: 741 EYLENNSLARALFGTEKQRLHLDWSTRNKVCIGIAKGLAYLHEESRLKIVHRDIKATNVL 800
Query: 795 LDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVAL 854
LD LNAKISDFGLAKLDE+ENTHISTRIAGT+GYMAPEYAMRGYLTDKADVYSFG+V L
Sbjct: 801 LDLSLNAKISDFGLAKLDEEENTHISTRIAGTIGYMAPEYAMRGYLTDKADVYSFGVVCL 860
Query: 855 EIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLC 914
EIVSGKSNTNYRPKEEF+YLLDWAYVLQEQG+LLELVDP LG++FSKKEAM MLNIALLC
Sbjct: 861 EIVSGKSNTNYRPKEEFIYLLDWAYVLQEQGSLLELVDPDLGTSFSKKEAMRMLNIALLC 920
Query: 915 TNPSPTLRPTMSSAVSMLEGKTAVQAPIIRRNSD---SQDARFRAFEILSQDSQTHVSTL 971
TNPSPTLRP MSS VSML+GK VQ P+++R +D S RF+A E LSQDS++ VST
Sbjct: 921 TNPSPTLRPPMSSVVSMLQGKIKVQPPLVKREADPSGSAAMRFKALEHLSQDSESQVSTY 980
Query: 972 SQESEMQRTMSIDAPWTDSSVS 993
++ E + + S+D PW DSS S
Sbjct: 981 TRNKEHKSSSSMDGPWVDSSFS 1002
|
|
| TAIR|locus:2009630 AT1G53420 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2247 (796.0 bits), Expect = 5.7e-233, P = 5.7e-233
Identities = 466/899 (51%), Positives = 605/899 (67%)
Query: 92 LKGFNLAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPL 151
LK NL G +P+E L LQE+DLSRNY NGS+P + L L + +LGNRL+G IP
Sbjct: 70 LKRENLQGSLPKELVGLPLLQEIDLSRNYLNGSIPPEWGVLP-LVNIWLLGNRLTGPIPK 128
Query: 152 EIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFR 211
E G+I+TL LVLE NQL G LP LGNL ++++++LSSNNF G IP ++ L L +FR
Sbjct: 129 EFGNITTLTSLVLEANQLSGELPLELGNLPNIQQMILSSNNFNGEIPSTFAKLTTLRDFR 188
Query: 212 IDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISDLKGSSSSFP 271
+ + L+G IP+FI WTKL+RL +Q + L GPIP I+ L L +LRISDL G S FP
Sbjct: 189 VSDNQLSGTIPDFIQKWTKLERLFIQASGLVGPIPIAIASLVELKDLRISDLNGPESPFP 248
Query: 272 NLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIF 331
L+++KKME LILRNC +TG +P+Y+ +T K LDLSFN+L+G +P NL+ YI+
Sbjct: 249 QLRNIKKMETLILRNCNLTGDLPDYLGKITSFKFLDLSFNKLSGAIPNTYINLRDGGYIY 308
Query: 332 LTNNSLSGTLPDWILTSEKNLDLSYNNFT-ESSPATCRESRVNILXXXXXXXXXXXXWCL 390
T N L+G++PDW++ +DLSYNNF+ + + A C+ + N+L C+
Sbjct: 309 FTGNMLNGSVPDWMVNKGYKIDLSYNNFSVDPTNAVCKYN--NVLS------------CM 354
Query: 391 KKDLPCPKEAKHYSLFINCGGSPTEFEENDYEEDLNTQGPSNFGIVSDRWAYSSTGVYVG 450
+ + CPK +L INCGG YE D + S + + W ++ GV+V
Sbjct: 355 R-NYQCPKTFN--ALHINCGGDEMSINGTIYESDKYDRLESWYES-RNGWFSNNVGVFVD 410
Query: 451 NE---SSKYLAANQYGLNVSGAEYYKTARLAPQSLKYYGLCMLKGSYTVKLHFAEIMFTN 507
++ + +N LNV Y AR++ SL YY LC+ G+Y V LHFAEIMF
Sbjct: 411 DKHVPERVTIESNSSELNVVDFGLYTQARISAISLTYYALCLENGNYNVNLHFAEIMFNG 470
Query: 508 DQTYKSLGKRMFDVSIQGKQVLKDFDIMEEAGGVGIGITREFKDVSVNGSTMEIHLYWAG 567
+ Y+SLG+R FD+ IQ K +KDF+I +EA VG + + F V + +EI LYWAG
Sbjct: 471 NNNYQSLGRRFFDIYIQRKLEVKDFNIAKEAKDVGNVVIKTFP-VEIKDGKLEIRLYWAG 529
Query: 568 KGTNAIPYRGVYGPLISAITVTPNFEVDTGGGLSAGAIVGIVAGSCAVVIILLF-ILWRL 626
+GT IP VYGPLISAI+V + G+S G + +V ++ L+F LW+
Sbjct: 530 RGTTVIPKERVYGPLISAISVDSSVNPSPRNGMSTGTLHTLVVILSIFIVFLVFGTLWKK 589
Query: 627 GYLGGKNVEDKELRGLDLQTGYFTLRQIKAATNNFDAANKIGEGGFGPVYKGTLSDGAVI 686
GYL K+ +K+ + L+L F+LRQIK ATNNFD+AN+IGEGGFGPVYKG L DG +I
Sbjct: 590 GYLRSKSQMEKDFKSLELMIASFSLRQIKIATNNFDSANRIGEGGFGPVYKGKLFDGTII 649
Query: 687 AVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYLENNSLARAL 746
AVKQLS+ SKQGNREF+NEIGMISAL H NLVKLYGCC+EG QLLLVYE++ENNSLARAL
Sbjct: 650 AVKQLSTGSKQGNREFLNEIGMISALHHPNLVKLYGCCVEGGQLLLVYEFVENNSLARAL 709
Query: 747 FGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDF 806
FG + L LDW TR++IC +ARGLAYLHEESRLKIVHRDIKATNVLLDK LN KISDF
Sbjct: 710 FGPQETQLRLDWPTRRKICIGVARGLAYLHEESRLKIVHRDIKATNVLLDKQLNPKISDF 769
Query: 807 GLAKLDEDENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYR 866
GLAKLDE+++THISTRIAGT GYMAPEYAMRG+LTDKADVYSFGIVALEIV G+SN R
Sbjct: 770 GLAKLDEEDSTHISTRIAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVHGRSNKIER 829
Query: 867 PKEEFVYLLDWAYVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMS 926
K YL+DW VL+E+ NLLELVDP LGS ++++EAMTM+ IA++CT+ P RP+MS
Sbjct: 830 SKNNTFYLIDWVEVLREKNNLLELVDPRLGSEYNREEAMTMIQIAIMCTSSEPCERPSMS 889
Query: 927 SAVSMLEGKTAVQ------APIIRRNS--DSQDARFRAFEILSQDSQTHVSTL-SQESE 976
V MLEGK V+ A + R ++ + + +E++ Q+ T +S + S SE
Sbjct: 890 EVVKMLEGKKMVEVEKLEEASVHRETKRLENMNTMKKYYEMIGQEISTSMSMIMSDRSE 948
|
|
| TAIR|locus:2203847 RKF1 "receptor-like kinase in flowers 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2051 (727.0 bits), Expect = 3.4e-212, P = 3.4e-212
Identities = 440/971 (45%), Positives = 612/971 (63%)
Query: 22 FGSHAQRLPDDEVQTLQSI-------FRKLNFRNGQVNQTSCTEGSWNVTIDDSNGSNFT 74
+ +A +LP EV LQ I F K + N ++ TE T +
Sbjct: 35 YSVNAIKLPQQEVDALQQIATTLGSKFWKFDAENCKIEMVGLTE-----TPPPTAKQEIE 89
Query: 75 CDCTYSNNTVCHVTVILLKGFNLAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQN 134
C+C+ +N+T CHV K NL G +P+ L +L+E+DL+ NY NG+LP+ +A N
Sbjct: 90 CECSPTNDTDCHVVKFAFKDHNLPGTLPQ-IVKLPYLREIDLAYNYINGTLPREWAS-SN 147
Query: 135 LTKLLILGNRLSGSIPLEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFT 194
LT + +L NRLSG IP E G+ S+L L LE N G +P+ LGNL L+++LLSSN T
Sbjct: 148 LTFISLLVNRLSGEIPKEFGN-SSLTYLDLESNAFSGTIPQELGNLVHLKKLLLSSNKLT 206
Query: 195 GSIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKN 254
G++P S L+N+T+FRI+ L+G IP++I NW +L+RL++ + L GPIPS IS L N
Sbjct: 207 GTLPASLARLQNMTDFRINDLQLSGTIPSYIQNWKQLERLEMIASGLTGPIPSVISVLSN 266
Query: 255 LTELRISDLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLT 314
L LRISD++G FP+L+++ + ++IL+NC I+G+IP Y+ + +L+ LDLSFN+L
Sbjct: 267 LVNLRISDIRGPVQPFPSLKNVTGLTKIILKNCNISGQIPTYLSHLKELETLDLSFNKLV 326
Query: 315 GPVPGILQNLKKIDYIFLTNNSLSGTLPDWILTSEKNLDLSYNNFTESSPAT--CRES-- 370
G +P Q + + +I L N L G PD +L +DLSYNN SP + CR +
Sbjct: 327 GGIPSFAQ-AENLRFIILAGNMLEGDAPDELLRDGITVDLSYNNLKWQSPESRACRPNMN 385
Query: 371 -RVNILXXXXXXXXXXXXWCLKKDLPCPKEAKHYSLFINCGGSPTEFEEND----YEEDL 425
+N+ C+K D CP+ + L +NCGGS +E YE D
Sbjct: 386 LNLNLFQSTSTKKSSKFLPCIK-DFKCPRYSS--CLHVNCGGSDMYVKEKKTKELYEGDG 442
Query: 426 NTQG-PSNFGIVSD-RWAYSSTGVYVGNESSKYLAANQYGLNVSGAEYYKTARLAPQSLK 483
N +G + + + D W +SSTG ++ + + + + + ++ YK+AR+AP SL
Sbjct: 443 NVEGGAAKYFLKPDANWGFSSTGDFMDDNNFQNTRFTMFVPASNQSDLYKSARIAPVSLT 502
Query: 484 YYGLCMLKGSYTVKLHFAEIMFTNDQTYKSLGKRMFDVSIQGKQVLKDFDIMEEAGGVGI 543
Y+ C+ G+YT+ L FAEI FTND+ Y LG+R+FD+ IQ K V KDF+IM+EA G
Sbjct: 503 YFHACLENGNYTINLDFAEIRFTNDENYNRLGRRLFDIYIQEKLVAKDFNIMDEAKGAQT 562
Query: 544 GITREFKDVSVNGSTMEIHLYWAGKGTNAIPYRGVYGPLISAITVTPNFEV--DTGGGLS 601
I + V + I L WAGKGT IP RGVYGP+ISAI++ + + G+S
Sbjct: 563 PIIKPLT-AYVTNHFLTIRLSWAGKGTTRIPTRGVYGPIISAISIVSDSKPCERPKTGMS 621
Query: 602 AGAIVGIVAGSCAVVIILLFILWRLGYLGGKNVEDKELRGLDLQTGYFTLRQIKAATNNF 661
GA + I G+ ++I +L LW G L + K+ +L +G FTLRQIK AT++F
Sbjct: 622 PGAYIAIGIGAPCLIIFILGFLWICGCLPRCGRQRKDPYEEELPSGTFTLRQIKFATDDF 681
Query: 662 DAANKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLY 721
+ NKIGEGGFG V+KG L+DG V+AVKQLSSKS+QGNREF+NEIG IS LQH NLVKL+
Sbjct: 682 NPTNKIGEGGFGAVFKGVLADGRVVAVKQLSSKSRQGNREFLNEIGAISCLQHPNLVKLH 741
Query: 722 GCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRL 781
G C+E QLLL YEY+ENNSL+ ALF + + + +DW TR +IC IA+GLA+LHEES L
Sbjct: 742 GFCVERAQLLLAYEYMENNSLSSALFSPKHKQIPMDWPTRFKICCGIAKGLAFLHEESPL 801
Query: 782 KIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRGYLT 841
K VHRDIKATN+LLDKDL KISDFGLA+LDE+E THIST++AGT+GYMAPEYA+ GYLT
Sbjct: 802 KFVHRDIKATNILLDKDLTPKISDFGLARLDEEEKTHISTKVAGTIGYMAPEYALWGYLT 861
Query: 842 DKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGSNFSK 901
KADVYSFG++ LEIV+G +N+N+ + V LL++A E G+L+++VD L +
Sbjct: 862 FKADVYSFGVLVLEIVAGITNSNFMGAGDSVCLLEFANECVESGHLMQVVDERLRPEVDR 921
Query: 902 KEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTAV--QAPIIRRNSDSQDARFRAFEI 959
KEA ++ +AL+C++ SPT RP MS V+MLEG V P + RN+ D RF+AF+
Sbjct: 922 KEAEAVIKVALVCSSASPTDRPLMSEVVAMLEGLYPVPESTPGVSRNAG--DIRFKAFKD 979
Query: 960 LSQDSQTHVST 970
L + + + T
Sbjct: 980 LRRGMENNSKT 990
|
|
| TAIR|locus:2019317 AT1G29730 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1087 (387.7 bits), Expect = 1.8e-209, Sum P(2) = 1.8e-209
Identities = 214/347 (61%), Positives = 263/347 (75%)
Query: 630 GGKNVEDKELRGLDLQTGYFTLRQIKAATNNFDAANKIGEGGFGPVYKGTLSDGAVIAVK 689
GG + +L+G DL+TG F+LRQ+K ATN+FD NKIGEGGFG VYKG L DG +IAVK
Sbjct: 609 GGMKKKISKLKGPDLRTGSFSLRQLKVATNDFDPLNKIGEGGFGSVYKGRLPDGTLIAVK 668
Query: 690 QLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGK 749
+LSSKS QGN+EFVNEIGMI+ LQH NLVKLYGCC+E NQLLLVYEYLENN L+ ALF
Sbjct: 669 KLSSKSHQGNKEFVNEIGMIACLQHPNLVKLYGCCVEKNQLLLVYEYLENNCLSDALFAG 728
Query: 750 EGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLA 809
CL L+W TR +IC IARGLA+LHE+S +KI+HRDIK TNVLLDKDLN+KISDFGLA
Sbjct: 729 RS-CLKLEWGTRHKICLGIARGLAFLHEDSAVKIIHRDIKGTNVLLDKDLNSKISDFGLA 787
Query: 810 KLDEDENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKE 869
+L ED +HI+TR+AGT+GYMAPEYAMRG+LT+KADVYSFG+VA+EIVSGKSN Y P +
Sbjct: 788 RLHEDNQSHITTRVAGTIGYMAPEYAMRGHLTEKADVYSFGVVAMEIVSGKSNAKYTPDD 847
Query: 870 EF-VYLLDWAYVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSA 928
E V LLDWA+VLQ++G++ E++DP L F EA M+ ++LLC N S TLRP MS
Sbjct: 848 ECCVGLLDWAFVLQKKGDIAEILDPRLEGMFDVMEAERMIKVSLLCANKSSTLRPNMSQV 907
Query: 929 VSMLEGKTAVQAPIIRRNSDSQDARFRAFEILSQDSQTHVSTLSQES 975
V MLEG+T ++ I S + F+ LS D + + S+ +
Sbjct: 908 VKMLEGETEIEQIISDPGVYSDNLHFKPSS-LSSDYILSIPSSSESA 953
|
|
| TAIR|locus:2019367 AT1G29740 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2017 (715.1 bits), Expect = 1.4e-208, P = 1.4e-208
Identities = 442/959 (46%), Positives = 597/959 (62%)
Query: 24 SHAQRLPDDEVQTLQSIFRKLNFRNGQVNQTSCTEGSWNVTIDD-SNGSNFT--CDCTYS 80
S + L DEV+ L+ I L ++ +++ C + +T D G N T CDC ++
Sbjct: 34 SASPSLHPDEVEALKDIALTLGVKHLNLSEDPCLTKTLVITQDVLKEGQNSTIRCDCHFN 93
Query: 81 NNTVCHVTVILLKGFNLAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLI 140
NN CH+T +LK F+L G +P EF L +L+ +DL RNY GS+P +A L L + +
Sbjct: 94 NNNTCHITHFVLKTFSLPGRLPPEFSKLRYLEFIDLCRNYLYGSIPMEWASLPYLKSISV 153
Query: 141 LGNRLSGSIPLEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPES 200
NRL+G IP +G L +L LE NQ G +P+ LGNL +L + SSN G +P++
Sbjct: 154 CANRLTGDIPKGLGKFINLTQLGLEANQFSGTIPKELGNLVNLEGLAFSSNQLVGGVPKT 213
Query: 201 YGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRI 260
LK LT R + L G IP FIGN +KL RL+L + L+ PIP +I +L+NL +LRI
Sbjct: 214 LARLKKLTNLRFSDNRLNGSIPEFIGNLSKLQRLELYASGLKDPIPYSIFRLENLIDLRI 273
Query: 261 SDLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGI 320
SD P L K ++ L+LRN +TG IP + D+ +L LDLSFN+LTG VP
Sbjct: 274 SDTAAGLGQVP-LITSKSLKFLVLRNMNLTGPIPTSLWDLPNLMTLDLSFNRLTGEVPAD 332
Query: 321 LQNLKKIDYIFLTNNSLSGTLPDW-ILTSEKNLDLSYNNFTESSPATCRESRVNILXXXX 379
K Y +L N LSG + LT+ N+DLSYNNFT S +C+E R NI
Sbjct: 333 ASAPK---YTYLAGNMLSGKVESGPFLTASTNIDLSYNNFTWSQ--SCKE-RNNINTYAS 386
Query: 380 XXXXXXXXWCLKKDLPCP--KEAKHY--SLFINCGGSPTEFEEND----YEEDLNTQGPS 431
L + LPC ++Y SL INCGG E + YE D S
Sbjct: 387 SRSTNS----LTRLLPCSAINLCQNYNRSLHINCGGPDVTIENSRGRFLYEGDNYGLTGS 442
Query: 432 NFGIVSDRWAYSSTGVYVGNESSK--YLAANQYGLNVSGAEYYKTARLAPQSLKYYGLCM 489
W +S+TG ++ + ++ Y +++ ++ + Y+ AR +P SL Y+ +C
Sbjct: 443 ATNYYGKNWGFSNTGDFMDDAITEDTYTVSSESAVSAKYPDLYQNARRSPLSLAYFAICF 502
Query: 490 LKGSYTVKLHFAEIMFTNDQTYKSLGKRMFDVSIQGKQVLKDFDIMEEAGGVGIGITREF 549
GSY VKLHFAEI F++++ + L KR+F++ +QGK + +DF I EEA G + +E
Sbjct: 503 ENGSYNVKLHFAEIQFSDEEPFSRLAKRVFNIYVQGKLIWEDFSIREEANGTHKEVIKEV 562
Query: 550 KDVSVNGSTMEIHLYWAGKGTNAIPYRGVYGPLISAITVTPNFEVDTGGGLSAGAIVG-- 607
+ +V +T+EI LYWAGKGT IP RG YG LISAI+V P+ E + G + +
Sbjct: 563 -NTTVTDNTLEIRLYWAGKGTTIIPKRGNYGSLISAISVCPSSESECGVPVQIHPVTKQQ 621
Query: 608 -------IVAGSCAVVIILLFILWRLGYLGGK---NVEDKELRGLDLQTGYFTLRQIKAA 657
++ G A+++ L F++ LG L + + D E RG F+LRQ+K A
Sbjct: 622 HKQRKYHLILGIAALIVSLSFLI--LGALYWRICVSNADGEKRGS------FSLRQLKVA 673
Query: 658 TNNFDAANKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNL 717
T++F+ NKIGEGGFG VYKG L +G +IAVK+LSSKS QGN+EF+NEIG+I+ LQH NL
Sbjct: 674 TDDFNPLNKIGEGGFGSVYKGRLPNGTLIAVKKLSSKSCQGNKEFINEIGIIACLQHPNL 733
Query: 718 VKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHE 777
VKLYGCC+E QLLLVYEYLENN LA ALFG+ G L LDW TR +IC IARGLA+LHE
Sbjct: 734 VKLYGCCVEKTQLLLVYEYLENNCLADALFGRSG--LKLDWRTRHKICLGIARGLAFLHE 791
Query: 778 ESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMR 837
+S +KI+HRDIK TN+LLDKDLN+KISDFGLA+L ED+ +HI+TR+AGT+GYMAPEYAMR
Sbjct: 792 DSAVKIIHRDIKGTNILLDKDLNSKISDFGLARLHEDDQSHITTRVAGTIGYMAPEYAMR 851
Query: 838 GYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEF-VYLLDWAYVLQEQGNLLELVDPSLG 896
G+LT+KADVYSFG+VA+EIVSGKSN NY P E V LLDWA+VLQ++G E++DP L
Sbjct: 852 GHLTEKADVYSFGVVAMEIVSGKSNANYTPDNECCVGLLDWAFVLQKKGAFDEILDPKLE 911
Query: 897 SNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTAVQAPIIRRNSDSQDARFR 955
F EA M+ ++LLC++ SPTLRPTMS V MLEG+T ++ I + + RF+
Sbjct: 912 GVFDVMEAERMIKVSLLCSSKSPTLRPTMSEVVKMLEGETEIEEIISDPGAYGDELRFK 970
|
|
| TAIR|locus:2205250 AT1G56130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1587 (563.7 bits), Expect = 5.0e-163, P = 5.0e-163
Identities = 363/873 (41%), Positives = 527/873 (60%)
Query: 83 TVCHVTVILLKGFN-LAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLIL 141
T+ ++T + L G N L G +P GNLT +Q + N +G +PK L +L L I
Sbjct: 121 TLTYLTNLNL-GQNVLTGSLPPAIGNLTRMQWMTFGINALSGPVPKEIGLLTDLRLLGIS 179
Query: 142 GNRLSGSIPLEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESY 201
N SGSIP EIG + L+++ ++ + L G +P + NL L + ++ T IP+
Sbjct: 180 SNNFSGSIPDEIGRCTKLQQMYIDSSGLSGRIPLSFANLVQLEQAWIADLEVTDQIPDFI 239
Query: 202 GNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTEL--R 259
G+ LT RI G+ L+G IP+ N T L L L S I +K+L+ L R
Sbjct: 240 GDWTKLTTLRIIGTGLSGPIPSSFSNLTSLTELRLGDISSGSSSLDFIKDMKSLSVLVLR 299
Query: 260 ISDLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPG 319
++L G+ S + + + ++ L + G IP + +++ L L L N L G P
Sbjct: 300 NNNLTGTIPS--TIGEHSSLRQVDLSFNKLHGPIPASLFNLSQLTHLFLGNNTLNGSFPT 357
Query: 320 I-LQNLKKIDYIFLTNNSLSGTLPDWILTSEKNLDLSYNNFTESSPATCRESRVNILXXX 378
Q+L+ +D + N LSG+LP W+ L+L NNFT ++RV L
Sbjct: 358 QKTQSLRNVDVSY---NDLSGSLPSWVSLPSLKLNLVANNFTLEG----LDNRV--LPGL 408
Query: 379 XXXXXXXXXWCLKKDLPCPKEAKHYSLF-INCGGSPTEFEEND-YEEDLNTQGPSNFGI- 435
CL+K+ PC + YS F INCGG +E + GP++F +
Sbjct: 409 N---------CLQKNFPCNRGKGIYSDFSINCGGPEKRSVTGALFEREDEDFGPASFFVS 459
Query: 436 VSDRWAYSSTGVYVGNESSKYLAANQYG-LNVSGAEYYKTARLAPQSLKYYGLCMLKGSY 494
RWA SS G++ G+ ++ Y+A +Q +N +E +++ARL+ S++YYGL + G Y
Sbjct: 460 AGQRWAASSVGLFAGSSNNIYIATSQSQFVNTLDSELFQSARLSASSVRYYGLGLENGGY 519
Query: 495 TVKLHFAEIMF--TNDQTYKSLGKRMFDVSIQGKQVLKDFDIMEEAGGVGI-GITREFKD 551
TV L FAEI + T+K LG+R FD+ +QG+ V KDFD+ AG + + R +K
Sbjct: 520 TVTLQFAEIQILGSTSTTWKGLGRRRFDIYVQGRLVEKDFDVRRTAGDSTVRAVQRVYK- 578
Query: 552 VSVNGSTMEIHLYWAGKGTNAIPYRGVYGPLISAITVTPNF------EVDTGGGLSAGAI 605
+V+ + +E+HL+WAGKGT IP +G YGPLISA++ TP+F + + G G I
Sbjct: 579 ANVSENHLEVHLFWAGKGTCCIPIQGAYGPLISAVSATPDFTPTVANKPPSKGKNRTGTI 638
Query: 606 VGIVAGSCAVVIILLFILWRLGYLGGKNVEDKELRGLDLQTGYFTLRQIKAATNNFDAAN 665
VG++ G + I+ +++ + + +D+EL G+D++ FT ++K+AT +FD +N
Sbjct: 639 VGVIVGVGLLSILAGVVMFTIRKRRKRYTDDEELLGMDVKPYIFTYSELKSATQDFDPSN 698
Query: 666 KIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCI 725
K+GEGGFGPVYKG L+DG V+AVK LS S+QG +FV EI IS++ H+NLVKLYGCC
Sbjct: 699 KLGEGGFGPVYKGNLNDGRVVAVKLLSVGSRQGKGQFVAEIVAISSVLHRNLVKLYGCCF 758
Query: 726 EGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVH 785
EG +LVYEYL N SL +ALFG + L+LDW+TR IC +ARGL YLHEE+ ++IVH
Sbjct: 759 EGEHRMLVYEYLPNGSLDQALFGDK--TLHLDWSTRYEICLGVARGLVYLHEEASVRIVH 816
Query: 786 RDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRGYLTDKAD 845
RD+KA+N+LLD L +ISDFGLAKL +D+ THISTR+AGT+GY+APEYAMRG+LT+K D
Sbjct: 817 RDVKASNILLDSRLVPQISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTD 876
Query: 846 VYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGSNFSKKEAM 905
VY+FG+VALE+VSG+ N++ +EE YLL+WA+ L E+ +EL+D L ++F+ +EA
Sbjct: 877 VYAFGVVALELVSGRPNSDENLEEEKKYLLEWAWNLHEKSRDIELIDDKL-TDFNMEEAK 935
Query: 906 TMLNIALLCTNPSPTLRPTMSSAVSMLEGKTAV 938
M+ IALLCT S LRP MS V+ML G +
Sbjct: 936 RMIGIALLCTQTSHALRPPMSRVVAMLSGDVEI 968
|
|
| TAIR|locus:2205260 AT1G56120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1518 (539.4 bits), Expect = 1.0e-155, P = 1.0e-155
Identities = 348/867 (40%), Positives = 515/867 (59%)
Query: 94 GFN-LAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLE 152
G N L+G IP+E G LT L+ + +S N F+GSLP L ++ I + LSG IPL
Sbjct: 130 GINALSGPIPKEIGLLTDLRLLGISSNNFSGSLPAEIGSCTKLQQMYIDSSGLSGGIPLS 189
Query: 153 IGDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRI 212
+ LE + D +L G +P+ +G L + + +G IP S+ NL LTE R+
Sbjct: 190 FANFVELEVAWIMDVELTGRIPDFIGFWTKLTTLRILGTGLSGPIPSSFSNLIALTELRL 249
Query: 213 -DGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISDLKGSSSSFP 271
D SN + + +FI + L L L+ +L G IPSTI +L ++ +S K
Sbjct: 250 GDISNGSSSL-DFIKDMKSLSVLVLRNNNLTGTIPSTIGGYTSLQQVDLSFNKLHGPIPA 308
Query: 272 NLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIF 331
+L ++ ++ L L N + G +P ++ + L LD+S+N L+G +P + +L +
Sbjct: 309 SLFNLSRLTHLFLGNNTLNGSLPT-LKGQS-LSNLDVSYNDLSGSLPSWV-SLPDLKLNL 365
Query: 332 LTNN-SLSGTLPDWILTS----EKNLDLSYNN----FTESSPATCRESRVNILXXXXXXX 382
+ NN +L G L + +L+ +KN + + P+ S +N+
Sbjct: 366 VANNFTLEG-LDNRVLSGLHCLQKNFPCNRGEGICKCNKKIPSQIMFSMLNVQTYGQGSN 424
Query: 383 XXXXXWCLKKDLPCPKEAKHYSLFINCGGSPTEFEEND-YEEDLNTQGPSNFGI-VSDRW 440
C K Y+ INCGG +E++ GP++F + + RW
Sbjct: 425 VLLEKNCFKTF--AIDWCLDYNFSINCGGPEIRSVSGALFEKEDADLGPASFVVSAAKRW 482
Query: 441 AYSSTGVYVGNESSKYLAAN--QYGLNVSGAEYYKTARLAPQSLKYYGLCMLKGSYTVKL 498
A SS G + G+ ++ Y+A + Q+ +N +E +++ARL+ SL+YYGL + G YTV L
Sbjct: 483 AASSVGNFAGSSNNIYIATSLAQF-INTMDSELFQSARLSASSLRYYGLGLENGGYTVTL 541
Query: 499 HFAEIMFTNDQTYKSLGKRMFDVSIQGKQVLKDFDIMEEAGGVGI-GITREFKDVSVNGS 557
FAE+ ++K +G+R F++ +QG+ V KDFDI AGG + + RE+K +V+ +
Sbjct: 542 QFAEVQIEGSNSWKGIGRRRFNIYVQGRLVEKDFDIRRTAGGSSVRAVQREYK-TNVSEN 600
Query: 558 TMEIHLYWAGKGTNAIPYRGVYGPLISAITVTPNFEVDTGG-----GLS-AGAIVGIVAG 611
+E+HL+WAGKGT IP +G YGPLI+A++ TP+F G S G IVG++ G
Sbjct: 601 HLEVHLFWAGKGTCCIPIQGAYGPLIAAVSATPDFTPTVANRPPSKGKSRTGTIVGVIVG 660
Query: 612 SCAVVIILLFILWRLGYLGGKNVEDKELRGLDLQTGYFTLRQIKAATNNFDAANKIGEGG 671
+ I ++ + +D+E+ +D++ FT ++K AT +FD +NK+GEGG
Sbjct: 661 VGLLSIFAGVVILVIRKRRKPYTDDEEILSMDVKPYTFTYSELKNATQDFDLSNKLGEGG 720
Query: 672 FGPVYKGTLSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLL 731
FG VYKG L+DG +AVKQLS S+QG +FV EI IS++ H+NLVKLYGCC EG+ L
Sbjct: 721 FGAVYKGNLNDGREVAVKQLSIGSRQGKGQFVAEIIAISSVLHRNLVKLYGCCFEGDHRL 780
Query: 732 LVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKAT 791
LVYEYL N SL +ALFG + L+LDW+TR IC +ARGL YLHEE+ ++I+HRD+KA+
Sbjct: 781 LVYEYLPNGSLDQALFGDKS--LHLDWSTRYEICLGVARGLVYLHEEASVRIIHRDVKAS 838
Query: 792 NVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGI 851
N+LLD +L K+SDFGLAKL +D+ THISTR+AGT+GY+APEYAMRG+LT+K DVY+FG+
Sbjct: 839 NILLDSELVPKVSDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVYAFGV 898
Query: 852 VALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIA 911
VALE+VSG+ N++ +E YLL+WA+ L E+ +EL+D L S ++ +E M+ IA
Sbjct: 899 VALELVSGRKNSDENLEEGKKYLLEWAWNLHEKNRDVELIDDEL-SEYNMEEVKRMIGIA 957
Query: 912 LLCTNPSPTLRPTMSSAVSMLEGKTAV 938
LLCT S LRP MS V+ML G V
Sbjct: 958 LLCTQSSYALRPPMSRVVAMLSGDAEV 984
|
|
| TAIR|locus:2020417 AT1G17230 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 543 (196.2 bits), Expect = 3.9e-88, Sum P(2) = 3.9e-88
Identities = 123/312 (39%), Positives = 179/312 (57%)
Query: 649 FTLRQIKAATNNFDAANKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSK--QGNREFVNEI 706
FT + + AT NF +G G G VYK +S G VIAVK+L+S+ + + F EI
Sbjct: 787 FTYQGLVDATRNFSEDVVLGRGACGTVYKAEMSGGEVIAVKKLNSRGEGASSDNSFRAEI 846
Query: 707 GMISALQHQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICS 766
+ ++H+N+VKLYG C N LL+YEY+ SL L E CL LDW R RI
Sbjct: 847 STLGKIRHRNIVKLYGFCYHQNSNLLLYEYMSKGSLGEQLQRGEKNCL-LDWNARYRIAL 905
Query: 767 DIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGT 826
A GL YLH + R +IVHRDIK+ N+LLD+ A + DFGLAKL + + + +AG+
Sbjct: 906 GAAEGLCYLHHDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAKLIDLSYSKSMSAVAGS 965
Query: 827 VGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAY-VLQEQG 885
GY+APEYA +T+K D+YSFG+V LE+++GK +P E+ L++W ++
Sbjct: 966 YGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKPPV--QPLEQGGDLVNWVRRSIRNMI 1023
Query: 886 NLLELVDPSLGSNFSKK--EAMTMLNIALLCTNPSPTLRPTMSSAVSML---EGKTAVQA 940
+E+ D L +N + E +L IAL CT+ SP RPTM V+M+ G +++ +
Sbjct: 1024 PTIEMFDARLDTNDKRTVHEMSLVLKIALFCTSNSPASRPTMREVVAMITEARGSSSLSS 1083
Query: 941 PIIRRNSDSQDA 952
I + ++A
Sbjct: 1084 SSITSETPLEEA 1095
|
|
| TAIR|locus:2182870 EMS1 "EXCESS MICROSPOROCYTES1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 577 (208.2 bits), Expect = 2.2e-87, Sum P(2) = 2.2e-87
Identities = 126/284 (44%), Positives = 166/284 (58%)
Query: 651 LRQIKAATNNFDAANKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGNREFVNEIGMIS 710
L I AT++F N IG+GGFG VYK L +AVK+LS QGNREF+ E+ +
Sbjct: 907 LGDIVEATDHFSKKNIIGDGGFGTVYKACLPGEKTVAVKKLSEAKTQGNREFMAEMETLG 966
Query: 711 ALQHQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIAR 770
++H NLV L G C + LLVYEY+ N SL L + G LDW+ R +I AR
Sbjct: 967 KVKHPNLVSLLGYCSFSEEKLLVYEYMVNGSLDHWLRNQTGMLEVLDWSKRLKIAVGAAR 1026
Query: 771 GLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYM 830
GLA+LH I+HRDIKA+N+LLD D K++DFGLA+L +H+ST IAGT GY+
Sbjct: 1027 GLAFLHHGFIPHIIHRDIKASNILLDGDFEPKVADFGLARLISACESHVSTVIAGTFGYI 1086
Query: 831 APEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKE-EFVYLLDWAYVLQEQGNLLE 889
PEY T K DVYSFG++ LE+V+GK T KE E L+ WA QG ++
Sbjct: 1087 PPEYGQSARATTKGDVYSFGVILLELVTGKEPTGPDFKESEGGNLVGWAIQKINQGKAVD 1146
Query: 890 LVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933
++DP L S K + +L IA+LC +P RP M + L+
Sbjct: 1147 VIDPLLVSVALKNSQLRLLQIAMLCLAETPAKRPNMLDVLKALK 1190
|
|
| TAIR|locus:2017923 AT1G16670 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 857 (306.7 bits), Expect = 1.1e-85, P = 1.1e-85
Identities = 175/354 (49%), Positives = 235/354 (66%)
Query: 636 DKELRGLDLQTGYFTLRQIKAATNNFDAANKIGEGGFGPVYKGTLSDGAVIAVKQLSSKS 695
D E+ +D + R+I+ AT++F A NKIGEGGFG VYKG L DG + A+K LS++S
Sbjct: 17 DGEIAAID-NVKIYKYREIRQATDDFSAENKIGEGGFGSVYKGCLKDGKLAAIKVLSAES 75
Query: 696 KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYLENNSLARALF--GKEGQC 753
+QG +EF+ EI +IS +QH+NLVKLYGCC+EGN +LVY +LENNSL + L G
Sbjct: 76 RQGVKEFLTEINVISEIQHENLVKLYGCCVEGNHRILVYNFLENNSLDKTLLAGGYTRSG 135
Query: 754 LNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDE 813
+ DW++R IC +A+GLA+LHEE R I+HRDIKA+N+LLDK L+ KISDFGLA+L
Sbjct: 136 IQFDWSSRANICVGVAKGLAFLHEEVRPHIIHRDIKASNILLDKYLSPKISDFGLARLMP 195
Query: 814 DENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVY 873
TH+STR+AGT+GY+APEYA+RG LT KAD+YSFG++ +EIVSG+SN N R E+ Y
Sbjct: 196 PNMTHVSTRVAGTIGYLAPEYAVRGQLTRKADIYSFGVLLMEIVSGRSNKNTRLPTEYQY 255
Query: 874 LLDWAYVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933
LL+ A+ L E+ L++LVD L F +EA L I LLCT SP LRP+MS+ V +L
Sbjct: 256 LLERAWELYERNELVDLVDSGLNGVFDAEEACRYLKIGLLCTQDSPKLRPSMSTVVRLLT 315
Query: 934 GKTAVQAPIIRRN---SDSQDARFRAFEILSQDSQTHVSTLSQESEMQRTMSID 984
G+ + I R SD D + R + ++ Q + + S S D
Sbjct: 316 GEKDIDYKKISRPGLISDFMDLKVRG-PVATKTEQVNRQNYTNPSSSSNGSSRD 368
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| C0LGG9 | Y5344_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.6370 | 0.9911 | 0.9729 | yes | no |
| C0LGG8 | Y5343_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.6537 | 0.9744 | 0.9537 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 1016 | |||
| pfam11721 | 164 | pfam11721, Malectin, Di-glucose binding within end | 4e-54 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-53 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 9e-53 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-52 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 6e-51 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-50 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-46 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-46 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-46 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-44 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-42 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-38 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-37 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-36 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-36 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-36 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 7e-35 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 8e-35 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-34 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-34 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-34 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 5e-33 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 6e-33 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-32 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-30 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-30 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-30 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-30 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-29 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-29 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-29 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 6e-29 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 9e-29 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-28 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-28 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 5e-28 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 9e-28 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-27 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-27 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-27 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-27 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 6e-27 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 8e-27 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 9e-27 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-26 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-26 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-26 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-26 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-26 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-26 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-26 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 6e-26 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 8e-26 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 9e-26 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 9e-26 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-25 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-25 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-25 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 6e-25 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 8e-25 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 8e-25 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-24 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-24 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-24 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-24 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-24 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-24 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-24 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-24 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-24 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 5e-24 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 9e-24 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-23 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-23 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-23 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-23 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-23 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-23 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-23 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-23 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 4e-23 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 6e-23 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 6e-23 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 8e-23 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-22 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-22 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-22 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-22 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-22 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-22 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-22 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-22 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 5e-22 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 5e-22 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 6e-22 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 6e-22 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 8e-22 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 9e-22 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-21 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-21 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-21 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-21 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-21 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-21 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-21 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 5e-21 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 7e-21 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 9e-21 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 9e-21 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-20 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-20 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-20 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-20 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-20 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-20 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-20 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 4e-20 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 7e-20 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 7e-20 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 9e-20 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-19 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-19 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-19 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-19 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-19 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-19 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-19 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 4e-19 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-19 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-19 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-19 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 6e-19 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 6e-19 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 9e-19 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 9e-19 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-18 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-18 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-18 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-18 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-18 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-18 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-18 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-18 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-18 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 5e-18 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 6e-18 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 6e-18 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 7e-18 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 7e-18 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 7e-18 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 8e-18 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 8e-18 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 9e-18 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-17 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-17 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-17 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-17 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-17 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-17 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-17 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 5e-17 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 5e-17 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 7e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 9e-17 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 9e-17 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 9e-17 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-16 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-16 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-16 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-16 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-16 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-16 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-16 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 5e-16 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 7e-16 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 7e-16 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 7e-16 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 7e-16 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 9e-16 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-15 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-15 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-15 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 7e-15 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-14 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-14 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-14 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-14 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-14 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 5e-14 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 5e-14 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 6e-14 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 7e-14 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-13 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-13 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-13 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-13 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-13 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-13 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-13 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-13 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-13 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-13 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-13 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-13 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-13 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 5e-13 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 5e-13 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 6e-13 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 6e-13 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 6e-13 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 7e-13 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 8e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-12 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-12 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-12 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-12 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-12 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-12 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-12 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-12 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-12 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-12 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-12 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-12 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 6e-12 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 6e-12 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-11 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-11 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-11 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-11 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-11 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-11 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-11 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-11 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-11 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-11 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-11 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-11 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-11 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-11 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-11 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 6e-11 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 7e-11 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 7e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 8e-11 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-10 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-10 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-10 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-10 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-10 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-10 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 4e-10 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 5e-10 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 6e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-09 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-09 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-09 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-09 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-09 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-09 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-09 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-09 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-09 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-09 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-09 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-09 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 4e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 5e-09 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 5e-09 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 5e-09 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 6e-09 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 7e-09 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 8e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-08 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-08 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-08 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-08 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-08 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-08 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-08 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-08 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 5e-08 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 5e-08 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 7e-08 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 7e-08 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-07 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-07 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 4e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 5e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 6e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 8e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-06 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-06 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 4e-06 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-06 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 1e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-05 | |
| PLN03210 | 1153 | PLN03210, PLN03210, Resistant to P | 3e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-05 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 5e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 9e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-04 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 2e-04 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 4e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 6e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.001 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 0.001 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.002 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 0.002 | |
| PRK09605 | 535 | PRK09605, PRK09605, bifunctional UGMP family prote | 0.002 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 0.003 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 0.004 |
| >gnl|CDD|221187 pfam11721, Malectin, Di-glucose binding within endoplasmic reticulum | Back alignment and domain information |
|---|
Score = 185 bits (471), Expect = 4e-54
Identities = 85/186 (45%), Positives = 101/186 (54%), Gaps = 24/186 (12%)
Query: 403 YSLFINCGGS-PTEFEENDYEEDLNTQGPSNFGIVSDRWAYSSTGVYVGNESSKYLAANQ 461
L INCGG T+ + YE D G S VSD SS
Sbjct: 1 VVLAINCGGPEHTDSDGITYEADTYFTGGSADYYVSDTNGSSSI---------------- 44
Query: 462 YGLNVSGAEYYKTARLAPQSLKYYGLCMLKGSYTVKLHFAEIMFTNDQTYKSLGKRMFDV 521
+ E Y+T R +P S YY C+ G+YTV LHFAEI F D LG+R+FDV
Sbjct: 45 --AGTTDPELYQTERYSPSSFSYYIPCLENGNYTVILHFAEIYFGED----GLGRRVFDV 98
Query: 522 SIQGKQVLKDFDIMEEAGGVGIGITREFKDVSVNGSTMEIHLYWAGKGTNAIPYRGVYG- 580
+QGK VLKDFDI+ EAGG G +E+ V+V T+EIH YWAGKGT IP+RGVYG
Sbjct: 99 YVQGKLVLKDFDIVAEAGGKGKTAHKEYIPVTVTDGTLEIHFYWAGKGTLLIPFRGVYGN 158
Query: 581 PLISAI 586
P ISAI
Sbjct: 159 PKISAI 164
|
Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan. It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan. Length = 164 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 185 bits (473), Expect = 5e-53
Identities = 90/278 (32%), Positives = 130/278 (46%), Gaps = 36/278 (12%)
Query: 666 KIGEGGFGPVYKGTLSDG-----AVIAVKQL-SSKSKQGNREFVNEIGMISALQHQNLVK 719
K+GEG FG VYKGTL +AVK L S+Q EF+ E ++ L H N+VK
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 720 LYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEES 779
L G C E L++V EY+ L L ++ + L + IARG+ YL
Sbjct: 66 LLGVCTEEEPLMIVMEYMPGGDLLDYL--RKNRPKELSLSDLLSFALQIARGMEYLE--- 120
Query: 780 RLKIVHRDIKATNVLLDKDLNAKISDFGLAKL--DEDENTHISTRIAGTVGYMAPEYAMR 837
+HRD+ A N L+ ++L KISDFGL++ D+D ++ + +MAPE
Sbjct: 121 SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL--PIRWMAPESLKE 178
Query: 838 GYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWAYVLQ--EQGNLLELVDPS 894
G T K+DV+SFG++ EI + G+ P + A VL+ ++G L P
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFTLGEE-----PYPG----MSNAEVLEYLKKGYRLPK--PP 227
Query: 895 LGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSML 932
+ + L C P RPT S V +L
Sbjct: 228 NCPPE-------LYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 185 bits (471), Expect = 9e-53
Identities = 89/278 (32%), Positives = 126/278 (45%), Gaps = 37/278 (13%)
Query: 666 KIGEGGFGPVYKGTLSD-----GAVIAVKQL-SSKSKQGNREFVNEIGMISALQHQNLVK 719
K+GEG FG VYKG L +AVK L S+Q EF+ E ++ L H N+VK
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65
Query: 720 LYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEES 779
L G C E L +V EY+E L L L + IARG+ YL
Sbjct: 66 LLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRP---KLSLSDLLSFALQIARGMEYLE--- 119
Query: 780 RLKIVHRDIKATNVLLDKDLNAKISDFGLAKL--DEDENTHISTRIAGTVGYMAPEYAMR 837
+HRD+ A N L+ ++L KISDFGL++ D+D ++ + +MAPE
Sbjct: 120 SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKL--PIRWMAPESLKE 177
Query: 838 GYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWAYVLQ--EQGNLLELVDPS 894
G T K+DV+SFG++ EI + G+ P + VL+ + G L
Sbjct: 178 GKFTSKSDVWSFGVLLWEIFTLGEQ-----PYPG----MSNEEVLEYLKNGYRLPQPP-- 226
Query: 895 LGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSML 932
N + + ++ L C P RPT S V +L
Sbjct: 227 ---NCPPE----LYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 184 bits (469), Expect = 2e-52
Identities = 91/284 (32%), Positives = 129/284 (45%), Gaps = 37/284 (13%)
Query: 665 NKIGEGGFGPVYKGTLSDGA----VIAVKQL-SSKSKQGNREFVNEIGMISALQHQNLVK 719
K+GEG FG VYKG L +AVK L S++ ++F+ E ++ L H N+V+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 720 LYGCCIEGNQLLLVYEYLENNSL------ARALFGKEGQCLNLDWATRKRICSDIARGLA 773
L G C E L LV EY+E L +R +F + L IA+G+
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEK-STLSLKDLLSFAIQIAKGME 119
Query: 774 YLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGT-VGYMAP 832
YL K VHRD+ A N L+ +DL KISDFGL++ D++ + + +MAP
Sbjct: 120 YLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAP 176
Query: 833 EYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWAYVLQ--EQGNLLE 889
E G T K+DV+SFG++ EI + G + P L VL+ +G L
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFTLGAT-----PYPG----LSNEEVLEYLRKGYRLP 227
Query: 890 LVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933
P + + + L C P RPT S V LE
Sbjct: 228 --KPEYCPD-------ELYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 178 bits (453), Expect = 6e-51
Identities = 75/194 (38%), Positives = 102/194 (52%), Gaps = 11/194 (5%)
Query: 667 IGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNRE-FVNEIGMISALQHQNLVKLYGCC 724
+GEGGFG VY G +A+K + + E + EI ++ L H N+VKLYG
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 725 IEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIV 784
+ N L LV EY E SL L EG L RI I GL YLH I+
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEG---KLSEDEILRILLQILEGLEYLHSN---GII 114
Query: 785 HRDIKATNVLLDKD-LNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPE-YAMRGYLTD 842
HRD+K N+LLD D K++DFGL+KL + + I GT YMAPE +GY ++
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKL-LTSDKSLLKTIVGTPAYMAPEVLLGKGYYSE 173
Query: 843 KADVYSFGIVALEI 856
K+D++S G++ E+
Sbjct: 174 KSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 178 bits (453), Expect = 2e-50
Identities = 71/199 (35%), Positives = 108/199 (54%), Gaps = 11/199 (5%)
Query: 665 NKIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNRE-FVNEIGMISALQHQNLVKLYG 722
K+GEG FG VY G ++A+K + K + +RE + EI ++ L+H N+V+LY
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 723 CCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLK 782
+ ++L LV EY E L L K+ L+ D A + I L YLH
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLL--KKRGRLSEDEA--RFYLRQILSALEYLHS---KG 117
Query: 783 IVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRGYLTD 842
IVHRD+K N+LLD+D + K++DFGLA+ D ++T + GT YMAPE +
Sbjct: 118 IVHRDLKPENILLDEDGHVKLADFGLARQ-LDPGEKLTTFV-GTPEYMAPEVLLGKGYGK 175
Query: 843 KADVYSFGIVALEIVSGKS 861
D++S G++ E+++GK
Sbjct: 176 AVDIWSLGVILYELLTGKP 194
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 167 bits (426), Expect = 1e-46
Identities = 93/284 (32%), Positives = 128/284 (45%), Gaps = 48/284 (16%)
Query: 666 KIGEGGFGPVYKGTL-----SDGAVIAVKQL-SSKSKQGNREFVNEIGMISALQHQNLVK 719
K+GEG FG VYKGTL +AVK L S++ EF+ E ++ L H N+V+
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 720 LYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEES 779
L G C +G L +V EY+ L K G+ L L ++ IA+G+ YL
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDL-LDFLRKHGEKLTLKD--LLQMALQIAKGMEYLES-- 120
Query: 780 RLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGT-VGYMAPEYAMRG 838
VHRD+ A N L+ ++L KISDFGL++ +++ + + +MAPE G
Sbjct: 121 -KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDG 179
Query: 839 YLTDKADVYSFGIVALEIVS-------GKSNTNYRPKEEFVYLLDWAYVLQEQGNLL--- 888
T K+DV+SFG++ EI + G SN EE + LL E G L
Sbjct: 180 KFTSKSDVWSFGVLLWEIFTLGEQPYPGMSN------EEVLELL-------EDGYRLPRP 226
Query: 889 ELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSML 932
E L E M C P RPT S V L
Sbjct: 227 ENCPDEL------YELMLQ------CWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 166 bits (423), Expect = 2e-46
Identities = 73/199 (36%), Positives = 104/199 (52%), Gaps = 12/199 (6%)
Query: 666 KIGEGGFGPVYKGT-LSDGAVIAVKQL--SSKSKQGNREFVNEIGMISALQHQNLVKLYG 722
K+G G FG VYK G ++AVK L S+ + ++ EI ++ L H N+V+L
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 723 CCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLK 782
+ + L LV EY E L L + G L K+I I RGL YLH
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYLS-RGG---PLSEDEAKKIALQILRGLEYLHSNG--- 118
Query: 783 IVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPE-YAMRGYLT 841
I+HRD+K N+LLD++ KI+DFGLAK ++ ++T GT YMAPE
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT-FVGTPWYMAPEVLLGGNGYG 177
Query: 842 DKADVYSFGIVALEIVSGK 860
K DV+S G++ E+++GK
Sbjct: 178 PKVDVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 166 bits (423), Expect = 3e-46
Identities = 75/204 (36%), Positives = 103/204 (50%), Gaps = 17/204 (8%)
Query: 665 NKIGEGGFGPVYKGTLSD-GAVIAVKQ--LSSKSKQGNREFVNEIGMISALQHQNLVKLY 721
+G G FG VY D G ++AVK LS S++ EI ++S+LQH N+V+ Y
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 722 GCCI--EGNQLLLVYEYLENNSLARAL--FGKEGQCLNLDWATRKRICSDIARGLAYLHE 777
G E N L + EY+ SL+ L FGK L ++ I GLAYLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGK------LPEPVIRKYTRQILEGLAYLHS 119
Query: 778 ESRLKIVHRDIKATNVLLDKDLNAKISDFGLAK-LDEDENTHISTRIAGTVGYMAPEYAM 836
IVHRDIK N+L+D D K++DFG AK L + E + + GT +MAPE
Sbjct: 120 N---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176
Query: 837 RGYLTDKADVYSFGIVALEIVSGK 860
AD++S G +E+ +GK
Sbjct: 177 GEEYGRAADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 3e-44
Identities = 86/266 (32%), Positives = 124/266 (46%), Gaps = 25/266 (9%)
Query: 661 FDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVK 719
F+ KIG+GGFG VYK G +A+K + +SK+ + +NEI ++ +H N+VK
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 720 LYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDW-ATRKRICSDIARGLAYLHEE 778
YG ++ ++L +V E+ SL L Q L A +C ++ +GL YLH
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLLKST-NQTLTESQIAY---VCKELLKGLEYLHSN 117
Query: 779 SRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRG 838
I+HRDIKA N+LL D K+ DFGL+ + +T + GT +MAPE
Sbjct: 118 ---GIIHRDIKAANILLTSDGEVKLIDFGLSA--QLSDTKARNTMVGTPYWMAPEVINGK 172
Query: 839 YLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGSN 898
KAD++S GI A+E+ GK P E + A L +P S
Sbjct: 173 PYDYKADIWSLGITAIELAEGKP-----PYSELPPMK--ALFKIATNGPPGLRNPEKWS- 224
Query: 899 FSKKEAMTMLNIALLCTNPSPTLRPT 924
E L C +P RPT
Sbjct: 225 ---DEFKDFLK---KCLQKNPEKRPT 244
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 168 bits (426), Expect = 2e-42
Identities = 130/402 (32%), Positives = 190/402 (47%), Gaps = 51/402 (12%)
Query: 10 VLGFLVLNCFANFG-SHAQRLPDDEVQTLQSIFRKLNFRNGQVNQTSCTEGSWNVTIDDS 68
L F++ F NF HA +E++ L L+F++ +N +WN + D
Sbjct: 11 YLIFMLFFLFLNFSMLHA-----EELELL------LSFKS-SINDPLKYLSNWNSSADVC 58
Query: 69 NGSNFTCDCTYSNNTVCHVTVILLKGFNLAGVIPEEFGNLTFLQEVDLSRNY-------- 120
TC N V I L G N++G I L ++Q ++LS N
Sbjct: 59 LWQGITC------NNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDD 112
Query: 121 -----------------FNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGDISTLEELV 163
F GS+P+ + NL L + N LSG IP +IG S+L+ L
Sbjct: 113 IFTTSSSLRYLNLSNNNFTGSIPRGS--IPNLETLDLSNNMLSGEIPNDIGSFSSLKVLD 170
Query: 164 LEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIPN 223
L N LVG +P +L NL SL + L+SN G IP G +K+L + +NL+G IP
Sbjct: 171 LGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPY 230
Query: 224 FIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISDLKGSSSSFPNLQDMKKMERLI 283
IG T L+ LDL +L GPIPS++ LKNL L + K S P++ ++K+ L
Sbjct: 231 EIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLD 290
Query: 284 LRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGTLPD 343
L + ++G IPE + + +L+IL L N TG +P L +L ++ + L +N SG +P
Sbjct: 291 LSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPK 350
Query: 344 WILTSEKN---LDLSYNNFTESSPAT-CRESRVNILSSFSST 381
L N LDLS NN T P C + L FS++
Sbjct: 351 -NLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNS 391
|
Length = 968 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 1e-38
Identities = 71/210 (33%), Positives = 110/210 (52%), Gaps = 23/210 (10%)
Query: 660 NFDAANKIGEGGFGPVYKG-TLSDGAVIAVKQLS--SKSKQGNREFVNEIGMISALQHQN 716
N+ + IG G FG VYKG L G +A+KQ+S ++ + + EI ++ L+H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 717 LVKLYGCCIEGNQLLLVYEYLENNSLARAL--FGK--EGQCLNLDWATRKRICSDIARGL 772
+VK G + L ++ EY EN SL + + FG E + +GL
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLV--------AVYVYQVLQGL 112
Query: 773 AYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLA-KLDEDENTHISTRIAGTVGYMA 831
AYLHE+ ++HRDIKA N+L KD K++DFG+A KL++ + GT +MA
Sbjct: 113 AYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--DASVVGTPYWMA 167
Query: 832 PE-YAMRGYLTDKADVYSFGIVALEIVSGK 860
PE M G + +D++S G +E+++G
Sbjct: 168 PEVIEMSG-ASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 4e-37
Identities = 103/303 (33%), Positives = 147/303 (48%), Gaps = 27/303 (8%)
Query: 96 NLAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGD 155
NL G IP GNL LQ + L +N +G +P S LQ L L + N LSG IP +
Sbjct: 247 NLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQ 306
Query: 156 ISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGS 215
+ LE L L N G +P L +L L+ + L SN F+G IP++ G NLT + +
Sbjct: 307 LQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTN 366
Query: 216 NLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISD--LKGS-SSSFPN 272
NLTG IP + + L +L L SLEG IP ++ ++L +R+ D G S F
Sbjct: 367 NLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTK 426
Query: 273 LQ---------------------DMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFN 311
L DM ++ L L G +P+ L+ LDLS N
Sbjct: 427 LPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS-KRLENLDLSRN 485
Query: 312 QLTGPVPGILQNLKKIDYIFLTNNSLSGTLPDWILTSEK--NLDLSYNNFTESSPATCRE 369
Q +G VP L +L ++ + L+ N LSG +PD + + +K +LDLS+N + PA+ E
Sbjct: 486 QFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSE 545
Query: 370 SRV 372
V
Sbjct: 546 MPV 548
|
Length = 968 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 139 bits (351), Expect = 1e-36
Identities = 73/192 (38%), Positives = 102/192 (53%), Gaps = 11/192 (5%)
Query: 667 IGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIE 726
IG+G FG V G G +AVK L S F+ E +++ L+H NLV+L G ++
Sbjct: 14 IGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQ-AFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 727 GNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHR 786
GN L +V EY+ SL L + + L A + D+ G+ YL E+ VHR
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLRSRGRAVITL--AQQLGFALDVCEGMEYLEEK---NFVHR 126
Query: 787 DIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRGYLTDKADV 846
D+ A NVL+ +DL AK+SDFGLAK E S ++ V + APE + K+DV
Sbjct: 127 DLAARNVLVSEDLVAKVSDFGLAK--EASQGQDSGKLP--VKWTAPEALREKKFSTKSDV 182
Query: 847 YSFGIVALEIVS 858
+SFGI+ EI S
Sbjct: 183 WSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 138 bits (351), Expect = 1e-36
Identities = 69/202 (34%), Positives = 103/202 (50%), Gaps = 12/202 (5%)
Query: 661 FDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVK 719
FD K+GEG +G VYK G V+A+K + + +E + EI ++ +VK
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYIVK 62
Query: 720 LYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEES 779
YG + L +V EY S++ + + L I +GL YLH
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSDIM---KITNKTLTEEEIAAILYQTLKGLEYLH--- 116
Query: 780 RLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMR-G 838
K +HRDIKA N+LL+++ AK++DFG++ D +T I GT +MAPE G
Sbjct: 117 SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI-GTPFWMAPEVIQEIG 175
Query: 839 YLTDKADVYSFGIVALEIVSGK 860
Y +KAD++S GI A+E+ GK
Sbjct: 176 Y-NNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 2e-36
Identities = 68/211 (32%), Positives = 111/211 (52%), Gaps = 25/211 (11%)
Query: 658 TNNFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQ--LSSKSKQGNREFVNEIGMISALQH 714
+ KIGEG G VYK T + G +A+K+ L ++K+ +NEI ++ +H
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELI---INEILIMKDCKH 74
Query: 715 QNLVKLYGCCIEGNQLLLVYEYLENNSLARALFG-----KEGQCLNLDWATRKRICSDIA 769
N+V Y + G++L +V EY++ SL + E Q +C ++
Sbjct: 75 PNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQI--------AYVCREVL 126
Query: 770 RGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGL-AKLDEDENTHISTRIAGTVG 828
+GL YLH ++HRDIK+ N+LL KD + K++DFG A+L ++++ S + GT
Sbjct: 127 QGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VVGTPY 181
Query: 829 YMAPEYAMRGYLTDKADVYSFGIVALEIVSG 859
+MAPE R K D++S GI+ +E+ G
Sbjct: 182 WMAPEVIKRKDYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 7e-35
Identities = 67/199 (33%), Positives = 107/199 (53%), Gaps = 8/199 (4%)
Query: 661 FDAANKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKL 720
F K+G G FG V++G + +A+K L S ++F E+ + L+H++L+ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 721 YGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESR 780
+ C G + ++ E +E SL L EGQ L A+ + +A G+AYL E+
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQ--VLPVASLIDMACQVAEGMAYLEEQ-- 123
Query: 781 LKIVHRDIKATNVLLDKDLNAKISDFGLAKL-DEDENTHISTRIAGTVGYMAPEYAMRGY 839
+HRD+ A N+L+ +DL K++DFGLA+L ED +I + APE A G
Sbjct: 124 -NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIP--YKWTAPEAASHGT 180
Query: 840 LTDKADVYSFGIVALEIVS 858
+ K+DV+SFGI+ E+ +
Sbjct: 181 FSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 8e-35
Identities = 78/202 (38%), Positives = 109/202 (53%), Gaps = 24/202 (11%)
Query: 666 KIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGN---REFVNEIGMISALQHQNLVKLYG 722
K+G G FG V+ GT + +AVK L K G F+ E ++ L+H LV+LY
Sbjct: 13 KLGAGQFGEVWMGTWNGTTKVAVKTL----KPGTMSPEAFLQEAQIMKKLRHDKLVQLYA 68
Query: 723 CCIEGNQLLLVYEYLENNSLARALFGKEGQCLNL----DWATRKRICSDIARGLAYLHEE 778
C E + +V EY+ SL L EG+ L L D A + IA G+AYL E
Sbjct: 69 VCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQ------IAEGMAYL--E 120
Query: 779 SRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDE--NTHISTRIAGTVGYMAPEYAM 836
SR +HRD+ A N+L+ ++L KI+DFGLA+L ED+ + + + APE A
Sbjct: 121 SR-NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFP--IKWTAPEAAN 177
Query: 837 RGYLTDKADVYSFGIVALEIVS 858
G T K+DV+SFGI+ EIV+
Sbjct: 178 YGRFTIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 72/216 (33%), Positives = 103/216 (47%), Gaps = 21/216 (9%)
Query: 665 NKIGEGGFGPVYKG-TLSDGAVIAVKQLSSKSKQGN--REFVNEIGMISALQHQNLVKLY 721
NKIG G FG VY L G ++AVK++ + +E +E+ ++ L+H NLVK Y
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 722 GCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRL 781
G + ++ + EY +L L + G+ LD + + GLAYLH
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELL--EHGR--ILDEHVIRVYTLQLLEGLAYLHSH--- 118
Query: 782 KIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVG---YMAPEYAMRG 838
IVHRDIK N+ LD + K+ DFG A ++ T + + G YMAPE G
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGG 178
Query: 839 YLTDK---ADVYSFGIVALEIVSGKSNTNYRPKEEF 871
AD++S G V LE+ +GK RP E
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGK-----RPWSEL 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 2e-34
Identities = 82/291 (28%), Positives = 130/291 (44%), Gaps = 52/291 (17%)
Query: 667 IGEGGFGPVYKG---TLSDGAV---IAVKQLSSKSKQGNR-EFVNEIGMISALQHQNLVK 719
+G+G FG VY+G + G +A+K ++ + R EF+NE ++ ++V+
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 720 LYGCCIEGNQLLLVYEYLENNSLA---RALFGKEGQCLNLDWATRKRI---CSDIARGLA 773
L G G L+V E + L R+ + L T ++ ++IA G+A
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 774 YLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGT----VGY 829
YL K VHRD+ A N ++ +DL KI DFG+ + D R G V +
Sbjct: 134 YLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTR---DIYETDYYRKGGKGLLPVRW 187
Query: 830 MAPEYAMRGYLTDKADVYSFGIVALEIVS-------GKSNTNYRPKEEFVYLLDWAYVLQ 882
MAPE G T K+DV+SFG+V E+ + G SN +E +++D
Sbjct: 188 MAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN-----EEVLKFVID------ 236
Query: 883 EQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933
G L+L P + +L + +C +P +RPT VS L+
Sbjct: 237 --GGHLDL--PENCPDK-------LLELMRMCWQYNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 75/272 (27%), Positives = 126/272 (46%), Gaps = 17/272 (6%)
Query: 665 NKIGEGGFGPVYKGTL-----SDGAVIAVKQLS-SKSKQGNREFVNEIGMISALQHQNLV 718
++GEG FG V + G +AVK L+ S +Q +F EI ++ L H+N+V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 719 KLYGCCIE--GNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLH 776
K G C + G L L+ EYL + SL L + ++ S I +G+ YL
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYL---QRHRDQINLKRLLLFSSQICKGMDYLG 126
Query: 777 EESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGT--VGYMAPEY 834
+ + +HRD+ A N+L++ + KISDFGLAK+ ++ + + G + + APE
Sbjct: 127 SQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPEC 183
Query: 835 AMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPS 894
+ +DV+SFG+ E+ + + + P EF+ ++ A LLEL+
Sbjct: 184 LRTSKFSSASDVWSFGVTLYELFT-YGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEG 242
Query: 895 LGSNFSKKEAMTMLNIALLCTNPSPTLRPTMS 926
+ ++ LC P RP+ +
Sbjct: 243 ERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFA 274
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 5e-33
Identities = 71/216 (32%), Positives = 107/216 (49%), Gaps = 28/216 (12%)
Query: 667 IGEGGFGPVYKGTLS------DGAVIAVKQLS-SKSKQGNREFVNEIGMISALQHQNLVK 719
+GEG FG V+ G D ++AVK L + S ++F E +++ QH+N+VK
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 720 LYGCCIEGNQLLLVYEYLENNSL----------ARALFGKEGQCLNLDWATRKRICSDIA 769
YG C EG+ ++V+EY+E+ L A L + L + +I IA
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 770 RGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGT--- 826
G+ YL + VHRD+ N L+ DL KI DFG+++ D T R+ G
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR---DVYTTDYYRVGGHTML 186
Query: 827 -VGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GK 860
+ +M PE M T ++DV+SFG+V EI + GK
Sbjct: 187 PIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGK 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 128 bits (322), Expect = 6e-33
Identities = 74/206 (35%), Positives = 115/206 (55%), Gaps = 13/206 (6%)
Query: 660 NFDAANKIGEGGFGPVYKGTL-SDGAVIAVKQ--LSSKSKQGNREFVNEIGMISALQHQN 716
+F+ NKIG+G FG V+K +D V A+KQ LS +++ E ++E +++ L
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 717 LVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCL--NLDWATRKRICSDIARGLAY 774
+++ Y ++ +L +V EY EN L + L + G+ L + W R I GLA+
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVW----RFFIQILLGLAH 116
Query: 775 LHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEY 834
LH + KI+HRDIK+ N+ LD N KI D G+AKL D NT+ + I GT Y++PE
Sbjct: 117 LHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD-NTNFANTIVGTPYYLSPEL 172
Query: 835 AMRGYLTDKADVYSFGIVALEIVSGK 860
+K+DV++ G+V E +GK
Sbjct: 173 CEDKPYNEKSDVWALGVVLYECCTGK 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 1e-32
Identities = 88/282 (31%), Positives = 130/282 (46%), Gaps = 26/282 (9%)
Query: 96 NLAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGD 155
NL+G IP E G LT L +DL N G +P S L+NL L + N+LSG IP I
Sbjct: 223 NLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFS 282
Query: 156 ISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGS 215
+ L L L DN L G +PE + L++L + L SNNFTG IP + +L L ++ +
Sbjct: 283 LQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSN 342
Query: 216 NLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISDLKGSSSSFPNLQD 275
+G IP +G L LDL +L G IP + NL
Sbjct: 343 KFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLF------------------- 383
Query: 276 MKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNN 335
+LIL + + G IP+ + L+ + L N +G +P L + ++ ++NN
Sbjct: 384 -----KLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNN 438
Query: 336 SLSGTLPD--WILTSEKNLDLSYNNFTESSPATCRESRVNIL 375
+L G + W + S + L L+ N F P + R+ L
Sbjct: 439 NLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENL 480
|
Length = 968 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 121 bits (307), Expect = 1e-30
Identities = 81/284 (28%), Positives = 127/284 (44%), Gaps = 51/284 (17%)
Query: 665 NKIGEGGFGPVYKGT-LSDGAVIAVKQLS-SKSKQGNREFV-NEIGMISALQHQNLVKLY 721
+IG+G FG VY SDG + +K++ S + RE NE+ ++ L H N++K Y
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 722 GCCIEGNQLLLVYEYLENNSLARAL--FGKEGQCLN----LDWATRKRICSDIARGLAYL 775
E +L +V EY + L++ + KEG+ LDW + +C L YL
Sbjct: 66 ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQ--LCL----ALKYL 119
Query: 776 HEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPE-Y 834
H KI+HRDIK N+ L + K+ DFG++K+ T + GT Y++PE
Sbjct: 120 HSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSPELC 175
Query: 835 AMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVD-- 892
+ Y K+D++S G V E+ + K P F E NLLEL
Sbjct: 176 QNKPY-NYKSDIWSLGCVLYELCTLK-----HP---F-----------EGENLLELALKI 215
Query: 893 -----PSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSM 931
P + S +S + + N+ P RP+++ +
Sbjct: 216 LKGQYPPIPSQYSSE----LRNLVSSLLQKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 65/200 (32%), Positives = 103/200 (51%), Gaps = 17/200 (8%)
Query: 666 KIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNREFVN-EIGMISALQHQNLVKLYGC 723
IG+G FG VYK V+A+K + + + E + EI +S + + K YG
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGS 67
Query: 724 CIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKI 783
++G++L ++ EY S L K G LD I ++ GL YLHEE
Sbjct: 68 FLKGSKLWIIMEYCGGGSCLDLL--KPG---KLDETYIAFILREVLLGLEYLHEE---GK 119
Query: 784 VHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVG---YMAPEYAMRGYL 840
+HRDIKA N+LL ++ + K++DFG++ + T ++ VG +MAPE +
Sbjct: 120 IHRDIKAANILLSEEGDVKLADFGVSG----QLTSTMSKRNTFVGTPFWMAPEVIKQSGY 175
Query: 841 TDKADVYSFGIVALEIVSGK 860
+KAD++S GI A+E+ G+
Sbjct: 176 DEKADIWSLGITAIELAKGE 195
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 124 bits (311), Expect = 2e-30
Identities = 99/367 (26%), Positives = 150/367 (40%), Gaps = 35/367 (9%)
Query: 666 KIGEGGFGPVYKGTLSDGAVIAVKQLSSK---SKQGNREFVNEIGMISALQHQ-NLVKLY 721
K+GEG FG VY D ++A+K L+ K + F+ EI ++++L H N+VKLY
Sbjct: 7 KLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 722 GCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRL 781
+ L LV EY++ SL L K G+ L + I + I L YLH +
Sbjct: 65 DFFQDEGSLYLVMEYVDGGSL-EDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG-- 121
Query: 782 KIVHRDIKATNVLLDKDLN-AKISDFGLAKLDEDENTHISTR-----IAGTVGYMAPEYA 835
I+HRDIK N+LLD+D K+ DFGLAKL D + S GT GYMAPE
Sbjct: 122 -IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVL 180
Query: 836 M---RGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVD 892
+ Y + +D++S GI E+++G F + + Q +LEL
Sbjct: 181 LGLSLAYASSSSDIWSLGITLYELLTGLP--------PFEGEKNSSATSQTLKIILELPT 232
Query: 893 PSLGSNFSKKEAMTML----NIALLCTNPSPTLRPTMSSAVSMLEGKTAVQAPIIRRNSD 948
PSL S S + ++ P R + SS +S + ++ +
Sbjct: 233 PSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS----HDLLAHLKLKESDL 288
Query: 949 SQDARFRAFEILSQDSQTHVSTLSQESEMQRTMSIDAPWTDSSVSVQIPDETREHSSSSL 1008
S + L + L D DS+ S ++ S +
Sbjct: 289 SDLLKPDDSAPLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKELAPNGVSSSPHNS 348
Query: 1009 LLQNENN 1015
+
Sbjct: 349 SSLLLST 355
|
Length = 384 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 64/199 (32%), Positives = 103/199 (51%), Gaps = 14/199 (7%)
Query: 667 IGEGGFGPVYKGTLS----DGAVIAVKQLSSKSKQGNR-EFVNEIGMISALQHQNLVKLY 721
IG G FG V +G L +A+K L + S R +F+ E ++ H N+++L
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71
Query: 722 GCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRL 781
G + ++++ EY+EN SL + L +G+ + IA G+ YL S +
Sbjct: 72 GVVTKSRPVMIITEYMENGSLDKFLRENDGK---FTVGQLVGMLRGIASGMKYL---SEM 125
Query: 782 KIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAG--TVGYMAPEYAMRGY 839
VHRD+ A N+L++ +L K+SDFGL++ ED +T+ G + + APE
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTK-GGKIPIRWTAPEAIAYRK 184
Query: 840 LTDKADVYSFGIVALEIVS 858
T +DV+SFGIV E++S
Sbjct: 185 FTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 1e-29
Identities = 76/247 (30%), Positives = 123/247 (49%), Gaps = 1/247 (0%)
Query: 96 NLAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGD 155
+G IP+ G L +DLS N G +P+ NL KL++ N L G IP +G
Sbjct: 343 KFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGA 402
Query: 156 ISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGS 215
+L + L+DN G LP L + + +S+NN G I ++ +L + +
Sbjct: 403 CRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARN 462
Query: 216 NLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISDLKGSSSSFPNLQD 275
G +P+ G+ +L+ LDL G +P + L L +L++S+ K S L
Sbjct: 463 KFFGGLPDSFGS-KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSS 521
Query: 276 MKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNN 335
KK+ L L + ++G+IP +M L LDLS NQL+G +P L N++ + + +++N
Sbjct: 522 CKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHN 581
Query: 336 SLSGTLP 342
L G+LP
Sbjct: 582 HLHGSLP 588
|
Length = 968 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 76/295 (25%), Positives = 130/295 (44%), Gaps = 60/295 (20%)
Query: 659 NNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSKQGNR-EFVNEIGMISALQHQN 716
++ + +G+G G VYK G + A+K++ + R + + E+ + + +
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60
Query: 717 LVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIAR----GL 772
+VK YG + ++ +V EY++ SLA L K+ + + + + IAR GL
Sbjct: 61 VVKCYGAFYKEGEISIVLEYMDGGSLADLL--KKVGKIP------EPVLAYIARQILKGL 112
Query: 773 AYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIA------GT 826
YLH ++ I+HRDIK +N+L++ KI+DFG++K + + GT
Sbjct: 113 DYLH--TKRHIIHRDIKPSNLLINSKGEVKIADFGISK-------VLENTLDQCNTFVGT 163
Query: 827 VGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGN 886
V YM+PE + AD++S G+ LE GK F +L Q +
Sbjct: 164 VTYMSPERIQGESYSYAADIWSLGLTLLECALGK----------FPFL------PPGQPS 207
Query: 887 LLELVD-------PSLGSN-FSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933
EL+ PSL + FS + + C P RP+ A +L+
Sbjct: 208 FFELMQAICDGPPPSLPAEEFSPE----FRDFISACLQKDPKKRPS---AAELLQ 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 68/201 (33%), Positives = 103/201 (51%), Gaps = 16/201 (7%)
Query: 667 IGEGGFGPVYKG-TLSDGAVIAVKQLS-----SKSKQGNREFVNEIGMISALQHQNLVKL 720
+G G FG VY+G L DG AVK++S ++ ++ EI ++S LQH N+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 721 YGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESR 780
G E + L + E + SLA+ L K G + + I GL YLH+
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAK-LLKKYG---SFPEPVIRLYTRQILLGLEYLHDR-- 121
Query: 781 LKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMR-GY 839
VHRDIK N+L+D + K++DFG+AK + + S + G+ +MAPE + G
Sbjct: 122 -NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFK--GSPYWMAPEVIAQQGG 178
Query: 840 LTDKADVYSFGIVALEIVSGK 860
AD++S G LE+ +GK
Sbjct: 179 YGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 6e-29
Identities = 66/202 (32%), Positives = 99/202 (49%), Gaps = 18/202 (8%)
Query: 667 IGEGGFGPVY----KGTLSDGAVIAVKQLSSKSKQGNREFV---NEIGMISALQHQNLVK 719
+G+G FG V K T G + A+K L K +E E ++S + H +VK
Sbjct: 1 LGKGSFGKVLLVRKKDT---GKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK 57
Query: 720 LYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEES 779
L+ +L LV EY L L KEG + + A + ++I L YLH
Sbjct: 58 LHYAFQTEEKLYLVLEYAPGGELFSHL-SKEG-RFSEERA--RFYAAEIVLALEYLH--- 110
Query: 780 RLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRGY 839
L I++RD+K N+LLD D + K++DFGLAK E + +T GT Y+APE +
Sbjct: 111 SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT-FCGTPEYLAPEVLLGKG 169
Query: 840 LTDKADVYSFGIVALEIVSGKS 861
D +S G++ E+++GK
Sbjct: 170 YGKAVDWWSLGVLLYEMLTGKP 191
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 9e-29
Identities = 62/195 (31%), Positives = 105/195 (53%), Gaps = 10/195 (5%)
Query: 666 KIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCI 725
K+G G FG V++G ++ +AVK L + +F+ E ++ L+H L++LY C
Sbjct: 13 KLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK-DFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 726 EGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVH 785
+ +V E ++ SL L G G+ L L + + +A G+AYL ++ +H
Sbjct: 72 LEEPIYIVTELMKYGSLLEYLQGGAGRALKLP--QLIDMAAQVASGMAYLEAQN---YIH 126
Query: 786 RDIKATNVLLDKDLNAKISDFGLAK-LDEDE-NTHISTRIAGTVGYMAPEYAMRGYLTDK 843
RD+ A NVL+ ++ K++DFGLA+ + ED + + + APE A+ + K
Sbjct: 127 RDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFP--IKWTAPEAALYNRFSIK 184
Query: 844 ADVYSFGIVALEIVS 858
+DV+SFGI+ EIV+
Sbjct: 185 SDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 84/274 (30%), Positives = 133/274 (48%), Gaps = 33/274 (12%)
Query: 665 NKIGEGGFGPVYKG-TLSDGAVIAVKQLSSKSKQGNREFV-NEIGMISALQHQNLVKLYG 722
IG G VY L + +A+K++ + Q + + + E+ +S H N+VK Y
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66
Query: 723 CCIEGNQLLLVYEYLENNSLA---RALFGKEGQCLNLDWATRKRICSDIARGLAYLHEES 779
+ G++L LV YL SL ++ + + G LD A + ++ +GL YLH
Sbjct: 67 SFVVGDELWLVMPYLSGGSLLDIMKSSYPRGG----LDEAIIATVLKEVLKGLEYLHSNG 122
Query: 780 RLKIVHRDIKATNVLLDKDLNAKISDFGL-AKLDEDENTHISTR--IAGTVGYMAPE--Y 834
+ +HRDIKA N+LL +D + KI+DFG+ A L + + R GT +MAPE
Sbjct: 123 Q---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVME 179
Query: 835 AMRGYLTDKADVYSFGIVALEIVSGKSN-TNYRPKEEFVYLLDWAYVLQEQGNLLELVDP 893
+ GY KAD++SFGI A+E+ +G + + Y P + + L Q + P
Sbjct: 180 QVHGY-DFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTL--------QND-----PP 225
Query: 894 SLGSNFS-KKEAMTMLNIALLCTNPSPTLRPTMS 926
SL + KK + + + LC P+ RPT
Sbjct: 226 SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAE 259
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 4e-28
Identities = 66/211 (31%), Positives = 106/211 (50%), Gaps = 21/211 (9%)
Query: 666 KIGEGGFGPVYKGTLS------DGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVK 719
++GEG FG V+ D ++AVK L S+ ++F E +++ LQHQ++V+
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 720 LYGCCIEGNQLLLVYEYLENNSLARALF-----------GKEGQCLNLDWATRKRICSDI 768
YG C EG LL+V+EY+ + L R L G++ L I S I
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 769 ARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAK-LDEDENTHISTRIAGTV 827
A G+ YL + L VHRD+ N L+ + L KI DFG+++ + + + R +
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188
Query: 828 GYMAPEYAMRGYLTDKADVYSFGIVALEIVS 858
+M PE + T ++D++SFG+V EI +
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 5e-28
Identities = 67/202 (33%), Positives = 109/202 (53%), Gaps = 20/202 (9%)
Query: 667 IGEGGFGPVYKGT---LSDGAVI--AVKQL-SSKSKQGNREFVNEIGMISALQHQNLVKL 720
+G G FG VYKG + I A+K L S + N+E ++E +++++ H ++V+L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 721 YGCCIEGNQLLLVYEYLENNSLARALF---GKEGQCLNLDWATRKRICSDIARGLAYLHE 777
G C+ +Q+ L+ + + L + G L+W C IA+G++YL E
Sbjct: 75 LGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNW------CVQIAKGMSYL-E 126
Query: 778 ESRLKIVHRDIKATNVLLDKDLNAKISDFGLAK-LDEDENTHISTRIAGTVGYMAPEYAM 836
E RL VHRD+ A NVL+ + KI+DFGLAK LD DE + + + +MA E +
Sbjct: 127 EKRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESIL 184
Query: 837 RGYLTDKADVYSFGIVALEIVS 858
T K+DV+S+G+ E+++
Sbjct: 185 HRIYTHKSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 9e-28
Identities = 68/212 (32%), Positives = 110/212 (51%), Gaps = 30/212 (14%)
Query: 660 NFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNREFV-NEIGMISALQHQNL 717
D KIGEG G V T S G +AVK++ + KQ RE + NE+ ++ QH N+
Sbjct: 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR-KQQRRELLFNEVVIMRDYQHPNI 78
Query: 718 VKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKR--------ICSDIA 769
V++Y + G++L +V E+LE +L D T R +C +
Sbjct: 79 VEMYSSYLVGDELWVVMEFLEGGALT-------------DIVTHTRMNEEQIATVCLAVL 125
Query: 770 RGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGL-AKLDEDENTHISTRIAGTVG 828
+ L++LH + ++HRDIK+ ++LL D K+SDFG A++ ++ S + GT
Sbjct: 126 KALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKS--LVGTPY 180
Query: 829 YMAPEYAMRGYLTDKADVYSFGIVALEIVSGK 860
+MAPE R + D++S GI+ +E+V G+
Sbjct: 181 WMAPEVISRLPYGTEVDIWSLGIMVIEMVDGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 2e-27
Identities = 67/193 (34%), Positives = 107/193 (55%), Gaps = 7/193 (3%)
Query: 666 KIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCI 725
K+G+G FG V+ GT + +A+K L + F+ E ++ L+H+ LV+LY
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 71
Query: 726 EGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVH 785
E + +V EY+ SL L G+ G+ L L + + IA G+AY+ R+ VH
Sbjct: 72 E-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVD--MAAQIASGMAYVE---RMNYVH 125
Query: 786 RDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRGYLTDKAD 845
RD++A N+L+ ++L K++DFGLA+L ED + + APE A+ G T K+D
Sbjct: 126 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185
Query: 846 VYSFGIVALEIVS 858
V+SFGI+ E+ +
Sbjct: 186 VWSFGILLTELTT 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 2e-27
Identities = 63/198 (31%), Positives = 97/198 (48%), Gaps = 17/198 (8%)
Query: 667 IGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIE 726
+G G FG V+ G +A+K + + +F+ E ++ L H NLV+LYG C +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 727 GNQLLLVYEYLENNSLA---RALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKI 783
+ +V EY+ N L R GK G LD +CSD+ + YL
Sbjct: 71 QRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLD------MCSDVCEAMEYLESNG---F 121
Query: 784 VHRDIKATNVLLDKDLNAKISDFGLAK--LDEDENTHISTRIAGTVGYMAPEYAMRGYLT 841
+HRD+ A N L+ +D K+SDFGLA+ LD+ + T+ V + PE +
Sbjct: 122 IHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFP--VKWAPPEVFDYSRFS 179
Query: 842 DKADVYSFGIVALEIVSG 859
K+DV+SFG++ E+ S
Sbjct: 180 SKSDVWSFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 3e-27
Identities = 86/274 (31%), Positives = 129/274 (47%), Gaps = 31/274 (11%)
Query: 96 NLAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGD 155
N G IP +L LQ + L N F+G +PK+ + NLT L + N L+G IP +
Sbjct: 319 NFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCS 378
Query: 156 ISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGS 215
L +L+L N L G +P++LG +SLRR+ L N+F+G +P + L + I +
Sbjct: 379 SGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNN 438
Query: 216 NLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISDLKGSSSSFPNLQD 275
NL GRI + + L L L G +P D GS
Sbjct: 439 NLQGRINSRKWDMPSLQMLSLARNKFFGGLP---------------DSFGS--------- 474
Query: 276 MKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNN 335
K++E L L +G +P + +++L L LS N+L+G +P L + KK+ + L++N
Sbjct: 475 -KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHN 533
Query: 336 SLSGTLPDWILTSE----KNLDLSYNNFTESSPA 365
LSG +P SE LDLS N + P
Sbjct: 534 QLSGQIPASF--SEMPVLSQLDLSQNQLSGEIPK 565
|
Length = 968 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 3e-27
Identities = 64/208 (30%), Positives = 108/208 (51%), Gaps = 8/208 (3%)
Query: 666 KIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCI 725
+IG G FG V+ G + +A+K + + +F+ E ++ L H LV+LYG C
Sbjct: 11 EIGSGQFGLVWLGYWLEKRKVAIKTIR-EGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 726 EGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVH 785
E + + LV+E++E+ L+ L + G+ T +C D+ G+AYL + ++H
Sbjct: 70 ERSPICLVFEFMEHGCLSDYLRAQRGK---FSQETLLGMCLDVCEGMAYLESSN---VIH 123
Query: 786 RDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRGYLTDKAD 845
RD+ A N L+ ++ K+SDFG+ + D+ ST V + +PE + K+D
Sbjct: 124 RDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSD 183
Query: 846 VYSFGIVALEIVS-GKSNTNYRPKEEFV 872
V+SFG++ E+ S GK+ R E V
Sbjct: 184 VWSFGVLMWEVFSEGKTPYENRSNSEVV 211
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 6e-27
Identities = 69/196 (35%), Positives = 105/196 (53%), Gaps = 13/196 (6%)
Query: 666 KIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGNRE---FVNEIGMISALQHQNLVKLYG 722
K+G G FG V+ G + +A+K L KQG+ F+ E ++ LQH LV+LY
Sbjct: 13 KLGAGQFGEVWMGYYNGHTKVAIKSL----KQGSMSPEAFLAEANLMKQLQHPRLVRLYA 68
Query: 723 CCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLK 782
+ + ++ EY+EN SL L EG L ++ + + IA G+A++ R
Sbjct: 69 V-VTQEPIYIITEYMENGSLVDFLKTPEGIKLTIN--KLIDMAAQIAEGMAFIE---RKN 122
Query: 783 IVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRGYLTD 842
+HRD++A N+L+ + L KI+DFGLA+L ED + + APE G T
Sbjct: 123 YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTI 182
Query: 843 KADVYSFGIVALEIVS 858
K+DV+SFGI+ EIV+
Sbjct: 183 KSDVWSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 8e-27
Identities = 69/199 (34%), Positives = 98/199 (49%), Gaps = 11/199 (5%)
Query: 667 IGEGGFGPVYKG-TLSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCI 725
+G+G +G VY LS IA+K++ + + + EI + S L+H+N+V+ G
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 726 EGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVH 785
E + E + SL+ L K G L + T I GL YLH+ +IVH
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLRSKWGP-LKDNEQTIIFYTKQILEGLKYLHD---NQIVH 131
Query: 786 RDIKATNVLLDKDLNA-KISDFGLAKLDEDENTHISTRIAGTVGYMAPE---YAMRGYLT 841
RDIK NVL++ KISDFG +K N T GT+ YMAPE RGY
Sbjct: 132 RDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTET-FTGTLQYMAPEVIDKGPRGY-G 189
Query: 842 DKADVYSFGIVALEIVSGK 860
AD++S G +E+ +GK
Sbjct: 190 APADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 9e-27
Identities = 75/271 (27%), Positives = 127/271 (46%), Gaps = 25/271 (9%)
Query: 660 NFDAANKIGEGGFGPVYK-GTLSDGAVIAVKQ--LSSKSKQGNREFVNEIGMISALQHQN 716
+F K+G+G +G VYK LSD A+K+ L S S++ + VNEI +++++ H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 717 LVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLH 776
++ ++GN+L +V EY L++A+ ++ + + RI + RGL LH
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 777 EESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAM 836
E KI+HRD+K+ N+LL + KI D G++K+ + T+I GT YMAPE
Sbjct: 121 E---QKILHRDLKSANILLVANDLVKIGDLGISKV--LKKNMAKTQI-GTPHYMAPEVWK 174
Query: 837 RGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLG 896
+ K+D++S G + E+ + R ++ Y + P +
Sbjct: 175 GRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKY------------PPIP 222
Query: 897 SNFSKKEAMTMLNIALLCTNPSPTLRPTMSS 927
+S+ + N P LRP
Sbjct: 223 PIYSQD----LQNFIRSMLQVKPKLRPNCDK 249
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 63/210 (30%), Positives = 103/210 (49%), Gaps = 23/210 (10%)
Query: 661 FDAANKIGEGGFGPVYKG-TLSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVK 719
++ +IG G +G VYK ++ G ++A+K + + EI M+ +H N+V
Sbjct: 5 YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVA 64
Query: 720 LYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEES 779
+G + ++L +V EY SL G L A +C + +GLAYLHE
Sbjct: 65 YFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIA---YVCRETLKGLAYLHE-- 119
Query: 780 RLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIA------GTVGYMAPE 833
+HRDIK N+LL +D + K++DFG++ ++ IA GT +MAPE
Sbjct: 120 -TGKIHRDIKGANILLTEDGDVKLADFGVS-------AQLTATIAKRKSFIGTPYWMAPE 171
Query: 834 YA---MRGYLTDKADVYSFGIVALEIVSGK 860
A +G K D+++ GI A+E+ +
Sbjct: 172 VAAVERKGGYDGKCDIWALGITAIELAELQ 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 74/209 (35%), Positives = 110/209 (52%), Gaps = 22/209 (10%)
Query: 667 IGEGGFGPVYKG-TLSDGAVIAVKQL-----SSKSKQGNREFVN----EIGMISALQHQN 716
IG G FG VY G S G ++AVKQ+ S+ SK R ++ EI ++ LQH+N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 717 LVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLH 776
+V+ G ++ + L + EY+ S+A AL G + + I +GL YLH
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVA-ALLNNYGA---FEETLVRNFVRQILKGLNYLH 123
Query: 777 EESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIA-----GTVGYMA 831
I+HRDIK N+L+D KISDFG++K E + T A G+V +MA
Sbjct: 124 NR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMA 180
Query: 832 PEYAMRGYLTDKADVYSFGIVALEIVSGK 860
PE + T KAD++S G + +E+++GK
Sbjct: 181 PEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 60/214 (28%), Positives = 98/214 (45%), Gaps = 37/214 (17%)
Query: 665 NKIGEGGFGPVYKG-TLSDGAVIAVKQLSSKSKQGNREF----VNEIGMISALQHQNLVK 719
+IGEG +G VYK G ++A+K++ + + F + EI ++ L+H N+V+
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKI--RMENEKEGFPITAIREIKLLQKLRHPNIVR 62
Query: 720 LYGCCIE--GNQLLLVYEYLEN--NSLARALFGK--EGQCLNLDWATRKRICSDIARGLA 773
L + +V+EY+++ L + K E Q K + GL
Sbjct: 63 LKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQI--------KCYMKQLLEGLQ 114
Query: 774 YLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPE 833
YLH I+HRDIK +N+L++ D K++DFGLA+ N+ T T+ Y PE
Sbjct: 115 YLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPE 171
Query: 834 -------YAMRGYLTDKADVYSFGIVALEIVSGK 860
Y + D++S G + E+ GK
Sbjct: 172 LLLGATRY------GPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 75/224 (33%), Positives = 104/224 (46%), Gaps = 32/224 (14%)
Query: 657 ATNNFDAANKIGEGGFGPVYKGTLSD-GAVIAVKQLSSKSKQGNREFVNEIGMISAL-QH 714
T F+ IGEG +G VYK G ++A+K + + E E ++ H
Sbjct: 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE-EEEIKEEYNILRKYSNH 62
Query: 715 QNLVKLYGC------CIEGNQLLLVYEYLENNS---LARALFGKEGQCLNLDWATRKRIC 765
N+ YG +QL LV E S L + L K+G+ L +W I
Sbjct: 63 PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLR-KKGKRLKEEWIAY--IL 119
Query: 766 SDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGL-AKLDEDE---NTHIST 821
+ RGLAYLHE K++HRDIK N+LL K+ K+ DFG+ A+LD NT I
Sbjct: 120 RETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI-- 174
Query: 822 RIAGTVGYMAPE-----YAMRGYLTDKADVYSFGIVALEIVSGK 860
GT +MAPE ++DV+S GI A+E+ GK
Sbjct: 175 ---GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGK 215
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 67/203 (33%), Positives = 100/203 (49%), Gaps = 19/203 (9%)
Query: 665 NKIGEGGFGPVYKGT--LSDGAVI--AVKQLS-SKSKQGNREFVNEIGMISALQHQNLVK 719
++G G FG V KG + G + AVK L G +EF+ E +++ L H +V+
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 720 LYGCCIEGNQLLLVYEYLENNSLARALFGK-EGQCLNL-DWATRKRICSDIARGLAYLHE 777
L G C +G L+LV E L + L + E +L + A + +A G+AYL E
Sbjct: 61 LIGVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQ------VAMGMAYL-E 112
Query: 778 ESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGT--VGYMAPEYA 835
VHRD+ A NVLL AKISDFG+++ + + AG + + APE
Sbjct: 113 SKHF--VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECI 170
Query: 836 MRGYLTDKADVYSFGIVALEIVS 858
G + K+DV+S+G+ E S
Sbjct: 171 NYGKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 66/193 (34%), Positives = 103/193 (53%), Gaps = 7/193 (3%)
Query: 666 KIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCI 725
K+G G FG V+ GT + +AVK L + F+ E ++ L+H LV+LY
Sbjct: 13 KLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYAVVS 71
Query: 726 EGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVH 785
E + +V EY+ SL F K+G+ L + + +A G+AY+ R+ +H
Sbjct: 72 E-EPIYIVTEYMSKGSLL--DFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIH 125
Query: 786 RDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRGYLTDKAD 845
RD+++ N+L+ L KI+DFGLA+L ED + + APE A+ G T K+D
Sbjct: 126 RDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185
Query: 846 VYSFGIVALEIVS 858
V+SFGI+ E+V+
Sbjct: 186 VWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 5e-26
Identities = 81/277 (29%), Positives = 123/277 (44%), Gaps = 19/277 (6%)
Query: 667 IGEGGFGPV----YKGTLSD-GAVIAVKQLSSKSKQGNRE-FVNEIGMISALQHQNLVKL 720
+GEG FG V Y G ++AVK L + Q N + EI ++ L H+N+VK
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 721 YGCCIEGNQ--LLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEE 778
GCC E L L+ EY+ SL L L+ A I G+AYLH +
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH-----KLNLAQLLLFAQQICEGMAYLHSQ 126
Query: 779 SRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGT--VGYMAPEYAM 836
+HRD+ A NVLLD D KI DFGLAK + + + R G V + A E
Sbjct: 127 ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLK 183
Query: 837 RGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLG 896
+ +DV+SFG+ E+++ ++ P ++F ++ L+EL++ +
Sbjct: 184 ENKFSYASDVWSFGVTLYELLT-HCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMR 242
Query: 897 SNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933
K + + C RPT S + +L+
Sbjct: 243 LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILK 279
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 6e-26
Identities = 65/214 (30%), Positives = 107/214 (50%), Gaps = 22/214 (10%)
Query: 661 FDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLS-----SKSKQGNREFVNEIGMISALQH 714
++ IG+G FG V K SDG ++ K++ K KQ + V+E+ ++ L+H
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQ---QLVSEVNILRELKH 58
Query: 715 QNLVKLYGCCI-EGNQLL-LVYEYLENNSLARAL--FGKEGQCLNLD--WATRKRICSDI 768
N+V+ Y I NQ L +V EY E LA+ + KE + + + W RI + +
Sbjct: 59 PNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIW----RILTQL 114
Query: 769 ARGLAYLH--EESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGT 826
L H + ++HRD+K N+ LD + N K+ DFGLAK+ +++ T GT
Sbjct: 115 LLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT-YVGT 173
Query: 827 VGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGK 860
YM+PE +K+D++S G + E+ +
Sbjct: 174 PYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 8e-26
Identities = 67/193 (34%), Positives = 103/193 (53%), Gaps = 7/193 (3%)
Query: 666 KIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCI 725
K+G+G FG V+ GT + +A+K L + F+ E ++ L+H LV LY
Sbjct: 13 KLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMM-PEAFLQEAQIMKKLRHDKLVPLYAVVS 71
Query: 726 EGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVH 785
E + +V E++ SL F KEG L + + IA G+AY+ R+ +H
Sbjct: 72 E-EPIYIVTEFMGKGSLLD--FLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIH 125
Query: 786 RDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRGYLTDKAD 845
RD++A N+L+ +L KI+DFGLA+L ED + + APE A+ G T K+D
Sbjct: 126 RDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185
Query: 846 VYSFGIVALEIVS 858
V+SFGI+ E+V+
Sbjct: 186 VWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 9e-26
Identities = 59/228 (25%), Positives = 101/228 (44%), Gaps = 35/228 (15%)
Query: 659 NNFDAANKIGEGGFGPVYKGTL-SDGAVIAVKQLSSK--SKQGNREFVN-EIGMISAL-Q 713
++F IGEG F V A+K L + K+ ++V E +++ L
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 714 HQNLVKLYGCCIEGNQLLLVYEYLENNSLARAL--FGKEGQCLNLDWATRKRICSDIARG 771
H ++KLY + L V EY N L + + +G L+ + ++I
Sbjct: 61 HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYG----SLDEKCT--RFYAAEILLA 114
Query: 772 LAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIA------- 824
L YLH I+HRD+K N+LLDKD++ KI+DFG AK+ + ++ S +
Sbjct: 115 LEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQ 171
Query: 825 ------------GTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGK 860
GT Y++PE +D+++ G + ++++GK
Sbjct: 172 IEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 9e-26
Identities = 64/198 (32%), Positives = 100/198 (50%), Gaps = 8/198 (4%)
Query: 666 KIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGNRE-FVNEIGMISALQHQNLVKLYGCC 724
KIG+G FG VYKG L +AVK S + F+ E ++ H N+VKL G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 725 IEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIV 784
++ + +V E + SL L K+ + L ++ D A G+ YL ES+ +
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKNR---LTVKKLLQMSLDAAAGMEYL--ESK-NCI 115
Query: 785 HRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGT-VGYMAPEYAMRGYLTDK 843
HRD+ A N L+ ++ KISDFG+++ +E +S + + + APE G T +
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSE 175
Query: 844 ADVYSFGIVALEIVSGKS 861
+DV+S+GI+ E S
Sbjct: 176 SDVWSYGILLWETFSLGD 193
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 63/199 (31%), Positives = 106/199 (53%), Gaps = 13/199 (6%)
Query: 667 IGEGGFGPVYKGTLS----DGAVIAVKQLSSKSKQGNR-EFVNEIGMISALQHQNLVKLY 721
IG G FG V++G L +A+K L + R +F++E ++ H N+++L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 722 GCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRL 781
G + +++ EY+EN +L + L +G+ + R IA G+ YL S +
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR---GIAAGMKYL---SDM 126
Query: 782 KIVHRDIKATNVLLDKDLNAKISDFGLAKLDED--ENTHISTRIAGTVGYMAPEYAMRGY 839
VHRD+ A N+L++ +L K+SDFGL+++ ED E T+ ++ + + APE
Sbjct: 127 NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRK 186
Query: 840 LTDKADVYSFGIVALEIVS 858
T +DV+SFGIV E++S
Sbjct: 187 FTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 65/211 (30%), Positives = 107/211 (50%), Gaps = 27/211 (12%)
Query: 667 IGEGGFGPVYKG-TLSDGAVIAVKQL------SSKSKQGNREFV----NEIGMISALQHQ 715
IG+G +G VY ++ G ++AVKQ+ + + ++ V +EI + L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 716 NLVKLYGCCIEGNQLLLVYEYLENNSLARAL--FGKEGQCLNLDWATRKRICSDIARGLA 773
N+V+ G L + EY+ S+ L +G+ + + + GLA
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGR------FEEQLVRFFTEQVLEGLA 122
Query: 774 YLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHIS-TRIAGTVGYMAP 832
YLH + I+HRD+KA N+L+D D KISDFG++K +D + + G+V +MAP
Sbjct: 123 YLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAP 179
Query: 833 EY---AMRGYLTDKADVYSFGIVALEIVSGK 860
E +GY + K D++S G V LE+ +G+
Sbjct: 180 EVIHSYSQGY-SAKVDIWSLGCVVLEMFAGR 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 4e-25
Identities = 71/208 (34%), Positives = 107/208 (51%), Gaps = 17/208 (8%)
Query: 666 KIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCI 725
K+G G FG V+ G ++ +AVK L + + F+ E ++ LQH LV+LY
Sbjct: 13 KLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVT 71
Query: 726 EGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRI--CSDIARGLAYLHEESRLKI 783
+ + ++ EY+ SL L EG + L K I + IA G+AY+ R
Sbjct: 72 KEEPIYIITEYMAKGSLLDFLKSDEGGKVLLP----KLIDFSAQIAEGMAYIE---RKNY 124
Query: 784 VHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRGYLTDK 843
+HRD++A NVL+ + L KI+DFGLA++ ED + + APE G T K
Sbjct: 125 IHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 184
Query: 844 ADVYSFGIVALEIVS-------GKSNTN 864
+DV+SFGI+ EIV+ G SN++
Sbjct: 185 SDVWSFGILLYEIVTYGKIPYPGMSNSD 212
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 6e-25
Identities = 81/276 (29%), Positives = 124/276 (44%), Gaps = 29/276 (10%)
Query: 667 IGEGGFGPVYK---GTLSD--GAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLY 721
+G+G FG V L D G V+AVK+L + + R+F EI ++ +LQH N+VK
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 722 GCCIEG--NQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEES 779
G C L LV EYL SL L + D S I +G+ YL
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERL---DHRKLLLYASQICKGMEYL---G 125
Query: 780 RLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGT--VGYMAPEYAMR 837
+ VHRD+ N+L++ + KI DFGL K+ + + R G + + APE
Sbjct: 126 SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTE 185
Query: 838 GYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQG-----NLLELVD 892
+ +DV+SFG+V E+ + S+ + P EF+ ++ +QG +L+EL+
Sbjct: 186 SKFSVASDVWSFGVVLYELFT-YSDKSCSPPAEFMRMMG----NDKQGQMIVYHLIELLK 240
Query: 893 PSLGSNFSKKEA--MTMLNIALLCTNPSPTLRPTMS 926
+ I C N P+ RP+ S
Sbjct: 241 N--NGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFS 274
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 8e-25
Identities = 73/244 (29%), Positives = 118/244 (48%), Gaps = 26/244 (10%)
Query: 659 NNFDAANKIGEGGFGPVYKGTL------SDGAVIAVKQLSSKSKQGNREFVNEIGMISAL 712
+N ++GEG FG V+ D ++AVK L S ++F E +++ L
Sbjct: 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL 64
Query: 713 QHQNLVKLYGCCIEGNQLLLVYEYLENNSLAR--------ALFGKEGQ-CLNLDWATRKR 763
QH+++VK YG C+EG+ L++V+EY+++ L + A+ EG L +
Sbjct: 65 QHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLH 124
Query: 764 ICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRI 823
I IA G+ YL + VHRD+ N L+ ++L KI DFG+++ D + R+
Sbjct: 125 IAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSR---DVYSTDYYRV 178
Query: 824 AG----TVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWA 878
G + +M PE M T ++DV+S G+V EI + GK E + +
Sbjct: 179 GGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQG 238
Query: 879 YVLQ 882
VLQ
Sbjct: 239 RVLQ 242
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 8e-25
Identities = 84/308 (27%), Positives = 130/308 (42%), Gaps = 58/308 (18%)
Query: 659 NNFDAANKIGEGGFGPVYKGTL------SDGAVIAVKQLSSK-SKQGNREFVNEIGMISA 711
NN + IG+G FG V++ ++AVK L + S +F E +++
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 64
Query: 712 LQHQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGK--EGQCLNLDWATRKRICS--- 766
H N+VKL G C G + L++EY+ L L + QC + R C
Sbjct: 65 FDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124
Query: 767 -------------DIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAK--- 810
+A G+AYL E K VHRD+ N L+ +++ KI+DFGL++
Sbjct: 125 LPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIY 181
Query: 811 ----LDEDENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNY- 865
EN I R +M PE T ++DV+++G+V EI S Y
Sbjct: 182 SADYYKASENDAIPIR------WMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYG 235
Query: 866 RPKEEFVYLLDWAYVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTM 925
EE +Y YV GN+L D + + N+ LC + P+ RP+
Sbjct: 236 MAHEEVIY-----YV--RDGNVLSCPDNC---------PLELYNLMRLCWSKLPSDRPSF 279
Query: 926 SSAVSMLE 933
+S +L+
Sbjct: 280 ASINRILQ 287
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 66/200 (33%), Positives = 105/200 (52%), Gaps = 15/200 (7%)
Query: 666 KIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGN--REFVNEIGMISALQHQNLVKLYG 722
+IGEG G V+K G +A+K+++ + +G + + EI + A QH +VKL
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66
Query: 723 CCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLK 782
G+ +LV EY+ + L+ L E + L A K + +G+AY+H
Sbjct: 67 VFPHGSGFVLVMEYMPS-DLSEVL-RDEERPLPE--AQVKSYMRMLLKGVAYMHAN---G 119
Query: 783 IVHRDIKATNVLLDKDLNAKISDFGLAKL-DEDENTHISTRIAGTVGYMAPE--YAMRGY 839
I+HRD+K N+L+ D KI+DFGLA+L E+E S ++A T Y APE Y R Y
Sbjct: 120 IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVA-TRWYRAPELLYGARKY 178
Query: 840 LTDKADVYSFGIVALEIVSG 859
D+++ G + E+++G
Sbjct: 179 -DPGVDLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 82/296 (27%), Positives = 129/296 (43%), Gaps = 48/296 (16%)
Query: 667 IGEGGFGPVYKGT------LSDGAVIAVKQLSSKSKQGN-REFVNEIGMISALQHQNLVK 719
+GEG FG V K T + +AVK L + R+ ++E ++ + H +++K
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 720 LYGCCIEGNQLLLVYEYLENNSLARAL-FGKEGQCLNLDWATRKRICSD----------- 767
LYG C + LLL+ EY + SL L ++ L +
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 768 --------IARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHI 819
I+RG+ YL E +K+VHRD+ A NVL+ + KISDFGL++ +E++++
Sbjct: 128 DLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 820 S-TRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDW 877
++ V +MA E T ++DV+SFG++ EIV+ G + E LL
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKT 244
Query: 878 AYVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933
Y ++ N E M N+ L C P RPT + LE
Sbjct: 245 GYRMERPENCSE----------------EMYNLMLTCWKQEPDKRPTFADISKELE 284
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 2e-24
Identities = 65/203 (32%), Positives = 105/203 (51%), Gaps = 23/203 (11%)
Query: 667 IGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNREFV-NEIGMISALQH---QNLVKLY 721
IG G +G VY+G + G V+A+K ++ + + + E+ ++S L+ N+ K Y
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 722 GCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIAR----GLAYLHE 777
G ++G +L ++ EY E S+ R L + + ++ S I R L Y+H+
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSV-RTLM--KAGPIA------EKYISVIIREVLVALKYIHK 119
Query: 778 ESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMR 837
++HRDIKA N+L+ N K+ DFG+A L ++ ST GT +MAPE
Sbjct: 120 VG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST-FVGTPYWMAPEVITE 175
Query: 838 GYLTD-KADVYSFGIVALEIVSG 859
G D KAD++S GI E+ +G
Sbjct: 176 GKYYDTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 79/271 (29%), Positives = 123/271 (45%), Gaps = 28/271 (10%)
Query: 666 KIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCI 725
K+G G FG V+ T + +AVK + S F+ E ++ LQH LVKL+ +
Sbjct: 13 KLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAV-V 70
Query: 726 EGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRI--CSDIARGLAYLHEESRLKI 783
+ ++ E++ SL L EG L K I + IA G+A++ + +
Sbjct: 71 TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLP----KLIDFSAQIAEGMAFIEQRN---Y 123
Query: 784 VHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRGYLTDK 843
+HRD++A N+L+ L KI+DFGLA++ ED + + APE G T K
Sbjct: 124 IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 183
Query: 844 ADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGSNFSKK 902
+DV+SFGI+ +EIV+ G+ E + L+ Y + N E
Sbjct: 184 SDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPE------------- 230
Query: 903 EAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933
+ NI + C P RPT S+L+
Sbjct: 231 ---ELYNIMMRCWKNRPEERPTFEYIQSVLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 72/215 (33%), Positives = 102/215 (47%), Gaps = 29/215 (13%)
Query: 667 IGEGGFGPVYKGTL------SDGAVIAVKQLSSK-SKQGNREFVNEIGMISALQHQNLVK 719
+GEG FG VYKG L +A+K L + +EF E ++S LQH N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 720 LYGCCIEGNQLLLVYEYLENNSLARALF------------GKEGQCLNLDWATRKRICSD 767
L G C + +++EYL + L L G E +LD + I
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 768 IARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGT- 826
IA G+ YL S VHRD+ A N L+ + L KISDFGL++ D + R+
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSR---DIYSADYYRVQSKS 186
Query: 827 ---VGYMAPEYAMRGYLTDKADVYSFGIVALEIVS 858
V +M PE + G T ++D++SFG+V EI S
Sbjct: 187 LLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 82/267 (30%), Positives = 124/267 (46%), Gaps = 29/267 (10%)
Query: 661 FDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSKQGNREFVN-EIGMISALQHQNLV 718
F +IG+G FG V+KG + V+A+K + + + E + EI ++S +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 719 KLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEE 778
K YG ++G +L ++ EYL S L + G AT + +I +GL YLH E
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALDLL--RAGPFDEFQIAT---MLKEILKGLDYLHSE 120
Query: 779 SRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRG 838
K +HRDIKA NVLL + + K++DFG+A D +T + GT +MAPE +
Sbjct: 121 ---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQS 176
Query: 839 YLTDKADVYSFGIVALEIVSGK-SNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGS 897
KAD++S GI A+E+ G+ N++ P + P+L
Sbjct: 177 AYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNN-------------PPTLTG 223
Query: 898 NFSKKEAMTMLNIALLCTNPSPTLRPT 924
FSK C N P+ RPT
Sbjct: 224 EFSK----PFKEFIDACLNKDPSFRPT 246
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 65/215 (30%), Positives = 109/215 (50%), Gaps = 28/215 (13%)
Query: 666 KIGEGGFGPVYKGT------LSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVK 719
++GEG FG V+ D ++AVK L + ++F E +++ LQH+++VK
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71
Query: 720 LYGCCIEGNQLLLVYEYLENNSLAR--------ALFGKEGQCLN----LDWATRKRICSD 767
YG C +G+ L++V+EY+++ L + A+ +GQ L + I S
Sbjct: 72 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131
Query: 768 IARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAG-- 825
IA G+ YL + VHRD+ N L+ +L KI DFG+++ D + R+ G
Sbjct: 132 IASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSR---DVYSTDYYRVGGHT 185
Query: 826 --TVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS 858
+ +M PE M T ++DV+SFG++ EI +
Sbjct: 186 MLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 63/196 (32%), Positives = 104/196 (53%), Gaps = 10/196 (5%)
Query: 666 KIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCC 724
KIG+G G VY ++ G +A+KQ++ + + +NEI ++ +H N+V
Sbjct: 26 KIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSY 85
Query: 725 IEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIV 784
+ G++L +V EYL SL + E +D +C + + L +LH +++
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVV--TETC---MDEGQIAAVCRECLQALEFLHSN---QVI 137
Query: 785 HRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRGYLTDKA 844
HRDIK+ N+LL D + K++DFG E + ST + GT +MAPE R K
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196
Query: 845 DVYSFGIVALEIVSGK 860
D++S GI+A+E+V G+
Sbjct: 197 DIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 65/206 (31%), Positives = 95/206 (46%), Gaps = 15/206 (7%)
Query: 660 NFDAANKIGEGGFGPVYKGTLSD-GAVIAVKQLSSK---SKQGNREFVNEIGMISALQHQ 715
+F+ IG+G FG V D + A+K ++ + K R +NE ++ L H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 716 NLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYL 775
LV L+ + + LV + L L L Q + K +I L YL
Sbjct: 61 FLVNLWYSFQDEENMYLVVDLLLGGDLRYHL----SQKVKFSEEQVKFWICEIVLALEYL 116
Query: 776 HEESRLKIVHRDIKATNVLLDKDLNAKISDFGLA-KLDEDENTHISTRIAGTVGYMAPEY 834
H + I+HRDIK N+LLD+ + I+DF +A K+ D T T +GT GYMAPE
Sbjct: 117 HSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT---TSTSGTPGYMAPEV 170
Query: 835 AMRGYLTDKADVYSFGIVALEIVSGK 860
R + D +S G+ A E + GK
Sbjct: 171 LCRQGYSVAVDWWSLGVTAYECLRGK 196
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 5e-24
Identities = 77/271 (28%), Positives = 129/271 (47%), Gaps = 28/271 (10%)
Query: 666 KIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCI 725
++G G FG V G +A+K + S + EF+ E ++ L H+ LV+LYG C
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 726 EGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVH 785
+ + +V EY+ N L L +E + +C D+ G+AYL ES+ + +H
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYL--REHG-KRFQPSQLLEMCKDVCEGMAYL--ESK-QFIH 123
Query: 786 RDIKATNVLLDKDLNAKISDFGLAK--LDEDENTHISTRIAGTVGYMAPEYAMRGYLTDK 843
RD+ A N L+D K+SDFGL++ LD++ + + ++ V + PE + + K
Sbjct: 124 RDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFP--VRWSPPEVLLYSKFSSK 181
Query: 844 ADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGSNFSKK 902
+DV++FG++ E+ S GK P E F + + +++ L L P L S
Sbjct: 182 SDVWAFGVLMWEVYSLGK-----MPYERF----NNSETVEKVSQGLRLYRPHLASE---- 228
Query: 903 EAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933
+ I C + RPT +S +E
Sbjct: 229 ---KVYAIMYSCWHEKAEERPTFQQLLSSIE 256
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 9e-24
Identities = 70/210 (33%), Positives = 106/210 (50%), Gaps = 22/210 (10%)
Query: 667 IGEGGFGPVYKGTLSD------GAV-IAVKQLSSKSK-QGNREFVNEIGMISALQHQNLV 718
+G G FG VY+GT +D G + +AVK L + Q +EF+ E ++S H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 719 KLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRK---RICSDIARGLAYL 775
KL G C+ ++ E +E L L + T K IC D+A+G YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 776 HEESRLKIVHRDIKATNVLL-----DKDLNAKISDFGLAKLDEDENTHISTRIAG--TVG 828
++ +HRD+ A N L+ D D KI DFGLA+ D ++ + G V
Sbjct: 123 E---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR-DIYKSDYYRKEGEGLLPVR 178
Query: 829 YMAPEYAMRGYLTDKADVYSFGIVALEIVS 858
+MAPE + G T ++DV+SFG++ EI++
Sbjct: 179 WMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 82/286 (28%), Positives = 121/286 (42%), Gaps = 38/286 (13%)
Query: 665 NKIGEGGFGPVYKGTLS--DGAV----IAVKQL-SSKSKQGNREFVNEIGMISALQHQNL 717
+G G FG VY+G DG +AVK L S S+Q +F+ E ++S HQN+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 718 VKLYGCCIEGNQLLLVYEYLENNSLARALFGKEG-----QCLNLDWATRKRICSDIARGL 772
V+L G E ++ E + L F +E + +L D+A+G
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKS--FLRENRPRPERPSSLTMKDLLFCARDVAKGC 129
Query: 773 AYLHEESRLKIVHRDIKATNVLLD---KDLNAKISDFGLAK-LDEDENTHISTRIAGTVG 828
YL EE+ +HRDI A N LL AKI+DFG+A+ + R +
Sbjct: 130 KYL-EENHF--IHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIK 186
Query: 829 YMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWAYVLQEQGNL 887
+M PE + G T K DV+SFG++ EI S G R +E + + G L
Sbjct: 187 WMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEF------VTGGGRL 240
Query: 888 LELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933
DP G MT C +P RP ++ + ++
Sbjct: 241 ----DPPKGCPGPVYRIMTD------CWQHTPEDRPNFATILERIQ 276
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 70/208 (33%), Positives = 102/208 (49%), Gaps = 21/208 (10%)
Query: 661 FDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSKQGN---REFVNEIGMISALQHQN 716
F +IG G FG VY V+A+K++S KQ N ++ + E+ + L+H N
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 717 LVKLYGCCIEGNQLLLVYEY-LENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYL 775
++ GC + + LV EY L + S + K Q + + IC +GLAYL
Sbjct: 77 TIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEI-----AAICHGALQGLAYL 131
Query: 776 HEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPE-- 833
H + +HRDIKA N+LL + K++DFG A L N+ + GT +MAPE
Sbjct: 132 HS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAPEVI 183
Query: 834 YAM-RGYLTDKADVYSFGIVALEIVSGK 860
AM G K DV+S GI +E+ K
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERK 211
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 1e-23
Identities = 66/212 (31%), Positives = 110/212 (51%), Gaps = 10/212 (4%)
Query: 650 TLRQIKAATNNFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNREFVNEIGM 708
T+ I + KIG+G G V+ ++ G +A+KQ++ + + +NEI +
Sbjct: 10 TIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILV 69
Query: 709 ISALQHQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDI 768
+ L++ N+V + G++L +V EYL SL + C +D A +C +
Sbjct: 70 MKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVV---TETC--MDEAQIAAVCREC 124
Query: 769 ARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVG 828
+ L +LH +++HRDIK+ NVLL D + K++DFG E + ST + GT
Sbjct: 125 LQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPY 180
Query: 829 YMAPEYAMRGYLTDKADVYSFGIVALEIVSGK 860
+MAPE R K D++S GI+A+E+V G+
Sbjct: 181 WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 85/290 (29%), Positives = 137/290 (47%), Gaps = 43/290 (14%)
Query: 667 IGEGGFGPVYKGTLSD------GAVIAVKQL-SSKSKQGNREFVNEIGMISAL-QHQNLV 718
+GEG FG V K + +AVK L +++ + V+E+ M+ + +H+N++
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 719 KLYGCCIEGNQLLLVYEYLENNSLARALFGKE--GQCLNLDWA-------TRKRICS--- 766
L G C + L +V EY + +L L + G+ + D T+K + S
Sbjct: 80 NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139
Query: 767 DIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAG- 825
+ARG+ +L S+ K +HRD+ A NVL+ +D KI+DFGLA+ D + G
Sbjct: 140 QVARGMEFL--ASK-KCIHRDLAARNVLVTEDHVMKIADFGLAR-DIHHIDYYRKTTNGR 195
Query: 826 -TVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWAYVLQE 883
V +MAPE T ++DV+SFG++ EI + G S P EE LL +
Sbjct: 196 LPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLL-------K 248
Query: 884 QGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933
+G +E P N +++ M + C + P+ RPT V L+
Sbjct: 249 EGYRME--KP---QNCTQELYHLMRD----CWHEVPSQRPTFKQLVEDLD 289
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 58/204 (28%), Positives = 103/204 (50%), Gaps = 22/204 (10%)
Query: 666 KIGEGGFGPVYKG-TLSDGAVIAVKQLSSKSKQG--NREFVNEIGMISALQHQNLVKLYG 722
KIGEG +G VYK G ++A+K++ + + + + EI ++ L H N++KL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 723 CCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLK 782
L LV+E+++ + L + + + + L + K + +GLA+ H
Sbjct: 66 VFRHKGDLYLVFEFMDTD-LYKLI---KDRQRGLPESLIKSYLYQLLQGLAFCH---SHG 118
Query: 783 IVHRDIKATNVLLDKDLNAKISDFGLAKL---DEDENTH-ISTRIAGTVGYMAPE--YAM 836
I+HRD+K N+L++ + K++DFGLA+ TH + TR Y APE
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRW-----YRAPELLLGD 173
Query: 837 RGYLTDKADVYSFGIVALEIVSGK 860
+GY + D++S G + E++S +
Sbjct: 174 KGY-STPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 80/266 (30%), Positives = 126/266 (47%), Gaps = 27/266 (10%)
Query: 661 FDAANKIGEGGFGPVYKGTLSDGA-VIAVKQLSSKSKQGNREFVN-EIGMISALQHQNLV 718
F +IG+G FG VYKG + V+A+K + + + E + EI ++S +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 719 KLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEE 778
+ YG ++G +L ++ EYL S L K G L+ I +I +GL YLH E
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLL--KPGP---LEETYIATILREILKGLDYLHSE 120
Query: 779 SRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRG 838
+ +HRDIKA NVLL + + K++DFG+A D +T + GT +MAPE +
Sbjct: 121 RK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQS 176
Query: 839 YLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGSN 898
KAD++S GI A+E+ G+ P ++ + +++ + P+L
Sbjct: 177 AYDFKADIWSLGITAIELAKGE------PPNSDLHPMRVLFLIPKNS------PPTLEGQ 224
Query: 899 FSKKEAMTMLNIALLCTNPSPTLRPT 924
+SK C N P RPT
Sbjct: 225 YSKP----FKEFVEACLNKDPRFRPT 246
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 2e-23
Identities = 68/279 (24%), Positives = 110/279 (39%), Gaps = 29/279 (10%)
Query: 667 IGEGGFGPVYKGTLS------DGAVIAVKQLSSKSKQG-NREFVNEIGMISALQHQNLVK 719
+G G FG V+ ++ VK L + EF E+ M L H+N+V+
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 720 LYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCL-----NLDWATRKRICSDIARGLAY 774
L G C E ++ EY + L + L + + L + +C+ IA G+ +
Sbjct: 73 LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132
Query: 775 LHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEY 834
L S + VHRD+ A N L+ K+S L+K + + + ++APE
Sbjct: 133 L---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEA 189
Query: 835 AMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPS 894
+ K+DV+SFG++ E+ P L D + + Q LEL P
Sbjct: 190 VQEDDFSTKSDVWSFGVLMWEVF----TQGELPFYG---LSDEEVLNRLQAGKLELPVPE 242
Query: 895 LGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933
+ + C +P RP+ S VS L
Sbjct: 243 -------GCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 63/207 (30%), Positives = 99/207 (47%), Gaps = 27/207 (13%)
Query: 666 KIGEGGFGPVYKGTL--SDGAVI--AVKQLSSKSKQGN-REFVNEIGMISALQHQNLVKL 720
K+G+G FG V +G S G VI AVK L S +F+ E ++ +L H+NL++L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 721 YGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICS---DIARGLAYLHE 777
YG + + L++V E SL L + L +C IA G+ YL
Sbjct: 62 YGVVLT-HPLMMVTELAPLGSLLDRL-----RKDALGHFLISTLCDYAVQIANGMRYLES 115
Query: 778 ESRLKIVHRDIKATNVLLDKDLNAKISDFGLAK-LDEDENTHISTR-----IAGTVGYMA 831
+ + +HRD+ A N+LL D KI DFGL + L ++E+ ++ A + A
Sbjct: 116 K---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFA----WCA 168
Query: 832 PEYAMRGYLTDKADVYSFGIVALEIVS 858
PE + +DV+ FG+ E+ +
Sbjct: 169 PESLRTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 4e-23
Identities = 80/266 (30%), Positives = 124/266 (46%), Gaps = 27/266 (10%)
Query: 661 FDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSKQGNREFVN-EIGMISALQHQNLV 718
F KIG+G FG V+KG + V+A+K + + + E + EI ++S +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 719 KLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEE 778
K YG ++ +L ++ EYL S L + G LD I +I +GL YLH E
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSALDLL--EPGP---LDETQIATILREILKGLDYLHSE 120
Query: 779 SRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRG 838
+ +HRDIKA NVLL + K++DFG+A D GT +MAPE +
Sbjct: 121 KK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK-RNTFVGTPFWMAPEVIKQS 176
Query: 839 YLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGSN 898
KAD++S GI A+E+ G+ P ++ + +++ + P+L N
Sbjct: 177 AYDSKADIWSLGITAIELAKGE------PPHSELHPMKVLFLIPKNN------PPTLEGN 224
Query: 899 FSKKEAMTMLNIALLCTNPSPTLRPT 924
+SK + C N P+ RPT
Sbjct: 225 YSKP----LKEFVEACLNKEPSFRPT 246
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 6e-23
Identities = 64/193 (33%), Positives = 106/193 (54%), Gaps = 13/193 (6%)
Query: 666 KIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCI 725
IGEG FG V +G + G +AVK + K + F+ E +++ L H+NLV+L G I
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNI--KCDVTAQAFLEETAVMTKLHHKNLVRLLGV-I 68
Query: 726 EGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVH 785
N L +V E + +L L + +++ + D+A G+ YL ES+ K+VH
Sbjct: 69 LHNGLYIVMELMSKGNLVNFLRTRGRALVSV--IQLLQFSLDVAEGMEYL--ESK-KLVH 123
Query: 786 RDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRGYLTDKAD 845
RD+ A N+L+ +D AK+SDFGLA++ ++++ V + APE + K+D
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLARVGSMGVD--NSKLP--VKWTAPEALKHKKFSSKSD 179
Query: 846 VYSFGIVALEIVS 858
V+S+G++ E+ S
Sbjct: 180 VWSYGVLLWEVFS 192
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.5 bits (249), Expect = 6e-23
Identities = 63/202 (31%), Positives = 104/202 (51%), Gaps = 18/202 (8%)
Query: 666 KIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNREF----VNEIGMISALQHQNLVKL 720
K+GEG +G VYK G ++A+K++ + + EI ++ L+H N+VKL
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKI--RLDNEEEGIPSTALREISLLKELKHPNIVKL 63
Query: 721 YGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESR 780
+L LV+EY + + L + K L+ + K I + RGLAY H S
Sbjct: 64 LDVIHTERKLYLVFEYCDMD-L-KKYLDKRPGPLSPNLI--KSIMYQLLRGLAYCH--SH 117
Query: 781 LKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPE--YAMRG 838
+I+HRD+K N+L+++D K++DFGLA+ + + T+ Y APE +
Sbjct: 118 -RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-TLWYRAPEILLGSKH 175
Query: 839 YLTDKADVYSFGIVALEIVSGK 860
Y T D++S G + E+++GK
Sbjct: 176 YST-AVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 8e-23
Identities = 64/205 (31%), Positives = 108/205 (52%), Gaps = 28/205 (13%)
Query: 666 KIGEGGFGPVYKGTL-SDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCC 724
KIGEG G V T+ S G ++AVK++ + +Q NE+ ++ QH+N+V++Y
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 725 IEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKR--------ICSDIARGLAYLH 776
+ G++L +V E+LE +L D T R +C + + L+ LH
Sbjct: 87 LVGDELWVVMEFLEGGALT-------------DIVTHTRMNEEQIAAVCLAVLKALSVLH 133
Query: 777 EESRLKIVHRDIKATNVLLDKDLNAKISDFGL-AKLDEDENTHISTRIAGTVGYMAPEYA 835
+ ++HRDIK+ ++LL D K+SDFG A++ ++ S + GT +MAPE
Sbjct: 134 AQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS--LVGTPYWMAPELI 188
Query: 836 MRGYLTDKADVYSFGIVALEIVSGK 860
R + D++S GI+ +E+V G+
Sbjct: 189 SRLPYGPEVDIWSLGIMVIEMVDGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 1e-22
Identities = 78/245 (31%), Positives = 117/245 (47%), Gaps = 40/245 (16%)
Query: 632 KNVEDKELRGLDLQTGYFTLRQIKAATNNFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQ 690
++++D +L L G F L ++ +G G +G VYKG + G + A+K
Sbjct: 1 RSLDDIDLSALRDPAGIFELVEV------------VGNGTYGQVYKGRHVKTGQLAAIKV 48
Query: 691 LSSKSKQGNREFVNEIGMISAL-QHQNLVKLYGCCIE------GNQLLLVYEYLENNSLA 743
+ + E EI M+ H+N+ YG I+ +QL LV E+ S+
Sbjct: 49 MDVTEDE-EEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVT 107
Query: 744 RALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKI 803
+ +G L DW IC +I RGLA+LH K++HRDIK NVLL ++ K+
Sbjct: 108 DLVKNTKGNALKEDWIAY--ICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKL 162
Query: 804 SDFGL-AKLDED---ENTHISTRIAGTVGYMAPEYAMRGYLTD-----KADVYSFGIVAL 854
DFG+ A+LD NT I GT +MAPE D ++D++S GI A+
Sbjct: 163 VDFGVSAQLDRTVGRRNTFI-----GTPYWMAPEVIACDENPDATYDYRSDIWSLGITAI 217
Query: 855 EIVSG 859
E+ G
Sbjct: 218 EMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 2e-22
Identities = 63/201 (31%), Positives = 106/201 (52%), Gaps = 15/201 (7%)
Query: 667 IGEGGFGPVYKGTLSDGA----VIAVKQLSSK-SKQGNREFVNEIGMISALQHQNLVKLY 721
IG G FG V +G L +A+K L S +++ R+F++E ++ H N++ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 722 GCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRL 781
G + ++++ E++EN +L L +GQ + R IA G+ YL E +
Sbjct: 72 GVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLR---GIAAGMKYLSE---M 125
Query: 782 KIVHRDIKATNVLLDKDLNAKISDFGLAK-LDEDENTHISTRIAG---TVGYMAPEYAMR 837
VHRD+ A N+L++ +L K+SDFGL++ L++D + T G + + APE
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY 185
Query: 838 GYLTDKADVYSFGIVALEIVS 858
T +DV+S+GIV E++S
Sbjct: 186 RKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 97.5 bits (242), Expect = 3e-22
Identities = 73/216 (33%), Positives = 107/216 (49%), Gaps = 28/216 (12%)
Query: 661 FDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNREFVNEIGMISAL-QHQNLV 718
F+ +G G +G VYKG + G + A+K + + E EI M+ H+N+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKYSHHRNIA 66
Query: 719 KLYGCCIEGN------QLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGL 772
YG I+ N QL LV E+ S+ + +G L +W IC +I RGL
Sbjct: 67 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGL 124
Query: 773 AYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGL-AKLDED---ENTHISTRIAGTVG 828
++LH+ K++HRDIK NVLL ++ K+ DFG+ A+LD NT I GT
Sbjct: 125 SHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-----GTPY 176
Query: 829 YMAPEYAMRGYLTD-----KADVYSFGIVALEIVSG 859
+MAPE D K+D++S GI A+E+ G
Sbjct: 177 WMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 3e-22
Identities = 68/211 (32%), Positives = 106/211 (50%), Gaps = 18/211 (8%)
Query: 659 NNFDAANKIGEGGFGPVYKGTL-----SDGAV-IAVKQLSSKSKQGNRE-FVNEIGMISA 711
NN +G G FG V + T SD + +AVK L + RE ++E+ ++S
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 712 L-QHQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIAR 770
L H+N+V L G C G +L++ EY L L K L L+ +A+
Sbjct: 95 LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLE--DLLSFSYQVAK 152
Query: 771 GLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHI---STRIAGTV 827
G+A+L ++ +HRD+ A NVLL KI DFGLA+ +++ ++ + R+ V
Sbjct: 153 GMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLP--V 207
Query: 828 GYMAPEYAMRGYLTDKADVYSFGIVALEIVS 858
+MAPE T ++DV+S+GI+ EI S
Sbjct: 208 KWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 96.9 bits (241), Expect = 4e-22
Identities = 62/209 (29%), Positives = 101/209 (48%), Gaps = 22/209 (10%)
Query: 665 NKIGEGGFGPVYKGTLSDGAVIAVKQL---SSKSKQGNREFVN---EIGMISALQHQNLV 718
+G+G +G VY G + G +IAVKQ+ +S +E+ E+ ++ +L+H N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 719 KLYGCCIEGNQLLLVYEYLENNSLARAL--FGKEGQCLNLDWATRKRICSDIARGLAYLH 776
+ G C++ N + + E++ S++ L FG L + I G+AYLH
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGP------LPEPVFCKYTKQILDGVAYLH 119
Query: 777 EESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHIS-----TRIAGTVGYMA 831
+VHRDIK NV+L + K+ DFG A+ H + + GT +MA
Sbjct: 120 NNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMA 176
Query: 832 PEYAMRGYLTDKADVYSFGIVALEIVSGK 860
PE K+D++S G E+ +GK
Sbjct: 177 PEVINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 4e-22
Identities = 70/211 (33%), Positives = 102/211 (48%), Gaps = 17/211 (8%)
Query: 659 NNFDAANKIGEGGFGPVYKGTLSD-GAVIAVKQ-----LSSKSKQGNREFVNEIGMISAL 712
N+ +G+G FG VY D G +AVKQ S ++K+ EI ++ L
Sbjct: 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61
Query: 713 QHQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGL 772
QH+ +V+ YGC + L + EY+ S+ L K L + TRK I G+
Sbjct: 62 QHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQL--KAYGALT-ETVTRK-YTRQILEGV 117
Query: 773 AYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHIS--TRIAGTVGYM 830
YLH IVHRDIK N+L D N K+ DFG +K + + + + GT +M
Sbjct: 118 EYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWM 174
Query: 831 APEYAM-RGYLTDKADVYSFGIVALEIVSGK 860
+PE GY KADV+S G +E+++ K
Sbjct: 175 SPEVISGEGY-GRKADVWSVGCTVVEMLTEK 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 4e-22
Identities = 76/285 (26%), Positives = 128/285 (44%), Gaps = 45/285 (15%)
Query: 658 TNNFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQ------LSSKSKQGNREFVNEIGMIS 710
NF KIG+G F VYK L DG V+A+K+ + +K++Q + + EI ++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQ---DCLKEIDLLK 57
Query: 711 ALQHQNLVKLYGCCIEGNQLLLVYEYLENNSLARAL--FGKEGQCLNLDWATRKRICSDI 768
L H N++K IE N+L +V E + L+R + F K+ + + T + +
Sbjct: 58 QLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRL--IPERTIWKYFVQL 115
Query: 769 ARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVG 828
L ++H + +I+HRDIK NV + K+ D GL + + T + + GT
Sbjct: 116 CSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPY 171
Query: 829 YMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLL 888
YM+PE K+D++S G + E+ + +S P ++ NL
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQS-----PFY------------GDKMNLY 214
Query: 889 ELVD-------PSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMS 926
L P L ++ +E +++ C NP P RP +S
Sbjct: 215 SLCKKIEKCDYPPLPADHYSEELRDLVSR---CINPDPEKRPDIS 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 4e-22
Identities = 61/197 (30%), Positives = 102/197 (51%), Gaps = 12/197 (6%)
Query: 666 KIGEGGFGPV-YKGTLSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCC 724
KIGEG G V G +AVK + + +Q NE+ ++ QHQN+V++Y
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 725 IEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIV 784
+ G +L ++ E+L+ +L + L+ +C + + L YLH + ++
Sbjct: 88 LVGEELWVLMEFLQGGALTDIV-----SQTRLNEEQIATVCESVLQALCYLHSQG---VI 139
Query: 785 HRDIKATNVLLDKDLNAKISDFGL-AKLDEDENTHISTRIAGTVGYMAPEYAMRGYLTDK 843
HRDIK+ ++LL D K+SDFG A++ +D S + GT +MAPE R +
Sbjct: 140 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVISRTPYGTE 197
Query: 844 ADVYSFGIVALEIVSGK 860
D++S GI+ +E+V G+
Sbjct: 198 VDIWSLGIMVIEMVDGE 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 5e-22
Identities = 65/199 (32%), Positives = 104/199 (52%), Gaps = 13/199 (6%)
Query: 667 IGEGGFGPVYKGTLS----DGAVIAVKQLSSK-SKQGNREFVNEIGMISALQHQNLVKLY 721
IG G FG V G L +A+K L + +++ R+F++E ++ H N++ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 722 GCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRL 781
G + +++V EY+EN SL L +GQ + R IA G+ YL S +
Sbjct: 72 GVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLR---GIASGMKYL---SDM 125
Query: 782 KIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGT--VGYMAPEYAMRGY 839
VHRD+ A N+L++ +L K+SDFGL+++ ED+ T G + + APE
Sbjct: 126 GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 185
Query: 840 LTDKADVYSFGIVALEIVS 858
T +DV+S+GIV E++S
Sbjct: 186 FTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 5e-22
Identities = 73/264 (27%), Positives = 117/264 (44%), Gaps = 32/264 (12%)
Query: 666 KIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCI 725
++G G FG V+ G +A+K ++ + +F+ E ++ L H LV+LYG C
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 726 EGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVH 785
+ L +V E++EN L L ++G+ L +C D+ G+ YL S +H
Sbjct: 70 QQKPLYIVTEFMENGCLLNYLRQRQGK---LSKDMLLSMCQDVCEGMEYLERNS---FIH 123
Query: 786 RDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRGYLTDKAD 845
RD+ A N L+ K+SDFG+ + D+ S+ V + PE + K+D
Sbjct: 124 RDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSD 183
Query: 846 VYSFGIVALEIVS-GK----SNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGSNFS 900
V+SFG++ E+ + GK +NY E +G L P L S
Sbjct: 184 VWSFGVLMWEVFTEGKMPFEKKSNYEVVEMI-----------SRGF--RLYRPKLAS--- 227
Query: 901 KKEAMTMLNIALLCTNPSPTLRPT 924
MT+ + C + P RPT
Sbjct: 228 ----MTVYEVMYSCWHEKPEGRPT 247
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 6e-22
Identities = 60/200 (30%), Positives = 106/200 (53%), Gaps = 15/200 (7%)
Query: 667 IGEGGFGP--VYKGTLSDGAVIAVKQ--LSSKSKQGNREFVNEIGMISALQHQNLVKLYG 722
+G+G FG +Y+ T D +++ K+ L+ S++ R+ +NEI ++S LQH N++ Y
Sbjct: 8 LGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66
Query: 723 CCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDW--ATRKRICSDIARGLAYLHEESR 780
++ N LL+ EY +L + ++GQ + +I S ++ Y+H+
Sbjct: 67 HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVS----YIHKAG- 121
Query: 781 LKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRGYL 840
I+HRDIK N+ L K K+ DFG++K+ E + T + GT YM+PE
Sbjct: 122 --ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET-VVGTPYYMSPELCQGVKY 178
Query: 841 TDKADVYSFGIVALEIVSGK 860
K+D+++ G V E+++ K
Sbjct: 179 NFKSDIWALGCVLYELLTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 97.1 bits (241), Expect = 6e-22
Identities = 62/196 (31%), Positives = 104/196 (53%), Gaps = 10/196 (5%)
Query: 666 KIGEGGFGPVYKG-TLSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCC 724
KIG+G G VY ++ G +A+KQ++ + + +NEI ++ ++ N+V
Sbjct: 26 KIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 85
Query: 725 IEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIV 784
+ G++L +V EYL SL + C+ D +C + + L +LH +++
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVV---TETCM--DEGQIAAVCRECLQALDFLHSN---QVI 137
Query: 785 HRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRGYLTDKA 844
HRDIK+ N+LL D + K++DFG E + ST + GT +MAPE R K
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196
Query: 845 DVYSFGIVALEIVSGK 860
D++S GI+A+E+V G+
Sbjct: 197 DIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 8e-22
Identities = 81/284 (28%), Positives = 133/284 (46%), Gaps = 37/284 (13%)
Query: 660 NFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQ------LSSKSKQGNREFVNEIGMISAL 712
NF KIG G F VY+ T L DG +A+K+ + +K++ + + EI ++ L
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARA---DCIKEIDLLKQL 59
Query: 713 QHQNLVKLYGCCIEGNQLLLVYEYLENNSLARAL--FGKEGQCL--NLDWATRKRICSDI 768
H N++K Y IE N+L +V E + L+R + F K+ + + W ++CS
Sbjct: 60 NHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCS-- 117
Query: 769 ARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVG 828
A H SR +++HRDIK NV + K+ D GL + + T + + GT
Sbjct: 118 ----ALEHMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-LVGTPY 171
Query: 829 YMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLL 888
YM+PE K+D++S G + E+ + +S Y K Y L ++ +
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQS-PFYGDKMNL-------YSLCKK---I 220
Query: 889 ELVD-PSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSM 931
E D P L S+ +E ++N +C NP P RP ++ +
Sbjct: 221 EQCDYPPLPSDHYSEELRQLVN---MCINPDPEKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 9e-22
Identities = 71/280 (25%), Positives = 122/280 (43%), Gaps = 44/280 (15%)
Query: 659 NNFDAANKIGEGGFGPVYKGT-LSDGAVIAVK--QLSSKSKQGNREFVNEIGMISALQHQ 715
++ + ++G G G V K G ++AVK +L ++ + E+ ++
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAI-QKQILRELDILHKCNSP 59
Query: 716 NLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYL 775
+V YG + + EY++ SL + L +G+ + +I + +GL YL
Sbjct: 60 YIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGR---IPERILGKIAVAVLKGLTYL 116
Query: 776 HEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRI--------AGTV 827
HE + KI+HRD+K +N+L++ K+ DFG +S ++ GT
Sbjct: 117 HE--KHKIIHRDVKPSNILVNSRGQIKLCDFG-----------VSGQLVNSLAKTFVGTS 163
Query: 828 GYMAPEYAMRGYLTDKADVYSFGIVALEIVSGK---SNTNYRPKEEFVYLLDWAYVLQEQ 884
YMAPE + K+D++S G+ +E+ +G+ N P F LL Y++ E
Sbjct: 164 SYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIF-ELLQ--YIVNEP 220
Query: 885 GNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPT 924
L PS FS + +N LC P RP+
Sbjct: 221 PPRL----PS--GKFS-PDFQDFVN---LCLIKDPRERPS 250
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.7 bits (239), Expect = 1e-21
Identities = 59/209 (28%), Positives = 102/209 (48%), Gaps = 32/209 (15%)
Query: 666 KIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNREFVN--EIGMISALQ-HQNLVKLY 721
++G+G FG VY G ++A+K++ K E +N E+ + L H N+VKL
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE-ECMNLREVKSLRKLNEHPNIVKLK 64
Query: 722 GCCIEGNQLLLVYEYLENNSLARALFG----KEGQCLNLDWATRKRICSDIARGLAYLHE 777
E ++L V+EY+E N L+ ++G+ + + I I +GLA++H
Sbjct: 65 EVFRENDELYFVFEYMEGN-----LYQLMKDRKGKPFSES--VIRSIIYQILQGLAHIH- 116
Query: 778 ESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDEN-----THISTRIAGTVGYMAP 832
+ HRD+K N+L+ KI+DFGLA+ E + ++STR Y AP
Sbjct: 117 --KHGFFHRDLKPENLLVSGPEVVKIADFGLAR--EIRSRPPYTDYVSTR-----WYRAP 167
Query: 833 EYAMR-GYLTDKADVYSFGIVALEIVSGK 860
E +R + D+++ G + E+ + +
Sbjct: 168 EILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 95.0 bits (237), Expect = 2e-21
Identities = 61/207 (29%), Positives = 93/207 (44%), Gaps = 24/207 (11%)
Query: 667 IGEGGFGPVYKG-TLSDGAVIAVKQLSSKSKQGNREF---VNEIGMISALQHQNLVKLYG 722
I +G +G V+ S G + A+K + + + E ++S Q +VKLY
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 723 CCIEGNQLLLVYEYLENNSLARAL--FGKEGQCLNLDWATRKRICSDIARGLAYLHEESR 780
L LV EYL LA L G L+ D A + ++I L YLH
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVG----SLDEDVA--RIYIAEIVLALEYLH---S 111
Query: 781 LKIVHRDIKATNVLLDKDLNAKISDFGLAKLD--------EDENTHISTRIAGTVGYMAP 832
I+HRD+K N+L+D + + K++DFGL+K+ D+ RI GT Y+AP
Sbjct: 112 NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDK-RIVGTPDYIAP 170
Query: 833 EYAMRGYLTDKADVYSFGIVALEIVSG 859
E + + D +S G + E + G
Sbjct: 171 EVILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 2e-21
Identities = 90/286 (31%), Positives = 131/286 (45%), Gaps = 50/286 (17%)
Query: 667 IGEGGFGPVYKGTL--SDGAVI--AVKQLSSKSKQGNRE-FVNEIGMISALQHQNLVKLY 721
IG+G FG VY GTL SDG I AVK L+ + E F+ E ++ H N++ L
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 722 GCCIEGNQL-LLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSD-------IARGLA 773
G C+ L+V Y+++ L R E T D +A+G+
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDL-RNFIRSE---------THNPTVKDLIGFGLQVAKGME 112
Query: 774 YLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAK--LD-EDENTHISTRIAGTVGYM 830
YL + K VHRD+ A N +LD+ K++DFGLA+ D E + H T V +M
Sbjct: 113 YLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWM 169
Query: 831 APEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEF---VYLLDWAYVLQEQGNL 887
A E T K+DV+SFG++ E+++ + Y + F VYLL +LQ +
Sbjct: 170 ALESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVDSFDITVYLLQGRRLLQPE--- 225
Query: 888 LELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933
DP + + L C +P P +RPT S VS +E
Sbjct: 226 -YCPDP-------------LYEVMLSCWHPKPEMRPTFSELVSRIE 257
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 2e-21
Identities = 59/196 (30%), Positives = 101/196 (51%), Gaps = 13/196 (6%)
Query: 667 IGEGGFGPVYKG-TLSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCI 725
+G+G FG VYK G A K + +S++ +F+ EI ++S +H N+V LY
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 726 EGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVH 785
N+L ++ E+ + +L ++ + + L + +C + L +LH K++H
Sbjct: 73 YENKLWILIEFCDGGALD-SIMLELERGLTEPQI--RYVCRQMLEALNFLHSH---KVIH 126
Query: 786 RDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRGYLTD--- 842
RD+KA N+LL D + K++DFG++ ++ T I GT +MAPE D
Sbjct: 127 RDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI-GTPYWMAPEVVACETFKDNPY 185
Query: 843 --KADVYSFGIVALEI 856
KAD++S GI +E+
Sbjct: 186 DYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 2e-21
Identities = 64/207 (30%), Positives = 102/207 (49%), Gaps = 18/207 (8%)
Query: 667 IGEGGFGPVYKGTLS--DGAV--IAVK--QLSSKSKQGNREFVNEIGMISALQHQNLVKL 720
+GEG FG V +G LS DG+ +AVK +L + EF++E + H N++KL
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 721 YGCCIEGNQL------LLVYEYLENNSLARALFGK--EGQCLNLDWATRKRICSDIARGL 772
G C E + L +++ ++++ L L G L T + DIA G+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 773 AYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGT-VGYMA 831
YL S +HRD+ A N +L +D+ ++DFGL+K + + RIA V ++A
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA 183
Query: 832 PEYAMRGYLTDKADVYSFGIVALEIVS 858
E T K+DV++FG+ EI +
Sbjct: 184 IESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 3e-21
Identities = 62/218 (28%), Positives = 105/218 (48%), Gaps = 28/218 (12%)
Query: 666 KIGEGGFGPVY-------KGTLSDGA--------VIAVKQLSSK-SKQGNREFVNEIGMI 709
K+GEG FG V+ L +GA ++AVK L + +K +F+ EI ++
Sbjct: 12 KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71
Query: 710 SALQHQNLVKLYGCCIEGNQLLLVYEYLENNSL--------ARALFGKEGQCLNLDWATR 761
S L++ N+++L G C+ + L ++ EY+EN L + F ++ A
Sbjct: 72 SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131
Query: 762 KRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAK-LDEDENTHIS 820
+ IA G+ YL + L VHRD+ N L+ KI+DFG+++ L + I
Sbjct: 132 LYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQ 188
Query: 821 TRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS 858
R + +MA E + G T +DV++FG+ E+ +
Sbjct: 189 GRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 3e-21
Identities = 70/200 (35%), Positives = 104/200 (52%), Gaps = 27/200 (13%)
Query: 667 IGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIE 726
IG+G FG V G G +AVK + K+ + F+ E +++ L+H NLV+L G +E
Sbjct: 14 IGKGEFGDVMLGDYR-GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 727 GN-QLLLVYEYLENNSL-------ARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEE 778
L +V EY+ SL R++ G G CL L ++ D+ + YL
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLG--GDCL-LKFSL------DVCEAMEYLEAN 121
Query: 779 SRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRG 838
+ VHRD+ A NVL+ +D AK+SDFGL K E +T + ++ V + APE
Sbjct: 122 N---FVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLP--VKWTAPEALREK 174
Query: 839 YLTDKADVYSFGIVALEIVS 858
+ K+DV+SFGI+ EI S
Sbjct: 175 KFSTKSDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 5e-21
Identities = 63/206 (30%), Positives = 101/206 (49%), Gaps = 30/206 (14%)
Query: 666 KIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCC 724
KIGEG G V T G +AVK++ + +Q NE+ ++ H+N+V +Y
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 725 IEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKR--------ICSDIARGLAYLH 776
+ G++L +V E+LE +L D T R +C + R L+YLH
Sbjct: 89 LVGDELWVVMEFLEGGALT-------------DIVTHTRMNEEQIATVCLSVLRALSYLH 135
Query: 777 EESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTR--IAGTVGYMAPEY 834
+ ++HRDIK+ ++LL D K+SDFG E + R + GT +MAPE
Sbjct: 136 NQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE---VPKRKSLVGTPYWMAPEV 189
Query: 835 AMRGYLTDKADVYSFGIVALEIVSGK 860
R + D++S GI+ +E++ G+
Sbjct: 190 ISRLPYGTEVDIWSLGIMVIEMIDGE 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 7e-21
Identities = 64/204 (31%), Positives = 104/204 (50%), Gaps = 27/204 (13%)
Query: 666 KIGEGGFGPVYKGTLSD-GAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCC 724
++G+G FG VYK + GA+ A K + +KS++ +++ EI +++ H +VKL G
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 725 IEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATR----KRICSDIARGLAYLHEESR 780
+L ++ E+ ++ + L LD + IC + L YLH
Sbjct: 79 YWDGKLWIMIEFCPGGAV-------DAIMLELDRGLTEPQIQVICRQMLEALQYLHS--- 128
Query: 781 LKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTR---IAGTVGYMAPEYAMR 837
+KI+HRD+KA NVLL D + K++DFG++ +N R GT +MAPE M
Sbjct: 129 MKIIHRDLKAGNVLLTLDGDIKLADFGVSA----KNVKTLQRRDSFIGTPYWMAPEVVMC 184
Query: 838 GYLTD-----KADVYSFGIVALEI 856
+ D KAD++S GI +E+
Sbjct: 185 ETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 9e-21
Identities = 59/196 (30%), Positives = 103/196 (52%), Gaps = 10/196 (5%)
Query: 666 KIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCC 724
KIG+G G VY ++ G +A++Q++ + + +NEI ++ ++ N+V
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 725 IEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIV 784
+ G++L +V EYL SL + C+ D +C + + L +LH +++
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVV---TETCM--DEGQIAAVCRECLQALEFLHSN---QVI 138
Query: 785 HRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRGYLTDKA 844
HRDIK+ N+LL D + K++DFG E + S + GT +MAPE R K
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS-TMVGTPYWMAPEVVTRKAYGPKV 197
Query: 845 DVYSFGIVALEIVSGK 860
D++S GI+A+E++ G+
Sbjct: 198 DIWSLGIMAIEMIEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 9e-21
Identities = 62/202 (30%), Positives = 102/202 (50%), Gaps = 20/202 (9%)
Query: 667 IGEGGFGPVYKGT-LSDGAVI----AVKQLSSKS-KQGNREFVNEIGMISALQHQNLVKL 720
+G G FG V+KG + +G I A+K + +S +Q +E + + + +L H +V+L
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 721 YGCCIEGNQLLLVYEYLENNSL---ARALFGKEGQCLNLDWATRKRICSDIARGLAYLHE 777
G C G L LV + SL R L+W C IA+G+ YL E
Sbjct: 75 LGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNW------CVQIAKGMYYLEE 127
Query: 778 ESRLKIVHRDIKATNVLLDKDLNAKISDFGLAK-LDEDENTHISTRIAGTVGYMAPEYAM 836
++VHR++ A N+LL D +I+DFG+A L D+ + + + +MA E +
Sbjct: 128 H---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESIL 184
Query: 837 RGYLTDKADVYSFGIVALEIVS 858
G T ++DV+S+G+ E++S
Sbjct: 185 FGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 1e-20
Identities = 62/205 (30%), Positives = 115/205 (56%), Gaps = 11/205 (5%)
Query: 660 NFDAANKIGEGGFGPVYKG-TLSDGAVIAVKQLSSKSKQGN-REFVNEIGMISALQHQNL 717
NF K+GEG + VYKG + G ++A+K++ +++G + EI ++ L+H+N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 718 VKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHE 777
V+L+ N+L+LV+EY++ + L + + + LD T K + +G+A+ HE
Sbjct: 61 VRLHDVIHTENKLMLVFEYMDKD-LKKYMDTHGVRG-ALDPNTVKSFTYQLLKGIAFCHE 118
Query: 778 ESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAM- 836
+++HRD+K N+L++K K++DFGLA+ S + T+ Y AP+ +
Sbjct: 119 N---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDVLLG 174
Query: 837 -RGYLTDKADVYSFGIVALEIVSGK 860
R Y T D++S G + E+++G+
Sbjct: 175 SRTYST-SIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 1e-20
Identities = 55/206 (26%), Positives = 95/206 (46%), Gaps = 13/206 (6%)
Query: 659 NNFDAANKIGEGGFGPVYKGTLSD-GAVIAVKQL--SSKSKQGNREFVNEIGMISALQHQ 715
N ++ +GEG +G V K G ++A+K+ S + + + E+ ++ L+H+
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60
Query: 716 NLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYL 775
N+V L +L LV+EY+E L E L + + + +AY
Sbjct: 61 NIVNLKEAFRRKGRLYLVFEYVERTLLELL----EASPGGLPPDAVRSYIWQLLQAIAYC 116
Query: 776 HEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAK-LDEDENTHISTRIAGTVGYMAPEY 834
H I+HRDIK N+L+ + K+ DFG A+ L + ++ +A T Y APE
Sbjct: 117 H---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVA-TRWYRAPEL 172
Query: 835 AMRGYLTDKA-DVYSFGIVALEIVSG 859
+ K DV++ G + E++ G
Sbjct: 173 LVGDTNYGKPVDVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 2e-20
Identities = 91/337 (27%), Positives = 155/337 (45%), Gaps = 35/337 (10%)
Query: 612 SCAVVIILLFILWRLGYL---GGKNVEDKELRGLD--LQTGYFTLRQIKAATNN-----F 661
+C + L+ L G++ G N+E K + D + +F + K+ T N
Sbjct: 633 TCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDILSSL 692
Query: 662 DAANKIGEGGFGPVYKG-TLSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKL 720
N I G G YKG ++ +G VK++ N +EI + LQH N+VKL
Sbjct: 693 KEENVISRGKKGASYKGKSIKNGMQFVVKEI----NDVNSIPSSEIADMGKLQHPNIVKL 748
Query: 721 YGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESR 780
G C L++EY+E +L+ L NL W R++I IA+ L +LH
Sbjct: 749 IGLCRSEKGAYLIHEYIEGKNLSEVL-------RNLSWERRRKIAIGIAKALRFLHCRCS 801
Query: 781 LKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRGYL 840
+V ++ +++D D +L T+ + Y+APE +
Sbjct: 802 PAVVVGNLSPEKIIID------GKDEPHLRLSLPGLLCTDTKCFISSAYVAPETRETKDI 855
Query: 841 TDKADVYSFGIVALEIVSGKSNTNYRPKEEFVY--LLDWAYVLQEQGNLLELVDPSLGSN 898
T+K+D+Y FG++ +E+++GKS + E V+ +++WA +L +DPS+ +
Sbjct: 856 TEKSDIYGFGLILIELLTGKSPAD---AEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGD 912
Query: 899 FS--KKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933
S + E + ++N+AL CT PT RP + + LE
Sbjct: 913 VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 2e-20
Identities = 53/153 (34%), Positives = 86/153 (56%), Gaps = 1/153 (0%)
Query: 96 NLAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGD 155
NL G I ++ LQ + L+RN F G LP SF + L L + N+ SG++P ++G
Sbjct: 439 NLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGS 497
Query: 156 ISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGS 215
+S L +L L +N+L G +P+ L + K L + LS N +G IP S+ + L++ + +
Sbjct: 498 LSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQN 557
Query: 216 NLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPST 248
L+G IP +GN L ++++ L G +PST
Sbjct: 558 QLSGEIPKNLGNVESLVQVNISHNHLHGSLPST 590
|
Length = 968 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 2e-20
Identities = 61/208 (29%), Positives = 105/208 (50%), Gaps = 24/208 (11%)
Query: 667 IGEGGFGPVYKGT-LSDGAVIAVKQLS----SKSKQGN--REFVNEIGMISALQHQNLVK 719
+G G F Y+ + G ++AVKQ++ + S+Q EI +++ L H ++++
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 720 LYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEES 779
+ G E + L E++ S++ L K G A + RGL+YLHE
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVS-HLLSKYGAFKE---AVIINYTEQLLRGLSYLHEN- 122
Query: 780 RLKIVHRDIKATNVLLD---KDLNAKISDFGLA-KLDED--ENTHISTRIAGTVGYMAPE 833
+I+HRD+K N+L+D + L +I+DFG A +L ++ GT+ +MAPE
Sbjct: 123 --QIIHRDVKGANLLIDSTGQRL--RIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPE 178
Query: 834 YAMRGYLTDKA-DVYSFGIVALEIVSGK 860
+RG ++ DV+S G V +E+ + K
Sbjct: 179 -VLRGEQYGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 3e-20
Identities = 65/203 (32%), Positives = 100/203 (49%), Gaps = 22/203 (10%)
Query: 666 KIGEGGFGPVYKGTL----SDGAVIAVKQLSSKSKQGNRE-FVNEIGMISALQHQNLVKL 720
IGEG FG VY+G ++ +AVK + + RE F+ E ++ H ++VKL
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 721 YGCCIEGNQLLLVYEYLENNSLARALFGKEGQCL-----NLDWATRKRICSDIARGLAYL 775
G E N + +V E A G+ L +LD A+ ++ LAYL
Sbjct: 73 IGVITE-NPVWIVMEL--------APLGELRSYLQVNKYSLDLASLILYSYQLSTALAYL 123
Query: 776 HEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYA 835
ES+ + VHRDI A NVL+ K+ DFGL++ EDE+ + +++ + +MAPE
Sbjct: 124 --ESK-RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESI 180
Query: 836 MRGYLTDKADVYSFGIVALEIVS 858
T +DV+ FG+ EI+
Sbjct: 181 NFRRFTSASDVWMFGVCMWEILM 203
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 3e-20
Identities = 60/213 (28%), Positives = 107/213 (50%), Gaps = 26/213 (12%)
Query: 660 NFDAANKIGEGGFGPVY--KGTLSDGAVIAVKQLS-----SKSKQGNREFVNEIGMISAL 712
++ KIGEG FG +Y K SD +K++ K K+ ++ E+ +++ +
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAK-SDSEHCVIKEIDLTKMPVKEKEASK---KEVILLAKM 56
Query: 713 QHQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLD----WATRKRICSDI 768
+H N+V + E +L +V EY + L + + + G + D W + I
Sbjct: 57 KHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQ------I 110
Query: 769 ARGLAYLHEESRLKIVHRDIKATNVLLDKD-LNAKISDFGLAKLDEDENTHISTRIAGTV 827
+ GL ++H+ KI+HRDIK+ N+ L K+ + AK+ DFG+A+ D + ++ GT
Sbjct: 111 SLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND-SMELAYTCVGTP 166
Query: 828 GYMAPEYAMRGYLTDKADVYSFGIVALEIVSGK 860
Y++PE +K D++S G V E+ + K
Sbjct: 167 YYLSPEICQNRPYNNKTDIWSLGCVLYELCTLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 4e-20
Identities = 69/208 (33%), Positives = 105/208 (50%), Gaps = 21/208 (10%)
Query: 661 FDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSKQGN---REFVNEIGMISALQHQN 716
F ++IG G FG VY T S V+AVK++S KQ N ++ + E+ + L+H N
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 717 LVKLYGCCIEGNQLLLVYEY-LENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYL 775
++ GC ++ + LV EY L + S + K Q + + T + +GLAYL
Sbjct: 83 TIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGAL-----QGLAYL 137
Query: 776 HEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYA 835
H + ++HRDIKA N+LL + K++DFG A N+ + GT +MAPE
Sbjct: 138 HSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVI 189
Query: 836 M---RGYLTDKADVYSFGIVALEIVSGK 860
+ G K DV+S GI +E+ K
Sbjct: 190 LAMDEGQYDGKVDVWSLGITCIELAERK 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 7e-20
Identities = 67/216 (31%), Positives = 109/216 (50%), Gaps = 16/216 (7%)
Query: 667 IGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGNR-EFVNEIGMISALQHQNLVKLYGCCI 725
+G+G FG V+KGTL D +AVK Q + +F++E ++ H N+VKL G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 726 EGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVH 785
+ + +V E + L K+ + L + D A G+AYL ES+ +H
Sbjct: 63 QRQPIYIVMELVPGGDFLSFLRKKKDE---LKTKQLVKFALDAAAGMAYL--ESK-NCIH 116
Query: 786 RDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGT-VGYMAPEYAMRGYLTDKA 844
RD+ A N L+ ++ KISDFG+++ ED+ + S+ + + + APE G + ++
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSR-QEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSES 175
Query: 845 DVYSFGIVALEIVS-------GKSNTNYRPKEEFVY 873
DV+S+GI+ E S G +N R + E Y
Sbjct: 176 DVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGY 211
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 7e-20
Identities = 71/209 (33%), Positives = 107/209 (51%), Gaps = 22/209 (10%)
Query: 667 IGEGGFGPVYKGTLS-DGAVI--AVKQLSS-KSKQGNREFVNEIGMISAL-QHQNLVKLY 721
IGEG FG V + + DG + A+K L S+ +R+F E+ ++ L H N++ L
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69
Query: 722 GCCIEGNQLLLVYEYLENNSL------ARAL-----FGKE-GQCLNLDWATRKRICSDIA 769
G C L + EY +L +R L F KE G L + SD+A
Sbjct: 70 GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVA 129
Query: 770 RGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGY 829
G+ YL E+ + +HRD+ A NVL+ ++L +KI+DFGL++ +E R+ V +
Sbjct: 130 TGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLP--VRW 184
Query: 830 MAPEYAMRGYLTDKADVYSFGIVALEIVS 858
MA E T K+DV+SFG++ EIVS
Sbjct: 185 MAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 9e-20
Identities = 60/197 (30%), Positives = 95/197 (48%), Gaps = 11/197 (5%)
Query: 667 IGEGGFGPVYKGTLS----DGAVIAVKQL-SSKSKQGNREFVNEIGMISALQHQNLVKLY 721
+G G FG + +G L +A+ L + S + R F+ E + H N+V+L
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72
Query: 722 GCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRL 781
G GN +++V EY+ N +L L EGQ L + +A G+ YL E +
Sbjct: 73 GVITRGNTMMIVTEYMSNGALDSFLRKHEGQ---LVAGQLMGMLPGLASGMKYLSE---M 126
Query: 782 KIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRGYLT 841
VH+ + A VL++ DL KIS F + D+ E + + V + APE + +
Sbjct: 127 GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFS 186
Query: 842 DKADVYSFGIVALEIVS 858
+DV+SFGIV E++S
Sbjct: 187 SASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 1e-19
Identities = 64/219 (29%), Positives = 110/219 (50%), Gaps = 29/219 (13%)
Query: 666 KIGEGGFGPVY----KGTL-------------SDGAVIAVKQLSSKSKQGNR-EFVNEIG 707
K+GEG FG V+ +G + ++AVK L + + R +F+ EI
Sbjct: 12 KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71
Query: 708 MISALQHQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQ-------CLNLDWAT 760
++S L+ N+++L CI + L ++ EY+EN L + L E Q + + ++T
Sbjct: 72 IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131
Query: 761 RKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAK-LDEDENTHI 819
+ + IA G+ YL S L VHRD+ N L+ K+ KI+DFG+++ L + I
Sbjct: 132 LIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI 188
Query: 820 STRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS 858
R + +M+ E + G T +DV++FG+ EI++
Sbjct: 189 QGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 1e-19
Identities = 64/209 (30%), Positives = 105/209 (50%), Gaps = 18/209 (8%)
Query: 660 NFDAANKIGEGGFGPVYKGTLSD-GAVIAVKQLS-SKSKQG-NREFVNEIGMISALQHQN 716
F+ N+IGEG +G VY+ + G ++A+K++ + G + EI ++ L+H N
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPN 67
Query: 717 LVKLYGCCIEGNQL---LLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLA 773
+V+L + G L LV EY E + LA L + + K + + RGL
Sbjct: 68 IVELKEV-VVGKHLDSIFLVMEYCEQD-LASLL---DNMPTPFSESQVKCLMLQLLRGLQ 122
Query: 774 YLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPE 833
YLHE I+HRD+K +N+LL KI+DFGLA+ ++ ++ T+ Y APE
Sbjct: 123 YLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLWYRAPE 178
Query: 834 --YAMRGYLTDKADVYSFGIVALEIVSGK 860
Y T D+++ G + E+++ K
Sbjct: 179 LLLGCTTY-TTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 1e-19
Identities = 67/202 (33%), Positives = 111/202 (54%), Gaps = 20/202 (9%)
Query: 667 IGEGGFGPVYKGT-LSDGAVI----AVKQLSSKS-KQGNREFVNEIGMISALQHQNLVKL 720
+G G FG VYKG + +G + A+K L+ + + N EF++E +++++ H +LV+L
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 721 YGCCIEGNQLLLVYEYLENNSLARALFGKE---GQCLNLDWATRKRICSDIARGLAYLHE 777
G C+ + LV + + + L + + G L L+W C IA+G+ YL E
Sbjct: 75 LGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNW------CVQIAKGMMYL-E 126
Query: 778 ESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDE-DENTHISTRIAGTVGYMAPEYAM 836
E RL VHRD+ A NVL+ + KI+DFGLA+L E DE + + + +MA E
Sbjct: 127 ERRL--VHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 184
Query: 837 RGYLTDKADVYSFGIVALEIVS 858
T ++DV+S+G+ E+++
Sbjct: 185 YRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 1e-19
Identities = 66/219 (30%), Positives = 101/219 (46%), Gaps = 51/219 (23%)
Query: 665 NKIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGN------REFVNEIGMISALQHQNL 717
N+IG G G VYK G + A+K + GN R+ EI ++ + H N+
Sbjct: 80 NRIGSGAGGTVYKVIHRPTGRLYALKVI-----YGNHEDTVRRQICREIEILRDVNHPNV 134
Query: 718 VKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIAR----GLA 773
VK + ++ ++ E+++ SL E +D+AR G+A
Sbjct: 135 VKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFL------------ADVARQILSGIA 182
Query: 774 YLHEESRLKIVHRDIKATNVLLDKDLNAKISDFG----LAKLDEDENTHISTRIAGTVGY 829
YLH R IVHRDIK +N+L++ N KI+DFG LA+ + N+ + GT+ Y
Sbjct: 183 YLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-----GTIAY 234
Query: 830 MAPEY--------AMRGYLTDKADVYSFGIVALEIVSGK 860
M+PE A GY D++S G+ LE G+
Sbjct: 235 MSPERINTDLNHGAYDGY---AGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 89.1 bits (222), Expect = 3e-19
Identities = 73/212 (34%), Positives = 107/212 (50%), Gaps = 29/212 (13%)
Query: 659 NNFDAANKIGEGGFGPV----YKGTLSDGAVIAVKQLSS----KSKQGNREFV-NEIGMI 709
++F+ +G G FG V +KG+ G A+K LS K KQ E V NE ++
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGS---GKYYALKILSKAKIVKLKQ--VEHVLNEKRIL 55
Query: 710 SALQHQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIA 769
+++H LV LYG + + L LV EY+ L + K G A + + +
Sbjct: 56 QSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELF-SHLRKSG-RFPEPVA--RFYAAQVV 111
Query: 770 RGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGY 829
L YLH L IV+RD+K N+LLD D KI+DFG AK T+ + GT Y
Sbjct: 112 LALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKR-VKGRTYT---LCGTPEY 164
Query: 830 MAPEYAM-RGYLTDKA-DVYSFGIVALEIVSG 859
+APE + +GY KA D ++ GI+ E+++G
Sbjct: 165 LAPEIILSKGY--GKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 3e-19
Identities = 63/200 (31%), Positives = 101/200 (50%), Gaps = 19/200 (9%)
Query: 666 KIGEGGFGPVYKGTLSDGAVIAV-KQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCC 724
++G+G FG VYK + V+A K + +KS++ +++ EI ++++ H N+VKL
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 725 IEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIV 784
N L ++ E+ ++ + E L + +C L YLHE KI+
Sbjct: 72 YYENNLWILIEFCAGGAVDAVMLELERP---LTEPQIRVVCKQTLEALNYLHEN---KII 125
Query: 785 HRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTR---IAGTVGYMAPEYAMRGYLT 841
HRD+KA N+L D + K++DFG++ +NT R GT +MAPE M
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVSA----KNTRTIQRRDSFIGTPYWMAPEVVMCETSK 181
Query: 842 D-----KADVYSFGIVALEI 856
D KADV+S GI +E+
Sbjct: 182 DRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 3e-19
Identities = 70/274 (25%), Positives = 115/274 (41%), Gaps = 29/274 (10%)
Query: 665 NKIGEGGFGPVYKGTLSDG---AVIAVKQL-SSKSKQGNREFVNEIGMISALQHQNLVKL 720
++IG G FG V G G A + VK+L +S + F+ E+ L H N+++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 721 YGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATR--KRICSDIARGLAYLHEE 778
G CIE LLV E+ L + + +R+ ++A GL +LH
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDL-KNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH-- 117
Query: 779 SRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHIST-RIAGTVGYMAPEYA-- 835
+ +H D+ N L DL+ KI D+GLA E+ +I+ A + ++APE
Sbjct: 118 -QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEI 176
Query: 836 -----MRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLEL 890
+ T K++++S G+ E+ +P + V++EQ ++L
Sbjct: 177 RGQDLLPKDQTKKSNIWSLGVTMWEL----FTAADQPYPDLSDEQVLKQVVREQD--IKL 230
Query: 891 VDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPT 924
P L +S + M L P RPT
Sbjct: 231 PKPQLDLKYSDRWYEVMQFCWL-----DPETRPT 259
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 4e-19
Identities = 66/209 (31%), Positives = 103/209 (49%), Gaps = 22/209 (10%)
Query: 667 IGEGGFGPVYKGTLS-DGAVI--AVKQLSS-KSKQGNREFVNEIGMISAL-QHQNLVKLY 721
IGEG FG V K + DG + A+K++ SK +R+F E+ ++ L H N++ L
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 722 GCCIEGNQLLLVYEYLENNSL------ARAL-----FGKE-GQCLNLDWATRKRICSDIA 769
G C L L EY + +L +R L F L +D+A
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 770 RGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGY 829
RG+ YL ++ + +HRD+ A N+L+ ++ AKI+DFGL++ E R+ V +
Sbjct: 123 RGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP--VRW 177
Query: 830 MAPEYAMRGYLTDKADVYSFGIVALEIVS 858
MA E T +DV+S+G++ EIVS
Sbjct: 178 MAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 4e-19
Identities = 58/212 (27%), Positives = 102/212 (48%), Gaps = 22/212 (10%)
Query: 659 NNFDAANKIGEGGFGPVYKGTL-SDGAVIAVKQLSSKSKQG-NREFVNEIGMISALQHQN 716
+++GEG G V K L + G + A+K +++ ++ + E+ + + +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 717 LVKLYGCCIE--GNQLLLVYEYLENNSL------ARALFGKEGQCLNLDWATRKRICSDI 768
+VK YG ++ + + + EY E SL + G+ G+ + +I +
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLG------KIAESV 114
Query: 769 ARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVG 828
+GL+YLH KI+HRDIK +N+LL + K+ DFG++ E N+ T GT
Sbjct: 115 LKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVS--GELVNSLAGT-FTGTSF 168
Query: 829 YMAPEYAMRGYLTDKADVYSFGIVALEIVSGK 860
YMAPE + +DV+S G+ LE+ +
Sbjct: 169 YMAPERIQGKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 4e-19
Identities = 54/198 (27%), Positives = 99/198 (50%), Gaps = 13/198 (6%)
Query: 665 NKIGEGGFGPVYKGTLSD-GAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGC 723
+K+G G +G VY+G +AVK L + + EF+ E ++ ++H NLV+L G
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 70
Query: 724 CIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKI 783
C ++ E++ +L L +E ++ + + I+ + YL E +
Sbjct: 71 CTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYL--EKK-NF 125
Query: 784 VHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGT---VGYMAPEYAMRGYL 840
+HRD+ A N L+ ++ K++DFGL++L + T AG + + APE
Sbjct: 126 IHRDLAARNCLVGENHLVKVADFGLSRLMTGD---TYTAHAGAKFPIKWTAPESLAYNKF 182
Query: 841 TDKADVYSFGIVALEIVS 858
+ K+DV++FG++ EI +
Sbjct: 183 SIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 5e-19
Identities = 65/208 (31%), Positives = 103/208 (49%), Gaps = 21/208 (10%)
Query: 661 FDAANKIGEGGFGPVY-KGTLSDGAVIAVKQLSSKSKQGN---REFVNEIGMISALQHQN 716
F +IG G FG VY + V+A+K++S KQ N ++ + E+ + ++H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 717 LVKLYGCCIEGNQLLLVYEY-LENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYL 775
++ GC + + LV EY L + S + K Q + + T + +GLAYL
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGAL-----QGLAYL 141
Query: 776 HEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYA 835
H + ++HRDIKA N+LL + K++DFG A + N+ + GT +MAPE
Sbjct: 142 HSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GTPYWMAPEVI 193
Query: 836 M---RGYLTDKADVYSFGIVALEIVSGK 860
+ G K DV+S GI +E+ K
Sbjct: 194 LAMDEGQYDGKVDVWSLGITCIELAERK 221
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 6e-19
Identities = 67/224 (29%), Positives = 104/224 (46%), Gaps = 39/224 (17%)
Query: 666 KIGEGGFGPVY----------------KGTLSDGAV-IAVKQL-SSKSKQGNREFVNEIG 707
K+GEG FG V+ + +D V +AVK L S +F+ E+
Sbjct: 12 KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71
Query: 708 MISALQHQNLVKLYGCCIEGNQLLLVYEYLENNSLARAL----FGKEGQCLN---LDWAT 760
++S L N+ +L G C L ++ EY+EN L + L G N L ++T
Sbjct: 72 ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFST 131
Query: 761 RKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHIS 820
+ + IA G+ YL L VHRD+ N L+ K+ KI+DFG+ N + S
Sbjct: 132 LLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGM-----SRNLYSS 183
Query: 821 T--RIAGT----VGYMAPEYAMRGYLTDKADVYSFGIVALEIVS 858
R+ G + +MA E + G T K+DV++FG+ EI++
Sbjct: 184 DYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 6e-19
Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 21/208 (10%)
Query: 661 FDAANKIGEGGFGPVYKG-TLSDGAVIAVKQLSSKSKQGN---REFVNEIGMISALQHQN 716
F +IG G FG VY + + V+A+K++S KQ N ++ + E+ + L+H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 717 LVKLYGCCIEGNQLLLVYEY-LENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYL 775
++ GC + + LV EY L + S + K Q + + T + +GLAYL
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGAL-----QGLAYL 131
Query: 776 HEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYA 835
H + ++HRD+KA N+LL + K+ DFG A + N + GT +MAPE
Sbjct: 132 HSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVI 183
Query: 836 M---RGYLTDKADVYSFGIVALEIVSGK 860
+ G K DV+S GI +E+ K
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERK 211
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 9e-19
Identities = 62/211 (29%), Positives = 103/211 (48%), Gaps = 35/211 (16%)
Query: 666 KIGEGGFGPVYKG-TLSDGAVIAVKQ--LSSKSKQGNREFVNEIGMISALQHQNLVKLYG 722
KIGEG +G VYK G ++A+K+ L ++ + + EI ++ L H N+V+L
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65
Query: 723 CCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLK 782
N+L LV+E+L + L + + L+ K + +G+AY H S +
Sbjct: 66 VVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLI--KSYLYQLLQGIAYCH--SH-R 119
Query: 783 IVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAG-----------TVGYMA 831
++HRD+K N+L+D++ K++DFGLA R G T+ Y A
Sbjct: 120 VLHRDLKPQNLLIDREGALKLADFGLA------------RAFGVPVRTYTHEVVTLWYRA 167
Query: 832 PEYAM--RGYLTDKADVYSFGIVALEIVSGK 860
PE + R Y T D++S G + E+V+ +
Sbjct: 168 PEILLGSRQYST-PVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 9e-19
Identities = 62/202 (30%), Positives = 108/202 (53%), Gaps = 20/202 (9%)
Query: 667 IGEGGFGPVYKGT-LSDGAVI----AVKQL-SSKSKQGNREFVNEIGMISALQHQNLVKL 720
+G G FG VYKG + DG + A+K L + S + N+E ++E +++ + + +L
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 721 YGCCIEGNQLLLVYEYLENNSL---ARALFGKEGQCLNLDWATRKRICSDIARGLAYLHE 777
G C+ + + LV + + L R + G L+W C IA+G++YL E
Sbjct: 75 LGICLT-STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNW------CVQIAKGMSYLEE 127
Query: 778 ESRLKIVHRDIKATNVLLDKDLNAKISDFGLAK-LDEDENTHISTRIAGTVGYMAPEYAM 836
+++VHRD+ A NVL+ + KI+DFGLA+ LD DE + + + +MA E +
Sbjct: 128 ---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL 184
Query: 837 RGYLTDKADVYSFGIVALEIVS 858
T ++DV+S+G+ E+++
Sbjct: 185 HRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.3 bits (217), Expect = 1e-18
Identities = 65/207 (31%), Positives = 106/207 (51%), Gaps = 24/207 (11%)
Query: 661 FDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLS-SKSKQGNREF-VNEIGM---ISALQH 714
++ +IGEG +G VYK L+ G +A+K++ S++G + EI + + + +H
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60
Query: 715 QNLVKLYGCCI-----EGNQLLLVYEYLENNSLARAL--FGKEGQCLNLDWATRKRICSD 767
N+V+L C +L LV+E+++ + LA L K G L T K +
Sbjct: 61 PNIVRLLDVCHGPRTDRELKLTLVFEHVDQD-LATYLSKCPKPG----LPPETIKDLMRQ 115
Query: 768 IARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTV 827
+ RG+ +LH +IVHRD+K N+L+ D KI+DFGLA++ E T + T+
Sbjct: 116 LLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA--LTSVVVTL 170
Query: 828 GYMAPEYAMRGYLTDKADVYSFG-IVA 853
Y APE ++ D++S G I A
Sbjct: 171 WYRAPEVLLQSSYATPVDMWSVGCIFA 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 1e-18
Identities = 60/227 (26%), Positives = 106/227 (46%), Gaps = 37/227 (16%)
Query: 666 KIGEGGFGPVYKGTLSD-----------------GAVIAVKQL-SSKSKQGNREFVNEIG 707
K+GEG FG V+ + + ++AVK L +K +F+ E+
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71
Query: 708 MISALQHQNLVKLYGCCIEGNQLLLVYEYLENNSLARAL---------------FGKEGQ 752
++S L+ N+++L G C++ + L ++ EY+EN L + L
Sbjct: 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131
Query: 753 CLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAK-L 811
+ +++ + IA G+ YL S L VHRD+ N L+ ++L KI+DFG+++ L
Sbjct: 132 LPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNL 188
Query: 812 DEDENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS 858
+ I R + +MA E + G T +DV++FG+ EI+
Sbjct: 189 YAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 2e-18
Identities = 64/243 (26%), Positives = 110/243 (45%), Gaps = 48/243 (19%)
Query: 667 IGEGGFGPVYK--GTLSDGAVIAVKQLS---------SKSKQGN-REFVNEIGMI-SALQ 713
+G G FG VYK + ++A+K+++ + + + + V+E+ +I L+
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 714 HQNLVKLYGCCIEGNQLLLVYEYLENNSLARAL--FGKEGQCLNLD--WATRKRICSDIA 769
H N+V+ Y +E ++L +V + +E L ++ Q + W ++
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMV---- 123
Query: 770 RGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGY 829
L YLH+E R IVHRD+ N++L +D I+DFGLAK + + + T + GT+ Y
Sbjct: 124 LALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK-QKQPESKL-TSVVGTILY 179
Query: 830 MAPEYAMRGYLTDKADVYSFGIV-------------------ALEIVSGKSNTNYRPKEE 870
PE +KADV++FG + A +IV Y P E
Sbjct: 180 SCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAV----YEPLPE 235
Query: 871 FVY 873
+Y
Sbjct: 236 GMY 238
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 2e-18
Identities = 76/280 (27%), Positives = 125/280 (44%), Gaps = 39/280 (13%)
Query: 660 NFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQ------LSSKSKQGNREFVNEIGMISAL 712
NF KIG G F VY+ T L D +A+K+ + +K++Q + V EI ++ L
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQ---DCVKEIDLLKQL 59
Query: 713 QHQNLVKLYGCCIEGNQLLLVYEYLENNSLARAL--FGKEGQCL--NLDWATRKRICSDI 768
H N++K IE N+L +V E + L++ + F K+ + + W ++CS
Sbjct: 60 NHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCS-- 117
Query: 769 ARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVG 828
A H SR +++HRDIK NV + K+ D GL + + T + + GT
Sbjct: 118 ----AVEHMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-LVGTPY 171
Query: 829 YMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLL 888
YM+PE K+D++S G + E+ + +S Y K L +
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQS-PFYGDKMNLFSLC----------QKI 220
Query: 889 ELVD--PSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMS 926
E D P ++S+K + + +C P P RP +
Sbjct: 221 EQCDYPPLPTEHYSEK----LRELVSMCIYPDPDQRPDIG 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 2e-18
Identities = 78/261 (29%), Positives = 117/261 (44%), Gaps = 30/261 (11%)
Query: 667 IGEGGFGPVYKG-TLSDGAVIAVKQLS-----SKSKQGNREFVNEIGMISALQHQNLVKL 720
I +G FG VY S G A+K L +K++ N + I MI + + KL
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQG-ESPYVAKL 62
Query: 721 YGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESR 780
Y + L LV EYL A +L G L DWA K+ +++ G+ LH+
Sbjct: 63 YYSFQSKDYLYLVMEYLNGGDCA-SLIKTLGG-LPEDWA--KQYIAEVVLGVEDLHQRG- 117
Query: 781 LKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRGYL 840
I+HRDIK N+L+D+ + K++DFGL+ N + + GT Y+APE +
Sbjct: 118 --IIHRDIKPENLLIDQTGHLKLTDFGLS-----RNGLENKKFVGTPDYLAPETILGVGD 170
Query: 841 TDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGSNFS 900
+D +S G V E + G Y P + +L + N E V F
Sbjct: 171 DKMSDWWSLGCVIFEFLFG-----YPPFHAETPDAVFDNILSRRINWPEEVK-----EFC 220
Query: 901 KKEAMTMLNIALLCTNPSPTL 921
EA+ ++N LLC +P+ L
Sbjct: 221 SPEAVDLIN-RLLCMDPAKRL 240
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 2e-18
Identities = 61/201 (30%), Positives = 95/201 (47%), Gaps = 15/201 (7%)
Query: 667 IGEGGFGPVYKGTLSD-GAVIAVKQLSSK---SKQGNREFVNEIGMISALQHQNLVKLYG 722
+G+GGFG V + G + A K+L K ++G + +NE ++ + + +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 723 CCIEGNQLLLVYEYLENNSLARALF--GKEGQCLNLDWATRKRICSDIARGLAYLHEESR 780
+ L LV + L ++ G+ G A + I GL +LH+
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPG----FPEARAIFYAAQIICGLEHLHQR-- 114
Query: 781 LKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRGYL 840
+IV+RD+K NVLLD N +ISD GLA ++ I R AGT GYMAPE
Sbjct: 115 -RIVYRDLKPENVLLDDHGNVRISDLGLA-VELKGGKKIKGR-AGTPGYMAPEVLQGEVY 171
Query: 841 TDKADVYSFGIVALEIVSGKS 861
D ++ G E+++G+S
Sbjct: 172 DFSVDWFALGCTLYEMIAGRS 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 2e-18
Identities = 78/295 (26%), Positives = 131/295 (44%), Gaps = 58/295 (19%)
Query: 666 KIGEGGFGPVYKGTLSD------GAVIAVKQLSSKSKQGNR-EFVNEIGMISALQHQNLV 718
++G+G FG VY+G D +AVK ++ + R EF+NE ++ ++V
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72
Query: 719 KLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRK-----------RICSD 767
+L G +G L+V E + + L L + L + ++ ++
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYL-----RSLRPEAENNPGRPPPTLQEMIQMAAE 127
Query: 768 IARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAG-- 825
IA G+AYL+ + K VHRD+ A N ++ D KI DFG+ + D E + G
Sbjct: 128 IADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR-DIYETDYYRKGGKGLL 183
Query: 826 TVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-------GKSNTNYRPKEEFVYLLDWA 878
V +MAPE G T +D++SFG+V EI S G SN ++ +++D
Sbjct: 184 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN-----EQVLKFVMDGG 238
Query: 879 YVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933
Y L + N E + ++ +C +P +RPT V++L+
Sbjct: 239 Y-LDQPDNCPE----------------RVTDLMRMCWQFNPKMRPTFLEIVNLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 86.5 bits (215), Expect = 2e-18
Identities = 55/199 (27%), Positives = 98/199 (49%), Gaps = 17/199 (8%)
Query: 660 NFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNREFVN-----EIGMISALQ 713
++ K+GEG + VYK G ++A+K++ ++ ++ +N EI ++ L+
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 714 HQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLA 773
H N++ L + + LV+E++E + + + + + L A K RGL
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFMETD--LEKVI--KDKSIVLTPADIKSYMLMTLRGLE 116
Query: 774 YLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPE 833
YLH I+HRD+K N+L+ D K++DFGLA+ N ++ ++ T Y APE
Sbjct: 117 YLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWYRAPE 172
Query: 834 --YAMRGYLTDKADVYSFG 850
+ R Y D++S G
Sbjct: 173 LLFGARHY-GVGVDMWSVG 190
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 2e-18
Identities = 73/243 (30%), Positives = 118/243 (48%), Gaps = 22/243 (9%)
Query: 666 KIGEGGFGPVYKGTLSDG---AVIAVKQL-SSKSKQGNREFVNEIGMISALQHQNLVKLY 721
+IG G FG V G ++ G A + VK+L S S Q +F+ E +LQH NL++
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 722 GCCIEGNQLLLVYEYLENNSLARALFG-KEGQCLNLDWATRKRICSDIARGLAYLHEESR 780
G C E LLV E+ L L ++ + + D T +R+ +IA GL +LH+ +
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN- 120
Query: 781 LKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHI-STRIAGTVGYMAPEYA--MR 837
+H D+ N LL DL KI D+GL+ E+ ++ ++ + ++APE +
Sbjct: 121 --FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVH 178
Query: 838 GYL-----TDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVD 892
G L T +++V+S G+ E+ + YR + L Y ++EQ L+L
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWELFE-LGSQPYRHLSDEQVL---TYTVREQQ--LKLPK 232
Query: 893 PSL 895
P L
Sbjct: 233 PRL 235
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 5e-18
Identities = 69/221 (31%), Positives = 108/221 (48%), Gaps = 30/221 (13%)
Query: 659 NNFDAANKIGEGGFGPVYK------GTLSDGAVIAVKQLSSKSKQGNREFVNEIGMISAL 712
N+ + IGEG FG V K G D A+ +K+ +SK +R+F E+ ++ L
Sbjct: 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD--HRDFAGELEVLCKL 64
Query: 713 -QHQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLD--WATRKRICS--- 766
H N++ L G C L L EY + +L F ++ + L D +A S
Sbjct: 65 GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLD--FLRKSRVLETDPAFAIANSTASTLS 122
Query: 767 ---------DIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENT 817
D+ARG+ YL S+ + +HRD+ A N+L+ ++ AKI+DFGL++ E
Sbjct: 123 SQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK 179
Query: 818 HISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS 858
R+ V +MA E T +DV+S+G++ EIVS
Sbjct: 180 KTMGRLP--VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 6e-18
Identities = 60/208 (28%), Positives = 104/208 (50%), Gaps = 19/208 (9%)
Query: 666 KIGEGGFGPVYKGTLSDGAV-------IAVKQLSSKSKQGNR-EFVNEIGMISALQHQNL 717
++G+G FG VY+G ++ G V +A+K ++ + R EF+NE ++ ++
Sbjct: 13 ELGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 71
Query: 718 VKLYGCCIEGNQLLLVYEYLENNSLA---RALFGKEGQCLNLDWATRKRI---CSDIARG 771
V+L G +G L++ E + L R+L + + K++ +IA G
Sbjct: 72 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131
Query: 772 LAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAK-LDEDENTHISTRIAGTVGYM 830
+AYL+ K VHRD+ A N ++ +D KI DFG+ + + E + + V +M
Sbjct: 132 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 188
Query: 831 APEYAMRGYLTDKADVYSFGIVALEIVS 858
+PE G T +DV+SFG+V EI +
Sbjct: 189 SPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 6e-18
Identities = 67/220 (30%), Positives = 112/220 (50%), Gaps = 19/220 (8%)
Query: 667 IGEGGFGPVY------KGTLSDGAVIAVKQLSSKSKQGN-REFVNEIGMISALQHQNLVK 719
+GEG FG V +G + G +AVK L +S + + EI ++ L H+N+VK
Sbjct: 12 LGEGHFGKVELCRYDPEGD-NTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70
Query: 720 LYGCCIE--GNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHE 777
G C E GN + L+ E+L + SL L + +NL + + I +G+ YL
Sbjct: 71 YKGICTEDGGNGIKLIMEFLPSGSLKEYL-PRNKNKINLK--QQLKYAVQICKGMDYLG- 126
Query: 778 ESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTR--IAGTVGYMAPEYA 835
SR + VHRD+ A NVL++ + KI DFGL K E + + + + + V + APE
Sbjct: 127 -SR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECL 184
Query: 836 MRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLL 875
++ +DV+SFG+ E+++ ++ P F+ ++
Sbjct: 185 IQSKFYIASDVWSFGVTLYELLT-YCDSESSPMTLFLKMI 223
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 7e-18
Identities = 81/283 (28%), Positives = 118/283 (41%), Gaps = 66/283 (23%)
Query: 647 GYFTL--RQIKAATNNFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNREFV 703
GY T+ ++ A N+ + +IG G G VYK G V+AVKQ+ + GN+E
Sbjct: 1 GYLTIDGQKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMR---RTGNKEEN 57
Query: 704 NEIGM---ISALQHQ--NLVKLYGCCIEGNQLLLVYEYLE----------NNSLARALFG 748
I M + H +VK YG I + + + E + + + G
Sbjct: 58 KRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILG 117
Query: 749 KEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGL 808
K + I + L YL E+ ++HRD+K +N+LLD N K+ DFG+
Sbjct: 118 K--------------MTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGI 161
Query: 809 AKLDEDENTHISTRIAGTVGYMAPE----------YAMRGYLTDKADVYSFGIVALEIVS 858
+ D TR AG YMAPE Y +R ADV+S GI +E+ +
Sbjct: 162 SGRLVDSKAK--TRSAGCAAYMAPERIDPPDPNPKYDIR------ADVWSLGISLVELAT 213
Query: 859 GKSNTNYR-PKEEFVYLLDWAYVLQEQGNLLELVDPSLGSNFS 900
G+ Y+ K EF L +LQE E FS
Sbjct: 214 GQF--PYKNCKTEFEVL---TKILQE-----EPPSLPPNEGFS 246
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 7e-18
Identities = 62/209 (29%), Positives = 106/209 (50%), Gaps = 17/209 (8%)
Query: 660 NFDAANKIGEGGFGPVYKG-TLSDGAVIAVKQ--LSSKSKQGNREFVNEIGMISALQHQN 716
NF KIGEG +G VYK G V+A+K+ L ++++ + EI ++ L H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 717 LVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLH 776
+VKL N+L LV+E+L + L + + + L K + +GLA+ H
Sbjct: 61 IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPL--PLIKSYLFQLLQGLAFCH 117
Query: 777 EESRLKIVHRDIKATNVLLDKDLNAKISDFGLAK---LDEDENTHISTRIAGTVGYMAPE 833
+++HRD+K N+L++ + K++DFGLA+ + TH T+ Y APE
Sbjct: 118 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TLWYRAPE 170
Query: 834 YAM-RGYLTDKADVYSFGIVALEIVSGKS 861
+ Y + D++S G + E+V+ ++
Sbjct: 171 ILLGCKYYSTAVDIWSLGCIFAEMVTRRA 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 7e-18
Identities = 57/209 (27%), Positives = 101/209 (48%), Gaps = 20/209 (9%)
Query: 659 NNFDAANKIGEGGFGPVYKGTLSD-GAVIAVKQL--SSKSKQGNREFVNEIGMISALQHQ 715
++ +GEG +G V K + G ++A+K+ S K + + EI M+ L+H+
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHE 60
Query: 716 NLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYL 775
NLV L +L LV+E++++ L E LD + ++ I RG+ +
Sbjct: 61 NLVNLIEVFRRKKRLYLVFEFVDHTVLDDL----EKYPNGLDESRVRKYLFQILRGIEFC 116
Query: 776 HEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKL----DEDENTHISTRIAGTVGYMA 831
H + I+HRDIK N+L+ + K+ DFG A+ E +++TR Y A
Sbjct: 117 HSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATR-----WYRA 168
Query: 832 PEYAMRGYLTDKA-DVYSFGIVALEIVSG 859
PE + +A D+++ G + E+++G
Sbjct: 169 PELLVGDTKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 8e-18
Identities = 62/208 (29%), Positives = 101/208 (48%), Gaps = 24/208 (11%)
Query: 659 NNFDAANKIGEGGFGPVYKG-TLSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNL 717
++++ ++G G +G VYK L G + AVK + + EI M+ +H N+
Sbjct: 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNI 68
Query: 718 VKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHE 777
V +G + +L + EY SL + ++ G L A +C + +GLAYLH
Sbjct: 69 VAYFGSYLSREKLWICMEYCGGGSL-QDIYHVTGPLSELQIAY---VCRETLQGLAYLHS 124
Query: 778 ESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIA------GTVGYMA 831
+ ++ HRDIK N+LL + + K++DFG+A I+ IA GT +MA
Sbjct: 125 KGKM---HRDIKGANILLTDNGDVKLADFGVA-------AKITATIAKRKSFIGTPYWMA 174
Query: 832 PEYAM---RGYLTDKADVYSFGIVALEI 856
PE A G D+++ GI A+E+
Sbjct: 175 PEVAAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 8e-18
Identities = 67/237 (28%), Positives = 124/237 (52%), Gaps = 23/237 (9%)
Query: 667 IGEGGFGPVYKGTLS-DGAV--IAVK--QLSSKSKQGNREFVNEIGMISALQHQNLVKLY 721
+GEG FG V +G L+ D ++ +AVK +++ ++ +F++E + H N+++L
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 722 GCCIEGNQL------LLVYEYLENNSL-ARALFGKEGQC-LNLDWATRKRICSDIARGLA 773
G C++ + +++ ++++ L + L+ + G C L + +DIA G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 774 YLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGT-VGYMAP 832
YL S +HRD+ A N +L++++N ++DFGL+K + + + RIA V ++A
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 833 EYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLE 889
E T K+DV+SFG+ EI + + T Y P E + D+ QGN L+
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIAT-RGQTPY-PGVENSEIYDYL----RQGNRLK 234
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 9e-18
Identities = 80/282 (28%), Positives = 130/282 (46%), Gaps = 59/282 (20%)
Query: 667 IGEGGFGPVYKGTLSD-GAVIAVKQLSSKS-KQGNREFVNEIGMISALQH-QNLVKLYG- 722
IG G FG V K G ++AVK++ S ++ + + ++ ++ +VK YG
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71
Query: 723 ------C--CIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIA----R 770
C C+E L+ L+ + ++ + + I IA +
Sbjct: 72 LFREGDCWICME-----LMDISLDK--FYKYVYEVLKSVIP------EEILGKIAVATVK 118
Query: 771 GLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLA-KLDEDENTHISTRIAGTVGY 829
L YL EE LKI+HRD+K +N+LLD++ N K+ DFG++ +L ++ TR AG Y
Sbjct: 119 ALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQL---VDSIAKTRDAGCRPY 173
Query: 830 MAPE----YAMRGYLTD-KADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQ 884
MAPE A GY D ++DV+S GI E+ +GK F Y W V +
Sbjct: 174 MAPERIDPSARDGY--DVRSDVWSLGITLYEVATGK----------FPY-PKWNSVFDQ- 219
Query: 885 GNLLELVD---PSLGSNFSKKEAMTMLNIALLCTNPSPTLRP 923
L ++V P L ++ ++ + + +N LC + RP
Sbjct: 220 --LTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRP 259
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 1e-17
Identities = 63/209 (30%), Positives = 110/209 (52%), Gaps = 34/209 (16%)
Query: 667 IGEGGFGPVYKGT-LSDGAVI----AVKQL-SSKSKQGNREFVNEIGMISALQHQNLVKL 720
+G G FG VYKG + +G + A+K+L + S + N+E ++E +++++ + ++ +L
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74
Query: 721 YGCCIEG-----NQLL---LVYEYLENNSLARALFGKEGQCLN--LDWATRKRICSDIAR 770
G C+ QL+ + +Y+ + K+ L+W C IA+
Sbjct: 75 LGICLTSTVQLITQLMPFGCLLDYVREH--------KDNIGSQYLLNW------CVQIAK 120
Query: 771 GLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAK-LDEDENTHISTRIAGTVGY 829
G+ YL EE RL VHRD+ A NVL+ + KI+DFGLAK L DE + + + +
Sbjct: 121 GMNYL-EERRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKW 177
Query: 830 MAPEYAMRGYLTDKADVYSFGIVALEIVS 858
MA E + T ++DV+S+G+ E+++
Sbjct: 178 MALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 1e-17
Identities = 86/296 (29%), Positives = 137/296 (46%), Gaps = 53/296 (17%)
Query: 667 IGEGGFGPVY--------KGTLSDGAVIAVKQLSSKSKQGN-REFVNEIGMISAL-QHQN 716
+GEG FG V K + +AVK L S + + + + ++E+ M+ + +H+N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 717 LVKLYGCCIEGNQLLLVYEYLENNSL-----ARALFGKEGQCLNLDWATRKRICS----- 766
++ L G C + L ++ EY +L AR G E C N +++
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGME-YCYNPTQVPEEQLSFKDLVS 144
Query: 767 ---DIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRI 823
+ARG+ YL + K +HRD+ A NVL+ +D KI+DFGLA+ + HI
Sbjct: 145 CAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYYK 197
Query: 824 AGTVG-----YMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDW 877
T G +MAPE T ++DV+SFG++ EI + G S P EE LL
Sbjct: 198 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL-- 255
Query: 878 AYVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933
++G+ ++ P SN + + M M + C + P+ RPT V L+
Sbjct: 256 -----KEGHRMD--KP---SNCTNELYMMMRD----CWHAVPSQRPTFKQLVEDLD 297
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 2e-17
Identities = 82/292 (28%), Positives = 132/292 (45%), Gaps = 45/292 (15%)
Query: 667 IGEGGFGPVY--------KGTLSDGAVIAVKQLSSKSKQGN-REFVNEIGMISAL-QHQN 716
+GEG FG V K + +AVK L + + + + V+E+ M+ + +H+N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 717 LVKLYGCCIEGNQLLLVYEYLENNSLARALFGKE--GQCLNLDWA-------TRKRICS- 766
++ L G C + L ++ EY +L L + G + D A T K + S
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 767 --DIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIA 824
+ARG+ YL + K +HRD+ A NVL+ ++ KI+DFGLA+ D + +
Sbjct: 143 TYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR-DVNNIDYYKKTTN 198
Query: 825 G--TVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWAYVL 881
G V +MAPE T ++DV+SFG++ EI + G S P EE LL + +
Sbjct: 199 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRM 258
Query: 882 QEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933
+ N + + M M + C + P+ RPT V L+
Sbjct: 259 DKPANC------------TNELYMMMRD----CWHAIPSHRPTFKQLVEDLD 294
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 2e-17
Identities = 84/293 (28%), Positives = 136/293 (46%), Gaps = 47/293 (16%)
Query: 667 IGEGGFGPVYKGTL--------SDGAVIAVKQLSSKSKQGN-REFVNEIGMISAL-QHQN 716
+GEG FG V + +AVK L + + + ++E+ ++ + +H+N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 717 LVKLYGCCIEGNQLLLVYEYLENNSLARALFGK---------EGQCLNLDWATRKRICS- 766
++ L G C + L ++ EY +L L + + + + + K + S
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 767 --DIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHIST--- 821
+ARG+ YL ESR + +HRD+ A NVL+ +D KI+DFGLA+ D + + T
Sbjct: 140 AYQVARGMEYL--ESR-RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196
Query: 822 RIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWAYV 880
R+ V +MAPE T ++DV+SFGI+ EI + G S P EE LL
Sbjct: 197 RLP--VKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLL----- 249
Query: 881 LQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933
+G+ ++ P SN + + M M C + PT RPT V L+
Sbjct: 250 --REGHRMD--KP---SNCTHELYMLMRE----CWHAVPTQRPTFKQLVEALD 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 3e-17
Identities = 63/223 (28%), Positives = 101/223 (45%), Gaps = 23/223 (10%)
Query: 62 NVTIDDSNGSNFTCDCTYSNNTVCHVTVILLKGFNLAGVIPEEFGNLTFLQEVDLSRNYF 121
N+T+ D + +N T + + ++ ++L +L G IP+ G L+ V L N F
Sbjct: 357 NLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSF 416
Query: 122 NGSLPKSFARLQNLTKLLILGNRLSGSI--------PLEIGDIS---------------T 158
+G LP F +L + L I N L G I L++ ++
Sbjct: 417 SGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKR 476
Query: 159 LEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLT 218
LE L L NQ G +P LG+L L ++ LS N +G IP+ + K L + + L+
Sbjct: 477 LENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLS 536
Query: 219 GRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRIS 261
G+IP L +LDL L G IP + +++L ++ IS
Sbjct: 537 GQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNIS 579
|
Length = 968 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 4e-17
Identities = 61/213 (28%), Positives = 99/213 (46%), Gaps = 23/213 (10%)
Query: 666 KIGEGGFGPVYKGTL-----SDGAVIAVKQLSS-KSKQGNREFVNEIGMISALQHQNLVK 719
++GE FG +YKG L ++A+K L + Q EF E +++ L H N+V
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 720 LYGCCIEGNQLLLVYEYLENNSLARALFGKEGQC-------------LNLDWATRKRICS 766
L G + + +++EYL L L + +LD I
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 767 DIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAK-LDEDENTHISTRIAG 825
IA G+ YL S VH+D+ A N+L+ + L+ KISD GL++ + + + +
Sbjct: 132 QIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188
Query: 826 TVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS 858
+ +M PE M G + +D++SFG+V EI S
Sbjct: 189 PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 4e-17
Identities = 62/206 (30%), Positives = 103/206 (50%), Gaps = 24/206 (11%)
Query: 666 KIGEGGFGPVYKG-TLSDGAVIAVKQ--LSSKSKQGNREFVNEIGMISALQHQNLVKLYG 722
KIGEG +G VYKG G ++A+K+ L S+ + + EI ++ LQH N+V L
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66
Query: 723 CCIEGNQLLLVYEYLENNSLARAL--FGKEGQCLNLDWATRKRICSDIARGLAYLHEESR 780
++ ++L L++E+L + L + L K +D K I +G+ + H
Sbjct: 67 VLMQESRLYLIFEFLSMD-LKKYLDSLPKGQY---MDAELVKSYLYQILQGILFCH---S 119
Query: 781 LKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRI----AGTVGYMAPEYAM 836
+++HRD+K N+L+D K++DFGLA+ I R+ T+ Y APE +
Sbjct: 120 RRVLHRDLKPQNLLIDNKGVIKLADFGLAR-----AFGIPVRVYTHEVVTLWYRAPEVLL 174
Query: 837 RG--YLTDKADVYSFGIVALEIVSGK 860
Y T D++S G + E+ + K
Sbjct: 175 GSPRYST-PVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 5e-17
Identities = 72/247 (29%), Positives = 117/247 (47%), Gaps = 33/247 (13%)
Query: 667 IGEGGFGPVY--------KGTLSDGAVIAVKQLSSKSKQGN-REFVNEIGMISAL-QHQN 716
+GEG FG V K + +AVK L + + + V+E+ M+ + +H+N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 717 LVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRK-----RICSD---- 767
++ L G C + L ++ EY +L L + ++ + T K D
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 768 ---IARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAK----LDEDENTHIS 820
+ARG+ YL + K +HRD+ A NVL+ +D KI+DFGLA+ +D + T +
Sbjct: 140 AYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKT-TN 195
Query: 821 TRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWAY 879
R+ V +MAPE T ++DV+SFG++ EI + G S P EE LL +
Sbjct: 196 GRLP--VKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGH 253
Query: 880 VLQEQGN 886
+ + N
Sbjct: 254 RMDKPAN 260
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 5e-17
Identities = 68/230 (29%), Positives = 105/230 (45%), Gaps = 37/230 (16%)
Query: 657 ATNNFDAANKIGEGGFGPVYKG-TLSDGAVIAVKQ-LSSKSKQGNREF----VNEIGMIS 710
+++ K+GEG FG VYK + G V+A+K+ L K G F + EI ++
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG---FPITALREIKILK 62
Query: 711 ALQHQNLVKLYGCCIE-----GNQLLLVY---EYLENNSLARALFGKEGQCLNLDWATRK 762
L+H N+V L +E + VY Y++++ L+ L E + L + K
Sbjct: 63 KLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHD-LSGLL---ENPSVKLTESQIK 118
Query: 763 RICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDED-------- 814
+ G+ YLHE I+HRDIKA N+L+D KI+DFGLA+ +
Sbjct: 119 CYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGG 175
Query: 815 --ENTHISTRIAGTVGYMAPEYAM--RGYLTDKADVYSFGIVALEIVSGK 860
T T + T Y PE + R Y T D++ G V E+ + +
Sbjct: 176 GGGGTRKYTNLVVTRWYRPPELLLGERRY-TTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 7e-17
Identities = 65/219 (29%), Positives = 106/219 (48%), Gaps = 26/219 (11%)
Query: 667 IGEGGFGPVYKGTL----SDGAVIAVKQLSSK--SKQGNREFVNEIGMISALQHQNLVKL 720
+G+G +G V +L +DG +K+L+ + S++ + E ++S L+H N+V
Sbjct: 8 VGKGSYGEV---SLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIV-A 63
Query: 721 YGCCIEGN--QLLLVYEYLENNSLARALFGKEGQCLN----LDWATRKRICSDIARGLAY 774
Y EG L +V + E L L ++G+ L ++W + IA L Y
Sbjct: 64 YRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQ------IAMALQY 117
Query: 775 LHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEY 834
LHE+ I+HRD+K NV L + K+ D G+A++ E++ ST I GT YM+PE
Sbjct: 118 LHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLI-GTPYYMSPEL 173
Query: 835 AMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVY 873
K+DV++ G E+ + K N + VY
Sbjct: 174 FSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVY 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 9e-17
Identities = 78/270 (28%), Positives = 129/270 (47%), Gaps = 35/270 (12%)
Query: 667 IGEGGFGPVYK-GTLSDGAVIAVKQLSSKSKQGNR-EFVNEIGMISALQHQNLVKLYGCC 724
+G G G V K + G V+A K + +K R + + E+ ++ + +V YG
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 725 IEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIA----RGLAYLHEESR 780
+ N + + E+++ SL R K+G + ++ I IA GL YL+ R
Sbjct: 73 LNENNICMCMEFMDCGSLDRIY--KKGGPIPVE------ILGKIAVAVVEGLTYLYNVHR 124
Query: 781 LKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRGYL 840
I+HRDIK +N+L++ K+ DFG++ E N+ I+ GT YM+PE G
Sbjct: 125 --IMHRDIKPSNILVNSRGQIKLCDFGVS--GELINS-IADTFVGTSTYMSPERIQGGKY 179
Query: 841 TDKADVYSFGIVALEIVSGK-----SNTNYRPKEEFVYLLDWAY-VLQEQGNLLELVDPS 894
T K+DV+S GI +E+ GK SN + +++ + +LD ++QE P
Sbjct: 180 TVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP-------PR 232
Query: 895 LGSNFSKKEAMTMLNIALLCTNPSPTLRPT 924
L S+ ++ ++ LL PT RPT
Sbjct: 233 LPSSDFPEDLRDFVDACLLKD---PTERPT 259
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 9e-17
Identities = 58/208 (27%), Positives = 97/208 (46%), Gaps = 17/208 (8%)
Query: 660 NFDAANKIGEGGFGPVY--KGTLSDGAVI----AVKQLSSKSKQGNREFVNEIGMISALQ 713
++ +G G FG V+ + VI V+Q++ + + NE ++ L
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQ---NECQVLKLLS 57
Query: 714 HQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLA 773
H N+++ Y +E L++V EY +LA K L LD T I L
Sbjct: 58 HPNIIEYYENFLEDKALMIVMEYAPGGTLAE-YIQKRCNSL-LDEDTILHFFVQILLALH 115
Query: 774 YLHEESRLKIVHRDIKATNVLLDKDLN-AKISDFGLAKLDEDENTHISTRIAGTVGYMAP 832
++H + I+HRD+K N+LLDK KI DFG++K+ ++ + + GT Y++P
Sbjct: 116 HVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK--AYTVVGTPCYISP 170
Query: 833 EYAMRGYLTDKADVYSFGIVALEIVSGK 860
E K+D+++ G V E+ S K
Sbjct: 171 ELCEGKPYNQKSDIWALGCVLYELASLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 9e-17
Identities = 45/154 (29%), Positives = 80/154 (51%), Gaps = 10/154 (6%)
Query: 660 NFDAANKIGEGGFGPVYKG-TLSDGAVIAVK--QLSSKSKQGNREFVNEIGMISALQHQN 716
++ KIGEG +G V+K ++A+K +L + + EI ++ L+H+N
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 60
Query: 717 LVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLH 776
+V+LY +L LV+EY + + L + G +D K + +GLA+ H
Sbjct: 61 IVRLYDVLHSDKKLTLVFEYCDQD-LKKYFDSCNGD---IDPEIVKSFMFQLLKGLAFCH 116
Query: 777 EESRLKIVHRDIKATNVLLDKDLNAKISDFGLAK 810
++HRD+K N+L++K+ K++DFGLA+
Sbjct: 117 SH---NVLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 1e-16
Identities = 56/221 (25%), Positives = 102/221 (46%), Gaps = 34/221 (15%)
Query: 661 FDAANKIGEGGFGPVYKG---TLSDGAVIAVKQLSSKSKQG---NREFVNEIGMISALQH 714
++ IG G +G VYK DG A+K+ +Q ++ EI ++ L+H
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 715 QNLVKLYGCCIEGNQ--LLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGL 772
+N+V L +E + L+++Y E++ F ++ + +++ + K + I G+
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGV 121
Query: 773 AYLHEESRLKIVHRDIKATNVLLDKDLNA----KISDFGLAKL---------DEDENTHI 819
YLH ++HRD+K N+L+ + KI D GLA+L D D
Sbjct: 122 HYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLD----- 173
Query: 820 STRIAGTVGYMAPEYAM--RGYLTDKADVYSFGIVALEIVS 858
+ T+ Y APE + R Y T D+++ G + E+++
Sbjct: 174 --PVVVTIWYRAPELLLGARHY-TKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 1e-16
Identities = 60/199 (30%), Positives = 101/199 (50%), Gaps = 13/199 (6%)
Query: 666 KIGEGGFGPVYKGTL---SDGAVIAVKQLSSKSKQGNR-EFVNEIGMISALQHQNLVKLY 721
++G G FG V KG +A+K L +++++ R E + E ++ L + +V++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 722 GCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRL 781
G C E L+LV E L + L GK+ + + + + ++ G+ YL ++
Sbjct: 62 GVC-EAEALMLVMEMASGGPLNKFLSGKKDE---ITVSNVVELMHQVSMGMKYLEGKN-- 115
Query: 782 KIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGT--VGYMAPEYAMRGY 839
VHRD+ A NVLL AKISDFGL+K ++++ R AG + + APE
Sbjct: 116 -FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRK 174
Query: 840 LTDKADVYSFGIVALEIVS 858
+ ++DV+S+GI E S
Sbjct: 175 FSSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 1e-16
Identities = 57/207 (27%), Positives = 101/207 (48%), Gaps = 24/207 (11%)
Query: 660 NFDAANKIGEGGFGPVYKG-TLSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLV 718
+F+ +IG G +G VYK ++ G + A+K + + + EI M+ +H N+V
Sbjct: 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIV 69
Query: 719 KLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEE 778
+G + ++L + E+ SL + ++ G A + + +GL YLH +
Sbjct: 70 AYFGSYLRRDKLWICMEFCGGGSL-QDIYHVTGPLSESQIAY---VSRETLQGLYYLHSK 125
Query: 779 SRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIA------GTVGYMAP 832
++ HRDIK N+LL + + K++DFG++ I+ IA GT +MAP
Sbjct: 126 GKM---HRDIKGANILLTDNGHVKLADFGVS-------AQITATIAKRKSFIGTPYWMAP 175
Query: 833 EYAM---RGYLTDKADVYSFGIVALEI 856
E A +G D+++ GI A+E+
Sbjct: 176 EVAAVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 3e-16
Identities = 68/213 (31%), Positives = 107/213 (50%), Gaps = 28/213 (13%)
Query: 661 FDAANKIGEGGFGPVYKGT-LSDGAVIAVKQ--LSSKSKQGNREFVNEIGMISALQHQNL 717
++ KIGEG +G VYK IA+K+ L + + + EI ++ +QH N+
Sbjct: 4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI 63
Query: 718 VKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICS----DIARGLA 773
V+L +L LV+EYL+ L K+ + D+A R+ I RG+A
Sbjct: 64 VRLQDVVHSEKRLYLVFEYLD-------LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIA 116
Query: 774 YLHEESRLKIVHRDIKATNVLLDKDLNA-KISDFGLAK---LDEDENTHISTRIAGTVGY 829
Y H +++HRD+K N+L+D+ NA K++DFGLA+ + TH T+ Y
Sbjct: 117 YCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV----TLWY 169
Query: 830 MAPEYAM--RGYLTDKADVYSFGIVALEIVSGK 860
APE + R Y T D++S G + E+V+ K
Sbjct: 170 RAPEILLGSRHYST-PVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 3e-16
Identities = 56/211 (26%), Positives = 95/211 (45%), Gaps = 38/211 (18%)
Query: 666 KIGEGGFGPVYKGTLSD-GAVIAVKQL--SSKSKQGNREFVNEIGMISALQHQNLVKLYG 722
KIGEG +G V+K + G ++A+K+ S + + EI M+ L+H NLV L
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67
Query: 723 CCIEGNQLLLVYEYLEN---NSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEES 779
+L LV+EY ++ N L + G + K+I + + + H
Sbjct: 68 VFRRKRKLHLVFEYCDHTVLNELEKNPRG-------VPEHLIKKIIWQTLQAVNFCH--- 117
Query: 780 RLKIVHRDIKATNVLLDKDLNAKISDFGLAKL----DEDENTHISTR-------IAGTVG 828
+ +HRD+K N+L+ K K+ DFG A++ +D +++TR + G
Sbjct: 118 KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQ 177
Query: 829 YMAPEYAMRGYLTDKADVYSFGIVALEIVSG 859
Y P DV++ G V E+++G
Sbjct: 178 YGPP-----------VDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 3e-16
Identities = 73/223 (32%), Positives = 105/223 (47%), Gaps = 21/223 (9%)
Query: 651 LRQIKAATNNFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNREFVNEIGMI 709
L + T+ ++ IG+G +G VYK T DG++ AVK L S + E E ++
Sbjct: 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDV-DEEIEAEYNIL 72
Query: 710 SAL-QHQNLVKLYGCCIE-----GNQLLLVYEYLENNSLARALFG--KEGQCLNLDWATR 761
+L H N+VK YG + G QL LV E S+ + G GQ LD A
Sbjct: 73 QSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQ--RLDEAMI 130
Query: 762 KRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHIST 821
I GL +LH +I+HRD+K N+LL + K+ DFG++ +T
Sbjct: 131 SYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNT 187
Query: 822 RIAGTVGYMAPEY----AMRGYLTD-KADVYSFGIVALEIVSG 859
+ GT +MAPE Y D + DV+S GI A+E+ G
Sbjct: 188 SV-GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 4e-16
Identities = 59/199 (29%), Positives = 96/199 (48%), Gaps = 15/199 (7%)
Query: 666 KIGEGGFGPVYKGTL-SDGAVIAVKQL-SSKSKQGNREFVNEIGMISALQHQNLVKLYGC 723
+IG G FG V+ G L +D +AVK + +F+ E ++ H N+V+L G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 724 CIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKI 783
C + + +V E ++ EG L + ++ + A G+ YL ES+
Sbjct: 62 CTQKQPIYIVMELVQGGDF-LTFLRTEGPRLKVK--ELIQMVENAAAGMEYL--ESK-HC 115
Query: 784 VHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGT----VGYMAPEYAMRGY 839
+HRD+ A N L+ + KISDFG+++ +ED + G V + APE G
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSREEED---GVYASTGGMKQIPVKWTAPEALNYGR 172
Query: 840 LTDKADVYSFGIVALEIVS 858
+ ++DV+SFGI+ E S
Sbjct: 173 YSSESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 5e-16
Identities = 69/203 (33%), Positives = 109/203 (53%), Gaps = 22/203 (10%)
Query: 667 IGEGGFGPVY---KGTLSD-GAVIAVKQLSSKSKQGNREFV---NEIGMISALQHQNLVK 719
+G+G FG V+ K T D G + A+K L K+ R+ V E +++ + H +VK
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLK-KATLKVRDRVRTKMERDILAEVNHPFIVK 62
Query: 720 L-YGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEE 778
L Y EG +L L+ ++L L L KE D K +++A L +LH
Sbjct: 63 LHYAFQTEG-KLYLILDFLRGGDLFTRL-SKEVMFTEED---VKFYLAELALALDHLH-- 115
Query: 779 SRLKIVHRDIKATNVLLDKDLNAKISDFGLAK--LDEDENTHISTRIAGTVGYMAPEYAM 836
L I++RD+K N+LLD++ + K++DFGL+K +D ++ + GTV YMAPE
Sbjct: 116 -SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY---SFCGTVEYMAPEVVN 171
Query: 837 RGYLTDKADVYSFGIVALEIVSG 859
R T AD +SFG++ E+++G
Sbjct: 172 RRGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 7e-16
Identities = 59/193 (30%), Positives = 96/193 (49%), Gaps = 29/193 (15%)
Query: 659 NNFDAANKIGEGGFGPVYKG-TLSDGAVIAVKQ-LSSKSKQGNREF----VNEIGMISAL 712
+ ++ KIG+G FG V+K ++A+K+ L K+G F + EI ++ L
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEG---FPITALREIKILQLL 68
Query: 713 QHQNLVKLYGCC----IEGN----QLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRI 764
+H+N+V L C N LV+E+ E++ LA L K + + K++
Sbjct: 69 KHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHD-LAGLLSNKNVK---FTLSEIKKV 124
Query: 765 CSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKL----DEDENTHIS 820
+ GL Y+H R KI+HRD+KA N+L+ KD K++DFGLA+ + +
Sbjct: 125 MKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYT 181
Query: 821 TRIAGTVGYMAPE 833
R+ T+ Y PE
Sbjct: 182 NRVV-TLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 7e-16
Identities = 65/216 (30%), Positives = 103/216 (47%), Gaps = 29/216 (13%)
Query: 666 KIGEGGFGPVYKGTLSDGA------VIAVKQLSSKSKQGNRE-FVNEIGMISALQHQNLV 718
++GE FG VYKG L A +A+K L K++ RE F +E M S LQH N+V
Sbjct: 12 ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIV 71
Query: 719 KLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQC------------LNLDWATRKRICS 766
L G + L +++ Y ++ L L + L+ A I +
Sbjct: 72 CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVT 131
Query: 767 DIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGT 826
IA G+ +L S +VH+D+ NVL+ LN KISD GL + + + ++ G
Sbjct: 132 QIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYY---KLMGN 185
Query: 827 ----VGYMAPEYAMRGYLTDKADVYSFGIVALEIVS 858
+ +M+PE M G + +D++S+G+V E+ S
Sbjct: 186 SLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 7e-16
Identities = 71/216 (32%), Positives = 108/216 (50%), Gaps = 27/216 (12%)
Query: 660 NFDAANKIGEGGFGPVYKGTLSD-GAVIAVKQL--SSKSKQGNREFVN----EIGMISAL 712
N+ +G G FG VY +D G +AVKQ+ S++ ++E VN EI ++ L
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKE-VNALECEIQLLKNL 61
Query: 713 QHQNLVKLYGCC--IEGNQLLLVYEYLENNSLARAL--FGKEGQCLNLDWATRKRICSDI 768
+H +V+ YGC E +L + EY+ S+ L +G L +R I
Sbjct: 62 RHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGA------LTENVTRRYTRQI 115
Query: 769 ARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDED---ENTHISTRIAG 825
+G++YLH IVHRDIK N+L D N K+ DFG +K + T I + + G
Sbjct: 116 LQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS-VTG 171
Query: 826 TVGYMAPEY-AMRGYLTDKADVYSFGIVALEIVSGK 860
T +M+PE + GY KADV+S +E+++ K
Sbjct: 172 TPYWMSPEVISGEGY-GRKADVWSVACTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 7e-16
Identities = 63/200 (31%), Positives = 94/200 (47%), Gaps = 15/200 (7%)
Query: 666 KIGEGGFGPVYKG---TLSDGAVIAVKQLSSKSKQG--NREFVNEIGMISALQHQNLVKL 720
++G G FG V KG +AVK L + + E + E ++ L + +V++
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 721 YGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESR 780
G C E +LV E E L + L + ++ + ++ G+ YL E +
Sbjct: 62 IGIC-EAESWMLVMELAELGPLNKFL----QKNKHVTEKNITELVHQVSMGMKYLEETN- 115
Query: 781 LKIVHRDIKATNVLLDKDLNAKISDFGLAK-LDEDENTH-ISTRIAGTVGYMAPEYAMRG 838
VHRD+ A NVLL AKISDFGL+K L DEN + T V + APE
Sbjct: 116 --FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYY 173
Query: 839 YLTDKADVYSFGIVALEIVS 858
+ K+DV+SFG++ E S
Sbjct: 174 KFSSKSDVWSFGVLMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 9e-16
Identities = 61/202 (30%), Positives = 95/202 (47%), Gaps = 17/202 (8%)
Query: 666 KIGEGGFGP---VYKGTLSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYG 722
KIGEG FG V VI +S S + E E+ ++S ++H N+V+
Sbjct: 7 KIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQE 66
Query: 723 CCIEGNQLLLVYEYLENNSLARALFGKEGQCLN----LDWATRKRICSDIARGLAYLHEE 778
E L +V +Y E L + + + G LDW + IC LA H
Sbjct: 67 SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQ--IC------LALKHVH 118
Query: 779 SRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRG 838
R KI+HRDIK+ N+ L KD K+ DFG+A++ + ++ GT Y++PE
Sbjct: 119 DR-KILHRDIKSQNIFLTKDGTIKLGDFGIARV-LNSTVELARTCIGTPYYLSPEICENR 176
Query: 839 YLTDKADVYSFGIVALEIVSGK 860
+K+D+++ G V E+ + K
Sbjct: 177 PYNNKSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-15
Identities = 74/261 (28%), Positives = 121/261 (46%), Gaps = 26/261 (9%)
Query: 667 IGEGGFGPVYKGTL-SDGAVIAVKQLSSK---SKQGNREFVNEIGMISALQHQNLVKLYG 722
+G+GGFG V + + G + A K+L K ++G +NE ++ + + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAY 67
Query: 723 CCIEGNQLLLVYEYLENNSLARALF--GKEGQCLNLDWATRKRICSDIARGLAYLHEESR 780
+ L LV + L ++ G+ G + ++I GL LH+E
Sbjct: 68 AYETKDALCLVLTLMNGGDLKFHIYHMGEAG----FEEGRAVFYAAEICCGLEDLHQE-- 121
Query: 781 LKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRGYL 840
+IV+RD+K N+LLD + +ISD GLA + E I R+ GTVGYMAPE
Sbjct: 122 -RIVYRDLKPENILLDDHGHIRISDLGLA-VHVPEGQTIKGRV-GTVGYMAPEVVKNERY 178
Query: 841 TDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGSNFS 900
T D ++ G + E+++G+S R K+ +E L++ V FS
Sbjct: 179 TFSPDWWALGCLLYEMIAGQSPFQQRKKK---------IKREEVERLVKEVQEEYSEKFS 229
Query: 901 KKEAMTMLNIALLCTNPSPTL 921
+A ++ + LLC +P L
Sbjct: 230 -PDARSLCKM-LLCKDPKERL 248
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-15
Identities = 67/208 (32%), Positives = 106/208 (50%), Gaps = 25/208 (12%)
Query: 667 IGEGGFGPVYKGTLSD-GAVIAVKQLS--SKSKQGNREFVN---EIGMISALQHQNLVKL 720
+G+G FG VY D G +A KQ+ +S + ++E EI ++ LQH+ +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 721 YGCCIE-GNQLLLVY-EYLENNSLARAL--FGKEGQCLNLDWATRKRICSDIARGLAYLH 776
YGC + + L ++ EY+ S+ L +G L + ++ I G++YLH
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGA------LTESVTRKYTRQILEGMSYLH 123
Query: 777 EESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDED---ENTHISTRIAGTVGYMAPE 833
IVHRDIK N+L D N K+ DFG +K + T I + + GT +M+PE
Sbjct: 124 SN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRS-VTGTPYWMSPE 179
Query: 834 Y-AMRGYLTDKADVYSFGIVALEIVSGK 860
+ GY KADV+S G +E+++ K
Sbjct: 180 VISGEGY-GRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 76.5 bits (189), Expect = 5e-15
Identities = 61/218 (27%), Positives = 108/218 (49%), Gaps = 36/218 (16%)
Query: 660 NFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLS-SKSKQGNREF----VNEIGMISALQ 713
++ N+I EG +G VY+ G ++A+K+L K K+G F + EI ++ LQ
Sbjct: 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEG---FPITSLREINILLKLQ 62
Query: 714 HQNLVKL----YGCCIEGNQLLLVYEYLEN------NSLARALFGKEGQCLNLDWATRKR 763
H N+V + G + +++ +V EY+E+ ++ + E +CL L
Sbjct: 63 HPNIVTVKEVVVGSNL--DKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQ------ 114
Query: 764 ICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRI 823
+ G+A+LH+ I+HRD+K +N+LL+ KI DFGLA+ T++
Sbjct: 115 ----LLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGS-PLKPYTQL 166
Query: 824 AGTVGYMAPEYAM-RGYLTDKADVYSFGIVALEIVSGK 860
T+ Y APE + + D++S G + E+++ K
Sbjct: 167 VVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 76.8 bits (190), Expect = 7e-15
Identities = 64/223 (28%), Positives = 104/223 (46%), Gaps = 55/223 (24%)
Query: 667 IGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNREFVN---------EIGMISALQHQN 716
IG G +G V G +A+K++ + F + EI ++ L+H+N
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKI-------SNVFDDLIDAKRILREIKLLRHLRHEN 60
Query: 717 LVKLYGCCI-----EGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICS---DI 768
++ L + N + +V E +E + L + + K Q L T I I
Sbjct: 61 IIGLLDILRPPSPEDFNDVYIVTELMETD-LHKVI--KSPQPL-----TDDHIQYFLYQI 112
Query: 769 ARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAK-LDEDENT------HIST 821
RGL YLH ++HRD+K +N+L++ + + KI DFGLA+ +D DE+ ++ T
Sbjct: 113 LRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVT 169
Query: 822 RIAGTVGYMAPE--YAMRGYLTDKA-DVYSFG-IVALEIVSGK 860
R Y APE + Y KA D++S G I A E+++ K
Sbjct: 170 RW-----YRAPELLLSSSRY--TKAIDIWSVGCIFA-ELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 1e-14
Identities = 55/200 (27%), Positives = 103/200 (51%), Gaps = 13/200 (6%)
Query: 665 NKIGEGGFGPVYKG--TLSDGAVIAVKQLSSKSKQGNR-EFVNEIGMISALQHQNLVKLY 721
+K+GEG + VYKG L+D ++A+K++ + ++G + E+ ++ L+H N+V L+
Sbjct: 12 DKLGEGTYATVYKGRSKLTDN-LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH 70
Query: 722 GCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRL 781
L LV+EYL+ + + G +N+ K + RGL Y H R
Sbjct: 71 DIIHTEKSLTLVFEYLDKD--LKQYLDDCGNSINMH--NVKLFLFQLLRGLNYCH---RR 123
Query: 782 KIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRGY-L 840
K++HRD+K N+L+++ K++DFGLA+ S + T+ Y P+ +
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILLGSTDY 182
Query: 841 TDKADVYSFGIVALEIVSGK 860
+ + D++ G + E+ +G+
Sbjct: 183 STQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 2e-14
Identities = 55/200 (27%), Positives = 103/200 (51%), Gaps = 13/200 (6%)
Query: 665 NKIGEGGFGPVYKG--TLSDGAVIAVKQLSSKSKQGNR-EFVNEIGMISALQHQNLVKLY 721
K+GEG + V+KG L++ ++A+K++ + ++G + E+ ++ L+H N+V L+
Sbjct: 12 EKLGEGTYATVFKGRSKLTEN-LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH 70
Query: 722 GCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRL 781
L LV+EYL+ + + G +++ K I RGLAY H R
Sbjct: 71 DIVHTDKSLTLVFEYLDKD--LKQYMDDCGNIMSMH--NVKIFLYQILRGLAYCH---RR 123
Query: 782 KIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAM-RGYL 840
K++HRD+K N+L+++ K++DFGLA+ S + T+ Y P+ +
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSSEY 182
Query: 841 TDKADVYSFGIVALEIVSGK 860
+ + D++ G + E+ SG+
Sbjct: 183 STQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 2e-14
Identities = 57/193 (29%), Positives = 94/193 (48%), Gaps = 24/193 (12%)
Query: 683 GAVIAVKQLSSKSKQGNRE---FVNEIGMISALQHQNLVKLY--GCCIEGNQLLLVYEYL 737
G +A+K L + + + + F E + + L H N+V L G G L V+EY+
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPG-LLFAVFEYV 61
Query: 738 ENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLL-- 795
+L R + +G L R+ + LA H + IVHRD+K N+++
Sbjct: 62 PGRTL-REVLAADGA---LPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQ 114
Query: 796 -DKDLNAKISDFGLAKL-----DEDENT-HISTRIAGTVGYMAPEYAMRGY-LTDKADVY 847
+AK+ DFG+ L D D T +T + GT Y APE +RG +T +D+Y
Sbjct: 115 TGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPE-QLRGEPVTPNSDLY 173
Query: 848 SFGIVALEIVSGK 860
++G++ LE ++G+
Sbjct: 174 AWGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 3e-14
Identities = 63/208 (30%), Positives = 102/208 (49%), Gaps = 30/208 (14%)
Query: 667 IGEGGFGPVY---KGTLSD-GAVIAVKQLSS----KSKQGNREFVNEIGMISALQHQNLV 718
+G+GG+G V+ K T +D G + A+K L ++++ E ++ A++H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 719 KLYGCCIEGNQLLLVYEYLENNSLARAL-----FGKEGQCLNLDWATRKRICSDIARGLA 773
L G +L L+ EYL L L F ++ C L S+I+ L
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYL---------SEISLALE 114
Query: 774 YLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAK--LDEDENTHISTRIAGTVGYMA 831
+LH + I++RD+K N+LLD + K++DFGL K + E TH GT+ YMA
Sbjct: 115 HLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT---FCGTIEYMA 168
Query: 832 PEYAMRGYLTDKADVYSFGIVALEIVSG 859
PE MR D +S G + ++++G
Sbjct: 169 PEILMRSGHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 4e-14
Identities = 67/216 (31%), Positives = 109/216 (50%), Gaps = 27/216 (12%)
Query: 660 NFDAANKIGEGGFGPVYKGTLSD-GAVIAVKQL--SSKSKQGNREFVN----EIGMISAL 712
N+ +G+G FG VY +D G +AVKQ+ +S + ++E VN EI ++ L
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKE-VNALECEIQLLKNL 61
Query: 713 QHQNLVKLYGCCIEGNQ--LLLVYEYLENNSLARAL--FGKEGQCLNLDWATRKRICSDI 768
H+ +V+ YGC + + L + E++ S+ L +G L ++ I
Sbjct: 62 LHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGA------LTENVTRKYTRQI 115
Query: 769 ARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDED---ENTHISTRIAG 825
G++YLH IVHRDIK N+L D N K+ DFG +K + T + + + G
Sbjct: 116 LEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS-VTG 171
Query: 826 TVGYMAPEY-AMRGYLTDKADVYSFGIVALEIVSGK 860
T +M+PE + GY KAD++S G +E+++ K
Sbjct: 172 TPYWMSPEVISGEGY-GRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 5e-14
Identities = 62/234 (26%), Positives = 102/234 (43%), Gaps = 26/234 (11%)
Query: 659 NNFDAANKIGEGGFGPVYKGTLSD-GAVIAVKQLSSK---SKQGNREFVNEIGMISALQH 714
+F ++G+GG+G V+ D G ++A+K++ R + E +++ +
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60
Query: 715 QNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAY 774
+ LVKL + L L EY+ R L G L+ D A + +++ +
Sbjct: 61 EWLVKLLYAFQDDEYLYLAMEYVPGGDF-RTLLNNLG-VLSEDHA--RFYMAEMFEAVDA 116
Query: 775 LHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEY 834
LH L +HRD+K N L+D + K++DFGL+K + + G+ YMAPE
Sbjct: 117 LH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSK----GIVTYANSVVGSPDYMAPEV 169
Query: 835 AM-RGYLTDKADVYSFGIVALEIVSG-----KSNTNYRPKEEFVYLLDWAYVLQ 882
+GY D +S G + E + G S N E + L W LQ
Sbjct: 170 LRGKGY-DFTVDYWSLGCMLYEFLCGFPPFSGSTPN----ETWENLKYWKETLQ 218
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 5e-14
Identities = 50/155 (32%), Positives = 78/155 (50%), Gaps = 10/155 (6%)
Query: 708 MISALQHQNLVKLYGCCIEGNQ-LLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICS 766
+ A +H L L+ C + + L V EYL L + D A + +
Sbjct: 49 LALAWEHPFLTHLF-CTFQTKEHLFFVMEYLNGGDLMFHI----QSSGRFDEARARFYAA 103
Query: 767 DIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGT 826
+I GL +LH++ I++RD+K NVLLDKD + KI+DFG+ K + + ST GT
Sbjct: 104 EIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST-FCGT 159
Query: 827 VGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKS 861
Y+APE + D +SFG++ E++ G+S
Sbjct: 160 PDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQS 194
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 6e-14
Identities = 38/111 (34%), Positives = 58/111 (52%), Gaps = 26/111 (23%)
Query: 763 RICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFG--------LAKLDED 814
+I I + L YLH +L ++HRD+K +NVL++++ K+ DFG +AK
Sbjct: 107 KIAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAK---- 160
Query: 815 ENTHISTRIAGTVGYMAPE-----YAMRGYLTDKADVYSFGIVALEIVSGK 860
T AG YMAPE +GY K+DV+S GI +E+ +G+
Sbjct: 161 ------TIDAGCKPYMAPERINPELNQKGYDV-KSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 7e-14
Identities = 68/268 (25%), Positives = 122/268 (45%), Gaps = 27/268 (10%)
Query: 665 NKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSKQGN-REFVNEIGMISALQHQNLVKLYG 722
+++G+G +G VYK G +A+K++ + + + + E+ ++ +V YG
Sbjct: 7 DELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYG 66
Query: 723 CCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLK 782
+ + EY++ SL + L+ + +RI + +GL +L EE
Sbjct: 67 AFFIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HN 123
Query: 783 IVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEY------AM 836
I+HRD+K TNVL++ + K+ DFG++ + T I G YMAPE
Sbjct: 124 IIHRDVKPTNVLVNGNGQVKLCDFGVS--GNLVASLAKTNI-GCQSYMAPERIKSGGPNQ 180
Query: 837 RGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLG 896
T ++DV+S G+ LE+ G+ Y P+ +A + + +++ P+L
Sbjct: 181 NPTYTVQSDVWSLGLSILEMALGR--YPYPPET-------YANIFAQLSAIVDGDPPTLP 231
Query: 897 SNFSKKEAMTMLNIALLCTNPSPTLRPT 924
S +S +A + C N P RPT
Sbjct: 232 SGYS-DDAQDFVA---KCLNKIPNRRPT 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 1e-13
Identities = 56/199 (28%), Positives = 102/199 (51%), Gaps = 13/199 (6%)
Query: 666 KIGEGGFGPVYKG-TLSDGAVIAVKQLSSKSKQG-NREFVNEIGMISALQHQNLVKLYGC 723
K+GEG + VYKG + +G ++A+K +S K+++G + E ++ L+H N+V L+
Sbjct: 12 KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDI 71
Query: 724 CIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKI 783
L V+EY+ + LA+ + G L + + RGLAY+H I
Sbjct: 72 IHTKETLTFVFEYMHTD-LAQYMIQHPG---GLHPYNVRLFMFQLLRGLAYIH---GQHI 124
Query: 784 VHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRG--YLT 841
+HRD+K N+L+ K++DFGLA+ + S+ + T+ Y P+ + Y +
Sbjct: 125 LHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-TLWYRPPDVLLGATDYSS 183
Query: 842 DKADVYSFGIVALEIVSGK 860
D++ G + +E++ G+
Sbjct: 184 A-LDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 1e-13
Identities = 64/214 (29%), Positives = 103/214 (48%), Gaps = 30/214 (14%)
Query: 667 IGEGGFGPVYKGTLSD-GAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLY---- 721
+G G G V+ SD +AVK++ Q + + EI +I L H N+VK+Y
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 722 ----------GCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARG 771
G E N + +V EY+E + LA L E L+ + A + + RG
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYMETD-LANVL---EQGPLSEEHA--RLFMYQLLRG 126
Query: 772 LAYLHEESRLKIVHRDIKATNVLLD-KDLNAKISDFGLAKLDEDENTHISTRIAGTVG-- 828
L Y+H + ++HRD+K NV ++ +DL KI DFGLA++ + +H G V
Sbjct: 127 LKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKW 183
Query: 829 YMAPEYAM--RGYLTDKADVYSFGIVALEIVSGK 860
Y +P + Y T D+++ G + E+++GK
Sbjct: 184 YRSPRLLLSPNNY-TKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 1e-13
Identities = 65/211 (30%), Positives = 102/211 (48%), Gaps = 15/211 (7%)
Query: 667 IGEGGFGPVYKGTL-SDGAVIAVKQLSSK---SKQGNREFVNEIGMISALQHQNLVKLYG 722
+G+GGFG V + + G + A K+L K ++G +NE ++ + Q +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAY 67
Query: 723 CCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLK 782
+ L LV + L ++ + A ++I GL LH E+
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALF--YAAEILCGLEDLHREN--- 122
Query: 783 IVHRDIKATNVLLDKDLNAKISDFGLA-KLDEDENTHISTRIAGTVGYMAPEYAMRGYLT 841
V+RD+K N+LLD + +ISD GLA K+ E E+ I R+ GTVGYMAPE T
Sbjct: 123 TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES--IRGRV-GTVGYMAPEVLNNQRYT 179
Query: 842 DKADVYSFGIVALEIVSGKSNTNYRPKEEFV 872
D + G + E++ G+S +R ++E V
Sbjct: 180 LSPDYWGLGCLIYEMIEGQS--PFRGRKEKV 208
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 57/201 (28%), Positives = 105/201 (52%), Gaps = 15/201 (7%)
Query: 665 NKIGEGGFGPVYKG-TLSDGAVIAVKQLSSKSKQGNR-EFVNEIGMISALQHQNLVKLYG 722
+K+GEG + V+KG + ++A+K++ + ++G + E+ ++ L+H N+V L+
Sbjct: 11 DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHD 70
Query: 723 CCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRI-CSDIARGLAYLHEESRL 781
L LV+EYL+++ L + L C NL +I + RGL+Y H+
Sbjct: 71 IIHTERCLTLVFEYLDSD-LKQYL----DNCGNLMSMHNVKIFMFQLLRGLSYCHKR--- 122
Query: 782 KIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRG--Y 839
KI+HRD+K N+L+++ K++DFGLA+ S + T+ Y P+ + Y
Sbjct: 123 KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSTEY 181
Query: 840 LTDKADVYSFGIVALEIVSGK 860
T D++ G + E+ +G+
Sbjct: 182 ST-PIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-13
Identities = 45/148 (30%), Positives = 74/148 (50%), Gaps = 9/148 (6%)
Query: 666 KIGEGGFGPVYKGTL---SDGAVIAVKQL--SSKSKQGNREFVNEIGMISALQHQNLVKL 720
+IG G FG V + + A + VK+L ++ SK+ N EF+ + LQH N+++
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQN-EFLQQGDPYRILQHPNILQC 60
Query: 721 YGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESR 780
G C+E LLV+EY E L L ++ N +R+ +IA G+ ++H +
Sbjct: 61 LGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---K 117
Query: 781 LKIVHRDIKATNVLLDKDLNAKISDFGL 808
+H D+ N L DL K+ D+G+
Sbjct: 118 HNFLHSDLALRNCFLTSDLTVKVGDYGI 145
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 2e-13
Identities = 39/96 (40%), Positives = 57/96 (59%), Gaps = 8/96 (8%)
Query: 768 IARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDE-DENTHISTRIAGT 826
I RGL YLH I+HRDIK N+L++ + KI DFGLA+++E DE+ H++ + T
Sbjct: 112 ILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV-T 167
Query: 827 VGYMAPEYAM--RGYLTDKADVYSFGIVALEIVSGK 860
Y APE M R Y T D++S G + E++ +
Sbjct: 168 QYYRAPEILMGSRHY-TSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 2e-13
Identities = 65/218 (29%), Positives = 103/218 (47%), Gaps = 29/218 (13%)
Query: 661 FDAANKIGEGGFGPVYKGTLSD-GAVIAVKQLS-SKSKQGNREF----VNEIGMISALQH 714
FD +IGEG +G VYK D G ++A+K++ K+G F + EI ++ L H
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEG---FPITAIREIKILRQLNH 65
Query: 715 QNLVKLYGCCIEGNQLL----------LVYEYLENNSLARALFG-KEGQCLNLDWATRKR 763
+N+V L + L LV+EY++++ L G E ++ K
Sbjct: 66 RNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHD-----LMGLLESGLVHFSEDHIKS 120
Query: 764 ICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRI 823
+ GL Y H+++ L HRDIK +N+LL+ K++DFGLA+L E + T
Sbjct: 121 FMKQLLEGLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNK 177
Query: 824 AGTVGYMAPEYAM-RGYLTDKADVYSFGIVALEIVSGK 860
T+ Y PE + DV+S G + E+ + K
Sbjct: 178 VITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 2e-13
Identities = 57/211 (27%), Positives = 101/211 (47%), Gaps = 24/211 (11%)
Query: 658 TNNFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLSS--KSKQGNREFVNEIGMISALQH 714
TN + +G G FG V G +A+K++ + + E+ ++ L+H
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68
Query: 715 QNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGK--EGQCLNLDWATRKRICSDIARGL 772
+N++ L I + + L L R L + E Q + + I RGL
Sbjct: 69 ENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFI-------QYFLYQILRGL 121
Query: 773 AYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENT-HISTRIAGTVGYMA 831
Y+H +VHRD+K +N+L++++ + KI DFGLA++ + + T ++STR Y A
Sbjct: 122 KYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY-----YRA 173
Query: 832 PEYAM--RGYLTDKADVYSFGIVALEIVSGK 860
PE + + Y + D++S G + E++ GK
Sbjct: 174 PEIMLTWQKY-DVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-13
Identities = 61/213 (28%), Positives = 102/213 (47%), Gaps = 18/213 (8%)
Query: 660 NFDAANKIGEGGFGPVY----KGTLSDGAVIAVKQLSSKS---KQGNREFV-NEIGMISA 711
NF+ +G G +G V+ G G + A+K L + K E E ++ A
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 712 LQHQN-LVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIAR 770
++ LV L+ +L L+ +Y+ L L+ +E + + + ++I
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQRE----HFTESEVRVYIAEIVL 116
Query: 771 GLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYM 830
L +LH+ L I++RDIK N+LLD + + ++DFGL+K E + GT+ YM
Sbjct: 117 ALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYM 173
Query: 831 APEYAMRGYLT-DKA-DVYSFGIVALEIVSGKS 861
APE G DKA D +S G++ E+++G S
Sbjct: 174 APEVIRGGSGGHDKAVDWWSLGVLTFELLTGAS 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 70.3 bits (173), Expect = 3e-13
Identities = 59/225 (26%), Positives = 96/225 (42%), Gaps = 20/225 (8%)
Query: 667 IGEGGFGPVYKGTL-SDGAVIAVKQLSSKSKQGNRE---FVNEIGMISALQHQNLVKLYG 722
+G GGFG V + S A+K + + + +E ++ H +VKLY
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 723 CCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLK 782
+ + ++ EY L L G D T + + + YLH
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILR-DRG---LFDEYTARFYIACVVLAFEYLH---NRG 113
Query: 783 IVHRDIKATNVLLDKDLNAKISDFGLAK-LDEDENTHISTRIAGTVGYMAPEYAM-RGYL 840
I++RD+K N+LLD + K+ DFG AK L + T GT Y+APE + +GY
Sbjct: 114 IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT---FCGTPEYVAPEIILNKGY- 169
Query: 841 TDKADVYSFGIVALEIVSGK---SNTNYRPKEEFVYLLDWAYVLQ 882
D +S GI+ E+++G+ + P E + +L L+
Sbjct: 170 DFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLE 214
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 4e-13
Identities = 62/212 (29%), Positives = 94/212 (44%), Gaps = 17/212 (8%)
Query: 667 IGEGGFGPVYKGTLS-DGAVIAVKQLSSKSKQGNREFVNEIGMIS------ALQHQNLVK 719
+G+G FG V+ L A+K L + + E M+ A +H L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDV--ECTMVEKRVLSLAWEHPFLTH 60
Query: 720 LYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEES 779
LY L V EYL L +F + C D ++I GL +LH +
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDL---MFHIQ-SCHKFDLPRATFYAAEIICGLQFLHSKG 116
Query: 780 RLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRGY 839
IV+RD+K N+LLD D + KI+DFG+ K + + T GT Y+APE +
Sbjct: 117 ---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT-FCGTPDYIAPEILLGQK 172
Query: 840 LTDKADVYSFGIVALEIVSGKSNTNYRPKEEF 871
D +SFG++ E++ G+S + +EE
Sbjct: 173 YNTSVDWWSFGVLLYEMLIGQSPFHGHDEEEL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 4e-13
Identities = 57/226 (25%), Positives = 101/226 (44%), Gaps = 39/226 (17%)
Query: 665 NKIGEGGFGPVYKG-TLSDGAVIAVKQLS----SKSKQGNREFVNEIGM----------I 709
+GEG +G V K G ++A+K++ S +R+ V G+ +
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 710 SALQHQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIA 769
+ ++H+N++ L +EG+ + LV + + ++ L + + K + L + K I I
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDIMASD-LKKVVDRK----IRLTESQVKCILLQIL 129
Query: 770 RGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLA----------KLDEDENTHI 819
GL LH+ +HRD+ N+ ++ KI+DFGLA L +DE
Sbjct: 130 NGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQR 186
Query: 820 STRIAG---TVGYMAPEYAM--RGYLTDKADVYSFGIVALEIVSGK 860
+ T+ Y APE M Y D++S G + E+++GK
Sbjct: 187 REEMTSKVVTLWYRAPELLMGAEKY-HFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 4e-13
Identities = 63/203 (31%), Positives = 96/203 (47%), Gaps = 18/203 (8%)
Query: 667 IGEGGFGPVYKGTLSD-GAVIAVKQLSSKS---KQGNREFVNEIGMISALQHQN---LVK 719
IG GGFG VY +D G + A+K L K KQG +NE M+S + + +V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 720 LYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEES 779
+ ++L + + + L L Q A + ++I GL ++H
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHL----SQHGVFSEAEMRFYAAEIILGLEHMHNRF 117
Query: 780 RLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRGY 839
+V+RD+K N+LLD+ + +ISD GLA + H S GT GYMAPE +G
Sbjct: 118 ---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGV 171
Query: 840 LTD-KADVYSFGIVALEIVSGKS 861
D AD +S G + +++ G S
Sbjct: 172 AYDSSADWFSLGCMLFKLLRGHS 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 5e-13
Identities = 53/196 (27%), Positives = 96/196 (48%), Gaps = 16/196 (8%)
Query: 667 IGEGGFGPVYKGT-LSDGAVIAVKQLS-SKSKQGNREFVNEIGMISALQHQNLVKLYGCC 724
+G G G VYK L ++AVK + + + ++ ++E+ ++ ++ YG
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 725 IEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIV 784
N++ + E+++ SL ++ K + RI + +GL YL LKI+
Sbjct: 69 FVENRISICTEFMDGGSLD--VYRK------IPEHVLGRIAVAVVKGLTYLWS---LKIL 117
Query: 785 HRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRGYLTDKA 844
HRD+K +N+L++ K+ DFG++ + N+ I+ GT YMAPE +
Sbjct: 118 HRDVKPSNMLVNTRGQVKLCDFGVST--QLVNS-IAKTYVGTNAYMAPERISGEQYGIHS 174
Query: 845 DVYSFGIVALEIVSGK 860
DV+S GI +E+ G+
Sbjct: 175 DVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 5e-13
Identities = 63/208 (30%), Positives = 99/208 (47%), Gaps = 29/208 (13%)
Query: 667 IGEGGFGPV----YKGTLSDGAVIAVKQLSSKSKQGNREFVNEIGM----ISALQ--HQN 716
+G+G FG V KGT + AVK L K + V E M + AL H
Sbjct: 3 LGKGSFGKVLLAELKGT---DELYAVKVLK-KDVILQDDDV-ECTMTEKRVLALAGKHPF 57
Query: 717 LVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLH 776
L +L+ C ++L V EY+ L +F + + D + ++I GL +LH
Sbjct: 58 LTQLHSCFQTKDRLFFVMEYVNGGDL---MFHIQ-RSGRFDEPRARFYAAEIVLGLQFLH 113
Query: 777 EESRLKIVHRDIKATNVLLDKDLNAKISDFGLAK--LDEDENTHISTRIAGTVGYMAPEY 834
E I++RD+K NVLLD + + KI+DFG+ K + T + GT Y+APE
Sbjct: 114 ER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT---STFCGTPDYIAPE- 166
Query: 835 AMRGYLTDKA-DVYSFGIVALEIVSGKS 861
+ A D ++ G++ E+++G+S
Sbjct: 167 ILSYQPYGPAVDWWALGVLLYEMLAGQS 194
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 6e-13
Identities = 58/208 (27%), Positives = 99/208 (47%), Gaps = 16/208 (7%)
Query: 659 NNFDAANKIGEGGFGPVYKGTLSD-GAVIAVKQLSSKSKQGNREF----VNEIGMISALQ 713
N F+ +GEG +G V K + ++A+K+ K + N E + E+ M+ L+
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKF--KDSEENEEVKETTLRELKMLRTLK 58
Query: 714 HQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLA 773
+N+V+L +L LV+EY+E N L G +++ S I + +
Sbjct: 59 QENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNG-------VPPEKVRSYIYQLIK 111
Query: 774 YLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAK-LDEDENTHISTRIAGTVGYMAP 832
+H + IVHRDIK N+L+ + K+ DFG A+ L E N + + +A T Y +P
Sbjct: 112 AIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVA-TRWYRSP 170
Query: 833 EYAMRGYLTDKADVYSFGIVALEIVSGK 860
E + D++S G + E+ G+
Sbjct: 171 ELLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 6e-13
Identities = 56/219 (25%), Positives = 99/219 (45%), Gaps = 49/219 (22%)
Query: 669 EGGFGPVYKGTLSDGA--------VIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKL 720
EG FG ++ G L D V VK +S+ Q + E ++ L HQN++ +
Sbjct: 16 EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEI-QVTL-LLQESCLLYGLSHQNILPI 73
Query: 721 YGCCIEGNQLLLVYE----------YLENNSLARALFGKEGQCLNLDWATRKRI--CSDI 768
CIE + V +L+ L A Q L +T++ + I
Sbjct: 74 LHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEA---NNPQAL----STQQLVHMAIQI 126
Query: 769 ARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAK---------LDEDENTHI 819
A G++YLH + ++H+DI A N ++D++L KI+D L++ L ++EN +
Sbjct: 127 ACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPV 183
Query: 820 STRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS 858
+MA E + + +DV+SFG++ E+++
Sbjct: 184 K--------WMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 6e-13
Identities = 63/207 (30%), Positives = 96/207 (46%), Gaps = 30/207 (14%)
Query: 665 NKIGEGGFGPVYKG-TLSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQ----HQNLVK 719
KIGEG F V K + G A+K + K + E VN + I AL+ H N+++
Sbjct: 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCM--KKHFKSLEQVNNLREIQALRRLSPHPNILR 62
Query: 720 LYGCCIE--GNQLLLVYEYLENN--SLARALFGKEGQCLNLDWATRKRICSDIARGLAYL 775
L + +L LV+E ++ N L + G+ L K + + L ++
Sbjct: 63 LIEVLFDRKTGRLALVFELMDMNLYELIK------GRKRPLPEKRVKSYMYQLLKSLDHM 116
Query: 776 HEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTH---ISTRIAGTVGYMAP 832
H R I HRDIK N+L+ D+ K++DFG + + + ISTR Y AP
Sbjct: 117 H---RNGIFHRDIKPENILIKDDI-LKLADFGSCRGIYSKPPYTEYISTR-----WYRAP 167
Query: 833 EYAMR-GYLTDKADVYSFGIVALEIVS 858
E + GY K D+++ G V EI+S
Sbjct: 168 ECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 7e-13
Identities = 60/201 (29%), Positives = 94/201 (46%), Gaps = 15/201 (7%)
Query: 667 IGEGGFGPVYKGTLSD-GAVIAVKQLSSK---SKQGNREFVNEIGMISALQHQNLVKLYG 722
+G+GGFG V + + G + A K+L K K G + + E ++ + +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 723 CCIEGNQLLLVYEYLENNSLARALF--GKEGQCLNLDWATRKRICSDIARGLAYLHEESR 780
L LV + L ++ G+ G L+ + I G+ +LH
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERG----LEMERVIHYSAQITCGILHLHS--- 113
Query: 781 LKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRGYL 840
+ IV+RD+K NVLLD N ++SD GLA +D T T+ AGT GYMAPE
Sbjct: 114 MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRAGTNGYMAPEILKEEPY 171
Query: 841 TDKADVYSFGIVALEIVSGKS 861
+ D ++ G E+V+G++
Sbjct: 172 SYPVDWFAMGCSIYEMVAGRT 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 8e-13
Identities = 53/204 (25%), Positives = 103/204 (50%), Gaps = 11/204 (5%)
Query: 659 NNFDAANKIGEGGFGPVYKG-TLSDGAVIAVKQLSSKSKQGNR-EFVNEIGMISALQHQN 716
++++ K+GEG + VYKG + +G ++A+K + + ++G + E ++ L+H N
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64
Query: 717 LVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLH 776
+V L+ L LV+EY+ + L + + G L K + RGL+Y+H
Sbjct: 65 IVLLHDIIHTKETLTLVFEYVHTD-LCQYMDKHPG---GLHPENVKLFLFQLLRGLSYIH 120
Query: 777 EESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAM 836
+ I+HRD+K N+L+ K++DFGLA+ + +H + T+ Y P+ +
Sbjct: 121 QRY---ILHRDLKPQNLLISDTGELKLADFGLARA-KSVPSHTYSNEVVTLWYRPPDVLL 176
Query: 837 RGY-LTDKADVYSFGIVALEIVSG 859
+ D++ G + +E++ G
Sbjct: 177 GSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 1e-12
Identities = 53/206 (25%), Positives = 106/206 (51%), Gaps = 15/206 (7%)
Query: 659 NNFDAANKIGEGGFGPVYK-GTLSDGAVIAVKQLSSKSKQGNR-EFVNEIGMISALQHQN 716
++F+ +++G G G V K G ++A K + + K R + + E+ ++
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 717 LVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLH 776
+V YG ++ + E+++ SL + L KE + + + + I + RGLAYL
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVL--KEAKRIPEEILGKVSIA--VLRGLAYLR 120
Query: 777 EESRLKIVHRDIKATNVLLDKDLNAKISDFGLAK--LDEDENTHISTRIAGTVGYMAPEY 834
E+ +I+HRD+K +N+L++ K+ DFG++ +D N+ + TR YM+PE
Sbjct: 121 EKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR-----SYMSPER 173
Query: 835 AMRGYLTDKADVYSFGIVALEIVSGK 860
+ + ++D++S G+ +E+ G+
Sbjct: 174 LQGTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 1e-12
Identities = 63/201 (31%), Positives = 96/201 (47%), Gaps = 15/201 (7%)
Query: 667 IGEGGFGPVYKGTL-SDGAVIAVKQLSSK---SKQGNREFVNEIGMISALQHQNLVKLYG 722
+G+GGFG V + + G + A K+L K ++G +NE ++ + + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 67
Query: 723 CCIEGNQLLLVYEYLENNSLARALF--GKEGQCLNLDWATRKRICSDIARGLAYLHEESR 780
+ L LV + L ++ G G D ++I GL LH E
Sbjct: 68 AYETKDALCLVLTLMNGGDLKFHIYNMGNPG----FDEERAVFYAAEITCGLEDLHRE-- 121
Query: 781 LKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRGYL 840
+IV+RD+K N+LLD + +ISD GLA ++ E I R+ GTVGYMAPE
Sbjct: 122 -RIVYRDLKPENILLDDYGHIRISDLGLA-VEIPEGETIRGRV-GTVGYMAPEVVKNERY 178
Query: 841 TDKADVYSFGIVALEIVSGKS 861
T D + G + E++ GKS
Sbjct: 179 TFSPDWWGLGCLIYEMIEGKS 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 1e-12
Identities = 32/93 (34%), Positives = 54/93 (58%)
Query: 110 FLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGDISTLEELVLEDNQL 169
F+ + L G +P ++L++L + + GN + G+IP +G I++LE L L N
Sbjct: 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSF 478
Query: 170 VGPLPENLGNLKSLRRILLSSNNFTGSIPESYG 202
G +PE+LG L SLR + L+ N+ +G +P + G
Sbjct: 479 NGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 62/203 (30%), Positives = 95/203 (46%), Gaps = 18/203 (8%)
Query: 667 IGEGGFGPVYKGTLSD-GAVIAVKQLSSKS---KQGNREFVNEIGMISALQHQN---LVK 719
IG GGFG VY +D G + A+K L K KQG +NE M+S + + +V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 720 LYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEES 779
+ ++L + + + L L Q + ++I GL ++H
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHL----SQHGVFSEKEMRFYATEIILGLEHMHNRF 117
Query: 780 RLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRGY 839
+V+RD+K N+LLD+ + +ISD GLA + H S GT GYMAPE +G
Sbjct: 118 ---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGT 171
Query: 840 LTD-KADVYSFGIVALEIVSGKS 861
D AD +S G + +++ G S
Sbjct: 172 AYDSSADWFSLGCMLFKLLRGHS 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 60/212 (28%), Positives = 103/212 (48%), Gaps = 29/212 (13%)
Query: 660 NFDAANKIGEGGFGPVY--KGTLSDGAVIAVKQLSSKS----KQGNREFV-NEIGMISAL 712
+ + +G G FG V+ + +S A+K ++ KQ + V NE ++ +
Sbjct: 2 DLERIKTVGTGTFGRVHLVRDRIS-EHYYALKVMAIPEVIRLKQ--EQHVHNEKRVLKEV 58
Query: 713 QHQNLVKLYGCCIEGNQLLLVYEYLENNSLARAL--FGKEGQCLNLDWATRKRICSDIAR 770
H +++L+ + L ++ EY+ L L G+ L +A S+I
Sbjct: 59 SHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYA------SEIVC 112
Query: 771 GLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYM 830
L YLH +IV+RD+K N+LLDK+ + K++DFG AK D + + GT Y+
Sbjct: 113 ALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR----TWTLCGTPEYL 165
Query: 831 APE-YAMRGYLTDKA-DVYSFGIVALEIVSGK 860
APE +G+ +KA D ++ GI+ E++ G
Sbjct: 166 APEVIQSKGH--NKAVDWWALGILIYEMLVGY 195
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 61/200 (30%), Positives = 94/200 (47%), Gaps = 17/200 (8%)
Query: 667 IGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNREFVNEIG----MISALQHQNLVKLY 721
IG+G FG V +DG AVK L K+ +E + + ++ ++H LV L+
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 722 GCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRI-CSDIARGLAYLHEESR 780
++L V +Y+ L L +E R R ++IA L YLH
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHL-QRERSFPE----PRARFYAAEIASALGYLHS--- 114
Query: 781 LKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRGYL 840
L I++RD+K N+LLD + ++DFGL K + + ST GT Y+APE +R
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTST-FCGTPEYLAPE-VLRKQP 172
Query: 841 TDKA-DVYSFGIVALEIVSG 859
D+ D + G V E++ G
Sbjct: 173 YDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 2e-12
Identities = 58/204 (28%), Positives = 103/204 (50%), Gaps = 25/204 (12%)
Query: 666 KIGEGGFGPVY----KGTLSDGAVIAVKQLSSKSKQGNREFVN---EIGMISALQHQNLV 718
++G+G FG VY K +++ + +K++ N E V E ++S L H +V
Sbjct: 7 RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPN-ETVQANQEAQLLSKLDHPAIV 65
Query: 719 KLYGCCIEGNQLLLVYEYLENNSLARAL--FGKEGQCLNLDWATRKRICS---DIARGLA 773
K + +E + ++ EY E L L G+ L + ++C + G+
Sbjct: 66 KFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTL-----SENQVCEWFIQLLLGVH 120
Query: 774 YLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPE 833
Y+H+ +I+HRD+KA N+ L +L KI DFG+++L + ++T GT YM+PE
Sbjct: 121 YMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMG-SCDLATTFTGTPYYMSPE 175
Query: 834 -YAMRGYLTDKADVYSFGIVALEI 856
+GY + K+D++S G + E+
Sbjct: 176 ALKHQGYDS-KSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 2e-12
Identities = 61/210 (29%), Positives = 99/210 (47%), Gaps = 27/210 (12%)
Query: 660 NFDAANKIGEGGFGPV----YKGTLSDGAVIAVKQLSS----KSKQGNREFVNEIGMISA 711
+F+ +G G FG V +KGT G A+K L K KQ + E ++
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGT---GEYYAIKCLKKREILKMKQ-VQHVAQEKSILME 74
Query: 712 LQHQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARG 771
L H +V + + N++ + E++ L L K G+ N D A K +++
Sbjct: 75 LSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHL-RKAGRFPN-DVA--KFYHAELVLA 130
Query: 772 LAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMA 831
YLH I++RD+K N+LLD + K++DFG AK D + + GT Y+A
Sbjct: 131 FEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR----TFTLCGTPEYLA 183
Query: 832 PEYAM-RGYLTDKA-DVYSFGIVALEIVSG 859
PE +G+ KA D ++ G++ E ++G
Sbjct: 184 PEVIQSKGH--GKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 2e-12
Identities = 61/241 (25%), Positives = 96/241 (39%), Gaps = 55/241 (22%)
Query: 659 NNFDAANKIGEGGFGPVYKGTL----SDGAVIAVKQLSSKSKQGNREFV------NEIGM 708
++F+ IG G FG V+ L G V A+K L KS R + +I +
Sbjct: 1 DDFEVIKVIGRGAFGEVW---LVRDKDTGQVYAMKVLR-KSDMIKRNQIAHVRAERDI-L 55
Query: 709 ISALQHQN--LVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICS 766
A + +VKLY + L LV EY+ L L K+ + A + +
Sbjct: 56 ADA---DSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKD--VFPEETA--RFYIA 108
Query: 767 DIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAK---------------- 810
++ L +H +L +HRDIK N+L+D D + K++DFGL K
Sbjct: 109 ELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSH 165
Query: 811 ------------LDEDENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS 858
D + + GT Y+APE + D +S G++ E++
Sbjct: 166 NLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLY 225
Query: 859 G 859
G
Sbjct: 226 G 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 2e-12
Identities = 55/198 (27%), Positives = 95/198 (47%), Gaps = 13/198 (6%)
Query: 667 IGEGGFGPVYKGTL-SDGAVIAVKQLSSKSKQGNREF---VNEIGMIS-ALQHQNLVKLY 721
+G+G FG V L G + AVK L + + + E ++S A H L +LY
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 722 GCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRL 781
C ++L V E++ L +F + + D A + ++I L +LH++
Sbjct: 63 CCFQTPDRLFFVMEFVNGGDL---MFHIQ-KSRRFDEARARFYAAEITSALMFLHDKG-- 116
Query: 782 KIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRGYLT 841
I++RD+K NVLLD + + K++DFG+ K + N ++ GT Y+APE
Sbjct: 117 -IIYRDLKLDNVLLDHEGHCKLADFGMCK-EGIFNGKTTSTFCGTPDYIAPEILQEMLYG 174
Query: 842 DKADVYSFGIVALEIVSG 859
D ++ G++ E++ G
Sbjct: 175 PSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 62/216 (28%), Positives = 107/216 (49%), Gaps = 29/216 (13%)
Query: 660 NFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQ--GNREFVNEIGMISALQHQN 716
+ + IGEG +G V T G +A+K++S Q R + EI ++ +H+N
Sbjct: 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRT-LREIKILRRFKHEN 64
Query: 717 LVKLYGCCIEG-----NQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICS---DI 768
++ + N + +V E +E + L + + + Q L+ D I I
Sbjct: 65 IIGILDIIRPPSFESFNDVYIVQELMETD-LYKLI---KTQHLSND-----HIQYFLYQI 115
Query: 769 ARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLD--EDENTHISTRIAGT 826
RGL Y+H + ++HRD+K +N+LL+ + + KI DFGLA++ E ++T T T
Sbjct: 116 LRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVAT 172
Query: 827 VGYMAPEYAM--RGYLTDKADVYSFGIVALEIVSGK 860
Y APE + +GY T D++S G + E++S +
Sbjct: 173 RWYRAPEIMLNSKGY-TKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 3e-12
Identities = 56/229 (24%), Positives = 102/229 (44%), Gaps = 37/229 (16%)
Query: 661 FDAANKIGEGGFGPVYKGTLSDGAV---IAVKQLS---SKSKQGNREFVNEIGMISALQH 714
+D IG+GG G VY D +A+K++ S++ + F+ E + + L H
Sbjct: 4 YDIIRLIGKGGMGEVYLA--YDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIH 61
Query: 715 QNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNL--------DWATRKRICS 766
+V +Y C +G+ + Y+E +L ++L Q +L I
Sbjct: 62 PGIVPVYSICSDGDPVYYTMPYIEGYTL-KSLLKSVWQKESLSKELAEKTSVGAFLSIFH 120
Query: 767 DIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAK---LDEDE-------- 815
I + Y+H S+ ++HRD+K N+LL I D+G A L+E++
Sbjct: 121 KICATIEYVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDE 177
Query: 816 ------NTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS 858
+ I +I GT YMAPE + ++ D+Y+ G++ ++++
Sbjct: 178 RNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 4e-12
Identities = 52/208 (25%), Positives = 103/208 (49%), Gaps = 20/208 (9%)
Query: 661 FDAANKIGEGGFGPVYKG-TLSDGA-VIAVKQLSSKSKQGNREF--VNEIGMISALQ--- 713
++ +IGEG +G V+K L +G +A+K++ ++ + + E+ ++ L+
Sbjct: 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 62
Query: 714 HQNLVKLYGCCI-----EGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDI 768
H N+V+L+ C +L LV+E+++ + + + + T K + +
Sbjct: 63 HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQD---LTTYLDKVPEPGVPTETIKDMMFQL 119
Query: 769 ARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVG 828
RGL +LH ++VHRD+K N+L+ K++DFGLA++ + T + T+
Sbjct: 120 LRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ--MALTSVVVTLW 174
Query: 829 YMAPEYAMRGYLTDKADVYSFGIVALEI 856
Y APE ++ D++S G + E+
Sbjct: 175 YRAPEVLLQSSYATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 4e-12
Identities = 56/212 (26%), Positives = 100/212 (47%), Gaps = 21/212 (9%)
Query: 661 FDAANKIGEGGFGPVYKG-TLSDGAVIAVKQLSSKSKQGNREF--VNEIGMISALQ---H 714
++ +IG G +G VYK G +A+K + ++ + V E+ ++ L+ H
Sbjct: 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDH 61
Query: 715 QNLVKLYGCCIEGN-----QLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIA 769
N+V+L C ++ LV+E+++ + L L L + T K +
Sbjct: 62 PNIVRLMDVCATSRTDRETKVTLVFEHVDQD-LRTYLDKVPPPGLPAE--TIKDLMRQFL 118
Query: 770 RGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHIS-TRIAGTVG 828
RGL +LH IVHRD+K N+L+ K++DFGLA++ + ++ T + T+
Sbjct: 119 RGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARI---YSCQMALTPVVVTLW 172
Query: 829 YMAPEYAMRGYLTDKADVYSFGIVALEIVSGK 860
Y APE ++ D++S G + E+ K
Sbjct: 173 YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 4e-12
Identities = 63/204 (30%), Positives = 96/204 (47%), Gaps = 18/204 (8%)
Query: 667 IGEGGFGPVYKGTLSD-GAVIAVKQLSSKSKQGNREFVNEIGMISALQHQN------LVK 719
IG+G FG VY+ D + A+K LS K +E + IG + L +V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 720 LYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEES 779
L + L LV +Y+ L L KEG+ K +++ L +LH+
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHL-QKEGR---FSEDRAKFYIAELVLALEHLHKYD 116
Query: 780 RLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAM--R 837
IV+RD+K N+LLD + + DFGL+K + +N +T GT Y+APE + +
Sbjct: 117 ---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT-FCGTTEYLAPEVLLDEK 172
Query: 838 GYLTDKADVYSFGIVALEIVSGKS 861
GY T D +S G++ E+ G S
Sbjct: 173 GY-TKHVDFWSLGVLVFEMCCGWS 195
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 6e-12
Identities = 61/214 (28%), Positives = 97/214 (45%), Gaps = 17/214 (7%)
Query: 658 TNNFDAANKIGEGGFGPVYK-GTLSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQ-HQ 715
++ ++ IG+G +G V+K +G+ AVK L + E E ++ AL H
Sbjct: 17 SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDP-IHDIDEEIEAEYNILKALSDHP 75
Query: 716 NLVKLYGC-----CIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIAR 770
N+VK YG G+QL LV E S+ + G + ++ I +
Sbjct: 76 NVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALM 135
Query: 771 GLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYM 830
GL +LH K +HRD+K N+LL + K+ DFG++ +T + GT +M
Sbjct: 136 GLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWM 191
Query: 831 APEY-----AMRGYLTDKADVYSFGIVALEIVSG 859
APE + + DV+S GI A+E+ G
Sbjct: 192 APEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 6e-12
Identities = 59/218 (27%), Positives = 98/218 (44%), Gaps = 27/218 (12%)
Query: 659 NNFDAANKIGEGGFGPVYKG-TLSDGAVIAVKQ--LSSKSKQGNREFVNEIGMISALQHQ 715
+ ++ KIGEG +G VYK + G ++A+K+ L + + EI ++ L
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60
Query: 716 N-LVKLYGCCIEGN-------QLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSD 767
+V+L +E L LV+EYL+++ G L T K
Sbjct: 61 IYIVRLL--DVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQ 118
Query: 768 IARGLAYLHEESRLKIVHRDIKATNVLLDKDLNA-KISDFGLAK---LDEDENTHISTRI 823
+ +G+A+ H + ++HRD+K N+L+DK KI+D GL + + TH I
Sbjct: 119 LLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTH---EI 172
Query: 824 AGTVGYMAPEYAM--RGYLTDKADVYSFGIVALEIVSG 859
T+ Y APE + Y T D++S G + E+
Sbjct: 173 V-TLWYRAPEVLLGSTHYST-PVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 58/204 (28%), Positives = 103/204 (50%), Gaps = 20/204 (9%)
Query: 667 IGEGGFGPVYKGTL-SDGAVIAVKQLSSK---SKQGNREFVNEIGMISALQHQNLVKLYG 722
+G+GGFG V + + G + A K+L+ K ++G + E +++ + + +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 723 CCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRIC---SDIARGLAYLHEES 779
L LV + L ++ + + R C + I GL +LH+
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFP---EPRACFYTAQIISGLEHLHQR- 116
Query: 780 RLKIVHRDIKATNVLLDKDLNAKISDFGLA-KLDEDENTHISTR-IAGTVGYMAPEYAMR 837
+I++RD+K NVLLD D N +ISD GLA +L + ++ T+ AGT G+MAPE ++
Sbjct: 117 --RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS---KTKGYAGTPGFMAPEL-LQ 170
Query: 838 GYLTDKA-DVYSFGIVALEIVSGK 860
G D + D ++ G+ E+++ +
Sbjct: 171 GEEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 62/212 (29%), Positives = 100/212 (47%), Gaps = 17/212 (8%)
Query: 667 IGEGGFGPVYKGTL-SDGAVIAVKQLSSK---SKQGNREFVNEIGMISALQHQNLVKLYG 722
+G+GGFG V + + G + A K+L K ++G +NE ++ + + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAY 67
Query: 723 CCIEGNQLLLVYEYLENNSLARALF--GKEGQCLNLDWATRKRICSDIARGLAYLHEESR 780
+ L LV + L ++ G G D +++ GL L E
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPG----FDEQRAIFYAAELCCGLEDLQRE-- 121
Query: 781 LKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRGYL 840
+IV+RD+K N+LLD + +ISD GLA + E + R+ GTVGYMAPE
Sbjct: 122 -RIVYRDLKPENILLDDRGHIRISDLGLA-VQIPEGETVRGRV-GTVGYMAPEVINNEKY 178
Query: 841 TDKADVYSFGIVALEIVSGKSNTNYRPKEEFV 872
T D + G + E++ G+S +R ++E V
Sbjct: 179 TFSPDWWGLGCLIYEMIQGQS--PFRKRKERV 208
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 1e-11
Identities = 60/199 (30%), Positives = 90/199 (45%), Gaps = 15/199 (7%)
Query: 667 IGEGGFGPVYKGTL-SDGAVIAVKQLSSKS----KQGNREFVNEIGMISALQHQNLVKLY 721
IG+G FG V SDG+ AVK L K+ K+ N ++ L+H LV L+
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 722 GCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRI-CSDIARGLAYLHEESR 780
+L V +Y+ L L + +C R R +++A + YLH
Sbjct: 63 YSFQTAEKLYFVLDYVNGGELFFHL--QRERCFL---EPRARFYAAEVASAIGYLHS--- 114
Query: 781 LKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRGYL 840
L I++RD+K N+LLD + ++DFGL K + ST GT Y+APE +
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTST-FCGTPEYLAPEVLRKEPY 173
Query: 841 TDKADVYSFGIVALEIVSG 859
D + G V E++ G
Sbjct: 174 DRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 1e-11
Identities = 51/206 (24%), Positives = 106/206 (51%), Gaps = 15/206 (7%)
Query: 659 NNFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNR-EFVNEIGMISALQHQN 716
++F+ +++G G G V+K + G ++A K + + K R + + E+ ++
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 717 LVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLH 776
+V YG ++ + E+++ SL + L K G+ + ++ + +GL YL
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVL-KKAGR---IPEQILGKVSIAVIKGLTYLR 120
Query: 777 EESRLKIVHRDIKATNVLLDKDLNAKISDFGLAK--LDEDENTHISTRIAGTVGYMAPEY 834
E+ KI+HRD+K +N+L++ K+ DFG++ +D N+ + TR YM+PE
Sbjct: 121 EKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR-----SYMSPER 173
Query: 835 AMRGYLTDKADVYSFGIVALEIVSGK 860
+ + ++D++S G+ +E+ G+
Sbjct: 174 LQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 60/199 (30%), Positives = 94/199 (47%), Gaps = 15/199 (7%)
Query: 667 IGEGGFGPVYKGT-LSDGAVIAVKQLSSKS---KQGNREFVNEIG-MISALQHQNLVKLY 721
IG+G FG V ++ AVK L K+ K+ + ++E ++ ++H LV L+
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 722 GCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRI-CSDIARGLAYLHEESR 780
++L V +Y+ L L + +C R R ++IA L YLH
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHL--QRERCF---LEPRARFYAAEIASALGYLHS--- 114
Query: 781 LKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRGYL 840
L IV+RD+K N+LLD + ++DFGL K + + N ST GT Y+APE +
Sbjct: 115 LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST-FCGTPEYLAPEVLHKQPY 173
Query: 841 TDKADVYSFGIVALEIVSG 859
D + G V E++ G
Sbjct: 174 DRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 66.8 bits (164), Expect = 1e-11
Identities = 63/228 (27%), Positives = 104/228 (45%), Gaps = 54/228 (23%)
Query: 661 FDAANKIGEGGFGPVYKGTLSD---GAVIAVK------QLSSKSKQGNRE--FVNEIGMI 709
++ K+G+G +G V+K D V+A+K + ++ +++ RE F+ E+G
Sbjct: 9 YEILQKLGKGAYGIVWKAI--DRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELG-- 64
Query: 710 SALQHQNLVKLYGC--CIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSD 767
H N+VKL + LV+EY+E + L R I D
Sbjct: 65 ---DHPNIVKLLNVIKAENDKDIYLVFEYMETD---------------LHAVIRANILED 106
Query: 768 I---------ARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAK----LDED 814
+ + L Y+H S ++HRD+K +N+LL+ D K++DFGLA+ L+E+
Sbjct: 107 VHKRYIMYQLLKALKYIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEEN 163
Query: 815 ENTHISTRIAGTVGYMAPE--YAMRGYLTDKADVYSFGIVALEIVSGK 860
+ T T Y APE Y T D++S G + E++ GK
Sbjct: 164 PENPVLTDYVATRWYRAPEILLGSTRY-TKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-11
Identities = 30/69 (43%), Positives = 44/69 (63%)
Query: 86 HVTVILLKGFNLAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRL 145
H+ I L G ++ G IP G++T L+ +DLS N FNGS+P+S +L +L L + GN L
Sbjct: 443 HLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSL 502
Query: 146 SGSIPLEIG 154
SG +P +G
Sbjct: 503 SGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 2e-11
Identities = 62/218 (28%), Positives = 99/218 (45%), Gaps = 26/218 (11%)
Query: 659 NNFDAANKIGEGGFGPVY----KGTLSDGAVIAVKQLSSKSKQGNRE---FVNEIGMISA 711
+FD + +G G FG V K T G + A+K + KS +E F E I +
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKAT---GDIYAMKVMK-KSVLLAQETVSFFEEERDILS 56
Query: 712 LQHQN-LVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIAR 770
+ + + +L + + L LV EY L L E Q D + +++
Sbjct: 57 ISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQ---FDEDMAQFYLAELVL 113
Query: 771 GLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFG-LAKLDEDENTHISTRIAGTVGY 829
+ +H+ + VHRDIK NVL+D+ + K++DFG A+L ++ S GT Y
Sbjct: 114 AIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV-NSKLPVGTPDY 169
Query: 830 MAPEY--AMRGYLTDKADV----YSFGIVALEIVSGKS 861
+APE M G V +S G++A E++ G+S
Sbjct: 170 IAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRS 207
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 2e-11
Identities = 41/159 (25%), Positives = 66/159 (41%), Gaps = 25/159 (15%)
Query: 708 MISALQHQNLVKLYGCCIEGNQLLLV--------YEYLENNSLARALFGKEGQCLNLDWA 759
++ + H +++++ + G +V Y YL S L
Sbjct: 110 LLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRSRP------------LPID 157
Query: 760 TRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHI 819
I I GL YLH + +I+HRD+K N+ ++ I D G A+ +
Sbjct: 158 QALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL 214
Query: 820 STRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS 858
+AGTV APE R KAD++S GIV E+++
Sbjct: 215 G--LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 2e-11
Identities = 49/201 (24%), Positives = 84/201 (41%), Gaps = 18/201 (8%)
Query: 670 GGFGPVYKGTLSDGAVIAVKQ--LSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIEG 727
+ K ++AVK+ L S SK+ + EI LQH N++ I
Sbjct: 13 LMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVD 71
Query: 728 NQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRD 787
++L +V + S L K L I D+ L Y+H +HR
Sbjct: 72 SELYVVSPLMAYGS-CEDLL-KTHFPEGLPELAIAFILKDVLNALDYIH---SKGFIHRS 126
Query: 788 IKATNVLLDKDLNAKISDF----GLAKLDEDENT-HISTR-IAGTVGYMAPEY---AMRG 838
+KA+++LL D +S + K + + H + + +++PE ++G
Sbjct: 127 VKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQG 186
Query: 839 YLTDKADVYSFGIVALEIVSG 859
Y +K+D+YS GI A E+ +G
Sbjct: 187 Y-NEKSDIYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 2e-11
Identities = 35/95 (36%), Positives = 56/95 (58%), Gaps = 10/95 (10%)
Query: 768 IARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENT-HISTRIAGT 826
I RGL Y+H I+HRD+K +N+ +++D KI DFGLA+ +DE T +++TR
Sbjct: 127 ILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR---- 179
Query: 827 VGYMAPEYAM-RGYLTDKADVYSFGIVALEIVSGK 860
Y APE + + D++S G + E+++GK
Sbjct: 180 -WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 2e-11
Identities = 56/207 (27%), Positives = 95/207 (45%), Gaps = 22/207 (10%)
Query: 667 IGEGGFGPVYKGT---LSDGAV-----IAVKQLSSKSKQGNREFVNEIGMISALQHQNLV 718
+G+G F ++KG + D + +K L + + F M+S L H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 719 KLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAY-LHE 777
YG C+ G++ ++V EY++ SL L K +N+ W ++A+ LA+ LH
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYL-KKNKNLINISWKL------EVAKQLAWALHF 115
Query: 778 ESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTR----IAGTVGYMAPE 833
+ H ++ A NVLL ++ + K + KL D I+ + + ++ PE
Sbjct: 116 LEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLS-DPGISITVLPKEILLERIPWVPPE 174
Query: 834 YAMRG-YLTDKADVYSFGIVALEIVSG 859
L+ AD +SFG EI SG
Sbjct: 175 CIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 3e-11
Identities = 62/211 (29%), Positives = 92/211 (43%), Gaps = 34/211 (16%)
Query: 667 IGEGGFGPV----YKGT--------LSDGAVIAVKQLSS-KSKQGNREFVNEIGMISALQ 713
+G G FG V YK T L G +IA ++ S ++ R F ++ +
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEK--RIFE----TANSER 60
Query: 714 HQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRIC---SDIAR 770
H LV L+ C + + V EY L + + D + R + +
Sbjct: 61 HPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHI--------HTDVFSEPRAVFYAACVVL 112
Query: 771 GLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYM 830
GL YLHE KIV+RD+K N+LLD + KI+DFGL K ST GT ++
Sbjct: 113 GLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTST-FCGTPEFL 168
Query: 831 APEYAMRGYLTDKADVYSFGIVALEIVSGKS 861
APE T D + G++ E++ G+S
Sbjct: 169 APEVLTETSYTRAVDWWGLGVLIYEMLVGES 199
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 3e-11
Identities = 70/291 (24%), Positives = 122/291 (41%), Gaps = 39/291 (13%)
Query: 661 FDAANKIGEGGFGPVYKGTL--SDGAV--IAVKQLSSK--SKQGNREFVNEIGMISALQH 714
F +G+G FG V + L DG+ +AVK L + S EF+ E + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 715 QNLVKLYGCCIEGNQL------LLVYEYLENNSL-ARALFGKEGQ-CLNLDWATRKRICS 766
N++KL G + +++ ++++ L L + G+ L T R
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 767 DIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAG- 825
DIA G+ YL S +HRD+ A N +L++++ ++DFGL+K + + +
Sbjct: 121 DIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177
Query: 826 TVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNY---RPKEEFVYLLDWAYVLQ 882
V ++A E T +DV++FG+ EI++ + T Y E + YL+ + Q
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIMT-RGQTPYAGVENSEIYNYLIKGNRLKQ 236
Query: 883 EQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933
L ++ + + C +P P RP+ LE
Sbjct: 237 PPDCLEDVYE-----------------LMCQCWSPEPKCRPSFQHLRDQLE 270
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 3e-11
Identities = 54/174 (31%), Positives = 84/174 (48%), Gaps = 22/174 (12%)
Query: 763 RICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAK-LDEDENTHIST 821
R S +A+G+ +L ++ +HRD+ A NVLL AKI DFGLA+ + D N +
Sbjct: 216 RFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG 272
Query: 822 RIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSN-TNYRPKEEFVYLLDWAY 879
V +MAPE T ++DV+S+GI+ EI S GKS +F ++ Y
Sbjct: 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGY 332
Query: 880 VLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933
++ P +F+ E + +I +C N PT RPT S +++
Sbjct: 333 ---------QMSRP----DFAPPE---IYSIMKMCWNLEPTERPTFSQISQLIQ 370
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 4e-11
Identities = 56/204 (27%), Positives = 98/204 (48%), Gaps = 21/204 (10%)
Query: 667 IGEGGFGPVYKG-TLSDGAVIAVKQLSS--KSKQGNREFVNEIGMISALQHQNLVKLYGC 723
+G G +G V G +AVK+LS +S + E+ ++ ++H+N++ L
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84
Query: 724 CIEGNQLLLVYEYLENNSLARALFGKE----GQCLNLDWATRKRICSDIARGLAYLHEES 779
L E + L L G + +C L + + I RGL Y+H
Sbjct: 85 FTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 140
Query: 780 RLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENT-HISTRIAGTVGYMAPEYAMRG 838
I+HRD+K +N+ +++D KI DFGLA+ +DE T +++TR Y APE +
Sbjct: 141 ---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 192
Query: 839 -YLTDKADVYSFGIVALEIVSGKS 861
+ D++S G + E+++G++
Sbjct: 193 MHYNQTVDIWSVGCIMAELLTGRT 216
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 6e-11
Identities = 53/205 (25%), Positives = 102/205 (49%), Gaps = 26/205 (12%)
Query: 667 IGEGGFGP--VYKGTLSDGAVIAVKQL----SSKSKQGNREFVNEIGMISALQHQNLVKL 720
+GEG FG + + SD A+K++ SS + + +R+ E +++ ++H N+V
Sbjct: 8 VGEGSFGRALLVQHVNSD-QKYAMKEIRLPKSSSAVEDSRK---EAVLLAKMKHPNIVA- 62
Query: 721 YGCCIEGN-QLLLVYEYLENNSLARALFGKEGQCLN----LDWATRKRICSDIARGLAYL 775
+ E + L +V EY + L + + + G+ L W + + G+ ++
Sbjct: 63 FKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQ------MCLGVQHI 116
Query: 776 HEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYA 835
HE+ +++HRDIK+ N+ L ++ K+ DFG A+L + T + GT Y+ PE
Sbjct: 117 HEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPEIW 172
Query: 836 MRGYLTDKADVYSFGIVALEIVSGK 860
+K+D++S G + E+ + K
Sbjct: 173 ENMPYNNKSDIWSLGCILYELCTLK 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 7e-11
Identities = 56/202 (27%), Positives = 96/202 (47%), Gaps = 17/202 (8%)
Query: 667 IGEGGFGPV---YKGTLSDGAVIAVKQLSS--KSKQGNREFVNEIGMISALQHQNLVKLY 721
+G G +G V Y L +AVK+LS +S R E+ ++ ++H+N++ L
Sbjct: 23 VGSGAYGSVCSAYDTRLRQK--VAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLL 80
Query: 722 GCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRL 781
+ E +L A +C L + + + RGL Y+H
Sbjct: 81 DVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAG-- 138
Query: 782 KIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENT-HISTRIAGTVGYMAPEYAMRG-Y 839
I+HRD+K +NV +++D +I DFGLA+ +DE T +++TR Y APE + +
Sbjct: 139 -IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----WYRAPEIMLNWMH 192
Query: 840 LTDKADVYSFGIVALEIVSGKS 861
D++S G + E++ GK+
Sbjct: 193 YNQTVDIWSVGCIMAELLKGKA 214
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 7e-11
Identities = 33/100 (33%), Positives = 58/100 (58%), Gaps = 9/100 (9%)
Query: 763 RICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAK--LDEDENTHIS 820
+I + RGL YL E+ KI+HRD+K +N+L++ K+ DFG++ +D N+ +
Sbjct: 103 KISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVG 160
Query: 821 TRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGK 860
TR YM+PE + T ++D++S G+ +E+ G+
Sbjct: 161 TR-----SYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 8e-11
Identities = 36/98 (36%), Positives = 51/98 (52%), Gaps = 4/98 (4%)
Query: 97 LAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGDI 156
L G IP + L LQ ++LS N G++P S + +L L + N +GSIP +G +
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489
Query: 157 STLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFT 194
++L L L N L G +P LG L R +S NFT
Sbjct: 490 TSLRILNLNGNSLSGRVPAALGGR-LLHR---ASFNFT 523
|
Length = 623 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 1e-10
Identities = 63/202 (31%), Positives = 95/202 (47%), Gaps = 17/202 (8%)
Query: 667 IGEGGFGPVYKGTLS-DGAVIAVKQLSSKSKQGNREFVNEIGMIS----ALQHQN--LVK 719
+G+G FG V L G AVK L + + E M+ AL +N L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDV--ECTMVEKRVLALAWENPFLTH 60
Query: 720 LYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEES 779
LY L V E+L L + ++ +L AT ++I GL +LH +
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDLMFHI--QDKGRFDLYRATF--YAAEIVCGLQFLHSKG 116
Query: 780 RLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRGY 839
I++RD+K NV+LD+D + KI+DFG+ K + + ST GT Y+APE
Sbjct: 117 ---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST-FCGTPDYIAPEILQGLK 172
Query: 840 LTDKADVYSFGIVALEIVSGKS 861
T D +SFG++ E++ G+S
Sbjct: 173 YTFSVDWWSFGVLLYEMLIGQS 194
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 61/221 (27%), Positives = 97/221 (43%), Gaps = 28/221 (12%)
Query: 650 TLRQIKAATNNFDAANKIGEGGFGPVYKGTLSDGAV--IAVKQLSS----KSKQGNREFV 703
R+ K +F+ +G G FG V T + +A+K+ K KQ + F
Sbjct: 21 PKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVF- 79
Query: 704 NEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKR 763
+E +++ + H V LYG + + L LV E++ L KR
Sbjct: 80 SERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFL------------RRNKR 127
Query: 764 ICSDI-----ARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTH 818
+D+ A+ + L IV+RD+K N+LLDKD K++DFG AK+ +
Sbjct: 128 FPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR--- 184
Query: 819 ISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSG 859
+ + GT Y+APE + AD ++ GI EI+ G
Sbjct: 185 -TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-10
Identities = 45/147 (30%), Positives = 77/147 (52%), Gaps = 14/147 (9%)
Query: 717 LVKLYGCCIEGNQLLLVYEYLENNSLARAL--FGKEGQCLNLDWATRKRICSDIARGLAY 774
L +L+ C ++L V EY+ L + GK + + +A ++IA GL +
Sbjct: 63 LTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYA------AEIAIGLFF 116
Query: 775 LHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTR-IAGTVGYMAPE 833
LH + I++RD+K NV+LD + + KI+DFG+ K E+ +TR GT Y+APE
Sbjct: 117 LHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCK--ENIFGGKTTRTFCGTPDYIAPE 171
Query: 834 YAMRGYLTDKADVYSFGIVALEIVSGK 860
D ++FG++ E+++G+
Sbjct: 172 IIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 57/214 (26%), Positives = 95/214 (44%), Gaps = 20/214 (9%)
Query: 660 NFDAANKIGEGGFGPVY---------KGTLSDGAVIAVKQLSSKSKQGNREFVNEIGMIS 710
NF+ +G G +G V+ G L V+ + K+K +
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 711 ALQHQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIAR 770
Q LV L+ +L L+ +Y+ L L +E + +I
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRE----RFKEQEVQIYSGEIVL 116
Query: 771 GLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYM 830
L +LH +L I++RDIK N+LLD + + ++DFGL+K ++ + GT+ YM
Sbjct: 117 ALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYM 173
Query: 831 APEYAMRGYLT--DKA-DVYSFGIVALEIVSGKS 861
AP+ +RG DKA D +S G++ E+++G S
Sbjct: 174 APD-IVRGGDGGHDKAVDWWSMGVLMYELLTGAS 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 3e-10
Identities = 33/82 (40%), Positives = 52/82 (63%)
Query: 145 LSGSIPLEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNL 204
L G IP +I + L+ + L N + G +P +LG++ SL + LS N+F GSIPES G L
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489
Query: 205 KNLTEFRIDGSNLTGRIPNFIG 226
+L ++G++L+GR+P +G
Sbjct: 490 TSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 3e-10
Identities = 64/216 (29%), Positives = 103/216 (47%), Gaps = 25/216 (11%)
Query: 660 NFDAANKIGEGGFGPVY---KGTLSD-GAVIAVKQLS-------SKSKQGNREFVNEIGM 708
NF+ +G G +G V+ K T D G + A+K L +K+ + R N +
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 709 ISALQHQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDI 768
+ Q LV L+ +L L+ +Y+ + L+ ++ N + +I
Sbjct: 61 VR--QSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRD----NFSEDEVRFYSGEI 114
Query: 769 ARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAK--LDEDENTHISTRIAGT 826
L +LH +L IV+RDIK N+LLD + + ++DFGL+K L E++ S GT
Sbjct: 115 ILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS--FCGT 169
Query: 827 VGYMAPEYAMRGYLTDKA-DVYSFGIVALEIVSGKS 861
+ YMAPE KA D +S GI+ E+++G S
Sbjct: 170 IEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGAS 205
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 3e-10
Identities = 75/283 (26%), Positives = 117/283 (41%), Gaps = 62/283 (21%)
Query: 667 IGEGGFGPVYKGTL----SDGAVIAVKQLSSKSK---QGNR---EFVNEIGMISALQHQN 716
+G+G F +YKG L V +++S K +R F ++S L H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 717 LVKLYGCCI-EGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYL 775
LVKLYG C+ + N +V EY++ L L +E ++L W + + +A L YL
Sbjct: 63 LVKLYGVCVRDENI--MVEEYVKFGPLDVFL-HREKNNVSLHW--KLDVAKQLASALHYL 117
Query: 776 HEESRLKIVHRDIKATNVLLDKD-------LNAKISDFGLAK--LDEDENTHISTRIAGT 826
++ K+VH ++ N+L+ + K+SD G+ L +E RI
Sbjct: 118 EDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERV---ERIP-- 169
Query: 827 VGYMAPEYAMRG--YLTDKADVYSFGIVALEIVSGK----SNTNYRPKEEFVYLLDWAYV 880
++APE G LT AD +SFG LEI S S + KE F
Sbjct: 170 --WIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERF--------- 218
Query: 881 LQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRP 923
+ + L + D + A + C PT RP
Sbjct: 219 -YQDQHRLPMPD-------CAELANLINQ----CWTYDPTKRP 249
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 3e-10
Identities = 61/223 (27%), Positives = 102/223 (45%), Gaps = 24/223 (10%)
Query: 651 LRQIKAATNNFDAANKIGEGGFGPV----YKGTLSDGAVIAVKQLSSKS--KQGNREFVN 704
+R+++ ++D IG G FG V +K S V A+K LS K+ + F
Sbjct: 35 IRKLQMKAEDYDVVKVIGRGAFGEVQLVRHK---SSQKVYAMKLLSKFEMIKRSDSAFFW 91
Query: 705 EIGMISALQHQNLVKLYGCCIEGNQ-LLLVYEYLENNSLARALFGKEGQCLNLDWATRKR 763
E I A + V C + ++ L +V EY+ L + + + WA K
Sbjct: 92 EERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD---VPEKWA--KF 146
Query: 764 ICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLA-KLDEDENTHISTR 822
+++ L +H + ++HRD+K N+LLDK + K++DFG K+DE T
Sbjct: 147 YTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTA 203
Query: 823 IAGTVGYMAPEYAMR----GYLTDKADVYSFGIVALEIVSGKS 861
+ GT Y++PE GY + D +S G+ E++ G +
Sbjct: 204 V-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDT 245
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 4e-10
Identities = 65/226 (28%), Positives = 100/226 (44%), Gaps = 11/226 (4%)
Query: 90 ILLKGFNLAGVIPEEFGNLTF-LQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGS 148
L N IP G L L+E+DLS N SLP L NL L + N LS
Sbjct: 120 SLDLDNNNITDIPPLIGLLKSNLKELDLSDNKI-ESLPSPLRNLPNLKNLDLSFNDLS-D 177
Query: 149 IPLEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLT 208
+P + ++S L L L N++ LP + L +L + LS+N+ + S NLKNL+
Sbjct: 178 LPKLLSNLSNLNNLDLSGNKI-SDLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLS 235
Query: 209 EFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISDLKGSSS 268
+ +N +P IGN + L+ LDL + S++ L NL EL +S S++
Sbjct: 236 GLELS-NNKLEDLPESIGNLSNLETLDLSNNQIS--SISSLGSLTNLRELDLSGNSLSNA 292
Query: 269 SFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLT 314
+ +L N L+T ++ + L ++ N T
Sbjct: 293 LPLIALLLLL--LELLLNLLLTL-KALELKLNSILLNNNILSNGET 335
|
Length = 394 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 5e-10
Identities = 45/147 (30%), Positives = 82/147 (55%), Gaps = 9/147 (6%)
Query: 666 KIGEGGFGPVYKG-TLSDGAVIAVKQLSSKSKQGNR-EFVNEIGMISALQHQNLVKLYGC 723
K+GEG + VYKG + G ++A+K++ + ++G + E ++ L+H N+V L+
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDI 71
Query: 724 CIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKI 783
L LV+EYL+ + L + + G L++ + + RGLAY H+ ++
Sbjct: 72 IHTKKTLTLVFEYLDTD-LKQYM-DDCGGGLSMHNV--RLFLFQLLRGLAYCHQR---RV 124
Query: 784 VHRDIKATNVLLDKDLNAKISDFGLAK 810
+HRD+K N+L+ + K++DFGLA+
Sbjct: 125 LHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 6e-10
Identities = 49/169 (28%), Positives = 78/169 (46%), Gaps = 22/169 (13%)
Query: 768 IARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAK-LDEDENTHISTRIAGT 826
+A+G+++L ++ +HRD+ A N+LL KI DFGLA+ + D N +
Sbjct: 223 VAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLP 279
Query: 827 VGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKE-EFVYLLDWAYVLQEQ 884
V +MAPE T ++DV+S+GI+ EI S G S P + +F ++ Y +
Sbjct: 280 VKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRM--- 336
Query: 885 GNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933
L + E M +I C + P RPT V ++E
Sbjct: 337 ----------LSPECAPSE---MYDIMKSCWDADPLKRPTFKQIVQLIE 372
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 1e-09
Identities = 31/85 (36%), Positives = 49/85 (57%), Gaps = 1/85 (1%)
Query: 166 DNQ-LVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIPNF 224
DNQ L G +P ++ L+ L+ I LS N+ G+IP S G++ +L + ++ G IP
Sbjct: 426 DNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPES 485
Query: 225 IGNWTKLDRLDLQGTSLEGPIPSTI 249
+G T L L+L G SL G +P+ +
Sbjct: 486 LGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 1e-09
Identities = 33/95 (34%), Positives = 50/95 (52%), Gaps = 4/95 (4%)
Query: 766 SDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAG 825
++I L YLH +V+RD+K N++LDKD + KI+DFGL K + + T G
Sbjct: 102 AEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCG 157
Query: 826 TVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGK 860
T Y+APE D + G+V E++ G+
Sbjct: 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-09
Identities = 45/145 (31%), Positives = 72/145 (49%), Gaps = 8/145 (5%)
Query: 717 LVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLH 776
LV L+ C ++L LV EY+ L +F + Q L + ++I L +LH
Sbjct: 58 LVGLHSCFQTTSRLFLVIEYVNGGDL---MFHMQRQ-RKLPEEHARFYAAEICIALNFLH 113
Query: 777 EESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAM 836
E I++RD+K NVLLD D + K++D+G+ K ST GT Y+APE
Sbjct: 114 ERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTST-FCGTPNYIAPEILR 169
Query: 837 RGYLTDKADVYSFGIVALEIVSGKS 861
D ++ G++ E+++G+S
Sbjct: 170 GEEYGFSVDWWALGVLMFEMMAGRS 194
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 2e-09
Identities = 36/118 (30%), Positives = 52/118 (44%), Gaps = 25/118 (21%)
Query: 225 IGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISDLKGSSSSFPNLQDMKKMERLIL 284
G W +D L L L G IP+ IS+L++L + +S
Sbjct: 415 KGKWF-IDGLGLDNQGLRGFIPNDISKLRHLQSINLS----------------------- 450
Query: 285 RNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGTLP 342
I G IP + +T L++LDLS+N G +P L L + + L NSLSG +P
Sbjct: 451 -GNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-09
Identities = 61/222 (27%), Positives = 99/222 (44%), Gaps = 8/222 (3%)
Query: 146 SGSIPLEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLK 205
S + ++ L L L N+L + E L L +L + L +NN T P
Sbjct: 82 SLDGSENLLNLLPLPSLDLNLNRLRSNISE-LLELTNLTSLDLDNNNITDIPPLIGLLKS 140
Query: 206 NLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISDLKG 265
NL E + + + +P+ + N L LDL L +P +S L NL L +S K
Sbjct: 141 NLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLSD-LPKLLSNLSNLNNLDLSGNK- 197
Query: 266 SSSSFPNLQDMK-KMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNL 324
S P ++ +E L L N I + + ++ +L L+LS N+L P + NL
Sbjct: 198 -ISDLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLEDL-PESIGNL 254
Query: 325 KKIDYIFLTNNSLSGTLPDWILTSEKNLDLSYNNFTESSPAT 366
++ + L+NN +S LT+ + LDLS N+ + + P
Sbjct: 255 SNLETLDLSNNQISSISSLGSLTNLRELDLSGNSLSNALPLI 296
|
Length = 394 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 2e-09
Identities = 56/204 (27%), Positives = 99/204 (48%), Gaps = 20/204 (9%)
Query: 667 IGEGGFGPVYKGTLSD-GAVIAVKQLSS--KSKQGNREFVNEIGMISALQHQNLVKLYGC 723
IG G +G V S+ +A+K++++ ++ + + EI ++ L H+N++ +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72
Query: 724 CI-----EGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEE 778
N + +VYE L + L + + + Q L+ D + + RGL Y+H
Sbjct: 73 MPPPHREAFNDVYIVYE-LMDTDLHQII--RSSQTLSDDHC--QYFLYQLLRGLKYIHSA 127
Query: 779 SRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMR- 837
+ ++HRD+K +N+LL+ + + KI DFGLA+ E T T Y APE +
Sbjct: 128 N---VLHRDLKPSNLLLNANCDLKICDFGLART-TSEKGDFMTEYVVTRWYRAPELLLNC 183
Query: 838 -GYLTDKADVYSFGIVALEIVSGK 860
Y T DV+S G + E++ K
Sbjct: 184 SEY-TTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 38/94 (40%), Positives = 55/94 (58%), Gaps = 8/94 (8%)
Query: 768 IARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAK---LDEDENTHISTRIA 824
+ARG+ +L SR K +HRD+ A N+LL ++ KI DFGLA+ D D S R+
Sbjct: 183 VARGMEFL--ASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239
Query: 825 GTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS 858
+ +MAPE T ++DV+SFG++ EI S
Sbjct: 240 --LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 2e-09
Identities = 46/153 (30%), Positives = 76/153 (49%), Gaps = 12/153 (7%)
Query: 711 ALQHQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIAR 770
A H LV L+ C ++L V EY+ L +F + Q L + ++I+
Sbjct: 52 ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQ-RKLPEEHARFYSAEISL 107
Query: 771 GLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAK--LDEDENTHISTRIAGTVG 828
L YLHE I++RD+K NVLLD + + K++D+G+ K L + T + GT
Sbjct: 108 ALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCGTPN 161
Query: 829 YMAPEYAMRGYLTDKADVYSFGIVALEIVSGKS 861
Y+APE D ++ G++ E+++G+S
Sbjct: 162 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRS 194
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 3e-09
Identities = 53/203 (26%), Positives = 98/203 (48%), Gaps = 21/203 (10%)
Query: 667 IGEGGFGPV-YKGTLSDGAVIAVKQLSS--KSKQGNREFVNEIGMISALQHQNLVKLYGC 723
+G G +G V GA +A+K+L +S+ + E+ ++ ++H+N++ L
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82
Query: 724 CIEGNQLLLVYEYLENNSLARALFGKE-GQCLNLDWATRKRI---CSDIARGLAYLHEES 779
L +++ L G + G+ + + + RI + +GL Y+H
Sbjct: 83 FTPDLSLDRFHDFY----LVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAG 138
Query: 780 RLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENT-HISTRIAGTVGYMAPEYAMRG 838
I+HRD+K N+ +++D KI DFGLA+ + E T ++ TR Y APE +
Sbjct: 139 ---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR-----WYRAPEVILNW 190
Query: 839 -YLTDKADVYSFGIVALEIVSGK 860
+ T D++S G + E+++GK
Sbjct: 191 MHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 3e-09
Identities = 85/343 (24%), Positives = 133/343 (38%), Gaps = 98/343 (28%)
Query: 667 IGEGGFGPVYKGT------LSDGAVIAVKQLSSKSKQGN-REFVNEIG-MISALQHQNLV 718
+G G FG V + + +AVK L + R ++E+ +I H N+V
Sbjct: 15 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 74
Query: 719 KLYGCCIE-GNQLLLVYEYLENNSL------------------ARALFGKEGQC-LNLDW 758
L G C + G L+++ E+ + +L AR GK G ++ D
Sbjct: 75 NLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDL 134
Query: 759 ATR------------------KRICS--------------------------DIARGLAY 774
R K + +A+G+ +
Sbjct: 135 KRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEF 194
Query: 775 LHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAK---LDEDENTHISTRIAGTVGYMA 831
L SR K +HRD+ A N+LL ++ KI DFGLA+ D D R+ + +MA
Sbjct: 195 L--ASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP--LKWMA 249
Query: 832 PEYAMRGYLTDKADVYSFGIVALEIVS-GKSN-TNYRPKEEFVYLLDWAYVLQEQGNLLE 889
PE T ++DV+SFG++ EI S G S + EEF L ++G +
Sbjct: 250 PETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL-------KEGTRMR 302
Query: 890 LVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSML 932
D + + + TML+ C + P+ RPT S V L
Sbjct: 303 APDYT-----TPEMYQTMLD----CWHGEPSQRPTFSELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 3e-09
Identities = 43/147 (29%), Positives = 76/147 (51%), Gaps = 14/147 (9%)
Query: 717 LVKLYGCCIEGNQLLLVYEYLENNSLARAL--FGKEGQCLNLDWATRKRICSDIARGLAY 774
L +L+ C ++L V EY+ L + GK + + +A ++I+ GL +
Sbjct: 63 LTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYA------AEISVGLFF 116
Query: 775 LHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTR-IAGTVGYMAPE 833
LH I++RD+K NV+LD + + KI+DFG+ K E ++TR GT Y+APE
Sbjct: 117 LHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGTPDYIAPE 171
Query: 834 YAMRGYLTDKADVYSFGIVALEIVSGK 860
D +++G++ E+++G+
Sbjct: 172 IIAYQPYGKSVDWWAYGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 3e-09
Identities = 37/94 (39%), Positives = 54/94 (57%), Gaps = 8/94 (8%)
Query: 768 IARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAK---LDEDENTHISTRIA 824
+ARG+ +L SR K +HRD+ A N+LL ++ KI DFGLA+ D D R+
Sbjct: 182 VARGMEFL--ASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238
Query: 825 GTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS 858
+ +MAPE T ++DV+SFG++ EI S
Sbjct: 239 --LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 3e-09
Identities = 35/87 (40%), Positives = 49/87 (56%), Gaps = 6/87 (6%)
Query: 772 LAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLA-KLDEDENTHISTRIAGTVGYM 830
LAYLH I+HRD+K N+ LD+ NA + DFG A KLD +T +GT+
Sbjct: 198 LAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETN 254
Query: 831 APEY-AMRGYLTDKADVYSFGIVALEI 856
+PE A+ Y K D++S G+V E+
Sbjct: 255 SPELLALDPYCA-KTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-09
Identities = 34/95 (35%), Positives = 51/95 (53%), Gaps = 3/95 (3%)
Query: 766 SDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAG 825
++I L YLH E +V+RD+K N++LDKD + KI+DFGL K + + T G
Sbjct: 102 AEIVSALDYLHSEK--NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCG 158
Query: 826 TVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGK 860
T Y+APE D + G+V E++ G+
Sbjct: 159 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 3e-09
Identities = 51/199 (25%), Positives = 88/199 (44%), Gaps = 28/199 (14%)
Query: 675 VYKGTLSDGAVI--AVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIEGN---- 728
+YKG ++ VI K+ K NEI + + N++K+YG I+
Sbjct: 36 IYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLP 95
Query: 729 QLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDI 788
+L L+ EY L R + KE +L + T+ + D +GL L++ + ++++
Sbjct: 96 RLSLILEYCTRGYL-REVLDKEK---DLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNL 149
Query: 789 KATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRGYLTD------ 842
+ + L+ ++ KI GL K+ +S+ V +M Y L D
Sbjct: 150 TSVSFLVTENYKLKIICHGLEKI-------LSSPPFKNVNFMV--YFSYKMLNDIFSEYT 200
Query: 843 -KADVYSFGIVALEIVSGK 860
K D+YS G+V EI +GK
Sbjct: 201 IKDDIYSLGVVLWEIFTGK 219
|
Length = 283 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 4e-09
Identities = 54/198 (27%), Positives = 88/198 (44%), Gaps = 13/198 (6%)
Query: 667 IGEGGFGPVYKGTLS-DGAVIAVKQLSSKSKQGNREFVNEIG----MISALQHQNLVKLY 721
IG+G FG V DG AVK L K +E + + ++ ++H LV L+
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 722 GCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRL 781
+L V +++ L F + + + ++IA L YLH +
Sbjct: 63 YSFQTTEKLYFVLDFVNGGEL----FFHLQRERSFPEPRARFYAAEIASALGYLHS---I 115
Query: 782 KIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRGYLT 841
IV+RD+K N+LLD + ++DFGL K + + +T GT Y+APE +
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCK-EGIAQSDTTTTFCGTPEYLAPEVIRKQPYD 174
Query: 842 DKADVYSFGIVALEIVSG 859
+ D + G V E++ G
Sbjct: 175 NTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 5e-09
Identities = 63/218 (28%), Positives = 103/218 (47%), Gaps = 28/218 (12%)
Query: 660 NFDAANKIGEGGFGPV----YKGTLSDGAVIAVKQLS---SKSKQGNREFVNEIGMISAL 712
++ ++G+G +G V T S+ +A+K+++ SK R + E+ ++
Sbjct: 1 RYELIKELGQGAYGIVCSARNAET-SEEETVAIKKITNVFSKKILAKRA-LRELKLLRHF 58
Query: 713 Q-HQNLVKLYGCCI----EGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSD 767
+ H+N+ LY I N+L L YE L L + + + GQ L A +
Sbjct: 59 RGHKNITCLYDMDIVFPGNFNELYL-YEELMEADLHQII--RSGQ--PLTDAHFQSFIYQ 113
Query: 768 IARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAK---LDEDENTHISTRIA 824
I GL Y+H + ++HRD+K N+L++ D KI DFGLA+ + EN T
Sbjct: 114 ILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV 170
Query: 825 GTVGYMAPEYAM--RGYLTDKADVYSFGIVALEIVSGK 860
T Y APE + + Y T DV+S G + E++ K
Sbjct: 171 ATRWYRAPEIMLSFQSY-TKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 5e-09
Identities = 60/221 (27%), Positives = 100/221 (45%), Gaps = 29/221 (13%)
Query: 659 NNFDAANKIGEGGFGPVY----KGTLSDGAVIAV-KQLSSKSKQGNREFVNEIGMISALQ 713
+F+ I G +G VY K T A+ + KQ Q + FV E +++ +
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFV-ERDILTFAE 59
Query: 714 HQNLVKLYGCCIEGNQ-LLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGL 772
+ +V ++ C E + L +V EY+E A L K L +D A + ++ L
Sbjct: 60 NPFVVSMF-CSFETKRHLCMVMEYVEGGDCATLL--KNIGALPVDMA--RMYFAETVLAL 114
Query: 773 AYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAK--------------LDEDENTH 818
YLH IVHRD+K N+L+ + K++DFGL+K +++D
Sbjct: 115 EYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREF 171
Query: 819 ISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSG 859
+ ++ GT Y+APE +R D ++ GI+ E + G
Sbjct: 172 LDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 5e-09
Identities = 46/153 (30%), Positives = 78/153 (50%), Gaps = 10/153 (6%)
Query: 710 SALQHQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIA 769
+A H LV L+ C ++L V E++ L +F + Q L + ++I+
Sbjct: 51 TASNHPFLVGLHSCFQTESRLFFVIEFVSGGDL---MFHMQRQ-RKLPEEHARFYSAEIS 106
Query: 770 RGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGY 829
L +LHE I++RD+K NVLLD + + K++D+G+ K ST GT Y
Sbjct: 107 LALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTST-FCGTPNY 162
Query: 830 MAPEYAMRGYLTD-KADVYSFGIVALEIVSGKS 861
+APE +RG D ++ G++ E+++G+S
Sbjct: 163 IAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRS 194
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 6e-09
Identities = 60/223 (26%), Positives = 101/223 (45%), Gaps = 28/223 (12%)
Query: 651 LRQIKAATNNFDAANKIGEGGFGPV----YKGTLSDGAVIAVKQLSSKS--KQGNREFVN 704
+ +++ +FD IG G FG V +K + V A+K LS K+ + F
Sbjct: 35 ITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSS---KQVYAMKLLSKFEMIKRSDSAFFW 91
Query: 705 EIGMISALQHQN---LVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATR 761
E I A H N +V+L+ + L +V EY+ L + + + WA
Sbjct: 92 EERDIMA--HANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYD---IPEKWA-- 144
Query: 762 KRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLA-KLDEDENTHIS 820
+ +++ L +H + +HRD+K N+LLDK + K++DFG K+D +
Sbjct: 145 RFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCD 201
Query: 821 TRIAGTVGYMAPEYAMR----GYLTDKADVYSFGIVALEIVSG 859
T + GT Y++PE GY + D +S G+ E++ G
Sbjct: 202 TAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 7e-09
Identities = 43/148 (29%), Positives = 79/148 (53%), Gaps = 14/148 (9%)
Query: 717 LVKLYGCCIEGNQLLLVYEYLENNSLARAL--FGKEGQCLNLDWATRKRICSDIARGLAY 774
L +L+ C ++L V EY+ L + G+ + + +A ++IA GL +
Sbjct: 63 LTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYA------AEIAIGLFF 116
Query: 775 LHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTR-IAGTVGYMAPE 833
LH + I++RD+K NV+LD + + KI+DFG+ K E+ ++T+ GT Y+APE
Sbjct: 117 LHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK--ENMWDGVTTKTFCGTPDYIAPE 171
Query: 834 YAMRGYLTDKADVYSFGIVALEIVSGKS 861
D ++FG++ E+++G++
Sbjct: 172 IIAYQPYGKSVDWWAFGVLLYEMLAGQA 199
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 8e-09
Identities = 48/217 (22%), Positives = 96/217 (44%), Gaps = 35/217 (16%)
Query: 660 NFDAANKIGEGGFGPVYKG--TLSDGAVIAVKQLSSKSK--QGNREFVNEIGMISALQHQ 715
+ IG G +G V T S G +A+K++ + + E+ ++ +H
Sbjct: 6 RYKPIENIGSGAYGVVCSAIDTRS-GKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHD 64
Query: 716 NLVKLYGCCI---------EGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICS 766
N++ I + + +V + +E++ L + Q L + +
Sbjct: 65 NII-----AIRDILRPPGADFKDVYVVMDLMESD-LHHIIHS--DQPLTEEHI--RYFLY 114
Query: 767 DIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKL----DEDENTHISTR 822
+ RGL Y+H ++HRD+K +N+L+++D +I DFG+A+ + ++
Sbjct: 115 QLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEY 171
Query: 823 IAGTVGYMAPE--YAMRGYLTDKADVYSFGIVALEIV 857
+A T Y APE ++ Y T D++S G + E++
Sbjct: 172 VA-TRWYRAPELLLSLPEY-TTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-08
Identities = 34/95 (35%), Positives = 50/95 (52%), Gaps = 4/95 (4%)
Query: 766 SDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAG 825
++I L YLH +V+RDIK N++LDKD + KI+DFGL K + + T G
Sbjct: 102 AEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCG 157
Query: 826 TVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGK 860
T Y+APE D + G+V E++ G+
Sbjct: 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-08
Identities = 50/189 (26%), Positives = 85/189 (44%), Gaps = 28/189 (14%)
Query: 683 GAVIAVKQLS------SKSKQGNREFVNEIGMISALQHQNLVKLYGCCI------EGNQL 730
G +AVK+LS + +K+ RE V ++ + H+N++ L E +
Sbjct: 46 GINVAVKKLSRPFQNQTHAKRAYRELV----LLKCVNHKNIISLLNVFTPQKSLEEFQDV 101
Query: 731 LLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKA 790
LV E ++ N L + + + LD + + G+ +LH I+HRD+K
Sbjct: 102 YLVMELMDAN-LCQVIH------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKP 151
Query: 791 TNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFG 850
+N+++ D KI DFGLA+ + T T Y APE + + D++S G
Sbjct: 152 SNIVVKSDCTLKILDFGLAR--TACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVG 209
Query: 851 IVALEIVSG 859
+ E+V G
Sbjct: 210 CIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 2e-08
Identities = 35/95 (36%), Positives = 51/95 (53%), Gaps = 4/95 (4%)
Query: 766 SDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAG 825
++I L YLH KIV+RD+K N++LDKD + KI+DFGL K + + T G
Sbjct: 102 AEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT-FCG 157
Query: 826 TVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGK 860
T Y+APE D + G+V E++ G+
Sbjct: 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-08
Identities = 32/95 (33%), Positives = 47/95 (49%), Gaps = 3/95 (3%)
Query: 768 IARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTV 827
+ R + YLHE I+HRDIKA N+ ++ + + DFG A D N + AGT+
Sbjct: 191 VLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTI 247
Query: 828 GYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSN 862
APE R D++S GIV E+ + +
Sbjct: 248 ATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDS 282
|
Length = 391 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 2e-08
Identities = 53/206 (25%), Positives = 101/206 (49%), Gaps = 26/206 (12%)
Query: 667 IGEGGFGPVYKGT-LSDGAVIAVKQLSS--KSKQGNREFVNEIGMISALQHQNLVKL--- 720
+G G +G V G +A+K+LS +S+ + E+ ++ +QH+N++ L
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82
Query: 721 YGCCIEGNQL---LLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHE 777
+ + G++ LV Y++ + + + G + + + +C GL Y+H
Sbjct: 83 FTSAVSGDEFQDFYLVMPYMQTD--LQKIMGHPLSEDKVQYLVYQMLC-----GLKYIHS 135
Query: 778 ESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENT-HISTRIAGTVGYMAPEYAM 836
I+HRD+K N+ +++D KI DFGLA+ + E T ++ TR Y APE +
Sbjct: 136 AG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WYRAPEVIL 187
Query: 837 RG-YLTDKADVYSFGIVALEIVSGKS 861
+ D++S G + E+++GK+
Sbjct: 188 NWMHYNQTVDIWSVGCIMAEMLTGKT 213
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 2e-08
Identities = 68/247 (27%), Positives = 102/247 (41%), Gaps = 58/247 (23%)
Query: 659 NNFDAANKIGEGGFGPV----YKGTLSDGAVIAVKQLSSKSKQGNREFV----NEIGMIS 710
++F++ IG G FG V K T G + A+K+L KS+ +E V E +++
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDT---GHIYAMKKLR-KSEMLEKEQVAHVRAERDILA 56
Query: 711 ALQHQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIAR 770
+ +VKLY + N L L+ EYL + L K D T + IA
Sbjct: 57 EADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKK-------DTFTEEETRFYIAE 109
Query: 771 GLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGL---------------------- 808
+ + +L +HRDIK N+LLD + K+SDFGL
Sbjct: 110 TILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPS 169
Query: 809 AKLDEDENTHISTRIA---------------GTVGYMAPEYAMR-GYLTDKADVYSFGIV 852
LD S R A GT Y+APE ++ GY + D +S G++
Sbjct: 170 NFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKECDWWSLGVI 228
Query: 853 ALEIVSG 859
E++ G
Sbjct: 229 MYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 2e-08
Identities = 44/159 (27%), Positives = 73/159 (45%), Gaps = 11/159 (6%)
Query: 704 NEIGMISALQHQNLVKLYGCC-IEGNQLLLVYEY---LENNSLARALFGKEGQCLNLDWA 759
NEI + L H+N++K+ E N ++ +Y L + A K+ L
Sbjct: 212 NEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLL---KQ 268
Query: 760 TRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHI 819
TR I + + Y+H++ K++HRDIK N+ L+ D + DFG A E E
Sbjct: 269 TR-AIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAF 324
Query: 820 STRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS 858
GTV +PE + D++S G++ L+++S
Sbjct: 325 DYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 3e-08
Identities = 36/95 (37%), Positives = 54/95 (56%), Gaps = 10/95 (10%)
Query: 768 IARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGT- 826
+ARG+ +L ++ VHRD+ A NVLL + KI DFGLA+ ++ ++S G+
Sbjct: 246 VARGMEFLASKN---CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSK---GST 299
Query: 827 ---VGYMAPEYAMRGYLTDKADVYSFGIVALEIVS 858
V +MAPE T +DV+S+GI+ EI S
Sbjct: 300 FLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 3e-08
Identities = 53/204 (25%), Positives = 93/204 (45%), Gaps = 23/204 (11%)
Query: 667 IGEGGFGPVY----KGTLSDGAVIAVKQLSSKSKQGNREFVNEIGMIS------ALQHQN 716
+G+G FG V KGT V A+K L + + + M A +H
Sbjct: 3 LGKGSFGKVMLAELKGT---DEVYAIKVLKKDVILQDDDV--DCTMTEKRILALAAKHPF 57
Query: 717 LVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLH 776
L L+ C ++L V EY+ L +F + + D + +++ L +LH
Sbjct: 58 LTALHCCFQTKDRLFFVMEYVNGGDL---MFQIQ-RSRKFDEPRSRFYAAEVTLALMFLH 113
Query: 777 EESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAM 836
R +++RD+K N+LLD + + K++DFG+ K + N +T GT Y+APE
Sbjct: 114 ---RHGVIYRDLKLDNILLDAEGHCKLADFGMCK-EGILNGVTTTTFCGTPDYIAPEILQ 169
Query: 837 RGYLTDKADVYSFGIVALEIVSGK 860
D ++ G++ E+++G+
Sbjct: 170 ELEYGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 4e-08
Identities = 46/165 (27%), Positives = 81/165 (49%), Gaps = 9/165 (5%)
Query: 704 NEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKR 763
+E+ ++A H +VK + ++LLL+ EY L + + + + L
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGL 173
Query: 764 ICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDE-NTHISTR 822
+ I L +H SR K++HRD+K+ N+ L K+ DFG +K D + +++
Sbjct: 174 LFYQIVLALDEVH--SR-KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASS 230
Query: 823 IAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRP 867
GT Y+APE R + KAD++S G++ E++ T +RP
Sbjct: 231 FCGTPYYLAPELWERKRYSKKADMWSLGVILYELL-----TLHRP 270
|
Length = 478 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 5e-08
Identities = 32/149 (21%), Positives = 56/149 (37%), Gaps = 16/149 (10%)
Query: 666 KIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLV--KLYGC 723
+ G VY D + +K S+ K +RE E+ ++ L + L K+
Sbjct: 5 LLKGGLTNRVYLLGTKDEDYV-LKINPSREKGADRE--REVAILQLLARKGLPVPKVLAS 61
Query: 724 CIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKI 783
L+ E++E +L + ++ I +A LA LH+ L +
Sbjct: 62 GESDGWSYLLMEWIEGETLD-----------EVSEEEKEDIAEQLAELLAKLHQLPLLVL 110
Query: 784 VHRDIKATNVLLDKDLNAKISDFGLAKLD 812
H D+ N+L+D I D+ A
Sbjct: 111 CHGDLHPGNILVDDGKILGIIDWEYAGYG 139
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.7 bits (136), Expect = 5e-08
Identities = 64/240 (26%), Positives = 109/240 (45%), Gaps = 48/240 (20%)
Query: 659 NNFDAANKIGEGGFGPVY----KGTLSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQH 714
N ++ KIG G FG V+ K T A+ K ++ + + V E+ ++ L+H
Sbjct: 13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKS-QLVIEVNVMRELKH 71
Query: 715 QNLVKLYGCCI-EGNQ-LLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIAR-- 770
+N+V+ + + NQ L ++ E+ + L+R + +C + + DI R
Sbjct: 72 KNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNI----QKCYKMFGKIEEHAIVDITRQL 127
Query: 771 --GLAYLHE----ESRLKIVHRDIKATNVLLD-------------KDLN----AKISDFG 807
LAY H + +++HRD+K N+ L +LN AKI DFG
Sbjct: 128 LHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFG 187
Query: 808 LAKLDEDENTHISTRIAGTVG---YMAPE---YAMRGYLTDKADVYSFGIVALEIVSGKS 861
L+K N I + VG Y +PE + + Y DK+D+++ G + E+ SGK+
Sbjct: 188 LSK-----NIGIESMAHSCVGTPYYWSPELLLHETKSY-DDKSDMWALGCIIYELCSGKT 241
|
Length = 1021 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 7e-08
Identities = 47/168 (27%), Positives = 77/168 (45%), Gaps = 32/168 (19%)
Query: 772 LAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVG--- 828
LA H S+ ++HRDIK+ N+LL + K+ DFG +K + ++ VG
Sbjct: 154 LAVHHVHSK-HMIHRDIKSANILLCSNGLVKLGDFGFSK-------MYAATVSDDVGRTF 205
Query: 829 -----YMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQE 883
Y+APE R + KAD++S G++ E+++ K + EE +
Sbjct: 206 CGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVM----------- 254
Query: 884 QGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSM 931
L DP L + S + M + ALL ++P RP+ S ++M
Sbjct: 255 HKTLAGRYDP-LPPSISPE--MQEIVTALLSSDPKR--RPSSSKLLNM 297
|
Length = 496 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 7e-08
Identities = 57/223 (25%), Positives = 102/223 (45%), Gaps = 24/223 (10%)
Query: 651 LRQIKAATNNFDAANKIGEGGFGPV----YKGTLSDGAVIAVKQLSSKS--KQGNREFVN 704
+R ++ +++ IG G FG V +K T V A+K LS K+ + F
Sbjct: 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKST---RKVYAMKLLSKFEMIKRSDSAFFW 91
Query: 705 EIGMISALQHQN-LVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKR 763
E I A + +V+L+ + L +V EY+ L + + + WA +
Sbjct: 92 EERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD---VPEKWA--RF 146
Query: 764 ICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLA-KLDEDENTHISTR 822
+++ L +H + +HRD+K N+LLDK + K++DFG K++++ T
Sbjct: 147 YTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA 203
Query: 823 IAGTVGYMAPEYAMR----GYLTDKADVYSFGIVALEIVSGKS 861
+ GT Y++PE GY + D +S G+ E++ G +
Sbjct: 204 V-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT 245
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.6 bits (132), Expect = 1e-07
Identities = 66/244 (27%), Positives = 95/244 (38%), Gaps = 63/244 (25%)
Query: 661 FDAANKIGEGGFGPVY----KGTLSDGAVIAVKQLSSKSKQGNREFVN----EIGMISAL 712
F +G+G G V+ KGT G + A+K L K R V E +++ L
Sbjct: 3 FKKIKLLGKGDVGRVFLVRLKGT---GKLFALKVLDKKEMI-KRNKVKRVLTEQEILATL 58
Query: 713 QHQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIAR-- 770
H L LY L LV +Y L R L + G K + ++AR
Sbjct: 59 DHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPG----------KCLSEEVARFY 108
Query: 771 ------GLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHIS---- 820
L YLH L IV+RD+K N+LL + + +SDF L+K + E +S
Sbjct: 109 AAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALR 165
Query: 821 --------------TRIA----------GTVGYMAPEYAMRGYLTDKA-DVYSFGIVALE 855
T GT Y+APE + G A D ++ GI+ E
Sbjct: 166 KGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPE-VISGDGHGSAVDWWTLGILLYE 224
Query: 856 IVSG 859
++ G
Sbjct: 225 MLYG 228
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 1e-07
Identities = 33/88 (37%), Positives = 50/88 (56%), Gaps = 7/88 (7%)
Query: 780 RLKIVHRDIKATNVLLDKDLNAKISDFG-LAKLDEDENTHISTRIAGTVGYMAPEY--AM 836
+L VHRDIK NVLLDK+ + +++DFG +L D T S GT Y++PE AM
Sbjct: 120 QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD-GTVQSNVAVGTPDYISPEILQAM 178
Query: 837 ---RGYLTDKADVYSFGIVALEIVSGKS 861
+G + D +S G+ E++ G++
Sbjct: 179 EDGKGRYGPECDWWSLGVCMYEMLYGET 206
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 49/198 (24%), Positives = 92/198 (46%), Gaps = 14/198 (7%)
Query: 667 IGEGGFGPVY----KGTLSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYG 722
IG+G FG V + T A+ +++ S+ + E +++ + +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 723 CCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICS-DIARGLAYLHEESRL 781
+L LV ++ L L +EG +L +R R + ++ L LH+
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHL-QREG-RFDL---SRARFYTAELLCALENLHK---F 112
Query: 782 KIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRGYLT 841
+++RD+K N+LLD + + DFGL KL+ ++ + GT Y+APE + T
Sbjct: 113 NVIYRDLKPENILLDYQGHIALCDFGLCKLNM-KDDDKTNTFCGTPEYLAPELLLGHGYT 171
Query: 842 DKADVYSFGIVALEIVSG 859
D ++ G++ E+++G
Sbjct: 172 KAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 2e-07
Identities = 41/105 (39%), Positives = 55/105 (52%), Gaps = 18/105 (17%)
Query: 494 YTVKLHFAEIMFTNDQTYKSLGKRMFDVSIQGKQVLKDFDIMEEAGGVGIGITREFKDVS 553
Y+V LHFAEI D + + GKR+FDV I G KD DI++ +G + K V+
Sbjct: 280 YSVWLHFAEI----DNSITAEGKRVFDVLINGDTAFKDVDIVKMSGERYTALVLN-KTVA 334
Query: 554 VNGSTMEIHLYWAGKGTNAIPYRGVYGPLISAITVTPNFEVDTGG 598
V+G T+ I L KGT+AI I+AI V FE+ T
Sbjct: 335 VSGRTLTIVLQ-PKKGTHAI---------INAIEV---FEIITAE 366
|
Length = 623 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 2e-07
Identities = 58/220 (26%), Positives = 101/220 (45%), Gaps = 29/220 (13%)
Query: 655 KAATNNFDAANKIGEGGFGPVYKGTLSDGA-VIAVKQLSSKSKQGNREFVNEIGMISALQ 713
++ ++ N IG G FG VY+ D + +A+K++ + NRE + ++ L
Sbjct: 62 RSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELL----IMKNLN 117
Query: 714 HQNLVKL----YGCCIEGNQ----LLLVYEYL-ENNSLARALFGKEGQCLNLDWATRKRI 764
H N++ L Y C + N+ L +V E++ + + + L L K
Sbjct: 118 HINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLV--KLY 175
Query: 765 CSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNA-KISDFGLAK---LDEDENTHIS 820
+ R LAY+H + I HRD+K N+L+D + + K+ DFG AK + ++I
Sbjct: 176 SYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYIC 232
Query: 821 TRIAGTVGYMAPEYAMRGY-LTDKADVYSFGIVALEIVSG 859
+R Y APE + T D++S G + E++ G
Sbjct: 233 SRF-----YRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 50/211 (23%), Positives = 97/211 (45%), Gaps = 21/211 (9%)
Query: 666 KIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQG---NREFVNEIGMISALQHQNLVKLYG 722
K+G G +G VYK DG K+ + K +G + EI ++ L+H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGK--DEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQK 65
Query: 723 CCIEGN--QLLLVYEYLENNSLARALFGKEGQC----LNLDWATRKRICSDIARGLAYLH 776
+ + ++ L+++Y E++ F + + + L + K + I G+ YLH
Sbjct: 66 VFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH 125
Query: 777 EESRLKIVHRDIKATNVLL----DKDLNAKISDFGLAKLDEDENTHIS--TRIAGTVGYM 830
++HRD+K N+L+ + KI+D G A+L ++ + T Y
Sbjct: 126 ANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182
Query: 831 APEYAMRG-YLTDKADVYSFGIVALEIVSGK 860
APE + + T D+++ G + E+++ +
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 53.2 bits (127), Expect = 3e-07
Identities = 60/234 (25%), Positives = 101/234 (43%), Gaps = 38/234 (16%)
Query: 667 IGEGGFGPV---YKGTLSDGAVIAVKQLS------SKSKQGNREFVNEIGMISALQHQNL 717
IG G G V Y L +A+K+LS + +K+ RE V ++ + H+N+
Sbjct: 25 IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELV----LMKCVNHKNI 78
Query: 718 VKLYGCCI------EGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARG 771
+ L E + LV E ++ N L + + + LD + + G
Sbjct: 79 ISLLNVFTPQKSLEEFQDVYLVMELMDAN-LCQVI------QMELDHERMSYLLYQMLCG 131
Query: 772 LAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMA 831
+ +LH I+HRD+K +N+++ D KI DFGLA+ + + T T Y A
Sbjct: 132 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRA 186
Query: 832 PEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQG 885
PE + + D++S G + E+V K R Y+ W V+++ G
Sbjct: 187 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD-----YIDQWNKVIEQLG 235
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 4e-07
Identities = 48/197 (24%), Positives = 83/197 (42%), Gaps = 48/197 (24%)
Query: 686 IAVKQLS------SKSKQGNREFVNEIGMISALQHQNLVKLYGCCI------EGNQLLLV 733
+A+K+LS + +K+ RE V ++ + H+N++ L E + +V
Sbjct: 52 VAIKKLSRPFQNQTHAKRAYRELV----LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIV 107
Query: 734 YEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNV 793
E ++ N L + + + LD + + G+ +LH I+HRD+K +N+
Sbjct: 108 MELMDAN-LCQVI------QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNI 157
Query: 794 LLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRGY----------LTDK 843
++ D KI DFGLA R AGT M P R Y +
Sbjct: 158 VVKSDCTLKILDFGLA------------RTAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 205
Query: 844 ADVYSFGIVALEIVSGK 860
D++S G + E++ G
Sbjct: 206 VDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 4e-07
Identities = 31/95 (32%), Positives = 47/95 (49%), Gaps = 7/95 (7%)
Query: 770 RGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAK--LDEDENTHISTRIAGTV 827
R L Y+H + + HRD+K N+L + D KI DFGLA+ ++ T T
Sbjct: 114 RALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 828 GYMAPEY--AMRGYLTDKADVYSFGIVALEIVSGK 860
Y APE + T D++S G + E+++GK
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 5e-07
Identities = 50/211 (23%), Positives = 94/211 (44%), Gaps = 21/211 (9%)
Query: 666 KIGEGGFGPVYKGTLSDG---AVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYG 722
K+G G +G VYK DG A+KQ+ + EI ++ L+H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQK 65
Query: 723 CCIE--GNQLLLVYEYLENNSLARALFGKEGQC----LNLDWATRKRICSDIARGLAYLH 776
+ ++ L+++Y E++ F + + + L K + I G+ YLH
Sbjct: 66 VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 125
Query: 777 EESRLKIVHRDIKATNVLL----DKDLNAKISDFGLAKLDEDENTHIS--TRIAGTVGYM 830
++HRD+K N+L+ + KI+D G A+L ++ + T Y
Sbjct: 126 ANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182
Query: 831 APEYAMRG-YLTDKADVYSFGIVALEIVSGK 860
APE + + T D+++ G + E+++ +
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 6e-07
Identities = 59/219 (26%), Positives = 97/219 (44%), Gaps = 31/219 (14%)
Query: 660 NFDAANKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVK 719
+F+ IG G FG V AV +L + K + +N+ M+ + +
Sbjct: 2 DFEILKVIGRGAFGEV-----------AVVKLKNADKVFAMKILNKWEMLKRAETACFRE 50
Query: 720 LYGCCIEGNQ---LLLVYEYLENNSLARAL-FGKEGQCLNLDWATRKRICSDIARGLAYL 775
+ G+ L Y + + N+L + + G L L R+ D+AR YL
Sbjct: 51 ERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMAR--FYL 108
Query: 776 HEE-------SRLKIVHRDIKATNVLLDKDLNAKISDFG-LAKLDEDENTHISTRIAGTV 827
E +L VHRDIK N+L+D + + +++DFG KL ED S + GT
Sbjct: 109 AEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTP 167
Query: 828 GYMAPEY--AM---RGYLTDKADVYSFGIVALEIVSGKS 861
Y++PE AM +G + D +S G+ E++ G++
Sbjct: 168 DYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGET 206
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 8e-07
Identities = 43/161 (26%), Positives = 76/161 (47%), Gaps = 17/161 (10%)
Query: 667 IGEGGFGPVYKG-TLSDGAVIAVKQLSSKSKQGNREFVNEI----GMISALQHQNLVKLY 721
I G FG VY G ++ + AVK + K+ N+ V+++ ++ + +V LY
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVK-VVKKADMINKNMVHQVQAERDALALSKSPFIVHLY 70
Query: 722 GCCIEGNQLLLVYEYLENNSLAR--ALFGKEGQCLNLDWATRKRICSDIARGLAYLHEES 779
N + LV EYL + ++G D + S++A L YLH
Sbjct: 71 YSLQSANNVYLVMEYLIGGDVKSLLHIYGY------FDEEMAVKYISEVALALDYLHRHG 124
Query: 780 RLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHIS 820
I+HRD+K N+L+ + + K++DFGL+K+ + ++
Sbjct: 125 ---IIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRELNMM 162
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 1e-06
Identities = 57/217 (26%), Positives = 92/217 (42%), Gaps = 25/217 (11%)
Query: 659 NNFDAANKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGNRE----FVNEIGMISALQH 714
++F+ IG G FG V + I ++ +K + R F E ++
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 715 QNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIAR---- 770
Q + L+ + N L LV +Y G L L R+ D+AR
Sbjct: 61 QWITTLHYAFQDENYLYLVMDYYVG-----------GDLLTLLSKFEDRLPEDMARFYIA 109
Query: 771 -GLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGY 829
+ +H +L VHRDIK NVLLD + + +++DFG + T S+ GT Y
Sbjct: 110 EMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDY 169
Query: 830 MAPEY--AMR---GYLTDKADVYSFGIVALEIVSGKS 861
++PE AM G + D +S G+ E++ G++
Sbjct: 170 ISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGET 206
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 1e-06
Identities = 34/95 (35%), Positives = 53/95 (55%), Gaps = 10/95 (10%)
Query: 768 IARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGT- 826
+A G+ +L ++ VHRD+ A NVL+ + KI DFGLA+ ++ +IS G+
Sbjct: 248 VANGMEFLASKN---CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISK---GST 301
Query: 827 ---VGYMAPEYAMRGYLTDKADVYSFGIVALEIVS 858
+ +MAPE T +DV+SFGI+ EI +
Sbjct: 302 FLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 50.6 bits (122), Expect = 1e-06
Identities = 43/149 (28%), Positives = 76/149 (51%), Gaps = 15/149 (10%)
Query: 714 HQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLA 773
+ N +KLY +L+ +Y+++ L L KEG+ L A K+I + L
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFD-LLKKEGK---LSEAEVKKIIRQLVEALN 123
Query: 774 YLHEESRLKIVHRDIKATNVLLDKDLN-AKISDFGLAKLDEDENTHISTRIAGTVGYMAP 832
LH + I+H DIK NVL D+ + + D+GL K+ + + GT+ Y +P
Sbjct: 124 DLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCY-----DGTLDYFSP 175
Query: 833 EYAMRGYLTDKA-DVYSFGIVALEIVSGK 860
E ++G+ D + D ++ G++ E+++GK
Sbjct: 176 E-KIKGHNYDVSFDWWAVGVLTYELLTGK 203
|
Length = 267 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 2e-06
Identities = 36/110 (32%), Positives = 52/110 (47%), Gaps = 24/110 (21%)
Query: 212 IDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISDLKGSSSSFP 271
+D L G IPN I L ++L G S+ G IP ++ ++T L + DL S +SF
Sbjct: 425 LDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLG---SITSLEVLDL--SYNSF- 478
Query: 272 NLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGIL 321
G IPE + +T L+IL+L+ N L+G VP L
Sbjct: 479 ------------------NGSIPESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 2e-06
Identities = 56/262 (21%), Positives = 101/262 (38%), Gaps = 46/262 (17%)
Query: 659 NNFDAANKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGNREFVNEI----GMISALQH 714
++F++ IG G FG V D I ++ K+ +E V I ++
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 715 QNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAY 774
+VK++ + L L+ E+L + L K+ L + ++ +
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKD----TLSEEATQFYIAETVLAIDA 116
Query: 775 LHEESRLKIVHRDIKATNVLLDKDLNAKISDFGL-------------------------- 808
+H+ L +HRDIK N+LLD + K+SDFGL
Sbjct: 117 IHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSF 173
Query: 809 --------AKLDEDENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGK 860
A+ + ++ GT Y+APE M+ D +S G++ E++ G
Sbjct: 174 QNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233
Query: 861 SN-TNYRPKEEFVYLLDWAYVL 881
+ P+E + +++W L
Sbjct: 234 PPFCSETPQETYRKVMNWKETL 255
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 2e-06
Identities = 49/197 (24%), Positives = 84/197 (42%), Gaps = 48/197 (24%)
Query: 686 IAVKQLS------SKSKQGNREFVNEIGMISALQHQNLVKLYGCCI------EGNQLLLV 733
+A+K+LS + +K+ RE V ++ + H+N++ L E + LV
Sbjct: 44 VAIKKLSRPFQNVTHAKRAYRELV----LMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLV 99
Query: 734 YEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNV 793
E ++ N L + + ++LD + + G+ +LH I+HRD+K +N+
Sbjct: 100 MELMDAN-LCQVIQ------MDLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNI 149
Query: 794 LLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRGY----------LTDK 843
++ D KI DFGLA R AGT M P R Y +
Sbjct: 150 VVKSDCTLKILDFGLA------------RTAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 197
Query: 844 ADVYSFGIVALEIVSGK 860
D++S G + E++ G
Sbjct: 198 VDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-06
Identities = 64/265 (24%), Positives = 106/265 (40%), Gaps = 54/265 (20%)
Query: 660 NFDAANKIGEGGFGPVYKGTLSD-GAVIAVKQLSSKSKQGNREFVNEIGMISA-----LQ 713
+F++ IG G FG V D G V A+K L K+ +E ++G I A ++
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILR-KADMLEKE---QVGHIRAERDILVE 57
Query: 714 HQNL--VKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARG 771
+L VK++ + L L+ E+L + L K D T + IA
Sbjct: 58 ADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKK-------DTLTEEETQFYIAET 110
Query: 772 LAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGL----------------------- 808
+ + +L +HRDIK N+LLD + K+SDFGL
Sbjct: 111 VLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSD 170
Query: 809 -----------AKLDEDENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIV 857
A+ + ++ GT Y+APE M+ D +S G++ E++
Sbjct: 171 FTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230
Query: 858 SGKSN-TNYRPKEEFVYLLDWAYVL 881
G + P+E + +++W L
Sbjct: 231 IGYPPFCSETPQETYKKVMNWKETL 255
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 44.8 bits (107), Expect = 4e-06
Identities = 18/60 (30%), Positives = 29/60 (48%)
Query: 278 KMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSL 337
++ L L N +T + + +LK+LDLS N LT P L + + L+ N+L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 5e-06
Identities = 30/82 (36%), Positives = 44/82 (53%), Gaps = 3/82 (3%)
Query: 188 LSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPS 247
L + G IP L++L + G+++ G IP +G+ T L+ LDL S G IP
Sbjct: 425 LDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPE 484
Query: 248 TISQLKNLTELRISDLKGSSSS 269
++ Q LT LRI +L G+S S
Sbjct: 485 SLGQ---LTSLRILNLNGNSLS 503
|
Length = 623 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 1e-05
Identities = 46/165 (27%), Positives = 83/165 (50%), Gaps = 23/165 (13%)
Query: 702 FVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATR 761
F ++S + H +L ++G C+ G++ ++V E++E+ L L ++G+ + + W +
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGR-VPVAW--K 119
Query: 762 KRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNA-------KISDFG--LAKLD 812
+ +A L+YL +++ +VH ++ A N+LL + A K+SD G L
Sbjct: 120 ITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALS 176
Query: 813 EDENTHISTRIAGTVGYMAPEYAMRG-YLTDKADVYSFGIVALEI 856
+E RI ++APE G L+ AD +SFG LEI
Sbjct: 177 REERVE---RIP----WIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 2e-05
Identities = 43/155 (27%), Positives = 70/155 (45%), Gaps = 11/155 (7%)
Query: 659 NNFDAANKIGEGGFGPV-YKGTLSDGAVIAVKQL--SSKSKQGNREFVN-EIGMISALQH 714
+F IG+G FG V G + A+K L S K+ V E +++
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 715 QNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAY 774
+V LY + L L+ E+L L L + + D TR + ++ +
Sbjct: 61 PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLI--KYDTFSED-VTRFYM-AECVLAIEA 116
Query: 775 LHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLA 809
+H +L +HRDIK N+L+D+ + K+SDFGL+
Sbjct: 117 VH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 2e-05
Identities = 71/317 (22%), Positives = 119/317 (37%), Gaps = 85/317 (26%)
Query: 661 FDAANKIGEGGFGPVYKGTLSD-GAVIAVKQLSSKSKQGNREFVNEIGMISA-------L 712
F IG G FG V D A+ A+K L K+ R N+ + A
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLR-KADVLMR---NQAAHVKAERDILAEA 58
Query: 713 QHQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGL 772
++ +VKLY + + L V +Y+ + L D A R I +++ +
Sbjct: 59 DNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLG--IFEEDLA-RFYI-AELTCAI 114
Query: 773 AYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGL------------------------ 808
+H ++ +HRDIK N+L+D+D + K++DFGL
Sbjct: 115 ESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSM 171
Query: 809 ------AKLDEDENTHISTR------------IAGTVGYMAPEYAMRGYLTDKADVYSFG 850
+++D + R + GT Y+APE +R T D +S G
Sbjct: 172 EPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 231
Query: 851 IVALEIVSGK----SNTNYRPKEEFVYLLDWAYVLQ--EQGNLLELVDPSLGSNFSKKEA 904
++ E++ G+ ++T P E + +++W L Q L +EA
Sbjct: 232 VILYEMLVGQPPFLADT---PAETQLKVINWETTLHIPSQAKL-------------SREA 275
Query: 905 MTMLNIALLCTNPSPTL 921
+ I LC L
Sbjct: 276 SDL--ILRLCCGAEDRL 290
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|215633 PLN03210, PLN03210, Resistant to P | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 3e-05
Identities = 83/292 (28%), Positives = 126/292 (43%), Gaps = 52/292 (17%)
Query: 125 LPKSFARLQNLTKLLILGNRLS------------------GSIPL-EIGDIS---TLEEL 162
+P +F R +NL KL + G++L GS L EI D+S LE L
Sbjct: 604 MPSNF-RPENLVKLQMQGSKLEKLWDGVHSLTGLRNIDLRGSKNLKEIPDLSMATNLETL 662
Query: 163 VLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIP 222
L D + LP ++ L L + +S +P NLK+L + G + R+
Sbjct: 663 KLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLYRLNLSGCS---RLK 718
Query: 223 NFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISDLKGSSSSFPNLQDMKKMERL 282
+F T + LDL T++E PS + +L+NL EL + ++K K ER+
Sbjct: 719 SFPDISTNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSE----------KLWERV 766
Query: 283 ILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGTLP 342
L+T P L L LS +P +QNL K++++ + N TLP
Sbjct: 767 QPLTPLMTMLSPS-------LTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLP 819
Query: 343 DWI-LTSEKNLDLSYNNFTESSPATCRESRVNILSSF-SSTGSNSVSWCLKK 392
I L S ++LDLS + + P + NI S TG V W ++K
Sbjct: 820 TGINLESLESLDLSGCSRLRTFP----DISTNISDLNLSRTGIEEVPWWIEK 867
|
syringae 6; Provisional. Length = 1153 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 3e-05
Identities = 31/83 (37%), Positives = 41/83 (49%), Gaps = 4/83 (4%)
Query: 774 YLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDE-NTHISTRIAGTVGYMAP 832
Y+H E I+HRDIK NVL++ + + DFG A +T IAGTV AP
Sbjct: 275 YIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAP 331
Query: 833 EYAMRGYLTDKADVYSFGIVALE 855
E T D++S G+V E
Sbjct: 332 EVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 5e-05
Identities = 49/241 (20%), Positives = 73/241 (30%), Gaps = 45/241 (18%)
Query: 99 GVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLIL---GNRLSGSIPLEIGD 155
+ + LQE+DLS N L + L L N L +
Sbjct: 71 QSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAK 130
Query: 156 -----ISTLEELVLEDNQLVGPLPENLGNL----KSLRRILLSSNNFTGSIPESYGNLKN 206
LE+LVL N+L G E L + L+ + L++N
Sbjct: 131 GLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGD----------- 179
Query: 207 LTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLE----GPIPSTISQLKNLTELRISD 262
G N L+ LDL L + T++ LK+L L + D
Sbjct: 180 ------AGIRALAEG--LKAN-CNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGD 230
Query: 263 LKGSSSSFPNLQDMKKME-----RLILRNCLIT----GRIPEYIEDMTDLKILDLSFNQL 313
+ + L L L IT + E + + L LDL N+
Sbjct: 231 NNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKF 290
Query: 314 T 314
Sbjct: 291 G 291
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 9e-05
Identities = 34/109 (31%), Positives = 51/109 (46%), Gaps = 8/109 (7%)
Query: 659 NNFDAANKIGEGGFGPVYKGTL-----SDGAV-IAVKQLSSKSKQGNRE-FVNEIGMISA 711
+N +G G FG V + T D + +AVK L + + RE ++E+ ++S
Sbjct: 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSH 97
Query: 712 L-QHQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWA 759
L QH+N+V L G C G +L++ EY L L K LN A
Sbjct: 98 LGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMA 146
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 40.6 bits (96), Expect = 1e-04
Identities = 23/59 (38%), Positives = 33/59 (55%), Gaps = 2/59 (3%)
Query: 303 LKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGTLPDWI--LTSEKNLDLSYNNF 359
LK LDLS N+LT G + L + + L+ N+L+ P+ L S ++LDLS NN
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 1e-04
Identities = 58/267 (21%), Positives = 103/267 (38%), Gaps = 58/267 (21%)
Query: 667 IGEGGFGPVYKGTLSD-GAVIAVKQLSSKSKQGNREFVN---EIGMISALQHQNLVKLYG 722
+G G FG V D A+ A+K L K + + E +++ ++ +VKLY
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68
Query: 723 CCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLK 782
+ + L V +Y+ + L E + + R I +++ + +H ++
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRME---VFPEVLARFYI-AELTLAIESVH---KMG 121
Query: 783 IVHRDIKATNVLLDKDLNAKISDFGLAK---------------------------LDEDE 815
+HRDIK N+L+D D + K++DFGL D+
Sbjct: 122 FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVS 181
Query: 816 NTHISTR-------------------IAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEI 856
N R + GT Y+APE +R T D +S G++ E+
Sbjct: 182 NCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEM 241
Query: 857 VSGKSN-TNYRPKEEFVYLLDWAYVLQ 882
+ G+ P E + +++W L
Sbjct: 242 LVGQPPFLAPTPTETQLKVINWENTLH 268
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-04
Identities = 53/256 (20%), Positives = 92/256 (35%), Gaps = 69/256 (26%)
Query: 661 FDAANKIGEGGFGPVYKGTLSD-GAVIAVKQLSSKSKQGNREFVN---EIGMISALQHQN 716
F +G G FG V D A+ A+K L K + + E +++ ++
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 717 LVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSD------IAR 770
+V+LY + + L V +Y+ + L R I + IA
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLI-------------RMGIFPEDLARFYIAE 109
Query: 771 GLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLA--------------------- 809
+ ++ +HRDIK N+L+D+D + K++DFGL
Sbjct: 110 LTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQD 169
Query: 810 ------KLDEDENTHISTR-------------------IAGTVGYMAPEYAMRGYLTDKA 844
+ + N R + GT Y+APE +R T
Sbjct: 170 SMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLC 229
Query: 845 DVYSFGIVALEIVSGK 860
D +S G++ E++ G+
Sbjct: 230 DWWSVGVILYEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 2e-04
Identities = 55/223 (24%), Positives = 86/223 (38%), Gaps = 69/223 (30%)
Query: 652 RQIKAATNNFDAANKIGEGGFGPVYKG---TLSDGAVIAVKQLSSKSK------------ 696
+ ++++F +K+G G FG ++G D V +L+++ K
Sbjct: 138 ANSRWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMD 197
Query: 697 -QGNR-EFVNEIGMISALQHQNLVKLYGC------------CIE---------------- 726
QG R +F+ + +V+ Y C C E
Sbjct: 198 RQGVRQDFLKTGTLAKGSAETGMVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTK 257
Query: 727 GNQLLLVYEYLENNSLARALFGKEG---QCLNLDWATRKRICSDIAR------------- 770
G+Q L V+++ + +L AL GK G CL K+I ++ +
Sbjct: 258 GSQWL-VWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMR 316
Query: 771 ----GLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLA 809
GL LH R+ IVHRDIK N+L+ D KI DFG A
Sbjct: 317 QVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356
|
Length = 507 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 4e-04
Identities = 31/107 (28%), Positives = 40/107 (37%), Gaps = 23/107 (21%)
Query: 751 GQCLNLD--WATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGL 808
G+ LN + WA +C L LH R K+ N+LL D K+ G
Sbjct: 11 GRPLNEEEIWA----VCLQCLGALRELH---------RQAKSGNILLTWDGLLKL--DGS 55
Query: 809 AKLDEDENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALE 855
E +MAPE T+KAD+YS GI E
Sbjct: 56 VAFKTPEQ-SRPDPY-----FMAPEVIQGQSYTEKADIYSLGITLYE 96
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 6e-04
Identities = 38/146 (26%), Positives = 64/146 (43%), Gaps = 11/146 (7%)
Query: 716 NLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYL 775
N+V L+ + + + LV ++ E L + + LN+ KR +++ L L
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI----SKFLNIPEECVKRWAAEMVVALDAL 101
Query: 776 HEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYA 835
H E IV RD+ N+LLD + +++ F ED A Y APE
Sbjct: 102 HREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMYCAPEVG 154
Query: 836 MRGYLTDKADVYSFGIVALEIVSGKS 861
T+ D +S G + E+++GK+
Sbjct: 155 GISEETEACDWWSLGAILFELLTGKT 180
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.5 bits (88), Expect = 0.001
Identities = 19/59 (32%), Positives = 30/59 (50%)
Query: 159 LEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNL 217
L+ L L +N+L L +L+ + LS NN T PE++ L +L + G+NL
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 0.001
Identities = 47/194 (24%), Positives = 89/194 (45%), Gaps = 27/194 (13%)
Query: 683 GAVIAVK--QLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYL--- 737
G ++ V+ L + +++ + NE+ + +H N++ + G+ L ++ ++
Sbjct: 25 GTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84
Query: 738 ENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDK 797
NSL + F EG + A I RGL YLH+ +HR+IKA+++L+
Sbjct: 85 SANSLLKTYF-PEG----MSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISG 136
Query: 798 DLNAKISDFGLAKLDEDENTHISTRIA--------GTVGYMAPEYA---MRGYLTDKADV 846
D +S GL+ L ++ + +++PE + GY K+D+
Sbjct: 137 DGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGY-NVKSDI 193
Query: 847 YSFGIVALEIVSGK 860
YS GI A E+ +G+
Sbjct: 194 YSVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.1 bits (87), Expect = 0.002
Identities = 17/60 (28%), Positives = 28/60 (46%)
Query: 86 HVTVILLKGFNLAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRL 145
++ + L L + F L L+ +DLS N P++F+ L +L L + GN L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.002
Identities = 46/182 (25%), Positives = 84/182 (46%), Gaps = 25/182 (13%)
Query: 686 IAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYLENNSLARA 745
+ +K L + + F M+ + H+++V LYG C+ + ++V E++E L
Sbjct: 35 VILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPL--D 92
Query: 746 LF-GKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKD-LNA-- 801
LF ++ L W + ++ +A L+YL ++ +VH ++ N+LL ++ ++
Sbjct: 93 LFMHRKSDVLTTPW--KFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGEC 147
Query: 802 ----KISDFG--LAKLDEDENTHISTRIAGTVGYMAPEYAM-RGYLTDKADVYSFGIVAL 854
K+SD G + L E RI ++APE L+ AD +SFG
Sbjct: 148 GPFIKLSDPGIPITVLSRQECVE---RIP----WIAPECVEDSKNLSIAADKWSFGTTLW 200
Query: 855 EI 856
EI
Sbjct: 201 EI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Score = 41.4 bits (98), Expect = 0.002
Identities = 23/86 (26%), Positives = 34/86 (39%), Gaps = 17/86 (19%)
Query: 732 LVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKAT 791
+V EY+ L L G + + +A LH + IVH D+ +
Sbjct: 413 IVMEYIGGKDLKDVLEG------------NPELVRKVGEIVAKLH---KAGIVHGDLTTS 457
Query: 792 NVLLDKDLNAKISDFGLAKL-DEDEN 816
N ++ D I DFGL K D E+
Sbjct: 458 NFIVRDDRLYLI-DFGLGKYSDLIED 482
|
Length = 535 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.003
Identities = 58/244 (23%), Positives = 82/244 (33%), Gaps = 68/244 (27%)
Query: 156 ISTLEELVLEDNQLVGP----LPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFR 211
+ L+ L LE N L L L SL+ + LS N TG IP
Sbjct: 22 LLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLN-ETGRIPRG----------- 69
Query: 212 IDGSNLTGRIPNFIGNWTKLDRLDLQGTSLE----GPIPS--TISQLKNLT------ELR 259
+ + L LDL +L G + S S L+ L R
Sbjct: 70 ------LQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDR 123
Query: 260 ISDLKGSSSSFPNLQDMK-KMERLILRNCLITGRIPEYIED----MTDLKILDLSFNQLT 314
L L+D+ +E+L+L + G E + DLK L+L+ N +
Sbjct: 124 GLRLLAKG-----LKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIG 178
Query: 315 GPVPGI---------LQNLKKIDYIFLTNNS--------LSGTLPDWILTSEKNLDLSYN 357
GI NL+ +D L NN L+ TL L+L N
Sbjct: 179 D--AGIRALAEGLKANCNLEVLD---LNNNGLTDEGASALAETLASLKSLEV--LNLGDN 231
Query: 358 NFTE 361
N T+
Sbjct: 232 NLTD 235
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.004
Identities = 23/63 (36%), Positives = 35/63 (55%), Gaps = 2/63 (3%)
Query: 306 LDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGTLPDWI--LTSEKNLDLSYNNFTESS 363
L L L G +P + L+ + I L+ NS+ G +P + +TS + LDLSYN+F S
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 364 PAT 366
P +
Sbjct: 483 PES 485
|
Length = 623 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1016 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.98 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.98 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.98 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.98 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.98 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.98 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.98 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.98 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.98 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.98 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.98 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.95 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.93 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.92 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.9 | |
| PF11721 | 174 | Malectin: Di-glucose binding within endoplasmic re | 99.89 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.88 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.88 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.88 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.86 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.86 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.85 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.84 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.83 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.83 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.83 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.81 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.8 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.79 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.79 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.78 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.78 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.78 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.77 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.77 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.77 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.76 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.76 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.76 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.76 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.75 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.75 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.74 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.73 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.73 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.7 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.7 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.67 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.67 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.67 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.66 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.66 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.66 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.65 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.56 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.55 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.51 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.5 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.49 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.37 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.35 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.35 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.31 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.29 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.28 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.25 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.25 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.25 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.24 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.21 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.16 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.15 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.14 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.1 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.07 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.07 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.05 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.05 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.04 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.04 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.03 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.0 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.0 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.94 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.9 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.9 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.88 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.8 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.79 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.77 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.74 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.71 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.7 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.58 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.58 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.57 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.56 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.53 | |
| COG5238 | 388 | RNA1 Ran GTPase-activating protein (RanGAP) involv | 98.46 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.41 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.4 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.4 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-75 Score=754.02 Aligned_cols=844 Identities=25% Similarity=0.377 Sum_probs=453.4
Q ss_pred CChhHHHHHHHHHHHcCCCCCCccCCCCCCCCCcccCCCCCCCCceeccCCCCCceeeEEEEEecCCccCccCccccCCC
Q 001768 29 LPDDEVQTLQSIFRKLNFRNGQVNQTSCTEGSWNVTIDDSNGSNFTCDCTYSNNTVCHVTVILLKGFNLAGVIPEEFGNL 108 (1016)
Q Consensus 29 ~~~~~~~al~~~~~~l~~~~~~~~~~~~~~~sW~~~~~~c~~~~v~c~~~~~~~~~~~v~~L~L~~~~l~~~~~~~l~~l 108 (1016)
.+++|.+||+++|+++. ++...+.+|+...+||.|.|++|+.. .+|+.|+|+++++++.++..|..+
T Consensus 26 ~~~~~~~~l~~~~~~~~-------~~~~~~~~w~~~~~~c~w~gv~c~~~------~~v~~L~L~~~~i~~~~~~~~~~l 92 (968)
T PLN00113 26 LHAEELELLLSFKSSIN-------DPLKYLSNWNSSADVCLWQGITCNNS------SRVVSIDLSGKNISGKISSAIFRL 92 (968)
T ss_pred CCHHHHHHHHHHHHhCC-------CCcccCCCCCCCCCCCcCcceecCCC------CcEEEEEecCCCccccCChHHhCC
Confidence 47799999999998775 23445689998889999999999732 379999999999999988889999
Q ss_pred CCCCEEEccCCCCCCCCchhhh-cccCcccccccccccCCCCC----------------------cccCCcCCccEEEcc
Q 001768 109 TFLQEVDLSRNYFNGSLPKSFA-RLQNLTKLLILGNRLSGSIP----------------------LEIGDISTLEELVLE 165 (1016)
Q Consensus 109 ~~L~~L~Ls~n~i~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p----------------------~~~~~l~~L~~L~Ls 165 (1016)
++|+.|+|++|++++.+|..+. .+++|++|+|++|.+++.+| ..++.+++|++|+|+
T Consensus 93 ~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~ 172 (968)
T PLN00113 93 PYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLG 172 (968)
T ss_pred CCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCccccCCCCEEECcCCcccccCChHHhcCCCCCEEECc
Confidence 9999999999999888887655 67777777777776665444 444445555555555
Q ss_pred cCCCCCCCCCCCCCCccchhhhccCCccCCCCCcccCCCCCccEEEecCCcCCCCCchhhhcCCCCCEEeecCCcCCCCC
Q 001768 166 DNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPI 245 (1016)
Q Consensus 166 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~ 245 (1016)
+|.+.+.+|..+.++++|++|+|++|++.+.+|..++++++|++|+|++|++++.+|..++++++|++|+|++|.+++.+
T Consensus 173 ~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~ 252 (968)
T PLN00113 173 GNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPI 252 (968)
T ss_pred cCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceecccc
Confidence 55555455555555555555555555555555555555555555555555555555555555555555555555555555
Q ss_pred chhhcCCCCCCEEEcCCCCCCCCCCcccccccccceeecccccccccCchhhcCCCCCceEeccCCCCCCCCccccCCCC
Q 001768 246 PSTISQLKNLTELRISDLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLK 325 (1016)
Q Consensus 246 p~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~L~~~~p~~l~~l~ 325 (1016)
|..|+++++|+.|+|++|.+....+..+..+++|+.|+|++|.+.+.+|..+..+++|+.|++++|.+.+.+|..+..++
T Consensus 253 p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~ 332 (968)
T PLN00113 253 PSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLP 332 (968)
T ss_pred ChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCC
Confidence 55555555555555555555554444555555555555555555555555555556666666666666555555556666
Q ss_pred CCCEEEccCCcCCCCCChhh--hccCCcccCCCCcCCCCCCcccc-ccccceec--cccccCC--CCcccccc-------
Q 001768 326 KIDYIFLTNNSLSGTLPDWI--LTSEKNLDLSYNNFTESSPATCR-ESRVNILS--SFSSTGS--NSVSWCLK------- 391 (1016)
Q Consensus 326 ~L~~L~L~~N~l~g~~p~~~--~~~L~~LdLs~N~l~~~~p~~~~-~~~~~~l~--~~~~~~~--~~~~~c~~------- 391 (1016)
+|+.|+|++|++++.+|..+ +++|+.|+|++|++++.+|.... ...+..+. +....+. .....|..
T Consensus 333 ~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~ 412 (968)
T PLN00113 333 RLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQ 412 (968)
T ss_pred CCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECc
Confidence 66666666666665555554 45566666666666655554321 11111110 0000000 00000000
Q ss_pred ----C-CCCCCccCCcceEEeecCCCCcc---ccCcccccCcCCCCCCCccc--cCCCcce---------e---cccc--
Q 001768 392 ----K-DLPCPKEAKHYSLFINCGGSPTE---FEENDYEEDLNTQGPSNFGI--VSDRWAY---------S---STGV-- 447 (1016)
Q Consensus 392 ----~-~~~c~~~~~~~~~~~~~~~~~~~---~~~~~~~~d~~~~~~~~~~~--~~~~w~~---------~---~~g~-- 447 (1016)
. ..|.....-+.--+++-.+.... +...........+..+++.. ..+.+.. | .+|.
T Consensus 413 ~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~~~L~~L~ls~n~l~~~~~ 492 (968)
T PLN00113 413 DNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVP 492 (968)
T ss_pred CCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCcccccccceEEECcCCccCCccC
Confidence 0 00000000000001111111100 00000000111111111110 0000000 0 0000
Q ss_pred --c--cCCCCccceecccccccccchhhhhccccCccccccceeeecccceEEEEEEEEEEecCCcccccccceeeEEEe
Q 001768 448 --Y--VGNESSKYLAANQYGLNVSGAEYYKTARLAPQSLKYYGLCMLKGSYTVKLHFAEIMFTNDQTYKSLGKRMFDVSI 523 (1016)
Q Consensus 448 --~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (1016)
| +.....+.+..|+..+.+.+. +.. -.+|.+..+ .+- .+.-.-...+..+. .+-..++
T Consensus 493 ~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~-----l~~L~~L~L--s~N---------~l~~~~p~~~~~l~-~L~~L~L 554 (968)
T PLN00113 493 RKLGSLSELMQLKLSENKLSGEIPDE-LSS-----CKKLVSLDL--SHN---------QLSGQIPASFSEMP-VLSQLDL 554 (968)
T ss_pred hhhhhhhccCEEECcCCcceeeCChH-HcC-----ccCCCEEEC--CCC---------cccccCChhHhCcc-cCCEEEC
Confidence 0 011112222222222211100 000 001111110 000 00000000111100 0101111
Q ss_pred cceeecccccceeccCCcCceEEEeeeeeEeeCceeE--EEE---EEcCCCccccCCCCccCCcccccccCCCccccCC-
Q 001768 524 QGKQVLKDFDIMEEAGGVGIGITREFKDVSVNGSTME--IHL---YWAGKGTNAIPYRGVYGPLISAITVTPNFEVDTG- 597 (1016)
Q Consensus 524 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~---~~~g~~~~~~p~~~~~gplis~~sv~~~~~~~~~- 597 (1016)
.+-..... +-..-.+ ....+...+.++.+. +.- +..-.........+..|+... ...+++..
T Consensus 555 s~N~l~~~--~p~~l~~-----l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~-----~~~~~c~~~ 622 (968)
T PLN00113 555 SQNQLSGE--IPKNLGN-----VESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTT-----SGLPPCKRV 622 (968)
T ss_pred CCCccccc--CChhHhc-----CcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccc-----cCCCCCccc
Confidence 11000000 0000000 001111222222221 000 000000000000001111100 00111111
Q ss_pred -CCcccchhHHHHHHHHHHHHHHHHHHHhhhcCCCCccccccc-ccC-C---CC---CCCcCHHHHHHHhcCccccCccc
Q 001768 598 -GGLSAGAIVGIVAGSCAVVIILLFILWRLGYLGGKNVEDKEL-RGL-D---LQ---TGYFTLRQIKAATNNFDAANKIG 668 (1016)
Q Consensus 598 -~~~~~~~i~~i~~~~~~~l~~~~~~~~r~~~~~~~~~~~~~~-~~~-~---~~---~~~~~~~~l~~~~~~f~~~~~LG 668 (1016)
......++++++++++++++++++++++.++++....+..+. .+. . .. ...+++ +.....|...+.||
T Consensus 623 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ig 699 (968)
T PLN00113 623 RKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITI---NDILSSLKEENVIS 699 (968)
T ss_pred cccceeeeehhHHHHHHHHHHHHHHHHHHHHhhhcccccccccccccccccccccccchhhhH---HHHHhhCCcccEEc
Confidence 111122233333333333322222222211111111110000 000 0 00 011222 33345678888999
Q ss_pred cCCCeeEEEEEc-CCCcEEEEEEccCCChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEeecCCCcHHHHhc
Q 001768 669 EGGFGPVYKGTL-SDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYLENNSLARALF 747 (1016)
Q Consensus 669 ~G~~G~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~ 747 (1016)
+|+||.||+|+. .++..||||++...... ..+|++++++++|||||+++|+|.+++..++||||+++|+|.++++
T Consensus 700 ~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~ 775 (968)
T PLN00113 700 RGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR 775 (968)
T ss_pred cCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh
Confidence 999999999996 57899999998644322 2346889999999999999999999999999999999999999994
Q ss_pred cCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCCcceeeecccCc
Q 001768 748 GKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTV 827 (1016)
Q Consensus 748 ~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~ 827 (1016)
.++|.++.+|+.|+++||+|||..+.++|+||||||+||+++.++..++. ||.+...... ....||+
T Consensus 776 -------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-----~~~~~t~ 842 (968)
T PLN00113 776 -------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-----TKCFISS 842 (968)
T ss_pred -------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-----CCccccc
Confidence 38999999999999999999996655699999999999999999888775 6655432211 2236789
Q ss_pred cccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCCC--CCCHHHHH
Q 001768 828 GYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGS--NFSKKEAM 905 (1016)
Q Consensus 828 ~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~--~~~~~~~~ 905 (1016)
.|+|||++.+..++.++|||||||++|||+||+.||+.... ......+|.............+|+.+.. ..+..+..
T Consensus 843 ~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (968)
T PLN00113 843 AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIV 921 (968)
T ss_pred cccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHH
Confidence 99999999988999999999999999999999999864322 1223455555444444455566666543 23455666
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHHHHhccCc
Q 001768 906 TMLNIALLCTNPSPTLRPTMSSAVSMLEGKT 936 (1016)
Q Consensus 906 ~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 936 (1016)
++.+++.+||+.||++||||.||+++|+...
T Consensus 922 ~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 952 (968)
T PLN00113 922 EVMNLALHCTATDPTARPCANDVLKTLESAS 952 (968)
T ss_pred HHHHHHHhhCcCCchhCcCHHHHHHHHHHhh
Confidence 8899999999999999999999999998653
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-51 Score=462.98 Aligned_cols=290 Identities=53% Similarity=0.879 Sum_probs=257.4
Q ss_pred CCCCcCHHHHHHHhcCccccCccccCCCeeEEEEEcCCCcEEEEEEccCCChhhhHHHHHHHHHHHhcCCCCeeeeeeeE
Q 001768 645 QTGYFTLRQIKAATNNFDAANKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCC 724 (1016)
Q Consensus 645 ~~~~~~~~~l~~~~~~f~~~~~LG~G~~G~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 724 (1016)
....|++++++.||++|+..+.||+|+||.||+|.+.+|+.||||++........++|.+|++++.+++|||+|+++|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 46789999999999999999999999999999999999999999988765443145699999999999999999999999
Q ss_pred eecc-eeEEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceee
Q 001768 725 IEGN-QLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKI 803 (1016)
Q Consensus 725 ~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL 803 (1016)
.+.+ +.+||||||++|+|.++|+..... +++|.+|++||.++|+||+|||+.+.++||||||||+|||+|+++++||
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl 218 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL 218 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence 9988 599999999999999999887654 7999999999999999999999998889999999999999999999999
Q ss_pred eccccccccCCCCcceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHH
Q 001768 804 SDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQE 883 (1016)
Q Consensus 804 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~ 883 (1016)
+|||+|+..+....+..+...||.+|+|||++..+..+.|+|||||||+++||+||++|.+...+.....+++|+.....
T Consensus 219 sDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~ 298 (361)
T KOG1187|consen 219 SDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLE 298 (361)
T ss_pred cCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHH
Confidence 99999976654122222222899999999999999999999999999999999999999886554555568899988888
Q ss_pred hCCcccccCCcCC-CCCCH-HHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCc
Q 001768 884 QGNLLELVDPSLG-SNFSK-KEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKT 936 (1016)
Q Consensus 884 ~~~~~~~~d~~l~-~~~~~-~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 936 (1016)
.+.+.+++|+.+. ..++. .+..++..++.+|++.+|.+||+|.||+++|+...
T Consensus 299 ~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 299 EGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred CcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 8899999999987 66664 67888999999999999999999999999996543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=381.98 Aligned_cols=258 Identities=27% Similarity=0.446 Sum_probs=214.0
Q ss_pred ccccCccccCCCeeEEEEEcC-CCcEEEEEEccCC-ChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecc-eeEEEEeec
Q 001768 661 FDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSK-SKQGNREFVNEIGMISALQHQNLVKLYGCCIEGN-QLLLVYEYL 737 (1016)
Q Consensus 661 f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~-~~~lV~E~~ 737 (1016)
.+..+.||+|..|+||+++++ +++.+|+|.+... .....+++.+|+++++..+||+||++||.|..++ +..++||||
T Consensus 81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYM 160 (364)
T KOG0581|consen 81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYM 160 (364)
T ss_pred hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhc
Confidence 345789999999999999976 6889999999654 3445678999999999999999999999999988 599999999
Q ss_pred CCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCCc
Q 001768 738 ENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENT 817 (1016)
Q Consensus 738 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 817 (1016)
++|+|++++.... ++++...-+|+.+|++||.|||+. ++||||||||+|||++..|++||||||.++.....
T Consensus 161 DgGSLd~~~k~~g----~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-- 232 (364)
T KOG0581|consen 161 DGGSLDDILKRVG----RIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-- 232 (364)
T ss_pred CCCCHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccccHHhhhh--
Confidence 9999999996542 699999999999999999999963 29999999999999999999999999999866554
Q ss_pred ceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCC--CchhhHhHHHHHHHHHHhCCcccccCCcC
Q 001768 818 HISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYR--PKEEFVYLLDWAYVLQEQGNLLELVDPSL 895 (1016)
Q Consensus 818 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 895 (1016)
....++||..|||||.+.+..|+.++||||||++++|+++|+.|+... .......+..+. ..-..|.+
T Consensus 233 -~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~I---------v~~ppP~l 302 (364)
T KOG0581|consen 233 -IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAI---------VDEPPPRL 302 (364)
T ss_pred -hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHH---------hcCCCCCC
Confidence 456689999999999999999999999999999999999999998753 112222222211 01112233
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCcCCcCccccCCCC
Q 001768 896 GSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTAVQAPIIRRNSD 948 (1016)
Q Consensus 896 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~p~~~~~~~ 948 (1016)
+.. .+..++..++..||++||.+||++.|++ +|||+++...
T Consensus 303 P~~---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl---------~Hpfi~~~~~ 343 (364)
T KOG0581|consen 303 PEG---EFSPEFRSFVSCCLRKDPSERPSAKQLL---------QHPFIKKFED 343 (364)
T ss_pred Ccc---cCCHHHHHHHHHHhcCCcccCCCHHHHh---------cCHHHhhccc
Confidence 322 2566799999999999999999999887 6888875443
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=401.98 Aligned_cols=255 Identities=35% Similarity=0.528 Sum_probs=213.2
Q ss_pred ccccCccccCCCeeEEEEEcCCCcEEEEEEccCCChhh--hHHHHHHHHHHHhcCCCCeeeeeeeEeecc-eeEEEEeec
Q 001768 661 FDAANKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQG--NREFVNEIGMISALQHQNLVKLYGCCIEGN-QLLLVYEYL 737 (1016)
Q Consensus 661 f~~~~~LG~G~~G~Vy~~~~~~~~~vAvK~~~~~~~~~--~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~-~~~lV~E~~ 737 (1016)
....+.||+|+||+||+|.++....||||++....... .++|.+|+.+|.+++|||||+++|+|.+.. .+++||||+
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~ 122 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM 122 (362)
T ss_pred hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence 34456699999999999999865569999998654322 568999999999999999999999999887 799999999
Q ss_pred CCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCC-eEeCCCCCceEEEccCC-ceeeeccccccccCCC
Q 001768 738 ENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLK-IVHRDIKATNVLLDKDL-NAKISDFGLAKLDEDE 815 (1016)
Q Consensus 738 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~-iiHrDlkp~NILl~~~~-~~kL~DFGla~~~~~~ 815 (1016)
++|+|.++++.. ....+++..+++++.|||+||.|||++ + ||||||||+|||++.++ ++||+|||+++.....
T Consensus 123 ~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~ 197 (362)
T KOG0192|consen 123 PGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS 197 (362)
T ss_pred CCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence 999999999874 224799999999999999999999998 6 99999999999999997 9999999999865543
Q ss_pred CcceeeecccCccccChhhhc--cCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCC
Q 001768 816 NTHISTRIAGTVGYMAPEYAM--RGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDP 893 (1016)
Q Consensus 816 ~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 893 (1016)
. ...+...||+.|||||++. ...++.|+||||||+++|||+||+.||......+....+ +..
T Consensus 198 ~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v---------------~~~ 261 (362)
T KOG0192|consen 198 K-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAV---------------VVG 261 (362)
T ss_pred c-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHH---------------Hhc
Confidence 2 2233368999999999999 568999999999999999999999999877653322211 111
Q ss_pred cCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCc
Q 001768 894 SLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKT 936 (1016)
Q Consensus 894 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 936 (1016)
..+..++..++..+..++.+||+.||.+||++.+++..|+...
T Consensus 262 ~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~ 304 (362)
T KOG0192|consen 262 GLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIM 304 (362)
T ss_pred CCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHH
Confidence 2223334446678999999999999999999999999998653
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=384.29 Aligned_cols=259 Identities=25% Similarity=0.389 Sum_probs=210.8
Q ss_pred HhcCccccCccccCCCeeEEEEE-cCCCcEEEEEEccCCChh-------hhHHHHHHHHHHHhcCCCCeeeeeeeEeecc
Q 001768 657 ATNNFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQ-------GNREFVNEIGMISALQHQNLVKLYGCCIEGN 728 (1016)
Q Consensus 657 ~~~~f~~~~~LG~G~~G~Vy~~~-~~~~~~vAvK~~~~~~~~-------~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 728 (1016)
..+.|.+.+.||+|+||.|-+|. .++|+.||||+++..... ......+|+++|++++|||||++++++...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 45668889999999999999998 457999999999754211 2234679999999999999999999999999
Q ss_pred eeEEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccC---Cceeeec
Q 001768 729 QLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKD---LNAKISD 805 (1016)
Q Consensus 729 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~---~~~kL~D 805 (1016)
..|+||||++||.|.+.+-.+. .+.+.....++.|++.|+.|||++ ||+||||||+|||+..+ ..+||+|
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk----~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItD 322 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANK----YLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITD 322 (475)
T ss_pred ceEEEEEEecCccHHHHHHhcc----ccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecc
Confidence 9999999999999999997664 578888899999999999999999 99999999999999766 6799999
Q ss_pred cccccccCCCCcceeeecccCccccChhhhccCC---CCCccchhHHHHHHHHHHhCCCCCCCCCchh-hHhHHHHHHHH
Q 001768 806 FGLAKLDEDENTHISTRIAGTVGYMAPEYAMRGY---LTDKADVYSFGIVALEIVSGKSNTNYRPKEE-FVYLLDWAYVL 881 (1016)
Q Consensus 806 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDVwSlGvvl~elltG~~P~~~~~~~~-~~~~~~~~~~~ 881 (1016)
||+|+..++. ....+.+||+.|.|||++.+.. +..++|+||+||+||-+++|.+||....... ....+
T Consensus 323 FGlAK~~g~~--sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI------ 394 (475)
T KOG0615|consen 323 FGLAKVSGEG--SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQI------ 394 (475)
T ss_pred cchhhccccc--eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHH------
Confidence 9999987643 3455689999999999998653 3458899999999999999999997543332 11111
Q ss_pred HHhCCcccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCcCCcCccccCC
Q 001768 882 QEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTAVQAPIIRRN 946 (1016)
Q Consensus 882 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~p~~~~~ 946 (1016)
..+.+.. .+.......++..++|.+||..||++|||++|++ +|||+...
T Consensus 395 -~~G~y~f------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL---------~hpW~~~~ 443 (475)
T KOG0615|consen 395 -LKGRYAF------GPLQWDRISEEALDLINWMLVVDPENRPSADEAL---------NHPWFKDA 443 (475)
T ss_pred -hcCcccc------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHh---------cChhhhcc
Confidence 1111111 1122345667899999999999999999998776 79998743
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-44 Score=379.34 Aligned_cols=207 Identities=30% Similarity=0.551 Sum_probs=187.1
Q ss_pred hcCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCC--ChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEE
Q 001768 658 TNNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSK--SKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVY 734 (1016)
Q Consensus 658 ~~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 734 (1016)
..+|...+.||+|+||+||+|+++ ++..||||.+... .....+-+..|+.+|+.++|||||++++++..++.+||||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 357888899999999999999965 6899999999766 5556677899999999999999999999999999999999
Q ss_pred eecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccC------Cceeeecccc
Q 001768 735 EYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKD------LNAKISDFGL 808 (1016)
Q Consensus 735 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~------~~~kL~DFGl 808 (1016)
|||.||+|.++++.++ .+++.+++.++.|+|.||++||++ +||||||||+|||++.. -.+||+|||+
T Consensus 89 EyC~gGDLs~yi~~~~----~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf 161 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRG----RLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGF 161 (429)
T ss_pred EeCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccch
Confidence 9999999999998775 699999999999999999999999 99999999999999764 4589999999
Q ss_pred ccccCCCCcceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHh
Q 001768 809 AKLDEDENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVY 873 (1016)
Q Consensus 809 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~ 873 (1016)
|+..... .+....+|++-|||||+++.++|+.|+|+||+|+++|||++|+.||......+...
T Consensus 162 AR~L~~~--~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~ 224 (429)
T KOG0595|consen 162 ARFLQPG--SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLL 224 (429)
T ss_pred hhhCCch--hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHH
Confidence 9987653 34566899999999999999999999999999999999999999999877766543
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=395.34 Aligned_cols=247 Identities=26% Similarity=0.447 Sum_probs=213.4
Q ss_pred cCccccCccccCCCeeEEEEEc-CCCcEEEEEEccCC---ChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEE
Q 001768 659 NNFDAANKIGEGGFGPVYKGTL-SDGAVIAVKQLSSK---SKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVY 734 (1016)
Q Consensus 659 ~~f~~~~~LG~G~~G~Vy~~~~-~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 734 (1016)
..|...+.||+|||+.||+++. ..|+.||+|++.+. .....+.+.+|+++.+.++|||||+++++|++.+..|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5689999999999999999997 78999999999764 3444667889999999999999999999999999999999
Q ss_pred eecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCC
Q 001768 735 EYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDED 814 (1016)
Q Consensus 735 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 814 (1016)
|+|+.++|.++++.+ .++++.+++.+++||+.||.|||++ +|+|||||..|++++++.++||+|||+|.....
T Consensus 98 ELC~~~sL~el~Krr----k~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRR----KPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred EecCCccHHHHHHhc----CCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecC
Confidence 999999999999744 3799999999999999999999999 999999999999999999999999999987664
Q ss_pred CCcceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCc
Q 001768 815 ENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPS 894 (1016)
Q Consensus 815 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 894 (1016)
+.. ...+.+|||.|+|||++.....+..+||||+|||+|-|++|++||......+...-+.. .+.
T Consensus 171 ~~E-rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~----------~~Y---- 235 (592)
T KOG0575|consen 171 DGE-RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKL----------NEY---- 235 (592)
T ss_pred ccc-ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHh----------cCc----
Confidence 422 23457999999999999998999999999999999999999999987665544322211 111
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 895 LGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 895 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
.+|.....+..+||.++|++||.+|||+++|+.
T Consensus 236 ---~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 236 ---SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred ---ccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 122234557889999999999999999999985
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=365.74 Aligned_cols=257 Identities=26% Similarity=0.403 Sum_probs=212.4
Q ss_pred CccccCccccCCCeeEEEEE-cCCCcEEEEEEccCC--ChhhhHHHHHHHHHHHhcCCCCeeeeee-eEeecce-eEEEE
Q 001768 660 NFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLSSK--SKQGNREFVNEIGMISALQHQNLVKLYG-CCIEGNQ-LLLVY 734 (1016)
Q Consensus 660 ~f~~~~~LG~G~~G~Vy~~~-~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~-~~~~~~~-~~lV~ 734 (1016)
+|++.++||+|.||+||++. ..+|..||.|.++-. .....++...|+.+|++++|||||++++ .+.++.+ +++||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 57789999999999999998 568999999998743 3445677899999999999999999999 4555555 89999
Q ss_pred eecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeEeCCCCCceEEEccCCceeeeccccccccC
Q 001768 735 EYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESR-LKIVHRDIKATNVLLDKDLNAKISDFGLAKLDE 813 (1016)
Q Consensus 735 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~-~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~ 813 (1016)
|||..|+|...++........+++.++|+++.|++.||.++|+..+ .-|+||||||.||+++.+|.+||+|||+++.+.
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~ 179 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS 179 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence 9999999999998877677789999999999999999999999532 139999999999999999999999999999877
Q ss_pred CCCcceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCC
Q 001768 814 DENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDP 893 (1016)
Q Consensus 814 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 893 (1016)
..... ....+|||.||+||.+....|+.|+||||+||++|||+.-++||.++.-.+.... ..+++.
T Consensus 180 s~~tf-A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~K-------I~qgd~------ 245 (375)
T KOG0591|consen 180 SKTTF-AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKK-------IEQGDY------ 245 (375)
T ss_pred chhHH-HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHH-------HHcCCC------
Confidence 65443 4457899999999999999999999999999999999999999988743332211 112211
Q ss_pred cCCCCCC-HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 001768 894 SLGSNFS-KKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933 (1016)
Q Consensus 894 ~l~~~~~-~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 933 (1016)
+..+ ...+..+..++..|+..||+.||+...++..+.
T Consensus 246 ---~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 246 ---PPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred ---CCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 1122 445678999999999999999998544444433
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=388.39 Aligned_cols=254 Identities=30% Similarity=0.480 Sum_probs=219.6
Q ss_pred CccccCccccCCCeeEEEEEcCCCcEEEEEEccCCChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEeecCC
Q 001768 660 NFDAANKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYLEN 739 (1016)
Q Consensus 660 ~f~~~~~LG~G~~G~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 739 (1016)
.+..++.||+|-||+||.|.++....||+|.++.. ....+.|.+|+++|++++|+|||+++|+|..++.++||||||+.
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~ 285 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPK 285 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEeccc
Confidence 34567999999999999999988889999999865 33346788999999999999999999999998899999999999
Q ss_pred CcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCCcce
Q 001768 740 NSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHI 819 (1016)
Q Consensus 740 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 819 (1016)
|+|.++|+... ...+...+.+.++.|||+|++||+++ ++|||||.++||||+++..+||+|||+|+...++....
T Consensus 286 GsLl~yLr~~~--~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~ 360 (468)
T KOG0197|consen 286 GSLLDYLRTRE--GGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTA 360 (468)
T ss_pred CcHHHHhhhcC--CCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCceee
Confidence 99999997733 34689999999999999999999999 99999999999999999999999999999666555444
Q ss_pred eeecccCccccChhhhccCCCCCccchhHHHHHHHHHHh-CCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCCCC
Q 001768 820 STRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGSN 898 (1016)
Q Consensus 820 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 898 (1016)
.....-+..|.|||.+..+.++.|||||||||+||||+| |+.|+......+.... ++...+..
T Consensus 361 ~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~----------------le~GyRlp 424 (468)
T KOG0197|consen 361 SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLEL----------------LERGYRLP 424 (468)
T ss_pred cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHH----------------HhccCcCC
Confidence 444455678999999999999999999999999999999 8999887776665433 33334444
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 001768 899 FSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGK 935 (1016)
Q Consensus 899 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 935 (1016)
.|..++..+.++|..||+.+|++|||++.+...|+..
T Consensus 425 ~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~ 461 (468)
T KOG0197|consen 425 RPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDF 461 (468)
T ss_pred CCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHh
Confidence 5666788999999999999999999999888888764
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=362.80 Aligned_cols=244 Identities=26% Similarity=0.374 Sum_probs=205.9
Q ss_pred HhcCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCC---hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEE
Q 001768 657 ATNNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS---KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLL 732 (1016)
Q Consensus 657 ~~~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 732 (1016)
..++|++.+.||+|+||+||.++.+ +++.+|+|++++.. ....+....|..+|++++||.||+++..|++.+.+||
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 3568999999999999999999855 58999999997652 3456778899999999999999999999999999999
Q ss_pred EEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeecccccccc
Q 001768 733 VYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLD 812 (1016)
Q Consensus 733 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~ 812 (1016)
|+||+.||.|..+|++.. .+++..+.-++.+|+.||.|||+. +||||||||+|||+|++|+++|+|||+++..
T Consensus 103 Vld~~~GGeLf~hL~~eg----~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~ 175 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQREG----RFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKED 175 (357)
T ss_pred EEeccCCccHHHHHHhcC----CcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhc
Confidence 999999999999997654 699999999999999999999999 9999999999999999999999999999854
Q ss_pred CCCCcceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccC
Q 001768 813 EDENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVD 892 (1016)
Q Consensus 813 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 892 (1016)
..... .+..++||+.|||||++.+..++..+|.||+|+++|||++|.+||...........+. ..+
T Consensus 176 ~~~~~-~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~-------~~k------ 241 (357)
T KOG0598|consen 176 LKDGD-ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKIL-------KGK------ 241 (357)
T ss_pred ccCCC-ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHh-------cCc------
Confidence 44332 3445899999999999999999999999999999999999999998766444322111 111
Q ss_pred CcCCCCCCHHHHHHHHHHHHHccCCCCCCCCC
Q 001768 893 PSLGSNFSKKEAMTMLNIALLCTNPSPTLRPT 924 (1016)
Q Consensus 893 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt 924 (1016)
....+.-...+..+++.+.+..||++|..
T Consensus 242 ---~~~~p~~ls~~ardll~~LL~rdp~~RLg 270 (357)
T KOG0598|consen 242 ---LPLPPGYLSEEARDLLKKLLKRDPRQRLG 270 (357)
T ss_pred ---CCCCCccCCHHHHHHHHHHhccCHHHhcC
Confidence 01112223456889999999999999963
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=349.99 Aligned_cols=263 Identities=23% Similarity=0.369 Sum_probs=210.6
Q ss_pred cCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCC--hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEe
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS--KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYE 735 (1016)
Q Consensus 659 ~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 735 (1016)
+.|+...++|+|+||.||+++.+ +|+.||||++.... +...+-.++|+++|++++|+|+|.++++|.....++||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 46888899999999999999976 59999999997543 3335567899999999999999999999999999999999
Q ss_pred ecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCC
Q 001768 736 YLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDE 815 (1016)
Q Consensus 736 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 815 (1016)
||+.. +.+-+.... ..++.+.+.+++.|+++|+.|+|++ ++|||||||+|||++.+|.+||||||+|+.....
T Consensus 82 ~~dhT-vL~eLe~~p---~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p 154 (396)
T KOG0593|consen 82 YCDHT-VLHELERYP---NGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAP 154 (396)
T ss_pred ecchH-HHHHHHhcc---CCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCC
Confidence 99884 444443332 3589999999999999999999999 9999999999999999999999999999977643
Q ss_pred CcceeeecccCccccChhhhcc-CCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHH---------HHHHhC
Q 001768 816 NTHISTRIAGTVGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAY---------VLQEQG 885 (1016)
Q Consensus 816 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~---------~~~~~~ 885 (1016)
....+.++.|..|+|||.+.+ .+|...+||||+||++.||++|.+-|.++++-+..+.+...- ......
T Consensus 155 -gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~ 233 (396)
T KOG0593|consen 155 -GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNP 233 (396)
T ss_pred -cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCC
Confidence 234456788999999999987 689999999999999999999999999888777666554311 111111
Q ss_pred CcccccCCc------CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 886 NLLELVDPS------LGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 886 ~~~~~~d~~------l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
-+.-+.-|. +...++ .....+.+++..|++.||++|++-+|++.
T Consensus 234 ~F~Gv~lP~~~~~epLe~k~p-~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 234 FFHGVRLPEPEHPEPLERKYP-KISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred ceeeeecCCCCCccchhhhcc-cchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 111111111 111222 23447899999999999999999998874
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=387.82 Aligned_cols=262 Identities=30% Similarity=0.506 Sum_probs=221.5
Q ss_pred HHhcCccccCccccCCCeeEEEEEcC------CCcEEEEEEccCCChh-hhHHHHHHHHHHHhcCCCCeeeeeeeEeecc
Q 001768 656 AATNNFDAANKIGEGGFGPVYKGTLS------DGAVIAVKQLSSKSKQ-GNREFVNEIGMISALQHQNLVKLYGCCIEGN 728 (1016)
Q Consensus 656 ~~~~~f~~~~~LG~G~~G~Vy~~~~~------~~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 728 (1016)
..+.+....+.||+|+||+||+|+.. +...||||.++..... ...+|++|++++..++|||||+++|+|.+++
T Consensus 483 i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~ 562 (774)
T KOG1026|consen 483 IPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGD 562 (774)
T ss_pred echhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC
Confidence 34455667899999999999999843 3578999999987665 7789999999999999999999999999999
Q ss_pred eeEEEEeecCCCcHHHHhccCcC------c----CcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccC
Q 001768 729 QLLLVYEYLENNSLARALFGKEG------Q----CLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKD 798 (1016)
Q Consensus 729 ~~~lV~E~~~~gsL~~~l~~~~~------~----~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~ 798 (1016)
.+++|+|||..|+|.++|..... . ..+|+..+.+.||.|||.|++||-++ .+|||||..+|+||.++
T Consensus 563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~ 639 (774)
T KOG1026|consen 563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGEN 639 (774)
T ss_pred eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccc
Confidence 99999999999999999965421 1 23489999999999999999999998 89999999999999999
Q ss_pred CceeeeccccccccCCCCcc-eeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHh-CCCCCCCCCchhhHhHHH
Q 001768 799 LNAKISDFGLAKLDEDENTH-ISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLD 876 (1016)
Q Consensus 799 ~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~ 876 (1016)
..|||+|||+++..-..+.+ ......-..+|||||.+..++++.+||||||||+|||+++ |+.|+.+...++....+.
T Consensus 640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~ 719 (774)
T KOG1026|consen 640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIR 719 (774)
T ss_pred eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHH
Confidence 99999999999854333322 2223345679999999999999999999999999999999 999999888887665442
Q ss_pred HHHHHHHhCCcccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCc
Q 001768 877 WAYVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKT 936 (1016)
Q Consensus 877 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 936 (1016)
.+++. ..+..++.++.+||..||+.+|++||+++||-..|+...
T Consensus 720 -------~g~lL---------~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~ 763 (774)
T KOG1026|consen 720 -------AGQLL---------SCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWA 763 (774)
T ss_pred -------cCCcc---------cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHH
Confidence 23322 234567778999999999999999999999999998653
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-41 Score=366.12 Aligned_cols=253 Identities=24% Similarity=0.355 Sum_probs=211.5
Q ss_pred HHHhcCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCC---ChhhhHHHHHHHHHHHhc-CCCCeeeeeeeEeecce
Q 001768 655 KAATNNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSK---SKQGNREFVNEIGMISAL-QHQNLVKLYGCCIEGNQ 729 (1016)
Q Consensus 655 ~~~~~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~ 729 (1016)
+...++|..++.||+|+|++|++|+.. .++.||||++.+. .......+..|-.+|.+| .||.|++|+-.|+++..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 344578999999999999999999854 6899999998654 223345567788899999 89999999999999999
Q ss_pred eEEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccc
Q 001768 730 LLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLA 809 (1016)
Q Consensus 730 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla 809 (1016)
+|+|+||+++|+|.++|...+ .+++..++.++.||+.||+|||+. |||||||||+|||+|+||+++|+|||.|
T Consensus 149 LYFvLe~A~nGdll~~i~K~G----sfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsA 221 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYG----SFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSA 221 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhC----cchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeecccc
Confidence 999999999999999997764 699999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCcc----------e--eeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHH
Q 001768 810 KLDEDENTH----------I--STRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDW 877 (1016)
Q Consensus 810 ~~~~~~~~~----------~--~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~ 877 (1016)
+.+...... . ...++||..|.+||++..+..+..+|+|+|||+||+|+.|.+||......-....+
T Consensus 222 K~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI-- 299 (604)
T KOG0592|consen 222 KILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKI-- 299 (604)
T ss_pred ccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHH--
Confidence 876543221 1 14489999999999999999999999999999999999999999876543322111
Q ss_pred HHHHHHhCCcccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001768 878 AYVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSM 931 (1016)
Q Consensus 878 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 931 (1016)
.. ++- .+++..++.+.+|+.+.|..||.+|+|.+||.+.
T Consensus 300 ---~~--------l~y----~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 300 ---QA--------LDY----EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred ---HH--------hcc----cCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 11 111 2333344578899999999999999999888764
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=365.24 Aligned_cols=266 Identities=23% Similarity=0.348 Sum_probs=212.8
Q ss_pred HHhcCccccCccccCCCeeEEEEE-cCCCcEEEEEEccCCChhhh-HHHHHHHHHHHhcC-CCCeeeeeeeEeecc-eeE
Q 001768 656 AATNNFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGN-REFVNEIGMISALQ-HQNLVKLYGCCIEGN-QLL 731 (1016)
Q Consensus 656 ~~~~~f~~~~~LG~G~~G~Vy~~~-~~~~~~vAvK~~~~~~~~~~-~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~-~~~ 731 (1016)
...++|.++++||.|.||.||+|+ ..+|..||||+++.+..... -.=.+|++.|+++. |||||++.+++.+.+ .++
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 345789999999999999999998 45789999999987644322 23368999999998 999999999999887 999
Q ss_pred EEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccc
Q 001768 732 LVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKL 811 (1016)
Q Consensus 732 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~ 811 (1016)
+|||||+. +|.++++.+. ..+++.+++.|+.||++||+|+|.+ |+.|||+||+|||+.....+||+|||+|+.
T Consensus 87 fVfE~Md~-NLYqLmK~R~---r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARe 159 (538)
T KOG0661|consen 87 FVFEFMDC-NLYQLMKDRN---RLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLARE 159 (538)
T ss_pred eeHHhhhh-hHHHHHhhcC---CcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccc
Confidence 99999966 8999997763 4799999999999999999999999 999999999999999999999999999997
Q ss_pred cCCCCcceeeecccCccccChhhhc-cCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhC-----
Q 001768 812 DEDENTHISTRIAGTVGYMAPEYAM-RGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQG----- 885 (1016)
Q Consensus 812 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~----- 885 (1016)
......+ +.++.|..|+|||++. .+.|+.+.||||+|||++|+.+-++-|.+...-+..+.+...-......
T Consensus 160 v~SkpPY--TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg 237 (538)
T KOG0661|consen 160 VRSKPPY--TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEG 237 (538)
T ss_pred cccCCCc--chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhH
Confidence 6655443 5678999999999875 5689999999999999999999999998876655443321110000000
Q ss_pred ---------CcccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001768 886 ---------NLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSM 931 (1016)
Q Consensus 886 ---------~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 931 (1016)
.+.....-.+..-++. ...+..+++.+|++.||.+|||++|++++
T Consensus 238 ~~La~~mnf~~P~~~~~~l~~L~p~-~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 238 YNLASAMNFRFPQVKPSPLKDLLPN-ASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHHHhccCCCcCCCCChHHhCcc-cCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 1111111111111222 56688999999999999999999999875
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=359.90 Aligned_cols=264 Identities=26% Similarity=0.390 Sum_probs=211.1
Q ss_pred hcCccccCccccCCCeeEEEEE-cCCCcEEEEEEccCCC--hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeec--ceeEE
Q 001768 658 TNNFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLSSKS--KQGNREFVNEIGMISALQHQNLVKLYGCCIEG--NQLLL 732 (1016)
Q Consensus 658 ~~~f~~~~~LG~G~~G~Vy~~~-~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~l 732 (1016)
.+.|+.+++||+|.||.||+|+ ..+|+.||+|++.... .....-..+||.||++++||||+++.+...+. ..+||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 3567788999999999999999 4579999999987654 34456678999999999999999999998876 78999
Q ss_pred EEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeecccccccc
Q 001768 733 VYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLD 812 (1016)
Q Consensus 733 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~ 812 (1016)
|+|||+. +|.-++.... ..+++.++..++.|++.||+|||.+ +|+|||||.+|||+|.+|.+||+|||+|+++
T Consensus 196 VFeYMdh-DL~GLl~~p~---vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSSPG---VKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred EEecccc-hhhhhhcCCC---cccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeec
Confidence 9999987 8888875543 4699999999999999999999999 9999999999999999999999999999988
Q ss_pred CCCCcceeeecccCccccChhhhccC-CCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcc---
Q 001768 813 EDENTHISTRIAGTVGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLL--- 888 (1016)
Q Consensus 813 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~--- 888 (1016)
........+..+-|..|+|||.+.+. .|+.++|+||.||||.||++|++.|.+...-+....+-..--......+.
T Consensus 269 ~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~k 348 (560)
T KOG0600|consen 269 TPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSK 348 (560)
T ss_pred cCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccccc
Confidence 77666555666789999999999875 79999999999999999999999998877655443332111000000111
Q ss_pred ----cccCCcCCCCCC-------HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 889 ----ELVDPSLGSNFS-------KKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 889 ----~~~d~~l~~~~~-------~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
..+.+. ..+. ...+....+|+..+|..||.+|.|+.++++
T Consensus 349 LP~~~~~kp~--~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 349 LPHATIFKPQ--QPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred CCcccccCCC--CcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 111111 1111 123346788999999999999999998875
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=367.23 Aligned_cols=249 Identities=29% Similarity=0.489 Sum_probs=213.7
Q ss_pred cCccccCccccCCCeeEEEEE-cCCCcEEEEEEccCCChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEeec
Q 001768 659 NNFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYL 737 (1016)
Q Consensus 659 ~~f~~~~~LG~G~~G~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 737 (1016)
..|....+||+|+.|.||.|+ ..+++.||||++........+-+.+|+.+|+..+|+|||.+++.|..++++|.|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 346667899999999999998 4568899999998777666778899999999999999999999999999999999999
Q ss_pred CCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCCc
Q 001768 738 ENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENT 817 (1016)
Q Consensus 738 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 817 (1016)
+||+|.+.+... .+++.++..|+++++.||+|||.+ +|+|||||.+|||++.+|.+||+|||++..+.....
T Consensus 353 ~ggsLTDvVt~~-----~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~ 424 (550)
T KOG0578|consen 353 EGGSLTDVVTKT-----RMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS 424 (550)
T ss_pred CCCchhhhhhcc-----cccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence 999999999654 499999999999999999999999 999999999999999999999999999987665544
Q ss_pred ceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCCC
Q 001768 818 HISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGS 897 (1016)
Q Consensus 818 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 897 (1016)
.....+|||.|||||+.....|++|+||||||++++||+-|++||-...+-...+++. ..+ .|.+
T Consensus 425 -KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa------~ng------~P~l-- 489 (550)
T KOG0578|consen 425 -KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA------TNG------TPKL-- 489 (550)
T ss_pred -ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHh------hcC------CCCc--
Confidence 3455789999999999999999999999999999999999999998665554444331 111 1111
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 898 NFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 898 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
..+......+.+++.+||..||++||++.|+++
T Consensus 490 k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 490 KNPEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred CCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 223345567999999999999999999998883
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=329.21 Aligned_cols=264 Identities=25% Similarity=0.349 Sum_probs=210.7
Q ss_pred cCccccCccccCCCeeEEEEEc-CCCcEEEEEEccCCChhh--hHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEe
Q 001768 659 NNFDAANKIGEGGFGPVYKGTL-SDGAVIAVKQLSSKSKQG--NREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYE 735 (1016)
Q Consensus 659 ~~f~~~~~LG~G~~G~Vy~~~~-~~~~~vAvK~~~~~~~~~--~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 735 (1016)
++|...++||+|.||.||+|+. .+|+.||||+++.....+ .....+|++.|+.++|+||+.++++|.+.+.+.||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4677889999999999999994 579999999997654332 4568899999999999999999999999999999999
Q ss_pred ecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCC
Q 001768 736 YLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDE 815 (1016)
Q Consensus 736 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 815 (1016)
||+. +|+..++.+. ..++..++..++.++++|++|||++ .|+||||||.|+|++++|.+||+|||+|+.+...
T Consensus 82 fm~t-dLe~vIkd~~---i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKN---IILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred eccc-cHHHHhcccc---cccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 9976 8999997654 5799999999999999999999999 8999999999999999999999999999988766
Q ss_pred CcceeeecccCccccChhhhccC-CCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCccc-----
Q 001768 816 NTHISTRIAGTVGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLE----- 889 (1016)
Q Consensus 816 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 889 (1016)
...... .+-|..|+|||.+.+. .|+..+||||.||++.||+-|.+-|.+..+-+....+-.+--.....++.+
T Consensus 155 ~~~~~~-~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lp 233 (318)
T KOG0659|consen 155 NRIQTH-QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLP 233 (318)
T ss_pred Cccccc-ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccc
Confidence 544333 3678899999998865 799999999999999999999988877665554332211111111111111
Q ss_pred -------ccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001768 890 -------LVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSM 931 (1016)
Q Consensus 890 -------~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 931 (1016)
.-.+.+.. .-..+.....+++..++..||.+|++++|++++
T Consensus 234 dY~~~~~~P~~~~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 234 DYVKIQQFPKPPLNN-LFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred cHHHHhcCCCCcccc-ccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 11111111 223445567999999999999999999988854
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=348.25 Aligned_cols=261 Identities=26% Similarity=0.408 Sum_probs=211.7
Q ss_pred hcCccccCccccCCCeeEEEEE-cCCCcEEEEEEccCCC-hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEe
Q 001768 658 TNNFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLSSKS-KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYE 735 (1016)
Q Consensus 658 ~~~f~~~~~LG~G~~G~Vy~~~-~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 735 (1016)
.+.|++...||.|..++||+|+ ...++.||||++.-+. ....+.+.+|+..++.++||||++++..|..+..+|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 4678999999999999999998 4567999999997543 3346789999999999999999999999999999999999
Q ss_pred ecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCC
Q 001768 736 YLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDE 815 (1016)
Q Consensus 736 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 815 (1016)
||.+|++.+++...-.. .+++..+..|++++++||.|||.+ |.||||||+.|||++++|.|||+|||.+......
T Consensus 105 fMa~GS~ldIik~~~~~--Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPD--GLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred hhcCCcHHHHHHHHccc--cccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 99999999999765433 499999999999999999999999 9999999999999999999999999987543332
Q ss_pred Cccee---eecccCccccChhhhcc--CCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccc
Q 001768 816 NTHIS---TRIAGTVGYMAPEYAMR--GYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLEL 890 (1016)
Q Consensus 816 ~~~~~---~~~~gt~~y~aPE~~~~--~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 890 (1016)
..... ....||++|||||+++. ..|+.|+||||||++..||.+|..||...++....... -++.....
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~t-------Lqn~pp~~ 252 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLT-------LQNDPPTL 252 (516)
T ss_pred CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHH-------hcCCCCCc
Confidence 22221 44689999999999654 36899999999999999999999999987776543211 11111111
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 891 VDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 891 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
....+..+-.+.....+.+++..|++.||.+|||++++++
T Consensus 253 ~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 253 LTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred ccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 1112222222334457899999999999999999999885
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=356.25 Aligned_cols=252 Identities=29% Similarity=0.471 Sum_probs=203.4
Q ss_pred hcCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecc--eeEEEE
Q 001768 658 TNNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIEGN--QLLLVY 734 (1016)
Q Consensus 658 ~~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~--~~~lV~ 734 (1016)
..+|...+.||+|+||.||++... +|+..|||..........+.+.+|+.+|++++|||||+++|...... .+++.|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 345677899999999999999965 48999999987654333667899999999999999999999855444 699999
Q ss_pred eecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEcc-CCceeeeccccccccC
Q 001768 735 EYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDK-DLNAKISDFGLAKLDE 813 (1016)
Q Consensus 735 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~-~~~~kL~DFGla~~~~ 813 (1016)
||+++|+|.+++....+ .+++..+..+++||++||+|||++ +||||||||+|||++. ++.+||+|||+++...
T Consensus 96 Ey~~~GsL~~~~~~~g~---~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~ 169 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGG---KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLE 169 (313)
T ss_pred eccCCCcHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccccc
Confidence 99999999999976653 599999999999999999999998 9999999999999999 7999999999998655
Q ss_pred C--CCcceeeecccCccccChhhhccC-CCCCccchhHHHHHHHHHHhCCCCCCCC-CchhhHhHHHHHHHHHHhCCccc
Q 001768 814 D--ENTHISTRIAGTVGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGKSNTNYR-PKEEFVYLLDWAYVLQEQGNLLE 889 (1016)
Q Consensus 814 ~--~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~P~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 889 (1016)
. ..........||+.|||||++..+ ....++|||||||++.||+||++||... ...+.. ......
T Consensus 170 ~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~------~~ig~~----- 238 (313)
T KOG0198|consen 170 SKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEAL------LLIGRE----- 238 (313)
T ss_pred cccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHH------HHHhcc-----
Confidence 3 222223457899999999999854 3445999999999999999999999753 111111 000111
Q ss_pred ccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 890 LVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 890 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
...| .++...+....+++.+|++.||++|||++++++
T Consensus 239 ~~~P----~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~ 275 (313)
T KOG0198|consen 239 DSLP----EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLE 275 (313)
T ss_pred CCCC----CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 1112 344445667999999999999999999999884
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=359.45 Aligned_cols=247 Identities=29% Similarity=0.437 Sum_probs=213.3
Q ss_pred cCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCC--ChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEe
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSK--SKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYE 735 (1016)
Q Consensus 659 ~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 735 (1016)
++|.+.+.||+|+||.||||+.+ +.+.||+|.+.+. .+++.+.+.+|+++++.++|||||.++++|+...++++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57888999999999999999965 6789999998754 34456779999999999999999999999999999999999
Q ss_pred ecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCC
Q 001768 736 YLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDE 815 (1016)
Q Consensus 736 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 815 (1016)
|+.| +|..++.... .++++.+..|+.|++.||.|||+. +|+|||+||.|||++..|.+|++|||+|+....
T Consensus 82 ~a~g-~L~~il~~d~----~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~- 152 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDG----KLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMST- 152 (808)
T ss_pred hhhh-hHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhccc-
Confidence 9987 9999996654 699999999999999999999999 999999999999999999999999999997665
Q ss_pred CcceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcC
Q 001768 816 NTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSL 895 (1016)
Q Consensus 816 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 895 (1016)
++.+.+.+.|||.|||||+..+++|+..+|.||+||++||+++|++||......+....+ ..||.
T Consensus 153 ~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I--------------~~d~v- 217 (808)
T KOG0597|consen 153 NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSI--------------LKDPV- 217 (808)
T ss_pred CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHH--------------hcCCC-
Confidence 455677889999999999999999999999999999999999999999754433322211 11221
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001768 896 GSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSM 931 (1016)
Q Consensus 896 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 931 (1016)
.++......+..++...+.+||.+|.|..+++..
T Consensus 218 --~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 218 --KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred --CCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 2234566689999999999999999999988753
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=363.70 Aligned_cols=265 Identities=28% Similarity=0.489 Sum_probs=216.2
Q ss_pred HHHHHHhcCccccCccccCCCeeEEEEEcCCCcEEEEEEccCCC--hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecce
Q 001768 652 RQIKAATNNFDAANKIGEGGFGPVYKGTLSDGAVIAVKQLSSKS--KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQ 729 (1016)
Q Consensus 652 ~~l~~~~~~f~~~~~LG~G~~G~Vy~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 729 (1016)
++.++..+.+.+..+||+|.||+||+|+|.. .||||++.... .+..+.|++|+.++++-+|.||+-++|+|..+..
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 5555566667789999999999999999863 59999997653 4457789999999999999999999999998877
Q ss_pred eEEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccc
Q 001768 730 LLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLA 809 (1016)
Q Consensus 730 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla 809 (1016)
.+|+.+|+|.+|+.+++..+ ..++..+.+.||+|||+|+.|||.+ +|||||||..||++.+++.|||+|||++
T Consensus 463 -AIiTqwCeGsSLY~hlHv~e---tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLa 535 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQE---TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLA 535 (678)
T ss_pred -eeeehhccCchhhhhccchh---hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccce
Confidence 99999999999999998876 3599999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCC-CcceeeecccCccccChhhhccC---CCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhC
Q 001768 810 KLDEDE-NTHISTRIAGTVGYMAPEYAMRG---YLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQG 885 (1016)
Q Consensus 810 ~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 885 (1016)
.....- .........|...|||||+++.+ +|++.+||||||+|+|||+||..||.....+++...+.. +
T Consensus 536 tvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGr-------G 608 (678)
T KOG0193|consen 536 TVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGR-------G 608 (678)
T ss_pred eeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecc-------c
Confidence 632211 11112334578899999999743 789999999999999999999999986555554432211 1
Q ss_pred CcccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCcC
Q 001768 886 NLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTA 937 (1016)
Q Consensus 886 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 937 (1016)
. ..++. ......++.++.+|+..||..++++||.+.+|+..|+....
T Consensus 609 ~----l~pd~-s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 609 Y----LMPDL-SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred c----cCccc-hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 0 01111 11234566789999999999999999999999998887644
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=360.54 Aligned_cols=249 Identities=23% Similarity=0.381 Sum_probs=206.0
Q ss_pred HHhcCccccCccccCCCeeEEEEEc-CCCcEEEEEEccCC----Ch-hhhHHHHHHHHHHHhcC-CCCeeeeeeeEeecc
Q 001768 656 AATNNFDAANKIGEGGFGPVYKGTL-SDGAVIAVKQLSSK----SK-QGNREFVNEIGMISALQ-HQNLVKLYGCCIEGN 728 (1016)
Q Consensus 656 ~~~~~f~~~~~LG~G~~G~Vy~~~~-~~~~~vAvK~~~~~----~~-~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~ 728 (1016)
...++|.+.+.||+|+||.|+.|.. .+++.||+|++... .. ...+.+.+|+.++++++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 4457899999999999999999975 46899999977653 12 23456778999999999 999999999999999
Q ss_pred eeEEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccC-Cceeeeccc
Q 001768 729 QLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKD-LNAKISDFG 807 (1016)
Q Consensus 729 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~-~~~kL~DFG 807 (1016)
.+++||||+.+|+|.+++.... ++.+.++..+++|++.|++|||++ +|+||||||+|||++.+ +++||+|||
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g----~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG 166 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKG----RLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFG 166 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcC----CCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccc
Confidence 9999999999999999997733 689999999999999999999998 99999999999999999 999999999
Q ss_pred cccccCCCCcceeeecccCccccChhhhccCC-CC-CccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhC
Q 001768 808 LAKLDEDENTHISTRIAGTVGYMAPEYAMRGY-LT-DKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQG 885 (1016)
Q Consensus 808 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 885 (1016)
++.... .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+.......... ...+
T Consensus 167 ~s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~k-------i~~~ 238 (370)
T KOG0583|consen 167 LSAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRK-------IRKG 238 (370)
T ss_pred cccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHH-------HhcC
Confidence 998774 2223345678999999999998765 64 789999999999999999999987443322111 1111
Q ss_pred CcccccCCcCCCCCCHHH-HHHHHHHHHHccCCCCCCCCCHHHHH
Q 001768 886 NLLELVDPSLGSNFSKKE-AMTMLNIALLCTNPSPTLRPTMSSAV 929 (1016)
Q Consensus 886 ~~~~~~d~~l~~~~~~~~-~~~l~~li~~cl~~dP~~RPt~~evl 929 (1016)
. -.++... ..++..++.+|+..||.+|+++.+++
T Consensus 239 ~----------~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 239 E----------FKIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred C----------ccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 1 1112222 55789999999999999999999988
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=328.74 Aligned_cols=253 Identities=25% Similarity=0.344 Sum_probs=210.4
Q ss_pred cCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCC---hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEE
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS---KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVY 734 (1016)
Q Consensus 659 ~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 734 (1016)
++|+..+.||.|+||.|.+++.+ +|..+|+|++.... ....+...+|..+|+.+.||.++++++.+.+.+.+++||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 46778999999999999999965 68899999997653 334566788999999999999999999999999999999
Q ss_pred eecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCC
Q 001768 735 EYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDED 814 (1016)
Q Consensus 735 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 814 (1016)
||++||.|..+++..+ ++++..++-+|.||+.||+|||+. +|++||+||+|||+|.+|.+||+|||+|+....
T Consensus 124 eyv~GGElFS~Lrk~~----rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~ 196 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSG----RFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG 196 (355)
T ss_pred eccCCccHHHHHHhcC----CCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence 9999999999997654 699999999999999999999998 999999999999999999999999999986654
Q ss_pred CCcceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCc
Q 001768 815 ENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPS 894 (1016)
Q Consensus 815 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 894 (1016)
. +...+|||.|+|||.+....+..++|.|||||++|||+.|.+||....+...... ... ..
T Consensus 197 r----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~K-----I~~----------~~ 257 (355)
T KOG0616|consen 197 R----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEK-----ILE----------GK 257 (355)
T ss_pred c----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHH-----HHh----------Cc
Confidence 3 5668999999999999999999999999999999999999999987665332211 111 11
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc-cC-cCCcCccccC
Q 001768 895 LGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLE-GK-TAVQAPIIRR 945 (1016)
Q Consensus 895 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~-~~-~~~~~p~~~~ 945 (1016)
-.+|.-....+.+|+...++.|-.+|-. -+. +. .-..|||++.
T Consensus 258 --v~fP~~fs~~~kdLl~~LL~vD~t~R~g------nlknG~~dIk~H~wF~~ 302 (355)
T KOG0616|consen 258 --VKFPSYFSSDAKDLLKKLLQVDLTKRFG------NLKNGVEDIKNHPWFKG 302 (355)
T ss_pred --ccCCcccCHHHHHHHHHHHhhhhHhhhc------CcCCCccccccCccccc
Confidence 1234444557889999999999998832 122 22 2245788763
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=365.66 Aligned_cols=261 Identities=27% Similarity=0.411 Sum_probs=205.5
Q ss_pred HhcCccccCccccCCCeeEEEEEc------CCCcEEEEEEccCCC-hhhhHHHHHHHHHHHhc-CCCCeeeeeeeEeec-
Q 001768 657 ATNNFDAANKIGEGGFGPVYKGTL------SDGAVIAVKQLSSKS-KQGNREFVNEIGMISAL-QHQNLVKLYGCCIEG- 727 (1016)
Q Consensus 657 ~~~~f~~~~~LG~G~~G~Vy~~~~------~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~- 727 (1016)
..++|++.+.||+|+||.||+|.+ .+++.||||++.... ......+.+|+++++.+ +||||+++++++...
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 456899999999999999999973 235789999987543 23346788999999999 899999999988764
Q ss_pred ceeEEEEeecCCCcHHHHhccCcCc-------------------------------------------------------
Q 001768 728 NQLLLVYEYLENNSLARALFGKEGQ------------------------------------------------------- 752 (1016)
Q Consensus 728 ~~~~lV~E~~~~gsL~~~l~~~~~~------------------------------------------------------- 752 (1016)
+.+++||||+++|+|.+++......
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 4689999999999999998653210
Q ss_pred ---CcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCCcce-eeecccCcc
Q 001768 753 ---CLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHI-STRIAGTVG 828 (1016)
Q Consensus 753 ---~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~-~~~~~gt~~ 828 (1016)
..++++.++..++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++......... .....+++.
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 13488899999999999999999998 99999999999999999999999999998543332221 223446788
Q ss_pred ccChhhhccCCCCCccchhHHHHHHHHHHh-CCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCCCCCCHHHHHHH
Q 001768 829 YMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGSNFSKKEAMTM 907 (1016)
Q Consensus 829 y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l 907 (1016)
|+|||++.+..++.++|||||||++|||++ |+.||......+... ... ..+. ... .+...+..+
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~-----~~~-~~~~-----~~~----~~~~~~~~l 306 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFC-----QRL-KDGT-----RMR----APENATPEI 306 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHH-----HHH-hcCC-----CCC----CCCCCCHHH
Confidence 999999998889999999999999999997 999997644322110 011 1111 111 122234568
Q ss_pred HHHHHHccCCCCCCCCCHHHHHHHhccC
Q 001768 908 LNIALLCTNPSPTLRPTMSSAVSMLEGK 935 (1016)
Q Consensus 908 ~~li~~cl~~dP~~RPt~~evl~~L~~~ 935 (1016)
.+++.+||+.||++|||+.|++++|+..
T Consensus 307 ~~li~~cl~~dp~~RPs~~el~~~l~~~ 334 (338)
T cd05102 307 YRIMLACWQGDPKERPTFSALVEILGDL 334 (338)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 9999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=368.50 Aligned_cols=254 Identities=27% Similarity=0.477 Sum_probs=218.3
Q ss_pred ccccCccccCCCeeEEEEEcC----CCcEEEEEEccCCC-hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEe
Q 001768 661 FDAANKIGEGGFGPVYKGTLS----DGAVIAVKQLSSKS-KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYE 735 (1016)
Q Consensus 661 f~~~~~LG~G~~G~Vy~~~~~----~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 735 (1016)
..+.+.||.|.||+|++|+++ ....||||.++... ....++|..|+.||.+++||||++|.|+.......++|.|
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTE 710 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITE 710 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhh
Confidence 346789999999999999975 24679999998764 4456789999999999999999999999999999999999
Q ss_pred ecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCC
Q 001768 736 YLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDE 815 (1016)
Q Consensus 736 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 815 (1016)
||++|+|+.+|+.+.+ .+++.+...++++||.|++||-+. ++|||||.++|||++.+..+|++|||+++...++
T Consensus 711 yMENGsLDsFLR~~DG---qftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd 784 (996)
T KOG0196|consen 711 YMENGSLDSFLRQNDG---QFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 784 (996)
T ss_pred hhhCCcHHHHHhhcCC---ceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeecccC
Confidence 9999999999987765 489999999999999999999988 9999999999999999999999999999977665
Q ss_pred Ccceeeeccc--CccccChhhhccCCCCCccchhHHHHHHHHHHh-CCCCCCCCCchhhHhHHHHHHHHHHhCCcccccC
Q 001768 816 NTHISTRIAG--TVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVD 892 (1016)
Q Consensus 816 ~~~~~~~~~g--t~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 892 (1016)
.....+...| +.+|.|||.+..++++.++||||||+|+||.++ |++||-....++....++
T Consensus 785 ~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe---------------- 848 (996)
T KOG0196|consen 785 PEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIE---------------- 848 (996)
T ss_pred CCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHH----------------
Confidence 5333232222 578999999999999999999999999999988 999987777666554332
Q ss_pred CcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCc
Q 001768 893 PSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKT 936 (1016)
Q Consensus 893 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 936 (1016)
...+-..|.+++..|.+||..||++|-.+||++.||+..|++..
T Consensus 849 ~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklI 892 (996)
T KOG0196|consen 849 QGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLI 892 (996)
T ss_pred hccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHh
Confidence 22333345678889999999999999999999999999998653
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=350.67 Aligned_cols=240 Identities=28% Similarity=0.445 Sum_probs=204.7
Q ss_pred ccCccccCCCeeEEEEEcCCCcEEEEEEccCCChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEeecCCCcH
Q 001768 663 AANKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYLENNSL 742 (1016)
Q Consensus 663 ~~~~LG~G~~G~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 742 (1016)
.++-||.|+.|.||+|+++ ++.||||+++.-. ..+++.|++++||||+.+.|+|.....+|+|||||..|-|
T Consensus 128 ELeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL 199 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQL 199 (904)
T ss_pred hhhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccH
Confidence 3678999999999999996 5789999875322 2478889999999999999999999999999999999999
Q ss_pred HHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCCcceeee
Q 001768 743 ARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTR 822 (1016)
Q Consensus 743 ~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 822 (1016)
.+.|+... +++......+..+||.|+.|||.+ +|||||||.-|||+..+..|||+|||.++...+..+. ..
T Consensus 200 ~~VLka~~----~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STk--MS 270 (904)
T KOG4721|consen 200 YEVLKAGR----PITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTK--MS 270 (904)
T ss_pred HHHHhccC----ccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhhhhh--hh
Confidence 99997654 688889999999999999999999 9999999999999999999999999999866554332 34
Q ss_pred cccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCCCCCCHH
Q 001768 823 IAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGSNFSKK 902 (1016)
Q Consensus 823 ~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 902 (1016)
++||..|||||++...+.++|+||||||||||||+||..||..-....+. |. +-...+.-..+..
T Consensus 271 FaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAII----wG-----------VGsNsL~LpvPst 335 (904)
T KOG4721|consen 271 FAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAII----WG-----------VGSNSLHLPVPST 335 (904)
T ss_pred hhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeE----Ee-----------ccCCcccccCccc
Confidence 78999999999999999999999999999999999999998753332221 11 1112333445667
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 001768 903 EAMTMLNIALLCTNPSPTLRPTMSSAVSMLEG 934 (1016)
Q Consensus 903 ~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 934 (1016)
+++.++-|+++||+..|..||++.+++..|+-
T Consensus 336 cP~GfklL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 336 CPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred CchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 78889999999999999999999999998873
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=347.57 Aligned_cols=248 Identities=23% Similarity=0.327 Sum_probs=204.9
Q ss_pred HHHhcCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCC---hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeeccee
Q 001768 655 KAATNNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS---KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQL 730 (1016)
Q Consensus 655 ~~~~~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 730 (1016)
+...++|+.+..||+|+||.||+|+.+ +|..+|+|++++.. ....+.+..|-.+|...++|.||+++..|++.+.+
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 335678999999999999999999954 69999999998753 34456788899999999999999999999999999
Q ss_pred EEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeecccccc
Q 001768 731 LLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAK 810 (1016)
Q Consensus 731 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~ 810 (1016)
||||||++||++..+|.... .|++..+..++.+++.|++-+|+. |+|||||||+|+|+|..|++||+|||++.
T Consensus 217 YLiMEylPGGD~mTLL~~~~----~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~ 289 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMRKD----TLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLST 289 (550)
T ss_pred EEEEEecCCccHHHHHHhcC----cCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccc
Confidence 99999999999999997665 799999999999999999999998 99999999999999999999999999984
Q ss_pred ccCC-----------------------CCc----ce-------------------eeecccCccccChhhhccCCCCCcc
Q 001768 811 LDED-----------------------ENT----HI-------------------STRIAGTVGYMAPEYAMRGYLTDKA 844 (1016)
Q Consensus 811 ~~~~-----------------------~~~----~~-------------------~~~~~gt~~y~aPE~~~~~~~~~~s 844 (1016)
-... +.. .. ....+|||.|||||++.+..|+..+
T Consensus 290 gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~c 369 (550)
T KOG0605|consen 290 GLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKEC 369 (550)
T ss_pred hhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccc
Confidence 2110 000 00 0125799999999999999999999
Q ss_pred chhHHHHHHHHHHhCCCCCCCCCchhh-HhHHHHHHHHHHhCCcccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCC
Q 001768 845 DVYSFGIVALEIVSGKSNTNYRPKEEF-VYLLDWAYVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRP 923 (1016)
Q Consensus 845 DVwSlGvvl~elltG~~P~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP 923 (1016)
|.||||||+|||+.|.+||....+.+. ..++.|........ ......+..+||.+|+. ||++|.
T Consensus 370 DwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~--------------~~~~s~eA~DLI~rll~-d~~~RL 434 (550)
T KOG0605|consen 370 DWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPE--------------EVDLSDEAKDLITRLLC-DPENRL 434 (550)
T ss_pred cHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCC--------------cCcccHHHHHHHHHHhc-CHHHhc
Confidence 999999999999999999987766554 34444432211110 01122578899999999 999998
Q ss_pred C
Q 001768 924 T 924 (1016)
Q Consensus 924 t 924 (1016)
.
T Consensus 435 G 435 (550)
T KOG0605|consen 435 G 435 (550)
T ss_pred C
Confidence 6
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=343.97 Aligned_cols=252 Identities=26% Similarity=0.359 Sum_probs=201.1
Q ss_pred HhcCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCCh--------------hhhHHHHHHHHHHHhcCCCCeeeee
Q 001768 657 ATNNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSK--------------QGNREFVNEIGMISALQHQNLVKLY 721 (1016)
Q Consensus 657 ~~~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~~--------------~~~~~~~~E~~~l~~l~HpnIv~l~ 721 (1016)
.-++|++.+.||+|.||.|-+|+.. +++.||||++.+... ...+...+|+.+|++++|||||+++
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 4578999999999999999999954 789999999975321 1125788999999999999999999
Q ss_pred eeEeec--ceeEEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCC
Q 001768 722 GCCIEG--NQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDL 799 (1016)
Q Consensus 722 ~~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~ 799 (1016)
++..+. +.+|||+|||..|.+...=. ....+++.++++++++++.||+|||.+ +||||||||+|+|++++|
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~p~----d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g 247 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWCPP----DKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDG 247 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccCCC----CcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCC
Confidence 999874 68999999999887654321 222399999999999999999999999 999999999999999999
Q ss_pred ceeeeccccccccCCC----CcceeeecccCccccChhhhccC----CCCCccchhHHHHHHHHHHhCCCCCCCCCchhh
Q 001768 800 NAKISDFGLAKLDEDE----NTHISTRIAGTVGYMAPEYAMRG----YLTDKADVYSFGIVALEIVSGKSNTNYRPKEEF 871 (1016)
Q Consensus 800 ~~kL~DFGla~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~ 871 (1016)
++||+|||.+...... ....-...+|||.|+|||...++ ..+.+.||||+||+||.|+.|+.||......+.
T Consensus 248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l 327 (576)
T KOG0585|consen 248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELEL 327 (576)
T ss_pred cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHH
Confidence 9999999999765322 11122347899999999998764 346688999999999999999999986544332
Q ss_pred HhHHHHHHHHHHhCCcccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 872 VYLLDWAYVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 872 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
.. .++...+.....++..+.+.+||.++|.+||++|.+..+|..
T Consensus 328 ~~---------------KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~ 371 (576)
T KOG0585|consen 328 FD---------------KIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKL 371 (576)
T ss_pred HH---------------HHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhhee
Confidence 21 122222222222345678999999999999999999988874
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=353.29 Aligned_cols=247 Identities=24% Similarity=0.375 Sum_probs=208.9
Q ss_pred cCccccCccccCCCeeEEEEEc-CCCcEEEEEEccCCC---hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEE
Q 001768 659 NNFDAANKIGEGGFGPVYKGTL-SDGAVIAVKQLSSKS---KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVY 734 (1016)
Q Consensus 659 ~~f~~~~~LG~G~~G~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 734 (1016)
..|+.++.||.|+.|.|.+|+. .+|+.+|||++.+.. ......+.+|+.+|+.+.|||++++|+++++..++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 3577889999999999999995 479999999997662 222456788999999999999999999999999999999
Q ss_pred eecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCC
Q 001768 735 EYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDED 814 (1016)
Q Consensus 735 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 814 (1016)
||+++|.|.+++..++ ++++.++.+++.||+.|+.|+|.. +|+|||+||+|+|+|..+++||+|||+|....+
T Consensus 92 Eyv~gGELFdylv~kG----~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~ 164 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKG----PLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVP 164 (786)
T ss_pred EecCCchhHHHHHhhC----CCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccC
Confidence 9999999999997765 799999999999999999999998 999999999999999999999999999986554
Q ss_pred CCcceeeecccCccccChhhhccCCC-CCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCC
Q 001768 815 ENTHISTRIAGTVGYMAPEYAMRGYL-TDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDP 893 (1016)
Q Consensus 815 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 893 (1016)
+. .-.+.+|+++|+|||++++.+| +.++||||.|||||.|+||+.||+++........+ ..+.+
T Consensus 165 gk--lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV-------~~G~f------ 229 (786)
T KOG0588|consen 165 GK--LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKV-------QRGVF------ 229 (786)
T ss_pred Cc--cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHH-------HcCcc------
Confidence 43 3355789999999999998865 57999999999999999999999965433322111 11111
Q ss_pred cCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001768 894 SLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSM 931 (1016)
Q Consensus 894 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 931 (1016)
+.+...+.+..+|+.+|+..||++|.|+.||++.
T Consensus 230 ----~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 230 ----EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred ----cCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 1223344578999999999999999999999974
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=346.13 Aligned_cols=248 Identities=27% Similarity=0.449 Sum_probs=211.6
Q ss_pred cCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCC-hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEee
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS-KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEY 736 (1016)
Q Consensus 659 ~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 736 (1016)
..|+..+.||+|.||.||+|... .++.||+|++.-.. ....+++++|+.++.+++++||.++|+.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 34667799999999999999964 68999999997653 44567899999999999999999999999999999999999
Q ss_pred cCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCC
Q 001768 737 LENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDEN 816 (1016)
Q Consensus 737 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 816 (1016)
|.||++.+.+.... .+++..+.-|+++++.|+.|||.+ +.+|||||+.|||+..+|.+||+|||.+-......
T Consensus 93 ~~gGsv~~lL~~~~----~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~ 165 (467)
T KOG0201|consen 93 CGGGSVLDLLKSGN----ILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV 165 (467)
T ss_pred hcCcchhhhhccCC----CCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechh
Confidence 99999999996543 458888899999999999999999 89999999999999999999999999997665544
Q ss_pred cceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCC
Q 001768 817 THISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLG 896 (1016)
Q Consensus 817 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 896 (1016)
... ..++||+.|||||++.+..|+.|+||||||++.+||++|.+|+....+.....+ +...-+
T Consensus 166 ~rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlfl----------------Ipk~~P 228 (467)
T KOG0201|consen 166 KRR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFL----------------IPKSAP 228 (467)
T ss_pred hcc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEe----------------ccCCCC
Confidence 433 668999999999999988999999999999999999999999987665443332 222222
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 897 SNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 897 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
+.........+.+++..|++.||+.||++.++++
T Consensus 229 P~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 229 PRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred CccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 2333344557999999999999999999999885
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=348.28 Aligned_cols=265 Identities=25% Similarity=0.389 Sum_probs=204.9
Q ss_pred hcCccccCccccCCCeeEEEEEcCC-----------------CcEEEEEEccCCC-hhhhHHHHHHHHHHHhcCCCCeee
Q 001768 658 TNNFDAANKIGEGGFGPVYKGTLSD-----------------GAVIAVKQLSSKS-KQGNREFVNEIGMISALQHQNLVK 719 (1016)
Q Consensus 658 ~~~f~~~~~LG~G~~G~Vy~~~~~~-----------------~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~ 719 (1016)
.++|++.++||+|+||.||+|.+++ +..||+|.+.... .....++.+|++++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3578889999999999999997532 3479999987653 334567899999999999999999
Q ss_pred eeeeEeecceeEEEEeecCCCcHHHHhccCcC---------------cCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 001768 720 LYGCCIEGNQLLLVYEYLENNSLARALFGKEG---------------QCLNLDWATRKRICSDIARGLAYLHEESRLKIV 784 (1016)
Q Consensus 720 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~---------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ii 784 (1016)
+++++.+.+..++||||+++++|.+++..... ....+++.++.+++.||+.||+|||+. +|+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Ccc
Confidence 99999999999999999999999999854321 113478899999999999999999998 899
Q ss_pred eCCCCCceEEEccCCceeeeccccccccCCCCc-ceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHh--CCC
Q 001768 785 HRDIKATNVLLDKDLNAKISDFGLAKLDEDENT-HISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS--GKS 861 (1016)
Q Consensus 785 HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt--G~~ 861 (1016)
||||||+|||++.++.+||+|||+++....... .......++..|+|||++.++.++.++|||||||++|||++ +..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 999999999999999999999999975433222 12233456788999999988889999999999999999987 556
Q ss_pred CCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 001768 862 NTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEG 934 (1016)
Q Consensus 862 P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 934 (1016)
||.....++..... ........ . .... ..+...+..+.+++.+||+.||++|||+.+|.+.|++
T Consensus 241 p~~~~~~~~~~~~~---~~~~~~~~-~-~~~~----~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 241 PYGELTDEQVIENA---GEFFRDQG-R-QVYL----FRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCCcCCHHHHHHHH---HHHhhhcc-c-cccc----cCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 77654433322111 11000000 0 0000 1112234578999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=343.90 Aligned_cols=246 Identities=21% Similarity=0.292 Sum_probs=200.6
Q ss_pred cCccccCCCeeEEEEEcCCCcEEEEEEccCCChhh---hHHHHHHHHHHHhcCCCCeeeeeeeEee----cceeEEEEee
Q 001768 664 ANKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQG---NREFVNEIGMISALQHQNLVKLYGCCIE----GNQLLLVYEY 736 (1016)
Q Consensus 664 ~~~LG~G~~G~Vy~~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~l~~~~~~----~~~~~lV~E~ 736 (1016)
...||+|++|.||+|.+ +|+.||||.+....... .+.+.+|++++++++||||++++|++.+ ....++||||
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 36799999999999998 58899999987643322 4678899999999999999999999877 3578999999
Q ss_pred cCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCC
Q 001768 737 LENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDEN 816 (1016)
Q Consensus 737 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 816 (1016)
+++|+|.+++.... .+++..+..++.|++.||+|||+.. +++||||||+||++++++.+||+|||+++......
T Consensus 104 ~~~g~L~~~l~~~~----~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~ 177 (283)
T PHA02988 104 CTRGYLREVLDKEK----DLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP 177 (283)
T ss_pred CCCCcHHHHHhhCC----CCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc
Confidence 99999999996543 5899999999999999999999742 68899999999999999999999999998544321
Q ss_pred cceeeecccCccccChhhhcc--CCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCc
Q 001768 817 THISTRIAGTVGYMAPEYAMR--GYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPS 894 (1016)
Q Consensus 817 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 894 (1016)
....|+..|+|||++.+ ..++.++|||||||++|||++|+.||......+....+ .... ..+
T Consensus 178 ----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i------~~~~-----~~~- 241 (283)
T PHA02988 178 ----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLI------INKN-----NSL- 241 (283)
T ss_pred ----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHH------HhcC-----CCC-
Confidence 23467899999999976 67899999999999999999999999865543322111 0000 011
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 001768 895 LGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGK 935 (1016)
Q Consensus 895 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 935 (1016)
..+...+..+.+++.+||+.||++|||++|+++.|+..
T Consensus 242 ---~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 242 ---KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred ---CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 12223455799999999999999999999999998754
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=349.15 Aligned_cols=249 Identities=22% Similarity=0.325 Sum_probs=200.5
Q ss_pred cccCCCeeEEEEEcC-CCcEEEEEEccCC---ChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEeecCCCcH
Q 001768 667 IGEGGFGPVYKGTLS-DGAVIAVKQLSSK---SKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYLENNSL 742 (1016)
Q Consensus 667 LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 742 (1016)
||+|+||.||+|+.. +++.||+|++... .......+.+|++++++++||||+++++++.+++..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999965 5789999998643 233445678899999999999999999999999999999999999999
Q ss_pred HHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCCcceeee
Q 001768 743 ARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTR 822 (1016)
Q Consensus 743 ~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 822 (1016)
.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 152 (312)
T cd05585 81 FHHLQREG----RFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNT 152 (312)
T ss_pred HHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Ccccc
Confidence 99996543 589999999999999999999998 99999999999999999999999999997543222 22334
Q ss_pred cccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCCCCCCHH
Q 001768 823 IAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGSNFSKK 902 (1016)
Q Consensus 823 ~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 902 (1016)
..||+.|+|||++.+..++.++|||||||++|||++|+.||......+.... .. .. . ..++..
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~-----~~--~~------~----~~~~~~ 215 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRK-----IL--QE------P----LRFPDG 215 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHH-----HH--cC------C----CCCCCc
Confidence 5799999999999988999999999999999999999999976543322110 00 00 0 112223
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCcCCcCccccCC
Q 001768 903 EAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTAVQAPIIRRN 946 (1016)
Q Consensus 903 ~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~p~~~~~ 946 (1016)
....+.+++.+||+.||++||++.++.+.| .|||+...
T Consensus 216 ~~~~~~~li~~~L~~dp~~R~~~~~~~e~l------~hp~~~~~ 253 (312)
T cd05585 216 FDRDAKDLLIGLLSRDPTRRLGYNGAQEIK------NHPFFSQL 253 (312)
T ss_pred CCHHHHHHHHHHcCCCHHHcCCCCCHHHHH------cCCCcCCC
Confidence 345688999999999999998765444433 46776643
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=343.52 Aligned_cols=257 Identities=26% Similarity=0.362 Sum_probs=205.3
Q ss_pred CccccCccccCCCeeEEEEEc-CCCcEEEEEEccCCC---hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEe
Q 001768 660 NFDAANKIGEGGFGPVYKGTL-SDGAVIAVKQLSSKS---KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYE 735 (1016)
Q Consensus 660 ~f~~~~~LG~G~~G~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 735 (1016)
.|+..+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+++++.++|+||+++++++.+++..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 377889999999999999986 478999999986432 2233467889999999999999999999999999999999
Q ss_pred ecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCC
Q 001768 736 YLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDE 815 (1016)
Q Consensus 736 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 815 (1016)
|+++|+|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+|||+++++.++|+|||++......
T Consensus 81 ~~~~g~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05631 81 IMNGGDLKFHIYNMGN--PGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG 155 (285)
T ss_pred ecCCCcHHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence 9999999988854322 3589999999999999999999998 9999999999999999999999999999865432
Q ss_pred CcceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcC
Q 001768 816 NTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSL 895 (1016)
Q Consensus 816 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 895 (1016)
.. .....||..|+|||++.+..++.++|||||||++|||++|+.||.............. .. . . .
T Consensus 156 ~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~--~~-~-----~-----~ 220 (285)
T cd05631 156 ET--VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDR--RV-K-----E-----D 220 (285)
T ss_pred Ce--ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHH--Hh-h-----c-----c
Confidence 21 2345789999999999998999999999999999999999999986543221111110 00 0 0 0
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHhccCcCCcCccccC
Q 001768 896 GSNFSKKEAMTMLNIALLCTNPSPTLRPT-----MSSAVSMLEGKTAVQAPIIRR 945 (1016)
Q Consensus 896 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~L~~~~~~~~p~~~~ 945 (1016)
...++......+.+++.+||+.||.+||+ +++++ +|||+..
T Consensus 221 ~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~---------~h~~~~~ 266 (285)
T cd05631 221 QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVK---------QHPIFKN 266 (285)
T ss_pred cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHh---------cCHhhcC
Confidence 01122233457889999999999999997 56555 5777654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=344.01 Aligned_cols=264 Identities=21% Similarity=0.312 Sum_probs=203.7
Q ss_pred cCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCC--hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEe
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS--KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYE 735 (1016)
Q Consensus 659 ~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 735 (1016)
++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+++++.++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 47899999999999999999975 57899999987542 2334567899999999999999999999999999999999
Q ss_pred ecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCC
Q 001768 736 YLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDE 815 (1016)
Q Consensus 736 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 815 (1016)
|++++.+..+.... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 81 YVEKNMLELLEEMP----NGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred cCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence 99998776654322 2589999999999999999999998 9999999999999999999999999999865433
Q ss_pred CcceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHH---------HHHHHhCC
Q 001768 816 NTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWA---------YVLQEQGN 886 (1016)
Q Consensus 816 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~---------~~~~~~~~ 886 (1016)
.........||+.|+|||++.+..++.++|||||||++|||++|++||......+....+... ........
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07848 154 SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR 233 (287)
T ss_pred ccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence 222233457899999999999888999999999999999999999999765443322111110 00000000
Q ss_pred cccccCCcCC------CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 001768 887 LLELVDPSLG------SNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAV 929 (1016)
Q Consensus 887 ~~~~~d~~l~------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 929 (1016)
......+... ..+....+..+.+++.+||+.||++|||++|++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l 282 (287)
T cd07848 234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCL 282 (287)
T ss_pred hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 1010011100 011112345689999999999999999999887
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=315.17 Aligned_cols=265 Identities=23% Similarity=0.292 Sum_probs=213.9
Q ss_pred HHhcCccccCccccCCCeeEEEEE-cCCCcEEEEEEccCCChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeec-----ce
Q 001768 656 AATNNFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIEG-----NQ 729 (1016)
Q Consensus 656 ~~~~~f~~~~~LG~G~~G~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-----~~ 729 (1016)
+..++|++.+.||+|||+.||+++ ..++..+|+|++.....++.+..++|++..++++|||+++++++...+ ..
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 456789999999999999999998 567899999999888878888999999999999999999999987643 35
Q ss_pred eEEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccc
Q 001768 730 LLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLA 809 (1016)
Q Consensus 730 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla 809 (1016)
.|++++|...|+|.+.+.........+++.++.+|+.+|++||++||+.. ++++||||||.|||+.+++.++|.|||.+
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCc
Confidence 89999999999999999877666667999999999999999999999984 36999999999999999999999999998
Q ss_pred cccCCCCcce--------eeecccCccccChhhhc---cCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHH
Q 001768 810 KLDEDENTHI--------STRIAGTVGYMAPEYAM---RGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWA 878 (1016)
Q Consensus 810 ~~~~~~~~~~--------~~~~~gt~~y~aPE~~~---~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~ 878 (1016)
...+-..... ......|..|+|||.+. +...++++|||||||+||+|+.|..||+.....
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~--------- 247 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ--------- 247 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc---------
Confidence 7433211100 11235788999999886 456899999999999999999999999632111
Q ss_pred HHHHHhCCc-ccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 001768 879 YVLQEQGNL-LELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGK 935 (1016)
Q Consensus 879 ~~~~~~~~~-~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 935 (1016)
.+.+ .....+.+.-.-....++.+.++++.|++.||.+||++.+++..++..
T Consensus 248 -----GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 248 -----GGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred -----CCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 1111 112222221111122566899999999999999999999999887653
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=340.16 Aligned_cols=255 Identities=26% Similarity=0.383 Sum_probs=206.3
Q ss_pred hcCccccCccccCCCeeEEEEEcC----CCcEEEEEEccCCC-hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEE
Q 001768 658 TNNFDAANKIGEGGFGPVYKGTLS----DGAVIAVKQLSSKS-KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLL 732 (1016)
Q Consensus 658 ~~~f~~~~~LG~G~~G~Vy~~~~~----~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 732 (1016)
.++|++.+.||+|+||.||+|.+. .+..||+|.++... ....+.+.+|+.++++++||||+++++++..++..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 456889999999999999999753 35789999987653 3334678899999999999999999999999999999
Q ss_pred EEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeecccccccc
Q 001768 733 VYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLD 812 (1016)
Q Consensus 733 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~ 812 (1016)
||||+++|+|.+++.... ..+++.+++.++.|++.||+|||+. +++||||||+||+++.++.++++|||.+...
T Consensus 84 v~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 84 VTEYMSNGALDSFLRKHE---GQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred EEEeCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 999999999999996543 2589999999999999999999998 9999999999999999999999999987654
Q ss_pred CCCCcceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHh-CCCCCCCCCchhhHhHHHHHHHHHHhCCccccc
Q 001768 813 EDENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELV 891 (1016)
Q Consensus 813 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 891 (1016)
............++..|+|||.+.+..++.++|||||||++||+++ |+.||......+....+ ....
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~-------~~~~----- 225 (266)
T cd05064 158 KSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAV-------EDGF----- 225 (266)
T ss_pred cccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH-------HCCC-----
Confidence 3222111222345678999999998999999999999999999775 99999765544322111 1110
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 001768 892 DPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEG 934 (1016)
Q Consensus 892 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 934 (1016)
.. ..+...+..+.+++.+||+.+|.+||++.++.+.|+.
T Consensus 226 ~~----~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~ 264 (266)
T cd05064 226 RL----PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK 264 (266)
T ss_pred CC----CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence 11 1122345578999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=346.49 Aligned_cols=250 Identities=22% Similarity=0.292 Sum_probs=206.0
Q ss_pred cCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCC---hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEE
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS---KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVY 734 (1016)
Q Consensus 659 ~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 734 (1016)
++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47889999999999999999965 68999999986432 233456889999999999999999999999999999999
Q ss_pred eecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCC
Q 001768 735 EYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDED 814 (1016)
Q Consensus 735 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 814 (1016)
||+++++|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 81 EYVPGGELFSYLRNSG----RFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred eCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 9999999999996543 589999999999999999999998 999999999999999999999999999986543
Q ss_pred CCcceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCc
Q 001768 815 ENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPS 894 (1016)
Q Consensus 815 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 894 (1016)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+ .... .
T Consensus 154 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i-------~~~~------~- 215 (291)
T cd05612 154 R----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKI-------LAGK------L- 215 (291)
T ss_pred C----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-------HhCC------c-
Confidence 2 12356899999999999888999999999999999999999999765543322111 0010 1
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHhccCcCCcCccccC
Q 001768 895 LGSNFSKKEAMTMLNIALLCTNPSPTLRPT-----MSSAVSMLEGKTAVQAPIIRR 945 (1016)
Q Consensus 895 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~L~~~~~~~~p~~~~ 945 (1016)
.++......+.+++.+||+.||.+||+ +++++ .|||+..
T Consensus 216 ---~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l---------~h~~~~~ 259 (291)
T cd05612 216 ---EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVK---------NHRWFKS 259 (291)
T ss_pred ---CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHh---------cCccccC
Confidence 112223446889999999999999995 66655 5787653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=341.44 Aligned_cols=265 Identities=27% Similarity=0.437 Sum_probs=217.6
Q ss_pred HhcCccccCccccCCCeeEEEEEcCCCcEEEEEEccCCChhh-hHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEe
Q 001768 657 ATNNFDAANKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQG-NREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYE 735 (1016)
Q Consensus 657 ~~~~f~~~~~LG~G~~G~Vy~~~~~~~~~vAvK~~~~~~~~~-~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 735 (1016)
......+.++||+|-||+|.+++...+..||||.++...... ..+|.+|+++|.+++|||||+++|+|..++.+++|+|
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E 615 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE 615 (807)
T ss_pred chhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence 344566789999999999999999888999999999876544 5899999999999999999999999999999999999
Q ss_pred ecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccC-C
Q 001768 736 YLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDE-D 814 (1016)
Q Consensus 736 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~-~ 814 (1016)
||++|+|.+++...+.. .+..+...+|+.||+.|++||.+- ++||||+.+.|+|+|.++++||+|||+++-.- .
T Consensus 616 YmEnGDLnqFl~aheap--t~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg 690 (807)
T KOG1094|consen 616 YMENGDLNQFLSAHELP--TAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG 690 (807)
T ss_pred HHhcCcHHHHHHhccCc--ccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccC
Confidence 99999999999877533 256667788999999999999998 99999999999999999999999999998443 3
Q ss_pred CCcceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHh--CCCCCCCCCchhhHhHHHHHHHHHHhCCcccccC
Q 001768 815 ENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS--GKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVD 892 (1016)
Q Consensus 815 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt--G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 892 (1016)
+..+...+.+-+.+|||||.+.-++++.++|||+||+++||+++ ...||.....++..... ..+..--.
T Consensus 691 ~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~---------~~~~~~~~ 761 (807)
T KOG1094|consen 691 DYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENA---------GEFFRDQG 761 (807)
T ss_pred CceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhh---------hhhcCCCC
Confidence 33344555667789999999999999999999999999999865 77888766555443211 11111111
Q ss_pred CcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 001768 893 PSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGK 935 (1016)
Q Consensus 893 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 935 (1016)
+......+..++..+.+++.+||..|-++||+++++...|++.
T Consensus 762 ~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 762 RQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred cceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 1111233455677899999999999999999999999887653
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=358.53 Aligned_cols=259 Identities=29% Similarity=0.452 Sum_probs=205.1
Q ss_pred hcCccccCccccCCCeeEEEEEc------CCCcEEEEEEccCCC-hhhhHHHHHHHHHHHhc-CCCCeeeeeeeEeecce
Q 001768 658 TNNFDAANKIGEGGFGPVYKGTL------SDGAVIAVKQLSSKS-KQGNREFVNEIGMISAL-QHQNLVKLYGCCIEGNQ 729 (1016)
Q Consensus 658 ~~~f~~~~~LG~G~~G~Vy~~~~------~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~ 729 (1016)
.++|++.+.||+|+||.||+|++ .++..||||+++... ....+.+.+|+++++.+ +||||+++++++.+++.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 45688899999999999999963 235689999987543 33456788999999999 89999999999999999
Q ss_pred eEEEEeecCCCcHHHHhccCcC----------------------------------------------------------
Q 001768 730 LLLVYEYLENNSLARALFGKEG---------------------------------------------------------- 751 (1016)
Q Consensus 730 ~~lV~E~~~~gsL~~~l~~~~~---------------------------------------------------------- 751 (1016)
.++||||+++|+|.+++.....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 9999999999999999865321
Q ss_pred -------------cCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCCcc
Q 001768 752 -------------QCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTH 818 (1016)
Q Consensus 752 -------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 818 (1016)
....+++..+.+++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 012578999999999999999999998 9999999999999999999999999999765433221
Q ss_pred -eeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHh-CCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCC
Q 001768 819 -ISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLG 896 (1016)
Q Consensus 819 -~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 896 (1016)
......++..|+|||.+.+..++.++|||||||++|||++ |..||.......... . ... .+. .+.
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~--~---~~~-~~~-----~~~-- 337 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFY--K---MIK-EGY-----RML-- 337 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHH--H---HHH-hCc-----cCC--
Confidence 1222345678999999999899999999999999999998 888887654332111 0 001 110 000
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 001768 897 SNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEG 934 (1016)
Q Consensus 897 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 934 (1016)
.+...+.++.+++.+||+.||++||++.||+++|+.
T Consensus 338 --~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 338 --SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred --CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 111123468999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=318.57 Aligned_cols=259 Identities=23% Similarity=0.318 Sum_probs=212.4
Q ss_pred HhcCccccCccccCCCeeEEEEEc-CCCcEEEEEEccCC--ChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEE
Q 001768 657 ATNNFDAANKIGEGGFGPVYKGTL-SDGAVIAVKQLSSK--SKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLV 733 (1016)
Q Consensus 657 ~~~~f~~~~~LG~G~~G~Vy~~~~-~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 733 (1016)
.++.|++.+.||+|.|+.||++.. .+|+.+|+|++.-. ...+.+.+.+|+.|.+.++|||||++.+.+.+.+..|+|
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 456788899999999999999874 46889999887533 344678899999999999999999999999999999999
Q ss_pred EeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEcc---CCceeeecccccc
Q 001768 734 YEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDK---DLNAKISDFGLAK 810 (1016)
Q Consensus 734 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~---~~~~kL~DFGla~ 810 (1016)
+|+|+|++|..-+-.+ ..+++..+-.+++||++||.|+|.+ +|||||+||+|+++-. ..-+||+|||+|.
T Consensus 89 Fe~m~G~dl~~eIV~R----~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi 161 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAR----EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAI 161 (355)
T ss_pred EecccchHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEE
Confidence 9999999998777554 3689999999999999999999999 9999999999999954 3459999999998
Q ss_pred ccCCCCcceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccc
Q 001768 811 LDEDENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLEL 890 (1016)
Q Consensus 811 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 890 (1016)
... ........+|||+|||||++...+++..+|||+.||+||-|+.|.+||.+.........+. .... .
T Consensus 162 ~l~--~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~-----~g~y----d 230 (355)
T KOG0033|consen 162 EVN--DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIK-----AGAY----D 230 (355)
T ss_pred EeC--CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHh-----cccc----C
Confidence 766 2334566789999999999999999999999999999999999999998755444322111 1111 1
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCcCCcCccccCC
Q 001768 891 VDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTAVQAPIIRRN 946 (1016)
Q Consensus 891 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~p~~~~~ 946 (1016)
+++.... ...+...+|+++||..||++|.|+.|.+ .|||+...
T Consensus 231 ~~~~~w~----~is~~Ak~LvrrML~~dP~kRIta~EAL---------~HpWi~~r 273 (355)
T KOG0033|consen 231 YPSPEWD----TVTPEAKSLIRRMLTVNPKKRITADEAL---------KHPWICNR 273 (355)
T ss_pred CCCcccC----cCCHHHHHHHHHHhccChhhhccHHHHh---------CCchhcch
Confidence 2222222 2345688999999999999999998665 78998653
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=347.58 Aligned_cols=270 Identities=21% Similarity=0.362 Sum_probs=209.6
Q ss_pred hcCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCC-hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEe
Q 001768 658 TNNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS-KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYE 735 (1016)
Q Consensus 658 ~~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 735 (1016)
.++|++.+.||+|+||.||+++.. ++..||+|.+.... ......+.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 468999999999999999999965 68899999987543 3345678999999999999999999999999999999999
Q ss_pred ecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCC
Q 001768 736 YLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDE 815 (1016)
Q Consensus 736 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 815 (1016)
|+++++|.+++.... .+++..+..++.|++.||.|||+.. +|+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 84 HMDGGSLDQVLKEAK----RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred cCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 999999999996543 5899999999999999999999852 6999999999999999999999999998755332
Q ss_pred CcceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCc--------
Q 001768 816 NTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNL-------- 887 (1016)
Q Consensus 816 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~-------- 887 (1016)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.................
T Consensus 158 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (331)
T cd06649 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPR 234 (331)
T ss_pred ---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccc
Confidence 123456899999999999888999999999999999999999999755443322111000000000000
Q ss_pred ----------------------cc-ccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCcCCcCcccc
Q 001768 888 ----------------------LE-LVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTAVQAPIIR 944 (1016)
Q Consensus 888 ----------------------~~-~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~p~~~ 944 (1016)
.+ ......+.........++.+++.+||+.||++|||+.|++ .|||+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell---------~h~~~~ 305 (331)
T cd06649 235 PPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLM---------NHTFIK 305 (331)
T ss_pred cccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHh---------cChHHh
Confidence 00 0000000000112345789999999999999999999987 467765
Q ss_pred C
Q 001768 945 R 945 (1016)
Q Consensus 945 ~ 945 (1016)
+
T Consensus 306 ~ 306 (331)
T cd06649 306 R 306 (331)
T ss_pred h
Confidence 4
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=351.05 Aligned_cols=250 Identities=20% Similarity=0.304 Sum_probs=205.3
Q ss_pred cCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCC---hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEE
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS---KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVY 734 (1016)
Q Consensus 659 ~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 734 (1016)
++|++.+.||+|+||.||+|+.. +++.||+|.+.... ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 57899999999999999999975 68999999986532 233456889999999999999999999999999999999
Q ss_pred eecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCC
Q 001768 735 EYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDED 814 (1016)
Q Consensus 735 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 814 (1016)
||+++++|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 98 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 98 EFVVGGELFTHLRKAG----RFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred cCCCCChHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 9999999999996543 588999999999999999999998 999999999999999999999999999986543
Q ss_pred CCcceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCc
Q 001768 815 ENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPS 894 (1016)
Q Consensus 815 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 894 (1016)
.. ....||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+ .... ..
T Consensus 171 ~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i-------~~~~------~~ 233 (329)
T PTZ00263 171 RT----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKI-------LAGR------LK 233 (329)
T ss_pred Cc----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHH-------hcCC------cC
Confidence 22 2357899999999999888999999999999999999999999765443221110 0111 01
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHhccCcCCcCccccC
Q 001768 895 LGSNFSKKEAMTMLNIALLCTNPSPTLRPT-----MSSAVSMLEGKTAVQAPIIRR 945 (1016)
Q Consensus 895 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~L~~~~~~~~p~~~~ 945 (1016)
+ +......+.+++.+||+.||.+||+ +++++ .|||+..
T Consensus 234 ~----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll---------~hp~f~~ 276 (329)
T PTZ00263 234 F----PNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVK---------NHPYFHG 276 (329)
T ss_pred C----CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHh---------cCCccCC
Confidence 1 1123346889999999999999997 45554 4677654
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=322.63 Aligned_cols=259 Identities=24% Similarity=0.343 Sum_probs=206.1
Q ss_pred cCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCChhh--hHHHHHHHHHHHhcCCCCeeeeeeeEeec--ceeEEE
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSKQG--NREFVNEIGMISALQHQNLVKLYGCCIEG--NQLLLV 733 (1016)
Q Consensus 659 ~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~~~~--~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~lV 733 (1016)
++|+.+++|++|.||.||+|+++ +++.||+|+++...... .-...+|+.+|.+.+|||||.+..+.... +.+|+|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 45788999999999999999965 68999999998654332 23467899999999999999999988754 679999
Q ss_pred EeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccC
Q 001768 734 YEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDE 813 (1016)
Q Consensus 734 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~ 813 (1016)
||||+. +|..++.... .++...++..++.|+++|++|||.+ .|+||||||+|+|+...|.+||+|||+|+.++
T Consensus 156 Me~~Eh-DLksl~d~m~---q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMK---QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred HHHHHh-hHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhc
Confidence 999987 8888887654 4689999999999999999999998 89999999999999999999999999999887
Q ss_pred CCCcceeeecccCccccChhhhccC-CCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccC
Q 001768 814 DENTHISTRIAGTVGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVD 892 (1016)
Q Consensus 814 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 892 (1016)
..... .+..+-|..|+|||.+.+. .|+.+.|+||+|||+.||+++++-|.+....+....+ ....+...+.+.
T Consensus 229 sp~k~-~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~I-----f~llGtPte~iw 302 (419)
T KOG0663|consen 229 SPLKP-YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKI-----FKLLGTPSEAIW 302 (419)
T ss_pred CCccc-CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHH-----HHHhCCCccccC
Confidence 76443 3456679999999998865 6999999999999999999999999877655443322 111111112222
Q ss_pred Cc-------------------CCCCCCHH-HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 893 PS-------------------LGSNFSKK-EAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 893 ~~-------------------l~~~~~~~-~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
|. ++..|... ..+.-.+|+...+..||.+|.|++|.++
T Consensus 303 pg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 303 PGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred CCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 21 11122211 2356678999999999999999987763
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=334.72 Aligned_cols=252 Identities=27% Similarity=0.479 Sum_probs=204.9
Q ss_pred cCccccCccccCCCeeEEEEEcCCCcEEEEEEccCCChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEeecC
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYLE 738 (1016)
Q Consensus 659 ~~f~~~~~LG~G~~G~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 738 (1016)
++|++.+.||+|+||.||+|++.++..+|+|.+.... .....+.+|++++++++||||+++++++..++..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 4588899999999999999999888899999886432 334678899999999999999999999999999999999999
Q ss_pred CCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCCcc
Q 001768 739 NNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTH 818 (1016)
Q Consensus 739 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 818 (1016)
+|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||++++++.+||+|||.++........
T Consensus 83 ~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05114 83 NGCLLNYLRQRQ---GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT 156 (256)
T ss_pred CCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCcee
Confidence 999999986543 2589999999999999999999998 8999999999999999999999999998754332222
Q ss_pred eeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHh-CCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCCC
Q 001768 819 ISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGS 897 (1016)
Q Consensus 819 ~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 897 (1016)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+....+ . ... ....
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i------~-~~~--~~~~----- 222 (256)
T cd05114 157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMI------S-RGF--RLYR----- 222 (256)
T ss_pred ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH------H-CCC--CCCC-----
Confidence 2222345678999999988889999999999999999999 89998765443322111 0 010 0011
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 001768 898 NFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933 (1016)
Q Consensus 898 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 933 (1016)
+......+.+++.+||+.+|++||+++++++.|.
T Consensus 223 --~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 223 --PKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred --CCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1112346899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=351.22 Aligned_cols=243 Identities=23% Similarity=0.370 Sum_probs=207.6
Q ss_pred HhcCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCC---hhhhHHHHHHHHHHHhc-CCCCeeeeeeeEeecceeE
Q 001768 657 ATNNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS---KQGNREFVNEIGMISAL-QHQNLVKLYGCCIEGNQLL 731 (1016)
Q Consensus 657 ~~~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~ 731 (1016)
.-++|...+.||+|+||+|+++..+ +++.+|||.+++.. ..+.+..+.|.+|+... +||.++.++.+|+..+++|
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 4467999999999999999999965 57899999998763 45567788899988887 5999999999999999999
Q ss_pred EEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccc
Q 001768 732 LVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKL 811 (1016)
Q Consensus 732 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~ 811 (1016)
.||||+.||++..+.+. ..+++..+.-++..|+.||+|||++ +||+||||.+|||+|.+|.+||+|||+++.
T Consensus 446 fvmey~~Ggdm~~~~~~-----~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe 517 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHHIHT-----DVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKE 517 (694)
T ss_pred EEEEecCCCcEEEEEec-----ccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccc
Confidence 99999999994443322 2599999999999999999999999 999999999999999999999999999985
Q ss_pred cCCCCcceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCccccc
Q 001768 812 DEDENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELV 891 (1016)
Q Consensus 812 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 891 (1016)
.-.. ...+.+++|||.|||||++.+..|+.++|.|||||+||||+.|..||.+...++....+. ..
T Consensus 518 ~m~~-g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~-------------~d 583 (694)
T KOG0694|consen 518 GMGQ-GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIV-------------ND 583 (694)
T ss_pred cCCC-CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh-------------cC
Confidence 4322 224667999999999999999999999999999999999999999999887776543321 01
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCH
Q 001768 892 DPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTM 925 (1016)
Q Consensus 892 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 925 (1016)
| ..||...+.+.+.++++++..+|++|.-+
T Consensus 584 ~----~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 584 E----VRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred C----CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 1 23455566788999999999999999987
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=346.65 Aligned_cols=241 Identities=24% Similarity=0.311 Sum_probs=196.4
Q ss_pred CccccCCCeeEEEEEcC-CCcEEEEEEccCCC---hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEeecCCC
Q 001768 665 NKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS---KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYLENN 740 (1016)
Q Consensus 665 ~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 740 (1016)
+.||+|+||.||+++.. +|+.||+|++.... ......+.+|+++++.++||||+++++++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46899999999999864 68999999987542 233456778999999999999999999999999999999999999
Q ss_pred cHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCCccee
Q 001768 741 SLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHIS 820 (1016)
Q Consensus 741 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 820 (1016)
+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 ~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~ 152 (323)
T cd05595 81 ELFFHLSRER----VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TM 152 (323)
T ss_pred cHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC-cc
Confidence 9998886543 589999999999999999999998 999999999999999999999999999874322211 12
Q ss_pred eecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCCCCCC
Q 001768 821 TRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGSNFS 900 (1016)
Q Consensus 821 ~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 900 (1016)
....||+.|+|||++.+..++.++|||||||++|||++|+.||............. . . ...+ +
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~-----~--~------~~~~----p 215 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL-----M--E------EIRF----P 215 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHh-----c--C------CCCC----C
Confidence 33568999999999998899999999999999999999999997654433221110 0 0 1111 2
Q ss_pred HHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 001768 901 KKEAMTMLNIALLCTNPSPTLRP-----TMSSAVS 930 (1016)
Q Consensus 901 ~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 930 (1016)
......+.+++.+||+.||++|| ++.++++
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 216 RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 22345688999999999999998 7777663
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=335.60 Aligned_cols=255 Identities=29% Similarity=0.458 Sum_probs=209.1
Q ss_pred hcCccccCccccCCCeeEEEEEcCCCcEEEEEEccCCChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEeec
Q 001768 658 TNNFDAANKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYL 737 (1016)
Q Consensus 658 ~~~f~~~~~LG~G~~G~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 737 (1016)
.++|++.++||+|+||.||+|...++..||+|.+.... ...+.+.+|+.++++++|+||+++++++.+++..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 46789999999999999999998888899999986543 23567899999999999999999999999999999999999
Q ss_pred CCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCCc
Q 001768 738 ENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENT 817 (1016)
Q Consensus 738 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 817 (1016)
++++|.+++.... ...+++.+++.++.|+++||+|||+. +++||||||+||+++.++.++|+|||++........
T Consensus 84 ~~~~L~~~l~~~~--~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05072 84 AKGSLLDFLKSDE--GGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY 158 (261)
T ss_pred CCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence 9999999996543 23588999999999999999999998 999999999999999999999999999986544322
Q ss_pred ceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHh-CCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCC
Q 001768 818 HISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLG 896 (1016)
Q Consensus 818 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 896 (1016)
.......++..|+|||++..+.++.++|||||||++|+|+| |+.||............ . .. ......
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~------~-~~-----~~~~~~ 226 (261)
T cd05072 159 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSAL------Q-RG-----YRMPRM 226 (261)
T ss_pred eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHH------H-cC-----CCCCCC
Confidence 22223346678999999988889999999999999999998 99998765443322111 0 00 001111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 001768 897 SNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEG 934 (1016)
Q Consensus 897 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 934 (1016)
. ..+..+.+++.+|++.+|++||+++++.++|+.
T Consensus 227 ~----~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 227 E----NCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred C----CCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1 233468899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=356.80 Aligned_cols=260 Identities=31% Similarity=0.464 Sum_probs=204.8
Q ss_pred hcCccccCccccCCCeeEEEEEcC------CCcEEEEEEccCCC-hhhhHHHHHHHHHHHhc-CCCCeeeeeeeEeecce
Q 001768 658 TNNFDAANKIGEGGFGPVYKGTLS------DGAVIAVKQLSSKS-KQGNREFVNEIGMISAL-QHQNLVKLYGCCIEGNQ 729 (1016)
Q Consensus 658 ~~~f~~~~~LG~G~~G~Vy~~~~~------~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~ 729 (1016)
.++|++.+.||+|+||.||+|++. ++..||+|++.... ......+.+|+++++.+ +||||+++++++..++.
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 457889999999999999998742 34589999997543 33456688999999999 89999999999999999
Q ss_pred eEEEEeecCCCcHHHHhccCcC----------------------------------------------------------
Q 001768 730 LLLVYEYLENNSLARALFGKEG---------------------------------------------------------- 751 (1016)
Q Consensus 730 ~~lV~E~~~~gsL~~~l~~~~~---------------------------------------------------------- 751 (1016)
.++||||+++|+|.+++.....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 9999999999999999854321
Q ss_pred --------cCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCCcc-eeee
Q 001768 752 --------QCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTH-ISTR 822 (1016)
Q Consensus 752 --------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~ 822 (1016)
...++++.++++++.||++||+|||++ +|+||||||+|||+++++.+||+|||+++........ ....
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 112478899999999999999999998 9999999999999999999999999999754333221 1222
Q ss_pred cccCccccChhhhccCCCCCccchhHHHHHHHHHHh-CCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCCCCCCH
Q 001768 823 IAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGSNFSK 901 (1016)
Q Consensus 823 ~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 901 (1016)
..++..|+|||++.+..++.++|||||||++|||++ |+.||.......... ... ... ..+.. +.
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~-----~~~-~~~-----~~~~~----~~ 338 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFY-----KMV-KRG-----YQMSR----PD 338 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHH-----HHH-Hcc-----cCccC----CC
Confidence 345678999999988899999999999999999997 999987543322111 000 000 01111 11
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 001768 902 KEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGK 935 (1016)
Q Consensus 902 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 935 (1016)
..+..+.+++.+||+.||++|||+.+|+++|+..
T Consensus 339 ~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 339 FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1235689999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=348.50 Aligned_cols=240 Identities=24% Similarity=0.313 Sum_probs=197.0
Q ss_pred CccccCCCeeEEEEEcC-CCcEEEEEEccCCC---hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEeecCCC
Q 001768 665 NKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS---KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYLENN 740 (1016)
Q Consensus 665 ~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 740 (1016)
+.||+|+||.||+|+.. +|+.||+|++.... ......+.+|++++++++||||+++++++..++..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999864 68999999987532 233456788999999999999999999999999999999999999
Q ss_pred cHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCCccee
Q 001768 741 SLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHIS 820 (1016)
Q Consensus 741 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 820 (1016)
+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 ~L~~~l~~~~----~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~ 152 (323)
T cd05571 81 ELFFHLSRER----VFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA-TM 152 (323)
T ss_pred cHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC-cc
Confidence 9999986543 689999999999999999999998 999999999999999999999999999875322211 22
Q ss_pred eecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCCCCCC
Q 001768 821 TRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGSNFS 900 (1016)
Q Consensus 821 ~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 900 (1016)
....||+.|+|||++.+..++.++|||||||++|||++|+.||.....+.....+ ... +.. ++
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~-------~~~------~~~----~p 215 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI-------LME------EIR----FP 215 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHH-------HcC------CCC----CC
Confidence 3457999999999999889999999999999999999999999765443322111 000 111 22
Q ss_pred HHHHHHHHHHHHHccCCCCCCCC-----CHHHHH
Q 001768 901 KKEAMTMLNIALLCTNPSPTLRP-----TMSSAV 929 (1016)
Q Consensus 901 ~~~~~~l~~li~~cl~~dP~~RP-----t~~evl 929 (1016)
......+.+++.+||+.||++|| ++.+++
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll 249 (323)
T cd05571 216 RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIM 249 (323)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHH
Confidence 23345688999999999999999 687776
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=350.11 Aligned_cols=252 Identities=21% Similarity=0.289 Sum_probs=205.7
Q ss_pred cCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCC---hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEE
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS---KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVY 734 (1016)
Q Consensus 659 ~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 734 (1016)
++|++.+.||+|+||.||+|+.. +++.||+|++.... ......+.+|++++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 46899999999999999999976 58899999987542 233456889999999999999999999999999999999
Q ss_pred eecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCC
Q 001768 735 EYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDED 814 (1016)
Q Consensus 735 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 814 (1016)
||+++++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLG----VLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred eCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 9999999999996543 589999999999999999999998 999999999999999999999999999975433
Q ss_pred CCcceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCc
Q 001768 815 ENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPS 894 (1016)
Q Consensus 815 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 894 (1016)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+.. ........
T Consensus 154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~---------~~~~~~~~ 220 (333)
T cd05600 154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKY---------WKETLQRP 220 (333)
T ss_pred ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHh---------ccccccCC
Confidence 22345789999999999988999999999999999999999999987655443221110 00001100
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 895 LGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 895 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
............+.+++.+||..+|.+||++.++++
T Consensus 221 ~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~ 256 (333)
T cd05600 221 VYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKN 256 (333)
T ss_pred CCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHh
Confidence 000001123457889999999999999999999885
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=335.72 Aligned_cols=257 Identities=29% Similarity=0.476 Sum_probs=213.9
Q ss_pred HHhcCccccCccccCCCeeEEEEEcCCCcEEEEEEccCCChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEe
Q 001768 656 AATNNFDAANKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYE 735 (1016)
Q Consensus 656 ~~~~~f~~~~~LG~G~~G~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 735 (1016)
+...+|++.+.||.|+||.||+|...+++.+|+|.+..........+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 34567899999999999999999988899999999987766566788999999999999999999999999999999999
Q ss_pred ecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCC
Q 001768 736 YLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDE 815 (1016)
Q Consensus 736 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 815 (1016)
|+++++|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||.+......
T Consensus 83 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~ 157 (261)
T cd05148 83 LMEKGSLLAFLRSPEG--QVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKED 157 (261)
T ss_pred ecccCCHHHHHhcCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCc
Confidence 9999999999976442 3689999999999999999999998 8999999999999999999999999999765433
Q ss_pred CcceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHh-CCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCc
Q 001768 816 NTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPS 894 (1016)
Q Consensus 816 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 894 (1016)
... .....++..|+|||.+.+..++.++||||||+++|+|++ |+.||......+..... .. .
T Consensus 158 ~~~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~------~~--~-------- 220 (261)
T cd05148 158 VYL-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQI------TA--G-------- 220 (261)
T ss_pred ccc-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHH------Hh--C--------
Confidence 221 223345678999999988889999999999999999998 89999765543322111 00 0
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 001768 895 LGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEG 934 (1016)
Q Consensus 895 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 934 (1016)
.....+...+..+.+++.+||+.||.+|||++++++.|+.
T Consensus 221 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 221 YRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 0111122334578899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=345.84 Aligned_cols=251 Identities=25% Similarity=0.410 Sum_probs=215.5
Q ss_pred cCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCC--hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecce-eEEEE
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS--KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQ-LLLVY 734 (1016)
Q Consensus 659 ~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~-~~lV~ 734 (1016)
++|..++.+|+|+||.++.++.+ ++..|++|.+.... ....+...+|+.++++++|||||.+.+.|.+++. .++||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 57889999999999999999865 67899999986543 3344578899999999999999999999999988 99999
Q ss_pred eecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCC
Q 001768 735 EYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDED 814 (1016)
Q Consensus 735 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 814 (1016)
+||+||++.+.+.... ...++++.+..++.|++.|+.|||++ +|+|||||+.||+++.++.|||+|||+|+....
T Consensus 84 ~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred eecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 9999999999997765 35799999999999999999999988 999999999999999999999999999998776
Q ss_pred CCcceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCc
Q 001768 815 ENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPS 894 (1016)
Q Consensus 815 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 894 (1016)
... ......||+.||.||.+.+.+|..|+|||||||++|||++-+++|...........+. +.
T Consensus 159 ~~~-~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~----------------~~ 221 (426)
T KOG0589|consen 159 EDS-LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKIN----------------RG 221 (426)
T ss_pred chh-hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHh----------------hc
Confidence 542 3455789999999999999999999999999999999999999998766554432211 11
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001768 895 LGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSM 931 (1016)
Q Consensus 895 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 931 (1016)
.....+.....++..++..|++.+|..||++.+++.+
T Consensus 222 ~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 222 LYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred cCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 1122344456679999999999999999999999876
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=372.80 Aligned_cols=261 Identities=32% Similarity=0.480 Sum_probs=215.7
Q ss_pred hcCccccCccccCCCeeEEEEEcCC--Cc----EEEEEEccCC-ChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeeccee
Q 001768 658 TNNFDAANKIGEGGFGPVYKGTLSD--GA----VIAVKQLSSK-SKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQL 730 (1016)
Q Consensus 658 ~~~f~~~~~LG~G~~G~Vy~~~~~~--~~----~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 730 (1016)
..+-+..+.||+|+||.||+|...+ +. .||||.+... +.+...+|.+|..+|+.++|||||+++|+|.+....
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 3445667899999999999998543 43 4899999765 455678999999999999999999999999999999
Q ss_pred EEEEeecCCCcHHHHhccCcC---cCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccc
Q 001768 731 LLVYEYLENNSLARALFGKEG---QCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFG 807 (1016)
Q Consensus 731 ~lV~E~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG 807 (1016)
++++|||++|+|..+|+..+. +...++..+.+.++.|||+|+.||+++ ++|||||.++|+|+++...+||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccc
Confidence 999999999999999976532 234689999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCcce-eeecccCccccChhhhccCCCCCccchhHHHHHHHHHHh-CCCCCCCCCchhhHhHHHHHHHHHHhC
Q 001768 808 LAKLDEDENTHI-STRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWAYVLQEQG 885 (1016)
Q Consensus 808 la~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~ 885 (1016)
+|+.+.....+. .....-...|||||.+..+.++.|+|||||||++||++| |..||......+....+ .+.+
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~------~~gg 921 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDV------LEGG 921 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHH------HhCC
Confidence 999443332222 222234578999999999999999999999999999999 99999887766654322 1111
Q ss_pred CcccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCcC
Q 001768 886 NLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTA 937 (1016)
Q Consensus 886 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 937 (1016)
+-..+..++..+.++|..||+.+|++||++..+++.+.....
T Consensus 922 ----------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~ 963 (1025)
T KOG1095|consen 922 ----------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISN 963 (1025)
T ss_pred ----------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhh
Confidence 122345577789999999999999999999999997776543
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=311.30 Aligned_cols=254 Identities=24% Similarity=0.382 Sum_probs=212.8
Q ss_pred HhcCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCC---hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEE
Q 001768 657 ATNNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS---KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLL 732 (1016)
Q Consensus 657 ~~~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 732 (1016)
+-++|++.+.||+|-||.||.|+.+ ++-.||+|++.+.. .+...++.+|+++-+.++||||+++|++|.+....||
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 3467899999999999999999954 67899999986542 3345688999999999999999999999999999999
Q ss_pred EEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeecccccccc
Q 001768 733 VYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLD 812 (1016)
Q Consensus 733 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~ 812 (1016)
++||.+.|++...|..... ..+++.....++.|+|.||.|+|.. +||||||||+|+|++.++.+|++|||-+-..
T Consensus 100 ilEya~~gel~k~L~~~~~--~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~ 174 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGRM--KRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA 174 (281)
T ss_pred EEEecCCchHHHHHHhccc--ccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeec
Confidence 9999999999999975443 4689999999999999999999998 9999999999999999999999999998754
Q ss_pred CCCCcceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccC
Q 001768 813 EDENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVD 892 (1016)
Q Consensus 813 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 892 (1016)
+. ......+||..|.|||...+...+..+|+|++|++.||++.|.+||......+....+. .++
T Consensus 175 p~---~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~-------------k~~ 238 (281)
T KOG0580|consen 175 PS---NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIR-------------KVD 238 (281)
T ss_pred CC---CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHH-------------Hcc
Confidence 42 23455789999999999999999999999999999999999999998655333221111 111
Q ss_pred CcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCcCCcCcccc
Q 001768 893 PSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTAVQAPIIR 944 (1016)
Q Consensus 893 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~p~~~ 944 (1016)
- .++........++|.+|+..+|.+|.+..|++ .|||+.
T Consensus 239 ~----~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~---------~hpwI~ 277 (281)
T KOG0580|consen 239 L----KFPSTISGGAADLISRLLVKNPIERLALTEVM---------DHPWIV 277 (281)
T ss_pred c----cCCcccChhHHHHHHHHhccCccccccHHHHh---------hhHHHH
Confidence 1 12233445688999999999999999999887 467764
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=339.80 Aligned_cols=263 Identities=21% Similarity=0.324 Sum_probs=201.0
Q ss_pred cCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCC-hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEee
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS-KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEY 736 (1016)
Q Consensus 659 ~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 736 (1016)
++|++.++||+|+||.||+|+.. +++.||+|.+.... ......+.+|++++++++||||+++++++.+++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 56899999999999999999865 68899999986543 22345678999999999999999999999999999999999
Q ss_pred cCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCC
Q 001768 737 LENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDEN 816 (1016)
Q Consensus 737 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 816 (1016)
+++ +|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++......
T Consensus 85 ~~~-~l~~~l~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~ 157 (288)
T cd07871 85 LDS-DLKQYLDNCG---NLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPT 157 (288)
T ss_pred CCc-CHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence 985 8988885443 2478999999999999999999998 99999999999999999999999999997543322
Q ss_pred cceeeecccCccccChhhhcc-CCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHH---------HHHhCC
Q 001768 817 THISTRIAGTVGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYV---------LQEQGN 886 (1016)
Q Consensus 817 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~---------~~~~~~ 886 (1016)
. ......+++.|+|||.+.+ ..++.++||||+||++|||++|++||......+....+..... ......
T Consensus 158 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07871 158 K-TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEE 236 (288)
T ss_pred c-cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchh
Confidence 1 1223467899999998865 4689999999999999999999999976654443222111000 000001
Q ss_pred cccccCCcCCCC----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 001768 887 LLELVDPSLGSN----FSKKEAMTMLNIALLCTNPSPTLRPTMSSAV 929 (1016)
Q Consensus 887 ~~~~~d~~l~~~----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 929 (1016)
+.....+..... .......++.+++.+|++.||.+|||++|++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l 283 (288)
T cd07871 237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAAL 283 (288)
T ss_pred hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHh
Confidence 111111111000 0011234678999999999999999999887
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=348.35 Aligned_cols=251 Identities=24% Similarity=0.305 Sum_probs=204.8
Q ss_pred hcCccccCccccCCCeeEEEEEcCC--CcEEEEEEccCC---ChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEE
Q 001768 658 TNNFDAANKIGEGGFGPVYKGTLSD--GAVIAVKQLSSK---SKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLL 732 (1016)
Q Consensus 658 ~~~f~~~~~LG~G~~G~Vy~~~~~~--~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 732 (1016)
.++|++.+.||+|+||.||+|++.. +..||+|++... .......+.+|+++++.++||||+++++++.+++..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 4578999999999999999998543 368999998643 22334568899999999999999999999999999999
Q ss_pred EEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeecccccccc
Q 001768 733 VYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLD 812 (1016)
Q Consensus 733 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~ 812 (1016)
||||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 109 v~Ey~~~g~L~~~i~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRNK----RFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred EEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 999999999999996543 589999999999999999999998 9999999999999999999999999999865
Q ss_pred CCCCcceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccC
Q 001768 813 EDENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVD 892 (1016)
Q Consensus 813 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 892 (1016)
... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+ . ...
T Consensus 182 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i-----~--~~~------ 244 (340)
T PTZ00426 182 DTR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKI-----L--EGI------ 244 (340)
T ss_pred CCC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHH-----h--cCC------
Confidence 432 23457999999999999888999999999999999999999999865443221111 0 110
Q ss_pred CcCCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHhccCcCCcCccccC
Q 001768 893 PSLGSNFSKKEAMTMLNIALLCTNPSPTLRP-----TMSSAVSMLEGKTAVQAPIIRR 945 (1016)
Q Consensus 893 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~L~~~~~~~~p~~~~ 945 (1016)
.. ++......+.+++.+|++.||++|+ ++++++ .|||+..
T Consensus 245 ~~----~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~---------~hp~f~~ 289 (340)
T PTZ00426 245 IY----FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVK---------EHPWFGN 289 (340)
T ss_pred CC----CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHH---------cCCCcCC
Confidence 01 1122334678999999999999995 777766 5677654
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=332.86 Aligned_cols=256 Identities=27% Similarity=0.450 Sum_probs=208.7
Q ss_pred HhcCccccCccccCCCeeEEEEEcCCCcEEEEEEccCCChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEee
Q 001768 657 ATNNFDAANKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEY 736 (1016)
Q Consensus 657 ~~~~f~~~~~LG~G~~G~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 736 (1016)
..++|++.+.||+|++|.||+|...+++.||+|.++... ...+++.+|++++++++||||+++++++..++..++||||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 346789999999999999999998778899999987543 2356788999999999999999999999999999999999
Q ss_pred cCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCC
Q 001768 737 LENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDEN 816 (1016)
Q Consensus 737 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 816 (1016)
+++++|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||+++......
T Consensus 83 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 83 MKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred ccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 99999999996543 23689999999999999999999998 89999999999999999999999999998655332
Q ss_pred cceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHh-CCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcC
Q 001768 817 THISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSL 895 (1016)
Q Consensus 817 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 895 (1016)
.........+..|+|||++.+..++.++||||||+++|||++ |+.||...........+ .. .. .
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~-------~~-~~----~--- 222 (261)
T cd05068 158 YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQV-------DQ-GY----R--- 222 (261)
T ss_pred ccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH-------Hc-CC----C---
Confidence 221122223457999999988889999999999999999999 99998765433221111 00 00 0
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 001768 896 GSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEG 934 (1016)
Q Consensus 896 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 934 (1016)
...+...+..+.+++.+|++.+|++||++.++++.|++
T Consensus 223 -~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 223 -MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred -CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 01112234578999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=352.00 Aligned_cols=259 Identities=31% Similarity=0.464 Sum_probs=211.1
Q ss_pred cCccccCccccCCCeeEEEEEcCC--C---cEEEEEEccCC---ChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeeccee
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLSD--G---AVIAVKQLSSK---SKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQL 730 (1016)
Q Consensus 659 ~~f~~~~~LG~G~~G~Vy~~~~~~--~---~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 730 (1016)
++-...++||+|+||.||+|++.. + ..||||..+.. ......+|.+|+++|+.++|||||+++|++.....+
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl 236 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL 236 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence 344456899999999999998653 2 23899998863 356678899999999999999999999999999999
Q ss_pred EEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeecccccc
Q 001768 731 LLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAK 810 (1016)
Q Consensus 731 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~ 810 (1016)
++|||+|.||+|.++|....+ .++..++..++.++|.||+|||++ ++|||||-++|+|++.++.+||+|||+++
T Consensus 237 ~ivmEl~~gGsL~~~L~k~~~---~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~ 310 (474)
T KOG0194|consen 237 MLVMELCNGGSLDDYLKKNKK---SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSR 310 (474)
T ss_pred EEEEEecCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCcccccc
Confidence 999999999999999977653 599999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCCcceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHh-CCCCCCCCCchhhHhHHHHHHHHHHhCCccc
Q 001768 811 LDEDENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWAYVLQEQGNLLE 889 (1016)
Q Consensus 811 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 889 (1016)
....... ......-+..|+|||.+..+.++.++|||||||++||+++ |..||.+....+....+.
T Consensus 311 ~~~~~~~-~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~------------- 376 (474)
T KOG0194|consen 311 AGSQYVM-KKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIV------------- 376 (474)
T ss_pred CCcceee-ccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHH-------------
Confidence 5431111 1111234678999999999999999999999999999999 888988765543322110
Q ss_pred ccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCcCCc
Q 001768 890 LVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTAVQ 939 (1016)
Q Consensus 890 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 939 (1016)
....+...+...+..+..++.+||..+|++||+|.++.+.|+......
T Consensus 377 --~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~ 424 (474)
T KOG0194|consen 377 --KNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKK 424 (474)
T ss_pred --hcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcc
Confidence 111222333455667889999999999999999999999998764443
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=327.62 Aligned_cols=248 Identities=23% Similarity=0.415 Sum_probs=211.7
Q ss_pred HhcCccccCccccCCCeeEEEEEc-CCCcEEEEEEccCC---ChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEE
Q 001768 657 ATNNFDAANKIGEGGFGPVYKGTL-SDGAVIAVKQLSSK---SKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLL 732 (1016)
Q Consensus 657 ~~~~f~~~~~LG~G~~G~Vy~~~~-~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 732 (1016)
...+|++.+.||+|.||.|-+|.. ..|+.||||.+++. +.++.-.+.+|++||+.++||||+.++.+|+..+.+.+
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 346789999999999999999985 67999999999765 34455567899999999999999999999999999999
Q ss_pred EEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeecccccccc
Q 001768 733 VYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLD 812 (1016)
Q Consensus 733 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~ 812 (1016)
||||..+|.|.+|+.... .|++.++..+++||..|+.|+|.+ +++|||||.+|||+|+++++||+|||++.++
T Consensus 131 vMEYaS~GeLYDYiSer~----~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly 203 (668)
T KOG0611|consen 131 VMEYASGGELYDYISERG----SLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLY 203 (668)
T ss_pred EEEecCCccHHHHHHHhc----cccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhh
Confidence 999999999999997654 699999999999999999999999 9999999999999999999999999999877
Q ss_pred CCCCcceeeecccCccccChhhhccCCC-CCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCccccc
Q 001768 813 EDENTHISTRIAGTVGYMAPEYAMRGYL-TDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELV 891 (1016)
Q Consensus 813 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 891 (1016)
.... ..+.++|++-|.+||+..+.+| .+.+|-|||||+||-|+.|..||++......+..+ ..+.+.+
T Consensus 204 ~~~k--fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQI-------s~GaYrE-- 272 (668)
T KOG0611|consen 204 ADKK--FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQI-------SRGAYRE-- 272 (668)
T ss_pred cccc--HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHh-------hcccccC--
Confidence 6654 3356899999999999998866 57899999999999999999999987654432211 2222222
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001768 892 DPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSM 931 (1016)
Q Consensus 892 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 931 (1016)
|. .+....-||++||..+|++|.|+.+|...
T Consensus 273 -P~--------~PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 273 -PE--------TPSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred -CC--------CCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 21 12246679999999999999999999874
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=333.18 Aligned_cols=256 Identities=23% Similarity=0.393 Sum_probs=207.9
Q ss_pred hcCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEee
Q 001768 658 TNNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEY 736 (1016)
Q Consensus 658 ~~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 736 (1016)
..+|++.+.||+|+||.||+|.+. .++.||+|.+... .....++.+|++++++++||||+++++++..++..++||||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 83 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence 346888999999999999999965 5889999998754 33456788999999999999999999999999999999999
Q ss_pred cCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCC
Q 001768 737 LENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDEN 816 (1016)
Q Consensus 737 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 816 (1016)
+++++|.+++..... ..+++..++.++.|+++||+|||+. +++||||||+||++++++.+||+|||++.......
T Consensus 84 ~~~~~L~~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~ 158 (263)
T cd05052 84 MTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 158 (263)
T ss_pred CCCCcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence 999999999965432 3589999999999999999999998 99999999999999999999999999998654432
Q ss_pred cceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHh-CCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcC
Q 001768 817 THISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSL 895 (1016)
Q Consensus 817 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 895 (1016)
........++..|+|||.+.+..++.++|||||||++|||++ |..||.....++..... .. ..
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~-------~~---------~~ 222 (263)
T cd05052 159 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-------EK---------GY 222 (263)
T ss_pred eeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-------HC---------CC
Confidence 222222334668999999988889999999999999999998 99998765443321111 00 01
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 001768 896 GSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGK 935 (1016)
Q Consensus 896 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 935 (1016)
....+...+..+.+++.+||+.+|++||++.+++++|+..
T Consensus 223 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 223 RMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 1112223345789999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=344.92 Aligned_cols=241 Identities=23% Similarity=0.305 Sum_probs=196.3
Q ss_pred CccccCCCeeEEEEEcC-CCcEEEEEEccCCC---hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEeecCCC
Q 001768 665 NKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS---KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYLENN 740 (1016)
Q Consensus 665 ~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 740 (1016)
+.||+|+||.||+++.. +++.||+|++.... ......+.+|+++++.++||||+++++++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999854 68999999987532 233456778999999999999999999999999999999999999
Q ss_pred cHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCCcce
Q 001768 741 SLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHE-ESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHI 819 (1016)
Q Consensus 741 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~-~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 819 (1016)
+|.+++.... .+++..+..++.||+.||+|||+ . +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~ 152 (325)
T cd05594 81 ELFFHLSRER----VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-T 152 (325)
T ss_pred cHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-c
Confidence 9999886543 58999999999999999999997 5 899999999999999999999999999874332221 1
Q ss_pred eeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCCCCC
Q 001768 820 STRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGSNF 899 (1016)
Q Consensus 820 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 899 (1016)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.....+.....+. .. ...+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~-------~~------~~~~---- 215 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL-------ME------EIRF---- 215 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHh-------cC------CCCC----
Confidence 233569999999999998899999999999999999999999997655443222110 00 1111
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 001768 900 SKKEAMTMLNIALLCTNPSPTLRP-----TMSSAVS 930 (1016)
Q Consensus 900 ~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 930 (1016)
+......+.+++.+||+.||++|+ ++.++++
T Consensus 216 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 216 PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 122334688999999999999997 8888773
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=358.88 Aligned_cols=266 Identities=22% Similarity=0.295 Sum_probs=216.8
Q ss_pred HHHhcCccccCccccCCCeeEEEEEcCCC-cEEEEEEccCCChhhhHHHHHHHHHHHhcC-CCCeeeeeee-Eee-----
Q 001768 655 KAATNNFDAANKIGEGGFGPVYKGTLSDG-AVIAVKQLSSKSKQGNREFVNEIGMISALQ-HQNLVKLYGC-CIE----- 726 (1016)
Q Consensus 655 ~~~~~~f~~~~~LG~G~~G~Vy~~~~~~~-~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~-~~~----- 726 (1016)
.....+.++.+.|.+|||+.||.|+...+ ..||+|++...++.+.+...+|+++|+.|+ |+|||.+++. ...
T Consensus 33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~ 112 (738)
T KOG1989|consen 33 TVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN 112 (738)
T ss_pred EECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence 34456778899999999999999998765 999999998888888899999999999996 9999999993 221
Q ss_pred -cceeEEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeec
Q 001768 727 -GNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISD 805 (1016)
Q Consensus 727 -~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~D 805 (1016)
.-+++|.||||+||.|-+++..+... .|++.++++|+.|+++|+++||.. +++|||||||-+|||++.++..||||
T Consensus 113 ~~~EvllLmEyC~gg~Lvd~mn~Rlq~--~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCD 189 (738)
T KOG1989|consen 113 GVWEVLLLMEYCKGGSLVDFMNTRLQT--RLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCD 189 (738)
T ss_pred ceeEEEeehhhccCCcHHHHHHHHHhc--cCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCc
Confidence 24689999999999999999776543 499999999999999999999997 56899999999999999999999999
Q ss_pred cccccccCCCC-cce-------eeecccCccccChhhhc---cCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhH
Q 001768 806 FGLAKLDEDEN-THI-------STRIAGTVGYMAPEYAM---RGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYL 874 (1016)
Q Consensus 806 FGla~~~~~~~-~~~-------~~~~~gt~~y~aPE~~~---~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~ 874 (1016)
||.|.-..... ... .-....|+.|+|||.+. +..+++|+|||||||+||-|+....||+....
T Consensus 190 FGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~------ 263 (738)
T KOG1989|consen 190 FGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK------ 263 (738)
T ss_pred ccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc------
Confidence 99996322211 100 11134689999999764 66899999999999999999999999975422
Q ss_pred HHHHHHHHHhCCcccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCcCCcCcc
Q 001768 875 LDWAYVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTAVQAPI 942 (1016)
Q Consensus 875 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~p~ 942 (1016)
..+++....-...+.....+.+||..||+.||.+||++-+|+..+-.+...+-|.
T Consensus 264 -------------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~ 318 (738)
T KOG1989|consen 264 -------------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPI 318 (738)
T ss_pred -------------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCc
Confidence 2233333322223457778999999999999999999999999887766555443
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=360.35 Aligned_cols=252 Identities=22% Similarity=0.304 Sum_probs=207.1
Q ss_pred CccccCccccCCCeeEEEEEcC-C-CcEEEEEEccCCChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEeec
Q 001768 660 NFDAANKIGEGGFGPVYKGTLS-D-GAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYL 737 (1016)
Q Consensus 660 ~f~~~~~LG~G~~G~Vy~~~~~-~-~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 737 (1016)
.|.+.+.||+|+||.||+|... + ++.||+|.+..........+.+|+++++.++|||||++++++..++..++||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 4889999999999999999854 3 6788999876655555667888999999999999999999999999999999999
Q ss_pred CCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCCc
Q 001768 738 ENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENT 817 (1016)
Q Consensus 738 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 817 (1016)
++|+|.+++........++++.++..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 99999998865433345689999999999999999999998 999999999999999999999999999986543322
Q ss_pred -ceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCC
Q 001768 818 -HISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLG 896 (1016)
Q Consensus 818 -~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 896 (1016)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||......+...... .+.. .
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~-------~~~~----~---- 289 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVL-------YGKY----D---- 289 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-------hCCC----C----
Confidence 22344679999999999998899999999999999999999999997654433221110 0110 0
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 897 SNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 897 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
.++......+.+++.+||+.||++||++.+++.
T Consensus 290 -~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 290 -PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred -CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 111223456899999999999999999999875
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=335.46 Aligned_cols=257 Identities=29% Similarity=0.477 Sum_probs=208.4
Q ss_pred cCccccCccccCCCeeEEEEEcCC------CcEEEEEEccCCC-hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeE
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLSD------GAVIAVKQLSSKS-KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLL 731 (1016)
Q Consensus 659 ~~f~~~~~LG~G~~G~Vy~~~~~~------~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 731 (1016)
++|++.+.||+|+||.||+|.... ...||+|.+.... ......+.+|++++++++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 468889999999999999998542 2579999987543 334567899999999999999999999999999999
Q ss_pred EEEeecCCCcHHHHhccCcC------------cCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCC
Q 001768 732 LVYEYLENNSLARALFGKEG------------QCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDL 799 (1016)
Q Consensus 732 lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~ 799 (1016)
++|||+++++|.+++..... ....+++.+++.++.|++.||+|||+. +++||||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCC
Confidence 99999999999999965421 113588999999999999999999998 899999999999999999
Q ss_pred ceeeeccccccccCCCCc-ceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHh-CCCCCCCCCchhhHhHHHH
Q 001768 800 NAKISDFGLAKLDEDENT-HISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDW 877 (1016)
Q Consensus 800 ~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~ 877 (1016)
.++|+|||+++....... .......+++.|+|||++.++.++.++|||||||++|||++ |..||......+....+
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i-- 239 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMI-- 239 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH--
Confidence 999999999975433221 22233456788999999988889999999999999999998 99999765544332211
Q ss_pred HHHHHHhCCcccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 001768 878 AYVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEG 934 (1016)
Q Consensus 878 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 934 (1016)
.... ....+...+..+.+++.+||+.||++||+++||++.|++
T Consensus 240 -----~~~~---------~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 240 -----RSRQ---------LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred -----HcCC---------cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 0111 111223345679999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=338.35 Aligned_cols=263 Identities=24% Similarity=0.363 Sum_probs=196.3
Q ss_pred cCccccCccccCCCeeEEEEEcC--CCcEEEEEEccCCCh--hhhHHHHHHHHHHHhc---CCCCeeeeeeeEee-----
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLS--DGAVIAVKQLSSKSK--QGNREFVNEIGMISAL---QHQNLVKLYGCCIE----- 726 (1016)
Q Consensus 659 ~~f~~~~~LG~G~~G~Vy~~~~~--~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l---~HpnIv~l~~~~~~----- 726 (1016)
++|++.+.||+|+||.||+|+.. +++.||+|.+..... .....+.+|+++++.+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 46889999999999999999863 468899998865322 2234566777777665 69999999998852
Q ss_pred cceeEEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeecc
Q 001768 727 GNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDF 806 (1016)
Q Consensus 727 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DF 806 (1016)
....++||||++ ++|.+++..... ..+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Df 154 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF 154 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccc
Confidence 456899999997 589998865432 3589999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCCCcceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCC
Q 001768 807 GLAKLDEDENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGN 886 (1016)
Q Consensus 807 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 886 (1016)
|+++..... .......||+.|+|||.+.+..++.++|||||||++|||++|++||......+....+...........
T Consensus 155 g~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~ 232 (290)
T cd07862 155 GLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 232 (290)
T ss_pred cceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhh
Confidence 999765433 223345689999999999888899999999999999999999999987654433221110000000000
Q ss_pred cc-------cccCCcCCC---CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 001768 887 LL-------ELVDPSLGS---NFSKKEAMTMLNIALLCTNPSPTLRPTMSSAV 929 (1016)
Q Consensus 887 ~~-------~~~d~~l~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 929 (1016)
+. ....+.... ......+..+.+++.+|++.||++|||+.|++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l 285 (290)
T cd07862 233 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 285 (290)
T ss_pred chhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHh
Confidence 00 000000000 01112345678999999999999999999988
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=342.23 Aligned_cols=241 Identities=25% Similarity=0.378 Sum_probs=194.9
Q ss_pred cCccccCCCeeEEEEEc----CCCcEEEEEEccCCC----hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEe
Q 001768 664 ANKIGEGGFGPVYKGTL----SDGAVIAVKQLSSKS----KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYE 735 (1016)
Q Consensus 664 ~~~LG~G~~G~Vy~~~~----~~~~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 735 (1016)
++.||+|+||.||+++. ..++.||+|++.... ......+.+|+++++.++||||+++++++..++..++|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 36899999999999985 357899999986532 2234567889999999999999999999999999999999
Q ss_pred ecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCC
Q 001768 736 YLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDE 815 (1016)
Q Consensus 736 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 815 (1016)
|+++++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 153 (323)
T cd05584 81 YLSGGELFMHLEREG----IFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE 153 (323)
T ss_pred CCCCchHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccC
Confidence 999999999986543 578899999999999999999998 9999999999999999999999999998743322
Q ss_pred CcceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcC
Q 001768 816 NTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSL 895 (1016)
Q Consensus 816 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 895 (1016)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+ .... ..+
T Consensus 154 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~-------~~~~------~~~ 219 (323)
T cd05584 154 GT-VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKI-------LKGK------LNL 219 (323)
T ss_pred CC-cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHH-------HcCC------CCC
Confidence 21 223457999999999998888899999999999999999999999765443221110 0010 111
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHH
Q 001768 896 GSNFSKKEAMTMLNIALLCTNPSPTLRP-----TMSSAV 929 (1016)
Q Consensus 896 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl 929 (1016)
+......+.+++.+||+.||++|| ++.+++
T Consensus 220 ----~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~ 254 (323)
T cd05584 220 ----PPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQ 254 (323)
T ss_pred ----CCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHh
Confidence 122334688999999999999999 676665
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=342.84 Aligned_cols=257 Identities=24% Similarity=0.323 Sum_probs=202.5
Q ss_pred CccccCccccCCCeeEEEEEc----CCCcEEEEEEccCCC----hhhhHHHHHHHHHHHhc-CCCCeeeeeeeEeeccee
Q 001768 660 NFDAANKIGEGGFGPVYKGTL----SDGAVIAVKQLSSKS----KQGNREFVNEIGMISAL-QHQNLVKLYGCCIEGNQL 730 (1016)
Q Consensus 660 ~f~~~~~LG~G~~G~Vy~~~~----~~~~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~ 730 (1016)
+|++.+.||+|+||.||+++. .+++.||+|++.... ....+.+..|+++++.+ +||||+++++++..++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 588899999999999999875 357899999986432 22345678899999999 599999999999999999
Q ss_pred EEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeecccccc
Q 001768 731 LLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAK 810 (1016)
Q Consensus 731 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~ 810 (1016)
++||||+++|+|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~ 153 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRD----NFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSK 153 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence 99999999999999986543 589999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCcceeeecccCccccChhhhccC-CCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCccc
Q 001768 811 LDEDENTHISTRIAGTVGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLE 889 (1016)
Q Consensus 811 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 889 (1016)
..............||+.|+|||++.+. .++.++|||||||++|||++|+.||............. ....
T Consensus 154 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~--~~~~------- 224 (332)
T cd05614 154 EFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVS--RRIL------- 224 (332)
T ss_pred cccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHH--HHHh-------
Confidence 6543333333446799999999998765 47889999999999999999999997433221111110 0000
Q ss_pred ccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHhccCcCCcCccccC
Q 001768 890 LVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRP-----TMSSAVSMLEGKTAVQAPIIRR 945 (1016)
Q Consensus 890 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~L~~~~~~~~p~~~~ 945 (1016)
..++.+.. .....+.+++.+||+.||++|| ++++++ .|||+..
T Consensus 225 ~~~~~~~~----~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l---------~h~~~~~ 272 (332)
T cd05614 225 KCDPPFPS----FIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIK---------EHPFFKG 272 (332)
T ss_pred cCCCCCCC----CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHH---------cCCCcCC
Confidence 11222222 2344688999999999999999 555555 4666654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=330.90 Aligned_cols=252 Identities=28% Similarity=0.448 Sum_probs=205.0
Q ss_pred cCccccCccccCCCeeEEEEEcCCCcEEEEEEccCCChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEeecC
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYLE 738 (1016)
Q Consensus 659 ~~f~~~~~LG~G~~G~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 738 (1016)
++|++.+.||+|+||.||+|++.++..||+|.+.... .....+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 4578899999999999999998777789999987543 234678999999999999999999999998889999999999
Q ss_pred CCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCCcc
Q 001768 739 NNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTH 818 (1016)
Q Consensus 739 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 818 (1016)
+++|.+++..... .+++..++.++.||+.||+|||+. +++|+||||+||+++.++.+||+|||.++........
T Consensus 83 ~~~l~~~i~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05113 83 NGCLLNYLREHGK---RFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT 156 (256)
T ss_pred CCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCcee
Confidence 9999999965432 589999999999999999999998 9999999999999999999999999998755433222
Q ss_pred eeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHh-CCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCCC
Q 001768 819 ISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGS 897 (1016)
Q Consensus 819 ~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 897 (1016)
......++..|+|||...+..++.++|||||||++|||++ |+.||......+....+ ..... +..
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~-------~~~~~-----~~~-- 222 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKV-------SQGLR-----LYR-- 222 (256)
T ss_pred ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH-------hcCCC-----CCC--
Confidence 2222345678999999988889999999999999999999 99998765543321111 01100 001
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 001768 898 NFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933 (1016)
Q Consensus 898 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 933 (1016)
+......+.+++.+||+.+|.+||++.++++.|+
T Consensus 223 --~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 223 --PHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred --CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 1112457899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=334.74 Aligned_cols=257 Identities=30% Similarity=0.506 Sum_probs=208.6
Q ss_pred hcCccccCccccCCCeeEEEEEcCC------CcEEEEEEccCCChh-hhHHHHHHHHHHHhcCCCCeeeeeeeEeeccee
Q 001768 658 TNNFDAANKIGEGGFGPVYKGTLSD------GAVIAVKQLSSKSKQ-GNREFVNEIGMISALQHQNLVKLYGCCIEGNQL 730 (1016)
Q Consensus 658 ~~~f~~~~~LG~G~~G~Vy~~~~~~------~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 730 (1016)
.++|.+.+.||+|+||.||+|+..+ ++.||+|.+...... ..+.+.+|+++++.++||||+++++++..+...
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 3568889999999999999998633 478999998765444 457899999999999999999999999999999
Q ss_pred EEEEeecCCCcHHHHhccCcC----------cCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCc
Q 001768 731 LLVYEYLENNSLARALFGKEG----------QCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLN 800 (1016)
Q Consensus 731 ~lV~E~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~ 800 (1016)
++||||+++++|.+++..... ....+++.++..++.|++.|++|||+. +++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCe
Confidence 999999999999999975421 224588999999999999999999998 8999999999999999999
Q ss_pred eeeeccccccccCCCCc-ceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHh-CCCCCCCCCchhhHhHHHHH
Q 001768 801 AKISDFGLAKLDEDENT-HISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWA 878 (1016)
Q Consensus 801 ~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~ 878 (1016)
+||+|||+++....... .......+++.|+|||++.++.++.++|||||||++|||++ |+.||.....++....+
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~--- 237 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECI--- 237 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH---
Confidence 99999999975432211 11223446788999999999999999999999999999998 99998765544322111
Q ss_pred HHHHHhCCcccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 001768 879 YVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933 (1016)
Q Consensus 879 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 933 (1016)
..+... ..+...+..+.+++.+||+.||++||++.||++.|+
T Consensus 238 ----~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 238 ----TQGRLL---------QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred ----HcCCcC---------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 111111 111223457899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=348.45 Aligned_cols=257 Identities=22% Similarity=0.319 Sum_probs=203.3
Q ss_pred cCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCC---hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEE
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS---KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVY 734 (1016)
Q Consensus 659 ~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 734 (1016)
++|++.+.||+|+||.||+|+.. +++.||||++.... ......+.+|+++++.++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47899999999999999999965 68999999986532 233456788999999999999999999999999999999
Q ss_pred eecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCC
Q 001768 735 EYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDED 814 (1016)
Q Consensus 735 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 814 (1016)
||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.++|+|||+++....
T Consensus 81 E~~~~g~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 81 EYLPGGDMMTLLMKKD----TFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred CCCCCcHHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 9999999999996543 589999999999999999999998 999999999999999999999999999864322
Q ss_pred CCcc-------------------------------------eeeecccCccccChhhhccCCCCCccchhHHHHHHHHHH
Q 001768 815 ENTH-------------------------------------ISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIV 857 (1016)
Q Consensus 815 ~~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ell 857 (1016)
.... ......||+.|+|||++.+..++.++|||||||++|||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence 1100 011246999999999999889999999999999999999
Q ss_pred hCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCC---HHHHHHHhcc
Q 001768 858 SGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPT---MSSAVSMLEG 934 (1016)
Q Consensus 858 tG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~evl~~L~~ 934 (1016)
+|+.||......+....+ .. ..... ..+.. ......+.+++.+|+. +|.+|++ +.|++
T Consensus 234 ~G~~Pf~~~~~~~~~~~i------~~---~~~~~--~~~~~--~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll----- 294 (364)
T cd05599 234 VGYPPFCSDNPQETYRKI------IN---WKETL--QFPDE--VPLSPEAKDLIKRLCC-EAERRLGNNGVNEIK----- 294 (364)
T ss_pred cCCCCCCCCCHHHHHHHH------Hc---CCCcc--CCCCC--CCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHh-----
Confidence 999999865543321111 00 00000 00000 0123467889999986 9999998 77665
Q ss_pred CcCCcCccccC
Q 001768 935 KTAVQAPIIRR 945 (1016)
Q Consensus 935 ~~~~~~p~~~~ 945 (1016)
.|||+..
T Consensus 295 ----~h~~~~~ 301 (364)
T cd05599 295 ----SHPFFKG 301 (364)
T ss_pred ----cCCCcCC
Confidence 4676654
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=327.12 Aligned_cols=264 Identities=30% Similarity=0.460 Sum_probs=198.1
Q ss_pred cCccccCccccCCCeeEEEEEcCCCcEEEEEEccCCChhhhHHHHHHHHHHHh--cCCCCeeeeeeeEeecc----eeEE
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGNREFVNEIGMISA--LQHQNLVKLYGCCIEGN----QLLL 732 (1016)
Q Consensus 659 ~~f~~~~~LG~G~~G~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~--l~HpnIv~l~~~~~~~~----~~~l 732 (1016)
...+..+.||+|.||.||+|.+. ++.||||++... ..+.|++|-+|.+. ++|+||++++++-.... +++|
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred CchhhHHHhhcCccceeehhhcc-CceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 34456788999999999999996 489999999654 34578888887775 58999999999887655 8999
Q ss_pred EEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhc------CCCCeEeCCCCCceEEEccCCceeeecc
Q 001768 733 VYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEE------SRLKIVHRDIKATNVLLDKDLNAKISDF 806 (1016)
Q Consensus 733 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~------~~~~iiHrDlkp~NILl~~~~~~kL~DF 806 (1016)
|+||.+.|+|.++|..+ .++|....+|+..+++||+|||+. .+++|+|||||.+||||..|+++.|+||
T Consensus 286 Vt~fh~kGsL~dyL~~n-----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF 360 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYLKAN-----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF 360 (534)
T ss_pred EeeeccCCcHHHHHHhc-----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence 99999999999999766 499999999999999999999986 3578999999999999999999999999
Q ss_pred ccccccCCCCcc-eeeecccCccccChhhhccCC-CC-----CccchhHHHHHHHHHHhCCCCCCCCCchhhH--h----
Q 001768 807 GLAKLDEDENTH-ISTRIAGTVGYMAPEYAMRGY-LT-----DKADVYSFGIVALEIVSGKSNTNYRPKEEFV--Y---- 873 (1016)
Q Consensus 807 Gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-~~-----~~sDVwSlGvvl~elltG~~P~~~~~~~~~~--~---- 873 (1016)
|+|..+...... .....+||.+|||||++.+.. +. .+.||||+|.|||||++...-++..+..+.+ +
T Consensus 361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ev 440 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEV 440 (534)
T ss_pred ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHh
Confidence 999876543222 122368999999999997652 22 3689999999999999866544311111110 0
Q ss_pred -----HHHHHHHHHHhCCcccccCCcCCCCCCH-HHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCc
Q 001768 874 -----LLDWAYVLQEQGNLLELVDPSLGSNFSK-KEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKT 936 (1016)
Q Consensus 874 -----~~~~~~~~~~~~~~~~~~d~~l~~~~~~-~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 936 (1016)
+-+..... +.+...|.++..+-. .....+.+.+..||+.||+.|.|+.=|.+.+.+..
T Consensus 441 G~hPt~e~mq~~V-----V~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~ 504 (534)
T KOG3653|consen 441 GNHPTLEEMQELV-----VRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELM 504 (534)
T ss_pred cCCCCHHHHHHHH-----HhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHh
Confidence 00111111 111222222222111 23457889999999999999999987777766543
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=327.03 Aligned_cols=261 Identities=27% Similarity=0.344 Sum_probs=202.4
Q ss_pred CccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeec--c---eeEEE
Q 001768 660 NFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIEG--N---QLLLV 733 (1016)
Q Consensus 660 ~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~---~~~lV 733 (1016)
.|+..+.+|.|+||.||+|... +++.||||+.-.+... -.+|+++|+.++|||||++.-+|... . ...+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 4667899999999999999965 5799999998654432 23689999999999999999988753 2 45789
Q ss_pred EeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccC-Cceeeecccccccc
Q 001768 734 YEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKD-LNAKISDFGLAKLD 812 (1016)
Q Consensus 734 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~-~~~kL~DFGla~~~ 812 (1016)
||||+. +|.+.++........++...++-++.||.+||+|||+. +|+||||||.|+|+|.+ |.+||||||.|+..
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999987 89999976444445788889999999999999999997 99999999999999976 89999999999977
Q ss_pred CCCCcceeeecccCccccChhhhccC-CCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHH-------HHHHh
Q 001768 813 EDENTHISTRIAGTVGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAY-------VLQEQ 884 (1016)
Q Consensus 813 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~-------~~~~~ 884 (1016)
...... .....|..|+|||.+.+. .|+.+.||||.|||+.||+-|++-|.+.+.-+....+-... .....
T Consensus 177 ~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn 254 (364)
T KOG0658|consen 177 VKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMN 254 (364)
T ss_pred ccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcC
Confidence 655443 335678899999998865 79999999999999999999999998866554433221110 00111
Q ss_pred CCcccccCCcCCC-----CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 885 GNLLELVDPSLGS-----NFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 885 ~~~~~~~d~~l~~-----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
....+...|.+.. -+....+.+..+++.++++.+|.+|.++.|++.
T Consensus 255 ~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 255 PNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred cccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 1111222222221 133445668999999999999999999988774
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=328.99 Aligned_cols=254 Identities=30% Similarity=0.496 Sum_probs=205.6
Q ss_pred hcCccccCccccCCCeeEEEEEcCCCcEEEEEEccCCChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEeec
Q 001768 658 TNNFDAANKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYL 737 (1016)
Q Consensus 658 ~~~f~~~~~LG~G~~G~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 737 (1016)
.++|++.++||+|+||.||+|...++..||+|.+..... ..+.+.+|+.++++++|||++++++++. ....++||||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM 82 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence 357889999999999999999988888999999875433 3457899999999999999999999885 45689999999
Q ss_pred CCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCCc
Q 001768 738 ENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENT 817 (1016)
Q Consensus 738 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 817 (1016)
++++|.+++..... ..+++.+++.++.|++.||+|||+. +|+||||||+||++++++.++|+|||.+........
T Consensus 83 ~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05070 83 SKGSLLDFLKDGEG--RALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence 99999999965432 3589999999999999999999998 899999999999999999999999999976544322
Q ss_pred ceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHh-CCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCC
Q 001768 818 HISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLG 896 (1016)
Q Consensus 818 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 896 (1016)
.......++..|+|||++.+..++.++||||||+++|||++ |+.||......+..... . . ...
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~------~-~---------~~~ 221 (260)
T cd05070 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQV------E-R---------GYR 221 (260)
T ss_pred ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH------H-c---------CCC
Confidence 22222345678999999988889999999999999999999 88898754433221110 0 0 011
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 001768 897 SNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEG 934 (1016)
Q Consensus 897 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 934 (1016)
...+...+..+.+++.+|++.+|++|||+.++.+.|+.
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 222 MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 11222344579999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=342.48 Aligned_cols=241 Identities=24% Similarity=0.320 Sum_probs=197.2
Q ss_pred CccccCCCeeEEEEEcC-CCcEEEEEEccCCC---hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEeecCCC
Q 001768 665 NKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS---KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYLENN 740 (1016)
Q Consensus 665 ~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 740 (1016)
+.||+|+||.||+++.. +++.||+|++.... ......+.+|+++++.++||||+++++++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999864 68999999987542 334467788999999999999999999999999999999999999
Q ss_pred cHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCCccee
Q 001768 741 SLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHIS 820 (1016)
Q Consensus 741 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 820 (1016)
+|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 ~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~ 152 (328)
T cd05593 81 ELFFHLSRER----VFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA-TM 152 (328)
T ss_pred CHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCccc-cc
Confidence 9999886543 589999999999999999999998 999999999999999999999999999875322211 22
Q ss_pred eecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCCCCCC
Q 001768 821 TRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGSNFS 900 (1016)
Q Consensus 821 ~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 900 (1016)
....||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+ . ..+..+ +
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~-------~------~~~~~~----p 215 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI-------L------MEDIKF----P 215 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHh-------c------cCCccC----C
Confidence 3457999999999999888999999999999999999999999765443322111 0 001112 2
Q ss_pred HHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 001768 901 KKEAMTMLNIALLCTNPSPTLRP-----TMSSAVS 930 (1016)
Q Consensus 901 ~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 930 (1016)
......+.+++.+||+.||++|| ++.|+++
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 250 (328)
T cd05593 216 RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR 250 (328)
T ss_pred CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence 22345688999999999999997 7887774
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=335.07 Aligned_cols=260 Identities=28% Similarity=0.509 Sum_probs=209.8
Q ss_pred hcCccccCccccCCCeeEEEEEc------CCCcEEEEEEccCCChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeE
Q 001768 658 TNNFDAANKIGEGGFGPVYKGTL------SDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLL 731 (1016)
Q Consensus 658 ~~~f~~~~~LG~G~~G~Vy~~~~------~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 731 (1016)
.++|.+.+.||+|+||.||++.. .++..+|+|.+..........+.+|++++++++||||+++++++..++..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 46788999999999999999974 234678999988766666678999999999999999999999999999999
Q ss_pred EEEeecCCCcHHHHhccCc---------CcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCcee
Q 001768 732 LVYEYLENNSLARALFGKE---------GQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAK 802 (1016)
Q Consensus 732 lV~E~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~k 802 (1016)
+||||+++++|.+++.... .....+++.+++.++.|++.||+|||++ +++||||||+||++++++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEE
Confidence 9999999999999996432 1223589999999999999999999998 999999999999999999999
Q ss_pred eeccccccccCCCCcc-eeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHh-CCCCCCCCCchhhHhHHHHHHH
Q 001768 803 ISDFGLAKLDEDENTH-ISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWAYV 880 (1016)
Q Consensus 803 L~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~ 880 (1016)
|+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||......+....+
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i----- 235 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI----- 235 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-----
Confidence 9999999754332211 1223345778999999988889999999999999999998 89998755443321111
Q ss_pred HHHhCCcccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCc
Q 001768 881 LQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKT 936 (1016)
Q Consensus 881 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 936 (1016)
..+... ..... .+..+.+++.+||+.||.+|||+.++.+.|+...
T Consensus 236 --~~~~~~-----~~~~~----~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~ 280 (288)
T cd05093 236 --TQGRVL-----QRPRT----CPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA 280 (288)
T ss_pred --HcCCcC-----CCCCC----CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 111111 11112 2346899999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=348.68 Aligned_cols=261 Identities=21% Similarity=0.300 Sum_probs=204.6
Q ss_pred HHHhcCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCC---ChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeeccee
Q 001768 655 KAATNNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSK---SKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQL 730 (1016)
Q Consensus 655 ~~~~~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 730 (1016)
....++|++.+.||+|+||.||+|+.. +++.||+|.+... .......+.+|+.+++.++||||+++++++.+++..
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL 118 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence 344578999999999999999999965 5789999998642 223345678999999999999999999999999999
Q ss_pred EEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeecccccc
Q 001768 731 LLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAK 810 (1016)
Q Consensus 731 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~ 810 (1016)
++||||+++|+|.+++... .+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||++.
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~-----~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~ 190 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSNY-----DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCM 190 (370)
T ss_pred EEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccce
Confidence 9999999999999998543 478999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCcceeeecccCccccChhhhccC----CCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCC
Q 001768 811 LDEDENTHISTRIAGTVGYMAPEYAMRG----YLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGN 886 (1016)
Q Consensus 811 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 886 (1016)
..............||+.|+|||++.+. .++.++||||+||++|||++|+.||........... . .....
T Consensus 191 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~-----i-~~~~~ 264 (370)
T cd05621 191 KMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSK-----I-MDHKN 264 (370)
T ss_pred ecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHH-----H-HhCCc
Confidence 6544332223456799999999998753 378899999999999999999999976554322111 1 11000
Q ss_pred cccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHHhccCcCCcCccccC
Q 001768 887 LLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTL--RPTMSSAVSMLEGKTAVQAPIIRR 945 (1016)
Q Consensus 887 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~L~~~~~~~~p~~~~ 945 (1016)
.. ..+. .......+.+++..|+..+|.+ ||++.|++ .|||+..
T Consensus 265 ~~-----~~p~--~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l---------~hp~~~~ 309 (370)
T cd05621 265 SL-----NFPE--DVEISKHAKNLICAFLTDREVRLGRNGVEEIK---------QHPFFKN 309 (370)
T ss_pred cc-----CCCC--cccCCHHHHHHHHHHccCchhccCCCCHHHHh---------cCcccCC
Confidence 00 0111 1123446788899999855543 88998877 3677654
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=347.05 Aligned_cols=251 Identities=24% Similarity=0.321 Sum_probs=204.0
Q ss_pred cCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCC---hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEE
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS---KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVY 734 (1016)
Q Consensus 659 ~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 734 (1016)
++|++.+.||+|+||.||+|+.. +++.||+|++.... ......+.+|++++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47899999999999999999965 68999999987532 233457889999999999999999999999999999999
Q ss_pred eecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCC
Q 001768 735 EYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDED 814 (1016)
Q Consensus 735 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 814 (1016)
||+++++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 81 EYMPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNK 153 (350)
T ss_pred cCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence 999999999999755 2689999999999999999999998 999999999999999999999999999976544
Q ss_pred CC----------------------------cceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCC
Q 001768 815 EN----------------------------THISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYR 866 (1016)
Q Consensus 815 ~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~ 866 (1016)
.. ........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 32 11223457899999999999999999999999999999999999999865
Q ss_pred CchhhHhHHHHHHHHHHhCCcccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCC-HHHHHH
Q 001768 867 PKEEFVYLLDWAYVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPT-MSSAVS 930 (1016)
Q Consensus 867 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~evl~ 930 (1016)
...+....+ .. ..+... .+.. ...+..+.+++.+|+. ||.+||+ ++++++
T Consensus 234 ~~~~~~~~i-----~~----~~~~~~--~p~~--~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~ 284 (350)
T cd05573 234 TLQETYNKI-----IN----WKESLR--FPPD--PPVSPEAIDLICRLLC-DPEDRLGSFEEIKS 284 (350)
T ss_pred CHHHHHHHH-----hc----cCCccc--CCCC--CCCCHHHHHHHHHHcc-ChhhcCCCHHHHhc
Confidence 533321110 00 000000 0000 1134568899999997 9999999 998873
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=334.86 Aligned_cols=249 Identities=35% Similarity=0.553 Sum_probs=195.3
Q ss_pred ccCccccCCCeeEEEEEcC-----CCcEEEEEEccCCC-hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEee
Q 001768 663 AANKIGEGGFGPVYKGTLS-----DGAVIAVKQLSSKS-KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEY 736 (1016)
Q Consensus 663 ~~~~LG~G~~G~Vy~~~~~-----~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 736 (1016)
+.+.||.|.||.||+|.+. .+..|+||.++... ....+.+.+|++.+++++||||++++|++...+..++||||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4678999999999999976 25789999996543 34478899999999999999999999999988889999999
Q ss_pred cCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCC
Q 001768 737 LENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDEN 816 (1016)
Q Consensus 737 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 816 (1016)
+++|+|.+++.... ...+++.++..|+.||++||+|||++ +++|+||+++||++++++.+||+|||++.......
T Consensus 83 ~~~g~L~~~L~~~~--~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 83 CPGGSLDDYLKSKN--KEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp -TTEBHHHHHHHTC--TTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred cccccccccccccc--cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 99999999998762 23689999999999999999999998 89999999999999999999999999998653221
Q ss_pred c-ceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHh-CCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCc
Q 001768 817 T-HISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPS 894 (1016)
Q Consensus 817 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 894 (1016)
. .......+...|+|||.+....++.++||||||+++|||++ |+.||......+....+ .....
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~-------~~~~~------- 223 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKL-------KQGQR------- 223 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHH-------HTTEE-------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-------ccccc-------
Confidence 1 12223456778999999998889999999999999999999 77888765443322111 11111
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 001768 895 LGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSML 932 (1016)
Q Consensus 895 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 932 (1016)
...+...+..+.+++.+||+.||++||++.++++.|
T Consensus 224 --~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 224 --LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp --TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred --ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 111222345688999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=338.22 Aligned_cols=254 Identities=22% Similarity=0.377 Sum_probs=200.0
Q ss_pred CccccCCCeeEEEEEcC-CCcEEEEEEccCCC---hhhhHHHHHHHHHHHhc-CCCCeeeeeeeEeecceeEEEEeecCC
Q 001768 665 NKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS---KQGNREFVNEIGMISAL-QHQNLVKLYGCCIEGNQLLLVYEYLEN 739 (1016)
Q Consensus 665 ~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~ 739 (1016)
+.||+|+||.||+|+.. +++.||+|++.... ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46899999999999965 58899999986532 23345677888888876 699999999999999999999999999
Q ss_pred CcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCCcce
Q 001768 740 NSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHI 819 (1016)
Q Consensus 740 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 819 (1016)
|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~~~~----~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~ 152 (320)
T cd05590 81 GDLMFHIQKSR----RFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KT 152 (320)
T ss_pred chHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Cc
Confidence 99999886543 589999999999999999999998 99999999999999999999999999987532221 12
Q ss_pred eeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCCCCC
Q 001768 820 STRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGSNF 899 (1016)
Q Consensus 820 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 899 (1016)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+ .... .. +
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i-------~~~~------~~----~ 215 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAI-------LNDE------VV----Y 215 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHH-------hcCC------CC----C
Confidence 23457999999999999888999999999999999999999999865544322111 0110 11 1
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCcCCcCccccCC
Q 001768 900 SKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTAVQAPIIRRN 946 (1016)
Q Consensus 900 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~p~~~~~ 946 (1016)
+......+.+++.+|++.||++||++.++ ......+.|||+...
T Consensus 216 ~~~~~~~~~~li~~~L~~dP~~R~~~~~~---~~~~~~~~h~~f~~~ 259 (320)
T cd05590 216 PTWLSQDAVDILKAFMTKNPTMRLGSLTL---GGEEAILRHPFFKEL 259 (320)
T ss_pred CCCCCHHHHHHHHHHcccCHHHCCCCCCC---CCHHHHHcCCCcCCC
Confidence 12234468899999999999999998442 011123367887643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=338.44 Aligned_cols=240 Identities=21% Similarity=0.341 Sum_probs=194.1
Q ss_pred CccccCCCeeEEEEEcC-CCcEEEEEEccCCC---hhhhHHHHHHHHHHHhc-CCCCeeeeeeeEeecceeEEEEeecCC
Q 001768 665 NKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS---KQGNREFVNEIGMISAL-QHQNLVKLYGCCIEGNQLLLVYEYLEN 739 (1016)
Q Consensus 665 ~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~ 739 (1016)
+.||+|+||.||+|+.. +++.||+|++.... ....+.+..|.+++..+ +||||+++++++.+++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999865 57899999987532 23345677888888876 799999999999999999999999999
Q ss_pred CcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCCcce
Q 001768 740 NSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHI 819 (1016)
Q Consensus 740 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 819 (1016)
++|...+.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....... .
T Consensus 81 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~ 152 (321)
T cd05591 81 GDLMFQIQRSR----KFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-T 152 (321)
T ss_pred CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCc-c
Confidence 99999886543 589999999999999999999998 999999999999999999999999999875332221 2
Q ss_pred eeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCCCCC
Q 001768 820 STRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGSNF 899 (1016)
Q Consensus 820 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 899 (1016)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+ .... .. +
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i-------~~~~------~~----~ 215 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESI-------LHDD------VL----Y 215 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHH-------HcCC------CC----C
Confidence 23456899999999999889999999999999999999999999876544322111 0010 01 1
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCC-------CHHHHH
Q 001768 900 SKKEAMTMLNIALLCTNPSPTLRP-------TMSSAV 929 (1016)
Q Consensus 900 ~~~~~~~l~~li~~cl~~dP~~RP-------t~~evl 929 (1016)
+......+.+++.+||+.||++|| ++.+++
T Consensus 216 p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~ 252 (321)
T cd05591 216 PVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIK 252 (321)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHh
Confidence 112234688999999999999999 565555
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=327.99 Aligned_cols=254 Identities=30% Similarity=0.477 Sum_probs=205.6
Q ss_pred hcCccccCccccCCCeeEEEEEcCCCcEEEEEEccCCChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEeec
Q 001768 658 TNNFDAANKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYL 737 (1016)
Q Consensus 658 ~~~f~~~~~LG~G~~G~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 737 (1016)
.++|++.++||+|+||.||+|++.++..||+|++..... ..+.+.+|++++++++||||+++++++.+ +..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcC
Confidence 356899999999999999999987777899999875332 34578899999999999999999998754 5689999999
Q ss_pred CCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCCc
Q 001768 738 ENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENT 817 (1016)
Q Consensus 738 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 817 (1016)
++++|.+++.... ...+++..+..++.|+++||+|||+. +++||||||+||++++++.++|+|||.++.......
T Consensus 83 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~ 157 (262)
T cd05071 83 SKGSLLDFLKGEM--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 157 (262)
T ss_pred CCCcHHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence 9999999996542 23579999999999999999999998 899999999999999999999999999976544332
Q ss_pred ceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHh-CCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCC
Q 001768 818 HISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLG 896 (1016)
Q Consensus 818 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 896 (1016)
.......++..|+|||+..+..++.++|||||||++|||+| |+.||......+..... ... ..
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~-------~~~---------~~ 221 (262)
T cd05071 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV-------ERG---------YR 221 (262)
T ss_pred ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHH-------hcC---------CC
Confidence 22223446778999999988889999999999999999999 88888755433321110 000 00
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 001768 897 SNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEG 934 (1016)
Q Consensus 897 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 934 (1016)
...+...+..+.+++.+|++.+|++||+++++++.|+.
T Consensus 222 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~ 259 (262)
T cd05071 222 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 259 (262)
T ss_pred CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 11123345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=328.77 Aligned_cols=251 Identities=28% Similarity=0.449 Sum_probs=203.7
Q ss_pred cCccccCccccCCCeeEEEEEcCCCcEEEEEEccCCChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEeecC
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYLE 738 (1016)
Q Consensus 659 ~~f~~~~~LG~G~~G~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 738 (1016)
.+|++.+.||+|+||.||+|++.++..+|+|.+..... ....+.+|++++++++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 35788999999999999999988778899999864332 33568889999999999999999999999999999999999
Q ss_pred CCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCCcc
Q 001768 739 NNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTH 818 (1016)
Q Consensus 739 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 818 (1016)
+++|.+++..... .+++..++.++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++........
T Consensus 83 ~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~ 156 (256)
T cd05059 83 NGCLLNYLRERKG---KLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT 156 (256)
T ss_pred CCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceeccccccc
Confidence 9999999965432 589999999999999999999998 8999999999999999999999999999755432222
Q ss_pred eeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHh-CCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCCC
Q 001768 819 ISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGS 897 (1016)
Q Consensus 819 ~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 897 (1016)
......++..|+|||.+.+..++.++|||||||++|||++ |+.||......+..... . ......
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~-------~-----~~~~~~--- 221 (256)
T cd05059 157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESV-------S-----AGYRLY--- 221 (256)
T ss_pred ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH-------H-----cCCcCC---
Confidence 1122234567999999998889999999999999999999 89998765443321111 0 001111
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 001768 898 NFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSML 932 (1016)
Q Consensus 898 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 932 (1016)
.+...+..+.+++.+||+.+|++|||+.|++++|
T Consensus 222 -~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 222 -RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred -CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 1122345799999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=337.60 Aligned_cols=260 Identities=25% Similarity=0.355 Sum_probs=218.6
Q ss_pred HHHhcCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCChh---hhHHHHHHHHHHHhcC-CCCeeeeeeeEeecce
Q 001768 655 KAATNNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSKQ---GNREFVNEIGMISALQ-HQNLVKLYGCCIEGNQ 729 (1016)
Q Consensus 655 ~~~~~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~~~---~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~ 729 (1016)
......|++.+.||+|.||.||+++.+ +|+.+|+|.+.+.... ....+.+|+++|+++. |||||.+++.+++...
T Consensus 31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~ 110 (382)
T KOG0032|consen 31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDS 110 (382)
T ss_pred ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe
Confidence 345667899999999999999999976 4999999999766443 3468899999999998 9999999999999999
Q ss_pred eEEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccC----Cceeeec
Q 001768 730 LLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKD----LNAKISD 805 (1016)
Q Consensus 730 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~----~~~kL~D 805 (1016)
.++|||++.||.|.+.+... .+++..+..++.|++.|++|||+. ||+||||||+|+|+... +.+|++|
T Consensus 111 ~~lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~D 182 (382)
T KOG0032|consen 111 VYLVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLID 182 (382)
T ss_pred EEEEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEee
Confidence 99999999999999999765 299999999999999999999998 99999999999999643 5799999
Q ss_pred cccccccCCCCcceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhC
Q 001768 806 FGLAKLDEDENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQG 885 (1016)
Q Consensus 806 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 885 (1016)
||++..... .......+||+.|+|||++....++..+||||+||++|.|++|.+||...........+ ..+
T Consensus 183 FGla~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i-------~~~ 253 (382)
T KOG0032|consen 183 FGLAKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAI-------LRG 253 (382)
T ss_pred CCCceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHH-------HcC
Confidence 999997766 33456689999999999999899999999999999999999999999876655433211 111
Q ss_pred CcccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCcCCcCccccCC
Q 001768 886 NLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTAVQAPIIRRN 946 (1016)
Q Consensus 886 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~p~~~~~ 946 (1016)
++ ......-......+.+++..|+..||.+|+|+.++++ |||+...
T Consensus 254 ~~------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~---------HpWi~~~ 299 (382)
T KOG0032|consen 254 DF------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ---------HPWIKSI 299 (382)
T ss_pred CC------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc---------CccccCC
Confidence 11 1222222344567899999999999999999998885 7887754
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=345.17 Aligned_cols=250 Identities=22% Similarity=0.353 Sum_probs=197.1
Q ss_pred CccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCC---hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEe
Q 001768 660 NFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS---KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYE 735 (1016)
Q Consensus 660 ~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 735 (1016)
.|++++.||+|+||+||+|+.. +++.||+|++.... ......+.+|+++++.++||||+++++++.+++.+++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5888999999999999999854 68899999986542 2334678899999999999999999999999999999999
Q ss_pred ecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCC
Q 001768 736 YLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDE 815 (1016)
Q Consensus 736 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 815 (1016)
|+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~ 154 (381)
T cd05626 82 YIPGGDMMSLLIRME----VFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT 154 (381)
T ss_pred cCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence 999999999986543 589999999999999999999998 9999999999999999999999999997532110
Q ss_pred Cc----------------------------------------------ceeeecccCccccChhhhccCCCCCccchhHH
Q 001768 816 NT----------------------------------------------HISTRIAGTVGYMAPEYAMRGYLTDKADVYSF 849 (1016)
Q Consensus 816 ~~----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSl 849 (1016)
.. .......||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (381)
T cd05626 155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234 (381)
T ss_pred cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence 00 00123579999999999998889999999999
Q ss_pred HHHHHHHHhCCCCCCCCCchhhHh-HHHHHHHHHHhCCcccccCCcCCCCCCHHHHHHHHHHHHH--ccCCCCCCCCCHH
Q 001768 850 GIVALEIVSGKSNTNYRPKEEFVY-LLDWAYVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALL--CTNPSPTLRPTMS 926 (1016)
Q Consensus 850 Gvvl~elltG~~P~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~--cl~~dP~~RPt~~ 926 (1016)
||++|||++|+.||......+... ...| ... . ..+. .......+.+++.+ |+..+|..||++.
T Consensus 235 G~il~elltG~~Pf~~~~~~~~~~~i~~~------~~~-~-----~~~~--~~~~s~~~~dli~~ll~~~~~~~~R~~~~ 300 (381)
T cd05626 235 GVILFEMLVGQPPFLAPTPTETQLKVINW------ENT-L-----HIPP--QVKLSPEAVDLITKLCCSAEERLGRNGAD 300 (381)
T ss_pred hhHHHHHHhCCCCCcCCCHHHHHHHHHcc------ccc-c-----CCCC--CCCCCHHHHHHHHHHccCcccccCCCCHH
Confidence 999999999999997655433211 1100 000 0 0100 01123456777777 5566777799999
Q ss_pred HHHH
Q 001768 927 SAVS 930 (1016)
Q Consensus 927 evl~ 930 (1016)
++++
T Consensus 301 ~~l~ 304 (381)
T cd05626 301 DIKA 304 (381)
T ss_pred HHhc
Confidence 8883
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=342.27 Aligned_cols=263 Identities=23% Similarity=0.359 Sum_probs=196.6
Q ss_pred CccccCccccCCCeeEEEEEcC-CCcEEEEEEccCC--ChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeec-----ceeE
Q 001768 660 NFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSK--SKQGNREFVNEIGMISALQHQNLVKLYGCCIEG-----NQLL 731 (1016)
Q Consensus 660 ~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-----~~~~ 731 (1016)
+|++.+.||+|+||.||+|+.. +++.||||++... .......+.+|+++++.++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 5888999999999999999954 6899999998643 223345688999999999999999999988643 3589
Q ss_pred EEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccc
Q 001768 732 LVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKL 811 (1016)
Q Consensus 732 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~ 811 (1016)
+||||++ ++|.+++.... .+++..+..++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 81 lv~e~~~-~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~ 152 (338)
T cd07859 81 VVFELME-SDLHQVIKAND----DLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARV 152 (338)
T ss_pred EEEecCC-CCHHHHHHhcc----cCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccc
Confidence 9999995 68988885443 589999999999999999999998 999999999999999999999999999975
Q ss_pred cCCCCc--ceeeecccCccccChhhhcc--CCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHH----------
Q 001768 812 DEDENT--HISTRIAGTVGYMAPEYAMR--GYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDW---------- 877 (1016)
Q Consensus 812 ~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~---------- 877 (1016)
...... .......||+.|+|||++.+ ..++.++|||||||++|||++|++||...........+..
T Consensus 153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 232 (338)
T cd07859 153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI 232 (338)
T ss_pred cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 432211 11234578999999999875 5789999999999999999999999976543221111100
Q ss_pred HHHH-HHhCCcccccCCcCCCCCC---HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 878 AYVL-QEQGNLLELVDPSLGSNFS---KKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 878 ~~~~-~~~~~~~~~~d~~l~~~~~---~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
.... .......+.+.+.....+. +.....+.+++.+||+.||++|||++|+++
T Consensus 233 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 233 SRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred HHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 0000 0000000001111100000 012346789999999999999999998883
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=332.79 Aligned_cols=260 Identities=25% Similarity=0.442 Sum_probs=206.7
Q ss_pred HHhcCccccCccccCCCeeEEEEEcC------CCcEEEEEEccCCC-hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecc
Q 001768 656 AATNNFDAANKIGEGGFGPVYKGTLS------DGAVIAVKQLSSKS-KQGNREFVNEIGMISALQHQNLVKLYGCCIEGN 728 (1016)
Q Consensus 656 ~~~~~f~~~~~LG~G~~G~Vy~~~~~------~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 728 (1016)
..+++|++.+.||+|+||.||+|.+. .+..||+|.+.... .....++.+|+.+++.++||||+++++++.++.
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 35678999999999999999998753 35679999986432 334557889999999999999999999999999
Q ss_pred eeEEEEeecCCCcHHHHhccCcCc------CcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCcee
Q 001768 729 QLLLVYEYLENNSLARALFGKEGQ------CLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAK 802 (1016)
Q Consensus 729 ~~~lV~E~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~k 802 (1016)
..++||||+++++|.+++...... ...+++..+..++.|+++||+|||+. +++||||||+||++++++.++
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEE
Confidence 999999999999999998653211 13468889999999999999999998 899999999999999999999
Q ss_pred eeccccccccCCCCcce-eeecccCccccChhhhccCCCCCccchhHHHHHHHHHHh-CCCCCCCCCchhhHhHHHHHHH
Q 001768 803 ISDFGLAKLDEDENTHI-STRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWAYV 880 (1016)
Q Consensus 803 L~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~ 880 (1016)
|+|||+++......... .....+++.|+|||++.++.++.++|||||||++|||++ |..||.....++.....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~----- 234 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV----- 234 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-----
Confidence 99999987543322211 122345778999999998889999999999999999999 78888765544322111
Q ss_pred HHHhCCcccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 001768 881 LQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEG 934 (1016)
Q Consensus 881 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 934 (1016)
...... ..+...+..+.+++.+||+.+|++|||+.|+++.|++
T Consensus 235 --~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 235 --MEGGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred --HcCCcC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 111111 1112234568999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=346.36 Aligned_cols=258 Identities=21% Similarity=0.263 Sum_probs=196.2
Q ss_pred hcCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEee
Q 001768 658 TNNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEY 736 (1016)
Q Consensus 658 ~~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 736 (1016)
.++|++.+.||+|+||.||+|... +++.||+|.... ..+.+|++++++++||||+++++++..+...++|||+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 357999999999999999999864 688999997532 3467899999999999999999999999999999999
Q ss_pred cCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCC
Q 001768 737 LENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDEN 816 (1016)
Q Consensus 737 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 816 (1016)
+. ++|.+++.... .+++.+++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+......
T Consensus 165 ~~-~~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~ 236 (391)
T PHA03212 165 YK-TDLYCYLAAKR----NIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN 236 (391)
T ss_pred CC-CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccccc
Confidence 95 68888885543 589999999999999999999998 99999999999999999999999999997543322
Q ss_pred cceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCch--------hhHhHHHHHHHHHH-----
Q 001768 817 THISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKE--------EFVYLLDWAYVLQE----- 883 (1016)
Q Consensus 817 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~--------~~~~~~~~~~~~~~----- 883 (1016)
........||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+........
T Consensus 237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~ 316 (391)
T PHA03212 237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID 316 (391)
T ss_pred ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence 22233467999999999999889999999999999999999999887532210 00000000000000
Q ss_pred -hCCccc---------ccCCcCCCCC--CHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 001768 884 -QGNLLE---------LVDPSLGSNF--SKKEAMTMLNIALLCTNPSPTLRPTMSSAV 929 (1016)
Q Consensus 884 -~~~~~~---------~~d~~l~~~~--~~~~~~~l~~li~~cl~~dP~~RPt~~evl 929 (1016)
...+.+ ...+.....+ ....+..+.+++.+||+.||++|||+.|++
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL 374 (391)
T PHA03212 317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALL 374 (391)
T ss_pred hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHh
Confidence 000000 0001000000 012345788999999999999999999888
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=339.96 Aligned_cols=259 Identities=20% Similarity=0.374 Sum_probs=203.1
Q ss_pred hcCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCC-hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEe
Q 001768 658 TNNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS-KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYE 735 (1016)
Q Consensus 658 ~~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 735 (1016)
.++|++.++||+|+||.||+++.. ++..+|+|.+.... ......+.+|++++++++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 478999999999999999999976 68889999887543 3345678999999999999999999999999999999999
Q ss_pred ecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCC
Q 001768 736 YLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDE 815 (1016)
Q Consensus 736 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 815 (1016)
|+++++|.+++.... .+++..+..++.|++.||.|||+.. +|+||||||+|||+++++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 84 HMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred cCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 999999999996533 5889999999999999999999752 7999999999999999999999999998754332
Q ss_pred CcceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCc--------
Q 001768 816 NTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNL-------- 887 (1016)
Q Consensus 816 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~-------- 887 (1016)
......|+..|+|||++.+..++.++|||||||++|||++|+.||.............. ...+..
T Consensus 158 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~ 230 (333)
T cd06650 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGC----PVEGDPAESETSPR 230 (333)
T ss_pred ---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcC----cccCCccccccCcc
Confidence 12335689999999999888899999999999999999999999976543322111100 000000
Q ss_pred ------------------------ccccCCcCCCCCC-HHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 001768 888 ------------------------LELVDPSLGSNFS-KKEAMTMLNIALLCTNPSPTLRPTMSSAV 929 (1016)
Q Consensus 888 ------------------------~~~~d~~l~~~~~-~~~~~~l~~li~~cl~~dP~~RPt~~evl 929 (1016)
.+.+........+ .....++.+++.+||+.||++|||+.|++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell 297 (333)
T cd06650 231 PRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLM 297 (333)
T ss_pred cCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHh
Confidence 0000000000000 01234688999999999999999999887
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=344.98 Aligned_cols=254 Identities=25% Similarity=0.398 Sum_probs=198.8
Q ss_pred cCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCC-hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEee
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS-KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEY 736 (1016)
Q Consensus 659 ~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 736 (1016)
++|+..++||+|+||.||+|+.. +++.||||++.... ......+.+|+++++.++|+||+++++++.+++.+++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 34566789999999999999865 68999999986543 33356788999999999999999999999999999999999
Q ss_pred cCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCC
Q 001768 737 LENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDEN 816 (1016)
Q Consensus 737 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 816 (1016)
+++++|.+.. ..++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 154 ~~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~ 222 (353)
T PLN00034 154 MDGGSLEGTH--------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM 222 (353)
T ss_pred CCCCcccccc--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence 9999986532 356778889999999999999998 99999999999999999999999999998654322
Q ss_pred cceeeecccCccccChhhhcc-----CCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCccccc
Q 001768 817 THISTRIAGTVGYMAPEYAMR-----GYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELV 891 (1016)
Q Consensus 817 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 891 (1016)
. ......||..|+|||++.. ...+.++|||||||++|||++|+.||......+........ ... .
T Consensus 223 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~----~~~-----~ 292 (353)
T PLN00034 223 D-PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAI----CMS-----Q 292 (353)
T ss_pred c-cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHH----hcc-----C
Confidence 1 1233578999999998743 23456899999999999999999999743332221111100 000 0
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCcCCcCccccCC
Q 001768 892 DPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTAVQAPIIRRN 946 (1016)
Q Consensus 892 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~p~~~~~ 946 (1016)
. ...+......+.+++.+||+.||++||++.|++ .|||+...
T Consensus 293 ~----~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell---------~hp~~~~~ 334 (353)
T PLN00034 293 P----PEAPATASREFRHFISCCLQREPAKRWSAMQLL---------QHPFILRA 334 (353)
T ss_pred C----CCCCCccCHHHHHHHHHHccCChhhCcCHHHHh---------cCcccccC
Confidence 0 111223445789999999999999999999888 47776643
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=349.51 Aligned_cols=252 Identities=20% Similarity=0.282 Sum_probs=201.6
Q ss_pred HhcCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCC---ChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEE
Q 001768 657 ATNNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSK---SKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLL 732 (1016)
Q Consensus 657 ~~~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 732 (1016)
..++|++.+.||+|+||.||+|+.. +++.||+|++... .......+.+|+.+++.++||||+++++++.+++..++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 4568999999999999999999865 6889999998643 22234557889999999999999999999999999999
Q ss_pred EEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeecccccccc
Q 001768 733 VYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLD 812 (1016)
Q Consensus 733 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~ 812 (1016)
||||+++|+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++...
T Consensus 121 v~Ey~~gg~L~~~l~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~ 192 (370)
T cd05596 121 VMEYMPGGDLVNLMSNY-----DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (370)
T ss_pred EEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence 99999999999998543 478889999999999999999998 9999999999999999999999999999765
Q ss_pred CCCCcceeeecccCccccChhhhccC----CCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcc
Q 001768 813 EDENTHISTRIAGTVGYMAPEYAMRG----YLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLL 888 (1016)
Q Consensus 813 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 888 (1016)
............||+.|+|||.+.+. .++.++|||||||++|||++|+.||........... .......
T Consensus 193 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~-----i~~~~~~-- 265 (370)
T cd05596 193 DANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSK-----IMDHKNS-- 265 (370)
T ss_pred cCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHH-----HHcCCCc--
Confidence 43322223345799999999998643 478899999999999999999999986554322111 1000000
Q ss_pred cccCCcCCCCCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHH
Q 001768 889 ELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTL--RPTMSSAV 929 (1016)
Q Consensus 889 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl 929 (1016)
. ..+. ....+..+.+++.+|++.+|++ ||+++|++
T Consensus 266 -~---~~~~--~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell 302 (370)
T cd05596 266 -L---TFPD--DIEISKQAKDLICAFLTDREVRLGRNGVDEIK 302 (370)
T ss_pred -C---CCCC--cCCCCHHHHHHHHHHccChhhccCCCCHHHHh
Confidence 0 0111 1123457889999999999988 99999887
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=333.72 Aligned_cols=269 Identities=21% Similarity=0.333 Sum_probs=202.1
Q ss_pred hcCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCCh-hhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEe
Q 001768 658 TNNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSK-QGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYE 735 (1016)
Q Consensus 658 ~~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 735 (1016)
.++|++.+.||+|+||.||+|+.. +++.||+|++..... .....+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999975 689999999875432 233467889999999999999999999999999999999
Q ss_pred ecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCC
Q 001768 736 YLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDE 815 (1016)
Q Consensus 736 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 815 (1016)
|++ ++|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++.....
T Consensus 84 ~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 84 YVH-TDLCQYMDKHP---GGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVP 156 (303)
T ss_pred CCC-cCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence 996 57777775433 3588999999999999999999998 9999999999999999999999999998754322
Q ss_pred CcceeeecccCccccChhhhcc-CCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhC---Cccc--
Q 001768 816 NTHISTRIAGTVGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQG---NLLE-- 889 (1016)
Q Consensus 816 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~---~~~~-- 889 (1016)
.. ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||......... ........... .+..
T Consensus 157 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 233 (303)
T cd07869 157 SH-TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQ--LERIFLVLGTPNEDTWPGVH 233 (303)
T ss_pred Cc-cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHH--HHHHHHHhCCCChhhccchh
Confidence 21 1233568899999998865 45788999999999999999999999764332111 10000000000 0000
Q ss_pred ---ccCCc-C----CCCCCH-----HHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCcCCcCccccC
Q 001768 890 ---LVDPS-L----GSNFSK-----KEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTAVQAPIIRR 945 (1016)
Q Consensus 890 ---~~d~~-l----~~~~~~-----~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~p~~~~ 945 (1016)
...+. . ...... .....+.+++.+|++.||++|||+.|++ .|||+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l---------~h~~f~~ 293 (303)
T cd07869 234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAAL---------SHEYFSD 293 (303)
T ss_pred hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHh---------cCccccc
Confidence 00000 0 000000 0123578999999999999999999887 5787654
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=342.97 Aligned_cols=251 Identities=24% Similarity=0.304 Sum_probs=202.7
Q ss_pred cCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCC---hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEE
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS---KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVY 734 (1016)
Q Consensus 659 ~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 734 (1016)
++|++.+.||+|+||.||+|+.. +++.||+|++.... ......+.+|+.+++.++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 47899999999999999999865 68999999987542 234456889999999999999999999999999999999
Q ss_pred eecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCC
Q 001768 735 EYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDED 814 (1016)
Q Consensus 735 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 814 (1016)
||+++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 81 EYQPGGDLLSLLNRYE---DQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTA 154 (330)
T ss_pred CCCCCCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence 9999999999996653 2589999999999999999999998 999999999999999999999999999986654
Q ss_pred CCcceeeecccCccccChhhhc------cCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcc
Q 001768 815 ENTHISTRIAGTVGYMAPEYAM------RGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLL 888 (1016)
Q Consensus 815 ~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 888 (1016)
..........||+.|+|||++. ...++.++|||||||++|||++|+.||........... . .......
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~-----i-~~~~~~~ 228 (330)
T cd05601 155 NKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNN-----I-MNFQRFL 228 (330)
T ss_pred CCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHH-----H-HcCCCcc
Confidence 4333334457999999999986 45678899999999999999999999976544332111 0 1111111
Q ss_pred cccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 001768 889 ELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAV 929 (1016)
Q Consensus 889 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 929 (1016)
.. +. .......+.+++..|++ +|++||++.+++
T Consensus 229 ~~--~~-----~~~~~~~~~~li~~ll~-~p~~R~t~~~l~ 261 (330)
T cd05601 229 KF--PE-----DPKVSSDFLDLIQSLLC-GQKERLGYEGLC 261 (330)
T ss_pred CC--CC-----CCCCCHHHHHHHHHHcc-ChhhCCCHHHHh
Confidence 10 00 01133468889999998 999999998876
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=327.45 Aligned_cols=256 Identities=29% Similarity=0.446 Sum_probs=207.1
Q ss_pred hcCccccCccccCCCeeEEEEEcCC----CcEEEEEEccCCC-hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEE
Q 001768 658 TNNFDAANKIGEGGFGPVYKGTLSD----GAVIAVKQLSSKS-KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLL 732 (1016)
Q Consensus 658 ~~~f~~~~~LG~G~~G~Vy~~~~~~----~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 732 (1016)
.++|++.+.||+|+||.||+|++.. ...||+|.+.... ......+.+|+.++++++||||+++++++.+++..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 3578899999999999999998642 4589999987543 3345678899999999999999999999999999999
Q ss_pred EEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeecccccccc
Q 001768 733 VYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLD 812 (1016)
Q Consensus 733 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~ 812 (1016)
||||+++++|.+++....+ .+++.+++.++.|++.||+|||+. +|+||||||+||++++++.++|+|||+++..
T Consensus 83 v~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 156 (266)
T cd05033 83 ITEYMENGSLDKFLRENDG---KFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRL 156 (266)
T ss_pred EEEcCCCCCHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence 9999999999999965432 589999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCc-ceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHh-CCCCCCCCCchhhHhHHHHHHHHHHhCCcccc
Q 001768 813 EDENT-HISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWAYVLQEQGNLLEL 890 (1016)
Q Consensus 813 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 890 (1016)
..... .......++..|+|||.+.+..++.++||||||+++|||++ |..||......+..... ....
T Consensus 157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~-------~~~~---- 225 (266)
T cd05033 157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAV-------EDGY---- 225 (266)
T ss_pred cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHH-------HcCC----
Confidence 52222 12222345678999999988889999999999999999998 99998654433321111 0000
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 001768 891 VDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGK 935 (1016)
Q Consensus 891 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 935 (1016)
.. ..+...+..+.+++.+||+.+|++||++.|++++|+..
T Consensus 226 ~~-----~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 226 RL-----PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred CC-----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00 01112345689999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=348.11 Aligned_cols=261 Identities=26% Similarity=0.393 Sum_probs=206.1
Q ss_pred HhcCccccCccccCCCeeEEEEEcC------CCcEEEEEEccCCC-hhhhHHHHHHHHHHHhcC-CCCeeeeeeeEeecc
Q 001768 657 ATNNFDAANKIGEGGFGPVYKGTLS------DGAVIAVKQLSSKS-KQGNREFVNEIGMISALQ-HQNLVKLYGCCIEGN 728 (1016)
Q Consensus 657 ~~~~f~~~~~LG~G~~G~Vy~~~~~------~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~ 728 (1016)
..++|.+.+.||+|+||.||+|+.. .+..||||++.... ....+.+.+|+++++++. ||||+++++++.+.+
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 3568889999999999999999852 13479999997543 333467899999999996 999999999999999
Q ss_pred eeEEEEeecCCCcHHHHhccCcC---------------------------------------------------------
Q 001768 729 QLLLVYEYLENNSLARALFGKEG--------------------------------------------------------- 751 (1016)
Q Consensus 729 ~~~lV~E~~~~gsL~~~l~~~~~--------------------------------------------------------- 751 (1016)
..++|||||++|+|.+++.....
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 99999999999999998865321
Q ss_pred -----------------------------------cCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEc
Q 001768 752 -----------------------------------QCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLD 796 (1016)
Q Consensus 752 -----------------------------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~ 796 (1016)
....+++.++..++.|+++||+|||+. +|+||||||+|||++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEe
Confidence 012478899999999999999999998 999999999999999
Q ss_pred cCCceeeeccccccccCCCCcc-eeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHh-CCCCCCCCCchhhHhH
Q 001768 797 KDLNAKISDFGLAKLDEDENTH-ISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYL 874 (1016)
Q Consensus 797 ~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~ 874 (1016)
+++.+||+|||+++........ ......+++.|+|||.+.+..++.++|||||||++|||++ |+.||..........
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~- 350 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFY- 350 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHH-
Confidence 9999999999999755432221 1223456788999999988889999999999999999997 989986543222110
Q ss_pred HHHHHHHHHhCCcccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 001768 875 LDWAYVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGK 935 (1016)
Q Consensus 875 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 935 (1016)
. . ...+ .. ...+...+..+.+++.+||+.||++||++.+|.++|+..
T Consensus 351 ---~-~-~~~~-----~~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l 397 (400)
T cd05105 351 ---N-K-IKSG-----YR----MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397 (400)
T ss_pred ---H-H-HhcC-----CC----CCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence 0 0 0010 00 111223445789999999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=333.40 Aligned_cols=259 Identities=28% Similarity=0.482 Sum_probs=210.5
Q ss_pred cCccccCccccCCCeeEEEEEcC------CCcEEEEEEccCCChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEE
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLS------DGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLL 732 (1016)
Q Consensus 659 ~~f~~~~~LG~G~~G~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 732 (1016)
++|.+.+.||+|+||.||+|+.. ++..+|+|.+........+.+.+|++++++++||||+++++++..++..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 46888899999999999999742 356799999877666666789999999999999999999999999999999
Q ss_pred EEeecCCCcHHHHhccCcC------------cCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCc
Q 001768 733 VYEYLENNSLARALFGKEG------------QCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLN 800 (1016)
Q Consensus 733 V~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~ 800 (1016)
||||+++++|.+++..... ....+++..++.++.||+.||+|||++ +|+||||||+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCc
Confidence 9999999999999965421 123489999999999999999999998 9999999999999999999
Q ss_pred eeeeccccccccCCCCc-ceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHh-CCCCCCCCCchhhHhHHHHH
Q 001768 801 AKISDFGLAKLDEDENT-HISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWA 878 (1016)
Q Consensus 801 ~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~ 878 (1016)
++|+|||++........ .......++..|+|||++.+..++.++|||||||++|||+| |+.||......+....
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~---- 237 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC---- 237 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----
Confidence 99999999975433221 11233456788999999998889999999999999999999 9999876554432211
Q ss_pred HHHHHhCCcccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCc
Q 001768 879 YVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKT 936 (1016)
Q Consensus 879 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 936 (1016)
.......+ .+...+..+.+++.+||+.+|++||++.+|+++|+...
T Consensus 238 ---~~~~~~~~---------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~ 283 (291)
T cd05094 238 ---ITQGRVLE---------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALG 283 (291)
T ss_pred ---HhCCCCCC---------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence 11111111 11223457899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=346.93 Aligned_cols=257 Identities=21% Similarity=0.290 Sum_probs=200.8
Q ss_pred cCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCC---hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEE
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS---KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVY 734 (1016)
Q Consensus 659 ~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 734 (1016)
.+|++.+.||+|+||.||+|+.. +++.||+|++.... ......+.+|++++++++||||+++++.+.+++.+++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36899999999999999999854 58999999986432 223456889999999999999999999999999999999
Q ss_pred eecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCC
Q 001768 735 EYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDED 814 (1016)
Q Consensus 735 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 814 (1016)
||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+|..+..
T Consensus 81 E~~~~g~L~~~i~~~~----~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~ 153 (376)
T cd05598 81 DYIPGGDMMSLLIRLG----IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (376)
T ss_pred eCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence 9999999999996543 588999999999999999999998 999999999999999999999999999753210
Q ss_pred CC------------------------------------------cceeeecccCccccChhhhccCCCCCccchhHHHHH
Q 001768 815 EN------------------------------------------THISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIV 852 (1016)
Q Consensus 815 ~~------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvv 852 (1016)
.. ........||+.|+|||++.+..++.++|||||||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 233 (376)
T cd05598 154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 233 (376)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccce
Confidence 00 000123479999999999998899999999999999
Q ss_pred HHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCC---CHHHHH
Q 001768 853 ALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRP---TMSSAV 929 (1016)
Q Consensus 853 l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP---t~~evl 929 (1016)
+|||++|+.||......+....+ . ............. ....+.+++.+|+ .+|.+|+ ++.|++
T Consensus 234 lyell~G~~Pf~~~~~~~~~~~i------~---~~~~~~~~~~~~~----~s~~~~~li~~l~-~~p~~R~~~~t~~ell 299 (376)
T cd05598 234 LYEMLVGQPPFLADTPAETQLKV------I---NWETTLHIPSQAK----LSREASDLILRLC-CGAEDRLGKNGADEIK 299 (376)
T ss_pred eeehhhCCCCCCCCCHHHHHHHH------h---ccCccccCCCCCC----CCHHHHHHHHHHh-cCHhhcCCCCCHHHHh
Confidence 99999999999876544322111 0 0000000000111 2335677777765 5999999 777776
Q ss_pred HHhccCcCCcCccccC
Q 001768 930 SMLEGKTAVQAPIIRR 945 (1016)
Q Consensus 930 ~~L~~~~~~~~p~~~~ 945 (1016)
.|||+..
T Consensus 300 ---------~h~~~~~ 306 (376)
T cd05598 300 ---------AHPFFKG 306 (376)
T ss_pred ---------CCCCcCC
Confidence 5677654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=336.43 Aligned_cols=241 Identities=23% Similarity=0.339 Sum_probs=195.9
Q ss_pred CccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCC---hhhhHHHHHHHHHHHhcCCC-CeeeeeeeEeecceeEEEE
Q 001768 660 NFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS---KQGNREFVNEIGMISALQHQ-NLVKLYGCCIEGNQLLLVY 734 (1016)
Q Consensus 660 ~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~Hp-nIv~l~~~~~~~~~~~lV~ 734 (1016)
+|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+..|.+++..++|+ +|+++++++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 5888999999999999999865 57899999987532 23445678899999999764 6888999999999999999
Q ss_pred eecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCC
Q 001768 735 EYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDED 814 (1016)
Q Consensus 735 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 814 (1016)
||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~~~----~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 81 EYVNGGDLMYHIQQVG----KFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF 153 (324)
T ss_pred cCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence 9999999999986543 589999999999999999999998 999999999999999999999999999874322
Q ss_pred CCcceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCc
Q 001768 815 ENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPS 894 (1016)
Q Consensus 815 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 894 (1016)
... ......||+.|+|||++.+..++.++|||||||++|||+||+.||......+....+ . .. ...
T Consensus 154 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i------~-~~------~~~ 219 (324)
T cd05587 154 GGK-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSI------M-EH------NVS 219 (324)
T ss_pred CCC-ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH------H-cC------CCC
Confidence 211 223457999999999999888999999999999999999999999865543322111 0 00 111
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCH
Q 001768 895 LGSNFSKKEAMTMLNIALLCTNPSPTLRPTM 925 (1016)
Q Consensus 895 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 925 (1016)
++......+.+++.+||+.||.+|++.
T Consensus 220 ----~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 220 ----YPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred ----CCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 122234568899999999999999987
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=341.89 Aligned_cols=259 Identities=22% Similarity=0.306 Sum_probs=200.2
Q ss_pred cCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCC---hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEE
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS---KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVY 734 (1016)
Q Consensus 659 ~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 734 (1016)
++|++.+.||+|+||+||+|+.. +++.||+|++.... ......+.+|+.++.+++||||+++++.+.++...++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47899999999999999999865 58999999986532 223456788999999999999999999999999999999
Q ss_pred eecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCC
Q 001768 735 EYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDED 814 (1016)
Q Consensus 735 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 814 (1016)
||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~ 153 (363)
T cd05628 81 EFLPGGDMMTLLMKKD----TLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153 (363)
T ss_pred cCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence 9999999999996543 689999999999999999999998 999999999999999999999999999875432
Q ss_pred CCc----------------------------------ceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCC
Q 001768 815 ENT----------------------------------HISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGK 860 (1016)
Q Consensus 815 ~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~ 860 (1016)
... .......||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence 110 0012357999999999999889999999999999999999999
Q ss_pred CCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCCCCCCHHHHHHHHHHHHHccC--CCCCCCCCHHHHHHHhccCcCC
Q 001768 861 SNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTN--PSPTLRPTMSSAVSMLEGKTAV 938 (1016)
Q Consensus 861 ~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~--~dP~~RPt~~evl~~L~~~~~~ 938 (1016)
.||......+....+ ..... ....|.. .. ....+.+++.+++. .++..||+++|++
T Consensus 234 ~Pf~~~~~~~~~~~i-----~~~~~---~~~~p~~-~~----~s~~~~~li~~l~~~~~~r~~r~~~~ei~--------- 291 (363)
T cd05628 234 PPFCSETPQETYKKV-----MNWKE---TLIFPPE-VP----ISEKAKDLILRFCCEWEHRIGAPGVEEIK--------- 291 (363)
T ss_pred CCCCCCCHHHHHHHH-----HcCcC---cccCCCc-CC----CCHHHHHHHHHHcCChhhcCCCCCHHHHh---------
Confidence 999865544322111 00000 0101110 01 12345666666443 3444578998886
Q ss_pred cCccccCC
Q 001768 939 QAPIIRRN 946 (1016)
Q Consensus 939 ~~p~~~~~ 946 (1016)
.|||+...
T Consensus 292 ~hp~f~~~ 299 (363)
T cd05628 292 TNPFFEGV 299 (363)
T ss_pred CCCCCCCC
Confidence 57777643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=331.18 Aligned_cols=257 Identities=28% Similarity=0.463 Sum_probs=205.4
Q ss_pred cCccccCccccCCCeeEEEEEc-----CCCcEEEEEEccCCC-hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEE
Q 001768 659 NNFDAANKIGEGGFGPVYKGTL-----SDGAVIAVKQLSSKS-KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLL 732 (1016)
Q Consensus 659 ~~f~~~~~LG~G~~G~Vy~~~~-----~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 732 (1016)
++|++.+.||+|+||.||+|.. .++..||+|.+.... ......+.+|++++++++||||+++++++..++..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4678889999999999999984 246789999997543 3344678899999999999999999999999999999
Q ss_pred EEeecCCCcHHHHhccCcC-------------cCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCC
Q 001768 733 VYEYLENNSLARALFGKEG-------------QCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDL 799 (1016)
Q Consensus 733 V~E~~~~gsL~~~l~~~~~-------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~ 799 (1016)
||||+++++|.+++..... ....+++.++..++.|++.||+|||++ +|+||||||+||++++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence 9999999999999853221 123588999999999999999999998 899999999999999999
Q ss_pred ceeeeccccccccCCCCc-ceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHh-CCCCCCCCCchhhHhHHHH
Q 001768 800 NAKISDFGLAKLDEDENT-HISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDW 877 (1016)
Q Consensus 800 ~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~ 877 (1016)
.+||+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |..||...........+
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~-- 239 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMV-- 239 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH--
Confidence 999999999975433221 12223445678999999988889999999999999999998 98898765433322111
Q ss_pred HHHHHHhCCcccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 001768 878 AYVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEG 934 (1016)
Q Consensus 878 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 934 (1016)
...... . .+...+..+.+++.+||+.||++||++.++.++|+.
T Consensus 240 -----~~~~~~-----~----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 240 -----RKRQLL-----P----CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred -----HcCCcC-----C----CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 111111 1 112234578999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=327.23 Aligned_cols=255 Identities=31% Similarity=0.503 Sum_probs=207.4
Q ss_pred HhcCccccCccccCCCeeEEEEEcCCCcEEEEEEccCCChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEee
Q 001768 657 ATNNFDAANKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEY 736 (1016)
Q Consensus 657 ~~~~f~~~~~LG~G~~G~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 736 (1016)
..++|++.++||+|+||.||+|...+++.||+|.+..... ....+.+|+.++++++||||+++++++. .+..++||||
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY 81 (260)
T ss_pred chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence 3567899999999999999999988899999999875443 3467889999999999999999999874 4568999999
Q ss_pred cCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCC
Q 001768 737 LENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDEN 816 (1016)
Q Consensus 737 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 816 (1016)
+++++|.+++..... ..+++.++..++.|++.||+|||+. +++||||||+||++++++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05067 82 MENGSLVDFLKTPEG--IKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNE 156 (260)
T ss_pred CCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence 999999999865432 3689999999999999999999988 99999999999999999999999999997655332
Q ss_pred cceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHh-CCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcC
Q 001768 817 THISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSL 895 (1016)
Q Consensus 817 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 895 (1016)
........++..|+|||++....++.++||||||+++|||++ |+.||......+..... ... .....
T Consensus 157 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~-------~~~-----~~~~~ 224 (260)
T cd05067 157 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNL-------ERG-----YRMPR 224 (260)
T ss_pred cccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHH-------HcC-----CCCCC
Confidence 222223346678999999988889999999999999999999 99999765443322111 000 00111
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 001768 896 GSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEG 934 (1016)
Q Consensus 896 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 934 (1016)
+...+..+.+++.+|++.+|++||+++++++.|+.
T Consensus 225 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 225 ----PDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred ----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 12234579999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=330.14 Aligned_cols=242 Identities=24% Similarity=0.340 Sum_probs=193.2
Q ss_pred cccCCCeeEEEEEcC-CCcEEEEEEccCCCh---hhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEeecCCCcH
Q 001768 667 IGEGGFGPVYKGTLS-DGAVIAVKQLSSKSK---QGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYLENNSL 742 (1016)
Q Consensus 667 LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 742 (1016)
||+|+||+||++... +++.||+|.+..... ...+.+..|+++++.++||||+++.+++..++..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999865 688999999865422 2335677899999999999999999999999999999999999999
Q ss_pred HHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCCcceeee
Q 001768 743 ARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTR 822 (1016)
Q Consensus 743 ~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 822 (1016)
.+++.........+++..+..++.||+.||+|||+. +|+||||||+||+++.++.++|+|||++........ ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence 988865433345699999999999999999999998 999999999999999999999999999975543322 1233
Q ss_pred cccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCCCCCCHH
Q 001768 823 IAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGSNFSKK 902 (1016)
Q Consensus 823 ~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 902 (1016)
..||+.|+|||++.+..++.++|||||||++|||++|+.||............ .. . ..... ..++..
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~--~~------~---~~~~~--~~~~~~ 223 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL--KQ------R---ILNDS--VTYPDK 223 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHH--HH------h---hcccC--CCCccc
Confidence 57899999999999999999999999999999999999999754322111000 00 0 00000 112233
Q ss_pred HHHHHHHHHHHccCCCCCCCCCH
Q 001768 903 EAMTMLNIALLCTNPSPTLRPTM 925 (1016)
Q Consensus 903 ~~~~l~~li~~cl~~dP~~RPt~ 925 (1016)
.+..+.+++.+||+.||++||++
T Consensus 224 ~~~~~~~li~~~l~~~P~~R~~~ 246 (280)
T cd05608 224 FSPASKSFCEALLAKDPEKRLGF 246 (280)
T ss_pred CCHHHHHHHHHHhcCCHHHhcCC
Confidence 45578899999999999999944
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=356.97 Aligned_cols=258 Identities=22% Similarity=0.312 Sum_probs=208.2
Q ss_pred HHHhcCccccCccccCCCeeEEEEEc-CCCcEEEEEEccCC--ChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecc---
Q 001768 655 KAATNNFDAANKIGEGGFGPVYKGTL-SDGAVIAVKQLSSK--SKQGNREFVNEIGMISALQHQNLVKLYGCCIEGN--- 728 (1016)
Q Consensus 655 ~~~~~~f~~~~~LG~G~~G~Vy~~~~-~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~--- 728 (1016)
+...++|++.+.||+|+||+||+|+. .+++.||||++... .......+.+|+.++..++|+||+++++.+...+
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 34467999999999999999999985 47899999998654 3344567889999999999999999988775432
Q ss_pred -----eeEEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceee
Q 001768 729 -----QLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKI 803 (1016)
Q Consensus 729 -----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL 803 (1016)
.+++||||+++|+|.+++.........+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL 184 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKL 184 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEE
Confidence 36899999999999999976544445799999999999999999999998 9999999999999999999999
Q ss_pred eccccccccCCCC-cceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHH
Q 001768 804 SDFGLAKLDEDEN-THISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQ 882 (1016)
Q Consensus 804 ~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~ 882 (1016)
+|||+++...... ........||+.|+|||++.+..++.++|||||||++|||++|+.||......+.....
T Consensus 185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~------- 257 (496)
T PTZ00283 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKT------- 257 (496)
T ss_pred EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH-------
Confidence 9999998654321 12233467999999999999889999999999999999999999999765543322111
Q ss_pred HhCCcccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001768 883 EQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSM 931 (1016)
Q Consensus 883 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 931 (1016)
.... .+ . .+...+..+.+++.+||+.||.+||++.++++.
T Consensus 258 ~~~~----~~-~----~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 258 LAGR----YD-P----LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred hcCC----CC-C----CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 0011 11 1 122234578999999999999999999999864
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=326.01 Aligned_cols=260 Identities=24% Similarity=0.365 Sum_probs=209.2
Q ss_pred cCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCC---ChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEE
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSK---SKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVY 734 (1016)
Q Consensus 659 ~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 734 (1016)
++|++.+.||+|+||.||+|+.. +++.||||.+... .......+.+|+++++.++||||+++++++.+.+..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57899999999999999999964 6899999987542 2333457889999999999999999999999999999999
Q ss_pred eecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCC
Q 001768 735 EYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDED 814 (1016)
Q Consensus 735 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 814 (1016)
||+++++|.+++.........+++..+..++.|+++||+|||++ +++||||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999998865433334689999999999999999999998 999999999999999999999999999886543
Q ss_pred CCcceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCc
Q 001768 815 ENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPS 894 (1016)
Q Consensus 815 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 894 (1016)
.... .....|++.|+|||.+.+..++.++||||||+++|||++|+.||........ .+..... . ...+
T Consensus 159 ~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~----~~~~~~~-~-----~~~~- 226 (267)
T cd08228 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLF----SLCQKIE-Q-----CDYP- 226 (267)
T ss_pred hhHH-HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHH----HHHHHHh-c-----CCCC-
Confidence 3221 1234688899999999888889999999999999999999999864332211 1111100 0 0011
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 001768 895 LGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGK 935 (1016)
Q Consensus 895 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 935 (1016)
.......+..+.+++.+||+.+|++||++.+|++.+++.
T Consensus 227 --~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 227 --PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred --CCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 111223456789999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=319.79 Aligned_cols=268 Identities=22% Similarity=0.327 Sum_probs=204.1
Q ss_pred hcCccccCccccCCCeeEEEEEc-CCCcEEEEEEccCCChh--hhHHHHHHHHHHHhcCCCC-eeeeeeeEeecc-----
Q 001768 658 TNNFDAANKIGEGGFGPVYKGTL-SDGAVIAVKQLSSKSKQ--GNREFVNEIGMISALQHQN-LVKLYGCCIEGN----- 728 (1016)
Q Consensus 658 ~~~f~~~~~LG~G~~G~Vy~~~~-~~~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~Hpn-Iv~l~~~~~~~~----- 728 (1016)
...|+.+++||+|+||+||+|+. .+|+.||+|++.-.... ......+|+.+++.++|+| ||++++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 34567788999999999999995 47899999998765442 3456789999999999999 999999998877
Q ss_pred -eeEEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccc
Q 001768 729 -QLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFG 807 (1016)
Q Consensus 729 -~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG 807 (1016)
.+++|+||++. +|..++.........++...+..++.||++||+|||++ +|+||||||+|||++++|.+||+|||
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccc
Confidence 89999999965 89999976543223577789999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCcceeeecccCccccChhhhccC-CCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCC
Q 001768 808 LAKLDEDENTHISTRIAGTVGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGN 886 (1016)
Q Consensus 808 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 886 (1016)
+|+...-.... .+..++|..|+|||++.+. .|+...||||+||+++||+++++-|.+....+....+-..........
T Consensus 166 lAra~~ip~~~-yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~ 244 (323)
T KOG0594|consen 166 LARAFSIPMRT-YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKD 244 (323)
T ss_pred hHHHhcCCccc-ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccC
Confidence 99965533222 3445789999999999876 799999999999999999999999987766443222111000000111
Q ss_pred ccccc-----CCcCC-----CCCCHHHH---HHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 887 LLELV-----DPSLG-----SNFSKKEA---MTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 887 ~~~~~-----d~~l~-----~~~~~~~~---~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
+.... ++..+ ..+....+ ....+++.+|++.+|++|.|++.+++
T Consensus 245 Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~ 301 (323)
T KOG0594|consen 245 WPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALT 301 (323)
T ss_pred CCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhc
Confidence 11110 00000 01111111 26789999999999999999987764
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=340.24 Aligned_cols=238 Identities=25% Similarity=0.348 Sum_probs=194.7
Q ss_pred CccccCCCeeEEEEEc----CCCcEEEEEEccCCCh--hhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEeecC
Q 001768 665 NKIGEGGFGPVYKGTL----SDGAVIAVKQLSSKSK--QGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYLE 738 (1016)
Q Consensus 665 ~~LG~G~~G~Vy~~~~----~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 738 (1016)
+.||+|+||.||+++. .+|+.||+|++..... .....+.+|++++++++||||+++++++.+++..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 6799999999999874 3578999999875422 233457789999999999999999999999999999999999
Q ss_pred CCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCCcc
Q 001768 739 NNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTH 818 (1016)
Q Consensus 739 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 818 (1016)
+++|.+++.... .+++..+..++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~- 153 (318)
T cd05582 82 GGDLFTRLSKEV----MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK- 153 (318)
T ss_pred CCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-
Confidence 999999985432 589999999999999999999998 999999999999999999999999999975443322
Q ss_pred eeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCCCC
Q 001768 819 ISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGSN 898 (1016)
Q Consensus 819 ~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 898 (1016)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+....+ . ... . .
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i------~-~~~------~----~ 216 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMI------L-KAK------L----G 216 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHH------H-cCC------C----C
Confidence 223457899999999998888899999999999999999999999765443322111 0 000 0 1
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 001768 899 FSKKEAMTMLNIALLCTNPSPTLRPTMSS 927 (1016)
Q Consensus 899 ~~~~~~~~l~~li~~cl~~dP~~RPt~~e 927 (1016)
++......+.+++.+||+.||++||++.+
T Consensus 217 ~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 217 MPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 12223456889999999999999999766
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=332.22 Aligned_cols=271 Identities=28% Similarity=0.398 Sum_probs=204.0
Q ss_pred cCccccCccccCCCeeEEEEEc-----CCCcEEEEEEccCCChhhhHHHHHHHHHHHhcCCCCeeeeeeeEee--cceeE
Q 001768 659 NNFDAANKIGEGGFGPVYKGTL-----SDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIE--GNQLL 731 (1016)
Q Consensus 659 ~~f~~~~~LG~G~~G~Vy~~~~-----~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~~ 731 (1016)
++|++.+.||+|+||.||++.. .++..||+|.+........+.+.+|++++++++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 5788899999999999999974 2578999999987766667789999999999999999999998754 34689
Q ss_pred EEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccc
Q 001768 732 LVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKL 811 (1016)
Q Consensus 732 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~ 811 (1016)
+||||+++++|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||++++++.+||+|||++..
T Consensus 84 lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHR---ERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred EEEEecCCCCHHHHHHhcC---cCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCccccc
Confidence 9999999999999996543 2589999999999999999999998 999999999999999999999999999986
Q ss_pred cCCCCccee--eecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCccc
Q 001768 812 DEDENTHIS--TRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLE 889 (1016)
Q Consensus 812 ~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 889 (1016)
......... ....++..|+|||++.+..++.++|||||||++|||++|..|+.......................+.+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05081 158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE 237 (284)
T ss_pred ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHH
Confidence 544322211 112234569999999888899999999999999999998877643321110000000000000000000
Q ss_pred ccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 001768 890 LVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGK 935 (1016)
Q Consensus 890 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 935 (1016)
.+........+...+..+.+++.+||+.+|++|||+.||++.|+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 238 LLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 0111111111222345799999999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=336.36 Aligned_cols=238 Identities=26% Similarity=0.391 Sum_probs=191.6
Q ss_pred CccccCCCeeEEEEEcC-CCcEEEEEEccCCC---hhhhHHHHHHHHHHHhc-CCCCeeeeeeeEeecceeEEEEeecCC
Q 001768 665 NKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS---KQGNREFVNEIGMISAL-QHQNLVKLYGCCIEGNQLLLVYEYLEN 739 (1016)
Q Consensus 665 ~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~ 739 (1016)
+.||+|+||.||+|+.. +++.||+|.++... ....+.+..|..++... +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999965 57899999987532 22334556677777654 899999999999999999999999999
Q ss_pred CcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCCcce
Q 001768 740 NSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHI 819 (1016)
Q Consensus 740 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 819 (1016)
|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~~~----~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~ 152 (316)
T cd05592 81 GDLMFHIQSSG----RFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GK 152 (316)
T ss_pred CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cc
Confidence 99999986543 589999999999999999999998 99999999999999999999999999997543322 22
Q ss_pred eeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCCCCC
Q 001768 820 STRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGSNF 899 (1016)
Q Consensus 820 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 899 (1016)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+ .. ..+. +
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i------~~-------~~~~----~ 215 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSI------LN-------DRPH----F 215 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHH------Hc-------CCCC----C
Confidence 33457999999999999888999999999999999999999999866543322111 00 0111 2
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 001768 900 SKKEAMTMLNIALLCTNPSPTLRPTMSS 927 (1016)
Q Consensus 900 ~~~~~~~l~~li~~cl~~dP~~RPt~~e 927 (1016)
+......+.+++.+||+.||++||++.+
T Consensus 216 ~~~~~~~~~~ll~~~l~~~P~~R~~~~~ 243 (316)
T cd05592 216 PRWISKEAKDCLSKLFERDPTKRLGVDG 243 (316)
T ss_pred CCCCCHHHHHHHHHHccCCHHHcCCChH
Confidence 2223446889999999999999999753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=340.41 Aligned_cols=260 Identities=27% Similarity=0.404 Sum_probs=203.9
Q ss_pred hcCccccCccccCCCeeEEEEEcC------CCcEEEEEEccCCC-hhhhHHHHHHHHHHHhc-CCCCeeeeeeeEeec-c
Q 001768 658 TNNFDAANKIGEGGFGPVYKGTLS------DGAVIAVKQLSSKS-KQGNREFVNEIGMISAL-QHQNLVKLYGCCIEG-N 728 (1016)
Q Consensus 658 ~~~f~~~~~LG~G~~G~Vy~~~~~------~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~-~ 728 (1016)
.++|++.+.||+|+||.||+|+.. .++.||+|++.... ....+.+..|+++++++ +||||+++++++... .
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 457899999999999999999642 25789999987543 23345678899999999 899999999988654 5
Q ss_pred eeEEEEeecCCCcHHHHhccCcCc--------------------------------------------------------
Q 001768 729 QLLLVYEYLENNSLARALFGKEGQ-------------------------------------------------------- 752 (1016)
Q Consensus 729 ~~~lV~E~~~~gsL~~~l~~~~~~-------------------------------------------------------- 752 (1016)
.++++|||+++++|.+++......
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 789999999999999998643211
Q ss_pred -CcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCCcce-eeecccCcccc
Q 001768 753 -CLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHI-STRIAGTVGYM 830 (1016)
Q Consensus 753 -~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~-~~~~~gt~~y~ 830 (1016)
...+++..+..++.||+.||+|||+. +|+||||||+|||+++++.++|+|||+++......... .....++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 12689999999999999999999998 99999999999999999999999999998654332221 22345677899
Q ss_pred ChhhhccCCCCCccchhHHHHHHHHHHh-CCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCCCCCCHHHHHHHHH
Q 001768 831 APEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGSNFSKKEAMTMLN 909 (1016)
Q Consensus 831 aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~ 909 (1016)
|||++.+..++.++|||||||++|||++ |+.||......+.. .... .... . + ..+......+.+
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~-----~~~~-~~~~-~----~----~~~~~~~~~~~~ 307 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEF-----CRRL-KEGT-R----M----RAPEYATPEIYS 307 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHH-----HHHH-hccC-C----C----CCCccCCHHHHH
Confidence 9999999999999999999999999998 99998754332211 0000 1110 0 0 111223456899
Q ss_pred HHHHccCCCCCCCCCHHHHHHHhccC
Q 001768 910 IALLCTNPSPTLRPTMSSAVSMLEGK 935 (1016)
Q Consensus 910 li~~cl~~dP~~RPt~~evl~~L~~~ 935 (1016)
++.+||+.+|++||++.|++++|+..
T Consensus 308 l~~~cl~~~p~~RPs~~ell~~l~~~ 333 (337)
T cd05054 308 IMLDCWHNNPEDRPTFSELVEILGDL 333 (337)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHH
Confidence 99999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=331.62 Aligned_cols=266 Identities=29% Similarity=0.428 Sum_probs=203.0
Q ss_pred ccccCccccCCCeeEEEEEc-----CCCcEEEEEEccCCC-hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeec--ceeEE
Q 001768 661 FDAANKIGEGGFGPVYKGTL-----SDGAVIAVKQLSSKS-KQGNREFVNEIGMISALQHQNLVKLYGCCIEG--NQLLL 732 (1016)
Q Consensus 661 f~~~~~LG~G~~G~Vy~~~~-----~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~l 732 (1016)
|++.+.||+|+||+||++.. .++..||+|.+.... ......+.+|++++++++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 37889999999999988652 357899999987643 23456788999999999999999999988753 46899
Q ss_pred EEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeecccccccc
Q 001768 733 VYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLD 812 (1016)
Q Consensus 733 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~ 812 (1016)
||||+++++|.+++... .+++.+++.++.|++.||+|||++ +|+||||||+||++++++.++|+|||+++..
T Consensus 86 v~e~~~~~~l~~~~~~~-----~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 86 IMEYVPLGSLRDYLPKH-----KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred EecCCCCCCHHHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeeccccccc
Confidence 99999999999999543 489999999999999999999998 9999999999999999999999999999865
Q ss_pred CCCCcc--eeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccc
Q 001768 813 EDENTH--ISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLEL 890 (1016)
Q Consensus 813 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 890 (1016)
...... ......++..|+|||.+.+..++.++|||||||++|||+||+.|+....... ...............+.+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQGQMTVVRLIEL 236 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhcccccccchhhhhhh
Confidence 443221 1122345667999999988889999999999999999999999986433211 1111000000000011111
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 001768 891 VDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGK 935 (1016)
Q Consensus 891 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 935 (1016)
++.......+...+..+.+++.+||+.+|++|||+++++++|+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 237 LERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred hhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 111111122233456799999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=344.19 Aligned_cols=251 Identities=21% Similarity=0.284 Sum_probs=197.0
Q ss_pred cCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCC---hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEE
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS---KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVY 734 (1016)
Q Consensus 659 ~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 734 (1016)
++|++.+.||+|+||.||+++.. +++.||||++.... ......+.+|+++++.++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47899999999999999999854 68999999986432 233456888999999999999999999999999999999
Q ss_pred eecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCC
Q 001768 735 EYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDED 814 (1016)
Q Consensus 735 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 814 (1016)
||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~gg~L~~~l~~~~----~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~ 153 (377)
T cd05629 81 EFLPGGDLMTMLIKYD----TFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153 (377)
T ss_pred eCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence 9999999999996543 588999999999999999999998 999999999999999999999999999863221
Q ss_pred CCc----------------------------------------------ceeeecccCccccChhhhccCCCCCccchhH
Q 001768 815 ENT----------------------------------------------HISTRIAGTVGYMAPEYAMRGYLTDKADVYS 848 (1016)
Q Consensus 815 ~~~----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS 848 (1016)
... .......||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 233 (377)
T cd05629 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence 000 0001246999999999999888999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCC---CCH
Q 001768 849 FGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLR---PTM 925 (1016)
Q Consensus 849 lGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~R---Pt~ 925 (1016)
|||++|||++|+.||......+....+ .. ....+ .++.. ......+.+++.+|+. +|.+| +++
T Consensus 234 lGvil~elltG~~Pf~~~~~~~~~~~i------~~---~~~~~--~~p~~--~~~s~~~~dli~~lL~-~~~~r~~r~~~ 299 (377)
T cd05629 234 LGAIMFECLIGWPPFCSENSHETYRKI------IN---WRETL--YFPDD--IHLSVEAEDLIRRLIT-NAENRLGRGGA 299 (377)
T ss_pred cchhhhhhhcCCCCCCCCCHHHHHHHH------Hc---cCCcc--CCCCC--CCCCHHHHHHHHHHhc-CHhhcCCCCCH
Confidence 999999999999999765543321111 00 00000 00110 0123468889999997 66665 588
Q ss_pred HHHHH
Q 001768 926 SSAVS 930 (1016)
Q Consensus 926 ~evl~ 930 (1016)
.|+++
T Consensus 300 ~~~l~ 304 (377)
T cd05629 300 HEIKS 304 (377)
T ss_pred HHHhc
Confidence 87773
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=323.92 Aligned_cols=261 Identities=26% Similarity=0.395 Sum_probs=210.6
Q ss_pred cCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCC---ChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEE
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSK---SKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVY 734 (1016)
Q Consensus 659 ~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 734 (1016)
++|++.+.||+|+||.||+|... +++.||+|.++.. .......+.+|++++++++|+|++++++++.+++..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57999999999999999999976 7899999988642 2233567889999999999999999999999999999999
Q ss_pred eecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCC
Q 001768 735 EYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDED 814 (1016)
Q Consensus 735 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 814 (1016)
||+++++|.+++.........+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999999865433345689999999999999999999998 999999999999999999999999999875543
Q ss_pred CCcceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCc
Q 001768 815 ENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPS 894 (1016)
Q Consensus 815 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 894 (1016)
.... .....+++.|+|||.+.+..++.++|||||||++|+|++|+.||....... ....+ . ..... .+.
T Consensus 159 ~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~---~-~~~~~-----~~~ 227 (267)
T cd08224 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-YSLCK---K-IEKCD-----YPP 227 (267)
T ss_pred CCcc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccH-HHHHh---h-hhcCC-----CCC
Confidence 3221 223468889999999988889999999999999999999999986443211 00100 0 00010 011
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCc
Q 001768 895 LGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKT 936 (1016)
Q Consensus 895 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 936 (1016)
. .....+..+.+++.+||..+|++||++.+|+++|+...
T Consensus 228 ~---~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 228 L---PADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred C---ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 1 11134557899999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=323.36 Aligned_cols=253 Identities=30% Similarity=0.472 Sum_probs=204.5
Q ss_pred cCccccCccccCCCeeEEEEEcCCCcEEEEEEccCCChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEeecC
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYLE 738 (1016)
Q Consensus 659 ~~f~~~~~LG~G~~G~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 738 (1016)
++|++.+.||+|++|.||+|.+.++..||+|.+.... ...+.+.+|++++++++|||++++++++. .+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 5688899999999999999998777789999886543 23467889999999999999999999875 456899999999
Q ss_pred CCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCCcc
Q 001768 739 NNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTH 818 (1016)
Q Consensus 739 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 818 (1016)
+++|.+++..... ..+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||.+.........
T Consensus 84 ~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 84 KGSLLDFLKEGDG--KYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence 9999999965432 3589999999999999999999998 8999999999999999999999999999765433222
Q ss_pred eeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHh-CCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCCC
Q 001768 819 ISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGS 897 (1016)
Q Consensus 819 ~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 897 (1016)
......++..|+|||+..+..++.++|||||||++|||++ |+.||......+..... .. . .. .
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~-------~~-~----~~----~ 222 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQV-------ER-G----YR----M 222 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-------Hc-C----CC----C
Confidence 2222346678999999988889999999999999999999 89998765443321110 00 0 00 1
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 001768 898 NFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEG 934 (1016)
Q Consensus 898 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 934 (1016)
..+...+..+.+++.+||+.||++||+++++++.|+.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 223 PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1122345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=328.56 Aligned_cols=250 Identities=27% Similarity=0.338 Sum_probs=201.2
Q ss_pred CccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCCh---hhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEe
Q 001768 660 NFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSK---QGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYE 735 (1016)
Q Consensus 660 ~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 735 (1016)
+|++.+.||+|+||.||++... +++.||+|++..... .....+.+|+.++++++||||+++++++..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4788999999999999999964 689999999865322 223457789999999999999999999999999999999
Q ss_pred ecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCC
Q 001768 736 YLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDE 815 (1016)
Q Consensus 736 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 815 (1016)
|+++|+|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 81 LMNGGDLKFHIYNMG--NPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred ccCCCcHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 999999998886432 23589999999999999999999998 9999999999999999999999999999765432
Q ss_pred CcceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcC
Q 001768 816 NTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSL 895 (1016)
Q Consensus 816 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 895 (1016)
.. .....|++.|+|||++.+..++.++||||+||++|||++|+.||.............. . +.. .
T Consensus 156 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~--~------~~~-----~ 220 (285)
T cd05605 156 ET--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVER--R------VKE-----D 220 (285)
T ss_pred Cc--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHH--H------hhh-----c
Confidence 22 1234689999999999888899999999999999999999999986544322111110 0 000 0
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHH
Q 001768 896 GSNFSKKEAMTMLNIALLCTNPSPTLRP-----TMSSAV 929 (1016)
Q Consensus 896 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl 929 (1016)
...++...+..+.+++.+||+.||++|| ++++++
T Consensus 221 ~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~ 259 (285)
T cd05605 221 QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVK 259 (285)
T ss_pred ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHh
Confidence 1112233455789999999999999999 666665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=321.34 Aligned_cols=267 Identities=26% Similarity=0.370 Sum_probs=204.1
Q ss_pred HHHhcCccccCccccCCCeeEEEEEcCCCcEEEEEEccCCChhhhHHHHHHHHHHHh--cCCCCeeeeeeeEeec----c
Q 001768 655 KAATNNFDAANKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGNREFVNEIGMISA--LQHQNLVKLYGCCIEG----N 728 (1016)
Q Consensus 655 ~~~~~~f~~~~~LG~G~~G~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~--l~HpnIv~l~~~~~~~----~ 728 (1016)
....++..+.+.||+|.||+||+|+|+ |+.||||++....+ +.+.+|.++.+. ++|+||+.+++.-..+ .
T Consensus 207 RTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T 282 (513)
T KOG2052|consen 207 RTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT 282 (513)
T ss_pred HhhhheeEEEEEecCccccceeecccc-CCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence 456678888999999999999999996 78999999975543 466778887775 5999999999886544 3
Q ss_pred eeEEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeEeCCCCCceEEEccCCceee
Q 001768 729 QLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEE-----SRLKIVHRDIKATNVLLDKDLNAKI 803 (1016)
Q Consensus 729 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~-----~~~~iiHrDlkp~NILl~~~~~~kL 803 (1016)
+++||.+|.+.|||.|+|... .++.+..++++..+|.||+|||.. ++|.|.|||||..||||..++.+.|
T Consensus 283 QLwLvTdYHe~GSL~DyL~r~-----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~I 357 (513)
T KOG2052|consen 283 QLWLVTDYHEHGSLYDYLNRN-----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI 357 (513)
T ss_pred EEEEeeecccCCcHHHHHhhc-----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEE
Confidence 799999999999999999664 599999999999999999999975 6789999999999999999999999
Q ss_pred eccccccccCCCCcc---eeeecccCccccChhhhccCC------CCCccchhHHHHHHHHHHhC----------CCCCC
Q 001768 804 SDFGLAKLDEDENTH---ISTRIAGTVGYMAPEYAMRGY------LTDKADVYSFGIVALEIVSG----------KSNTN 864 (1016)
Q Consensus 804 ~DFGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~sDVwSlGvvl~elltG----------~~P~~ 864 (1016)
+|+|+|-........ .....+||.+|||||++...- .-..+||||||.|+||++.. +.||.
T Consensus 358 ADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyy 437 (513)
T KOG2052|consen 358 ADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYY 437 (513)
T ss_pred eeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcc
Confidence 999999755444222 134468999999999996431 12368999999999999752 34554
Q ss_pred CCCchhhHhHHHHHHHHHHhCCcccccCCcCCCCCC-HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCc
Q 001768 865 YRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGSNFS-KKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKT 936 (1016)
Q Consensus 865 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~-~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 936 (1016)
+--+.+.. .. ....--..+.+.|.++..+. ......+.++|+.||..+|..|-|+-.+-+.|.+..
T Consensus 438 d~Vp~DPs-~e-----eMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~ 504 (513)
T KOG2052|consen 438 DVVPSDPS-FE-----EMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS 504 (513)
T ss_pred cCCCCCCC-HH-----HHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence 31111100 00 01111222334444444333 345568899999999999999999988888776543
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=338.12 Aligned_cols=240 Identities=25% Similarity=0.361 Sum_probs=193.0
Q ss_pred ccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCC---hhhhHHHHHHHHHH---HhcCCCCeeeeeeeEeecceeEEE
Q 001768 661 FDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS---KQGNREFVNEIGMI---SALQHQNLVKLYGCCIEGNQLLLV 733 (1016)
Q Consensus 661 f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l---~~l~HpnIv~l~~~~~~~~~~~lV 733 (1016)
|++.+.||+|+||.||+|+.. +++.||||+++... ....+.+.+|++++ +.++||||+++++++.+++..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 677899999999999999865 68999999987542 22334566676655 566899999999999999999999
Q ss_pred EeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccC
Q 001768 734 YEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDE 813 (1016)
Q Consensus 734 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~ 813 (1016)
|||+++++|..++... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 81 ~E~~~~~~L~~~~~~~-----~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 81 MEYAAGGDLMMHIHTD-----VFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred EcCCCCCcHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 9999999999888542 589999999999999999999998 99999999999999999999999999987432
Q ss_pred CCCcceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCC
Q 001768 814 DENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDP 893 (1016)
Q Consensus 814 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 893 (1016)
.... ......|++.|+|||.+.+..++.++|||||||++|||++|+.||......+....+ .. . .+
T Consensus 153 ~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i------~~-~------~~ 218 (324)
T cd05589 153 GFGD-RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSI------VN-D------EV 218 (324)
T ss_pred CCCC-cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHH------Hh-C------CC
Confidence 2211 223467999999999999888999999999999999999999999866544322111 00 0 01
Q ss_pred cCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHH
Q 001768 894 SLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMS 926 (1016)
Q Consensus 894 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 926 (1016)
.. +...+..+.+++.+||+.||.+||++.
T Consensus 219 ~~----p~~~~~~~~~li~~~L~~dP~~R~~~~ 247 (324)
T cd05589 219 RY----PRFLSREAISIMRRLLRRNPERRLGSG 247 (324)
T ss_pred CC----CCCCCHHHHHHHHHHhhcCHhHcCCCC
Confidence 11 122345688999999999999999543
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=345.68 Aligned_cols=256 Identities=21% Similarity=0.300 Sum_probs=198.3
Q ss_pred CccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCC---hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEe
Q 001768 660 NFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS---KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYE 735 (1016)
Q Consensus 660 ~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 735 (1016)
.|++++.||+|+||.||+|+.. +++.||+|++.... ......+.+|++++++++||||+++++++.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5889999999999999999864 68899999986532 2334578899999999999999999999999999999999
Q ss_pred ecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCC
Q 001768 736 YLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDE 815 (1016)
Q Consensus 736 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 815 (1016)
|+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 82 YIPGGDMMSLLIRMG----IFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred CCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence 999999999986542 588999999999999999999998 9999999999999999999999999997532100
Q ss_pred C----------------------------------------------cceeeecccCccccChhhhccCCCCCccchhHH
Q 001768 816 N----------------------------------------------THISTRIAGTVGYMAPEYAMRGYLTDKADVYSF 849 (1016)
Q Consensus 816 ~----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSl 849 (1016)
. ........||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (382)
T cd05625 155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence 0 000122468999999999998899999999999
Q ss_pred HHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCC---HH
Q 001768 850 GIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPT---MS 926 (1016)
Q Consensus 850 Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~ 926 (1016)
||++|||++|+.||......+....+ .. .. ..............+.+++.+++ .+|.+|++ +.
T Consensus 235 Gvil~elltG~~Pf~~~~~~~~~~~i------~~---~~----~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ 300 (382)
T cd05625 235 GVILYEMLVGQPPFLAQTPLETQMKV------IN---WQ----TSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGAD 300 (382)
T ss_pred hHHHHHHHhCCCCCCCCCHHHHHHHH------Hc---cC----CCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHH
Confidence 99999999999999865543321110 00 00 00000001112335667777765 49999998 66
Q ss_pred HHHHHhccCcCCcCccccC
Q 001768 927 SAVSMLEGKTAVQAPIIRR 945 (1016)
Q Consensus 927 evl~~L~~~~~~~~p~~~~ 945 (1016)
|++ .|||+..
T Consensus 301 ei~---------~hp~f~~ 310 (382)
T cd05625 301 EIK---------AHPFFKT 310 (382)
T ss_pred HHh---------cCCCcCC
Confidence 555 4677654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=325.50 Aligned_cols=260 Identities=26% Similarity=0.401 Sum_probs=209.7
Q ss_pred cCccccCccccCCCeeEEEEEc-CCCcEEEEEEccCC---ChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEE
Q 001768 659 NNFDAANKIGEGGFGPVYKGTL-SDGAVIAVKQLSSK---SKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVY 734 (1016)
Q Consensus 659 ~~f~~~~~LG~G~~G~Vy~~~~-~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 734 (1016)
++|++.+.||+|+||.||+|+. .+++.||||.+... ......++.+|+++++.++||||+++++++.+++..++||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4688899999999999999995 47899999987643 2233467889999999999999999999999999999999
Q ss_pred eecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCC
Q 001768 735 EYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDED 814 (1016)
Q Consensus 735 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 814 (1016)
||+++++|.+++.........+++..++.++.|+++||+|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999999865333334689999999999999999999998 999999999999999999999999999876543
Q ss_pred CCcceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCc
Q 001768 815 ENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPS 894 (1016)
Q Consensus 815 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 894 (1016)
.... .....|+..|+|||.+.+..++.++||||||+++|+|++|..||........ ... . ...+...+.
T Consensus 159 ~~~~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~---~------~~~~~~~~~ 227 (267)
T cd08229 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY-SLC---K------KIEQCDYPP 227 (267)
T ss_pred CCcc-cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHH-HHh---h------hhhcCCCCC
Confidence 3221 2234688999999999888899999999999999999999999865432211 000 0 011111111
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 001768 895 LGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGK 935 (1016)
Q Consensus 895 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 935 (1016)
. ........+.+++.+||+.||++|||+.+|+++++..
T Consensus 228 ~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 228 L---PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred C---CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 1 1123455799999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=342.68 Aligned_cols=263 Identities=24% Similarity=0.352 Sum_probs=199.9
Q ss_pred CccccCccccCCCeeEEEEEc-CCCcEEEEEEccCC--ChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecc-----eeE
Q 001768 660 NFDAANKIGEGGFGPVYKGTL-SDGAVIAVKQLSSK--SKQGNREFVNEIGMISALQHQNLVKLYGCCIEGN-----QLL 731 (1016)
Q Consensus 660 ~f~~~~~LG~G~~G~Vy~~~~-~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~-----~~~ 731 (1016)
+|++.+.||+|+||.||+|+. .+++.||+|++... .....+.+.+|+++++.++||||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478899999999999999996 47899999998653 2234567889999999999999999999998776 789
Q ss_pred EEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccc
Q 001768 732 LVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKL 811 (1016)
Q Consensus 732 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~ 811 (1016)
+||||+. ++|.+.+... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 81 lv~e~~~-~~l~~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~ 152 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP----QPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARV 152 (372)
T ss_pred EEeeccc-cCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceee
Confidence 9999997 4787777543 2689999999999999999999998 999999999999999999999999999986
Q ss_pred cCCCCcceeeecccCccccChhhhccC-CCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHH----------HH
Q 001768 812 DEDENTHISTRIAGTVGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWA----------YV 880 (1016)
Q Consensus 812 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~----------~~ 880 (1016)
.............+++.|+|||++.+. .++.++|||||||++|||++|+.||......+....+... ..
T Consensus 153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 232 (372)
T cd07853 153 EEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSA 232 (372)
T ss_pred cccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence 543333233345678999999998764 5789999999999999999999999866544322211100 00
Q ss_pred HHHh-CCcc-cccCC-cCC--CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 881 LQEQ-GNLL-ELVDP-SLG--SNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 881 ~~~~-~~~~-~~~d~-~l~--~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
.... ..+. ....+ ... ..........+.+++.+||+.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 287 (372)
T cd07853 233 CEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA 287 (372)
T ss_pred hHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence 0000 0000 00000 000 0111223457889999999999999999998874
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=335.12 Aligned_cols=243 Identities=21% Similarity=0.310 Sum_probs=191.5
Q ss_pred CccccCCCeeEEEEEcC-CCcEEEEEEccCCC---hhhhHHHHHHHHHHHhc-CCCCeeeeeeeEeecceeEEEEeecCC
Q 001768 665 NKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS---KQGNREFVNEIGMISAL-QHQNLVKLYGCCIEGNQLLLVYEYLEN 739 (1016)
Q Consensus 665 ~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~ 739 (1016)
+.||+|+||.||+|+.. +++.||+|+++... ......+..|..+++.+ +||||+++++++.+++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46899999999999865 68899999997542 23345678899999998 799999999999999999999999999
Q ss_pred CcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCCcce
Q 001768 740 NSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHI 819 (1016)
Q Consensus 740 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 819 (1016)
|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~~~----~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~ 152 (329)
T cd05588 81 GDLMFHMQRQR----KLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DT 152 (329)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCC-Cc
Confidence 99999885443 699999999999999999999998 99999999999999999999999999987422211 12
Q ss_pred eeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchh--hHhHHHHHHHHHHhCCcccccCCcCCC
Q 001768 820 STRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEE--FVYLLDWAYVLQEQGNLLELVDPSLGS 897 (1016)
Q Consensus 820 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~d~~l~~ 897 (1016)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... .....++......... ..+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~------~~~-- 224 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ------IRI-- 224 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC------CCC--
Confidence 234579999999999999899999999999999999999999996422111 0001111111111110 111
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCH
Q 001768 898 NFSKKEAMTMLNIALLCTNPSPTLRPTM 925 (1016)
Q Consensus 898 ~~~~~~~~~l~~li~~cl~~dP~~RPt~ 925 (1016)
+......+.+++.+||+.||.+||++
T Consensus 225 --p~~~~~~~~~li~~~L~~dP~~R~~~ 250 (329)
T cd05588 225 --PRSLSVKASSVLKGFLNKDPKERLGC 250 (329)
T ss_pred --CCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 22234468899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=351.67 Aligned_cols=264 Identities=22% Similarity=0.288 Sum_probs=196.0
Q ss_pred HhcCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeec--------
Q 001768 657 ATNNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIEG-------- 727 (1016)
Q Consensus 657 ~~~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-------- 727 (1016)
..++|++.+.||+|+||.||+|+.. +++.||||++.... ....+|+.+++.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 3467999999999999999999864 68899999885432 2345799999999999999999886432
Q ss_pred ceeEEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCC-ceeeecc
Q 001768 728 NQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDL-NAKISDF 806 (1016)
Q Consensus 728 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~-~~kL~DF 806 (1016)
..+++||||+++ +|.+++.........+++..++.++.||+.||+|||+. +|+||||||+|||++.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeecc
Confidence 246799999985 67777654333334699999999999999999999998 999999999999999665 6999999
Q ss_pred ccccccCCCCcceeeecccCccccChhhhccC-CCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHH------
Q 001768 807 GLAKLDEDENTHISTRIAGTVGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAY------ 879 (1016)
Q Consensus 807 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~------ 879 (1016)
|+|+....... .....||+.|+|||++.+. .++.++|||||||++|||++|++||......+....+....
T Consensus 216 Gla~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~ 293 (440)
T PTZ00036 216 GSAKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTED 293 (440)
T ss_pred ccchhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 99986543322 2235689999999998754 68999999999999999999999998765443221111000
Q ss_pred -HHHHhCCcccccCC-----cCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 880 -VLQEQGNLLELVDP-----SLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 880 -~~~~~~~~~~~~d~-----~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
.......+.+..-+ .+...++...+.++.+++.+||+.||.+|||+.|+++
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 00000001111001 1111122223457899999999999999999999884
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=332.18 Aligned_cols=262 Identities=29% Similarity=0.447 Sum_probs=209.8
Q ss_pred HHHhcCccccCccccCCCeeEEEEEcC------CCcEEEEEEccCCC-hhhhHHHHHHHHHHHhc-CCCCeeeeeeeEee
Q 001768 655 KAATNNFDAANKIGEGGFGPVYKGTLS------DGAVIAVKQLSSKS-KQGNREFVNEIGMISAL-QHQNLVKLYGCCIE 726 (1016)
Q Consensus 655 ~~~~~~f~~~~~LG~G~~G~Vy~~~~~------~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~ 726 (1016)
+...++|++.+.||+|+||.||++... ....+|+|.+.... .....++.+|+++++++ +||||+++++++..
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ 87 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence 445567999999999999999999864 23689999987542 33456788999999999 89999999999999
Q ss_pred cceeEEEEeecCCCcHHHHhccCc------------CcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEE
Q 001768 727 GNQLLLVYEYLENNSLARALFGKE------------GQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVL 794 (1016)
Q Consensus 727 ~~~~~lV~E~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NIL 794 (1016)
++..++||||+++|+|.+++.... .....+++..++.++.|++.||+|||+. +|+||||||+||+
T Consensus 88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil 164 (293)
T cd05053 88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVL 164 (293)
T ss_pred CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEE
Confidence 999999999999999999996532 2234689999999999999999999998 9999999999999
Q ss_pred EccCCceeeeccccccccCCCCcce-eeecccCccccChhhhccCCCCCccchhHHHHHHHHHHh-CCCCCCCCCchhhH
Q 001768 795 LDKDLNAKISDFGLAKLDEDENTHI-STRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFV 872 (1016)
Q Consensus 795 l~~~~~~kL~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~ 872 (1016)
+++++.+||+|||+++......... .....++..|+|||++.+..++.++|||||||++|||++ |..||.....++..
T Consensus 165 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~ 244 (293)
T cd05053 165 VTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF 244 (293)
T ss_pred EcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHH
Confidence 9999999999999998654332211 122335678999999988889999999999999999998 99998765544322
Q ss_pred hHHHHHHHHHHhCCcccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 001768 873 YLLDWAYVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGK 935 (1016)
Q Consensus 873 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 935 (1016)
... .... ....+......+.+++.+||+.||++|||+.|+++.|+..
T Consensus 245 ~~~-------~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 245 KLL-------KEGY---------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred HHH-------HcCC---------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 111 0110 0111222345788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=320.42 Aligned_cols=247 Identities=28% Similarity=0.417 Sum_probs=200.4
Q ss_pred CccccCCCeeEEEEEcCCCcEEEEEEccCCCh-hhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEeecCCCcHH
Q 001768 665 NKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSK-QGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYLENNSLA 743 (1016)
Q Consensus 665 ~~LG~G~~G~Vy~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~ 743 (1016)
+.||+|+||.||+|...+++.||+|.+..... .....+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 46899999999999988889999999876543 33456889999999999999999999999999999999999999999
Q ss_pred HHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCCcceeeec
Q 001768 744 RALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRI 823 (1016)
Q Consensus 744 ~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 823 (1016)
+++.... ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++..............
T Consensus 81 ~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (250)
T cd05085 81 SFLRKKK---DELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK 154 (250)
T ss_pred HHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCC
Confidence 9986543 2588999999999999999999998 999999999999999999999999999875433222112223
Q ss_pred ccCccccChhhhccCCCCCccchhHHHHHHHHHHh-CCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCCCCCCHH
Q 001768 824 AGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGSNFSKK 902 (1016)
Q Consensus 824 ~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 902 (1016)
.++..|+|||++.++.++.++||||||+++||+++ |..||...........+ .... . ...+..
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~-------~~~~-----~----~~~~~~ 218 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQV-------EKGY-----R----MSCPQK 218 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH-------HcCC-----C----CCCCCC
Confidence 44678999999988889999999999999999998 99998755433221111 1110 0 111122
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 001768 903 EAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933 (1016)
Q Consensus 903 ~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 933 (1016)
.+..+.+++.+|++.+|++||++.|++++|.
T Consensus 219 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 219 CPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 3457899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=336.59 Aligned_cols=255 Identities=25% Similarity=0.449 Sum_probs=203.9
Q ss_pred cCccccCccccCCCeeEEEEEcC-CCc----EEEEEEccCCC-hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEE
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLS-DGA----VIAVKQLSSKS-KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLL 732 (1016)
Q Consensus 659 ~~f~~~~~LG~G~~G~Vy~~~~~-~~~----~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 732 (1016)
.+|+..+.||+|+||.||+|++. +++ .||+|.+.... ....+++.+|+.+++.++||||++++|++..+ ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 56899999999999999999854 333 48999987543 34456788999999999999999999999865 5789
Q ss_pred EEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeecccccccc
Q 001768 733 VYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLD 812 (1016)
Q Consensus 733 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~ 812 (1016)
|+||+++|+|.+++.... ..+++..++.++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++..
T Consensus 86 v~e~~~~g~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 86 ITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred eeecCCCCCHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccc
Confidence 999999999999997643 2588999999999999999999998 9999999999999999999999999999865
Q ss_pred CCCCcce-eeecccCccccChhhhccCCCCCccchhHHHHHHHHHHh-CCCCCCCCCchhhHhHHHHHHHHHHhCCcccc
Q 001768 813 EDENTHI-STRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWAYVLQEQGNLLEL 890 (1016)
Q Consensus 813 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 890 (1016)
....... .....++..|+|||++.+..++.++|||||||++|||++ |+.||......+..... ......
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~------~~~~~~--- 230 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL------EKGERL--- 230 (316)
T ss_pred cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH------hCCCCC---
Confidence 5433222 122334678999999999999999999999999999998 99999765543322111 111000
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCc
Q 001768 891 VDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKT 936 (1016)
Q Consensus 891 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 936 (1016)
.. +......+.+++.+||+.+|++||++.+++..+....
T Consensus 231 ---~~----~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~ 269 (316)
T cd05108 231 ---PQ----PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 269 (316)
T ss_pred ---CC----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 00 1122346889999999999999999999999887553
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=335.28 Aligned_cols=237 Identities=26% Similarity=0.364 Sum_probs=191.6
Q ss_pred CccccCCCeeEEEEEcC-CCcEEEEEEccCCC---hhhhHHHHHHHHHHHhc-CCCCeeeeeeeEeecceeEEEEeecCC
Q 001768 665 NKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS---KQGNREFVNEIGMISAL-QHQNLVKLYGCCIEGNQLLLVYEYLEN 739 (1016)
Q Consensus 665 ~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~ 739 (1016)
+.||+|+||.||+|+.. +|+.||+|.++... ......+..|..++... +||||+++++++.+++..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999965 68899999987542 22344566788887754 899999999999999999999999999
Q ss_pred CcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCCcce
Q 001768 740 NSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHI 819 (1016)
Q Consensus 740 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 819 (1016)
|+|.+++.... .+++.++..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (316)
T cd05620 81 GDLMFHIQDKG----RFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NR 152 (316)
T ss_pred CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Cc
Confidence 99999986542 589999999999999999999998 99999999999999999999999999987432211 12
Q ss_pred eeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCCCCC
Q 001768 820 STRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGSNF 899 (1016)
Q Consensus 820 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 899 (1016)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+ .. ..+..+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~-------~~------~~~~~~--- 216 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESI-------RV------DTPHYP--- 216 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH-------Hh------CCCCCC---
Confidence 33467999999999999889999999999999999999999999765543322111 00 011121
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHH
Q 001768 900 SKKEAMTMLNIALLCTNPSPTLRPTMS 926 (1016)
Q Consensus 900 ~~~~~~~l~~li~~cl~~dP~~RPt~~ 926 (1016)
.....++.+++.+||+.||++||++.
T Consensus 217 -~~~~~~~~~li~~~l~~dP~~R~~~~ 242 (316)
T cd05620 217 -RWITKESKDILEKLFERDPTRRLGVV 242 (316)
T ss_pred -CCCCHHHHHHHHHHccCCHHHcCCCh
Confidence 12334688999999999999999984
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=321.63 Aligned_cols=247 Identities=26% Similarity=0.408 Sum_probs=198.3
Q ss_pred CccccCCCeeEEEEEcC-CCcEEEEEEccCCC-hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEeecCCCcH
Q 001768 665 NKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS-KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYLENNSL 742 (1016)
Q Consensus 665 ~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 742 (1016)
+.||+|+||.||+|+.. +++.||+|.+.... ......+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999965 68999999876543 33456789999999999999999999999999999999999999999
Q ss_pred HHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCCccee-e
Q 001768 743 ARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHIS-T 821 (1016)
Q Consensus 743 ~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~-~ 821 (1016)
.+++.... ..+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++........... .
T Consensus 81 ~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 81 LTFLRTEG---PRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred HHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 99986432 3589999999999999999999998 899999999999999999999999999875432211110 1
Q ss_pred ecccCccccChhhhccCCCCCccchhHHHHHHHHHHh-CCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCCCCCC
Q 001768 822 RIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGSNFS 900 (1016)
Q Consensus 822 ~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 900 (1016)
...++..|+|||.+.++.++.++|||||||++|||++ |..||.....+...... .. ......+
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~-------~~---------~~~~~~~ 218 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAI-------EQ---------GVRLPCP 218 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHH-------Hc---------CCCCCCc
Confidence 1123457999999988889999999999999999998 88888654433221111 00 0111122
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 001768 901 KKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933 (1016)
Q Consensus 901 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 933 (1016)
...+..+.+++.+|++.+|++|||+.++.++|+
T Consensus 219 ~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 219 ELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 233457899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=323.87 Aligned_cols=256 Identities=32% Similarity=0.504 Sum_probs=208.9
Q ss_pred HhcCccccCccccCCCeeEEEEEcCCCcEEEEEEccCCChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEee
Q 001768 657 ATNNFDAANKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEY 736 (1016)
Q Consensus 657 ~~~~f~~~~~LG~G~~G~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 736 (1016)
..++|++.+.||+|+||.||+|..++++.||+|.+..... ...++.+|+.++++++||||+++++++..+...++||||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 4578999999999999999999988888999999875432 346789999999999999999999999998999999999
Q ss_pred cCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCC
Q 001768 737 LENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDEN 816 (1016)
Q Consensus 737 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 816 (1016)
+++++|.+++..... ..+++.++..++.|++.|++|||+. +++|+||||+||++++++.++|+|||.+.......
T Consensus 83 ~~~~~L~~~i~~~~~--~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 83 MSKGSLLDFLKSGEG--KKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred cCCCCHHHHHhcccc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 999999999976432 3589999999999999999999998 89999999999999999999999999997654322
Q ss_pred cceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHh-CCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcC
Q 001768 817 THISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSL 895 (1016)
Q Consensus 817 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 895 (1016)
........++..|+|||.+.+..++.++|||||||++|||++ |+.||............ . ... .
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~------~--~~~----~--- 222 (261)
T cd05034 158 YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQV------E--RGY----R--- 222 (261)
T ss_pred hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH------H--cCC----C---
Confidence 221222334568999999998889999999999999999999 99998755433221110 0 000 0
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 001768 896 GSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEG 934 (1016)
Q Consensus 896 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 934 (1016)
...+...+..+.+++.+|++.+|++||+++++++.|+.
T Consensus 223 -~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 223 -MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred -CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 01111224578999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=332.80 Aligned_cols=247 Identities=24% Similarity=0.366 Sum_probs=199.1
Q ss_pred CccccCCCeeEEEEEcC-CCcEEEEEEccCCC---hhhhHHHHHHHHHHHhc-CCCCeeeeeeeEeecceeEEEEeecCC
Q 001768 665 NKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS---KQGNREFVNEIGMISAL-QHQNLVKLYGCCIEGNQLLLVYEYLEN 739 (1016)
Q Consensus 665 ~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~ 739 (1016)
+.||+|+||.||+|+.. +++.||+|++.... ......+..|.++++.+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999865 57899999987542 23345677888998888 799999999999999999999999999
Q ss_pred CcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCCcce
Q 001768 740 NSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHI 819 (1016)
Q Consensus 740 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 819 (1016)
++|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++....... .
T Consensus 81 ~~L~~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~ 152 (318)
T cd05570 81 GDLMFHIQRSG----RFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-T 152 (318)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-c
Confidence 99999886543 589999999999999999999998 999999999999999999999999999874322211 2
Q ss_pred eeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCCCCC
Q 001768 820 STRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGSNF 899 (1016)
Q Consensus 820 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 899 (1016)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+ ... .. .+
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i-------~~~------~~----~~ 215 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSI-------LED------EV----RY 215 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHH-------HcC------CC----CC
Confidence 23356899999999999999999999999999999999999999765543322111 011 01 11
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHHHhccCcCCcCccccC
Q 001768 900 SKKEAMTMLNIALLCTNPSPTLRPTM-----SSAVSMLEGKTAVQAPIIRR 945 (1016)
Q Consensus 900 ~~~~~~~l~~li~~cl~~dP~~RPt~-----~evl~~L~~~~~~~~p~~~~ 945 (1016)
+...+..+.+++.+||+.||++||++ .+++ .+||+..
T Consensus 216 ~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll---------~~~~~~~ 257 (318)
T cd05570 216 PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIK---------GHPFFRE 257 (318)
T ss_pred CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHh---------cCCCcCC
Confidence 22234568999999999999999999 6555 4677654
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=330.03 Aligned_cols=257 Identities=32% Similarity=0.466 Sum_probs=205.9
Q ss_pred CccccCccccCCCeeEEEEEcC------CCcEEEEEEccCCC-hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEE
Q 001768 660 NFDAANKIGEGGFGPVYKGTLS------DGAVIAVKQLSSKS-KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLL 732 (1016)
Q Consensus 660 ~f~~~~~LG~G~~G~Vy~~~~~------~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 732 (1016)
+|++.+.||+|+||.||+|+.. ....+|+|.+.... ......+.+|+++++.++||||+++++.+..++..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4778899999999999999853 23578999887553 3345678899999999999999999999999999999
Q ss_pred EEeecCCCcHHHHhccCc--------------------CcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCce
Q 001768 733 VYEYLENNSLARALFGKE--------------------GQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATN 792 (1016)
Q Consensus 733 V~E~~~~gsL~~~l~~~~--------------------~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~N 792 (1016)
||||+++++|.+++.... .....+++.+++.++.|++.||+|||+. +|+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence 999999999999986421 1123588999999999999999999998 99999999999
Q ss_pred EEEccCCceeeeccccccccCCCCcce-eeecccCccccChhhhccCCCCCccchhHHHHHHHHHHh-CCCCCCCCCchh
Q 001768 793 VLLDKDLNAKISDFGLAKLDEDENTHI-STRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEE 870 (1016)
Q Consensus 793 ILl~~~~~~kL~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~ 870 (1016)
|++++++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||....+++
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 999999999999999997543332211 122345678999999988889999999999999999999 999997665444
Q ss_pred hHhHHHHHHHHHHhCCcccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 001768 871 FVYLLDWAYVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGK 935 (1016)
Q Consensus 871 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 935 (1016)
...... .. ... ..+...+..+.+++.+||+.+|++||++.|+++.|++.
T Consensus 238 ~~~~~~-------~~-----~~~----~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~ 286 (290)
T cd05045 238 LFNLLK-------TG-----YRM----ERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286 (290)
T ss_pred HHHHHh-------CC-----CCC----CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHH
Confidence 322110 00 011 11222345788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=333.36 Aligned_cols=237 Identities=26% Similarity=0.390 Sum_probs=191.9
Q ss_pred CccccCCCeeEEEEEcC-CCcEEEEEEccCCC---hhhhHHHHHHHHHHHhc-CCCCeeeeeeeEeecceeEEEEeecCC
Q 001768 665 NKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS---KQGNREFVNEIGMISAL-QHQNLVKLYGCCIEGNQLLLVYEYLEN 739 (1016)
Q Consensus 665 ~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~ 739 (1016)
+.||+|+||.||+|+.. +++.||+|+++... ......+..|..++... +||||+++++++.+++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999965 57899999987542 22344566778888764 899999999999999999999999999
Q ss_pred CcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCCcce
Q 001768 740 NSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHI 819 (1016)
Q Consensus 740 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 819 (1016)
|+|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 g~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 152 (316)
T cd05619 81 GDLMFHIQSCH----KFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-K 152 (316)
T ss_pred CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-c
Confidence 99999986532 589999999999999999999998 999999999999999999999999999874322211 2
Q ss_pred eeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCCCCC
Q 001768 820 STRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGSNF 899 (1016)
Q Consensus 820 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 899 (1016)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+. . ..+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~-------~------~~~~~---- 215 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIR-------M------DNPCY---- 215 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHH-------h------CCCCC----
Confidence 234578999999999998889999999999999999999999998655443221110 0 01111
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHH
Q 001768 900 SKKEAMTMLNIALLCTNPSPTLRPTMS 926 (1016)
Q Consensus 900 ~~~~~~~l~~li~~cl~~dP~~RPt~~ 926 (1016)
+......+.+++.+||+.||++||++.
T Consensus 216 ~~~~~~~~~~li~~~l~~~P~~R~~~~ 242 (316)
T cd05619 216 PRWLTREAKDILVKLFVREPERRLGVK 242 (316)
T ss_pred CccCCHHHHHHHHHHhccCHhhcCCCh
Confidence 122334688999999999999999996
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=327.15 Aligned_cols=258 Identities=28% Similarity=0.411 Sum_probs=205.4
Q ss_pred HhcCccccCccccCCCeeEEEEEcCC------CcEEEEEEccCCC-hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecce
Q 001768 657 ATNNFDAANKIGEGGFGPVYKGTLSD------GAVIAVKQLSSKS-KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQ 729 (1016)
Q Consensus 657 ~~~~f~~~~~LG~G~~G~Vy~~~~~~------~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 729 (1016)
.+++|++.+.||+|+||.||+|.+.+ +..||+|.+.... ......+.+|+.+++.++|+||+++++++.+.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 35679999999999999999998753 5689999886543 3344578999999999999999999999999889
Q ss_pred eEEEEeecCCCcHHHHhccCcC---cCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCC---ceee
Q 001768 730 LLLVYEYLENNSLARALFGKEG---QCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDL---NAKI 803 (1016)
Q Consensus 730 ~~lV~E~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~---~~kL 803 (1016)
.++||||+++++|.+++..... ....+++.++++++.||+.||+|||+. +++||||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEe
Confidence 9999999999999999965431 123589999999999999999999998 899999999999998765 5999
Q ss_pred eccccccccCCCCcce-eeecccCccccChhhhccCCCCCccchhHHHHHHHHHHh-CCCCCCCCCchhhHhHHHHHHHH
Q 001768 804 SDFGLAKLDEDENTHI-STRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWAYVL 881 (1016)
Q Consensus 804 ~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~ 881 (1016)
+|||+++......... ......+..|+|||++.+..++.++|||||||++|||++ |+.||.....++....+
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~------ 234 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFV------ 234 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH------
Confidence 9999998653222111 112233568999999998899999999999999999997 99999765544322111
Q ss_pred HHhCCcccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 001768 882 QEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933 (1016)
Q Consensus 882 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 933 (1016)
.... ....+...+..+.+++.+|++.+|++||++.+|++.|+
T Consensus 235 ~~~~----------~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 235 TGGG----------RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HcCC----------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 1110 01112223457889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=323.31 Aligned_cols=245 Identities=28% Similarity=0.409 Sum_probs=196.9
Q ss_pred ccccCCCeeEEEEEc---CCCcEEEEEEccCCC--hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEeecCCC
Q 001768 666 KIGEGGFGPVYKGTL---SDGAVIAVKQLSSKS--KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYLENN 740 (1016)
Q Consensus 666 ~LG~G~~G~Vy~~~~---~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 740 (1016)
.||+|+||.||+|.+ .++..||+|++.... ....+++.+|+.+++.++||||+++++++. ++..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 689999999999974 357889999986543 234567899999999999999999999885 45679999999999
Q ss_pred cHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCCccee
Q 001768 741 SLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHIS 820 (1016)
Q Consensus 741 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 820 (1016)
+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 ~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 81 PLNKFLQKNK----HVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred cHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 9999996432 589999999999999999999998 899999999999999999999999999986544332211
Q ss_pred --eecccCccccChhhhccCCCCCccchhHHHHHHHHHHh-CCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCCC
Q 001768 821 --TRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGS 897 (1016)
Q Consensus 821 --~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 897 (1016)
....++..|+|||.+....++.++|||||||++|||++ |+.||......+....+ ..+.. +.
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i-------~~~~~-----~~--- 218 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMI-------ESGER-----ME--- 218 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-------HCCCC-----CC---
Confidence 12234578999999988888999999999999999998 99999765443322111 11110 11
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 001768 898 NFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEG 934 (1016)
Q Consensus 898 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 934 (1016)
.+...+..+.+++.+||+.||++||++++|++.|++
T Consensus 219 -~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 219 -CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred -CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 122234578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=333.76 Aligned_cols=260 Identities=22% Similarity=0.268 Sum_probs=200.4
Q ss_pred cCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCC---ChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEE
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSK---SKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVY 734 (1016)
Q Consensus 659 ~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 734 (1016)
++|++.+.||+|+||.||+++.. +++.||+|++... .......+.+|+.+++.++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47899999999999999999965 6899999998642 2223456888999999999999999999999999999999
Q ss_pred eecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCC
Q 001768 735 EYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDED 814 (1016)
Q Consensus 735 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 814 (1016)
||+++|+|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 81 DYYVGGDLLTLLSKFE---DRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred ecCCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 9999999999996532 2589999999999999999999998 999999999999999999999999999876544
Q ss_pred CCcceeeecccCccccChhhhcc-----CCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCccc
Q 001768 815 ENTHISTRIAGTVGYMAPEYAMR-----GYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLE 889 (1016)
Q Consensus 815 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 889 (1016)
..........||+.|+|||++.. +.++.++|||||||++|||++|+.||......+.... . ........
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~-----i-~~~~~~~~ 228 (331)
T cd05597 155 DGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK-----I-MNHKEHFQ 228 (331)
T ss_pred CCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHH-----H-HcCCCccc
Confidence 33333333569999999999863 4578899999999999999999999976543322111 1 11111001
Q ss_pred ccCCcCCCCCCHHHHHHHHHHHHHccCCCC--CCCCCHHHHHHHhccCcCCcCccccC
Q 001768 890 LVDPSLGSNFSKKEAMTMLNIALLCTNPSP--TLRPTMSSAVSMLEGKTAVQAPIIRR 945 (1016)
Q Consensus 890 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP--~~RPt~~evl~~L~~~~~~~~p~~~~ 945 (1016)
+ +.... ..+..+.+++.+|+..++ ..||++.+++ .|||+..
T Consensus 229 -~-~~~~~----~~~~~~~~li~~ll~~~~~r~~r~~~~~~l---------~hp~~~~ 271 (331)
T cd05597 229 -F-PPDVT----DVSEEAKDLIRRLICSPETRLGRNGLQDFK---------DHPFFEG 271 (331)
T ss_pred -C-CCccC----CCCHHHHHHHHHHccCcccccCCCCHHHHh---------cCCCCCC
Confidence 0 11111 133467788888775433 3478888777 4677654
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=317.90 Aligned_cols=266 Identities=23% Similarity=0.338 Sum_probs=205.0
Q ss_pred HhcCccccCccccCCCeeEEEEEcC-CCcEEEEEEccC--CChhhhHHHHHHHHHHHhcCCCCeeeeeeeEee-----cc
Q 001768 657 ATNNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSS--KSKQGNREFVNEIGMISALQHQNLVKLYGCCIE-----GN 728 (1016)
Q Consensus 657 ~~~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-----~~ 728 (1016)
+...|...+.||+|+||.|..|... +|+.||||++.. ......++..+|+++|+.++|+||+.+.+.+.. -+
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 4455666799999999999999854 789999999973 355567788899999999999999999998865 35
Q ss_pred eeEEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeecccc
Q 001768 729 QLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGL 808 (1016)
Q Consensus 729 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGl 808 (1016)
..|+|+|+| +.+|...++... .|+.+.+..++.|+++||.|+|+. +|+|||+||+|++++.+..+||+|||+
T Consensus 100 DvYiV~elM-etDL~~iik~~~----~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGL 171 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIKSQQ----DLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGL 171 (359)
T ss_pred eeEEehhHH-hhHHHHHHHcCc----cccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccc
Confidence 789999999 458999996653 599999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCC-CcceeeecccCccccChhhhc-cCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHH-------
Q 001768 809 AKLDEDE-NTHISTRIAGTVGYMAPEYAM-RGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAY------- 879 (1016)
Q Consensus 809 a~~~~~~-~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~------- 879 (1016)
|+..... .....+..+.|..|+|||++. ...|+.+.||||.|||+.||++|++-|.+...-....++....
T Consensus 172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~ 251 (359)
T KOG0660|consen 172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEED 251 (359)
T ss_pred eeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHH
Confidence 9976432 122335677899999999876 4579999999999999999999999998765544333221100
Q ss_pred -HHHH---hCCcccccCCcCCCCCC---HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 880 -VLQE---QGNLLELVDPSLGSNFS---KKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 880 -~~~~---~~~~~~~~d~~l~~~~~---~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
.... .........+.-+..+. +.......+|+.+||..||.+|+|++|+++
T Consensus 252 l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 252 LQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred HHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 0000 00011111111111111 123446889999999999999999998875
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=328.36 Aligned_cols=257 Identities=27% Similarity=0.409 Sum_probs=204.9
Q ss_pred cCccccCccccCCCeeEEEEEcC------CCcEEEEEEccCCChh-hhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeE
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLS------DGAVIAVKQLSSKSKQ-GNREFVNEIGMISALQHQNLVKLYGCCIEGNQLL 731 (1016)
Q Consensus 659 ~~f~~~~~LG~G~~G~Vy~~~~~------~~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 731 (1016)
.+|++.+.||+|+||.||+|... ++..||+|++...... ..+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 34778899999999999999853 2578999999755432 3466889999999999999999999999999999
Q ss_pred EEEeecCCCcHHHHhccCc------------CcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCC
Q 001768 732 LVYEYLENNSLARALFGKE------------GQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDL 799 (1016)
Q Consensus 732 lV~E~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~ 799 (1016)
+++||+++++|.+++.... .....+++..+..++.|++.||+|||+. +|+||||||+||++++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCC
Confidence 9999999999999985321 1123588999999999999999999998 999999999999999999
Q ss_pred ceeeeccccccccCCCCc-ceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHh-CCCCCCCCCchhhHhHHHH
Q 001768 800 NAKISDFGLAKLDEDENT-HISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDW 877 (1016)
Q Consensus 800 ~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~ 877 (1016)
.+||+|||+++....... .......+++.|+|||.+.++.++.++|||||||++|||++ |..||......+....+
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i-- 239 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMI-- 239 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH--
Confidence 999999999875433221 12223456789999999988889999999999999999998 88888765443322111
Q ss_pred HHHHHHhCCcccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 001768 878 AYVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEG 934 (1016)
Q Consensus 878 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 934 (1016)
..... ..++...+..+.+++.+||+.+|++||++++|++.|+.
T Consensus 240 -----~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 240 -----RNRQV---------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred -----HcCCc---------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 11111 11222345568999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=324.81 Aligned_cols=255 Identities=27% Similarity=0.417 Sum_probs=203.1
Q ss_pred hcCccccCccccCCCeeEEEEEc-CCCcEEEEEEccCCChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEee
Q 001768 658 TNNFDAANKIGEGGFGPVYKGTL-SDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEY 736 (1016)
Q Consensus 658 ~~~f~~~~~LG~G~~G~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 736 (1016)
.++|++.+.||+|+||.||+|+. .+++.||+|++..........+.+|+.++++++||||+++++++..++..++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 35789999999999999999996 46889999998765555556788999999999999999999999999999999999
Q ss_pred cCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCC
Q 001768 737 LENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDEN 816 (1016)
Q Consensus 737 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 816 (1016)
+++++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++.......
T Consensus 88 ~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06646 88 CGGGSLQDIYHVTG----PLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATI 160 (267)
T ss_pred CCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence 99999999986442 589999999999999999999998 99999999999999999999999999997553321
Q ss_pred cceeeecccCccccChhhhc---cCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCC
Q 001768 817 THISTRIAGTVGYMAPEYAM---RGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDP 893 (1016)
Q Consensus 817 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 893 (1016)
. ......|++.|+|||.+. ...++.++|||||||++|||++|+.||....+.+..... .... ...+
T Consensus 161 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~-------~~~~---~~~~ 229 (267)
T cd06646 161 A-KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM-------SKSN---FQPP 229 (267)
T ss_pred c-ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheee-------ecCC---CCCC
Confidence 1 122346889999999874 345788999999999999999999998644322211000 0000 0111
Q ss_pred cCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 001768 894 SLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSML 932 (1016)
Q Consensus 894 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 932 (1016)
... .....+..+.+++.+||+.+|++||+++++++.|
T Consensus 230 ~~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 230 KLK--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCc--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 111 0112345789999999999999999999998643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=326.84 Aligned_cols=257 Identities=29% Similarity=0.470 Sum_probs=206.7
Q ss_pred hcCccccCccccCCCeeEEEEEcC------CCcEEEEEEccCCChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeE
Q 001768 658 TNNFDAANKIGEGGFGPVYKGTLS------DGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLL 731 (1016)
Q Consensus 658 ~~~f~~~~~LG~G~~G~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 731 (1016)
.++|+..++||+|+||.||++... ++..+|+|.+..........+.+|+++++.++|+||+++++++.+++..+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence 356788999999999999999632 35689999988776666778999999999999999999999999999999
Q ss_pred EEEeecCCCcHHHHhccCcC-----------cCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCc
Q 001768 732 LVYEYLENNSLARALFGKEG-----------QCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLN 800 (1016)
Q Consensus 732 lV~E~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~ 800 (1016)
+||||+++++|.+++..... ....+++..++.++.|++.|++|||+. +++||||||+||++++++.
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLV 160 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCC
Confidence 99999999999999965421 113589999999999999999999998 9999999999999999999
Q ss_pred eeeeccccccccCCCCcc-eeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHh-CCCCCCCCCchhhHhHHHHH
Q 001768 801 AKISDFGLAKLDEDENTH-ISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWA 878 (1016)
Q Consensus 801 ~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~ 878 (1016)
+||+|||+++........ ......+++.|+|||.+.+..++.++|||||||++|||++ |++||......+.....
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~--- 237 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI--- 237 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH---
Confidence 999999998754332211 1122345678999999998889999999999999999998 89998654433321111
Q ss_pred HHHHHhCCcccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 001768 879 YVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933 (1016)
Q Consensus 879 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 933 (1016)
.... ... .+...+..+.+++.+||+.||++||++.+|.+.|+
T Consensus 238 ----~~~~-----~~~----~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 238 ----TQGR-----ELE----RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred ----HcCc-----cCC----CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 0100 011 11123346889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=327.82 Aligned_cols=257 Identities=27% Similarity=0.423 Sum_probs=202.6
Q ss_pred cCccccCccccCCCeeEEEEEcC-CCc----EEEEEEccCCC-hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEE
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLS-DGA----VIAVKQLSSKS-KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLL 732 (1016)
Q Consensus 659 ~~f~~~~~LG~G~~G~Vy~~~~~-~~~----~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 732 (1016)
++|++.+.||+|+||.||+|++. +++ .||+|.+.... .....++..|+.++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 46788899999999999999864 344 47888875443 2334567888889999999999999998864 55789
Q ss_pred EEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeecccccccc
Q 001768 733 VYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLD 812 (1016)
Q Consensus 733 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~ 812 (1016)
++||+++|+|.+++.... ..+++..+..++.||+.||+|||+. +++||||||+||++++++.+||+|||+++..
T Consensus 86 i~e~~~~gsL~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHR---DSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred EEEeCCCCcHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceec
Confidence 999999999999996543 2589999999999999999999998 8999999999999999999999999999865
Q ss_pred CCCCc-ceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHh-CCCCCCCCCchhhHhHHHHHHHHHHhCCcccc
Q 001768 813 EDENT-HISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWAYVLQEQGNLLEL 890 (1016)
Q Consensus 813 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 890 (1016)
..... .......++..|+|||++.++.++.++|||||||++|||++ |+.||............ ..+...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~-------~~~~~~-- 230 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL-------EKGERL-- 230 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-------HCCCcC--
Confidence 43322 12233457788999999988889999999999999999998 99999765443322111 111110
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCcCC
Q 001768 891 VDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTAV 938 (1016)
Q Consensus 891 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 938 (1016)
..+. .....+.+++.+||..||++|||+.|+++.|+....-
T Consensus 231 ~~~~-------~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 231 AQPQ-------ICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred CCCC-------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 1111 1234578899999999999999999999998775443
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=326.29 Aligned_cols=258 Identities=27% Similarity=0.453 Sum_probs=207.7
Q ss_pred hcCccccCccccCCCeeEEEEEcCC------CcEEEEEEccCCC-hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeeccee
Q 001768 658 TNNFDAANKIGEGGFGPVYKGTLSD------GAVIAVKQLSSKS-KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQL 730 (1016)
Q Consensus 658 ~~~f~~~~~LG~G~~G~Vy~~~~~~------~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 730 (1016)
.++|++.+.||+|+||.||+|...+ +..||+|.+.... ......+.+|+.+++.++||||+++++++..+...
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 4678999999999999999998642 4689999987543 34456788999999999999999999999999999
Q ss_pred EEEEeecCCCcHHHHhccCcCc------CcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeee
Q 001768 731 LLVYEYLENNSLARALFGKEGQ------CLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKIS 804 (1016)
Q Consensus 731 ~lV~E~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~ 804 (1016)
++||||+++++|.+++...... ...+++..++.++.|++.||+|||+. +|+||||||+||++++++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEEC
Confidence 9999999999999999654321 12478999999999999999999998 99999999999999999999999
Q ss_pred ccccccccCCCCc-ceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHh-CCCCCCCCCchhhHhHHHHHHHHH
Q 001768 805 DFGLAKLDEDENT-HISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWAYVLQ 882 (1016)
Q Consensus 805 DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~ 882 (1016)
|||+++....... .......++..|+|||.+.++.++.++|||||||++||+++ |+.||......+..... .
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~------~ 235 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFV------I 235 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHH------h
Confidence 9999875433221 11223456788999999988889999999999999999998 99998765544332211 0
Q ss_pred HhCCcccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 001768 883 EQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEG 934 (1016)
Q Consensus 883 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 934 (1016)
.... +.. +...+..+.+++.+||+.+|++|||+.++++.|+.
T Consensus 236 -~~~~-----~~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 236 -DGGH-----LDL----PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred -cCCC-----CCC----CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 1111 111 11234578999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=329.62 Aligned_cols=264 Identities=25% Similarity=0.413 Sum_probs=203.7
Q ss_pred hcCccccCccccCCCeeEEEEEcCC---------------CcEEEEEEccCCC-hhhhHHHHHHHHHHHhcCCCCeeeee
Q 001768 658 TNNFDAANKIGEGGFGPVYKGTLSD---------------GAVIAVKQLSSKS-KQGNREFVNEIGMISALQHQNLVKLY 721 (1016)
Q Consensus 658 ~~~f~~~~~LG~G~~G~Vy~~~~~~---------------~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~ 721 (1016)
.++|++.+.||+|+||.||+++... ...||+|.++... ......+.+|++++++++|||+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 3578999999999999999987532 2358999987653 33456789999999999999999999
Q ss_pred eeEeecceeEEEEeecCCCcHHHHhccCcC--------cCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceE
Q 001768 722 GCCIEGNQLLLVYEYLENNSLARALFGKEG--------QCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNV 793 (1016)
Q Consensus 722 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~--------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NI 793 (1016)
+++...+..++||||+++++|.+++..... ....+++..++.++.|++.||+|||+. +++||||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhE
Confidence 999999999999999999999999854321 112478999999999999999999998 999999999999
Q ss_pred EEccCCceeeeccccccccCCCCc-ceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHh--CCCCCCCCCchh
Q 001768 794 LLDKDLNAKISDFGLAKLDEDENT-HISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS--GKSNTNYRPKEE 870 (1016)
Q Consensus 794 Ll~~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt--G~~P~~~~~~~~ 870 (1016)
++++++.+||+|||++........ .......++..|+|||++.++.++.++|||||||++|||++ |..||.....++
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 999999999999999975433221 11222345778999999988889999999999999999998 566776544433
Q ss_pred hHhHHHHHHHHHHhCCcccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 001768 871 FVYLLDWAYVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933 (1016)
Q Consensus 871 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 933 (1016)
...... ........... ...+...+..+.+++.+||+.||++||++++|++.|+
T Consensus 241 ~~~~~~--~~~~~~~~~~~-------~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 241 VIENTG--EFFRNQGRQIY-------LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHHHH--Hhhhhcccccc-------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 221111 00000000000 0011123457999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=334.54 Aligned_cols=251 Identities=24% Similarity=0.332 Sum_probs=196.6
Q ss_pred CccccCCCeeEEEEEcC-CCcEEEEEEccCCC---hhhhHHHHHHHH-HHHhcCCCCeeeeeeeEeecceeEEEEeecCC
Q 001768 665 NKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS---KQGNREFVNEIG-MISALQHQNLVKLYGCCIEGNQLLLVYEYLEN 739 (1016)
Q Consensus 665 ~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~-~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 739 (1016)
+.||+|+||+||+|+.. +|+.||+|++.... ......+..|.. +++.++||||+++++++.+++..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999965 68999999986532 222334455544 56789999999999999999999999999999
Q ss_pred CcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCCcce
Q 001768 740 NSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHI 819 (1016)
Q Consensus 740 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 819 (1016)
|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (323)
T cd05575 81 GELFFHLQRER----SFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KT 152 (323)
T ss_pred CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Cc
Confidence 99999986543 689999999999999999999998 99999999999999999999999999987432221 12
Q ss_pred eeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCCCCC
Q 001768 820 STRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGSNF 899 (1016)
Q Consensus 820 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 899 (1016)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+ . .. ...+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i------~-~~------~~~~~~~- 218 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNI------L-NK------PLRLKPN- 218 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHH------H-cC------CCCCCCC-
Confidence 33457899999999999889999999999999999999999999765543321111 0 00 0111122
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCcCCcCccccC
Q 001768 900 SKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTAVQAPIIRR 945 (1016)
Q Consensus 900 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~p~~~~ 945 (1016)
.+..+.+++.+|++.||++||++.+.++.+ +.+||+..
T Consensus 219 ---~~~~~~~li~~~l~~~p~~R~~~~~~~~~i-----l~~~~~~~ 256 (323)
T cd05575 219 ---ISVSARHLLEGLLQKDRTKRLGAKDDFLEI-----KNHVFFSS 256 (323)
T ss_pred ---CCHHHHHHHHHHhhcCHHhCCCCCCCHHHH-----HcCCCcCC
Confidence 244688999999999999999986433322 24666654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=333.43 Aligned_cols=243 Identities=31% Similarity=0.450 Sum_probs=207.1
Q ss_pred ccccCCCeeEEEEEcCC-CcEEEEEEccCCChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEeecCCCcHHH
Q 001768 666 KIGEGGFGPVYKGTLSD-GAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYLENNSLAR 744 (1016)
Q Consensus 666 ~LG~G~~G~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~ 744 (1016)
.||+|.||+||-|++.+ ...+|||.+........+.+.+|+..-+.++|.|||+++|.+.+++.+-+.||-++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 79999999999999764 56789999988877778899999999999999999999999999999999999999999999
Q ss_pred HhccCcCcCcCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEc-cCCceeeeccccccccCCCCcceee
Q 001768 745 ALFGKEGQCLNL--DWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLD-KDLNAKISDFGLAKLDEDENTHIST 821 (1016)
Q Consensus 745 ~l~~~~~~~~~l--~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~-~~~~~kL~DFGla~~~~~~~~~~~~ 821 (1016)
++..+-+ ++ .+.++--+.+||++||.|||++ .|||||||-+|||++ -.|.+||+|||.++....-+. .+.
T Consensus 662 LLrskWG---PlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP-~TE 734 (1226)
T KOG4279|consen 662 LLRSKWG---PLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP-CTE 734 (1226)
T ss_pred HHHhccC---CCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCCc-ccc
Confidence 9977653 45 7888889999999999999999 899999999999996 578999999999986654332 455
Q ss_pred ecccCccccChhhhccC--CCCCccchhHHHHHHHHHHhCCCCCCCCCchh-hHhHHHHHHHHHHhCCcccccCCcCCCC
Q 001768 822 RIAGTVGYMAPEYAMRG--YLTDKADVYSFGIVALEIVSGKSNTNYRPKEE-FVYLLDWAYVLQEQGNLLELVDPSLGSN 898 (1016)
Q Consensus 822 ~~~gt~~y~aPE~~~~~--~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 898 (1016)
.+.||..|||||++..+ .|..++|||||||++.||.||++||....... .+..+ -.-...+.
T Consensus 735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkV---------------GmyKvHP~ 799 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKV---------------GMYKVHPP 799 (1226)
T ss_pred ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhh---------------cceecCCC
Confidence 67899999999999866 58999999999999999999999997533222 11111 00112355
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 899 FSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 899 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
+|.+...+...+|.+|+.+||.+||+++++++
T Consensus 800 iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 800 IPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred CcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 67788889999999999999999999998874
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=330.26 Aligned_cols=243 Identities=30% Similarity=0.456 Sum_probs=201.5
Q ss_pred ccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCCh---hhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEee
Q 001768 661 FDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSK---QGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEY 736 (1016)
Q Consensus 661 f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 736 (1016)
|.-++.||.|+||.||-|+.. +.+.||||++....+ ....++..|+..|++++|||+|.+.|+|..+...||||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 566789999999999999954 678999999875443 3346788999999999999999999999999999999999
Q ss_pred cCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCC
Q 001768 737 LENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDEN 816 (1016)
Q Consensus 737 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 816 (1016)
|-| +-.|++.-.. .++.+.++..|+.+.+.||+|||+. +.||||||+.|||+++.|.|||+|||.|.+....+
T Consensus 108 ClG-SAsDlleVhk---KplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAn 180 (948)
T KOG0577|consen 108 CLG-SASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPAN 180 (948)
T ss_pred Hhc-cHHHHHHHHh---ccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCchh
Confidence 954 7777775443 4799999999999999999999999 89999999999999999999999999998765543
Q ss_pred cceeeecccCccccChhhhc---cCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCC
Q 001768 817 THISTRIAGTVGYMAPEYAM---RGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDP 893 (1016)
Q Consensus 817 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 893 (1016)
.++|||.|||||++. .+.|+-|+||||||++..||.-.++|..........+-+ ... -.|
T Consensus 181 -----sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHI-------AQN-----esP 243 (948)
T KOG0577|consen 181 -----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI-------AQN-----ESP 243 (948)
T ss_pred -----cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHH-------Hhc-----CCC
Confidence 468999999999885 578999999999999999999999997655443322211 111 112
Q ss_pred cCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 894 SLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 894 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
.+. ..+....+.+++..||++-|.+|||..++++
T Consensus 244 tLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 244 TLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred CCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 222 2345667999999999999999999998874
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=334.26 Aligned_cols=243 Identities=22% Similarity=0.326 Sum_probs=191.0
Q ss_pred CccccCCCeeEEEEEcC-CCcEEEEEEccCC---ChhhhHHHHHHHHHHHhc-CCCCeeeeeeeEeecceeEEEEeecCC
Q 001768 665 NKIGEGGFGPVYKGTLS-DGAVIAVKQLSSK---SKQGNREFVNEIGMISAL-QHQNLVKLYGCCIEGNQLLLVYEYLEN 739 (1016)
Q Consensus 665 ~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~ 739 (1016)
+.||+|+||.||+|+.. +++.||+|++... .......+.+|+.++.++ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999965 5789999998754 223345677888888877 899999999999999999999999999
Q ss_pred CcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCCcce
Q 001768 740 NSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHI 819 (1016)
Q Consensus 740 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 819 (1016)
|+|..++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++....... .
T Consensus 81 ~~L~~~~~~~~----~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-~ 152 (329)
T cd05618 81 GDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-T 152 (329)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-c
Confidence 99998885443 689999999999999999999998 999999999999999999999999999874322211 2
Q ss_pred eeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhh--HhHHHHHHHHHHhCCcccccCCcCCC
Q 001768 820 STRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEF--VYLLDWAYVLQEQGNLLELVDPSLGS 897 (1016)
Q Consensus 820 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~d~~l~~ 897 (1016)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||........ .....+......... .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~------~---- 222 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ------I---- 222 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC------C----
Confidence 2345789999999999998999999999999999999999999963211110 001111111111110 1
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCH
Q 001768 898 NFSKKEAMTMLNIALLCTNPSPTLRPTM 925 (1016)
Q Consensus 898 ~~~~~~~~~l~~li~~cl~~dP~~RPt~ 925 (1016)
.++......+.+++.+||+.||++||++
T Consensus 223 ~~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 223 RIPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 1222334568899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=327.84 Aligned_cols=264 Identities=25% Similarity=0.401 Sum_probs=206.4
Q ss_pred hcCccccCccccCCCeeEEEEEcCC-----------------CcEEEEEEccCCC-hhhhHHHHHHHHHHHhcCCCCeee
Q 001768 658 TNNFDAANKIGEGGFGPVYKGTLSD-----------------GAVIAVKQLSSKS-KQGNREFVNEIGMISALQHQNLVK 719 (1016)
Q Consensus 658 ~~~f~~~~~LG~G~~G~Vy~~~~~~-----------------~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~ 719 (1016)
..+|++.+.||+|+||.||+|+..+ +..||+|.+.... ......+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4578999999999999999987542 2468999987653 344567889999999999999999
Q ss_pred eeeeEeecceeEEEEeecCCCcHHHHhccCcCc-------CcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCce
Q 001768 720 LYGCCIEGNQLLLVYEYLENNSLARALFGKEGQ-------CLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATN 792 (1016)
Q Consensus 720 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~-------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~N 792 (1016)
+++++..++..++||||+++++|.+++...... ...+++..++.++.|++.||+|||+. +|+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhc
Confidence 999999999999999999999999999654311 12589999999999999999999998 99999999999
Q ss_pred EEEccCCceeeeccccccccCCCCc-ceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHh--CCCCCCCCCch
Q 001768 793 VLLDKDLNAKISDFGLAKLDEDENT-HISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS--GKSNTNYRPKE 869 (1016)
Q Consensus 793 ILl~~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt--G~~P~~~~~~~ 869 (1016)
|+++.++.++|+|||+++....... .......+++.|+|||++.++.++.++|||||||++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 9999999999999999875433221 12233456788999999988889999999999999999998 67777654433
Q ss_pred hhHhHHHHHHHHHHhCCcccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 001768 870 EFVYLLDWAYVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933 (1016)
Q Consensus 870 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 933 (1016)
+... ......... ........+...+.++.+++.+|++.||++|||+.|+++.|+
T Consensus 241 ~~~~---~~~~~~~~~------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 241 QVIE---NAGHFFRDD------GRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred HHHH---HHHhccccc------cccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 3211 111000000 000001112223457999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=322.63 Aligned_cols=262 Identities=23% Similarity=0.372 Sum_probs=205.0
Q ss_pred cCccccCccccCCCeeEEEEEc-CCCcEEEEEEccCC-ChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEee
Q 001768 659 NNFDAANKIGEGGFGPVYKGTL-SDGAVIAVKQLSSK-SKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEY 736 (1016)
Q Consensus 659 ~~f~~~~~LG~G~~G~Vy~~~~-~~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 736 (1016)
++|++.+.||+|+||.||+|+. .+++.||+|.+... .......+.+|++++++++||||+++++++..++..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 4678899999999999999985 46889999998654 233456788999999999999999999999999999999999
Q ss_pred cCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCC
Q 001768 737 LENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDEN 816 (1016)
Q Consensus 737 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 816 (1016)
+++++|..+. .+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~- 148 (279)
T cd06619 81 MDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS- 148 (279)
T ss_pred CCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecccc-
Confidence 9999997653 478889999999999999999998 9999999999999999999999999999754332
Q ss_pred cceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhH-hHHHHHHHHHHhCCcccccCCcC
Q 001768 817 THISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFV-YLLDWAYVLQEQGNLLELVDPSL 895 (1016)
Q Consensus 817 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~d~~l 895 (1016)
......||..|+|||++.+..++.++|||||||++|+|++|+.||......... ........... . ..+..
T Consensus 149 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~-----~~~~~ 220 (279)
T cd06619 149 --IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVD-E-----DPPVL 220 (279)
T ss_pred --cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhc-c-----CCCCC
Confidence 123357899999999999888999999999999999999999998643221110 00011000000 0 01111
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCcCCcCccccCCCChhhh
Q 001768 896 GSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTAVQAPIIRRNSDSQDA 952 (1016)
Q Consensus 896 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~p~~~~~~~~~~~ 952 (1016)
. .......+.+++.+|++.+|++||+++|+++ +||+.........
T Consensus 221 ~---~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~---------~~~~~~~~~~~~~ 265 (279)
T cd06619 221 P---VGQFSEKFVHFITQCMRKQPKERPAPENLMD---------HPFIVQYNDGNAE 265 (279)
T ss_pred C---CCcCCHHHHHHHHHHhhCChhhCCCHHHHhc---------CcccccccCccHH
Confidence 1 1112346889999999999999999998884 6777655444433
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=334.70 Aligned_cols=241 Identities=23% Similarity=0.343 Sum_probs=196.2
Q ss_pred CccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCC---hhhhHHHHHHHHHHHhc-CCCCeeeeeeeEeecceeEEEE
Q 001768 660 NFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS---KQGNREFVNEIGMISAL-QHQNLVKLYGCCIEGNQLLLVY 734 (1016)
Q Consensus 660 ~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~ 734 (1016)
+|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+..|..++..+ +|++|+++++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 5788999999999999999865 57899999987542 22334566788888777 5899999999999999999999
Q ss_pred eecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCC
Q 001768 735 EYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDED 814 (1016)
Q Consensus 735 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 814 (1016)
||+++|+|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 81 EYVNGGDLMYQIQQVG----RFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW 153 (323)
T ss_pred cCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence 9999999999986543 589999999999999999999998 999999999999999999999999999974332
Q ss_pred CCcceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCc
Q 001768 815 ENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPS 894 (1016)
Q Consensus 815 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 894 (1016)
... ......||+.|+|||++.+..++.++|||||||++|||+||+.||......+....+ .. . ..
T Consensus 154 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i------~~-~------~~- 218 (323)
T cd05616 154 DGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI------ME-H------NV- 218 (323)
T ss_pred CCC-ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHH------Hh-C------CC-
Confidence 211 223467999999999999999999999999999999999999999866544322111 00 0 01
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCH
Q 001768 895 LGSNFSKKEAMTMLNIALLCTNPSPTLRPTM 925 (1016)
Q Consensus 895 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 925 (1016)
.++......+.+++.+|++.||.+|++.
T Consensus 219 ---~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 219 ---AYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred ---CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 1222334568899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=330.74 Aligned_cols=258 Identities=28% Similarity=0.441 Sum_probs=206.4
Q ss_pred HhcCccccCccccCCCeeEEEEEcC------CCcEEEEEEccCCC-hhhhHHHHHHHHHHHhc-CCCCeeeeeeeEeecc
Q 001768 657 ATNNFDAANKIGEGGFGPVYKGTLS------DGAVIAVKQLSSKS-KQGNREFVNEIGMISAL-QHQNLVKLYGCCIEGN 728 (1016)
Q Consensus 657 ~~~~f~~~~~LG~G~~G~Vy~~~~~------~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~ 728 (1016)
..++|++.+.||+|+||.||+|... .+..||+|.++... ....+.+.+|+++++++ +||||+++++++...+
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 112 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG 112 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence 3467999999999999999999741 34579999987553 33356789999999999 7999999999999999
Q ss_pred eeEEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeecccc
Q 001768 729 QLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGL 808 (1016)
Q Consensus 729 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGl 808 (1016)
..++||||+++|+|.+++..... ..+++.++..++.|++.||+|||++ +|+|+||||+||+++.++.++|+|||+
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRRKRE--SFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCcc
Confidence 99999999999999999965432 2489999999999999999999998 899999999999999999999999999
Q ss_pred ccccCCCCcc-eeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHh-CCCCCCCCCchhhHhHHHHHHHHHHhCC
Q 001768 809 AKLDEDENTH-ISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWAYVLQEQGN 886 (1016)
Q Consensus 809 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~ 886 (1016)
++........ ......++..|+|||.+.++.++.++|||||||++|||++ |+.||......+.... . ....
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~-----~-~~~~- 260 (302)
T cd05055 188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYK-----L-IKEG- 260 (302)
T ss_pred cccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHH-----H-HHcC-
Confidence 9855433221 1222345778999999998889999999999999999998 9999875443221110 0 0111
Q ss_pred cccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 001768 887 LLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEG 934 (1016)
Q Consensus 887 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 934 (1016)
.....+...+..+.+++.+|++.+|++|||+.|+++.|+.
T Consensus 261 --------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 261 --------YRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred --------CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence 0011111234578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=329.86 Aligned_cols=257 Identities=28% Similarity=0.409 Sum_probs=203.1
Q ss_pred cCccccCccccCCCeeEEEEEcCC-C--cEEEEEEccCC-ChhhhHHHHHHHHHHHhc-CCCCeeeeeeeEeecceeEEE
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLSD-G--AVIAVKQLSSK-SKQGNREFVNEIGMISAL-QHQNLVKLYGCCIEGNQLLLV 733 (1016)
Q Consensus 659 ~~f~~~~~LG~G~~G~Vy~~~~~~-~--~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV 733 (1016)
++|++.+.||+|+||.||+|...+ + ..+|+|.++.. .....+.+.+|++++.++ +||||+++++++...+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578899999999999999998653 3 34788888743 334456789999999999 799999999999999999999
Q ss_pred EeecCCCcHHHHhccCcC------------cCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCce
Q 001768 734 YEYLENNSLARALFGKEG------------QCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNA 801 (1016)
Q Consensus 734 ~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ 801 (1016)
|||+++++|.+++..... ....+++..++.++.|++.||+|||+. +|+||||||+||++++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeE
Confidence 999999999999965321 113588999999999999999999998 99999999999999999999
Q ss_pred eeeccccccccCCCCcceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHh-CCCCCCCCCchhhHhHHHHHHH
Q 001768 802 KISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWAYV 880 (1016)
Q Consensus 802 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~ 880 (1016)
||+|||++........ ......+..|+|||+..+..++.++|||||||++|||++ |+.||......+.....
T Consensus 159 kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~----- 231 (297)
T cd05089 159 KIADFGLSRGEEVYVK--KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKL----- 231 (297)
T ss_pred EECCcCCCccccceec--cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-----
Confidence 9999999864322111 111223567999999988889999999999999999998 99999765543321110
Q ss_pred HHHhCCcccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCc
Q 001768 881 LQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKT 936 (1016)
Q Consensus 881 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 936 (1016)
. .......+...+..+.+++.+||+.+|.+||+++++++.|+...
T Consensus 232 --~---------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~ 276 (297)
T cd05089 232 --P---------QGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRML 276 (297)
T ss_pred --h---------cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0 00111112223456889999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=340.99 Aligned_cols=259 Identities=20% Similarity=0.279 Sum_probs=203.2
Q ss_pred HHHHHHHhcCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCC---ChhhhHHHHHHHHHHHhcCCCCeeeeeeeEee
Q 001768 651 LRQIKAATNNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSK---SKQGNREFVNEIGMISALQHQNLVKLYGCCIE 726 (1016)
Q Consensus 651 ~~~l~~~~~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 726 (1016)
++++....++|++.+.||+|+||.||+|+.. +++.||+|++... .......+.+|+.+++.++||||+++++++.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 4455566789999999999999999999965 5789999998642 22234567889999999999999999999999
Q ss_pred cceeEEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeecc
Q 001768 727 GNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDF 806 (1016)
Q Consensus 727 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DF 806 (1016)
++..++||||+++|+|.+++... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~Df 186 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADF 186 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeC
Confidence 99999999999999999998543 478899999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCCCcceeeecccCccccChhhhccC----CCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHH
Q 001768 807 GLAKLDEDENTHISTRIAGTVGYMAPEYAMRG----YLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQ 882 (1016)
Q Consensus 807 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~ 882 (1016)
|+++..............||+.|+|||++.+. .++.++|||||||++|||++|+.||........... . .
T Consensus 187 G~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~-----i-~ 260 (371)
T cd05622 187 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSK-----I-M 260 (371)
T ss_pred CceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHH-----H-H
Confidence 99986544333333456799999999998753 378899999999999999999999986554322111 1 1
Q ss_pred HhCCcccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHH
Q 001768 883 EQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTL--RPTMSSAVS 930 (1016)
Q Consensus 883 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~ 930 (1016)
......... ........+.+++..|+..++.+ ||++.++++
T Consensus 261 ~~~~~~~~~-------~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~ 303 (371)
T cd05622 261 NHKNSLTFP-------DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR 303 (371)
T ss_pred cCCCcccCC-------CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhc
Confidence 111101110 01123446888999999844433 678887774
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=324.08 Aligned_cols=256 Identities=26% Similarity=0.409 Sum_probs=202.3
Q ss_pred ccccCccccCCCeeEEEEEcCC----CcEEEEEEccCCC--hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecce-----
Q 001768 661 FDAANKIGEGGFGPVYKGTLSD----GAVIAVKQLSSKS--KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQ----- 729 (1016)
Q Consensus 661 f~~~~~LG~G~~G~Vy~~~~~~----~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~----- 729 (1016)
|++.+.||+|+||.||+|.... +..||+|+++... ......+.+|+++++.++||||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5678999999999999998642 3679999987542 3345678999999999999999999998876544
Q ss_pred -eEEEEeecCCCcHHHHhccCcC--cCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeecc
Q 001768 730 -LLLVYEYLENNSLARALFGKEG--QCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDF 806 (1016)
Q Consensus 730 -~~lV~E~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DF 806 (1016)
.++||||+++++|..++..... ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence 7999999999999999855421 224689999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCCCcce-eeecccCccccChhhhccCCCCCccchhHHHHHHHHHHh-CCCCCCCCCchhhHhHHHHHHHHHHh
Q 001768 807 GLAKLDEDENTHI-STRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWAYVLQEQ 884 (1016)
Q Consensus 807 Gla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~ 884 (1016)
|+++......... .....++..|+|||++.+..++.++|||||||++|||++ |..||......+..... . .
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~------~-~ 230 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYL------R-H 230 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH------H-c
Confidence 9998654332221 122335678999999988889999999999999999999 88888654433221110 0 1
Q ss_pred CCcccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 001768 885 GNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGK 935 (1016)
Q Consensus 885 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 935 (1016)
.. .+ ..+......+.+++.+||+.||++||++.|+++.|+..
T Consensus 231 ~~-----~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 231 GN-----RL----KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CC-----CC----CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11 11 11223445789999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=322.79 Aligned_cols=250 Identities=26% Similarity=0.386 Sum_probs=202.7
Q ss_pred cCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCC-----hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEE
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS-----KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLL 732 (1016)
Q Consensus 659 ~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~-----~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 732 (1016)
++|++.+.||+|++|.||+|... +++.||+|.+.... ......+.+|++++++++||||+++++++.+++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57899999999999999999854 68999999886432 1223568889999999999999999999999999999
Q ss_pred EEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeecccccccc
Q 001768 733 VYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLD 812 (1016)
Q Consensus 733 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~ 812 (1016)
||||+++++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||+++..
T Consensus 82 v~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~ 154 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG----ALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL 154 (263)
T ss_pred EEEECCCCcHHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence 999999999999986543 588999999999999999999998 9999999999999999999999999998754
Q ss_pred CCCCccee--eecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccc
Q 001768 813 EDENTHIS--TRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLEL 890 (1016)
Q Consensus 813 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 890 (1016)
........ ....|+..|+|||.+.+..++.++||||||+++|||++|+.||........... . ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~-----~-~~~------ 222 (263)
T cd06625 155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFK-----I-ATQ------ 222 (263)
T ss_pred cccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHH-----H-hcc------
Confidence 33221111 234578899999999988899999999999999999999999875433221110 0 000
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 891 VDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 891 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
.....++......+.+++.+||..+|.+|||+.++++
T Consensus 223 ---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 259 (263)
T cd06625 223 ---PTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLR 259 (263)
T ss_pred ---CCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhh
Confidence 0111222334457899999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=328.03 Aligned_cols=264 Identities=26% Similarity=0.440 Sum_probs=204.7
Q ss_pred hcCccccCccccCCCeeEEEEEcC-----------------CCcEEEEEEccCCC-hhhhHHHHHHHHHHHhcCCCCeee
Q 001768 658 TNNFDAANKIGEGGFGPVYKGTLS-----------------DGAVIAVKQLSSKS-KQGNREFVNEIGMISALQHQNLVK 719 (1016)
Q Consensus 658 ~~~f~~~~~LG~G~~G~Vy~~~~~-----------------~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~ 719 (1016)
.++|++.++||+|+||.||+++.. ++..||+|.+.... .....++.+|+++++.++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 356899999999999999998632 23468999987543 334567899999999999999999
Q ss_pred eeeeEeecceeEEEEeecCCCcHHHHhccCcCc-------CcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCce
Q 001768 720 LYGCCIEGNQLLLVYEYLENNSLARALFGKEGQ-------CLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATN 792 (1016)
Q Consensus 720 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~-------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~N 792 (1016)
+++++..++..++||||+++++|.+++...... ...+++.++..++.|++.||+|||+. +++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhe
Confidence 999999999999999999999999999654311 23478899999999999999999998 89999999999
Q ss_pred EEEccCCceeeeccccccccCCCCcc-eeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHh--CCCCCCCCCch
Q 001768 793 VLLDKDLNAKISDFGLAKLDEDENTH-ISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS--GKSNTNYRPKE 869 (1016)
Q Consensus 793 ILl~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt--G~~P~~~~~~~ 869 (1016)
|++++++.++|+|||+++........ ......++..|+|||...++.++.++|||||||++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 99999999999999999754332211 1222344678999999888889999999999999999998 77788655443
Q ss_pred hhHhHHHHHHHHHHhCCcccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 001768 870 EFVYLLDWAYVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933 (1016)
Q Consensus 870 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 933 (1016)
+...... ........ ....+ .+..++..+.+++.+||+.||.+||++.+|++.|+
T Consensus 241 ~~~~~~~--~~~~~~~~--~~~~~-----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 241 QVIENTG--EFFRDQGR--QVYLP-----KPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HHHHHHH--HHHhhccc--cccCC-----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 3221110 00000000 00001 11123357899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=318.62 Aligned_cols=249 Identities=29% Similarity=0.431 Sum_probs=205.5
Q ss_pred CccccCccccCCCeeEEEEEcC-CCcEEEEEEccCC--ChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEee
Q 001768 660 NFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSK--SKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEY 736 (1016)
Q Consensus 660 ~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 736 (1016)
+|++.+.||+|++|.||+|+.. +++.||+|.+... .......+.+|+++++.++||||+++++++.+++..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4778899999999999999865 6899999998643 344567788999999999999999999999999999999999
Q ss_pred cCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCC
Q 001768 737 LENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDEN 816 (1016)
Q Consensus 737 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 816 (1016)
+++++|.+++.... ...+++..++.++.|++.||.|||+. +++||||||+||+++.++.++|+|||+++......
T Consensus 81 ~~~~~L~~~l~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 81 AENGDLHKLLKMQR--GRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred CCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 99999999997643 23689999999999999999999998 99999999999999999999999999988654432
Q ss_pred cceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCC
Q 001768 817 THISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLG 896 (1016)
Q Consensus 817 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 896 (1016)
.. .....|++.|+|||+..+..++.++|||||||++|||++|+.||........... ..... .
T Consensus 156 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-------~~~~~---------~ 218 (256)
T cd08529 156 NF-ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILK-------IIRGV---------F 218 (256)
T ss_pred ch-hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH-------HHcCC---------C
Confidence 22 2334688999999999988899999999999999999999999976553321110 00111 1
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 897 SNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 897 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
...+......+.+++.+||+.+|++||++.++++
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 219 PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred CCCccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 1122234457899999999999999999999885
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=326.76 Aligned_cols=250 Identities=25% Similarity=0.447 Sum_probs=205.0
Q ss_pred hcCccccCccccCCCeeEEEEEc-CCCcEEEEEEccCCChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEee
Q 001768 658 TNNFDAANKIGEGGFGPVYKGTL-SDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEY 736 (1016)
Q Consensus 658 ~~~f~~~~~LG~G~~G~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 736 (1016)
..+|++.+.||+|+||.||+|+. .+++.||+|.+........+.+.+|+.+++.++||||+++++.+..+...++||||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 35788899999999999999985 46889999998766555567788999999999999999999999999999999999
Q ss_pred cCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCC
Q 001768 737 LENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDEN 816 (1016)
Q Consensus 737 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 816 (1016)
+++++|.+++... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++.......
T Consensus 99 ~~~~~L~~~~~~~-----~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~ 170 (296)
T cd06654 99 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (296)
T ss_pred cCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence 9999999998542 478999999999999999999998 99999999999999999999999999987543322
Q ss_pred cceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCC
Q 001768 817 THISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLG 896 (1016)
Q Consensus 817 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 896 (1016)
.. .....|++.|+|||.+.+..++.++|||||||++|+|++|+.||........... .... . .+.
T Consensus 171 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~------~~~~-~-----~~~-- 235 (296)
T cd06654 171 SK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL------IATN-G-----TPE-- 235 (296)
T ss_pred cc-cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHH------HhcC-C-----CCC--
Confidence 11 2234688999999999888889999999999999999999999975543221110 0000 0 000
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 897 SNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 897 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
...+......+.+++.+||..+|++||++.++++
T Consensus 236 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 236 LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 1112334457889999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=332.04 Aligned_cols=237 Identities=23% Similarity=0.336 Sum_probs=189.1
Q ss_pred CccccCCCeeEEEEEcC-CCcEEEEEEccCCC---hhhhHHHHHHH-HHHHhcCCCCeeeeeeeEeecceeEEEEeecCC
Q 001768 665 NKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS---KQGNREFVNEI-GMISALQHQNLVKLYGCCIEGNQLLLVYEYLEN 739 (1016)
Q Consensus 665 ~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~-~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 739 (1016)
+.||+|+||.||+|+.. +++.||+|++.... ......+..|. .+++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999965 68899999986532 22233455554 467889999999999999999999999999999
Q ss_pred CcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCCcce
Q 001768 740 NSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHI 819 (1016)
Q Consensus 740 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 819 (1016)
++|...+.... .+++..+..++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (321)
T cd05603 81 GELFFHLQRER----CFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ET 152 (321)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Cc
Confidence 99998885432 588999999999999999999998 99999999999999999999999999987532221 12
Q ss_pred eeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCCCCC
Q 001768 820 STRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGSNF 899 (1016)
Q Consensus 820 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 899 (1016)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||...........+ . ... ..+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i------~-~~~----------~~~ 215 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNI------L-HKP----------LQL 215 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHH------h-cCC----------CCC
Confidence 33457899999999999888999999999999999999999999765433221110 0 000 111
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHH
Q 001768 900 SKKEAMTMLNIALLCTNPSPTLRPTMS 926 (1016)
Q Consensus 900 ~~~~~~~l~~li~~cl~~dP~~RPt~~ 926 (1016)
+......+.+++.+|++.||.+||++.
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 216 PGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 222344688999999999999999874
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=331.52 Aligned_cols=264 Identities=27% Similarity=0.438 Sum_probs=210.4
Q ss_pred HHhcCccccCccccCCCeeEEEEEcC--------CCcEEEEEEccCCC-hhhhHHHHHHHHHHHhc-CCCCeeeeeeeEe
Q 001768 656 AATNNFDAANKIGEGGFGPVYKGTLS--------DGAVIAVKQLSSKS-KQGNREFVNEIGMISAL-QHQNLVKLYGCCI 725 (1016)
Q Consensus 656 ~~~~~f~~~~~LG~G~~G~Vy~~~~~--------~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~ 725 (1016)
...++|++.+.||+|+||.||+|+.. ++..||+|.+.... ....+++.+|+.+++.+ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 44567889999999999999999731 24579999987543 34456789999999999 8999999999999
Q ss_pred ecceeEEEEeecCCCcHHHHhccCcC------------cCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceE
Q 001768 726 EGNQLLLVYEYLENNSLARALFGKEG------------QCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNV 793 (1016)
Q Consensus 726 ~~~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NI 793 (1016)
..+..++||||+++++|.+++..... ....+++.++..++.||++||+|||++ +|+||||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceE
Confidence 99999999999999999999975421 113578999999999999999999998 999999999999
Q ss_pred EEccCCceeeeccccccccCCCCcce-eeecccCccccChhhhccCCCCCccchhHHHHHHHHHHh-CCCCCCCCCchhh
Q 001768 794 LLDKDLNAKISDFGLAKLDEDENTHI-STRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEF 871 (1016)
Q Consensus 794 Ll~~~~~~kL~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~ 871 (1016)
++++++.+||+|||+++......... .....+++.|+|||++.+..++.++||||||+++|||++ |..||...+..+.
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~ 248 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 248 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH
Confidence 99999999999999998654432221 222345678999999988889999999999999999998 7888876554432
Q ss_pred HhHHHHHHHHHHhCCcccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCcCC
Q 001768 872 VYLLDWAYVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTAV 938 (1016)
Q Consensus 872 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 938 (1016)
.... . ... ....+...+..+.+++.+||+.+|++||++.|+++.|+....+
T Consensus 249 ~~~~------~-~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 249 FKLL------K-EGH---------RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred HHHH------H-cCC---------cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 2211 1 110 0011123445788999999999999999999999999876544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=320.56 Aligned_cols=250 Identities=32% Similarity=0.492 Sum_probs=207.3
Q ss_pred hcCccccCccccCCCeeEEEEEcCCCcEEEEEEccCCChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEeec
Q 001768 658 TNNFDAANKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYL 737 (1016)
Q Consensus 658 ~~~f~~~~~LG~G~~G~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 737 (1016)
.++|++.+.||+|+||.||+|... ++.||+|.+..... ..+++.+|+.+++.++|+||+++++++.+++..++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 457888999999999999999875 78899999976654 4567899999999999999999999999999999999999
Q ss_pred CCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCCc
Q 001768 738 ENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENT 817 (1016)
Q Consensus 738 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 817 (1016)
++++|.+++..... ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||.++.......
T Consensus 83 ~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~ 157 (256)
T cd05039 83 AKGSLVDYLRSRGR--AVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD 157 (256)
T ss_pred CCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccc
Confidence 99999999965432 2589999999999999999999998 999999999999999999999999999986533221
Q ss_pred ceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHh-CCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCC
Q 001768 818 HISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLG 896 (1016)
Q Consensus 818 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 896 (1016)
...++..|+|||++..+.++.++||||||+++|||++ |+.||......+..... ... ..
T Consensus 158 ----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~-------~~~---------~~ 217 (256)
T cd05039 158 ----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHV-------EKG---------YR 217 (256)
T ss_pred ----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH-------hcC---------CC
Confidence 2234667999999988889999999999999999997 99998765544322111 000 00
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 001768 897 SNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEG 934 (1016)
Q Consensus 897 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 934 (1016)
...+...+..+.+++.+||..+|++||++.|++++|+.
T Consensus 218 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 218 MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 11122234578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=333.13 Aligned_cols=253 Identities=21% Similarity=0.256 Sum_probs=197.5
Q ss_pred cCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCC---hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEE
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS---KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVY 734 (1016)
Q Consensus 659 ~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 734 (1016)
++|++.+.||+|+||.||+++.. +++.||+|.+.... ......+.+|..++..++|+||+++++++.+++..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47899999999999999999965 67899999986432 223445788999999999999999999999999999999
Q ss_pred eecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCC
Q 001768 735 EYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDED 814 (1016)
Q Consensus 735 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 814 (1016)
||+++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 Ey~~gg~L~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 81 DYYVGGDLLTLLSKFE---DRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred eCCCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence 9999999999996533 2589999999999999999999998 999999999999999999999999999976554
Q ss_pred CCcceeeecccCccccChhhhcc-----CCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCccc
Q 001768 815 ENTHISTRIAGTVGYMAPEYAMR-----GYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLE 889 (1016)
Q Consensus 815 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 889 (1016)
..........||+.|+|||++.+ +.++.++|||||||++|||++|+.||......+.... .......
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~-----i~~~~~~--- 226 (331)
T cd05624 155 DGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK-----IMNHEER--- 226 (331)
T ss_pred CCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHH-----HHcCCCc---
Confidence 43333334579999999999875 4678899999999999999999999976543322110 0000000
Q ss_pred ccCCcCCCCCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHH
Q 001768 890 LVDPSLGSNFSKKEAMTMLNIALLCTNPSPTL--RPTMSSAV 929 (1016)
Q Consensus 890 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl 929 (1016)
...+... ...+..+.+++.+|+..++++ |+++++++
T Consensus 227 ---~~~p~~~-~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~ 264 (331)
T cd05624 227 ---FQFPSHI-TDVSEEAKDLIQRLICSRERRLGQNGIEDFK 264 (331)
T ss_pred ---ccCCCcc-ccCCHHHHHHHHHHccCchhhcCCCCHHHHh
Confidence 0011111 123456888999998865544 45676665
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=318.73 Aligned_cols=247 Identities=26% Similarity=0.388 Sum_probs=197.4
Q ss_pred ccccCCCeeEEEEEcC---CCcEEEEEEccCCCh-hhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEeecCCCc
Q 001768 666 KIGEGGFGPVYKGTLS---DGAVIAVKQLSSKSK-QGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYLENNS 741 (1016)
Q Consensus 666 ~LG~G~~G~Vy~~~~~---~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gs 741 (1016)
.||+|+||.||+|.+. .+..||+|++..... ...+.+.+|++++++++||||+++++++.. +..++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 4899999999999754 355799999876533 334678999999999999999999998864 57899999999999
Q ss_pred HHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCCcceee
Q 001768 742 LARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHIST 821 (1016)
Q Consensus 742 L~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 821 (1016)
|.+++.... ..+++.++++++.|++.||+|||++ +++||||||+||+++.++.+||+|||++............
T Consensus 81 L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 81 LNKFLSGKK---DEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred HHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 999986543 2589999999999999999999998 9999999999999999999999999999755433222111
Q ss_pred --ecccCccccChhhhccCCCCCccchhHHHHHHHHHHh-CCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCCCC
Q 001768 822 --RIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGSN 898 (1016)
Q Consensus 822 --~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 898 (1016)
...++..|+|||.+....++.++|||||||++||+++ |..||......+....+ ..+. ...
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~-------~~~~---------~~~ 218 (257)
T cd05115 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFI-------EQGK---------RLD 218 (257)
T ss_pred cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH-------HCCC---------CCC
Confidence 1233578999999988889999999999999999996 99999765544322111 1111 111
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 001768 899 FSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGK 935 (1016)
Q Consensus 899 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 935 (1016)
.+...+..+.+++.+||..+|++||++.+|.+.|+..
T Consensus 219 ~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 219 CPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 2223445788999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=331.09 Aligned_cols=260 Identities=28% Similarity=0.435 Sum_probs=207.0
Q ss_pred hcCccccCccccCCCeeEEEEEcC--------CCcEEEEEEccCCC-hhhhHHHHHHHHHHHhc-CCCCeeeeeeeEeec
Q 001768 658 TNNFDAANKIGEGGFGPVYKGTLS--------DGAVIAVKQLSSKS-KQGNREFVNEIGMISAL-QHQNLVKLYGCCIEG 727 (1016)
Q Consensus 658 ~~~f~~~~~LG~G~~G~Vy~~~~~--------~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~ 727 (1016)
.++|.+.+.||+|+||.||+|+.. ++..||+|.+.... .....++.+|+++++.+ +||||+++++++..+
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 467999999999999999999752 23579999997543 33456788899999999 799999999999999
Q ss_pred ceeEEEEeecCCCcHHHHhccCcC------------cCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEE
Q 001768 728 NQLLLVYEYLENNSLARALFGKEG------------QCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLL 795 (1016)
Q Consensus 728 ~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl 795 (1016)
+..++||||+++++|.+++..... ....+++.+++.++.|++.||+|||+. +++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEE
Confidence 999999999999999999975432 113589999999999999999999998 99999999999999
Q ss_pred ccCCceeeeccccccccCCCCcce-eeecccCccccChhhhccCCCCCccchhHHHHHHHHHHh-CCCCCCCCCchhhHh
Q 001768 796 DKDLNAKISDFGLAKLDEDENTHI-STRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVY 873 (1016)
Q Consensus 796 ~~~~~~kL~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~ 873 (1016)
+.++.+||+|||.++......... .....++..|+|||.+.+..++.++|||||||++|||++ |+.||...+.++...
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~ 253 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 253 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHH
Confidence 999999999999987554322111 112234568999999988889999999999999999998 888887655433222
Q ss_pred HHHHHHHHHHhCCcccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCc
Q 001768 874 LLDWAYVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKT 936 (1016)
Q Consensus 874 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 936 (1016)
.. .... ....+......+.+++.+||+.+|++||++.+|++.|+...
T Consensus 254 ~~-------~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~ 300 (307)
T cd05098 254 LL-------KEGH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 300 (307)
T ss_pred HH-------HcCC---------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence 11 1111 01112233457889999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=341.73 Aligned_cols=262 Identities=26% Similarity=0.412 Sum_probs=206.5
Q ss_pred HHhcCccccCccccCCCeeEEEEEcC------CCcEEEEEEccCCC-hhhhHHHHHHHHHHHhcC-CCCeeeeeeeEeec
Q 001768 656 AATNNFDAANKIGEGGFGPVYKGTLS------DGAVIAVKQLSSKS-KQGNREFVNEIGMISALQ-HQNLVKLYGCCIEG 727 (1016)
Q Consensus 656 ~~~~~f~~~~~LG~G~~G~Vy~~~~~------~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~ 727 (1016)
...++|.+.++||+|+||.||+|++. .++.||+|++.... ....+.+.+|++++.++. ||||+++++++..+
T Consensus 34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~ 113 (401)
T cd05107 34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG 113 (401)
T ss_pred ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence 34456888999999999999999853 34689999997543 233457889999999997 99999999999999
Q ss_pred ceeEEEEeecCCCcHHHHhccCcC--------------------------------------------------------
Q 001768 728 NQLLLVYEYLENNSLARALFGKEG-------------------------------------------------------- 751 (1016)
Q Consensus 728 ~~~~lV~E~~~~gsL~~~l~~~~~-------------------------------------------------------- 751 (1016)
+..++||||+++|+|.++++....
T Consensus 114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (401)
T cd05107 114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ 193 (401)
T ss_pred CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence 999999999999999999965321
Q ss_pred --------------------------------------cCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceE
Q 001768 752 --------------------------------------QCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNV 793 (1016)
Q Consensus 752 --------------------------------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NI 793 (1016)
....+++..+..++.|++.||+|||+. +|+||||||+||
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~Ni 270 (401)
T cd05107 194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNV 270 (401)
T ss_pred cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceE
Confidence 112467888999999999999999988 999999999999
Q ss_pred EEccCCceeeeccccccccCCCCc-ceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHh-CCCCCCCCCchhh
Q 001768 794 LLDKDLNAKISDFGLAKLDEDENT-HISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEF 871 (1016)
Q Consensus 794 Ll~~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~ 871 (1016)
|+++++.+||+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |+.||...+..+.
T Consensus 271 Ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~ 350 (401)
T cd05107 271 LICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ 350 (401)
T ss_pred EEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH
Confidence 999999999999999975432221 11223456788999999988889999999999999999998 8889875443322
Q ss_pred HhHHHHHHHHHHhCCcccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 001768 872 VYLLDWAYVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGK 935 (1016)
Q Consensus 872 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 935 (1016)
... . ...+ .....+......+.+++.+||+.+|.+||+++||++.|+..
T Consensus 351 ~~~-----~-~~~~---------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 351 FYN-----A-IKRG---------YRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred HHH-----H-HHcC---------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 110 0 0011 00111222345789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=323.31 Aligned_cols=255 Identities=25% Similarity=0.306 Sum_probs=199.1
Q ss_pred cccCCCeeEEEEEcC-CCcEEEEEEccCCC---hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEeecCCCcH
Q 001768 667 IGEGGFGPVYKGTLS-DGAVIAVKQLSSKS---KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYLENNSL 742 (1016)
Q Consensus 667 LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 742 (1016)
||+|+||.||+++.. +|+.||+|.+.... ......+..|++++++++||||+++++++.++...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999864 68999999986432 12234556799999999999999999999999999999999999999
Q ss_pred HHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCCcceeee
Q 001768 743 ARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTR 822 (1016)
Q Consensus 743 ~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 822 (1016)
.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~ 153 (277)
T cd05607 81 KYHIYNVGE--RGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQ 153 (277)
T ss_pred HHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeec
Confidence 988865432 3589999999999999999999998 99999999999999999999999999987654332 2234
Q ss_pred cccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCCCCCCHH
Q 001768 823 IAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGSNFSKK 902 (1016)
Q Consensus 823 ~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 902 (1016)
..|+..|+|||++.+..++.++||||+||++|||++|+.||...........+ ... .....+.. . ...
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~--~~~-----~~~~~~~~-~----~~~ 221 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEEL--KRR-----TLEDEVKF-E----HQN 221 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHH--HHH-----hhcccccc-c----ccc
Confidence 56899999999999888999999999999999999999998753321111000 000 00000000 0 012
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCcCCcCccccC
Q 001768 903 EAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTAVQAPIIRR 945 (1016)
Q Consensus 903 ~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~p~~~~ 945 (1016)
....+.+++.+||+.||++||++.|+++.+. .|||+..
T Consensus 222 ~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~-----~h~~f~~ 259 (277)
T cd05607 222 FTEESKDICRLFLAKKPEDRLGSREKNDDPR-----KHEFFKT 259 (277)
T ss_pred CCHHHHHHHHHHhccCHhhCCCCccchhhhh-----cChhhcC
Confidence 3446899999999999999999988764433 4777653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=322.36 Aligned_cols=255 Identities=25% Similarity=0.408 Sum_probs=199.3
Q ss_pred ccccCccccCCCeeEEEEEcCC-Cc--EEEEEEccCC--ChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeec------ce
Q 001768 661 FDAANKIGEGGFGPVYKGTLSD-GA--VIAVKQLSSK--SKQGNREFVNEIGMISALQHQNLVKLYGCCIEG------NQ 729 (1016)
Q Consensus 661 f~~~~~LG~G~~G~Vy~~~~~~-~~--~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------~~ 729 (1016)
|.+.+.||+|+||.||+|++.+ +. .||+|.++.. .....+.+.+|+++++.++||||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3567899999999999999754 32 6899988654 344456788999999999999999999987532 25
Q ss_pred eEEEEeecCCCcHHHHhccCc--CcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccc
Q 001768 730 LLLVYEYLENNSLARALFGKE--GQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFG 807 (1016)
Q Consensus 730 ~~lV~E~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG 807 (1016)
.++||||+++|+|.+++.... .....+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCC
Confidence 689999999999999874322 1224589999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCCcce-eeecccCccccChhhhccCCCCCccchhHHHHHHHHHHh-CCCCCCCCCchhhHhHHHHHHHHHHhC
Q 001768 808 LAKLDEDENTHI-STRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWAYVLQEQG 885 (1016)
Q Consensus 808 la~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~ 885 (1016)
+++......... .....+++.|+|||+..+..++.++|||||||++|||++ |+.||......+.... . ..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~------~-~~~ 230 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDY------L-RQG 230 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH------H-HcC
Confidence 998654332211 122345678999999998889999999999999999999 8888875443322111 1 111
Q ss_pred CcccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 001768 886 NLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEG 934 (1016)
Q Consensus 886 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 934 (1016)
... .. +...+..+.+++.+||+.||++|||+.++++.|+.
T Consensus 231 ~~~-----~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~ 270 (272)
T cd05075 231 NRL-----KQ----PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK 270 (272)
T ss_pred CCC-----CC----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 110 11 11234468999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=320.32 Aligned_cols=255 Identities=29% Similarity=0.458 Sum_probs=206.9
Q ss_pred HhcCccccCccccCCCeeEEEEEcCCCcEEEEEEccCCChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEee
Q 001768 657 ATNNFDAANKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEY 736 (1016)
Q Consensus 657 ~~~~f~~~~~LG~G~~G~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 736 (1016)
..++|++.++||+|+||.||+|...++..+|+|.+.... ...+.+.+|++++++++|+||+++++++.+ ...+++|||
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~ 81 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF 81 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence 346789999999999999999998778889999887543 335678899999999999999999999887 778999999
Q ss_pred cCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCC
Q 001768 737 LENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDEN 816 (1016)
Q Consensus 737 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 816 (1016)
+++++|.+++.... ...+++.++..++.|++.||+|||+. +++||||||+||+++.++.+||+|||.+.......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 82 MAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred CCCCcHHHHHHhCC--ccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 99999999996643 23588999999999999999999998 89999999999999999999999999997654332
Q ss_pred cceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHh-CCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcC
Q 001768 817 THISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSL 895 (1016)
Q Consensus 817 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 895 (1016)
........++..|+|||++..+.++.++|||||||++|++++ |+.||............ .... .
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~-------~~~~-----~--- 221 (260)
T cd05073 157 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL-------ERGY-----R--- 221 (260)
T ss_pred cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHH-------hCCC-----C---
Confidence 222223345678999999988889999999999999999999 89998765443322111 0110 0
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 001768 896 GSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEG 934 (1016)
Q Consensus 896 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 934 (1016)
...+...+..+.+++.+|++.+|++||++.++.++|+.
T Consensus 222 -~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 222 -MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred -CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 01112234568899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=331.83 Aligned_cols=244 Identities=22% Similarity=0.311 Sum_probs=192.6
Q ss_pred CccccCCCeeEEEEEcC-CCcEEEEEEccCCC---hhhhHHHHHHHHHHHhc-CCCCeeeeeeeEeecceeEEEEeecCC
Q 001768 665 NKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS---KQGNREFVNEIGMISAL-QHQNLVKLYGCCIEGNQLLLVYEYLEN 739 (1016)
Q Consensus 665 ~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~ 739 (1016)
+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999865 57899999997542 23345678899999888 699999999999999999999999999
Q ss_pred CcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCCcce
Q 001768 740 NSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHI 819 (1016)
Q Consensus 740 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 819 (1016)
|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~~~----~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (327)
T cd05617 81 GDLMFHMQRQR----KLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DT 152 (327)
T ss_pred CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Cc
Confidence 99999886443 599999999999999999999998 99999999999999999999999999987432221 12
Q ss_pred eeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCCCCC
Q 001768 820 STRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGSNF 899 (1016)
Q Consensus 820 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 899 (1016)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||............++........ .. .+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~------~~----~~ 222 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK------PI----RI 222 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC------CC----CC
Confidence 234679999999999998899999999999999999999999996432221111111111111111 01 11
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHH
Q 001768 900 SKKEAMTMLNIALLCTNPSPTLRPTMS 926 (1016)
Q Consensus 900 ~~~~~~~l~~li~~cl~~dP~~RPt~~ 926 (1016)
+...+..+.+++.+||+.||++||++.
T Consensus 223 p~~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 223 PRFLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 222335688999999999999999864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=319.59 Aligned_cols=251 Identities=29% Similarity=0.445 Sum_probs=201.0
Q ss_pred ccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCChhhhH--HHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEeec
Q 001768 661 FDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSKQGNR--EFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYL 737 (1016)
Q Consensus 661 f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~~~~~~--~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 737 (1016)
|++.+.||+|+||+||+++.. +++.||+|.+......... ...+|+.++++++||||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 678899999999999999965 5678999999876544332 3456999999999999999999999999999999999
Q ss_pred CCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCCc
Q 001768 738 ENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENT 817 (1016)
Q Consensus 738 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 817 (1016)
++++|.+++... ..+++.++..++.|+++||+|||+. +|+|+||||+||++++++.++|+|||.+...... .
T Consensus 81 ~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~-~ 152 (260)
T PF00069_consen 81 PGGSLQDYLQKN----KPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSEN-N 152 (260)
T ss_dssp TTEBHHHHHHHH----SSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTST-T
T ss_pred cccccccccccc----ccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc-c
Confidence 999999999722 3689999999999999999999998 9999999999999999999999999999754221 2
Q ss_pred ceeeecccCccccChhhhc-cCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCC
Q 001768 818 HISTRIAGTVGYMAPEYAM-RGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLG 896 (1016)
Q Consensus 818 ~~~~~~~gt~~y~aPE~~~-~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 896 (1016)
.......++..|+|||++. +..++.++||||+|+++|+|++|+.||................. ........
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~---- 224 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILK----RPLPSSSQ---- 224 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHH----THHHHHTT----
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccc----cccccccc----
Confidence 2334567899999999998 78899999999999999999999999986632222222211110 00000000
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 001768 897 SNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAV 929 (1016)
Q Consensus 897 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 929 (1016)
. .......+.+++.+||+.||++||++.+++
T Consensus 225 ~--~~~~~~~l~~li~~~l~~~p~~R~~~~~l~ 255 (260)
T PF00069_consen 225 Q--SREKSEELRDLIKKMLSKDPEQRPSAEELL 255 (260)
T ss_dssp S--HTTSHHHHHHHHHHHSSSSGGGSTTHHHHH
T ss_pred c--cchhHHHHHHHHHHHccCChhHCcCHHHHh
Confidence 0 000126799999999999999999999988
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=319.54 Aligned_cols=252 Identities=29% Similarity=0.519 Sum_probs=204.6
Q ss_pred cCccccCccccCCCeeEEEEEcCCCcEEEEEEccCCChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEeecC
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYLE 738 (1016)
Q Consensus 659 ~~f~~~~~LG~G~~G~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 738 (1016)
.+|++.+.||+|+||.||+|.+.+++.+|+|.+..... ....+.+|++++++++|||++++++++......++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 46788899999999999999987788999999865432 34578899999999999999999999999999999999999
Q ss_pred CCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCCcc
Q 001768 739 NNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTH 818 (1016)
Q Consensus 739 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 818 (1016)
+++|.+++.... ..++++.++.++.|++.|++|||+. +++||||||+||+++.++.++|+|||.+.........
T Consensus 83 ~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 156 (256)
T cd05112 83 HGCLSDYLRAQR---GKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT 156 (256)
T ss_pred CCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCccc
Confidence 999999986543 2588999999999999999999998 8999999999999999999999999998755433221
Q ss_pred eeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHh-CCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCCC
Q 001768 819 ISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGS 897 (1016)
Q Consensus 819 ~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 897 (1016)
......++.+|+|||++.++.++.++||||||+++|||++ |+.||......+..... . .. .....+.
T Consensus 157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~------~-~~--~~~~~~~--- 224 (256)
T cd05112 157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETI------N-AG--FRLYKPR--- 224 (256)
T ss_pred ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHH------h-CC--CCCCCCC---
Confidence 1222335678999999988889999999999999999998 99998765543322111 0 00 0111111
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 001768 898 NFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933 (1016)
Q Consensus 898 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 933 (1016)
..+..+.+++.+||+.+|++||++.+++++|.
T Consensus 225 ----~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 225 ----LASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred ----CCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 12357899999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=329.14 Aligned_cols=257 Identities=29% Similarity=0.422 Sum_probs=202.3
Q ss_pred hcCccccCccccCCCeeEEEEEcC-CCc--EEEEEEccCC-ChhhhHHHHHHHHHHHhc-CCCCeeeeeeeEeecceeEE
Q 001768 658 TNNFDAANKIGEGGFGPVYKGTLS-DGA--VIAVKQLSSK-SKQGNREFVNEIGMISAL-QHQNLVKLYGCCIEGNQLLL 732 (1016)
Q Consensus 658 ~~~f~~~~~LG~G~~G~Vy~~~~~-~~~--~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~l 732 (1016)
.++|++.+.||+|+||.||+|+++ ++. .+|+|.+... .......+.+|++++.++ +||||+++++++.+++..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 357889999999999999999864 444 4688877643 334456788999999999 89999999999999999999
Q ss_pred EEeecCCCcHHHHhccCcC------------cCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCc
Q 001768 733 VYEYLENNSLARALFGKEG------------QCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLN 800 (1016)
Q Consensus 733 V~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~ 800 (1016)
||||+++++|.+++..... ....+++.+++.++.|++.|++|||+. +|+||||||+|||+++++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCc
Confidence 9999999999999965421 123589999999999999999999998 9999999999999999999
Q ss_pred eeeeccccccccCCCCcceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHh-CCCCCCCCCchhhHhHHHHHH
Q 001768 801 AKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWAY 879 (1016)
Q Consensus 801 ~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~ 879 (1016)
+||+|||++....... ......++..|+|||++.+..++.++|||||||++|||+| |..||......+....
T Consensus 163 ~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~----- 235 (303)
T cd05088 163 AKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK----- 235 (303)
T ss_pred EEeCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHH-----
Confidence 9999999986322111 1111234667999999988889999999999999999998 9999875544332110
Q ss_pred HHHHhCCcccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 001768 880 VLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGK 935 (1016)
Q Consensus 880 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 935 (1016)
. ... ... ..+...+..+.+++.+||+.+|++||++++++++|+..
T Consensus 236 -~-~~~-----~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~ 280 (303)
T cd05088 236 -L-PQG-----YRL----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 280 (303)
T ss_pred -H-hcC-----CcC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0 000 000 11112334688999999999999999999999988743
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=320.51 Aligned_cols=254 Identities=28% Similarity=0.446 Sum_probs=205.0
Q ss_pred cCccccCccccCCCeeEEEEEcC----CCcEEEEEEccCCC-hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEE
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLS----DGAVIAVKQLSSKS-KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLV 733 (1016)
Q Consensus 659 ~~f~~~~~LG~G~~G~Vy~~~~~----~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 733 (1016)
.+|++.+.||+|+||.||+|++. .+..||+|.++... ....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 57888999999999999999853 23479999987543 33456789999999999999999999999999999999
Q ss_pred EeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccC
Q 001768 734 YEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDE 813 (1016)
Q Consensus 734 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~ 813 (1016)
|||+++++|.+++.... ..+++.++..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++....
T Consensus 84 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 84 TEYMENGSLDAFLRKHD---GQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred EEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence 99999999999996543 2589999999999999999999998 99999999999999999999999999998655
Q ss_pred CCCcceee--ecccCccccChhhhccCCCCCccchhHHHHHHHHHHh-CCCCCCCCCchhhHhHHHHHHHHHHhCCcccc
Q 001768 814 DENTHIST--RIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWAYVLQEQGNLLEL 890 (1016)
Q Consensus 814 ~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 890 (1016)
........ ...++..|+|||++.+..++.++|||||||++||+++ |+.||......+....+ .+ .
T Consensus 158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~------~~-~----- 225 (267)
T cd05066 158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAI------EE-G----- 225 (267)
T ss_pred cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHH------hC-C-----
Confidence 43322221 1223568999999998889999999999999999887 99998765443321111 00 0
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 001768 891 VDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEG 934 (1016)
Q Consensus 891 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 934 (1016)
.... .+...+..+.+++.+|++.+|.+||++.++++.|+.
T Consensus 226 ~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 265 (267)
T cd05066 226 YRLP----APMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDK 265 (267)
T ss_pred CcCC----CCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence 0011 111234568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=322.83 Aligned_cols=259 Identities=26% Similarity=0.431 Sum_probs=205.2
Q ss_pred hcCccccCccccCCCeeEEEEEcC-CCc----EEEEEEccCCC-hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeE
Q 001768 658 TNNFDAANKIGEGGFGPVYKGTLS-DGA----VIAVKQLSSKS-KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLL 731 (1016)
Q Consensus 658 ~~~f~~~~~LG~G~~G~Vy~~~~~-~~~----~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 731 (1016)
.++|++.+.||+|+||+||+|++. +++ .||+|.+.... .....++.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence 457889999999999999999853 444 48999987543 33456788999999999999999999999754 578
Q ss_pred EEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccc
Q 001768 732 LVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKL 811 (1016)
Q Consensus 732 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~ 811 (1016)
++|||+++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.
T Consensus 85 l~~~~~~~g~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENK---DRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred EEEEcCCCCCHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceee
Confidence 9999999999999996543 2589999999999999999999998 999999999999999999999999999986
Q ss_pred cCCCCcce-eeecccCccccChhhhccCCCCCccchhHHHHHHHHHHh-CCCCCCCCCchhhHhHHHHHHHHHHhCCccc
Q 001768 812 DEDENTHI-STRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWAYVLQEQGNLLE 889 (1016)
Q Consensus 812 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 889 (1016)
........ .....+++.|+|||...+..++.++|||||||++|||++ |..||............ .....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~-------~~~~~-- 229 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLL-------EKGER-- 229 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-------HCCCc--
Confidence 54332211 112235678999999988889999999999999999998 89998765443322111 11100
Q ss_pred ccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCcCCc
Q 001768 890 LVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTAVQ 939 (1016)
Q Consensus 890 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 939 (1016)
+. .+...+..+.+++.+||+.||++||++.++++.|+.....+
T Consensus 230 ---~~----~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 230 ---LP----QPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred ---CC----CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 01 11123446889999999999999999999999987665444
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=332.39 Aligned_cols=258 Identities=23% Similarity=0.389 Sum_probs=217.2
Q ss_pred HHHhcCccccCccccCCCeeEEEEEcCC-CcEEEEEEccCCChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEE
Q 001768 655 KAATNNFDAANKIGEGGFGPVYKGTLSD-GAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLV 733 (1016)
Q Consensus 655 ~~~~~~f~~~~~LG~G~~G~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 733 (1016)
+.-..+....++||-|-||.||.|.|+. .-.||||.++.+ ....++|..|+.+|+.++|||+|+++|+|..+..+|+|
T Consensus 263 EmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIi 341 (1157)
T KOG4278|consen 263 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYII 341 (1157)
T ss_pred hccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEE
Confidence 3334456678999999999999999874 567999999754 44568999999999999999999999999999999999
Q ss_pred EeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccC
Q 001768 734 YEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDE 813 (1016)
Q Consensus 734 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~ 813 (1016)
+|||..|+|.+||..... ..++.-..+.++.||+.|++||..+ ++|||||.++|.|+.++-.+|++|||+++++.
T Consensus 342 TEfM~yGNLLdYLRecnr--~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlMt 416 (1157)
T KOG4278|consen 342 TEFMCYGNLLDYLRECNR--SEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLMT 416 (1157)
T ss_pred EecccCccHHHHHHHhch--hhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhhc
Confidence 999999999999976543 3577788889999999999999998 99999999999999999999999999999887
Q ss_pred CCCcceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHh-CCCCCCCCCchhhHhHHHHHHHHHHhCCcccccC
Q 001768 814 DENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVD 892 (1016)
Q Consensus 814 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 892 (1016)
.+.........-.+-|.|||.+.-..++.|+|||+|||+|||+.| |..||.+-.-.+.. ++++
T Consensus 417 gDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY----------------~LLE 480 (1157)
T KOG4278|consen 417 GDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY----------------GLLE 480 (1157)
T ss_pred CCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHH----------------HHHh
Confidence 654332222334678999999988899999999999999999999 88888765433322 2334
Q ss_pred CcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 001768 893 PSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEG 934 (1016)
Q Consensus 893 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 934 (1016)
...+.+-+..++..+.+||+.||+.+|.+||++.|+-+.+|.
T Consensus 481 kgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEt 522 (1157)
T KOG4278|consen 481 KGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFET 522 (1157)
T ss_pred ccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHH
Confidence 445555667788899999999999999999999999888764
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=331.04 Aligned_cols=263 Identities=22% Similarity=0.336 Sum_probs=199.9
Q ss_pred cCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCCh-hhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEee
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSK-QGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEY 736 (1016)
Q Consensus 659 ~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 736 (1016)
++|.+.++||+|+||.||+|+.. +++.||+|.+..... .....+.+|++++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 56889999999999999999865 678999999875432 2334677899999999999999999999999999999999
Q ss_pred cCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCC
Q 001768 737 LENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDEN 816 (1016)
Q Consensus 737 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 816 (1016)
+++ +|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 86 ~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 86 LDK-DLKQYMDDCG---NIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPT 158 (309)
T ss_pred CCC-CHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence 975 7888775443 2588999999999999999999998 99999999999999999999999999997543322
Q ss_pred cceeeecccCccccChhhhcc-CCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHH----------HHHHHHhC
Q 001768 817 THISTRIAGTVGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDW----------AYVLQEQG 885 (1016)
Q Consensus 817 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~----------~~~~~~~~ 885 (1016)
. ......+|+.|+|||.+.+ ..++.++|||||||++|||+||+.||......+....+.. .... ...
T Consensus 159 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 236 (309)
T cd07872 159 K-TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGIS-SND 236 (309)
T ss_pred c-ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhc-chh
Confidence 1 1223467899999998865 4678999999999999999999999976654433222111 0000 000
Q ss_pred CcccccCCcCCC----CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 886 NLLELVDPSLGS----NFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 886 ~~~~~~d~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
.....-.+.... .........+.+++.+|++.||.+|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 237 EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 000000000000 001123446789999999999999999998873
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=325.52 Aligned_cols=261 Identities=26% Similarity=0.439 Sum_probs=206.1
Q ss_pred HHhcCccccCccccCCCeeEEEEEcC------CCcEEEEEEccCCC-hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecc
Q 001768 656 AATNNFDAANKIGEGGFGPVYKGTLS------DGAVIAVKQLSSKS-KQGNREFVNEIGMISALQHQNLVKLYGCCIEGN 728 (1016)
Q Consensus 656 ~~~~~f~~~~~LG~G~~G~Vy~~~~~------~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 728 (1016)
...++|++.+.||+|+||.||+|..+ .+..||+|.+.... ......+.+|+.++++++||||+++++++.+++
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 34678999999999999999999743 24589999886443 233456788999999999999999999999999
Q ss_pred eeEEEEeecCCCcHHHHhccCcC------cCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCcee
Q 001768 729 QLLLVYEYLENNSLARALFGKEG------QCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAK 802 (1016)
Q Consensus 729 ~~~lV~E~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~k 802 (1016)
..++||||+++|+|.+++..... ....+++..+..++.|++.||+|||++ +|+||||||+||++++++.++
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEE
Confidence 99999999999999999965321 123457788999999999999999998 999999999999999999999
Q ss_pred eeccccccccCCCCcc-eeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHh-CCCCCCCCCchhhHhHHHHHHH
Q 001768 803 ISDFGLAKLDEDENTH-ISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWAYV 880 (1016)
Q Consensus 803 L~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~ 880 (1016)
|+|||+++........ ......++..|+|||.+.++.++.++|||||||++|||++ |..||.....++.....
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~----- 234 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV----- 234 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-----
Confidence 9999998754332211 1122345678999999998889999999999999999999 78888765443322110
Q ss_pred HHHhCCcccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 001768 881 LQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGK 935 (1016)
Q Consensus 881 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 935 (1016)
.. .... ..+...+..+.+++.+|++.||++|||+.++++.|+..
T Consensus 235 -~~-~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 235 -MD-GGYL---------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred -Hc-CCCC---------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 11 1110 11122345799999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=314.71 Aligned_cols=252 Identities=22% Similarity=0.278 Sum_probs=206.3
Q ss_pred cCccccCccccCCCeeEEEEEcCC-CcEEEEEEccCCC---hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEE
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLSD-GAVIAVKQLSSKS---KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVY 734 (1016)
Q Consensus 659 ~~f~~~~~LG~G~~G~Vy~~~~~~-~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 734 (1016)
+.|+.++.||+|.-|+||++++.+ +..+|+|++.+.. .....+.+.|.+||+.++||.++.+|+.++.++..||||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 456678999999999999999764 5899999997653 334557788999999999999999999999999999999
Q ss_pred eecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCC
Q 001768 735 EYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDED 814 (1016)
Q Consensus 735 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 814 (1016)
|||+||+|..+.+.+.+. .+++..++-++.+|+-||+|||-. |||.|||||+||||.++|++-|+||.++.....
T Consensus 157 eyCpGGdL~~LrqkQp~~--~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQPGK--RFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPV 231 (459)
T ss_pred ecCCCccHHHHHhhCCCC--ccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence 999999999999877654 699999999999999999999998 999999999999999999999999998742210
Q ss_pred ---------------------------------CCc----------------------ceeeecccCccccChhhhccCC
Q 001768 815 ---------------------------------ENT----------------------HISTRIAGTVGYMAPEYAMRGY 839 (1016)
Q Consensus 815 ---------------------------------~~~----------------------~~~~~~~gt~~y~aPE~~~~~~ 839 (1016)
... ..+..++||-.|+|||++.+..
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G 311 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG 311 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence 000 0112257999999999999999
Q ss_pred CCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCCCCCCHHHHHHHHHHHHHccCCCC
Q 001768 840 LTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSP 919 (1016)
Q Consensus 840 ~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP 919 (1016)
.+.++|.|+|||++|||+.|+.||.+....+....+ ..+...+. -.......+.+||++.|.+||
T Consensus 312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NI-----v~~~l~Fp----------~~~~vs~~akDLIr~LLvKdP 376 (459)
T KOG0610|consen 312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNI-----VGQPLKFP----------EEPEVSSAAKDLIRKLLVKDP 376 (459)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHH-----hcCCCcCC----------CCCcchhHHHHHHHHHhccCh
Confidence 999999999999999999999999987766543221 11111111 112345678999999999999
Q ss_pred CCCCC----HHHHHH
Q 001768 920 TLRPT----MSSAVS 930 (1016)
Q Consensus 920 ~~RPt----~~evl~ 930 (1016)
.+|.. +.||-+
T Consensus 377 ~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 377 SKRLGSKRGAAEIKR 391 (459)
T ss_pred hhhhccccchHHhhc
Confidence 99998 655553
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=325.25 Aligned_cols=260 Identities=24% Similarity=0.360 Sum_probs=208.3
Q ss_pred HhcCccccCccccCCCeeEEEEEcCC-----CcEEEEEEccCC-ChhhhHHHHHHHHHHHhcCCCCeeeeeeeEee-cce
Q 001768 657 ATNNFDAANKIGEGGFGPVYKGTLSD-----GAVIAVKQLSSK-SKQGNREFVNEIGMISALQHQNLVKLYGCCIE-GNQ 729 (1016)
Q Consensus 657 ~~~~f~~~~~LG~G~~G~Vy~~~~~~-----~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~ 729 (1016)
..++|++.+.||+|+||.||+|...+ +..||+|++... .......+.+|+.++++++||||+++++++.. +..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 45789999999999999999999765 688999998754 33445678899999999999999999998776 467
Q ss_pred eEEEEeecCCCcHHHHhccCcCc----CcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeec
Q 001768 730 LLLVYEYLENNSLARALFGKEGQ----CLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISD 805 (1016)
Q Consensus 730 ~~lV~E~~~~gsL~~~l~~~~~~----~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~D 805 (1016)
.++++||+++++|.+++...... ...+++.+++.++.|++.||+|||+. +++||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECC
Confidence 89999999999999998654322 14689999999999999999999998 999999999999999999999999
Q ss_pred cccccccCCCCcc-eeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHh-CCCCCCCCCchhhHhHHHHHHHHHH
Q 001768 806 FGLAKLDEDENTH-ISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWAYVLQE 883 (1016)
Q Consensus 806 FGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~ 883 (1016)
||+++........ ......++..|+|||++.+..++.++|||||||++||+++ |+.||......+... ....
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~------~~~~ 234 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAA------YLKD 234 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHH------HHHc
Confidence 9999855433222 1222345778999999988889999999999999999999 999997654333211 1111
Q ss_pred hCCcccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 001768 884 QGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGK 935 (1016)
Q Consensus 884 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 935 (1016)
.. .... +...+..+.+++.+||+.||++|||+.++++.|+..
T Consensus 235 ~~------~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~ 276 (280)
T cd05043 235 GY------RLAQ----PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDF 276 (280)
T ss_pred CC------CCCC----CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 10 0011 112345689999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=356.54 Aligned_cols=261 Identities=22% Similarity=0.343 Sum_probs=204.4
Q ss_pred cCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCC---hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEE
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS---KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVY 734 (1016)
Q Consensus 659 ~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 734 (1016)
++|++.++||+|+||.||+|+.. +++.||+|++.... ....+++.+|++++++++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57999999999999999999965 58999999987532 233467899999999999999999999999999999999
Q ss_pred eecCCCcHHHHhccCcC-------cCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccc
Q 001768 735 EYLENNSLARALFGKEG-------QCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFG 807 (1016)
Q Consensus 735 E~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG 807 (1016)
||+++++|.+++..... ....+++..++.++.||++||+|||+. +|+||||||+||+++.++.++|+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence 99999999999864211 123467788899999999999999998 99999999999999999999999999
Q ss_pred cccccCCCCc-----------------ceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchh
Q 001768 808 LAKLDEDENT-----------------HISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEE 870 (1016)
Q Consensus 808 la~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~ 870 (1016)
+++....... .......||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9975521110 01123569999999999999999999999999999999999999997643322
Q ss_pred hHhHHHHHHHHHHhCCcccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHhccCc
Q 001768 871 FVYLLDWAYVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRP-TMSSAVSMLEGKT 936 (1016)
Q Consensus 871 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~evl~~L~~~~ 936 (1016)
.... .. ..++.... .....+..+.+++.+|++.||++|| +++++.+.|+...
T Consensus 239 i~~~----------~~---i~~P~~~~-p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~l 291 (932)
T PRK13184 239 ISYR----------DV---ILSPIEVA-PYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHL 291 (932)
T ss_pred hhhh----------hh---ccChhhcc-ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 1110 00 00110000 0112345688999999999999997 5666777776543
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=318.07 Aligned_cols=248 Identities=29% Similarity=0.441 Sum_probs=200.9
Q ss_pred cCccccCccccCCCeeEEEEEcCCCcEEEEEEccCCChhhhHHHHHHHHHHHhcCCCCeeeeeeeEe-ecceeEEEEeec
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCI-EGNQLLLVYEYL 737 (1016)
Q Consensus 659 ~~f~~~~~LG~G~~G~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~~lV~E~~ 737 (1016)
++|++.+.||+|+||.||++... +..||+|.+.... ..+.+.+|+.++++++|+|++++++++. .++..++||||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 47888999999999999999875 7789999986443 2457889999999999999999999765 456789999999
Q ss_pred CCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCCc
Q 001768 738 ENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENT 817 (1016)
Q Consensus 738 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 817 (1016)
++++|.+++..... ..+++..++.++.|++.||+|||++ +|+||||||+||++++++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~- 156 (256)
T cd05082 83 AKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 156 (256)
T ss_pred CCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC-
Confidence 99999999965432 3588999999999999999999998 99999999999999999999999999987543321
Q ss_pred ceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHh-CCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCC
Q 001768 818 HISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLG 896 (1016)
Q Consensus 818 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 896 (1016)
....++..|+|||++.+..++.++|||||||++|||++ |+.||......+....+ ... ..
T Consensus 157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~-------~~~---------~~ 217 (256)
T cd05082 157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV-------EKG---------YK 217 (256)
T ss_pred ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-------hcC---------CC
Confidence 22344668999999988889999999999999999998 99998654433221111 011 01
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 001768 897 SNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEG 934 (1016)
Q Consensus 897 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 934 (1016)
...+...+..+.+++.+|++.+|++|||+.++++.|+.
T Consensus 218 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 218 MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 11122334578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=319.55 Aligned_cols=256 Identities=26% Similarity=0.443 Sum_probs=205.2
Q ss_pred hcCccccCccccCCCeeEEEEEcC-CC---cEEEEEEccCCC-hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEE
Q 001768 658 TNNFDAANKIGEGGFGPVYKGTLS-DG---AVIAVKQLSSKS-KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLL 732 (1016)
Q Consensus 658 ~~~f~~~~~LG~G~~G~Vy~~~~~-~~---~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 732 (1016)
.++|+..+.||+|+||.||+|+.. ++ ..+|+|.+.... ....+.+.+|++++++++||||+++.+++.+.+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 457888999999999999999864 23 379999987553 3345678899999999999999999999999999999
Q ss_pred EEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeecccccccc
Q 001768 733 VYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLD 812 (1016)
Q Consensus 733 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~ 812 (1016)
||||+++++|.+++.... ..+++.++..++.|++.|++|||+. +++||||||+||++++++.+||+|||++...
T Consensus 84 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 84 ITEYMENGALDKYLRDHD---GEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVL 157 (268)
T ss_pred EEEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceec
Confidence 999999999999996543 3589999999999999999999998 8999999999999999999999999998755
Q ss_pred CCCCcceee--ecccCccccChhhhccCCCCCccchhHHHHHHHHHHh-CCCCCCCCCchhhHhHHHHHHHHHHhCCccc
Q 001768 813 EDENTHIST--RIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWAYVLQEQGNLLE 889 (1016)
Q Consensus 813 ~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 889 (1016)
......... ....+..|+|||++.+..++.++|||||||++|||++ |+.||......+....+ ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i------~~~~---- 227 (268)
T cd05063 158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAI------NDGF---- 227 (268)
T ss_pred ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHH------hcCC----
Confidence 432221111 1223457999999988889999999999999999998 99998755433221111 1100
Q ss_pred ccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 001768 890 LVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGK 935 (1016)
Q Consensus 890 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 935 (1016)
........+..+.+++.+||+.+|++||++.+|++.|++.
T Consensus 228 ------~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 228 ------RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0011112345689999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=326.01 Aligned_cols=266 Identities=23% Similarity=0.362 Sum_probs=205.3
Q ss_pred cCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCC-hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEee
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS-KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEY 736 (1016)
Q Consensus 659 ~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 736 (1016)
++|++.+.||+|+||.||+++.. ++..||+|.+.... ......+.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 46899999999999999999865 57889999887543 33345688999999999999999999999999999999999
Q ss_pred cCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCC
Q 001768 737 LENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDEN 816 (1016)
Q Consensus 737 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 816 (1016)
+++++|.+++... ..+++..+..++.|+++||.|||+.. +++||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (308)
T cd06615 81 MDGGSLDQVLKKA----GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 154 (308)
T ss_pred cCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCcccccccc
Confidence 9999999999654 25899999999999999999999742 89999999999999999999999999987543321
Q ss_pred cceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhC-----------
Q 001768 817 THISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQG----------- 885 (1016)
Q Consensus 817 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~----------- 885 (1016)
.....|+..|+|||.+.+..++.++|||||||++|||++|+.||......................
T Consensus 155 ---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
T cd06615 155 ---ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPP 231 (308)
T ss_pred ---cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCC
Confidence 233568899999999988889999999999999999999999986543222111110000000000
Q ss_pred -------------CcccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCcCCcCccccC
Q 001768 886 -------------NLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTAVQAPIIRR 945 (1016)
Q Consensus 886 -------------~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~p~~~~ 945 (1016)
.......+..+. ......+.+++.+||+.+|++||++.+++ .+||+.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~P~~Rpt~~~ll---------~~~~~~~ 292 (308)
T cd06615 232 DSPRPMAIFELLDYIVNEPPPKLPS---GAFSDEFQDFVDKCLKKNPKERADLKELT---------KHPFIKR 292 (308)
T ss_pred CccchhhHHHHHHHHhcCCCccCcC---cccCHHHHHHHHHHccCChhhCcCHHHHh---------cChhhhh
Confidence 000000011100 11344689999999999999999999887 5677653
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=324.51 Aligned_cols=261 Identities=24% Similarity=0.345 Sum_probs=194.8
Q ss_pred CccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCCh--hhhHHHHHHHHHHHhc---CCCCeeeeeeeEee-----cc
Q 001768 660 NFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSK--QGNREFVNEIGMISAL---QHQNLVKLYGCCIE-----GN 728 (1016)
Q Consensus 660 ~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l---~HpnIv~l~~~~~~-----~~ 728 (1016)
+|++.+.||+|+||.||+|+.. +++.||+|.+..... .....+.+|+++++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 5888999999999999999865 688999999875422 2234556777777665 79999999998864 34
Q ss_pred eeEEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeecccc
Q 001768 729 QLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGL 808 (1016)
Q Consensus 729 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGl 808 (1016)
..++||||+++ +|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPP--PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCc
Confidence 68999999985 88888865432 3589999999999999999999998 899999999999999999999999999
Q ss_pred ccccCCCCcceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhH-HHHHHHHHHhCCc
Q 001768 809 AKLDEDENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYL-LDWAYVLQEQGNL 887 (1016)
Q Consensus 809 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~-~~~~~~~~~~~~~ 887 (1016)
++...... ......||..|+|||++.+..++.++||||+||++|||++|++||......+.... ...... .....+
T Consensus 155 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~-~~~~~~ 231 (288)
T cd07863 155 ARIYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGL-PPEDDW 231 (288)
T ss_pred cccccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCC-CChhhC
Confidence 98654322 12335688999999999888899999999999999999999999976544332111 110000 000000
Q ss_pred cc-------ccCCcCC---CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 001768 888 LE-------LVDPSLG---SNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAV 929 (1016)
Q Consensus 888 ~~-------~~d~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 929 (1016)
.. ...+... ..........+.+++.+|++.||++|||+.|++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l 283 (288)
T cd07863 232 PRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRAL 283 (288)
T ss_pred cccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHh
Confidence 00 0000000 011112345688999999999999999999887
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=338.13 Aligned_cols=260 Identities=21% Similarity=0.308 Sum_probs=201.1
Q ss_pred cCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCC---hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEE
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS---KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVY 734 (1016)
Q Consensus 659 ~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 734 (1016)
++|+..+.||+|+||.||+|+.. +++.||+|++.... ......+.+|+.++..++||||+++++.+.+++..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46889999999999999999865 68999999986432 233456788999999999999999999999999999999
Q ss_pred eecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCC
Q 001768 735 EYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDED 814 (1016)
Q Consensus 735 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 814 (1016)
||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~ 153 (360)
T cd05627 81 EFLPGGDMMTLLMKKD----TLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK 153 (360)
T ss_pred eCCCCccHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence 9999999999996543 589999999999999999999998 999999999999999999999999999864322
Q ss_pred CCc----------------------------------ceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCC
Q 001768 815 ENT----------------------------------HISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGK 860 (1016)
Q Consensus 815 ~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~ 860 (1016)
... .......||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~ 233 (360)
T cd05627 154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (360)
T ss_pred ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence 100 0012347999999999999999999999999999999999999
Q ss_pred CCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCcCCcC
Q 001768 861 SNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTAVQA 940 (1016)
Q Consensus 861 ~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 940 (1016)
.||...........+ .. ...... .+... .....+.+++.+++ .||.+|++...+-+. +.|
T Consensus 234 ~Pf~~~~~~~~~~~i------~~---~~~~~~--~p~~~--~~s~~~~~li~~l~-~~p~~R~~~~~~~ei------~~h 293 (360)
T cd05627 234 PPFCSETPQETYRKV------MN---WKETLV--FPPEV--PISEKAKDLILRFC-TDSENRIGSNGVEEI------KSH 293 (360)
T ss_pred CCCCCCCHHHHHHHH------Hc---CCCcee--cCCCC--CCCHHHHHHHHHhc-cChhhcCCCCCHHHH------hcC
Confidence 999866544322111 00 000000 01110 12345777888766 499999964322222 257
Q ss_pred ccccC
Q 001768 941 PIIRR 945 (1016)
Q Consensus 941 p~~~~ 945 (1016)
||+..
T Consensus 294 p~f~~ 298 (360)
T cd05627 294 PFFEG 298 (360)
T ss_pred CCCCC
Confidence 77654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=316.86 Aligned_cols=250 Identities=21% Similarity=0.326 Sum_probs=204.3
Q ss_pred CccccCccccCCCeeEEEEEcC-CCcEEEEEEccCC-ChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEeec
Q 001768 660 NFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSK-SKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYL 737 (1016)
Q Consensus 660 ~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 737 (1016)
+|++.+.||+|+||.||+++.. +++.||+|.+... .....+.+.+|+.+++.++||||+++++++.+++..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 5788999999999999999865 6889999998643 3344567889999999999999999999999999999999999
Q ss_pred CCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCCc
Q 001768 738 ENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENT 817 (1016)
Q Consensus 738 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 817 (1016)
++++|.+++..... ..+++..+..++.|++.||+|||++ +|+|+||||+||++++++.++++|||.+........
T Consensus 81 ~~~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 155 (255)
T cd08219 81 DGGDLMQKIKLQRG--KLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA 155 (255)
T ss_pred CCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccccc
Confidence 99999998865432 3588999999999999999999998 999999999999999999999999999976543322
Q ss_pred ceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCCC
Q 001768 818 HISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGS 897 (1016)
Q Consensus 818 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 897 (1016)
......|++.|+|||++.+..++.++||||||+++|+|++|+.||........... .......
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~-------~~~~~~~--------- 218 (255)
T cd08219 156 -YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILK-------VCQGSYK--------- 218 (255)
T ss_pred -ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHH-------HhcCCCC---------
Confidence 22345688999999999888899999999999999999999999976543322110 0111111
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001768 898 NFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSM 931 (1016)
Q Consensus 898 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 931 (1016)
..+......+.+++.+||+.||++||++.+++..
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 219 PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 1122234568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=323.54 Aligned_cols=258 Identities=30% Similarity=0.515 Sum_probs=205.9
Q ss_pred hcCccccCccccCCCeeEEEEEcC------CCcEEEEEEccCCC-hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeeccee
Q 001768 658 TNNFDAANKIGEGGFGPVYKGTLS------DGAVIAVKQLSSKS-KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQL 730 (1016)
Q Consensus 658 ~~~f~~~~~LG~G~~G~Vy~~~~~------~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 730 (1016)
.++|++.+.||+|+||.||+|... ++..||+|.+.... ......+.+|++++++++||||+++++++.+++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467999999999999999999853 46789999987543 33456788999999999999999999999999999
Q ss_pred EEEEeecCCCcHHHHhccCc------------------CcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCce
Q 001768 731 LLVYEYLENNSLARALFGKE------------------GQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATN 792 (1016)
Q Consensus 731 ~lV~E~~~~gsL~~~l~~~~------------------~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~N 792 (1016)
++||||+++++|.+++.... .....+++.+++.++.|++.||+|||+. +++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhh
Confidence 99999999999999996432 1113578999999999999999999998 99999999999
Q ss_pred EEEccCCceeeeccccccccCCCCc-ceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHh-CCCCCCCCCchh
Q 001768 793 VLLDKDLNAKISDFGLAKLDEDENT-HISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEE 870 (1016)
Q Consensus 793 ILl~~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~ 870 (1016)
|++++++.++|+|||++........ .......++..|+|||.+.+..++.++|||||||++|||++ |..||.....++
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999875432211 11122334678999999988889999999999999999998 888886554433
Q ss_pred hHhHHHHHHHHHHhCCcccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 001768 871 FVYLLDWAYVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEG 934 (1016)
Q Consensus 871 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 934 (1016)
....+ ...... ..+...+..+.+++.+||+.+|++|||+.|+++.|+.
T Consensus 241 ~~~~~-------~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 241 VIYYV-------RDGNVL---------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HHHHH-------hcCCCC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 22111 111111 0112234578999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=311.18 Aligned_cols=247 Identities=28% Similarity=0.429 Sum_probs=207.8
Q ss_pred ccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEeecCC
Q 001768 661 FDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYLEN 739 (1016)
Q Consensus 661 f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 739 (1016)
|+++.+||+|+||.||+|.++ .|..||+|.+... .+.+++..|+.++++.+.|++|++||.+.....+|+|||||..
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 778999999999999999865 6999999998654 3567889999999999999999999999999999999999999
Q ss_pred CcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCCcce
Q 001768 740 NSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHI 819 (1016)
Q Consensus 740 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 819 (1016)
|++.+.+..++ .+|++.++..+++..++||+|||.. .-||||||+.|||++.+|.+||+|||.|....+.- ..
T Consensus 113 GSiSDI~R~R~---K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM-AK 185 (502)
T KOG0574|consen 113 GSISDIMRARR---KPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM-AK 185 (502)
T ss_pred CcHHHHHHHhc---CCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhH-Hh
Confidence 99999997654 4799999999999999999999988 78999999999999999999999999997554322 22
Q ss_pred eeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCCCCC
Q 001768 820 STRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGSNF 899 (1016)
Q Consensus 820 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 899 (1016)
...+.||+.|||||++..-.|..++||||||++..||..|++||..-.+......+ .. .|.-.-.-
T Consensus 186 RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI------------PT--~PPPTF~K 251 (502)
T KOG0574|consen 186 RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI------------PT--KPPPTFKK 251 (502)
T ss_pred hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEec------------cC--CCCCCCCC
Confidence 34578999999999999999999999999999999999999999765443322111 00 11111122
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 900 SKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 900 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
+..-...+-++++.||-+.|++|-|+.++++
T Consensus 252 PE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 252 PEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred hHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 3445668999999999999999999988775
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=324.56 Aligned_cols=250 Identities=25% Similarity=0.432 Sum_probs=204.9
Q ss_pred hcCccccCccccCCCeeEEEEEc-CCCcEEEEEEccCCChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEee
Q 001768 658 TNNFDAANKIGEGGFGPVYKGTL-SDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEY 736 (1016)
Q Consensus 658 ~~~f~~~~~LG~G~~G~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 736 (1016)
..+|++.+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 36789999999999999999995 47899999999766555567788999999999999999999999999999999999
Q ss_pred cCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCC
Q 001768 737 LENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDEN 816 (1016)
Q Consensus 737 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 816 (1016)
+++++|.+++... .+++.++..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++.......
T Consensus 98 ~~~~~L~~~~~~~-----~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~ 169 (297)
T cd06656 98 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (297)
T ss_pred cCCCCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence 9999999998543 478999999999999999999998 99999999999999999999999999987544332
Q ss_pred cceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCC
Q 001768 817 THISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLG 896 (1016)
Q Consensus 817 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 896 (1016)
.. .....+++.|+|||.+.+..++.++|||||||++|+|++|+.||............ .......
T Consensus 170 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~--------------~~~~~~~ 234 (297)
T cd06656 170 SK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI--------------ATNGTPE 234 (297)
T ss_pred cC-cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeee--------------ccCCCCC
Confidence 21 22346888999999998888999999999999999999999999754332211100 0000000
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 897 SNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 897 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
...+...+..+.+++.+||+.+|++||++.++++
T Consensus 235 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 235 LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1112234456889999999999999999998884
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=331.93 Aligned_cols=244 Identities=25% Similarity=0.326 Sum_probs=192.6
Q ss_pred CccccCCCeeEEEEEcC-CCcEEEEEEccCCC---hhhhHHHHHHH-HHHHhcCCCCeeeeeeeEeecceeEEEEeecCC
Q 001768 665 NKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS---KQGNREFVNEI-GMISALQHQNLVKLYGCCIEGNQLLLVYEYLEN 739 (1016)
Q Consensus 665 ~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~-~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 739 (1016)
+.||+|+||.||+|+.. +++.||+|++.... ......+..|. .+++.++||||+++++++..++..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999965 57889999986532 12223444444 456788999999999999999999999999999
Q ss_pred CcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCCcce
Q 001768 740 NSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHI 819 (1016)
Q Consensus 740 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 819 (1016)
++|.+++.... .+++..+..++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~~L~~~~~~~~----~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~-~ 152 (325)
T cd05602 81 GELFYHLQRER----CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-T 152 (325)
T ss_pred CcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC-C
Confidence 99999996543 578889999999999999999998 999999999999999999999999999974322211 2
Q ss_pred eeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCCCCC
Q 001768 820 STRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGSNF 899 (1016)
Q Consensus 820 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 899 (1016)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+ .. .. .....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i-----~~--~~------~~~~~-- 217 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI-----LN--KP------LQLKP-- 217 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHH-----Hh--CC------cCCCC--
Confidence 33457999999999999989999999999999999999999999765543321111 00 00 01111
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 001768 900 SKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933 (1016)
Q Consensus 900 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 933 (1016)
.....+.+++.+|++.||.+||++.+.+..+.
T Consensus 218 --~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~ 249 (325)
T cd05602 218 --NITNSARHLLEGLLQKDRTKRLGAKDDFMEIK 249 (325)
T ss_pred --CCCHHHHHHHHHHcccCHHHCCCCCCCHHHHh
Confidence 23346889999999999999999886554443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=330.15 Aligned_cols=242 Identities=21% Similarity=0.347 Sum_probs=195.8
Q ss_pred CccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCC---hhhhHHHHHHHHHHHhcC-CCCeeeeeeeEeecceeEEEE
Q 001768 660 NFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS---KQGNREFVNEIGMISALQ-HQNLVKLYGCCIEGNQLLLVY 734 (1016)
Q Consensus 660 ~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~ 734 (1016)
+|+..+.||+|+||.||+|+.. +++.||+|++.... ....+.+..|..+++.+. |++|+++++++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4778899999999999999865 68999999987532 233456778888888885 577888999999999999999
Q ss_pred eecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCC
Q 001768 735 EYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDED 814 (1016)
Q Consensus 735 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 814 (1016)
||+++|+|.+++.... .+++.++..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 Ey~~~g~L~~~i~~~~----~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~ 153 (323)
T cd05615 81 EYVNGGDLMYHIQQVG----KFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV 153 (323)
T ss_pred cCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence 9999999999986543 589999999999999999999998 999999999999999999999999999875332
Q ss_pred CCcceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCc
Q 001768 815 ENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPS 894 (1016)
Q Consensus 815 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 894 (1016)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+ .. . ..
T Consensus 154 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i-----~~--~------~~- 218 (323)
T cd05615 154 DGV-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSI-----ME--H------NV- 218 (323)
T ss_pred CCc-cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH-----Hh--C------CC-
Confidence 211 223356899999999999888999999999999999999999999866543322111 00 0 01
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHH
Q 001768 895 LGSNFSKKEAMTMLNIALLCTNPSPTLRPTMS 926 (1016)
Q Consensus 895 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 926 (1016)
.++......+.+++.+|++.+|.+|++..
T Consensus 219 ---~~p~~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 219 ---SYPKSLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred ---CCCccCCHHHHHHHHHHcccCHhhCCCCC
Confidence 11222345688999999999999999864
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=327.09 Aligned_cols=259 Identities=28% Similarity=0.452 Sum_probs=206.0
Q ss_pred hcCccccCccccCCCeeEEEEEcC--------CCcEEEEEEccCCC-hhhhHHHHHHHHHHHhc-CCCCeeeeeeeEeec
Q 001768 658 TNNFDAANKIGEGGFGPVYKGTLS--------DGAVIAVKQLSSKS-KQGNREFVNEIGMISAL-QHQNLVKLYGCCIEG 727 (1016)
Q Consensus 658 ~~~f~~~~~LG~G~~G~Vy~~~~~--------~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~ 727 (1016)
.++|.+.+.||+|+||.||+|+.. ....||+|.+.... ......+.+|+++++++ +||||+++++++.++
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 457889999999999999999742 24579999987543 33456788999999999 699999999999999
Q ss_pred ceeEEEEeecCCCcHHHHhccCcC------------cCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEE
Q 001768 728 NQLLLVYEYLENNSLARALFGKEG------------QCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLL 795 (1016)
Q Consensus 728 ~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl 795 (1016)
+..++||||+++|+|.+++..... ....+++.++..++.|++.||+|||++ +|+||||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEE
Confidence 999999999999999999965421 123589999999999999999999998 99999999999999
Q ss_pred ccCCceeeeccccccccCCCCcce-eeecccCccccChhhhccCCCCCccchhHHHHHHHHHHh-CCCCCCCCCchhhHh
Q 001768 796 DKDLNAKISDFGLAKLDEDENTHI-STRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVY 873 (1016)
Q Consensus 796 ~~~~~~kL~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~ 873 (1016)
++++.+||+|||+++......... .....++..|+|||.+.++.++.++|||||||++|||++ |+.||...+.++...
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~ 247 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFK 247 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 999999999999998554322111 112234567999999988889999999999999999999 888987655443322
Q ss_pred HHHHHHHHHHhCCcccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 001768 874 LLDWAYVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGK 935 (1016)
Q Consensus 874 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 935 (1016)
.. ..... ...+...+..+.+++.+||+.+|++||++.++++.|+..
T Consensus 248 ~~-------~~~~~---------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~ 293 (314)
T cd05099 248 LL-------REGHR---------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKV 293 (314)
T ss_pred HH-------HcCCC---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 11 11110 011222344688999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=319.46 Aligned_cols=256 Identities=26% Similarity=0.417 Sum_probs=204.9
Q ss_pred ccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEeecCC
Q 001768 661 FDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYLEN 739 (1016)
Q Consensus 661 f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 739 (1016)
|++.+.||+|+||.||+|... ++..+|+|.+..........+.+|+++++.++||||+++++++..++..++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 677899999999999999965 5788999998766666667889999999999999999999999999999999999999
Q ss_pred CcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCCcce
Q 001768 740 NSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHI 819 (1016)
Q Consensus 740 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 819 (1016)
++|..++.... .++++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++........ .
T Consensus 87 ~~l~~~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-~ 159 (282)
T cd06643 87 GAVDAVMLELE---RPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-R 159 (282)
T ss_pred CcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccccccccc-c
Confidence 99999886432 3689999999999999999999998 999999999999999999999999999875433221 1
Q ss_pred eeecccCccccChhhhc-----cCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCc
Q 001768 820 STRIAGTVGYMAPEYAM-----RGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPS 894 (1016)
Q Consensus 820 ~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 894 (1016)
.....++..|+|||++. +..++.++|||||||++|||++|++||......+..... ........
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~-------~~~~~~~~---- 228 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKI-------AKSEPPTL---- 228 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHH-------hhcCCCCC----
Confidence 23356889999999884 345778999999999999999999998754432221110 00000010
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCcCCcCccccCC
Q 001768 895 LGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTAVQAPIIRRN 946 (1016)
Q Consensus 895 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~p~~~~~ 946 (1016)
..+...+..+.+++.+||+.||.+||++.+++ .+||....
T Consensus 229 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il---------~~~~~~~~ 268 (282)
T cd06643 229 ---AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLL---------QHPFVTVN 268 (282)
T ss_pred ---CCccccCHHHHHHHHHHccCChhhCcCHHHHh---------cCCCEecc
Confidence 11122345789999999999999999998876 56776543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=322.97 Aligned_cols=257 Identities=26% Similarity=0.377 Sum_probs=203.1
Q ss_pred CccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCC---hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEe
Q 001768 660 NFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS---KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYE 735 (1016)
Q Consensus 660 ~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 735 (1016)
.|+..+.||+|+||.||++... +++.||+|.+.... ......+.+|+.++++++|++++++++.+.+++..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 3677889999999999999865 68899999986542 2223457789999999999999999999999999999999
Q ss_pred ecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCC
Q 001768 736 YLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDE 815 (1016)
Q Consensus 736 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 815 (1016)
|+++++|.+++..... ..+++.++..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++......
T Consensus 81 ~~~g~~L~~~l~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05630 81 LMNGGDLKFHIYHMGE--AGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 155 (285)
T ss_pred ecCCCcHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence 9999999998864332 3589999999999999999999998 9999999999999999999999999998754432
Q ss_pred CcceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcC
Q 001768 816 NTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSL 895 (1016)
Q Consensus 816 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 895 (1016)
.. .....|+..|+|||++.+..++.++|||||||++|||++|+.||............. .... . ....
T Consensus 156 ~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~--~~~~---~----~~~~- 223 (285)
T cd05630 156 QT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE--RLVK---E----VQEE- 223 (285)
T ss_pred cc--ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHH--hhhh---h----hhhh-
Confidence 22 123468999999999998889999999999999999999999997643321111000 0000 0 0011
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHhccCcCCcCccccC
Q 001768 896 GSNFSKKEAMTMLNIALLCTNPSPTLRPT-----MSSAVSMLEGKTAVQAPIIRR 945 (1016)
Q Consensus 896 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~L~~~~~~~~p~~~~ 945 (1016)
++......+.+++.+||+.||++||| +.|++ .|||+.+
T Consensus 224 ---~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~---------~h~~~~~ 266 (285)
T cd05630 224 ---YSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVK---------EHPLFKQ 266 (285)
T ss_pred ---cCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHH---------cChhhhc
Confidence 11223346889999999999999999 66666 5777654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=319.26 Aligned_cols=250 Identities=29% Similarity=0.426 Sum_probs=196.7
Q ss_pred CccccCCCeeEEEEEcCC-Cc--EEEEEEccCCC-hhhhHHHHHHHHHHHhc-CCCCeeeeeeeEeecceeEEEEeecCC
Q 001768 665 NKIGEGGFGPVYKGTLSD-GA--VIAVKQLSSKS-KQGNREFVNEIGMISAL-QHQNLVKLYGCCIEGNQLLLVYEYLEN 739 (1016)
Q Consensus 665 ~~LG~G~~G~Vy~~~~~~-~~--~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~ 739 (1016)
+.||+|+||.||+|++.+ +. .+|+|.+.... ....+.+.+|+++++++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 468999999999999753 43 46888887533 34456788999999999 899999999999999999999999999
Q ss_pred CcHHHHhccCcC------------cCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccc
Q 001768 740 NSLARALFGKEG------------QCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFG 807 (1016)
Q Consensus 740 gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG 807 (1016)
++|.+++..... ....+++.++..++.|++.||+|||+. +++||||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence 999999965431 123588999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCCcceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHh-CCCCCCCCCchhhHhHHHHHHHHHHhCC
Q 001768 808 LAKLDEDENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWAYVLQEQGN 886 (1016)
Q Consensus 808 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~ 886 (1016)
++....... .......+..|+|||++....++.++|||||||++|||++ |..||......+..... . ..
T Consensus 158 l~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~------~-~~- 227 (270)
T cd05047 158 LSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL------P-QG- 227 (270)
T ss_pred Cccccchhh--hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHH------h-CC-
Confidence 986322111 1111234567999999988889999999999999999997 99998654433221110 0 00
Q ss_pred cccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 001768 887 LLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGK 935 (1016)
Q Consensus 887 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 935 (1016)
.....+......+.+++.+||+.+|.+|||+.++++.|+..
T Consensus 228 --------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 228 --------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred --------CCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 00011112334688999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=320.52 Aligned_cols=259 Identities=25% Similarity=0.448 Sum_probs=209.2
Q ss_pred hcCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEee
Q 001768 658 TNNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEY 736 (1016)
Q Consensus 658 ~~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 736 (1016)
.++|++.+.||+|+||.||+|... ++..||+|.+........+.+.+|++++++++||||+++++++..+...++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 457899999999999999999965 6899999999876666667899999999999999999999999999999999999
Q ss_pred cCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCC
Q 001768 737 LENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDEN 816 (1016)
Q Consensus 737 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 816 (1016)
+++++|.+++.... ..+++..++.++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (280)
T cd06611 84 CDGGALDSIMLELE---RGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL 157 (280)
T ss_pred cCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhcccc
Confidence 99999999986543 2589999999999999999999998 99999999999999999999999999987543322
Q ss_pred cceeeecccCccccChhhhc-----cCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCccccc
Q 001768 817 THISTRIAGTVGYMAPEYAM-----RGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELV 891 (1016)
Q Consensus 817 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 891 (1016)
. ......+++.|+|||.+. ...++.++|||||||++|||++|+.||.......... . .....
T Consensus 158 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~--~-----~~~~~----- 224 (280)
T cd06611 158 Q-KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLL--K-----ILKSE----- 224 (280)
T ss_pred c-ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHH--H-----HhcCC-----
Confidence 2 123356899999999875 3356789999999999999999999997654332211 0 01110
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCcCCcCccccCC
Q 001768 892 DPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTAVQAPIIRRN 946 (1016)
Q Consensus 892 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~p~~~~~ 946 (1016)
.+.+ ..+......+.+++.+||+.+|++||++.+++ .+||+...
T Consensus 225 ~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il---------~~~~~~~~ 268 (280)
T cd06611 225 PPTL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELL---------KHPFVSDQ 268 (280)
T ss_pred CCCc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHh---------cChhhccc
Confidence 0111 11122344688999999999999999999886 47877654
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=319.88 Aligned_cols=257 Identities=26% Similarity=0.405 Sum_probs=205.3
Q ss_pred cCccccCccccCCCeeEEEEEcC------CCcEEEEEEccCCChh-hhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeE
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLS------DGAVIAVKQLSSKSKQ-GNREFVNEIGMISALQHQNLVKLYGCCIEGNQLL 731 (1016)
Q Consensus 659 ~~f~~~~~LG~G~~G~Vy~~~~~------~~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 731 (1016)
++|++.+.||+|+||.||+|+.. +.+.||+|.+...... ....+.+|++++++++||||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 57888999999999999999853 3467999988654433 4567899999999999999999999999989999
Q ss_pred EEEeecCCCcHHHHhccCcCcC-----cCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeecc
Q 001768 732 LVYEYLENNSLARALFGKEGQC-----LNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDF 806 (1016)
Q Consensus 732 lV~E~~~~gsL~~~l~~~~~~~-----~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DF 806 (1016)
+||||+++++|.+++....... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999997554221 2589999999999999999999998 8999999999999999999999999
Q ss_pred ccccccCCCCcceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHh-CCCCCCCCCchhhHhHHHHHHHHHHhC
Q 001768 807 GLAKLDEDENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWAYVLQEQG 885 (1016)
Q Consensus 807 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~ 885 (1016)
|+++..............++..|+|||.+.+...+.++||||||+++|+|++ |..||............ ...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~-------~~~ 234 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRL-------QAG 234 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHH-------HcC
Confidence 9987543322222223456778999999988888999999999999999999 78888654433221111 111
Q ss_pred CcccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 001768 886 NLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933 (1016)
Q Consensus 886 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 933 (1016)
... ...+...+..+.+++.+||+.+|++||++.|++++|.
T Consensus 235 ~~~--------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 235 KLE--------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CcC--------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 111 0011123457899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=317.25 Aligned_cols=240 Identities=23% Similarity=0.373 Sum_probs=191.3
Q ss_pred CccccCCCeeEEEEEcCC-------------CcEEEEEEccCCChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeE
Q 001768 665 NKIGEGGFGPVYKGTLSD-------------GAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLL 731 (1016)
Q Consensus 665 ~~LG~G~~G~Vy~~~~~~-------------~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 731 (1016)
+.||+|+||.||+|++.+ ...||+|.+..........+.+|+.+++.++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998532 2358999887665555667889999999999999999999999999999
Q ss_pred EEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCc-------eeee
Q 001768 732 LVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLN-------AKIS 804 (1016)
Q Consensus 732 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~-------~kL~ 804 (1016)
+||||+++++|..++.... ..+++..++.++.||++||+|||+. +|+||||||+|||++.++. ++++
T Consensus 81 lv~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~ 154 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKS---DVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLS 154 (262)
T ss_pred EEEecccCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeC
Confidence 9999999999999886543 2589999999999999999999998 9999999999999987664 8999
Q ss_pred ccccccccCCCCcceeeecccCccccChhhhc-cCCCCCccchhHHHHHHHHHH-hCCCCCCCCCchhhHhHHHHHHHHH
Q 001768 805 DFGLAKLDEDENTHISTRIAGTVGYMAPEYAM-RGYLTDKADVYSFGIVALEIV-SGKSNTNYRPKEEFVYLLDWAYVLQ 882 (1016)
Q Consensus 805 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDVwSlGvvl~ell-tG~~P~~~~~~~~~~~~~~~~~~~~ 882 (1016)
|||++...... ....++..|+|||.+. +..++.++|||||||++|||+ +|+.|+......+.... .
T Consensus 155 d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~-------~ 222 (262)
T cd05077 155 DPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERF-------Y 222 (262)
T ss_pred CCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHH-------H
Confidence 99998754322 2245788899999886 467889999999999999998 58888765433221110 0
Q ss_pred HhCCcccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 001768 883 EQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933 (1016)
Q Consensus 883 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 933 (1016)
.... . ... .....+.+++.+||+.||.+||++.++++.++
T Consensus 223 -~~~~-~-----~~~----~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 223 -EGQC-M-----LVT----PSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred -hcCc-c-----CCC----CChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 0000 0 011 12346889999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=327.51 Aligned_cols=253 Identities=21% Similarity=0.253 Sum_probs=196.9
Q ss_pred cCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCC---hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEE
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS---KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVY 734 (1016)
Q Consensus 659 ~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 734 (1016)
++|++.+.||+|+||.||+++.+ +++.||+|++.... ......+.+|+.++..++|++|+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47899999999999999999965 57889999986432 223345788999999999999999999999999999999
Q ss_pred eecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCC
Q 001768 735 EYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDED 814 (1016)
Q Consensus 735 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 814 (1016)
||+++|+|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 ey~~~g~L~~~l~~~~---~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 81 DYYVGGDLLTLLSKFE---DRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred eccCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 9999999999996533 2589999999999999999999998 999999999999999999999999999875443
Q ss_pred CCcceeeecccCccccChhhhc-----cCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCccc
Q 001768 815 ENTHISTRIAGTVGYMAPEYAM-----RGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLE 889 (1016)
Q Consensus 815 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 889 (1016)
..........||+.|+|||++. ...++.++|||||||++|||++|+.||......+....+ .... ..
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i------~~~~--~~ 226 (332)
T cd05623 155 DGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI------MNHK--ER 226 (332)
T ss_pred CCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHH------hCCC--cc
Confidence 3333334457999999999986 346788999999999999999999999765433321111 0000 00
Q ss_pred ccCCcCCCCCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHH
Q 001768 890 LVDPSLGSNFSKKEAMTMLNIALLCTNPSPTL--RPTMSSAV 929 (1016)
Q Consensus 890 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl 929 (1016)
..-+.. .......+.+++.+|+..++++ |+++.|++
T Consensus 227 ~~~p~~----~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~ 264 (332)
T cd05623 227 FQFPAQ----VTDVSEDAKDLIRRLICSREHRLGQNGIEDFK 264 (332)
T ss_pred ccCCCc----cccCCHHHHHHHHHHccChhhhcCCCCHHHHh
Confidence 000111 1123456788888888654443 67888777
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=319.18 Aligned_cols=254 Identities=26% Similarity=0.460 Sum_probs=203.3
Q ss_pred cCccccCccccCCCeeEEEEEcCC-C---cEEEEEEccCC-ChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEE
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLSD-G---AVIAVKQLSSK-SKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLV 733 (1016)
Q Consensus 659 ~~f~~~~~LG~G~~G~Vy~~~~~~-~---~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 733 (1016)
.+|++.+.||+|+||.||+|++.. + ..||+|.+... ......+|..|+.+++.++||||+++++++.+++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 357889999999999999998652 3 36999998764 344466899999999999999999999999999999999
Q ss_pred EeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccC
Q 001768 734 YEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDE 813 (1016)
Q Consensus 734 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~ 813 (1016)
|||+++++|.+++.... ..+++.+++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++....
T Consensus 84 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 84 TEFMENGALDSFLRQND---GQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred EecCCCCcHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccc
Confidence 99999999999986543 2589999999999999999999998 99999999999999999999999999987554
Q ss_pred CCCcce--eeecc--cCccccChhhhccCCCCCccchhHHHHHHHHHHh-CCCCCCCCCchhhHhHHHHHHHHHHhCCcc
Q 001768 814 DENTHI--STRIA--GTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWAYVLQEQGNLL 888 (1016)
Q Consensus 814 ~~~~~~--~~~~~--gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 888 (1016)
...... ..... .+..|+|||++.+..++.++|||||||++|||++ |..||......+....+ ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i------~~~~--- 228 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAI------EQDY--- 228 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHH------HcCC---
Confidence 322111 11111 2457999999998889999999999999999886 99998765433321111 0000
Q ss_pred cccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 001768 889 ELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEG 934 (1016)
Q Consensus 889 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 934 (1016)
. ...+.+.+..+.+++.+||+.+|++||++.++++.|+.
T Consensus 229 ---~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 267 (269)
T cd05065 229 ---R----LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDK 267 (269)
T ss_pred ---c----CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 0 01112334568899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=315.10 Aligned_cols=247 Identities=30% Similarity=0.463 Sum_probs=197.9
Q ss_pred CccccCCCeeEEEEEcCC----CcEEEEEEccCCCh-hhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEeecCC
Q 001768 665 NKIGEGGFGPVYKGTLSD----GAVIAVKQLSSKSK-QGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYLEN 739 (1016)
Q Consensus 665 ~~LG~G~~G~Vy~~~~~~----~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 739 (1016)
++||+|+||.||+|++.. +..||+|.+..... ...+.+.+|+++++.++||||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 479999999999997532 36899999876543 34567889999999999999999999876 4568999999999
Q ss_pred CcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCCcce
Q 001768 740 NSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHI 819 (1016)
Q Consensus 740 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 819 (1016)
++|.+++.... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 80 GPLLKYLKKRR----EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 99999996543 589999999999999999999998 89999999999999999999999999998654433222
Q ss_pred ee--ecccCccccChhhhccCCCCCccchhHHHHHHHHHHh-CCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCC
Q 001768 820 ST--RIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLG 896 (1016)
Q Consensus 820 ~~--~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 896 (1016)
.. ...++..|+|||.+.+..++.++|||||||++|||++ |..||......+....+ . ....
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~------~-~~~~--------- 216 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAML------E-SGER--------- 216 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH------H-cCCc---------
Confidence 11 1223567999999988889999999999999999998 99998765443322111 1 1110
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 001768 897 SNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGK 935 (1016)
Q Consensus 897 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 935 (1016)
...+...+..+.+++.+||..+|++||++.++++.|++.
T Consensus 217 ~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 217 LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 011122345788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=317.48 Aligned_cols=254 Identities=27% Similarity=0.404 Sum_probs=195.3
Q ss_pred CccccCCCeeEEEEEcCC---CcEEEEEEccCCC-hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEeecCCC
Q 001768 665 NKIGEGGFGPVYKGTLSD---GAVIAVKQLSSKS-KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYLENN 740 (1016)
Q Consensus 665 ~~LG~G~~G~Vy~~~~~~---~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 740 (1016)
+.||+|+||.||+|.+.+ +..+|+|.+.... ......+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 468999999999998643 4579999887543 233457889999999999999999999999989999999999999
Q ss_pred cHHHHhccCcC-cCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCCcce
Q 001768 741 SLARALFGKEG-QCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHI 819 (1016)
Q Consensus 741 sL~~~l~~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 819 (1016)
+|.+++..... .....++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999965432 223567888889999999999999998 99999999999999999999999999997543332211
Q ss_pred -eeecccCccccChhhhccC-------CCCCccchhHHHHHHHHHHh-CCCCCCCCCchhhHhHHHHHHHHHHhCCcccc
Q 001768 820 -STRIAGTVGYMAPEYAMRG-------YLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWAYVLQEQGNLLEL 890 (1016)
Q Consensus 820 -~~~~~gt~~y~aPE~~~~~-------~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 890 (1016)
.....++..|+|||++.+. .++.++|||||||++|||++ |+.||......+..... ........
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~-------~~~~~~~~ 230 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYT-------VREQQLKL 230 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHH-------hhcccCCC
Confidence 2234577889999988642 35789999999999999996 99999765443321110 01111122
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 001768 891 VDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933 (1016)
Q Consensus 891 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 933 (1016)
.++.+... ....+.+++.+|+ .+|++|||++||++.|+
T Consensus 231 ~~~~~~~~----~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PKPRLKLP----LSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCccCCC----CChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 22222222 2335788999999 68999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=314.86 Aligned_cols=249 Identities=29% Similarity=0.451 Sum_probs=205.2
Q ss_pred cCccccCccccCCCeeEEEEEcCC-CcEEEEEEccCCChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEeec
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLSD-GAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYL 737 (1016)
Q Consensus 659 ~~f~~~~~LG~G~~G~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 737 (1016)
++|++.+.||+|+||.||+|+..+ ++.||+|.+..... .+++.+|++++++++||||+++++++.++...++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 678999999999999999999764 78999999865433 678999999999999999999999999999999999999
Q ss_pred CCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCCc
Q 001768 738 ENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENT 817 (1016)
Q Consensus 738 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 817 (1016)
++++|.+++.... ..+++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~L~~~l~~~~---~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (256)
T cd06612 81 GAGSVSDIMKITN---KTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA 154 (256)
T ss_pred CCCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence 9999999986433 3689999999999999999999998 899999999999999999999999999986544322
Q ss_pred ceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCCC
Q 001768 818 HISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGS 897 (1016)
Q Consensus 818 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 897 (1016)
......++..|+|||++.+..++.++|||||||++|+|++|+.||............ .....+. .
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~------------~~~~~~~--~ 219 (256)
T cd06612 155 -KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI------------PNKPPPT--L 219 (256)
T ss_pred -ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhh------------ccCCCCC--C
Confidence 223345788999999998888999999999999999999999999764433211100 0000011 1
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 898 NFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 898 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
..+......+.+++.+||+.||++|||+.|+++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 220 SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 112233457899999999999999999999884
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=331.06 Aligned_cols=194 Identities=24% Similarity=0.330 Sum_probs=165.9
Q ss_pred HHhcCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEE
Q 001768 656 AATNNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVY 734 (1016)
Q Consensus 656 ~~~~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 734 (1016)
....+|++.+.||+|+||.||+|+.. +++.||+|..... ....|+.++++++||||+++++++..++..++||
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 34567999999999999999999965 5788999975432 2346899999999999999999999999999999
Q ss_pred eecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCC
Q 001768 735 EYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDED 814 (1016)
Q Consensus 735 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 814 (1016)
||+. ++|.+++.... ..+++..+..|+.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 137 e~~~-~~l~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 209 (357)
T PHA03209 137 PHYS-SDLYTYLTKRS---RPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV 209 (357)
T ss_pred EccC-CcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCcccccccc
Confidence 9995 58888875433 3689999999999999999999998 999999999999999999999999999975332
Q ss_pred CCcceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCC
Q 001768 815 ENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTN 864 (1016)
Q Consensus 815 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~ 864 (1016)
.. ......||+.|+|||++.+..++.++|||||||++|||+++..|+.
T Consensus 210 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f 257 (357)
T PHA03209 210 AP--AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIF 257 (357)
T ss_pred Cc--ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccc
Confidence 21 1234568999999999998899999999999999999999665543
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=327.30 Aligned_cols=257 Identities=27% Similarity=0.440 Sum_probs=216.6
Q ss_pred HHhcCccccCccccCCCeeEEEEEcCC---C--cEEEEEEccCC-ChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecce
Q 001768 656 AATNNFDAANKIGEGGFGPVYKGTLSD---G--AVIAVKQLSSK-SKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQ 729 (1016)
Q Consensus 656 ~~~~~f~~~~~LG~G~~G~Vy~~~~~~---~--~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 729 (1016)
...+.....+.||+|-||.||+|.+.+ | -.||||.-+.+ .....+.|..|+.+|+.++|||||+++|+|.+. .
T Consensus 386 l~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P 464 (974)
T KOG4257|consen 386 LRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-P 464 (974)
T ss_pred eehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-c
Confidence 334445567899999999999998543 2 36899988764 445577899999999999999999999999864 5
Q ss_pred eEEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccc
Q 001768 730 LLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLA 809 (1016)
Q Consensus 730 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla 809 (1016)
.|+|||+++-|.|..+++.+.. .|+......++.||+.||+|||+. ++|||||..+|||+.....+||+|||++
T Consensus 465 ~WivmEL~~~GELr~yLq~nk~---sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLS 538 (974)
T KOG4257|consen 465 MWIVMELAPLGELREYLQQNKD---SLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLS 538 (974)
T ss_pred eeEEEecccchhHHHHHHhccc---cchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchh
Confidence 8999999999999999987664 589999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCcceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHh-CCCCCCCCCchhhHhHHHHHHHHHHhCCcc
Q 001768 810 KLDEDENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWAYVLQEQGNLL 888 (1016)
Q Consensus 810 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 888 (1016)
+...++..+..+...-+.-|||||.+.-..++.++|||-|||.+||++. |..||.+-...+. .
T Consensus 539 R~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV----------------I 602 (974)
T KOG4257|consen 539 RYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV----------------I 602 (974)
T ss_pred hhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccce----------------E
Confidence 9888877666666666788999999999999999999999999999987 9999986443322 2
Q ss_pred cccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 001768 889 ELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGK 935 (1016)
Q Consensus 889 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 935 (1016)
-.++..-+...++.++..+..++.+||+.||.+||++.|+...|...
T Consensus 603 ~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv 649 (974)
T KOG4257|consen 603 GHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDV 649 (974)
T ss_pred EEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHH
Confidence 22333333445666778899999999999999999999999887654
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=324.50 Aligned_cols=261 Identities=26% Similarity=0.390 Sum_probs=202.2
Q ss_pred cCccccCccccCCCeeEEEEEc-----CCCcEEEEEEccCCC-hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeec--cee
Q 001768 659 NNFDAANKIGEGGFGPVYKGTL-----SDGAVIAVKQLSSKS-KQGNREFVNEIGMISALQHQNLVKLYGCCIEG--NQL 730 (1016)
Q Consensus 659 ~~f~~~~~LG~G~~G~Vy~~~~-----~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~ 730 (1016)
+.|++.+.||+|+||.||+++. .++..||+|.++... ......+.+|++++++++||||+++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3478899999999999999973 357889999987553 33456789999999999999999999998875 568
Q ss_pred EEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeecccccc
Q 001768 731 LLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAK 810 (1016)
Q Consensus 731 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~ 810 (1016)
++||||+++++|.+++.... ..+++.++..++.|++.||+|||++ +|+||||||+||+++.++.++|+|||+++
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNK---NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK 157 (284)
T ss_pred EEEEEccCCCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcccc
Confidence 99999999999999986542 2589999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCcc--eeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchh---------hHhHHHHHH
Q 001768 811 LDEDENTH--ISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEE---------FVYLLDWAY 879 (1016)
Q Consensus 811 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~---------~~~~~~~~~ 879 (1016)
........ ......++..|+|||++.+..++.++|||||||++|||++++.|........ .........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR 237 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH
Confidence 65433221 1223456778999999988889999999999999999999877643211000 000000000
Q ss_pred HHHHhCCcccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 001768 880 VLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGK 935 (1016)
Q Consensus 880 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 935 (1016)
. ..... ....+...+..+.+++.+||+.+|++||+++++++.|+..
T Consensus 238 ~-~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 238 V-LEEGK---------RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred H-HHcCc---------cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 0 01110 0111122345799999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=318.76 Aligned_cols=255 Identities=27% Similarity=0.395 Sum_probs=205.0
Q ss_pred hcCccccCccccCCCeeEEEEEcCC----CcEEEEEEccCCC-hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEE
Q 001768 658 TNNFDAANKIGEGGFGPVYKGTLSD----GAVIAVKQLSSKS-KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLL 732 (1016)
Q Consensus 658 ~~~f~~~~~LG~G~~G~Vy~~~~~~----~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 732 (1016)
.++|.+.+.||+|+||.||+|.+.+ ...||+|...... ....+.+.+|+.++++++||||+++++++.+ +..++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 3568889999999999999998643 3478999887654 4456689999999999999999999999875 45789
Q ss_pred EEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeecccccccc
Q 001768 733 VYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLD 812 (1016)
Q Consensus 733 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~ 812 (1016)
||||+++++|.+++.... ..+++..++.++.|++.||+|||+. +++||||||+||+++.++.++|+|||+++..
T Consensus 84 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 84 VMELAPLGELRSYLQVNK---YSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157 (270)
T ss_pred EEEcCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeec
Confidence 999999999999996543 2589999999999999999999998 9999999999999999999999999999865
Q ss_pred CCCCcceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHh-CCCCCCCCCchhhHhHHHHHHHHHHhCCccccc
Q 001768 813 EDENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELV 891 (1016)
Q Consensus 813 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 891 (1016)
............++..|+|||.+....++.++|||||||++|||++ |+.||......+..... ....
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~-------~~~~----- 225 (270)
T cd05056 158 EDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRI-------ENGE----- 225 (270)
T ss_pred ccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH-------HcCC-----
Confidence 4443222233345568999999988889999999999999999996 99999765543321111 1111
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 001768 892 DPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGK 935 (1016)
Q Consensus 892 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 935 (1016)
... .+...+..+.+++.+|+..+|++|||+.++++.|++.
T Consensus 226 ~~~----~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~ 265 (270)
T cd05056 226 RLP----MPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDI 265 (270)
T ss_pred cCC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 001 1122345789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=317.96 Aligned_cols=253 Identities=25% Similarity=0.400 Sum_probs=202.3
Q ss_pred hcCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEee
Q 001768 658 TNNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEY 736 (1016)
Q Consensus 658 ~~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 736 (1016)
.++|++.+.||+|+||.||+|+.. +++.||+|.++.........+.+|+.+++.++||||+++++++..++..++||||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 357888999999999999999864 6889999998766555556788999999999999999999999999999999999
Q ss_pred cCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCC
Q 001768 737 LENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDEN 816 (1016)
Q Consensus 737 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 816 (1016)
+++++|.+++.... .+++.++..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 88 ~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06645 88 CGGGSLQDIYHVTG----PLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATI 160 (267)
T ss_pred cCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCcc
Confidence 99999999986543 589999999999999999999998 99999999999999999999999999987543321
Q ss_pred cceeeecccCccccChhhhc---cCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCC
Q 001768 817 THISTRIAGTVGYMAPEYAM---RGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDP 893 (1016)
Q Consensus 817 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 893 (1016)
.......|+..|+|||++. .+.++.++|||||||++|||++|+.||............ ..... ..+
T Consensus 161 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~-------~~~~~---~~~ 229 (267)
T cd06645 161 -AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM-------TKSNF---QPP 229 (267)
T ss_pred -cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhh-------hccCC---CCC
Confidence 1123356899999999874 456888999999999999999999998654332211110 00010 011
Q ss_pred cCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 894 SLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 894 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
.... ....+..+.+++.+|++.+|++||+++++++
T Consensus 230 ~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 230 KLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred cccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 1110 0012346889999999999999999998874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=314.74 Aligned_cols=248 Identities=28% Similarity=0.453 Sum_probs=201.8
Q ss_pred CccccCCCeeEEEEEcCC--C--cEEEEEEccCCCh-hhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEeecCC
Q 001768 665 NKIGEGGFGPVYKGTLSD--G--AVIAVKQLSSKSK-QGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYLEN 739 (1016)
Q Consensus 665 ~~LG~G~~G~Vy~~~~~~--~--~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 739 (1016)
+.||+|++|.||+|.+.+ + ..||+|.+..... ...+.+.+|++++++++||||+++++++.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998643 3 3699999987665 556789999999999999999999999988 889999999999
Q ss_pred CcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCCcce
Q 001768 740 NSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHI 819 (1016)
Q Consensus 740 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 819 (1016)
++|.+++..... ..+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 999999976532 3689999999999999999999998 99999999999999999999999999998654422211
Q ss_pred --eeecccCccccChhhhccCCCCCccchhHHHHHHHHHHh-CCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCC
Q 001768 820 --STRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLG 896 (1016)
Q Consensus 820 --~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 896 (1016)
.....++..|+|||++.+..++.++|||||||++|||++ |+.||......+...... .... .
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~------~~~~--~------- 219 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKID------KEGE--R------- 219 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH------hcCC--c-------
Confidence 122457789999999988889999999999999999999 999997554443222111 0000 0
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 001768 897 SNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933 (1016)
Q Consensus 897 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 933 (1016)
...+...+..+.+++.+|++.+|++||++.++++.|.
T Consensus 220 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 220 LERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 0111223457899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=315.78 Aligned_cols=250 Identities=35% Similarity=0.524 Sum_probs=204.9
Q ss_pred CccccCCCeeEEEEEcCC----CcEEEEEEccCCChhh-hHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEeecCC
Q 001768 665 NKIGEGGFGPVYKGTLSD----GAVIAVKQLSSKSKQG-NREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYLEN 739 (1016)
Q Consensus 665 ~~LG~G~~G~Vy~~~~~~----~~~vAvK~~~~~~~~~-~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 739 (1016)
+.||+|+||.||+|.... +..||+|.+....... .+.+.+|+++++.++|+||+++++++..+...++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999999753 7899999997654433 67889999999999999999999999999999999999999
Q ss_pred CcHHHHhccCcCc-----CcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCC
Q 001768 740 NSLARALFGKEGQ-----CLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDED 814 (1016)
Q Consensus 740 gsL~~~l~~~~~~-----~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 814 (1016)
++|.+++...... ...+++.+++.++.|++.||+|||++ +++||||||+||++++++.++|+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999765211 24699999999999999999999998 999999999999999999999999999986554
Q ss_pred CCc-ceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHh-CCCCCCCCCchhhHhHHHHHHHHHHhCCcccccC
Q 001768 815 ENT-HISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVD 892 (1016)
Q Consensus 815 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 892 (1016)
... .......++..|+|||.+....++.++||||+||++|||++ |+.||......+..... .. ..
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~------~~-~~------ 224 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYL------RK-GY------ 224 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH------Hc-CC------
Confidence 321 12233457889999999988889999999999999999999 69999776443322111 00 00
Q ss_pred CcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 001768 893 PSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933 (1016)
Q Consensus 893 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 933 (1016)
....+...+..+.+++.+||+.+|++|||+.|+++.|+
T Consensus 225 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 225 ---RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ---CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 11112233557899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=329.50 Aligned_cols=206 Identities=24% Similarity=0.367 Sum_probs=176.9
Q ss_pred HHHhcCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCChhhhHHHHHHHHHHHhcC-C-----CCeeeeeeeEeec
Q 001768 655 KAATNNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSKQGNREFVNEIGMISALQ-H-----QNLVKLYGCCIEG 727 (1016)
Q Consensus 655 ~~~~~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H-----pnIv~l~~~~~~~ 727 (1016)
+....+|++.+.||+|.||.|-+|... +++.||||+++.... -.++.+.|+.+|..++ | -|+|+++++|...
T Consensus 182 d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr 260 (586)
T KOG0667|consen 182 DHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFR 260 (586)
T ss_pred ceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccc
Confidence 334458999999999999999999854 699999999976533 3456778999999997 4 4899999999999
Q ss_pred ceeEEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCC--ceeeec
Q 001768 728 NQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDL--NAKISD 805 (1016)
Q Consensus 728 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~--~~kL~D 805 (1016)
+++|||+|.++. +|.++++.+. ...++...++.++.||+.||..||+. +|||+||||+|||+.+.+ .+||+|
T Consensus 261 ~HlciVfELL~~-NLYellK~n~--f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVID 334 (586)
T KOG0667|consen 261 NHLCIVFELLST-NLYELLKNNK--FRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVID 334 (586)
T ss_pred cceeeeehhhhh-hHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEe
Confidence 999999999854 9999997654 45699999999999999999999998 999999999999997543 699999
Q ss_pred cccccccCCCCcceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhh
Q 001768 806 FGLAKLDEDENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEF 871 (1016)
Q Consensus 806 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~ 871 (1016)
||.|+...... .....+..|+|||++.+.+|+.+.||||||||++||++|.+-|.+....+.
T Consensus 335 FGSSc~~~q~v----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQ 396 (586)
T KOG0667|consen 335 FGSSCFESQRV----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQ 396 (586)
T ss_pred cccccccCCcc----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHH
Confidence 99998655432 245678889999999999999999999999999999999988877665544
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=345.30 Aligned_cols=272 Identities=19% Similarity=0.252 Sum_probs=200.1
Q ss_pred HHHHHhcCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCChhhhHHHHHHHHHHHhcCC------CCeeeeeeeEe
Q 001768 653 QIKAATNNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSKQGNREFVNEIGMISALQH------QNLVKLYGCCI 725 (1016)
Q Consensus 653 ~l~~~~~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H------pnIv~l~~~~~ 725 (1016)
++...+++|++.+.||+|+||+||+|... .++.||||+++... ...+.+..|+++++.++| ++++++++++.
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 34456788999999999999999999864 57899999986432 223456677877777754 45889999887
Q ss_pred ec-ceeEEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCC-----
Q 001768 726 EG-NQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDL----- 799 (1016)
Q Consensus 726 ~~-~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~----- 799 (1016)
.+ ++.++|||++ +++|.+++.... .+++..+..|+.||+.||+|||++ .+||||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~~~----~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~~ 274 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMKHG----PFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDP 274 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCccccc
Confidence 64 5789999988 678888886542 689999999999999999999973 2899999999999998765
Q ss_pred -----------ceeeeccccccccCCCCcceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCc
Q 001768 800 -----------NAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPK 868 (1016)
Q Consensus 800 -----------~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~ 868 (1016)
.+||+|||.+..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 275 ~~~~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~ 350 (467)
T PTZ00284 275 VTNRALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDN 350 (467)
T ss_pred ccccccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 499999998864322 22346799999999999999999999999999999999999999987654
Q ss_pred hhhHhHHHHH---------HH---------HHHhCCcccccCCcC-----CCC-C-CHHHHHHHHHHHHHccCCCCCCCC
Q 001768 869 EEFVYLLDWA---------YV---------LQEQGNLLELVDPSL-----GSN-F-SKKEAMTMLNIALLCTNPSPTLRP 923 (1016)
Q Consensus 869 ~~~~~~~~~~---------~~---------~~~~~~~~~~~d~~l-----~~~-~-~~~~~~~l~~li~~cl~~dP~~RP 923 (1016)
.+....+... .. ......+....++.. ... . .......+.+|+.+||+.||++||
T Consensus 351 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ 430 (467)
T PTZ00284 351 LEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRL 430 (467)
T ss_pred HHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCC
Confidence 4333222110 00 000000000000000 000 0 001134578999999999999999
Q ss_pred CHHHHHHHhccCcCCcCccccC
Q 001768 924 TMSSAVSMLEGKTAVQAPIIRR 945 (1016)
Q Consensus 924 t~~evl~~L~~~~~~~~p~~~~ 945 (1016)
|+.|++ .|||+..
T Consensus 431 ta~e~L---------~Hp~~~~ 443 (467)
T PTZ00284 431 NARQMT---------THPYVLK 443 (467)
T ss_pred CHHHHh---------cCccccc
Confidence 999888 5788754
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=331.82 Aligned_cols=251 Identities=24% Similarity=0.344 Sum_probs=196.5
Q ss_pred CccccCCCeeEEEEEcC-CCcEEEEEEccCCC---hhhhHHHHHHHH-HHHhcCCCCeeeeeeeEeecceeEEEEeecCC
Q 001768 665 NKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS---KQGNREFVNEIG-MISALQHQNLVKLYGCCIEGNQLLLVYEYLEN 739 (1016)
Q Consensus 665 ~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~-~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 739 (1016)
+.||+|+||.||+|+.. +|+.||+|++.... ......+..|.. +++.++||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999864 68999999986532 223344555554 56778999999999999999999999999999
Q ss_pred CcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCCcce
Q 001768 740 NSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHI 819 (1016)
Q Consensus 740 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 819 (1016)
|+|..++.... .+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~ 152 (325)
T cd05604 81 GELFFHLQRER----SFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DT 152 (325)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CC
Confidence 99998886443 689999999999999999999998 99999999999999999999999999987432221 12
Q ss_pred eeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCCCCC
Q 001768 820 STRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGSNF 899 (1016)
Q Consensus 820 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 899 (1016)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+..... . ... ......
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~------~-~~~------~~~~~~- 218 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNI------L-HKP------LVLRPG- 218 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHH------H-cCC------ccCCCC-
Confidence 23457999999999999989999999999999999999999999865543322111 0 000 011111
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCcCCcCccccC
Q 001768 900 SKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTAVQAPIIRR 945 (1016)
Q Consensus 900 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~p~~~~ 945 (1016)
....+.+++.+|++.+|.+||++.+.++.+. .|||+..
T Consensus 219 ---~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~-----~h~~f~~ 256 (325)
T cd05604 219 ---ASLTAWSILEELLEKDRQRRLGAKEDFLEIQ-----EHPFFES 256 (325)
T ss_pred ---CCHHHHHHHHHHhccCHHhcCCCCCCHHHHh-----cCCCcCC
Confidence 2346788999999999999999875444332 4566543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=331.64 Aligned_cols=263 Identities=22% Similarity=0.276 Sum_probs=198.8
Q ss_pred HHhcCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCC--hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeec-----
Q 001768 656 AATNNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS--KQGNREFVNEIGMISALQHQNLVKLYGCCIEG----- 727 (1016)
Q Consensus 656 ~~~~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~----- 727 (1016)
...++|++.+.||+|+||.||++... .++.||||++.... ......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 34578999999999999999999864 58899999987542 33346778899999999999999999988643
Q ss_pred -ceeEEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeecc
Q 001768 728 -NQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDF 806 (1016)
Q Consensus 728 -~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DF 806 (1016)
...++||||+++ ++.+.+.. .+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Df 163 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF 163 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeC
Confidence 357999999976 56666632 478899999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCCCcceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHH---------
Q 001768 807 GLAKLDEDENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDW--------- 877 (1016)
Q Consensus 807 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~--------- 877 (1016)
|+++...... ......||..|+|||++.+..++.++|||||||++|||++|+.||......+.......
T Consensus 164 g~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (355)
T cd07874 164 GLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 241 (355)
T ss_pred cccccCCCcc--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 9998544322 22345789999999999988899999999999999999999999976543322110000
Q ss_pred --------HHHHHHhCCcccccCCcC--------CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 878 --------AYVLQEQGNLLELVDPSL--------GSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 878 --------~~~~~~~~~~~~~~d~~l--------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
...............+.. ...........+.+++.+|++.||++|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~ 310 (355)
T cd07874 242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQ 310 (355)
T ss_pred HHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhc
Confidence 000000000000000000 00111122456889999999999999999999884
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=324.87 Aligned_cols=269 Identities=21% Similarity=0.347 Sum_probs=203.4
Q ss_pred cCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCC-hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEee
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS-KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEY 736 (1016)
Q Consensus 659 ~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 736 (1016)
++|++.+.||+|+||.||+|+.. +++.||+|.+.... ......+.+|+.+++.++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 56889999999999999999865 67899999986443 22345677899999999999999999999999999999999
Q ss_pred cCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCC
Q 001768 737 LENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDEN 816 (1016)
Q Consensus 737 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 816 (1016)
++ ++|.+++.... ..+++..+..++.|+++||+|||+. +|+||||||+||++++++.++|+|||++.......
T Consensus 86 ~~-~~l~~~l~~~~---~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 86 LD-KDLKQYLDDCG---NSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 158 (301)
T ss_pred cc-cCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence 97 58888886543 2588999999999999999999998 99999999999999999999999999997543322
Q ss_pred cceeeecccCccccChhhhccC-CCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHH----------HHHHHHHhC
Q 001768 817 THISTRIAGTVGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLD----------WAYVLQEQG 885 (1016)
Q Consensus 817 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~----------~~~~~~~~~ 885 (1016)
.. .....+++.|+|||.+.+. .++.++|||||||++|||++|++||......+...... |... ....
T Consensus 159 ~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 236 (301)
T cd07873 159 KT-YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGI-LSNE 236 (301)
T ss_pred Cc-ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhh-hccc
Confidence 11 1234568899999988654 57889999999999999999999998655433221110 0000 0000
Q ss_pred CcccccCCcCCCC----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCcCCcCccccC
Q 001768 886 NLLELVDPSLGSN----FSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTAVQAPIIRR 945 (1016)
Q Consensus 886 ~~~~~~d~~l~~~----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~p~~~~ 945 (1016)
.......+..... ........+.+++.+|++.||.+|||++|++ .|||+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil---------~h~~f~~ 291 (301)
T cd07873 237 EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAM---------KHPYFHC 291 (301)
T ss_pred cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHh---------cCccccc
Confidence 0000000111000 0112234678999999999999999999887 5777643
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=300.55 Aligned_cols=253 Identities=24% Similarity=0.362 Sum_probs=202.6
Q ss_pred HHhcCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCCh--------hhhHHHHHHHHHHHhc-CCCCeeeeeeeEe
Q 001768 656 AATNNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSK--------QGNREFVNEIGMISAL-QHQNLVKLYGCCI 725 (1016)
Q Consensus 656 ~~~~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~~--------~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~ 725 (1016)
..-++|...+.||.|..++|.++..+ .|..+|+|++..... .-.+.-.+|+.+|+++ .||+|+++.++++
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 34467788899999999999888754 678899998853211 1123446789999998 6999999999999
Q ss_pred ecceeEEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeec
Q 001768 726 EGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISD 805 (1016)
Q Consensus 726 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~D 805 (1016)
.+..+++|+|.|+.|.|.+++... ..+++.+..+|++|+.+|++|||.. .||||||||+|||+|++.++||+|
T Consensus 94 s~sF~FlVFdl~prGELFDyLts~----VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isD 166 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYLTSK----VTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISD 166 (411)
T ss_pred CcchhhhhhhhcccchHHHHhhhh----eeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEec
Confidence 999999999999999999999655 4799999999999999999999998 999999999999999999999999
Q ss_pred cccccccCCCCcceeeecccCccccChhhhcc------CCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHH
Q 001768 806 FGLAKLDEDENTHISTRIAGTVGYMAPEYAMR------GYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAY 879 (1016)
Q Consensus 806 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~ 879 (1016)
||+|+....... -...+|||+|+|||.+.. ..|+..+|+||+||++|-|+.|.+||-.+...-... .
T Consensus 167 FGFa~~l~~Gek--LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR-----~ 239 (411)
T KOG0599|consen 167 FGFACQLEPGEK--LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLR-----M 239 (411)
T ss_pred cceeeccCCchh--HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHH-----H
Confidence 999997766543 345799999999998863 357889999999999999999999985432211111 1
Q ss_pred HHHHhCCcccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 880 VLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 880 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
....+.+ .-.|. -.+......+||.+|++.||.+|.|++|+++
T Consensus 240 ImeGkyq---F~spe-----Wadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 240 IMEGKYQ---FRSPE-----WADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred HHhcccc---cCCcc-----hhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 1111111 11111 1234557899999999999999999998875
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=317.39 Aligned_cols=256 Identities=27% Similarity=0.384 Sum_probs=204.5
Q ss_pred HHHHhcCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEE
Q 001768 654 IKAATNNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLL 732 (1016)
Q Consensus 654 l~~~~~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 732 (1016)
++.+++++.....||+|+||.||+|+.. ++..||+|.+........+.+.+|++++++++|+||+++++++..++..++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 3456677777889999999999999854 678899999887766667789999999999999999999999999999999
Q ss_pred EEeecCCCcHHHHhccCcCcCcCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEcc-CCceeeeccccc
Q 001768 733 VYEYLENNSLARALFGKEGQCLNL--DWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDK-DLNAKISDFGLA 809 (1016)
Q Consensus 733 V~E~~~~gsL~~~l~~~~~~~~~l--~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~-~~~~kL~DFGla 809 (1016)
||||+++++|.+++..... .+ ++..+..++.||+.||+|||+. +|+||||||+||+++. ++.++|+|||.+
T Consensus 83 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~ 156 (268)
T cd06624 83 FMEQVPGGSLSALLRSKWG---PLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTS 156 (268)
T ss_pred EEecCCCCCHHHHHHHhcc---cCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhh
Confidence 9999999999999975431 34 7888999999999999999998 9999999999999986 679999999998
Q ss_pred cccCCCCcceeeecccCccccChhhhccC--CCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCc
Q 001768 810 KLDEDENTHISTRIAGTVGYMAPEYAMRG--YLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNL 887 (1016)
Q Consensus 810 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 887 (1016)
........ ......|++.|+|||++.+. .++.++||||||+++|+|++|+.||......... .+... .
T Consensus 157 ~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~---~~~~~------~ 226 (268)
T cd06624 157 KRLAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA---MFKVG------M 226 (268)
T ss_pred eecccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh---Hhhhh------h
Confidence 75543222 12234578999999998654 3788999999999999999999998643222111 00000 0
Q ss_pred ccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 888 LELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 888 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
. .....++......+.+++.+||+.+|++|||+.|+++
T Consensus 227 ~-----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 227 F-----KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred h-----ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 0 0111223334557899999999999999999999884
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=318.13 Aligned_cols=255 Identities=24% Similarity=0.433 Sum_probs=203.1
Q ss_pred CccccCccccCCCeeEEEEEcCC--CcEEEEEEccCC----------ChhhhHHHHHHHHHHHh-cCCCCeeeeeeeEee
Q 001768 660 NFDAANKIGEGGFGPVYKGTLSD--GAVIAVKQLSSK----------SKQGNREFVNEIGMISA-LQHQNLVKLYGCCIE 726 (1016)
Q Consensus 660 ~f~~~~~LG~G~~G~Vy~~~~~~--~~~vAvK~~~~~----------~~~~~~~~~~E~~~l~~-l~HpnIv~l~~~~~~ 726 (1016)
+|++.+.||+|+||.||+|.+.. ++.+|+|.+... ......++.+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888999999999999999764 688999987532 12233457778888875 799999999999999
Q ss_pred cceeEEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeecc
Q 001768 727 GNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDF 806 (1016)
Q Consensus 727 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DF 806 (1016)
++..++||||+++++|.+++.........+++..++.++.|++.||.|||+.. +++|+||||+||++++++.++|+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence 99999999999999999988553333346899999999999999999999631 7999999999999999999999999
Q ss_pred ccccccCCCCcceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCC
Q 001768 807 GLAKLDEDENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGN 886 (1016)
Q Consensus 807 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 886 (1016)
|.+....... ......|+..|+|||.+.++.++.++||||||+++|||++|+.||............ ....
T Consensus 159 g~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~-------~~~~ 229 (269)
T cd08528 159 GLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKI-------VEAV 229 (269)
T ss_pred cceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHH-------hhcc
Confidence 9998654432 223456889999999999888999999999999999999999998754433211100 0011
Q ss_pred cccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 001768 887 LLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933 (1016)
Q Consensus 887 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 933 (1016)
. .+.. .......+.+++.+||+.||++||++.|+.++++
T Consensus 230 ~----~~~~----~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 230 Y----EPLP----EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred C----CcCC----cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 1 0100 1123356889999999999999999999999886
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=319.56 Aligned_cols=247 Identities=27% Similarity=0.350 Sum_probs=197.6
Q ss_pred CccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCC---hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEe
Q 001768 660 NFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS---KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYE 735 (1016)
Q Consensus 660 ~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 735 (1016)
.|+..+.||+|+||+||+|... +++.||+|.+.... ......+.+|++++++++|+||+++.+++..++..++|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 3677889999999999999864 68899999986542 2223457789999999999999999999999999999999
Q ss_pred ecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCC
Q 001768 736 YLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDE 815 (1016)
Q Consensus 736 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 815 (1016)
|+++++|.+++..... ..+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05632 81 IMNGGDLKFHIYNMGN--PGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG 155 (285)
T ss_pred eccCccHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCC
Confidence 9999999988864332 3699999999999999999999998 9999999999999999999999999998754332
Q ss_pred CcceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcC
Q 001768 816 NTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSL 895 (1016)
Q Consensus 816 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 895 (1016)
.. .....|+..|+|||++.+..++.++|+|||||++|||++|+.||.............. . ..+. ..
T Consensus 156 ~~--~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~--~------~~~~-~~-- 222 (285)
T cd05632 156 ES--IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDR--R------VLET-EE-- 222 (285)
T ss_pred Cc--ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH--h------hhcc-cc--
Confidence 21 1234689999999999888899999999999999999999999976544322111110 0 0000 01
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHH
Q 001768 896 GSNFSKKEAMTMLNIALLCTNPSPTLRPTMS 926 (1016)
Q Consensus 896 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 926 (1016)
.++......+.+++..|++.||++||++.
T Consensus 223 --~~~~~~~~~~~~li~~~l~~~P~~R~~~~ 251 (285)
T cd05632 223 --VYSAKFSEEAKSICKMLLTKDPKQRLGCQ 251 (285)
T ss_pred --ccCccCCHHHHHHHHHHccCCHhHcCCCc
Confidence 11222344678999999999999999954
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=312.26 Aligned_cols=247 Identities=29% Similarity=0.437 Sum_probs=200.8
Q ss_pred CccccCCCeeEEEEEcCCCcEEEEEEccCCChh-hhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEeecCCCcHH
Q 001768 665 NKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQ-GNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYLENNSLA 743 (1016)
Q Consensus 665 ~~LG~G~~G~Vy~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~ 743 (1016)
++||+|+||.||+|...+++.||+|.+...... ....+.+|++++++++||||+++++++.+....++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 479999999999999877999999998765433 4567899999999999999999999999999999999999999999
Q ss_pred HHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCCccee-ee
Q 001768 744 RALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHIS-TR 822 (1016)
Q Consensus 744 ~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~-~~ 822 (1016)
+++.... ..+++..+..++.+++.||+|||++ +++||||||+||+++.++.++|+|||.+........... ..
T Consensus 81 ~~l~~~~---~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (251)
T cd05041 81 TFLRKKK---NRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL 154 (251)
T ss_pred HHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence 9996543 2588999999999999999999998 899999999999999999999999999975442211111 11
Q ss_pred cccCccccChhhhccCCCCCccchhHHHHHHHHHHh-CCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCCCCCCH
Q 001768 823 IAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGSNFSK 901 (1016)
Q Consensus 823 ~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 901 (1016)
..++..|+|||.+.++.++.++|||||||++|||+| |..||............ .. ......+.
T Consensus 155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~-------~~---------~~~~~~~~ 218 (251)
T cd05041 155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERI-------ES---------GYRMPAPQ 218 (251)
T ss_pred CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHH-------hc---------CCCCCCCc
Confidence 233567999999988889999999999999999999 88888655433221111 00 00111222
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 001768 902 KEAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933 (1016)
Q Consensus 902 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 933 (1016)
..+..+.+++.+|+..+|++||++.|+++.|+
T Consensus 219 ~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 219 LCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred cCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 34557999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=319.45 Aligned_cols=239 Identities=23% Similarity=0.377 Sum_probs=189.8
Q ss_pred ccccCCCeeEEEEEcCC-------------------------CcEEEEEEccCCChhhhHHHHHHHHHHHhcCCCCeeee
Q 001768 666 KIGEGGFGPVYKGTLSD-------------------------GAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKL 720 (1016)
Q Consensus 666 ~LG~G~~G~Vy~~~~~~-------------------------~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l 720 (1016)
.||+|+||.||+|.+.. ...||+|.+..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997421 23589999876555556678899999999999999999
Q ss_pred eeeEeecceeEEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCC-
Q 001768 721 YGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDL- 799 (1016)
Q Consensus 721 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~- 799 (1016)
++++.++...++||||+++|+|..++.... ..+++..+..++.||++||+|||++ +|+||||||+||+++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK---GRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGL 155 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCc
Confidence 999999999999999999999999986533 2588999999999999999999998 999999999999998644
Q ss_pred ------ceeeeccccccccCCCCcceeeecccCccccChhhhcc-CCCCCccchhHHHHHHHHHH-hCCCCCCCCCchhh
Q 001768 800 ------NAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMR-GYLTDKADVYSFGIVALEIV-SGKSNTNYRPKEEF 871 (1016)
Q Consensus 800 ------~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~ell-tG~~P~~~~~~~~~ 871 (1016)
.+|++|||.+...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|+.||......+.
T Consensus 156 ~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 230 (274)
T cd05076 156 AEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK 230 (274)
T ss_pred ccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH
Confidence 3899999988643221 12356788999998865 56899999999999999995 69999876544332
Q ss_pred HhHHHHHHHHHHhCCcccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 001768 872 VYLLDWAYVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933 (1016)
Q Consensus 872 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 933 (1016)
.... ... ...... ....+.+++.+||+.+|++||++.++++.|.
T Consensus 231 ~~~~------~~~--------~~~~~~----~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 231 ERFY------EKK--------HRLPEP----SCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HHHH------Hhc--------cCCCCC----CChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 1111 000 011111 1236889999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=320.91 Aligned_cols=264 Identities=27% Similarity=0.372 Sum_probs=206.6
Q ss_pred CcCHHHHHHHhcCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCChhhhHHHHHHHHHHHhc-CCCCeeeeeeeEe
Q 001768 648 YFTLRQIKAATNNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSKQGNREFVNEIGMISAL-QHQNLVKLYGCCI 725 (1016)
Q Consensus 648 ~~~~~~l~~~~~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~ 725 (1016)
.+++.++..+.++|++.+.||+|+||.||+|... +++.+|+|.+..... ....+.+|+.+++++ +|||++++++++.
T Consensus 11 ~~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~~h~ni~~~~~~~~ 89 (291)
T cd06639 11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD-VDEEIEAEYNILQSLPNHPNVVKFYGMFY 89 (291)
T ss_pred hhhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc-HHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence 3556667778899999999999999999999864 688999999865422 245677899999999 8999999999987
Q ss_pred ec-----ceeEEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCc
Q 001768 726 EG-----NQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLN 800 (1016)
Q Consensus 726 ~~-----~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~ 800 (1016)
.. +..++||||+++++|.+++.........+++..++.++.|++.||+|||+. +++||||||+||++++++.
T Consensus 90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~ 166 (291)
T cd06639 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGG 166 (291)
T ss_pred eccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCC
Confidence 53 368999999999999998865433334689999999999999999999998 9999999999999999999
Q ss_pred eeeeccccccccCCCCcceeeecccCccccChhhhccC-----CCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHH
Q 001768 801 AKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRG-----YLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLL 875 (1016)
Q Consensus 801 ~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~ 875 (1016)
+||+|||++........ ......|+..|+|||.+... .++.++|||||||++|||++|+.||......... .
T Consensus 167 ~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~--~ 243 (291)
T cd06639 167 VKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTL--F 243 (291)
T ss_pred EEEeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHH--H
Confidence 99999999875443221 12234688999999987643 3688999999999999999999999754432211 1
Q ss_pred HHHHHHHHhCCcccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 876 DWAYVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 876 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
.+ ......... .+......+.+++.+||+.+|++||++.|+++
T Consensus 244 ~~-----~~~~~~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 244 KI-----PRNPPPTLL-------HPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred HH-----hcCCCCCCC-------cccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 00 011111111 11223346899999999999999999999883
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=319.99 Aligned_cols=253 Identities=29% Similarity=0.468 Sum_probs=200.0
Q ss_pred HHhcCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCChhhhHHHHHHHHHHHhc-CCCCeeeeeeeEeec------
Q 001768 656 AATNNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSKQGNREFVNEIGMISAL-QHQNLVKLYGCCIEG------ 727 (1016)
Q Consensus 656 ~~~~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~------ 727 (1016)
.+++.|++.+.||+|+||.||+|... +++.||+|.+.... .....+..|+.+++++ +||||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 45678899999999999999999865 58899999986543 3345788899999998 799999999998753
Q ss_pred ceeEEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccc
Q 001768 728 NQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFG 807 (1016)
Q Consensus 728 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG 807 (1016)
...++||||+++++|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg 156 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKG--NTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFG 156 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCC
Confidence 468999999999999999975432 3589999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCCcceeeecccCccccChhhhc-----cCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHH
Q 001768 808 LAKLDEDENTHISTRIAGTVGYMAPEYAM-----RGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQ 882 (1016)
Q Consensus 808 la~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~ 882 (1016)
++........ ......|+..|+|||++. +..++.++|||||||++|||++|+.||............
T Consensus 157 ~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~------- 228 (272)
T cd06637 157 VSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI------- 228 (272)
T ss_pred Cceecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHH-------
Confidence 9975433221 223456899999999986 335788999999999999999999999654332211110
Q ss_pred HhCCcccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 883 EQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 883 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
.... .+.. .....+..+.+++.+||..+|.+|||+.++++
T Consensus 229 ~~~~-----~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 229 PRNP-----APRL---KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred hcCC-----CCCC---CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 0011 1111 01123346889999999999999999998873
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=331.53 Aligned_cols=260 Identities=27% Similarity=0.398 Sum_probs=201.4
Q ss_pred hcCccccCccccCCCeeEEEEEc------CCCcEEEEEEccCCC-hhhhHHHHHHHHHHHhc-CCCCeeeeeeeEeec-c
Q 001768 658 TNNFDAANKIGEGGFGPVYKGTL------SDGAVIAVKQLSSKS-KQGNREFVNEIGMISAL-QHQNLVKLYGCCIEG-N 728 (1016)
Q Consensus 658 ~~~f~~~~~LG~G~~G~Vy~~~~------~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~-~ 728 (1016)
.++|++.+.||+|+||.||+|.+ .+++.||||+++... ......+.+|+.++.++ +||||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 45789999999999999999973 347899999997543 33345788999999999 689999999988654 5
Q ss_pred eeEEEEeecCCCcHHHHhccCcCc--------------------------------------------------------
Q 001768 729 QLLLVYEYLENNSLARALFGKEGQ-------------------------------------------------------- 752 (1016)
Q Consensus 729 ~~~lV~E~~~~gsL~~~l~~~~~~-------------------------------------------------------- 752 (1016)
..++||||+++|+|.+++......
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 689999999999999998653210
Q ss_pred -------CcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCCcc-eeeecc
Q 001768 753 -------CLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTH-ISTRIA 824 (1016)
Q Consensus 753 -------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~~~ 824 (1016)
...+++.++..++.|+++||+|||+. +|+||||||+||++++++.+||+|||++......... ......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 12478889999999999999999998 9999999999999999999999999999754332211 112234
Q ss_pred cCccccChhhhccCCCCCccchhHHHHHHHHHHh-CCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCCCCCCHHH
Q 001768 825 GTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGSNFSKKE 903 (1016)
Q Consensus 825 gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 903 (1016)
+++.|+|||.+.+..++.++|||||||++|||++ |..||.......... ... ..... ...+. ..
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~-----~~~-~~~~~-----~~~~~----~~ 307 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC-----RRL-KEGTR-----MRAPD----YT 307 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHH-----HHH-hccCC-----CCCCC----CC
Confidence 5678999999988889999999999999999997 898986543221110 000 11110 01111 12
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 001768 904 AMTMLNIALLCTNPSPTLRPTMSSAVSMLEGK 935 (1016)
Q Consensus 904 ~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 935 (1016)
...+.+++..||+.||++|||+.|+++.|+..
T Consensus 308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~ 339 (343)
T cd05103 308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 339 (343)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 34688999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=316.13 Aligned_cols=250 Identities=25% Similarity=0.423 Sum_probs=201.6
Q ss_pred CccccCccccCCCeeEEEEEcCCCcEEEEEEccCCC------hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEE
Q 001768 660 NFDAANKIGEGGFGPVYKGTLSDGAVIAVKQLSSKS------KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLV 733 (1016)
Q Consensus 660 ~f~~~~~LG~G~~G~Vy~~~~~~~~~vAvK~~~~~~------~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 733 (1016)
+|++.+.||+|+||.||+|...+++.+|+|.+.... ......+.+|++++++++|+||+++++++.+++..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 477889999999999999998889999999886432 12235688999999999999999999999999999999
Q ss_pred EeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccC
Q 001768 734 YEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDE 813 (1016)
Q Consensus 734 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~ 813 (1016)
|||+++++|.+++.... .+++..+..++.|++.||+|||+. +|+|+||+|+||++++++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 153 (265)
T cd06631 81 MEFVPGGSISSILNRFG----PLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLA 153 (265)
T ss_pred EecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence 99999999999996542 588999999999999999999998 89999999999999999999999999987542
Q ss_pred CCC-----cceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcc
Q 001768 814 DEN-----THISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLL 888 (1016)
Q Consensus 814 ~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 888 (1016)
... ........|+..|+|||++.+..++.++|||||||++|||++|+.||............ ...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~------~~~---- 223 (265)
T cd06631 154 WVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYI------GAH---- 223 (265)
T ss_pred hccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHh------hhc----
Confidence 211 11122356889999999998888999999999999999999999999754332211100 000
Q ss_pred cccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 889 ELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 889 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
....+... ......+.+++.+||+.+|++||++.++++
T Consensus 224 ~~~~~~~~----~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 224 RGLMPRLP----DSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred cCCCCCCC----CCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00111222 223456899999999999999999998873
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=330.09 Aligned_cols=262 Identities=22% Similarity=0.292 Sum_probs=197.3
Q ss_pred HhcCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCC--ChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecc-----
Q 001768 657 ATNNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSK--SKQGNREFVNEIGMISALQHQNLVKLYGCCIEGN----- 728 (1016)
Q Consensus 657 ~~~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~----- 728 (1016)
..++|++.+.||+|+||.||+++.. +|+.||+|++... .......+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 4578999999999999999999864 6899999998643 2334567789999999999999999999986543
Q ss_pred -eeEEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccc
Q 001768 729 -QLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFG 807 (1016)
Q Consensus 729 -~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG 807 (1016)
..++||||+++ +|.+.+.. .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg 168 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 168 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCC
Confidence 57999999976 56665532 478899999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCCcceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHH------------
Q 001768 808 LAKLDEDENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLL------------ 875 (1016)
Q Consensus 808 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~------------ 875 (1016)
+++...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||............
T Consensus 169 ~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 246 (359)
T cd07876 169 LARTACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFM 246 (359)
T ss_pred CccccccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHH
Confidence 997543321 223457899999999999889999999999999999999999999765432211000
Q ss_pred H----HHH-HHHHhCCcc-----cccCCcC---CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 876 D----WAY-VLQEQGNLL-----ELVDPSL---GSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 876 ~----~~~-~~~~~~~~~-----~~~d~~l---~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
. ... ......... +...... ...........+.+++.+||+.||++|||+.|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 314 (359)
T cd07876 247 NRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR 314 (359)
T ss_pred HHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence 0 000 000000000 0000000 00011122356889999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=321.53 Aligned_cols=249 Identities=27% Similarity=0.458 Sum_probs=204.6
Q ss_pred cCccccCccccCCCeeEEEEEc-CCCcEEEEEEccCCChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEeec
Q 001768 659 NNFDAANKIGEGGFGPVYKGTL-SDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYL 737 (1016)
Q Consensus 659 ~~f~~~~~LG~G~~G~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 737 (1016)
.+|++.+.||.|++|.||+|.. .+++.||+|.+........+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4689999999999999999985 478999999987655555677889999999999999999999999999999999999
Q ss_pred CCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCCc
Q 001768 738 ENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENT 817 (1016)
Q Consensus 738 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 817 (1016)
++++|.+++... .+++.++..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 170 (296)
T cd06655 99 AGGSLTDVVTET-----CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS 170 (296)
T ss_pred CCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence 999999988543 489999999999999999999998 999999999999999999999999999875443322
Q ss_pred ceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCCC
Q 001768 818 HISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGS 897 (1016)
Q Consensus 818 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 897 (1016)
. .....++..|+|||.+.+..++.++|||||||++|+|++|+.||............ .. ..... +
T Consensus 171 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~------~~-~~~~~-----~-- 235 (296)
T cd06655 171 K-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI------AT-NGTPE-----L-- 235 (296)
T ss_pred c-CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------Hh-cCCcc-----c--
Confidence 1 22346888999999998888999999999999999999999999765543322111 00 00000 0
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 898 NFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 898 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
..+......+.+++.+||..||++||++.++++
T Consensus 236 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 236 QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 111223446889999999999999999998883
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=321.55 Aligned_cols=264 Identities=25% Similarity=0.353 Sum_probs=205.3
Q ss_pred cCHHHHHHHhcCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCChhhhHHHHHHHHHHHhc-CCCCeeeeeeeEe-
Q 001768 649 FTLRQIKAATNNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSKQGNREFVNEIGMISAL-QHQNLVKLYGCCI- 725 (1016)
Q Consensus 649 ~~~~~l~~~~~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~- 725 (1016)
+.++.+..+.++|++.+.||+|+||.||+|+.. +++.+|+|++..... ....+.+|+.+++++ +||||+++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD-IDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc-hHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 445566778899999999999999999999864 578999998764322 235678899999999 6999999999874
Q ss_pred ----ecceeEEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCce
Q 001768 726 ----EGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNA 801 (1016)
Q Consensus 726 ----~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ 801 (1016)
.++..++||||+++++|.+++.........+++..+..++.|+++||.|||+. +|+||||||+||++++++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCE
Confidence 34578999999999999998864333334689999999999999999999998 99999999999999999999
Q ss_pred eeeccccccccCCCCcceeeecccCccccChhhhcc-----CCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHH
Q 001768 802 KISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMR-----GYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLD 876 (1016)
Q Consensus 802 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~ 876 (1016)
+|+|||+++....... ......|++.|+|||++.. ..++.++|||||||++|||++|+.||.......... .
T Consensus 164 kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~--~ 240 (286)
T cd06638 164 KLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALF--K 240 (286)
T ss_pred EEccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHh--h
Confidence 9999999875543221 1233468999999998753 457889999999999999999999987543322110 0
Q ss_pred HHHHHHHhCCcccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001768 877 WAYVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSM 931 (1016)
Q Consensus 877 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 931 (1016)
..........+ +......+.+++.+||+.||++|||+.|+++.
T Consensus 241 -----~~~~~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 241 -----IPRNPPPTLHQ-------PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred -----ccccCCCcccC-------CCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 00000001111 11123468899999999999999999999853
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=318.89 Aligned_cols=251 Identities=27% Similarity=0.439 Sum_probs=202.6
Q ss_pred cCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEeec
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYL 737 (1016)
Q Consensus 659 ~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 737 (1016)
+.|++.+.||+|+||.||+|+.. +++.||+|.+........+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 56889999999999999999975 58899999998776666778899999999999999999999999999999999999
Q ss_pred CCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCCc
Q 001768 738 ENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENT 817 (1016)
Q Consensus 738 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 817 (1016)
++++|..++.... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++........
T Consensus 92 ~~~~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~ 165 (292)
T cd06644 92 PGGAVDAIMLELD---RGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ 165 (292)
T ss_pred CCCcHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceecccccc
Confidence 9999998875443 2589999999999999999999998 999999999999999999999999999875332211
Q ss_pred ceeeecccCccccChhhhc-----cCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccC
Q 001768 818 HISTRIAGTVGYMAPEYAM-----RGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVD 892 (1016)
Q Consensus 818 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 892 (1016)
......+++.|+|||++. ...++.++|||||||++|||++|+.||......... .. ..... .
T Consensus 166 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~--~~-----~~~~~-----~ 232 (292)
T cd06644 166 -RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL--LK-----IAKSE-----P 232 (292)
T ss_pred -ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHH--HH-----HhcCC-----C
Confidence 123356888999999885 345678999999999999999999998754432211 00 00000 1
Q ss_pred CcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 893 PSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 893 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
+.. ..+......+.+++.+||+.+|++||++.++++
T Consensus 233 ~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 233 PTL--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred ccC--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 111 111223446889999999999999999998873
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=334.52 Aligned_cols=261 Identities=19% Similarity=0.214 Sum_probs=197.8
Q ss_pred HhcCccccCccccCCCeeEEEEEcC---CCcEEEEEEccCCChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEE
Q 001768 657 ATNNFDAANKIGEGGFGPVYKGTLS---DGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLV 733 (1016)
Q Consensus 657 ~~~~f~~~~~LG~G~~G~Vy~~~~~---~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 733 (1016)
...+|++.+.||+|+||.||++... .++.||+|.+... ....+|++++++++||||+++++++......++|
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 164 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV 164 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence 3467999999999999999999743 3578999988643 2346799999999999999999999999999999
Q ss_pred EeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccC
Q 001768 734 YEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDE 813 (1016)
Q Consensus 734 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~ 813 (1016)
||++. ++|.+++... ..+++.+++.++.||+.||+|||+. +|+||||||+|||++.++.++|+|||+++...
T Consensus 165 ~e~~~-~~l~~~l~~~----~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~ 236 (392)
T PHA03207 165 MPKYK-CDLFTYVDRS----GPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLD 236 (392)
T ss_pred ehhcC-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccC
Confidence 99996 5888888332 3699999999999999999999998 99999999999999999999999999997554
Q ss_pred CCCc-ceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHh--------
Q 001768 814 DENT-HISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQ-------- 884 (1016)
Q Consensus 814 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~-------- 884 (1016)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....................
T Consensus 237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~ 316 (392)
T PHA03207 237 AHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQN 316 (392)
T ss_pred cccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCc
Confidence 3322 1223457999999999999888999999999999999999999999764432211100000000000
Q ss_pred ---------CCcccccCCcCC--CCC-CHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 885 ---------GNLLELVDPSLG--SNF-SKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 885 ---------~~~~~~~d~~l~--~~~-~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
..+.....+... ..+ .......+.+++.+|+..||++|||+.|++.
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~ 374 (392)
T PHA03207 317 GSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILS 374 (392)
T ss_pred cchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhh
Confidence 000000000000 000 0012346788999999999999999999883
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=313.11 Aligned_cols=254 Identities=26% Similarity=0.428 Sum_probs=207.3
Q ss_pred hcCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEee
Q 001768 658 TNNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEY 736 (1016)
Q Consensus 658 ~~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 736 (1016)
.++|++.+.||+|+||.||+|... +++.+|+|.+........+.+.+|++++++++||||+++++++.+++..+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 367899999999999999999864 5788999999866555667899999999999999999999999999999999999
Q ss_pred cCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCC
Q 001768 737 LENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDEN 816 (1016)
Q Consensus 737 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 816 (1016)
+++++|.+++.... ..+++.++..++.|++.||+|||+. +|+|+||||+||++++++.++|+|||.+.......
T Consensus 82 ~~~~~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 155 (262)
T cd06613 82 CGGGSLQDIYQVTR---GPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI 155 (262)
T ss_pred CCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhh
Confidence 99999999986542 2589999999999999999999998 99999999999999999999999999987554322
Q ss_pred cceeeecccCccccChhhhccC---CCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCC
Q 001768 817 THISTRIAGTVGYMAPEYAMRG---YLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDP 893 (1016)
Q Consensus 817 ~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 893 (1016)
. ......++..|+|||.+.+. .++.++|||||||++|||++|+.||............ ....+ ..+
T Consensus 156 ~-~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~-------~~~~~---~~~ 224 (262)
T cd06613 156 A-KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLI-------SKSNF---PPP 224 (262)
T ss_pred h-ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-------HhccC---CCc
Confidence 1 12335688899999998766 7889999999999999999999999765433321111 01100 001
Q ss_pred cCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 894 SLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 894 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
. .......+..+.+++.+||..+|.+|||+++++.
T Consensus 225 ~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 225 K--LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred c--ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 1 1112334567999999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=322.50 Aligned_cols=261 Identities=26% Similarity=0.427 Sum_probs=206.0
Q ss_pred cCccccCccccCCCeeEEEEEcC-----CCcEEEEEEccCCChh-hhHHHHHHHHHHHhcCCCCeeeeeeeEee--ccee
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLS-----DGAVIAVKQLSSKSKQ-GNREFVNEIGMISALQHQNLVKLYGCCIE--GNQL 730 (1016)
Q Consensus 659 ~~f~~~~~LG~G~~G~Vy~~~~~-----~~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~ 730 (1016)
+.|++.+.||+|+||.||+|++. ++..||||.+...... ..+.+.+|+++++.++||||+++++++.. +...
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 45777899999999999999854 3689999999765443 46789999999999999999999999887 5678
Q ss_pred EEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeecccccc
Q 001768 731 LLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAK 810 (1016)
Q Consensus 731 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~ 810 (1016)
++||||+++++|.+++..... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||.+.
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~---~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRD---QINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAK 157 (284)
T ss_pred EEEEecCCCCCHHHHHHhCcc---ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccccc
Confidence 999999999999999965432 589999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCcce--eeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhH---------hHHHHHH
Q 001768 811 LDEDENTHI--STRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFV---------YLLDWAY 879 (1016)
Q Consensus 811 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~---------~~~~~~~ 879 (1016)
......... .....++..|+|||.+.+..++.++|||||||++|||++|+.|+......... ....+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE 237 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence 665332211 11234556799999998888999999999999999999999998653322210 0000111
Q ss_pred HHHHhCCcccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 001768 880 VLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGK 935 (1016)
Q Consensus 880 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 935 (1016)
.. ........+...+..+.+++.+||+.+|++|||+.||+++|+..
T Consensus 238 ~~----------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 238 LL----------KEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HH----------HcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 10 11111111223345789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=325.78 Aligned_cols=197 Identities=25% Similarity=0.409 Sum_probs=161.4
Q ss_pred cCccccCCCeeEEEEEcC---CCcEEEEEEccCCChhhhHHHHHHHHHHHhcCCCCeeeeeeeEee--cceeEEEEeecC
Q 001768 664 ANKIGEGGFGPVYKGTLS---DGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIE--GNQLLLVYEYLE 738 (1016)
Q Consensus 664 ~~~LG~G~~G~Vy~~~~~---~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~~lV~E~~~ 738 (1016)
.++||+|+||.||+|+.. +++.||+|.+.... ....+.+|++++++++||||+++++++.. +...++||||++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999854 46789999986543 23457789999999999999999998864 457899999986
Q ss_pred CCcHHHHhccCc-----CcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEE----ccCCceeeeccccc
Q 001768 739 NNSLARALFGKE-----GQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLL----DKDLNAKISDFGLA 809 (1016)
Q Consensus 739 ~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl----~~~~~~kL~DFGla 809 (1016)
+ +|.+++.... .....+++..+..++.||+.||+|||++ +|+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 5 7887775321 1123589999999999999999999998 99999999999999 45678999999999
Q ss_pred cccCCCCcc--eeeecccCccccChhhhcc-CCCCCccchhHHHHHHHHHHhCCCCCCCC
Q 001768 810 KLDEDENTH--ISTRIAGTVGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGKSNTNYR 866 (1016)
Q Consensus 810 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~~ 866 (1016)
+........ ......||+.|+|||++.+ ..++.++||||+||++|||++|++||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 865433211 1234578999999999876 45889999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=314.12 Aligned_cols=248 Identities=29% Similarity=0.465 Sum_probs=200.4
Q ss_pred CccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCChh---------hhHHHHHHHHHHHhcCCCCeeeeeeeEeecce
Q 001768 660 NFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSKQ---------GNREFVNEIGMISALQHQNLVKLYGCCIEGNQ 729 (1016)
Q Consensus 660 ~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~~~---------~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 729 (1016)
+|.+.+.||+|++|.||+|... +++.||+|.+...... ..+.+.+|++++++++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4677899999999999999864 5789999988654221 12567889999999999999999999999999
Q ss_pred eEEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccc
Q 001768 730 LLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLA 809 (1016)
Q Consensus 730 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla 809 (1016)
.++||||+++++|.+++.... .+++..+..++.|++.||+|||+. +++||||+|+||++++++.++|+|||.+
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~ 153 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYG----AFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGIS 153 (267)
T ss_pred cEEEEEecCCCCHHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCC
Confidence 999999999999999996543 588999999999999999999998 8999999999999999999999999998
Q ss_pred cccCCCCcc-----eeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHh
Q 001768 810 KLDEDENTH-----ISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQ 884 (1016)
Q Consensus 810 ~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~ 884 (1016)
+........ ......|+..|+|||.+.+..++.++|||||||++|+|++|+.||.......... .
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~---------~- 223 (267)
T cd06628 154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIF---------K- 223 (267)
T ss_pred cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHH---------H-
Confidence 765422111 1122457889999999988888999999999999999999999997543222110 0
Q ss_pred CCcccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 885 GNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 885 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
......+.. +...+..+.+++.+||+.||.+||++.|+++
T Consensus 224 --~~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 224 --IGENASPEI----PSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred --HhccCCCcC----CcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 001112222 2234457889999999999999999999884
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=349.11 Aligned_cols=258 Identities=24% Similarity=0.382 Sum_probs=201.2
Q ss_pred HHHhcCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCC--ChhhhHHHHHHHHHHHhcCCCCeeeeeeeEee--cce
Q 001768 655 KAATNNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSK--SKQGNREFVNEIGMISALQHQNLVKLYGCCIE--GNQ 729 (1016)
Q Consensus 655 ~~~~~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~ 729 (1016)
....++|++.+.||+|+||.||+|+.. .+..||+|.+... .......+..|+.+++.++|||||++++++.+ ...
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 445678999999999999999999965 5778999988643 23345678899999999999999999998864 357
Q ss_pred eEEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCC----CCeEeCCCCCceEEEcc--------
Q 001768 730 LLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESR----LKIVHRDIKATNVLLDK-------- 797 (1016)
Q Consensus 730 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~----~~iiHrDlkp~NILl~~-------- 797 (1016)
+++||||+++++|.++|.........+++..++.|+.||+.||+|||+.+. .+||||||||+|||++.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 899999999999999997643333469999999999999999999998521 25999999999999964
Q ss_pred ---------CCceeeeccccccccCCCCcceeeecccCccccChhhhcc--CCCCCccchhHHHHHHHHHHhCCCCCCCC
Q 001768 798 ---------DLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMR--GYLTDKADVYSFGIVALEIVSGKSNTNYR 866 (1016)
Q Consensus 798 ---------~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDVwSlGvvl~elltG~~P~~~~ 866 (1016)
.+.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||...
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred cccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 2348999999998654322 2234579999999999864 45889999999999999999999999754
Q ss_pred CchhhHhHHHHHHHHHHhCCcccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 867 PKEEFVYLLDWAYVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 867 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
...... . ..... . +.+.. ...+..+.+||..||+.+|.+||++.|++.
T Consensus 247 ~~~~ql--i---~~lk~-~-------p~lpi---~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 247 NNFSQL--I---SELKR-G-------PDLPI---KGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CcHHHH--H---HHHhc-C-------CCCCc---CCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 332211 1 01010 0 11110 112356889999999999999999999984
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=313.20 Aligned_cols=247 Identities=22% Similarity=0.349 Sum_probs=209.5
Q ss_pred cCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCCh--hhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEe
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSK--QGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYE 735 (1016)
Q Consensus 659 ~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 735 (1016)
.=|+..+.||+|.|..|-+|++- .|..||||++.+..- -....+.+|+++|+.++|||||++|++......+|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 44777889999999999999854 799999999976543 335678899999999999999999999999999999999
Q ss_pred ecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEc-cCCceeeeccccccccCC
Q 001768 736 YLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLD-KDLNAKISDFGLAKLDED 814 (1016)
Q Consensus 736 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~-~~~~~kL~DFGla~~~~~ 814 (1016)
+-++|+|.++|...+. .+.++.+.+++.||+.|+.|+|+. .+|||||||+||.+- .-|-+||.|||++-.+..
T Consensus 98 LGD~GDl~DyImKHe~---Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEE---GLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred ecCCchHHHHHHhhhc---cccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 9999999999977653 599999999999999999999998 899999999999875 568899999999976655
Q ss_pred CCcceeeecccCccccChhhhccCCCC-CccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCC
Q 001768 815 ENTHISTRIAGTVGYMAPEYAMRGYLT-DKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDP 893 (1016)
Q Consensus 815 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 893 (1016)
... -+..+|+..|-|||++.+..|+ +++||||||||||-|++|++||....+.+.... ++|=
T Consensus 172 G~k--L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTm---------------ImDC 234 (864)
T KOG4717|consen 172 GKK--LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTM---------------IMDC 234 (864)
T ss_pred cch--hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhh---------------hhcc
Confidence 433 3457899999999999987665 578999999999999999999987665543321 1221
Q ss_pred cCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 894 SLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 894 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
.-.++.....++.+||..||..||++|.+.+||+.
T Consensus 235 --KYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 235 --KYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred --cccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 12356667788999999999999999999999985
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=314.51 Aligned_cols=254 Identities=26% Similarity=0.398 Sum_probs=192.5
Q ss_pred CccccCCCeeEEEEEcCC---CcEEEEEEccCCC-hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEeecCCC
Q 001768 665 NKIGEGGFGPVYKGTLSD---GAVIAVKQLSSKS-KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYLENN 740 (1016)
Q Consensus 665 ~~LG~G~~G~Vy~~~~~~---~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 740 (1016)
+.||+|+||.||+|...+ ...+|+|.+.... ......+.+|+++++.++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 368999999999997543 4578899876543 333567889999999999999999999999999999999999999
Q ss_pred cHHHHhccCcCc-CcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCCcc-
Q 001768 741 SLARALFGKEGQ-CLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTH- 818 (1016)
Q Consensus 741 sL~~~l~~~~~~-~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~- 818 (1016)
+|.+++...... ....++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 999999765422 22357888899999999999999998 9999999999999999999999999998743322211
Q ss_pred eeeecccCccccChhhhcc-------CCCCCccchhHHHHHHHHHHh-CCCCCCCCCchhhHhHHHHHHHHHHhCCcccc
Q 001768 819 ISTRIAGTVGYMAPEYAMR-------GYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWAYVLQEQGNLLEL 890 (1016)
Q Consensus 819 ~~~~~~gt~~y~aPE~~~~-------~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 890 (1016)
......++..|+|||+... ..++.++|||||||++|||++ |..||......+.... . ........
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~-----~--~~~~~~~~ 230 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQ-----V--VREQDIKL 230 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHH-----H--hhccCccC
Confidence 1122345678999998753 356789999999999999999 7788865443322110 0 01111122
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 001768 891 VDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933 (1016)
Q Consensus 891 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 933 (1016)
..+.+.. .....+.+++..|| .||++|||+++|++.|.
T Consensus 231 ~~~~~~~----~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 231 PKPQLDL----KYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCcccc----cCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 2222222 23446777888998 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=327.58 Aligned_cols=262 Identities=29% Similarity=0.442 Sum_probs=207.5
Q ss_pred HhcCccccCccccCCCeeEEEEEcC--------CCcEEEEEEccCCC-hhhhHHHHHHHHHHHhc-CCCCeeeeeeeEee
Q 001768 657 ATNNFDAANKIGEGGFGPVYKGTLS--------DGAVIAVKQLSSKS-KQGNREFVNEIGMISAL-QHQNLVKLYGCCIE 726 (1016)
Q Consensus 657 ~~~~f~~~~~LG~G~~G~Vy~~~~~--------~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~ 726 (1016)
...+|.+.+.||+|+||.||+|+.. .+..||+|.+.... ....+++.+|+++++++ +||||+++++++..
T Consensus 10 ~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (334)
T cd05100 10 SRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 89 (334)
T ss_pred CHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc
Confidence 3456889999999999999999742 12368999887543 33456889999999999 79999999999999
Q ss_pred cceeEEEEeecCCCcHHHHhccCcC------------cCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEE
Q 001768 727 GNQLLLVYEYLENNSLARALFGKEG------------QCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVL 794 (1016)
Q Consensus 727 ~~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NIL 794 (1016)
++..++||||+++|+|.+++..... ....+++.++..++.|++.||+|||+. +|+||||||+||+
T Consensus 90 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nil 166 (334)
T cd05100 90 DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVL 166 (334)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEE
Confidence 9999999999999999999965321 123588999999999999999999998 9999999999999
Q ss_pred EccCCceeeeccccccccCCCCcce-eeecccCccccChhhhccCCCCCccchhHHHHHHHHHHh-CCCCCCCCCchhhH
Q 001768 795 LDKDLNAKISDFGLAKLDEDENTHI-STRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFV 872 (1016)
Q Consensus 795 l~~~~~~kL~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~ 872 (1016)
+++++.+||+|||+++......... .....++..|+|||++.+..++.++|||||||++|||++ |..||...+.++..
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~ 246 (334)
T cd05100 167 VTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF 246 (334)
T ss_pred EcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence 9999999999999997554322111 122334567999999998889999999999999999998 88888765544322
Q ss_pred hHHHHHHHHHHhCCcccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCcC
Q 001768 873 YLLDWAYVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTA 937 (1016)
Q Consensus 873 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 937 (1016)
..+ . .... ...+......+.+++.+||+.+|++||++.|+++.|+....
T Consensus 247 ~~~------~-~~~~---------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 247 KLL------K-EGHR---------MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred HHH------H-cCCC---------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 111 1 1110 11112234578899999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=334.88 Aligned_cols=259 Identities=21% Similarity=0.266 Sum_probs=195.9
Q ss_pred HhcCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEe
Q 001768 657 ATNNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYE 735 (1016)
Q Consensus 657 ~~~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 735 (1016)
...+|.+.+.||+|+||.||+|+.. .++.||||.... ..+.+|++++++++|||||++++++..++..++|||
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e 240 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP 240 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence 3567999999999999999999975 478899996432 245689999999999999999999999999999999
Q ss_pred ecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCC
Q 001768 736 YLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDE 815 (1016)
Q Consensus 736 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 815 (1016)
++. ++|.+++.... ..+++.+++.|+.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 241 ~~~-~~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 313 (461)
T PHA03211 241 KYR-SDLYTYLGARL---RPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGS 313 (461)
T ss_pred ccC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceecccc
Confidence 995 68888885433 2599999999999999999999998 9999999999999999999999999999865432
Q ss_pred Cc-ceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCc--------hhhHhHHHHHHHHHHhCC
Q 001768 816 NT-HISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPK--------EEFVYLLDWAYVLQEQGN 886 (1016)
Q Consensus 816 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~--------~~~~~~~~~~~~~~~~~~ 886 (1016)
.. .......||+.|+|||++.+..++.++|||||||++|||++|..|+..... .+....+....... ..
T Consensus 314 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~--~~ 391 (461)
T PHA03211 314 WSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHV--DE 391 (461)
T ss_pred cccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcccc--cc
Confidence 21 122345799999999999998999999999999999999998876532211 11111111111000 00
Q ss_pred cccc----------------cCCcC-CCCCCH--HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 887 LLEL----------------VDPSL-GSNFSK--KEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 887 ~~~~----------------~d~~l-~~~~~~--~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
+... ..+.. ...+.. .....+.+|+.+||+.||.+|||+.|+++
T Consensus 392 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~ 454 (461)
T PHA03211 392 FPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLR 454 (461)
T ss_pred CCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhh
Confidence 0000 00000 000000 12236889999999999999999999884
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=316.40 Aligned_cols=251 Identities=29% Similarity=0.459 Sum_probs=199.0
Q ss_pred CccccCCCeeEEEEEcCC-------CcEEEEEEccCCC-hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEee
Q 001768 665 NKIGEGGFGPVYKGTLSD-------GAVIAVKQLSSKS-KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEY 736 (1016)
Q Consensus 665 ~~LG~G~~G~Vy~~~~~~-------~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 736 (1016)
+.||+|+||.||+|+..+ ++.||+|.+.... ......+.+|+++++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 468999999999998643 2579999886543 23456788999999999999999999999999999999999
Q ss_pred cCCCcHHHHhccCcC---cCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCC-----ceeeecccc
Q 001768 737 LENNSLARALFGKEG---QCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDL-----NAKISDFGL 808 (1016)
Q Consensus 737 ~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~-----~~kL~DFGl 808 (1016)
+++++|.+++..... ....+++.++..++.|++.||+|||+. +++|+||||+||+++.++ .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 999999999965322 123588999999999999999999988 899999999999999877 899999999
Q ss_pred ccccCCCCc-ceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHh-CCCCCCCCCchhhHhHHHHHHHHHHhCC
Q 001768 809 AKLDEDENT-HISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWAYVLQEQGN 886 (1016)
Q Consensus 809 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~ 886 (1016)
++....... .......++..|+|||++.++.++.++|||||||++|||++ |+.||......+....+ . ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~------~-~~- 229 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHV------T-AG- 229 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHH------h-cC-
Confidence 875432211 11122345678999999999999999999999999999998 99998754433221111 0 00
Q ss_pred cccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 001768 887 LLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEG 934 (1016)
Q Consensus 887 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 934 (1016)
.....+...+..+.+++.+||+.+|.+||+++++++.|++
T Consensus 230 --------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 230 --------GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred --------CccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 0111122345678999999999999999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=319.24 Aligned_cols=256 Identities=25% Similarity=0.400 Sum_probs=204.1
Q ss_pred hcCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCC-hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEe
Q 001768 658 TNNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS-KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYE 735 (1016)
Q Consensus 658 ~~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 735 (1016)
.++|++.+.||+|+||+||++... +++.||+|++.... ......+.+|+++++.++||||+++++++...+..++|||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 357888999999999999999865 68899999876543 3345678999999999999999999999999999999999
Q ss_pred ecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCC
Q 001768 736 YLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDE 815 (1016)
Q Consensus 736 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 815 (1016)
|+++++|.+++.... .+++..+..++.|++.||.|||+.. +++||||||+||++++++.++|+|||++......
T Consensus 84 ~~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 84 FMDCGSLDRIYKKGG----PIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred cCCCCCHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 999999999886532 5899999999999999999999742 7999999999999999999999999998644222
Q ss_pred CcceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhh-----HhHHHHHHHHHHhCCcccc
Q 001768 816 NTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEF-----VYLLDWAYVLQEQGNLLEL 890 (1016)
Q Consensus 816 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~ 890 (1016)
. .....|+..|+|||++.++.++.++|||||||++|+|++|+.||......+. ....++.......
T Consensus 158 ~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 228 (284)
T cd06620 158 I---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE------ 228 (284)
T ss_pred c---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhc------
Confidence 1 1235689999999999888899999999999999999999999975443211 0111111110000
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001768 891 VDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSM 931 (1016)
Q Consensus 891 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 931 (1016)
..+.+. ....+..+.+++.+|++.||++|||+.|++++
T Consensus 229 ~~~~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~ 266 (284)
T cd06620 229 PPPRLP---SSDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266 (284)
T ss_pred cCCCCC---chhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 011111 11244578999999999999999999999965
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=325.41 Aligned_cols=262 Identities=18% Similarity=0.277 Sum_probs=198.3
Q ss_pred ccCccccC--CCeeEEEEEcC-CCcEEEEEEccCCC--hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEeec
Q 001768 663 AANKIGEG--GFGPVYKGTLS-DGAVIAVKQLSSKS--KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYL 737 (1016)
Q Consensus 663 ~~~~LG~G--~~G~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 737 (1016)
++++||+| +||+||+++.+ +|+.||+|++.... ....+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 46789999 68899999864 78999999987542 233456788999999999999999999999999999999999
Q ss_pred CCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCCc
Q 001768 738 ENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENT 817 (1016)
Q Consensus 738 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 817 (1016)
++|+|.+++..... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.++++||+.+........
T Consensus 82 ~~~~l~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 82 AYGSAKDLICTHFM--DGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred CCCcHHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 99999999965432 2489999999999999999999998 999999999999999999999999986543211110
Q ss_pred c------eeeecccCccccChhhhcc--CCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCccc
Q 001768 818 H------ISTRIAGTVGYMAPEYAMR--GYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLE 889 (1016)
Q Consensus 818 ~------~~~~~~gt~~y~aPE~~~~--~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 889 (1016)
. ......++..|+|||++.+ ..++.++|||||||++|||++|+.||............. ......
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~-------~~~~~~ 229 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKL-------NGTVPC 229 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHh-------cCCccc
Confidence 0 0112346778999999875 458899999999999999999999997544322111000 000000
Q ss_pred cc-------------------CC-----------------cCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 001768 890 LV-------------------DP-----------------SLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933 (1016)
Q Consensus 890 ~~-------------------d~-----------------~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 933 (1016)
.. +. .....+.......+.+++.+||+.||++|||++|++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell---- 305 (327)
T cd08227 230 LLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLL---- 305 (327)
T ss_pred cccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHh----
Confidence 00 00 000011223345789999999999999999999888
Q ss_pred cCcCCcCccccC
Q 001768 934 GKTAVQAPIIRR 945 (1016)
Q Consensus 934 ~~~~~~~p~~~~ 945 (1016)
++||++.
T Consensus 306 -----~~p~f~~ 312 (327)
T cd08227 306 -----NHSFFKQ 312 (327)
T ss_pred -----cChhhhh
Confidence 5777653
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=328.38 Aligned_cols=262 Identities=20% Similarity=0.261 Sum_probs=198.1
Q ss_pred HhcCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCC--hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeec------
Q 001768 657 ATNNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS--KQGNREFVNEIGMISALQHQNLVKLYGCCIEG------ 727 (1016)
Q Consensus 657 ~~~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------ 727 (1016)
..++|++.+.||+|+||.||+|... .++.||||++.... ......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 4578999999999999999999854 58899999987532 33446778899999999999999999987543
Q ss_pred ceeEEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccc
Q 001768 728 NQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFG 807 (1016)
Q Consensus 728 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG 807 (1016)
...++||||+++ +|.+.+.. .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG 171 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 171 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh------cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCC
Confidence 357999999976 67666632 478899999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCCcceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHH----------
Q 001768 808 LAKLDEDENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDW---------- 877 (1016)
Q Consensus 808 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~---------- 877 (1016)
+++...... ......||..|+|||++.+..++.++|||||||++|||++|+.||......+....+..
T Consensus 172 ~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 249 (364)
T cd07875 172 LARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM 249 (364)
T ss_pred CccccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 998554322 22345789999999999998999999999999999999999999976554332111100
Q ss_pred -------HHHHHHhCCcccc----cCCcC----CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 878 -------AYVLQEQGNLLEL----VDPSL----GSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 878 -------~~~~~~~~~~~~~----~d~~l----~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
............. ..+.. ...........+.+++.+|++.||.+|||+.|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~ 317 (364)
T cd07875 250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 317 (364)
T ss_pred HhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0000000000000 00000 00111112346889999999999999999998873
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=317.97 Aligned_cols=246 Identities=30% Similarity=0.488 Sum_probs=201.5
Q ss_pred CccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCC-hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEeec
Q 001768 660 NFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS-KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYL 737 (1016)
Q Consensus 660 ~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 737 (1016)
.|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++..++..++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 4677889999999999999864 57899999987443 334567889999999999999999999999999999999999
Q ss_pred CCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCCc
Q 001768 738 ENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENT 817 (1016)
Q Consensus 738 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 817 (1016)
++++|.+++... .+++..+..++.|+++|+.|||++ +++|+||+|+||++++++.++|+|||++........
T Consensus 85 ~~~~L~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 85 GGGSALDLLKPG-----PLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence 999999998542 589999999999999999999998 999999999999999999999999999976543321
Q ss_pred ceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCCC
Q 001768 818 HISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGS 897 (1016)
Q Consensus 818 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 897 (1016)
......|+..|+|||++.+..++.++|||||||++|||++|+.|+........... ......+.
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~------------~~~~~~~~--- 220 (277)
T cd06642 157 -KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFL------------IPKNSPPT--- 220 (277)
T ss_pred -hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhh------------hhcCCCCC---
Confidence 12234678899999999988899999999999999999999999865433221110 00011111
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 898 NFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 898 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
.....+..+.+++.+||+.+|++||++.++++
T Consensus 221 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 221 -LEGQYSKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred -CCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 22234457899999999999999999999986
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=320.80 Aligned_cols=254 Identities=26% Similarity=0.416 Sum_probs=203.5
Q ss_pred HHHhcCccccCccccCCCeeEEEEEcCCCcEEEEEEccC--CChhhhHHHHHHHHHHHhcC-CCCeeeeeeeEeecceeE
Q 001768 655 KAATNNFDAANKIGEGGFGPVYKGTLSDGAVIAVKQLSS--KSKQGNREFVNEIGMISALQ-HQNLVKLYGCCIEGNQLL 731 (1016)
Q Consensus 655 ~~~~~~f~~~~~LG~G~~G~Vy~~~~~~~~~vAvK~~~~--~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~ 731 (1016)
....+.|++.++||+||.+.||++...+.+.||+|++.. .+.+...-|.+|++.|.+++ |.+||++++|-..++.+|
T Consensus 357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lY 436 (677)
T KOG0596|consen 357 KVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLY 436 (677)
T ss_pred EECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEE
Confidence 344567889999999999999999998889999998753 35556778999999999994 999999999999999999
Q ss_pred EEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccc
Q 001768 732 LVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKL 811 (1016)
Q Consensus 732 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~ 811 (1016)
+||||= ..+|..+|..+... ...| .++.+..||+.|+.+.|++ ||||.||||.|+|+- .|.+||+|||.|..
T Consensus 437 mvmE~G-d~DL~kiL~k~~~~--~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlV-kG~LKLIDFGIA~a 508 (677)
T KOG0596|consen 437 MVMECG-DIDLNKILKKKKSI--DPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLV-KGRLKLIDFGIANA 508 (677)
T ss_pred EEeecc-cccHHHHHHhccCC--CchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEE-eeeEEeeeechhcc
Confidence 999965 55999999776532 2334 7889999999999999999 999999999999996 47899999999997
Q ss_pred cCCCCcce-eeecccCccccChhhhccC-----------CCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHH
Q 001768 812 DEDENTHI-STRIAGTVGYMAPEYAMRG-----------YLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAY 879 (1016)
Q Consensus 812 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~-----------~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~ 879 (1016)
+..+.+.+ ....+||+.||+||.+... +.+.++||||+|||||+|+.|++||..... .|+
T Consensus 509 I~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n-------~~a- 580 (677)
T KOG0596|consen 509 IQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN-------QIA- 580 (677)
T ss_pred cCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH-------HHH-
Confidence 77665443 3457899999999988632 256799999999999999999999863211 122
Q ss_pred HHHHhCCcccccCCcCCCCCCHHHH-HHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 880 VLQEQGNLLELVDPSLGSNFSKKEA-MTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 880 ~~~~~~~~~~~~d~~l~~~~~~~~~-~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
++..+.+|...-.|+..-. .+++++++.||+.||++||++.|+++
T Consensus 581 ------Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 581 ------KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred ------HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 2334455543333332111 13999999999999999999999883
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=310.53 Aligned_cols=250 Identities=24% Similarity=0.389 Sum_probs=205.4
Q ss_pred CccccCccccCCCeeEEEEEcC-CCcEEEEEEccCC--ChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEee
Q 001768 660 NFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSK--SKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEY 736 (1016)
Q Consensus 660 ~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 736 (1016)
+|+..+.||+|+||.||.++.. +++.+++|.+... .......+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 5888999999999999999854 6889999987643 344456788999999999999999999999999999999999
Q ss_pred cCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCC
Q 001768 737 LENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDEN 816 (1016)
Q Consensus 737 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 816 (1016)
+++++|.+++.... ...+++.++..++.|++.||+|||+. +++||||+|+||++++++.+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 81 ANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred cCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 99999999997543 23689999999999999999999998 89999999999999999999999999998654433
Q ss_pred cceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCC
Q 001768 817 THISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLG 896 (1016)
Q Consensus 817 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 896 (1016)
. ......|++.|+|||.+.+..++.++||||||+++|||++|+.||......+....+ ..+...
T Consensus 156 ~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~-------~~~~~~-------- 219 (256)
T cd08221 156 S-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKI-------VQGNYT-------- 219 (256)
T ss_pred c-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHH-------HcCCCC--------
Confidence 2 223456899999999998888899999999999999999999999764433322111 011111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001768 897 SNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSM 931 (1016)
Q Consensus 897 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 931 (1016)
..+...+..+.+++.+||+.+|++||++.++++.
T Consensus 220 -~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 220 -PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred -CCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 1112334568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=313.33 Aligned_cols=254 Identities=24% Similarity=0.400 Sum_probs=192.6
Q ss_pred CccccCCCeeEEEEEcCCC---cEEEEEEccCCC-hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEeecCCC
Q 001768 665 NKIGEGGFGPVYKGTLSDG---AVIAVKQLSSKS-KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYLENN 740 (1016)
Q Consensus 665 ~~LG~G~~G~Vy~~~~~~~---~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 740 (1016)
+.||+|+||.||+|+..++ ..+++|.+.... ....+.+.+|+.+++.++||||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999975433 356677765443 334568999999999999999999999999999999999999999
Q ss_pred cHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCC-Ccce
Q 001768 741 SLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDE-NTHI 819 (1016)
Q Consensus 741 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~-~~~~ 819 (1016)
+|.+++..........++..+..++.||++||+|||+. +++||||||+|||++.++.++|+|||++...... ....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 99999976543334567788899999999999999998 8999999999999999999999999998642211 1112
Q ss_pred eeecccCccccChhhhcc-------CCCCCccchhHHHHHHHHHHh-CCCCCCCCCchhhHhHHHHHHHHHHhCCccccc
Q 001768 820 STRIAGTVGYMAPEYAMR-------GYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELV 891 (1016)
Q Consensus 820 ~~~~~gt~~y~aPE~~~~-------~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 891 (1016)
.....++..|+|||++.. ..++.++|||||||++|||++ |..||......+..... . .+......
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~-----~--~~~~~~~~ 230 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHV-----I--KDQQVKLF 230 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-----H--hhcccccC
Confidence 233567889999998753 245789999999999999997 56677644332221110 0 11122233
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 001768 892 DPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933 (1016)
Q Consensus 892 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 933 (1016)
++.+...+ ...+.+++..|| .+|++||++++|++.|.
T Consensus 231 ~~~~~~~~----~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 231 KPQLELPY----SERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCccCCCC----cHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 44443333 346788999999 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=315.09 Aligned_cols=255 Identities=29% Similarity=0.472 Sum_probs=208.2
Q ss_pred cCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCC-hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEee
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS-KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEY 736 (1016)
Q Consensus 659 ~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 736 (1016)
++|++.+.||.|++|.||+|+.. +++.||+|.+.... ......+.+|+++++.++||||+++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 46888999999999999999965 68899999987543 33456788999999999999999999999999999999999
Q ss_pred cCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCC
Q 001768 737 LENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDEN 816 (1016)
Q Consensus 737 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 816 (1016)
+++++|.+++... ++++..++.++.|++.|+.|||+. +++||||+|+||++++++.++|+|||+++......
T Consensus 81 ~~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 152 (274)
T cd06609 81 CGGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM 152 (274)
T ss_pred eCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence 9999999998643 589999999999999999999998 89999999999999999999999999998655432
Q ss_pred cceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCC
Q 001768 817 THISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLG 896 (1016)
Q Consensus 817 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 896 (1016)
. ......+++.|+|||++.+..++.++|||||||++|||+||+.||...........+ ... ..+.+.
T Consensus 153 ~-~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~-------~~~-----~~~~~~ 219 (274)
T cd06609 153 S-KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLI-------PKN-----NPPSLE 219 (274)
T ss_pred c-ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHh-------hhc-----CCCCCc
Confidence 1 223356888999999999888999999999999999999999999754432211100 001 111111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCcCCcCccccCC
Q 001768 897 SNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTAVQAPIIRRN 946 (1016)
Q Consensus 897 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~p~~~~~ 946 (1016)
.. ..+..+.+++.+||..+|++|||++++++ +||+...
T Consensus 220 ~~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~---------~~~~~~~ 257 (274)
T cd06609 220 GN---KFSKPFKDFVSLCLNKDPKERPSAKELLK---------HKFIKKA 257 (274)
T ss_pred cc---ccCHHHHHHHHHHhhCChhhCcCHHHHhh---------ChhhcCC
Confidence 11 13446889999999999999999999884 6776653
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=317.08 Aligned_cols=240 Identities=23% Similarity=0.412 Sum_probs=191.3
Q ss_pred CccccCCCeeEEEEEcCC--------CcEEEEEEccCCChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEee
Q 001768 665 NKIGEGGFGPVYKGTLSD--------GAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEY 736 (1016)
Q Consensus 665 ~~LG~G~~G~Vy~~~~~~--------~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 736 (1016)
+.||+|+||.||+|.... ...||+|.+........+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999998642 234888888665555567888999999999999999999999999999999999
Q ss_pred cCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCc--------eeeecccc
Q 001768 737 LENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLN--------AKISDFGL 808 (1016)
Q Consensus 737 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~--------~kL~DFGl 808 (1016)
+++|+|.+++..... .+++..++.++.||+.||+|||+. +|+||||||+||+++.++. ++++|||.
T Consensus 81 ~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~ 154 (258)
T cd05078 81 VKFGSLDTYLKKNKN---LINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI 154 (258)
T ss_pred CCCCcHHHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccccc
Confidence 999999999976542 589999999999999999999998 9999999999999987765 69999998
Q ss_pred ccccCCCCcceeeecccCccccChhhhcc-CCCCCccchhHHHHHHHHHHhCC-CCCCCCCchhhHhHHHHHHHHHHhCC
Q 001768 809 AKLDEDENTHISTRIAGTVGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGK-SNTNYRPKEEFVYLLDWAYVLQEQGN 886 (1016)
Q Consensus 809 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~-~P~~~~~~~~~~~~~~~~~~~~~~~~ 886 (1016)
+...... ....++..|+|||++.+ ..++.++|||||||++|||++|. .|+........... ....
T Consensus 155 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~------~~~~-- 221 (258)
T cd05078 155 SITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQF------YEDR-- 221 (258)
T ss_pred ccccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHH------HHcc--
Confidence 8644321 22457889999999976 45789999999999999999985 55543332221110 0000
Q ss_pred cccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 001768 887 LLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933 (1016)
Q Consensus 887 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 933 (1016)
..+ +.....++.+++.+||+.||++|||++++++.|+
T Consensus 222 ------~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 222 ------HQL----PAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ------ccC----CCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 111 1112346899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=314.38 Aligned_cols=247 Identities=29% Similarity=0.481 Sum_probs=204.8
Q ss_pred cCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCC-hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEee
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS-KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEY 736 (1016)
Q Consensus 659 ~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 736 (1016)
..|+..+.||+|+||.||+|... +++.||+|.+.... ......+.+|++++++++||||+++++++.++...++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 35777899999999999999965 58899999987543 34456788999999999999999999999999999999999
Q ss_pred cCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCC
Q 001768 737 LENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDEN 816 (1016)
Q Consensus 737 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 816 (1016)
+++++|.+++... ++++.++..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~i~~~-----~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06640 84 LGGGSALDLLRAG-----PFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred CCCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence 9999999998542 488999999999999999999998 99999999999999999999999999997554332
Q ss_pred cceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCC
Q 001768 817 THISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLG 896 (1016)
Q Consensus 817 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 896 (1016)
. ......++..|+|||++.+..++.++|||||||++|||++|+.||........... ......
T Consensus 156 ~-~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~----------------~~~~~~ 218 (277)
T cd06640 156 I-KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFL----------------IPKNNP 218 (277)
T ss_pred c-ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhh----------------hhcCCC
Confidence 1 12234678899999999888899999999999999999999999875443322111 011112
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 897 SNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 897 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
.......+..+.+++.+||+.+|++||++.++++
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06640 219 PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLK 252 (277)
T ss_pred CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHh
Confidence 2334456678999999999999999999999974
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=310.82 Aligned_cols=251 Identities=35% Similarity=0.545 Sum_probs=203.6
Q ss_pred ccccCccccCCCeeEEEEEcCC-----CcEEEEEEccCCChh-hhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEE
Q 001768 661 FDAANKIGEGGFGPVYKGTLSD-----GAVIAVKQLSSKSKQ-GNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVY 734 (1016)
Q Consensus 661 f~~~~~LG~G~~G~Vy~~~~~~-----~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 734 (1016)
|++.+.||+|+||.||++++.+ +..||+|.+...... ....+.+|+++++.++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 4567899999999999999753 488999999765433 5678899999999999999999999999999999999
Q ss_pred eecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCC
Q 001768 735 EYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDED 814 (1016)
Q Consensus 735 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 814 (1016)
||+++++|.+++...... .+++.+++.++.|++.||+|||+. +++||||||+||++++++.++|+|||.+.....
T Consensus 81 e~~~~~~l~~~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPK--ELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred eccCCCCHHHHHHhhhhc--cCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccc
Confidence 999999999999764321 289999999999999999999998 999999999999999999999999999986654
Q ss_pred CCcceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHh-CCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCC
Q 001768 815 ENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDP 893 (1016)
Q Consensus 815 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 893 (1016)
..........+++.|+|||.+.+..++.++||||+||++|+|++ |+.||............ ......
T Consensus 156 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~-------~~~~~~----- 223 (258)
T smart00219 156 DDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYL-------KKGYRL----- 223 (258)
T ss_pred ccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-------hcCCCC-----
Confidence 42222222347789999999988889999999999999999998 78888754433322111 111110
Q ss_pred cCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 001768 894 SLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSML 932 (1016)
Q Consensus 894 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 932 (1016)
..+...+..+.+++.+|+..||++|||+.|+++.|
T Consensus 224 ----~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 224 ----PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ----CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 11112445789999999999999999999999765
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=311.85 Aligned_cols=247 Identities=28% Similarity=0.450 Sum_probs=200.2
Q ss_pred cCccccCccccCCCeeEEEEEcCCCcEEEEEEccCCChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEeecC
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYLE 738 (1016)
Q Consensus 659 ~~f~~~~~LG~G~~G~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 738 (1016)
++|++.+.||+|+||.||++.. .++.||+|.+.... ....+.+|+.++++++|||++++++++..+ ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4688899999999999999975 57789999986543 245788999999999999999999998765 4799999999
Q ss_pred CCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCCcc
Q 001768 739 NNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTH 818 (1016)
Q Consensus 739 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 818 (1016)
+++|.+++..... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~-- 154 (254)
T cd05083 82 KGNLVNFLRTRGR--ALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV-- 154 (254)
T ss_pred CCCHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC--
Confidence 9999999965432 3588999999999999999999998 99999999999999999999999999987543221
Q ss_pred eeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHh-CCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCCC
Q 001768 819 ISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGS 897 (1016)
Q Consensus 819 ~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 897 (1016)
.....+..|+|||.+.++.++.++|||||||++|||++ |+.||......+..... .... ..
T Consensus 155 --~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~-------~~~~---------~~ 216 (254)
T cd05083 155 --DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECV-------EKGY---------RM 216 (254)
T ss_pred --CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHH-------hCCC---------CC
Confidence 12234567999999988889999999999999999998 99998765543322111 1110 01
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 001768 898 NFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEG 934 (1016)
Q Consensus 898 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 934 (1016)
..+...+..+.+++.+||+.+|++||+++++++.|+.
T Consensus 217 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 217 EPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 1112234578899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=317.58 Aligned_cols=264 Identities=25% Similarity=0.370 Sum_probs=198.4
Q ss_pred CccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCC--hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEee
Q 001768 660 NFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS--KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEY 736 (1016)
Q Consensus 660 ~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 736 (1016)
+|++.+.||+|++|.||+|+.. +++.||+|.+.... ......+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 5788999999999999999965 68999999986432 22345788999999999999999999999999999999999
Q ss_pred cCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCC
Q 001768 737 LENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDEN 816 (1016)
Q Consensus 737 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 816 (1016)
++ ++|.+++..... ...+++..++.++.|+++||+|||+. +|+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 81 LS-MDLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred CC-CCHHHHHhcCCC-CCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 97 588888854332 23689999999999999999999998 99999999999999999999999999987543322
Q ss_pred cceeeecccCccccChhhhccC-CCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHH-H---------HHHH---HH
Q 001768 817 THISTRIAGTVGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLL-D---------WAYV---LQ 882 (1016)
Q Consensus 817 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~-~---------~~~~---~~ 882 (1016)
. ......+++.|+|||.+.+. .++.++|||||||++|||+||++||............ . |... ..
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd07861 156 R-VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD 234 (285)
T ss_pred c-cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence 1 12234568899999988654 5788999999999999999999999765433211100 0 0000 00
Q ss_pred HhCCcccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 883 EQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 883 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
............. .........++.+++.+||+.||++|||+.+|++
T Consensus 235 ~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 235 YKNTFPKWKKGSL-RSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHhhccccCcchh-HHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000000000 0001113456789999999999999999998874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=310.56 Aligned_cols=249 Identities=25% Similarity=0.387 Sum_probs=201.6
Q ss_pred CccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCC--hhhhHHHHHHHHHHHhcCCCCeeeeeeeEee-cceeEEEEe
Q 001768 660 NFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS--KQGNREFVNEIGMISALQHQNLVKLYGCCIE-GNQLLLVYE 735 (1016)
Q Consensus 660 ~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~~lV~E 735 (1016)
+|++.+.||+|++|.||++... +++.||+|.+.... ....+.+.+|++++++++|||++++++.+.. +...++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4888999999999999999865 57899999986432 3345678899999999999999999998764 456899999
Q ss_pred ecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCC
Q 001768 736 YLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDE 815 (1016)
Q Consensus 736 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 815 (1016)
|+++++|.+++.... ...+++.+++.++.|++.|++|||+. +|+||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~l~~~~--~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 81 FCEGGDLYHKLKEQK--GKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred ccCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 999999999996543 23589999999999999999999998 9999999999999999999999999999765433
Q ss_pred CcceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcC
Q 001768 816 NTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSL 895 (1016)
Q Consensus 816 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 895 (1016)
.. ......+++.|+|||++.+..++.++|||||||++|+|++|+.||........... .. .+.. +
T Consensus 156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~------~~-~~~~-----~-- 220 (257)
T cd08223 156 CD-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYR------II-EGKL-----P-- 220 (257)
T ss_pred CC-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHH------HH-hcCC-----C--
Confidence 22 22345688999999999988899999999999999999999999875543322111 00 1111 1
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 896 GSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 896 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
..+......+.+++.+|++.+|++||++.++++
T Consensus 221 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 221 --PMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred --CCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 112234457899999999999999999999884
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=327.24 Aligned_cols=261 Identities=22% Similarity=0.335 Sum_probs=196.3
Q ss_pred HHhcCccccCccccCCCeeEEEEEc-CCCcEEEEEEccCCC--hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeec-----
Q 001768 656 AATNNFDAANKIGEGGFGPVYKGTL-SDGAVIAVKQLSSKS--KQGNREFVNEIGMISALQHQNLVKLYGCCIEG----- 727 (1016)
Q Consensus 656 ~~~~~f~~~~~LG~G~~G~Vy~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~----- 727 (1016)
...++|++.+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|++++++++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 4567899999999999999999985 468899999987542 22345677899999999999999999987643
Q ss_pred -ceeEEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeecc
Q 001768 728 -NQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDF 806 (1016)
Q Consensus 728 -~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DF 806 (1016)
...+++||++ +++|.+++... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Df 162 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKCQ-----KLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDF 162 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCC
Confidence 4579999988 77898887432 589999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCCCcceeeecccCccccChhhhcc-CCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHH-HHHH-----
Q 001768 807 GLAKLDEDENTHISTRIAGTVGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLL-DWAY----- 879 (1016)
Q Consensus 807 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~-~~~~----- 879 (1016)
|+++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......+..... ....
T Consensus 163 g~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 238 (343)
T cd07878 163 GLARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPE 238 (343)
T ss_pred ccceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 999865432 223568999999999876 46889999999999999999999999764432221110 0000
Q ss_pred HHH--Hh---CCcccccCCcCCC----CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 880 VLQ--EQ---GNLLELVDPSLGS----NFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 880 ~~~--~~---~~~~~~~d~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
... .. ......+ +.... .........+.+++.+|++.||.+|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 239 VLKKISSEHARKYIQSL-PHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred HHHhcchhhHHHHhhcc-ccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000 00 0000000 00000 000011235789999999999999999999883
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=327.64 Aligned_cols=248 Identities=26% Similarity=0.364 Sum_probs=209.4
Q ss_pred cccCccccCCCeeEEEEEcCC--Cc--EEEEEEccCCChh-hhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEee
Q 001768 662 DAANKIGEGGFGPVYKGTLSD--GA--VIAVKQLSSKSKQ-GNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEY 736 (1016)
Q Consensus 662 ~~~~~LG~G~~G~Vy~~~~~~--~~--~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 736 (1016)
...++||+|.||.|++|.|.. |+ .||||.+...... ...+|.+|+.+|.+++|||++++||+..+ ....+|||+
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL 191 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL 191 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence 346899999999999999863 43 5899999876554 56889999999999999999999999987 678999999
Q ss_pred cCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCC
Q 001768 737 LENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDEN 816 (1016)
Q Consensus 737 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 816 (1016)
++.|+|.+.|+. .....|-......++.|||.|+.||.++ ++|||||..+|+|+-....+||+|||+.+..+...
T Consensus 192 aplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 192 APLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENE 266 (1039)
T ss_pred cccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence 999999999977 2334688889999999999999999998 99999999999999999999999999999766554
Q ss_pred cce--eeecccCccccChhhhccCCCCCccchhHHHHHHHHHHh-CCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCC
Q 001768 817 THI--STRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDP 893 (1016)
Q Consensus 817 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 893 (1016)
.+. .....-.+.|+|||.+....++.++|||+|||++|||+| |+.||.+.....+...+ |.
T Consensus 267 d~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~i----------------D~ 330 (1039)
T KOG0199|consen 267 DMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNI----------------DA 330 (1039)
T ss_pred cceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhc----------------cc
Confidence 432 222334678999999999999999999999999999999 88899887765544332 22
Q ss_pred cCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001768 894 SLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSM 931 (1016)
Q Consensus 894 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 931 (1016)
.-.-..++.+++++.++++.||..+|++|||+..+.+.
T Consensus 331 ~erLpRPk~csedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 331 GERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred cccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence 22233456788899999999999999999999999754
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=325.17 Aligned_cols=259 Identities=23% Similarity=0.412 Sum_probs=211.5
Q ss_pred cCccccCccccCCCeeEEEEEcCC-CcEEEEEEccCCChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEeec
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLSD-GAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYL 737 (1016)
Q Consensus 659 ~~f~~~~~LG~G~~G~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 737 (1016)
+-|+++..||.|+||.||+|..++ +-..|.|++...+....+++.-|++||...+||+||++++.|..++.++++.|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 346788999999999999999765 4455788888888888899999999999999999999999999999999999999
Q ss_pred CCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCCc
Q 001768 738 ENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENT 817 (1016)
Q Consensus 738 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 817 (1016)
.||-++.++..-. ..|++.++..+++|++.||.|||++ +|||||||+.|||++-+|.++|+|||.+...... .
T Consensus 112 ~GGAVDaimlEL~---r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t-~ 184 (1187)
T KOG0579|consen 112 GGGAVDAIMLELG---RVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST-R 184 (1187)
T ss_pred CCchHhHHHHHhc---cccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhH-H
Confidence 9999998886543 3699999999999999999999999 9999999999999999999999999987532211 1
Q ss_pred ceeeecccCccccChhhhc-----cCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccC
Q 001768 818 HISTRIAGTVGYMAPEYAM-----RGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVD 892 (1016)
Q Consensus 818 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 892 (1016)
.....++|||+|||||+.. ..+|+.++||||||++|.||..+.+|.+.-.+...... ....+...++.
T Consensus 185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllK-------iaKSePPTLlq 257 (1187)
T KOG0579|consen 185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLK-------IAKSEPPTLLQ 257 (1187)
T ss_pred hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHH-------HhhcCCCcccC
Confidence 2234578999999999876 45799999999999999999999999876554432211 11122222222
Q ss_pred CcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCcCCcCccccCCC
Q 001768 893 PSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTAVQAPIIRRNS 947 (1016)
Q Consensus 893 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~p~~~~~~ 947 (1016)
| ......+.+++.+||..||..||++++++ +|||+....
T Consensus 258 P-------S~Ws~~F~DfLk~cL~Knp~~Rp~aaqll---------~Hpfv~~~~ 296 (1187)
T KOG0579|consen 258 P-------SHWSRSFSDFLKRCLVKNPRNRPPAAQLL---------KHPFVQNAP 296 (1187)
T ss_pred c-------chhhhHHHHHHHHHHhcCCccCCCHHHHh---------hCcccccCC
Confidence 2 23455789999999999999999999887 578776433
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=327.97 Aligned_cols=236 Identities=25% Similarity=0.322 Sum_probs=185.5
Q ss_pred cccCCCeeEEEEEcC-CCcEEEEEEccCCC---hhhhHHHHHHHHHHHhc---CCCCeeeeeeeEeecceeEEEEeecCC
Q 001768 667 IGEGGFGPVYKGTLS-DGAVIAVKQLSSKS---KQGNREFVNEIGMISAL---QHQNLVKLYGCCIEGNQLLLVYEYLEN 739 (1016)
Q Consensus 667 LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l---~HpnIv~l~~~~~~~~~~~lV~E~~~~ 739 (1016)
||+|+||.||+|+.. +++.||+|++.... ......+..|..++... +||||+++++++.+++..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999865 68999999986432 12233455667777665 699999999999999999999999999
Q ss_pred CcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCCcce
Q 001768 740 NSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHI 819 (1016)
Q Consensus 740 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 819 (1016)
|+|.+++.... .+++..+..++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 g~L~~~l~~~~----~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-~ 152 (330)
T cd05586 81 GELFWHLQKEG----RFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-T 152 (330)
T ss_pred ChHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-C
Confidence 99999986543 589999999999999999999998 999999999999999999999999999875332221 2
Q ss_pred eeecccCccccChhhhccC-CCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCCCC
Q 001768 820 STRIAGTVGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGSN 898 (1016)
Q Consensus 820 ~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 898 (1016)
.....||+.|+|||++.+. .++.++|||||||++|||++|+.||......+....+ ..+. ..+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i-------~~~~------~~~~~- 218 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNI-------AFGK------VRFPK- 218 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHH-------HcCC------CCCCC-
Confidence 2345799999999998754 4789999999999999999999999765443321111 0111 11111
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHH
Q 001768 899 FSKKEAMTMLNIALLCTNPSPTLRPTMS 926 (1016)
Q Consensus 899 ~~~~~~~~l~~li~~cl~~dP~~RPt~~ 926 (1016)
......+.+++.+||+.||++||++.
T Consensus 219 --~~~~~~~~~li~~~L~~~P~~R~~~~ 244 (330)
T cd05586 219 --NVLSDEGRQFVKGLLNRNPQHRLGAH 244 (330)
T ss_pred --ccCCHHHHHHHHHHcCCCHHHCCCCC
Confidence 11234678999999999999999644
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=316.55 Aligned_cols=252 Identities=24% Similarity=0.409 Sum_probs=201.0
Q ss_pred cCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCC-ChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEee
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSK-SKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEY 736 (1016)
Q Consensus 659 ~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 736 (1016)
++|++.+.||+|+||.||+|+.. +++.||+|.+... .......+.+|++++++++||||+++++++..++..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 46888999999999999999976 6899999988654 333456788999999999999999999999999999999999
Q ss_pred cCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCC
Q 001768 737 LENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDEN 816 (1016)
Q Consensus 737 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 816 (1016)
+++++|.+++.... ....+++..+..++.|++.||.|||+. .+|+||||||+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (286)
T cd06622 81 MDAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL 157 (286)
T ss_pred cCCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence 99999999886532 123689999999999999999999964 289999999999999999999999999987543321
Q ss_pred cceeeecccCccccChhhhccC------CCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccc
Q 001768 817 THISTRIAGTVGYMAPEYAMRG------YLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLEL 890 (1016)
Q Consensus 817 ~~~~~~~~gt~~y~aPE~~~~~------~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 890 (1016)
.....+++.|+|||.+.+. .++.++|||||||++|+|++|+.||............. . ....
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~----~-----~~~~ 225 (286)
T cd06622 158 ---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLS----A-----IVDG 225 (286)
T ss_pred ---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHH----H-----Hhhc
Confidence 2234578899999998544 34789999999999999999999996543322111100 0 0000
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 001768 891 VDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAV 929 (1016)
Q Consensus 891 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 929 (1016)
.. ...+......+.+++.+||+.+|++||++.+++
T Consensus 226 ~~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~ 260 (286)
T cd06622 226 DP----PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLL 260 (286)
T ss_pred CC----CCCCcccCHHHHHHHHHHcccCcccCCCHHHHh
Confidence 11 122333556788999999999999999999888
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=313.78 Aligned_cols=264 Identities=23% Similarity=0.349 Sum_probs=201.9
Q ss_pred cCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCC--hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEe
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS--KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYE 735 (1016)
Q Consensus 659 ~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 735 (1016)
++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++|||++++++++..+...++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 47889999999999999999976 58999999886432 2234567899999999999999999999999999999999
Q ss_pred ecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCC
Q 001768 736 YLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDE 815 (1016)
Q Consensus 736 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 815 (1016)
|++++.|..++.... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~~~----~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 81 YCDHTVLNELEKNPR----GVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred ccCccHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 999998888764432 589999999999999999999998 9999999999999999999999999999865443
Q ss_pred CcceeeecccCccccChhhhcc-CCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHH--------HHHHhCC
Q 001768 816 NTHISTRIAGTVGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAY--------VLQEQGN 886 (1016)
Q Consensus 816 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~--------~~~~~~~ 886 (1016)
.. ......++..|+|||++.+ ..++.++|||||||++|||++|+.||......+......... .......
T Consensus 154 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07847 154 GD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ 232 (286)
T ss_pred cc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccc
Confidence 21 1223457889999999875 457889999999999999999999998655443222111000 0000000
Q ss_pred c-ccccCCcCCCCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 887 L-LELVDPSLGSNFS-----KKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 887 ~-~~~~d~~l~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
. .....+......+ ......+.+++.+||+.+|++||++.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 0 0000111000000 122456889999999999999999998873
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=311.55 Aligned_cols=248 Identities=26% Similarity=0.394 Sum_probs=196.0
Q ss_pred cCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCC-----hhhhHHHHHHHHHHHhcCCCCeeeeeeeEee--ccee
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS-----KQGNREFVNEIGMISALQHQNLVKLYGCCIE--GNQL 730 (1016)
Q Consensus 659 ~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~-----~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~ 730 (1016)
.+|+..+.||+|+||.||+|... +++.||+|.+.... ......+.+|++++++++||||+++++++.+ +...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 47889999999999999999864 58899999876432 2234568889999999999999999998875 3678
Q ss_pred EEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeecccccc
Q 001768 731 LLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAK 810 (1016)
Q Consensus 731 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~ 810 (1016)
+++|||+++++|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.++|+|||+++
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~ 154 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG----ALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence 99999999999999996543 588999999999999999999988 89999999999999999999999999987
Q ss_pred ccCCCCc--ceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcc
Q 001768 811 LDEDENT--HISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLL 888 (1016)
Q Consensus 811 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 888 (1016)
....... .......++..|+|||++.+..++.++|||||||++|||++|+.||.......... .. . .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~-----~~-~-----~ 223 (266)
T cd06651 155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIF-----KI-A-----T 223 (266)
T ss_pred ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHH-----HH-h-----c
Confidence 5432111 11123458889999999988889999999999999999999999997543222110 00 0 0
Q ss_pred cccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 001768 889 ELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAV 929 (1016)
Q Consensus 889 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 929 (1016)
....+ .++......+.+++ .||..+|++||+++||+
T Consensus 224 ~~~~~----~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil 259 (266)
T cd06651 224 QPTNP----QLPSHISEHARDFL-GCIFVEARHRPSAEELL 259 (266)
T ss_pred CCCCC----CCchhcCHHHHHHH-HHhcCChhhCcCHHHHh
Confidence 11112 22333344567777 68889999999999987
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=312.55 Aligned_cols=238 Identities=28% Similarity=0.455 Sum_probs=190.5
Q ss_pred CccccCCCeeEEEEEcCCCc-----------EEEEEEccCCChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEE
Q 001768 665 NKIGEGGFGPVYKGTLSDGA-----------VIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLV 733 (1016)
Q Consensus 665 ~~LG~G~~G~Vy~~~~~~~~-----------~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 733 (1016)
+.||+|+||.||+|.+.+.. .|++|.+...... ...+.+|+.++++++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46899999999999976432 5788877654433 6788999999999999999999999988 778999
Q ss_pred EeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCC-------ceeeecc
Q 001768 734 YEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDL-------NAKISDF 806 (1016)
Q Consensus 734 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~-------~~kL~DF 806 (1016)
|||+++++|.+++..... .+++..+..++.||+.||+|||++ +|+||||||+||+++.++ .+||+||
T Consensus 79 ~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df 152 (259)
T cd05037 79 EEYVKFGPLDVFLHREKN---NVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDP 152 (259)
T ss_pred EEcCCCCcHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCC
Confidence 999999999999976432 589999999999999999999998 999999999999999887 7999999
Q ss_pred ccccccCCCCcceeeecccCccccChhhhccC--CCCCccchhHHHHHHHHHHh-CCCCCCCCCchhhHhHHHHHHHHHH
Q 001768 807 GLAKLDEDENTHISTRIAGTVGYMAPEYAMRG--YLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWAYVLQE 883 (1016)
Q Consensus 807 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~ 883 (1016)
|++...... ....++..|+|||++.+. .++.++|||||||++|||++ |..|+......+..... ..
T Consensus 153 g~a~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~------~~ 221 (259)
T cd05037 153 GIPITVLSR-----EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFY------QD 221 (259)
T ss_pred Ccccccccc-----cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHH------hc
Confidence 999854331 223467789999998876 78999999999999999999 57777654322211100 00
Q ss_pred hCCcccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 001768 884 QGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933 (1016)
Q Consensus 884 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 933 (1016)
.. ..... ....+.+++.+||..+|.+|||+.++++.|+
T Consensus 222 -~~-------~~~~~----~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 222 -QH-------RLPMP----DCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred -CC-------CCCCC----CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00 00000 1157889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=315.62 Aligned_cols=256 Identities=27% Similarity=0.468 Sum_probs=205.2
Q ss_pred hcCccccCccccCCCeeEEEEEcC-CCc----EEEEEEccCCC-hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeE
Q 001768 658 TNNFDAANKIGEGGFGPVYKGTLS-DGA----VIAVKQLSSKS-KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLL 731 (1016)
Q Consensus 658 ~~~f~~~~~LG~G~~G~Vy~~~~~-~~~----~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 731 (1016)
..+|++.+.||+|+||.||+|.+. +|+ .||+|.+.... ......+.+|+.++++++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 356888999999999999999864 232 68999887554 3345678899999999999999999999987 7889
Q ss_pred EEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccc
Q 001768 732 LVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKL 811 (1016)
Q Consensus 732 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~ 811 (1016)
+||||+++|+|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||.++.
T Consensus 85 ~v~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 85 LITQLMPLGCLLDYVRNHKD---NIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (279)
T ss_pred EEEecCCCCcHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCccccc
Confidence 99999999999999976432 489999999999999999999998 999999999999999999999999999986
Q ss_pred cCCCCccee-eecccCccccChhhhccCCCCCccchhHHHHHHHHHHh-CCCCCCCCCchhhHhHHHHHHHHHHhCCccc
Q 001768 812 DEDENTHIS-TRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWAYVLQEQGNLLE 889 (1016)
Q Consensus 812 ~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 889 (1016)
......... ....++..|+|||.+....++.++|||||||++||+++ |+.||.....++....+ . ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~------~-~~~~-- 229 (279)
T cd05057 159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLL------E-KGER-- 229 (279)
T ss_pred ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH------h-CCCC--
Confidence 543322211 11224568999999988889999999999999999999 99999876544322111 1 1100
Q ss_pred ccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCc
Q 001768 890 LVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKT 936 (1016)
Q Consensus 890 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 936 (1016)
...+......+.+++.+||..+|++||++.++++.|+...
T Consensus 230 -------~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05057 230 -------LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMA 269 (279)
T ss_pred -------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 0111112346889999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=312.48 Aligned_cols=249 Identities=29% Similarity=0.422 Sum_probs=192.5
Q ss_pred CccccCCCeeEEEEEcC----CCcEEEEEEccCC-ChhhhHHHHHHHHHHHhcCCCCeeeeeeeEe-ecceeEEEEeecC
Q 001768 665 NKIGEGGFGPVYKGTLS----DGAVIAVKQLSSK-SKQGNREFVNEIGMISALQHQNLVKLYGCCI-EGNQLLLVYEYLE 738 (1016)
Q Consensus 665 ~~LG~G~~G~Vy~~~~~----~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~~lV~E~~~ 738 (1016)
+.||+|+||.||+|.+. +...||+|.+... .....+.+.+|+.+++.++||||+++++++. .++..++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999853 2457999998643 3344567889999999999999999999775 4556899999999
Q ss_pred CCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCCcc
Q 001768 739 NNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTH 818 (1016)
Q Consensus 739 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 818 (1016)
+++|.+++.... ..+++..+..++.|+++||+|||+. +++||||||+||++++++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 81 HGDLRNFIRSET---HNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 999999996543 2467888899999999999999998 9999999999999999999999999999754332111
Q ss_pred ---eeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhC-CCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCc
Q 001768 819 ---ISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSG-KSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPS 894 (1016)
Q Consensus 819 ---~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG-~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 894 (1016)
......++..|+|||.+.+..++.++|||||||++|||++| .+||......+.. . .... +. .+.
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~---~---~~~~-~~-----~~~ 222 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDIT---V---YLLQ-GR-----RLL 222 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH---H---HHhc-CC-----CCC
Confidence 11223457789999999888899999999999999999995 5555443322211 1 1111 00 011
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 001768 895 LGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGK 935 (1016)
Q Consensus 895 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 935 (1016)
. +...+..+.+++.+||+.+|++||++.++++.|+..
T Consensus 223 ~----~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~ 259 (262)
T cd05058 223 Q----PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259 (262)
T ss_pred C----CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 1 112234688999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=311.63 Aligned_cols=254 Identities=24% Similarity=0.406 Sum_probs=204.1
Q ss_pred CccccCccccCCCeeEEEEEcC-CCcEEEEEEccCC--ChhhhHHHHHHHHHHHhcCCCCeeeeeeeEee--cceeEEEE
Q 001768 660 NFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSK--SKQGNREFVNEIGMISALQHQNLVKLYGCCIE--GNQLLLVY 734 (1016)
Q Consensus 660 ~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~~lV~ 734 (1016)
+|++.+.||.|+||.||+|... +++.||+|.+... .....+.+.+|++++++++||||+++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4788999999999999999854 6789999998643 33445678899999999999999999998764 45689999
Q ss_pred eecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEeCCCCCceEEEccCCceeeecccccccc
Q 001768 735 EYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEES--RLKIVHRDIKATNVLLDKDLNAKISDFGLAKLD 812 (1016)
Q Consensus 735 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~--~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~ 812 (1016)
||+++++|.+++.........+++..++.++.|++.||+|||..+ ..+++|+||||+||+++.++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999999765433457999999999999999999999221 228999999999999999999999999999866
Q ss_pred CCCCcceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccC
Q 001768 813 EDENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVD 892 (1016)
Q Consensus 813 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 892 (1016)
...... .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||........... .....
T Consensus 161 ~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~-------~~~~~------ 226 (265)
T cd08217 161 GHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASK-------IKEGK------ 226 (265)
T ss_pred cCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHH-------HhcCC------
Confidence 543321 2334689999999999888899999999999999999999999986543221110 01111
Q ss_pred CcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 893 PSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 893 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
...++...+..+.+++.+|++.+|++||++.+|++
T Consensus 227 ---~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 227 ---FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred ---CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 11223334567899999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=310.37 Aligned_cols=251 Identities=24% Similarity=0.428 Sum_probs=201.8
Q ss_pred CccccCccccCCCeeEEEEEc-CCCcEEEEEEccCCC------hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEE
Q 001768 660 NFDAANKIGEGGFGPVYKGTL-SDGAVIAVKQLSSKS------KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLL 732 (1016)
Q Consensus 660 ~f~~~~~LG~G~~G~Vy~~~~-~~~~~vAvK~~~~~~------~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 732 (1016)
+|+..+.||+|++|.||+|.. .+++.||+|.+.... ....+.+.+|++++++++|+||+++++++.+++..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477889999999999999985 568999999986433 1234678899999999999999999999999999999
Q ss_pred EEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCC-ceeeeccccccc
Q 001768 733 VYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDL-NAKISDFGLAKL 811 (1016)
Q Consensus 733 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~-~~kL~DFGla~~ 811 (1016)
||||+++++|.+++.... ++++..+..++.|++.||+|||+. +++|+||||+||+++.++ .++|+|||.+..
T Consensus 81 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~ 153 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG----AFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAAR 153 (268)
T ss_pred EEeccCCCcHHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence 999999999999986532 588999999999999999999998 999999999999998776 599999999876
Q ss_pred cCCCCcc---eeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcc
Q 001768 812 DEDENTH---ISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLL 888 (1016)
Q Consensus 812 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 888 (1016)
....... ......|+..|+|||.+.+..++.++||||+||++|+|++|+.||............. ..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~---~~------- 223 (268)
T cd06630 154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIF---KI------- 223 (268)
T ss_pred cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHH---HH-------
Confidence 5433111 1223468889999999988888999999999999999999999996543322111110 00
Q ss_pred cccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 001768 889 ELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAV 929 (1016)
Q Consensus 889 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 929 (1016)
.........+......+.+++.+|+..+|++||++.+++
T Consensus 224 --~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll 262 (268)
T cd06630 224 --ASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELL 262 (268)
T ss_pred --hccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHh
Confidence 000111223344556789999999999999999999888
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=317.51 Aligned_cols=265 Identities=23% Similarity=0.384 Sum_probs=204.3
Q ss_pred cCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCC--hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEe
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS--KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYE 735 (1016)
Q Consensus 659 ~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 735 (1016)
++|++.+.||+|+||.||+|... +++.||+|.++... ......+.+|++++++++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 46899999999999999999975 57899999986532 3334678899999999999999999999999999999999
Q ss_pred ecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCC
Q 001768 736 YLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDE 815 (1016)
Q Consensus 736 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 815 (1016)
|++++.+..+.... ..+++.++..++.||+.||+|||+. +++||||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~ 153 (288)
T cd07833 81 YVERTLLELLEASP----GGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRAR 153 (288)
T ss_pred cCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence 99987776665432 2589999999999999999999998 9999999999999999999999999999866554
Q ss_pred CcceeeecccCccccChhhhccC-CCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHH---------HHHHhC
Q 001768 816 NTHISTRIAGTVGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAY---------VLQEQG 885 (1016)
Q Consensus 816 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~---------~~~~~~ 885 (1016)
.........++..|+|||++.+. .++.++||||||+++|+|++|++||......+......... ......
T Consensus 154 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07833 154 PASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNP 233 (288)
T ss_pred ccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCc
Confidence 33233345678899999999887 78999999999999999999999997654433221111000 000000
Q ss_pred Ccc--cccCCc----CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 886 NLL--ELVDPS----LGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 886 ~~~--~~~d~~----l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
... +..+.. ....++...+..+.+++.+||..+|++||+++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 000 000000 000122223567999999999999999999998874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=311.91 Aligned_cols=267 Identities=25% Similarity=0.371 Sum_probs=206.9
Q ss_pred cCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCCh-hhhHHHHHHHHHHHhcCCCCeeeeeeeEeec--ceeEEEE
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSK-QGNREFVNEIGMISALQHQNLVKLYGCCIEG--NQLLLVY 734 (1016)
Q Consensus 659 ~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~lV~ 734 (1016)
++|+..+.||.|++|.||+|... +++.+|+|.+..... .....+.+|++++++++||||+++++++.+. +.+++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46888999999999999999974 588999999875432 3456789999999999999999999998653 4789999
Q ss_pred eecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCC
Q 001768 735 EYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDED 814 (1016)
Q Consensus 735 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 814 (1016)
||+++++|.+++.........+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 99999999998765333334689999999999999999999998 999999999999999999999999999875433
Q ss_pred CCcceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCch--hhHhHHHHHHHHHHhCCcccccC
Q 001768 815 ENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKE--EFVYLLDWAYVLQEQGNLLELVD 892 (1016)
Q Consensus 815 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~d 892 (1016)
.. .....++..|+|||.+.+..++.++|||||||++|+|++|+.||.....+ .......+. .. ..... +.
T Consensus 158 ~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~-~~~~~-~~ 229 (287)
T cd06621 158 SL---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYI---VN-MPNPE-LK 229 (287)
T ss_pred cc---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHH---hc-CCchh-hc
Confidence 21 12345788999999998888999999999999999999999999755321 111111111 11 01001 11
Q ss_pred CcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCcCCcCccccCCC
Q 001768 893 PSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTAVQAPIIRRNS 947 (1016)
Q Consensus 893 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~p~~~~~~ 947 (1016)
.... ........+.+++.+||+.+|++|||+.|++ .+||+....
T Consensus 230 ~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil---------~~~~~~~~~ 273 (287)
T cd06621 230 DEPG--NGIKWSEEFKDFIKQCLEKDPTRRPTPWDML---------EHPWIKAQM 273 (287)
T ss_pred cCCC--CCCchHHHHHHHHHHHcCCCcccCCCHHHHH---------hCccccccc
Confidence 0000 0012345789999999999999999999888 467765443
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=315.83 Aligned_cols=259 Identities=29% Similarity=0.453 Sum_probs=203.0
Q ss_pred CHHHHHHHhcCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCChhhhHHHHHHHHHHHhc-CCCCeeeeeeeEee-
Q 001768 650 TLRQIKAATNNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSKQGNREFVNEIGMISAL-QHQNLVKLYGCCIE- 726 (1016)
Q Consensus 650 ~~~~l~~~~~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~- 726 (1016)
++.++....+.|++.+.||+|+||.||+|+.. +++.||+|.+.... .....+..|+.+++++ +||||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 45555667788999999999999999999964 68899999986543 2345688899999998 69999999999853
Q ss_pred -----cceeEEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCce
Q 001768 727 -----GNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNA 801 (1016)
Q Consensus 727 -----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ 801 (1016)
.+..++||||+++|+|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~ 160 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKG--NALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEV 160 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCE
Confidence 4678999999999999999965432 3588899999999999999999998 99999999999999999999
Q ss_pred eeeccccccccCCCCcceeeecccCccccChhhhc-----cCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHH
Q 001768 802 KISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAM-----RGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLD 876 (1016)
Q Consensus 802 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~ 876 (1016)
+|+|||++........ ......|++.|+|||.+. +..++.++|||||||++|||++|+.||....+.......
T Consensus 161 ~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~- 238 (282)
T cd06636 161 KLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLI- 238 (282)
T ss_pred EEeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhH-
Confidence 9999999875432211 123356889999999875 345788999999999999999999999654322211100
Q ss_pred HHHHHHHhCCcccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 877 WAYVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 877 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
.....+.. .....+..+.+++.+||+.||.+||++.|+++
T Consensus 239 -----------~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 239 -----------PRNPPPKL---KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred -----------hhCCCCCC---cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 00111111 11123457999999999999999999998873
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=318.51 Aligned_cols=264 Identities=24% Similarity=0.370 Sum_probs=200.4
Q ss_pred cCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCCh--hhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEe
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSK--QGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYE 735 (1016)
Q Consensus 659 ~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 735 (1016)
++|++.+.||+|+||.||+|.+. +++.||+|++..... ...+.+.+|+++++.++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46889999999999999999976 589999999865332 234568899999999999999999999999999999999
Q ss_pred ecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCC
Q 001768 736 YLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDE 815 (1016)
Q Consensus 736 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 815 (1016)
|+++++|.++..... .+++.++..++.|++.||+|||+. +++||||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07846 81 FVDHTVLDDLEKYPN----GLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 153 (286)
T ss_pred cCCccHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence 999999988765432 489999999999999999999998 8999999999999999999999999998765443
Q ss_pred CcceeeecccCccccChhhhcc-CCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHH-H-------HHHHhCC
Q 001768 816 NTHISTRIAGTVGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWA-Y-------VLQEQGN 886 (1016)
Q Consensus 816 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~-~-------~~~~~~~ 886 (1016)
.. ......++..|+|||++.+ ..++.++|||||||++|||++|++||......+........ . .......
T Consensus 154 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07846 154 GE-VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNP 232 (286)
T ss_pred cc-ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccch
Confidence 22 2233457889999999875 45788999999999999999999998654432211111000 0 0000000
Q ss_pred c-ccccCCcCCC-----CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 887 L-LELVDPSLGS-----NFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 887 ~-~~~~d~~l~~-----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
. .....+.... ...+..+..+.+++.+||+.+|++||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 0 0000000000 001123457899999999999999999998874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=320.59 Aligned_cols=252 Identities=24% Similarity=0.309 Sum_probs=201.3
Q ss_pred cCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCCh---hhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEE
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSK---QGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVY 734 (1016)
Q Consensus 659 ~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 734 (1016)
++|++.+.||+|++|.||+|... +++.||+|.+..... ...+.+.+|+++++.++||||+++++.+.+++..++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 46889999999999999999975 489999999875432 24457889999999999999999999999999999999
Q ss_pred eecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCC
Q 001768 735 EYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDED 814 (1016)
Q Consensus 735 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 814 (1016)
||+.+++|.+++.... ...+++..+..++.|+++||+|||+. +++||||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 81 DYCPGGELFRLLQRQP--GKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EecCCCCHHHHHHhCC--CCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 9999999999986543 23689999999999999999999998 999999999999999999999999999864432
Q ss_pred CCcc----------------------------eeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCC
Q 001768 815 ENTH----------------------------ISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYR 866 (1016)
Q Consensus 815 ~~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~ 866 (1016)
.... ......||..|+|||++.+..++.++||||||+++|+|++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 235 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS 235 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence 1110 111246788999999999888999999999999999999999999765
Q ss_pred CchhhHhHHHHHHHHHHhCCcccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 867 PKEEFVYLLDWAYVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 867 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
........ .. ............+..+.+++.+||+.||++||++...++
T Consensus 236 ~~~~~~~~-----~~----------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~ 284 (316)
T cd05574 236 NRDETFSN-----IL----------KKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAA 284 (316)
T ss_pred chHHHHHH-----Hh----------cCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHH
Confidence 44322110 00 000000001114567999999999999999999444333
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=320.87 Aligned_cols=198 Identities=25% Similarity=0.413 Sum_probs=161.1
Q ss_pred cCccccCCCeeEEEEEcC---CCcEEEEEEccCCChhhhHHHHHHHHHHHhcCCCCeeeeeeeEee--cceeEEEEeecC
Q 001768 664 ANKIGEGGFGPVYKGTLS---DGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIE--GNQLLLVYEYLE 738 (1016)
Q Consensus 664 ~~~LG~G~~G~Vy~~~~~---~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~~lV~E~~~ 738 (1016)
..+||+|+||.||+|+.. ++..||+|.+..... ...+.+|++++++++||||+++++++.. +...++||||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 368999999999999864 357899999865432 3467889999999999999999998854 567899999987
Q ss_pred CCcHHHHhccCc-----CcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEE----ccCCceeeeccccc
Q 001768 739 NNSLARALFGKE-----GQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLL----DKDLNAKISDFGLA 809 (1016)
Q Consensus 739 ~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl----~~~~~~kL~DFGla 809 (1016)
+ +|.+++.... .....+++..+..++.||+.||+|||+. +|+||||||+||++ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5 7777764321 1223589999999999999999999998 99999999999999 56678999999999
Q ss_pred cccCCCCcc--eeeecccCccccChhhhcc-CCCCCccchhHHHHHHHHHHhCCCCCCCCC
Q 001768 810 KLDEDENTH--ISTRIAGTVGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGKSNTNYRP 867 (1016)
Q Consensus 810 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~~~ 867 (1016)
+........ ......||+.|+|||++.+ ..++.++|||||||++|||+||++||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 865433221 1233568999999999876 457899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=317.90 Aligned_cols=247 Identities=26% Similarity=0.423 Sum_probs=200.3
Q ss_pred ccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEeecCC
Q 001768 661 FDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYLEN 739 (1016)
Q Consensus 661 f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 739 (1016)
|+....||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++||||+++++++..++..++||||+++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 344568999999999999864 6899999998765545556788999999999999999999999999999999999999
Q ss_pred CcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCCcce
Q 001768 740 NSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHI 819 (1016)
Q Consensus 740 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 819 (1016)
++|.+++... .+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++........ .
T Consensus 103 ~~L~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~ 173 (297)
T cd06659 103 GALTDIVSQT-----RLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-K 173 (297)
T ss_pred CCHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccc-c
Confidence 9999987442 489999999999999999999998 899999999999999999999999999875443321 1
Q ss_pred eeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCCCCC
Q 001768 820 STRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGSNF 899 (1016)
Q Consensus 820 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 899 (1016)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||......+..... .... .+.. ..
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~-------~~~~-----~~~~--~~ 239 (297)
T cd06659 174 RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL-------RDSP-----PPKL--KN 239 (297)
T ss_pred ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-------hccC-----CCCc--cc
Confidence 23356889999999998888999999999999999999999999765433322111 0000 0000 00
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 900 SKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 900 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
.......+.+++.+||+.+|++||+++++++
T Consensus 240 ~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~ 270 (297)
T cd06659 240 AHKISPVLRDFLERMLTREPQERATAQELLD 270 (297)
T ss_pred cCCCCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 1122346889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=309.75 Aligned_cols=249 Identities=24% Similarity=0.346 Sum_probs=197.6
Q ss_pred cCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCC-----hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeec--cee
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS-----KQGNREFVNEIGMISALQHQNLVKLYGCCIEG--NQL 730 (1016)
Q Consensus 659 ~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~-----~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~ 730 (1016)
++|++.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 57899999999999999999865 58999999875321 22345788899999999999999999998764 568
Q ss_pred EEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeecccccc
Q 001768 731 LLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAK 810 (1016)
Q Consensus 731 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~ 810 (1016)
++||||+++++|.+++.... .+++..+.+++.|++.||+|||+. +|+|+||||+||+++.++.++|+|||+++
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~ 154 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG----ALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASK 154 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccc
Confidence 89999999999999986442 578899999999999999999998 89999999999999999999999999987
Q ss_pred ccCCCCcc--eeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcc
Q 001768 811 LDEDENTH--ISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLL 888 (1016)
Q Consensus 811 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 888 (1016)
........ ......|+..|+|||.+.+..++.++|||||||++|||++|+.||.......... .. . .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~-----~~---~---~ 223 (265)
T cd06652 155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIF-----KI---A---T 223 (265)
T ss_pred ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHH-----HH---h---c
Confidence 54321111 1123458889999999988888999999999999999999999987543222110 00 0 0
Q ss_pred cccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 889 ELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 889 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
.. .....+......+.+++.+|+. +|++||+++|+++
T Consensus 224 ~~----~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 224 QP----TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred CC----CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 00 1122334455678889999985 9999999999884
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=308.23 Aligned_cols=249 Identities=25% Similarity=0.407 Sum_probs=203.3
Q ss_pred CccccCccccCCCeeEEEEEcC-CCcEEEEEEccCC--ChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEee
Q 001768 660 NFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSK--SKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEY 736 (1016)
Q Consensus 660 ~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 736 (1016)
+|++.+.||+|+||.||+++.. +++.||+|.+... ......++.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 5888999999999999999854 6899999998643 233456788999999999999999999999999999999999
Q ss_pred cCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCC
Q 001768 737 LENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDEN 816 (1016)
Q Consensus 737 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 816 (1016)
+++++|.+++..... ..+++.++..++.|++.|++|||+. +++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 81 CEGGDLYKKINAQRG--VLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred CCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 999999999865432 2578999999999999999999998 99999999999999999999999999997554322
Q ss_pred cceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCC
Q 001768 817 THISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLG 896 (1016)
Q Consensus 817 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 896 (1016)
. ......|++.|+|||++.++..+.++|||||||++|+|++|+.||......+..... ..+.. +
T Consensus 156 ~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~-------~~~~~-----~--- 219 (256)
T cd08218 156 E-LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKI-------IRGSY-----P--- 219 (256)
T ss_pred h-hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHH-------hcCCC-----C---
Confidence 1 122345788999999998888999999999999999999999998754433221100 01110 1
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 897 SNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 897 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
..+......+.+++.+||+.+|++||++.+|++
T Consensus 220 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 220 -PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred -CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 112233457899999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=310.14 Aligned_cols=247 Identities=29% Similarity=0.453 Sum_probs=201.2
Q ss_pred CccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCC-----hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEE
Q 001768 660 NFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS-----KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLV 733 (1016)
Q Consensus 660 ~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~-----~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 733 (1016)
+|+..+.||+|++|.||+|... +++.||+|.+.... .+..+.+.+|+++++.++||||+++++++..++..++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4677899999999999999976 78999999886533 23456788999999999999999999999999999999
Q ss_pred EeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccC
Q 001768 734 YEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDE 813 (1016)
Q Consensus 734 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~ 813 (1016)
|||+++++|.+++.... .+++..+..++.|++.||+|||+. +|+|+||+|+||+++.++.+||+|||.+....
T Consensus 81 ~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~ 153 (258)
T cd06632 81 LELVPGGSLAKLLKKYG----SFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVV 153 (258)
T ss_pred EEecCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 99999999999996542 588999999999999999999998 99999999999999999999999999987654
Q ss_pred CCCcceeeecccCccccChhhhccCC-CCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccC
Q 001768 814 DENTHISTRIAGTVGYMAPEYAMRGY-LTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVD 892 (1016)
Q Consensus 814 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 892 (1016)
... ......|+..|+|||.+.... ++.++|+|||||++|+|++|+.||.......... .+ ......
T Consensus 154 ~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~--~~----~~~~~~----- 220 (258)
T cd06632 154 EFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVF--KI----GRSKEL----- 220 (258)
T ss_pred ccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHH--HH----HhcccC-----
Confidence 332 223456889999999987666 8999999999999999999999997544222111 00 010111
Q ss_pred CcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 893 PSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 893 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
..++......+.+++.+||+.+|++||++.++++
T Consensus 221 ----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 221 ----PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred ----CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 1112223456889999999999999999999884
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=317.90 Aligned_cols=254 Identities=21% Similarity=0.309 Sum_probs=202.5
Q ss_pred cCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCC---hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEE
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS---KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVY 734 (1016)
Q Consensus 659 ~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 734 (1016)
++|++.+.||+|+||.||+++.. .++.||+|.+.... ......+.+|+++++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 47889999999999999999965 57899999987543 223457889999999999999999999999999999999
Q ss_pred eecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCC
Q 001768 735 EYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDED 814 (1016)
Q Consensus 735 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 814 (1016)
||+++++|.+++.... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||+++....
T Consensus 81 e~~~g~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~ 153 (305)
T cd05609 81 EYVEGGDCATLLKNIG----ALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM 153 (305)
T ss_pred ecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence 9999999999996543 589999999999999999999998 999999999999999999999999999863211
Q ss_pred CC--------------cceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHH
Q 001768 815 EN--------------THISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYV 880 (1016)
Q Consensus 815 ~~--------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~ 880 (1016)
.. ........++..|+|||++.+..++.++|||||||++|||++|+.||.....++.....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~----- 228 (305)
T cd05609 154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV----- 228 (305)
T ss_pred CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-----
Confidence 00 00111245788999999998888999999999999999999999999765443322111
Q ss_pred HHHhCCcccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 001768 881 LQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933 (1016)
Q Consensus 881 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 933 (1016)
... ....+.... ..+..+.+++.+||+.||++||++.++.+.|+
T Consensus 229 --~~~---~~~~~~~~~----~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~ 272 (305)
T cd05609 229 --ISD---DIEWPEGDE----ALPADAQDLISRLLRQNPLERLGTGGAFEVKQ 272 (305)
T ss_pred --Hhc---ccCCCCccc----cCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence 000 011111111 23446899999999999999999877776665
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=316.87 Aligned_cols=248 Identities=27% Similarity=0.453 Sum_probs=201.4
Q ss_pred CccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEeecC
Q 001768 660 NFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYLE 738 (1016)
Q Consensus 660 ~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 738 (1016)
.|.....||+|+||.||++... ++..||||.+........+.+.+|+.+++.++||||+++++.+..++..++||||++
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 102 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE 102 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence 3444578999999999999864 688999999876655566778999999999999999999999999999999999999
Q ss_pred CCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCCcc
Q 001768 739 NNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTH 818 (1016)
Q Consensus 739 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 818 (1016)
+++|.+++... .+++.++..++.||+.||+|||+. +|+||||||+||++++++.++|+|||++.........
T Consensus 103 ~~~L~~~~~~~-----~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~ 174 (292)
T cd06658 103 GGALTDIVTHT-----RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK 174 (292)
T ss_pred CCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhccccccc
Confidence 99999988432 488999999999999999999998 8999999999999999999999999998754332221
Q ss_pred eeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCCCC
Q 001768 819 ISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGSN 898 (1016)
Q Consensus 819 ~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 898 (1016)
.....|+..|+|||.+.+..++.++|||||||++|||++|+.||............ .....+....
T Consensus 175 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~------------~~~~~~~~~~- 240 (292)
T cd06658 175 -RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRI------------RDNLPPRVKD- 240 (292)
T ss_pred -CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------------HhcCCCcccc-
Confidence 23356889999999998888999999999999999999999999765443321111 0011111111
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 899 FSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 899 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
.......+.+++.+|+..||.+|||+.++++
T Consensus 241 -~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 271 (292)
T cd06658 241 -SHKVSSVLRGFLDLMLVREPSQRATAQELLQ 271 (292)
T ss_pred -ccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 1123346889999999999999999999885
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=314.22 Aligned_cols=243 Identities=26% Similarity=0.362 Sum_probs=200.4
Q ss_pred cCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCC---hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEE
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS---KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVY 734 (1016)
Q Consensus 659 ~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 734 (1016)
++|++.+.||+|+||.||++... +++.||+|.+.... ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47889999999999999999865 58999999986432 233467889999999999999999999999999999999
Q ss_pred eecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCC
Q 001768 735 EYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDED 814 (1016)
Q Consensus 735 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 814 (1016)
||+++++|.+++.... .+++..+..++.|++.||+|||+. +|+||||+|+||+++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~~----~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 153 (290)
T cd05580 81 EYVPGGELFSHLRKSG----RFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153 (290)
T ss_pred ecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence 9999999999996543 689999999999999999999998 999999999999999999999999999986544
Q ss_pred CCcceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCc
Q 001768 815 ENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPS 894 (1016)
Q Consensus 815 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 894 (1016)
. .....|++.|+|||.+.+...+.++||||||+++|+|++|+.||........... .. .. ...
T Consensus 154 ~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-----~~--~~------~~~ 216 (290)
T cd05580 154 R----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEK-----IL--EG------KVR 216 (290)
T ss_pred C----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-----Hh--cC------Ccc
Confidence 3 2335688999999999888889999999999999999999999976543221110 00 11 111
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHH
Q 001768 895 LGSNFSKKEAMTMLNIALLCTNPSPTLRP-----TMSSAV 929 (1016)
Q Consensus 895 l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl 929 (1016)
++......+.+++.+||..||.+|| +++|++
T Consensus 217 ----~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 217 ----FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK 252 (290)
T ss_pred ----CCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence 1222345788999999999999999 555554
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=308.60 Aligned_cols=256 Identities=30% Similarity=0.465 Sum_probs=205.7
Q ss_pred cCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCC-hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEee
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS-KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEY 736 (1016)
Q Consensus 659 ~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 736 (1016)
++|++.+.||.|+||.||+|... ++..+|+|++.... ......+.+|+++++.++|+||+++++.+..++..++||||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 47899999999999999999954 67899999986543 33567789999999999999999999999999999999999
Q ss_pred cCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCC
Q 001768 737 LENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDEN 816 (1016)
Q Consensus 737 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 816 (1016)
+++++|.+++..... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 81 LSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred cCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 999999999965432 13589999999999999999999998 99999999999999999999999999987554332
Q ss_pred cc---eeeecccCccccChhhhccC-CCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccC
Q 001768 817 TH---ISTRIAGTVGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVD 892 (1016)
Q Consensus 817 ~~---~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 892 (1016)
.. ......|+..|+|||++... ..+.++|||||||++|||++|+.||............ .. . ..
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~-----~~--~-----~~ 224 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLT-----LQ--N-----DP 224 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHH-----hc--C-----CC
Confidence 22 22335688999999998876 7899999999999999999999999765443211100 00 0 01
Q ss_pred CcCCCCC-CHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 893 PSLGSNF-SKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 893 ~~l~~~~-~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
+.+.... ....+..+.+++.+||+.||++||++.++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 225 PSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 1111111 1234467899999999999999999999884
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=311.45 Aligned_cols=251 Identities=23% Similarity=0.395 Sum_probs=202.6
Q ss_pred cCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCC-hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEee
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS-KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEY 736 (1016)
Q Consensus 659 ~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 736 (1016)
++|+..+.||+|++|.||++... +++.||+|.+.... ......+.+|++++++++||||+++++.+..++..++|+||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 46788899999999999999976 68999999987653 34456788999999999999999999999999999999999
Q ss_pred cCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeCCCCCceEEEccCCceeeeccccccccCCC
Q 001768 737 LENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHE-ESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDE 815 (1016)
Q Consensus 737 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~-~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 815 (1016)
+++++|.+++.... ..+++..+..++.|++.||+|||+ . +++||||||+||++++++.++|+|||.+......
T Consensus 81 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~ 154 (265)
T cd06605 81 MDGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS 154 (265)
T ss_pred cCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence 99999999996543 368999999999999999999999 6 9999999999999999999999999998754332
Q ss_pred CcceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcC
Q 001768 816 NTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSL 895 (1016)
Q Consensus 816 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 895 (1016)
... ...++..|+|||.+.+..++.++||||||+++|+|++|+.||........ ...+...... ....+.+
T Consensus 155 ~~~---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~------~~~~~~~ 224 (265)
T cd06605 155 LAK---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD-GIFELLQYIV------NEPPPRL 224 (265)
T ss_pred Hhh---cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc-cHHHHHHHHh------cCCCCCC
Confidence 211 25688899999999888999999999999999999999999865421100 0011110000 0011111
Q ss_pred CCCCCHH-HHHHHHHHHHHccCCCCCCCCCHHHHH
Q 001768 896 GSNFSKK-EAMTMLNIALLCTNPSPTLRPTMSSAV 929 (1016)
Q Consensus 896 ~~~~~~~-~~~~l~~li~~cl~~dP~~RPt~~evl 929 (1016)
+.. ....+.+++.+||..+|++|||+.+++
T Consensus 225 ----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll 255 (265)
T cd06605 225 ----PSGKFSPDFQDFVNLCLIKDPRERPSYKELL 255 (265)
T ss_pred ----ChhhcCHHHHHHHHHHcCCCchhCcCHHHHh
Confidence 111 455689999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=310.54 Aligned_cols=255 Identities=29% Similarity=0.428 Sum_probs=202.0
Q ss_pred HhcCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCChhhhHHHHHHHHHHHhc-CCCCeeeeeeeEeecc------
Q 001768 657 ATNNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSKQGNREFVNEIGMISAL-QHQNLVKLYGCCIEGN------ 728 (1016)
Q Consensus 657 ~~~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~------ 728 (1016)
.+++|++.+.||+|++|.||+|... +++.+|+|.+..... ..+.+.+|+++++++ +|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 5688999999999999999999975 578999999875543 346789999999999 7999999999997643
Q ss_pred eeEEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeecccc
Q 001768 729 QLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGL 808 (1016)
Q Consensus 729 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGl 808 (1016)
..++||||+++++|.+++.........+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCcc
Confidence 58999999999999999865442334689999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCcceeeecccCccccChhhhcc-----CCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHH
Q 001768 809 AKLDEDENTHISTRIAGTVGYMAPEYAMR-----GYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQE 883 (1016)
Q Consensus 809 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~ 883 (1016)
+........ ......|+..|+|||++.. ..++.++|||||||++|+|++|+.||........... ..
T Consensus 160 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~-------~~ 231 (275)
T cd06608 160 SAQLDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFK-------IP 231 (275)
T ss_pred ceecccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHH-------hh
Confidence 875443222 1233568899999998753 3467899999999999999999999965432221110 00
Q ss_pred hCCcccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 884 QGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 884 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
.. ..+.. ..+......+.+++.+||..||++|||+.++++
T Consensus 232 ~~-----~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 232 RN-----PPPTL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred cc-----CCCCC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 00 01111 112224557899999999999999999999884
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=309.89 Aligned_cols=253 Identities=28% Similarity=0.419 Sum_probs=198.7
Q ss_pred CccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCCh----------hhhHHHHHHHHHHHhcCCCCeeeeeeeEeecc
Q 001768 660 NFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSK----------QGNREFVNEIGMISALQHQNLVKLYGCCIEGN 728 (1016)
Q Consensus 660 ~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~~----------~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 728 (1016)
+|.+.+.||+|+||.||+|... +++.||+|.+..... ...+.+.+|+.+++.++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4677899999999999999854 688999998753211 11246788999999999999999999999999
Q ss_pred eeEEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeecccc
Q 001768 729 QLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGL 808 (1016)
Q Consensus 729 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGl 808 (1016)
..++||||+++++|.+++... ..+++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~ 154 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY----GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGI 154 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccc
Confidence 999999999999999999654 2689999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCcc-eeeecccCccccChhhhccCC--CCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhC
Q 001768 809 AKLDEDENTH-ISTRIAGTVGYMAPEYAMRGY--LTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQG 885 (1016)
Q Consensus 809 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 885 (1016)
++........ ......|+..|+|||.+.... ++.++||||||+++||+++|..||......+... + . ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~--~----~-~~~ 227 (272)
T cd06629 155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMF--K----L-GNK 227 (272)
T ss_pred cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHH--H----h-hcc
Confidence 9754432111 123346888999999987654 7899999999999999999999986433221110 0 0 001
Q ss_pred CcccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 886 NLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 886 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
... +..........+..+.+++.+||+.+|++||++++|++
T Consensus 228 ~~~----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 228 RSA----PPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred ccC----CcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 111 11111122234557899999999999999999999884
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=314.41 Aligned_cols=263 Identities=25% Similarity=0.363 Sum_probs=202.4
Q ss_pred CccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCC--hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEee
Q 001768 660 NFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS--KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEY 736 (1016)
Q Consensus 660 ~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 736 (1016)
+|++.+.||+|+||.||+|+.. +++.||+|++.... ......+.+|+.++++++||||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 5788999999999999999964 68999999987553 33356788999999999999999999999999999999999
Q ss_pred cCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCC
Q 001768 737 LENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDEN 816 (1016)
Q Consensus 737 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 816 (1016)
+ +++|.+++.... ..+++.+++.++.||++||+|||+. +++|+||||+||+++.++.++|+|||.+.......
T Consensus 81 ~-~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (286)
T cd07832 81 M-PSDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153 (286)
T ss_pred c-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence 9 999999986543 3689999999999999999999998 99999999999999999999999999998655433
Q ss_pred cceeeecccCccccChhhhccC-CCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHH----------HHHHHHHhC
Q 001768 817 THISTRIAGTVGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLD----------WAYVLQEQG 885 (1016)
Q Consensus 817 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~----------~~~~~~~~~ 885 (1016)
........|+..|+|||.+.+. .++.++||||+||++|||++|.+||............. |... ....
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 232 (286)
T cd07832 154 PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGL-TSLP 232 (286)
T ss_pred CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhc-cCcc
Confidence 2223345688999999988654 46899999999999999999988876544332211110 0000 0000
Q ss_pred CcccccCCcCCC----CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 886 NLLELVDPSLGS----NFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 886 ~~~~~~d~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
.......+.... .........+.+++.+|++.+|++||+++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 000000000000 001123467899999999999999999998884
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=308.79 Aligned_cols=251 Identities=31% Similarity=0.484 Sum_probs=202.0
Q ss_pred CccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCCh--hhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEee
Q 001768 660 NFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSK--QGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEY 736 (1016)
Q Consensus 660 ~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 736 (1016)
+|++.+.||+|+||.||+|... +++.||+|.+..... ...+.+.+|++++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 5788899999999999999864 689999999876543 3567899999999999999999999999999999999999
Q ss_pred cCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCC
Q 001768 737 LENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDEN 816 (1016)
Q Consensus 737 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 816 (1016)
+++++|.+++.... .+++..+..++.|++.||+|||+. +|+|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 81 CSGGTLEELLEHGR----ILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred CCCCcHHHHHhhcC----CCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence 99999999996542 578999999999999999999998 89999999999999999999999999998654433
Q ss_pred cceee---ecccCccccChhhhccCC---CCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccc
Q 001768 817 THIST---RIAGTVGYMAPEYAMRGY---LTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLEL 890 (1016)
Q Consensus 817 ~~~~~---~~~gt~~y~aPE~~~~~~---~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 890 (1016)
..... ...++..|+|||++.+.. .+.++||||||+++|||++|+.||.......... .... ..
T Consensus 154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~-----~~~~-~~----- 222 (264)
T cd06626 154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIM-----FHVG-AG----- 222 (264)
T ss_pred CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHH-----HHHh-cC-----
Confidence 22211 346788999999998765 8899999999999999999999997543221110 0000 00
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 891 VDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 891 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
..+.++.. ......+.+++.+||+.+|.+||++.+++.
T Consensus 223 ~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 223 HKPPIPDS--LQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCCCCCcc--cccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 11111111 112456789999999999999999998873
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=316.48 Aligned_cols=255 Identities=27% Similarity=0.471 Sum_probs=201.3
Q ss_pred hcCccccCccccCCCeeEEEEEcC-CCc----EEEEEEccCCC-hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeE
Q 001768 658 TNNFDAANKIGEGGFGPVYKGTLS-DGA----VIAVKQLSSKS-KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLL 731 (1016)
Q Consensus 658 ~~~f~~~~~LG~G~~G~Vy~~~~~-~~~----~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 731 (1016)
.++|+..+.||+|+||.||+|.+. ++. .||+|.+.... .....++.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 356788899999999999999864 343 57899886543 23345788999999999999999999998754 467
Q ss_pred EEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccc
Q 001768 732 LVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKL 811 (1016)
Q Consensus 732 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~ 811 (1016)
+++||+++|+|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 85 ~v~e~~~~g~l~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEHK---DNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (303)
T ss_pred eeehhcCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEcccccccc
Confidence 9999999999999986543 2588999999999999999999998 999999999999999999999999999986
Q ss_pred cCCCCcc-eeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHh-CCCCCCCCCchhhHhHHHHHHHHHHhCCccc
Q 001768 812 DEDENTH-ISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWAYVLQEQGNLLE 889 (1016)
Q Consensus 812 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 889 (1016)
....... ......++..|+|||.+.+..++.++|||||||++|||++ |+.||............ . ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~------~-~~~~-- 229 (303)
T cd05110 159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL------E-KGER-- 229 (303)
T ss_pred ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH------H-CCCC--
Confidence 5433221 1222345678999999988889999999999999999997 89998765433322111 1 1100
Q ss_pred ccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 001768 890 LVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGK 935 (1016)
Q Consensus 890 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 935 (1016)
. .. +......+.+++..||..+|++||++.++++.|+..
T Consensus 230 ~---~~----~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~ 268 (303)
T cd05110 230 L---PQ----PPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM 268 (303)
T ss_pred C---CC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0 00 111234688999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=313.17 Aligned_cols=260 Identities=24% Similarity=0.392 Sum_probs=198.7
Q ss_pred cCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCC-hhhhHHHHHHHHH-HHhcCCCCeeeeeeeEeecceeEEEEe
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS-KQGNREFVNEIGM-ISALQHQNLVKLYGCCIEGNQLLLVYE 735 (1016)
Q Consensus 659 ~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~-l~~l~HpnIv~l~~~~~~~~~~~lV~E 735 (1016)
++|++.+.||+|+||.||+|+.. +|+.||+|++.... ......+..|+.+ ++..+||||+++++++..++..++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 47899999999999999999965 68999999987543 2233455556654 666789999999999999999999999
Q ss_pred ecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCC
Q 001768 736 YLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDE 815 (1016)
Q Consensus 736 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 815 (1016)
|++ ++|.+++.........+++..++.++.||+.||+|||++. +++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 997 5888887654333357999999999999999999999852 7999999999999999999999999999765432
Q ss_pred CcceeeecccCccccChhhhcc----CCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCccccc
Q 001768 816 NTHISTRIAGTVGYMAPEYAMR----GYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELV 891 (1016)
Q Consensus 816 ~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 891 (1016)
. ......|+..|+|||.+.+ ..++.++|+|||||++|||++|+.||....... .... ... ...
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~---~~~-------~~~ 224 (283)
T cd06617 158 V--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF-QQLK---QVV-------EEP 224 (283)
T ss_pred c--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH-HHHH---HHH-------hcC
Confidence 1 1223468889999998864 346889999999999999999999986422110 0000 000 011
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCcCCcCccccCC
Q 001768 892 DPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTAVQAPIIRRN 946 (1016)
Q Consensus 892 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~p~~~~~ 946 (1016)
.+... ....+..+.+++.+||..+|++||++.+++ .+||+...
T Consensus 225 ~~~~~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il---------~~~~~~~~ 267 (283)
T cd06617 225 SPQLP---AEKFSPEFQDFVNKCLKKNYKERPNYPELL---------QHPFFELH 267 (283)
T ss_pred CCCCC---ccccCHHHHHHHHHHccCChhhCcCHHHHh---------cCchhhhc
Confidence 11111 112345689999999999999999999887 36776543
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=314.00 Aligned_cols=260 Identities=23% Similarity=0.340 Sum_probs=195.9
Q ss_pred CccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCC--hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEee
Q 001768 660 NFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS--KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEY 736 (1016)
Q Consensus 660 ~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 736 (1016)
+|++.+.||+|+||.||+|+.. +|+.||+|.+.... ......+.+|++++++++||||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4788899999999999999965 68999999986532 22235677899999999999999999999999999999999
Q ss_pred cCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCC
Q 001768 737 LENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDEN 816 (1016)
Q Consensus 737 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 816 (1016)
+++ +|.+++.... ..+++..++.++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 153 (284)
T cd07839 81 CDQ-DLKKYFDSCN---GDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 153 (284)
T ss_pred CCC-CHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence 975 7877775432 2589999999999999999999998 99999999999999999999999999997544322
Q ss_pred cceeeecccCccccChhhhccC-CCCCccchhHHHHHHHHHHhCCCCCCCCCch-hhHhHH----------HHHHHHHHh
Q 001768 817 THISTRIAGTVGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGKSNTNYRPKE-EFVYLL----------DWAYVLQEQ 884 (1016)
Q Consensus 817 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~P~~~~~~~-~~~~~~----------~~~~~~~~~ 884 (1016)
.. .....++..|+|||.+.+. .++.++|||||||++|||+||+.|+...... +....+ .|.... ..
T Consensus 154 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 231 (284)
T cd07839 154 RC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVS-KL 231 (284)
T ss_pred CC-cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhh-hc
Confidence 11 1234578899999998764 4689999999999999999999886433222 111100 000000 00
Q ss_pred CCcccccCCcCCC-----CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 885 GNLLELVDPSLGS-----NFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 885 ~~~~~~~d~~l~~-----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
..... .+.... ...+.....+.+++.+||+.||.+|||++++++
T Consensus 232 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 232 PDYKP--YPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred ccccc--cCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 00000 000000 011123457889999999999999999998874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=313.74 Aligned_cols=249 Identities=26% Similarity=0.439 Sum_probs=203.5
Q ss_pred cCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEeec
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYL 737 (1016)
Q Consensus 659 ~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 737 (1016)
++|++.+.||+|+||.||++... ++..||+|.+........+.+.+|+.+++.++||||+++++++..++..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 67889999999999999999854 67899999987655555677889999999999999999999999999999999999
Q ss_pred CCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCCc
Q 001768 738 ENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENT 817 (1016)
Q Consensus 738 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 817 (1016)
++++|.+++... .+++.++..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++........
T Consensus 99 ~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 99 AGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred CCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 999999998543 478999999999999999999998 999999999999999999999999998875443322
Q ss_pred ceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCCC
Q 001768 818 HISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGS 897 (1016)
Q Consensus 818 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 897 (1016)
. .....|++.|+|||.+.+..++.++|||||||++|++++|+.||............ .. .+....
T Consensus 171 ~-~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~------~~--------~~~~~~ 235 (293)
T cd06647 171 K-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI------AT--------NGTPEL 235 (293)
T ss_pred c-cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeeh------hc--------CCCCCC
Confidence 1 22346888999999998888899999999999999999999999754332211100 00 000001
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 898 NFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 898 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
..+......+.+++.+||+.+|++||++.+++.
T Consensus 236 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 268 (293)
T cd06647 236 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 268 (293)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 112234457889999999999999999998884
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=308.30 Aligned_cols=247 Identities=27% Similarity=0.474 Sum_probs=200.2
Q ss_pred CccccCccccCCCeeEEEEEc-CCCcEEEEEEccCC-ChhhhHHHHHHHHHHHhcC---CCCeeeeeeeEeecceeEEEE
Q 001768 660 NFDAANKIGEGGFGPVYKGTL-SDGAVIAVKQLSSK-SKQGNREFVNEIGMISALQ---HQNLVKLYGCCIEGNQLLLVY 734 (1016)
Q Consensus 660 ~f~~~~~LG~G~~G~Vy~~~~-~~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~---HpnIv~l~~~~~~~~~~~lV~ 734 (1016)
.|+..+.||+|+||.||+|.. .+++.||+|.+... ......++.+|++++++++ |||++++++++..+...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 477889999999999999996 46899999998654 3334567889999999997 999999999999999999999
Q ss_pred eecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCC
Q 001768 735 EYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDED 814 (1016)
Q Consensus 735 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 814 (1016)
||+++++|.+++... .+++..+..++.|++.||.|||+. +|+||||+|+||++++++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 82 EYAEGGSVRTLMKAG-----PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153 (277)
T ss_pred ecCCCCcHHHHHHcc-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence 999999999998543 589999999999999999999998 999999999999999999999999999976554
Q ss_pred CCcceeeecccCccccChhhhccC-CCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCC
Q 001768 815 ENTHISTRIAGTVGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDP 893 (1016)
Q Consensus 815 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 893 (1016)
.... .....|+..|+|||.+.++ .++.++|||||||++|+|++|+.||........... ......+
T Consensus 154 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~------------~~~~~~~ 220 (277)
T cd06917 154 NSSK-RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMML------------IPKSKPP 220 (277)
T ss_pred Cccc-cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhc------------cccCCCC
Confidence 3322 2334688999999988754 568899999999999999999999975433221110 0011111
Q ss_pred cCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 894 SLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 894 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
.+... .....+.+++.+||+.||++||++.++++
T Consensus 221 ~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 221 RLEDN---GYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 22111 13456889999999999999999999974
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=305.10 Aligned_cols=248 Identities=26% Similarity=0.409 Sum_probs=201.5
Q ss_pred CccccCccccCCCeeEEEEEcC-CCcEEEEEEccCC--ChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEee
Q 001768 660 NFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSK--SKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEY 736 (1016)
Q Consensus 660 ~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 736 (1016)
+|+..+.||+|+||.||++... +++.+|+|.+... .......+.+|++++++++|||++++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 5888999999999999999864 6889999998654 233456788999999999999999999999999999999999
Q ss_pred cCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCC-ceeeeccccccccCCC
Q 001768 737 LENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDL-NAKISDFGLAKLDEDE 815 (1016)
Q Consensus 737 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~-~~kL~DFGla~~~~~~ 815 (1016)
+++++|.+++..... ..+++..+.+++.|++.||+|||++ +++||||||+||++++++ .+||+|||.+......
T Consensus 81 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 81 APGGTLAEYIQKRCN--SLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred CCCCCHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 999999999966432 3589999999999999999999998 999999999999998654 6899999999865433
Q ss_pred CcceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcC
Q 001768 816 NTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSL 895 (1016)
Q Consensus 816 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 895 (1016)
.. .....|+..|+|||.+.+..++.++||||||+++|+|++|+.||............ ..... .
T Consensus 156 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~-------~~~~~-----~-- 219 (256)
T cd08220 156 SK--AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKI-------MSGTF-----A-- 219 (256)
T ss_pred cc--ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHH-------HhcCC-----C--
Confidence 21 22356888999999998888899999999999999999999999765433221100 00110 0
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 896 GSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 896 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
..+......+.+++.+||+.+|++|||+.|+++
T Consensus 220 --~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 220 --PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred --CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 111123446889999999999999999999884
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=307.56 Aligned_cols=251 Identities=27% Similarity=0.434 Sum_probs=206.6
Q ss_pred cCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCCh-hhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEee
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSK-QGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEY 736 (1016)
Q Consensus 659 ~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 736 (1016)
++|++.+.||+|++|.||+|+.. +++.||+|++..... .....+.+|++++++++|+||+++++++..++..++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 46889999999999999999976 589999999876544 4467899999999999999999999999999999999999
Q ss_pred cCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeCCCCCceEEEccCCceeeeccccccccCCC
Q 001768 737 LENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHE-ESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDE 815 (1016)
Q Consensus 737 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~-~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 815 (1016)
+++++|.+++... ..+++..+..++.|+++|++|||+ . +++||||+|+||+++.++.++|+|||.+......
T Consensus 81 ~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~ 153 (264)
T cd06623 81 MDGGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENT 153 (264)
T ss_pred cCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence 9999999999654 368999999999999999999999 7 9999999999999999999999999999865443
Q ss_pred CcceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcC
Q 001768 816 NTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSL 895 (1016)
Q Consensus 816 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 895 (1016)
... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||............... . ....+..
T Consensus 154 ~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~---~------~~~~~~~ 223 (264)
T cd06623 154 LDQ-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI---C------DGPPPSL 223 (264)
T ss_pred CCc-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHH---h------cCCCCCC
Confidence 322 12346788999999998888999999999999999999999999765421111111110 0 1111111
Q ss_pred CCCCCHH-HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 896 GSNFSKK-EAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 896 ~~~~~~~-~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
+.. .+..+.+++.+|++.+|++||++.++++
T Consensus 224 ----~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~ 255 (264)
T cd06623 224 ----PAEEFSPEFRDFISACLQKDPKKRPSAAELLQ 255 (264)
T ss_pred ----CcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 122 4457999999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=308.33 Aligned_cols=256 Identities=24% Similarity=0.390 Sum_probs=199.7
Q ss_pred ccccCccccCCCeeEEEEEcC----CCcEEEEEEccCC--ChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecc------
Q 001768 661 FDAANKIGEGGFGPVYKGTLS----DGAVIAVKQLSSK--SKQGNREFVNEIGMISALQHQNLVKLYGCCIEGN------ 728 (1016)
Q Consensus 661 f~~~~~LG~G~~G~Vy~~~~~----~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~------ 728 (1016)
|.+.+.||+|+||.||+|.+. .++.||+|++... .....+++.+|++++++++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567889999999999999853 3688999998754 2334567889999999999999999999886532
Q ss_pred eeEEEEeecCCCcHHHHhccCc--CcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeecc
Q 001768 729 QLLLVYEYLENNSLARALFGKE--GQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDF 806 (1016)
Q Consensus 729 ~~~lV~E~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DF 806 (1016)
..++++||+++|+|.+++.... .....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence 3478999999999998875322 1223588999999999999999999998 8999999999999999999999999
Q ss_pred ccccccCCCCcc-eeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHh-CCCCCCCCCchhhHhHHHHHHHHHHh
Q 001768 807 GLAKLDEDENTH-ISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWAYVLQEQ 884 (1016)
Q Consensus 807 Gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~ 884 (1016)
|.++........ ......+++.|++||.+....++.++|||||||++|||++ |++||......+..... ...
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~------~~~ 231 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYL------IKG 231 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHH------HcC
Confidence 999865432211 1122345678999999988889999999999999999999 88888755433221111 010
Q ss_pred CCcccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 001768 885 GNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGK 935 (1016)
Q Consensus 885 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 935 (1016)
.. ... +......+.+++.+||+.+|++||++.++++.|++.
T Consensus 232 ~~------~~~----~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 232 NR------LKQ----PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred Cc------CCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00 011 112345799999999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=314.84 Aligned_cols=267 Identities=24% Similarity=0.317 Sum_probs=197.7
Q ss_pred CccccCccccCCCeeEEEEEcC---CCcEEEEEEccCCC---hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeec--ceeE
Q 001768 660 NFDAANKIGEGGFGPVYKGTLS---DGAVIAVKQLSSKS---KQGNREFVNEIGMISALQHQNLVKLYGCCIEG--NQLL 731 (1016)
Q Consensus 660 ~f~~~~~LG~G~~G~Vy~~~~~---~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~ 731 (1016)
+|++.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+++++.++||||+++++++.+. +..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4788899999999999999965 47899999987633 33346678899999999999999999999988 8899
Q ss_pred EEEeecCCCcHHHHhccCcCc-CcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEcc----CCceeeecc
Q 001768 732 LVYEYLENNSLARALFGKEGQ-CLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDK----DLNAKISDF 806 (1016)
Q Consensus 732 lV~E~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~----~~~~kL~DF 806 (1016)
+||||+++ ++.+.+...... ...+++..++.++.|++.||+|||+. +|+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999976 666666433222 23689999999999999999999998 8999999999999999 899999999
Q ss_pred ccccccCCCCc--ceeeecccCccccChhhhccC-CCCCccchhHHHHHHHHHHhCCCCCCCCCchhh-------HhHHH
Q 001768 807 GLAKLDEDENT--HISTRIAGTVGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGKSNTNYRPKEEF-------VYLLD 876 (1016)
Q Consensus 807 Gla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~-------~~~~~ 876 (1016)
|++........ .......+++.|+|||++.+. .++.++|||||||++|||++|++||........ ..+..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99986543322 112335678899999988764 578999999999999999999999975443320 00000
Q ss_pred HHHHH-----------HHhCCcccccCCcCCCCCC-----H------HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 877 WAYVL-----------QEQGNLLELVDPSLGSNFS-----K------KEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 877 ~~~~~-----------~~~~~~~~~~d~~l~~~~~-----~------~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
..... ..........+......++ . .....+.+++.+|++.||++|||+.|+++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00000 0000000000000000111 0 22346889999999999999999999883
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=310.74 Aligned_cols=263 Identities=24% Similarity=0.363 Sum_probs=197.8
Q ss_pred CccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCC--hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEee
Q 001768 660 NFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS--KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEY 736 (1016)
Q Consensus 660 ~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 736 (1016)
+|+..+.||.|++|.||+|+.. +++.||||++.... ......+.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 5888999999999999999865 68999999986543 22335788999999999999999999999999999999999
Q ss_pred cCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCC
Q 001768 737 LENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDEN 816 (1016)
Q Consensus 737 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 816 (1016)
+. ++|.+++..... ..+++..+..++.|++.||+|||+. +++||||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 81 LH-QDLKKFMDASPL--SGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred cc-cCHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence 96 588888865432 3689999999999999999999998 89999999999999999999999999987544322
Q ss_pred cceeeecccCccccChhhhccC-CCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHh-HHHHHH------------HHH
Q 001768 817 THISTRIAGTVGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVY-LLDWAY------------VLQ 882 (1016)
Q Consensus 817 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~-~~~~~~------------~~~ 882 (1016)
.. .....++..|+|||.+.+. .++.++|||||||++|||+||+.||.......... ...... ...
T Consensus 155 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07860 155 RT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPD 233 (284)
T ss_pred cc-cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHH
Confidence 11 2223568899999988654 46889999999999999999999997654332111 110000 000
Q ss_pred HhCCcccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 883 EQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 883 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
....+........ ..........+.+++.+|++.||++|||+.++++
T Consensus 234 ~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 234 YKPSFPKWARQDF-SKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHhhcccccccCH-HHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 0000000000000 0001112346789999999999999999998883
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=306.94 Aligned_cols=246 Identities=31% Similarity=0.500 Sum_probs=200.9
Q ss_pred CccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCC-hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEeec
Q 001768 660 NFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS-KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYL 737 (1016)
Q Consensus 660 ~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 737 (1016)
-|+..+.||+|+||.||+|... +++.||+|.+.... ......+.+|++++++++||||+++++++..++..++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 3677899999999999999864 68899999876433 334467889999999999999999999999999999999999
Q ss_pred CCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCCc
Q 001768 738 ENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENT 817 (1016)
Q Consensus 738 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 817 (1016)
++++|.+++... .+++..+..++.|++.|+.|||+. +++|+||||+||+++.++.++|+|||++........
T Consensus 85 ~~~~l~~~i~~~-----~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06641 85 GGGSALDLLEPG-----PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence 999999998542 589999999999999999999998 999999999999999999999999999875543221
Q ss_pred ceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCCC
Q 001768 818 HISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGS 897 (1016)
Q Consensus 818 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 897 (1016)
......++..|+|||.+.+..++.++|||||||++|+|++|..||...........+ .... .+
T Consensus 157 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~-------~~~~-----~~---- 219 (277)
T cd06641 157 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLI-------PKNN-----PP---- 219 (277)
T ss_pred -hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHH-------hcCC-----CC----
Confidence 122346788999999998888899999999999999999999998754332211110 0000 11
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 898 NFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 898 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
......+..+.+++.+||+.+|.+||++.++++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 252 (277)
T cd06641 220 TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLK 252 (277)
T ss_pred CCCcccCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 122234456889999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=310.77 Aligned_cols=263 Identities=24% Similarity=0.302 Sum_probs=200.2
Q ss_pred CccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCChh-----hhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEE
Q 001768 660 NFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSKQ-----GNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLV 733 (1016)
Q Consensus 660 ~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 733 (1016)
+|++.+.||+|+||.||+|... +++.||+|.+...... ....+..|++++++++|+||+++++++.+++..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4788899999999999999965 6899999998754322 234577899999999999999999999999999999
Q ss_pred EeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccC
Q 001768 734 YEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDE 813 (1016)
Q Consensus 734 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~ 813 (1016)
|||+ +++|.+++.... ..+++..+..++.||++||+|||++ +|+||||||+||+++.++.++|+|||+++...
T Consensus 81 ~e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 153 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFG 153 (298)
T ss_pred Eccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence 9999 889999996543 2589999999999999999999998 99999999999999999999999999998654
Q ss_pred CCCcceeeecccCccccChhhhcc-CCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHH------HHHHhCC
Q 001768 814 DENTHISTRIAGTVGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAY------VLQEQGN 886 (1016)
Q Consensus 814 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~------~~~~~~~ 886 (1016)
..... .....+++.|+|||.+.+ ..++.++|||||||++|||++|.+||......+......... .......
T Consensus 154 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (298)
T cd07841 154 SPNRK-MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTS 232 (298)
T ss_pred CCCcc-ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccc
Confidence 43221 122356788999998864 467899999999999999999988876554432211110000 0000000
Q ss_pred cccccCCcCCCC-----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 887 LLELVDPSLGSN-----FSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 887 ~~~~~d~~l~~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
............ ........+.+++.+||+.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 233 LPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred ccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 001111000011 11223457899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=308.82 Aligned_cols=265 Identities=22% Similarity=0.309 Sum_probs=196.2
Q ss_pred HhcCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCChh-hhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEE
Q 001768 657 ATNNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSKQ-GNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVY 734 (1016)
Q Consensus 657 ~~~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 734 (1016)
++++|.+.+.||+|+||.||+|... +++.||+|.+...... ....+.+|+++++.++|+||+++++++..++..++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 4578999999999999999999854 6889999998654322 2346778999999999999999999999999999999
Q ss_pred eecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCC
Q 001768 735 EYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDED 814 (1016)
Q Consensus 735 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 814 (1016)
||++ +++.+.+.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 83 e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 155 (291)
T cd07870 83 EYMH-TDLAQYMIQHP---GGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSI 155 (291)
T ss_pred eccc-CCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCC
Confidence 9996 57766664432 2478888999999999999999998 899999999999999999999999999875433
Q ss_pred CCcceeeecccCccccChhhhccC-CCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHH----------HHH
Q 001768 815 ENTHISTRIAGTVGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYV----------LQE 883 (1016)
Q Consensus 815 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~----------~~~ 883 (1016)
.... .....+++.|+|||.+.+. .++.++|||||||++|||++|+.||.............|... ...
T Consensus 156 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07870 156 PSQT-YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSK 234 (291)
T ss_pred CCCC-CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhh
Confidence 2211 1233578899999998754 578899999999999999999999975443211111111000 000
Q ss_pred hCCcccccCCc-CCCCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 001768 884 QGNLLELVDPS-LGSNFS-----KKEAMTMLNIALLCTNPSPTLRPTMSSAV 929 (1016)
Q Consensus 884 ~~~~~~~~d~~-l~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl 929 (1016)
.....+...+. ...... ......+.+++.+|++.||++|||+.|++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l 286 (291)
T cd07870 235 LPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDAL 286 (291)
T ss_pred cccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHh
Confidence 00000000000 000000 01134678999999999999999999887
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=311.26 Aligned_cols=264 Identities=23% Similarity=0.336 Sum_probs=201.2
Q ss_pred cCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCChh--hhHHHHHHHHHHHhcCCCCeeeeeeeEeec--ceeEEE
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSKQ--GNREFVNEIGMISALQHQNLVKLYGCCIEG--NQLLLV 733 (1016)
Q Consensus 659 ~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~lV 733 (1016)
++|++.+.||+|+||.||+|... +++.+|+|.++..... ....+.+|++++++++||||+++++++..+ +..++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 57889999999999999999976 5889999998754322 234567899999999999999999999877 889999
Q ss_pred EeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccC
Q 001768 734 YEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDE 813 (1016)
Q Consensus 734 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~ 813 (1016)
|||+++ +|.+++.... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++....
T Consensus 85 ~e~~~~-~L~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 85 MEYVEH-DLKSLMETMK---QPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred ehhcCc-CHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 999975 8988886543 2589999999999999999999998 89999999999999999999999999998655
Q ss_pred CCCcceeeecccCccccChhhhccC-CCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHH----------HHHHH-
Q 001768 814 DENTHISTRIAGTVGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLD----------WAYVL- 881 (1016)
Q Consensus 814 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~----------~~~~~- 881 (1016)
..... .....+++.|+|||.+.+. .++.++|+||||+++|||++|++||...........+. |....
T Consensus 158 ~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (293)
T cd07843 158 SPLKP-YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE 236 (293)
T ss_pred CCccc-cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence 43221 1234578899999988754 46889999999999999999999998655433221110 10000
Q ss_pred ---HHhCCcccccCCcCCCCCCHH-HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 882 ---QEQGNLLELVDPSLGSNFSKK-EAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 882 ---~~~~~~~~~~d~~l~~~~~~~-~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
.......+.....+...++.. ....+.+++.+||+.+|++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 000001111111111222222 3556889999999999999999999884
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=311.43 Aligned_cols=265 Identities=23% Similarity=0.283 Sum_probs=195.9
Q ss_pred cCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCCh--hhhHHHHHHHHHHHhcC-CCCeeeeeeeEeecce-----
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSK--QGNREFVNEIGMISALQ-HQNLVKLYGCCIEGNQ----- 729 (1016)
Q Consensus 659 ~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~----- 729 (1016)
++|++.+.||+|+||.||+|+.. +++.||+|.+..... .....+.+|+.++++++ ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46889999999999999999965 689999998765432 23457888999999995 6999999999987655
Q ss_pred eEEEEeecCCCcHHHHhccCcCc-CcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEcc-CCceeeeccc
Q 001768 730 LLLVYEYLENNSLARALFGKEGQ-CLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDK-DLNAKISDFG 807 (1016)
Q Consensus 730 ~~lV~E~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~-~~~~kL~DFG 807 (1016)
.++||||+++ +|.+++...... ...+++..++.++.||+.||+|||+. +|+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999986 788888654322 34689999999999999999999998 9999999999999998 8899999999
Q ss_pred cccccCCCCcceeeecccCccccChhhhcc-CCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHh-HHHHHHHHHHhC
Q 001768 808 LAKLDEDENTHISTRIAGTVGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVY-LLDWAYVLQEQG 885 (1016)
Q Consensus 808 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~-~~~~~~~~~~~~ 885 (1016)
+++....... ......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||.......... ....... ....
T Consensus 157 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~-~~~~ 234 (295)
T cd07837 157 LGRAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGT-PTEQ 234 (295)
T ss_pred cceecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCC-CChh
Confidence 9875432211 1122356788999998865 457899999999999999999999997644322111 1000000 0000
Q ss_pred Ccccc---cC----CcCC----CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 001768 886 NLLEL---VD----PSLG----SNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAV 929 (1016)
Q Consensus 886 ~~~~~---~d----~~l~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 929 (1016)
.+... .+ +... ....+.....+.+++.+||+.||++||++.|++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil 289 (295)
T cd07837 235 VWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAAL 289 (295)
T ss_pred hCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHh
Confidence 00000 00 0000 000112345688999999999999999999887
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=311.01 Aligned_cols=263 Identities=22% Similarity=0.352 Sum_probs=196.3
Q ss_pred cCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCChh-hhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEee
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSKQ-GNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEY 736 (1016)
Q Consensus 659 ~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 736 (1016)
++|++.+.||+|++|.||+|... +++.||+|.+...... ....+.+|++++++++||||+++++++.+++..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 67899999999999999999965 6899999998654322 234567899999999999999999999999999999999
Q ss_pred cCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCC
Q 001768 737 LENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDEN 816 (1016)
Q Consensus 737 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 816 (1016)
+++ +|.+++.... ..+++..+..++.|+++||.|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 85 ~~~-~L~~~~~~~~---~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 85 LDT-DLKQYMDDCG---GGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPS 157 (291)
T ss_pred CCC-CHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence 985 8999886543 2589999999999999999999998 99999999999999999999999999987433221
Q ss_pred cceeeecccCccccChhhhcc-CCCCCccchhHHHHHHHHHHhCCCCCCCCCch-hhHhHHH----------HHHHHHHh
Q 001768 817 THISTRIAGTVGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGKSNTNYRPKE-EFVYLLD----------WAYVLQEQ 884 (1016)
Q Consensus 817 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~-~~~~~~~----------~~~~~~~~ 884 (1016)
. ......++..|+|||.+.+ ..++.++||||+||++|||++|+.||...... +...... |.... ..
T Consensus 158 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 235 (291)
T cd07844 158 K-TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVS-SN 235 (291)
T ss_pred c-cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhh-hc
Confidence 1 1122346788999998875 45789999999999999999999999754421 1111100 00000 00
Q ss_pred CCccccc-----CCcCCCCCC-HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 885 GNLLELV-----DPSLGSNFS-KKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 885 ~~~~~~~-----d~~l~~~~~-~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
....... ...+....+ ......+.+++.+|++.+|++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred cccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0000000 000000000 001146789999999999999999998873
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=307.80 Aligned_cols=247 Identities=28% Similarity=0.441 Sum_probs=200.6
Q ss_pred ccccCccccCCCeeEEEEEc-CCCcEEEEEEccCCChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEeecCC
Q 001768 661 FDAANKIGEGGFGPVYKGTL-SDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYLEN 739 (1016)
Q Consensus 661 f~~~~~LG~G~~G~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 739 (1016)
|...+.||+|++|.||++.. .+++.||+|++........+.+.+|+.+++.++||||+++++++..++..++|+||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 44567999999999999985 46889999998765555566788999999999999999999999999999999999999
Q ss_pred CcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCCcce
Q 001768 740 NSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHI 819 (1016)
Q Consensus 740 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 819 (1016)
++|.+++... .+++..+..++.|++.||+|||+. +|+||||+|+||+++.++.++|+|||.+........ .
T Consensus 101 ~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~ 171 (285)
T cd06648 101 GALTDIVTHT-----RMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-R 171 (285)
T ss_pred CCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-c
Confidence 9999998652 589999999999999999999998 999999999999999999999999998875433221 1
Q ss_pred eeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCCCCC
Q 001768 820 STRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGSNF 899 (1016)
Q Consensus 820 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 899 (1016)
.....|++.|+|||.+.+..++.++|||||||++|||++|+.||............ .. . ..+... .
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~------~~-~-----~~~~~~--~ 237 (285)
T cd06648 172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRI------RD-N-----LPPKLK--N 237 (285)
T ss_pred cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHH------Hh-c-----CCCCCc--c
Confidence 22346889999999998888999999999999999999999998754432221110 00 0 011111 1
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 900 SKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 900 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
....+..+.+++.+||+.+|++||++.++++
T Consensus 238 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 238 LHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred cccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 1123457899999999999999999998883
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=323.01 Aligned_cols=254 Identities=28% Similarity=0.428 Sum_probs=212.2
Q ss_pred ccccCccccCCCeeEEEEEc-CCC----cEEEEEEccCC-ChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEE
Q 001768 661 FDAANKIGEGGFGPVYKGTL-SDG----AVIAVKQLSSK-SKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVY 734 (1016)
Q Consensus 661 f~~~~~LG~G~~G~Vy~~~~-~~~----~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 734 (1016)
....++||+|+||+||+|.| ..| -+||+|++... ..+...++.+|+-+|.+++|||+++++|+|.... ..||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 34568999999999999985 333 47899988654 4556788999999999999999999999998776 88999
Q ss_pred eecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCC
Q 001768 735 EYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDED 814 (1016)
Q Consensus 735 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 814 (1016)
+||+.|+|.++++..++ ++-.+..+.|..|||+||.|||++ ++|||||-++||||.+-..+|+.|||+|+....
T Consensus 777 q~mP~G~LlDyvr~hr~---~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~ 850 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREHRD---NIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAP 850 (1177)
T ss_pred HhcccchHHHHHHHhhc---cccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence 99999999999987654 588899999999999999999998 999999999999999999999999999998766
Q ss_pred CCcceeee-cccCccccChhhhccCCCCCccchhHHHHHHHHHHh-CCCCCCCCCchhhHhHHHHHHHHHHhCCcccccC
Q 001768 815 ENTHISTR-IAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVD 892 (1016)
Q Consensus 815 ~~~~~~~~-~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 892 (1016)
+....... ..-.+.|||-|.+....++.++|||||||++||++| |..|++..+.+++..+.+..
T Consensus 851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~g-------------- 916 (1177)
T KOG1025|consen 851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKG-------------- 916 (1177)
T ss_pred ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcc--------------
Confidence 55443322 233567999999999999999999999999999999 99999988877765544211
Q ss_pred CcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCcC
Q 001768 893 PSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTA 937 (1016)
Q Consensus 893 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 937 (1016)
.+-..++.+..++..++.+||..|++.||+++++.+.+.....
T Consensus 917 --eRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 917 --ERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred --ccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 1112234466678999999999999999999999888765443
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=307.00 Aligned_cols=253 Identities=28% Similarity=0.500 Sum_probs=206.6
Q ss_pred HHhcCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEE
Q 001768 656 AATNNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVY 734 (1016)
Q Consensus 656 ~~~~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 734 (1016)
..++.|+..+.||+|++|.||+|..+ +++.||+|++..... ....+.+|+++++.++|+|++++++++..++..++|+
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 35667888999999999999999976 688999999876544 4567889999999999999999999999999999999
Q ss_pred eecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCC
Q 001768 735 EYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDED 814 (1016)
Q Consensus 735 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 814 (1016)
||+++++|.+++.... ..+++..+..++.|++.||+|||+. +|+|+||+|+||+++.++.++|+|||.+.....
T Consensus 95 e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 168 (286)
T cd06614 95 EYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTK 168 (286)
T ss_pred eccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhcc
Confidence 9999999999997643 3699999999999999999999998 999999999999999999999999999865433
Q ss_pred CCcceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCc
Q 001768 815 ENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPS 894 (1016)
Q Consensus 815 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 894 (1016)
... ......++..|+|||.+.+..++.++|||||||++|+|++|+.||............ .......
T Consensus 169 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~-------~~~~~~~----- 235 (286)
T cd06614 169 EKS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLI-------TTKGIPP----- 235 (286)
T ss_pred chh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-------HhcCCCC-----
Confidence 221 122345788999999998888999999999999999999999998755443221110 0111111
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 895 LGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 895 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
. ......+..+.+++.+||+.+|.+||++.++++
T Consensus 236 ~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 236 L--KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred C--cchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 0 011123457899999999999999999999884
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=319.84 Aligned_cols=265 Identities=23% Similarity=0.357 Sum_probs=196.5
Q ss_pred hcCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCC-hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeec-----cee
Q 001768 658 TNNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS-KQGNREFVNEIGMISALQHQNLVKLYGCCIEG-----NQL 730 (1016)
Q Consensus 658 ~~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-----~~~ 730 (1016)
+++|++.+.||+|+||.||+|+.. +++.||+|.+.... ......+.+|+.++++++||||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 578999999999999999999854 68999999986432 23445678899999999999999999987654 358
Q ss_pred EEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeecccccc
Q 001768 731 LLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAK 810 (1016)
Q Consensus 731 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~ 810 (1016)
++||||+++ +|.+++... .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 84 ~lv~e~~~~-~l~~~~~~~-----~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~ 154 (336)
T cd07849 84 YIVQELMET-DLYKLIKTQ-----HLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLAR 154 (336)
T ss_pred EEEehhccc-CHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECccccee
Confidence 999999975 788777433 589999999999999999999998 99999999999999999999999999987
Q ss_pred ccCCCCcc--eeeecccCccccChhhhcc-CCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHH----------H
Q 001768 811 LDEDENTH--ISTRIAGTVGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLD----------W 877 (1016)
Q Consensus 811 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~----------~ 877 (1016)
........ ......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||............. +
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 234 (336)
T cd07849 155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDL 234 (336)
T ss_pred eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence 54332211 1123568899999998754 468899999999999999999999997544322111000 0
Q ss_pred HHHHH-HhCCcccccCCcCCCC---CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001768 878 AYVLQ-EQGNLLELVDPSLGSN---FSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSM 931 (1016)
Q Consensus 878 ~~~~~-~~~~~~~~~d~~l~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 931 (1016)
..... ................ ........+.+++.+||+.||++|||+.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000 0000000000000000 001124568899999999999999999988853
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=333.96 Aligned_cols=278 Identities=18% Similarity=0.248 Sum_probs=194.1
Q ss_pred HHhcCccccCccccCCCeeEEEEEcCC--CcEEEEEE--------------cc---CCChhhhHHHHHHHHHHHhcCCCC
Q 001768 656 AATNNFDAANKIGEGGFGPVYKGTLSD--GAVIAVKQ--------------LS---SKSKQGNREFVNEIGMISALQHQN 716 (1016)
Q Consensus 656 ~~~~~f~~~~~LG~G~~G~Vy~~~~~~--~~~vAvK~--------------~~---~~~~~~~~~~~~E~~~l~~l~Hpn 716 (1016)
...++|++++.||+|+||+||++..+. +..+++|. +. .........+.+|++++++++|||
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence 345789999999999999999987532 22222221 10 011223456889999999999999
Q ss_pred eeeeeeeEeecceeEEEEeecCCCcHHHHhccCcC-cCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEE
Q 001768 717 LVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEG-QCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLL 795 (1016)
Q Consensus 717 Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl 795 (1016)
|+++++++.+.+..++|+|++. ++|.+++..... ........++..|+.||+.||+|||++ +||||||||+|||+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEE
Confidence 9999999999999999999985 467776644321 112234667889999999999999998 99999999999999
Q ss_pred ccCCceeeeccccccccCCCCcceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCC-CCCCCchhhHhH
Q 001768 796 DKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSN-TNYRPKEEFVYL 874 (1016)
Q Consensus 796 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P-~~~~~~~~~~~~ 874 (1016)
+.++.+||+|||+++..............||..|+|||++.+..++.++|||||||++|||++|+.+ +..........+
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~ 380 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL 380 (501)
T ss_pred CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence 9999999999999986654433333446799999999999988999999999999999999998754 432221111111
Q ss_pred HHHHHHHH-HhCCc-------ccccCC----cCCCCCCH-----HHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCcC
Q 001768 875 LDWAYVLQ-EQGNL-------LELVDP----SLGSNFSK-----KEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTA 937 (1016)
Q Consensus 875 ~~~~~~~~-~~~~~-------~~~~d~----~l~~~~~~-----~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 937 (1016)
........ ....+ .+.++. .....++. .....+.+++.+||+.||++|||+.|++
T Consensus 381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL-------- 452 (501)
T PHA03210 381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELL-------- 452 (501)
T ss_pred HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHh--------
Confidence 11100000 00000 000000 00000000 1123567889999999999999999987
Q ss_pred CcCccccCC
Q 001768 938 VQAPIIRRN 946 (1016)
Q Consensus 938 ~~~p~~~~~ 946 (1016)
.+||+...
T Consensus 453 -~hp~f~~~ 460 (501)
T PHA03210 453 -ALPLFSAE 460 (501)
T ss_pred -hChhhhcC
Confidence 47777553
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=308.41 Aligned_cols=259 Identities=27% Similarity=0.413 Sum_probs=198.1
Q ss_pred CccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCC-hhhhHHHHHHHHHHHhcC-CCCeeeeeeeEeecceeEEEEee
Q 001768 660 NFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS-KQGNREFVNEIGMISALQ-HQNLVKLYGCCIEGNQLLLVYEY 736 (1016)
Q Consensus 660 ~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~E~ 736 (1016)
+|+..+.||+|+||.||++... +++.||+|.+.... ......+.+|+.++.++. ||||+++++++..++..+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 5566789999999999999864 58999999987543 334567889999999996 99999999999999999999999
Q ss_pred cCCCcHHHHh---ccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccC
Q 001768 737 LENNSLARAL---FGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDE 813 (1016)
Q Consensus 737 ~~~gsL~~~l---~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~ 813 (1016)
++. ++.++. .... ...+++..+..++.|++.||+|||+.. +|+||||||+||+++.++.++|+|||+++...
T Consensus 85 ~~~-~l~~l~~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 85 MDI-SLDKFYKYVYEVL--KSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred ccC-CHHHHHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 864 554433 2221 236899999999999999999999742 89999999999999999999999999997543
Q ss_pred CCCcceeeecccCccccChhhhccC---CCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccc
Q 001768 814 DENTHISTRIAGTVGYMAPEYAMRG---YLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLEL 890 (1016)
Q Consensus 814 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 890 (1016)
.... .....|+..|+|||++.+. .++.++|||||||++|||++|+.||...... .... ......
T Consensus 160 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~----------~~~~~~ 226 (288)
T cd06616 160 DSIA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSV-FDQL----------TQVVKG 226 (288)
T ss_pred cCCc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchH-HHHH----------hhhcCC
Confidence 3221 1234688999999998765 6889999999999999999999998643310 0000 000111
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCcCCcCccccC
Q 001768 891 VDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTAVQAPIIRR 945 (1016)
Q Consensus 891 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~p~~~~ 945 (1016)
..+.+........+..+.+++.+||+.+|++|||+.+|+ .+||++.
T Consensus 227 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~---------~~~~~~~ 272 (288)
T cd06616 227 DPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELL---------EHPFIKD 272 (288)
T ss_pred CCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHh---------cChhhhc
Confidence 112222222233455799999999999999999999888 4666654
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=298.16 Aligned_cols=249 Identities=32% Similarity=0.526 Sum_probs=205.7
Q ss_pred CccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEeecC
Q 001768 660 NFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYLE 738 (1016)
Q Consensus 660 ~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 738 (1016)
+|+..+.||+|++|.||++... +++.+++|++..........+.+|+++++.++|||++++++++..++..++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4778899999999999999975 688999999987665566789999999999999999999999999999999999999
Q ss_pred CCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCCcc
Q 001768 739 NNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTH 818 (1016)
Q Consensus 739 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 818 (1016)
+++|.+++.... ..+++..+..++.|++.||+|||+. +++||||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 153 (253)
T cd05122 81 GGSLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA- 153 (253)
T ss_pred CCcHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence 999999986643 3689999999999999999999997 999999999999999999999999999976554332
Q ss_pred eeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCCCC
Q 001768 819 ISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGSN 898 (1016)
Q Consensus 819 ~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 898 (1016)
.....++..|+|||.+.+...+.++||||||+++|+|++|+.||............ ..........
T Consensus 154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~-------~~~~~~~~~~------ 219 (253)
T cd05122 154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKI-------ATNGPPGLRN------ 219 (253)
T ss_pred -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHH-------HhcCCCCcCc------
Confidence 23456889999999998888899999999999999999999998755332211110 0111111111
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 899 FSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 899 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
.......+.+++.+||+.||++|||+.++++
T Consensus 220 -~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 220 -PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred -ccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1112457899999999999999999999884
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=305.29 Aligned_cols=247 Identities=26% Similarity=0.356 Sum_probs=202.5
Q ss_pred CccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCC---hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEe
Q 001768 660 NFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS---KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYE 735 (1016)
Q Consensus 660 ~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 735 (1016)
+|++.+.||+|+||.||+|+.. +++.||+|.+.... ....+.+.+|++++++++||||+++++++.++...++|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5888999999999999999975 58999999987542 2345678999999999999999999999999999999999
Q ss_pred ecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCC
Q 001768 736 YLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDE 815 (1016)
Q Consensus 736 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 815 (1016)
|+++++|.+++... ..+++..+..++.|+++||.|||+. +++|+||+|+||++++++.++|+|||.+......
T Consensus 81 ~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 81 LLLGGDLRYHLSQK----VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred CCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 99999999999654 2689999999999999999999998 8999999999999999999999999998765443
Q ss_pred CcceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcC
Q 001768 816 NTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSL 895 (1016)
Q Consensus 816 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 895 (1016)
. ......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||............ ..... ..
T Consensus 154 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~------~~~~~----~~--- 218 (258)
T cd05578 154 T--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIR------AKQET----AD--- 218 (258)
T ss_pred c--cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHH------HHhcc----cc---
Confidence 2 123356888999999998888999999999999999999999999865542111111 00000 01
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCH--HHHH
Q 001768 896 GSNFSKKEAMTMLNIALLCTNPSPTLRPTM--SSAV 929 (1016)
Q Consensus 896 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~--~evl 929 (1016)
...+...+..+.+++.+||+.||.+||++ +|++
T Consensus 219 -~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 219 -VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred -ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 11222334678999999999999999999 5544
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=301.50 Aligned_cols=249 Identities=27% Similarity=0.436 Sum_probs=206.0
Q ss_pred CccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCC--hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEee
Q 001768 660 NFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS--KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEY 736 (1016)
Q Consensus 660 ~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 736 (1016)
+|++.+.||+|+||.||+++.. +++.+|+|.+.... ......+.+|+++++.++||||+++++++.++...++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 5788999999999999999854 67899999987532 33456778899999999999999999999999999999999
Q ss_pred cCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCC
Q 001768 737 LENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDEN 816 (1016)
Q Consensus 737 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 816 (1016)
+++++|.+++.........+++..++.++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 999999999876443335689999999999999999999998 9999999999999999999999999999865543
Q ss_pred cceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCC
Q 001768 817 THISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLG 896 (1016)
Q Consensus 817 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 896 (1016)
......+++.|+|||.+.+..++.++|+||||+++|||++|+.||.....++..... .... .
T Consensus 157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~-------~~~~---------~ 218 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKV-------QRGK---------Y 218 (256)
T ss_pred --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-------hcCC---------C
Confidence 122345788999999999888999999999999999999999999765543322111 1111 1
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 897 SNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 897 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
...+......+.+++.+|++.+|++||++.++++
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 219 PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 1122344567999999999999999999999884
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=302.49 Aligned_cols=249 Identities=25% Similarity=0.420 Sum_probs=201.0
Q ss_pred CccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCC--hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEee
Q 001768 660 NFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS--KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEY 736 (1016)
Q Consensus 660 ~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 736 (1016)
+|++.+.||+|+||.||+|... +|..||+|.+.... ....+.+.+|+++++.++|+||+++++.+..++..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 5788999999999999999975 57899999986532 23345788999999999999999999999999999999999
Q ss_pred cCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCC-ceeeeccccccccCCC
Q 001768 737 LENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDL-NAKISDFGLAKLDEDE 815 (1016)
Q Consensus 737 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~-~~kL~DFGla~~~~~~ 815 (1016)
+++++|.+++..... ..+++..+..++.|+++||+|||+. +++|+||||+||++++++ .+||+|||.+......
T Consensus 81 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 81 CDGGDLMKRINRQRG--VLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred CCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 999999999965432 3589999999999999999999998 899999999999999886 4699999999765433
Q ss_pred CcceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcC
Q 001768 816 NTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSL 895 (1016)
Q Consensus 816 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 895 (1016)
.. ......|++.|+|||+..+..++.++|||||||++|||++|+.||......+... ... ... ..
T Consensus 156 ~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~------~~~-~~~----~~--- 220 (257)
T cd08225 156 ME-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVL------KIC-QGY----FA--- 220 (257)
T ss_pred cc-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHH------HHh-ccc----CC---
Confidence 22 2223468899999999988889999999999999999999999987543322111 000 111 11
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 896 GSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 896 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
.........+.+++.+|+..+|++|||+.++++
T Consensus 221 --~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 221 --PISPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred --CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 111123346899999999999999999999984
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=310.18 Aligned_cols=245 Identities=30% Similarity=0.462 Sum_probs=196.8
Q ss_pred cCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCC---hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEE
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS---KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVY 734 (1016)
Q Consensus 659 ~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 734 (1016)
+.|+..+.||+|+||.||+|+.. +++.||+|.+.... .....++.+|+++++.++||||+++++++.+++..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45888899999999999999865 68999999886432 233457889999999999999999999999999999999
Q ss_pred eecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCC
Q 001768 735 EYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDED 814 (1016)
Q Consensus 735 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 814 (1016)
||++ |++.+.+.... ..+++..+..++.|++.||.|||+. +|+||||+|+||++++++.++|+|||++.....
T Consensus 95 e~~~-g~l~~~~~~~~---~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 95 EYCL-GSASDILEVHK---KPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred HhhC-CCHHHHHHHcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 9997 46777664332 2589999999999999999999998 899999999999999999999999999875443
Q ss_pred CCcceeeecccCccccChhhhc---cCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCccccc
Q 001768 815 ENTHISTRIAGTVGYMAPEYAM---RGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELV 891 (1016)
Q Consensus 815 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 891 (1016)
. ....+++.|+|||++. .+.++.++||||||+++|||++|+.||............ . ...
T Consensus 168 ~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~------~-~~~----- 230 (307)
T cd06607 168 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI------A-QND----- 230 (307)
T ss_pred C-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHH------h-cCC-----
Confidence 2 2246788999999874 456888999999999999999999998755433221111 0 000
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 892 DPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 892 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
.+.. ........+.+++.+||+.+|++||++.+++.
T Consensus 231 ~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 266 (307)
T cd06607 231 SPTL---SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLK 266 (307)
T ss_pred CCCC---CchhhCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0111 11234557899999999999999999999984
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-33 Score=304.70 Aligned_cols=247 Identities=23% Similarity=0.289 Sum_probs=190.4
Q ss_pred ccccCCCeeEEEEEcC-CCcEEEEEEccCCC---hhhhHHHHHHHHHHH---hcCCCCeeeeeeeEeecceeEEEEeecC
Q 001768 666 KIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS---KQGNREFVNEIGMIS---ALQHQNLVKLYGCCIEGNQLLLVYEYLE 738 (1016)
Q Consensus 666 ~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~---~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 738 (1016)
.||+|+||.||++... +++.||+|.+.... ......+.+|..+++ ..+||||+++++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999964 58999999886532 122233444544443 3479999999999999999999999999
Q ss_pred CCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCCcc
Q 001768 739 NNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTH 818 (1016)
Q Consensus 739 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 818 (1016)
+++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~~~----~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-- 151 (279)
T cd05633 81 GGDLHYHLSQHG----VFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (279)
T ss_pred CCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--
Confidence 999999886543 599999999999999999999998 89999999999999999999999999987543322
Q ss_pred eeeecccCccccChhhhcc-CCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCCC
Q 001768 819 ISTRIAGTVGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGS 897 (1016)
Q Consensus 819 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 897 (1016)
.....|+..|+|||.+.+ ..++.++||||+||++|||++|+.||.............. . .....
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~------~----~~~~~---- 216 (279)
T cd05633 152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM------T----LTVNV---- 216 (279)
T ss_pred -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHH------h----hcCCc----
Confidence 123468999999998864 5678999999999999999999999975433221111100 0 00111
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHhccCcCCcCccccC
Q 001768 898 NFSKKEAMTMLNIALLCTNPSPTLRP-----TMSSAVSMLEGKTAVQAPIIRR 945 (1016)
Q Consensus 898 ~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~L~~~~~~~~p~~~~ 945 (1016)
..+...+..+.+++.+||+.||++|| +++|++ +|||++.
T Consensus 217 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~---------~h~~~~~ 260 (279)
T cd05633 217 ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVK---------EHVFFKG 260 (279)
T ss_pred CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHH---------hCccccC
Confidence 12233455789999999999999999 587775 5777654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=290.70 Aligned_cols=254 Identities=19% Similarity=0.303 Sum_probs=198.4
Q ss_pred cCccccCCCeeEEEEE-cCCCcEEEEEEccCCChhhhHHHHHHHHHHHhc-CCCCeeeeeeeEeecceeEEEEeecCCCc
Q 001768 664 ANKIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNREFVNEIGMISAL-QHQNLVKLYGCCIEGNQLLLVYEYLENNS 741 (1016)
Q Consensus 664 ~~~LG~G~~G~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~gs 741 (1016)
.+.||+|+|+.|--++ ..+|..||||++.+.......+..+|++++... .|+||++++++|+++..+|||||.|.||+
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp 162 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP 162 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence 3689999999999887 678999999999888777788899999999988 59999999999999999999999999999
Q ss_pred HHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCC---ceeeeccccccccCC--CC
Q 001768 742 LARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDL---NAKISDFGLAKLDED--EN 816 (1016)
Q Consensus 742 L~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~---~~kL~DFGla~~~~~--~~ 816 (1016)
|..+|+.+. .+++.++.++.++|+.||.+||.+ ||.|||+||+|||..... -+||+||.+..-... +-
T Consensus 163 lLshI~~~~----~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~ 235 (463)
T KOG0607|consen 163 LLSHIQKRK----HFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDC 235 (463)
T ss_pred HHHHHHHhh----hccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccccccccCCCC
Confidence 999997765 699999999999999999999999 999999999999997654 489999988753221 11
Q ss_pred c----ceeeecccCccccChhhhc-----cCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhH--------HHHHH
Q 001768 817 T----HISTRIAGTVGYMAPEYAM-----RGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYL--------LDWAY 879 (1016)
Q Consensus 817 ~----~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~--------~~~~~ 879 (1016)
+ ..-...+|+..|||||+.. ...|+.++|.||||||+|-|++|.+||.+...++.-+. ...-.
T Consensus 236 spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LF 315 (463)
T KOG0607|consen 236 SPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLF 315 (463)
T ss_pred CCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHH
Confidence 1 1123467889999999764 33689999999999999999999999976554332110 00001
Q ss_pred HHHHhCCcccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 880 VLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 880 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
...+.+ ..+..|..+ .....+..+++...+..||.+|-++.+++.
T Consensus 316 esIQEG-kYeFPdkdW-----ahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 316 ESIQEG-KYEFPDKDW-----AHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HHHhcc-CCcCChhhh-----HHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 111111 112222111 123456788999999999999999977664
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=314.67 Aligned_cols=262 Identities=21% Similarity=0.308 Sum_probs=198.8
Q ss_pred HhcCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCC--ChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeec------
Q 001768 657 ATNNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSK--SKQGNREFVNEIGMISALQHQNLVKLYGCCIEG------ 727 (1016)
Q Consensus 657 ~~~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------ 727 (1016)
..++|++.+.||+|+||.||+|+.. +++.||+|.+... .......+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4678999999999999999999854 6899999998643 233345677899999999999999999988643
Q ss_pred ceeEEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccc
Q 001768 728 NQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFG 807 (1016)
Q Consensus 728 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG 807 (1016)
...++||||+++ +|.+.+.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg 163 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 163 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCc
Confidence 357999999965 78887742 278899999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCCcceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHH-H--------H-
Q 001768 808 LAKLDEDENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLL-D--------W- 877 (1016)
Q Consensus 808 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~-~--------~- 877 (1016)
+++....... .....++..|+|||.+.+..++.++|||||||++|+|++|+.||...........+ . +
T Consensus 164 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 241 (353)
T cd07850 164 LARTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFM 241 (353)
T ss_pred cceeCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 9986543221 23346788999999999989999999999999999999999999755432211100 0 0
Q ss_pred -------HHHHHHhCC-----cccccC----CcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 878 -------AYVLQEQGN-----LLELVD----PSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 878 -------~~~~~~~~~-----~~~~~d----~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
......... +.+... +..........+..+.+++.+||+.||++|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ 310 (353)
T ss_pred HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 000000000 000100 00001112234557889999999999999999999884
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=299.28 Aligned_cols=251 Identities=24% Similarity=0.418 Sum_probs=207.2
Q ss_pred CccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCCh--hhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEee
Q 001768 660 NFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSK--QGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEY 736 (1016)
Q Consensus 660 ~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 736 (1016)
+|++.+.||.|+||.||++... +++.||+|++..... .....+.+|+++++.++|||++++.+.+..++..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5788999999999999999965 688999999876533 4566788999999999999999999999999999999999
Q ss_pred cCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCC
Q 001768 737 LENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDEN 816 (1016)
Q Consensus 737 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 816 (1016)
+++++|.+++.........+++.++..++.+++.||+|||+. +++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 999999999976543335799999999999999999999998 99999999999999999999999999998654443
Q ss_pred cceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCC
Q 001768 817 THISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLG 896 (1016)
Q Consensus 817 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 896 (1016)
.......|++.|+|||...+..++.++||||+|+++|+|++|+.||......+.... . .... .+.+
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~------~-~~~~-----~~~~- 223 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALK------I-LKGQ-----YPPI- 223 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHH------H-hcCC-----CCCC-
Confidence 223335688899999999888899999999999999999999999876543322110 0 0111 1111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 897 SNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 897 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
+......+.+++.+||..+|++||++.++++
T Consensus 224 ---~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 224 ---PSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred ---CCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 2233457899999999999999999999884
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=311.04 Aligned_cols=265 Identities=27% Similarity=0.359 Sum_probs=197.3
Q ss_pred hcCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCChh--hhHHHHHHHHHHHhcCCCCeeeeeeeEeec--ceeEE
Q 001768 658 TNNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSKQ--GNREFVNEIGMISALQHQNLVKLYGCCIEG--NQLLL 732 (1016)
Q Consensus 658 ~~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~l 732 (1016)
.++|++.+.||+|+||.||+|... +|+.||+|.+...... ....+.+|++++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 467999999999999999999965 6899999998644322 233566899999999999999999998765 56899
Q ss_pred EEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeecccccccc
Q 001768 733 VYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLD 812 (1016)
Q Consensus 733 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~ 812 (1016)
||||+++ +|.+++.... ..+++.++..++.|+++||+|||+. +++||||||+||++++++.+||+|||.+...
T Consensus 86 v~e~~~~-~l~~~l~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 86 VMEYCEQ-DLASLLDNMP---TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEecCCC-CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeec
Confidence 9999975 7888876533 3689999999999999999999998 8999999999999999999999999999865
Q ss_pred CCCCcceeeecccCccccChhhhcc-CCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCC-----
Q 001768 813 EDENTHISTRIAGTVGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGN----- 886 (1016)
Q Consensus 813 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~----- 886 (1016)
...... .....++..|+|||.+.+ ..++.++|||||||++|||++|++||......+....+...........
T Consensus 159 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07845 159 GLPAKP-MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFS 237 (309)
T ss_pred CCccCC-CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhh
Confidence 433211 122345788999998865 4578999999999999999999999976554433221110000000000
Q ss_pred ---cccccC-CcCC-CCCC---HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 887 ---LLELVD-PSLG-SNFS---KKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 887 ---~~~~~d-~~l~-~~~~---~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
...... +... .... ......+.+++.+|++.||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000000 0000 0000 112456789999999999999999998883
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=307.20 Aligned_cols=263 Identities=25% Similarity=0.353 Sum_probs=199.7
Q ss_pred ccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCC--hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeec--ceeEEEEe
Q 001768 661 FDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS--KQGNREFVNEIGMISALQHQNLVKLYGCCIEG--NQLLLVYE 735 (1016)
Q Consensus 661 f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~lV~E 735 (1016)
|++.+.||+|+||.||+|+.. +++.||+|.+.... ......+.+|++++++++|||++++++++... +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 677899999999999999966 58899999997653 33345688999999999999999999999988 89999999
Q ss_pred ecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCC
Q 001768 736 YLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDE 815 (1016)
Q Consensus 736 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 815 (1016)
|+++ +|.+++.... ..+++..++.++.|+++||+|||+. +++|+||||+||++++++.+||+|||++......
T Consensus 81 ~~~~-~l~~~~~~~~---~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 81 YMDH-DLTGLLDSPE---VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred cccc-cHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 9975 8888886542 3689999999999999999999998 8999999999999999999999999999865544
Q ss_pred CcceeeecccCccccChhhhcc-CCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccc----
Q 001768 816 NTHISTRIAGTVGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLEL---- 890 (1016)
Q Consensus 816 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 890 (1016)
.........++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+...........+...
T Consensus 154 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07840 154 NSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLP 233 (287)
T ss_pred CcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccch
Confidence 3222233456888999997764 45789999999999999999999999765543322111100000000000000
Q ss_pred ----c------CCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 891 ----V------DPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 891 ----~------d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
. ...+...+...++..+.+++.+||+.+|.+||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0 000000011112557899999999999999999998874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-33 Score=302.40 Aligned_cols=236 Identities=22% Similarity=0.315 Sum_probs=192.4
Q ss_pred cccCCCeeEEEEEcC-CCcEEEEEEccCCC---hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEeecCCCcH
Q 001768 667 IGEGGFGPVYKGTLS-DGAVIAVKQLSSKS---KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYLENNSL 742 (1016)
Q Consensus 667 LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 742 (1016)
||.|++|.||+|+.. +++.||+|.+.... ....+.+.+|+++++.++||||+++++++.++...++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999975 48899999986543 23346789999999999999999999999999999999999999999
Q ss_pred HHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCCcceeee
Q 001768 743 ARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTR 822 (1016)
Q Consensus 743 ~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 822 (1016)
.+++.... .+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||.+....... ....
T Consensus 81 ~~~l~~~~----~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~ 151 (262)
T cd05572 81 WTILRDRG----LFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWT 151 (262)
T ss_pred HHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccc
Confidence 99996543 489999999999999999999998 99999999999999999999999999998654432 1233
Q ss_pred cccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCCCCCCHH
Q 001768 823 IAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGSNFSKK 902 (1016)
Q Consensus 823 ~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 902 (1016)
..|+..|+|||.+.+..++.++|+||||+++|+|++|+.||.....+... .. .. .........++..
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~---~~---------~~~~~~~~~~~~~ 218 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPME-IY---ND---------ILKGNGKLEFPNY 218 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHH-HH---HH---------HhccCCCCCCCcc
Confidence 46888999999998888899999999999999999999999765421111 00 00 0000111122222
Q ss_pred HHHHHHHHHHHccCCCCCCCCC
Q 001768 903 EAMTMLNIALLCTNPSPTLRPT 924 (1016)
Q Consensus 903 ~~~~l~~li~~cl~~dP~~RPt 924 (1016)
....+.+++.+||+.+|++||+
T Consensus 219 ~~~~~~~~i~~~l~~~p~~R~~ 240 (262)
T cd05572 219 IDKAAKDLIKQLLRRNPEERLG 240 (262)
T ss_pred cCHHHHHHHHHHccCChhhCcC
Confidence 3567999999999999999999
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=309.63 Aligned_cols=247 Identities=28% Similarity=0.429 Sum_probs=196.7
Q ss_pred ccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCC---hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEee
Q 001768 661 FDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS---KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEY 736 (1016)
Q Consensus 661 f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 736 (1016)
|+..+.||+|+||.||+|+.. ++..||+|.+.... ......+.+|++++++++|||++++++++.+++..++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 667889999999999999964 68899999986432 23345788899999999999999999999999999999999
Q ss_pred cCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCC
Q 001768 737 LENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDEN 816 (1016)
Q Consensus 737 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 816 (1016)
+++ ++.+.+.... .++++.++..++.|++.||.|||+. +|+||||+|+||+++.++.++|+|||++......
T Consensus 107 ~~g-~l~~~~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~- 178 (317)
T cd06635 107 CLG-SASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA- 178 (317)
T ss_pred CCC-CHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc-
Confidence 975 7777775432 3589999999999999999999998 9999999999999999999999999998754332
Q ss_pred cceeeecccCccccChhhhc---cCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCC
Q 001768 817 THISTRIAGTVGYMAPEYAM---RGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDP 893 (1016)
Q Consensus 817 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 893 (1016)
....|++.|+|||++. .+.++.++|||||||++|||++|+.||............ ... .. +
T Consensus 179 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~------~~~-~~-----~ 242 (317)
T cd06635 179 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI------AQN-ES-----P 242 (317)
T ss_pred ----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHH------Hhc-cC-----C
Confidence 2346888999999874 456889999999999999999999998654322211110 000 00 0
Q ss_pred cCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 001768 894 SLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEG 934 (1016)
Q Consensus 894 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 934 (1016)
. .........+.+++.+||+.+|.+||++.++++.+--
T Consensus 243 ~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 280 (317)
T cd06635 243 T---LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV 280 (317)
T ss_pred C---CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence 0 1112234568999999999999999999999975543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=300.93 Aligned_cols=249 Identities=25% Similarity=0.356 Sum_probs=198.5
Q ss_pred cCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCC-----ChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeec--cee
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSK-----SKQGNREFVNEIGMISALQHQNLVKLYGCCIEG--NQL 730 (1016)
Q Consensus 659 ~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~-----~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~ 730 (1016)
.+|++.+.||+|+||.||+|+.. +++.||+|.+... .......+.+|++++++++||||+++++++.+. +.+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47899999999999999999864 6899999987532 123345788999999999999999999998764 568
Q ss_pred EEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeecccccc
Q 001768 731 LLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAK 810 (1016)
Q Consensus 731 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~ 810 (1016)
++||||+++++|.+++.... .+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+++
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~----~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 154 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG----ALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccc
Confidence 89999999999999986432 588999999999999999999998 89999999999999999999999999997
Q ss_pred ccCCCCc--ceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcc
Q 001768 811 LDEDENT--HISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLL 888 (1016)
Q Consensus 811 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 888 (1016)
....... .......|+..|+|||.+.+..++.++|||||||++|+|++|+.||.......... .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~--~------------ 220 (264)
T cd06653 155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIF--K------------ 220 (264)
T ss_pred ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHH--H------------
Confidence 5432111 11123568899999999988888999999999999999999999997543222111 0
Q ss_pred cccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 889 ELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 889 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
.........++......+.+++.+|++ +|.+||++.+++.
T Consensus 221 -~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 221 -IATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred -HHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 000111122334455679999999999 5799999997764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-33 Score=309.12 Aligned_cols=268 Identities=25% Similarity=0.374 Sum_probs=199.5
Q ss_pred HHHhcCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCC--hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecc---
Q 001768 655 KAATNNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS--KQGNREFVNEIGMISALQHQNLVKLYGCCIEGN--- 728 (1016)
Q Consensus 655 ~~~~~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~--- 728 (1016)
+.+.++|++.+.||+|+||.||+|... +++.||+|.+.... ......+.+|++++++++||||+++++++.+..
T Consensus 3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence 456788999999999999999999975 58899999987543 223356778999999999999999999987654
Q ss_pred -------eeEEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCce
Q 001768 729 -------QLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNA 801 (1016)
Q Consensus 729 -------~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ 801 (1016)
..++||||+++ ++...+.... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~ 155 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDH-DLMGLLESGL---VHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQI 155 (302)
T ss_pred hccccCCcEEEEEcccCc-cHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcE
Confidence 78999999986 6767665432 3589999999999999999999998 99999999999999999999
Q ss_pred eeeccccccccCCCCcceeeecccCccccChhhhcc-CCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHH
Q 001768 802 KISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYV 880 (1016)
Q Consensus 802 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~ 880 (1016)
||+|||.+...............++..|+|||.+.+ ..++.++|||||||++|||++|++||......+....+.....
T Consensus 156 kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~ 235 (302)
T cd07864 156 KLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCG 235 (302)
T ss_pred EeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence 999999998654433222222346788999998864 3578899999999999999999999975443222111110000
Q ss_pred HHHhCCcccc--------cCC------cCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 881 LQEQGNLLEL--------VDP------SLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 881 ~~~~~~~~~~--------~d~------~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
......+.+. .++ .....+ ...+..+.+++.+||+.||.+||++.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 236 SPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEF-SFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred CCChhhcccccccccccccccccccccchhhhc-CCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0000000000 000 000000 112457899999999999999999998884
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=306.35 Aligned_cols=262 Identities=24% Similarity=0.359 Sum_probs=197.5
Q ss_pred ccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCC--hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEeec
Q 001768 661 FDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS--KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYL 737 (1016)
Q Consensus 661 f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 737 (1016)
|++.+.||.|++|.||+|... +|+.||+|++.... ......+.+|+++++.++|||++++++++.+++..++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 677899999999999999864 78999999986543 223356888999999999999999999999999999999999
Q ss_pred CCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCCc
Q 001768 738 ENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENT 817 (1016)
Q Consensus 738 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 817 (1016)
+ ++|.+++..... ..+++..+..++.|+++||+|||+. +++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~-~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 81 D-LDLKKYMDSSPL--TGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR 154 (283)
T ss_pred C-cCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence 5 689998865432 3589999999999999999999998 999999999999999999999999999975433221
Q ss_pred ceeeecccCccccChhhhccC-CCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHh-HHHHHH--------HHHHhCCc
Q 001768 818 HISTRIAGTVGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVY-LLDWAY--------VLQEQGNL 887 (1016)
Q Consensus 818 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~-~~~~~~--------~~~~~~~~ 887 (1016)
. .....++..|+|||++.+. .++.++|||||||++|+|++|+.||.......... ..++.. ......+.
T Consensus 155 ~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07835 155 T-YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDY 233 (283)
T ss_pred c-cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhh
Confidence 1 1223568899999987654 56889999999999999999999997654332111 110000 00000000
Q ss_pred ----ccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 888 ----LELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 888 ----~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
.....+.. ..........+.+++.+|++.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 234 KPTFPKWARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhcccccccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00000000 0111122356889999999999999999999884
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=304.85 Aligned_cols=264 Identities=24% Similarity=0.390 Sum_probs=200.5
Q ss_pred CccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCChh-hhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEeec
Q 001768 660 NFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSKQ-GNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYL 737 (1016)
Q Consensus 660 ~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 737 (1016)
+|++.++||+|++|.||+|+.. +|+.||+|.+...... ....+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5888999999999999999975 6889999998755332 3456778999999999999999999999999999999999
Q ss_pred CCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCCc
Q 001768 738 ENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENT 817 (1016)
Q Consensus 738 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 817 (1016)
++ +|.+++..... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||++........
T Consensus 81 ~~-~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~ 155 (284)
T cd07836 81 DK-DLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN 155 (284)
T ss_pred Cc-cHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence 85 88888865432 24689999999999999999999998 899999999999999999999999999975433221
Q ss_pred ceeeecccCccccChhhhccC-CCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHH-H---------HHHHHHHhCC
Q 001768 818 HISTRIAGTVGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLL-D---------WAYVLQEQGN 886 (1016)
Q Consensus 818 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~-~---------~~~~~~~~~~ 886 (1016)
......++..|+|||.+.+. .++.++|||||||++|+|++|+.||......+....+ + |.... ....
T Consensus 156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 233 (284)
T cd07836 156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGIS-QLPE 233 (284)
T ss_pred -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHh-cCch
Confidence 11224568899999988654 5688999999999999999999999866544322111 0 00000 0000
Q ss_pred cccccCCcC---CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 887 LLELVDPSL---GSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 887 ~~~~~d~~l---~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
+........ ...+.+..+..+.+++.+|++.||.+||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000000000 00011123457889999999999999999998883
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=297.81 Aligned_cols=250 Identities=29% Similarity=0.428 Sum_probs=205.9
Q ss_pred CccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCCh--hhhHHHHHHHHHHHhcCCCCeeeeeeeEeec--ceeEEEE
Q 001768 660 NFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSK--QGNREFVNEIGMISALQHQNLVKLYGCCIEG--NQLLLVY 734 (1016)
Q Consensus 660 ~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~lV~ 734 (1016)
+|+..+.||+|++|.||+|... +++.|++|++..... ...+.+.+|++++++++||||+++++.+.+. +..++||
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4778899999999999999976 689999999876542 4567889999999999999999999999988 8999999
Q ss_pred eecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCC
Q 001768 735 EYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDED 814 (1016)
Q Consensus 735 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 814 (1016)
||+++++|.+++.... .+++..++.++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 153 (260)
T cd06606 81 EYVSGGSLSSLLKKFG----KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153 (260)
T ss_pred EecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence 9999999999996543 689999999999999999999998 999999999999999999999999999986654
Q ss_pred CCcc-eeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCC
Q 001768 815 ENTH-ISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDP 893 (1016)
Q Consensus 815 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 893 (1016)
.... ......++..|+|||...+...+.++||||||+++|+|++|+.||......... . + . ....
T Consensus 154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-~--~-----~------~~~~ 219 (260)
T cd06606 154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAA-L--Y-----K------IGSS 219 (260)
T ss_pred ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHH-H--H-----h------cccc
Confidence 4321 123356888999999998888999999999999999999999999765511110 0 0 0 0001
Q ss_pred cCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 894 SLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 894 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
.....++...+..+.+++.+|++.+|++||++.++++
T Consensus 220 ~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 220 GEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred CCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 1112233334567999999999999999999999884
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=303.94 Aligned_cols=248 Identities=26% Similarity=0.352 Sum_probs=205.1
Q ss_pred hcCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCC---ChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEE
Q 001768 658 TNNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSK---SKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLV 733 (1016)
Q Consensus 658 ~~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 733 (1016)
.+.|+.-+.||+||||.||-++.+ +|+.+|.|.+.++ ...+.....+|-.+|++++.+.||.+--.|+..+.+++|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 356788899999999999999854 6999999988654 344556678999999999999999999999999999999
Q ss_pred EeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccC
Q 001768 734 YEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDE 813 (1016)
Q Consensus 734 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~ 813 (1016)
|..|.||+|.-+|..... ..++++.+.-++.+|+.||++||+. +||.||+||+|||+|+.|+++|+|.|+|..+.
T Consensus 264 LtlMNGGDLkfHiyn~g~--~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGN--PGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIP 338 (591)
T ss_pred EEeecCCceeEEeeccCC--CCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecC
Confidence 999999999999976654 4699999999999999999999998 99999999999999999999999999999777
Q ss_pred CCCcceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCC
Q 001768 814 DENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDP 893 (1016)
Q Consensus 814 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 893 (1016)
+.... ...+||.+|||||++.++.|+...|.||+||++|||+.|+.||...........++.. . .
T Consensus 339 ~g~~~--~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr-~---------~--- 403 (591)
T KOG0986|consen 339 EGKPI--RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRR-T---------L--- 403 (591)
T ss_pred CCCcc--ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHH-H---------h---
Confidence 66544 2238999999999999999999999999999999999999999643321111111100 0 0
Q ss_pred cCCCCCCHHHHHHHHHHHHHccCCCCCCCCCH
Q 001768 894 SLGSNFSKKEAMTMLNIALLCTNPSPTLRPTM 925 (1016)
Q Consensus 894 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 925 (1016)
.....++....++...+....|..||++|...
T Consensus 404 ~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 404 EDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred cchhhcccccCHHHHHHHHHHHccCHHHhccC
Confidence 01123455566678899999999999999754
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=344.43 Aligned_cols=250 Identities=31% Similarity=0.448 Sum_probs=203.2
Q ss_pred hcCccccCccccCCCeeEEEEE-cCCCcEEEEEEccCC--ChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEE
Q 001768 658 TNNFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLSSK--SKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVY 734 (1016)
Q Consensus 658 ~~~f~~~~~LG~G~~G~Vy~~~-~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 734 (1016)
+-+++....||.|.||.||-|. ..+|...|+|.+... .........+|..++..++|||+|+++|+-.+.+..++.|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 3466778899999999999998 457899999988644 2344567889999999999999999999999999999999
Q ss_pred eecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCC
Q 001768 735 EYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDED 814 (1016)
Q Consensus 735 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 814 (1016)
|||++|+|.+.+...+ ..++.....+..|++.|++|||++ |||||||||.||+++.+|.+|++|||.|.....
T Consensus 1314 EyC~~GsLa~ll~~gr----i~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGR----IEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred HHhccCcHHHHHHhcc----hhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecC
Confidence 9999999999996543 467777788899999999999999 999999999999999999999999999986654
Q ss_pred CCcce---eeecccCccccChhhhccC---CCCCccchhHHHHHHHHHHhCCCCCCCCCch-hhHhHHHHHHHHHHhCCc
Q 001768 815 ENTHI---STRIAGTVGYMAPEYAMRG---YLTDKADVYSFGIVALEIVSGKSNTNYRPKE-EFVYLLDWAYVLQEQGNL 887 (1016)
Q Consensus 815 ~~~~~---~~~~~gt~~y~aPE~~~~~---~~~~~sDVwSlGvvl~elltG~~P~~~~~~~-~~~~~~~~~~~~~~~~~~ 887 (1016)
....+ ....+||+.|||||++.+. .-.-++||||+|||+.||+||+.||...+.+ .+++-+ ..+
T Consensus 1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V-------~~g-- 1457 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHV-------AAG-- 1457 (1509)
T ss_pred chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHH-------hcc--
Confidence 42111 2346899999999999754 3456899999999999999999999754332 222111 111
Q ss_pred ccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 888 LELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 888 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
-.+.+|.....+-.+++..|+..||++|.++.|+++
T Consensus 1458 -------h~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1458 -------HKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred -------CCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 123344456667889999999999999999987775
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=298.51 Aligned_cols=248 Identities=22% Similarity=0.285 Sum_probs=193.4
Q ss_pred HHHHHHhcCccccCcc--ccCCCeeEEEEEcC-CCcEEEEEEccCCChhhhHHHHHHHHHHHhc-CCCCeeeeeeeEeec
Q 001768 652 RQIKAATNNFDAANKI--GEGGFGPVYKGTLS-DGAVIAVKQLSSKSKQGNREFVNEIGMISAL-QHQNLVKLYGCCIEG 727 (1016)
Q Consensus 652 ~~l~~~~~~f~~~~~L--G~G~~G~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~ 727 (1016)
.+.....++|++.+.+ |+|+||.||+++.. ++..+|+|.+........ |+.....+ +||||+++++++..+
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~ 81 (267)
T PHA03390 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTL 81 (267)
T ss_pred HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecC
Confidence 3444556778887777 99999999999854 688899999865422111 22222222 799999999999999
Q ss_pred ceeEEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCC-ceeeecc
Q 001768 728 NQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDL-NAKISDF 806 (1016)
Q Consensus 728 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~-~~kL~DF 806 (1016)
+..++||||+++++|.+++.... .+++.++..++.|+++||+|||+. +++||||||+||+++.++ .++|+||
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~df 154 (267)
T PHA03390 82 KGHVLIMDYIKDGDLFDLLKKEG----KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDY 154 (267)
T ss_pred CeeEEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecC
Confidence 99999999999999999996543 689999999999999999999998 899999999999999998 9999999
Q ss_pred ccccccCCCCcceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCC
Q 001768 807 GLAKLDEDENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGN 886 (1016)
Q Consensus 807 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 886 (1016)
|+++...... ...++..|+|||++.+..++.++|||||||++|||++|+.||.....+.. ....+.... ..
T Consensus 155 g~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~---~~ 225 (267)
T PHA03390 155 GLCKIIGTPS-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEEL-DLESLLKRQ---QK 225 (267)
T ss_pred ccceecCCCc-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchh-hHHHHHHhh---cc
Confidence 9987554321 24588999999999988899999999999999999999999985443321 111111111 00
Q ss_pred cccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCC-HHHHH
Q 001768 887 LLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPT-MSSAV 929 (1016)
Q Consensus 887 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~evl 929 (1016)
. ....+.....+.+++.+||+.+|.+||+ ++|++
T Consensus 226 -----~----~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l 260 (267)
T PHA03390 226 -----K----LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEII 260 (267)
T ss_pred -----c----CCcccccCHHHHHHHHHHhccChhhCCchHHHHh
Confidence 0 0112234557899999999999999996 58777
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=300.94 Aligned_cols=250 Identities=26% Similarity=0.404 Sum_probs=200.7
Q ss_pred cccCCCeeEEEEEcC-CCcEEEEEEccCCCh---hhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEeecCCCcH
Q 001768 667 IGEGGFGPVYKGTLS-DGAVIAVKQLSSKSK---QGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYLENNSL 742 (1016)
Q Consensus 667 LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 742 (1016)
||+|+||.||+++.. +++.||+|.+..... ...+.+.+|++++++++||||+++++.+..++..++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999976 489999999875433 3456788999999999999999999999999999999999999999
Q ss_pred HHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCCc-----
Q 001768 743 ARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENT----- 817 (1016)
Q Consensus 743 ~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~----- 817 (1016)
.+++.... .+++..+..++.|+++||+|||+. +++||||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~~----~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 81 ASLLENVG----SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred HHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 99996543 589999999999999999999998 999999999999999999999999999875433211
Q ss_pred --ceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcC
Q 001768 818 --HISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSL 895 (1016)
Q Consensus 818 --~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 895 (1016)
.......++..|+|||...+...+.++||||||+++|+|++|+.||.....++..... . .... . .
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~------~-~~~~----~--~ 220 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNI------L-NGKI----E--W 220 (265)
T ss_pred ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------h-cCCc----C--C
Confidence 1223346788999999998888899999999999999999999999766544322111 0 0000 0 0
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCcCCcCcccc
Q 001768 896 GSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTAVQAPIIR 944 (1016)
Q Consensus 896 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~p~~~ 944 (1016)
.... ..+..+.+++.+||+.+|++|||+.++.+.|+ +||+.
T Consensus 221 ~~~~--~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~------~~~~~ 261 (265)
T cd05579 221 PEDV--EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN------HPFFK 261 (265)
T ss_pred Cccc--cCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc------Ccccc
Confidence 0000 02457899999999999999999966666554 56654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=291.11 Aligned_cols=243 Identities=26% Similarity=0.343 Sum_probs=203.8
Q ss_pred HhcCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCC---hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEE
Q 001768 657 ATNNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS---KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLL 732 (1016)
Q Consensus 657 ~~~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 732 (1016)
.-++|+.++.||+|.||.|-+++-+ .++.+|+|++++.. +.....-..|-++|+..+||.+..+.-.|+..+++|+
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 3467888999999999999999854 78999999998764 3333445678899999999999999999999999999
Q ss_pred EEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeecccccccc
Q 001768 733 VYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLD 812 (1016)
Q Consensus 733 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~ 812 (1016)
||||..||.|.-+|...+ .++++..+-+-.+|+.||.|||++ +||.||+|.+|.|+|.+|++||+|||+++..
T Consensus 246 VMeyanGGeLf~HLsrer----~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~ 318 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSRER----VFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEE 318 (516)
T ss_pred EEEEccCceEeeehhhhh----cccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhc
Confidence 999999999999886543 689999999999999999999998 9999999999999999999999999999843
Q ss_pred CCCCcceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccC
Q 001768 813 EDENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVD 892 (1016)
Q Consensus 813 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 892 (1016)
-.. ...+..++|||.|+|||++....|..++|.|.+||++|||++|+.||.....+....++-. + |
T Consensus 319 I~~-g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~-----e--------d 384 (516)
T KOG0690|consen 319 IKY-GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILM-----E--------D 384 (516)
T ss_pred ccc-cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHh-----h--------h
Confidence 222 2335568999999999999999999999999999999999999999987766654443311 1 1
Q ss_pred CcCCCCCCHHHHHHHHHHHHHccCCCCCCCCC
Q 001768 893 PSLGSNFSKKEAMTMLNIALLCTNPSPTLRPT 924 (1016)
Q Consensus 893 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt 924 (1016)
-.++.....+...|+...+.+||.+|..
T Consensus 385 ----~kFPr~ls~eAktLLsGLL~kdP~kRLG 412 (516)
T KOG0690|consen 385 ----LKFPRTLSPEAKTLLSGLLKKDPKKRLG 412 (516)
T ss_pred ----ccCCccCCHHHHHHHHHHhhcChHhhcC
Confidence 1233444456788899999999999973
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=313.56 Aligned_cols=265 Identities=20% Similarity=0.307 Sum_probs=198.9
Q ss_pred hcCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCC--hhhhHHHHHHHHHHHhcCCCCeeeeeeeEee----ccee
Q 001768 658 TNNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS--KQGNREFVNEIGMISALQHQNLVKLYGCCIE----GNQL 730 (1016)
Q Consensus 658 ~~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----~~~~ 730 (1016)
.++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 478999999999999999999854 68999999987542 2334567789999999999999999998763 3568
Q ss_pred EEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeecccccc
Q 001768 731 LLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAK 810 (1016)
Q Consensus 731 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~ 810 (1016)
++||||+. ++|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||++.
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~ 155 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQ----PLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMAR 155 (334)
T ss_pred EEEEehhh-hhHHHHhccCC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccce
Confidence 99999996 58988885443 589999999999999999999998 99999999999999999999999999997
Q ss_pred ccCCCCc---ceeeecccCccccChhhhcc-CCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHH------H
Q 001768 811 LDEDENT---HISTRIAGTVGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAY------V 880 (1016)
Q Consensus 811 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~------~ 880 (1016)
....... .......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+.... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~ 235 (334)
T cd07855 156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEV 235 (334)
T ss_pred eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHh
Confidence 5433221 11223568899999998865 468899999999999999999999997654332211110000 0
Q ss_pred H--HHhCCccc---ccCCcCCC---CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 881 L--QEQGNLLE---LVDPSLGS---NFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 881 ~--~~~~~~~~---~~d~~l~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
. .......+ ........ ......+..+.+++.+||+.+|++||+++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred hhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 0 00000000 00000000 011223567999999999999999999998884
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=316.16 Aligned_cols=242 Identities=24% Similarity=0.444 Sum_probs=192.2
Q ss_pred cCccccCCCeeEEEEEcC-CCcEEE---EEEcc-CCChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecc--eeEEEEee
Q 001768 664 ANKIGEGGFGPVYKGTLS-DGAVIA---VKQLS-SKSKQGNREFVNEIGMISALQHQNLVKLYGCCIEGN--QLLLVYEY 736 (1016)
Q Consensus 664 ~~~LG~G~~G~Vy~~~~~-~~~~vA---vK~~~-~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~--~~~lV~E~ 736 (1016)
...||+|+|-+||+|.+. +|-.|| ||.-. ..+....++|..|+.+|+.|+||||++++.++.+.. .+-+|+|+
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 468999999999999875 466666 33221 123445688999999999999999999999998764 48899999
Q ss_pred cCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccC-CceeeeccccccccCCC
Q 001768 737 LENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKD-LNAKISDFGLAKLDEDE 815 (1016)
Q Consensus 737 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~-~~~kL~DFGla~~~~~~ 815 (1016)
+..|+|..|+.+.+ .++...+..|++||++||.|||++ .|+|||||||.+||+|+.+ |.|||+|+|+|......
T Consensus 125 ~TSGtLr~Y~kk~~----~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 125 FTSGTLREYRKKHR----RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred ccCCcHHHHHHHhc----cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 99999999997665 688899999999999999999998 5699999999999999865 89999999999876543
Q ss_pred CcceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCC-CchhhHhHHHHHHHHHHhCCcccccCCc
Q 001768 816 NTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYR-PKEEFVYLLDWAYVLQEQGNLLELVDPS 894 (1016)
Q Consensus 816 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 894 (1016)
. ...++|||.|||||... ..|.+.+||||||+.++||+|+..||..- .+.++...+ ..+ +.|
T Consensus 200 ~---aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV-------~SG-----iKP- 262 (632)
T KOG0584|consen 200 H---AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKV-------TSG-----IKP- 262 (632)
T ss_pred c---cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHH-------HcC-----CCH-
Confidence 2 23478999999999886 77899999999999999999999998642 222221111 011 111
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 895 LGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 895 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
..+.+-...++.++|.+|+.. .++|||+.|+++
T Consensus 263 --~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 263 --AALSKVKDPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred --HHhhccCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 111111234688999999999 999999999986
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=296.07 Aligned_cols=247 Identities=29% Similarity=0.476 Sum_probs=203.9
Q ss_pred CccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCCh--hhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEee
Q 001768 660 NFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSK--QGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEY 736 (1016)
Q Consensus 660 ~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 736 (1016)
+|++.+.||+|++|.||+|+.. +++.||+|.+..... .....+.+|++++++++|||++++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4788899999999999999865 678999999876543 4556889999999999999999999999999999999999
Q ss_pred cCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCC
Q 001768 737 LENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDEN 816 (1016)
Q Consensus 737 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 816 (1016)
+++++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 81 AENGSLRQIIKKF----GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred CCCCcHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence 9999999998654 2689999999999999999999998 99999999999999999999999999998665443
Q ss_pred cceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCC
Q 001768 817 THISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLG 896 (1016)
Q Consensus 817 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 896 (1016)
.. .....++..|+|||...+..++.++||||+|+++|+|++|+.||......... +.. .... .+.
T Consensus 154 ~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~----~~~---~~~~-----~~~-- 218 (254)
T cd06627 154 KD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAAL----FRI---VQDD-----HPP-- 218 (254)
T ss_pred cc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHH----HHH---hccC-----CCC--
Confidence 22 23356888999999998878899999999999999999999998754422211 110 0011 111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 897 SNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 897 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
++......+.+++.+||..+|++||++.+++.
T Consensus 219 --~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 219 --LPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred --CCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 12223457889999999999999999998873
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=298.35 Aligned_cols=249 Identities=23% Similarity=0.313 Sum_probs=194.0
Q ss_pred CccccCCCeeEEEEEcC-CCcEEEEEEccCCCh---hhhHHHHHHHHHH-HhcCCCCeeeeeeeEeecceeEEEEeecCC
Q 001768 665 NKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSK---QGNREFVNEIGMI-SALQHQNLVKLYGCCIEGNQLLLVYEYLEN 739 (1016)
Q Consensus 665 ~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~E~~~l-~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 739 (1016)
+.||+|+||.||+|... +++.||+|.+..... .....+..|..++ ...+|||++++++++..++..++||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 57999999999999864 588999999865432 2223344555444 445899999999999999999999999999
Q ss_pred CcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCCcce
Q 001768 740 NSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHI 819 (1016)
Q Consensus 740 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 819 (1016)
++|.+++.... .+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||+++....
T Consensus 82 ~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----- 149 (260)
T cd05611 82 GDCASLIKTLG----GLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----- 149 (260)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence 99999996543 589999999999999999999998 999999999999999999999999999875433
Q ss_pred eeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCCCCC
Q 001768 820 STRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGSNF 899 (1016)
Q Consensus 820 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 899 (1016)
.....|+..|+|||.+.+..++.++||||||+++|||++|..||............ ...... .....
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~-----~~~~~~--------~~~~~ 216 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNI-----LSRRIN--------WPEEV 216 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHH-----HhcccC--------CCCcc
Confidence 22346788999999998888899999999999999999999999765443322111 000000 01111
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCcCCcCcccc
Q 001768 900 SKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTAVQAPIIR 944 (1016)
Q Consensus 900 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~p~~~ 944 (1016)
....+..+.+++.+||+.+|++||++.++.+.| .|||+.
T Consensus 217 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l------~~~~~~ 255 (260)
T cd05611 217 KEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK------SHPFFK 255 (260)
T ss_pred cccCCHHHHHHHHHHccCCHHHccCCCcHHHHH------cChHhh
Confidence 122345789999999999999999887666544 356654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=303.79 Aligned_cols=244 Identities=27% Similarity=0.445 Sum_probs=198.4
Q ss_pred cCccccCCCeeEEEEEcC-CCcEEEEEEccCCChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEeecCCCcH
Q 001768 664 ANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYLENNSL 742 (1016)
Q Consensus 664 ~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 742 (1016)
..+||+|+||.||++... +++.||+|++..........+.+|+.+++.++|+||+++++++..++..++||||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 367999999999999864 6899999998665555567789999999999999999999999999999999999999999
Q ss_pred HHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCCcceeee
Q 001768 743 ARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTR 822 (1016)
Q Consensus 743 ~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 822 (1016)
.+++... .+++..+..++.|++.||+|||+. +++||||+|+||++++++.++|+|||.+........ ....
T Consensus 105 ~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~ 175 (292)
T cd06657 105 TDIVTHT-----RMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKS 175 (292)
T ss_pred HHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccc-cccc
Confidence 9987432 478999999999999999999998 999999999999999999999999999875433221 1233
Q ss_pred cccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCCCCCCHH
Q 001768 823 IAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGSNFSKK 902 (1016)
Q Consensus 823 ~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 902 (1016)
..|++.|+|||++.+..++.++||||+||++|||++|+.||......+...... . ...+.+.. ...
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~------~------~~~~~~~~--~~~ 241 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR------D------NLPPKLKN--LHK 241 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH------h------hCCcccCC--ccc
Confidence 568899999999988888999999999999999999999997654433221111 0 01111110 112
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 903 EAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 903 ~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
....+.+++.+||+.+|.+||++.++++
T Consensus 242 ~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 242 VSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred CCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 3346889999999999999999999884
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=304.66 Aligned_cols=265 Identities=24% Similarity=0.346 Sum_probs=196.3
Q ss_pred cCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCCh--hhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEe
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSK--QGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYE 735 (1016)
Q Consensus 659 ~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 735 (1016)
++|++.+.||+|++|.||+|+.. +++.||+|.+..... ...+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 57899999999999999999965 688999999865422 234568899999999999999999999999999999999
Q ss_pred ecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEcc-CCceeeeccccccccCC
Q 001768 736 YLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDK-DLNAKISDFGLAKLDED 814 (1016)
Q Consensus 736 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~-~~~~kL~DFGla~~~~~ 814 (1016)
|++ ++|.+++..... ..+++..+..++.||+.||+|||++ +++||||+|+||+++. ++.+||+|||++.....
T Consensus 82 ~~~-~~l~~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 82 YLD-LDLKKHMDSSPD--FAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred ccc-ccHHHHHHhCCC--CCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 996 478777754332 2468888999999999999999998 9999999999999985 55799999999975443
Q ss_pred CCcceeeecccCccccChhhhccC-CCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhC------Cc
Q 001768 815 ENTHISTRIAGTVGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQG------NL 887 (1016)
Q Consensus 815 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~------~~ 887 (1016)
... ......+++.|+|||++.+. .++.++|||||||++|+|+||++||......+............... .+
T Consensus 156 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (294)
T PLN00009 156 PVR-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSL 234 (294)
T ss_pred Ccc-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccc
Confidence 221 11234578899999988654 57899999999999999999999997654432211110000000000 00
Q ss_pred ccc--cCCcCCCC----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 888 LEL--VDPSLGSN----FSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 888 ~~~--~d~~l~~~----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
.+. .-+..... ........+.+++.+|++.+|++||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 235 PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred hhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 00000000 01122346889999999999999999999884
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=314.36 Aligned_cols=263 Identities=22% Similarity=0.341 Sum_probs=197.9
Q ss_pred hcCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCC--ChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeec-----ce
Q 001768 658 TNNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSK--SKQGNREFVNEIGMISALQHQNLVKLYGCCIEG-----NQ 729 (1016)
Q Consensus 658 ~~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-----~~ 729 (1016)
.++|.+.+.||+|+||.||+|+.. +++.||||.+... .......+.+|+.+++.++||||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 467999999999999999999854 6899999998653 233345677899999999999999999988654 35
Q ss_pred eEEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccc
Q 001768 730 LLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLA 809 (1016)
Q Consensus 730 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla 809 (1016)
.++||||+. ++|.+++.... .+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 155 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQ----TLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLA 155 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccc
Confidence 899999996 68888885432 599999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCcceeeecccCccccChhhhcc-CCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHH--------H
Q 001768 810 KLDEDENTHISTRIAGTVGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAY--------V 880 (1016)
Q Consensus 810 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~--------~ 880 (1016)
+....... ......++..|+|||.+.+ ..++.++|||||||++|+|++|++||................ .
T Consensus 156 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (337)
T cd07858 156 RTTSEKGD-FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLG 234 (337)
T ss_pred cccCCCcc-cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhh
Confidence 86543321 2233467889999998865 468899999999999999999999997654322111110000 0
Q ss_pred HHHhCC-------cccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 881 LQEQGN-------LLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 881 ~~~~~~-------~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
...... .....++... ...+.....+.+++.+||+.+|++|||+.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~ 290 (337)
T cd07858 235 FIRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALA 290 (337)
T ss_pred hcCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHc
Confidence 000000 0000000000 011123457899999999999999999999884
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=303.86 Aligned_cols=254 Identities=23% Similarity=0.343 Sum_probs=200.1
Q ss_pred CccccCccccCCCeeEEEEEc----CCCcEEEEEEccCCC----hhhhHHHHHHHHHHHhc-CCCCeeeeeeeEeeccee
Q 001768 660 NFDAANKIGEGGFGPVYKGTL----SDGAVIAVKQLSSKS----KQGNREFVNEIGMISAL-QHQNLVKLYGCCIEGNQL 730 (1016)
Q Consensus 660 ~f~~~~~LG~G~~G~Vy~~~~----~~~~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~ 730 (1016)
+|++.+.||+|++|.||+++. .+++.||||.+.... ......+.+|+++++++ +||||+++++.+..++..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 478889999999999999974 357889999986432 22345678899999999 599999999999999999
Q ss_pred EEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeecccccc
Q 001768 731 LLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAK 810 (1016)
Q Consensus 731 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~ 810 (1016)
++||||+++++|.+++.... .+++..+..++.|+++||+|||+. +++||||||+||+++.++.++|+|||+++
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~ 153 (288)
T cd05583 81 HLILDYVNGGELFTHLYQRE----HFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSK 153 (288)
T ss_pred EEEEecCCCCcHHHHHhhcC----CcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccc
Confidence 99999999999999986432 588999999999999999999998 99999999999999999999999999987
Q ss_pred ccCCCCcceeeecccCccccChhhhccCC--CCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcc
Q 001768 811 LDEDENTHISTRIAGTVGYMAPEYAMRGY--LTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLL 888 (1016)
Q Consensus 811 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 888 (1016)
..............|+..|+|||.+.+.. .+.++||||||+++|||++|..||......... .........
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~--~~~~~~~~~----- 226 (288)
T cd05583 154 EFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQ--SEISRRILK----- 226 (288)
T ss_pred ccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchH--HHHHHHHHc-----
Confidence 65443322233356889999999987654 788999999999999999999998643221111 011111000
Q ss_pred cccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 001768 889 ELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933 (1016)
Q Consensus 889 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 933 (1016)
..+.. +......+.+++.+||+.||++|||+.++.+.|+
T Consensus 227 --~~~~~----~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~ 265 (288)
T cd05583 227 --SKPPF----PKTMSAEARDFIQKLLEKDPKKRLGANGADEIKN 265 (288)
T ss_pred --cCCCC----CcccCHHHHHHHHHHhcCCHhhccCcchHHHHhc
Confidence 01111 2223346889999999999999999998887665
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-32 Score=302.17 Aligned_cols=259 Identities=19% Similarity=0.240 Sum_probs=186.0
Q ss_pred HhcCccccCccccCCCeeEEEEEcCC----CcEEEEEEccCCChhhh-----------HHHHHHHHHHHhcCCCCeeeee
Q 001768 657 ATNNFDAANKIGEGGFGPVYKGTLSD----GAVIAVKQLSSKSKQGN-----------REFVNEIGMISALQHQNLVKLY 721 (1016)
Q Consensus 657 ~~~~f~~~~~LG~G~~G~Vy~~~~~~----~~~vAvK~~~~~~~~~~-----------~~~~~E~~~l~~l~HpnIv~l~ 721 (1016)
..++|++.+.||+|+||.||+|++.+ +..+|+|.......... .....+...+..++|+|+++++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 45689999999999999999999654 35667775432221110 1122333455667899999999
Q ss_pred eeEeecc----eeEEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEcc
Q 001768 722 GCCIEGN----QLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDK 797 (1016)
Q Consensus 722 ~~~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~ 797 (1016)
+++.... ..++++|++.. ++.+.+.... ..++..+..|+.|+++||+|||+. +|+||||||+|||++.
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~ 161 (294)
T PHA02882 90 GCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIK----CKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDG 161 (294)
T ss_pred EeeeEecCCceEEEEEEehhcc-CHHHHHHhhc----cCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcC
Confidence 9776543 44778887744 5666654321 357888999999999999999998 9999999999999999
Q ss_pred CCceeeeccccccccCCCCcc------eeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCc-hh
Q 001768 798 DLNAKISDFGLAKLDEDENTH------ISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPK-EE 870 (1016)
Q Consensus 798 ~~~~kL~DFGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~-~~ 870 (1016)
++.++|+|||+|+........ ......||+.|+|||+..+..++.++|||||||++|||++|+.||..... ..
T Consensus 162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~ 241 (294)
T PHA02882 162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN 241 (294)
T ss_pred CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH
Confidence 999999999999765332211 11224699999999999999999999999999999999999999986532 22
Q ss_pred hHhHHHHHHHHHHhCCcccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 001768 871 FVYLLDWAYVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933 (1016)
Q Consensus 871 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 933 (1016)
.......... .. ...+... ....+..+.+++..|++.+|++||+++++++.++
T Consensus 242 ~~~~~~~~~~-~~------~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 242 LIHAAKCDFI-KR------LHEGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHHhHHHHH-HH------hhhhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 2211111100 00 0000000 0112456899999999999999999999998763
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=302.22 Aligned_cols=260 Identities=23% Similarity=0.289 Sum_probs=194.0
Q ss_pred ccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCC-hhhhHHHHHHHHHHHhcC-CCCeeeeeeeEeec--ceeEEEEe
Q 001768 661 FDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS-KQGNREFVNEIGMISALQ-HQNLVKLYGCCIEG--NQLLLVYE 735 (1016)
Q Consensus 661 f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~--~~~~lV~E 735 (1016)
|++.+.||+|+||.||+|+.. +++.||+|+++... ........+|+.++.++. |||++++++++.++ +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 677899999999999999854 68999999987542 222234457888899885 99999999999987 88999999
Q ss_pred ecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCC
Q 001768 736 YLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDE 815 (1016)
Q Consensus 736 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 815 (1016)
|+++ +|.+.+.... ..+++.+++.++.|++.||+|||+. +++||||||+||+++. +.+||+|||+++.....
T Consensus 81 ~~~~-~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 81 LMDM-NLYELIKGRK---RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred cCCc-cHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 9974 7888775533 3589999999999999999999998 9999999999999999 99999999999865433
Q ss_pred CcceeeecccCccccChhhhc-cCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHH--------HHHHHhCC
Q 001768 816 NTHISTRIAGTVGYMAPEYAM-RGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWA--------YVLQEQGN 886 (1016)
Q Consensus 816 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~--------~~~~~~~~ 886 (1016)
... ....++..|+|||++. ++.++.++|||||||++|||++|+.||......+........ ........
T Consensus 153 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07831 153 PPY--TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSR 230 (282)
T ss_pred CCc--CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccc
Confidence 221 2345788999999765 456788999999999999999999999765443321111000 00000000
Q ss_pred cccccCCcCC-C---CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 887 LLELVDPSLG-S---NFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 887 ~~~~~d~~l~-~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
......+... . ......+..+.+++.+||+.+|++||+++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 231 HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 0000000000 0 001133568999999999999999999999884
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=307.38 Aligned_cols=263 Identities=24% Similarity=0.337 Sum_probs=194.7
Q ss_pred hcCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCCh--hhhHHHHHHHHHHHhcCCCCeeeeeeeEeecc------
Q 001768 658 TNNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSK--QGNREFVNEIGMISALQHQNLVKLYGCCIEGN------ 728 (1016)
Q Consensus 658 ~~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~------ 728 (1016)
-++|++.++||+|+||.||+|+.. +++.||+|.+..... .....+.+|++++++++||||+++++++...+
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 357999999999999999999965 689999998864422 22345678999999999999999999987643
Q ss_pred --eeEEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeecc
Q 001768 729 --QLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDF 806 (1016)
Q Consensus 729 --~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DF 806 (1016)
..++||||+.+ +|.+.+.... ..+++.+++.++.|++.||+|||++ +++|+||||+||+++.++.+||+||
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSNKN---VKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcC
Confidence 45999999975 7887775432 3589999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCCCcc---eeeecccCccccChhhhccC-CCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHH
Q 001768 807 GLAKLDEDENTH---ISTRIAGTVGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQ 882 (1016)
Q Consensus 807 Gla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~ 882 (1016)
|++......... ......++..|+|||.+.+. .++.++||||||+++|||++|+.||...........+.......
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~ 243 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI 243 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 999755332211 11234578889999988654 46889999999999999999999997655433222111100000
Q ss_pred Hh------------------CCcccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 883 EQ------------------GNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 883 ~~------------------~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
.. ..........+... .....+.+++.+||..||++|||++|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~---~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPY---VKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred ChhhcccccchhhhhhccCCCccchhhHHhcccc---cCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 00 00000000000000 01235678999999999999999998883
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=303.60 Aligned_cols=261 Identities=23% Similarity=0.348 Sum_probs=201.1
Q ss_pred ccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCChh--hhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEeec
Q 001768 661 FDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSKQ--GNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYL 737 (1016)
Q Consensus 661 f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 737 (1016)
|++.+.||+|++|.||+|... +++.+|+|.+...... ....+.+|++++++++|+||+++++++..++..++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 567889999999999999865 6889999998754332 4567888999999999999999999999999999999999
Q ss_pred CCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCCc
Q 001768 738 ENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENT 817 (1016)
Q Consensus 738 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 817 (1016)
++ ++.+++.... ..+++.++..++.|++.||+|||+. +|+|+||||+||+++.++.++|+|||.+........
T Consensus 81 ~~-~l~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~ 153 (283)
T cd05118 81 DT-DLYKLIKDRQ---RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR 153 (283)
T ss_pred CC-CHHHHHHhhc---ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc
Confidence 76 8888886543 3689999999999999999999998 999999999999999999999999999976554331
Q ss_pred ceeeecccCccccChhhhccC-CCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHH----------HHHH--H-
Q 001768 818 HISTRIAGTVGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWA----------YVLQ--E- 883 (1016)
Q Consensus 818 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~----------~~~~--~- 883 (1016)
......++..|+|||.+.+. .++.++||||||+++|+|++|+.||......+........ .... .
T Consensus 154 -~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd05118 154 -PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARN 232 (283)
T ss_pred -cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhh
Confidence 12234578899999998776 7899999999999999999999999765543322111000 0000 0
Q ss_pred -hCCcccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 884 -QGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 884 -~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
............ .......+.++.+++.+||+.||.+||++.+++.
T Consensus 233 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 233 YKFSFPKKAGMPL-PKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhccccccCH-HHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 000000000000 1112234568999999999999999999999884
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=310.98 Aligned_cols=265 Identities=23% Similarity=0.352 Sum_probs=198.7
Q ss_pred HhcCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCC--ChhhhHHHHHHHHHHHhc-CCCCeeeeeeeEeec--cee
Q 001768 657 ATNNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSK--SKQGNREFVNEIGMISAL-QHQNLVKLYGCCIEG--NQL 730 (1016)
Q Consensus 657 ~~~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~--~~~ 730 (1016)
..++|++.+.||+|+||.||+|... +++.||+|++... .......+.+|+.+++++ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 4678999999999999999999965 5889999988543 223345677899999999 999999999998653 468
Q ss_pred EEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeecccccc
Q 001768 731 LLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAK 810 (1016)
Q Consensus 731 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~ 810 (1016)
++||||++ ++|..++... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 85 ~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~ 155 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN-----ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLAR 155 (337)
T ss_pred EEEecccc-cCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchh
Confidence 99999997 4898888543 588999999999999999999998 99999999999999999999999999997
Q ss_pred ccCCCCc----ceeeecccCccccChhhhcc-CCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHH------
Q 001768 811 LDEDENT----HISTRIAGTVGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAY------ 879 (1016)
Q Consensus 811 ~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~------ 879 (1016)
....... .......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||......+.........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07852 156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAE 235 (337)
T ss_pred ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 5543321 12234568999999998764 467889999999999999999999997654433211110000
Q ss_pred ----H-HHHhCCcccccCCcCC---CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 880 ----V-LQEQGNLLELVDPSLG---SNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 880 ----~-~~~~~~~~~~~d~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
. ......+.+.....-. ....+..+..+.+++.+||+.||++|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~ 294 (337)
T cd07852 236 DIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALE 294 (337)
T ss_pred HHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhh
Confidence 0 0000000000000000 0011113457899999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=302.67 Aligned_cols=244 Identities=23% Similarity=0.349 Sum_probs=193.3
Q ss_pred CccccCccccCCCeeEEEEEc----CCCcEEEEEEccCCC----hhhhHHHHHHHHHHHhc-CCCCeeeeeeeEeeccee
Q 001768 660 NFDAANKIGEGGFGPVYKGTL----SDGAVIAVKQLSSKS----KQGNREFVNEIGMISAL-QHQNLVKLYGCCIEGNQL 730 (1016)
Q Consensus 660 ~f~~~~~LG~G~~G~Vy~~~~----~~~~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~ 730 (1016)
+|++.+.||+|+||.||+|+. .+|+.||+|++.... ....+.+.+|+++++++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 478899999999999999985 368999999987532 22346678899999999 599999999999999999
Q ss_pred EEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeecccccc
Q 001768 731 LLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAK 810 (1016)
Q Consensus 731 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~ 810 (1016)
++||||+++++|.+++.... .+++..+..++.|+++||+|||+. +++||||||+||++++++.+||+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 153 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE----RFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK 153 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccce
Confidence 99999999999999996543 588999999999999999999998 99999999999999999999999999997
Q ss_pred ccCCCCcceeeecccCccccChhhhccC--CCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcc
Q 001768 811 LDEDENTHISTRIAGTVGYMAPEYAMRG--YLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLL 888 (1016)
Q Consensus 811 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 888 (1016)
..............|+..|+|||.+.+. .++.++||||||+++|+|++|+.||......... .........
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~--~~~~~~~~~----- 226 (290)
T cd05613 154 EFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQ--AEISRRILK----- 226 (290)
T ss_pred ecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccH--HHHHHHhhc-----
Confidence 6544332223345688999999998753 4678999999999999999999998643221111 111110000
Q ss_pred cccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCC
Q 001768 889 ELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRP 923 (1016)
Q Consensus 889 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP 923 (1016)
..+ .++......+.+++.+||+.||++||
T Consensus 227 --~~~----~~~~~~~~~~~~ll~~~l~~~p~~R~ 255 (290)
T cd05613 227 --SEP----PYPQEMSALAKDIIQRLLMKDPKKRL 255 (290)
T ss_pred --cCC----CCCccCCHHHHHHHHHHhcCCHHHhc
Confidence 011 12223445788999999999999998
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=300.57 Aligned_cols=254 Identities=26% Similarity=0.361 Sum_probs=197.3
Q ss_pred cccCCCeeEEEEEcC-CCcEEEEEEccCCC---hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEeecCCCcH
Q 001768 667 IGEGGFGPVYKGTLS-DGAVIAVKQLSSKS---KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYLENNSL 742 (1016)
Q Consensus 667 LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 742 (1016)
||+|+||+||+|... +|+.||+|.+.... ......+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999854 68999999986532 22344567899999999999999999999999999999999999999
Q ss_pred HHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCCcceeee
Q 001768 743 ARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTR 822 (1016)
Q Consensus 743 ~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 822 (1016)
.+++..... ..+++.++..++.|++.||.|||+. +++||||+|+||++++++.++|+|||.+....... ....
T Consensus 81 ~~~l~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~ 153 (277)
T cd05577 81 KYHIYNVGE--PGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKG 153 (277)
T ss_pred HHHHHHcCc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCC--cccc
Confidence 999965432 3589999999999999999999998 99999999999999999999999999987554321 1223
Q ss_pred cccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCCCCCCHH
Q 001768 823 IAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGSNFSKK 902 (1016)
Q Consensus 823 ~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 902 (1016)
..++..|+|||.+.+..++.++|||||||++|+|++|+.||............. .... . ....++..
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-------~~~~-~-----~~~~~~~~ 220 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELK-------RRTL-E-----MAVEYPDK 220 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHH-------hccc-c-----ccccCCcc
Confidence 457889999999988889999999999999999999999997544321111000 0000 0 01112223
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHH-HHHHhccCcCCcCccccC
Q 001768 903 EAMTMLNIALLCTNPSPTLRPTMSS-AVSMLEGKTAVQAPIIRR 945 (1016)
Q Consensus 903 ~~~~l~~li~~cl~~dP~~RPt~~e-vl~~L~~~~~~~~p~~~~ 945 (1016)
....+.+++.+||+.||++||++.+ ..+.|. .|||+.+
T Consensus 221 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll-----~h~~~~~ 259 (277)
T cd05577 221 FSPEAKDLCEALLQKDPEKRLGCRGGSADEVR-----EHPLFKD 259 (277)
T ss_pred CCHHHHHHHHHHccCChhHccCCCcccHHHHH-----hChhhhc
Confidence 3457899999999999999995544 333332 3777653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-32 Score=304.53 Aligned_cols=259 Identities=20% Similarity=0.266 Sum_probs=192.5
Q ss_pred ccCccccCCCeeEEEEEcCCCcEEEEEEccCC--ChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEeecCCC
Q 001768 663 AANKIGEGGFGPVYKGTLSDGAVIAVKQLSSK--SKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYLENN 740 (1016)
Q Consensus 663 ~~~~LG~G~~G~Vy~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 740 (1016)
+.+.+|.|+++.||++.. +++.||+|++... .....+.+.+|+++++.++||||+++++++.+++..+++|||++++
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 344555556666666555 6899999998754 3445678999999999999999999999999999999999999999
Q ss_pred cHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCCc---
Q 001768 741 SLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENT--- 817 (1016)
Q Consensus 741 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~--- 817 (1016)
+|.+++..... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.+........
T Consensus 85 ~l~~~l~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 85 SCEDLLKTHFP--EGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred CHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence 99999975432 2588999999999999999999998 999999999999999999999999998864322111
Q ss_pred ---ceeeecccCccccChhhhccC--CCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHH-----------HH
Q 001768 818 ---HISTRIAGTVGYMAPEYAMRG--YLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAY-----------VL 881 (1016)
Q Consensus 818 ---~~~~~~~gt~~y~aPE~~~~~--~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~-----------~~ 881 (1016)
.......++..|+|||++.+. .++.++|||||||++|||++|+.||......... .+... ..
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 237 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQML--LEKVRGTVPCLLDKSTYP 237 (314)
T ss_pred ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHhccCccccccCchh
Confidence 111234577889999998753 5788999999999999999999999764432211 10000 00
Q ss_pred HHhCCccc----ccCCc----CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 001768 882 QEQGNLLE----LVDPS----LGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAV 929 (1016)
Q Consensus 882 ~~~~~~~~----~~d~~----l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 929 (1016)
........ ..++. ............+.+++.+||+.||++|||+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll 293 (314)
T cd08216 238 LYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLL 293 (314)
T ss_pred hhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHh
Confidence 00000000 00000 01112233456788999999999999999999888
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-32 Score=306.05 Aligned_cols=261 Identities=21% Similarity=0.304 Sum_probs=192.6
Q ss_pred CccccC--CCeeEEEEEcC-CCcEEEEEEccCCC--hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEeecCC
Q 001768 665 NKIGEG--GFGPVYKGTLS-DGAVIAVKQLSSKS--KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYLEN 739 (1016)
Q Consensus 665 ~~LG~G--~~G~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 739 (1016)
..||+| +||+||+++.. +|+.||+|++.... ....+.+.+|+.+++.++||||+++++++..++..++||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456666 99999999964 78999999986532 23346788999999999999999999999999999999999999
Q ss_pred CcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCCcce
Q 001768 740 NSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHI 819 (1016)
Q Consensus 740 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 819 (1016)
+++.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 84 GSANSLLKTYFP--EGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred CCHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 999999866432 2589999999999999999999998 99999999999999999999999998653221111100
Q ss_pred ------eeecccCccccChhhhccC--CCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHh-HHHH-----------HH
Q 001768 820 ------STRIAGTVGYMAPEYAMRG--YLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVY-LLDW-----------AY 879 (1016)
Q Consensus 820 ------~~~~~gt~~y~aPE~~~~~--~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~-~~~~-----------~~ 879 (1016)
.....++..|+|||++.+. .++.++|||||||++|||++|+.||.......... .... ..
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPC 238 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccch
Confidence 1112346679999998764 47899999999999999999999997543322110 0000 00
Q ss_pred HHHH----hCC----c----------ccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 880 VLQE----QGN----L----------LELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 880 ~~~~----~~~----~----------~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
.... ... + ....+..+...........+.+++.+||+.||++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 0000 000 0 0011111112223345668999999999999999999998883
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=313.92 Aligned_cols=269 Identities=25% Similarity=0.372 Sum_probs=203.7
Q ss_pred CccccCccccCCCeeEEEEE-cCCCcEEEEEEccCCC-hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeec------ceeE
Q 001768 660 NFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLSSKS-KQGNREFVNEIGMISALQHQNLVKLYGCCIEG------NQLL 731 (1016)
Q Consensus 660 ~f~~~~~LG~G~~G~Vy~~~-~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------~~~~ 731 (1016)
.|...+.||+||||.||+|+ ...|+.||||.+.... ....+...+|+++|++++|||||++.+.-++. ....
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 34556889999999999999 4579999999998653 34456788999999999999999999986653 3579
Q ss_pred EEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEc--cCC--ceeeeccc
Q 001768 732 LVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLD--KDL--NAKISDFG 807 (1016)
Q Consensus 732 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~--~~~--~~kL~DFG 807 (1016)
+|||||.+|+|...+...++ +..|++.+.+.++.+++.||.|||++ +|+||||||.||++- ++| .-||+|||
T Consensus 94 lvmEyC~gGsL~~~L~~PEN-~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG 169 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPEN-AYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFG 169 (732)
T ss_pred EEEeecCCCcHHHHhcCccc-ccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccc
Confidence 99999999999999987664 45799999999999999999999998 999999999999983 334 37999999
Q ss_pred cccccCCCCcceeeecccCccccChhhhcc-CCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCC
Q 001768 808 LAKLDEDENTHISTRIAGTVGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGN 886 (1016)
Q Consensus 808 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 886 (1016)
.|+..+++. ......||..|.+||...+ +.++..+|.|||||++|+.+||..||...........+.|.........
T Consensus 170 ~Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~ 247 (732)
T KOG4250|consen 170 AARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSG 247 (732)
T ss_pred ccccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCc
Confidence 999776654 4466899999999999984 8899999999999999999999999964332221111222211111111
Q ss_pred cccccCC------------cCCCCCCHHHHHHHHHHHHHccCCCCCCCC--CHHHHHHHhcc
Q 001768 887 LLELVDP------------SLGSNFSKKEAMTMLNIALLCTNPSPTLRP--TMSSAVSMLEG 934 (1016)
Q Consensus 887 ~~~~~d~------------~l~~~~~~~~~~~l~~li~~cl~~dP~~RP--t~~evl~~L~~ 934 (1016)
..-...+ ..+..........+-..+..++..+|++|. .+.+....+..
T Consensus 248 v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~d 309 (732)
T KOG4250|consen 248 VAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDD 309 (732)
T ss_pred eeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHH
Confidence 1111110 012223344555667777788888999998 65555555443
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-32 Score=300.26 Aligned_cols=261 Identities=26% Similarity=0.354 Sum_probs=195.7
Q ss_pred ccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCCh--hhhHHHHHHHHHHHhc---CCCCeeeeeeeEeecce-----
Q 001768 661 FDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSK--QGNREFVNEIGMISAL---QHQNLVKLYGCCIEGNQ----- 729 (1016)
Q Consensus 661 f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l---~HpnIv~l~~~~~~~~~----- 729 (1016)
|++.+.||+|+||.||+|+.+ +++.||+|++..... .....+.+|+.+++++ +|||++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 677899999999999999976 489999999874322 2234566788777666 59999999999988776
Q ss_pred eEEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccc
Q 001768 730 LLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLA 809 (1016)
Q Consensus 730 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla 809 (1016)
.+++|||+++ +|.+++..... ..+++..++.++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||.+
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPK--PGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred eEEEehhccc-CHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcc
Confidence 9999999975 78888865432 2589999999999999999999998 8999999999999999999999999999
Q ss_pred cccCCCCcceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHH-HHHHHHHHhC--C
Q 001768 810 KLDEDENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLL-DWAYVLQEQG--N 886 (1016)
Q Consensus 810 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~-~~~~~~~~~~--~ 886 (1016)
........ .....++..|+|||++.+..++.++|||||||++|||++|++||......+....+ +......... .
T Consensus 155 ~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07838 155 RIYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPR 232 (287)
T ss_pred eeccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCC
Confidence 76543322 12235788999999999888999999999999999999999998765443321111 0000000000 0
Q ss_pred c----ccccCCcCC---CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 001768 887 L----LELVDPSLG---SNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAV 929 (1016)
Q Consensus 887 ~----~~~~d~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 929 (1016)
. ......... ....+.....+.+++.+||+.||++||++.+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il 282 (287)
T cd07838 233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEAL 282 (287)
T ss_pred CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHh
Confidence 0 000000000 111123346788999999999999999999888
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=278.83 Aligned_cols=258 Identities=26% Similarity=0.403 Sum_probs=200.2
Q ss_pred CccccCccccCCCeeEEEEEcC-CCcEEEEEEccCC-ChhhhHHHHHHHHHHHhc-CCCCeeeeeeeEeecceeEEEEee
Q 001768 660 NFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSK-SKQGNREFVNEIGMISAL-QHQNLVKLYGCCIEGNQLLLVYEY 736 (1016)
Q Consensus 660 ~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~ 736 (1016)
+.+.+..||.|..|.|++++.+ .|..+|||.+... ..+..+++...+.++..- ++|.||+.+|||..+...++.||.
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMel 172 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMEL 172 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHH
Confidence 3455788999999999999965 5899999998765 344566777777776655 499999999999999999999999
Q ss_pred cCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCC
Q 001768 737 LENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDEN 816 (1016)
Q Consensus 737 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 816 (1016)
|.. .++.++..-. .++++..+-++...+++||.||.++. +|+|||+||+|||+|+.|++||||||.+...-+..
T Consensus 173 Ms~-C~ekLlkrik---~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk 246 (391)
T KOG0983|consen 173 MST-CAEKLLKRIK---GPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK 246 (391)
T ss_pred HHH-HHHHHHHHhc---CCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccc
Confidence 843 5555554332 36888889999999999999999874 99999999999999999999999999997665543
Q ss_pred cceeeecccCccccChhhhcc---CCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCC
Q 001768 817 THISTRIAGTVGYMAPEYAMR---GYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDP 893 (1016)
Q Consensus 817 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 893 (1016)
..++.+|-+.|||||.+.- ..|+.++||||||++++||+||+.||..-..+- ..+. ....+ ..|
T Consensus 247 --AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdF-e~lt---kvln~-------ePP 313 (391)
T KOG0983|consen 247 --AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDF-EVLT---KVLNE-------EPP 313 (391)
T ss_pred --ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccH-HHHH---HHHhc-------CCC
Confidence 3356689999999999863 368889999999999999999999998633221 1111 11111 113
Q ss_pred cCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCcCCcCccccCCC
Q 001768 894 SLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTAVQAPIIRRNS 947 (1016)
Q Consensus 894 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~p~~~~~~ 947 (1016)
.++.. ......+.+++..||.+|+.+||...+++ +||++.+..
T Consensus 314 ~L~~~--~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll---------~h~Fi~~ye 356 (391)
T KOG0983|consen 314 LLPGH--MGFSPDFQSFVKDCLTKDHRKRPKYNKLL---------EHPFIKRYE 356 (391)
T ss_pred CCCcc--cCcCHHHHHHHHHHhhcCcccCcchHHHh---------cCcceeecc
Confidence 33221 12455789999999999999999998877 577766543
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-32 Score=307.98 Aligned_cols=264 Identities=21% Similarity=0.279 Sum_probs=195.2
Q ss_pred hcCccc-cCccccCCCeeEEEEEcC-CCcEEEEEEccCCChhh--------------hHHHHHHHHHHHhcCCCCeeeee
Q 001768 658 TNNFDA-ANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSKQG--------------NREFVNEIGMISALQHQNLVKLY 721 (1016)
Q Consensus 658 ~~~f~~-~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~~~~--------------~~~~~~E~~~l~~l~HpnIv~l~ 721 (1016)
.++|.. .+.||+|+||.||+|+.. +++.||+|.+....... ...+.+|+++++.++||||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 345654 467999999999999965 68999999986432211 12477899999999999999999
Q ss_pred eeEeecceeEEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCce
Q 001768 722 GCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNA 801 (1016)
Q Consensus 722 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ 801 (1016)
+++..++..++||||++ ++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~----~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~ 158 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVDRKI----RLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGIC 158 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCE
Confidence 99999999999999997 58998885432 589999999999999999999998 99999999999999999999
Q ss_pred eeeccccccccCCCC-------------cceeeecccCccccChhhhccC-CCCCccchhHHHHHHHHHHhCCCCCCCCC
Q 001768 802 KISDFGLAKLDEDEN-------------THISTRIAGTVGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGKSNTNYRP 867 (1016)
Q Consensus 802 kL~DFGla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~P~~~~~ 867 (1016)
+|+|||++....... ........++..|+|||.+.+. .++.++|||||||++|||++|+.||....
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~ 238 (335)
T PTZ00024 159 KIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238 (335)
T ss_pred EECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999997554111 0111223467889999998764 46889999999999999999999997665
Q ss_pred chhhHhHHHHHHHHHHhCCcccc--------cCCcCCC---CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 001768 868 KEEFVYLLDWAYVLQEQGNLLEL--------VDPSLGS---NFSKKEAMTMLNIALLCTNPSPTLRPTMSSAV 929 (1016)
Q Consensus 868 ~~~~~~~~~~~~~~~~~~~~~~~--------~d~~l~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 929 (1016)
..+....+...........+.+. ..+.... .........+.+++.+|++.+|++||+++|++
T Consensus 239 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l 311 (335)
T PTZ00024 239 EIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEAL 311 (335)
T ss_pred HHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHh
Confidence 43322111000000000000000 0000000 00112245688999999999999999999888
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-32 Score=300.38 Aligned_cols=251 Identities=28% Similarity=0.430 Sum_probs=192.8
Q ss_pred hcCccccCccccCCCeeEEEEEcCC-CcEEEEEEccCCC-hhhhHHHHHHHHHHHhcC-CCCeeeeeeeEeecceeEEEE
Q 001768 658 TNNFDAANKIGEGGFGPVYKGTLSD-GAVIAVKQLSSKS-KQGNREFVNEIGMISALQ-HQNLVKLYGCCIEGNQLLLVY 734 (1016)
Q Consensus 658 ~~~f~~~~~LG~G~~G~Vy~~~~~~-~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~ 734 (1016)
.++|++.+.||+|+||.||+|.+.+ ++.||||.+.... ......+..|+.++.+.. ||||+++++++.++...++||
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 4678889999999999999999764 8999999987543 233455667777776664 999999999999999999999
Q ss_pred eecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCC
Q 001768 735 EYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDED 814 (1016)
Q Consensus 735 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 814 (1016)
||+++ ++.+++.... ..+++..+..++.|++.||+|||+.. +|+||||+|+||++++++.+||+|||++.....
T Consensus 94 e~~~~-~l~~l~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 94 ELMST-CLDKLLKRIQ---GPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred eccCc-CHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 99854 6777664432 26899999999999999999999732 899999999999999999999999999876543
Q ss_pred CCcceeeecccCccccChhhhccC----CCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccc
Q 001768 815 ENTHISTRIAGTVGYMAPEYAMRG----YLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLEL 890 (1016)
Q Consensus 815 ~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 890 (1016)
.... ....++..|+|||.+.+. .++.++||||||+++|||++|+.||........ .+. .... ...
T Consensus 168 ~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~---~~~~--~~~--- 236 (296)
T cd06618 168 SKAK--TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFE-VLT---KILQ--EEP--- 236 (296)
T ss_pred CCcc--cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHH-HHH---HHhc--CCC---
Confidence 3221 233578899999998754 378899999999999999999999865322110 000 0000 000
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 001768 891 VDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAV 929 (1016)
Q Consensus 891 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 929 (1016)
+.... .......+.+++.+||+.||++||++.+++
T Consensus 237 --~~~~~--~~~~~~~l~~li~~~l~~~p~~Rp~~~~il 271 (296)
T cd06618 237 --PSLPP--NEGFSPDFCSFVDLCLTKDHRKRPKYRELL 271 (296)
T ss_pred --CCCCC--CCCCCHHHHHHHHHHccCChhhCCCHHHHh
Confidence 11110 112345689999999999999999999888
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=300.65 Aligned_cols=247 Identities=24% Similarity=0.365 Sum_probs=202.0
Q ss_pred cCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCC---ChhhhHHHHHHHHHHHhcC-CCCeeeeeeeEeecceeEEE
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSK---SKQGNREFVNEIGMISALQ-HQNLVKLYGCCIEGNQLLLV 733 (1016)
Q Consensus 659 ~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV 733 (1016)
++|.+.+.||+|+||.||+|+.. +++.||+|++... .....+.+.+|++++++++ ||||+++++++.+++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47889999999999999999965 6899999998653 2233467889999999998 99999999999999999999
Q ss_pred EeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccC
Q 001768 734 YEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDE 813 (1016)
Q Consensus 734 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~ 813 (1016)
|||+++++|.+++.... .+++..++.++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~~~----~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 81 LEYAPNGELLQYIRKYG----SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLD 153 (280)
T ss_pred EcCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence 99999999999996543 699999999999999999999998 99999999999999999999999999987554
Q ss_pred CCCc-------------------ceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhH
Q 001768 814 DENT-------------------HISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYL 874 (1016)
Q Consensus 814 ~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~ 874 (1016)
.... .......++..|+|||...+..++.++||||||++++++++|+.||..........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~- 232 (280)
T cd05581 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQ- 232 (280)
T ss_pred CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHH-
Confidence 3321 11223467889999999988889999999999999999999999997654221110
Q ss_pred HHHHHHHHHhCCcccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCH----HHHH
Q 001768 875 LDWAYVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTM----SSAV 929 (1016)
Q Consensus 875 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~----~evl 929 (1016)
.... .. ..++...+..+.+++.+||+.+|.+||++ .+++
T Consensus 233 ----~~~~--------~~----~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll 275 (280)
T cd05581 233 ----KILK--------LE----YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELK 275 (280)
T ss_pred ----HHHh--------cC----CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHh
Confidence 0000 01 11222234568999999999999999999 6665
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=311.21 Aligned_cols=263 Identities=22% Similarity=0.320 Sum_probs=201.8
Q ss_pred CccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCC--hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecc-----eeE
Q 001768 660 NFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS--KQGNREFVNEIGMISALQHQNLVKLYGCCIEGN-----QLL 731 (1016)
Q Consensus 660 ~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~-----~~~ 731 (1016)
+|++.+.||+|++|.||+|+.. +++.||+|++.... ....+.+.+|+++++.++||||+++++++...+ ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5888999999999999999965 48999999987643 334567889999999999999999999998765 789
Q ss_pred EEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccc
Q 001768 732 LVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKL 811 (1016)
Q Consensus 732 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~ 811 (1016)
+||||+++ +|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.++|+|||.+..
T Consensus 81 lv~e~~~~-~l~~~l~~~~----~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~ 152 (330)
T cd07834 81 IVTELMET-DLHKVIKSPQ----PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARG 152 (330)
T ss_pred EEecchhh-hHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence 99999984 8888885543 699999999999999999999998 999999999999999999999999999986
Q ss_pred cCCCCc--ceeeecccCccccChhhhccC-CCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHH-------
Q 001768 812 DEDENT--HISTRIAGTVGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVL------- 881 (1016)
Q Consensus 812 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~------- 881 (1016)
...... .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||......+....+......
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 232 (330)
T cd07834 153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLK 232 (330)
T ss_pred ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhh
Confidence 544321 112334678899999999877 7899999999999999999999999766544322111100000
Q ss_pred -HHhCCcccccC---CcCC---CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 882 -QEQGNLLELVD---PSLG---SNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 882 -~~~~~~~~~~d---~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
.......+.+. .... .......+..+.+++.+||+.+|.+||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 288 (330)
T cd07834 233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA 288 (330)
T ss_pred hccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 00000000000 0000 0001123457899999999999999999999883
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-32 Score=303.18 Aligned_cols=247 Identities=29% Similarity=0.436 Sum_probs=195.7
Q ss_pred hcCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCC---ChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEE
Q 001768 658 TNNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSK---SKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLV 733 (1016)
Q Consensus 658 ~~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 733 (1016)
.+.|+..+.||+|+||.||+|+.. +++.||+|.+... ......++.+|+++++.++|+|++++++++..+...++|
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 93 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence 344777899999999999999964 5789999988642 223345678899999999999999999999999999999
Q ss_pred EeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccC
Q 001768 734 YEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDE 813 (1016)
Q Consensus 734 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~ 813 (1016)
|||+. |++.+.+.... ..+++.++..++.|++.|+.|||+. +++||||||+||+++.++.++|+|||++....
T Consensus 94 ~e~~~-~~l~~~~~~~~---~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 166 (308)
T cd06634 94 MEYCL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166 (308)
T ss_pred EEccC-CCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeec
Confidence 99997 57877775432 2589999999999999999999998 99999999999999999999999999987544
Q ss_pred CCCcceeeecccCccccChhhhc---cCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccc
Q 001768 814 DENTHISTRIAGTVGYMAPEYAM---RGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLEL 890 (1016)
Q Consensus 814 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 890 (1016)
.. ....+++.|+|||.+. .+.++.++|||||||++|||++|+.||......+..... . ....
T Consensus 167 ~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~------~-~~~~--- 231 (308)
T cd06634 167 PA-----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI------A-QNES--- 231 (308)
T ss_pred Cc-----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHH------h-hcCC---
Confidence 32 2345788999999875 346788999999999999999999998654322211100 0 0000
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001768 891 VDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSM 931 (1016)
Q Consensus 891 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 931 (1016)
+.. ........+.+++.+||+.+|++||++.++++.
T Consensus 232 --~~~---~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~ 267 (308)
T cd06634 232 --PAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (308)
T ss_pred --CCc---CcccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence 111 112344568899999999999999999999853
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-32 Score=296.81 Aligned_cols=247 Identities=24% Similarity=0.300 Sum_probs=190.6
Q ss_pred ccccCCCeeEEEEEcC-CCcEEEEEEccCCCh---hhhHHHHHHH---HHHHhcCCCCeeeeeeeEeecceeEEEEeecC
Q 001768 666 KIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSK---QGNREFVNEI---GMISALQHQNLVKLYGCCIEGNQLLLVYEYLE 738 (1016)
Q Consensus 666 ~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~E~---~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 738 (1016)
.||+|+||.||+|+.. +++.||+|.+..... .....+..|. +.++...||+|+++++++.+++..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999864 588999999865421 1122233443 34445689999999999999999999999999
Q ss_pred CCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCCcc
Q 001768 739 NNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTH 818 (1016)
Q Consensus 739 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 818 (1016)
+++|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.++|+|||++.......
T Consensus 81 g~~L~~~l~~~----~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~-- 151 (278)
T cd05606 81 GGDLHYHLSQH----GVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (278)
T ss_pred CCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC--
Confidence 99999988543 2699999999999999999999998 89999999999999999999999999987543322
Q ss_pred eeeecccCccccChhhhccC-CCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCCC
Q 001768 819 ISTRIAGTVGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGS 897 (1016)
Q Consensus 819 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 897 (1016)
.....|+..|+|||.+.++ .++.++||||+||++|||++|+.||............ .. .....+.++
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~-~~---------~~~~~~~~~- 219 (278)
T cd05606 152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID-RM---------TLTMAVELP- 219 (278)
T ss_pred -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH-HH---------hhccCCCCC-
Confidence 1234689999999998754 6889999999999999999999999764322211100 00 001112222
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHhccCcCCcCccccC
Q 001768 898 NFSKKEAMTMLNIALLCTNPSPTLRP-----TMSSAVSMLEGKTAVQAPIIRR 945 (1016)
Q Consensus 898 ~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~L~~~~~~~~p~~~~ 945 (1016)
...+..+.+++.+|+..+|.+|| ++.+++ .+||+..
T Consensus 220 ---~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll---------~~~~~~~ 260 (278)
T cd05606 220 ---DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVK---------EHPFFRS 260 (278)
T ss_pred ---CcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHH---------hCccccC
Confidence 22345789999999999999999 888886 4677654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=328.24 Aligned_cols=259 Identities=23% Similarity=0.294 Sum_probs=210.0
Q ss_pred HHHHHHHhcCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCC---ChhhhHHHHHHHHHHHhcCCCCeeeeeeeEee
Q 001768 651 LRQIKAATNNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSK---SKQGNREFVNEIGMISALQHQNLVKLYGCCIE 726 (1016)
Q Consensus 651 ~~~l~~~~~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 726 (1016)
.+++....++|++++.||+|+||.|..++.+ .++.||.|++.+. ......-|.+|-.+|.-.+.+-|+.+.-.|++
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 3555667789999999999999999999965 6889999999863 23344568889999999999999999999999
Q ss_pred cceeEEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeecc
Q 001768 727 GNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDF 806 (1016)
Q Consensus 727 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DF 806 (1016)
+.++|+|||||+||+|..++.... ++++..++-++..|+.||.-+|+. |+|||||||+|||+|..|++||+||
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~~----~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADF 219 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKFD----RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADF 219 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhcC----CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccc
Confidence 999999999999999999996554 699999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCCCcceeeecccCccccChhhhc----c-CCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHH
Q 001768 807 GLAKLDEDENTHISTRIAGTVGYMAPEYAM----R-GYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVL 881 (1016)
Q Consensus 807 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~ 881 (1016)
|.+-.+..++...+...+|||.|++||++. + +.|++.+|.||+||++|||+.|..||....-.+. +..+.
T Consensus 220 GsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveT-----Y~KIm 294 (1317)
T KOG0612|consen 220 GSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVET-----YGKIM 294 (1317)
T ss_pred hhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHH-----HHHHh
Confidence 999888877777777889999999999986 2 5789999999999999999999999975432221 11111
Q ss_pred HHhCCcccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCC---HHHHHH
Q 001768 882 QEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPT---MSSAVS 930 (1016)
Q Consensus 882 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~evl~ 930 (1016)
.. .+...+.+ ....+....+||.+.+. +|+.|.. +.++-.
T Consensus 295 ~h-k~~l~FP~-------~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 295 NH-KESLSFPD-------ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN 337 (1317)
T ss_pred ch-hhhcCCCc-------ccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence 11 11111110 02244567777776654 6788887 777764
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=300.50 Aligned_cols=250 Identities=30% Similarity=0.474 Sum_probs=197.4
Q ss_pred ccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCC---hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEee
Q 001768 661 FDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS---KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEY 736 (1016)
Q Consensus 661 f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 736 (1016)
|...+.||+|+||.||+|+.. +++.||+|.+.... ......+.+|+++++.++|||++++++++.++...++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 556788999999999999864 68899999986432 23345688899999999999999999999999999999999
Q ss_pred cCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCC
Q 001768 737 LENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDEN 816 (1016)
Q Consensus 737 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 816 (1016)
+. +++.+.+.... .++++.++..++.|++.|++|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 103 ~~-~~l~~~l~~~~---~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~- 174 (313)
T cd06633 103 CL-GSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA- 174 (313)
T ss_pred CC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCCC-
Confidence 96 57777775432 3589999999999999999999998 9999999999999999999999999998643221
Q ss_pred cceeeecccCccccChhhhc---cCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCC
Q 001768 817 THISTRIAGTVGYMAPEYAM---RGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDP 893 (1016)
Q Consensus 817 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 893 (1016)
....|+..|+|||++. .+.++.++|||||||++|||++|+.||............ . .... +
T Consensus 175 ----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~------~-~~~~-----~ 238 (313)
T cd06633 175 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI------A-QNDS-----P 238 (313)
T ss_pred ----CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH------H-hcCC-----C
Confidence 2346888999999974 456888999999999999999999998754432221111 0 0111 1
Q ss_pred cCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCcCCcCccccCC
Q 001768 894 SLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTAVQAPIIRRN 946 (1016)
Q Consensus 894 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~p~~~~~ 946 (1016)
.. ........+.+++.+||+.+|.+||++.+++ .+||++..
T Consensus 239 ~~---~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l---------~~~~~~~~ 279 (313)
T cd06633 239 TL---QSNEWTDSFRGFVDYCLQKIPQERPASAELL---------RHDFVRRD 279 (313)
T ss_pred CC---CccccCHHHHHHHHHHccCChhhCcCHHHHh---------cCcccCCC
Confidence 11 1112234688999999999999999999888 46776654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=296.92 Aligned_cols=262 Identities=23% Similarity=0.344 Sum_probs=197.5
Q ss_pred ccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCCh-hhhHHHHHHHHHHHhcC-CCCeeeeeeeEeecceeEEEEeec
Q 001768 661 FDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSK-QGNREFVNEIGMISALQ-HQNLVKLYGCCIEGNQLLLVYEYL 737 (1016)
Q Consensus 661 f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~E~~ 737 (1016)
|++.+.||+|++|+||+|+.. +++.||+|++..... .......+|+..+++++ ||||+++++++.+++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 677899999999999999975 578999999865432 22334567999999999 999999999999999999999999
Q ss_pred CCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCCc
Q 001768 738 ENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENT 817 (1016)
Q Consensus 738 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 817 (1016)
+++|.+++.... ...+++..+..++.|++.+|.|||+. +++|+||+|+||++++++.++|+|||.+........
T Consensus 81 -~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 81 -EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP 154 (283)
T ss_pred -CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence 789999886543 23689999999999999999999998 999999999999999999999999999975543322
Q ss_pred ceeeecccCccccChhhhcc-CCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHH----------HHHHHHHhCC
Q 001768 818 HISTRIAGTVGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLD----------WAYVLQEQGN 886 (1016)
Q Consensus 818 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~----------~~~~~~~~~~ 886 (1016)
.....++..|+|||.+.+ ..++.++|+||||+++|||++|++||......+...... |.........
T Consensus 155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07830 155 --YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK 232 (283)
T ss_pred --cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence 123467889999998754 457899999999999999999999997654433211110 1000000000
Q ss_pred cccccCCcCC---CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 887 LLELVDPSLG---SNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 887 ~~~~~d~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
....+..... ..........+.+++.+||+.+|++|||+.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 0000000000 0000112357899999999999999999999874
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-32 Score=306.77 Aligned_cols=248 Identities=23% Similarity=0.338 Sum_probs=206.1
Q ss_pred hcCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCCh--hhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEE
Q 001768 658 TNNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSK--QGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVY 734 (1016)
Q Consensus 658 ~~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 734 (1016)
...|.+...||+|.|+.|.+|+.. .+..||+|.+.+..- ...+.+.+|+++|+.++|||||+++.+......+|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 456888999999999999999965 689999999986542 23355889999999999999999999999999999999
Q ss_pred eecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCC
Q 001768 735 EYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDED 814 (1016)
Q Consensus 735 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 814 (1016)
||+.+|.+.+++.... ...+..+..++.|+.+|++|||++ .|||||||++|||++.+..+||+|||++..+..
T Consensus 135 eya~~ge~~~yl~~~g----r~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~ 207 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHG----RMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFDY 207 (596)
T ss_pred EeccCchhHHHHHhcc----cchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeecc
Confidence 9999999999997664 466688999999999999999999 899999999999999999999999999987764
Q ss_pred CCcceeeecccCccccChhhhccCC-CCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCC
Q 001768 815 ENTHISTRIAGTVGYMAPEYAMRGY-LTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDP 893 (1016)
Q Consensus 815 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 893 (1016)
. ......+|++.|.|||++.+.. .++++|+||+|+++|-|+.|..||++..-.+... ..+-.
T Consensus 208 ~--~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~---------------rvl~g 270 (596)
T KOG0586|consen 208 G--LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRP---------------RVLRG 270 (596)
T ss_pred c--ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccc---------------hheee
Confidence 3 3445679999999999998764 5789999999999999999999998643222110 00001
Q ss_pred cCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001768 894 SLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSM 931 (1016)
Q Consensus 894 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 931 (1016)
.+ .++.-...++.+++++++..+|.+|++++++.+.
T Consensus 271 k~--rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 271 KY--RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred ee--cccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 11 1222233467889999999999999999999874
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-32 Score=310.52 Aligned_cols=263 Identities=25% Similarity=0.332 Sum_probs=194.8
Q ss_pred hcCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeec---------
Q 001768 658 TNNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIEG--------- 727 (1016)
Q Consensus 658 ~~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--------- 727 (1016)
..+|++.+.||+|+||.||+|+.. +++.||+|.+........+.+.+|++++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 468999999999999999999864 6899999998766656667788999999999999999999876543
Q ss_pred -----ceeEEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEcc-CCce
Q 001768 728 -----NQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDK-DLNA 801 (1016)
Q Consensus 728 -----~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~-~~~~ 801 (1016)
...++||||++ ++|.+++... .+++..++.++.||++||+|||+. +|+||||||+||+++. ++.+
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~ 154 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQG-----PLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVL 154 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceE
Confidence 35799999997 5888887432 488999999999999999999998 9999999999999984 5678
Q ss_pred eeeccccccccCCCCcc--eeeecccCccccChhhhcc-CCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHH
Q 001768 802 KISDFGLAKLDEDENTH--ISTRIAGTVGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWA 878 (1016)
Q Consensus 802 kL~DFGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~ 878 (1016)
||+|||.++........ ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||......+........
T Consensus 155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~ 234 (342)
T cd07854 155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES 234 (342)
T ss_pred EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 99999999754322111 1122357889999998754 46788999999999999999999999755432221111000
Q ss_pred HHHH---HhCC----cccccC-CcCCCC-----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 001768 879 YVLQ---EQGN----LLELVD-PSLGSN-----FSKKEAMTMLNIALLCTNPSPTLRPTMSSAV 929 (1016)
Q Consensus 879 ~~~~---~~~~----~~~~~d-~~l~~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 929 (1016)
.... .... ...... ...... .......++.+++.+||+.||.+|||+.|++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell 298 (342)
T cd07854 235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEAL 298 (342)
T ss_pred cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHh
Confidence 0000 0000 000000 000000 0112335688999999999999999999888
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.8e-32 Score=294.51 Aligned_cols=250 Identities=24% Similarity=0.322 Sum_probs=196.4
Q ss_pred CccccCccccCCCeeEEEEEcCC-CcEEEEEEccCC-----ChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEE
Q 001768 660 NFDAANKIGEGGFGPVYKGTLSD-GAVIAVKQLSSK-----SKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLV 733 (1016)
Q Consensus 660 ~f~~~~~LG~G~~G~Vy~~~~~~-~~~vAvK~~~~~-----~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 733 (1016)
+|.+.+.||+|+||.||+++... +..+++|.++.. ......++..|+.+++.++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 47888999999999999998653 444555555431 222334577899999999999999999999999999999
Q ss_pred EeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccC
Q 001768 734 YEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDE 813 (1016)
Q Consensus 734 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~ 813 (1016)
|||+++++|.+++.........+++.+++.++.|+++||.|||+. +++|+||||+||++++ +.++|+|||.+....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999999875443445799999999999999999999998 9999999999999975 569999999987654
Q ss_pred CCCcceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCC
Q 001768 814 DENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDP 893 (1016)
Q Consensus 814 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 893 (1016)
.... ......|++.|+|||...+..++.++|+||||+++|+|++|..||.......... . .. ....
T Consensus 157 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~------~-~~-----~~~~- 222 (260)
T cd08222 157 GSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVL------R-IV-----EGPT- 222 (260)
T ss_pred CCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHH------H-HH-----cCCC-
Confidence 3322 2233567889999999988888999999999999999999999986433221110 0 00 0011
Q ss_pred cCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 894 SLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 894 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
...+...+..+.+++.+||+.+|++||++.|+++
T Consensus 223 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 223 ---PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred ---CCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 1223345567899999999999999999999884
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=304.09 Aligned_cols=259 Identities=22% Similarity=0.338 Sum_probs=193.4
Q ss_pred hcCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCC--hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeec------c
Q 001768 658 TNNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS--KQGNREFVNEIGMISALQHQNLVKLYGCCIEG------N 728 (1016)
Q Consensus 658 ~~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------~ 728 (1016)
.++|.+.+.||+|+||.||+|+.. +++.||+|++.... ......+.+|+++++.++||||+++++++... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 478999999999999999999964 68999999986532 22345678999999999999999999998754 3
Q ss_pred eeEEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeecccc
Q 001768 729 QLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGL 808 (1016)
Q Consensus 729 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGl 808 (1016)
..++|+||+.. +|..+.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 94 ~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG------HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred eEEEEeccccc-CHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCC
Confidence 56999999964 6766652 2488999999999999999999998 899999999999999999999999999
Q ss_pred ccccCCCCcceeeecccCccccChhhhcc-CCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHH--------
Q 001768 809 AKLDEDENTHISTRIAGTVGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAY-------- 879 (1016)
Q Consensus 809 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~-------- 879 (1016)
++...... ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||................
T Consensus 164 ~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (342)
T cd07879 164 ARHADAEM----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFV 239 (342)
T ss_pred CcCCCCCC----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 97543321 23457888999999876 468899999999999999999999998654332211110000
Q ss_pred -HHHH--hCCcccccCCcCCCCCC---HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 880 -VLQE--QGNLLELVDPSLGSNFS---KKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 880 -~~~~--~~~~~~~~d~~l~~~~~---~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
.... ................. +.....+.+++.+||+.||++||+++++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~ 296 (342)
T cd07879 240 QKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALE 296 (342)
T ss_pred HHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0000 00000000000000000 112346889999999999999999999874
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.9e-32 Score=305.98 Aligned_cols=269 Identities=23% Similarity=0.331 Sum_probs=200.8
Q ss_pred cCHHHHHHHhcCccccCccccCCCeeEEEEEc-CCCcEEEEEEccCCC--hhhhHHHHHHHHHHHhcCCCCeeeeeeeEe
Q 001768 649 FTLRQIKAATNNFDAANKIGEGGFGPVYKGTL-SDGAVIAVKQLSSKS--KQGNREFVNEIGMISALQHQNLVKLYGCCI 725 (1016)
Q Consensus 649 ~~~~~l~~~~~~f~~~~~LG~G~~G~Vy~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 725 (1016)
....++..++++|++.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|++++++++||||+++++++.
T Consensus 7 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~ 86 (345)
T cd07877 7 ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 86 (345)
T ss_pred hHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeee
Confidence 34466777889999999999999999999985 478999999987532 223456788999999999999999999886
Q ss_pred ec------ceeEEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCC
Q 001768 726 EG------NQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDL 799 (1016)
Q Consensus 726 ~~------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~ 799 (1016)
.. ...+++++++ +++|.+++... .+++..+..++.|+++||+|||+. +|+||||||+||++++++
T Consensus 87 ~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~ 157 (345)
T cd07877 87 PARSLEEFNDVYLVTHLM-GADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDC 157 (345)
T ss_pred ecccccccccEEEEehhc-ccCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCC
Confidence 43 3468888877 77998887532 489999999999999999999998 999999999999999999
Q ss_pred ceeeeccccccccCCCCcceeeecccCccccChhhhcc-CCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHH-HH
Q 001768 800 NAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLL-DW 877 (1016)
Q Consensus 800 ~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~-~~ 877 (1016)
.+||+|||+++..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+ ..
T Consensus 158 ~~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~ 233 (345)
T cd07877 158 ELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 233 (345)
T ss_pred CEEEeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 9999999998754322 223467889999998866 46788999999999999999999999654433221111 00
Q ss_pred HH-----HHHH-----hCCcccccCCcCCCCCC---HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 878 AY-----VLQE-----QGNLLELVDPSLGSNFS---KKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 878 ~~-----~~~~-----~~~~~~~~d~~l~~~~~---~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
.. .... .......++......+. ......+.+++.+|++.||.+||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 299 (345)
T cd07877 234 VGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 299 (345)
T ss_pred hCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence 00 0000 00000000000000000 012346889999999999999999998874
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.4e-32 Score=322.42 Aligned_cols=253 Identities=29% Similarity=0.432 Sum_probs=192.0
Q ss_pred HHHhcCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCC-hhhhHHHHHHHHHHHhcCCCCeeeeeeeEee------
Q 001768 655 KAATNNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS-KQGNREFVNEIGMISALQHQNLVKLYGCCIE------ 726 (1016)
Q Consensus 655 ~~~~~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~------ 726 (1016)
.+-..+|+..+.||+||||.||+++.+ ||+.||||++.-.. ......+.+|+.++.+++|||||+++..+.+
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 456678999999999999999999966 89999999997653 3445678899999999999999998722000
Q ss_pred --------------------------------------------------------------------------------
Q 001768 727 -------------------------------------------------------------------------------- 726 (1016)
Q Consensus 727 -------------------------------------------------------------------------------- 726 (1016)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred -------------------------c--------ceeEEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHH
Q 001768 727 -------------------------G--------NQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLA 773 (1016)
Q Consensus 727 -------------------------~--------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~ 773 (1016)
+ ..+|+-||||+..++.+++..+.- .-.....++++++|++||+
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~---~~~~d~~wrLFreIlEGLa 711 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHF---NSQRDEAWRLFREILEGLA 711 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhccc---chhhHHHHHHHHHHHHHHH
Confidence 0 135889999999888888865531 1147789999999999999
Q ss_pred HHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccC-----------------CCCcceeeecccCccccChhhhc
Q 001768 774 YLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDE-----------------DENTHISTRIAGTVGYMAPEYAM 836 (1016)
Q Consensus 774 yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~-----------------~~~~~~~~~~~gt~~y~aPE~~~ 836 (1016)
|+|++ |||||||||.||++|++..|||+|||+|.... .......+..+||.-|+|||++.
T Consensus 712 YIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~ 788 (1351)
T KOG1035|consen 712 YIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLS 788 (1351)
T ss_pred HHHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhc
Confidence 99999 89999999999999999999999999997511 01111235578999999999997
Q ss_pred cC---CCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCC--CCCCHHHHHHHHHHH
Q 001768 837 RG---YLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLG--SNFSKKEAMTMLNIA 911 (1016)
Q Consensus 837 ~~---~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~--~~~~~~~~~~l~~li 911 (1016)
+. .|+.|+|+||+|||++||+. ||... .+.. .....- -++.++ ..+.......-..+|
T Consensus 789 ~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~Ts-MERa-------~iL~~L------R~g~iP~~~~f~~~~~~~e~slI 851 (1351)
T KOG1035|consen 789 DTSSNKYNSKIDMYSLGIVLFEMLY---PFGTS-MERA-------SILTNL------RKGSIPEPADFFDPEHPEEASLI 851 (1351)
T ss_pred ccccccccchhhhHHHHHHHHHHhc---cCCch-HHHH-------HHHHhc------ccCCCCCCcccccccchHHHHHH
Confidence 55 49999999999999999984 44321 1111 111111 122222 223333444567899
Q ss_pred HHccCCCCCCCCCHHHHHH
Q 001768 912 LLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 912 ~~cl~~dP~~RPt~~evl~ 930 (1016)
.+++++||.+|||+.|++.
T Consensus 852 ~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 852 RWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHHhcCCCccCCCHHHHhh
Confidence 9999999999999999884
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=305.46 Aligned_cols=263 Identities=22% Similarity=0.333 Sum_probs=197.8
Q ss_pred HHHHhcCccccCccccCCCeeEEEEEc-CCCcEEEEEEccCCC--hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecc--
Q 001768 654 IKAATNNFDAANKIGEGGFGPVYKGTL-SDGAVIAVKQLSSKS--KQGNREFVNEIGMISALQHQNLVKLYGCCIEGN-- 728 (1016)
Q Consensus 654 l~~~~~~f~~~~~LG~G~~G~Vy~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~-- 728 (1016)
+....++|++.+.||+|+||.||+|.. .+++.||||++.... ......+.+|++++++++||||+++++++..+.
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 344678899999999999999999985 478999999986432 223456889999999999999999999987643
Q ss_pred ----eeEEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeee
Q 001768 729 ----QLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKIS 804 (1016)
Q Consensus 729 ----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~ 804 (1016)
.+++||||+ +++|.+++... .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.++|+
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~~~-----~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~ 160 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMKHE-----KLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKIL 160 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEe
Confidence 469999999 67898888532 589999999999999999999998 99999999999999999999999
Q ss_pred ccccccccCCCCcceeeecccCccccChhhhcc-CCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHH-H------
Q 001768 805 DFGLAKLDEDENTHISTRIAGTVGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLL-D------ 876 (1016)
Q Consensus 805 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~-~------ 876 (1016)
|||++....... ....+++.|+|||.+.+ ..++.++|+|||||++|+|++|+.||............ .
T Consensus 161 dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 236 (343)
T cd07880 161 DFGLARQTDSEM----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPS 236 (343)
T ss_pred ecccccccccCc----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 999997544321 23457889999999875 45789999999999999999999999765432211100 0
Q ss_pred --HHHHHHH------hCCcccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 877 --WAYVLQE------QGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 877 --~~~~~~~------~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
+...... ...+.......+ ..........+.+++.+|++.||++|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 237 KEFVQKLQSEDAKNYVKKLPRFRKKDF-RSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHHHHhhcchhHHHHHHhccccCcchH-HHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000000 000000000000 0011123346889999999999999999998884
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-32 Score=279.86 Aligned_cols=254 Identities=20% Similarity=0.259 Sum_probs=197.7
Q ss_pred HHhcCcccc-CccccCCCeeEEEEEcC-CCcEEEEEEccCCChhhhHHHHHHHHHHHhc-CCCCeeeeeeeEee----cc
Q 001768 656 AATNNFDAA-NKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSKQGNREFVNEIGMISAL-QHQNLVKLYGCCIE----GN 728 (1016)
Q Consensus 656 ~~~~~f~~~-~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~----~~ 728 (1016)
.++++|++. ++||-|-.|.|-.+..+ +++.+|+|++... ....+|++.--.. .|||||.++++++. ..
T Consensus 58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk 132 (400)
T KOG0604|consen 58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRK 132 (400)
T ss_pred cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence 356777764 57999999999988754 6899999998643 2345677764444 69999999999875 35
Q ss_pred eeEEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEcc---CCceeeec
Q 001768 729 QLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDK---DLNAKISD 805 (1016)
Q Consensus 729 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~---~~~~kL~D 805 (1016)
.+.+|||.|+||.|...++.+.. ..+++.++..|++||+.|+.|||+. +|.||||||+|+|.+. +..+||+|
T Consensus 133 cLLiVmE~meGGeLfsriq~~g~--~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtD 207 (400)
T KOG0604|consen 133 CLLIVMECMEGGELFSRIQDRGD--QAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTD 207 (400)
T ss_pred eeEeeeecccchHHHHHHHHccc--ccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecc
Confidence 68899999999999999987764 3699999999999999999999998 9999999999999975 45699999
Q ss_pred cccccccCCCCcceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhC
Q 001768 806 FGLAKLDEDENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQG 885 (1016)
Q Consensus 806 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 885 (1016)
||+|+....... ....+-|+.|.|||++...+|+..+|+||+||++|-|++|.+||.......+-.-. ..+. ..+
T Consensus 208 fGFAK~t~~~~~--L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgM-k~rI--~~g 282 (400)
T KOG0604|consen 208 FGFAKETQEPGD--LMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM-KRRI--RTG 282 (400)
T ss_pred cccccccCCCcc--ccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhH-HhHh--hcc
Confidence 999996554322 23467899999999999999999999999999999999999999754432211000 0001 111
Q ss_pred CcccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 886 NLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 886 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
..++-++. -...++...++|+.+|..+|.+|.|+.++++
T Consensus 283 -qy~FP~pE-----Ws~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 283 -QYEFPEPE-----WSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred -CccCCChh-----HhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 11121221 1345668899999999999999999998874
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-32 Score=281.33 Aligned_cols=205 Identities=26% Similarity=0.418 Sum_probs=173.1
Q ss_pred hcCccccCccccCCCeeEEEEEcC---C--CcEEEEEEccCCChh--hhHHHHHHHHHHHhcCCCCeeeeeeeEee-cce
Q 001768 658 TNNFDAANKIGEGGFGPVYKGTLS---D--GAVIAVKQLSSKSKQ--GNREFVNEIGMISALQHQNLVKLYGCCIE-GNQ 729 (1016)
Q Consensus 658 ~~~f~~~~~LG~G~~G~Vy~~~~~---~--~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~ 729 (1016)
-..|+.+..||+|.||.||+|... + ...+|+|+++..... -.....+|+..++.++|||++.+..++.. +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 346889999999999999999633 2 237999999866432 23567899999999999999999999887 788
Q ss_pred eEEEEeecCCCcHHHHhccCcC-cCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccC----Cceeee
Q 001768 730 LLLVYEYLENNSLARALFGKEG-QCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKD----LNAKIS 804 (1016)
Q Consensus 730 ~~lV~E~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~----~~~kL~ 804 (1016)
.++++||.+. +|.+.|+..+. ....++...+..|+.||+.|+.|||++ =|+||||||.|||+..+ |.|||+
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEee
Confidence 9999999987 89998865432 235789999999999999999999999 69999999999999877 899999
Q ss_pred ccccccccCCCCcce--eeecccCccccChhhhccC-CCCCccchhHHHHHHHHHHhCCCCCCCC
Q 001768 805 DFGLAKLDEDENTHI--STRIAGTVGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGKSNTNYR 866 (1016)
Q Consensus 805 DFGla~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~P~~~~ 866 (1016)
|||+++.+...-... ...++-|+.|+|||.+.+. .|+++.||||.|||+.||+|-++-|.++
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~ 243 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR 243 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence 999999876653332 3456779999999999875 6999999999999999999999888654
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=299.51 Aligned_cols=266 Identities=26% Similarity=0.337 Sum_probs=195.0
Q ss_pred hcCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCChh--hhHHHHHHHHHHHhcCCCCeeeeeeeEeec-------
Q 001768 658 TNNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSKQ--GNREFVNEIGMISALQHQNLVKLYGCCIEG------- 727 (1016)
Q Consensus 658 ~~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------- 727 (1016)
.++|++.+.||+|+||.||+|+.. +++.||+|++...... ....+.+|++++++++||||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 478999999999999999999965 6889999988644322 234677899999999999999999987543
Q ss_pred -ceeEEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeecc
Q 001768 728 -NQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDF 806 (1016)
Q Consensus 728 -~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DF 806 (1016)
..+++||||+++ ++...+.... ..+++.++..++.|+++||+|||+. +|+||||||+||++++++.++|+||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~---~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~df 159 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPS---VKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADF 159 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcC
Confidence 357999999975 6766665432 3699999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCCCcc----------eeeecccCccccChhhhccC-CCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHH
Q 001768 807 GLAKLDEDENTH----------ISTRIAGTVGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLL 875 (1016)
Q Consensus 807 Gla~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~ 875 (1016)
|+++........ ..+...+++.|+|||.+.+. .++.++|||||||++|||++|++||...........+
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~ 239 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI 239 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 999754332211 11234568889999987654 5789999999999999999999999765543322111
Q ss_pred HHHHH------HHHhCCccccc----CCcCCCCC---CHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 876 DWAYV------LQEQGNLLELV----DPSLGSNF---SKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 876 ~~~~~------~~~~~~~~~~~----d~~l~~~~---~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
..... ......+.... ........ .......+.+++.+|++.||++|||+.|++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 10000 00000000000 00000000 0112246889999999999999999998873
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=302.82 Aligned_cols=262 Identities=24% Similarity=0.360 Sum_probs=197.5
Q ss_pred HHHhcCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCC--hhhhHHHHHHHHHHHhcCCCCeeeeeeeEee-ccee
Q 001768 655 KAATNNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS--KQGNREFVNEIGMISALQHQNLVKLYGCCIE-GNQL 730 (1016)
Q Consensus 655 ~~~~~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~ 730 (1016)
..++++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.. ....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 457889999999999999999999854 78999999876432 2334677889999999999999999999876 5678
Q ss_pred EEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeecccccc
Q 001768 731 LLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAK 810 (1016)
Q Consensus 731 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~ 810 (1016)
++||||+ +++|.+++... ++++..+..++.|+++||+|||+. +|+||||+|+||++++++.++|+|||.+.
T Consensus 86 ~lv~e~~-~~~L~~~~~~~-----~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~ 156 (328)
T cd07856 86 YFVTELL-GTDLHRLLTSR-----PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLAR 156 (328)
T ss_pred EEEeehh-ccCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCcccccc
Confidence 9999998 56898888532 478888999999999999999998 89999999999999999999999999987
Q ss_pred ccCCCCcceeeecccCccccChhhhcc-CCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHH-HH--------HHH
Q 001768 811 LDEDENTHISTRIAGTVGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLL-DW--------AYV 880 (1016)
Q Consensus 811 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~-~~--------~~~ 880 (1016)
..... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||............ +. ...
T Consensus 157 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd07856 157 IQDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT 232 (328)
T ss_pred ccCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 54322 122457888999998765 56899999999999999999999999765432211110 00 000
Q ss_pred HHHhCCccccc-CCcCCCCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 881 LQEQGNLLELV-DPSLGSNFS-----KKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 881 ~~~~~~~~~~~-d~~l~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
.... ...+.. ........+ +.....+.+++.+|++.+|++||++++++.
T Consensus 233 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~ 287 (328)
T cd07856 233 ICSE-NTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA 287 (328)
T ss_pred ccch-hhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000 000000 000000111 113457899999999999999999998863
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.2e-32 Score=307.45 Aligned_cols=261 Identities=23% Similarity=0.358 Sum_probs=197.7
Q ss_pred HHhcCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCC--ChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecce---
Q 001768 656 AATNNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSK--SKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQ--- 729 (1016)
Q Consensus 656 ~~~~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~--- 729 (1016)
...++|++.+.||+|++|.||+|+.. +++.||+|++... .......+.+|+.++++++||||+++++++..++.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 45778999999999999999999975 5789999998653 22334567789999999999999999998876554
Q ss_pred ---eEEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeecc
Q 001768 730 ---LLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDF 806 (1016)
Q Consensus 730 ---~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DF 806 (1016)
.++|+||+ +++|.+++.. ..+++..+..++.|+++||+|||+. +|+||||||+||++++++.++|+||
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~df 162 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDF 162 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEccc
Confidence 89999998 5699998854 2589999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCCCcceeeecccCccccChhhhcc-CCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhH-HHHHH-----
Q 001768 807 GLAKLDEDENTHISTRIAGTVGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYL-LDWAY----- 879 (1016)
Q Consensus 807 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~-~~~~~----- 879 (1016)
|++...... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||........... .+...
T Consensus 163 g~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 238 (343)
T cd07851 163 GLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEE 238 (343)
T ss_pred ccccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHH
Confidence 999865432 223467889999998865 3678899999999999999999999976543322111 00000
Q ss_pred HHH-----HhCCcccccCCcCCCCCC---HHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 001768 880 VLQ-----EQGNLLELVDPSLGSNFS---KKEAMTMLNIALLCTNPSPTLRPTMSSAV 929 (1016)
Q Consensus 880 ~~~-----~~~~~~~~~d~~l~~~~~---~~~~~~l~~li~~cl~~dP~~RPt~~evl 929 (1016)
... ....+...+.......+. ......+.+++.+|++.||++|||+.+|+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell 296 (343)
T cd07851 239 LLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEAL 296 (343)
T ss_pred HHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHh
Confidence 000 000000000000000000 11245789999999999999999999987
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=295.64 Aligned_cols=262 Identities=25% Similarity=0.363 Sum_probs=199.4
Q ss_pred ccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCC--hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEeec
Q 001768 661 FDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS--KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYL 737 (1016)
Q Consensus 661 f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 737 (1016)
|+..+.||+|++|.||+|+.. +++.||+|.+.... ......+..|++++++++|+|++++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 566789999999999999976 58999999987653 333467788999999999999999999999999999999999
Q ss_pred CCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCCc
Q 001768 738 ENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENT 817 (1016)
Q Consensus 738 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 817 (1016)
+ ++|.+++.... ..+++..+..++.|++.||+|||+. +|+||||+|+||++++++.++|+|||.++.......
T Consensus 81 ~-~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 81 D-MDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred C-cCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence 8 58999997543 3589999999999999999999998 899999999999999999999999999976544322
Q ss_pred ceeeecccCccccChhhhccC-CCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHH-HHHH-----HHHHhCCc--c
Q 001768 818 HISTRIAGTVGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLL-DWAY-----VLQEQGNL--L 888 (1016)
Q Consensus 818 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~-~~~~-----~~~~~~~~--~ 888 (1016)
. .....++..|+|||.+.+. .++.++|||||||++|||++|++||......+....+ .... ........ .
T Consensus 154 ~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07829 154 T-YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDY 232 (282)
T ss_pred c-cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccc
Confidence 1 1223457789999998766 7899999999999999999999999765433221110 0000 00000000 0
Q ss_pred cccCCcCCC----CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 889 ELVDPSLGS----NFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 889 ~~~d~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
+..-+.... ...+.....+.+++.+||+.||++||++.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 233 KPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 000000000 001112457999999999999999999999883
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-32 Score=255.25 Aligned_cols=262 Identities=22% Similarity=0.332 Sum_probs=199.4
Q ss_pred CccccCccccCCCeeEEEEEc-CCCcEEEEEEccCCC--hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEee
Q 001768 660 NFDAANKIGEGGFGPVYKGTL-SDGAVIAVKQLSSKS--KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEY 736 (1016)
Q Consensus 660 ~f~~~~~LG~G~~G~Vy~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 736 (1016)
+|...++||+|.||+||+|+. +.++.||+|++.-.. +.......+|+.+++.++|.|||++++....++.+-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 466678999999999999994 468999999986543 23346788999999999999999999999999999999999
Q ss_pred cCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCC
Q 001768 737 LENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDEN 816 (1016)
Q Consensus 737 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 816 (1016)
|.. +|..+...-.+ .++.+.+..++.|+++||.++|++ ++.|||+||.|.|++.+|++|++|||+++.++-..
T Consensus 83 cdq-dlkkyfdslng---~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipv 155 (292)
T KOG0662|consen 83 CDQ-DLKKYFDSLNG---DLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV 155 (292)
T ss_pred hhH-HHHHHHHhcCC---cCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence 965 78887765443 589999999999999999999999 99999999999999999999999999999877654
Q ss_pred cceeeecccCccccChhhhccC-CCCCccchhHHHHHHHHHHh-CCCCCCCCCchhhHhHHHHHHHHHHhCCccc---cc
Q 001768 817 THISTRIAGTVGYMAPEYAMRG-YLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWAYVLQEQGNLLE---LV 891 (1016)
Q Consensus 817 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~ 891 (1016)
...+ ..+-|..|++|.++.+. -|+...|+||-||++.|+.. |++.|.+....+....+-|.-......++.. ..
T Consensus 156 rcys-aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lp 234 (292)
T KOG0662|consen 156 RCYS-AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLP 234 (292)
T ss_pred Eeee-ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCC
Confidence 3333 23568899999999876 47889999999999999987 6666766655544333322221111112111 11
Q ss_pred CCcCCCCCCH---------HHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 001768 892 DPSLGSNFSK---------KEAMTMLNIALLCTNPSPTLRPTMSSAV 929 (1016)
Q Consensus 892 d~~l~~~~~~---------~~~~~l~~li~~cl~~dP~~RPt~~evl 929 (1016)
|-..-+.++. .....-.+++.+.+.-+|..|.++++.+
T Consensus 235 dyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaal 281 (292)
T KOG0662|consen 235 DYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAAL 281 (292)
T ss_pred CCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHh
Confidence 1111111211 1122346788888888999999997655
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=324.08 Aligned_cols=262 Identities=31% Similarity=0.467 Sum_probs=211.5
Q ss_pred HHHHhcCccccCccccCCCeeEEEEEcC--------CCcEEEEEEccCCC-hhhhHHHHHHHHHHHhc-CCCCeeeeeee
Q 001768 654 IKAATNNFDAANKIGEGGFGPVYKGTLS--------DGAVIAVKQLSSKS-KQGNREFVNEIGMISAL-QHQNLVKLYGC 723 (1016)
Q Consensus 654 l~~~~~~f~~~~~LG~G~~G~Vy~~~~~--------~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~ 723 (1016)
++...++..+.+.||+|+||.|++|... ....||||.++... ..+.+.+..|+++|+.+ +|+||+.++|+
T Consensus 291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~ 370 (609)
T KOG0200|consen 291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA 370 (609)
T ss_pred eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence 3444455566779999999999999732 14579999998653 34567899999999998 69999999999
Q ss_pred EeecceeEEEEeecCCCcHHHHhccCc---Cc-------C--cCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCc
Q 001768 724 CIEGNQLLLVYEYLENNSLARALFGKE---GQ-------C--LNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKAT 791 (1016)
Q Consensus 724 ~~~~~~~~lV~E~~~~gsL~~~l~~~~---~~-------~--~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~ 791 (1016)
|...+..++|+||++.|+|.+++...+ .- . ..++..+.+.++.|||.|++||++. ++|||||.++
T Consensus 371 ~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaR 447 (609)
T KOG0200|consen 371 CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAAR 447 (609)
T ss_pred eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhhh
Confidence 999999999999999999999998766 00 0 1389999999999999999999998 8999999999
Q ss_pred eEEEccCCceeeeccccccccCCCCcceeeeccc--CccccChhhhccCCCCCccchhHHHHHHHHHHh-CCCCCCCCC-
Q 001768 792 NVLLDKDLNAKISDFGLAKLDEDENTHISTRIAG--TVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRP- 867 (1016)
Q Consensus 792 NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~- 867 (1016)
|||+.++..+||+|||+|+..............| ...|||||.+....++.|+|||||||+||||+| |..||..-.
T Consensus 448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~ 527 (609)
T KOG0200|consen 448 NVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP 527 (609)
T ss_pred hEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc
Confidence 9999999999999999999655544443332333 456999999999999999999999999999999 888887533
Q ss_pred chhhHhHHHHHHHHHHhCCcccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 001768 868 KEEFVYLLDWAYVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEG 934 (1016)
Q Consensus 868 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 934 (1016)
.++.. + .+.+..+...|..+..++.++|+.||+.+|++||++.++++.++.
T Consensus 528 ~~~l~---~-------------~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~ 578 (609)
T KOG0200|consen 528 TEELL---E-------------FLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEK 578 (609)
T ss_pred HHHHH---H-------------HHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence 22211 1 111222223344556788999999999999999999999999987
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=301.90 Aligned_cols=262 Identities=23% Similarity=0.312 Sum_probs=191.8
Q ss_pred CccccCccccCCCeeEEEEEcC-C--CcEEEEEEccCCC--hhhhHHHHHHHHHHHhc-CCCCeeeeeeeEeec----ce
Q 001768 660 NFDAANKIGEGGFGPVYKGTLS-D--GAVIAVKQLSSKS--KQGNREFVNEIGMISAL-QHQNLVKLYGCCIEG----NQ 729 (1016)
Q Consensus 660 ~f~~~~~LG~G~~G~Vy~~~~~-~--~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~----~~ 729 (1016)
+|++.+.||+|+||.||+++.. . +..||+|++.... ......+.+|+++++++ +||||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4788899999999999999965 3 7789999986432 22345678899999999 599999999875432 45
Q ss_pred eEEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccc
Q 001768 730 LLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLA 809 (1016)
Q Consensus 730 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla 809 (1016)
.++++||+. ++|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a 152 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQ----PLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLA 152 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence 788999886 58988885432 689999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCcc---eeeecccCccccChhhhcc-CCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHH-------
Q 001768 810 KLDEDENTH---ISTRIAGTVGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWA------- 878 (1016)
Q Consensus 810 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~------- 878 (1016)
+........ ......||..|+|||++.+ ..++.++||||+||++|+|++|++||...............
T Consensus 153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 232 (332)
T cd07857 153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE 232 (332)
T ss_pred eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 754432211 1223568999999998765 46889999999999999999999999765433221110000
Q ss_pred --HHHHHhC--CcccccC--CcC-CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 001768 879 --YVLQEQG--NLLELVD--PSL-GSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAV 929 (1016)
Q Consensus 879 --~~~~~~~--~~~~~~d--~~l-~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 929 (1016)
....... ....... +.. ...........+.+++.+|++.||++|||+.+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll 290 (332)
T cd07857 233 TLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEAL 290 (332)
T ss_pred HHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 0000000 0000000 000 0000011234688999999999999999999886
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=285.58 Aligned_cols=236 Identities=26% Similarity=0.346 Sum_probs=193.9
Q ss_pred cccCCCeeEEEEEcC-CCcEEEEEEccCCCh---hhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEeecCCCcH
Q 001768 667 IGEGGFGPVYKGTLS-DGAVIAVKQLSSKSK---QGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYLENNSL 742 (1016)
Q Consensus 667 LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 742 (1016)
||+|+||.||++... +++.||+|.+..... .....+.+|++++++++||||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999965 589999999875432 2456788999999999999999999999999999999999999999
Q ss_pred HHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCCcceeee
Q 001768 743 ARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTR 822 (1016)
Q Consensus 743 ~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 822 (1016)
.+++.... .+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~ 152 (250)
T cd05123 81 FSHLSKEG----RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNT 152 (250)
T ss_pred HHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccC
Confidence 99996543 589999999999999999999997 99999999999999999999999999997654432 12234
Q ss_pred cccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCCCCCCHH
Q 001768 823 IAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGSNFSKK 902 (1016)
Q Consensus 823 ~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 902 (1016)
..++..|+|||...+...+.++|+||||+++|+|++|+.||............ .. ... .++..
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~------~~-------~~~----~~~~~ 215 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKI------LK-------DPL----RFPEF 215 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH------hc-------CCC----CCCCC
Confidence 56788999999998888899999999999999999999999765432211110 00 011 12222
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHH
Q 001768 903 EAMTMLNIALLCTNPSPTLRPTMSS 927 (1016)
Q Consensus 903 ~~~~l~~li~~cl~~dP~~RPt~~e 927 (1016)
.+..+.+++.+||..||++||++.+
T Consensus 216 ~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 216 LSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCHHHHHHHHHHhcCCHhhCCCccc
Confidence 3457899999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=323.00 Aligned_cols=145 Identities=30% Similarity=0.449 Sum_probs=131.0
Q ss_pred cCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCC---hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEE
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS---KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVY 734 (1016)
Q Consensus 659 ~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 734 (1016)
++|++.++||+|+||.||+|+.. +++.||+|++.... ......+..|+.+++.++||||+++++++...+..++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 67999999999999999999976 68999999987542 233467889999999999999999999999999999999
Q ss_pred eecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeecccccc
Q 001768 735 EYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAK 810 (1016)
Q Consensus 735 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~ 810 (1016)
||+++++|.+++.... .+++..++.|+.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~~----~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIYG----YFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999996543 588999999999999999999998 99999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-32 Score=304.01 Aligned_cols=239 Identities=24% Similarity=0.324 Sum_probs=195.0
Q ss_pred HhcCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCChhhhHHHHHHHHHHHhc-CCCCeeeeeeeEeecceeEEEE
Q 001768 657 ATNNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSKQGNREFVNEIGMISAL-QHQNLVKLYGCCIEGNQLLLVY 734 (1016)
Q Consensus 657 ~~~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~ 734 (1016)
+++.|.....+|.|+|+.|..+... +++..+||++.... .+-.+|+.++... +||||+++.+.+.++.+.|+||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 4567778888999999999888854 67889999997652 2334677666665 7999999999999999999999
Q ss_pred eecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEE-ccCCceeeeccccccccC
Q 001768 735 EYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLL-DKDLNAKISDFGLAKLDE 813 (1016)
Q Consensus 735 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl-~~~~~~kL~DFGla~~~~ 813 (1016)
|++.++-+.+.+.... ....++..|+.+|+.|+.|||++ ||||||+||+|||+ ++.++++|+|||.++...
T Consensus 396 e~l~g~ell~ri~~~~-----~~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~ 467 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKP-----EFCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELE 467 (612)
T ss_pred hhccccHHHHHHHhcc-----hhHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence 9999998888886554 22267788999999999999998 99999999999999 588999999999998665
Q ss_pred CCCcceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCC
Q 001768 814 DENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDP 893 (1016)
Q Consensus 814 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 893 (1016)
.. ....+-|..|.|||++....+++++|+||||++||+|++|+.||...+.+... . ...
T Consensus 468 ~~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei--~----~~i----------- 526 (612)
T KOG0603|consen 468 RS----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEI--H----TRI----------- 526 (612)
T ss_pred hh----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHH--H----Hhh-----------
Confidence 54 12235578899999999999999999999999999999999999877766211 0 000
Q ss_pred cCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 001768 894 SLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAV 929 (1016)
Q Consensus 894 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 929 (1016)
..+.+....+...++|+.+||+.||.+||+|+++.
T Consensus 527 -~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~ 561 (612)
T KOG0603|consen 527 -QMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIG 561 (612)
T ss_pred -cCCccccccCHHHHHHHHHhccCChhhCcChhhhc
Confidence 11222344566789999999999999999999876
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-33 Score=281.12 Aligned_cols=254 Identities=26% Similarity=0.334 Sum_probs=190.5
Q ss_pred cccCccccCCCeeEEEEEcC-CCcEEEEEEccCCCh-hhhHHHHHHHHHHH-hcCCCCeeeeeeeEeecceeEEEEeecC
Q 001768 662 DAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSK-QGNREFVNEIGMIS-ALQHQNLVKLYGCCIEGNQLLLVYEYLE 738 (1016)
Q Consensus 662 ~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~-~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 738 (1016)
+-...||.|+||+|++-.++ .|+..|||++..... .+..++..|.+... .-+.||||+++|.+..++..|+.||+|+
T Consensus 67 qdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd 146 (361)
T KOG1006|consen 67 QDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD 146 (361)
T ss_pred HHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh
Confidence 34578999999999999865 699999999986643 55677888887654 4579999999999999999999999995
Q ss_pred CCcHHHHhcc-CcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCCc
Q 001768 739 NNSLARALFG-KEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENT 817 (1016)
Q Consensus 739 ~gsL~~~l~~-~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 817 (1016)
- |++.+-.. ..-+...+++...-+|+.-.+.||.||-+. ..|||||+||+|||+|..|.+||||||.+....+.
T Consensus 147 ~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S-- 221 (361)
T KOG1006|consen 147 I-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS-- 221 (361)
T ss_pred h-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHhHHHH--
Confidence 4 55543321 111223688988899999999999999987 48999999999999999999999999998754432
Q ss_pred ceeeecccCccccChhhhcc--CCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcC
Q 001768 818 HISTRIAGTVGYMAPEYAMR--GYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSL 895 (1016)
Q Consensus 818 ~~~~~~~gt~~y~aPE~~~~--~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 895 (1016)
...+.-+|-..|||||.+.. ..|+.++||||||++|||+.||+.|+..-.. ....+ .....++...+..+.-
T Consensus 222 iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s--vfeql----~~Vv~gdpp~l~~~~~ 295 (361)
T KOG1006|consen 222 IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS--VFEQL----CQVVIGDPPILLFDKE 295 (361)
T ss_pred HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH--HHHHH----HHHHcCCCCeecCccc
Confidence 23345578889999999863 3589999999999999999999999853111 00000 0011112111111111
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 896 GSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 896 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
.......+..++..|+.+|-..||..+++.+
T Consensus 296 ----~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 296 ----CVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred ----ccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 1234557999999999999999999988774
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-32 Score=292.52 Aligned_cols=254 Identities=23% Similarity=0.332 Sum_probs=204.1
Q ss_pred cCccccCCCeeEEEEEcC-CCcEEEEEEccCC--ChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEeecCCC
Q 001768 664 ANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSK--SKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYLENN 740 (1016)
Q Consensus 664 ~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 740 (1016)
.+.||.|-||+||-|+.+ +|+.||||++.+. .+.....+.+|+.||+.++||.||.+...|+..+..++|||.+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 579999999999999854 7999999999764 3445578999999999999999999999999999999999999765
Q ss_pred cHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccC---CceeeeccccccccCCCCc
Q 001768 741 SLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKD---LNAKISDFGLAKLDEDENT 817 (1016)
Q Consensus 741 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~---~~~kL~DFGla~~~~~~~~ 817 (1016)
-|+-+|.... .+|++....-++.||+.||.|||.+ +|+|+||||+|||+.+. -++||||||.|+++++...
T Consensus 649 MLEMILSsEk---gRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF 722 (888)
T KOG4236|consen 649 MLEMILSSEK---GRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF 722 (888)
T ss_pred HHHHHHHhhc---ccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhhh
Confidence 5554544333 3699999999999999999999998 99999999999999754 3699999999999887643
Q ss_pred ceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCCC
Q 001768 818 HISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGS 897 (1016)
Q Consensus 818 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 897 (1016)
...++||+.|+|||++++..|...-|+||.||++|--++|.-||+...+ +...++. .+.+-| .
T Consensus 723 --RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd--IndQIQN----------AaFMyP---p 785 (888)
T KOG4236|consen 723 --RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED--INDQIQN----------AAFMYP---P 785 (888)
T ss_pred --hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc--hhHHhhc----------cccccC---C
Confidence 3457899999999999999999999999999999999999999975432 2211111 111111 1
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCcCCcCccccCCCCh
Q 001768 898 NFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTAVQAPIIRRNSDS 949 (1016)
Q Consensus 898 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~p~~~~~~~~ 949 (1016)
..-++.....+++|...|+..-.+|-+.+.. +.|||.+.....
T Consensus 786 ~PW~eis~~AidlIn~LLqVkm~kRysvdk~---------lsh~Wlq~yq~w 828 (888)
T KOG4236|consen 786 NPWSEISPEAIDLINNLLQVKMRKRYSVDKS---------LSHPWLQDYQTW 828 (888)
T ss_pred CchhhcCHHHHHHHHHHHHHHHHHhcchHhh---------ccchhhhcchHH
Confidence 2223455578899999999999999998644 468887755433
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-31 Score=301.66 Aligned_cols=265 Identities=28% Similarity=0.433 Sum_probs=214.6
Q ss_pred HHHHHHHhcCccccCccccCCCeeEEEEEc-CCCcEEEEEEccCCChhhhHHHHHHHHHHHhc-CCCCeeeeeeeEee--
Q 001768 651 LRQIKAATNNFDAANKIGEGGFGPVYKGTL-SDGAVIAVKQLSSKSKQGNREFVNEIGMISAL-QHQNLVKLYGCCIE-- 726 (1016)
Q Consensus 651 ~~~l~~~~~~f~~~~~LG~G~~G~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~-- 726 (1016)
+..+..-++.|++.+.||.|.+|.||+++. ++++.+|+|++...... .+++..|+++++.. .|||++.++|++..
T Consensus 11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~~k~~ 89 (953)
T KOG0587|consen 11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAFIKKD 89 (953)
T ss_pred hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence 344445567899999999999999999984 57899999998765443 35677899999988 69999999999864
Q ss_pred ---cceeEEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceee
Q 001768 727 ---GNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKI 803 (1016)
Q Consensus 727 ---~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL 803 (1016)
++++|||||||.+||..|+++.-. ...+.|+.+..|++.++.|+.|||.+ .++|||||-.|||++.++.+||
T Consensus 90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKL 164 (953)
T KOG0587|consen 90 PGNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKL 164 (953)
T ss_pred CCCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEE
Confidence 579999999999999999997665 45799999999999999999999998 8999999999999999999999
Q ss_pred eccccccccCCCCcceeeecccCccccChhhhccC-----CCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHH
Q 001768 804 SDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRG-----YLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWA 878 (1016)
Q Consensus 804 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~ 878 (1016)
+|||.+....... .......||+.|||||++... .|+.++|+||||++..||.-|.+|+....+......+
T Consensus 165 vDFGvSaQldsT~-grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~I--- 240 (953)
T KOG0587|consen 165 VDFGVSAQLDSTV-GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI--- 240 (953)
T ss_pred eeeeeeeeeeccc-ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccC---
Confidence 9999987544332 234457899999999998643 4778999999999999999999998766554432211
Q ss_pred HHHHHhCCcccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCcCCcCccccC
Q 001768 879 YVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTAVQAPIIRR 945 (1016)
Q Consensus 879 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~p~~~~ 945 (1016)
.. .|...-.-+..-..++.++|..|+..|-++||++.+++ .||++..
T Consensus 241 ---------pR--NPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll---------~hpFi~e 287 (953)
T KOG0587|consen 241 ---------PR--NPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELL---------KHPFITE 287 (953)
T ss_pred ---------CC--CCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhc---------cCCcccc
Confidence 11 12222223455677899999999999999999998776 4666663
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=343.41 Aligned_cols=279 Identities=34% Similarity=0.508 Sum_probs=148.4
Q ss_pred EEEEEecCCccCccCccccCCCCCCCEEEccCCCCCCCCchhhhcccCcccccccccccCCCCCcccCCcCCccEEEccc
Q 001768 87 VTVILLKGFNLAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGDISTLEELVLED 166 (1016)
Q Consensus 87 v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 166 (1016)
++.|+|++|.+++.+|..++++++|++|+|++|.+.+.+|..|+++++|++|+|++|.+.+.+|..++.+++|++|+|++
T Consensus 142 L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~ 221 (968)
T PLN00113 142 LETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGY 221 (968)
T ss_pred CCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcC
Confidence 44444444444444455555555555555555555555555555555555555555555555555555555555555555
Q ss_pred CCCCCCCCCCCCCCccchhhhccCCccCCCCCcccCCCCCccEEEecCCcCCCCCchhhhcCCCCCEEeecCCcCCCCCc
Q 001768 167 NQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIP 246 (1016)
Q Consensus 167 N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p 246 (1016)
|++++.+|..++++++|++|+|++|++++.+|..++++++|++|+|++|++++.+|..+.++++|+.|+|++|.+++.+|
T Consensus 222 n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p 301 (968)
T PLN00113 222 NNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIP 301 (968)
T ss_pred CccCCcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCC
Confidence 55555555555555555555555555555555555555555555555555555555555555555555555555555555
Q ss_pred hhhcCCCCCCEEEcCCCCCCCCCCcccccccccceeecccccccccCchhhcCCCCCceEeccCCCCCCCCccccCCCCC
Q 001768 247 STISQLKNLTELRISDLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLKK 326 (1016)
Q Consensus 247 ~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~L~~~~p~~l~~l~~ 326 (1016)
..+..+++|+.|++++|.+....+..+..+++|+.|+|++|.+.+.+|..++.+++|+.|+|++|++++.+|..+..+++
T Consensus 302 ~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~ 381 (968)
T PLN00113 302 ELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGN 381 (968)
T ss_pred hhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCC
Confidence 55555555555555555555444444555555555555555555555555555555555555555555555554444444
Q ss_pred CCEEEccCCcCCCCCChhh--hccCCcccCCCCcCCCCCCc
Q 001768 327 IDYIFLTNNSLSGTLPDWI--LTSEKNLDLSYNNFTESSPA 365 (1016)
Q Consensus 327 L~~L~L~~N~l~g~~p~~~--~~~L~~LdLs~N~l~~~~p~ 365 (1016)
|+.|++++|++.+.+|..+ +++|+.|+|++|++++.+|.
T Consensus 382 L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~ 422 (968)
T PLN00113 382 LFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPS 422 (968)
T ss_pred CCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECCh
Confidence 5555555555544444444 44555555555555555443
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-32 Score=285.58 Aligned_cols=283 Identities=20% Similarity=0.298 Sum_probs=214.0
Q ss_pred CCCCCcCHHHHHHHhcCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCChhhhHHHHHHHHHHHhcC--CC----C
Q 001768 644 LQTGYFTLRQIKAATNNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSKQGNREFVNEIGMISALQ--HQ----N 716 (1016)
Q Consensus 644 ~~~~~~~~~~l~~~~~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~--Hp----n 716 (1016)
...|.+-++.....+++|.+...+|+|.||.|-++... .+..||||+++.-.. -.+..+-|+++++++. -| -
T Consensus 74 D~dGH~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k-YreAa~iEi~vLqki~~~DP~g~~r 152 (415)
T KOG0671|consen 74 DKDGHYVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK-YREAALIEIEVLQKINESDPNGKFR 152 (415)
T ss_pred CCCceEEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH-HhhHHHHHHHHHHHHHhcCCCCceE
Confidence 34455555666677899999999999999999998754 478999999875432 3445677999999993 23 3
Q ss_pred eeeeeeeEeecceeEEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEc
Q 001768 717 LVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLD 796 (1016)
Q Consensus 717 Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~ 796 (1016)
+|.+.++|.-.++.|+|+|.+ |.|+.+++..+ ...+++...+..|+.|+++++++||+. +++|-||||+|||+.
T Consensus 153 cv~m~~wFdyrghiCivfell-G~S~~dFlk~N--~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfv 226 (415)
T KOG0671|consen 153 CVQMRDWFDYRGHICIVFELL-GLSTFDFLKEN--NYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFV 226 (415)
T ss_pred EEeeehhhhccCceEEEEecc-ChhHHHHhccC--CccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEe
Confidence 888999999999999999988 66999999654 346799999999999999999999998 999999999999993
Q ss_pred c--------------------CCceeeeccccccccCCCCcceeeecccCccccChhhhccCCCCCccchhHHHHHHHHH
Q 001768 797 K--------------------DLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEI 856 (1016)
Q Consensus 797 ~--------------------~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~el 856 (1016)
+ +..++|+|||.|....+.. ..++.|..|+|||++.+-.++.++||||+||||+|+
T Consensus 227 ss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~El 302 (415)
T KOG0671|consen 227 SSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVEL 302 (415)
T ss_pred ccceEEEeccCCccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEe
Confidence 1 3358999999998766543 346789999999999999999999999999999999
Q ss_pred HhCCCCCCCCCchhhHhHHHHHH-----HHH---------HhCC--ccc---------c---cCCc-CCCCCCHHHHHHH
Q 001768 857 VSGKSNTNYRPKEEFVYLLDWAY-----VLQ---------EQGN--LLE---------L---VDPS-LGSNFSKKEAMTM 907 (1016)
Q Consensus 857 ltG~~P~~~~~~~~~~~~~~~~~-----~~~---------~~~~--~~~---------~---~d~~-l~~~~~~~~~~~l 907 (1016)
.||...|...+..+.....+..- ... ..+. +.+ . ..|- ........+...+
T Consensus 303 ytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~L 382 (415)
T KOG0671|consen 303 YTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQL 382 (415)
T ss_pred eccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHH
Confidence 99999988765444322221100 000 0000 000 0 0000 0011123455689
Q ss_pred HHHHHHccCCCCCCCCCHHHHHHHhccCcCCcCccccCC
Q 001768 908 LNIALLCTNPSPTLRPTMSSAVSMLEGKTAVQAPIIRRN 946 (1016)
Q Consensus 908 ~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~p~~~~~ 946 (1016)
.+|+.+||..||.+|+|+.|++ .||++.+.
T Consensus 383 fDLl~~mL~fDP~~RiTl~EAL---------~HpFF~~~ 412 (415)
T KOG0671|consen 383 FDLLRRMLEFDPARRITLREAL---------SHPFFARL 412 (415)
T ss_pred HHHHHHHHccCccccccHHHHh---------cCHHhhcC
Confidence 9999999999999999998776 67776543
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-31 Score=281.40 Aligned_cols=220 Identities=23% Similarity=0.204 Sum_probs=177.0
Q ss_pred CCCeeEEEEEcC-CCcEEEEEEccCCChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEeecCCCcHHHHhcc
Q 001768 670 GGFGPVYKGTLS-DGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFG 748 (1016)
Q Consensus 670 G~~G~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~ 748 (1016)
|.+|.||+++.. +++.||+|++.... .+.+|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 899999999964 68899999987543 233455555666799999999999999999999999999999999865
Q ss_pred CcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCCcceeeecccCcc
Q 001768 749 KEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVG 828 (1016)
Q Consensus 749 ~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~ 828 (1016)
.. .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.++++|||.+...... .....++..
T Consensus 79 ~~----~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~ 147 (237)
T cd05576 79 FL----NIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENM 147 (237)
T ss_pred hc----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCcc
Confidence 43 589999999999999999999998 9999999999999999999999999987654332 122345678
Q ss_pred ccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCCCCCCHHHHHHHH
Q 001768 829 YMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGSNFSKKEAMTML 908 (1016)
Q Consensus 829 y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 908 (1016)
|+|||...+..++.++||||+||++|||++|+.|+...+... ...... ..+......+.
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-----------------~~~~~~----~~~~~~~~~~~ 206 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-----------------NTHTTL----NIPEWVSEEAR 206 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-----------------cccccc----CCcccCCHHHH
Confidence 999999988888999999999999999999998865322110 000000 11222345688
Q ss_pred HHHHHccCCCCCCCCCHH
Q 001768 909 NIALLCTNPSPTLRPTMS 926 (1016)
Q Consensus 909 ~li~~cl~~dP~~RPt~~ 926 (1016)
+++.+|++.||++||++.
T Consensus 207 ~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 207 SLLQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHHHccCCHHHhcCCC
Confidence 999999999999999974
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=282.30 Aligned_cols=245 Identities=22% Similarity=0.330 Sum_probs=201.6
Q ss_pred HHhcCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCCh---hhhHHHHHHHHHHHhc-CCCCeeeeeeeEeeccee
Q 001768 656 AATNNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSK---QGNREFVNEIGMISAL-QHQNLVKLYGCCIEGNQL 730 (1016)
Q Consensus 656 ~~~~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~ 730 (1016)
....+|..+..||+|+||.|.+|..+ ..+.+|||++++..- .+.+--+.|-++|... +-|.++++..+|+.-+++
T Consensus 346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRL 425 (683)
T KOG0696|consen 346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRL 425 (683)
T ss_pred eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhe
Confidence 34457888999999999999999865 467899999987632 2222334566677665 578999999999999999
Q ss_pred EEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeecccccc
Q 001768 731 LLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAK 810 (1016)
Q Consensus 731 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~ 810 (1016)
|+||||+.||+|-.++++-. .+.+..+.-+|.+||-||-+||++ +||.||||.+|||+|.+|++||+|||+++
T Consensus 426 yFVMEyvnGGDLMyhiQQ~G----kFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcK 498 (683)
T KOG0696|consen 426 YFVMEYVNGGDLMYHIQQVG----KFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK 498 (683)
T ss_pred eeEEEEecCchhhhHHHHhc----ccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeeccccc
Confidence 99999999999999987654 577888999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCcceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccc
Q 001768 811 LDEDENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLEL 890 (1016)
Q Consensus 811 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 890 (1016)
.---+ ...+..++|||.|+|||++...+|+..+|.|||||+||||+.|++||++...++....+.
T Consensus 499 Eni~~-~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~-------------- 563 (683)
T KOG0696|consen 499 ENIFD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIM-------------- 563 (683)
T ss_pred ccccC-CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH--------------
Confidence 42222 223456899999999999999999999999999999999999999999887766543221
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCH
Q 001768 891 VDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTM 925 (1016)
Q Consensus 891 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 925 (1016)
+. .-.+++..+.+...+....+...|.+|...
T Consensus 564 -eh--nvsyPKslSkEAv~ickg~ltK~P~kRLGc 595 (683)
T KOG0696|consen 564 -EH--NVSYPKSLSKEAVAICKGLLTKHPGKRLGC 595 (683)
T ss_pred -Hc--cCcCcccccHHHHHHHHHHhhcCCccccCC
Confidence 11 124566667778889999999999999754
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=309.54 Aligned_cols=260 Identities=22% Similarity=0.283 Sum_probs=171.0
Q ss_pred HhcCccccCccccCCCeeEEEEEcC-C----CcEEEEEEccCCChhhhHHHHHHHHHHHhcCCCCeeeeeee------Ee
Q 001768 657 ATNNFDAANKIGEGGFGPVYKGTLS-D----GAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGC------CI 725 (1016)
Q Consensus 657 ~~~~f~~~~~LG~G~~G~Vy~~~~~-~----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~------~~ 725 (1016)
..++|++.+.||+|+||.||+|++. + +..||+|++...... +...+| .+....+.+++.++.. ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 5678999999999999999999975 4 689999987643221 111111 1122222233322221 24
Q ss_pred ecceeEEEEeecCCCcHHHHhccCcCc----------------CcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCC
Q 001768 726 EGNQLLLVYEYLENNSLARALFGKEGQ----------------CLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIK 789 (1016)
Q Consensus 726 ~~~~~~lV~E~~~~gsL~~~l~~~~~~----------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlk 789 (1016)
.+...++||||+++++|.+++...... ........+..++.|++.||+|||++ +|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCC
Confidence 567899999999999999998654210 00112345668999999999999998 99999999
Q ss_pred CceEEEcc-CCceeeeccccccccCCCCcceeeecccCccccChhhhccC----------------------CCCCccch
Q 001768 790 ATNVLLDK-DLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRG----------------------YLTDKADV 846 (1016)
Q Consensus 790 p~NILl~~-~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~sDV 846 (1016)
|+|||++. ++.+||+|||+|+..............+++.|+|||.+... .++.++||
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 99999986 57999999999986554434444557889999999965322 23456799
Q ss_pred hHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhC----CcccccCCcCCCC----C--CHHHHHHHHHHHHHccC
Q 001768 847 YSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQG----NLLELVDPSLGSN----F--SKKEAMTMLNIALLCTN 916 (1016)
Q Consensus 847 wSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~d~~l~~~----~--~~~~~~~l~~li~~cl~ 916 (1016)
|||||++|||+++..|++... ... .......+ .+.....+..... + .........+|+.+|++
T Consensus 363 wSlGviL~el~~~~~~~~~~~----~~~---~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~ 435 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDSNL----IQF---NRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMR 435 (566)
T ss_pred HHHHHHHHHHHhCcCCCchHH----HHH---HHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHcc
Confidence 999999999999776543211 000 00000000 0001111110000 0 00112245689999999
Q ss_pred CCCCCCCCHHHHHH
Q 001768 917 PSPTLRPTMSSAVS 930 (1016)
Q Consensus 917 ~dP~~RPt~~evl~ 930 (1016)
.||++|||+.|+++
T Consensus 436 ~dP~kR~ta~e~L~ 449 (566)
T PLN03225 436 FKGRQRISAKAALA 449 (566)
T ss_pred CCcccCCCHHHHhC
Confidence 99999999998884
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-30 Score=298.24 Aligned_cols=267 Identities=20% Similarity=0.238 Sum_probs=186.2
Q ss_pred HhcCccccCccccCCCeeEEEEEc-----------------CCCcEEEEEEccCCChhhhHH--------------HHHH
Q 001768 657 ATNNFDAANKIGEGGFGPVYKGTL-----------------SDGAVIAVKQLSSKSKQGNRE--------------FVNE 705 (1016)
Q Consensus 657 ~~~~f~~~~~LG~G~~G~Vy~~~~-----------------~~~~~vAvK~~~~~~~~~~~~--------------~~~E 705 (1016)
..++|++.++||+|+||.||+|.+ ..++.||||++........++ ...|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467899999999999999999963 235689999987543322222 3346
Q ss_pred HHHHHhcCCCCe-----eeeeeeEee--------cceeEEEEeecCCCcHHHHhccCcCc--------------------
Q 001768 706 IGMISALQHQNL-----VKLYGCCIE--------GNQLLLVYEYLENNSLARALFGKEGQ-------------------- 752 (1016)
Q Consensus 706 ~~~l~~l~HpnI-----v~l~~~~~~--------~~~~~lV~E~~~~gsL~~~l~~~~~~-------------------- 752 (1016)
+.++.+++|.++ ++++++|.. .+..+|||||+++++|.++++...+.
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777776654 677887753 35689999999999999999753211
Q ss_pred CcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCCcceeeecccCccccCh
Q 001768 753 CLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAP 832 (1016)
Q Consensus 753 ~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aP 832 (1016)
...+++..+..++.|+++||.|||+. +|+||||||+|||++.++.+||+|||++...............+|+.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 12357788999999999999999998 899999999999999999999999999975433222212223457899999
Q ss_pred hhhccCC----------------------CCCccchhHHHHHHHHHHhCCC-CCCCCCch--hh----HhHHHHHHHHHH
Q 001768 833 EYAMRGY----------------------LTDKADVYSFGIVALEIVSGKS-NTNYRPKE--EF----VYLLDWAYVLQE 883 (1016)
Q Consensus 833 E~~~~~~----------------------~~~~sDVwSlGvvl~elltG~~-P~~~~~~~--~~----~~~~~~~~~~~~ 883 (1016)
|.+.... ...+.||||+||++|||++|.. |+...... +. .....|.....
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~- 458 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG- 458 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc-
Confidence 9875322 1234799999999999999875 55421110 00 00111111000
Q ss_pred hCCcccccCCcCCCCCCHHHHHHHHHHHHHccCCCC---CCCCCHHHHHHHhccCcCCcCccccC
Q 001768 884 QGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSP---TLRPTMSSAVSMLEGKTAVQAPIIRR 945 (1016)
Q Consensus 884 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP---~~RPt~~evl~~L~~~~~~~~p~~~~ 945 (1016)
................+++.+++..+| .+|+|++|++ .|||+.+
T Consensus 459 ---------~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL---------~Hp~f~~ 505 (507)
T PLN03224 459 ---------QKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQAL---------SHRFFLP 505 (507)
T ss_pred ---------cCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHh---------CCCCcCC
Confidence 001111112234568899999999766 6899999887 6888653
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=281.94 Aligned_cols=256 Identities=25% Similarity=0.357 Sum_probs=198.3
Q ss_pred hcCccccCccccCCCeeEEEEE-cCCCcEEEEEEccCCCh-------hhhHHHHHHHHHHHhcCCCCeeeeeeeEee-cc
Q 001768 658 TNNFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSK-------QGNREFVNEIGMISALQHQNLVKLYGCCIE-GN 728 (1016)
Q Consensus 658 ~~~f~~~~~LG~G~~G~Vy~~~-~~~~~~vAvK~~~~~~~-------~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~ 728 (1016)
.++|-.++.||+|||+.||+|. +...+.||||+-..... .-.+...+|.+|-+.++||.||++|+++.- .+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 3567778999999999999998 45678999998643211 113456789999999999999999999974 57
Q ss_pred eeEEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEc---cCCceeeec
Q 001768 729 QLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLD---KDLNAKISD 805 (1016)
Q Consensus 729 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~---~~~~~kL~D 805 (1016)
.+|-|+|||+|.+|+-+|.... .+++.++..|+.||+.||.||.+. .++|||-||||.|||+. ..|.+||.|
T Consensus 542 sFCTVLEYceGNDLDFYLKQhk----lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITD 616 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQHK----LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITD 616 (775)
T ss_pred cceeeeeecCCCchhHHHHhhh----hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeee
Confidence 8999999999999999997664 689999999999999999999998 56999999999999995 357899999
Q ss_pred cccccccCCCCc------ceeeecccCccccChhhhccC----CCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHH
Q 001768 806 FGLAKLDEDENT------HISTRIAGTVGYMAPEYAMRG----YLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLL 875 (1016)
Q Consensus 806 FGla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~----~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~ 875 (1016)
||+++++.++.. ..+...+||+.|++||.+.-+ .++.|+||||.||++|+.+.|+.||........ +.
T Consensus 617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQd--IL 694 (775)
T KOG1151|consen 617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQD--IL 694 (775)
T ss_pred cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHH--HH
Confidence 999998765432 235567899999999977533 578899999999999999999999975443321 11
Q ss_pred HHHHHHHHhCCcccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 001768 876 DWAYVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAV 929 (1016)
Q Consensus 876 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 929 (1016)
+... +...-+-.++. -+....+..++|++||+..-++|....++.
T Consensus 695 qeNT-------IlkAtEVqFP~--KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 695 QENT-------ILKATEVQFPP--KPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred hhhc-------hhcceeccCCC--CCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 1111 11111111111 112344678899999999999998776554
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-32 Score=269.10 Aligned_cols=266 Identities=25% Similarity=0.376 Sum_probs=197.3
Q ss_pred hcCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCC-hh-hhHHHHHHHHHHHhcCCCCeeeeeeeEeec-------
Q 001768 658 TNNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS-KQ-GNREFVNEIGMISALQHQNLVKLYGCCIEG------- 727 (1016)
Q Consensus 658 ~~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~-~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------- 727 (1016)
...|+...+||+|.||+||+|+.. .|+.||+|+.-... +. -.....+|+++|+.++|+|++.+++.|...
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~ 95 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD 95 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence 345667789999999999999965 57888988764322 22 245678899999999999999999988642
Q ss_pred -ceeEEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeecc
Q 001768 728 -NQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDF 806 (1016)
Q Consensus 728 -~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DF 806 (1016)
..+|+||.+|+. +|.-++.... ..++..++.+++.++..||.|+|.. .|+|||+||.|+|++.+|.+||+||
T Consensus 96 r~t~ylVf~~ceh-DLaGlLsn~~---vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADF 168 (376)
T KOG0669|consen 96 RATFYLVFDFCEH-DLAGLLSNRK---VRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADF 168 (376)
T ss_pred cceeeeeHHHhhh-hHHHHhcCcc---ccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeecc
Confidence 358999999987 7888885442 4689999999999999999999998 8999999999999999999999999
Q ss_pred ccccccCCCCcc---eeeecccCccccChhhhccC-CCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHH
Q 001768 807 GLAKLDEDENTH---ISTRIAGTVGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQ 882 (1016)
Q Consensus 807 Gla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~ 882 (1016)
|+++.+...... ..+..+-|..|++||.+.+. .++++.|||+-||++.||+||.+-+.+........++..--...
T Consensus 169 Glar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~ 248 (376)
T KOG0669|consen 169 GLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSI 248 (376)
T ss_pred ccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccC
Confidence 999755432211 12334568999999988764 79999999999999999999999888776665544433211000
Q ss_pred HhC--------Cccccc--CCcCCCCCC--HHH------HHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 883 EQG--------NLLELV--DPSLGSNFS--KKE------AMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 883 ~~~--------~~~~~~--d~~l~~~~~--~~~------~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
... .+.+.+ .|-....+. ++. .....+|+..++..||.+|+++++++.
T Consensus 249 tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 249 TKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred CcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 111 111111 110000000 011 125778999999999999999998773
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=286.79 Aligned_cols=242 Identities=22% Similarity=0.312 Sum_probs=204.5
Q ss_pred cCccccCccccCCCeeEEEEEcCCCc-EEEEEEccCC---ChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEE
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLSDGA-VIAVKQLSSK---SKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVY 734 (1016)
Q Consensus 659 ~~f~~~~~LG~G~~G~Vy~~~~~~~~-~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 734 (1016)
.+++++..||-||||.|-++..+... .+|+|++++. .....+.+..|-.+|...+.|.||++|..|.++...|+.|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 45566789999999999999876443 4788887654 3455667888999999999999999999999999999999
Q ss_pred eecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCC
Q 001768 735 EYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDED 814 (1016)
Q Consensus 735 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 814 (1016)
|-|-||.|+..+..+. .++..++.-++.-+++|++|||.+ +||.|||||+|.++|.+|-+||.|||+|+....
T Consensus 500 EaClGGElWTiLrdRg----~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~ 572 (732)
T KOG0614|consen 500 EACLGGELWTILRDRG----SFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS 572 (732)
T ss_pred HhhcCchhhhhhhhcC----CcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence 9999999999997664 588889999999999999999999 999999999999999999999999999998766
Q ss_pred CCcceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCc
Q 001768 815 ENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPS 894 (1016)
Q Consensus 815 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 894 (1016)
.. .+.+++|||.|.|||++.+...+.++|.||||+++|||++|.+||....+.....++-.. +|
T Consensus 573 g~--KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkG------------id-- 636 (732)
T KOG0614|consen 573 GR--KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKG------------ID-- 636 (732)
T ss_pred CC--ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhh------------hh--
Confidence 54 356789999999999999988899999999999999999999999887665544433211 11
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCC
Q 001768 895 LGSNFSKKEAMTMLNIALLCTNPSPTLRPT 924 (1016)
Q Consensus 895 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt 924 (1016)
.-.+|........+++++.+..+|.+|..
T Consensus 637 -~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 637 -KIEFPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred -hhhcccccchhHHHHHHHHHhcCcHhhhc
Confidence 01234455567888999999999999986
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=270.97 Aligned_cols=264 Identities=20% Similarity=0.281 Sum_probs=209.3
Q ss_pred HHHHHHhcCccccCccccCCCeeEEEEEcCC------CcEEEEEEccCC-ChhhhHHHHHHHHHHHhcCCCCeeeeeeeE
Q 001768 652 RQIKAATNNFDAANKIGEGGFGPVYKGTLSD------GAVIAVKQLSSK-SKQGNREFVNEIGMISALQHQNLVKLYGCC 724 (1016)
Q Consensus 652 ~~l~~~~~~f~~~~~LG~G~~G~Vy~~~~~~------~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 724 (1016)
+++..-..+++....+-+|.||.||+|.|.+ .+.|-+|.++.. +......+..|.-.+..+.|||+.++.+++
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ 356 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS 356 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence 3444556678888899999999999997653 345667776644 344556788888889999999999999998
Q ss_pred eec-ceeEEEEeecCCCcHHHHhccCc----CcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCC
Q 001768 725 IEG-NQLLLVYEYLENNSLARALFGKE----GQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDL 799 (1016)
Q Consensus 725 ~~~-~~~~lV~E~~~~gsL~~~l~~~~----~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~ 799 (1016)
.++ ...+.+|.++.-|+|..++...+ .....++..+...++.|++.|++|||++ +|||.||.++|.++|+..
T Consensus 357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~L 433 (563)
T KOG1024|consen 357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQL 433 (563)
T ss_pred eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehhhe
Confidence 765 56789999999999999997322 1224678888999999999999999999 999999999999999999
Q ss_pred ceeeeccccccccCCCCcc-eeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHh-CCCCCCCCCchhhHhHHHH
Q 001768 800 NAKISDFGLAKLDEDENTH-ISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDW 877 (1016)
Q Consensus 800 ~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~ 877 (1016)
++||+|=.+++..-....+ .....-.+..||+||.+....++.++|||||||++|||+| |+.|+..-++.+....+.
T Consensus 434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylk- 512 (563)
T KOG1024|consen 434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLK- 512 (563)
T ss_pred eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHh-
Confidence 9999999999854333222 2222234568999999999999999999999999999999 999998766665443221
Q ss_pred HHHHHHhCCcccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 001768 878 AYVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEG 934 (1016)
Q Consensus 878 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 934 (1016)
+..+ -..|..++.++..++.-||+.+|++||+++|++..|.+
T Consensus 513 -----dGyR----------laQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 513 -----DGYR----------LAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred -----ccce----------ecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 1111 12234567789999999999999999999999998865
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-30 Score=281.34 Aligned_cols=205 Identities=24% Similarity=0.387 Sum_probs=174.3
Q ss_pred CccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCC---hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEe
Q 001768 660 NFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS---KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYE 735 (1016)
Q Consensus 660 ~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 735 (1016)
-|..++.||-|+||+|-+++.. +...||.|.+.+.+ .......+.|-.||...+.+-||+||-.|.+.+.+|+|||
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence 4778899999999999999844 46778999987654 3334567889999999999999999999999999999999
Q ss_pred ecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeecccccccc---
Q 001768 736 YLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLD--- 812 (1016)
Q Consensus 736 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~--- 812 (1016)
|++||++-.+|...+ -+.+..++-++.++..|+++.|.. |+|||||||+|||+|.+|++||.|||++.-+
T Consensus 710 YIPGGDmMSLLIrmg----IFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT 782 (1034)
T KOG0608|consen 710 YIPGGDMMSLLIRMG----IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 782 (1034)
T ss_pred ccCCccHHHHHHHhc----cCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceec
Confidence 999999999887654 588889999999999999999988 9999999999999999999999999998421
Q ss_pred ------CCCCcc--------------------------------eeeecccCccccChhhhccCCCCCccchhHHHHHHH
Q 001768 813 ------EDENTH--------------------------------ISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVAL 854 (1016)
Q Consensus 813 ------~~~~~~--------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ 854 (1016)
.+...+ .....+||+.|+|||++....++..+|.||.|||||
T Consensus 783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~ 862 (1034)
T KOG0608|consen 783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY 862 (1034)
T ss_pred cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence 111000 001147999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCchhh
Q 001768 855 EIVSGKSNTNYRPKEEF 871 (1016)
Q Consensus 855 elltG~~P~~~~~~~~~ 871 (1016)
||+.|++||....+.+.
T Consensus 863 em~~g~~pf~~~tp~~t 879 (1034)
T KOG0608|consen 863 EMLVGQPPFLADTPGET 879 (1034)
T ss_pred HHhhCCCCccCCCCCcc
Confidence 99999999987665543
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=269.49 Aligned_cols=238 Identities=27% Similarity=0.403 Sum_probs=193.4
Q ss_pred CCeeEEEEEcC-CCcEEEEEEccCCChhh-hHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEeecCCCcHHHHhcc
Q 001768 671 GFGPVYKGTLS-DGAVIAVKQLSSKSKQG-NREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFG 748 (1016)
Q Consensus 671 ~~G~Vy~~~~~-~~~~vAvK~~~~~~~~~-~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~ 748 (1016)
+||.||+|+.. +++.+|+|++....... .+.+.+|++.+++++|+|++++++++......+++|||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999976 48999999997665444 67899999999999999999999999999999999999999999999865
Q ss_pred CcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCCcceeeecccCcc
Q 001768 749 KEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVG 828 (1016)
Q Consensus 749 ~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~ 828 (1016)
.. .+++..+..++.+++.++.|||+. +++|+||+|+||++++++.++|+|||.+....... ......++..
T Consensus 81 ~~----~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~ 151 (244)
T smart00220 81 RG----RLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPE 151 (244)
T ss_pred cc----CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcC
Confidence 43 389999999999999999999998 99999999999999999999999999998655432 2234567889
Q ss_pred ccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCCCCCCHHHHHHHH
Q 001768 829 YMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGSNFSKKEAMTML 908 (1016)
Q Consensus 829 y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 908 (1016)
|+|||...+..++.++||||||+++|+|++|..||........ ..+. ...... .. .......+..+.
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~--~~~~----~~~~~~-~~------~~~~~~~~~~~~ 218 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLE--LFKK----IGKPKP-PF------PPPEWKISPEAK 218 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHH--HHHH----HhccCC-CC------ccccccCCHHHH
Confidence 9999999888889999999999999999999999876322211 1110 000000 00 000000345789
Q ss_pred HHHHHccCCCCCCCCCHHHHHH
Q 001768 909 NIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 909 ~li~~cl~~dP~~RPt~~evl~ 930 (1016)
+++.+|+..+|++||++.++++
T Consensus 219 ~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 219 DLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHccCCchhccCHHHHhh
Confidence 9999999999999999999985
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=260.17 Aligned_cols=248 Identities=21% Similarity=0.337 Sum_probs=198.9
Q ss_pred HhcCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCC---ChhhhHHHHHHHHHHHhc-CCCCeeeeeeeEeecceeE
Q 001768 657 ATNNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSK---SKQGNREFVNEIGMISAL-QHQNLVKLYGCCIEGNQLL 731 (1016)
Q Consensus 657 ~~~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~ 731 (1016)
.-++|+..+.||+|+|..|.++++. +.+.+|+|++++. ..++.+..+.|-.+..+. +||.+|.+..+|+.+.+++
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf 327 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF 327 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence 3468999999999999999999965 5789999998764 344556677888887776 7999999999999999999
Q ss_pred EEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccc
Q 001768 732 LVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKL 811 (1016)
Q Consensus 732 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~ 811 (1016)
+|.||++||+|--+++.++ .++++.+.-+..+|..||.|||++ |||.||+|.+|||+|..|++||.|+|+++.
T Consensus 328 fvieyv~ggdlmfhmqrqr----klpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke 400 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKE 400 (593)
T ss_pred EEEEEecCcceeeehhhhh----cCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhc
Confidence 9999999999988886654 699999999999999999999999 999999999999999999999999999984
Q ss_pred cCCCCcceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCC---CchhhHhHHHHHHHHHHhCCcc
Q 001768 812 DEDENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYR---PKEEFVYLLDWAYVLQEQGNLL 888 (1016)
Q Consensus 812 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~---~~~~~~~~~~~~~~~~~~~~~~ 888 (1016)
.-.+ ...+..++|||.|.|||.+++..|...+|.|++||+++||+.|+.||+.- .+++. ..++.....
T Consensus 401 ~l~~-gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~n--tedylfqvi------ 471 (593)
T KOG0695|consen 401 GLGP-GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMN--TEDYLFQVI------ 471 (593)
T ss_pred CCCC-CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccc--hhHHHHHHH------
Confidence 3322 23456689999999999999999999999999999999999999999731 11111 111111111
Q ss_pred cccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCC
Q 001768 889 ELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPT 924 (1016)
Q Consensus 889 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt 924 (1016)
++..+ .++.....+...+++.-+++||.+|..
T Consensus 472 --lekqi--riprslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 472 --LEKQI--RIPRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred --hhhcc--cccceeehhhHHHHHHhhcCCcHHhcC
Confidence 11111 123333445667888889999999864
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-30 Score=295.15 Aligned_cols=244 Identities=28% Similarity=0.373 Sum_probs=188.6
Q ss_pred cccCccccCCCe-eEEEEEcCCCcEEEEEEccCCChhhhHHHHHHHHHHHhc-CCCCeeeeeeeEeecceeEEEEeecCC
Q 001768 662 DAANKIGEGGFG-PVYKGTLSDGAVIAVKQLSSKSKQGNREFVNEIGMISAL-QHQNLVKLYGCCIEGNQLLLVYEYLEN 739 (1016)
Q Consensus 662 ~~~~~LG~G~~G-~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~ 739 (1016)
.-.+.+|.|+.| .||+|... |+.||||++-... ....++|+..|+.- +|||||++++.-.+....|+..|.|..
T Consensus 512 ~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~ 587 (903)
T KOG1027|consen 512 SPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC 587 (903)
T ss_pred ccHHHcccCCCCcEEEEEeeC-CceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh
Confidence 335678999998 67999984 7899999986443 34567899999887 699999999999999999999999965
Q ss_pred CcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEcc---C--CceeeeccccccccCC
Q 001768 740 NSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDK---D--LNAKISDFGLAKLDED 814 (1016)
Q Consensus 740 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~---~--~~~kL~DFGla~~~~~ 814 (1016)
+|.+++...............+.+..|+++||+|||+- +||||||||.|||++. + .+++|+|||+++....
T Consensus 588 -sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~ 663 (903)
T KOG1027|consen 588 -SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAG 663 (903)
T ss_pred -hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccCC
Confidence 99999977411111122245678999999999999997 9999999999999976 3 4799999999997765
Q ss_pred CCcce--eeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhC-CCCCCCCCchhhHhHHHHHHHHHHhCCccccc
Q 001768 815 ENTHI--STRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSG-KSNTNYRPKEEFVYLLDWAYVLQEQGNLLELV 891 (1016)
Q Consensus 815 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG-~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 891 (1016)
+.... .....||-+|+|||.+....-+.++||||+||++|+.++| ++||......+ +.+......+..+.
T Consensus 664 ~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~-------~NIl~~~~~L~~L~ 736 (903)
T KOG1027|consen 664 GKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ-------ANILTGNYTLVHLE 736 (903)
T ss_pred CcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh-------hhhhcCccceeeec
Confidence 54332 3457899999999999988888899999999999999995 88987543222 11222222222211
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 001768 892 DPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAV 929 (1016)
Q Consensus 892 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 929 (1016)
. ..++ +..+||.+|++++|..||++.+|+
T Consensus 737 ~-------~~d~--eA~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 737 P-------LPDC--EAKDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred c-------CchH--HHHHHHHHhcCCCcccCCCHHHHh
Confidence 1 0111 678999999999999999999988
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-30 Score=249.75 Aligned_cols=207 Identities=24% Similarity=0.398 Sum_probs=170.1
Q ss_pred HHHHhcCccccCccccCCCeeEEEEEc-CCCcEEEEEEccCCC-hhhhHHHHHHHHHHHh-cCCCCeeeeeeeEeeccee
Q 001768 654 IKAATNNFDAANKIGEGGFGPVYKGTL-SDGAVIAVKQLSSKS-KQGNREFVNEIGMISA-LQHQNLVKLYGCCIEGNQL 730 (1016)
Q Consensus 654 l~~~~~~f~~~~~LG~G~~G~Vy~~~~-~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~-l~HpnIv~l~~~~~~~~~~ 730 (1016)
++...+....+..||+|++|.|-+.++ .+|+..|+|++...- .+...+..+|+.+..+ ..+|.+|.++|...+....
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 344555666788999999999988774 479999999997653 3445567778876554 4799999999999999999
Q ss_pred EEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeecccccc
Q 001768 731 LLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAK 810 (1016)
Q Consensus 731 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~ 810 (1016)
++.||.|.- ||+.+-..--.....+++...-+|+..+.+||.|||++ ..+||||+||+|||++.+|++|+||||.+.
T Consensus 121 wIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 121 WICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred EEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccce
Confidence 999999954 77776655444556799999999999999999999998 589999999999999999999999999997
Q ss_pred ccCCCCcceeeecccCccccChhhhcc----CCCCCccchhHHHHHHHHHHhCCCCCCC
Q 001768 811 LDEDENTHISTRIAGTVGYMAPEYAMR----GYLTDKADVYSFGIVALEIVSGKSNTNY 865 (1016)
Q Consensus 811 ~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDVwSlGvvl~elltG~~P~~~ 865 (1016)
...+.-. .+...|-..|||||.+.. ..|+.|+||||||+++.||.+++.||+.
T Consensus 198 ~L~dSiA--kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 198 YLVDSIA--KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred eehhhhH--HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence 6554321 222467788999998863 3688999999999999999999999863
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-28 Score=262.89 Aligned_cols=282 Identities=23% Similarity=0.361 Sum_probs=205.4
Q ss_pred CCCCcCHHHHHHHh-cCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCChhhhHHHHHHHHHHHhcC-----C---
Q 001768 645 QTGYFTLRQIKAAT-NNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSKQGNREFVNEIGMISALQ-----H--- 714 (1016)
Q Consensus 645 ~~~~~~~~~l~~~~-~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-----H--- 714 (1016)
..|+.+.+...... .+|.+.++||.|.|++||++.+. +.+.||+|+.+... .-.+....|+++|++++ |
T Consensus 63 kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~ 141 (590)
T KOG1290|consen 63 KGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGK 141 (590)
T ss_pred cCCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCC
Confidence 34555555555555 78999999999999999999854 57899999987543 23456778999999984 3
Q ss_pred CCeeeeeeeEee----cceeEEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCC
Q 001768 715 QNLVKLYGCCIE----GNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKA 790 (1016)
Q Consensus 715 pnIv~l~~~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp 790 (1016)
.+||+++++|.. +.++++|+|++ |.+|..+|.... ...++...+.+|++||+.||.|||.++ +|||-||||
T Consensus 142 ~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~--YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKP 216 (590)
T KOG1290|consen 142 KCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSN--YRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKP 216 (590)
T ss_pred ceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhC--CCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCc
Confidence 369999999975 46899999998 668888886654 346899999999999999999999997 999999999
Q ss_pred ceEEEccC------------------------------------------------------------------------
Q 001768 791 TNVLLDKD------------------------------------------------------------------------ 798 (1016)
Q Consensus 791 ~NILl~~~------------------------------------------------------------------------ 798 (1016)
+|||+..+
T Consensus 217 ENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~ 296 (590)
T KOG1290|consen 217 ENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEE 296 (590)
T ss_pred ceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccc
Confidence 99999100
Q ss_pred --------------------------------------------------------------------------------
Q 001768 799 -------------------------------------------------------------------------------- 798 (1016)
Q Consensus 799 -------------------------------------------------------------------------------- 798 (1016)
T Consensus 297 ~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~ 376 (590)
T KOG1290|consen 297 EPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIAS 376 (590)
T ss_pred cccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCcccccc
Confidence
Q ss_pred --------------CceeeeccccccccCCCCcceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCC
Q 001768 799 --------------LNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTN 864 (1016)
Q Consensus 799 --------------~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~ 864 (1016)
-++||+|||-|+..... .+.-+.|..|+|||++.+..|++.+||||++|+++||+||...|+
T Consensus 377 n~~v~p~~~~~~~di~vKIaDlGNACW~~kh----FT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFe 452 (590)
T KOG1290|consen 377 NPLVNPDIPLPECDIRVKIADLGNACWVHKH----FTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFE 452 (590)
T ss_pred ccccCCCCCCCccceeEEEeeccchhhhhhh----hchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeec
Confidence 01344444444432211 112346788999999999999999999999999999999999886
Q ss_pred CCCchh-------hHhHHHH---------------HHHHHHhCCcccccCCcC---------CCCCCHHHHHHHHHHHHH
Q 001768 865 YRPKEE-------FVYLLDW---------------AYVLQEQGNLLELVDPSL---------GSNFSKKEAMTMLNIALL 913 (1016)
Q Consensus 865 ~~~~~~-------~~~~~~~---------------~~~~~~~~~~~~~~d~~l---------~~~~~~~~~~~l~~li~~ 913 (1016)
....+. +..+++. .......+++..+-.-.. +-.++.+.+..+.+++.-
T Consensus 453 PhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~P 532 (590)
T KOG1290|consen 453 PHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSP 532 (590)
T ss_pred CCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHH
Confidence 533222 1111111 111112222222111110 124667888899999999
Q ss_pred ccCCCCCCCCCHHHHHHHhccCcCCcCccccC
Q 001768 914 CTNPSPTLRPTMSSAVSMLEGKTAVQAPIIRR 945 (1016)
Q Consensus 914 cl~~dP~~RPt~~evl~~L~~~~~~~~p~~~~ 945 (1016)
||+.+|++|||+.+.+ +|||+..
T Consensus 533 mLef~PeKR~tA~~cl---------~hPwLn~ 555 (590)
T KOG1290|consen 533 MLEFDPEKRPTAAQCL---------KHPWLNP 555 (590)
T ss_pred HHhcCccccccHHHHh---------cCccccC
Confidence 9999999999998777 5788654
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-29 Score=254.59 Aligned_cols=263 Identities=24% Similarity=0.322 Sum_probs=198.0
Q ss_pred cccCccccCCCeeEEEEEcC-CCcEEEEEEccCCC--hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeec-----ceeEEE
Q 001768 662 DAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS--KQGNREFVNEIGMISALQHQNLVKLYGCCIEG-----NQLLLV 733 (1016)
Q Consensus 662 ~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-----~~~~lV 733 (1016)
+..+.||.|+||.||.+++. +|+.||+|++.... -...+.+.+|+++|..++|.|++..++...-. .++|+|
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 44689999999999999864 79999999986432 23456788999999999999999998876543 357889
Q ss_pred EeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccC
Q 001768 734 YEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDE 813 (1016)
Q Consensus 734 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~ 813 (1016)
+|+|.. +|..++-.. ..++.+.+.-+..||++||.|||+. +|.||||||.|.|++.+..+||||||+|+..+
T Consensus 136 TELmQS-DLHKIIVSP----Q~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee 207 (449)
T KOG0664|consen 136 TELMQS-DLHKIIVSP----QALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWD 207 (449)
T ss_pred HHHHHh-hhhheeccC----CCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccc
Confidence 998854 777777544 3689999999999999999999999 99999999999999999999999999999776
Q ss_pred CCCcceeeecccCccccChhhhccC-CCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHH-H---------HHHHH
Q 001768 814 DENTHISTRIAGTVGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLD-W---------AYVLQ 882 (1016)
Q Consensus 814 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~-~---------~~~~~ 882 (1016)
.+.....+..+-|-.|+|||.+++. .|+.+.||||.||++.|++..+..|....+-+...++. . .....
T Consensus 208 ~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACE 287 (449)
T KOG0664|consen 208 QRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACE 287 (449)
T ss_pred hhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhh
Confidence 6555555556678899999999875 69999999999999999999998887655544333221 1 00000
Q ss_pred Hh-CCc-ccc-cCCcCCC----CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 001768 883 EQ-GNL-LEL-VDPSLGS----NFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSML 932 (1016)
Q Consensus 883 ~~-~~~-~~~-~d~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 932 (1016)
.. ..+ +.. -.|.... .-+.....+...+..+++..||++|.+..+.+..+
T Consensus 288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 00 000 000 0111110 01112233567788899999999999999888765
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-28 Score=241.70 Aligned_cols=256 Identities=19% Similarity=0.318 Sum_probs=192.5
Q ss_pred HhcCccccCccccCCCeeEEEEE-cCCCcEEEEEEccCCChhhhHHHHHHHHHHHhcC-CCCeeeeeeeEeec--ceeEE
Q 001768 657 ATNNFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQ-HQNLVKLYGCCIEG--NQLLL 732 (1016)
Q Consensus 657 ~~~~f~~~~~LG~G~~G~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~--~~~~l 732 (1016)
..++|++.+++|+|-+++||.|. ..+.+.++||++++-.. ..+.+|+.+|+.+. ||||+++++...+. ....|
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkk---kKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKK---KKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHH---HHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 34689999999999999999998 45678899999976543 46789999999996 99999999999875 56789
Q ss_pred EEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccC-Cceeeeccccccc
Q 001768 733 VYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKD-LNAKISDFGLAKL 811 (1016)
Q Consensus 733 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~-~~~kL~DFGla~~ 811 (1016)
|+||+.+.+...+- ..++..++..++.++++||.|+|+. ||+|||+||+|+++|.. -.++|+|+|+|.+
T Consensus 113 iFE~v~n~Dfk~ly-------~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEF 182 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLY-------PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 182 (338)
T ss_pred HhhhhccccHHHHh-------hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhh
Confidence 99999998776665 2577888999999999999999998 99999999999999965 5699999999998
Q ss_pred cCCCCcceeeecccCccccChhhhcc-CCCCCccchhHHHHHHHHHHhCCCCCCC-CCchhhHhHHHHHHHHHH------
Q 001768 812 DEDENTHISTRIAGTVGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGKSNTNY-RPKEEFVYLLDWAYVLQE------ 883 (1016)
Q Consensus 812 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~-~~~~~~~~~~~~~~~~~~------ 883 (1016)
....... .-.+.+..|.-||.+.. ..++..-|+|||||++..|+..+.||.. .+..+. ++..+.....
T Consensus 183 YHp~~eY--nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQ--LVkIakVLGt~el~~Y 258 (338)
T KOG0668|consen 183 YHPGKEY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ--LVKIAKVLGTDELYAY 258 (338)
T ss_pred cCCCcee--eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHH--HHHHHHHhChHHHHHH
Confidence 7765433 22345667899998875 4578889999999999999999999864 222221 2221111110
Q ss_pred --------hCCcccccCCcCCCC---C----CHH-HHHHHHHHHHHccCCCCCCCCCHHHHH
Q 001768 884 --------QGNLLELVDPSLGSN---F----SKK-EAMTMLNIALLCTNPSPTLRPTMSSAV 929 (1016)
Q Consensus 884 --------~~~~~~~~d~~l~~~---~----~~~-~~~~l~~li~~cl~~dP~~RPt~~evl 929 (1016)
..++..++....+.. | .+. ...+..+++.+.+..|-.+|||+.|++
T Consensus 259 l~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam 320 (338)
T KOG0668|consen 259 LNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAM 320 (338)
T ss_pred HHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHh
Confidence 001111111111000 0 111 125788999999999999999998766
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-29 Score=277.78 Aligned_cols=326 Identities=20% Similarity=0.231 Sum_probs=219.1
Q ss_pred eeeEEEEEecCCccCccCccccCCCCCCCEEEccCCCCCCCCchhhhcccCcccccccccccCCCCCcccCCcCCccEEE
Q 001768 84 VCHVTVILLKGFNLAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGDISTLEELV 163 (1016)
Q Consensus 84 ~~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 163 (1016)
.+|++.|+|.+|.++.+-.+++..++.|+.||||.|.|+.+--.+|..=.++++|+|++|.|+..-...|..+.+|..|.
T Consensus 124 sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlk 203 (873)
T KOG4194|consen 124 SGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLK 203 (873)
T ss_pred ccceeEEeeeccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeee
Confidence 35799999999999988888888899999999999888866666677777888888888888877777888888888888
Q ss_pred cccCCCCCCCCCCCCCCccchhhhccCCccCCCCCcccCCCCC------------------------ccEEEecCCcCCC
Q 001768 164 LEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKN------------------------LTEFRIDGSNLTG 219 (1016)
Q Consensus 164 Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~------------------------L~~L~L~~N~l~~ 219 (1016)
|+.|+++...+..|.+|++|+.|+|..|+|.-.--..|.+|++ +++|+|+.|+++.
T Consensus 204 LsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~ 283 (873)
T KOG4194|consen 204 LSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQA 283 (873)
T ss_pred cccCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhh
Confidence 8888888555566666888888888888776222334445544 4555555555544
Q ss_pred CCchhhhcCCCCCEEeecCCcCCCCCchhhcCCCCCCEEEcCCCCCCCCCCcccccccccceeecccccccccCchhhcC
Q 001768 220 RIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISDLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYIED 299 (1016)
Q Consensus 220 ~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~ 299 (1016)
.-..++.++++|+.|+||+|.|....++..+-.++|++|+|+.|+++..+...|..+..|++|+|++|+|...-...|..
T Consensus 284 vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~ 363 (873)
T KOG4194|consen 284 VNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVG 363 (873)
T ss_pred hhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHH
Confidence 44445555566666666666666555555666666666666666666666666666666666666666666555556677
Q ss_pred CCCCceEeccCCCCCCCCc---cccCCCCCCCEEEccCCcCCCCCChhh--hccCCcccCCCCcCCCCCCccccccccce
Q 001768 300 MTDLKILDLSFNQLTGPVP---GILQNLKKIDYIFLTNNSLSGTLPDWI--LTSEKNLDLSYNNFTESSPATCRESRVNI 374 (1016)
Q Consensus 300 l~~L~~L~Ls~N~L~~~~p---~~l~~l~~L~~L~L~~N~l~g~~p~~~--~~~L~~LdLs~N~l~~~~p~~~~~~~~~~ 374 (1016)
+++|+.|||++|.|+..+. ..|.+|++|+.|+|.+|+|...--..+ ++.|+.|||.+|.+...-|..+..-.+..
T Consensus 364 lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m~Lk~ 443 (873)
T KOG4194|consen 364 LSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPMELKE 443 (873)
T ss_pred hhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccchhhh
Confidence 7777777777777775443 356778888888888888884333444 78888899999988877776655443333
Q ss_pred eccccccCCCCccccccC---CCCCCccCCcceEEeecCCCC
Q 001768 375 LSSFSSTGSNSVSWCLKK---DLPCPKEAKHYSLFINCGGSP 413 (1016)
Q Consensus 375 l~~~~~~~~~~~~~c~~~---~~~c~~~~~~~~~~~~~~~~~ 413 (1016)
+ ....++-+|.|.-. ...-.... ..+....|+=|+
T Consensus 444 L---v~nSssflCDCql~Wl~qWl~~~~l-q~sv~a~CayPe 481 (873)
T KOG4194|consen 444 L---VMNSSSFLCDCQLKWLAQWLYRRKL-QSSVIAKCAYPE 481 (873)
T ss_pred h---hhcccceEEeccHHHHHHHHHhccc-ccceeeeccCCc
Confidence 3 23333334445432 11111111 145666677664
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-28 Score=270.48 Aligned_cols=277 Identities=22% Similarity=0.225 Sum_probs=202.5
Q ss_pred ceeeEEEEEecCCccCccCccccCCCCCCCEEEccCCCCCCCCchhhhcccCcccccccccccCCCCCcccCCcCCccEE
Q 001768 83 TVCHVTVILLKGFNLAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGDISTLEEL 162 (1016)
Q Consensus 83 ~~~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 162 (1016)
-+..+..|++++|.|..+.+..|.++++|++++|..|.++ .+|...+...+|+.|+|.+|.|+..-.+++..++.|+.|
T Consensus 76 lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrsl 154 (873)
T KOG4194|consen 76 LPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSL 154 (873)
T ss_pred CccceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhh
Confidence 3456888999999999888888999999999999999998 778755666779999999998887777888888889999
Q ss_pred EcccCCCCCCCCCCCCCCccchhhhccCCccCCCCCcccCCCCCccEEEecCCcCCCCCchhhhcCCCCCEEeecCCcCC
Q 001768 163 VLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLE 242 (1016)
Q Consensus 163 ~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~ 242 (1016)
|||.|.|+...-+.|..-.+|++|+|++|+|+..-...|.++.+|..|.|++|+++...+..|.++++|+.|+|..|+|.
T Consensus 155 DLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~ir 234 (873)
T KOG4194|consen 155 DLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIR 234 (873)
T ss_pred hhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhcccccee
Confidence 99999888444456666678888999999888777788888888888888888888777778888888888888888887
Q ss_pred CCCchhhcCCCCCCEEEcCCCCCCCCCCcccccccccceeecccccccccCchhhcCCCCCceEeccCCCCCCCCccccC
Q 001768 243 GPIPSTISQLKNLTELRISDLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQ 322 (1016)
Q Consensus 243 ~~~p~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~L~~~~p~~l~ 322 (1016)
-.--.+|..|++|+.|.|..|.+..+....|-.+.++++|+|+.|++...-..++-+++.|+.|+||+|.|...-++...
T Consensus 235 ive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~Ws 314 (873)
T KOG4194|consen 235 IVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWS 314 (873)
T ss_pred eehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhh
Confidence 44355677777777777777777666666666666666666666666655555555566666666666666555555555
Q ss_pred CCCCCCEEEccCCcCCCCCChhh--hccCCcccCCCCcCC
Q 001768 323 NLKKIDYIFLTNNSLSGTLPDWI--LTSEKNLDLSYNNFT 360 (1016)
Q Consensus 323 ~l~~L~~L~L~~N~l~g~~p~~~--~~~L~~LdLs~N~l~ 360 (1016)
..++|+.|+|++|+|+..-+..+ +..|+.|+|++|.++
T Consensus 315 ftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~ 354 (873)
T KOG4194|consen 315 FTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSID 354 (873)
T ss_pred hcccceeEeccccccccCChhHHHHHHHhhhhcccccchH
Confidence 55666666666666653333333 444445555555443
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.4e-26 Score=239.30 Aligned_cols=210 Identities=36% Similarity=0.596 Sum_probs=183.3
Q ss_pred cccCCCeeEEEEEcCC-CcEEEEEEccCCChh-hhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEeecCCCcHHH
Q 001768 667 IGEGGFGPVYKGTLSD-GAVIAVKQLSSKSKQ-GNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYLENNSLAR 744 (1016)
Q Consensus 667 LG~G~~G~Vy~~~~~~-~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~ 744 (1016)
||+|++|.||++...+ ++.+++|++...... ....+.+|++.++.++|++++++++++......+++|||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999764 899999998765443 34678999999999999999999999999999999999999999999
Q ss_pred HhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEcc-CCceeeeccccccccCCCCcceeeec
Q 001768 745 ALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDK-DLNAKISDFGLAKLDEDENTHISTRI 823 (1016)
Q Consensus 745 ~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~-~~~~kL~DFGla~~~~~~~~~~~~~~ 823 (1016)
++.... ..+++..+..++.++++++++||+. +++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~ 153 (215)
T cd00180 81 LLKENE---GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTI 153 (215)
T ss_pred HHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcc
Confidence 986542 2589999999999999999999998 9999999999999999 89999999999986544321 12234
Q ss_pred ccCccccChhhhccC-CCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCCCCCCHH
Q 001768 824 AGTVGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGSNFSKK 902 (1016)
Q Consensus 824 ~gt~~y~aPE~~~~~-~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 902 (1016)
.+...|++||..... ..+.+.|+|++|+++++|
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------- 187 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------- 187 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence 577889999999877 788999999999999997
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001768 903 EAMTMLNIALLCTNPSPTLRPTMSSAVSM 931 (1016)
Q Consensus 903 ~~~~l~~li~~cl~~dP~~RPt~~evl~~ 931 (1016)
..+.+++..|++.+|++||++.++++.
T Consensus 188 --~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 --PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred --HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 357889999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.9e-28 Score=260.57 Aligned_cols=278 Identities=21% Similarity=0.292 Sum_probs=213.7
Q ss_pred CCCCCCcCHHHHHHHhcCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCChhhhHHHHHHHHHHHhcC------CC
Q 001768 643 DLQTGYFTLRQIKAATNNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSKQGNREFVNEIGMISALQ------HQ 715 (1016)
Q Consensus 643 ~~~~~~~~~~~l~~~~~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~------Hp 715 (1016)
+-..|+|.+.-.+....+|.+....|+|-|++|-+|... -|..||||++...... ...=+.|+++|++|. --
T Consensus 416 dDaEGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~ 494 (752)
T KOG0670|consen 416 DDAEGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKF 494 (752)
T ss_pred ccccceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhh
Confidence 345689999999999999999999999999999999865 4789999999765432 233467999999995 34
Q ss_pred CeeeeeeeEeecceeEEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEE
Q 001768 716 NLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLL 795 (1016)
Q Consensus 716 nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl 795 (1016)
|+++++..|...+++|||+|-+ .-+|.++|.... ....|....+..++.|+.-||..|-.. +|+|.||||+||||
T Consensus 495 Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG-~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLV 569 (752)
T KOG0670|consen 495 HCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYG-RNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILV 569 (752)
T ss_pred HHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhC-cccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEe
Confidence 8999999999999999999987 458999997654 446789999999999999999999987 99999999999999
Q ss_pred ccC-CceeeeccccccccCCCCcceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhH
Q 001768 796 DKD-LNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYL 874 (1016)
Q Consensus 796 ~~~-~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~ 874 (1016)
++. ..+||||||.|....+... +.+.-+..|.|||++.+-+|+...|+||.||+||||.||+..|.+........+
T Consensus 570 NE~k~iLKLCDfGSA~~~~enei---tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl 646 (752)
T KOG0670|consen 570 NESKNILKLCDFGSASFASENEI---TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRL 646 (752)
T ss_pred ccCcceeeeccCccccccccccc---cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHH
Confidence 976 4689999999986654422 223345569999999999999999999999999999999999988765544322
Q ss_pred HH-H----HHHHHHhCCc---------------------------ccccCC------cC--CCCCCH---HHHHHHHHHH
Q 001768 875 LD-W----AYVLQEQGNL---------------------------LELVDP------SL--GSNFSK---KEAMTMLNIA 911 (1016)
Q Consensus 875 ~~-~----~~~~~~~~~~---------------------------~~~~d~------~l--~~~~~~---~~~~~l~~li 911 (1016)
.. . ...+...+.+ ...+.| .+ ...++. .....+.+|+
T Consensus 647 ~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLL 726 (752)
T KOG0670|consen 647 FMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLL 726 (752)
T ss_pred HHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHH
Confidence 11 0 0000111100 011111 00 011222 2345788999
Q ss_pred HHccCCCCCCCCCHHHHH
Q 001768 912 LLCTNPSPTLRPTMSSAV 929 (1016)
Q Consensus 912 ~~cl~~dP~~RPt~~evl 929 (1016)
..|+..||++|.|..+++
T Consensus 727 dkml~LdP~KRit~nqAL 744 (752)
T KOG0670|consen 727 DKMLILDPEKRITVNQAL 744 (752)
T ss_pred HHHhccChhhcCCHHHHh
Confidence 999999999999998665
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-27 Score=262.23 Aligned_cols=196 Identities=26% Similarity=0.374 Sum_probs=167.4
Q ss_pred cCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCCh--------hhhHHHHHHHHHHHhcC---CCCeeeeeeeEee
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSK--------QGNREFVNEIGMISALQ---HQNLVKLYGCCIE 726 (1016)
Q Consensus 659 ~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~~--------~~~~~~~~E~~~l~~l~---HpnIv~l~~~~~~ 726 (1016)
.+|...+.+|+|+||.|+.|.++ +...|+||.+.+..- ...-..-.|++||..++ |+||+|++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 45888999999999999999976 456789998875421 11112456999999997 9999999999999
Q ss_pred cceeEEEEeec-CCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeec
Q 001768 727 GNQLLLVYEYL-ENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISD 805 (1016)
Q Consensus 727 ~~~~~lV~E~~-~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~D 805 (1016)
++.+||+||-- ++-+|.++|..+. .+++.++..|++||+.|+++||++ +|||||||-+||.++.+|-+||+|
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp----~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klid 713 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKP----RMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLID 713 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccC----ccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEee
Confidence 99999999975 5668999996654 699999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCcceeeecccCccccChhhhccCCC-CCccchhHHHHHHHHHHhCCCCCC
Q 001768 806 FGLAKLDEDENTHISTRIAGTVGYMAPEYAMRGYL-TDKADVYSFGIVALEIVSGKSNTN 864 (1016)
Q Consensus 806 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwSlGvvl~elltG~~P~~ 864 (1016)
||.|.+...... ..++||..|.|||++.+.+| ...-|||++|++||-++....||.
T Consensus 714 fgsaa~~ksgpf---d~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 714 FGSAAYTKSGPF---DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred ccchhhhcCCCc---ceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 999986655432 34689999999999987755 566899999999999998888874
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.6e-28 Score=268.36 Aligned_cols=252 Identities=25% Similarity=0.396 Sum_probs=205.3
Q ss_pred hcCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEee
Q 001768 658 TNNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEY 736 (1016)
Q Consensus 658 ~~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 736 (1016)
.++|+...++|.|.||.||+++.. .++..|+|+++-....+..-.++|+-+++..+|||||.++|.+...+..++.|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 467888999999999999999954 6899999999887777777888999999999999999999999999999999999
Q ss_pred cCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCC
Q 001768 737 LENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDEN 816 (1016)
Q Consensus 737 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 816 (1016)
|.+|+|++.-+.-. ++++.++..+++..++|++|||+. +-+|||||-.||++++.|.+|++|||.+..+....
T Consensus 94 cgggslQdiy~~Tg----plselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitati 166 (829)
T KOG0576|consen 94 CGGGSLQDIYHVTG----PLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITATI 166 (829)
T ss_pred cCCCcccceeeecc----cchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhhh
Confidence 99999999876543 799999999999999999999998 78999999999999999999999999986443321
Q ss_pred cceeeecccCccccChhhhc---cCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCC
Q 001768 817 THISTRIAGTVGYMAPEYAM---RGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDP 893 (1016)
Q Consensus 817 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 893 (1016)
.....+.||+.|||||+.. .+.|..++|||++|+...|+---++|.....+.....+.... ..+-..+-|+
T Consensus 167 -~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS-----~~qpp~lkDk 240 (829)
T KOG0576|consen 167 -AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKS-----GFQPPTLKDK 240 (829)
T ss_pred -hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhcc-----CCCCCcccCC
Confidence 1234578999999999764 567899999999999999998888876655544433332110 0011111111
Q ss_pred cCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 001768 894 SLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAV 929 (1016)
Q Consensus 894 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 929 (1016)
..-.+.+.++++.|+..+|++||+++.++
T Consensus 241 -------~kws~~fh~fvK~altknpKkRptaeklL 269 (829)
T KOG0576|consen 241 -------TKWSEFFHNFVKGALTKNPKKRPTAEKLL 269 (829)
T ss_pred -------ccchHHHHHHHHHHhcCCCccCCChhhhe
Confidence 12234688999999999999999997654
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=240.48 Aligned_cols=260 Identities=23% Similarity=0.307 Sum_probs=194.0
Q ss_pred cCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCC--ChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeec------ce
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSK--SKQGNREFVNEIGMISALQHQNLVKLYGCCIEG------NQ 729 (1016)
Q Consensus 659 ~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------~~ 729 (1016)
.+|.-.+.+|.|+- .|-.|.+. .+++||+|+.... .....++..+|..++..+.|+||++++.++.-. ..
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 45667788999988 55555433 5889999987654 233456778999999999999999999998632 46
Q ss_pred eEEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccc
Q 001768 730 LLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLA 809 (1016)
Q Consensus 730 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla 809 (1016)
.|+|||||.. +|...+.- .++-+++..|..|++.|++|||+. +|+||||||+||++..+..+||.|||+|
T Consensus 96 ~y~v~e~m~~-nl~~vi~~------elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 96 VYLVMELMDA-NLCQVILM------ELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred HHHHHHhhhh-HHHHHHHH------hcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhh
Confidence 8999999955 88888762 478889999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCcceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHh----------------
Q 001768 810 KLDEDENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVY---------------- 873 (1016)
Q Consensus 810 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~---------------- 873 (1016)
+..... ...+.++.|..|+|||++.+..+.+.+||||.||++.||++|+.-|.+...-+...
T Consensus 166 r~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~q 243 (369)
T KOG0665|consen 166 RTEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQ 243 (369)
T ss_pred cccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHH
Confidence 854433 45667888999999999998889999999999999999999999887543222110
Q ss_pred HHHHHH-HHHHh-----CCcccccCCcC-C--CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001768 874 LLDWAY-VLQEQ-----GNLLELVDPSL-G--SNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSM 931 (1016)
Q Consensus 874 ~~~~~~-~~~~~-----~~~~~~~d~~l-~--~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 931 (1016)
+...+. ..... -.+.+.+.... + ...++-....+.+++.+||..+|++|.+++++++.
T Consensus 244 L~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 244 LQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred hhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 000010 00000 01111111110 0 01112234467889999999999999999999874
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-25 Score=238.58 Aligned_cols=199 Identities=34% Similarity=0.535 Sum_probs=173.4
Q ss_pred ccccCccccCCCeeEEEEEcCC-CcEEEEEEccCCChh-hhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEeecC
Q 001768 661 FDAANKIGEGGFGPVYKGTLSD-GAVIAVKQLSSKSKQ-GNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYLE 738 (1016)
Q Consensus 661 f~~~~~LG~G~~G~Vy~~~~~~-~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 738 (1016)
|++.+.||+|++|.||++...+ ++.+|+|.+...... ....+.+|++.+++++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 5677899999999999999765 889999999876554 56788999999999999999999999999899999999999
Q ss_pred CCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCCcc
Q 001768 739 NNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTH 818 (1016)
Q Consensus 739 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 818 (1016)
+++|.+++..... .+++..+..++.+++.++.+||+. +++|+||+|+||+++.++.++|+|||.+.........
T Consensus 81 ~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 81 GGDLFDYLRKKGG---KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred CCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence 9999999965431 188999999999999999999998 9999999999999999999999999999866544211
Q ss_pred eeeecccCccccChhhh-ccCCCCCccchhHHHHHHHHHHhCCCCCCC
Q 001768 819 ISTRIAGTVGYMAPEYA-MRGYLTDKADVYSFGIVALEIVSGKSNTNY 865 (1016)
Q Consensus 819 ~~~~~~gt~~y~aPE~~-~~~~~~~~sDVwSlGvvl~elltG~~P~~~ 865 (1016)
......++..|++||.. ....++.++|||+||++++||++|+.||..
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 22334677889999998 666778899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-27 Score=264.34 Aligned_cols=332 Identities=22% Similarity=0.281 Sum_probs=200.8
Q ss_pred eeEEEEEecCCccCccCccccCCCCCCCEEEccCCCCCCCCchhhhcccCcccccccccccCC-CCCcccCCcCCccEEE
Q 001768 85 CHVTVILLKGFNLAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSG-SIPLEIGDISTLEELV 163 (1016)
Q Consensus 85 ~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~ 163 (1016)
.+++.|.|...+|. .+|++++.|.+|++|.+++|++. .+-..+..|+.|+.+.+..|++.. -+|..+..|..|..||
T Consensus 32 t~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lD 109 (1255)
T KOG0444|consen 32 TQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILD 109 (1255)
T ss_pred hheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhhhccccccCCCCchhcccccceeee
Confidence 45666666666555 45666666666666666666666 444556666666666666666652 3566666666667777
Q ss_pred cccCCCCCCCCCCCCCCccchhhhccCCccCCCCCcccCCCCCccEEEecCCcCCCCCchhhhcCCCCCEEeecCCcCCC
Q 001768 164 LEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEG 243 (1016)
Q Consensus 164 Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~ 243 (1016)
||+|+++ ..|..+..-+++-.|+||+|+|..+....|.+|..|-.|+|++|++. .+|..+..+..|+.|+|++|.+..
T Consensus 110 LShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~h 187 (1255)
T KOG0444|consen 110 LSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNH 187 (1255)
T ss_pred cchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhH
Confidence 7777666 66666666666666677777666322233456666666677766666 455556666666667777666653
Q ss_pred CCchhhcCCCCCCEEEcCCCCCCC-CCCcccccccccceeecccccccccCchhhcCCCCCceEeccCCCCCCCCccccC
Q 001768 244 PIPSTISQLKNLTELRISDLKGSS-SSFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQ 322 (1016)
Q Consensus 244 ~~p~~l~~l~~L~~L~Ls~n~l~~-~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~L~~~~p~~l~ 322 (1016)
.--..+..+++|+.|.+++.+-+. ..+..+..+.+|..+|||.|.+. .+|+.+-++++|+.|+||+|+|+ .+.....
T Consensus 188 fQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~ 265 (1255)
T KOG0444|consen 188 FQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEG 265 (1255)
T ss_pred HHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHH
Confidence 323333445555566666544432 23445666777777777777777 67777777777777777777777 4444555
Q ss_pred CCCCCCEEEccCCcCCCCCChhh--hccCCcccCCCCcCC--CCCCccccccccceeccccccCCCCccccccCCCCCCc
Q 001768 323 NLKKIDYIFLTNNSLSGTLPDWI--LTSEKNLDLSYNNFT--ESSPATCRESRVNILSSFSSTGSNSVSWCLKKDLPCPK 398 (1016)
Q Consensus 323 ~l~~L~~L~L~~N~l~g~~p~~~--~~~L~~LdLs~N~l~--~~~p~~~~~~~~~~l~~~~~~~~~~~~~c~~~~~~c~~ 398 (1016)
...+|+.|+|+.|+|+ .+|+.+ ++.|+.|.+.+|+|+ |.+..+....+++.+.. .+|.+.. -|...|+|
T Consensus 266 ~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~a----anN~LEl--VPEglcRC 338 (1255)
T KOG0444|consen 266 EWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHA----ANNKLEL--VPEGLCRC 338 (1255)
T ss_pred HHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHh----hcccccc--Cchhhhhh
Confidence 5667777777777777 677766 667777777777753 43333333333333221 1222211 12223333
Q ss_pred cCCcceEEeecCCCCccccCcccccCcCCCCC
Q 001768 399 EAKHYSLFINCGGSPTEFEENDYEEDLNTQGP 430 (1016)
Q Consensus 399 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 430 (1016)
. +.-.+.++|+-..+-++.++..+|...++-
T Consensus 339 ~-kL~kL~L~~NrLiTLPeaIHlL~~l~vLDl 369 (1255)
T KOG0444|consen 339 V-KLQKLKLDHNRLITLPEAIHLLPDLKVLDL 369 (1255)
T ss_pred H-HHHHhcccccceeechhhhhhcCCcceeec
Confidence 1 223356677766666777777776665543
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.2e-28 Score=265.55 Aligned_cols=282 Identities=26% Similarity=0.380 Sum_probs=141.6
Q ss_pred eEEEEEecCCccC-ccCccccCCCCCCCEEEccCCCCCCCCchhhhcccCcccccccccccCCCCCcccCCcCCccEEEc
Q 001768 86 HVTVILLKGFNLA-GVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGDISTLEELVL 164 (1016)
Q Consensus 86 ~v~~L~L~~~~l~-~~~~~~l~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 164 (1016)
-|..+|+++|+++ +..|.....+++++.|.|...++. .+|..++.|.+|+.|.+++|++. .+-..++.|+.|+.+++
T Consensus 8 FVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~ 85 (1255)
T KOG0444|consen 8 FVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIV 85 (1255)
T ss_pred eeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhh
Confidence 3444555555555 234445555555555555555554 45555555555555555555554 34444455555555555
Q ss_pred ccCCCCC-CCCCCCCCCccchhhhccCCccCCCCCcccCCCCCccEEEecCCcCCCCCchhhhcCCCCCEEeecCCcCCC
Q 001768 165 EDNQLVG-PLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEG 243 (1016)
Q Consensus 165 s~N~l~~-~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~ 243 (1016)
.+|++.. -+|..+..|..|+.||||+|++. ..|..+...+++-.|+|++|+|..+....+.+++.|-.||||+|++.
T Consensus 86 R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe- 163 (1255)
T KOG0444|consen 86 RDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE- 163 (1255)
T ss_pred hccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh-
Confidence 5555432 24445555555555555555555 44555555555555555555555333334445555555555555555
Q ss_pred CCchhhcCCCCCCEEEcCCCCCCCCCCcccccccccceeeccccccc-ccCchhhcCCCCCceEeccCCCCCCCCccccC
Q 001768 244 PIPSTISQLKNLTELRISDLKGSSSSFPNLQDMKKMERLILRNCLIT-GRIPEYIEDMTDLKILDLSFNQLTGPVPGILQ 322 (1016)
Q Consensus 244 ~~p~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~-~~~p~~l~~l~~L~~L~Ls~N~L~~~~p~~l~ 322 (1016)
.+|..+..|..|+.|.|++|.+.......+..+++|+.|++++.+-+ ..+|.++..+.+|..+|||.|.|. .+|+.+-
T Consensus 164 ~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly 242 (1255)
T KOG0444|consen 164 MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLY 242 (1255)
T ss_pred hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHh
Confidence 33444555555555555555555544444555555555555544322 234445555555555555555555 5555555
Q ss_pred CCCCCCEEEccCCcCCCCC-ChhhhccCCcccCCCCcCCCCCCcccccccc
Q 001768 323 NLKKIDYIFLTNNSLSGTL-PDWILTSEKNLDLSYNNFTESSPATCRESRV 372 (1016)
Q Consensus 323 ~l~~L~~L~L~~N~l~g~~-p~~~~~~L~~LdLs~N~l~~~~p~~~~~~~~ 372 (1016)
.+++|+.|+|++|+|+..- -.....+|++|+||.|+|+..+...|...++
T Consensus 243 ~l~~LrrLNLS~N~iteL~~~~~~W~~lEtLNlSrNQLt~LP~avcKL~kL 293 (1255)
T KOG0444|consen 243 KLRNLRRLNLSGNKITELNMTEGEWENLETLNLSRNQLTVLPDAVCKLTKL 293 (1255)
T ss_pred hhhhhheeccCcCceeeeeccHHHHhhhhhhccccchhccchHHHhhhHHH
Confidence 5555555555555554211 1112444555555555555544444544433
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-25 Score=241.05 Aligned_cols=203 Identities=31% Similarity=0.482 Sum_probs=168.6
Q ss_pred HHHHhcCccccCccccCCCeeEEEEEcC----CCcEEEEEEccCCChhhhHHHHHHHHHHHhc-CCCCeeeeeeeEeecc
Q 001768 654 IKAATNNFDAANKIGEGGFGPVYKGTLS----DGAVIAVKQLSSKSKQGNREFVNEIGMISAL-QHQNLVKLYGCCIEGN 728 (1016)
Q Consensus 654 l~~~~~~f~~~~~LG~G~~G~Vy~~~~~----~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~ 728 (1016)
+....+.|..+++||+|.|++||++.+. ..+.||+|.+...+. ..++.+|+++|..+ .+.||+++.+++..++
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 3445678999999999999999999854 367899999876543 35688999999999 5999999999999999
Q ss_pred eeEEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEcc-CCceeeeccc
Q 001768 729 QLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDK-DLNAKISDFG 807 (1016)
Q Consensus 729 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~-~~~~kL~DFG 807 (1016)
+..+|+||++.....++.. .++..++..+++.++.||+++|.+ |||||||||+|+|.+. -++-.|+|||
T Consensus 109 ~v~ivlp~~~H~~f~~l~~-------~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFg 178 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYR-------SLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFG 178 (418)
T ss_pred eeEEEecccCccCHHHHHh-------cCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEech
Confidence 9999999999988888873 477889999999999999999999 9999999999999985 4678999999
Q ss_pred cccccCC-C--------------C------------------c----------ceeeecccCccccChhhhcc-CCCCCc
Q 001768 808 LAKLDED-E--------------N------------------T----------HISTRIAGTVGYMAPEYAMR-GYLTDK 843 (1016)
Q Consensus 808 la~~~~~-~--------------~------------------~----------~~~~~~~gt~~y~aPE~~~~-~~~~~~ 843 (1016)
+|..... . . . ......+||++|+|||++.. ...+++
T Consensus 179 LA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtta 258 (418)
T KOG1167|consen 179 LAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTA 258 (418)
T ss_pred hHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCc
Confidence 9961100 0 0 0 00112479999999999875 467889
Q ss_pred cchhHHHHHHHHHHhCCCCCCCCCc
Q 001768 844 ADVYSFGIVALEIVSGKSNTNYRPK 868 (1016)
Q Consensus 844 sDVwSlGvvl~elltG~~P~~~~~~ 868 (1016)
+||||.||+++-+++++.||.....
T Consensus 259 iDiws~GVI~Lslls~~~PFf~a~d 283 (418)
T KOG1167|consen 259 IDIWSAGVILLSLLSRRYPFFKAKD 283 (418)
T ss_pred cceeeccceeehhhccccccccCcc
Confidence 9999999999999999999975443
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.4e-25 Score=223.78 Aligned_cols=253 Identities=21% Similarity=0.345 Sum_probs=186.8
Q ss_pred HhcCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCChhhhHHHHHHHHHHHhc-CCCCeeeeeee-EeecceeEEE
Q 001768 657 ATNNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSKQGNREFVNEIGMISAL-QHQNLVKLYGC-CIEGNQLLLV 733 (1016)
Q Consensus 657 ~~~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~-~~~~~~~~lV 733 (1016)
..+.|.+.+.||+|.||.+-+++++ ..+.+++|.+..... ..++|.+|...--.+ .|.||+.-|++ |+..+.++++
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t-t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT-TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh-hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 3467899999999999999999976 567899998865432 356888888754445 58999988764 6677889999
Q ss_pred EeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEc--cCCceeeeccccccc
Q 001768 734 YEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLD--KDLNAKISDFGLAKL 811 (1016)
Q Consensus 734 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~--~~~~~kL~DFGla~~ 811 (1016)
+||++-|+|.+-+... .+-+....+++.|+++|+.|||++ ++||||||.+|||+- +..++||||||+.+.
T Consensus 101 qE~aP~gdL~snv~~~-----GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k 172 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVEAA-----GIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRK 172 (378)
T ss_pred eccCccchhhhhcCcc-----cccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccc
Confidence 9999999999988553 478888999999999999999999 999999999999993 335899999999875
Q ss_pred cCCCCcceeeecccCccccChhhhccC-----CCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCC
Q 001768 812 DEDENTHISTRIAGTVGYMAPEYAMRG-----YLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGN 886 (1016)
Q Consensus 812 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 886 (1016)
.+.... ...-+..|.|||..... ...+.+|||.||+++|.++||+.||......+..+ .+|.. ...+
T Consensus 173 ~g~tV~----~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y-~~~~~--w~~r- 244 (378)
T KOG1345|consen 173 VGTTVK----YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPY-WEWEQ--WLKR- 244 (378)
T ss_pred cCceeh----hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchH-HHHHH--Hhcc-
Confidence 433211 12335679999977532 35678999999999999999999998433322211 12211 1111
Q ss_pred cccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001768 887 LLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSM 931 (1016)
Q Consensus 887 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 931 (1016)
..+.++..+. ...+.+.++.++-+.++|++|=...++.++
T Consensus 245 ----k~~~~P~~F~-~fs~~a~r~Fkk~lt~~~~drcki~~~kk~ 284 (378)
T KOG1345|consen 245 ----KNPALPKKFN-PFSEKALRLFKKSLTPRFKDRCKIWTAKKM 284 (378)
T ss_pred ----cCccCchhhc-ccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence 1223332222 234567888899999999999555555444
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.8e-24 Score=271.98 Aligned_cols=195 Identities=17% Similarity=0.237 Sum_probs=138.8
Q ss_pred hcCC-CCeeeeeeeEe-------ecceeEEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 001768 711 ALQH-QNLVKLYGCCI-------EGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLK 782 (1016)
Q Consensus 711 ~l~H-pnIv~l~~~~~-------~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ 782 (1016)
.++| +||++++++|. +.+.++++|||+ +++|.+++.... ..+++.+++.++.||++||+|||++ +
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---g 100 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD---RSVDAFECFHVFRQIVEIVNAAHSQ---G 100 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc---ccccHHHHHHHHHHHHHHHHHHHhC---C
Confidence 3455 57888888772 334678888987 559999996432 3599999999999999999999998 9
Q ss_pred eEeCCCCCceEEEcc-------------------CCceeeeccccccccCCCC---------------cceeeecccCcc
Q 001768 783 IVHRDIKATNVLLDK-------------------DLNAKISDFGLAKLDEDEN---------------THISTRIAGTVG 828 (1016)
Q Consensus 783 iiHrDlkp~NILl~~-------------------~~~~kL~DFGla~~~~~~~---------------~~~~~~~~gt~~ 828 (1016)
|+||||||+|||++. ++.+|++|||+++...... ........||+.
T Consensus 101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (793)
T PLN00181 101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW 180 (793)
T ss_pred eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence 999999999999954 4456666777665321100 000112458889
Q ss_pred ccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCCCCCCHHHHHHHH
Q 001768 829 YMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGSNFSKKEAMTML 908 (1016)
Q Consensus 829 y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 908 (1016)
|||||++.+..++.++|||||||+||||++|.+|+.... ... .... . ....+... .......
T Consensus 181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~--~~~~----~-----~~~~~~~~-----~~~~~~~ 242 (793)
T PLN00181 181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS--RTM--SSLR----H-----RVLPPQIL-----LNWPKEA 242 (793)
T ss_pred eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHH--HHHH----H-----hhcChhhh-----hcCHHHH
Confidence 999999999899999999999999999999988764211 000 0000 0 00111110 1123456
Q ss_pred HHHHHccCCCCCCCCCHHHHHH
Q 001768 909 NIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 909 ~li~~cl~~dP~~RPt~~evl~ 930 (1016)
.++.+||+.+|.+||++.|+++
T Consensus 243 ~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 243 SFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHHhCCCChhhCcChHHHhh
Confidence 7889999999999999999975
|
|
| >PF11721 Malectin: Di-glucose binding within endoplasmic reticulum; InterPro: IPR021720 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.6e-24 Score=214.69 Aligned_cols=171 Identities=39% Similarity=0.651 Sum_probs=116.0
Q ss_pred ceEEeecCCCCc-cccCcccccCcCCCCCCCccccCCCcceeccccccCCC-CccceecccccccccchhhhhccccCcc
Q 001768 403 YSLFINCGGSPT-EFEENDYEEDLNTQGPSNFGIVSDRWAYSSTGVYVGNE-SSKYLAANQYGLNVSGAEYYKTARLAPQ 480 (1016)
Q Consensus 403 ~~~~~~~~~~~~-~~~~~~~~~d~~~~~~~~~~~~~~~w~~~~~g~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 480 (1016)
|.+.|||||+.. ...++.|++|..-.+.+ |.|... +. .............+.+..||+|+|.+|.
T Consensus 1 ~~~~IN~Gg~~~~~~~g~~w~~D~~~~~g~--------~~y~~~-----~~~~~~~~~~~~~i~~t~d~~Lyqt~R~g~~ 67 (174)
T PF11721_consen 1 VVLRINAGGPAYTDSSGIVWEADQYYTGGS--------WGYYVS-----SDNNGSTSSTNSSIPGTTDDPLYQTERYGPS 67 (174)
T ss_dssp EEEEEEETSSSEEETTTEEE-SSSSSTTSS------------------------SSTTS--TTS-HHHHHTTT-----SS
T ss_pred CEEEEECCCCcccCCCCCEEcCCCCCCCCC--------cccccc-----cccccccccccccccCCCchhhhHhhcCCCC
Confidence 468999999996 67788999997654432 211000 00 0000112222334677799999999999
Q ss_pred ccccceeeecccceEEEEEEEEEEecCCcccccccceeeEEEecceeecccccceeccCCcCceEEEeeeeeEeeCceeE
Q 001768 481 SLKYYGLCMLKGSYTVKLHFAEIMFTNDQTYKSLGKRMFDVSIQGKQVLKDFDIMEEAGGVGIGITREFKDVSVNGSTME 560 (1016)
Q Consensus 481 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 560 (1016)
+++|...|+.+|.|+|+|||||+.|..+..+...|+|||||+|+|+++++||||.+++|+.++++++.|..+.|+++.|.
T Consensus 68 ~f~Y~ip~~~~G~Y~V~L~FaE~~~~~~~~~~~~G~RvFdV~v~g~~vl~~~Di~~~~G~~~~~~~~~~~~v~v~dg~L~ 147 (174)
T PF11721_consen 68 SFSYDIPVVPNGTYTVRLHFAELYFGASGGASGPGQRVFDVYVNGETVLKNFDIYAEAGGFNKAAVRRFFNVTVTDGTLN 147 (174)
T ss_dssp SEEEEEE--S-EEEEEEEEEE-SSS--------SSSS-EEEEETTEEEEEEE-HHHHHSSSS---EEEEEEEEEETTEEE
T ss_pred ceEEEEecCCCcEEEEEEEeccccccccccccCCCceEEEEEecceEEEeccCHHHHcCCCceEEEEEEEEEEEeCCcEE
Confidence 99999999999999999999999999999999999999999999999999999999999999999999988999999999
Q ss_pred EEEEEcCCCccccCCCCccC-Cccccc
Q 001768 561 IHLYWAGKGTNAIPYRGVYG-PLISAI 586 (1016)
Q Consensus 561 ~~~~~~g~~~~~~p~~~~~g-plis~~ 586 (1016)
|++.|+++++.++|..+.++ |+|+||
T Consensus 148 i~f~~~~~~~~~i~~~~~~~~p~IsaI 174 (174)
T PF11721_consen 148 IQFVWAGKGTLCIPFIGSYGNPLISAI 174 (174)
T ss_dssp TTEEEE--SEEEEEEESSSSSSSEEEE
T ss_pred EEEEecCCCcEEeeccccCCCcEEeeC
Confidence 99999999999999988888 999885
|
It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan [. This entry represents a malectin domain, and can also be found in probable receptor-like serine/threonine-protein kinases from plants [] and in proteins described as glycoside hydrolases. ; PDB: 2KR2_A 2JWP_A 2K46_A. |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.3e-23 Score=208.96 Aligned_cols=165 Identities=23% Similarity=0.209 Sum_probs=124.3
Q ss_pred CcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCCcce
Q 001768 740 NSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHI 819 (1016)
Q Consensus 740 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 819 (1016)
|+|.+++.... ..+++.+++.|+.|+++||+|||++ + ||+|||++.++.+|+ ||.++......
T Consensus 1 GsL~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~--- 63 (176)
T smart00750 1 VSLADILEVRG---RPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ--- 63 (176)
T ss_pred CcHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc---
Confidence 68999996543 3599999999999999999999998 4 999999999999999 99998654322
Q ss_pred eeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCCCCC
Q 001768 820 STRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGSNF 899 (1016)
Q Consensus 820 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 899 (1016)
..||+.|+|||++.+..++.++|||||||++|||+||+.||......... ...... .. .. .++.. ...
T Consensus 64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~-~~~~~~---~~---~~-~~~~~-~~~ 131 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAI-LEILLN---GM---PA-DDPRD-RSN 131 (176)
T ss_pred ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHH-HHHHHH---Hh---cc-CCccc-ccc
Confidence 25889999999999999999999999999999999999998654321110 011100 00 00 00000 011
Q ss_pred CHHHHH--HHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 001768 900 SKKEAM--TMLNIALLCTNPSPTLRPTMSSAVSMLE 933 (1016)
Q Consensus 900 ~~~~~~--~l~~li~~cl~~dP~~RPt~~evl~~L~ 933 (1016)
...... .+.+++.+||+.+|++||++.|+++.+.
T Consensus 132 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~ 167 (176)
T smart00750 132 LESVSAARSFADFMRVCASRLPQRREAANHYLAHCR 167 (176)
T ss_pred HHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHH
Confidence 122223 6899999999999999999999998764
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.1e-22 Score=227.53 Aligned_cols=167 Identities=23% Similarity=0.234 Sum_probs=131.7
Q ss_pred HHHHHhcCccccCccccCCCeeEEEEEcC--CCcEEEEEEccCC-----ChhhhHHHHHHHHHHHhcCCCCeee-eeeeE
Q 001768 653 QIKAATNNFDAANKIGEGGFGPVYKGTLS--DGAVIAVKQLSSK-----SKQGNREFVNEIGMISALQHQNLVK-LYGCC 724 (1016)
Q Consensus 653 ~l~~~~~~f~~~~~LG~G~~G~Vy~~~~~--~~~~vAvK~~~~~-----~~~~~~~~~~E~~~l~~l~HpnIv~-l~~~~ 724 (1016)
+.....++|++.+.||+|+||+||+|+.. +++.||||++... .....+.+.+|++++++++|+|+++ ++++
T Consensus 12 ~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~- 90 (365)
T PRK09188 12 QIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT- 90 (365)
T ss_pred ccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc-
Confidence 34566788999999999999999999864 5788899987533 1223556899999999999999985 4432
Q ss_pred eecceeEEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCC-CCceEEEccCCceee
Q 001768 725 IEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDI-KATNVLLDKDLNAKI 803 (1016)
Q Consensus 725 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDl-kp~NILl~~~~~~kL 803 (1016)
+..++||||++|++|.... . .. ...++.|+++||+|||+. +|+|||| ||+|||++.++.+||
T Consensus 91 ---~~~~LVmE~~~G~~L~~~~--~------~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikL 153 (365)
T PRK09188 91 ---GKDGLVRGWTEGVPLHLAR--P------HG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAV 153 (365)
T ss_pred ---CCcEEEEEccCCCCHHHhC--c------cc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEE
Confidence 4579999999999996321 1 11 146789999999999998 9999999 999999999999999
Q ss_pred eccccccccCCCCcce-------eeecccCccccChhhhcc
Q 001768 804 SDFGLAKLDEDENTHI-------STRIAGTVGYMAPEYAMR 837 (1016)
Q Consensus 804 ~DFGla~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~ 837 (1016)
+|||+|+......... -....+++.|+|||++..
T Consensus 154 iDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 154 IDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred EECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 9999998655432111 134678889999999864
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.3e-21 Score=220.04 Aligned_cols=258 Identities=20% Similarity=0.213 Sum_probs=192.6
Q ss_pred CccccCccccCCCeeEEEEEcCCC--cEEEEEEccCCChhhhHHHHHHHHHHHhcCC----CCeeeeeeeE-eecceeEE
Q 001768 660 NFDAANKIGEGGFGPVYKGTLSDG--AVIAVKQLSSKSKQGNREFVNEIGMISALQH----QNLVKLYGCC-IEGNQLLL 732 (1016)
Q Consensus 660 ~f~~~~~LG~G~~G~Vy~~~~~~~--~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H----pnIv~l~~~~-~~~~~~~l 732 (1016)
+|.+.++||+|+||.||.+..... ..+|+|............+..|+.++..+.+ +++.++++.. ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999996543 5789998766543333378889999998873 6899999998 47778999
Q ss_pred EEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccC-----Cceeeeccc
Q 001768 733 VYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKD-----LNAKISDFG 807 (1016)
Q Consensus 733 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~-----~~~kL~DFG 807 (1016)
||+.+ |.+|.++..... ...++..++.+|+.|++.+|++||+. |++||||||.|+++... ..+.|.|||
T Consensus 99 VM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred EEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 99987 779999875544 34799999999999999999999998 99999999999999865 358999999
Q ss_pred ccc--ccCCCCc----ce---eeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHH
Q 001768 808 LAK--LDEDENT----HI---STRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWA 878 (1016)
Q Consensus 808 la~--~~~~~~~----~~---~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~ 878 (1016)
+++ .+..... .. .....||..|+++....+...+.+.|+||++.++.|+..|..||...............
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~ 252 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKD 252 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHH
Confidence 998 3222111 11 12356999999999999999999999999999999999999999654432211111000
Q ss_pred HHHHHhCCcccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 001768 879 YVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGK 935 (1016)
Q Consensus 879 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 935 (1016)
... ..... .....+..+.++...+-..+..++|....+.+.++..
T Consensus 253 ---~~~----~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~ 297 (322)
T KOG1164|consen 253 ---PRK----LLTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDV 297 (322)
T ss_pred ---hhh----hcccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHH
Confidence 000 00000 1111223455555555568999999999988886543
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.6e-23 Score=208.59 Aligned_cols=247 Identities=24% Similarity=0.365 Sum_probs=192.3
Q ss_pred cccCccccCCCeeEEEEEcCCCcEEEEEEccCC--ChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEeecCC
Q 001768 662 DAANKIGEGGFGPVYKGTLSDGAVIAVKQLSSK--SKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYLEN 739 (1016)
Q Consensus 662 ~~~~~LG~G~~G~Vy~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 739 (1016)
....+|.+...|+.|+|+|+. ..+++|++... .....++|.+|.-.|+-+.||||+.++|.|.....+.++..||+.
T Consensus 193 nl~tkl~e~hsgelwrgrwqg-ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~ 271 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRWQG-NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF 271 (448)
T ss_pred hhhhhhccCCCcccccccccC-cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence 345688999999999999974 45566766533 334457899999999999999999999999999999999999999
Q ss_pred CcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeee--ccccccccCCCCc
Q 001768 740 NSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKIS--DFGLAKLDEDENT 817 (1016)
Q Consensus 740 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~--DFGla~~~~~~~~ 817 (1016)
|+|...+++.. ....+..++.+++.+||+|++|||+.. +-|.---+....|++|++.+++|. |--++. .
T Consensus 272 gslynvlhe~t--~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kfsf--q---- 342 (448)
T KOG0195|consen 272 GSLYNVLHEQT--SVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFSF--Q---- 342 (448)
T ss_pred hHHHHHHhcCc--cEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecccceeee--e----
Confidence 99999997764 346788999999999999999999984 234444688999999999887764 322221 1
Q ss_pred ceeeecccCccccChhhhccCCC---CCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCc
Q 001768 818 HISTRIAGTVGYMAPEYAMRGYL---TDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPS 894 (1016)
Q Consensus 818 ~~~~~~~gt~~y~aPE~~~~~~~---~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 894 (1016)
.....-.+.||+||.+++.+- -.++|+|||.+++||+.|.+.||..-++.+.--.+ .-..
T Consensus 343 --e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmki---------------aleg 405 (448)
T KOG0195|consen 343 --EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI---------------ALEG 405 (448)
T ss_pred --ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh---------------hhcc
Confidence 111233578999999987653 34789999999999999999999876665532111 1123
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 001768 895 LGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGK 935 (1016)
Q Consensus 895 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 935 (1016)
++..+++.....+.+++.-|++.||.+||.++.|+-.||..
T Consensus 406 lrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 406 LRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred ccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 34445556666789999999999999999999999888753
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.7e-25 Score=232.42 Aligned_cols=263 Identities=27% Similarity=0.423 Sum_probs=236.0
Q ss_pred eEEEEEecCCccCccCccccCCCCCCCEEEccCCCCCCCCchhhhcccCcccccccccccCCCCCcccCCcCCccEEEcc
Q 001768 86 HVTVILLKGFNLAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGDISTLEELVLE 165 (1016)
Q Consensus 86 ~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 165 (1016)
.+..+.+++|++. .+.+.+.+|..|.+|++.+|++. ..|++++.+..++.|+.++|.++ .+|..++.+.+|..|+++
T Consensus 46 ~l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s 122 (565)
T KOG0472|consen 46 DLQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCS 122 (565)
T ss_pred chhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcc
Confidence 3677889999988 55677899999999999999999 78889999999999999999999 899999999999999999
Q ss_pred cCCCCCCCCCCCCCCccchhhhccCCccCCCCCcccCCCCCccEEEecCCcCCCCCchhhhcCCCCCEEeecCCcCCCCC
Q 001768 166 DNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPI 245 (1016)
Q Consensus 166 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~ 245 (1016)
+|.+. .+|+.++.+-.|+.|+..+|+++ ..|+.+.++.+|..|++.+|+++...|+.+. ++.|++||+.+|-++ .+
T Consensus 123 ~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~-tl 198 (565)
T KOG0472|consen 123 SNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLE-TL 198 (565)
T ss_pred cccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhh-cC
Confidence 99998 78889999999999999999999 8889999999999999999999966555555 999999999999998 78
Q ss_pred chhhcCCCCCCEEEcCCCCCCCCCCcccccccccceeecccccccccCchhh-cCCCCCceEeccCCCCCCCCccccCCC
Q 001768 246 PSTISQLKNLTELRISDLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYI-EDMTDLKILDLSFNQLTGPVPGILQNL 324 (1016)
Q Consensus 246 p~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l-~~l~~L~~L~Ls~N~L~~~~p~~l~~l 324 (1016)
|..++.+.+|..|+|..|++...+ .|.++..|.+|+++.|+|. .+|.+. .++++|..|||..|+|. +.|..+.-+
T Consensus 199 P~~lg~l~~L~~LyL~~Nki~~lP--ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clL 274 (565)
T KOG0472|consen 199 PPELGGLESLELLYLRRNKIRFLP--EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLL 274 (565)
T ss_pred ChhhcchhhhHHHHhhhcccccCC--CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHh
Confidence 888999999999999999998876 7899999999999999999 566654 58999999999999999 899999999
Q ss_pred CCCCEEEccCCcCCCCCChhh--hccCCcccCCCCcCCC
Q 001768 325 KKIDYIFLTNNSLSGTLPDWI--LTSEKNLDLSYNNFTE 361 (1016)
Q Consensus 325 ~~L~~L~L~~N~l~g~~p~~~--~~~L~~LdLs~N~l~~ 361 (1016)
.+|++||+++|.+++ +|..+ + +|+.|-+-+|++..
T Consensus 275 rsL~rLDlSNN~is~-Lp~sLgnl-hL~~L~leGNPlrT 311 (565)
T KOG0472|consen 275 RSLERLDLSNNDISS-LPYSLGNL-HLKFLALEGNPLRT 311 (565)
T ss_pred hhhhhhcccCCcccc-CCcccccc-eeeehhhcCCchHH
Confidence 999999999999994 55554 4 88899999998753
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2e-24 Score=228.81 Aligned_cols=243 Identities=26% Similarity=0.413 Sum_probs=226.8
Q ss_pred eeEEEEEecCCccCccCccccCCCCCCCEEEccCCCCCCCCchhhhcccCcccccccccccCCCCCcccCCcCCccEEEc
Q 001768 85 CHVTVILLKGFNLAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGDISTLEELVL 164 (1016)
Q Consensus 85 ~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 164 (1016)
..+++|++++|+++ ..|++++.+..++.|+.++|+++ .+|..++.+.+|+.|++++|.+. .+|+.++.+..|+.|+.
T Consensus 68 ~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n~~~-el~~~i~~~~~l~dl~~ 144 (565)
T KOG0472|consen 68 ACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSNELK-ELPDSIGRLLDLEDLDA 144 (565)
T ss_pred cceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcccccee-ecCchHHHHhhhhhhhc
Confidence 35789999999998 56889999999999999999999 89999999999999999999999 88999999999999999
Q ss_pred ccCCCCCCCCCCCCCCccchhhhccCCccCCCCCcccCCCCCccEEEecCCcCCCCCchhhhcCCCCCEEeecCCcCCCC
Q 001768 165 EDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGP 244 (1016)
Q Consensus 165 s~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ 244 (1016)
.+|+++ ..|..+..+.+|..|++.+|++....|..+. ++.|++|++..|.+. .+|..++.+.+|+.|+|.+|+|. .
T Consensus 145 ~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~ 220 (565)
T KOG0472|consen 145 TNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR-F 220 (565)
T ss_pred cccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccc-c
Confidence 999999 7888999999999999999999955555444 999999999999988 78999999999999999999999 5
Q ss_pred CchhhcCCCCCCEEEcCCCCCCCCCCcccccccccceeecccccccccCchhhcCCCCCceEeccCCCCCCCCccccCCC
Q 001768 245 IPSTISQLKNLTELRISDLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNL 324 (1016)
Q Consensus 245 ~p~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~L~~~~p~~l~~l 324 (1016)
+| .|..+..|++|+++.|.+..+.......+++|..|||.+|+++ ..|+.+.-+.+|.+||+|+|.|+ ..|..++++
T Consensus 221 lP-ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl 297 (565)
T KOG0472|consen 221 LP-EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDIS-SLPYSLGNL 297 (565)
T ss_pred CC-CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccc-cCCcccccc
Confidence 67 7999999999999999999999999999999999999999999 88999999999999999999999 778889999
Q ss_pred CCCCEEEccCCcCC
Q 001768 325 KKIDYIFLTNNSLS 338 (1016)
Q Consensus 325 ~~L~~L~L~~N~l~ 338 (1016)
.|++|-+.||++.
T Consensus 298 -hL~~L~leGNPlr 310 (565)
T KOG0472|consen 298 -HLKFLALEGNPLR 310 (565)
T ss_pred -eeeehhhcCCchH
Confidence 9999999999997
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.8e-21 Score=192.45 Aligned_cols=260 Identities=22% Similarity=0.250 Sum_probs=196.3
Q ss_pred HHhcCccccCccccCCCeeEEEEE-cCCCcEEEEEEccCCChhhhHHHHHHHHHHHhcCC-CCeeeeeeeEeecceeEEE
Q 001768 656 AATNNFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQH-QNLVKLYGCCIEGNQLLLV 733 (1016)
Q Consensus 656 ~~~~~f~~~~~LG~G~~G~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H-pnIv~l~~~~~~~~~~~lV 733 (1016)
....+|.++++||.|+||.+|.|. ..+|+.||||.-...... .++.-|.++...++| ..|..+..+..+...-.+|
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlV 89 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLV 89 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceee
Confidence 345789999999999999999998 568999999987654433 456778889998864 6788888888888899999
Q ss_pred EeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEcc---CCceeeecccccc
Q 001768 734 YEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDK---DLNAKISDFGLAK 810 (1016)
Q Consensus 734 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~---~~~~kL~DFGla~ 810 (1016)
||++ |.+|+++..-.. ..++..+++-++-|++.-++|+|.+ ++|||||||+|+|+.- ...+.++|||+|+
T Consensus 90 MdLL-GPsLEdLfnfC~---R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK 162 (341)
T KOG1163|consen 90 MDLL-GPSLEDLFNFCS---RRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK 162 (341)
T ss_pred eecc-CccHHHHHHHHh---hhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchh
Confidence 9988 779999886543 2589999999999999999999998 8999999999999964 3468999999998
Q ss_pred ccCCCCc--ce----eeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHh
Q 001768 811 LDEDENT--HI----STRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQ 884 (1016)
Q Consensus 811 ~~~~~~~--~~----~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~ 884 (1016)
.+.+..+ +. .....||.+|.+--...+...+.+.|+=|+|.+|.++--|..||.+..........+....
T Consensus 163 ky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~E---- 238 (341)
T KOG1163|consen 163 KYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISE---- 238 (341)
T ss_pred hhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHH----
Confidence 6554322 11 2346799999998888777888999999999999999999999987544332221111111
Q ss_pred CCcccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 001768 885 GNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933 (1016)
Q Consensus 885 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 933 (1016)
.+.. ..-..+...+ +.++...+.-|-..--++-|...-+-++..
T Consensus 239 kK~s-~~ie~LC~G~----P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFr 282 (341)
T KOG1163|consen 239 KKMS-TPIEVLCKGF----PAEFAMYLNYCRGLGFEEKPDYMYLRQLFR 282 (341)
T ss_pred hhcC-CCHHHHhCCC----cHHHHHHHHHHhhcCCCCCCcHHHHHHHHH
Confidence 1110 0011122233 345666777888888888898776665543
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.5e-20 Score=206.83 Aligned_cols=260 Identities=31% Similarity=0.452 Sum_probs=198.6
Q ss_pred ccccCccccCCCeeEEEEEcCCCcEEEEEEccCCChh---hhHHHHHHHHHHHhcCCC-CeeeeeeeEeecceeEEEEee
Q 001768 661 FDAANKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQ---GNREFVNEIGMISALQHQ-NLVKLYGCCIEGNQLLLVYEY 736 (1016)
Q Consensus 661 f~~~~~LG~G~~G~Vy~~~~~~~~~vAvK~~~~~~~~---~~~~~~~E~~~l~~l~Hp-nIv~l~~~~~~~~~~~lV~E~ 736 (1016)
|.+.+.||.|+||.||++... ..+|+|.+...... ....+.+|+.+++.+.|+ +++++.+++......++++||
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 677889999999999999987 78899998765433 367899999999999988 799999999877778999999
Q ss_pred cCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCC-ceeeeccccccccCCC
Q 001768 737 LENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDL-NAKISDFGLAKLDEDE 815 (1016)
Q Consensus 737 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~-~~kL~DFGla~~~~~~ 815 (1016)
+.++++.+++...... ..++......++.|++.++.|+|+. +++|||+||+||+++..+ .++++|||.++.....
T Consensus 80 ~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 80 VDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred CCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 9999999777544211 2588999999999999999999998 899999999999999988 7999999999855443
Q ss_pred Ccc-----eeeecccCccccChhhhcc---CCCCCccchhHHHHHHHHHHhCCCCCCCCCch-hhHhHHHHHHHHHHhCC
Q 001768 816 NTH-----ISTRIAGTVGYMAPEYAMR---GYLTDKADVYSFGIVALEIVSGKSNTNYRPKE-EFVYLLDWAYVLQEQGN 886 (1016)
Q Consensus 816 ~~~-----~~~~~~gt~~y~aPE~~~~---~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~-~~~~~~~~~~~~~~~~~ 886 (1016)
... ......||..|+|||.+.+ .......|+||+|++++++++|..||...... ....... ........
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~--~~~~~~~~ 233 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLK--IILELPTP 233 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHH--HHHhcCCc
Confidence 322 2355789999999999987 57889999999999999999999997654431 0000010 00000000
Q ss_pred cccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001768 887 LLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSM 931 (1016)
Q Consensus 887 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 931 (1016)
.................+.+++..|+..+|..|.++.+....
T Consensus 234 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 ---SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ---ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000111111111223468889999999999999999877654
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=7e-21 Score=197.91 Aligned_cols=201 Identities=25% Similarity=0.344 Sum_probs=170.4
Q ss_pred cCccccCccccCCCeeEEEEE-cCCCcEEEEEEccCCChhhhHHHHHHHHHHHhc-CCCCeeeeeeeEeecceeEEEEee
Q 001768 659 NNFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNREFVNEIGMISAL-QHQNLVKLYGCCIEGNQLLLVYEY 736 (1016)
Q Consensus 659 ~~f~~~~~LG~G~~G~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~ 736 (1016)
-.|++.++||+|.||.++.|+ +-++++||||.-...+ ...++..|.+..+.+ ..++|..++-+..++.+-.||+|+
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 468899999999999999998 4578999999865443 335677888888888 579999999999999899999998
Q ss_pred cCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCC-----ceeeeccccccc
Q 001768 737 LENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDL-----NAKISDFGLAKL 811 (1016)
Q Consensus 737 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~-----~~kL~DFGla~~ 811 (1016)
+ |.+|+|+..-.. ..++..++..||.|++.-++|+|++ .+|.|||||+|+|+..-+ .+.++|||+|+.
T Consensus 106 L-GPSLEDLFD~Cg---R~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 106 L-GPSLEDLFDLCG---RRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred h-CcCHHHHHHHhc---CcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 8 679998885443 3699999999999999999999999 899999999999997543 489999999997
Q ss_pred cCCCCcce------eeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCc
Q 001768 812 DEDENTHI------STRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPK 868 (1016)
Q Consensus 812 ~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~ 868 (1016)
+.+..+.. .....||.+||+---..+...+.+.|+=|+|-|+.+.+-|..||.+...
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA 241 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 241 (449)
T ss_pred hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccC
Confidence 66554322 2336799999999988899999999999999999999999999987543
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.1e-23 Score=221.15 Aligned_cols=268 Identities=21% Similarity=0.264 Sum_probs=188.6
Q ss_pred CCceeccC----CCCCceeeEEEEEecCCccCccCccccCCCCCCCEEEccCCCCCCCCchhhhcccCcccccccc-ccc
Q 001768 71 SNFTCDCT----YSNNTVCHVTVILLKGFNLAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILG-NRL 145 (1016)
Q Consensus 71 ~~v~c~~~----~~~~~~~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~Ls~-N~l 145 (1016)
..|.|... .+.+.++..+.|+|..|+|+.+.+.+|+.+++|++|||++|+|+.+-|++|..|++|..|-+.+ |+|
T Consensus 49 ~~VdCr~~GL~eVP~~LP~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI 128 (498)
T KOG4237|consen 49 GIVDCRGKGLTEVPANLPPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKI 128 (498)
T ss_pred ceEEccCCCcccCcccCCCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCch
Confidence 34666543 3345567889999999999999899999999999999999999999999999999999988887 899
Q ss_pred CCCCCcccCCcCCccEEEcccCCCCCCCCCCCCCCccchhhhccCCccCCCCCcccCCCCCccEEEecCCcCC-------
Q 001768 146 SGSIPLEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLT------- 218 (1016)
Q Consensus 146 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~------- 218 (1016)
+......|++|..|+.|.+.-|++.-.....|..|++|..|.|.+|.+...--..|..+..++.+++..|.+.
T Consensus 129 ~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~w 208 (498)
T KOG4237|consen 129 TDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPW 208 (498)
T ss_pred hhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccch
Confidence 9766788999999999999999999888888999999999999999999444458999999999999999832
Q ss_pred -----CCCchhhhcCCCCCEEeecCCcCCCCCc--------------------------hhhcCCCCCCEEEcCCCCCCC
Q 001768 219 -----GRIPNFIGNWTKLDRLDLQGTSLEGPIP--------------------------STISQLKNLTELRISDLKGSS 267 (1016)
Q Consensus 219 -----~~~~~~l~~l~~L~~L~Ls~N~l~~~~p--------------------------~~l~~l~~L~~L~Ls~n~l~~ 267 (1016)
...|-.++...-..-..+.++++....+ ..|..|++|+.|+|++|+++.
T Consensus 209 la~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~ 288 (498)
T KOG4237|consen 209 LADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITR 288 (498)
T ss_pred hhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccch
Confidence 1122222222222222233333322222 345555555555555555555
Q ss_pred CCCcccccccccceeecccccccccCchhhcCCCCCceEeccCCCCCCCCccccCCCCCCCEEEccCCcCC
Q 001768 268 SSFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLS 338 (1016)
Q Consensus 268 ~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~L~~~~p~~l~~l~~L~~L~L~~N~l~ 338 (1016)
+....|.++..|++|.|..|+|...-...|.++..|+.|+|.+|+|+...|..|..+.+|..|+|-.|++.
T Consensus 289 i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~ 359 (498)
T KOG4237|consen 289 IEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFN 359 (498)
T ss_pred hhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCccc
Confidence 55555555555555555555555444444555555555555555555555555555555555555555554
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=9.7e-22 Score=234.35 Aligned_cols=252 Identities=22% Similarity=0.264 Sum_probs=188.6
Q ss_pred ccCccccCCCeeEEEEEcC-CCcEEEEEEcc----C-CChhh-hHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEe
Q 001768 663 AANKIGEGGFGPVYKGTLS-DGAVIAVKQLS----S-KSKQG-NREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYE 735 (1016)
Q Consensus 663 ~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~----~-~~~~~-~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 735 (1016)
..+.+|.|++|.|+..... ..+..+.|... . ..... ...+..|+.+-..++|||++..+..+.+.....-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 3578999999988877633 33334444332 1 11111 1226667778888999999998888877766666699
Q ss_pred ecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCC
Q 001768 736 YLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDE 815 (1016)
Q Consensus 736 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 815 (1016)
||++ +|...+.... .++..++..++.|++.|++|+|+. ||.|||+|++|++++.+|.+||+|||.+..+...
T Consensus 402 ~~~~-Dlf~~~~~~~----~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSNG----KLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred cccH-HHHHHHhccc----ccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 9999 9999996652 588889999999999999999998 9999999999999999999999999999765433
Q ss_pred C---cceeeecccCccccChhhhccCCCCC-ccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCccccc
Q 001768 816 N---THISTRIAGTVGYMAPEYAMRGYLTD-KADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELV 891 (1016)
Q Consensus 816 ~---~~~~~~~~gt~~y~aPE~~~~~~~~~-~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 891 (1016)
. .......+|+..|+|||.+.+..|.+ ..||||.|++++.|++|+.||.....++..+ .......+.-
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~--------~~~~~~~~~~ 545 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF--------KTNNYSDQRN 545 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch--------hhhccccccc
Confidence 2 25566788999999999999888776 5799999999999999999997655443321 0000001111
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 892 DPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 892 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
...-........+.....++.++++.||.+|.|+++|++
T Consensus 546 ~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 546 IFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred cccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 111112233455667889999999999999999998883
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.7e-20 Score=223.82 Aligned_cols=226 Identities=22% Similarity=0.358 Sum_probs=168.1
Q ss_pred CCCCEEEccCCCCCCCCchhhhcccCcccccccccccCCCCCcccCCcCCccEEEcccCCCCCCCCCCCCCCccchhhhc
Q 001768 109 TFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRILL 188 (1016)
Q Consensus 109 ~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 188 (1016)
.+..+|+|+++.++ .+|..+. ++|+.|+|++|.|+ .+|..+. ++|++|+|++|+|+ .+|..+. .+|+.|+|
T Consensus 178 ~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~L 248 (754)
T PRK15370 178 NNKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMEL 248 (754)
T ss_pred cCceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEEC
Confidence 45678888888888 4665553 47888888888888 5665543 58888888888887 5665543 47888888
Q ss_pred cCCccCCCCCcccCCCCCccEEEecCCcCCCCCchhhhcCCCCCEEeecCCcCCCCCchhhcCCCCCCEEEcCCCCCCCC
Q 001768 189 SSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISDLKGSSS 268 (1016)
Q Consensus 189 s~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~ 268 (1016)
++|++. .+|..+. ++|+.|+|++|+++ .+|..+. ++|+.|+|++|+|+. +|..+. ++|+.|++++|.++.+
T Consensus 249 s~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls~N~Lt~L 319 (754)
T PRK15370 249 SINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRT-LPAHLP--SGITHLNVQSNSLTAL 319 (754)
T ss_pred cCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCcccc-Ccccch--hhHHHHHhcCCccccC
Confidence 888888 6676654 57888888888888 4666553 478888888888884 444332 4688888888888765
Q ss_pred CCcccccccccceeecccccccccCchhhcCCCCCceEeccCCCCCCCCccccCCCCCCCEEEccCCcCCCCCChhhhcc
Q 001768 269 SFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGTLPDWILTS 348 (1016)
Q Consensus 269 ~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~L~~~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~~ 348 (1016)
+... .++|+.|++++|.+++ +|..+. ++|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|+ .+|..+...
T Consensus 320 P~~l---~~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt-~LP~~l~~s 389 (754)
T PRK15370 320 PETL---PPGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALT-NLPENLPAA 389 (754)
T ss_pred Cccc---cccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCC-CCCHhHHHH
Confidence 4322 3678888888888884 665553 68888999988888 5666553 68888899988888 677777778
Q ss_pred CCcccCCCCcCCCC
Q 001768 349 EKNLDLSYNNFTES 362 (1016)
Q Consensus 349 L~~LdLs~N~l~~~ 362 (1016)
|+.||+++|+|++.
T Consensus 390 L~~LdLs~N~L~~L 403 (754)
T PRK15370 390 LQIMQASRNNLVRL 403 (754)
T ss_pred HHHHhhccCCcccC
Confidence 88888999888843
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=2e-20 Score=194.78 Aligned_cols=173 Identities=16% Similarity=0.169 Sum_probs=135.7
Q ss_pred HHHhcCccccCccccCCCeeEEEEEcCCCcEEEEEEccCCChhhhH---------HHHHHHHHHHhcCCCCeeeeeeeEe
Q 001768 655 KAATNNFDAANKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGNR---------EFVNEIGMISALQHQNLVKLYGCCI 725 (1016)
Q Consensus 655 ~~~~~~f~~~~~LG~G~~G~Vy~~~~~~~~~vAvK~~~~~~~~~~~---------~~~~E~~~l~~l~HpnIv~l~~~~~ 725 (1016)
+...++|+..+.||.|+||.||++.. ++..+|+|.+......... .+.+|++.+.++.||+|..+.+++.
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 45678999999999999999999766 5778999999755332222 2678999999999999999998866
Q ss_pred ec--------ceeEEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEcc
Q 001768 726 EG--------NQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDK 797 (1016)
Q Consensus 726 ~~--------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~ 797 (1016)
.. +..++||||++|.+|.++. .++. ....+++.++..+|+. |++|||+||+||+++.
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~--------~~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~ 170 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMP--------EISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSK 170 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhh--------hccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeC
Confidence 43 3579999999999998873 1232 2456999999999998 9999999999999999
Q ss_pred CCceeeeccccccccCCCCcceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHH
Q 001768 798 DLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIV 857 (1016)
Q Consensus 798 ~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ell 857 (1016)
++ ++|+|||......+.... ..+.....+..++|+|+||+++..+.
T Consensus 171 ~g-i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 171 NG-LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CC-EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence 88 999999988754322111 11344455668999999999976643
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.6e-20 Score=224.43 Aligned_cols=240 Identities=24% Similarity=0.333 Sum_probs=118.2
Q ss_pred EEEecCCccCccCccccCCCCCCCEEEccCCCCCCCCchhhhcccCcccccccccccCCCCCcccCCcCCccEEEcccCC
Q 001768 89 VILLKGFNLAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGDISTLEELVLEDNQ 168 (1016)
Q Consensus 89 ~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 168 (1016)
.|+|+.++|+ .+|+.+. ++|+.|+|.+|+|+ .+|. .+++|++|+|++|+|+ .+|.. .++|+.|+|++|+
T Consensus 205 ~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~---lp~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~Ls~N~ 273 (788)
T PRK15387 205 VLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLT-SLPVL---PPGLLELSIFSNP 273 (788)
T ss_pred EEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCC---CCCCCcEEEecCCccC-cccCc---ccccceeeccCCc
Confidence 3455555555 3444443 24555555555555 2332 1345555555555555 23321 2344444444444
Q ss_pred CCCCCCCCCC-----------------CCccchhhhccCCccCCCCCcccCCCCCccEEEecCCcCCCCCchhhhcCCCC
Q 001768 169 LVGPLPENLG-----------------NLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKL 231 (1016)
Q Consensus 169 l~~~~p~~l~-----------------~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L 231 (1016)
++ .+|..+. .+++|+.|+|++|+|++ +|.. ..+|+.|++++|++++ +|.. ..+|
T Consensus 274 L~-~Lp~lp~~L~~L~Ls~N~Lt~LP~~p~~L~~LdLS~N~L~~-Lp~l---p~~L~~L~Ls~N~L~~-LP~l---p~~L 344 (788)
T PRK15387 274 LT-HLPALPSGLCKLWIFGNQLTSLPVLPPGLQELSVSDNQLAS-LPAL---PSELCKLWAYNNQLTS-LPTL---PSGL 344 (788)
T ss_pred hh-hhhhchhhcCEEECcCCccccccccccccceeECCCCcccc-CCCC---cccccccccccCcccc-cccc---cccc
Confidence 44 2222110 12445555555555552 2321 1234455555555542 3321 1345
Q ss_pred CEEeecCCcCCCCCchhhcCCCCCCEEEcCCCCCCCCCCcccccccccceeecccccccccCchhhcCCCCCceEeccCC
Q 001768 232 DRLDLQGTSLEGPIPSTISQLKNLTELRISDLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFN 311 (1016)
Q Consensus 232 ~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N 311 (1016)
+.|+|++|+|++ +|.. ..+|+.|++++|.+..++. .+.+|+.|+|++|+|++ +|.. .++|+.|++++|
T Consensus 345 q~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~~LP~----l~~~L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N 412 (788)
T PRK15387 345 QELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTSLPA----LPSGLKELIVSGNRLTS-LPVL---PSELKELMVSGN 412 (788)
T ss_pred ceEecCCCccCC-CCCC---CcccceehhhccccccCcc----cccccceEEecCCcccC-CCCc---ccCCCEEEccCC
Confidence 666666666653 3321 2345555666666554321 12456666666666663 3332 245666666666
Q ss_pred CCCCCCccccCCCCCCCEEEccCCcCCCCCChhh--hccCCcccCCCCcCCCCCCc
Q 001768 312 QLTGPVPGILQNLKKIDYIFLTNNSLSGTLPDWI--LTSEKNLDLSYNNFTESSPA 365 (1016)
Q Consensus 312 ~L~~~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~--~~~L~~LdLs~N~l~~~~p~ 365 (1016)
+|+ .+|.. ..+|+.|+|++|+|+ .+|..+ ++.|+.|+|++|+|++.+|.
T Consensus 413 ~Ls-sIP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~ 463 (788)
T PRK15387 413 RLT-SLPML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ 463 (788)
T ss_pred cCC-CCCcc---hhhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHH
Confidence 666 34432 234566666666666 556555 55666666666666666554
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=7.4e-20 Score=188.62 Aligned_cols=139 Identities=17% Similarity=0.196 Sum_probs=108.6
Q ss_pred cCccccCCCeeEEEEEcCCCcEEEEEEccCCChh--h-------h-----------------HHHHHHHHHHHhcCCCCe
Q 001768 664 ANKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQ--G-------N-----------------REFVNEIGMISALQHQNL 717 (1016)
Q Consensus 664 ~~~LG~G~~G~Vy~~~~~~~~~vAvK~~~~~~~~--~-------~-----------------~~~~~E~~~l~~l~HpnI 717 (1016)
...||+|+||.||+|...+|+.||||+++..... . . .....|++++.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4689999999999999888999999998754211 0 0 122459999999988877
Q ss_pred eeeeeeEeecceeEEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEeCCCCCceEEEc
Q 001768 718 VKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYL-HEESRLKIVHRDIKATNVLLD 796 (1016)
Q Consensus 718 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yL-H~~~~~~iiHrDlkp~NILl~ 796 (1016)
.....+.. ...++||||++++++....... ..++..++..++.|++.+|.|+ |+. +|+||||||+|||++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~----~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~ 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKD----APLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE
Confidence 44333322 2248999999998776543222 2588999999999999999999 677 899999999999998
Q ss_pred cCCceeeecccccccc
Q 001768 797 KDLNAKISDFGLAKLD 812 (1016)
Q Consensus 797 ~~~~~kL~DFGla~~~ 812 (1016)
++.++|+|||+|...
T Consensus 153 -~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 -DGKLYIIDVSQSVEH 167 (190)
T ss_pred -CCcEEEEEccccccC
Confidence 478999999999744
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.1e-20 Score=217.80 Aligned_cols=251 Identities=20% Similarity=0.261 Sum_probs=183.8
Q ss_pred CccccCccccCCCeeEEEEEcCCCcEEEEEEccCCC-hhhhHHHHHHHHH--HHhcCCCCeeeeeeeEeecceeEEEEee
Q 001768 660 NFDAANKIGEGGFGPVYKGTLSDGAVIAVKQLSSKS-KQGNREFVNEIGM--ISALQHQNLVKLYGCCIEGNQLLLVYEY 736 (1016)
Q Consensus 660 ~f~~~~~LG~G~~G~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~--l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 736 (1016)
+|...+.||.+.|=+|.+|++++|. |+||++-+.. ....+.|.++++- ...++|||.+++.-+...+...|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5777899999999999999998887 8889876544 4445555554433 4456899999998888888888999999
Q ss_pred cCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeecccccc--ccCC
Q 001768 737 LENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAK--LDED 814 (1016)
Q Consensus 737 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~--~~~~ 814 (1016)
+.+ +|.|.+..+. -+...+.+.|+.|++.||.-+|.. ||+|||||.+|||++.-.-+.|+||..-+ +.++
T Consensus 103 vkh-nLyDRlSTRP----FL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe 174 (1431)
T KOG1240|consen 103 VKH-NLYDRLSTRP----FLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPE 174 (1431)
T ss_pred Hhh-hhhhhhccch----HHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCC
Confidence 966 8999885543 578888999999999999999998 99999999999999999999999998754 3344
Q ss_pred CCcceeeec----ccCccccChhhhccC----------C-CCCccchhHHHHHHHHHHh-CCCCCCCCCchhhHhHHHHH
Q 001768 815 ENTHISTRI----AGTVGYMAPEYAMRG----------Y-LTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWA 878 (1016)
Q Consensus 815 ~~~~~~~~~----~gt~~y~aPE~~~~~----------~-~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~ 878 (1016)
++....+-+ ..-..|+|||.+... . .+++-||||+||++.||++ |++||... .+..+.
T Consensus 175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS------QL~aYr 248 (1431)
T KOG1240|consen 175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS------QLLAYR 248 (1431)
T ss_pred CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH------HHHhHh
Confidence 433222211 122469999987531 1 5778899999999999998 68777521 111111
Q ss_pred HHHHHhCCcccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 001768 879 YVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGK 935 (1016)
Q Consensus 879 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 935 (1016)
. .. ....+.+-..+ +...+++++..|++.||++|.++++.++.-.+.
T Consensus 249 ~--~~-~~~~e~~Le~I-------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~ 295 (1431)
T KOG1240|consen 249 S--GN-ADDPEQLLEKI-------EDVSLRNLILSMIQRDPSKRLSAEDYLQKYRGL 295 (1431)
T ss_pred c--cC-ccCHHHHHHhC-------cCccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence 0 00 00111110011 112578899999999999999999999875543
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.1e-21 Score=225.63 Aligned_cols=244 Identities=30% Similarity=0.353 Sum_probs=150.6
Q ss_pred CCCEEEccCCCCCCCCchhhhcccCcccccccccccCCCCCcccCCcCCccEEEcccCCCCCCCCCCCCCCccchhhhcc
Q 001768 110 FLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLS 189 (1016)
Q Consensus 110 ~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls 189 (1016)
+|+++++++|+++ .+|..++.+.+|+.|++.+|+|+ .+|..+..+++|+.|++.+|.+. .+|+.+..++.|++|+|.
T Consensus 242 nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~ 318 (1081)
T KOG0618|consen 242 NLQYLDISHNNLS-NLPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQ 318 (1081)
T ss_pred cceeeecchhhhh-cchHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeeh
Confidence 3444444444444 23344444444444444444443 44444444444444444444444 444444444444444444
Q ss_pred CCccCCCCCcccCCCC-CccEEEecCCcCCCCCchhhhcCCCCCEEeecCCcCCCCCchhhcCCCCCCEEEcCCCCCCCC
Q 001768 190 SNNFTGSIPESYGNLK-NLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISDLKGSSS 268 (1016)
Q Consensus 190 ~N~l~~~~p~~l~~l~-~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~ 268 (1016)
.|+|....+..+.-+. .|+.|+.+.|.+.....-.=..++.|+.|++.+|.++...-..|.+.++|+.|+|++|++...
T Consensus 319 ~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~f 398 (1081)
T KOG0618|consen 319 SNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSF 398 (1081)
T ss_pred hccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccC
Confidence 4444422111122222 134444444444311111111234577788888888877777788888888888888888888
Q ss_pred CCcccccccccceeecccccccccCchhhcCCCCCceEeccCCCCCCCCccccCCCCCCCEEEccCCcCCC-CCChhhh-
Q 001768 269 SFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSG-TLPDWIL- 346 (1016)
Q Consensus 269 ~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~L~~~~p~~l~~l~~L~~L~L~~N~l~g-~~p~~~~- 346 (1016)
+...+.++..|++|+||+|+++ .+|..+..++.|+.|...+|+|. ..| .+..++.|+.+||+.|+|+. .+|....
T Consensus 399 pas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~ 475 (1081)
T KOG0618|consen 399 PASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPS 475 (1081)
T ss_pred CHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCC
Confidence 8888888888888888888888 77788888888888888888888 667 67888888888888888874 4444444
Q ss_pred ccCCcccCCCCcC
Q 001768 347 TSEKNLDLSYNNF 359 (1016)
Q Consensus 347 ~~L~~LdLs~N~l 359 (1016)
++|+.|||++|.-
T Consensus 476 p~LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 476 PNLKYLDLSGNTR 488 (1081)
T ss_pred cccceeeccCCcc
Confidence 7888888888863
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.4e-19 Score=181.91 Aligned_cols=141 Identities=18% Similarity=0.198 Sum_probs=111.5
Q ss_pred cCccccCCCeeEEEEEcCCCcEEEEEEccCCChh--------------------------hhHHHHHHHHHHHhcCCCCe
Q 001768 664 ANKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQ--------------------------GNREFVNEIGMISALQHQNL 717 (1016)
Q Consensus 664 ~~~LG~G~~G~Vy~~~~~~~~~vAvK~~~~~~~~--------------------------~~~~~~~E~~~l~~l~HpnI 717 (1016)
.+.||+|++|.||+|+..+|+.||||++...... ....+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 5789999999999999878999999998754211 01224678999999999987
Q ss_pred eeeeeeEeecceeEEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeCCCCCceEEEc
Q 001768 718 VKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHE-ESRLKIVHRDIKATNVLLD 796 (1016)
Q Consensus 718 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~-~~~~~iiHrDlkp~NILl~ 796 (1016)
.....+... ..++||||++++++....... ..++..++..++.|++.++.++|+ . ||+||||||+||+++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~----~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~ 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD----VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh----ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE
Confidence 554444333 248999999988654432221 247888999999999999999999 7 999999999999999
Q ss_pred cCCceeeeccccccccCC
Q 001768 797 KDLNAKISDFGLAKLDED 814 (1016)
Q Consensus 797 ~~~~~kL~DFGla~~~~~ 814 (1016)
++.++|+|||++.....
T Consensus 153 -~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 -DGKPYIIDVSQAVELDH 169 (190)
T ss_pred -CCCEEEEEcccceecCC
Confidence 88999999999985543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.7e-18 Score=224.66 Aligned_cols=265 Identities=23% Similarity=0.339 Sum_probs=161.0
Q ss_pred EEEEEecCCccCccCccccCCCCCCCEEEccCCCCCCCCchhhhcccCcccccccccccCCCCCcccCCcCCccEEEccc
Q 001768 87 VTVILLKGFNLAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGDISTLEELVLED 166 (1016)
Q Consensus 87 v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 166 (1016)
++.|.+.++.+. .+|..| .+.+|++|+|++|++. .++..+..+++|+.|+|++|.....+| .++.+++|++|+|++
T Consensus 591 Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~ 666 (1153)
T PLN03210 591 LRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSD 666 (1153)
T ss_pred cEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecC
Confidence 455555554443 334433 3456666666666655 445555556666666666554333444 355566666666666
Q ss_pred CCCCCCCCCCCCCCccchhhhccCCccCCCCCcccCCCCCccEEEecCCcCCCCCchhhhcCCCCCEEeecCCcCCCCCc
Q 001768 167 NQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIP 246 (1016)
Q Consensus 167 N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p 246 (1016)
|.....+|..+.++++|+.|+|++|.....+|..+ ++++|+.|+|++|.....+|.. ..+|+.|+|++|.++ .+|
T Consensus 667 c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP 741 (1153)
T PLN03210 667 CSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFP 741 (1153)
T ss_pred CCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-ccc
Confidence 55444556666666666666666654333555443 4566666666666544444432 235666666666655 344
Q ss_pred hhhcCCCCCCEEEcCCCCCCCC-------CCcccccccccceeecccccccccCchhhcCCCCCceEeccCCCCCCCCcc
Q 001768 247 STISQLKNLTELRISDLKGSSS-------SFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPG 319 (1016)
Q Consensus 247 ~~l~~l~~L~~L~Ls~n~l~~~-------~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~L~~~~p~ 319 (1016)
..+ .+++|+.|++.++..... .......+++|+.|+|++|.....+|..++++++|+.|+|++|..-+.+|.
T Consensus 742 ~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~ 820 (1153)
T PLN03210 742 SNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPT 820 (1153)
T ss_pred ccc-cccccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCC
Confidence 333 455666665554322111 111122346888899998887778888899999999999998765557776
Q ss_pred ccCCCCCCCEEEccCCcCCCCCChhhhccCCcccCCCCcCCCCC
Q 001768 320 ILQNLKKIDYIFLTNNSLSGTLPDWILTSEKNLDLSYNNFTESS 363 (1016)
Q Consensus 320 ~l~~l~~L~~L~L~~N~l~g~~p~~~~~~L~~LdLs~N~l~~~~ 363 (1016)
.+ ++++|+.|+|++|.....+|.. ..+|+.|+|++|.++..+
T Consensus 821 ~~-~L~sL~~L~Ls~c~~L~~~p~~-~~nL~~L~Ls~n~i~~iP 862 (1153)
T PLN03210 821 GI-NLESLESLDLSGCSRLRTFPDI-STNISDLNLSRTGIEEVP 862 (1153)
T ss_pred CC-CccccCEEECCCCCcccccccc-ccccCEeECCCCCCccCh
Confidence 65 7888999999988666566653 568888999999887643
|
syringae 6; Provisional |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.4e-18 Score=176.74 Aligned_cols=185 Identities=15% Similarity=0.056 Sum_probs=140.0
Q ss_pred ccccCccccCCCeeEEEEEcCCCcEEEEEEccCCChh----hhHHHHHHHHHHHhcC-CCCeeeeeeeEeecceeEEEEe
Q 001768 661 FDAANKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQ----GNREFVNEIGMISALQ-HQNLVKLYGCCIEGNQLLLVYE 735 (1016)
Q Consensus 661 f~~~~~LG~G~~G~Vy~~~~~~~~~vAvK~~~~~~~~----~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~E 735 (1016)
+.+...|++|+||+||.+.. .+..++.+.+...... ....+.+|+++|+++. |+++++++++ +..+++||
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred cccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 34578899999999998776 5777887777654321 1235789999999995 5889999886 34699999
Q ss_pred ecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCC-CCceEEEccCCceeeeccccccccCC
Q 001768 736 YLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDI-KATNVLLDKDLNAKISDFGLAKLDED 814 (1016)
Q Consensus 736 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDl-kp~NILl~~~~~~kL~DFGla~~~~~ 814 (1016)
|++|.+|.+.+.. ....++.|++++|+++|++ ||+|||| ||+|||++.++.++|+|||+|.....
T Consensus 79 yI~G~~L~~~~~~-----------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~ 144 (218)
T PRK12274 79 YLAGAAMYQRPPR-----------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNP 144 (218)
T ss_pred eecCccHHhhhhh-----------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCC
Confidence 9999998754311 1135788999999999999 9999999 79999999999999999999985544
Q ss_pred CCcc----e--------eeecccCccccChhhhcc--CCCCCccchhHHHHHHHHHHhCCCCCC
Q 001768 815 ENTH----I--------STRIAGTVGYMAPEYAMR--GYLTDKADVYSFGIVALEIVSGKSNTN 864 (1016)
Q Consensus 815 ~~~~----~--------~~~~~gt~~y~aPE~~~~--~~~~~~sDVwSlGvvl~elltG~~P~~ 864 (1016)
.... . ......++.|++|+...- ..--.+.+.++-|+-+|.++|++.+.-
T Consensus 145 ~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 145 RARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred cchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 3310 0 111235778888885432 222356789999999999999998754
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.2e-18 Score=222.13 Aligned_cols=268 Identities=25% Similarity=0.329 Sum_probs=204.7
Q ss_pred eeeEEEEEecCCccCccCccccCCCCCCCEEEccCCCCCCCCchhhhcccCcccccccccccCCCCCcccCCcCCccEEE
Q 001768 84 VCHVTVILLKGFNLAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGDISTLEELV 163 (1016)
Q Consensus 84 ~~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 163 (1016)
+.+++.|+|.++.+. .++..+..+++|+.|+|+++.....+|. ++.+++|+.|+|++|.....+|..++++++|+.|+
T Consensus 610 ~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~ 687 (1153)
T PLN03210 610 PENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLD 687 (1153)
T ss_pred ccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEe
Confidence 357899999999987 5677889999999999999765556774 88999999999999887778999999999999999
Q ss_pred cccCCCCCCCCCCCCCCccchhhhccCCccCCCCCcccCCCCCccEEEecCCcCCCCCchhhhcCCCCCEEeecCCcCC-
Q 001768 164 LEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLE- 242 (1016)
Q Consensus 164 Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~- 242 (1016)
|++|.....+|..+ ++++|+.|+|++|.....+|.. ..+|++|+|++|.+. .+|..+ .+++|+.|++.++...
T Consensus 688 L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~ 761 (1153)
T PLN03210 688 MSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEK 761 (1153)
T ss_pred CCCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccc-cccccccccccccchhh
Confidence 99986555788766 7899999999999876666653 468999999999987 566554 4677888877764321
Q ss_pred ------CCCchhhcCCCCCCEEEcCCCCCCCCCCcccccccccceeecccccccccCchhhcCCCCCceEeccCCCCCCC
Q 001768 243 ------GPIPSTISQLKNLTELRISDLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGP 316 (1016)
Q Consensus 243 ------~~~p~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~L~~~ 316 (1016)
...+..+...++|+.|+|++|......+..+..+++|+.|+|++|..-+.+|..+ .+++|+.|+|++|..-..
T Consensus 762 l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~ 840 (1153)
T PLN03210 762 LWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRT 840 (1153)
T ss_pred ccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccc
Confidence 1122233345678888888887666666678888888888888875544666655 678888888888765545
Q ss_pred CccccCCCCCCCEEEccCCcCCCCCChhh--hccCCcccCCC-CcCCCCCC
Q 001768 317 VPGILQNLKKIDYIFLTNNSLSGTLPDWI--LTSEKNLDLSY-NNFTESSP 364 (1016)
Q Consensus 317 ~p~~l~~l~~L~~L~L~~N~l~g~~p~~~--~~~L~~LdLs~-N~l~~~~p 364 (1016)
+|.. ..+|+.|+|++|.++ .+|.++ +++|+.|+|++ |+|++.++
T Consensus 841 ~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~~l~~ 887 (1153)
T PLN03210 841 FPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQRVSL 887 (1153)
T ss_pred cccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcCccCc
Confidence 5543 357888888888887 677766 77888888887 55665443
|
syringae 6; Provisional |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.7e-18 Score=185.72 Aligned_cols=234 Identities=20% Similarity=0.205 Sum_probs=151.3
Q ss_pred CccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCC---hhhhHHHHHHHHHHHhcCC----------CCeeeeeeeE-
Q 001768 660 NFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS---KQGNREFVNEIGMISALQH----------QNLVKLYGCC- 724 (1016)
Q Consensus 660 ~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H----------pnIv~l~~~~- 724 (1016)
.....+.||.|+++.||.+++. +++.+|+|++.... ....+.+++|.-....+.+ -.++.-++..
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 4456789999999999999976 48999999975433 2334566666655544332 1222222221
Q ss_pred --------eec---c-----eeEEEEeecCCCcHHHHhcc---CcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 001768 725 --------IEG---N-----QLLLVYEYLENNSLARALFG---KEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVH 785 (1016)
Q Consensus 725 --------~~~---~-----~~~lV~E~~~~gsL~~~l~~---~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH 785 (1016)
... . ..+++|+-+ .++|.+++.. .......+....+..+..|+++.+++||+. |++|
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEe
Confidence 111 1 237788877 4588877642 221123455666778889999999999999 9999
Q ss_pred CCCCCceEEEccCCceeeeccccccccCCCCcceeeecccCccccChhhhccC--------CCCCccchhHHHHHHHHHH
Q 001768 786 RDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRG--------YLTDKADVYSFGIVALEIV 857 (1016)
Q Consensus 786 rDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~sDVwSlGvvl~ell 857 (1016)
+||||+|++++.+|.++|+||+.....+.... . ...+..|.|||..... .++.+.|.|++|+++|.|+
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~---~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW 244 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYR---C-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW 244 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEEEE---G-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCceee---c-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence 99999999999999999999998765443211 1 3445789999977542 4788999999999999999
Q ss_pred hCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCC
Q 001768 858 SGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLR 922 (1016)
Q Consensus 858 tG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~R 922 (1016)
+|+.||+....+..... .+ .... +.++.+..||..+|+.+|.+|
T Consensus 245 C~~lPf~~~~~~~~~~~-------------------~f-~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 245 CGRLPFGLSSPEADPEW-------------------DF-SRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HSS-STCCCGGGSTSGG-------------------GG-TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HccCCCCCCCccccccc-------------------cc-hhcC-CcCHHHHHHHHHHccCCcccC
Confidence 99999986544322110 11 1222 567789999999999999988
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.1e-18 Score=210.41 Aligned_cols=226 Identities=27% Similarity=0.370 Sum_probs=167.6
Q ss_pred eEEEEEecCCccCccCccccCCCCCCCEEEccCCCCCCCCchhhhc-----------------ccCcccccccccccCCC
Q 001768 86 HVTVILLKGFNLAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFAR-----------------LQNLTKLLILGNRLSGS 148 (1016)
Q Consensus 86 ~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~p~~~~~-----------------l~~L~~L~Ls~N~l~~~ 148 (1016)
+++.|++.+|+++. +|. .+++|++|+|++|+|+. +|..+.+ +.+|+.|+|++|+++ .
T Consensus 223 ~L~~L~L~~N~Lt~-LP~---lp~~Lk~LdLs~N~Lts-LP~lp~sL~~L~Ls~N~L~~Lp~lp~~L~~L~Ls~N~Lt-~ 296 (788)
T PRK15387 223 HITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLTS-LPVLPPGLLELSIFSNPLTHLPALPSGLCKLWIFGNQLT-S 296 (788)
T ss_pred CCCEEEccCCcCCC-CCC---CCCCCcEEEecCCccCc-ccCcccccceeeccCCchhhhhhchhhcCEEECcCCccc-c
Confidence 56667777777664 332 24667777777777663 3321111 134555666666666 3
Q ss_pred CCcccCCcCCccEEEcccCCCCCCCCCCCCCCccchhhhccCCccCCCCCcccCCCCCccEEEecCCcCCCCCchhhhcC
Q 001768 149 IPLEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNW 228 (1016)
Q Consensus 149 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l 228 (1016)
+|. .+++|+.|+|++|+|++ +|... .+|+.|++++|+|+ .+|.. ..+|++|+|++|+|++ +|.. .
T Consensus 297 LP~---~p~~L~~LdLS~N~L~~-Lp~lp---~~L~~L~Ls~N~L~-~LP~l---p~~Lq~LdLS~N~Ls~-LP~l---p 361 (788)
T PRK15387 297 LPV---LPPGLQELSVSDNQLAS-LPALP---SELCKLWAYNNQLT-SLPTL---PSGLQELSVSDNQLAS-LPTL---P 361 (788)
T ss_pred ccc---cccccceeECCCCcccc-CCCCc---ccccccccccCccc-ccccc---ccccceEecCCCccCC-CCCC---C
Confidence 443 24789999999999984 55432 46888999999998 45642 2589999999999994 5543 3
Q ss_pred CCCCEEeecCCcCCCCCchhhcCCCCCCEEEcCCCCCCCCCCcccccccccceeecccccccccCchhhcCCCCCceEec
Q 001768 229 TKLDRLDLQGTSLEGPIPSTISQLKNLTELRISDLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDL 308 (1016)
Q Consensus 229 ~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 308 (1016)
.+|+.|++++|+|+. +|.. ..+|+.|+|++|.++.++. ..++|+.|+|++|+|+. +|.. ..+|+.|+|
T Consensus 362 ~~L~~L~Ls~N~L~~-LP~l---~~~L~~LdLs~N~Lt~LP~----l~s~L~~LdLS~N~Lss-IP~l---~~~L~~L~L 429 (788)
T PRK15387 362 SELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLTSLPV----LPSELKELMVSGNRLTS-LPML---PSGLLSLSV 429 (788)
T ss_pred cccceehhhcccccc-Cccc---ccccceEEecCCcccCCCC----cccCCCEEEccCCcCCC-CCcc---hhhhhhhhh
Confidence 578899999999994 5643 3579999999999987553 24689999999999994 6653 347899999
Q ss_pred cCCCCCCCCccccCCCCCCCEEEccCCcCCCCCChhh
Q 001768 309 SFNQLTGPVPGILQNLKKIDYIFLTNNSLSGTLPDWI 345 (1016)
Q Consensus 309 s~N~L~~~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~ 345 (1016)
++|+|+ .+|..+..+++|+.|+|++|+|+|..|..+
T Consensus 430 s~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L 465 (788)
T PRK15387 430 YRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQAL 465 (788)
T ss_pred ccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHH
Confidence 999999 789999999999999999999998877755
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.2e-18 Score=211.75 Aligned_cols=205 Identities=26% Similarity=0.412 Sum_probs=127.3
Q ss_pred cCcccccccccccCCCCCcccCCcCCccEEEcccCCCCCCCCCCCCCCccchhhhccCCccCCCCCcccCCCCCccEEEe
Q 001768 133 QNLTKLLILGNRLSGSIPLEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRI 212 (1016)
Q Consensus 133 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 212 (1016)
.+...|+|+++.++ .+|..+. ++|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|+ .+|..+. ++|+.|+|
T Consensus 178 ~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~L 248 (754)
T PRK15370 178 NNKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMEL 248 (754)
T ss_pred cCceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEEC
Confidence 34566777777766 4555442 46777777777776 4555443 46777777777776 4554442 36777777
Q ss_pred cCCcCCCCCchhhhcCCCCCEEeecCCcCCCCCchhhcCCCCCCEEEcCCCCCCCCCCcccccccccceeeccccccccc
Q 001768 213 DGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISDLKGSSSSFPNLQDMKKMERLILRNCLITGR 292 (1016)
Q Consensus 213 ~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ 292 (1016)
++|++. .+|..+. ++|+.|+|++|+|+ .+|..+. ++|+.|+|++|+++.++.. + .++|+.|+|++|.++.
T Consensus 249 s~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~LP~~-l--p~sL~~L~Ls~N~Lt~- 318 (754)
T PRK15370 249 SINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRTLPAH-L--PSGITHLNVQSNSLTA- 318 (754)
T ss_pred cCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCccccCccc-c--hhhHHHHHhcCCcccc-
Confidence 777776 4555543 36777777777776 3454442 4677777777776654321 1 2456777777777763
Q ss_pred CchhhcCCCCCceEeccCCCCCCCCccccCCCCCCCEEEccCCcCCCCCChhhhccCCcccCCCCcCCCC
Q 001768 293 IPEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGTLPDWILTSEKNLDLSYNNFTES 362 (1016)
Q Consensus 293 ~p~~l~~l~~L~~L~Ls~N~L~~~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~~L~~LdLs~N~l~~~ 362 (1016)
+|..+. ++|+.|++++|.|++ +|..+. ++|+.|+|++|+|+ .+|..+.++|+.|+|++|+|+..
T Consensus 319 LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp~~L~~LdLs~N~Lt~L 382 (754)
T PRK15370 319 LPETLP--PGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETLPPTITTLDVSRNALTNL 382 (754)
T ss_pred CCcccc--ccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhhcCCcCEEECCCCcCCCC
Confidence 443332 467777777777763 554442 56777777777776 46666666777777777777654
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=6.2e-20 Score=213.45 Aligned_cols=267 Identities=24% Similarity=0.318 Sum_probs=222.2
Q ss_pred ceeeEEEEEecCCccCccCccccCCCCCCCEEEccCCCCCCCCchhhhcccCcccccccccccCCCCCcccCCcCCccEE
Q 001768 83 TVCHVTVILLKGFNLAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGDISTLEEL 162 (1016)
Q Consensus 83 ~~~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 162 (1016)
.+.+++.++++++++++. |+.++.+.+|+.|+..+|+++ .+|..+....+|+.|.+..|.++ .+|.....++.|++|
T Consensus 239 ~p~nl~~~dis~n~l~~l-p~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tL 315 (1081)
T KOG0618|consen 239 VPLNLQYLDISHNNLSNL-PEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTL 315 (1081)
T ss_pred ccccceeeecchhhhhcc-hHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeee
Confidence 345788999999999965 589999999999999999996 88999999999999999999999 888889999999999
Q ss_pred EcccCCCCCCCCCCC-CCCc-cchhhhccCCccCCCCCcccCCCCCccEEEecCCcCCCCCchhhhcCCCCCEEeecCCc
Q 001768 163 VLEDNQLVGPLPENL-GNLK-SLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTS 240 (1016)
Q Consensus 163 ~Ls~N~l~~~~p~~l-~~l~-~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~ 240 (1016)
+|..|+|. ..|+.+ .-+. .|+.|+.+.|.+....--.=..++.|+.|+|.+|.++......+.+..+|+.|+|++|+
T Consensus 316 dL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNr 394 (1081)
T KOG0618|consen 316 DLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNR 394 (1081)
T ss_pred eehhcccc-ccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccc
Confidence 99999998 555544 3333 38899999999984332223456799999999999998888899999999999999999
Q ss_pred CCCCCchhhcCCCCCCEEEcCCCCCCCCCCcccccccccceeecccccccccCchhhcCCCCCceEeccCCCCCCCCccc
Q 001768 241 LEGPIPSTISQLKNLTELRISDLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGI 320 (1016)
Q Consensus 241 l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~L~~~~p~~ 320 (1016)
|.......+.+++.|++|+||+|+++.++ ..+..+..|++|...+|+|. ..| .+..++.|+.+|||.|+|+...-..
T Consensus 395 L~~fpas~~~kle~LeeL~LSGNkL~~Lp-~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~ 471 (1081)
T KOG0618|consen 395 LNSFPASKLRKLEELEELNLSGNKLTTLP-DTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPE 471 (1081)
T ss_pred cccCCHHHHhchHHhHHHhcccchhhhhh-HHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhh
Confidence 99666678899999999999999999987 77889999999999999999 677 8999999999999999998543333
Q ss_pred cCCCCCCCEEEccCCcCCCCCChhh---hccCCcccCCCC
Q 001768 321 LQNLKKIDYIFLTNNSLSGTLPDWI---LTSEKNLDLSYN 357 (1016)
Q Consensus 321 l~~l~~L~~L~L~~N~l~g~~p~~~---~~~L~~LdLs~N 357 (1016)
-..-++|++|||++|... .+.... ++++..+++.-|
T Consensus 472 ~~p~p~LkyLdlSGN~~l-~~d~~~l~~l~~l~~~~i~~~ 510 (1081)
T KOG0618|consen 472 ALPSPNLKYLDLSGNTRL-VFDHKTLKVLKSLSQMDITLN 510 (1081)
T ss_pred hCCCcccceeeccCCccc-ccchhhhHHhhhhhheecccC
Confidence 233389999999999853 333333 444445555555
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.8e-19 Score=203.92 Aligned_cols=233 Identities=23% Similarity=0.275 Sum_probs=185.1
Q ss_pred ccccCCCeeEEEEE----cCCCcEEEEEEccCCChh--hhHHHHHHHHHHHhcC-CCCeeeeeeeEeecceeEEEEeecC
Q 001768 666 KIGEGGFGPVYKGT----LSDGAVIAVKQLSSKSKQ--GNREFVNEIGMISALQ-HQNLVKLYGCCIEGNQLLLVYEYLE 738 (1016)
Q Consensus 666 ~LG~G~~G~Vy~~~----~~~~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~ 738 (1016)
.+|+|+||.|++++ .+.|..+|.|.+++.... .......|-.++...+ ||.+|++...++.+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999875 234778899988754321 1124566788888887 9999999999999999999999999
Q ss_pred CCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCCcc
Q 001768 739 NNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTH 818 (1016)
Q Consensus 739 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 818 (1016)
+|.|...+.... .+++.....+...++-+++++|+. +|+|||+|++||+++.+|++++.|||+++..-.....
T Consensus 81 gg~lft~l~~~~----~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~ 153 (612)
T KOG0603|consen 81 GGDLFTRLSKEV----MFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA 153 (612)
T ss_pred cchhhhccccCC----chHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc
Confidence 999998886554 578888888999999999999998 9999999999999999999999999999855433221
Q ss_pred eeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCCCC
Q 001768 819 ISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGSN 898 (1016)
Q Consensus 819 ~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 898 (1016)
+||..|||||++. ....++|.||||++++||+||..||.. +....+ +.....
T Consensus 154 -----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~I-----------------l~~~~~ 205 (612)
T KOG0603|consen 154 -----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRI-----------------LKAELE 205 (612)
T ss_pred -----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHH-----------------hhhccC
Confidence 7999999999997 457889999999999999999999976 111111 011123
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHH--HHHHHhc
Q 001768 899 FSKKEAMTMLNIALLCTNPSPTLRPTMS--SAVSMLE 933 (1016)
Q Consensus 899 ~~~~~~~~l~~li~~cl~~dP~~RPt~~--evl~~L~ 933 (1016)
++........+++..++..+|..|--.. .+.+..+
T Consensus 206 ~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~ 242 (612)
T KOG0603|consen 206 MPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQ 242 (612)
T ss_pred CchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhc
Confidence 4556667788899999999999998663 4444443
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.6e-20 Score=199.44 Aligned_cols=270 Identities=21% Similarity=0.268 Sum_probs=200.7
Q ss_pred EEEecCCccCccCccccCCCCCCCEEEccCCCCCCCCchhhhcccCcccccccccccCCCCCcccCCcCCccEEEccc-C
Q 001768 89 VILLKGFNLAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGDISTLEELVLED-N 167 (1016)
Q Consensus 89 ~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~-N 167 (1016)
..+.++-+|+.+ |..+. +.-.+++|..|+|+.+.|.+|..+++|+.||||+|+|+.+-|.+|.++++|..|-+.+ |
T Consensus 50 ~VdCr~~GL~eV-P~~LP--~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~N 126 (498)
T KOG4237|consen 50 IVDCRGKGLTEV-PANLP--PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNN 126 (498)
T ss_pred eEEccCCCcccC-cccCC--CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCC
Confidence 446777788754 44332 4567899999999988899999999999999999999988999999999988887766 9
Q ss_pred CCCCCCCCCCCCCccchhhhccCCccCCCCCcccCCCCCccEEEecCCcCCCCCchhhhcCCCCCEEeecCCcCCC----
Q 001768 168 QLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEG---- 243 (1016)
Q Consensus 168 ~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~---- 243 (1016)
+|+...-..|.+|..|+.|.+.-|++.-...+.|..|++|..|.+..|.+...--..|..+..++.+.+..|.+-.
T Consensus 127 kI~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL 206 (498)
T KOG4237|consen 127 KITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNL 206 (498)
T ss_pred chhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCcccccccc
Confidence 9996666788999999999999999998888999999999999999999984444588899999999999998421
Q ss_pred --------CCchhhcCCCCCCEEEcCCCCCCCCC--------------------------Ccccccccccceeecccccc
Q 001768 244 --------PIPSTISQLKNLTELRISDLKGSSSS--------------------------FPNLQDMKKMERLILRNCLI 289 (1016)
Q Consensus 244 --------~~p~~l~~l~~L~~L~Ls~n~l~~~~--------------------------~~~l~~l~~L~~L~Ls~N~l 289 (1016)
..|..++...-.....+.++++..+. ...|..+++|+.|+|++|+|
T Consensus 207 ~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i 286 (498)
T KOG4237|consen 207 PWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKI 286 (498)
T ss_pred chhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCcc
Confidence 12333333332222222222222221 12256667777777777777
Q ss_pred cccCchhhcCCCCCceEeccCCCCCCCCccccCCCCCCCEEEccCCcCCCCCChhh--hccCCcccCCCCcCCC
Q 001768 290 TGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGTLPDWI--LTSEKNLDLSYNNFTE 361 (1016)
Q Consensus 290 ~~~~p~~l~~l~~L~~L~Ls~N~L~~~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~--~~~L~~LdLs~N~l~~ 361 (1016)
+++-+.+|.....|+.|.|..|+|...-...|.++..|+.|+|.+|+|+...|..| +.+|..|+|-.|+|.+
T Consensus 287 ~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~C 360 (498)
T KOG4237|consen 287 TRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNC 360 (498)
T ss_pred chhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccC
Confidence 76667777777777777777777765555666777777777777777776666666 5566777777777665
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.5e-20 Score=208.72 Aligned_cols=271 Identities=20% Similarity=0.208 Sum_probs=194.0
Q ss_pred EEEecCCccC-ccCccccCCCCCCCEEEccCCCCCCC----CchhhhcccCcccccccccccCC------CCCcccCCcC
Q 001768 89 VILLKGFNLA-GVIPEEFGNLTFLQEVDLSRNYFNGS----LPKSFARLQNLTKLLILGNRLSG------SIPLEIGDIS 157 (1016)
Q Consensus 89 ~L~L~~~~l~-~~~~~~l~~l~~L~~L~Ls~n~i~~~----~p~~~~~l~~L~~L~Ls~N~l~~------~~p~~~~~l~ 157 (1016)
.|+|..++++ ......+..++.|++|+|+++.+++. ++..+...++|++|+++++.+.+ .++..+..++
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~ 81 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence 3567777776 34455567778888888888888643 45556677778888888887762 2344566778
Q ss_pred CccEEEcccCCCCCCCCCCCCCCcc---chhhhccCCccCC----CCCcccCCC-CCccEEEecCCcCCCC----Cchhh
Q 001768 158 TLEELVLEDNQLVGPLPENLGNLKS---LRRILLSSNNFTG----SIPESYGNL-KNLTEFRIDGSNLTGR----IPNFI 225 (1016)
Q Consensus 158 ~L~~L~Ls~N~l~~~~p~~l~~l~~---L~~L~Ls~N~l~~----~~p~~l~~l-~~L~~L~L~~N~l~~~----~~~~l 225 (1016)
+|+.|+|++|.+.+..+..+..+.+ |++|++++|++++ .+...+..+ ++|++|+|++|.+++. ++..+
T Consensus 82 ~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~ 161 (319)
T cd00116 82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKAL 161 (319)
T ss_pred ceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHH
Confidence 8899999888887655555555554 8888998888873 233345566 8899999999998843 34456
Q ss_pred hcCCCCCEEeecCCcCCCC----CchhhcCCCCCCEEEcCCCCCCCCCCc----ccccccccceeecccccccccCchhh
Q 001768 226 GNWTKLDRLDLQGTSLEGP----IPSTISQLKNLTELRISDLKGSSSSFP----NLQDMKKMERLILRNCLITGRIPEYI 297 (1016)
Q Consensus 226 ~~l~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~Ls~n~l~~~~~~----~l~~l~~L~~L~Ls~N~l~~~~p~~l 297 (1016)
..+++|+.|+|++|.+++. ++..+..+++|+.|+|++|.++..... .+..+++|+.|++++|.+++.....+
T Consensus 162 ~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l 241 (319)
T cd00116 162 RANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAAL 241 (319)
T ss_pred HhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHH
Confidence 6778899999999988853 334556667999999999888755433 34567889999999999886433333
Q ss_pred c-----CCCCCceEeccCCCCCC----CCccccCCCCCCCEEEccCCcCCCCC----Chhh--h-ccCCcccCCCCcC
Q 001768 298 E-----DMTDLKILDLSFNQLTG----PVPGILQNLKKIDYIFLTNNSLSGTL----PDWI--L-TSEKNLDLSYNNF 359 (1016)
Q Consensus 298 ~-----~l~~L~~L~Ls~N~L~~----~~p~~l~~l~~L~~L~L~~N~l~g~~----p~~~--~-~~L~~LdLs~N~l 359 (1016)
. ..+.|++|++++|.++. .+...+..+++|+++++++|.++..- ...+ . +.|+.||+.+|+|
T Consensus 242 ~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 242 ASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF 319 (319)
T ss_pred HHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence 2 24789999999999872 33455667788999999999998552 2222 2 5788899888865
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=4.2e-18 Score=193.70 Aligned_cols=216 Identities=28% Similarity=0.417 Sum_probs=162.6
Q ss_pred HHhcCCCCeeeeeeeEeecceeEEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCe-EeCC
Q 001768 709 ISALQHQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKI-VHRD 787 (1016)
Q Consensus 709 l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~i-iHrD 787 (1016)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+... ...+++.-...++++|++||+|+|+. +| .|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~---~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~ 74 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE---DIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGA 74 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc---ccCccHHHHHHHHHHHHHHHHHHhcC---cceeeee
Confidence 35678999999999999999999999999999999999763 25699999999999999999999987 34 9999
Q ss_pred CCCceEEEccCCceeeeccccccccCCCC-cceeeecccCccccChhhhccC-------CCCCccchhHHHHHHHHHHhC
Q 001768 788 IKATNVLLDKDLNAKISDFGLAKLDEDEN-THISTRIAGTVGYMAPEYAMRG-------YLTDKADVYSFGIVALEIVSG 859 (1016)
Q Consensus 788 lkp~NILl~~~~~~kL~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-------~~~~~sDVwSlGvvl~elltG 859 (1016)
+++.|.++|....+||+|||+........ ........-..-|.|||.+... ..+.+.||||||++++|+++.
T Consensus 75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence 99999999999999999999987654210 0111112234569999998753 147789999999999999999
Q ss_pred CCCCCCCCchhhH-hHHHHHHHHHHhCCcccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCcC
Q 001768 860 KSNTNYRPKEEFV-YLLDWAYVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTA 937 (1016)
Q Consensus 860 ~~P~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 937 (1016)
+.||+........ .++.. ... .......|.+.... +....+..++..||..+|.+||++++|-..++....
T Consensus 155 ~~~~~~~~~~~~~~eii~~---~~~--~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 155 SGPFDLRNLVEDPDEIILR---VKK--GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred cCccccccccCChHHHHHH---HHh--cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 9999863332211 11111 111 11222223222111 334478999999999999999999999988876544
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=4.9e-18 Score=180.42 Aligned_cols=197 Identities=24% Similarity=0.353 Sum_probs=140.8
Q ss_pred CCCCeeeeeeeEee---------------------------cceeEEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHH
Q 001768 713 QHQNLVKLYGCCIE---------------------------GNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRIC 765 (1016)
Q Consensus 713 ~HpnIv~l~~~~~~---------------------------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~ 765 (1016)
+|||||++.++|.+ +..+|+||...+. +|.+++..+. .+.....-|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~-----~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH-----RSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC-----CchHHHHHHH
Confidence 59999999887643 2357999998865 8999996653 6677788899
Q ss_pred HHHHHHHHHHHhcCCCCeEeCCCCCceEEEc--cCC--ceeeeccccccccCCCCc---ce--eeecccCccccChhhhc
Q 001768 766 SDIARGLAYLHEESRLKIVHRDIKATNVLLD--KDL--NAKISDFGLAKLDEDENT---HI--STRIAGTVGYMAPEYAM 836 (1016)
Q Consensus 766 ~qia~~L~yLH~~~~~~iiHrDlkp~NILl~--~~~--~~kL~DFGla~~~~~~~~---~~--~~~~~gt~~y~aPE~~~ 836 (1016)
.|+++|+.|||.+ ||.|||+|.+|||+. +|+ .+.|+|||++-......- +. .-...|...-||||+..
T Consensus 348 aQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 348 AQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 9999999999999 999999999999983 443 478899998753322111 11 11235777899999886
Q ss_pred cCC------CCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCCCCCCHHHHHHHHHH
Q 001768 837 RGY------LTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGSNFSKKEAMTMLNI 910 (1016)
Q Consensus 837 ~~~------~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l 910 (1016)
..+ .-.|+|.|+.|.+.||+++...||........ + ...+.+.--|.+ +..++..+.++
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L----~-------~r~Yqe~qLPal----p~~vpp~~rql 489 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLL----D-------TRTYQESQLPAL----PSRVPPVARQL 489 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhee----c-------hhhhhhhhCCCC----cccCChHHHHH
Confidence 432 23589999999999999999999976332111 0 011112112223 33444568899
Q ss_pred HHHccCCCCCCCCCHHHHHHHhc
Q 001768 911 ALLCTNPSPTLRPTMSSAVSMLE 933 (1016)
Q Consensus 911 i~~cl~~dP~~RPt~~evl~~L~ 933 (1016)
+...++.||.+||+..-....|.
T Consensus 490 V~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 490 VFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHHHhcCCccccCCccHHHhHHH
Confidence 99999999999999875555543
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.7e-17 Score=172.62 Aligned_cols=135 Identities=16% Similarity=0.249 Sum_probs=106.3
Q ss_pred ccCccccCCCeeEEEEEcCCCcEEEEEEccCCChhhhHHHHHHHHHHHhc-----CCCCeeeeeeeEeecc---e-eEEE
Q 001768 663 AANKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGNREFVNEIGMISAL-----QHQNLVKLYGCCIEGN---Q-LLLV 733 (1016)
Q Consensus 663 ~~~~LG~G~~G~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-----~HpnIv~l~~~~~~~~---~-~~lV 733 (1016)
-.+.||+|+||.||. ..+....+||++........+.+.+|+++++.+ .||||++++|++.++. . +.+|
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred CcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 457899999999996 433333479988765444567899999999999 5799999999999863 3 3478
Q ss_pred Eee--cCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHH-HHHHhcCCCCeEeCCCCCceEEEcc----CCceeeecc
Q 001768 734 YEY--LENNSLARALFGKEGQCLNLDWATRKRICSDIARGL-AYLHEESRLKIVHRDIKATNVLLDK----DLNAKISDF 806 (1016)
Q Consensus 734 ~E~--~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L-~yLH~~~~~~iiHrDlkp~NILl~~----~~~~kL~DF 806 (1016)
||| +++++|.+++... .+++. ..++.|++.++ +|||++ +|+||||||+|||++. ++.++|+||
T Consensus 84 ~e~~G~~~~tL~~~l~~~-----~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQC-----RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred ecCCCCcchhHHHHHHcc-----cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 999 5689999999542 25554 35678888887 999999 9999999999999974 347999995
Q ss_pred ccc
Q 001768 807 GLA 809 (1016)
Q Consensus 807 Gla 809 (1016)
+.+
T Consensus 154 ~G~ 156 (210)
T PRK10345 154 IGE 156 (210)
T ss_pred CCC
Confidence 444
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.1e-19 Score=170.21 Aligned_cols=162 Identities=31% Similarity=0.519 Sum_probs=146.9
Q ss_pred eeeEEEEEecCCccCccCccccCCCCCCCEEEccCCCCCCCCchhhhcccCcccccccccccCCCCCcccCCcCCccEEE
Q 001768 84 VCHVTVILLKGFNLAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGDISTLEELV 163 (1016)
Q Consensus 84 ~~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 163 (1016)
..+++.|.|++|.++ .+|+.+..|.+|+.|++++|+|+ .+|.+++++++|+.|+++-|++. ..|..|+.++.|+.||
T Consensus 32 ~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levld 108 (264)
T KOG0617|consen 32 MSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLD 108 (264)
T ss_pred hhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhh
Confidence 347889999999998 56888999999999999999999 78899999999999999999998 8999999999999999
Q ss_pred cccCCCC-CCCCCCCCCCccchhhhccCCccCCCCCcccCCCCCccEEEecCCcCCCCCchhhhcCCCCCEEeecCCcCC
Q 001768 164 LEDNQLV-GPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLE 242 (1016)
Q Consensus 164 Ls~N~l~-~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~ 242 (1016)
|++|++. ..+|..|..|..|+.|+|++|.+. .+|..++.+++|+.|.+..|.+. .+|..++.++.|++|++.+|+++
T Consensus 109 ltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~ 186 (264)
T KOG0617|consen 109 LTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLT 186 (264)
T ss_pred ccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceee
Confidence 9999986 458999999999999999999998 89999999999999999999998 78999999999999999999999
Q ss_pred CCCchhhcC
Q 001768 243 GPIPSTISQ 251 (1016)
Q Consensus 243 ~~~p~~l~~ 251 (1016)
.+|..+++
T Consensus 187 -vlppel~~ 194 (264)
T KOG0617|consen 187 -VLPPELAN 194 (264)
T ss_pred -ecChhhhh
Confidence 55554544
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.73 E-value=2e-17 Score=200.47 Aligned_cols=250 Identities=20% Similarity=0.214 Sum_probs=183.6
Q ss_pred HHHHHHhcCccccCccccCCCeeEEEEEcCCCcEEEEEEccCCChhhhHHHHHHHHHHHhcC---CCCeeeeeeeEeecc
Q 001768 652 RQIKAATNNFDAANKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQ---HQNLVKLYGCCIEGN 728 (1016)
Q Consensus 652 ~~l~~~~~~f~~~~~LG~G~~G~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~---HpnIv~l~~~~~~~~ 728 (1016)
.+.+.-...|.+.+.||+|+||+||+|...+|+.||+|+-+...... |.--.+++.+|+ -+.|..+...+.-.+
T Consensus 691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~ 767 (974)
T KOG1166|consen 691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQN 767 (974)
T ss_pred ceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCC
Confidence 44556677899999999999999999998889999999987765542 222234445554 244555666666677
Q ss_pred eeEEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEcc-------CCce
Q 001768 729 QLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDK-------DLNA 801 (1016)
Q Consensus 729 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~-------~~~~ 801 (1016)
.-+||+||.+.|+|.+++... ..++|..++.++.|+++.+++||.. +|||+||||+|+|+.. ..-+
T Consensus 768 ~S~lv~ey~~~Gtlld~~N~~----~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l 840 (974)
T KOG1166|consen 768 ASVLVSEYSPYGTLLDLINTN----KVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGL 840 (974)
T ss_pred cceeeeeccccccHHHhhccC----CCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccce
Confidence 789999999999999999733 3689999999999999999999998 9999999999999942 3458
Q ss_pred eeeccccccc---cCCCCcceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHH
Q 001768 802 KISDFGLAKL---DEDENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWA 878 (1016)
Q Consensus 802 kL~DFGla~~---~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~ 878 (1016)
+|+|||.+-. +.+. ..-...++|-.+-.+|...+..++..+|.|.++.+++-|+.|+..-
T Consensus 841 ~lIDfG~siDm~lfp~~--~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q--------------- 903 (974)
T KOG1166|consen 841 YLIDFGRSIDMKLFPDG--TKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME--------------- 903 (974)
T ss_pred EEEecccceeeeEcCCC--cEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH---------------
Confidence 9999999853 3332 2334567888999999999999999999999999999999997421
Q ss_pred HHHHHhCCcccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 001768 879 YVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGK 935 (1016)
Q Consensus 879 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 935 (1016)
..+.....++..++..+..+ .+-++...+|+.|-..=|...++...+++.
T Consensus 904 ----~~~g~~~~~~~~~~Ry~~~~---~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~ 953 (974)
T KOG1166|consen 904 ----VKNGSSWMVKTNFPRYWKRD---MWNKFFDLLLNPDCDTLPNLQELRTELEEV 953 (974)
T ss_pred ----hcCCcceeccccchhhhhHH---HHHHHHHHHhCcCcccchhHHHHHHHHHHH
Confidence 01111112222222222222 244566666676666666666776666653
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.70 E-value=7.9e-19 Score=197.67 Aligned_cols=252 Identities=21% Similarity=0.274 Sum_probs=198.8
Q ss_pred eEEEEEecCCccCcc----CccccCCCCCCCEEEccCCCCCC------CCchhhhcccCcccccccccccCCCCCcccCC
Q 001768 86 HVTVILLKGFNLAGV----IPEEFGNLTFLQEVDLSRNYFNG------SLPKSFARLQNLTKLLILGNRLSGSIPLEIGD 155 (1016)
Q Consensus 86 ~v~~L~L~~~~l~~~----~~~~l~~l~~L~~L~Ls~n~i~~------~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 155 (1016)
+++.|++.++.++.. ++..+...+.|++|+++++.+.+ .++..+..+++|+.|+|++|.+.+..+..+..
T Consensus 24 ~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~ 103 (319)
T cd00116 24 CLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLES 103 (319)
T ss_pred hccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHHHHHH
Confidence 489999999998543 56677888999999999998873 24456788899999999999998767777766
Q ss_pred cCC---ccEEEcccCCCCC----CCCCCCCCC-ccchhhhccCCccCCC----CCcccCCCCCccEEEecCCcCCCC---
Q 001768 156 IST---LEELVLEDNQLVG----PLPENLGNL-KSLRRILLSSNNFTGS----IPESYGNLKNLTEFRIDGSNLTGR--- 220 (1016)
Q Consensus 156 l~~---L~~L~Ls~N~l~~----~~p~~l~~l-~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~--- 220 (1016)
+.+ |++|++++|++++ .+...+..+ ++|+.|+|++|.+++. ++..+..+++|++|+|++|.+++.
T Consensus 104 l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~ 183 (319)
T cd00116 104 LLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIR 183 (319)
T ss_pred HhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHH
Confidence 665 9999999999873 223345566 8999999999999843 344567778999999999999853
Q ss_pred -CchhhhcCCCCCEEeecCCcCCCCC----chhhcCCCCCCEEEcCCCCCCCCCCccccc-----ccccceeeccccccc
Q 001768 221 -IPNFIGNWTKLDRLDLQGTSLEGPI----PSTISQLKNLTELRISDLKGSSSSFPNLQD-----MKKMERLILRNCLIT 290 (1016)
Q Consensus 221 -~~~~l~~l~~L~~L~Ls~N~l~~~~----p~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~-----l~~L~~L~Ls~N~l~ 290 (1016)
++..+..+++|+.|+|++|.+++.. +..+..+++|+.|++++|.++......+.. .++|+.|++++|.++
T Consensus 184 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~ 263 (319)
T cd00116 184 ALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDIT 263 (319)
T ss_pred HHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCC
Confidence 3345566789999999999998543 455677899999999999988654444332 379999999999997
Q ss_pred c----cCchhhcCCCCCceEeccCCCCCCC----CccccCCC-CCCCEEEccCCcC
Q 001768 291 G----RIPEYIEDMTDLKILDLSFNQLTGP----VPGILQNL-KKIDYIFLTNNSL 337 (1016)
Q Consensus 291 ~----~~p~~l~~l~~L~~L~Ls~N~L~~~----~p~~l~~l-~~L~~L~L~~N~l 337 (1016)
+ .+...+..+++|++|++++|.++.. ....+... +.|+.|++.+|++
T Consensus 264 ~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 264 DDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF 319 (319)
T ss_pred cHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence 3 3445677789999999999999965 44455555 7899999999875
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.70 E-value=9.5e-17 Score=171.25 Aligned_cols=141 Identities=19% Similarity=0.174 Sum_probs=111.0
Q ss_pred CccccCccccCCCeeEEEEE--cCCCcEEEEEEccCCChh------------------------hhHHHHHHHHHHHhcC
Q 001768 660 NFDAANKIGEGGFGPVYKGT--LSDGAVIAVKQLSSKSKQ------------------------GNREFVNEIGMISALQ 713 (1016)
Q Consensus 660 ~f~~~~~LG~G~~G~Vy~~~--~~~~~~vAvK~~~~~~~~------------------------~~~~~~~E~~~l~~l~ 713 (1016)
-|++.+.||+|+||.||+|. ..+|+.||+|++...... ....+..|++++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47788999999999999998 568999999998643210 1123568999999997
Q ss_pred CCC--eeeeeeeEeecceeEEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCC-eEeCCCCC
Q 001768 714 HQN--LVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLK-IVHRDIKA 790 (1016)
Q Consensus 714 Hpn--Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~-iiHrDlkp 790 (1016)
+.+ +++++++ ...++||||+++.+|....... ..+...++..++.|++.++++||+. + |+||||||
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp 177 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD----VEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSE 177 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccccc----CCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCCh
Confidence 533 3444443 2358999999998887654222 2356667789999999999999998 8 99999999
Q ss_pred ceEEEccCCceeeecccccccc
Q 001768 791 TNVLLDKDLNAKISDFGLAKLD 812 (1016)
Q Consensus 791 ~NILl~~~~~~kL~DFGla~~~ 812 (1016)
+||+++ ++.++|+|||.+...
T Consensus 178 ~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 178 YNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred hhEEEE-CCCEEEEEChhhhcc
Confidence 999999 889999999998743
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.67 E-value=9.6e-17 Score=189.97 Aligned_cols=215 Identities=23% Similarity=0.303 Sum_probs=149.8
Q ss_pred hcCccccCccccCCCeeEEEEEcCC-CcEEEEEEccCCChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEee
Q 001768 658 TNNFDAANKIGEGGFGPVYKGTLSD-GAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEY 736 (1016)
Q Consensus 658 ~~~f~~~~~LG~G~~G~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 736 (1016)
..+|+.++.|..|+||.||.++++. .+.+|.|+ .+..- -+.+ ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~l----ilRn---ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNL----ILRN---ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcc-cccch----hhhc---cccccCCccee------------------
Confidence 4678899999999999999998764 56778743 22211 0011 22223334333
Q ss_pred cCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCC
Q 001768 737 LENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDEN 816 (1016)
Q Consensus 737 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 816 (1016)
|+-...++... +++. +++.+++|||+. +|+|||+||+|.+++.-|++|+.|||+++......
T Consensus 136 ---gDc~tllk~~g----~lPv--------dmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~ 197 (1205)
T KOG0606|consen 136 ---GDCATLLKNIG----PLPV--------DMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSL 197 (1205)
T ss_pred ---chhhhhcccCC----CCcc--------hhhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhc
Confidence 33333332221 2332 237899999999 99999999999999999999999999986432111
Q ss_pred --------------cceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHH
Q 001768 817 --------------THISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQ 882 (1016)
Q Consensus 817 --------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~ 882 (1016)
......++||+.|+|||++....|...+|.|++|+++||.+-|+.||+++.+++....+ ..
T Consensus 198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~v-----is 272 (1205)
T KOG0606|consen 198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV-----IS 272 (1205)
T ss_pred cchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhh-----hh
Confidence 01134468999999999999999999999999999999999999999998888754321 12
Q ss_pred HhCCcccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 883 EQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 883 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
+...+.|- |. ....+.++++.+.|+.+|..|--....++
T Consensus 273 d~i~wpE~-de--------a~p~Ea~dli~~LL~qnp~~Rlgt~ga~e 311 (1205)
T KOG0606|consen 273 DDIEWPEE-DE--------ALPPEAQDLIEQLLRQNPLCRLGTGGALE 311 (1205)
T ss_pred hhcccccc-Cc--------CCCHHHHHHHHHHHHhChHhhcccchhhh
Confidence 22222222 11 22346888999999999999985554443
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.67 E-value=4e-16 Score=164.54 Aligned_cols=134 Identities=21% Similarity=0.328 Sum_probs=113.9
Q ss_pred CccccCCCeeEEEEEcCCCcEEEEEEccCCChh--------hhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEee
Q 001768 665 NKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQ--------GNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEY 736 (1016)
Q Consensus 665 ~~LG~G~~G~Vy~~~~~~~~~vAvK~~~~~~~~--------~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 736 (1016)
+.||+|++|.||+|.+ +|..|++|+....... ....+.+|++++..++|++++....++...+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 6799999999999987 5678899986543211 124578899999999999998888887777888999999
Q ss_pred cCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccc
Q 001768 737 LENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKL 811 (1016)
Q Consensus 737 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~ 811 (1016)
++|++|.+.+.... + ++..++.+++.+|.++|+. +++|||++|.||+++ ++.++|+|||.+..
T Consensus 81 ~~G~~L~~~~~~~~-------~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG-------M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc-------H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999985321 2 7889999999999999998 999999999999999 78899999999874
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.67 E-value=4.5e-16 Score=162.42 Aligned_cols=145 Identities=21% Similarity=0.224 Sum_probs=113.4
Q ss_pred HHHHHHhcCccccCccccCCCeeEEEEEcCCCcEEEEEEccCCCh----------------------hhhHHHHHHHHHH
Q 001768 652 RQIKAATNNFDAANKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSK----------------------QGNREFVNEIGMI 709 (1016)
Q Consensus 652 ~~l~~~~~~f~~~~~LG~G~~G~Vy~~~~~~~~~vAvK~~~~~~~----------------------~~~~~~~~E~~~l 709 (1016)
+++......|.+.+.||+|+||.||++...+|+.||||++..... .....+..|+.++
T Consensus 8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 87 (198)
T cd05144 8 HTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL 87 (198)
T ss_pred HHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence 344444555888999999999999999988899999998654220 0112356789999
Q ss_pred HhcCCCC--eeeeeeeEeecceeEEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCC
Q 001768 710 SALQHQN--LVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRD 787 (1016)
Q Consensus 710 ~~l~Hpn--Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrD 787 (1016)
..+.|++ +++.++ ....++||||+++++|...... .....++.+++.++.++|+. +|+|||
T Consensus 88 ~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~---gi~H~D 150 (198)
T cd05144 88 KALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKH---GIIHGD 150 (198)
T ss_pred HHHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHC---CCCcCC
Confidence 9998874 444443 2456899999999998765421 23567899999999999998 999999
Q ss_pred CCCceEEEccCCceeeeccccccccC
Q 001768 788 IKATNVLLDKDLNAKISDFGLAKLDE 813 (1016)
Q Consensus 788 lkp~NILl~~~~~~kL~DFGla~~~~ 813 (1016)
|||+||++++++.++|+|||.+....
T Consensus 151 l~p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 151 LSEFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred CCcccEEEcCCCcEEEEECCccccCC
Confidence 99999999999999999999996443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.66 E-value=3.6e-18 Score=161.89 Aligned_cols=178 Identities=25% Similarity=0.438 Sum_probs=104.0
Q ss_pred CcCCccEEEcccCCCCCCCCCCCCCCccchhhhccCCccCCCCCcccCCCCCccEEEecCCcCCCCCchhhhcCCCCCEE
Q 001768 155 DISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRL 234 (1016)
Q Consensus 155 ~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L 234 (1016)
++.+.+.|.||+|+++ .+|+.++.+.+|+.|++++|+|+ .+|..++++++|+.|+++-|++. .+|..|+.++.|+.|
T Consensus 31 ~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levl 107 (264)
T KOG0617|consen 31 NMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVL 107 (264)
T ss_pred chhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhh
Confidence 4556666667777776 56666667777777777777766 56666666666666666666665 556666666666666
Q ss_pred eecCCcCCC-CCchhhcCCCCCCEEEcCCCCCCCCCCcccccccccceeecccccccccCchhhcCCCCCceEeccCCCC
Q 001768 235 DLQGTSLEG-PIPSTISQLKNLTELRISDLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQL 313 (1016)
Q Consensus 235 ~Ls~N~l~~-~~p~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~L 313 (1016)
||.+|++.. .+|..|. .+..|+.|.|++|.+. .+|..++++++|+.|.+..|.+
T Consensus 108 dltynnl~e~~lpgnff------------------------~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndl 162 (264)
T KOG0617|consen 108 DLTYNNLNENSLPGNFF------------------------YMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDL 162 (264)
T ss_pred hccccccccccCCcchh------------------------HHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCch
Confidence 666665542 2344444 4455555555555555 4555555556666666655555
Q ss_pred CCCCccccCCCCCCCEEEccCCcCCCCCChhh-----hccCCcccCCCCcCCCC
Q 001768 314 TGPVPGILQNLKKIDYIFLTNNSLSGTLPDWI-----LTSEKNLDLSYNNFTES 362 (1016)
Q Consensus 314 ~~~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~-----~~~L~~LdLs~N~l~~~ 362 (1016)
- .+|..++.+..|+.|.+.+|+++ .+|.++ ..+-+.+.+.+|++...
T Consensus 163 l-~lpkeig~lt~lrelhiqgnrl~-vlppel~~l~l~~~k~v~r~E~NPwv~p 214 (264)
T KOG0617|consen 163 L-SLPKEIGDLTRLRELHIQGNRLT-VLPPELANLDLVGNKQVMRMEENPWVNP 214 (264)
T ss_pred h-hCcHHHHHHHHHHHHhcccceee-ecChhhhhhhhhhhHHHHhhhhCCCCCh
Confidence 5 55555555556666666666655 344333 12223455555655433
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.66 E-value=9e-16 Score=184.40 Aligned_cols=139 Identities=19% Similarity=0.287 Sum_probs=113.1
Q ss_pred HHhcCccccCccccCCCeeEEEEEcCCCcEEEEEE-ccCC-C------hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeec
Q 001768 656 AATNNFDAANKIGEGGFGPVYKGTLSDGAVIAVKQ-LSSK-S------KQGNREFVNEIGMISALQHQNLVKLYGCCIEG 727 (1016)
Q Consensus 656 ~~~~~f~~~~~LG~G~~G~Vy~~~~~~~~~vAvK~-~~~~-~------~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 727 (1016)
.....|...+.||+|+||.||+|.+.+.. +++|+ .... . ....+.+.+|+++++.++|++++....++...
T Consensus 330 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~ 408 (535)
T PRK09605 330 EVKRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP 408 (535)
T ss_pred ccccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC
Confidence 33455667899999999999999876544 33333 2211 1 11235688999999999999999888888777
Q ss_pred ceeEEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccc
Q 001768 728 NQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFG 807 (1016)
Q Consensus 728 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG 807 (1016)
...++||||+++++|.+++. ....++.|++++|.|||+. +++||||||+|||+ +++.++|+|||
T Consensus 409 ~~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFG 472 (535)
T PRK09605 409 EEKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFG 472 (535)
T ss_pred CCCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCc
Confidence 78899999999999999874 3567999999999999998 99999999999999 67899999999
Q ss_pred cccc
Q 001768 808 LAKL 811 (1016)
Q Consensus 808 la~~ 811 (1016)
+++.
T Consensus 473 la~~ 476 (535)
T PRK09605 473 LGKY 476 (535)
T ss_pred cccc
Confidence 9974
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.66 E-value=7.3e-16 Score=161.01 Aligned_cols=130 Identities=24% Similarity=0.349 Sum_probs=107.4
Q ss_pred ccccCCCeeEEEEEcCCCcEEEEEEccCCCh--------hhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEeec
Q 001768 666 KIGEGGFGPVYKGTLSDGAVIAVKQLSSKSK--------QGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYL 737 (1016)
Q Consensus 666 ~LG~G~~G~Vy~~~~~~~~~vAvK~~~~~~~--------~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 737 (1016)
.||+|+||.||+|.+ ++..|++|....... ....++.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999996 567899998654321 11356778999999999988766666666677789999999
Q ss_pred CCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccc
Q 001768 738 ENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKL 811 (1016)
Q Consensus 738 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~ 811 (1016)
+|++|.+.+.... ..++.+++.+|.+||+. +++|||++|.||+++ ++.++++|||++..
T Consensus 80 ~g~~l~~~~~~~~-----------~~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN-----------DELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH-----------HHHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999998874321 07899999999999998 999999999999999 88999999999874
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.65 E-value=6e-17 Score=180.27 Aligned_cols=173 Identities=23% Similarity=0.377 Sum_probs=128.4
Q ss_pred eeEEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeecccc
Q 001768 729 QLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGL 808 (1016)
Q Consensus 729 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGl 808 (1016)
.+++.|++|+..+|.++|.+++.. ...++.....++.|++.|++| + +.+|||+||.||++..+..+||+|||+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~-e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTG-EERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcc-cccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhh
Confidence 579999999999999999755432 357888999999999999999 5 899999999999999999999999999
Q ss_pred ccccCCCC-----cceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHh-CCCCCCCCCchhhHhHHHHHHHHH
Q 001768 809 AKLDEDEN-----THISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWAYVLQ 882 (1016)
Q Consensus 809 a~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~ 882 (1016)
........ ....+.-.||..||+||.+.+..|+.|+||||||++|+|++. -..++. .
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e-----r------------ 465 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE-----R------------ 465 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH-----H------------
Confidence 87554443 122345679999999999999999999999999999999986 111110 0
Q ss_pred HhCCcccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 001768 883 EQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSS 927 (1016)
Q Consensus 883 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 927 (1016)
...+.++-+..+++.+..+.+ .-..++.+++...|.+||++.+
T Consensus 466 -~~t~~d~r~g~ip~~~~~d~p-~e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 466 -IATLTDIRDGIIPPEFLQDYP-EEYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred -HHhhhhhhcCCCChHHhhcCc-HHHHHHHHhcCCCcccCchHHH
Confidence 001111112222111111111 2356889999999999995443
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.56 E-value=2.8e-14 Score=141.18 Aligned_cols=135 Identities=21% Similarity=0.257 Sum_probs=114.6
Q ss_pred ccCccccCCCeeEEEEEcCCCcEEEEEEccCCChhhhHHHHHHHHHHHhcCC--CCeeeeeeeEeecceeEEEEeecCCC
Q 001768 663 AANKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQH--QNLVKLYGCCIEGNQLLLVYEYLENN 740 (1016)
Q Consensus 663 ~~~~LG~G~~G~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H--pnIv~l~~~~~~~~~~~lV~E~~~~g 740 (1016)
+.+.||+|.++.||++...+ ..+++|....... ...+.+|+..++.++| .++++++++...++..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 45789999999999999854 7899999865543 4578899999999976 58999999888888899999999887
Q ss_pred cHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccc
Q 001768 741 SLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKL 811 (1016)
Q Consensus 741 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~ 811 (1016)
.+..+ +......++.+++++++++|.....+++|+|++|+||++++.+.+++.|||.+..
T Consensus 79 ~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 66433 4566778899999999999986444799999999999999989999999999873
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.55 E-value=2.1e-14 Score=148.42 Aligned_cols=136 Identities=22% Similarity=0.255 Sum_probs=98.0
Q ss_pred cCccccCCCeeEEEEEcCCCcEEEEEEccCCChh--hhHH----------------------HHHHHHHHHhcCCCC--e
Q 001768 664 ANKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQ--GNRE----------------------FVNEIGMISALQHQN--L 717 (1016)
Q Consensus 664 ~~~LG~G~~G~Vy~~~~~~~~~vAvK~~~~~~~~--~~~~----------------------~~~E~~~l~~l~Hpn--I 717 (1016)
.+.||+|+||.||+|...+++.||||++...... .... ...|.+.+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 5789999999999999888999999988653211 1111 134566666664433 4
Q ss_pred eeeeeeEeecceeEEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeCCCCCceEEEc
Q 001768 718 VKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHE-ESRLKIVHRDIKATNVLLD 796 (1016)
Q Consensus 718 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~-~~~~~iiHrDlkp~NILl~ 796 (1016)
.+.+++ ...++||||++++.+........ ... .++..++.+++.++.++|. . +|+||||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~----~~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~ 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV----RLL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhh----hhc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE
Confidence 444443 24589999999954322111110 011 5678999999999999998 6 899999999999999
Q ss_pred cCCceeeecccccccc
Q 001768 797 KDLNAKISDFGLAKLD 812 (1016)
Q Consensus 797 ~~~~~kL~DFGla~~~ 812 (1016)
++.++|+|||.+...
T Consensus 150 -~~~~~liDfg~a~~~ 164 (187)
T cd05119 150 -DGKVYIIDVPQAVEI 164 (187)
T ss_pred -CCcEEEEECcccccc
Confidence 899999999999743
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.2e-13 Score=147.65 Aligned_cols=135 Identities=20% Similarity=0.260 Sum_probs=105.1
Q ss_pred cCccc-cCCCeeEEEEEcCCCcEEEEEEccCCC-------------hhhhHHHHHHHHHHHhcCCCCe--eeeeeeEeec
Q 001768 664 ANKIG-EGGFGPVYKGTLSDGAVIAVKQLSSKS-------------KQGNREFVNEIGMISALQHQNL--VKLYGCCIEG 727 (1016)
Q Consensus 664 ~~~LG-~G~~G~Vy~~~~~~~~~vAvK~~~~~~-------------~~~~~~~~~E~~~l~~l~HpnI--v~l~~~~~~~ 727 (1016)
...|| .||.|+||.+... +..++||.+.... ......+.+|++++..++|+++ ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35687 8999999999875 6778998875321 1223467889999999998885 6777765433
Q ss_pred c----eeEEEEeecCC-CcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCcee
Q 001768 728 N----QLLLVYEYLEN-NSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAK 802 (1016)
Q Consensus 728 ~----~~~lV~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~k 802 (1016)
. ..++||||+++ .+|.+++... .++.. .+.+++.++.+||+. ||+||||||.|||++.++.++
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~-----~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~ 182 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA-----PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFW 182 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC-----CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEE
Confidence 2 23599999997 6899887532 34443 367899999999998 999999999999999999999
Q ss_pred eeccccccc
Q 001768 803 ISDFGLAKL 811 (1016)
Q Consensus 803 L~DFGla~~ 811 (1016)
|+|||.+..
T Consensus 183 LIDfg~~~~ 191 (239)
T PRK01723 183 LIDFDRGEL 191 (239)
T ss_pred EEECCCccc
Confidence 999998874
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.50 E-value=3.8e-15 Score=178.02 Aligned_cols=252 Identities=23% Similarity=0.299 Sum_probs=188.9
Q ss_pred hcCccccCccccCCCeeEEEEEcC--CCcEEEEEEccCCC--hhhhHHHHHHHHHHHhcC-CCCeeeeeeeEeecceeEE
Q 001768 658 TNNFDAANKIGEGGFGPVYKGTLS--DGAVIAVKQLSSKS--KQGNREFVNEIGMISALQ-HQNLVKLYGCCIEGNQLLL 732 (1016)
Q Consensus 658 ~~~f~~~~~LG~G~~G~Vy~~~~~--~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~l 732 (1016)
...|.+.+.||+|+|+.|-..... ....+|+|.+.... .........|..+-+.+. |+|++++++...+.+..++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 345777888999999999888753 34566777765443 233344555777777776 9999999999999999999
Q ss_pred EEeecCCCcHHHHhc-cCcCcCcCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeEeCCCCCceEEEccCC-ceeeeccccc
Q 001768 733 VYEYLENNSLARALF-GKEGQCLNLDWATRKRICSDIARGLAYLH-EESRLKIVHRDIKATNVLLDKDL-NAKISDFGLA 809 (1016)
Q Consensus 733 V~E~~~~gsL~~~l~-~~~~~~~~l~~~~~~~i~~qia~~L~yLH-~~~~~~iiHrDlkp~NILl~~~~-~~kL~DFGla 809 (1016)
++||..++++.+-+. ... ...+...+-.++.|+..++.|+| +. ++.|||+||+|.+++..+ ..+++|||+|
T Consensus 99 ~~~~s~g~~~f~~i~~~~~---~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~A 172 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDS---TGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLA 172 (601)
T ss_pred ccCcccccccccccccCCc---cCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhh
Confidence 999999999988883 222 14566677889999999999999 76 899999999999999999 9999999999
Q ss_pred cccCC--CCcceeeeccc-CccccChhhhcc-CCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhC
Q 001768 810 KLDED--ENTHISTRIAG-TVGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQG 885 (1016)
Q Consensus 810 ~~~~~--~~~~~~~~~~g-t~~y~aPE~~~~-~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 885 (1016)
..+.. ..........| ++.|+|||...+ ....+..|+||.|+++.-+++|..|+.........+
T Consensus 173 t~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~------------ 240 (601)
T KOG0590|consen 173 TAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY------------ 240 (601)
T ss_pred ccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccc------------
Confidence 86655 33333445678 999999999887 466788999999999999999999987544333111
Q ss_pred CcccccCCcC--CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 001768 886 NLLELVDPSL--GSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAV 929 (1016)
Q Consensus 886 ~~~~~~d~~l--~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 929 (1016)
........ .............+++.+++..+|..|.+.+++.
T Consensus 241 --~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 241 --SSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred --eeecccccccccCccccCChhhhhcccccccCCchhcccccccc
Confidence 11111100 0111122233567788899999999999987655
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.1e-13 Score=168.23 Aligned_cols=155 Identities=27% Similarity=0.399 Sum_probs=123.5
Q ss_pred CCChhHHHHHHHHHHHcCCCCCCccCCCCCCCCCcccCCCC-----CCCCceeccCCCCCceeeEEEEEecCCccCccCc
Q 001768 28 RLPDDEVQTLQSIFRKLNFRNGQVNQTSCTEGSWNVTIDDS-----NGSNFTCDCTYSNNTVCHVTVILLKGFNLAGVIP 102 (1016)
Q Consensus 28 ~~~~~~~~al~~~~~~l~~~~~~~~~~~~~~~sW~~~~~~c-----~~~~v~c~~~~~~~~~~~v~~L~L~~~~l~~~~~ 102 (1016)
...+.|.+||..+|+.++.. . ..+|+. ++| .|.|+.|..... .....++.|+|++|++.|.+|
T Consensus 368 ~t~~~~~~aL~~~k~~~~~~-------~--~~~W~g--~~C~p~~~~w~Gv~C~~~~~-~~~~~v~~L~L~~n~L~g~ip 435 (623)
T PLN03150 368 KTLLEEVSALQTLKSSLGLP-------L--RFGWNG--DPCVPQQHPWSGADCQFDST-KGKWFIDGLGLDNQGLRGFIP 435 (623)
T ss_pred ccCchHHHHHHHHHHhcCCc-------c--cCCCCC--CCCCCcccccccceeeccCC-CCceEEEEEECCCCCccccCC
Confidence 45778999999999887621 1 137853 445 699999964211 112368899999999999999
Q ss_pred cccCCCCCCCEEEccCCCCCCCCchhhhcccCcccccccccccCCCCCcccCCcCCccEEEcccCCCCCCCCCCCCCC-c
Q 001768 103 EEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGDISTLEELVLEDNQLVGPLPENLGNL-K 181 (1016)
Q Consensus 103 ~~l~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l-~ 181 (1016)
..++.|++|+.|+|++|.++|.+|..++.+++|+.|+|++|+++|.+|..++++++|+.|+|++|+++|.+|..+..+ .
T Consensus 436 ~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~ 515 (623)
T PLN03150 436 NDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLL 515 (623)
T ss_pred HHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccc
Confidence 999999999999999999999999999999999999999999999999999999999999999999998888877653 3
Q ss_pred cchhhhccCCccC
Q 001768 182 SLRRILLSSNNFT 194 (1016)
Q Consensus 182 ~L~~L~Ls~N~l~ 194 (1016)
++..+++.+|...
T Consensus 516 ~~~~l~~~~N~~l 528 (623)
T PLN03150 516 HRASFNFTDNAGL 528 (623)
T ss_pred cCceEEecCCccc
Confidence 4556666666543
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.37 E-value=2.4e-12 Score=149.67 Aligned_cols=141 Identities=21% Similarity=0.254 Sum_probs=100.8
Q ss_pred cCccccCCCeeEEEEEcCCCcEEEEEEccCCChhhh----------------------------------------HHHH
Q 001768 664 ANKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGN----------------------------------------REFV 703 (1016)
Q Consensus 664 ~~~LG~G~~G~Vy~~~~~~~~~vAvK~~~~~~~~~~----------------------------------------~~~~ 703 (1016)
.+.||.|++|.||+|++.+|+.||||+.++...... -+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 368999999999999999999999999875421110 0244
Q ss_pred HHHHHHHhcC----CCCeeeeeeeE-eecceeEEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHH-HHHHHHh
Q 001768 704 NEIGMISALQ----HQNLVKLYGCC-IEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIAR-GLAYLHE 777 (1016)
Q Consensus 704 ~E~~~l~~l~----HpnIv~l~~~~-~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~-~L~yLH~ 777 (1016)
+|++.+.+++ |.+-+.+-.++ ......+|||||++|++|.+....... .. .+.+++.+++. .+..+|.
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~---~~---~~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA---GL---DRKALAENLARSFLNQVLR 275 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc---CC---CHHHHHHHHHHHHHHHHHh
Confidence 5666555552 22223322222 223457999999999999887643211 12 24567777766 4788898
Q ss_pred cCCCCeEeCCCCCceEEEccCCceeeeccccccccC
Q 001768 778 ESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDE 813 (1016)
Q Consensus 778 ~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~ 813 (1016)
. |++|+|+||.||+++.+++++++|||++....
T Consensus 276 ~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 276 D---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred C---CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 7 99999999999999999999999999987544
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.35 E-value=8.9e-14 Score=154.80 Aligned_cols=169 Identities=25% Similarity=0.384 Sum_probs=98.7
Q ss_pred EEEcccCCCCCCCCCCCCCCccchhhhccCCccCCCCCcccCCCCCccEEEecCCcCCCCCchhhhcCCCCCEEeecCCc
Q 001768 161 ELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTS 240 (1016)
Q Consensus 161 ~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~ 240 (1016)
..||+.|++. ++|..+..+..|+.|.|+.|.+. .+|..++++..|++|+|+.|+++ .+|..++.|+ |+.|-+++|+
T Consensus 79 ~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNk 154 (722)
T KOG0532|consen 79 FADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNK 154 (722)
T ss_pred hhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEecCc
Confidence 3344444444 44444444444444444444444 44444444444444444444444 3444444442 5555555555
Q ss_pred CCCCCchhhcCCCCCCEEEcCCCCCCCCCCcccccccccceeecccccccccCchhhcCCCCCceEeccCCCCCCCCccc
Q 001768 241 LEGPIPSTISQLKNLTELRISDLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGI 320 (1016)
Q Consensus 241 l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~L~~~~p~~ 320 (1016)
++ .+|..++.+..|..|+.+.|.+..+. ..++.+.+|+.|.+..|++. .+|..+..| .|..||+|.|++. .+|..
T Consensus 155 l~-~lp~~ig~~~tl~~ld~s~nei~slp-sql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis-~iPv~ 229 (722)
T KOG0532|consen 155 LT-SLPEEIGLLPTLAHLDVSKNEIQSLP-SQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKIS-YLPVD 229 (722)
T ss_pred cc-cCCcccccchhHHHhhhhhhhhhhch-HHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCcee-ecchh
Confidence 55 44444554455555555555544432 23555666777777788877 566666655 4888888888888 78888
Q ss_pred cCCCCCCCEEEccCCcCC
Q 001768 321 LQNLKKIDYIFLTNNSLS 338 (1016)
Q Consensus 321 l~~l~~L~~L~L~~N~l~ 338 (1016)
|..|..|++|-|.+|+|.
T Consensus 230 fr~m~~Lq~l~LenNPLq 247 (722)
T KOG0532|consen 230 FRKMRHLQVLQLENNPLQ 247 (722)
T ss_pred hhhhhhheeeeeccCCCC
Confidence 888888888888888887
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.35 E-value=6.4e-14 Score=155.93 Aligned_cols=196 Identities=29% Similarity=0.457 Sum_probs=135.0
Q ss_pred CCCCCCEEEccCCCCCCCCchhhhcccCcccccccccccCCCCCcccCCcCCccEEEcccCCCCCCCCCCCCCCccchhh
Q 001768 107 NLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRI 186 (1016)
Q Consensus 107 ~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L 186 (1016)
.|+.-...||+.|++. .+|..+..+-.|..|.|..|.+. .+|..+.++..|++|||+.|+++ .+|..++.|+ |+.|
T Consensus 73 ~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvl 148 (722)
T KOG0532|consen 73 DLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVL 148 (722)
T ss_pred cccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeE
Confidence 4555566677777777 66767777777777777777776 66777777777777777777776 6666666554 6777
Q ss_pred hccCCccCCCCCcccCCCCCccEEEecCCcCCCCCchhhhcCCCCCEEeecCCcCCCCCchhhcCCCCCCEEEcCCCCCC
Q 001768 187 LLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISDLKGS 266 (1016)
Q Consensus 187 ~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~n~l~ 266 (1016)
.+++|+++ .+|+.++.+..|..|+.+.|.+. .+|..++.+.+|+.|.+..|++. .+|..+..|
T Consensus 149 i~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-------------- 211 (722)
T KOG0532|consen 149 IVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-------------- 211 (722)
T ss_pred EEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC--------------
Confidence 77777776 66666666667777777777766 55666666677777777777666 344444332
Q ss_pred CCCCcccccccccceeecccccccccCchhhcCCCCCceEeccCCCCCCCCccccCCCC---CCCEEEccCCc
Q 001768 267 SSSFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLK---KIDYIFLTNNS 336 (1016)
Q Consensus 267 ~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~L~~~~p~~l~~l~---~L~~L~L~~N~ 336 (1016)
.|..||+++|+++ .+|..|.+|+.|++|-|.+|.|+ ..|..+.... -.++|+...++
T Consensus 212 -----------pLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC~kGkVHIFKyL~~qA~q 271 (722)
T KOG0532|consen 212 -----------PLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQICEKGKVHIFKYLSTQACQ 271 (722)
T ss_pred -----------ceeeeecccCcee-ecchhhhhhhhheeeeeccCCCC-CChHHHHhccceeeeeeecchhcc
Confidence 3566788888888 78888999999999999999998 6666554322 24455555553
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.31 E-value=1.8e-12 Score=150.47 Aligned_cols=200 Identities=33% Similarity=0.469 Sum_probs=146.6
Q ss_pred EEEccCCCCCCCCchhhhcccCcccccccccccCCCCCcccCCcC-CccEEEcccCCCCCCCCCCCCCCccchhhhccCC
Q 001768 113 EVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGDIS-TLEELVLEDNQLVGPLPENLGNLKSLRRILLSSN 191 (1016)
Q Consensus 113 ~L~Ls~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N 191 (1016)
.|++..|.+.. ....+..++.++.|++.+|.++ .++.....++ +|+.|++++|++. .+|..+..+++|+.|++++|
T Consensus 97 ~l~~~~~~~~~-~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLRS-NISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeecccccccc-CchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence 57777777642 2334666677888888888887 6676776774 8888888888887 56566778888888888888
Q ss_pred ccCCCCCcccCCCCCccEEEecCCcCCCCCchhhhcCCCCCEEeecCCcCCCCCchhhcCCCCCCEEEcCCCCCCCCCCc
Q 001768 192 NFTGSIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISDLKGSSSSFP 271 (1016)
Q Consensus 192 ~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~~ 271 (1016)
+++ .+|...+.+++|+.|++++|++. .+|..+..+..|++|.+++|++. ..+..+..+.++..|.+.+|++... ..
T Consensus 174 ~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~~-~~ 249 (394)
T COG4886 174 DLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLEDL-PE 249 (394)
T ss_pred hhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceeeec-cc
Confidence 887 56655557788888888888887 56665555666888888888544 3556677788888888777777654 34
Q ss_pred ccccccccceeecccccccccCchhhcCCCCCceEeccCCCCCCCCcccc
Q 001768 272 NLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGIL 321 (1016)
Q Consensus 272 ~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~L~~~~p~~l 321 (1016)
.+..+++|++|++++|.++.. +. ++.+.+|+.|++++|.+....|...
T Consensus 250 ~~~~l~~l~~L~~s~n~i~~i-~~-~~~~~~l~~L~~s~n~~~~~~~~~~ 297 (394)
T COG4886 250 SIGNLSNLETLDLSNNQISSI-SS-LGSLTNLRELDLSGNSLSNALPLIA 297 (394)
T ss_pred hhccccccceecccccccccc-cc-ccccCccCEEeccCccccccchhhh
Confidence 466777788888888888843 33 8888888888888888886666443
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.29 E-value=3.8e-12 Score=145.32 Aligned_cols=248 Identities=23% Similarity=0.274 Sum_probs=182.0
Q ss_pred cCccccCcccc--CCCeeEEEEEc---CCCcEEEEEEccCCC--hhhhHHHHHHHHHHHhc-CCCCeeeeeeeEeeccee
Q 001768 659 NNFDAANKIGE--GGFGPVYKGTL---SDGAVIAVKQLSSKS--KQGNREFVNEIGMISAL-QHQNLVKLYGCCIEGNQL 730 (1016)
Q Consensus 659 ~~f~~~~~LG~--G~~G~Vy~~~~---~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~ 730 (1016)
..|.+.+.+|. |.+|.||.+.. .++..+|+|+-+... ......=.+|+....++ .|+|.++.+..+...+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 45667889999 99999999986 367889999854332 22233334566666666 499999999999999999
Q ss_pred EEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHH----HHHHHHhcCCCCeEeCCCCCceEEEccC-Cceeeec
Q 001768 731 LLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIAR----GLAYLHEESRLKIVHRDIKATNVLLDKD-LNAKISD 805 (1016)
Q Consensus 731 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~----~L~yLH~~~~~~iiHrDlkp~NILl~~~-~~~kL~D 805 (1016)
++-+|++. .+|..+.+... ..++....+.+..+... ||.++|+. +++|-|+||.||+...+ ...+++|
T Consensus 194 fiqtE~~~-~sl~~~~~~~~---~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~d 266 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHTPC---NFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTD 266 (524)
T ss_pred eeeecccc-chhHHhhhccc---ccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCC
Confidence 99999985 67888775543 34778888889999999 99999998 99999999999999999 8899999
Q ss_pred cccccccCCCCcc----eeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHH
Q 001768 806 FGLAKLDEDENTH----ISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVL 881 (1016)
Q Consensus 806 FGla~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~ 881 (1016)
||+...+...... ...+..|...|++||... +.++.+.|+|++|.++.+..++..+........ |..
T Consensus 267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~------W~~-- 337 (524)
T KOG0601|consen 267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSS------WSQ-- 337 (524)
T ss_pred cceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCC------ccc--
Confidence 9999876654422 223346778899999874 556889999999999999998877654331111 110
Q ss_pred HHhCCcccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 001768 882 QEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 882 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 930 (1016)
+... .++.++-.....++...+.++++.+|..|++.+.+..
T Consensus 338 -----~r~~---~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 338 -----LRQG---YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred -----cccc---cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 0000 0111121122234555889999999999999877665
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.28 E-value=3.5e-12 Score=148.12 Aligned_cols=201 Identities=31% Similarity=0.492 Sum_probs=167.6
Q ss_pred ccccccccccCCCCCcccCCcCCccEEEcccCCCCCCCCCCCCCCc-cchhhhccCCccCCCCCcccCCCCCccEEEecC
Q 001768 136 TKLLILGNRLSGSIPLEIGDISTLEELVLEDNQLVGPLPENLGNLK-SLRRILLSSNNFTGSIPESYGNLKNLTEFRIDG 214 (1016)
Q Consensus 136 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~-~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~ 214 (1016)
..|+++.|.+. .....+..++.++.|++.+|.++ .++.....+. +|+.|++++|++. .+|..+..+++|+.|++++
T Consensus 96 ~~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~ 172 (394)
T COG4886 96 PSLDLNLNRLR-SNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSF 172 (394)
T ss_pred ceeeccccccc-cCchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCC
Confidence 46888888885 33445566789999999999999 6777777774 9999999999999 6767789999999999999
Q ss_pred CcCCCCCchhhhcCCCCCEEeecCCcCCCCCchhhcCCCCCCEEEcCCCCCCCCCCcccccccccceeecccccccccCc
Q 001768 215 SNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISDLKGSSSSFPNLQDMKKMERLILRNCLITGRIP 294 (1016)
Q Consensus 215 N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p 294 (1016)
|+++ .+|...+.+++|+.|++++|+++ .+|.....+..|++|.++.|.+... ...+..+.++..|.+.+|++. ..+
T Consensus 173 N~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~~~-~~~~~~~~~l~~l~l~~n~~~-~~~ 248 (394)
T COG4886 173 NDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSIIEL-LSSLSNLKNLSGLELSNNKLE-DLP 248 (394)
T ss_pred chhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcceec-chhhhhcccccccccCCceee-ecc
Confidence 9999 66766668899999999999999 6677666777799999999963322 234677888888889999998 446
Q ss_pred hhhcCCCCCceEeccCCCCCCCCccccCCCCCCCEEEccCCcCCCCCChhh
Q 001768 295 EYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGTLPDWI 345 (1016)
Q Consensus 295 ~~l~~l~~L~~L~Ls~N~L~~~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~ 345 (1016)
..+..+++|+.|++++|+++ .++. +..+.+|++|++++|.++...|...
T Consensus 249 ~~~~~l~~l~~L~~s~n~i~-~i~~-~~~~~~l~~L~~s~n~~~~~~~~~~ 297 (394)
T COG4886 249 ESIGNLSNLETLDLSNNQIS-SISS-LGSLTNLRELDLSGNSLSNALPLIA 297 (394)
T ss_pred chhccccccceecccccccc-cccc-ccccCccCEEeccCccccccchhhh
Confidence 77899999999999999999 4444 8899999999999999998877766
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.25 E-value=8.5e-12 Score=146.38 Aligned_cols=146 Identities=15% Similarity=0.211 Sum_probs=95.2
Q ss_pred hcCccccCccccCCCeeEEEEEcCC-CcEEEEEEccCCChhh----------------------------------hH--
Q 001768 658 TNNFDAANKIGEGGFGPVYKGTLSD-GAVIAVKQLSSKSKQG----------------------------------NR-- 700 (1016)
Q Consensus 658 ~~~f~~~~~LG~G~~G~Vy~~~~~~-~~~vAvK~~~~~~~~~----------------------------------~~-- 700 (1016)
...|+. +.||.|++|.||+|++++ |+.||||+.++..... .+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345776 799999999999999887 9999999997542110 01
Q ss_pred ----HHHHHHHHHHhcC----CCCeeeeeeeEee-cceeEEEEeecCCCcHHHHh--ccCcCcCcCCCHHHHHHHHHHHH
Q 001768 701 ----EFVNEIGMISALQ----HQNLVKLYGCCIE-GNQLLLVYEYLENNSLARAL--FGKEGQCLNLDWATRKRICSDIA 769 (1016)
Q Consensus 701 ----~~~~E~~~l~~l~----HpnIv~l~~~~~~-~~~~~lV~E~~~~gsL~~~l--~~~~~~~~~l~~~~~~~i~~qia 769 (1016)
++.+|+..+.+++ +...+.+-.++.+ ....+|||||++|+.+.+.- .........+....+..++.|+
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi- 276 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV- 276 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-
Confidence 2344444444442 3333333333322 34568999999999998742 2211111123333333344444
Q ss_pred HHHHHHHhcCCCCeEeCCCCCceEEEccCC----ceeeeccccccccCC
Q 001768 770 RGLAYLHEESRLKIVHRDIKATNVLLDKDL----NAKISDFGLAKLDED 814 (1016)
Q Consensus 770 ~~L~yLH~~~~~~iiHrDlkp~NILl~~~~----~~kL~DFGla~~~~~ 814 (1016)
+.. |++|+|+||.||+++.++ ++++.|||++.....
T Consensus 277 ------f~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 ------FRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred ------HhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 334 999999999999999888 999999999976544
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.25 E-value=7e-13 Score=140.44 Aligned_cols=182 Identities=16% Similarity=0.233 Sum_probs=86.6
Q ss_pred cCCccEEEcccCCCCCCCCCC----CCCCccchhhhccCCccCCCCC-------------cccCCCCCccEEEecCCcCC
Q 001768 156 ISTLEELVLEDNQLVGPLPEN----LGNLKSLRRILLSSNNFTGSIP-------------ESYGNLKNLTEFRIDGSNLT 218 (1016)
Q Consensus 156 l~~L~~L~Ls~N~l~~~~p~~----l~~l~~L~~L~Ls~N~l~~~~p-------------~~l~~l~~L~~L~L~~N~l~ 218 (1016)
.++|++||||+|-+....+.. +.++..|++|.|.+|.+...-. .-.++-+.|+++...+|++.
T Consensus 91 ~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrle 170 (382)
T KOG1909|consen 91 CPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLE 170 (382)
T ss_pred CCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccc
Confidence 345555555555554332222 2334555555555555541111 11223346666666666665
Q ss_pred CC----CchhhhcCCCCCEEeecCCcCCCC----CchhhcCCCCCCEEEcCCCCCCCCCCc----ccccccccceeeccc
Q 001768 219 GR----IPNFIGNWTKLDRLDLQGTSLEGP----IPSTISQLKNLTELRISDLKGSSSSFP----NLQDMKKMERLILRN 286 (1016)
Q Consensus 219 ~~----~~~~l~~l~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~Ls~n~l~~~~~~----~l~~l~~L~~L~Ls~ 286 (1016)
.. +...|...+.|+.+.++.|.|... +...|..+++|+.|||.+|.++..... .+..++.|+.|++++
T Consensus 171 n~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~d 250 (382)
T KOG1909|consen 171 NGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGD 250 (382)
T ss_pred cccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccc
Confidence 22 223444556666666666665422 223455566666666666655443322 233445555555555
Q ss_pred ccccccCchhh-----cCCCCCceEeccCCCCCC----CCccccCCCCCCCEEEccCCcC
Q 001768 287 CLITGRIPEYI-----EDMTDLKILDLSFNQLTG----PVPGILQNLKKIDYIFLTNNSL 337 (1016)
Q Consensus 287 N~l~~~~p~~l-----~~l~~L~~L~Ls~N~L~~----~~p~~l~~l~~L~~L~L~~N~l 337 (1016)
|.++..-..++ ...|+|+.|.|.+|.++. .+...+...+.|+.|+|++|++
T Consensus 251 cll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l 310 (382)
T KOG1909|consen 251 CLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL 310 (382)
T ss_pred cccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence 55554332221 124555555555555542 1112233344555555555554
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.25 E-value=9.1e-12 Score=130.49 Aligned_cols=204 Identities=22% Similarity=0.292 Sum_probs=141.8
Q ss_pred HHHHhcCCCCeeeeeeeEeec-----ceeEEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 001768 707 GMISALQHQNLVKLYGCCIEG-----NQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRL 781 (1016)
Q Consensus 707 ~~l~~l~HpnIv~l~~~~~~~-----~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~ 781 (1016)
.-+-.+.|.|||+++.|+.+. .+..++.|||..|++..+|++.......+....-.+++-||+.||.|||+. .+
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CC
Confidence 445566799999999998764 357899999999999999987655556788888899999999999999996 57
Q ss_pred CeEeCCCCCceEEEccCCceeeeccccccccCC---CCcceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHh
Q 001768 782 KIVHRDIKATNVLLDKDLNAKISDFGLAKLDED---ENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS 858 (1016)
Q Consensus 782 ~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~ellt 858 (1016)
+|+|+++..+-|++..+|-+|++----...... ..........+-++|.|||+=.....+.++|||+||+..+||..
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 999999999999999999888752111100000 00011122346789999998766677889999999999999988
Q ss_pred CCCC-CCCCCchhhHhHHHHHHHHHHhCCcccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 001768 859 GKSN-TNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSM 931 (1016)
Q Consensus 859 G~~P-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 931 (1016)
+..- .......+....+ + ...-..... .-..++..|++..|..||+|.+++..
T Consensus 278 lEiq~tnseS~~~~ee~i--a-------~~i~~len~-----------lqr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 278 LEIQSTNSESKVEVEENI--A-------NVIIGLENG-----------LQRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred heeccCCCcceeehhhhh--h-------hheeeccCc-----------cccCcCcccccCCCCCCcchhhhhcC
Confidence 7643 2111111100000 0 000000001 12347789999999999999987653
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.24 E-value=3.4e-13 Score=142.76 Aligned_cols=229 Identities=21% Similarity=0.270 Sum_probs=178.7
Q ss_pred eEEEEEecCCccCc----cCccccCCCCCCCEEEccCC---CCCCCCchhh-------hcccCcccccccccccCCCCCc
Q 001768 86 HVTVILLKGFNLAG----VIPEEFGNLTFLQEVDLSRN---YFNGSLPKSF-------ARLQNLTKLLILGNRLSGSIPL 151 (1016)
Q Consensus 86 ~v~~L~L~~~~l~~----~~~~~l~~l~~L~~L~Ls~n---~i~~~~p~~~-------~~l~~L~~L~Ls~N~l~~~~p~ 151 (1016)
.++.|+|++|.+.. .+.+.+.+.++|++.++++- ++...+|.++ ..+++|++|+||.|.+....+.
T Consensus 31 s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G~~g~~ 110 (382)
T KOG1909|consen 31 SLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFGPKGIR 110 (382)
T ss_pred ceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccCccchH
Confidence 58999999998754 45566888899999999973 3444556543 4567999999999999855554
Q ss_pred cc----CCcCCccEEEcccCCCCCCCC-------------CCCCCCccchhhhccCCccCCC----CCcccCCCCCccEE
Q 001768 152 EI----GDISTLEELVLEDNQLVGPLP-------------ENLGNLKSLRRILLSSNNFTGS----IPESYGNLKNLTEF 210 (1016)
Q Consensus 152 ~~----~~l~~L~~L~Ls~N~l~~~~p-------------~~l~~l~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L 210 (1016)
.| ..+..|++|.|.+|.+...-- .....-++|+++...+|++... +...|...+.|+.+
T Consensus 111 ~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~leev 190 (382)
T KOG1909|consen 111 GLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLENGGATALAEAFQSHPTLEEV 190 (382)
T ss_pred HHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccccccHHHHHHHHHhccccceE
Confidence 44 457899999999999863211 1233457899999999999743 23456777999999
Q ss_pred EecCCcCCC----CCchhhhcCCCCCEEeecCCcCCCC----CchhhcCCCCCCEEEcCCCCCCCCCCcccc-----ccc
Q 001768 211 RIDGSNLTG----RIPNFIGNWTKLDRLDLQGTSLEGP----IPSTISQLKNLTELRISDLKGSSSSFPNLQ-----DMK 277 (1016)
Q Consensus 211 ~L~~N~l~~----~~~~~l~~l~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~Ls~n~l~~~~~~~l~-----~l~ 277 (1016)
.++.|.|.. .+...+..+++|+.|||.+|-++.. +...+..+++|++|++++|.+.......+. ..+
T Consensus 191 r~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p 270 (382)
T KOG1909|consen 191 RLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAIAFVDALKESAP 270 (382)
T ss_pred EEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccHHHHHHHHhccCC
Confidence 999999873 2346788999999999999999854 456788899999999999999887665542 478
Q ss_pred ccceeeccccccccc----CchhhcCCCCCceEeccCCCCC
Q 001768 278 KMERLILRNCLITGR----IPEYIEDMTDLKILDLSFNQLT 314 (1016)
Q Consensus 278 ~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~Ls~N~L~ 314 (1016)
+|+.|.|.+|.|+.. +...+...+.|..|+|++|++.
T Consensus 271 ~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 271 SLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred CCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence 999999999999842 3345667899999999999994
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.21 E-value=4.3e-11 Score=121.38 Aligned_cols=130 Identities=21% Similarity=0.181 Sum_probs=97.2
Q ss_pred cCccccCCCeeEEEEEcCCCcEEEEEEccCCChhhhHHHHHHHHHHHhcCCCCee-eeeeeEeecceeEEEEeecCCCcH
Q 001768 664 ANKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLV-KLYGCCIEGNQLLLVYEYLENNSL 742 (1016)
Q Consensus 664 ~~~LG~G~~G~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv-~l~~~~~~~~~~~lV~E~~~~gsL 742 (1016)
++.|+.|.++.||+++.. +..|++|....... ....+..|+++++.+.+.+++ +++.+. ....++||||++|.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 467899999999999875 77899998765432 223467899999998665544 455443 2345899999999877
Q ss_pred HHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEeCCCCCceEEEccCCceeeecccccc
Q 001768 743 ARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEES--RLKIVHRDIKATNVLLDKDLNAKISDFGLAK 810 (1016)
Q Consensus 743 ~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~--~~~iiHrDlkp~NILl~~~~~~kL~DFGla~ 810 (1016)
.+.- . ....++.+++++|+.||+.. +.+++|+|++|.||+++ ++.++++|||.+.
T Consensus 79 ~~~~---------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 79 LTED---------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred cccc---------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 5430 0 12346789999999999883 23469999999999999 6789999999886
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.16 E-value=4.9e-12 Score=137.39 Aligned_cols=183 Identities=18% Similarity=0.195 Sum_probs=103.1
Q ss_pred cccCcccccccccccCCCCC--cccCCcCCccEEEcccCCCCCCC--CCCCCCCccchhhhccCCccCCCCCccc-CCCC
Q 001768 131 RLQNLTKLLILGNRLSGSIP--LEIGDISTLEELVLEDNQLVGPL--PENLGNLKSLRRILLSSNNFTGSIPESY-GNLK 205 (1016)
Q Consensus 131 ~l~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~Ls~N~l~~~~--p~~l~~l~~L~~L~Ls~N~l~~~~p~~l-~~l~ 205 (1016)
++.+|+.+.|.+..+. ..+ .....|++++.|||++|-+.... -.....||+|+.|+|+.|++........ ..++
T Consensus 119 n~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~ 197 (505)
T KOG3207|consen 119 NLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLS 197 (505)
T ss_pred hHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhh
Confidence 4667777777777665 222 24556777777777777765321 1233457777777777777763222211 2456
Q ss_pred CccEEEecCCcCCCC-CchhhhcCCCCCEEeecCCcCCCCCchhhcCCCCCCEEEcCCCCCCCCC-Ccccccccccceee
Q 001768 206 NLTEFRIDGSNLTGR-IPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISDLKGSSSS-FPNLQDMKKMERLI 283 (1016)
Q Consensus 206 ~L~~L~L~~N~l~~~-~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~-~~~l~~l~~L~~L~ 283 (1016)
.|+.|.|+.|.++.. +-..+..+|+|+.|+|..|..-..-......+..|++|+|++|.+...+ ......++.|+.|+
T Consensus 198 ~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Ln 277 (505)
T KOG3207|consen 198 HLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLN 277 (505)
T ss_pred hhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhh
Confidence 777777777777622 2233445677777777777432222333444556666666666654433 33355566666666
Q ss_pred cccccccccC-chh-----hcCCCCCceEeccCCCCC
Q 001768 284 LRNCLITGRI-PEY-----IEDMTDLKILDLSFNQLT 314 (1016)
Q Consensus 284 Ls~N~l~~~~-p~~-----l~~l~~L~~L~Ls~N~L~ 314 (1016)
++.|.|...- |+. ...+++|++|+++.|++.
T Consensus 278 ls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~ 314 (505)
T KOG3207|consen 278 LSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIR 314 (505)
T ss_pred ccccCcchhcCCCccchhhhcccccceeeecccCccc
Confidence 6666665321 221 234455555555555554
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.15 E-value=3.1e-12 Score=138.91 Aligned_cols=211 Identities=19% Similarity=0.190 Sum_probs=151.7
Q ss_pred cCCCCCCCEEEccCCCCCCCCc-hhhhcccCcccccccccccCCC--CCcccCCcCCccEEEcccCCCCCCCCCCC-CCC
Q 001768 105 FGNLTFLQEVDLSRNYFNGSLP-KSFARLQNLTKLLILGNRLSGS--IPLEIGDISTLEELVLEDNQLVGPLPENL-GNL 180 (1016)
Q Consensus 105 l~~l~~L~~L~Ls~n~i~~~~p-~~~~~l~~L~~L~Ls~N~l~~~--~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l-~~l 180 (1016)
=.++.+|++..|.+..+..... .....|++++.|||+.|-+... +-.-...|++|+.|+|+.|++........ ..+
T Consensus 117 Qsn~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l 196 (505)
T KOG3207|consen 117 QSNLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLL 196 (505)
T ss_pred hhhHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhh
Confidence 3577889999998887772211 3567789999999999987743 22345678999999999998863322221 246
Q ss_pred ccchhhhccCCccCCC-CCcccCCCCCccEEEecCCcCCCCCchhhhcCCCCCEEeecCCcCCCCC-chhhcCCCCCCEE
Q 001768 181 KSLRRILLSSNNFTGS-IPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPI-PSTISQLKNLTEL 258 (1016)
Q Consensus 181 ~~L~~L~Ls~N~l~~~-~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~-p~~l~~l~~L~~L 258 (1016)
++|+.|.|+.|.|+.. +...+..+|+|+.|+|..|............+..|+.|||++|++-... -...+.++.|+.|
T Consensus 197 ~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~L 276 (505)
T KOG3207|consen 197 SHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQL 276 (505)
T ss_pred hhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhh
Confidence 8889999999988732 2223456789999999998533333444455678999999999876332 2567888999999
Q ss_pred EcCCCCCCCCCCccc------ccccccceeecccccccccC-chhhcCCCCCceEeccCCCCCC
Q 001768 259 RISDLKGSSSSFPNL------QDMKKMERLILRNCLITGRI-PEYIEDMTDLKILDLSFNQLTG 315 (1016)
Q Consensus 259 ~Ls~n~l~~~~~~~l------~~l~~L~~L~Ls~N~l~~~~-p~~l~~l~~L~~L~Ls~N~L~~ 315 (1016)
+++.+.+.++..+.. ..+++|++|++..|+|...- -..+..+++|+.|.+..|.|+.
T Consensus 277 nls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln~ 340 (505)
T KOG3207|consen 277 NLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLNK 340 (505)
T ss_pred hccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhcccccccc
Confidence 999999988777665 56899999999999997321 1345566777778877787763
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.14 E-value=2.7e-10 Score=131.09 Aligned_cols=166 Identities=17% Similarity=0.206 Sum_probs=127.0
Q ss_pred cCCCcEEEEEEccCCChhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEeecCCCcHHHHhccCcCcCcCCCHH
Q 001768 680 LSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWA 759 (1016)
Q Consensus 680 ~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~ 759 (1016)
..++.+|.|...+...........+-++.|+.++||||+++++.++.++..|+|+|-+. .|..++.. +...
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~-------l~~~ 104 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE-------LGKE 104 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH-------hHHH
Confidence 45688888888876655444556777889999999999999999999999999999885 46666633 3466
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCCcceeeecccCccccChhhhccCC
Q 001768 760 TRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRGY 839 (1016)
Q Consensus 760 ~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 839 (1016)
.+...+.||+.||.+||+.+ +++|++|.-+-|++++.|+.||++|.++.....-.. ......--..|..|+.+....
T Consensus 105 ~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~ 181 (690)
T KOG1243|consen 105 EVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE 181 (690)
T ss_pred HHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc
Confidence 77788999999999999875 899999999999999999999999998864332211 011111122466676543222
Q ss_pred CCCccchhHHHHHHHHHHhC
Q 001768 840 LTDKADVYSFGIVALEIVSG 859 (1016)
Q Consensus 840 ~~~~sDVwSlGvvl~elltG 859 (1016)
-..|.|-|||+++|++.|
T Consensus 182 --~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 --WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred --cchhhhhHHHHHHHHhCc
Confidence 346999999999999998
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.10 E-value=1e-09 Score=112.24 Aligned_cols=136 Identities=15% Similarity=0.145 Sum_probs=98.5
Q ss_pred cCccccCCCeeEEEEEcCC-------CcEEEEEEccCCC----------------------hhhhHHH----HHHHHHHH
Q 001768 664 ANKIGEGGFGPVYKGTLSD-------GAVIAVKQLSSKS----------------------KQGNREF----VNEIGMIS 710 (1016)
Q Consensus 664 ~~~LG~G~~G~Vy~~~~~~-------~~~vAvK~~~~~~----------------------~~~~~~~----~~E~~~l~ 710 (1016)
...||.|--+.||.|...+ +..+|||+.+... ......+ .+|++.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3578999999999998653 4799999875210 0011122 37999999
Q ss_pred hcCC--CCeeeeeeeEeecceeEEEEeecCCCcHHH-HhccCcCcCcCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEeC
Q 001768 711 ALQH--QNLVKLYGCCIEGNQLLLVYEYLENNSLAR-ALFGKEGQCLNLDWATRKRICSDIARGLAYL-HEESRLKIVHR 786 (1016)
Q Consensus 711 ~l~H--pnIv~l~~~~~~~~~~~lV~E~~~~gsL~~-~l~~~~~~~~~l~~~~~~~i~~qia~~L~yL-H~~~~~~iiHr 786 (1016)
++.. -++++++++ ...++||||+.+..+.. .+.. ..++.++...+..+++.+|..| |+. ++|||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-----~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHG 149 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-----AKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHA 149 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-----cccCHHHHHHHHHHHHHHHHHHHHhC---CeecC
Confidence 9853 456666664 45689999997753321 2211 1355566778899999999999 777 99999
Q ss_pred CCCCceEEEccCCceeeecccccccc
Q 001768 787 DIKATNVLLDKDLNAKISDFGLAKLD 812 (1016)
Q Consensus 787 Dlkp~NILl~~~~~~kL~DFGla~~~ 812 (1016)
|+++.||+++ ++.+.|+|||.+-..
T Consensus 150 DLs~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 150 DLSEYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred CCCHHHEEEE-CCcEEEEECCCceeC
Confidence 9999999997 468999999988643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.7e-10 Score=140.33 Aligned_cols=107 Identities=31% Similarity=0.607 Sum_probs=77.6
Q ss_pred CCCEEEccCCCCCCCCchhhhcccCcccccccccccCCCCCcccCCcCCccEEEcccCCCCCCCCCCCCCCccchhhhcc
Q 001768 110 FLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLS 189 (1016)
Q Consensus 110 ~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls 189 (1016)
.++.|+|++|.++|.+|..|+.+++|+.|+|++|.+.|.+|..++.+++|+.|+|++|++++.+|..+++|++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 46777888888888888888888888888888888877777777777777777777777777777777777777777777
Q ss_pred CCccCCCCCcccCCC-CCccEEEecCCc
Q 001768 190 SNNFTGSIPESYGNL-KNLTEFRIDGSN 216 (1016)
Q Consensus 190 ~N~l~~~~p~~l~~l-~~L~~L~L~~N~ 216 (1016)
+|+++|.+|..+..+ .++..+++.+|.
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~ 526 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNA 526 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCc
Confidence 777777777665542 234444444443
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.07 E-value=3.1e-11 Score=124.59 Aligned_cols=130 Identities=25% Similarity=0.241 Sum_probs=67.4
Q ss_pred CCCccEEEecCCcCCCCCchhhhcCCCCCEEeecCCcCCCCCchhhcCCCCCCEEEcCCCCCCCCCCcccccccccceee
Q 001768 204 LKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISDLKGSSSSFPNLQDMKKMERLI 283 (1016)
Q Consensus 204 l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~ 283 (1016)
...|++|+|++|.|+ .+.++..-++.++.|++++|.|... ..+..+++|+.||||+|.++....- -.++-+++.|.
T Consensus 283 Wq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls~~~Gw-h~KLGNIKtL~ 358 (490)
T KOG1259|consen 283 WQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLAECVGW-HLKLGNIKTLK 358 (490)
T ss_pred Hhhhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhHhhhhh-HhhhcCEeeee
Confidence 344555555555555 3444444455555555555555522 1244555555555555554433211 12344555556
Q ss_pred cccccccccCchhhcCCCCCceEeccCCCCCCCCc-cccCCCCCCCEEEccCCcCCC
Q 001768 284 LRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVP-GILQNLKKIDYIFLTNNSLSG 339 (1016)
Q Consensus 284 Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~L~~~~p-~~l~~l~~L~~L~L~~N~l~g 339 (1016)
|+.|.|... ..++.+-+|..||+++|+|..... ..++++|-|+.|.|.+|+|.+
T Consensus 359 La~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~ 413 (490)
T KOG1259|consen 359 LAQNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAG 413 (490)
T ss_pred hhhhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccc
Confidence 666655521 225555566666666666653221 345666666666666666663
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.05 E-value=2.2e-11 Score=141.77 Aligned_cols=246 Identities=26% Similarity=0.324 Sum_probs=135.6
Q ss_pred CCCCCCEEEccCCCCCCCCchhhhcccCcccccccccccCCCCCcccCCcCCccEEEcccCCCCCCCCCCCCCCccchhh
Q 001768 107 NLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRI 186 (1016)
Q Consensus 107 ~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L 186 (1016)
.+..++.+.+..|.|.. +-..+..+++|..|++.+|.|. .+...+..+++|++|+|++|+|+... .+..++.|+.|
T Consensus 70 ~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~L 145 (414)
T KOG0531|consen 70 SLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIE-KIENLLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKEL 145 (414)
T ss_pred HhHhHHhhccchhhhhh-hhcccccccceeeeeccccchh-hcccchhhhhcchheecccccccccc--chhhccchhhh
Confidence 45555666666666662 2334666667777777777766 33333556677777777777776432 25556667777
Q ss_pred hccCCccCCCCCcccCCCCCccEEEecCCcCCCCCc-hhhhcCCCCCEEeecCCcCCCCCchhhcCCCCCCEEEcCCCCC
Q 001768 187 LLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIP-NFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISDLKG 265 (1016)
Q Consensus 187 ~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~-~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~n~l 265 (1016)
++++|.|+ .+ ..+..+++|+.+++++|++...-+ . +..+.+|+.+++.+|.+... ..+..+..+..+++.+|.+
T Consensus 146 ~l~~N~i~-~~-~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~i--~~~~~~~~l~~~~l~~n~i 220 (414)
T KOG0531|consen 146 NLSGNLIS-DI-SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIREI--EGLDLLKKLVLLSLLDNKI 220 (414)
T ss_pred eeccCcch-hc-cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhcc--cchHHHHHHHHhhcccccc
Confidence 77777766 22 234446667777777777663333 2 45566667777777766632 2233344444445666665
Q ss_pred CCCCCcccccccccceeecccccccccCchhhcCCCCCceEeccCCCCCCCCccccCCCCCCCEEEccCCcCCCC---CC
Q 001768 266 SSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGT---LP 342 (1016)
Q Consensus 266 ~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~L~~~~p~~l~~l~~L~~L~L~~N~l~g~---~p 342 (1016)
..+.......+..|+.+++++|++. .++..+..+.++..|+++.|++...- .+...+.+..+.+..|++... ..
T Consensus 221 ~~~~~l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (414)
T KOG0531|consen 221 SKLEGLNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNLE--GLERLPKLSELWLNDNKLALSEAISQ 297 (414)
T ss_pred eeccCcccchhHHHHHHhcccCccc-cccccccccccccccchhhccccccc--cccccchHHHhccCcchhcchhhhhc
Confidence 5443322111113666667777666 33344556666666777766665221 234445555556666655421 11
Q ss_pred h---hhhccCCcccCCCCcCCCCCC
Q 001768 343 D---WILTSEKNLDLSYNNFTESSP 364 (1016)
Q Consensus 343 ~---~~~~~L~~LdLs~N~l~~~~p 364 (1016)
. .-.+.+..+.+.+|++....+
T Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (414)
T KOG0531|consen 298 EYITSAAPTLVTLTLELNPIRKISS 322 (414)
T ss_pred cccccccccccccccccCccccccc
Confidence 1 114455566666666655444
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.05 E-value=3.1e-11 Score=124.66 Aligned_cols=138 Identities=21% Similarity=0.289 Sum_probs=112.6
Q ss_pred CCCchhhhcCCCCCEEeecCCcCCCCCchhhcCCCCCCEEEcCCCCCCCCCCcccccccccceeecccccccccCchhhc
Q 001768 219 GRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISDLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYIE 298 (1016)
Q Consensus 219 ~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~ 298 (1016)
|.....+..+..|++|||++|.|+ .+.+...-+|.++.|++|+|.+..+.. +..+++|+.|||++|.++ .+..+-.
T Consensus 274 G~~~~~~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v~n--La~L~~L~~LDLS~N~Ls-~~~Gwh~ 349 (490)
T KOG1259|consen 274 GSALVSADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTVQN--LAELPQLQLLDLSGNLLA-ECVGWHL 349 (490)
T ss_pred CceEEecchHhhhhhccccccchh-hhhhhhhhccceeEEeccccceeeehh--hhhcccceEeecccchhH-hhhhhHh
Confidence 333344445678999999999999 667778888999999999999987765 888999999999999999 5666777
Q ss_pred CCCCCceEeccCCCCCCCCccccCCCCCCCEEEccCCcCCCCCCh--h--hhccCCcccCCCCcCCCCC
Q 001768 299 DMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGTLPD--W--ILTSEKNLDLSYNNFTESS 363 (1016)
Q Consensus 299 ~l~~L~~L~Ls~N~L~~~~p~~l~~l~~L~~L~L~~N~l~g~~p~--~--~~~~L~~LdLs~N~l~~~~ 363 (1016)
.+.+++.|.|++|.|. .-..+..+-+|.+|++++|+|.. +.. . -+|.|+.|.|.+|++.+.+
T Consensus 350 KLGNIKtL~La~N~iE--~LSGL~KLYSLvnLDl~~N~Ie~-ldeV~~IG~LPCLE~l~L~~NPl~~~v 415 (490)
T KOG1259|consen 350 KLGNIKTLKLAQNKIE--TLSGLRKLYSLVNLDLSSNQIEE-LDEVNHIGNLPCLETLRLTGNPLAGSV 415 (490)
T ss_pred hhcCEeeeehhhhhHh--hhhhhHhhhhheeccccccchhh-HHHhcccccccHHHHHhhcCCCccccc
Confidence 8889999999999997 23456778899999999999972 211 1 1788999999999998763
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.04 E-value=2.6e-11 Score=141.29 Aligned_cols=240 Identities=25% Similarity=0.220 Sum_probs=179.0
Q ss_pred CCCCEEEccCCCCCCCCchhhhcccCcccccccccccCCCCCcccCCcCCccEEEcccCCCCCCCCCCCCCCccchhhhc
Q 001768 109 TFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRILL 188 (1016)
Q Consensus 109 ~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 188 (1016)
+.++.++...+.+.+.--. ...+..++.+++..|.+. .+-..+..+++|+.|++.+|+|.. +...+..+++|++|+|
T Consensus 49 ~~~~~~~~~~~~~~~~~~~-~~~l~~l~~l~l~~n~i~-~~~~~l~~~~~l~~l~l~~n~i~~-i~~~l~~~~~L~~L~l 125 (414)
T KOG0531|consen 49 SDLEEIDLIFNLDGSDEDL-VESLTSLKELNLRQNLIA-KILNHLSKLKSLEALDLYDNKIEK-IENLLSSLVNLQVLDL 125 (414)
T ss_pred chhhhhcchhccccchhhh-HHHhHhHHhhccchhhhh-hhhcccccccceeeeeccccchhh-cccchhhhhcchheec
Confidence 4566666666655532222 256788888889999998 455568889999999999999984 4444788999999999
Q ss_pred cCCccCCCCCcccCCCCCccEEEecCCcCCCCCchhhhcCCCCCEEeecCCcCCCCCc-hhhcCCCCCCEEEcCCCCCCC
Q 001768 189 SSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIP-STISQLKNLTELRISDLKGSS 267 (1016)
Q Consensus 189 s~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p-~~l~~l~~L~~L~Ls~n~l~~ 267 (1016)
++|+|+...+ +..++.|+.|++++|.|+. ...+..+..|+.+++++|++...-+ . +..+.+|+.+++..|.+..
T Consensus 126 s~N~I~~i~~--l~~l~~L~~L~l~~N~i~~--~~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~ 200 (414)
T KOG0531|consen 126 SFNKITKLEG--LSTLTLLKELNLSGNLISD--ISGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIRE 200 (414)
T ss_pred cccccccccc--hhhccchhhheeccCcchh--ccCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhc
Confidence 9999985444 6677789999999999983 2345558899999999999985444 2 5788899999999998876
Q ss_pred CCCcccccccccceeecccccccccCchhhcCCCC--CceEeccCCCCCCCCccccCCCCCCCEEEccCCcCCCCCChhh
Q 001768 268 SSFPNLQDMKKMERLILRNCLITGRIPEYIEDMTD--LKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGTLPDWI 345 (1016)
Q Consensus 268 ~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~--L~~L~Ls~N~L~~~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~ 345 (1016)
+.. +..+..+..+++..|.++..-+ +..+.. |+.+++++|++. .++..+..+..+..|++.+|++...-....
T Consensus 201 i~~--~~~~~~l~~~~l~~n~i~~~~~--l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~~~~~~ 275 (414)
T KOG0531|consen 201 IEG--LDLLKKLVLLSLLDNKISKLEG--LNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNLEGLER 275 (414)
T ss_pred ccc--hHHHHHHHHhhcccccceeccC--cccchhHHHHHHhcccCccc-cccccccccccccccchhhccccccccccc
Confidence 543 3344555555888888884332 233333 899999999998 554667788889999999999886555555
Q ss_pred hccCCcccCCCCcCCC
Q 001768 346 LTSEKNLDLSYNNFTE 361 (1016)
Q Consensus 346 ~~~L~~LdLs~N~l~~ 361 (1016)
...+..+.+..|.+..
T Consensus 276 ~~~~~~~~~~~~~~~~ 291 (414)
T KOG0531|consen 276 LPKLSELWLNDNKLAL 291 (414)
T ss_pred cchHHHhccCcchhcc
Confidence 6677777888887653
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.5e-09 Score=115.22 Aligned_cols=141 Identities=21% Similarity=0.299 Sum_probs=111.4
Q ss_pred CccccCCCeeEEEEEcCCCcEEEEEEccCCCh-hhhHHHHHHHHHHHhcCCC--CeeeeeeeEeec---ceeEEEEeecC
Q 001768 665 NKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSK-QGNREFVNEIGMISALQHQ--NLVKLYGCCIEG---NQLLLVYEYLE 738 (1016)
Q Consensus 665 ~~LG~G~~G~Vy~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~Hp--nIv~l~~~~~~~---~~~~lV~E~~~ 738 (1016)
+.|+.|.++.||+++..+|+.+++|....... .....+..|+++++.+++. .+++++.+.... +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 67899999999999987778999999765432 2345788999999999763 457777777654 36689999999
Q ss_pred CCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 001768 739 NNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEES--------------------------------------- 779 (1016)
Q Consensus 739 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~--------------------------------------- 779 (1016)
|.++.+.+.. ..++..+...++.+++++|.+||+..
T Consensus 84 G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 84 GRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred CEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 9888776531 14677888889999999999998531
Q ss_pred --------------CCCeEeCCCCCceEEEcc--CCceeeecccccc
Q 001768 780 --------------RLKIVHRDIKATNVLLDK--DLNAKISDFGLAK 810 (1016)
Q Consensus 780 --------------~~~iiHrDlkp~NILl~~--~~~~kL~DFGla~ 810 (1016)
+..++|+|++|.||+++. ++.+.|+||+.+.
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 246899999999999998 5668999999886
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.03 E-value=2.4e-10 Score=130.72 Aligned_cols=247 Identities=21% Similarity=0.210 Sum_probs=174.7
Q ss_pred HHHhcCccccCccccCCCeeEEEEEcC--CCcEEEEEEccCCChhhhH--HHHHHHHHHHhc-CCCCeeeeeeeEeecce
Q 001768 655 KAATNNFDAANKIGEGGFGPVYKGTLS--DGAVIAVKQLSSKSKQGNR--EFVNEIGMISAL-QHQNLVKLYGCCIEGNQ 729 (1016)
Q Consensus 655 ~~~~~~f~~~~~LG~G~~G~Vy~~~~~--~~~~vAvK~~~~~~~~~~~--~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~ 729 (1016)
.....+|..+..||.|.|+.|+....+ ++..|++|.+......... .-..|+.+...+ .|.++++....+...++
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence 344567889999999999999987743 5788999988655332222 224566666665 58899998888888888
Q ss_pred eEEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccC-Cceeeecccc
Q 001768 730 LLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKD-LNAKISDFGL 808 (1016)
Q Consensus 730 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~-~~~kL~DFGl 808 (1016)
.++--|||+++++...+.- ...+++..++++..|++.++.++|+. .++|+|+||+||++..+ +..+++|||.
T Consensus 341 ~~ip~e~~~~~s~~l~~~~----~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~ 413 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRSVT----SQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGC 413 (524)
T ss_pred ccCchhhhcCcchhhhhHH----HHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhcccccc
Confidence 8899999999988777622 23578889999999999999999987 89999999999999886 7889999999
Q ss_pred ccccCCCCcceeeecccCcccc--ChhhhccCCCCCccchhHHHHHHHHHHhCCCCCCCCCchhhHhHHHHHHHHHHhCC
Q 001768 809 AKLDEDENTHISTRIAGTVGYM--APEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGN 886 (1016)
Q Consensus 809 a~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 886 (1016)
+....-. .....+.-++. +|+......+..+.|+||||..+.+.+++..--.... .|. .
T Consensus 414 ~t~~~~~----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~--------~~~-------~ 474 (524)
T KOG0601|consen 414 WTRLAFS----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV--------QSL-------T 474 (524)
T ss_pred cccccee----cccccccccccccchhhccccccccccccccccccccccccCcccCcccc--------cce-------e
Confidence 8632111 11112233344 4555556678899999999999999999875321100 010 0
Q ss_pred cccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 001768 887 LLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSML 932 (1016)
Q Consensus 887 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 932 (1016)
+.+-.-+.. +. ....+..+...+..+++..||.+.+...+.
T Consensus 475 i~~~~~p~~----~~-~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~ 515 (524)
T KOG0601|consen 475 IRSGDTPNL----PG-LKLQLQVLLKVMINPDRKRRPSAVELSLHS 515 (524)
T ss_pred eecccccCC----Cc-hHHhhhhhhhhhcCCccccchhhhhhcccc
Confidence 111111111 11 125677788888899999999987766543
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.00 E-value=4.6e-09 Score=103.45 Aligned_cols=131 Identities=23% Similarity=0.320 Sum_probs=102.2
Q ss_pred CccccCCCeeEEEEEcCCCcEEEEEEccCCCh--------hhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEEee
Q 001768 665 NKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSK--------QGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEY 736 (1016)
Q Consensus 665 ~~LG~G~~G~Vy~~~~~~~~~vAvK~~~~~~~--------~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 736 (1016)
..+++|+-+.||.+.+. |..+++|.-.++.. -..++-.+|+.++.+++--.|.-.+=+..+.+...++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 46789999999999875 44466665433321 1124567899999998766666656666677788999999
Q ss_pred cCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccc
Q 001768 737 LENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKL 811 (1016)
Q Consensus 737 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~ 811 (1016)
++|..|.+.+... ...++..+-.-+.-||.. +|+|+||.++||++..+. +.++|||++..
T Consensus 81 I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA-----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999888543 245778888889999998 999999999999998765 99999999974
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.00 E-value=1.7e-10 Score=115.60 Aligned_cols=124 Identities=29% Similarity=0.394 Sum_probs=33.1
Q ss_pred cccCcccccccccccCCCCCcccC-CcCCccEEEcccCCCCCCCCCCCCCCccchhhhccCCccCCCCCccc-CCCCCcc
Q 001768 131 RLQNLTKLLILGNRLSGSIPLEIG-DISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESY-GNLKNLT 208 (1016)
Q Consensus 131 ~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l-~~l~~L~ 208 (1016)
+..++++|+|.+|.|+ .+. .++ .+.+|+.|+|++|.|+. ++ .+..+++|+.|+|++|+|+. +.+.+ ..+++|+
T Consensus 17 n~~~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~~-l~-~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~L~ 91 (175)
T PF14580_consen 17 NPVKLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQITK-LE-GLPGLPRLKTLDLSNNRISS-ISEGLDKNLPNLQ 91 (175)
T ss_dssp ---------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S--CHHHHHH-TT--
T ss_pred cccccccccccccccc-ccc-chhhhhcCCCEEECCCCCCcc-cc-CccChhhhhhcccCCCCCCc-cccchHHhCCcCC
Confidence 3344555555555555 222 233 34555666666666552 22 34455555555666665552 22222 2355555
Q ss_pred EEEecCCcCCCC-CchhhhcCCCCCEEeecCCcCCCCC---chhhcCCCCCCEEE
Q 001768 209 EFRIDGSNLTGR-IPNFIGNWTKLDRLDLQGTSLEGPI---PSTISQLKNLTELR 259 (1016)
Q Consensus 209 ~L~L~~N~l~~~-~~~~l~~l~~L~~L~Ls~N~l~~~~---p~~l~~l~~L~~L~ 259 (1016)
+|+|++|+|... .-..+..+++|+.|+|.+|.++... ...+..+|+|+.||
T Consensus 92 ~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD 146 (175)
T PF14580_consen 92 ELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLD 146 (175)
T ss_dssp EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEET
T ss_pred EEECcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeC
Confidence 555555555421 1134455566666666666655321 12345555555554
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.94 E-value=9.9e-10 Score=110.18 Aligned_cols=84 Identities=25% Similarity=0.266 Sum_probs=24.5
Q ss_pred hhcCCCCCEEeecCCcCCCCCchhhcCCCCCCEEEcCCCCCCCC-CCcccccccccceeecccccccccC---chhhcCC
Q 001768 225 IGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISDLKGSSS-SFPNLQDMKKMERLILRNCLITGRI---PEYIEDM 300 (1016)
Q Consensus 225 l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~-~~~~l~~l~~L~~L~Ls~N~l~~~~---p~~l~~l 300 (1016)
+..+++|+.|++++|+|+...+.....+++|+.|+|++|++... ....+..+++|+.|+|.+|.++... ...+..+
T Consensus 60 l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~l 139 (175)
T PF14580_consen 60 LPGLPRLKTLDLSNNRISSISEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKL 139 (175)
T ss_dssp ----TT--EEE--SS---S-CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-
T ss_pred ccChhhhhhcccCCCCCCccccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHc
Confidence 33344444444444444422111112344444444444444332 1233445555666666666655321 1124455
Q ss_pred CCCceEec
Q 001768 301 TDLKILDL 308 (1016)
Q Consensus 301 ~~L~~L~L 308 (1016)
|+|+.||-
T Consensus 140 P~Lk~LD~ 147 (175)
T PF14580_consen 140 PSLKVLDG 147 (175)
T ss_dssp TT-SEETT
T ss_pred ChhheeCC
Confidence 56665553
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.90 E-value=7e-10 Score=132.70 Aligned_cols=250 Identities=17% Similarity=0.212 Sum_probs=171.5
Q ss_pred HHhcCccccCccccCCCeeEEEEEcC-CCcEEEEEEccCCC---hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeE
Q 001768 656 AATNNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS---KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLL 731 (1016)
Q Consensus 656 ~~~~~f~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 731 (1016)
...+.|.+.+.+-.|+++.++.+.-. .|...+.|...... ....+....+-.++-..+||-++.....+.-....+
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 34567788888999999999887632 23333344332211 111122222222333334566666555555566789
Q ss_pred EEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccc
Q 001768 732 LVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKL 811 (1016)
Q Consensus 732 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~ 811 (1016)
||++|..+++|...++... ..+.+-.......+..+++|||.. .+.|||++|.|.+...++..++.|||....
T Consensus 881 L~~~~~~~~~~~Skl~~~~----~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~ 953 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNSG----CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSK 953 (1205)
T ss_pred hhhHHhccCCchhhhhcCC----CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccc
Confidence 9999999999999987654 456666677788889999999987 699999999999999999999999984321
Q ss_pred cCCC----------C--------------------cceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCC
Q 001768 812 DEDE----------N--------------------THISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKS 861 (1016)
Q Consensus 812 ~~~~----------~--------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~ 861 (1016)
...- . ........||+.|.+||...+......+|.|+.|++++|.++|.+
T Consensus 954 vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~p 1033 (1205)
T KOG0606|consen 954 VGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIP 1033 (1205)
T ss_pred cccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCC
Confidence 1100 0 001223578999999999999999999999999999999999999
Q ss_pred CCCCCCchhhHhHHHHHHHHHHhCCcccccCCcCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHH
Q 001768 862 NTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMS 926 (1016)
Q Consensus 862 P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 926 (1016)
||+...++..... +.....+ +...+........+++...+..+|.+|-.+.
T Consensus 1034 p~na~tpq~~f~n------------i~~~~~~--~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1034 PFNAETPQQIFEN------------ILNRDIP--WPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCCcchhhhhhc------------cccCCCC--CCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 9987766654311 1111000 1122233444677888888899999998875
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.90 E-value=1.5e-08 Score=99.18 Aligned_cols=143 Identities=19% Similarity=0.288 Sum_probs=105.6
Q ss_pred ccCccccCCCeeEEEEEcCCCcEEEEEEccCCC--------hhhhHHHHHHHHHHHhcCCCCeeeeeeeEeecceeEEEE
Q 001768 663 AANKIGEGGFGPVYKGTLSDGAVIAVKQLSSKS--------KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVY 734 (1016)
Q Consensus 663 ~~~~LG~G~~G~Vy~~~~~~~~~vAvK~~~~~~--------~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 734 (1016)
....+-||+-+.|+++.+. |+...||.-..+. .-...+..+|++.+.+++--.|.-..=++.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 4678899999999999985 6676676543221 123456788999999887555555555566666678999
Q ss_pred eecCC-CcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCC---ceeeecccccc
Q 001768 735 EYLEN-NSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDL---NAKISDFGLAK 810 (1016)
Q Consensus 735 E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~---~~kL~DFGla~ 810 (1016)
||++| .++.+++...... ....+....++..|-+.+.-||.. +|||+||..+||++..++ .+.++|||++.
T Consensus 90 E~~~g~~~vk~~i~~~~~~--~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMED--ESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EeccchhHHHHHHHHHccC--cccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchh
Confidence 99987 4777777654321 122223368899999999999998 999999999999997655 35899999986
Q ss_pred c
Q 001768 811 L 811 (1016)
Q Consensus 811 ~ 811 (1016)
.
T Consensus 165 ~ 165 (229)
T KOG3087|consen 165 V 165 (229)
T ss_pred c
Confidence 3
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.88 E-value=3.2e-08 Score=110.60 Aligned_cols=169 Identities=21% Similarity=0.325 Sum_probs=129.4
Q ss_pred eeEEEEEc-CCCcEEEEEEccCCChhhhHHHHHHHHHHHhcCCCCeeeeeeeEee----cceeEEEEeecCC-CcHHHHh
Q 001768 673 GPVYKGTL-SDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIE----GNQLLLVYEYLEN-NSLARAL 746 (1016)
Q Consensus 673 G~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----~~~~~lV~E~~~~-gsL~~~l 746 (1016)
.+.|++.. .||..|++|+++.........-..-+++++++.|+|+|++.+++.. +..+++||+|.++ ++|.++-
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~ 369 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY 369 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence 47799984 4899999999965543333233456788999999999999998873 4578999999986 5777765
Q ss_pred ccCc-----------CcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCC
Q 001768 747 FGKE-----------GQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDE 815 (1016)
Q Consensus 747 ~~~~-----------~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 815 (1016)
.... ......+++..|.++.|+..||.++|+. |..-+-|.|.+|+++.+.+++|+..|.......+
T Consensus 370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 4322 1223578899999999999999999999 8999999999999999999999888877654443
Q ss_pred CcceeeecccCccccChhhhccCCCCCccchhHHHHHHHHHHhCCCC
Q 001768 816 NTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSN 862 (1016)
Q Consensus 816 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvvl~elltG~~P 862 (1016)
.. |-+. --.+-|.-.||.+++.|.||...
T Consensus 447 ~~---------------~~le---~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 447 PT---------------EPLE---SQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CC---------------cchh---HHhhhhHHHHHHHHHHHhhcccc
Confidence 21 1111 12457899999999999999754
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.80 E-value=2.2e-09 Score=133.27 Aligned_cols=126 Identities=29% Similarity=0.343 Sum_probs=73.9
Q ss_pred CCCEEEccCCC--CCCCCchhhhcccCcccccccccccCCCCCcccCCcCCccEEEcccCCCCCCCCCCCCCCccchhhh
Q 001768 110 FLQEVDLSRNY--FNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRIL 187 (1016)
Q Consensus 110 ~L~~L~Ls~n~--i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 187 (1016)
.|+.|-+..|. +.......|..++.|++|||++|.=.+.+|..+++|-+|++|+|++..+. .+|..+.+|++|.+|+
T Consensus 546 ~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~Ln 624 (889)
T KOG4658|consen 546 KLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYLN 624 (889)
T ss_pred ccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhheec
Confidence 56666666664 44333444556666666666666555566666666666666666666666 6666666666666666
Q ss_pred ccCCccCCCCCcccCCCCCccEEEecCCcC--CCCCchhhhcCCCCCEEee
Q 001768 188 LSSNNFTGSIPESYGNLKNLTEFRIDGSNL--TGRIPNFIGNWTKLDRLDL 236 (1016)
Q Consensus 188 Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l--~~~~~~~l~~l~~L~~L~L 236 (1016)
+..+.-...+|..+..|++|++|.+..... +...-..+.++.+|+.|..
T Consensus 625 l~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~ 675 (889)
T KOG4658|consen 625 LEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSI 675 (889)
T ss_pred cccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhhee
Confidence 666655445555555566666666654432 2222333444455555544
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.79 E-value=3.7e-08 Score=100.58 Aligned_cols=125 Identities=26% Similarity=0.305 Sum_probs=84.6
Q ss_pred eEEEEEcCCCcEEEEEEccCCC--------------h------------hhhHHHHHHHHHHHhcCCC--CeeeeeeeEe
Q 001768 674 PVYKGTLSDGAVIAVKQLSSKS--------------K------------QGNREFVNEIGMISALQHQ--NLVKLYGCCI 725 (1016)
Q Consensus 674 ~Vy~~~~~~~~~vAvK~~~~~~--------------~------------~~~~~~~~E~~~l~~l~Hp--nIv~l~~~~~ 725 (1016)
.||.|...+|..+|||+.+... . .......+|++.|.++... ++++++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 3899999899999999875310 0 0123467899999999765 466666543
Q ss_pred ecceeEEEEeecC--CCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEeCCCCCceEEEccCCcee
Q 001768 726 EGNQLLLVYEYLE--NNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYL-HEESRLKIVHRDIKATNVLLDKDLNAK 802 (1016)
Q Consensus 726 ~~~~~~lV~E~~~--~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yL-H~~~~~~iiHrDlkp~NILl~~~~~~k 802 (1016)
...+||||++ |..+..+.... ++.+....++.+++..+..+ |.. ||+|+|+.+.||+++++ .+.
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~------~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~ 146 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD------LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVY 146 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG------GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEE
T ss_pred ---CCEEEEEecCCCccchhhHHhcc------ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEE
Confidence 3479999998 65554443221 22455677888888866665 666 99999999999999988 899
Q ss_pred eecccccccc
Q 001768 803 ISDFGLAKLD 812 (1016)
Q Consensus 803 L~DFGla~~~ 812 (1016)
++|||.+...
T Consensus 147 iIDf~qav~~ 156 (188)
T PF01163_consen 147 IIDFGQAVDS 156 (188)
T ss_dssp E--GTTEEET
T ss_pred EEecCcceec
Confidence 9999988643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.77 E-value=1.4e-07 Score=102.73 Aligned_cols=261 Identities=14% Similarity=0.159 Sum_probs=157.8
Q ss_pred cccCccccCCCeeEEEEEcCCCcEEEEEEccCCChhhhHHHHHHHHHHHhc-CCCCeeeeeeeE-------eecceeEEE
Q 001768 662 DAANKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGNREFVNEIGMISAL-QHQNLVKLYGCC-------IEGNQLLLV 733 (1016)
Q Consensus 662 ~~~~~LG~G~~G~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~-------~~~~~~~lV 733 (1016)
...+.||+|+-+.+|-.--- +. .+.|+++........+ .++.|... .||-+-.-+.+= ..+....+.
T Consensus 14 ~~gr~LgqGgea~ly~l~e~-~d-~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEV-RD-QVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCCccccCCccceeeecchh-hc-hhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 34688999999999954311 11 2446665443322222 22233333 455433211111 122347889
Q ss_pred EeecCCCc-HHHHhcc--CcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeecccccc
Q 001768 734 YEYLENNS-LARALFG--KEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAK 810 (1016)
Q Consensus 734 ~E~~~~gs-L~~~l~~--~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~ 810 (1016)
|..+++.- +..+... ++.++....|.-..++++.++.+.+-||+. |.+-+|+.++|+|+.+++.+.|.|=..-.
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEccccee
Confidence 99887752 2222221 234456689999999999999999999999 89999999999999999999999865444
Q ss_pred ccCCCCcceeeecccCccccChhhhc-----cCCCCCccchhHHHHHHHHHHhC-CCCCCCCCchh---hHhHHHHHH--
Q 001768 811 LDEDENTHISTRIAGTVGYMAPEYAM-----RGYLTDKADVYSFGIVALEIVSG-KSNTNYRPKEE---FVYLLDWAY-- 879 (1016)
Q Consensus 811 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwSlGvvl~elltG-~~P~~~~~~~~---~~~~~~~~~-- 879 (1016)
....+. ...-.+|...|.+||.-. +..-+...|-|.||+++++++.| ++||.+-.... .....+.+.
T Consensus 166 i~~ng~--~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~ 243 (637)
T COG4248 166 INANGT--LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGR 243 (637)
T ss_pred eccCCc--eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcce
Confidence 332222 222356889999999764 33456789999999999999986 99986522110 000001000
Q ss_pred HHHHhCCcccccCCcCCCCCC-HHHHHHHHHHHHHccCC--CCCCCCCHHHHHHHhcc
Q 001768 880 VLQEQGNLLELVDPSLGSNFS-KKEAMTMLNIALLCTNP--SPTLRPTMSSAVSMLEG 934 (1016)
Q Consensus 880 ~~~~~~~~~~~~d~~l~~~~~-~~~~~~l~~li~~cl~~--dP~~RPt~~evl~~L~~ 934 (1016)
.......-.-...+. ..++ ...+..+..+..+|+.. .|.-|||++..+..|..
T Consensus 244 f~ya~~~~~g~~p~P--~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~a 299 (637)
T COG4248 244 FAYASDQRRGLKPPP--RSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDA 299 (637)
T ss_pred eeechhccCCCCCCC--CCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Confidence 000000000011111 1111 22344677888888875 36689999987777654
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.74 E-value=4.9e-09 Score=130.27 Aligned_cols=104 Identities=30% Similarity=0.375 Sum_probs=53.6
Q ss_pred EEEEEecCCc--cCccCccccCCCCCCCEEEccCCCCCCCCchhhhcccCcccccccccccCCCCCcccCCcCCccEEEc
Q 001768 87 VTVILLKGFN--LAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGDISTLEELVL 164 (1016)
Q Consensus 87 v~~L~L~~~~--l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 164 (1016)
+++|-+.+|. +.......|..++.|+.|||++|.--+.+|..++.|-+|++|+|+++.++ .+|..+++|+.|.+|++
T Consensus 547 L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl 625 (889)
T KOG4658|consen 547 LRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYLNL 625 (889)
T ss_pred cceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhheecc
Confidence 4455555443 23222333455555555555555444455555555555555555555555 55555555555555555
Q ss_pred ccCCCCCCCCCCCCCCccchhhhccCC
Q 001768 165 EDNQLVGPLPENLGNLKSLRRILLSSN 191 (1016)
Q Consensus 165 s~N~l~~~~p~~l~~l~~L~~L~Ls~N 191 (1016)
..+.-...+|..+..|.+|++|.|...
T Consensus 626 ~~~~~l~~~~~i~~~L~~Lr~L~l~~s 652 (889)
T KOG4658|consen 626 EVTGRLESIPGILLELQSLRVLRLPRS 652 (889)
T ss_pred ccccccccccchhhhcccccEEEeecc
Confidence 555443334444444555555555443
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.71 E-value=1.7e-07 Score=101.57 Aligned_cols=133 Identities=17% Similarity=0.070 Sum_probs=97.1
Q ss_pred CeeEEEEEcCCCcEEEEEEccCCChh-----------hhHHHHHHHHHHHhcCCCCe--eeeeeeEee-----cceeEEE
Q 001768 672 FGPVYKGTLSDGAVIAVKQLSSKSKQ-----------GNREFVNEIGMISALQHQNL--VKLYGCCIE-----GNQLLLV 733 (1016)
Q Consensus 672 ~G~Vy~~~~~~~~~vAvK~~~~~~~~-----------~~~~~~~E~~~l~~l~HpnI--v~l~~~~~~-----~~~~~lV 733 (1016)
...|+++.+ +|+.|.||........ ....+.+|...+.++...+| ++.+++... ....++|
T Consensus 35 ~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LV 113 (268)
T PRK15123 35 GRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFII 113 (268)
T ss_pred CceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEE
Confidence 344667766 5778999977543311 11247789988888854333 344555543 2357899
Q ss_pred EeecCCC-cHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEcc-------CCceeeec
Q 001768 734 YEYLENN-SLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDK-------DLNAKISD 805 (1016)
Q Consensus 734 ~E~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~-------~~~~kL~D 805 (1016)
||++++. +|.+++..... .+.+...+..++.+++..+.-||.. ||+|+|++++|||++. ++.+.++|
T Consensus 114 te~l~~~~sL~~~~~~~~~--~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LID 188 (268)
T PRK15123 114 TEDLAPTISLEDYCADWAT--NPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLKLSVID 188 (268)
T ss_pred EeeCCCCccHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCceEEEEE
Confidence 9999986 89988853211 2356677889999999999999999 9999999999999985 46799999
Q ss_pred ccccc
Q 001768 806 FGLAK 810 (1016)
Q Consensus 806 FGla~ 810 (1016)
|+.++
T Consensus 189 l~r~~ 193 (268)
T PRK15123 189 LHRAQ 193 (268)
T ss_pred CCccc
Confidence 99886
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.70 E-value=1.2e-07 Score=99.14 Aligned_cols=134 Identities=25% Similarity=0.254 Sum_probs=100.1
Q ss_pred ccccCccccCCCeeEEEEEcCCCcEEEEEEccCCCh----------------------hhhHHHHHHHHHHHhcCCC--C
Q 001768 661 FDAANKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSK----------------------QGNREFVNEIGMISALQHQ--N 716 (1016)
Q Consensus 661 f~~~~~LG~G~~G~Vy~~~~~~~~~vAvK~~~~~~~----------------------~~~~~~~~E~~~l~~l~Hp--n 716 (1016)
..+..+||.|--+.||.|..+.|.++|||.-+.... -.....++|.++|+++.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 456789999999999999999999999996532110 1123467899999998644 6
Q ss_pred eeeeeeeEeecceeEEEEeecCCCcHHHHhccCcCcCcCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCceEEEc
Q 001768 717 LVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLD 796 (1016)
Q Consensus 717 Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~ 796 (1016)
+++.+++ +...+||||++|-.|... +++.+....|+..|++-+..+-.. ||||+|+.+-||+++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~---------r~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~ 236 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRL---------RLDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVT 236 (304)
T ss_pred CCCcccc----ccceeeeehcccceeecc---------cCcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEe
Confidence 6666654 467899999998655443 223444555666666666655555 899999999999999
Q ss_pred cCCceeeecccccc
Q 001768 797 KDLNAKISDFGLAK 810 (1016)
Q Consensus 797 ~~~~~kL~DFGla~ 810 (1016)
++|.+.++||-.+.
T Consensus 237 ~dg~~~vIDwPQ~v 250 (304)
T COG0478 237 EDGDIVVIDWPQAV 250 (304)
T ss_pred cCCCEEEEeCcccc
Confidence 99999999997765
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.58 E-value=1.1e-09 Score=125.29 Aligned_cols=127 Identities=23% Similarity=0.228 Sum_probs=76.1
Q ss_pred CccEEEecCCcCCCCCchhhhcCCCCCEEeecCCcCCCCCchhhcCCCCCCEEEcCCCCCCCCCCcccccccccceeecc
Q 001768 206 NLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISDLKGSSSSFPNLQDMKKMERLILR 285 (1016)
Q Consensus 206 ~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls 285 (1016)
.|...+.+.|.+. .+..++.-++.|+.|+|++|+++... .+..++.|+.|||++|.+..++.-....+. |..|.|+
T Consensus 165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lr 240 (1096)
T KOG1859|consen 165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLR 240 (1096)
T ss_pred hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhccccccchhhhh-heeeeec
Confidence 4555555555555 44455555566666666666666332 556666666666666666555444433433 7777777
Q ss_pred cccccccCchhhcCCCCCceEeccCCCCCCCCc-cccCCCCCCCEEEccCCcCC
Q 001768 286 NCLITGRIPEYIEDMTDLKILDLSFNQLTGPVP-GILQNLKKIDYIFLTNNSLS 338 (1016)
Q Consensus 286 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~L~~~~p-~~l~~l~~L~~L~L~~N~l~ 338 (1016)
+|.++.. ..+.++.+|+.|||++|-|.+.-- ..+..|..|..|+|.+|++.
T Consensus 241 nN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 241 NNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred ccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 7777632 236667777777777777764322 23455666777777777775
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.58 E-value=2.8e-08 Score=81.99 Aligned_cols=61 Identities=36% Similarity=0.513 Sum_probs=46.2
Q ss_pred cccceeecccccccccCchhhcCCCCCceEeccCCCCCCCCccccCCCCCCCEEEccCCcC
Q 001768 277 KKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSL 337 (1016)
Q Consensus 277 ~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~L~~~~p~~l~~l~~L~~L~L~~N~l 337 (1016)
++|++|+|++|+|+...+..|..+++|++|++++|+|+...|..|.++++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 4577777777777766666777788888888888888766667778888888888887764
|
... |
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.57 E-value=3e-09 Score=121.91 Aligned_cols=195 Identities=25% Similarity=0.304 Sum_probs=140.6
Q ss_pred CCccEEEcccCCCCCCC-CCCCCCCccchhhhccCCccCCCCCcccCCC-CCccEEEecCCcCC----------CCCchh
Q 001768 157 STLEELVLEDNQLVGPL-PENLGNLKSLRRILLSSNNFTGSIPESYGNL-KNLTEFRIDGSNLT----------GRIPNF 224 (1016)
Q Consensus 157 ~~L~~L~Ls~N~l~~~~-p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l-~~L~~L~L~~N~l~----------~~~~~~ 224 (1016)
++++.|.+-.-.-.+.. |-.+....+|+.|.|.++.|.. ...+..+ ..|+.|... |.+. |.+.++
T Consensus 84 qkt~~lkl~~~pa~~pt~pi~ifpF~sLr~LElrg~~L~~--~~GL~~lr~qLe~LIC~-~Sl~Al~~v~ascggd~~ns 160 (1096)
T KOG1859|consen 84 QKTKVLKLLPSPARDPTEPISIFPFRSLRVLELRGCDLST--AKGLQELRHQLEKLICH-NSLDALRHVFASCGGDISNS 160 (1096)
T ss_pred hhheeeeecccCCCCCCCCceeccccceeeEEecCcchhh--hhhhHHHHHhhhhhhhh-ccHHHHHHHHHHhccccccc
Confidence 44445544443333222 5567788899999999998873 1222222 245555332 3322 111111
Q ss_pred hhcCCCCCEEeecCCcCCCCCchhhcCCCCCCEEEcCCCCCCCCCCcccccccccceeecccccccccCch-hhcCCCCC
Q 001768 225 IGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISDLKGSSSSFPNLQDMKKMERLILRNCLITGRIPE-YIEDMTDL 303 (1016)
Q Consensus 225 l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~-~l~~l~~L 303 (1016)
+ ....|...+++.|++. .+..++.-++.|+.|+|++|++...+ .+..+++|+.|||+.|.++ .+|. ....+ +|
T Consensus 161 ~-~Wn~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc-~L 234 (1096)
T KOG1859|consen 161 P-VWNKLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLR-HVPQLSMVGC-KL 234 (1096)
T ss_pred h-hhhhHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhc-cccccchhhh-hh
Confidence 1 1236888999999998 66778889999999999999999887 7889999999999999999 5554 23344 49
Q ss_pred ceEeccCCCCCCCCccccCCCCCCCEEEccCCcCCC---CCChhhhccCCcccCCCCcCCCC
Q 001768 304 KILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSG---TLPDWILTSEKNLDLSYNNFTES 362 (1016)
Q Consensus 304 ~~L~Ls~N~L~~~~p~~l~~l~~L~~L~L~~N~l~g---~~p~~~~~~L~~LdLs~N~l~~~ 362 (1016)
+.|+|++|.++. + ..+.+|.+|+.|||+.|-|.+ ..|.|.+..|+.|+|.+|++.+.
T Consensus 235 ~~L~lrnN~l~t-L-~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~ 294 (1096)
T KOG1859|consen 235 QLLNLRNNALTT-L-RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCA 294 (1096)
T ss_pred eeeeecccHHHh-h-hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccC
Confidence 999999999983 2 347789999999999998875 45667789999999999999765
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.56 E-value=5.9e-09 Score=108.22 Aligned_cols=86 Identities=26% Similarity=0.301 Sum_probs=41.0
Q ss_pred CCCCCCEEEccCCCCCC--CCchhhhcccCcccccccccccCCCCCcccCCcCCccEEEcccCCCCCC-CCCCCCCCccc
Q 001768 107 NLTFLQEVDLSRNYFNG--SLPKSFARLQNLTKLLILGNRLSGSIPLEIGDISTLEELVLEDNQLVGP-LPENLGNLKSL 183 (1016)
Q Consensus 107 ~l~~L~~L~Ls~n~i~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~l~~l~~L 183 (1016)
..+.+++|||.+|.|+. .+-..+.+||.|++|+|+.|++...|-..-..+.+|+.|-|.+..+.-. ....+..+|.+
T Consensus 69 ~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~v 148 (418)
T KOG2982|consen 69 SVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRVLVLNGTGLSWTQSTSSLDDLPKV 148 (418)
T ss_pred HhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEEEEEcCCCCChhhhhhhhhcchhh
Confidence 34555666666666552 2233344555666666666655533322112344555555555544311 12233445555
Q ss_pred hhhhccCCc
Q 001768 184 RRILLSSNN 192 (1016)
Q Consensus 184 ~~L~Ls~N~ 192 (1016)
+.|++|.|+
T Consensus 149 telHmS~N~ 157 (418)
T KOG2982|consen 149 TELHMSDNS 157 (418)
T ss_pred hhhhhccch
Confidence 555555553
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.53 E-value=4.1e-08 Score=80.96 Aligned_cols=59 Identities=32% Similarity=0.434 Sum_probs=31.2
Q ss_pred CCCEEEccCCCCCCCCchhhhcccCcccccccccccCCCCCcccCCcCCccEEEcccCC
Q 001768 110 FLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGDISTLEELVLEDNQ 168 (1016)
Q Consensus 110 ~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 168 (1016)
+|++|+|++|+|+...+..|..+++|++|+|++|.++...|..|..+++|++|+|++|+
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 45555555555554444455555555555555555554444455555555555555554
|
... |
| >COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.46 E-value=1.7e-08 Score=103.52 Aligned_cols=112 Identities=14% Similarity=0.155 Sum_probs=53.5
Q ss_pred CCCccEEEecCCcCCCCCc----hhhhcCCCCCEEeecCCcCCCC-----CchhhcCCCCCCEEEcCCCCCCCCCCcc--
Q 001768 204 LKNLTEFRIDGSNLTGRIP----NFIGNWTKLDRLDLQGTSLEGP-----IPSTISQLKNLTELRISDLKGSSSSFPN-- 272 (1016)
Q Consensus 204 l~~L~~L~L~~N~l~~~~~----~~l~~l~~L~~L~Ls~N~l~~~-----~p~~l~~l~~L~~L~Ls~n~l~~~~~~~-- 272 (1016)
-|.|+.+....|++..... ..+..-.+|+.+.+..|.|.-. +-..+..+.+|+.|+|.+|.++......
T Consensus 156 kp~Le~vicgrNRlengs~~~~a~~l~sh~~lk~vki~qNgIrpegv~~L~~~gl~y~~~LevLDlqDNtft~~gS~~La 235 (388)
T COG5238 156 KPKLEVVICGRNRLENGSKELSAALLESHENLKEVKIQQNGIRPEGVTMLAFLGLFYSHSLEVLDLQDNTFTLEGSRYLA 235 (388)
T ss_pred CCCceEEEeccchhccCcHHHHHHHHHhhcCceeEEeeecCcCcchhHHHHHHHHHHhCcceeeeccccchhhhhHHHHH
Confidence 3456666666665542111 1122223566666666655522 1112344556666666666555433322
Q ss_pred --cccccccceeecccccccccCchhh------cCCCCCceEeccCCCCCC
Q 001768 273 --LQDMKKMERLILRNCLITGRIPEYI------EDMTDLKILDLSFNQLTG 315 (1016)
Q Consensus 273 --l~~l~~L~~L~Ls~N~l~~~~p~~l------~~l~~L~~L~Ls~N~L~~ 315 (1016)
+...+.|+.|.+.+|-++..-..++ ...|+|..|-+.+|...+
T Consensus 236 ~al~~W~~lrEL~lnDClls~~G~~~v~~~f~e~~~p~l~~L~~~Yne~~~ 286 (388)
T COG5238 236 DALCEWNLLRELRLNDCLLSNEGVKSVLRRFNEKFVPNLMPLPGDYNERRG 286 (388)
T ss_pred HHhcccchhhhccccchhhccccHHHHHHHhhhhcCCCccccccchhhhcC
Confidence 2334455666666666554332221 123556666666666554
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.41 E-value=8.4e-08 Score=111.37 Aligned_cols=151 Identities=19% Similarity=0.298 Sum_probs=102.8
Q ss_pred HHHHHHHHHHHHhcCCCCeEeCCCCCceEEEccCCceeeeccccccccCCCCcc--------eeeecccCccccChhhhc
Q 001768 765 CSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTH--------ISTRIAGTVGYMAPEYAM 836 (1016)
Q Consensus 765 ~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~--------~~~~~~gt~~y~aPE~~~ 836 (1016)
+.+++.|+.|+|... ++||++|.|++|.++..+.+||+.|+.+......... ...-..-...|.|||++.
T Consensus 105 l~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 445669999999874 8999999999999999999999999987543321111 111122345799999999
Q ss_pred cCCCCCccchhHHHHHHHHHHhCCCC-CCCCCchhhHhHHHHHHHHHHhCCcccccCCcCCCCCCHHHHHHHHHHHHHcc
Q 001768 837 RGYLTDKADVYSFGIVALEIVSGKSN-TNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCT 915 (1016)
Q Consensus 837 ~~~~~~~sDVwSlGvvl~elltG~~P-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl 915 (1016)
....+.++|+||+||++|.+..|..+ +........... ....+..-...+....+.++.+=+.+++
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~-------------~~~~~~~~~~~~s~~~p~el~~~l~k~l 249 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSF-------------SRNLLNAGAFGYSNNLPSELRESLKKLL 249 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchhhh-------------hhcccccccccccccCcHHHHHHHHHHh
Confidence 88889999999999999999855444 332211111000 0001111111233445567888888999
Q ss_pred CCCCCCCCCHHHHHH
Q 001768 916 NPSPTLRPTMSSAVS 930 (1016)
Q Consensus 916 ~~dP~~RPt~~evl~ 930 (1016)
..++..||++.++..
T Consensus 250 ~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 250 NGDSAVRPTLDLLLS 264 (700)
T ss_pred cCCcccCcchhhhhc
Confidence 999999998776654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.40 E-value=2.2e-06 Score=89.83 Aligned_cols=106 Identities=23% Similarity=0.248 Sum_probs=84.1
Q ss_pred hHHHHHHHHHHHhcCCC--CeeeeeeeEeec----ceeEEEEeecCCC-cHHHHhccCcCcCcCCCHHHHHHHHHHHHHH
Q 001768 699 NREFVNEIGMISALQHQ--NLVKLYGCCIEG----NQLLLVYEYLENN-SLARALFGKEGQCLNLDWATRKRICSDIARG 771 (1016)
Q Consensus 699 ~~~~~~E~~~l~~l~Hp--nIv~l~~~~~~~----~~~~lV~E~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~qia~~ 771 (1016)
.....+|...+..+... ..++.+++.... ...++|+|++++. +|.+++.... ..+......++.++++.
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~----~~~~~~~~~ll~~l~~~ 130 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE----QLDPSQRRELLRALARL 130 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc----ccchhhHHHHHHHHHHH
Confidence 34677888888887533 345566666542 2458999999884 7999886533 25666788999999999
Q ss_pred HHHHHhcCCCCeEeCCCCCceEEEccCC---ceeeeccccccc
Q 001768 772 LAYLHEESRLKIVHRDIKATNVLLDKDL---NAKISDFGLAKL 811 (1016)
Q Consensus 772 L~yLH~~~~~~iiHrDlkp~NILl~~~~---~~kL~DFGla~~ 811 (1016)
++-||+. ||+|+|+++.|||++.+. .+.++||+.++.
T Consensus 131 i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 131 IAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9999999 999999999999999887 899999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.40 E-value=3.3e-08 Score=102.77 Aligned_cols=86 Identities=22% Similarity=0.268 Sum_probs=36.9
Q ss_pred CCCCCEEEccCCCCCCCC-chhhh-cccCcccccccccccCC--CCCcccCCcCCccEEEcccCCCCCCCCCCCCCCccc
Q 001768 108 LTFLQEVDLSRNYFNGSL-PKSFA-RLQNLTKLLILGNRLSG--SIPLEIGDISTLEELVLEDNQLVGPLPENLGNLKSL 183 (1016)
Q Consensus 108 l~~L~~L~Ls~n~i~~~~-p~~~~-~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L 183 (1016)
+..++.|.|.++.|...- ...|+ ..+.++.|||.+|.|+. ++-.-+.+|+.|+.|+|+.|++...|-..-..+.+|
T Consensus 44 ~ra~ellvln~~~id~~gd~~~~~~~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl 123 (418)
T KOG2982|consen 44 LRALELLVLNGSIIDNEGDVMLFGSSVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNL 123 (418)
T ss_pred ccchhhheecCCCCCcchhHHHHHHHhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccce
Confidence 334444555555544221 11122 24556666666666552 122233445555555555555543222111223344
Q ss_pred hhhhccCCcc
Q 001768 184 RRILLSSNNF 193 (1016)
Q Consensus 184 ~~L~Ls~N~l 193 (1016)
++|.|.+..+
T Consensus 124 ~~lVLNgT~L 133 (418)
T KOG2982|consen 124 RVLVLNGTGL 133 (418)
T ss_pred EEEEEcCCCC
Confidence 4444444443
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 1016 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 5e-65 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-64 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-55 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 5e-55 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-43 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-43 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-41 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-39 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 8e-27 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 9e-27 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-25 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 7e-25 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 9e-25 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-24 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-24 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-24 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-24 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-24 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-24 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-24 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-24 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-24 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-24 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-24 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-24 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-24 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-24 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-24 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-24 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-24 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-24 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 2e-24 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 3e-10 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-24 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-24 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-24 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-24 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-24 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 3e-24 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 4e-10 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-24 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-24 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-24 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-24 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-24 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 5e-24 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-24 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-23 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-23 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-23 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-23 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-23 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-23 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-23 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-23 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 7e-23 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 8e-23 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 8e-23 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 8e-23 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 9e-23 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 9e-23 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 9e-23 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 9e-23 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-22 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-22 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-22 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-22 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-22 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-22 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-22 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-22 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-22 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-22 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-22 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-22 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-22 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-22 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 5e-22 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-22 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-22 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-21 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-21 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-21 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 4e-21 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-21 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-21 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-21 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 5e-21 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 6e-21 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-20 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-20 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-20 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-20 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-20 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-20 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-20 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-20 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-20 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-20 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-20 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 6e-20 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 7e-20 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-20 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-19 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-19 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-19 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-19 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-19 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-19 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-19 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-19 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-19 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-19 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-19 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-19 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-19 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-19 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-19 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-19 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-19 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-19 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-19 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-19 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 4e-19 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-19 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 5e-19 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 5e-19 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 5e-19 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 5e-19 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 7e-19 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 8e-19 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-18 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-18 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-18 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-18 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-18 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-18 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-18 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-18 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-18 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-18 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-18 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-18 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-18 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-18 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-18 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-18 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-18 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-18 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-18 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-18 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-18 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-18 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-18 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-18 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-18 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-18 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-18 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-18 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-18 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-18 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-18 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 5e-18 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 5e-18 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 5e-18 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 5e-18 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 5e-18 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 5e-18 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 5e-18 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 5e-18 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 5e-18 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-18 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 6e-18 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 6e-18 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 6e-18 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 6e-18 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 7e-18 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 7e-18 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 7e-18 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 8e-18 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 8e-18 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 9e-18 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 9e-18 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 9e-18 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-17 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-17 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-17 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-17 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-17 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-17 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-17 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-17 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-17 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-17 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-17 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-17 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-17 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-17 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-17 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-17 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-17 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-17 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-17 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-17 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-17 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-17 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-17 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-17 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-17 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-17 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-17 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 3e-17 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 2e-07 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-17 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-17 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-17 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-17 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-17 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-17 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-17 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-17 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-17 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-17 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-17 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-17 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-17 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-17 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-17 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-17 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-17 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-17 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-17 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-17 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-17 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-17 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-17 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-17 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-17 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-17 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-17 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-17 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-17 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-17 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 5e-17 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-17 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 6e-17 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 6e-17 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 6e-17 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 6e-17 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 7e-17 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-17 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 7e-17 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 7e-17 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 9e-17 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 9e-17 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 9e-17 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-17 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-16 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-16 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-16 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-16 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-16 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-16 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-16 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-16 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-16 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-16 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-16 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-16 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-16 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-16 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-16 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-16 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-16 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-16 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-16 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-16 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-16 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-16 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-16 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-16 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-16 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-16 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 3e-16 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-16 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-16 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-16 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-16 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-16 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-16 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-16 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 4e-16 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-16 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-16 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 4e-16 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-16 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 4e-16 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-16 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 4e-16 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 4e-16 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-16 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 4e-16 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-16 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 4e-16 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-16 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 4e-16 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 4e-16 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 4e-16 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 4e-16 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-16 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-16 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-16 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-16 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-16 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-16 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 5e-16 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-16 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-16 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-16 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-16 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 5e-16 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-16 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 5e-16 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 5e-16 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 5e-16 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-16 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-16 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 6e-16 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 6e-16 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-16 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-16 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 6e-16 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-16 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 6e-16 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-16 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 6e-16 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 6e-16 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-16 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 7e-16 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-16 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-16 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 7e-16 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 7e-16 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-16 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 7e-16 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 8e-16 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-16 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 8e-16 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-16 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 8e-16 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 8e-16 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 9e-16 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 9e-16 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-16 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 9e-16 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 9e-16 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 9e-16 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-15 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-15 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-15 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-15 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-15 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-15 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-15 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-15 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-15 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-15 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-15 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-15 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-15 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-15 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-15 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-15 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-15 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-15 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-15 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-15 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-15 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-15 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-15 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-15 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-15 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-15 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-15 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-15 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-15 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-15 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 4e-15 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-15 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 4e-15 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-15 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 4e-15 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 4e-15 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-15 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-15 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 5e-15 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 5e-15 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 5e-15 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 5e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-15 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 5e-15 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 5e-15 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-15 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 5e-15 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 5e-15 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 5e-15 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-15 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 5e-15 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 5e-15 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 6e-15 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 6e-15 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 6e-15 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 6e-15 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 6e-15 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 6e-15 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-15 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-15 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 7e-15 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 7e-15 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 7e-15 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 7e-15 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 7e-15 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 7e-15 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-15 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 7e-15 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 7e-15 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 8e-15 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 8e-15 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 8e-15 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 8e-15 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 9e-15 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 9e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 9e-15 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 9e-15 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-14 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-14 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-14 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-14 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-14 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-14 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-14 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-14 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-14 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-14 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-14 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-14 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-14 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-14 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-14 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-14 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-14 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-14 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-14 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-14 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-14 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-14 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-14 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-14 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-14 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-14 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-14 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-14 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-14 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-14 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-14 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-14 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-14 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-14 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-14 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-14 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-14 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-14 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-14 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-14 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-14 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-14 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-14 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-14 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-14 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-14 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-14 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 4e-14 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-14 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-14 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-14 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-14 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-14 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-14 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-14 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 5e-14 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-14 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-14 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-14 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-14 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 5e-14 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-14 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 5e-14 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 6e-14 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-14 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-14 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-14 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 7e-14 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 7e-14 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 7e-14 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 9e-14 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-13 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-13 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-13 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-13 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-13 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-13 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-13 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-13 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-13 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-13 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-13 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-13 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-13 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-13 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-13 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-13 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-13 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-13 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-13 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-13 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-13 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-13 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-13 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-13 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-13 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-13 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-13 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-13 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-13 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-13 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-13 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-13 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-13 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-13 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-13 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 4e-13 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-13 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 4e-13 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 4e-13 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-13 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-13 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-13 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-13 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-13 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-13 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-13 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-13 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-13 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-13 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-13 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-13 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 5e-13 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 5e-13 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 5e-13 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 5e-13 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-13 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 5e-13 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-13 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-13 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 5e-13 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 5e-13 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 6e-13 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-13 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 7e-13 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 8e-13 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 8e-13 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 8e-13 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-12 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-12 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-12 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-12 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-12 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-12 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-12 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-12 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-12 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-12 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-12 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-12 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-12 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-12 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-12 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-12 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-12 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-12 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-12 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-12 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-12 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-12 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-12 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-12 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-12 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-12 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-12 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-12 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-12 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-12 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-12 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-12 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-12 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-12 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-12 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-12 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-12 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-12 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-12 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-12 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-12 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-12 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-12 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-12 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-12 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-12 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-12 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-12 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-12 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-12 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-12 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-12 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-12 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-12 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-12 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-12 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-12 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-12 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-12 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-12 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 4e-12 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-12 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-12 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 5e-12 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 5e-12 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 5e-12 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 5e-12 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-12 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-12 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 6e-12 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-12 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-12 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 6e-12 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 6e-12 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 6e-12 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 7e-12 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 7e-12 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 7e-12 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 7e-12 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 7e-12 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 8e-12 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 8e-12 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 8e-12 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 8e-12 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-12 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 8e-12 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 8e-12 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 8e-12 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 8e-12 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 8e-12 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 8e-12 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 8e-12 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 8e-12 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 8e-12 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 8e-12 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 8e-12 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 8e-12 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 8e-12 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 8e-12 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 9e-12 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 9e-12 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 9e-12 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 9e-12 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 9e-12 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 9e-12 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-11 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-11 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-11 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-11 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-11 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-11 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-11 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-11 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-11 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-11 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-11 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-11 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-11 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-11 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-11 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-11 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-11 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-11 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-11 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-11 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-11 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-11 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-11 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-11 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-11 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-11 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-11 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-11 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-11 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-11 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-11 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-11 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-11 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-11 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-11 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-11 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-11 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-11 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-11 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-11 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-11 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-11 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-11 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-11 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-11 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-11 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-11 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-11 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-11 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 5e-11 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 5e-11 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 5e-11 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 5e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 6e-11 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 6e-11 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 7e-11 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 7e-11 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 7e-11 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 7e-11 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 7e-11 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 8e-11 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 8e-11 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 8e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-11 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-10 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-10 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-10 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-10 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-10 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-10 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-10 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-10 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-10 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-10 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-10 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-10 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-10 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-10 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-10 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-10 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-10 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-10 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-10 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-10 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-10 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-10 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-10 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-10 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-10 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-10 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-10 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-10 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-10 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 3e-10 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-10 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-10 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-10 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-10 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-10 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-10 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 4e-10 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-10 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-10 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 4e-10 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-10 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 4e-10 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 4e-10 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-10 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 4e-10 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 5e-10 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 5e-10 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 5e-10 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 6e-10 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-10 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 6e-10 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 6e-10 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 7e-10 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 7e-10 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 7e-10 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 9e-10 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-09 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-09 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-09 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-09 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-09 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 4e-09 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-09 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 5e-09 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 5e-09 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 5e-09 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 5e-09 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 5e-09 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 6e-09 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 6e-09 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 6e-09 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 7e-09 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 8e-09 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 9e-09 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 9e-09 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-09 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-09 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-08 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-08 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 1e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-08 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 2e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-08 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-08 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 2e-08 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-08 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 2e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-08 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-08 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-08 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-08 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-08 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-08 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-08 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-08 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-08 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-08 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-08 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-08 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-08 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-08 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-08 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 4e-08 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-08 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 4e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-08 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 4e-08 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 5e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 5e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 5e-08 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 5e-08 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 6e-08 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 6e-08 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 6e-08 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 7e-08 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 7e-08 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 7e-08 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 7e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 7e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 7e-08 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 7e-08 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 8e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-08 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 8e-08 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 9e-08 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 9e-08 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-07 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-07 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-07 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-07 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-07 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-07 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-07 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-07 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-07 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-07 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-07 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-07 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-07 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-07 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-07 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-07 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-07 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-07 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-07 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-07 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-07 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-07 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-07 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-07 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-07 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-07 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-07 | ||
| 4fcg_A | 328 | Structure Of The Leucine-Rich Repeat Domain Of The | 3e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-07 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-07 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-07 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-07 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-07 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-07 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 4e-07 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-07 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-07 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 4e-07 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-07 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 5e-07 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 6e-07 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-07 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 7e-07 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 7e-07 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 7e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 7e-07 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 8e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 8e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 9e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 9e-07 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 1e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-06 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-06 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-06 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-06 | ||
| 2id5_A | 477 | Crystal Structure Of The Lingo-1 Ectodomain Length | 2e-06 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 2e-06 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-06 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-06 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-06 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-06 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-06 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-06 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 4e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 4e-06 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 6e-06 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 7e-06 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 8e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 9e-06 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-05 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-05 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-05 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-05 | ||
| 3b2d_A | 603 | Crystal Structure Of Human Rp105MD-1 Complex Length | 3e-05 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-05 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 4e-05 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 5e-05 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 6e-05 | ||
| 1xku_A | 330 | Crystal Structure Of The Dimeric Protein Core Of De | 6e-05 | ||
| 1xcd_A | 329 | Dimeric Bovine Tissue-Extracted Decorin, Crystal Fo | 6e-05 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 8e-05 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 9e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 9e-05 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|4FCG|A Chain A, Structure Of The Leucine-Rich Repeat Domain Of The Type Iii Effector Xcv3220 (Xopl) Length = 328 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2ID5|A Chain A, Crystal Structure Of The Lingo-1 Ectodomain Length = 477 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3B2D|A Chain A, Crystal Structure Of Human Rp105MD-1 Complex Length = 603 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|1XKU|A Chain A, Crystal Structure Of The Dimeric Protein Core Of Decorin, The Archetypal Small Leucine-Rich Repeat Proteoglycan Length = 330 | Back alignment and structure |
|
| >pdb|1XCD|A Chain A, Dimeric Bovine Tissue-Extracted Decorin, Crystal Form 1 Length = 329 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 549 bits (1416), Expect = 0.0
Identities = 129/305 (42%), Positives = 190/305 (62%), Gaps = 4/305 (1%)
Query: 634 VEDKELRGLDL-QTGYFTLRQIKAATNNFDAANKIGEGGFGPVYKGTLSDGAVIAVKQLS 692
V +E + L Q F+LR+++ A++NF N +G GGFG VYKG L+DG ++AVK+L
Sbjct: 4 VPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLK 63
Query: 693 SKSKQGN-REFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEG 751
+ QG +F E+ MIS H+NL++L G C+ + LLVY Y+ N S+A L +
Sbjct: 64 EERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPE 123
Query: 752 QCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKL 811
LDW R+RI ARGLAYLH+ KI+HRD+KA N+LLD++ A + DFGLAKL
Sbjct: 124 SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 183
Query: 812 DEDENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYR--PKE 869
+ ++TH++T + GT+G++APEY G ++K DV+ +G++ LE+++G+ + +
Sbjct: 184 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAND 243
Query: 870 EFVYLLDWAYVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAV 929
+ V LLDW L ++ L LVD L N+ +E ++ +ALLCT SP RP MS V
Sbjct: 244 DDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVV 303
Query: 930 SMLEG 934
MLEG
Sbjct: 304 RMLEG 308
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 492 bits (1268), Expect = e-167
Identities = 119/303 (39%), Positives = 178/303 (58%), Gaps = 4/303 (1%)
Query: 642 LDLQTGYFTLRQIKAATNNFDAANKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGNRE 701
+ ++ L ++ ATNNFD IG G FG VYKG L DGA +A+K+ + +S QG E
Sbjct: 22 VPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEE 81
Query: 702 FVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATR 761
F EI +S +H +LV L G C E N+++L+Y+Y+EN +L R L+G + +++ W R
Sbjct: 82 FETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQR 141
Query: 762 KRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKL-DEDENTHIS 820
IC ARGL YLH + I+HRD+K+ N+LLD++ KI+DFG++K E + TH+S
Sbjct: 142 LEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLS 198
Query: 821 TRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYV 880
T + GT+GY+ PEY ++G LT+K+DVYSFG+V E++ +S E V L +WA
Sbjct: 199 TVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVE 258
Query: 881 LQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTAVQA 940
G L ++VDP+L + + A+ C S RP+M + LE +Q
Sbjct: 259 SHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQE 318
Query: 941 PII 943
+I
Sbjct: 319 SVI 321
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 482 bits (1244), Expect = e-164
Identities = 112/315 (35%), Positives = 174/315 (55%), Gaps = 21/315 (6%)
Query: 635 EDKELRGLDLQTGYFTLRQIKAATNNFD------AANKIGEGGFGPVYKGTLSDGAVIAV 688
E+K L D + F+ ++K TNNFD NK+GEGGFG VYKG + + +AV
Sbjct: 1 ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAV 59
Query: 689 KQLSS----KSKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYLENNSLAR 744
K+L++ +++ ++F EI +++ QH+NLV+L G +G+ L LVY Y+ N SL
Sbjct: 60 KKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLD 119
Query: 745 ALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKIS 804
L +G L W R +I A G+ +LHE +HRDIK+ N+LLD+ AKIS
Sbjct: 120 RLSCLDGT-PPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKIS 175
Query: 805 DFGLAKL-DEDENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNT 863
DFGLA+ ++ T +++RI GT YMAPE +RG +T K+D+YSFG+V LEI++G
Sbjct: 176 DFGLARASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAV 234
Query: 864 NYRPKEEFVYLLDWAY-VLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLR 922
+ + + LLD + E+ + + +D + + M ++A C + R
Sbjct: 235 DEHREPQ--LLLDIKEEIEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKR 291
Query: 923 PTMSSAVSMLEGKTA 937
P + +L+ TA
Sbjct: 292 PDIKKVQQLLQEMTA 306
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 283 bits (725), Expect = 1e-87
Identities = 75/308 (24%), Positives = 119/308 (38%), Gaps = 30/308 (9%)
Query: 649 FTLRQIKAATNNFDAANKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGNREFVNEIGM 708
+ + G FG V+K L +AVK + KQ + E+
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQS-WQNEYEVYS 71
Query: 709 ISALQHQNLVKLYGCCIEGN----QLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRI 764
+ ++H+N+++ G G L L+ + E SL+ L + W I
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV-----VSWNELCHI 126
Query: 765 CSDIARGLAYLHEE-------SRLKIVHRDIKATNVLLDKDLNAKISDFGLAK-LDEDEN 816
+ARGLAYLHE+ + I HRDIK+ NVLL +L A I+DFGLA + ++
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS 186
Query: 817 THISTRIAGTVGYMAPEYAMRGYLTD-----KADVYSFGIVALEIVSGKSNTNYRPKEEF 871
+ GT YMAPE + D+Y+ G+V E+ S + + E
Sbjct: 187 AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM 246
Query: 872 VYLLDWAYVLQEQGNLLELV-----DPSLGSNFSKKEAMTML-NIALLCTNPSPTLRPTM 925
+ + ++ E+V P L + K M ML C + R +
Sbjct: 247 LPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSA 306
Query: 926 SSAVSMLE 933
+
Sbjct: 307 GCVGERIT 314
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 244 bits (625), Expect = 3e-73
Identities = 76/315 (24%), Positives = 119/315 (37%), Gaps = 49/315 (15%)
Query: 657 ATNNFDAANKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGNREFVNE--IGMISALQH 714
+N IG G +G VYKG+L D +AVK S ++Q F+NE I + ++H
Sbjct: 11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEKNIYRVPLMEH 66
Query: 715 QNLVKLYGCCIEGN-----QLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIA 769
N+ + + LLV EY N SL + L DW + R+ +
Sbjct: 67 DNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT-----SDWVSSCRLAHSVT 121
Query: 770 RGLAYLHEE------SRLKIVHRDIKATNVLLDKDLNAKISDFGLAKL-------DEDEN 816
RGLAYLH E + I HRD+ + NVL+ D ISDFGL+ E
Sbjct: 122 RGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEE 181
Query: 817 THISTRIAGTVGYMAPEYAM-------RGYLTDKADVYSFGIVALEIVSGKSNTN-YRPK 868
+ + GT+ YMAPE + D+Y+ G++ EI ++
Sbjct: 182 DNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV 241
Query: 869 EEFVYLLDWAYVLQEQGNLLELVD--------PSLGSNFSKKEAM--TMLNIALLCTNPS 918
E Y + + + ++ P + + ++ C +
Sbjct: 242 PE--YQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQD 299
Query: 919 PTLRPTMSSAVSMLE 933
R T A +
Sbjct: 300 AEARLTAQXAEERMA 314
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 237 bits (606), Expect = 1e-70
Identities = 88/290 (30%), Positives = 123/290 (42%), Gaps = 19/290 (6%)
Query: 60 SWNVTIDDSNGS--NFTCDCTYSNNTVCHVTVILLKGFNLAGV--IPEEFGNLTFLQEVD 115
SW T D N + CD V + L G NL IP NL +L +
Sbjct: 26 SWLPTTDCCNRTWLGVLCDTDTQTY---RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLY 82
Query: 116 LS-RNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGDISTLEELVLEDNQLVGPLP 174
+ N G +P + A+L L L I +SG+IP + I TL L N L G LP
Sbjct: 83 IGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLP 142
Query: 175 ENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEF-RIDGSNLTGRIPNFIGNWTKLDR 233
++ +L +L I N +G+IP+SYG+ L I + LTG+IP N L
Sbjct: 143 PSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAF 201
Query: 234 LDLQGTSLEGPIPSTISQLKNLTELRISD--LKGSSSSFPNLQDMKKMERLILRNCLITG 291
+DL LEG KN ++ ++ L + K + L LRN I G
Sbjct: 202 VDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAF---DLGKVGLSKNLNGLDLRNNRIYG 258
Query: 292 RIPEYIEDMTDLKILDLSFNQLTGPVP--GILQNLKKIDYIFLTNNSLSG 339
+P+ + + L L++SFN L G +P G LQ Y N L G
Sbjct: 259 TLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYAN--NKCLCG 306
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 4e-58
Identities = 62/274 (22%), Positives = 102/274 (37%), Gaps = 32/274 (11%)
Query: 101 IPEEFGNLTFLQ----EVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGS--IPLEIG 154
I ++ GN T L D + G L + + + L + G L IP +
Sbjct: 14 IKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLA 73
Query: 155 DISTLEELVLED-NQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRID 213
++ L L + N LVGP+P + L L + ++ N +G+IP+ +K L
Sbjct: 74 NLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFS 133
Query: 214 GSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISDLKGSSSSFPNL 273
+ L+G +P I + L + G + G IP + L
Sbjct: 134 YNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTS--------------- 178
Query: 274 QDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLT 333
+ + +TG+IP ++ +L +DLS N L G + + K I L
Sbjct: 179 --------MTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLA 229
Query: 334 NNSLSGTLPDWI-LTSEKNLDLSYNNFTESSPAT 366
NSL+ L + LDL N + P
Sbjct: 230 KNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQG 263
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 58.3 bits (142), Expect = 4e-09
Identities = 14/56 (25%), Positives = 23/56 (41%), Gaps = 1/56 (1%)
Query: 96 NLAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPL 151
+ G +P+ L FL +++S N G +P+ LQ N+ PL
Sbjct: 255 RIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGG-NLQRFDVSAYANNKCLCGSPL 309
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 242 bits (620), Expect = 4e-68
Identities = 76/273 (27%), Positives = 133/273 (48%), Gaps = 12/273 (4%)
Query: 96 NLAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGD 155
N + IP G+ + LQ +D+S N +G ++ + L L I N+ G IP
Sbjct: 211 NFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLP-- 267
Query: 156 ISTLEELVLEDNQLVGPLPENL-GNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDG 214
+ +L+ L L +N+ G +P+ L G +L + LS N+F G++P +G+ L +
Sbjct: 268 LKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSS 327
Query: 215 SNLTGRIP-NFIGNWTKLDRLDLQGTSLEGPIPSTISQLK-NLTELRISD--LKGS-SSS 269
+N +G +P + + L LDL G +P +++ L +L L +S G +
Sbjct: 328 NNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPN 387
Query: 270 FPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDY 329
++ L L+N TG+IP + + ++L L LSFN L+G +P L +L K+
Sbjct: 388 LCQNP-KNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRD 446
Query: 330 IFLTNNSLSGTLPDWI--LTSEKNLDLSYNNFT 360
+ L N L G +P + + + + L L +N+ T
Sbjct: 447 LKLWLNMLEGEIPQELMYVKTLETLILDFNDLT 479
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 238 bits (610), Expect = 9e-67
Identities = 73/267 (27%), Positives = 119/267 (44%), Gaps = 4/267 (1%)
Query: 96 NLAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGD 155
G IP N + L + LS NY +G++P S L L L + N L G IP E+
Sbjct: 405 GFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMY 464
Query: 156 ISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGS 215
+ TLE L+L+ N L G +P L N +L I LS+N TG IP+ G L+NL ++ +
Sbjct: 465 VKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNN 524
Query: 216 NLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISDLKGSSSSFPNLQD 275
+ +G IP +G+ L LDL G IP+ + + + + + G +
Sbjct: 525 SFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGK--IAANFIAGKRYVYIKNDG 582
Query: 276 MKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNN 335
MKK G E + ++ +++ G N + ++ ++ N
Sbjct: 583 MKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYN 642
Query: 336 SLSGTLPDWI--LTSEKNLDLSYNNFT 360
LSG +P I + L+L +N+ +
Sbjct: 643 MLSGYIPKEIGSMPYLFILNLGHNDIS 669
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 227 bits (580), Expect = 8e-63
Identities = 74/274 (27%), Positives = 114/274 (41%), Gaps = 16/274 (5%)
Query: 96 NLAGVIPEEFGN--LTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEI 153
N +G I LQE+ L N F G +P + + L L + N LSG+IP +
Sbjct: 379 NFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSL 438
Query: 154 GDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRID 213
G +S L +L L N L G +P+ L +K+L ++L N+ TG IP N NL +
Sbjct: 439 GSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLS 498
Query: 214 GSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISD--LKGS-SSSF 270
+ LTG IP +IG L L L S G IP+ + ++L L ++ G+ ++
Sbjct: 499 NNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAM 558
Query: 271 PNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFN--QLTGPVPGILQNLKKID 328
+ I G+ YI++ K + N + G L L +
Sbjct: 559 FKQSGK-------IAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRN 611
Query: 329 YIFLTNNSLSGTLPDWI--LTSEKNLDLSYNNFT 360
+T+ G S LD+SYN +
Sbjct: 612 PCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLS 645
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 225 bits (576), Expect = 3e-62
Identities = 72/269 (26%), Positives = 123/269 (45%), Gaps = 8/269 (2%)
Query: 96 NLAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGD 155
L G IP+E + L+ + L N G +P + NL + + NRL+G IP IG
Sbjct: 453 MLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGR 512
Query: 156 ISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGS 215
+ L L L +N G +P LG+ +SL + L++N F G+IP + I +
Sbjct: 513 LENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGK----IAAN 568
Query: 216 NLTGRIPNFIGNWTKLDRLDLQG--TSLEGPIPSTISQLKNLTELRISDLKGSSSSFPNL 273
+ G+ +I N G +G +++L I+ + P
Sbjct: 569 FIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTF 628
Query: 274 QDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLT 333
+ M L + +++G IP+ I M L IL+L N ++G +P + +L+ ++ + L+
Sbjct: 629 DNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLS 688
Query: 334 NNSLSGTLPDWI--LTSEKNLDLSYNNFT 360
+N L G +P + LT +DLS NN +
Sbjct: 689 SNKLDGRIPQAMSALTMLTEIDLSNNNLS 717
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 190 bits (486), Expect = 1e-50
Identities = 61/284 (21%), Positives = 102/284 (35%), Gaps = 61/284 (21%)
Query: 86 HVTVILLKGFNLA---GVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILG 142
VT I L L + +LT L+ + LS ++ NGS+ F +LT L +
Sbjct: 51 KVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSR 109
Query: 143 NRLSGSIP--LEIGDISTLEELVLEDNQLVGPLP-ENLGNLKSLRRILLSSNNFTGSIPE 199
N LSG + +G S L+ L + N L P L SL + LS+N+ +G+
Sbjct: 110 NSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVV 169
Query: 200 SY---GNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLT 256
+ L I G+ ++G + + L+ LD+ + IP + L
Sbjct: 170 GWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQ 226
Query: 257 ELRISDLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGP 316
L D+S N+L+G
Sbjct: 227 HL------------------------------------------------DISGNKLSGD 238
Query: 317 VPGILQNLKKIDYIFLTNNSLSGTLPDWILTSEKNLDLSYNNFT 360
+ ++ + +++N G +P L S + L L+ N FT
Sbjct: 239 FSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQYLSLAENKFT 282
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 2e-47
Identities = 60/247 (24%), Positives = 103/247 (41%), Gaps = 32/247 (12%)
Query: 88 TVILLKGFNLAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSG 147
++ L + +G IP E G+ L +DL+ N FNG++P + + I N ++G
Sbjct: 517 AILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQS----GKIAANFIAG 572
Query: 148 SIPLEIGDISTLEELVLEDN--QLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLK 205
+ I + +E N + G E L L + ++S + G ++ N
Sbjct: 573 KRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNG 632
Query: 206 NLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISDLKG 265
++ + + L+G IP IG+ L L+L + G IP + L+ L L +S
Sbjct: 633 SMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLS---- 688
Query: 266 SSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVP--GILQN 323
N L GRIP+ + +T L +DLS N L+GP+P G +
Sbjct: 689 -------------------SNKL-DGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFET 728
Query: 324 LKKIDYI 330
++
Sbjct: 729 FPPAKFL 735
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 4e-31
Identities = 43/159 (27%), Positives = 70/159 (44%), Gaps = 11/159 (6%)
Query: 80 SNNTVCHVTVILLKGFNLAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLL 139
N+ + G+ E+ L+ +++ + G +F ++ L
Sbjct: 579 KNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLD 638
Query: 140 ILGNRLSGSIPLEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPE 199
+ N LSG IP EIG + L L L N + G +P+ +G+L+ L + LSSN G IP+
Sbjct: 639 MSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQ 698
Query: 200 SYGNLKNLTEFRIDGSNLTGRIPN-----------FIGN 227
+ L LTE + +NL+G IP F+ N
Sbjct: 699 AMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNN 737
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 3e-13
Identities = 30/140 (21%), Positives = 51/140 (36%), Gaps = 33/140 (23%)
Query: 234 LDLQGTSLE---GPIPSTISQLKNLTELRISDLKGSSSSFPNLQDMKKMERLILRNCLIT 290
+DL L + S++ L L L L N I
Sbjct: 55 IDLSSKPLNVGFSAVSSSLLSLTGLE------------------------SLFLSNSHIN 90
Query: 291 GRIPEYIEDMTDLKILDLSFNQLTGPVPGILQ--NLKKIDYIFLTNNSLSGTLPDWI--- 345
G + + L LDLS N L+GPV + + + ++ +++N+L
Sbjct: 91 GSVSG-FKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLK 149
Query: 346 LTSEKNLDLSYNNFTESSPA 365
L S + LDLS N+ + ++
Sbjct: 150 LNSLEVLDLSANSISGANVV 169
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 1e-62
Identities = 80/289 (27%), Positives = 131/289 (45%), Gaps = 30/289 (10%)
Query: 665 NKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGN--REFVNEIGMISALQHQNLVKLYG 722
KIG G FG V++ G+ +AVK L + EF+ E+ ++ L+H N+V G
Sbjct: 43 EKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 723 CCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLK 782
+ L +V EYL SL R L + LD R + D+A+G+ YLH +
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGAR-EQLDERRRLSMAYDVAKGMNYLHNRNP-P 159
Query: 783 IVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPE-YAMRGYLT 841
IVHR++K+ N+L+DK K+ DFGL++L + S AGT +MAPE
Sbjct: 160 IVHRNLKSPNLLVDKKYTVKVCDFGLSRL-KASTFLSSKSAAGTPEWMAPEVLRDEPS-N 217
Query: 842 DKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLEL---VDPSLGSN 898
+K+DVYSFG++ E+ + + +P + + LE+ ++P +
Sbjct: 218 EKSDVYSFGVILWELATLQ-----QPWGNLNP-AQVVAAVGFKCKRLEIPRNLNPQV--- 268
Query: 899 FSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEG-KTAVQAPIIRRN 946
+ C P RP+ ++ + +L + P R +
Sbjct: 269 ---AAIIEG------CWTNEPWKRPSFATIMDLLRPLIKSAVPPPNRSD 308
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 214 bits (546), Expect = 1e-62
Identities = 84/325 (25%), Positives = 135/325 (41%), Gaps = 39/325 (12%)
Query: 665 NKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCC 724
+G G FG V K +A+KQ+ +S+ + F+ E+ +S + H N+VKLYG C
Sbjct: 14 EVVGRGAFGVVCKAKW-RAKDVAIKQI--ESESERKAFIVELRQLSRVNHPNIVKLYGAC 70
Query: 725 IEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIV 784
+ N + LV EY E SL L G E A C ++G+AYLH ++
Sbjct: 71 L--NPVCLVMEYAEGGSLYNVLHGAEPLP-YYTAAHAMSWCLQCSQGVAYLHSMQPKALI 127
Query: 785 HRDIKATNVLLDKDLN-AKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRGYLTDK 843
HRD+K N+LL KI DFG A + T G+ +MAPE ++K
Sbjct: 128 HRDLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNNKGSAAWMAPEVFEGSNYSEK 183
Query: 844 ADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLEL---VDPSLGSNFS 900
DV+S+GI+ E+++ + +P +E G L + +
Sbjct: 184 CDVFSWGIILWEVITRR-----KPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPI----- 233
Query: 901 KKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTAVQAPIIRRNSDS-QDARFRAFEI 959
+ MT C + P+ RP+M V ++ ++R + + ++
Sbjct: 234 -ESLMTR------CWSKDPSQRPSMEEIVKIMT-------HLMRYFPGADEPLQYPCQHS 279
Query: 960 LSQDSQTHVSTLSQESEMQRTMSID 984
L V +E R S+D
Sbjct: 280 LPPGEDGRVEPYVDFAEFYRLWSVD 304
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 6e-62
Identities = 74/286 (25%), Positives = 119/286 (41%), Gaps = 40/286 (13%)
Query: 665 NKIGEGGFGPVYKGTL-SDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGC 723
+G+G FG K T G V+ +K+L ++ R F+ E+ ++ L+H N++K G
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 724 CIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKI 783
+ +L + EY++ +L + + Q W+ R DIA G+AYLH + I
Sbjct: 76 LYKDKRLNFITEYIKGGTLRGIIKSMDSQ---YPWSQRVSFAKDIASGMAYLHS---MNI 129
Query: 784 VHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTH-------------ISTRIAGTVGYM 830
+HRD+ + N L+ ++ N ++DFGLA+L DE T + G +M
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189
Query: 831 APEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLEL 890
APE +K DV+SFGIV EI+ + + L+
Sbjct: 190 APEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN-----VRGFLDRYC 244
Query: 891 ---VDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933
PS I + C + P RP+ LE
Sbjct: 245 PPNCPPSF------------FPITVRCCDLDPEKRPSFVKLEHWLE 278
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 2e-60
Identities = 82/288 (28%), Positives = 139/288 (48%), Gaps = 46/288 (15%)
Query: 665 NKIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGN-------REFVNEIGMISALQHQN 716
+IG+GGFG V+KG + D +V+A+K L +G +EF E+ ++S L H N
Sbjct: 25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 717 LVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLH 776
+VKLYG N +V E++ L L K + W+ + R+ DIA G+ Y+
Sbjct: 85 IVKLYGLMH--NPPRMVMEFVPCGDLYHRLLDKAHP---IKWSVKLRLMLDIALGIEYMQ 139
Query: 777 EESRLKIVHRDIKATNVLLDK-----DLNAKISDFGLAKLDEDENTHISTRIAGTVGYMA 831
++ IVHRD+++ N+ L + AK++DFGL++ ++ H + + G +MA
Sbjct: 140 NQNP-PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ----QSVHSVSGLLGNFQWMA 194
Query: 832 PE-YAMRGYL-TDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYL-LDWAYVLQEQGNLL 888
PE T+KAD YSF ++ I++G+ P +E+ Y + + +++E+G
Sbjct: 195 PETIGAEEESYTEKADTYSFAMILYTILTGE-----GPFDEYSYGKIKFINMIREEGLRP 249
Query: 889 EL---VDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933
+ P L + + + C + P RP S V L
Sbjct: 250 TIPEDCPPRL------RNVIEL------CWSGDPKKRPHFSYIVKELS 285
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 4e-60
Identities = 72/277 (25%), Positives = 126/277 (45%), Gaps = 30/277 (10%)
Query: 665 NKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGN--REFVNEIGMISALQHQNLVKLYG 722
+IG G FG VYKG G V AVK L+ + + F NE+G++ +H N++ G
Sbjct: 30 QRIGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 723 CCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLK 782
L +V ++ E +SL L E + + I ARG+ YLH
Sbjct: 88 YSTAPQ-LAIVTQWCEGSSLYHHLHASETK---FEMKKLIDIARQTARGMDYLH---AKS 140
Query: 783 IVHRDIKATNVLLDKDLNAKISDFGLAKL-DEDENTHISTRIAGTVGYMAPEYAMRGYL- 840
I+HRD+K+ N+ L +D KI DFGLA +H +++G++ +MAPE +R
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE-VIRMQDS 199
Query: 841 ---TDKADVYSFGIVALEIVSGKS-NTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLG 896
+ ++DVY+FGIV E+++G+ +N +++ + ++ + + + +
Sbjct: 200 NPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMK 259
Query: 897 SNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933
+ C RP+ ++ +E
Sbjct: 260 ------------RLMAECLKKKRDERPSFPRILAEIE 284
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 202 bits (517), Expect = 4e-59
Identities = 62/277 (22%), Positives = 115/277 (41%), Gaps = 34/277 (12%)
Query: 665 NKIGEGGFGPVYKGTLSDGAVIAVKQLSSK--SKQGNREFVNEIGMISALQHQNLVKLYG 722
K+ E G ++KG G I VK L + S + +R+F E + H N++ + G
Sbjct: 16 TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 723 CCIE--GNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESR 780
C L+ ++ SL L EG +D + + D+ARG+A+LH
Sbjct: 75 ACQSPPAPHPTLITHWMPYGSLYNVL--HEGTNFVVDQSQAVKFALDMARGMAFLHTLEP 132
Query: 781 LKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRG-- 838
I + + +V++D+D+ A+IS + + S ++APE A++
Sbjct: 133 -LIPRHALNSRSVMIDEDMTARISMADVKFSFQ------SPGRMYAPAWVAPE-ALQKKP 184
Query: 839 --YLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLG 896
AD++SF ++ E+V+ + P + ++ + +G + P++
Sbjct: 185 EDTNRRSADMWSFAVLLWELVTRE-----VPFADLSN-MEIGMKVALEG-----LRPTIP 233
Query: 897 SNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933
S + + +C N P RP V +LE
Sbjct: 234 PGISPH----VSKLMKICMNEDPAKRPKFDMIVPILE 266
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 5e-59
Identities = 75/284 (26%), Positives = 118/284 (41%), Gaps = 42/284 (14%)
Query: 665 NKIGEGGFGPVYKGTLSDGAVIAVKQL----SSKSKQGNREFVNEIGMISALQHQNLVKL 720
IG GGFG VY+ G +AVK Q E + + L+H N++ L
Sbjct: 13 EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 721 YGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESR 780
G C++ L LV E+ L R L GK + IARG+ YLH+E+
Sbjct: 72 RGVCLKEPNLCLVMEFARGGPLNRVLSGKR-----IPPDILVNWAVQIARGMNYLHDEAI 126
Query: 781 LKIVHRDIKATNVLLDKDL--------NAKISDFGLAKLDEDENTHISTRIAGTVGYMAP 832
+ I+HRD+K++N+L+ + + KI+DFGLA+ AG +MAP
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK---MSAAGAYAWMAP 183
Query: 833 EYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLEL-- 890
E + +DV+S+G++ E+++G+ P L AY + L +
Sbjct: 184 EVIRASMFSKGSDVWSYGVLLWELLTGE-----VPFRGIDG-LAVAYGVAMNKLALPIPS 237
Query: 891 -VDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933
+ C NP P RP+ ++ + L
Sbjct: 238 TCPEPFA------------KLMEDCWNPDPHSRPSFTNILDQLT 269
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 204 bits (520), Expect = 1e-58
Identities = 70/298 (23%), Positives = 116/298 (38%), Gaps = 42/298 (14%)
Query: 665 NKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGNREFVNE--IGMISALQHQNLVKLYG 722
+IG+G +G V+ G V AVK + + E I ++H+N++
Sbjct: 43 KQIGKGRYGEVWMGKWRGEKV-AVKVFFT---TEEASWFRETEIYQTVLMRHENILGFIA 98
Query: 723 CCIEGN----QLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEE 778
I+G QL L+ +Y EN SL L + LD + ++ GL +LH E
Sbjct: 99 ADIKGTGSWTQLYLITDYHENGSLYDYL-----KSTTLDAKSMLKLAYSSVSGLCHLHTE 153
Query: 779 -----SRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHI---STRIAGTVGYM 830
+ I HRD+K+ N+L+ K+ I+D GLA + + GT YM
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYM 213
Query: 831 APE------YAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQ 884
PE AD+YSFG++ E+ + + Y L + ++
Sbjct: 214 PPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEE----YQLPYHDLVPSD 269
Query: 885 GNLLELVD--------PSLGSNFSKKEAM-TMLNIALLCTNPSPTLRPTMSSAVSMLE 933
+ ++ + PS + +S E + M + C +P R T L
Sbjct: 270 PSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA 327
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 3e-57
Identities = 69/298 (23%), Positives = 119/298 (39%), Gaps = 42/298 (14%)
Query: 665 NKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGNREFVNE--IGMISALQHQNLVKLYG 722
+G+G +G V++G+ V AVK SS + + + E + L+H+N++
Sbjct: 14 ECVGKGRYGEVWRGSWQGENV-AVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 723 CCIEGN----QLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEE 778
+ QL L+ Y E SL L Q LD + RI IA GLA+LH E
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYL-----QLTTLDTVSCLRIVLSIASGLAHLHIE 124
Query: 779 -----SRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHI---STRIAGTVGYM 830
+ I HRD+K+ N+L+ K+ I+D GLA + + + GT YM
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184
Query: 831 APE------YAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQ 884
APE + D+++FG+V E+ + Y + V+
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVED----YKPPFYDVVPND 240
Query: 885 GNLLELVD--------PSLGSNFSKKEAM-TMLNIALLCTNPSPTLRPTMSSAVSMLE 933
+ ++ P++ + + + ++ + C +P+ R T L
Sbjct: 241 PSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 196 bits (499), Expect = 8e-56
Identities = 77/299 (25%), Positives = 119/299 (39%), Gaps = 44/299 (14%)
Query: 665 NKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGNREFVNE--IGMISALQHQNLVKLYG 722
IG+G FG V++G V AVK SS + R + E I L+H+N++
Sbjct: 48 ESIGKGRFGEVWRGKWRGEEV-AVKIFSS---REERSWFREAEIYQTVMLRHENILGFIA 103
Query: 723 CCIEGN----QLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEE 778
+ N QL LV +Y E+ SL L + ++ A GLA+LH E
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALSTASGLAHLHME 158
Query: 779 -----SRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHI---STRIAGTVGYM 830
+ I HRD+K+ N+L+ K+ I+D GLA + I GT YM
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 218
Query: 831 APEYAMRGYL-------TDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQE 883
APE + + +AD+Y+ G+V EI S Y L + ++
Sbjct: 219 APE-VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED----YQLPYYDLVPS 273
Query: 884 QGNLLELVD--------PSLGSNFSKKEAM-TMLNIALLCTNPSPTLRPTMSSAVSMLE 933
++ E+ P++ + + EA+ M I C + R T L
Sbjct: 274 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 332
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 7e-55
Identities = 63/284 (22%), Positives = 113/284 (39%), Gaps = 39/284 (13%)
Query: 665 NKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGN--REFVNEIGMISALQHQNLVKLYG 722
IG+G FG VY G G V A++ + + + + F E+ +H+N+V G
Sbjct: 39 ELIGKGRFGQVYHGRW-HGEV-AIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 723 CCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLK 782
C+ L ++ + +L + + LD ++I +I +G+ YLH +
Sbjct: 97 ACMSPPHLAIITSLCKGRTLYSVVRDAKIV---LDVNKTRQIAQEIVKGMGYLHAK---G 150
Query: 783 IVHRDIKATNVLLDKDLNAKISDFGLAKL----DEDENTHISTRIAGTVGYMAPE----- 833
I+H+D+K+ NV D I+DFGL + G + ++APE
Sbjct: 151 ILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQL 209
Query: 834 ----YAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLE 889
+ + +DV++ G + E+ + + +P E ++ + G
Sbjct: 210 SPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQM-------GTGMKPN 262
Query: 890 LVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933
L +G S +I L C RPT + + MLE
Sbjct: 263 LSQIGMGKEIS--------DILLFCWAFEQEERPTFTKLMDMLE 298
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 9e-54
Identities = 60/371 (16%), Positives = 127/371 (34%), Gaps = 50/371 (13%)
Query: 32 DEVQTLQSIFRKLNFRNGQVNQTSCTEGS-WNVTIDDSNGSNF---TCDCTYSNNTVCHV 87
+ L+ I+ LN +N G+ WN + + + +N V
Sbjct: 30 KDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLN----SNG--RV 83
Query: 88 TVILLKGFNLAGVIPEEFGNLTFLQEVDLSRNYFNG----SLPKSFARLQNLTKLLILGN 143
T + L+GF +G +P+ G LT L+ + L + PK + + + +
Sbjct: 84 TGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRM 143
Query: 144 RLSGSIPLEIG--DISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESY 201
+ D S L + + + + ++ +I SNN T + ++
Sbjct: 144 HYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNIT-FVSKAV 202
Query: 202 GNLKNLTEFRIDGSNLTG-------------------RIPNFIGNWTKLDRLDLQGTSLE 242
L L +F + S N L +++
Sbjct: 203 MRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNL 262
Query: 243 GPIPSTISQLKNLTELRISD--------LKGSSSSFPNLQDMKKMERLILR-NCLITGRI 293
+P+ + L + + ++ LK + + +K++ + + N L T +
Sbjct: 263 TKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPV 322
Query: 294 PEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGTLPDWI---LTSEK 350
++ M L +L+ +NQL G +P + K+ + L N ++ +P +
Sbjct: 323 ETSLQKMKKLGMLECLYNQLEGKLPAF-GSEIKLASLNLAYNQITE-IPANFCGFTEQVE 380
Query: 351 NLDLSYNNFTE 361
NL ++N
Sbjct: 381 NLSFAHNKLKY 391
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 3e-51
Identities = 54/298 (18%), Positives = 100/298 (33%), Gaps = 28/298 (9%)
Query: 91 LLKGFNLAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRL----- 145
+ ++ NL L +V++ LP L + + + NR
Sbjct: 231 NSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQ 290
Query: 146 ---SGSIPLEIGDISTLEELVLEDNQL-VGPLPENLGNLKSLRRILLSSNNFTGSIPESY 201
+ ++ + + N L P+ +L +K L + N G +P +
Sbjct: 291 LKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPA-F 349
Query: 202 GNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEG-PIPSTISQLKNLTELRI 260
G+ L + + +T NF G +++ L L+ P + ++ +
Sbjct: 350 GSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDF 409
Query: 261 S-------DLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQL 313
S D K P + + L N I+ E + L ++L N L
Sbjct: 410 SYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNML 469
Query: 314 TG-------PVPGILQNLKKIDYIFLTNNSLSGTLPDWILTSEKNL---DLSYNNFTE 361
T +N + I L N L+ D+ T+ L DLSYN+F++
Sbjct: 470 TEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK 527
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 6e-49
Identities = 51/375 (13%), Positives = 116/375 (30%), Gaps = 49/375 (13%)
Query: 36 TLQSIFRKLNFRNGQVNQTSCTEGSWNVTIDDSNGSNFTCDCTYSNNTVCHVTVILLKGF 95
+ + + E ++ D N S+ T I
Sbjct: 134 SDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSN 193
Query: 96 NLAGVIPEEFGNLTFLQEVDLSRNYFNG-------------------SLPKSFARLQNLT 136
N+ + + LT L++ + + F + + L++LT
Sbjct: 194 NITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLT 252
Query: 137 KLLILGNRLSGSIPLEIGDISTLEELVLEDNQLV--------GPLPENLGNLKSLRRILL 188
+ + +P + + ++ + + N+ + + + ++ I +
Sbjct: 253 DVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYI 312
Query: 189 SSNNF-TGSIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPS 247
NN T + S +K L + L G++P F G+ KL L+L + +
Sbjct: 313 GYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPAF-GSEIKLASLNLAYNQITEIPAN 371
Query: 248 TISQLKNLTELRISD--LKGSSSSFPNLQDMKKMERLILRNCLITG-------RIPEYIE 298
+ + L + LK + F + + + M + I +
Sbjct: 372 FCGFTEQVENLSFAHNKLKYIPNIF-DAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPF 430
Query: 299 DMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSG-------TLPDWI--LTSE 349
++ ++LS NQ++ + + I L N L+ +
Sbjct: 431 KGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLL 490
Query: 350 KNLDLSYNNFTESSP 364
++DL +N T+ S
Sbjct: 491 TSIDLRFNKLTKLSD 505
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 3e-48
Identities = 51/315 (16%), Positives = 96/315 (30%), Gaps = 41/315 (13%)
Query: 88 TVILLKGFNLAGVIPEEFGNLTFLQEVDLSRNYF--------NGSLPKSFARLQNLTKLL 139
T + + +P L +Q ++++ N + + + +
Sbjct: 252 TDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIY 311
Query: 140 ILGNRL-SGSIPLEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIP 198
I N L + + + + L L NQL G LP G+ L + L+ N T
Sbjct: 312 IGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPA-FGSEIKLASLNLAYNQITEIPA 370
Query: 199 ESYGNLKNLTEFRIDGSNLTGRIPN--FIGNWTKLDRLDLQGTSLEG-------PIPSTI 249
G + + + L IPN + + + +D + P+ T
Sbjct: 371 NFCGFTEQVENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTP 429
Query: 250 SQLKNLTELRISD--LKGSSSSFPNLQDMKKMERLILRNCLITG-------RIPEYIEDM 300
+ N++ + +S+ + + + L ++T E ++
Sbjct: 430 FKGINVSSINLSNNQISKFPKEL--FSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNT 487
Query: 301 TDLKILDLSFNQLTG-PVPGILQNLKKIDYIFLTNNSLSGTLPDWI--------LTSEKN 351
L +DL FN+LT L + I L+ NS S P
Sbjct: 488 YLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQ 546
Query: 352 LDLSYNNFTESSPAT 366
D N P
Sbjct: 547 RDAQGNRTLREWPEG 561
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 2e-47
Identities = 40/289 (13%), Positives = 85/289 (29%), Gaps = 27/289 (9%)
Query: 99 GVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGDIST 158
+ + L ++ N G LP +F L L + N+++ G
Sbjct: 320 FPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIPANFCGFTEQ 378
Query: 159 LEELVLEDNQLVG-PLPENLGNLKSLRRILLSSNNFTG-------SIPESYGNLKNLTEF 210
+E L N+L P + ++ + I S N + + N++
Sbjct: 379 VENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSI 438
Query: 211 RIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEG-------PIPSTISQLKNLTELRISD- 262
+ + ++ + L ++L G L LT + +
Sbjct: 439 NLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFN 498
Query: 263 -LKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKIL------DLSFNQLTG 315
L S F + + + L + P + + LK D N+
Sbjct: 499 KLTKLSDDFRATT-LPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLR 556
Query: 316 PVPGILQNLKKIDYIFLTNNSLSGTLPDWILTSEKNLDLSYNNFTESSP 364
P + + + + +N + + + I + LD+ N
Sbjct: 557 EWPEGITLCPSLTQLQIGSNDIR-KVNEKITPNISVLDIKDNPNISIDL 604
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 3e-47
Identities = 47/291 (16%), Positives = 89/291 (30%), Gaps = 31/291 (10%)
Query: 96 NLAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIP--LEI 153
L G +P FG+ L ++L+ N + + L N+L IP +
Sbjct: 341 QLEGKLPA-FGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDA 398
Query: 154 GDISTLEELVLEDNQLVG-------PLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKN 206
+S + + N++ PL ++ I LS+N + E +
Sbjct: 399 KSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSP 458
Query: 207 LTEFRIDGSNLTG-------RIPNFIGNWTKLDRLDLQGTSLEGPIPSTI--SQLKNLTE 257
L+ + G+ LT N L +DL+ L + + L L
Sbjct: 459 LSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVG 517
Query: 258 LRISD--LKG---SSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQ 312
+ +S + L+ + + PE I L L + N
Sbjct: 518 IDLSYNSFSKFPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSND 577
Query: 313 LTGPVPGILQNLKKIDYIFLTNNSLSGTLPDWI--LTSEKNLDLSYNNFTE 361
+ I N+ +D + +N ++ L Y+ +
Sbjct: 578 IRKVNEKITPNISVLD---IKDNPNISIDLSYVCPYIEAGMYMLFYDKTQD 625
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 1e-15
Identities = 24/169 (14%), Positives = 54/169 (31%), Gaps = 9/169 (5%)
Query: 225 IGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISD----LKGSSSSFPNLQDMKKME 280
+ + ++ L L+G G +P I QL L L + + + E
Sbjct: 77 LNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDE 136
Query: 281 RLILRNCLITGRIPEYI--EDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLS 338
+ +Y ED +DL ++ + + + K I +N+++
Sbjct: 137 QKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNIT 196
Query: 339 GTLPDWI--LTSEKNLDLSYNNFTESSPATCRESRVNILSSFSSTGSNS 385
+ + LT + + + F + E+ + + T
Sbjct: 197 F-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLK 244
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 2e-07
Identities = 10/79 (12%), Positives = 22/79 (27%), Gaps = 3/79 (3%)
Query: 91 LLKGFNLAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIP 150
+G PE L ++ + N + + N++ L I N
Sbjct: 548 DAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKI--TPNISVLDIKDNPNISIDL 604
Query: 151 LEIGDISTLEELVLEDNQL 169
+ +L ++
Sbjct: 605 SYVCPYIEAGMYMLFYDKT 623
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 5e-47
Identities = 81/267 (30%), Positives = 122/267 (45%), Gaps = 33/267 (12%)
Query: 667 IGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCI 725
+G+G +G VY G LS+ IA+K++ + + ++ EI + L+H+N+V+ G
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 726 EGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVH 785
E + + E + SL+ L K G L + T I GL YLH+ +IVH
Sbjct: 90 ENGFIKIFMEQVPGGSLSALLRSKWGP-LKDNEQTIGFYTKQILEGLKYLHDN---QIVH 145
Query: 786 RDIKATNVLLD-KDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPE---YAMRGYLT 841
RDIK NVL++ KISDFG +K N T GT+ YMAPE RGY
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEIIDKGPRGY-G 203
Query: 842 DKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLEL----VDPSLGS 897
AD++S G +E+ +GK P + + + Q + ++ V P +
Sbjct: 204 KAADIWSLGCTIIEMATGK-----PP---------FYELGEPQAAMFKVGMFKVHPEIPE 249
Query: 898 NFSKKEAMTMLNIALLCTNPSPTLRPT 924
+ S EA + L C P P R
Sbjct: 250 SMS-AEAKAFI---LKCFEPDPDKRAC 272
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 4e-45
Identities = 58/205 (28%), Positives = 89/205 (43%), Gaps = 21/205 (10%)
Query: 666 KIGEGGFGPVYKGT-LSDGAVIAVKQ--LSSKSKQGNREFVNEIGMISALQHQNLVKLYG 722
+IG G F VYKG +A + +K + F E M+ LQH N+V+ Y
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 723 CCI----EGNQLLLVYEYLENNSLARAL--FGKEGQCLNLDWATRKRICSDIARGLAYLH 776
++LV E + + +L L F + + C I +GL +LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV------MKIKVLRSWCRQILKGLQFLH 146
Query: 777 EESRLKIVHRDIKATNVLLD-KDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYA 835
+ I+HRD+K N+ + + KI D GLA L + GT +MAPE
Sbjct: 147 TRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK---AVIGTPEFMAPEMY 202
Query: 836 MRGYLTDKADVYSFGIVALEIVSGK 860
Y + DVY+FG+ LE+ + +
Sbjct: 203 EEKY-DESVDVYAFGMCMLEMATSE 226
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 6e-45
Identities = 55/302 (18%), Positives = 95/302 (31%), Gaps = 32/302 (10%)
Query: 88 TVILLKGFNLAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSG 147
+ NL L +V+L LP L L L I NR
Sbjct: 470 EDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGIS 529
Query: 148 ---------SIPLEIGDISTLEELVLEDNQLVG-PLPENLGNLKSLRRILLSSNNFTGSI 197
+ + ++ + N L P +L + L + N
Sbjct: 530 AAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR--H 587
Query: 198 PESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTK-LDRLDLQGTSLEG-PIPSTISQLKNL 255
E++G LT+ ++D + + IP +T ++ L L+ P + +
Sbjct: 588 LEAFGTNVKLTDLKLDYNQIEE-IPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVM 646
Query: 256 TEL-----RISDLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSF 310
+ +I + S + + L I E + + + LS
Sbjct: 647 GSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSN 706
Query: 311 NQLT-------GPVPGILQNLKKIDYIFLTNNSLSGTLPDWI----LTSEKNLDLSYNNF 359
N +T P G +N + I L N L+ +L D L N+D+SYN F
Sbjct: 707 NLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCF 765
Query: 360 TE 361
+
Sbjct: 766 SS 767
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 6e-41
Identities = 43/307 (14%), Positives = 93/307 (30%), Gaps = 35/307 (11%)
Query: 91 LLKGFNLAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIP 150
+ N I + LT LQ + + + F N + +
Sbjct: 430 IGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANS-----DYAKQYENEE 484
Query: 151 LEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTG---------SIPESY 201
L ++ L ++ L + + LP+ L +L L+ + ++ N + +
Sbjct: 485 LSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDE 544
Query: 202 GNLKNLTEFRIDGSNLTGRIPN-FIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRI 260
+ F + +NL + + KL LD + LT+L++
Sbjct: 545 DTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR--HLEAFGTNVKLTDLKL 602
Query: 261 SD--LKGSSSSFPN--LQDMKKMERLILRNCLITGRIPEY--IEDMTDLKILDLSFNQLT 314
+ P ++E L + + IP + + + +D S+N++
Sbjct: 603 DYNQI----EEIPEDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIG 657
Query: 315 GPVPGIL-----QNLKKIDYIFLTNNSLSGTLPDWI--LTSEKNLDLSYNNFTESSPATC 367
I + L+ N + + + + LS N T +
Sbjct: 658 SEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSL 717
Query: 368 RESRVNI 374
+ N
Sbjct: 718 KPKDGNY 724
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 153 bits (387), Expect = 4e-38
Identities = 47/313 (15%), Positives = 86/313 (27%), Gaps = 39/313 (12%)
Query: 88 TVILLKGFNLAGVIPEEFGNLTFLQEVDLSRNYFNG---------SLPKSFARLQNLTKL 138
T + L +P+ +L LQ ++++ N L +
Sbjct: 494 TDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIF 553
Query: 139 LILGNRLSG-SIPLEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSI 197
+ N L + + L L N++ L G L + L N I
Sbjct: 554 YMGYNNLEEFPASASLQKMVKLGLLDCVHNKVRH-LEA-FGTNVKLTDLKLDYNQIE-EI 610
Query: 198 PESYG-NLKNLTEFRIDGSNLTGRIPN--FIGNWTKLDRLDLQGTSLEG-----PIPSTI 249
PE + + + L IPN + + +D +
Sbjct: 611 PEDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDD 669
Query: 250 SQLKNLTELRISDLKGSSSSFPNLQDMKKMERLILRNCLIT-------GRIPEYIEDMTD 302
+ N + + +S + + +IL N L+T ++
Sbjct: 670 YKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYL 729
Query: 303 LKILDLSFNQLTG-PVPGILQNLKKIDYIFLTNNSLSGTLPDWI--------LTSEKNLD 353
L +DL FN+LT L + + ++ N S + P D
Sbjct: 730 LTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRD 788
Query: 354 LSYNNFTESSPAT 366
N P
Sbjct: 789 AEGNRILRQWPTG 801
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 2e-35
Identities = 41/292 (14%), Positives = 80/292 (27%), Gaps = 34/292 (11%)
Query: 101 IPEEFGNLTFLQEVDLSRNYFNGSLPKS-FARLQNLTKLLILGNRLSGSIP--LEIGDIS 157
E FG L ++ L N +P+ A + L N+L IP +
Sbjct: 587 HLEAFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVY 644
Query: 158 TLEELVLEDNQLVGPLPENLG------NLKSLRRILLSSNNFTGSIPESYGNLKNLTEFR 211
+ + N++ N+ + + LS N E + ++
Sbjct: 645 VMGSVDFSYNKIGS-EGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTII 703
Query: 212 IDGSNLT-------GRIPNFIGNWTKLDRLDLQGTSLEGPIPSTI--SQLKNLTEL---- 258
+ + +T N L +DL+ L + + L L+ +
Sbjct: 704 LSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTS-LSDDFRATTLPYLSNMDVSY 762
Query: 259 -RISDLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPV 317
S + L+ + I + P I L L + N +
Sbjct: 763 NCFSSFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRKVD 822
Query: 318 PGILQNLKKIDYIFLTNNSLS----GTLPDWILTSEKNLDLSYNNFTESSPA 365
+ L +D + +N ++ +I L A
Sbjct: 823 EKLTPQLYILD---IADNPNISIDVTSVCPYIEAGMYVLLYDKTQDIRGCDA 871
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 9e-33
Identities = 41/280 (14%), Positives = 91/280 (32%), Gaps = 22/280 (7%)
Query: 99 GVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGDIST 158
+ N + + L+ G +P + +L L L + + S L + T
Sbjct: 313 DQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELT 372
Query: 159 LEELVLEDNQLVGPLPEN-LGNLKSLRRILLSSNNFTG---SIPESYGNLKNLTEFRIDG 214
+ +++ + L + L L + P + +L + +I
Sbjct: 373 PDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGN 432
Query: 215 -SNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISDLKGSSSSFPNL 273
+N I I TKL + + + + N + + + S
Sbjct: 433 LTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELS-----W 487
Query: 274 QDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGP---------VPGILQNL 324
++K + + L NC ++P+++ D+ +L+ L+++ N+ +
Sbjct: 488 SNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTG 547
Query: 325 KKIDYIFLTNNSLSGTLPDWILTSEKNL---DLSYNNFTE 361
KI ++ N+L L L D +N
Sbjct: 548 PKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVRH 587
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 78.0 bits (192), Expect = 1e-14
Identities = 44/276 (15%), Positives = 81/276 (29%), Gaps = 28/276 (10%)
Query: 135 LTKLLILGNRLSGSIPLEIGDISTLEELVLEDNQLVGP------LPENLGN------LKS 182
+ LE + E + DN+L L E LK+
Sbjct: 218 VVAYTTYSQSGIKRSELETQSVRG-ESFTVIDNKLTKDANVPIQLKETAEYIKDYKALKA 276
Query: 183 LRRILLSSNN-FTGSIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSL 241
+ L N + + + N F + + + N ++ L L G
Sbjct: 277 IWEALDGKNWRYYSGTINNTIHSLN-WNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGA 335
Query: 242 EGPIPSTISQLKNLTELRISD--LKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYIED 299
+G +P I QL L L S F +++ ++ + +++
Sbjct: 336 KGRVPDAIGQLTELKVLSFGTHSETVSGRLF-GDEELTPDMSEERKHRIRMHYKKMFLDY 394
Query: 300 MTDLKILDLS------FNQLTGPVPGILQNLKKIDYIFLTNNSLSGTLPDWI--LTSEKN 351
L + DL ++ +LK LTN + I LT +
Sbjct: 395 DQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRI--TFISKAIQRLTKLQI 452
Query: 352 LDLSYNNFTESSPATCRESRVNILSSFSSTGSNSVS 387
+ + + FT + A E + + S S
Sbjct: 453 IYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWS 488
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 47.9 bits (114), Expect = 2e-05
Identities = 10/103 (9%), Positives = 25/103 (24%), Gaps = 28/103 (27%)
Query: 91 LLKGFNLAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIP 150
+G + P L ++ + N + +
Sbjct: 788 DAEGNRILRQWPTGITTCPSLIQLQIG------------------------SNDIR-KVD 822
Query: 151 LEIGDISTLEELVLEDNQL-VGPLPENLGNLKSLRRILLSSNN 192
++ L L + DN + +++ +LL
Sbjct: 823 EKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKT 863
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 1e-44
Identities = 70/285 (24%), Positives = 113/285 (39%), Gaps = 52/285 (18%)
Query: 666 KIGEGGFGPVYKGTLSDGAV-IAVKQL-SSKSKQGNREFVNEIGMISALQHQNLVKLYGC 723
+IG G FG V+ G L +AVK + +F+ E ++ H N+V+L G
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180
Query: 724 CIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKI 783
C + + +V E ++ L EG L + T ++ D A G+ YL +
Sbjct: 181 CTQKQPIYIVMELVQGGDFLTFL-RTEGARLRVK--TLLQMVGDAAAGMEYLESK---CC 234
Query: 784 VHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGT----VGYMAPEYAMRGY 839
+HRD+ A N L+ + KISDFG+++ + D + G V + APE G
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSREEADG---VYAASGGLRQVPVKWTAPEALNYGR 291
Query: 840 LTDKADVYSFGIVALEIVS-------GKSNTNYRPKEEFVYLLDWAYVLQ--EQGNLLEL 890
+ ++DV+SFGI+ E S SN + E+G L
Sbjct: 292 YSSESDVWSFGILLWETFSLGASPYPNLSNQQ---------------TREFVEKGGRLPC 336
Query: 891 VD--PSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933
+ P + + C P RP+ S+ L+
Sbjct: 337 PELCPD-----------AVFRLMEQCWAYEPGQRPSFSTIYQELQ 370
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 2e-44
Identities = 57/318 (17%), Positives = 101/318 (31%), Gaps = 26/318 (8%)
Query: 86 HVTVILLKGFNLAGVIPEEFGNLTF--LQEVDLSRNYFNGSLPKSFARLQNLTKLLILGN 143
+ + L L+ F L + L +DLS N N SFA L L + N
Sbjct: 223 SIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYN 282
Query: 144 RLSGSIPLEIGDISTLEELVLEDNQLVGPLPEN---------LGNLKSLRRILLSSNNFT 194
+ + + + L L+ + + LK L + + N+
Sbjct: 283 NIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIP 342
Query: 195 GSIPESYGNLKNLTEFRIDGSNLTGRIPN---FIGNW-TKLDRLDLQGTSLEGPIPSTIS 250
G + L NL + S + R F+ + L L+L + S
Sbjct: 343 GIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFS 402
Query: 251 QLKNLTELRISD--LKG--SSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKIL 306
L +L L + + + + L + + + L + L+ L
Sbjct: 403 WLGHLEVLDLGLNEIGQELTGQEWRGL---ENIFEIYLSYNKYLQLTRNSFALVPSLQRL 459
Query: 307 DLSFNQLTG--PVPGILQNLKKIDYIFLTNNSLSGTLPDWI--LTSEKNLDLSYNNFTES 362
L L P Q L+ + + L+NN+++ D + L + LDL +NN
Sbjct: 460 MLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARL 519
Query: 363 SPATCRESRVNILSSFSS 380
+ L S
Sbjct: 520 WKHANPGGPIYFLKGLSH 537
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 1e-43
Identities = 61/300 (20%), Positives = 114/300 (38%), Gaps = 17/300 (5%)
Query: 92 LKGFNLAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIP- 150
+ +L + F L L+ +++ N G F L NL L + + S
Sbjct: 312 ISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLT 371
Query: 151 ---LEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIP-ESYGNLKN 206
S L L L N++ + L L + L N + + + L+N
Sbjct: 372 NETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLEN 431
Query: 207 LTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEG--PIPSTISQLKNLTELRISDLK 264
+ E + + N L RL L+ +L+ PS L+NLT L +S+
Sbjct: 432 IFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNN 491
Query: 265 GSSSSFPNLQDMKKMERLILRNCLIT--------GRIPEYIEDMTDLKILDLSFNQLTGP 316
++ + L+ ++K+E L L++ + G +++ ++ L IL+L N
Sbjct: 492 IANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEI 551
Query: 317 VPGILQNLKKIDYIFLTNNSLSGTLPDWI--LTSEKNLDLSYNNFTESSPATCRESRVNI 374
+ ++L ++ I L N+L+ S K+L+L N T + N+
Sbjct: 552 PVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNL 611
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 2e-43
Identities = 55/294 (18%), Positives = 107/294 (36%), Gaps = 20/294 (6%)
Query: 86 HVTVILLKGFNLAGVIPEEFGNLTFLQEVDLSRNYFNGS--LPKSFARLQNLTKLLIL-- 141
+ + ++ ++ G+ F L L+ + LS ++ + ++F L + + L IL
Sbjct: 330 CLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAH-SPLHILNL 388
Query: 142 -GNRLSGSIPLEIGDISTLEELVLEDNQLVGPLPEN-LGNLKSLRRILLSSNNFTGSIPE 199
N++S + LE L L N++ L L+++ I LS N +
Sbjct: 389 TKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRN 448
Query: 200 SYGNLKNLTEFRIDGSNLTG--RIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTE 257
S+ + +L + L P+ L LDL ++ + L+ L
Sbjct: 449 SFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEI 508
Query: 258 LRISD--------LKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLS 309
L + L+ + + L L + E +D+ +LKI+DL
Sbjct: 509 LDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLG 568
Query: 310 FNQLTGPVPGILQNLKKIDYIFLTNNSLSGTLPDWILTSEKNL---DLSYNNFT 360
N L + N + + L N ++ + +NL D+ +N F
Sbjct: 569 LNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFD 622
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 2e-42
Identities = 58/291 (19%), Positives = 100/291 (34%), Gaps = 12/291 (4%)
Query: 85 CHVTVILLKGFNLAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNR 144
V L V + N+T L +L+ N +F R LT L + N
Sbjct: 4 VSHEVADCSHLKLTQVPDDLPTNITVL---NLTHNQLRRLPAANFTRYSQLTSLDVGFNT 60
Query: 145 LSGSIPLEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNL 204
+S P + L+ L L+ N+L + +L + L SN+ +
Sbjct: 61 ISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQ 120
Query: 205 KNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKN--LTELRISD 262
KNL + + L+ L L L ++ + N L +L +S
Sbjct: 121 KNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSS 180
Query: 263 LKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYIED---MTDLKILDLSFNQLTGPVPG 319
+ S + ++ L L N + + E + T ++ L LS +QL+
Sbjct: 181 NQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNT 240
Query: 320 ILQNLK--KIDYIFLTNNSLSGTLPDWI--LTSEKNLDLSYNNFTESSPAT 366
LK + + L+ N+L+ D L + L YNN +
Sbjct: 241 TFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHS 291
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 1e-40
Identities = 61/297 (20%), Positives = 115/297 (38%), Gaps = 26/297 (8%)
Query: 96 NLAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGN---------RLS 146
NL V + F L L+ L N S L N+ L + + L
Sbjct: 259 NLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLP 318
Query: 147 GSIPLEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGS--IPESYGNL 204
+ LE L +EDN + G L +L+ + LS++ + E++ +L
Sbjct: 319 KIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSL 378
Query: 205 KN--LTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIP-STISQLKNLTELRIS 261
+ L + + ++ + L+ LDL + + L+N+ E+ +S
Sbjct: 379 AHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLS 438
Query: 262 DLKGSSSSFPNLQDMKKMERLILRNCLITG--RIPEYIEDMTDLKILDLSFNQLTGPVPG 319
K + + + ++RL+LR + P + + +L ILDLS N +
Sbjct: 439 YNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDD 498
Query: 320 ILQNLKKIDYIFLTNNSLS--------GTLPDWI--LTSEKNLDLSYNNFTESSPAT 366
+L+ L+K++ + L +N+L+ G ++ L+ L+L N F E
Sbjct: 499 MLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEV 555
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 3e-36
Identities = 53/279 (18%), Positives = 99/279 (35%), Gaps = 21/279 (7%)
Query: 96 NLAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKS-FARLQNLTKLLILGNRLSGSIPLEIG 154
++ + + F L L+ +DL N L + L+N+ ++ + N+
Sbjct: 392 KISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFA 451
Query: 155 DISTLEELVLEDNQL--VGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRI 212
+ +L+ L+L L V P L++L + LS+NN + L+ L +
Sbjct: 452 LVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDL 511
Query: 213 DGSNLT--------GRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISD-- 262
+NL G F+ + L L+L+ + L L + +
Sbjct: 512 QHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNN 571
Query: 263 LKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYIED-MTDLKILDLSFNQLTGPVPGIL 321
L +S + ++ L L+ LIT + +L LD+ FN I
Sbjct: 572 LNTLPASV--FNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIA 629
Query: 322 Q-----NLKKIDYIFLTNNSLSGTLPDWILTSEKNLDLS 355
N + L+++ L T P + + D S
Sbjct: 630 WFVNWINETHTNIPELSSHYLCNTPPHYHGFPVRLFDTS 668
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-31
Identities = 44/236 (18%), Positives = 78/236 (33%), Gaps = 27/236 (11%)
Query: 134 NLTKLLILGNRLSGSIPLEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNF 193
+ +L+ +P ++ + + L L NQL N L + + N
Sbjct: 5 SHEVADCSHLKLT-QVPDDLP--TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61
Query: 194 TGSIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLK 253
+ PE L L + + L+ T L L L S++ + + K
Sbjct: 62 SKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQK 121
Query: 254 NLTELRISDLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDM--TDLKILDLSFN 311
NL L +S SS+ ++ ++ L+L N I E ++ + LK L+LS N
Sbjct: 122 NLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSN 181
Query: 312 QLTGPVPGILQNLKKIDYIFLTNNSLSGTLPDWILTSEKNLDLSYNNFTESSPATC 367
Q+ PG + ++ L L+ S
Sbjct: 182 QIKEFSPGCFHAIGRL----------------------FGLFLNNVQLGPSLTEKL 215
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 1e-14
Identities = 22/131 (16%), Positives = 45/131 (34%), Gaps = 1/131 (0%)
Query: 92 LKGFNLAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPL 151
L G L+ L ++L N F+ + F L L + + N L+
Sbjct: 519 LWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPAS 578
Query: 152 EIGDISTLEELVLEDNQLVGPLPENLG-NLKSLRRILLSSNNFTGSIPESYGNLKNLTEF 210
+ +L+ L L+ N + + G ++L + + N F + + + E
Sbjct: 579 VFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINET 638
Query: 211 RIDGSNLTGRI 221
+ L+
Sbjct: 639 HTNIPELSSHY 649
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 2e-11
Identities = 20/117 (17%), Positives = 39/117 (33%), Gaps = 5/117 (4%)
Query: 86 HVTVILLKGFNLAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRL 145
H+ ++ L+ + E F +L L+ +DL N N F +L L + N +
Sbjct: 537 HLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLI 596
Query: 146 SGSIPLEIGDI-STLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESY 201
+ G L EL + N ++ + ++ + Y
Sbjct: 597 TSVEKKVFGPAFRNLTELDMRFNPFDCTCE----SIAWFVNWINETHTNIPELSSHY 649
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 3e-04
Identities = 14/70 (20%), Positives = 29/70 (41%), Gaps = 5/70 (7%)
Query: 301 TDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGTLPDWI--LTSEKNLDLSYNN 358
++ D S +LT + N+ ++ LT+N L + +LD+ +N
Sbjct: 4 VSHEVADCSHLKLTQVPDDLPTNITVLN---LTHNQLRRLPAANFTRYSQLTSLDVGFNT 60
Query: 359 FTESSPATCR 368
++ P C+
Sbjct: 61 ISKLEPELCQ 70
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 2e-44
Identities = 70/286 (24%), Positives = 124/286 (43%), Gaps = 31/286 (10%)
Query: 665 NKIGEGGFGPVYKGTL-----SDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVK 719
++G+G FG V + G V+AVK+L +++ R+F EI ++ +LQH N+VK
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 720 LYGCCIEGNQ--LLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHE 777
G C + L L+ EYL SL L + + +D + S I +G+ YL
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYL-- 130
Query: 778 ESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGT--VGYMAPEYA 835
++ + +HRD+ N+L++ + KI DFGL K+ + + G + + APE
Sbjct: 131 GTK-RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESL 189
Query: 836 MRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSL 895
+ +DV+SFG+V E+ + + P E + + +L+EL+
Sbjct: 190 TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK--- 246
Query: 896 GSNFSKKEAM--------TMLNIALLCTNPSPTLRPTMSSAVSMLE 933
+ + I C N + RP+ ++
Sbjct: 247 -----NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 287
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 3e-44
Identities = 49/296 (16%), Positives = 97/296 (32%), Gaps = 29/296 (9%)
Query: 91 LLKGFNLAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLS---- 146
L I + F LT + L S+ L ++ +
Sbjct: 264 LAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSY--NFGWQHLELVNCKFGQFPT 321
Query: 147 ---------------GSIPLEIGDISTLEELVLEDNQL--VGPLPENLGNLKSLRRILLS 189
G D+ +LE L L N L G ++ SL+ + LS
Sbjct: 322 LKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLS 381
Query: 190 SNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIP-NFIGNWTKLDRLDLQGTSLEGPIPST 248
N + ++ L+ L SNL + + L LD+ T
Sbjct: 382 FNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGI 440
Query: 249 ISQLKNLTELRISDLKGSSSSFPN-LQDMKKMERLILRNCLITGRIPEYIEDMTDLKILD 307
+ L +L L+++ + P+ +++ + L L C + P ++ L++L+
Sbjct: 441 FNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLN 500
Query: 308 LSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGTLPDWILTSEKNL---DLSYNNFT 360
+S N + L + + + N + + + +L +L+ N+F
Sbjct: 501 MSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 556
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 5e-43
Identities = 53/335 (15%), Positives = 113/335 (33%), Gaps = 22/335 (6%)
Query: 72 NFTCDCTYSNNTV------CHVTVILLKGFNLAGVIPEEFGNLTFLQEVDLSRNYFNGSL 125
N T C N + L L + F + LQ +DLSR
Sbjct: 9 NITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIE 68
Query: 126 PKSFARLQNLTKLLILGNRLSGSIPLEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRR 185
++ L +L+ L++ GN + +S+L++LV + L +G+LK+L+
Sbjct: 69 DGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKE 128
Query: 186 ILLSSNNFTG-SIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLD----RLDLQGTS 240
+ ++ N +PE + NL NL + + + + ++ LDL
Sbjct: 129 LNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP 188
Query: 241 LEGPIPSTISQLKNLTELRISD-------LKGSSSSFPNLQDMKKMERLILRNCLITGRI 293
+ P ++ L +L + + +K L+ + + +
Sbjct: 189 MNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFD 247
Query: 294 PEYIEDMTDLKILDLSFNQL---TGPVPGILQNLKKIDYIFLTNNSLSGTLPDWILTSEK 350
+E + +L I + L + + L + L + ++ +
Sbjct: 248 KSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQ 307
Query: 351 NLDLSYNNFTESSPATCRESRVNILSSFSSTGSNS 385
+L+L F + + + +S + S
Sbjct: 308 HLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFS 342
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 1e-37
Identities = 48/274 (17%), Positives = 98/274 (35%), Gaps = 13/274 (4%)
Query: 92 LKGFNLAGVIPEEFGNLTFLQEVDLSRN--YFNGSLPKSFARLQNLTKLLILGNRLSGSI 149
L + G +L L+ +DLSRN F G +S +L L + N + +
Sbjct: 330 LTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-M 388
Query: 150 PLEIGDISTLEELVLEDNQLVGPLPEN-LGNLKSLRRILLSSNNFTGSIPESYGNLKNLT 208
+ LE L + + L + +L++L + +S + + + L +L
Sbjct: 389 SSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLE 448
Query: 209 EFRIDGSNLTGRI-PNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISD--LKG 265
++ G++ P+ L LDL LE P+ + L +L L +S
Sbjct: 449 VLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFS 508
Query: 266 SSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDM-TDLKILDLSFNQLTG--PVPGILQ 322
+ + + ++ L I + ++ + L L+L+ N LQ
Sbjct: 509 LDTFP--YKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQ 566
Query: 323 NLKKIDYIFLTNNSLSGTLPDWIL-TSEKNLDLS 355
+K + + + P +L+++
Sbjct: 567 WIKDQRQLLVEVERMECATPSDKQGMPVLSLNIT 600
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 1e-36
Identities = 52/284 (18%), Positives = 91/284 (32%), Gaps = 27/284 (9%)
Query: 100 VIPEEFGNLTFLQEVDLSRNYFNGS---LPKSFARLQNLTKLLILGNRLS------GSIP 150
V+ L L+ L F + L+ L L I RL+ I
Sbjct: 216 VMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDII 275
Query: 151 LEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEF 210
++ + L + + + L + F +LK L
Sbjct: 276 DLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQFPTLKLKSLKRL--- 330
Query: 211 RIDGSNLTGRIPNFIGNWTKLDRLDLQGTSL--EGPIPSTISQLKNLTELRISD--LKGS 266
++ G + L+ LDL L +G + +L L +S +
Sbjct: 331 --TFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITM 388
Query: 267 SSSFPNLQDMKKMERLILRNCLITGRIPEYI-EDMTDLKILDLSFNQLTGPVPGILQNLK 325
SS+F L+ ++E L ++ + + + +L LD+S GI L
Sbjct: 389 SSNFLGLE---QLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLS 445
Query: 326 KIDYIFLTNNSLSGTLPDWILTSEKN---LDLSYNNFTESSPAT 366
++ + + NS I T +N LDLS + SP
Sbjct: 446 SLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTA 489
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 3e-36
Identities = 52/284 (18%), Positives = 98/284 (34%), Gaps = 21/284 (7%)
Query: 96 NLAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRL-SGSIPLEIG 154
+ + F L+ LQ++ L+ L +L + N + S +P
Sbjct: 87 PIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFS 146
Query: 155 DISTLEELVLEDNQLVGPLPENLGNLKSLRRIL----LSSNNFTGSIPESYGNLKNLTEF 210
+++ LE L L N++ +L L + + LS N P ++ + L +
Sbjct: 147 NLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKL 205
Query: 211 RIDGSNLTGRIP-NFIGNWTKLDRLDLQG------TSLEGPIPSTISQLKNLT--ELRIS 261
+ + + + I L+ L +LE S + L NLT E R++
Sbjct: 206 TLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLA 265
Query: 262 DLKGSSSSFPNL-QDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGI 320
L +L + + L + I + L+L +
Sbjct: 266 YLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQFPTLK 323
Query: 321 LQNLKKIDYIFLTNNSLSGTLPDWILTSEKNLDLSYNNFTESSP 364
L++LK++ T+N + L S + LDLS N +
Sbjct: 324 LKSLKRLT---FTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGC 364
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-31
Identities = 58/301 (19%), Positives = 112/301 (37%), Gaps = 28/301 (9%)
Query: 86 HVTVILLKGFNLAGVIPEEFGNLTFLQ----EVDLSRNYFNGSLPKSFARLQNLTKLLIL 141
++ + L + + + L + +DLS N N P +F + L KL +
Sbjct: 150 NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLR 208
Query: 142 GNRLSGSIP-LEIGDISTLEELVLEDNQLVG---------PLPENLGNLKSLRRILLSSN 191
N S ++ I ++ LE L + E L NL L +
Sbjct: 209 NNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLD 268
Query: 192 NFTGSIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQ 251
+ I + + L N++ F + + + +F N L+L
Sbjct: 269 YYLDDIIDLFNCLTNVSSFSLVSVTIER-VKDFSYN-FGWQHLELVNCKFGQFPTLK--- 323
Query: 252 LKNLTELRISDLKGSSSSFPNLQDMKKMERLILRNCLIT--GRIPEYIEDMTDLKILDLS 309
LK+L L + KG ++ + D+ +E L L ++ G + T LK LDLS
Sbjct: 324 LKSLKRLTFTSNKGGNA--FSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLS 381
Query: 310 FNQLTGPVPGILQNLKKIDYIFLTNNSLSGTLPDWILTSEKNL---DLSYNNFTESSPAT 366
FN + + L++++++ +++L + S +NL D+S+ + +
Sbjct: 382 FNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGI 440
Query: 367 C 367
Sbjct: 441 F 441
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 2e-19
Identities = 27/153 (17%), Positives = 58/153 (37%), Gaps = 5/153 (3%)
Query: 88 TVILLKGFNLAGVI-PEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLS 146
V+ + G + P+ F L L +DLS+ P +F L +L L + N
Sbjct: 448 EVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFF 507
Query: 147 GSIPLEIGDISTLEELVLEDNQLVGPLPENLGNL-KSLRRILLSSNNFTGSIPESY--GN 203
+++L+ L N ++ + L + SL + L+ N+F +
Sbjct: 508 SLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQW 567
Query: 204 LKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDL 236
+K+ + ++ + P+ + L++
Sbjct: 568 IKDQRQLLVEVERMECATPSDKQG-MPVLSLNI 599
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 4e-44
Identities = 70/280 (25%), Positives = 126/280 (45%), Gaps = 19/280 (6%)
Query: 665 NKIGEGGFGPVYKGTL-----SDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVK 719
++G+G FG V + G V+AVK+L +++ R+F EI ++ +LQH N+VK
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 720 LYGCCIEGNQ--LLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHE 777
G C + L L+ EYL SL L + + +D + S I +G+ YL
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYL-- 161
Query: 778 ESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGT--VGYMAPEYA 835
++ + +HRD+ N+L++ + KI DFGL K+ + + + G + + APE
Sbjct: 162 GTK-RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESL 220
Query: 836 MRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSL 895
+ +DV+SFG+V E+ + + P E + + +L+EL+
Sbjct: 221 TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN-- 278
Query: 896 GSNFSKKEA--MTMLNIALLCTNPSPTLRPTMSSAVSMLE 933
+ + + I C N + RP+ ++
Sbjct: 279 NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 318
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 8e-44
Identities = 75/298 (25%), Positives = 129/298 (43%), Gaps = 57/298 (19%)
Query: 665 NKIGEGGFGPVYKGTLSDGA------VIAVKQLSSKSKQGNREFVNEIGMISALQHQNLV 718
++GEG FG V+ + + ++AVK L + ++F E +++ LQH+++V
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 719 KLYGCCIEGNQLLLVYEYLENNSLA---RALFGKEGQCLNLDWATRKR---------ICS 766
K YG C +G+ L++V+EY+++ L RA ++ K I S
Sbjct: 81 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 767 DIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGT 826
IA G+ YL + VHRD+ N L+ +L KI DFG+++ + + R+ G
Sbjct: 141 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY---RVGGH 194
Query: 827 ----VGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-------GKSNTNYRPKEEFVYLL 875
+ +M PE M T ++DV+SFG++ EI + SN E + +
Sbjct: 195 TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN------TEVIECI 248
Query: 876 DWAYVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933
QG +LE P + + ++ L C P R + +L
Sbjct: 249 -------TQGRVLE--RPRVCPK-------EVYDVMLGCWQREPQQRLNIKEIYKILH 290
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 161 bits (408), Expect = 1e-43
Identities = 60/209 (28%), Positives = 88/209 (42%), Gaps = 32/209 (15%)
Query: 665 NKIGEGGFGPVYKGT-LSDGAVIAVKQ--LSSKSKQGNREFVNEIGMISALQHQNLVKLY 721
++G G FG V++ G AVK+ L + E+ + L +V LY
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-------ELVACAGLSSPRIVPLY 116
Query: 722 GCCIEGNQLLLVYEYLENNSLARAL--FGK--EGQCLNLDWATRKRICSDIARGLAYLHE 777
G EG + + E LE SL + + G E + L GL YLH
Sbjct: 117 GAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALY--------YLGQALEGLEYLHT 168
Query: 778 ESRLKIVHRDIKATNVLLDKD-LNAKISDFGLAKLDEDENTHISTR----IAGTVGYMAP 832
+I+H D+KA NVLL D A + DFG A + + S I GT +MAP
Sbjct: 169 R---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAP 225
Query: 833 EYAM-RGYLTDKADVYSFGIVALEIVSGK 860
E M + K D++S + L +++G
Sbjct: 226 EVVMGKPC-DAKVDIWSSCCMMLHMLNGC 253
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 1e-43
Identities = 82/287 (28%), Positives = 133/287 (46%), Gaps = 34/287 (11%)
Query: 665 NKIGEGGFGPVYKGTL-----SDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVK 719
+++G+G FG V + GA++AVKQL R+F EI ++ AL +VK
Sbjct: 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 720 LYGCCIEGNQ--LLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHE 777
G + L LV EYL + L L + LD + S I +G+ YL
Sbjct: 89 YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR---LDASRLLLYSSQICKGMEYL-- 143
Query: 778 ESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGT--VGYMAPEYA 835
SR + VHRD+ A N+L++ + + KI+DFGLAKL + + R G + + APE
Sbjct: 144 GSR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESL 202
Query: 836 MRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPS 894
+ ++DV+SFG+V E+ + + P EF+ ++ + LLEL++
Sbjct: 203 SDNIFSRQSDVWSFGVVLYELFTYCDK--SCSPSAEFLRMMGCERDVPALSRLLELLE-- 258
Query: 895 LGSNFSKKEAM--------TMLNIALLCTNPSPTLRPTMSSAVSMLE 933
+ + + + + LC PSP RP+ S+ L+
Sbjct: 259 ------EGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLD 299
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 2e-43
Identities = 74/297 (24%), Positives = 123/297 (41%), Gaps = 56/297 (18%)
Query: 665 NKIGEGGFGPVYKGTLSDGA------VIAVKQLSSKSKQGNREFVNEIGMISALQHQNLV 718
++GEG FG V+ + ++AVK L S+ ++F E +++ LQHQ++V
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106
Query: 719 KLYGCCIEGNQLLLVYEYLENNSLA---RALFGKEGQCLNLDWATRKR--------ICSD 767
+ +G C EG LL+V+EY+ + L R+ + + S
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166
Query: 768 IARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGT- 826
+A G+ YL + L VHRD+ N L+ + L KI DFG+++ + R+ G
Sbjct: 167 VAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY---YRVGGRT 220
Query: 827 ---VGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-------GKSNTNYRPKEEFVYLLD 876
+ +M PE + T ++DV+SFG+V EI + SN E + +
Sbjct: 221 MLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN------TEAIDCI- 273
Query: 877 WAYVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933
QG LE P + I C P R ++ + L+
Sbjct: 274 ------TQGRELE--RPRACPP-------EVYAIMRGCWQREPQQRHSIKDVHARLQ 315
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 3e-43
Identities = 71/288 (24%), Positives = 124/288 (43%), Gaps = 35/288 (12%)
Query: 665 NKIGEGGFGPVYKGTL-----SDGAVIAVKQL-SSKSKQGNREFVNEIGMISALQHQNLV 718
+GEG FG V + G +AVK L + EI ++ L H+N+V
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 719 KLYGCCIE--GNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLH 776
K G C E GN + L+ E+L + SL L + + ++ + + I +G+ YL
Sbjct: 87 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK---INLKQQLKYAVQICKGMDYLG 143
Query: 777 EESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGT--VGYMAPEY 834
+ VHRD+ A NVL++ + KI DFGL K E + + + + V + APE
Sbjct: 144 S---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPEC 200
Query: 835 AMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAY-------VLQ--EQG 885
M+ +DV+SFG+ E+++ +++ P F+ ++ + ++ ++G
Sbjct: 201 LMQSKFYIASDVWSFGVTLHELLT-YCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEG 259
Query: 886 NLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933
L P N + M C P+ R + + + E
Sbjct: 260 KRLPC--P---PNCPDEVYQLMRK----CWEFQPSNRTSFQNLIEGFE 298
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 1e-42
Identities = 82/298 (27%), Positives = 128/298 (42%), Gaps = 38/298 (12%)
Query: 665 NKIGEGGFGPVYKGTL-----SDGAVIAVKQL-SSKSKQGNREFVNEIGMISALQHQNLV 718
+GEG FG V G ++AVK L + Q + EI ++ L H++++
Sbjct: 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 719 KLYGCCIE--GNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLH 776
K GCC + L LV EY+ SL L ++ A I G+AYLH
Sbjct: 97 KYKGCCEDAGAASLQLVMEYVPLGSLRDYL-----PRHSIGLAQLLLFAQQICEGMAYLH 151
Query: 777 EESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGT--VGYMAPEY 834
+HRD+ A NVLLD D KI DFGLAK + + + R G V + APE
Sbjct: 152 A---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC 208
Query: 835 AMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPS 894
+DV+SFG+ E+++ +++ P +F+ L+ A L EL++
Sbjct: 209 LKEYKFYYASDVWSFGVTLYELLT-HCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE-- 265
Query: 895 LGSNFSKKEAM--------TMLNIALLCTNPSPTLRPTMSSAVSMLEG---KTAVQAP 941
+ E + + ++ C + RPT + + +L+ K QAP
Sbjct: 266 ------RGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQAP 317
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 1e-42
Identities = 70/290 (24%), Positives = 123/290 (42%), Gaps = 46/290 (15%)
Query: 665 NKIGEGGFGPVYKGTLSDGA------VIAVKQLSSKSKQGNR-EFVNEIGMISALQHQNL 717
++G+G FG VY+G +A+K ++ + R EF+NE ++ ++
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 718 VKLYGCCIEGNQLLLVYEYLENNSL------ARALFGKEGQCLNLDWATRKRICSDIARG 771
V+L G +G L++ E + L R + ++ +IA G
Sbjct: 91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150
Query: 772 LAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLA-KLDEDENTHISTRIAGTVGYM 830
+AYL+ K VHRD+ A N ++ +D KI DFG+ + E + + V +M
Sbjct: 151 MAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 207
Query: 831 APEYAMRGYLTDKADVYSFGIVALEIVS-------GKSNTNYRPKEEFVYLLDWAYVLQE 883
+PE G T +DV+SFG+V EI + G SN E+ + +
Sbjct: 208 SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN------EQVLRFV-------M 254
Query: 884 QGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933
+G LL+ P N + + +C +P +RP+ +S ++
Sbjct: 255 EGGLLDK--P---DNCPDM----LFELMRMCWQYNPKMRPSFLEIISSIK 295
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 2e-42
Identities = 74/308 (24%), Positives = 130/308 (42%), Gaps = 47/308 (15%)
Query: 659 NNFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQL---SSKSKQGNREFVNEIGMISALQH 714
NF KIG G F VY+ L DG +A+K++ + + + EI ++ L H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 715 QNLVKLYGCCIEGNQLLLVYEYLENNSLARAL--FGKEGQCL--NLDWATRKRICSDIAR 770
N++K Y IE N+L +V E + L+R + F K+ + + W + +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVW----KYFVQLCS 147
Query: 771 GLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYM 830
L ++H +++HRDIK NV + K+ D GL + + T + + GT YM
Sbjct: 148 ALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYM 203
Query: 831 APE-YAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLE 889
+PE GY K+D++S G + E+ + + P F ++ NL
Sbjct: 204 SPERIHENGY-NFKSDIWSLGCLLYEMAALQ-----SP---FY---------GDKMNLYS 245
Query: 890 LV--------DPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTAVQAP 941
L P ++S++ + + +C NP P RP ++ + + A A
Sbjct: 246 LCKKIEQCDYPPLPSDHYSEE----LRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTAS 301
Query: 942 IIRRNSDS 949
+ +
Sbjct: 302 SLEHHHHH 309
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 2e-42
Identities = 67/318 (21%), Positives = 115/318 (36%), Gaps = 68/318 (21%)
Query: 658 TNNFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQ--LSSKSKQGNREFVNEIGMISAL-Q 713
T F KIG G FG V+K DG + A+K+ + + E+ + L Q
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 714 HQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLA 773
H ++V+ + E + +L+ EY SLA A+ A K + + RGL
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 774 YLHEESRLKIVHRDIKATNVLLDKD-------------------LNAKISDFGLAKLDED 814
Y+H +VH DIK +N+ + + + KI D G
Sbjct: 130 YIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186
Query: 815 ENTHISTRIAGTVGYMAPEYAM--RGYLTDKADVYSFGIVALEIVSGK---SNTNYRPKE 869
G ++A E +L KAD+++ + + + N +
Sbjct: 187 PQVEE-----GDSRFLANEVLQENYTHLP-KADIFALALTVVCAAGAEPLPRNGD----- 235
Query: 870 EFVYLLDWAYVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAV 929
W + Q G L P + S+ E +L + +P P RP SA+
Sbjct: 236 ------QWHEIRQ--GRL-----PRIPQVLSQ-EFTELLK---VMIHPDPERRP---SAM 275
Query: 930 SMLEGKTAVQAPIIRRNS 947
+++ + ++ S
Sbjct: 276 ALV------KHSVLLSAS 287
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 2e-42
Identities = 78/307 (25%), Positives = 116/307 (37%), Gaps = 45/307 (14%)
Query: 645 QTGYFTLRQIKAATNNFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNRE-- 701
GY R +F +++G G +G V+K DG + AVK+ S +G ++
Sbjct: 43 SPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKR-SMSPFRGPKDRA 101
Query: 702 -FVNEIGMISAL-QHQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWA 759
+ E+G + QH V+L EG L L E SL + G L
Sbjct: 102 RKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELCGP-SLQQHC-EAWGASLPEAQV 159
Query: 760 TRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAK-LDEDENTH 818
D LA+LH + +VH D+K N+ L K+ DFGL L
Sbjct: 160 --WGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGE 214
Query: 819 ISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWA 878
+ G YMAPE Y ADV+S G+ LE+ E W
Sbjct: 215 --VQE-GDPRYMAPELLQGSY-GTAADVFSLGLTILEVACN--------MELPHGGEGWQ 262
Query: 879 YVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTAV 938
+ QG L P + S E ++L + P P LR T + +++
Sbjct: 263 QLR--QGYL----PPEFTAGLS-SELRSVLV---MMLEPDPKLRATAEALLAL------- 305
Query: 939 QAPIIRR 945
P++R+
Sbjct: 306 --PVLRQ 310
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 3e-42
Identities = 62/269 (23%), Positives = 108/269 (40%), Gaps = 10/269 (3%)
Query: 101 IPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLE-IGDISTL 159
+P L+ L+++ LS N F S + +LT L I GN + + ++ L
Sbjct: 293 LPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENL 352
Query: 160 EELVLEDNQL--VGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNL 217
EL L + + L NL L+ + LS N E++ L + + L
Sbjct: 353 RELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRL 412
Query: 218 TGRIP-NFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISD--LKGSSSSFPN-L 273
+ + N L L+L + L+ L L L + + N L
Sbjct: 413 KVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSL 472
Query: 274 QDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLT 333
Q + ++E L+L C ++ + + +DLS N+LT L +LK I Y+ L
Sbjct: 473 QTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLA 531
Query: 334 NNSLSGTLPDWI--LTSEKNLDLSYNNFT 360
+N +S LP + L+ ++ ++L N
Sbjct: 532 SNHISIILPSLLPILSQQRTINLRQNPLD 560
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 2e-39
Identities = 51/325 (15%), Positives = 94/325 (28%), Gaps = 25/325 (7%)
Query: 68 SNGSNFTCDCTYSNNTV-C--------------HVTVILLKGFNLAGVIPEEFGNLTFLQ 112
+ S+ C N T C + L + F L L
Sbjct: 1 TTSSDQKCIEKEVNKTYNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLT 60
Query: 113 EVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGDISTLEELVLEDNQLVGP 172
+DL+R +F L L++ N L + L+ L +
Sbjct: 61 FLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSI 120
Query: 173 LPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLD 232
L N K+L + L SN+ + + L + + + + +
Sbjct: 121 DFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQAT 180
Query: 233 R--LDLQGTSLEGPIPSTISQLKNLTELRISDLKGSSSSFPNLQ--DMKKMERLILRNCL 288
L+L G + G I L + F L+ ++ + +
Sbjct: 181 NLSLNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMD 239
Query: 289 ITGRIPEYIEDMTD--LKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGTLPDWI- 345
P E + + ++ ++L + + + LT LS LP +
Sbjct: 240 DEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLV 298
Query: 346 -LTSEKNLDLSYNNFTESSPATCRE 369
L++ K L LS N F +
Sbjct: 299 GLSTLKKLVLSANKFENLCQISASN 323
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 1e-36
Identities = 47/295 (15%), Positives = 99/295 (33%), Gaps = 14/295 (4%)
Query: 86 HVTVILLKGFNLAGVIPEEFGNLTFLQEV--DLSRNYFNGSLPKSFARLQNLTKLLILGN 143
+ V+ + + + E+ +L + +L+ N + L G
Sbjct: 154 KLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDI-AGIEPGAFDSAVFQSLNFGGT 212
Query: 144 RLSGSIPLEIG--DISTLEELVLEDNQLVGPLPENLGNLK--SLRRILLSSNNFTGSIPE 199
+ I + I +L ED P L S+ I L + F
Sbjct: 213 QNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSN 272
Query: 200 SYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELR 259
++ L E + ++L+ +P+ + + L +L L E + S +LT L
Sbjct: 273 TFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLS 331
Query: 260 ISDLKGSSSSFPN-LQDMKKMERLILRNCLIT--GRIPEYIEDMTDLKILDLSFNQLTGP 316
I L++++ + L L + I + +++ L+ L+LS+N+
Sbjct: 332 IKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSL 391
Query: 317 VPGILQNLKKIDYIFLTNNSLSGTLPDWILTSEKNL---DLSYNNFTESSPATCR 368
+ +++ + L L + L +LS++ SS
Sbjct: 392 KTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFD 446
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-35
Identities = 53/287 (18%), Positives = 96/287 (33%), Gaps = 26/287 (9%)
Query: 96 NLAGVIPEEFGNLTFLQEVDLSRNYFNGSL-PKSFARLQNLTKLLILGNRL--SGSIPLE 152
+ N L + + N L L+NL +L + + + S L+
Sbjct: 312 KFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQ 371
Query: 153 IGDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPES-YGNLKNLTEFR 211
+ ++S L+ L L N+ + E L + L+ +S + NL L
Sbjct: 372 LRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLN 431
Query: 212 IDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISDLKG------ 265
+ S L L L+LQG + L+ L L I L
Sbjct: 432 LSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSI 491
Query: 266 SSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLK 325
+F +L+ M + L + +T E + + + L+L+ N ++ +P +L L
Sbjct: 492 DQHAFTSLK---MMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILS 547
Query: 326 KIDYIFLTNNSLSGT-----LPDWILTSEKNLDLSYNNFTESSPATC 367
+ I L N L T +W + ++ C
Sbjct: 548 QQRTINLRQNPLDCTCSNIYFLEW-------YKENMQKLEDTEDTLC 587
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-23
Identities = 33/239 (13%), Positives = 65/239 (27%), Gaps = 30/239 (12%)
Query: 142 GNRLSGSIPLEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESY 201
L+ IP + ++ E L N L L +L + L+ +++
Sbjct: 21 NLGLN-EIPGTLP--NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTF 77
Query: 202 GNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRIS 261
+ L + + L + L L T + + K L L
Sbjct: 78 QSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLY-- 135
Query: 262 DLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGIL 321
L + I+ LK+LD N + +
Sbjct: 136 ----------------------LGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDM 173
Query: 322 QNLKKIDYIFL--TNNSLSGTLPDWI-LTSEKNLDLSYNNFTESSPATCRESRVNILSS 377
+L++ + L N ++G P ++L+ + S + L
Sbjct: 174 SSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWL 232
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 4e-42
Identities = 77/301 (25%), Positives = 120/301 (39%), Gaps = 62/301 (20%)
Query: 665 NKIGEGGFGPVYKGTLSDGA------VIAVKQLSSK-SKQGNREFVNEIGMISALQHQNL 717
++GE FG VYKG L A +A+K L K EF +E + + LQH N+
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 718 VKLYGCCIEGNQLLLVYEYLENNSLA---RALFGKEGQCLNLDWATRKR---------IC 765
V L G + L +++ Y + L D T K +
Sbjct: 75 VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 766 SDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAG 825
+ IA G+ YL S +VH+D+ NVL+ LN KISD GL + + ++ G
Sbjct: 135 AQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADY---YKLLG 188
Query: 826 T----VGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-------GKSNTNYRPKEEFVYL 874
+ +MAPE M G + +D++S+G+V E+ S G SN ++ V +
Sbjct: 189 NSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN------QDVVEM 242
Query: 875 LDWAYVLQEQGNLLELVD--PSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSML 932
+ +L D P+ + + + C N P+ RP S L
Sbjct: 243 I-------RNRQVLPCPDDCPA-----------WVYALMIECWNEFPSRRPRFKDIHSRL 284
Query: 933 E 933
Sbjct: 285 R 285
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 6e-42
Identities = 56/199 (28%), Positives = 94/199 (47%), Gaps = 17/199 (8%)
Query: 665 NKIGEGGFGPVYKGTLSDGAVIAVKQL--SSKSKQGNREFVNEIGMISALQHQNLVKLYG 722
++G G FG V G +A+K + S S+ EF+ E ++ L H+ LV+LYG
Sbjct: 30 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLSHEKLVQLYG 86
Query: 723 CCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLK 782
C + + ++ EY+ N L L + +C D+ + YL +
Sbjct: 87 VCTKQRPIFIITEYMANGCLLNYLREMRHR---FQTQQLLEMCKDVCEAMEYL---ESKQ 140
Query: 783 IVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGT---VGYMAPEYAMRGY 839
+HRD+ A N L++ K+SDFGL++ D+ T G+ V + PE M
Sbjct: 141 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY---TSSVGSKFPVRWSPPEVLMYSK 197
Query: 840 LTDKADVYSFGIVALEIVS 858
+ K+D+++FG++ EI S
Sbjct: 198 FSSKSDIWAFGVLMWEIYS 216
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 8e-42
Identities = 51/198 (25%), Positives = 97/198 (48%), Gaps = 13/198 (6%)
Query: 665 NKIGEGGFGPVYKGTLSDGAV-IAVKQLSSKSKQGN---REFVNEIGMISALQHQNLVKL 720
+K+G G +G VY+G ++ +AVK L K+ EF+ E ++ ++H NLV+L
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKHPNLVQL 281
Query: 721 YGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESR 780
G C ++ E++ +L L Q ++ + + I+ + YL E +
Sbjct: 282 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSA--VVLLYMATQISSAMEYL--EKK 337
Query: 781 LKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRGYL 840
+HR++ A N L+ ++ K++DFGL++L + + + APE
Sbjct: 338 -NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 396
Query: 841 TDKADVYSFGIVALEIVS 858
+ K+DV++FG++ EI +
Sbjct: 397 SIKSDVWAFGVLLWEIAT 414
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 1e-41
Identities = 63/201 (31%), Positives = 108/201 (53%), Gaps = 14/201 (6%)
Query: 666 KIGEGGFGPVYKGTLSDGAV-----IAVKQL-SSKSKQGNREFVNEIGMISALQHQNLVK 719
IG G FG VYKG L + +A+K L + +++ +F+ E G++ H N+++
Sbjct: 51 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 720 LYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEES 779
L G + ++++ EY+EN +L + L K+G+ + IA G+ YL +
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFLREKDGE---FSVLQLVGMLRGIAAGMKYL---A 164
Query: 780 RLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGT--VGYMAPEYAMR 837
+ VHRD+ A N+L++ +L K+SDFGL+++ ED+ T G + + APE
Sbjct: 165 NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY 224
Query: 838 GYLTDKADVYSFGIVALEIVS 858
T +DV+SFGIV E+++
Sbjct: 225 RKFTSASDVWSFGIVMWEVMT 245
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 1e-41
Identities = 63/201 (31%), Positives = 101/201 (50%), Gaps = 13/201 (6%)
Query: 665 NKIGEGGFGPVYKGTLSDGA----VIAVKQL-SSKSKQGNREFVNEIGMISALQHQNLVK 719
IG G G V G L +A+K L + +++ R+F++E ++ H N+++
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 720 LYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEES 779
L G G ++V EY+EN SL L +GQ + + G+ YL S
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ---FTIMQLVGMLRGVGAGMRYL---S 168
Query: 780 RLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGT--VGYMAPEYAMR 837
L VHRD+ A NVL+D +L K+SDFGL+++ ED+ T G + + APE
Sbjct: 169 DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAF 228
Query: 838 GYLTDKADVYSFGIVALEIVS 858
+ +DV+SFG+V E+++
Sbjct: 229 RTFSSASDVWSFGVVMWEVLA 249
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 1e-41
Identities = 57/262 (21%), Positives = 101/262 (38%), Gaps = 23/262 (8%)
Query: 101 IPEEFGNLTF--LQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGDIST 158
+ + T ++L P RL +L + I L +P + +
Sbjct: 71 TADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAG 128
Query: 159 LEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGN---------LKNLTE 209
LE L L N L LP ++ +L LR + + + +PE + L NL
Sbjct: 129 LETLTLARNPLRA-LPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQS 187
Query: 210 FRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISDLKGSSSS 269
R++ + + +P I N L L ++ + L + I L L EL + + +
Sbjct: 188 LRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCT-ALRN 244
Query: 270 FPN-LQDMKKMERLILRNC--LITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLKK 326
+P ++RLIL++C L+T +P I +T L+ LDL +P ++ L
Sbjct: 245 YPPIFGGRAPLKRLILKDCSNLLT--LPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPA 302
Query: 327 IDYIFLTNNSLSGTLPDWILTS 348
I + + L L +
Sbjct: 303 NCIILVPPH-LQAQLDQHRPVA 323
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 4e-39
Identities = 57/295 (19%), Positives = 98/295 (33%), Gaps = 49/295 (16%)
Query: 101 IPEEFGNLTFLQEVDLSRNYFNGSLPKS---------------------FARLQNLTKLL 139
+ D +R + S A L
Sbjct: 28 YHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALE 87
Query: 140 ILGNRLSGSIPLEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPE 199
+ L P + +S L+ + ++ L+ LP+ + L + L+ N ++P
Sbjct: 88 LRSVPLP-QFPDQAFRLSHLQHMTIDAAGLME-LPDTMQQFAGLETLTLARNPLR-ALPA 144
Query: 200 SYGNLKNLTEFRIDGSNLTGRIPNFIGNW---------TKLDRLDLQGTSLEGPIPSTIS 250
S +L L E I +P + + L L L+ T + +P++I+
Sbjct: 145 SIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIRS-LPASIA 203
Query: 251 QLKNLTELRISD--LKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDL 308
L+NL L+I + L + +L K+E L LR C P LK L L
Sbjct: 204 NLQNLKSLKIRNSPLSALGPAIHHL---PKLEELDLRGCTALRNYPPIFGGRAPLKRLIL 260
Query: 309 S-FNQLTGPVP---GILQNLKKIDYIFLTNNSLSGTLPDWI--LTSEKNLDLSYN 357
+ L +P L L+K+D L LP I L + + + +
Sbjct: 261 KDCSNLLT-LPLDIHRLTQLEKLD---LRGCVNLSRLPSLIAQLPANCIILVPPH 311
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-34
Identities = 43/281 (15%), Positives = 82/281 (29%), Gaps = 47/281 (16%)
Query: 99 GVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGDIST 158
G + + + + + +L L + + +
Sbjct: 2 GSSHHHHHHSSGRENLYFQGST---ALRPYHDVLSQWQRHYNADRNRW-HSAWRQANSNN 57
Query: 159 LEELVLEDNQLVGPLPENLGNLKS--LRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSN 216
+ L + L + + L S P+ L +L ID +
Sbjct: 58 PQIETRTGRALKA-TADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAG 115
Query: 217 LTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISDLK---------GSS 267
L +P+ + + L+ L L L +P++I+ L L EL I S+
Sbjct: 116 LM-ELPDTMQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELTELPEPLAST 173
Query: 268 SSFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKI 327
+ Q + ++ L L I +P I ++ +LK L + + L+
Sbjct: 174 DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS------------- 219
Query: 328 DYIFLTNNSLSGTLPDWI--LTSEKNLDLSYNNFTESSPAT 366
L I L + LDL + P
Sbjct: 220 ------------ALGPAIHHLPKLEELDLRGCTALRNYPPI 248
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 3e-25
Identities = 36/154 (23%), Positives = 58/154 (37%), Gaps = 11/154 (7%)
Query: 92 LKGFNLAGVIPEEFGNLTF---------LQEVDLSRNYFNGSLPKSFARLQNLTKLLILG 142
++ +PE + LQ + L SLP S A LQNL L I
Sbjct: 157 IRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRN 215
Query: 143 NRLSGSIPLEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYG 202
+ LS ++ I + LEEL L + P G L+R++L + ++P
Sbjct: 216 SPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIH 274
Query: 203 NLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDL 236
L L + + G R+P+ I + +
Sbjct: 275 RLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILV 308
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 1e-19
Identities = 22/207 (10%), Positives = 62/207 (29%), Gaps = 25/207 (12%)
Query: 170 VGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWT 229
+G + + + + + + + + R N
Sbjct: 1 MGSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA----NSN 56
Query: 230 KLDRLDLQGTSLEGPIPSTISQLK--NLTELRISDLKGSS-SSFPN-LQDMKKMERLILR 285
G +L+ + L +L+ FP+ + ++ + +
Sbjct: 57 NPQIETRTGRALKA-TADLLEDATQPGRVAL---ELRSVPLPQFPDQAFRLSHLQHMTID 112
Query: 286 NCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGTLPDWI 345
+ +P+ ++ L+ L L+ N L +P + +L ++ + + LP+ +
Sbjct: 113 AAGLM-ELPDTMQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELTELPEPL 170
Query: 346 -----------LTSEKNLDLSYNNFTE 361
L + ++L L +
Sbjct: 171 ASTDASGEHQGLVNLQSLRLEWTGIRS 197
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 3e-12
Identities = 18/86 (20%), Positives = 31/86 (36%), Gaps = 1/86 (1%)
Query: 92 LKGFNLAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPL 151
L+G P FG L+ + L +LP RL L KL + G +P
Sbjct: 236 LRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPS 295
Query: 152 EIGDISTLEELVLEDNQLVGPLPENL 177
I + +++ + L ++
Sbjct: 296 LIAQLPANCIILVPPHLQ-AQLDQHR 320
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 1e-41
Identities = 76/295 (25%), Positives = 112/295 (37%), Gaps = 56/295 (18%)
Query: 665 NKIGEGGFGPVYKGTLSDGA------VIAVKQLSSKSKQGNR-EFVNEIGMISALQHQNL 717
+G G FG VY+G +S +AVK L + + +F+ E +IS HQN+
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 718 VKLYGCCIEGNQLLLVYEYLENNSLA---RALFGKEGQCLNLDWATRKRICSDIARGLAY 774
V+ G ++ ++ E + L R + Q +L + DIA G Y
Sbjct: 96 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 775 LHEESRLKIVHRDIKATNVLLDK---DLNAKISDFGLAKLDEDENTHISTRIAGT----V 827
L +HRDI A N LL AKI DFG+A+ + R G V
Sbjct: 156 L---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY---YRKGGCAMLPV 209
Query: 828 GYMAPEYAMRGYLTDKADVYSFGIVALEIVS-------GKSNTNYRPKEEFVYLLDWAYV 880
+M PE M G T K D +SFG++ EI S KSN +E + +
Sbjct: 210 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN------QEVLEFV----- 258
Query: 881 LQEQGNLLELVD--PSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933
G ++ P + I C P RP + + +E
Sbjct: 259 --TSGGRMDPPKNCPG-----------PVYRIMTQCWQHQPEDRPNFAIILERIE 300
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 2e-41
Identities = 61/217 (28%), Positives = 114/217 (52%), Gaps = 17/217 (7%)
Query: 650 TLRQIKAATN---NFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNREFVNE 705
LR I + + + KIG+G G VY ++ G +A++Q++ + + +NE
Sbjct: 8 KLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINE 67
Query: 706 IGMISALQHQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDW-ATRKRI 764
I ++ ++ N+V + G++L +V EYL SL + C++ A +
Sbjct: 68 ILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAA---V 121
Query: 765 CSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGL-AKLDEDENTHISTRI 823
C + + L +LH +++HRDIK+ N+LL D + K++DFG A++ +++ + +
Sbjct: 122 CRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--M 176
Query: 824 AGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGK 860
GT +MAPE R K D++S GI+A+E++ G+
Sbjct: 177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 2e-41
Identities = 63/198 (31%), Positives = 95/198 (47%), Gaps = 17/198 (8%)
Query: 666 KIGEGGFGPVYKGTLSDGAVIAVKQL--SSKSKQGNREFVNEIGMISALQHQNLVKLYGC 723
++G G FG V G +AVK + S S+ EF E + L H LVK YG
Sbjct: 15 ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSED---EFFQEAQTMMKLSHPKLVKFYGV 71
Query: 724 CIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKI 783
C + + +V EY+ N L L L+ + +C D+ G+A+L +
Sbjct: 72 CSKEYPIYIVTEYISNGCLLNYLRSHGKG---LEPSQLLEMCYDVCEGMAFL---ESHQF 125
Query: 784 VHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGT---VGYMAPEYAMRGYL 840
+HRD+ A N L+D+DL K+SDFG+ + D+ GT V + APE
Sbjct: 126 IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY---VSSVGTKFPVKWSAPEVFHYFKY 182
Query: 841 TDKADVYSFGIVALEIVS 858
+ K+DV++FGI+ E+ S
Sbjct: 183 SSKSDVWAFGILMWEVFS 200
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 2e-41
Identities = 68/195 (34%), Positives = 98/195 (50%), Gaps = 13/195 (6%)
Query: 665 NKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCC 724
IG+G FG V G V AVK + K+ + F+ E +++ L+H NLV+L G
Sbjct: 27 QTIGKGEFGDVMLGDYRGNKV-AVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 725 IEGN-QLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKI 783
+E L +V EY+ SL L + L D + D+ + YL E
Sbjct: 84 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLK--FSLDVCEAMEYL--EGN-NF 138
Query: 784 VHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRGYLTDK 843
VHRD+ A NVL+ +D AK+SDFGL K E +T + ++ V + APE + K
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLP--VKWTAPEALREKKFSTK 194
Query: 844 ADVYSFGIVALEIVS 858
+DV+SFGI+ EI S
Sbjct: 195 SDVWSFGILLWEIYS 209
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 2e-41
Identities = 59/198 (29%), Positives = 103/198 (52%), Gaps = 15/198 (7%)
Query: 665 NKIGEGGFGPVYKGTLSDGAVIAVKQL--SSKSKQGNREFVNEIGMISALQHQNLVKLYG 722
+IG G FG V+ G + +A+K + + S++ +F+ E ++ L H LV+LYG
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHPKLVQLYG 70
Query: 723 CCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLK 782
C+E + LV E++E+ L+ L + G T +C D+ G+AYL
Sbjct: 71 VCLEQAPICLVTEFMEHGCLSDYLRTQRGL---FAAETLLGMCLDVCEGMAYL---EEAC 124
Query: 783 IVHRDIKATNVLLDKDLNAKISDFGLAKLDEDEN--THISTRIAGTVGYMAPEYAMRGYL 840
++HRD+ A N L+ ++ K+SDFG+ + D+ + T+ V + +PE
Sbjct: 125 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFP--VKWASPEVFSFSRY 182
Query: 841 TDKADVYSFGIVALEIVS 858
+ K+DV+SFG++ E+ S
Sbjct: 183 SSKSDVWSFGVLMWEVFS 200
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 2e-41
Identities = 67/219 (30%), Positives = 110/219 (50%), Gaps = 21/219 (9%)
Query: 650 TLRQIKAATN---NFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNREFVNE 705
LR + + D+ KIGEG G V G +AVK + + +Q NE
Sbjct: 33 ALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNE 92
Query: 706 IGMISALQHQNLVKLYGCCIEGNQLLLVYEYLENNSLA---RALFGKEGQCLNLDWATRK 762
+ ++ QH N+V++Y + G +L ++ E+L+ +L + E Q AT
Sbjct: 93 VVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQI-----AT-- 145
Query: 763 RICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGL-AKLDEDENTHIST 821
+C + + LAYLH + ++HRDIK+ ++LL D K+SDFG A++ +D S
Sbjct: 146 -VCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS- 200
Query: 822 RIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGK 860
+ GT +MAPE R + D++S GI+ +E+V G+
Sbjct: 201 -LVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGE 238
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 2e-41
Identities = 68/199 (34%), Positives = 105/199 (52%), Gaps = 17/199 (8%)
Query: 665 NKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGN---REFVNEIGMISALQHQNLVKLY 721
++G G FG V+ G + +AVK L KQG+ F+ E ++ LQHQ LV+LY
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSL----KQGSMSPDAFLAEANLMKQLQHQRLVRLY 74
Query: 722 GCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRL 781
+ + ++ EY+EN SL L G L ++ + + IA G+A++
Sbjct: 75 AVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFI---EER 128
Query: 782 KIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDEN--THISTRIAGTVGYMAPEYAMRGY 839
+HRD++A N+L+ L+ KI+DFGLA+L ED + + + APE G
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP--IKWTAPEAINYGT 186
Query: 840 LTDKADVYSFGIVALEIVS 858
T K+DV+SFGI+ EIV+
Sbjct: 187 FTIKSDVWSFGILLTEIVT 205
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 2e-41
Identities = 53/200 (26%), Positives = 99/200 (49%), Gaps = 17/200 (8%)
Query: 665 NKIGEGGFGPVYKGTLSDGAV-IAVKQLSSKSKQGN---REFVNEIGMISALQHQNLVKL 720
+K+G G +G VY+G ++ +AVK L K+ EF+ E ++ ++H NLV+L
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKHPNLVQL 74
Query: 721 YGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESR 780
G C ++ E++ +L L Q ++ + + I+ + YL E +
Sbjct: 75 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAV--VLLYMATQISSAMEYL--EKK 130
Query: 781 LKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDE--NTHISTRIAGTVGYMAPEYAMRG 838
+HRD+ A N L+ ++ K++DFGL++L + H + + + APE
Sbjct: 131 -NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP--IKWTAPESLAYN 187
Query: 839 YLTDKADVYSFGIVALEIVS 858
+ K+DV++FG++ EI +
Sbjct: 188 KFSIKSDVWAFGVLLWEIAT 207
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 2e-41
Identities = 78/369 (21%), Positives = 141/369 (38%), Gaps = 64/369 (17%)
Query: 659 NNFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQ--LSSKSKQGNREFVNEIGMISALQHQ 715
+ KIGEG FG DG +K+ +S S + E E+ +++ ++H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 716 NLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLN----LDWATRKRICSDIARG 771
N+V+ E L +V +Y E L + + ++G LDW I
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFV------QICLA 137
Query: 772 LAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMA 831
L ++H+ KI+HRDIK+ N+ L KD ++ DFG+A++ I GT Y++
Sbjct: 138 LKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLS 193
Query: 832 PE-YAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLEL 890
PE + Y +K+D+++ G V E+ + K F E G++ L
Sbjct: 194 PEICENKPY-NNKSDIWALGCVLYELCTLK-----HA---F-----------EAGSMKNL 233
Query: 891 VD-------PSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTAVQAPII 943
V P + ++S + ++ +P RP S S+L + I
Sbjct: 234 VLKIISGSFPPVSLHYSYD----LRSLVSQLFKRNPRDRP---SVNSIL------EKGFI 280
Query: 944 RRNSD----SQDARFRAFEILSQDSQTHVSTLSQESEMQRTMSIDAPW--TDSSVSVQIP 997
+ + Q + + + Q ++S+ T + IP
Sbjct: 281 AKRIEKFLSPQLIAEEFCLKTFSKFGSQPIPAKRPASGQNSISVMPAQKITKPAAKYGIP 340
Query: 998 DETREHSSS 1006
+++
Sbjct: 341 LAYKKYGDK 349
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 4e-41
Identities = 55/201 (27%), Positives = 104/201 (51%), Gaps = 14/201 (6%)
Query: 665 NKIGEGGFGPVYKGTLSDGA-----VIAVKQL-SSKSKQGNREFVNEIGMISALQHQNLV 718
+G G FG VYKG +A+K+L + S + N+E ++E +++++ + ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 719 KLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEE 778
+L G C+ + + L+ + + L + + + C IA+G+ YL E
Sbjct: 81 RLLGICLT-STVQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGMNYL--E 134
Query: 779 SRLKIVHRDIKATNVLLDKDLNAKISDFGLAK-LDEDENTHISTRIAGTVGYMAPEYAMR 837
R ++VHRD+ A NVL+ + KI+DFGLAK L +E + + + +MA E +
Sbjct: 135 DR-RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 193
Query: 838 GYLTDKADVYSFGIVALEIVS 858
T ++DV+S+G+ E+++
Sbjct: 194 RIYTHQSDVWSYGVTVWELMT 214
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 4e-41
Identities = 65/197 (32%), Positives = 94/197 (47%), Gaps = 17/197 (8%)
Query: 665 NKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGN--REFVNEIGMISALQHQNLVKLYG 722
IG+G FG V G V AVK + K + F+ E +++ L+H NLV+L G
Sbjct: 199 QTIGKGEFGDVMLGDYRGNKV-AVKCI----KNDATAQAFLAEASVMTQLRHSNLVQLLG 253
Query: 723 CCIEGN-QLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRL 781
+E L +V EY+ SL L + L + D+ + YL E
Sbjct: 254 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGG--DCLLKFSLDVCEAMEYL--EGN- 308
Query: 782 KIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRGYLT 841
VHRD+ A NVL+ +D AK+SDFGL K + + ++ V + APE +
Sbjct: 309 NFVHRDLAARNVLVSEDNVAKVSDFGLTK-EASSTQD-TGKLP--VKWTAPEALREKKFS 364
Query: 842 DKADVYSFGIVALEIVS 858
K+DV+SFGI+ EI S
Sbjct: 365 TKSDVWSFGILLWEIYS 381
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 6e-41
Identities = 61/201 (30%), Positives = 101/201 (50%), Gaps = 13/201 (6%)
Query: 665 NKIGEGGFGPVYKGTLSDGA----VIAVKQL-SSKSKQGNREFVNEIGMISALQHQNLVK 719
+G G FG V G L + +A+K L +++ R+F+ E ++ H N+++
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 720 LYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEES 779
L G + +++V EY+EN SL L + Q + IA G+ YL S
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ---FTVIQLVGMLRGIASGMKYL---S 164
Query: 780 RLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGT--VGYMAPEYAMR 837
+ VHRD+ A N+L++ +L K+SDFGL ++ ED+ T G + + +PE
Sbjct: 165 DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 224
Query: 838 GYLTDKADVYSFGIVALEIVS 858
T +DV+S+GIV E++S
Sbjct: 225 RKFTSASDVWSYGIVLWEVMS 245
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 6e-41
Identities = 69/197 (35%), Positives = 107/197 (54%), Gaps = 13/197 (6%)
Query: 665 NKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGN---REFVNEIGMISALQHQNLVKLY 721
K+G+G FG V+ GT + +A+K L K G F+ E ++ L+H+ LV+LY
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTL----KPGTMSPEAFLQEAQVMKKLRHEKLVQLY 245
Query: 722 GCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRL 781
E + +V EY+ SL L G+ G+ L L + + IA G+AY+ E
Sbjct: 246 AVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRL--PQLVDMAAQIASGMAYV--ERM- 299
Query: 782 KIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRGYLT 841
VHRD++A N+L+ ++L K++DFGLA+L ED + + APE A+ G T
Sbjct: 300 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 359
Query: 842 DKADVYSFGIVALEIVS 858
K+DV+SFGI+ E+ +
Sbjct: 360 IKSDVWSFGILLTELTT 376
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 8e-41
Identities = 73/285 (25%), Positives = 116/285 (40%), Gaps = 44/285 (15%)
Query: 665 NKIGEGGFGPVYKGTLSDGA----VIAVKQLSSKSKQGNR-EFVNEIGMISALQHQNLVK 719
IG G FG VY GTL D AVK L+ + G +F+ E ++ H N++
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 720 LYGCCIEG-NQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEE 778
L G C+ L+V Y+++ L + + +A+G+ YL
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN---PTVKDLIGFGLQVAKGMKYLAS- 146
Query: 779 SRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGT---VGYMAPEYA 835
K VHRD+ A N +LD+ K++DFGLA+ D+ + G V +MA E
Sbjct: 147 --KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 204
Query: 836 MRGYLTDKADVYSFGIVALEIVS-------GKSNTNYRPKEEFVYLLDWAYVLQEQGNLL 888
T K+DV+SFG++ E+++ + + L QG L
Sbjct: 205 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT------FDITVYL-------LQGRRL 251
Query: 889 ELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933
P + + + L C +P +RP+ S VS +
Sbjct: 252 LQ--PEYCPD-------PLYEVMLKCWHPKAEMRPSFSELVSRIS 287
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 1e-40
Identities = 58/199 (29%), Positives = 95/199 (47%), Gaps = 13/199 (6%)
Query: 666 KIGEGGFGPVYKGTLSDGAV---IAVKQL-SSKSKQGNREFVNEIGMISALQHQNLVKLY 721
++G G FG V +G +A+K L K E + E ++ L + +V+L
Sbjct: 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 722 GCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRL 781
G C + L+LV E L + L GK + + + + ++ G+ YL
Sbjct: 77 GVC-QAEALMLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKYL---EEK 129
Query: 782 KIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGT--VGYMAPEYAMRGY 839
VHRD+ A NVLL AKISDFGL+K ++++ + R AG + + APE
Sbjct: 130 NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 189
Query: 840 LTDKADVYSFGIVALEIVS 858
+ ++DV+S+G+ E +S
Sbjct: 190 FSSRSDVWSYGVTMWEALS 208
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 1e-40
Identities = 66/291 (22%), Positives = 111/291 (38%), Gaps = 47/291 (16%)
Query: 665 NKIGEGGFGPVYKGTLSDGA----VIAVKQL--SSKSKQGNREFVNEIGMISALQHQNLV 718
+G+G FG V + L +AVK L + EF+ E + H ++
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 719 KLYGCCIEG------NQLLLVYEYLENNSLARAL--FGKEGQCLNLDWATRKRICSDIAR 770
KL G + +++ ++++ L L NL T R DIA
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 771 GLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGT-VGY 829
G+ YL SR +HRD+ A N +L +D+ ++DFGL++ + + + V +
Sbjct: 149 GMEYL--SSR-NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKW 205
Query: 830 MAPEYAMRGYLTDKADVYSFGIVALEIVS-------GKSNTNYRPKEEFVYLLDWAYVLQ 882
+A E T +DV++FG+ EI++ G N E L
Sbjct: 206 LALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN------AEIYNYL------- 252
Query: 883 EQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933
GN L+ P + ++ C + P RP+ + LE
Sbjct: 253 IGGNRLKQ--PPECME-------EVYDLMYQCWSADPKQRPSFTCLRMELE 294
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 1e-40
Identities = 70/205 (34%), Positives = 105/205 (51%), Gaps = 12/205 (5%)
Query: 658 TNNFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQN 716
FD K+GEG +G VYK G ++A+KQ+ +S +E + EI ++ +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEIIKEISIMQQCDSPH 85
Query: 717 LVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDW-ATRKRICSDIARGLAYL 775
+VK YG + L +V EY S++ + + L D AT I +GL YL
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVS-DIIRLRNKTLTEDEIAT---ILQSTLKGLEYL 141
Query: 776 HEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYA 835
H + +HRDIKA N+LL+ + +AK++DFG+A D +T I GT +MAPE
Sbjct: 142 HFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEVI 197
Query: 836 MRGYLTDKADVYSFGIVALEIVSGK 860
AD++S GI A+E+ GK
Sbjct: 198 QEIGYNCVADIWSLGITAIEMAEGK 222
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 1e-40
Identities = 68/285 (23%), Positives = 112/285 (39%), Gaps = 44/285 (15%)
Query: 665 NKIGEGGFGPVYKGTLSDGA----VIAVKQLSSKSKQGNR-EFVNEIGMISALQHQNLVK 719
IG+G FG VY G D A A+K LS ++ F+ E ++ L H N++
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 720 LYGCCIEGN-QLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEE 778
L G + ++ Y+ + L + + + N +ARG+ YL
Sbjct: 87 LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQR---NPTVKDLISFGLQVARGMEYL--- 140
Query: 779 SRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGT---VGYMAPEYA 835
+ K VHRD+ A N +LD+ K++DFGLA+ D + + V + A E
Sbjct: 141 AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESL 200
Query: 836 MRGYLTDKADVYSFGIVALEIVS-------GKSNTNYRPKEEFVYLLDWAYVLQEQGNLL 888
T K+DV+SFG++ E+++ + + L QG L
Sbjct: 201 QTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP------FDLTHFL-------AQGRRL 247
Query: 889 ELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933
P + ++ + C P +RPT V +E
Sbjct: 248 PQ--PEYCPD-------SLYQVMQQCWEADPAVRPTFRVLVGEVE 283
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 1e-40
Identities = 58/211 (27%), Positives = 108/211 (51%), Gaps = 23/211 (10%)
Query: 661 FDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVK 719
++ ++G+G FG VYK GA+ A K + +KS++ +++ EI +++ H +VK
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 720 LYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDW-ATRKRICSDIARGLAYLHEE 778
L G +L ++ E+ ++ A+ + + L +C + L +LH +
Sbjct: 81 LLGAYYHDGKLWIMIEFCPGGAVD-AIMLELDRGLTEPQIQV---VCRQMLEALNFLHSK 136
Query: 779 SRLKIVHRDIKATNVLLDKDLNAKISDFGL-AKLDEDE---NTHISTRIAGTVGYMAPEY 834
+I+HRD+KA NVL+ + + +++DFG+ AK + ++ I GT +MAPE
Sbjct: 137 ---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-----GTPYWMAPEV 188
Query: 835 AMRGYLTD-----KADVYSFGIVALEIVSGK 860
M + D KAD++S GI +E+ +
Sbjct: 189 VMCETMKDTPYDYKADIWSLGITLIEMAQIE 219
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 1e-40
Identities = 75/290 (25%), Positives = 120/290 (41%), Gaps = 46/290 (15%)
Query: 665 NKIGEGGFGPVYKGTLSDGA----VIAVKQL--SSKSKQGNREFVNEIGMISALQHQNLV 718
+GEG FG V +G L +AVK + + S++ EF++E + H N++
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 719 KLYGCCIEGN-----QLLLVYEYLENNSLARAL--FGKEGQCLNLDWATRKRICSDIARG 771
+L G CIE + + +++ +++ L L E ++ T + DIA G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 772 LAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGT-VGYM 830
+ YL S +HRD+ A N +L D+ ++DFGL+K + + RIA V ++
Sbjct: 160 MEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 216
Query: 831 APEYAMRGYLTDKADVYSFGIVALEIVS-------GKSNTNYRPKEEFVYLLDWAYVLQE 883
A E T K+DV++FG+ EI + G N E L
Sbjct: 217 AIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN------HEMYDYL-------L 263
Query: 884 QGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933
G+ L+ P + + I C P RPT S LE
Sbjct: 264 HGHRLKQ--PEDCLD-------ELYEIMYSCWRTDPLDRPTFSVLRLQLE 304
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 2e-40
Identities = 76/304 (25%), Positives = 122/304 (40%), Gaps = 60/304 (19%)
Query: 665 NKIGEGGFGPVYKGTLSDGA------VIAVKQLSSKSKQGNR-EFVNEIGMISALQHQNL 717
+GEG FG V K T +AVK L + + ++E ++ + H ++
Sbjct: 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 718 VKLYGCCIEGNQLLLVYEYLENNSL------ARALFGKEGQCLNLDWATRK--------- 762
+KLYG C + LLL+ EY + SL +R + ++
Sbjct: 89 IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 763 -----RICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENT 817
I++G+ YL K+VHRD+ A N+L+ + KISDFGL++ +E++
Sbjct: 149 MGDLISFAWQISQGMQYL--AEM-KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS 205
Query: 818 HISTRIAGT-VGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-------GKSNTNYRPKE 869
++ V +MA E T ++DV+SFG++ EIV+ G E
Sbjct: 206 YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP------E 259
Query: 870 EFVYLLDWAYVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAV 929
LL + G+ +E P S M + L C P RP +
Sbjct: 260 RLFNLL-------KTGHRMER--PDNCSE-------EMYRLMLQCWKQEPDKRPVFADIS 303
Query: 930 SMLE 933
LE
Sbjct: 304 KDLE 307
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 156 bits (395), Expect = 2e-40
Identities = 69/197 (35%), Positives = 107/197 (54%), Gaps = 13/197 (6%)
Query: 665 NKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGN---REFVNEIGMISALQHQNLVKLY 721
K+G+G FG V+ GT + +A+K L K G F+ E ++ L+H+ LV+LY
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTL----KPGTMSPEAFLQEAQVMKKLRHEKLVQLY 328
Query: 722 GCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRL 781
E + +V EY+ SL L G+ G+ L L + + IA G+AY+ E
Sbjct: 329 AVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRL--PQLVDMAAQIASGMAYV--ERM- 382
Query: 782 KIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRGYLT 841
VHRD++A N+L+ ++L K++DFGLA+L ED + + APE A+ G T
Sbjct: 383 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 442
Query: 842 DKADVYSFGIVALEIVS 858
K+DV+SFGI+ E+ +
Sbjct: 443 IKSDVWSFGILLTELTT 459
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 3e-40
Identities = 77/294 (26%), Positives = 112/294 (38%), Gaps = 54/294 (18%)
Query: 665 NKIGEGGFGPVYKGTLSDGA------VIAVKQLSSKSKQGNR-EFVNEIGMISALQHQNL 717
+G G FG VY+G +S +AVK L + + +F+ E +IS HQN+
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136
Query: 718 VKLYGCCIEGNQLLLVYEYLENNSLA---RALFGKEGQCLNLDWATRKRICSDIARGLAY 774
V+ G ++ ++ E + L R + Q +L + DIA G Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 775 LHEESRLKIVHRDIKATNVLLDK---DLNAKISDFGLAKLDEDENTHISTRIAGT----V 827
L +HRDI A N LL AKI DFG+A+ R G V
Sbjct: 197 L---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGY---YRKGGCAMLPV 250
Query: 828 GYMAPEYAMRGYLTDKADVYSFGIVALEIVS-------GKSNTNYRPKEEFVYLLDWAYV 880
+M PE M G T K D +SFG++ EI S KSN +E + +
Sbjct: 251 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN------QEVLEFV----- 299
Query: 881 LQEQGNLLELVDPSLGSNFSKKEAMTML-NIALLCTNPSPTLRPTMSSAVSMLE 933
G ++ P K + I C P RP + + +E
Sbjct: 300 --TSGGRMDP--P--------KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 341
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 3e-40
Identities = 76/293 (25%), Positives = 120/293 (40%), Gaps = 51/293 (17%)
Query: 665 NKIGEGGFGPVYKGTLSDGAV---IAVKQL-SSKSKQGNREFVNEIGMISAL-QHQNLVK 719
+ IGEG FG V K + + A+K++ SK +R+F E+ ++ L H N++
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 720 LYGCCIEGNQLLLVYEYLENNSL------------ARALFGKEGQCLNLDWATRKRICSD 767
L G C L L EY + +L A L +D
Sbjct: 91 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 768 IARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTV 827
+ARG+ YL S+ + +HRD+ A N+L+ ++ AKI+DFGL++ E R+ V
Sbjct: 151 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP--V 205
Query: 828 GYMAPEYAMRGYLTDKADVYSFGIVALEIVS-------GKSNTNYRPKEEFVYLLDWAYV 880
+MA E T +DV+S+G++ EIVS G + E L
Sbjct: 206 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC------AELYEKL----- 254
Query: 881 LQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933
QG LE P + + ++ C P RP+ + + L
Sbjct: 255 --PQGYRLE--KPLNCDD-------EVYDLMRQCWREKPYERPSFAQILVSLN 296
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 3e-40
Identities = 81/294 (27%), Positives = 119/294 (40%), Gaps = 48/294 (16%)
Query: 665 NKIGEGGFGPVYKGTLSDGA------VIAVKQL-SSKSKQGNREFVNEIGMISAL-QHQN 716
+G G FG V + T +AVK L S+ ++E+ ++S L QH+N
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 717 LVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRK----------RICS 766
+V L G C G +L++ EY L L K S
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171
Query: 767 DIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLA-KLDEDENTHISTRIAG 825
+A+G+A+L S+ +HRD+ A NVLL AKI DFGLA + D N +
Sbjct: 172 QVAQGMAFL--ASK-NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 228
Query: 826 TVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKS-----NTNYRPKEEFVYLLDWAY 879
V +MAPE T ++DV+S+GI+ EI S G + N +F L+
Sbjct: 229 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN----SKFYKLV---- 280
Query: 880 VLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933
+ G + P+ + +I C PT RPT S L+
Sbjct: 281 ---KDGYQMA--QPAFAPK-------NIYSIMQACWALEPTHRPTFQQICSFLQ 322
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 5e-40
Identities = 69/286 (24%), Positives = 117/286 (40%), Gaps = 51/286 (17%)
Query: 659 NNFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNL 717
+F IG GGFG V+K DG +K++ K N + E+ ++ L H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV----KYNNEKAEREVKALAKLDHVNI 66
Query: 718 VKLYGCCIE----------------GNQLLLVYEYLENNSLARALFGKEGQCLNLDWATR 761
V GC L + E+ + +L + + + G+ L+ A
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLA-- 124
Query: 762 KRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHIST 821
+ I +G+ Y+H + K+++RD+K +N+ L KI DFGL +++ T
Sbjct: 125 LELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR--T 179
Query: 822 RIAGTVGYMAPE-YAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYV 880
R GT+ YM+PE + + Y + D+Y+ G++ E++ E
Sbjct: 180 RSKGTLRYMSPEQISSQDY-GKEVDLYALGLILAELLHVCD----TAFE----------- 223
Query: 881 LQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMS 926
+L D + F K+ T+L LL P RP S
Sbjct: 224 --TSKFFTDLRDGIISDIFD-KKEKTLLQ-KLLSKKPE--DRPNTS 263
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 5e-40
Identities = 63/197 (31%), Positives = 99/197 (50%), Gaps = 13/197 (6%)
Query: 665 NKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGN---REFVNEIGMISALQHQNLVKLY 721
K+G G FG V+ T + +AVK + K G+ F+ E ++ LQH LVKL+
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTM----KPGSMSVEAFLAEANVMKTLQHDKLVKLH 249
Query: 722 GCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRL 781
+ + ++ E++ SL L EG L + IA G+A++ +
Sbjct: 250 AVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFI---EQR 303
Query: 782 KIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRGYLT 841
+HRD++A N+L+ L KI+DFGLA++ ED + + APE G T
Sbjct: 304 NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT 363
Query: 842 DKADVYSFGIVALEIVS 858
K+DV+SFGI+ +EIV+
Sbjct: 364 IKSDVWSFGILLMEIVT 380
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 7e-40
Identities = 70/284 (24%), Positives = 113/284 (39%), Gaps = 49/284 (17%)
Query: 666 KIGEGGFGPVYKGTLSDGA----VIAVKQL-SSKSKQGNREFVNEIGMISALQHQNLVKL 720
IGEG FG V++G +A+K + S +F+ E + H ++VKL
Sbjct: 22 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 721 YGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESR 780
G E N + ++ E L L ++ LD A+ ++ LAYL
Sbjct: 82 IGVITE-NPVWIIMELCTLGELRSFLQVRKYS---LDLASLILYAYQLSTALAYL---ES 134
Query: 781 LKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRGYL 840
+ VHRDI A NVL+ + K+ DFGL++ ED + +++ + +MAPE
Sbjct: 135 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 194
Query: 841 TDKADVYSFGIVALEIVS-------GKSNTNYRPKEEFVYLLDWAYVLQ--EQGNLLELV 891
T +DV+ FG+ EI+ G N + V+ E G L +
Sbjct: 195 TSASDVWMFGVCMWEILMHGVKPFQGVKNND---------------VIGRIENGERLPMP 239
Query: 892 D--PSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933
P T+ ++ C P+ RP + + L
Sbjct: 240 PNCPP-----------TLYSLMTKCWAYDPSRRPRFTELKAQLS 272
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 7e-40
Identities = 76/299 (25%), Positives = 127/299 (42%), Gaps = 55/299 (18%)
Query: 665 NKIGEGGFGPVYKGTLSDGA--------VIAVKQLSSKSKQGNR-EFVNEIGMISAL-QH 714
+GEG FG V +AVK L + + + + V+E+ M+ + +H
Sbjct: 87 KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146
Query: 715 QNLVKLYGCCIEGNQLLLVYEYLENNSL-----ARALFGKEGQCLNLDWATRK------- 762
+N++ L G C + L ++ EY +L AR G E +
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 763 RICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTR 822
+ARG+ YL S+ K +HRD+ A NVL+ ++ KI+DFGLA+ + + + T
Sbjct: 207 SCTYQLARGMEYL--ASQ-KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 263
Query: 823 IAGT-VGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-------GKSNTNYRPKEEFVYL 874
V +MAPE T ++DV+SFG++ EI + G EE L
Sbjct: 264 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV------EELFKL 317
Query: 875 LDWAYVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933
L ++G+ ++ P+ +N + + C + P+ RPT V L+
Sbjct: 318 L-------KEGHRMDK--PANCTN-------ELYMMMRDCWHAVPSQRPTFKQLVEDLD 360
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 9e-40
Identities = 73/299 (24%), Positives = 127/299 (42%), Gaps = 55/299 (18%)
Query: 665 NKIGEGGFGPVYKGTLSDGA--------VIAVKQLSSKSKQGNR-EFVNEIGMISAL-QH 714
+GEG FG V +AVK L + + + + V+E+ M+ + +H
Sbjct: 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 715 QNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRK------------ 762
+N++ L G C + L ++ EY +L L + + + +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 763 RICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTR 822
+ARG+ YL S+ K +HRD+ A NVL+ ++ KI+DFGLA+ + + + T
Sbjct: 161 SCTYQLARGMEYL--ASQ-KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 823 IAGT-VGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-------GKSNTNYRPKEEFVYL 874
V +MAPE T ++DV+SFG++ EI + G EE L
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV------EELFKL 271
Query: 875 LDWAYVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933
L ++G+ ++ P+ +N + + C + P+ RPT V L+
Sbjct: 272 L-------KEGHRMD--KPANCTN-------ELYMMMRDCWHAVPSQRPTFKQLVEDLD 314
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 1e-39
Identities = 61/231 (26%), Positives = 105/231 (45%), Gaps = 37/231 (16%)
Query: 658 TNNFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQN 716
++F+ +G+G FG V K D A+K++ +++ ++E+ ++++L HQ
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLNHQY 63
Query: 717 LVKLYGCCIEGNQ-------------LLLVYEYLENNSLARALFGKEGQCLNLDWATRKR 763
+V+ Y +E L + EY EN +L L E D R
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTL-YDLIHSENLNQQRDEY--WR 120
Query: 764 ICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKL------------ 811
+ I L+Y+H + I+HRD+K N+ +D+ N KI DFGLAK
Sbjct: 121 LFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 812 --DEDENTHISTRIAGTVGYMAPE-YAMRGYLTDKADVYSFGIVALEIVSG 859
+ ++++ I GT Y+A E G+ +K D+YS GI+ E++
Sbjct: 178 QNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 1e-39
Identities = 70/287 (24%), Positives = 110/287 (38%), Gaps = 55/287 (19%)
Query: 666 KIGEGGFGPVYKGTL--SDGAVI--AVKQL-SSKSKQGNREFVNEIGMISALQHQNLVKL 720
+GEG FG VY+G G I AVK + +F++E ++ L H ++VKL
Sbjct: 19 ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 721 YGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESR 780
G E ++ E L L + L T I + +AYL
Sbjct: 79 IGII-EEEPTWIIMELYPYGELGHYLERNKNS---LKVLTLVLYSLQICKAMAYL---ES 131
Query: 781 LKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGT---VGYMAPEYAMR 837
+ VHRDI N+L+ K+ DFGL++ EDE+ + + T + +M+PE
Sbjct: 132 INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY---YKASVTRLPIKWMSPESINF 188
Query: 838 GYLTDKADVYSFGIVALEIVS-------GKSNTNYRPKEEFVYLLDWAYVLQ--EQGNLL 888
T +DV+ F + EI+S N + V+ E+G+ L
Sbjct: 189 RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD---------------VIGVLEKGDRL 233
Query: 889 ELVD--PSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933
D P + + C + P+ RP + V L
Sbjct: 234 PKPDLCPP-----------VLYTLMTRCWDYDPSDRPRFTELVCSLS 269
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 1e-39
Identities = 59/200 (29%), Positives = 92/200 (46%), Gaps = 15/200 (7%)
Query: 666 KIGEGGFGPVYKGTLSDGAV---IAVKQL--SSKSKQGNREFVNEIGMISALQHQNLVKL 720
++G G FG V KG V +AVK L + E + E ++ L + +V++
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 721 YGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESR 780
G C E +LV E E L + L ++ + ++ + ++ G+ YL
Sbjct: 84 IGIC-EAESWMLVMEMAELGPLNKYL--QQNR--HVKDKNIIELVHQVSMGMKYL---EE 135
Query: 781 LKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGT--VGYMAPEYAMRG 838
VHRD+ A NVLL AKISDFGL+K + + + G V + APE
Sbjct: 136 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 195
Query: 839 YLTDKADVYSFGIVALEIVS 858
+ K+DV+SFG++ E S
Sbjct: 196 KFSSKSDVWSFGVLMWEAFS 215
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 1e-39
Identities = 75/304 (24%), Positives = 121/304 (39%), Gaps = 60/304 (19%)
Query: 665 NKIGEGGFGPVYKGTLSDGA------VIAVKQLSSK-SKQGNREFVNEIGMISALQHQNL 717
IGEG FG V++ ++AVK L + S +F E +++ + N+
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112
Query: 718 VKLYGCCIEGNQLLLVYEYLENNSL------ARALFGKEGQCLNLDWATRK--------- 762
VKL G C G + L++EY+ L +L R
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172
Query: 763 -----RICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLA-KLDEDEN 816
I +A G+AYL S K VHRD+ N L+ +++ KI+DFGL+ + +
Sbjct: 173 CAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 229
Query: 817 THISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-------GKSNTNYRPKE 869
A + +M PE T ++DV+++G+V EI S G ++ E
Sbjct: 230 YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH------E 283
Query: 870 EFVYLLDWAYVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAV 929
E +Y + GN+L P + N+ LC + P RP+ S
Sbjct: 284 EVIYYV-------RDGNILAC--PENCPL-------ELYNLMRLCWSKLPADRPSFCSIH 327
Query: 930 SMLE 933
+L+
Sbjct: 328 RILQ 331
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 2e-39
Identities = 71/285 (24%), Positives = 113/285 (39%), Gaps = 44/285 (15%)
Query: 665 NKIGEGGFGPVYKGTLSDGA----VIAVKQL-SSKSKQGNREFVNEIGMISALQHQNLVK 719
IG G FG VY GTL D AVK L +F+ E ++ H N++
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 720 LYGCCIEG-NQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEE 778
L G C+ L+V Y+++ L + + +A+G+ +L
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN---PTVKDLIGFGLQVAKGMKFL--- 208
Query: 779 SRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGT---VGYMAPEYA 835
+ K VHRD+ A N +LD+ K++DFGLA+ D+ G V +MA E
Sbjct: 209 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 268
Query: 836 MRGYLTDKADVYSFGIVALEIVS-------GKSNTNYRPKEEFVYLLDWAYVLQEQGNLL 888
T K+DV+SFG++ E+++ + + L QG L
Sbjct: 269 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT------FDITVYL-------LQGRRL 315
Query: 889 ELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933
P + + + L C +P +RP+ S VS +
Sbjct: 316 LQ--PEYCPD-------PLYEVMLKCWHPKAEMRPSFSELVSRIS 351
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 2e-39
Identities = 56/201 (27%), Positives = 94/201 (46%), Gaps = 14/201 (6%)
Query: 665 NKIGEGGFGPVYKGTLSDGA-----VIAVKQL-SSKSKQGNREFVNEIGMISALQHQNLV 718
+G G FG V+KG + +K + +Q + + + I +L H ++V
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 719 KLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEE 778
+L G C + L LV +YL SL + G L IA+G+ YL E
Sbjct: 79 RLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGA---LGPQLLLNWGVQIAKGMYYL--E 132
Query: 779 SRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGT-VGYMAPEYAMR 837
+VHR++ A NVLL +++DFG+A L ++ + A T + +MA E
Sbjct: 133 EH-GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHF 191
Query: 838 GYLTDKADVYSFGIVALEIVS 858
G T ++DV+S+G+ E+++
Sbjct: 192 GKYTHQSDVWSYGVTVWELMT 212
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 2e-39
Identities = 74/298 (24%), Positives = 114/298 (38%), Gaps = 52/298 (17%)
Query: 665 NKIGEGGFGPVYKGTLSDGA------VIAVKQLSSKSKQGNR-EFVNEIGMISAL-QHQN 716
+G G FG V + T +AVK L + R ++E+ ++S L H N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 717 LVKLYGCCIEGNQLLLVYEYLENNSL------ARALFGKEGQCLNLDWATRK-------- 762
+V L G C G L++ EY L R F +
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 763 RICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLA-KLDEDENTHIST 821
+A+G+A+L + +HRD+ A N+LL KI DFGLA + D N +
Sbjct: 149 SFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205
Query: 822 RIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKS-----NTNYRPKEEFVYLL 875
V +MAPE T ++DV+S+GI E+ S G S + +F ++
Sbjct: 206 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD----SKFYKMI 261
Query: 876 DWAYVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933
++G + P M +I C + P RPT V ++E
Sbjct: 262 -------KEGFRML--SPEHAPA-------EMYDIMKTCWDADPLKRPTFKQIVQLIE 303
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 3e-39
Identities = 55/201 (27%), Positives = 104/201 (51%), Gaps = 14/201 (6%)
Query: 665 NKIGEGGFGPVYKGTLSDGA-----VIAVKQL-SSKSKQGNREFVNEIGMISALQHQNLV 718
+G G FG VYKG +A+K+L + S + N+E ++E +++++ + ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 719 KLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEE 778
+L G C+ + + L+ + + L + + + C IA+G+ YL E
Sbjct: 81 RLLGICLT-STVQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGMNYL--E 134
Query: 779 SRLKIVHRDIKATNVLLDKDLNAKISDFGLAK-LDEDENTHISTRIAGTVGYMAPEYAMR 837
R ++VHRD+ A NVL+ + KI+DFGLAK L +E + + + +MA E +
Sbjct: 135 DR-RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 193
Query: 838 GYLTDKADVYSFGIVALEIVS 858
T ++DV+S+G+ E+++
Sbjct: 194 RIYTHQSDVWSYGVTVWELMT 214
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 6e-39
Identities = 56/236 (23%), Positives = 96/236 (40%), Gaps = 25/236 (10%)
Query: 641 GLDLQTGYFTLRQIKAATNNFDAANKIGEGGFGPVYKGTLSDGAVIAVKQ--LSSKSKQG 698
G+DL T + + + +IG GG V++ + A+K L Q
Sbjct: 10 GVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQT 69
Query: 699 NREFVNEIGMISALQHQNL--VKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNL 756
+ NEI ++ LQ + ++LY I + +V E N L L K+ + ++
Sbjct: 70 LDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL--KKKKSIDP 126
Query: 757 DWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAK-LDEDE 815
K ++ + +H+ IVH D+K N L+ K+ DFG+A + D
Sbjct: 127 WER--KSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDT 180
Query: 816 NTHISTRIAGTVGYMAPE-----------YAMRGYLTDKADVYSFGIVALEIVSGK 860
+ + GTV YM PE + ++ K+DV+S G + + GK
Sbjct: 181 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 7e-39
Identities = 56/295 (18%), Positives = 108/295 (36%), Gaps = 65/295 (22%)
Query: 666 KIGEGGFGPVYKGTLSDGAV--------IAVKQLSSKSKQGNREFVNEIGMISALQHQNL 717
+G+G F ++KG + + +K L + + F M+S L H++L
Sbjct: 15 SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74
Query: 718 VKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHE 777
V YG C+ G++ +LV E+++ SL L + ++ + + +A + +L
Sbjct: 75 VLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNC---INILWKLEVAKQLAAAMHFL-- 129
Query: 778 ESRLKIVHRDIKATNVLLDKDLN--------AKISDFGLAK-LDEDENTHISTRIAGTVG 828
E ++H ++ A N+LL ++ + K+SD G++ + +
Sbjct: 130 EEN-TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIP------ 182
Query: 829 YMAPE-YAMRGYLTDKADVYSFGIVALEIVS-------GKSNTNYRPKEEFVYLLDWAYV 880
++ PE L D +SFG EI S +
Sbjct: 183 WVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR---------------K 227
Query: 881 LQ--EQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933
LQ E + L + + N+ C + P RP+ + + L
Sbjct: 228 LQFYEDRHQLPAPKAA-----------ELANLINNCMDYEPDHRPSFRAIIRDLN 271
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 7e-39
Identities = 71/203 (34%), Positives = 103/203 (50%), Gaps = 13/203 (6%)
Query: 661 FDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNRE-FVNEIGMISALQHQNLV 718
F KIG+G FG V+KG V+A+K + + + E EI ++S +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 719 KLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDW-ATRKRICSDIARGLAYLHE 777
K YG ++ +L ++ EYL S L E L+ AT I +I +GL YLH
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGGGSALDLL---EPGPLDETQIAT---ILREILKGLDYLHS 137
Query: 778 ESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMR 837
E K +HRDIKA NVLL + K++DFG+A D +T + GT +MAPE +
Sbjct: 138 E---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQ 193
Query: 838 GYLTDKADVYSFGIVALEIVSGK 860
KAD++S GI A+E+ G+
Sbjct: 194 SAYDSKADIWSLGITAIELARGE 216
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 8e-39
Identities = 56/202 (27%), Positives = 92/202 (45%), Gaps = 16/202 (7%)
Query: 666 KIGEGGFGPVYKGTL--SDGAVI--AVKQL---SSKSKQGNREFVNEIGMISALQHQNLV 718
K+G+G FG V +G G + AVK L + +F+ E+ + +L H+NL+
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 719 KLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEE 778
+LYG + + +V E SL L +G T R +A G+ YL E
Sbjct: 85 RLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGH---FLLGTLSRYAVQVAEGMGYL-ES 139
Query: 779 SRLKIVHRDIKATNVLLDKDLNAKISDFGLAK-LDEDENTHISTRIAGT-VGYMAPEYAM 836
R +HRD+ A N+LL KI DFGL + L ++++ ++ + APE
Sbjct: 140 KRF--IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 197
Query: 837 RGYLTDKADVYSFGIVALEIVS 858
+ +D + FG+ E+ +
Sbjct: 198 TRTFSHASDTWMFGVTLWEMFT 219
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 1e-38
Identities = 73/297 (24%), Positives = 120/297 (40%), Gaps = 51/297 (17%)
Query: 665 NKIGEGGFGPVYKGTLSDGA------VIAVKQLSSKSKQGNR-EFVNEIGMISAL-QHQN 716
+G G FG V + +AVK L + ++E+ ++ + H N
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 717 LVKLYGCC-IEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRK------------R 763
+V L G C G L+++ E+ + +L+ L K + + A
Sbjct: 93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 764 ICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRI 823
+A+G+ +L + K +HRD+ A N+LL + KI DFGLA+ + ++
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 209
Query: 824 AGT-VGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKS-----NTNYRPKEEFVYLLD 876
A + +MAPE T ++DV+SFG++ EI S G S + EEF L
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID----EEFCRRL- 264
Query: 877 WAYVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933
++G + P + M L C + P+ RPT S V L
Sbjct: 265 ------KEGTRMR--APDYTTP-------EMYQTMLDCWHGEPSQRPTFSELVEHLG 306
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 1e-38
Identities = 58/199 (29%), Positives = 95/199 (47%), Gaps = 13/199 (6%)
Query: 666 KIGEGGFGPVYKGTL-SDGAVI--AVKQL-SSKSKQGNREFVNEIGMISALQHQNLVKLY 721
++G G FG V +G I A+K L K E + E ++ L + +V+L
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 722 GCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRL 781
G C + L+LV E L + L GK + + + + ++ G+ YL
Sbjct: 403 GVC-QAEALMLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKYL---EEK 455
Query: 782 KIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGT--VGYMAPEYAMRGY 839
VHR++ A NVLL AKISDFGL+K ++++ + R AG + + APE
Sbjct: 456 NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 515
Query: 840 LTDKADVYSFGIVALEIVS 858
+ ++DV+S+G+ E +S
Sbjct: 516 FSSRSDVWSYGVTMWEALS 534
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 153 bits (387), Expect = 1e-38
Identities = 69/282 (24%), Positives = 114/282 (40%), Gaps = 45/282 (15%)
Query: 666 KIGEGGFGPVYKGTL--SDGAVI--AVKQL-SSKSKQGNREFVNEIGMISALQHQNLVKL 720
IGEG FG V++G + + A+K + S +F+ E + H ++VKL
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456
Query: 721 YGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESR 780
G E N + ++ E L L ++ LD A+ ++ LAYL
Sbjct: 457 IGVITE-NPVWIIMELCTLGELRSFLQVRKFS---LDLASLILYAYQLSTALAYL---ES 509
Query: 781 LKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRGYL 840
+ VHRDI A NVL+ + K+ DFGL++ ED + +++ + +MAPE
Sbjct: 510 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 569
Query: 841 TDKADVYSFGIVALEIVS-------GKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVD- 892
T +DV+ FG+ EI+ G N + + + E G L +
Sbjct: 570 TSASDVWMFGVCMWEILMHGVKPFQGVKN------NDVIGRI-------ENGERLPMPPN 616
Query: 893 -PSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933
P T+ ++ C P+ RP + + L
Sbjct: 617 CPP-----------TLYSLMTKCWAYDPSRRPRFTELKAQLS 647
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 1e-38
Identities = 73/303 (24%), Positives = 116/303 (38%), Gaps = 57/303 (18%)
Query: 665 NKIGEGGFGPVYKGTLSDGA------VIAVKQLSSKSKQGNR-EFVNEIGMISAL-QHQN 716
+G G FG V T + +AVK L K+ R ++E+ M++ L H+N
Sbjct: 51 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 717 LVKLYGCCIEGNQLLLVYEYLENNSL------ARALFGKEGQCLNLDWATRK-------- 762
+V L G C + L++EY L R F ++ +
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170
Query: 763 -----RICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENT 817
+A+G+ +L VHRD+ A NVL+ KI DFGLA+ ++
Sbjct: 171 FEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 227
Query: 818 HISTRIAGT-VGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKS-----NTNYRPKEE 870
++ A V +MAPE G T K+DV+S+GI+ EI S G + +
Sbjct: 228 YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD----AN 283
Query: 871 FVYLLDWAYVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930
F L+ + G ++ P + + I C RP+ + S
Sbjct: 284 FYKLI-------QNGFKMD--QPFYATE-------EIYIIMQSCWAFDSRKRPSFPNLTS 327
Query: 931 MLE 933
L
Sbjct: 328 FLG 330
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 2e-38
Identities = 63/216 (29%), Positives = 98/216 (45%), Gaps = 37/216 (17%)
Query: 661 FDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNREF---VNEIGMISALQHQN 716
F +IG G FG VY + + V+A+K++S KQ N ++ + E+ + L+H N
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 717 LVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKR--------ICSDI 768
++ GC + + LV EY G +L +K +
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCL------------GSASDLLEVHKKPLQEVEIAAVTHGA 163
Query: 769 ARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVG 828
+GLAYLH ++HRD+KA N+LL + K+ DFG A + N+ + GT
Sbjct: 164 LQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPY 215
Query: 829 YMAPEYAMR----GYLTDKADVYSFGIVALEIVSGK 860
+MAPE + Y K DV+S GI +E+ K
Sbjct: 216 WMAPEVILAMDEGQY-DGKVDVWSLGITCIELAERK 250
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 2e-38
Identities = 77/330 (23%), Positives = 134/330 (40%), Gaps = 57/330 (17%)
Query: 665 NKIGEGGFGPVYKGTLSDGA--------VIAVKQLSSKSKQGNR-EFVNEIGMISAL-QH 714
+GEG FG V +AVK L S + + + + ++E+ M+ + +H
Sbjct: 75 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134
Query: 715 QNLVKLYGCCIEGNQLLLVYEYLENNSLA---RALFGKEGQCLNLDWATRKR-------- 763
+N++ L G C + L ++ EY +L +A + +
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194
Query: 764 -ICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTR 822
+ARG+ YL S+ K +HRD+ A NVL+ +D KI+DFGLA+ + + T
Sbjct: 195 SCAYQVARGMEYL--ASK-KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 251
Query: 823 IAGT-VGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-------GKSNTNYRPKEEFVYL 874
V +MAPE T ++DV+SFG++ EI + G EE L
Sbjct: 252 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV------EELFKL 305
Query: 875 LDWAYVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEG 934
L ++G+ ++ PS +N + + C + P+ RPT V L+
Sbjct: 306 L-------KEGHRMD--KPSNCTN-------ELYMMMRDCWHAVPSQRPTFKQLVEDLD- 348
Query: 935 KTAVQAPIIRRNSDSQDARFRAFEILSQDS 964
V + ++I + ++
Sbjct: 349 -RIVALTSNQEMGYYHHHHHHDYDIPTTEN 377
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 4e-38
Identities = 52/212 (24%), Positives = 88/212 (41%), Gaps = 25/212 (11%)
Query: 665 NKIGEGGFGPVYKGTLSDGAVIAVKQ--LSSKSKQGNREFVNEIGMISALQHQNL--VKL 720
+IG GG V++ + A+K L Q + NEI ++ LQ + ++L
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 721 YGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESR 780
Y I + +V E N L L K+ + ++ K ++ + +H+
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWL--KKKKSIDPWER--KSYWKNMLEAVHTIHQH-- 127
Query: 781 LKIVHRDIKATNVLLDKDLNAKISDFGLAK-LDEDENTHISTRIAGTVGYMAPE------ 833
IVH D+K N L+ K+ DFG+A + D + + GTV YM PE
Sbjct: 128 -GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 185
Query: 834 -----YAMRGYLTDKADVYSFGIVALEIVSGK 860
+ ++ K+DV+S G + + GK
Sbjct: 186 SSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-37
Identities = 61/294 (20%), Positives = 115/294 (39%), Gaps = 49/294 (16%)
Query: 659 NNFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNRE-FVNEIGMISALQHQN 716
+F+ +G GGFG V++ D A+K++ +++ RE + E+ ++ L+H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 717 LVKLYGCCIEGNQ------------LLLVYEYLENNSLARALFGKEGQCLNLDWATRKRI 764
+V+ + +E N L + + +L + G+ + + I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTI-EERERSVCLHI 123
Query: 765 CSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIA 824
IA + +LH + ++HRD+K +N+ D K+ DFGL + + +
Sbjct: 124 FLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180
Query: 825 -----------GTVGYMAPE-YAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFV 872
GT YM+PE Y + K D++S G++ E++ + + E V
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSY-SHKVDIFSLGLILFELL-----YPFSTQMERV 234
Query: 873 YLLDWAYVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMS 926
L ++ L P L + E + +PSP RP
Sbjct: 235 RTLT---------DVRNLKFPPLFTQKYPCEY----VMVQDMLSPSPMERPEAI 275
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 1e-37
Identities = 51/233 (21%), Positives = 94/233 (40%), Gaps = 19/233 (8%)
Query: 645 QTGYFTLRQIKAATNNFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNREFV 703
+ YF + ++ K+GEGGF V L DG A+K++ +Q E
Sbjct: 15 ENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQ 74
Query: 704 NEIGMISALQHQNLVKLYGCCIE----GNQLLLVYEYLENNSLARALFGKEGQCLNLDWA 759
E M H N+++L C+ ++ L+ + + +L + + + L
Sbjct: 75 READMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTED 134
Query: 760 TRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHI 819
+ I RGL +H + HRD+K TN+LL + + D G
Sbjct: 135 QILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGS 191
Query: 820 STRIA--------GTVGYMAPE-YAMRGY--LTDKADVYSFGIVALEIVSGKS 861
+ T+ Y APE ++++ + + ++ DV+S G V ++ G+
Sbjct: 192 RQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEG 244
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 1e-37
Identities = 51/212 (24%), Positives = 87/212 (41%), Gaps = 25/212 (11%)
Query: 665 NKIGEGGFGPVYKGTLSDGAVIAVKQ--LSSKSKQGNREFVNEIGMISALQHQNL--VKL 720
+IG GG V++ + A+K L Q + NEI ++ LQ + ++L
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 721 YGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESR 780
Y I + +V E N L L K+ + ++ K ++ + +H+
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWL--KKKKSIDPWER--KSYWKNMLEAVHTIHQH-- 174
Query: 781 LKIVHRDIKATNVLLDKDLNAKISDFGLAK-LDEDENTHISTRIAGTVGYMAPE------ 833
IVH D+K N L+ K+ DFG+A + D + + G V YM PE
Sbjct: 175 -GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMS 232
Query: 834 -----YAMRGYLTDKADVYSFGIVALEIVSGK 860
+ ++ K+DV+S G + + GK
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-37
Identities = 51/263 (19%), Positives = 107/263 (40%), Gaps = 19/263 (7%)
Query: 101 IPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGDISTLE 160
NLT L+E+ L+ + + A L + L + N + + +++ L
Sbjct: 102 DISALQNLTNLRELYLNEDNISD--ISPLANLTKMYSLNLGANHNLSDLS-PLSNMTGLN 158
Query: 161 ELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGR 220
L + ++++ + NL L + L+ N P +L +L F + +T
Sbjct: 159 YLTVTESKVKDV--TPIANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDI 214
Query: 221 IPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISD--LKGSSSSFPNLQDMKK 278
P + N T+L+ L + + P ++ L LT L I + S ++D+ K
Sbjct: 215 TP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQI----SDINAVKDLTK 266
Query: 279 MERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLS 338
++ L + + I+ + +++ L L L+ NQL ++ L + +FL+ N ++
Sbjct: 267 LKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHIT 324
Query: 339 GTLPDWILTSEKNLDLSYNNFTE 361
P L+ + D + +
Sbjct: 325 DIRPLASLSKMDSADFANQVIKK 347
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 4e-37
Identities = 55/266 (20%), Positives = 110/266 (41%), Gaps = 23/266 (8%)
Query: 103 EEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGDISTLEEL 162
NL L + + N + + L NL +L + + +S PL +++ + L
Sbjct: 82 SPLSNLVKLTNLYIGTNKI--TDISALQNLTNLRELYLNEDNISDISPL--ANLTKMYSL 137
Query: 163 VLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIP 222
L N + L N+ L + ++ + P NL +L ++ + + P
Sbjct: 138 NLGANHNLS-DLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP 194
Query: 223 NFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISD--LKGSSSSFPNLQDMKKME 280
+ + T L + P ++ + L L+I + + + L ++ ++
Sbjct: 195 --LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKI----TDLSPLANLSQLT 246
Query: 281 RLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGT 340
L + I+ ++D+T LK+L++ NQ++ L NL +++ +FL NN L
Sbjct: 247 WLEIGTNQISD--INAVKDLTKLKMLNVGSNQISDISV--LNNLSQLNSLFLNNNQLGNE 302
Query: 341 LPDWI--LTSEKNLDLSYNNFTESSP 364
+ I LT+ L LS N+ T+ P
Sbjct: 303 DMEVIGGLTNLTTLFLSQNHITDIRP 328
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-34
Identities = 56/262 (21%), Positives = 107/262 (40%), Gaps = 17/262 (6%)
Query: 103 EEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGDISTLEEL 162
+L L + + L+++TKL++ G +++ SI I ++ LE L
Sbjct: 16 FPDADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVA-SIQ-GIEYLTNLEYL 71
Query: 163 VLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIP 222
L NQ+ L NL L + + +N T + NL NL E ++ N++ I
Sbjct: 72 NLNGNQITDI--SPLSNLVKLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNISD-IS 126
Query: 223 NFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISDLKGSSSSFPNLQDMKKMERL 282
N TK+ L+L S +S + L L +++ K + ++ + L
Sbjct: 127 PL-ANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESK--VKDVTPIANLTDLYSL 182
Query: 283 ILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGTLP 342
L I P + +T L NQ+T P + N+ +++ + + NN ++ P
Sbjct: 183 SLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP 238
Query: 343 DWILTSEKNLDLSYNNFTESSP 364
L+ L++ N ++ +
Sbjct: 239 LANLSQLTWLEIGTNQISDINA 260
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-33
Identities = 49/283 (17%), Positives = 104/283 (36%), Gaps = 35/283 (12%)
Query: 102 PEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLE--------- 152
L + ++ ++ + L NL L + GN+++ PL
Sbjct: 37 VVTQEELESITKLVVAGEKVAS--IQGIEYLTNLEYLNLNGNQITDISPLSNLVKLTNLY 94
Query: 153 -----------IGDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESY 201
+ +++ L EL L ++ + L NL + + L +N+ S
Sbjct: 95 IGTNKITDISALQNLTNLRELYLNEDNISD--ISPLANLTKMYSLNLGANHNL-SDLSPL 151
Query: 202 GNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRIS 261
N+ L + S + + N T L L L +E P ++ L +L
Sbjct: 152 SNMTGLNYLTVTESKVKD-VTPI-ANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAY 207
Query: 262 DLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGIL 321
+ + + +M ++ L + N IT P + +++ L L++ NQ++ +
Sbjct: 208 VNQ--ITDITPVANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDINA--V 261
Query: 322 QNLKKIDYIFLTNNSLSGTLPDWILTSEKNLDLSYNNFTESSP 364
++L K+ + + +N +S L+ +L L+ N
Sbjct: 262 KDLTKLKMLNVGSNQISDISVLNNLSQLNSLFLNNNQLGNEDM 304
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 76.8 bits (190), Expect = 5e-15
Identities = 31/141 (21%), Positives = 62/141 (43%), Gaps = 8/141 (5%)
Query: 225 IGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISDLKGSSSSFPNLQDMKKMERLIL 284
+ + R LQ S+ + +L+++T+L ++ K +S ++ + +E L L
Sbjct: 18 DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEK--VASIQGIEYLTNLEYLNL 73
Query: 285 RNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGTLPDW 344
IT P + ++ L L + N++T LQNL + ++L +++S P
Sbjct: 74 NGNQITDISP--LSNLVKLTNLYIGTNKITDISA--LQNLTNLRELYLNEDNISDISPLA 129
Query: 345 ILTSEKNLDLSYNNFTESSPA 365
LT +L+L N+
Sbjct: 130 NLTKMYSLNLGANHNLSDLSP 150
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 61.0 bits (149), Expect = 6e-10
Identities = 20/110 (18%), Positives = 43/110 (39%), Gaps = 6/110 (5%)
Query: 255 LTELRISDLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLT 314
L + D+ + R +L+ +T + E++ + L ++ ++
Sbjct: 2 AATLATLPAP--INQIFPDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57
Query: 315 GPVPGILQNLKKIDYIFLTNNSLSGTLPDWILTSEKNLDLSYNNFTESSP 364
+ GI + L ++Y+ L N ++ P L NL + N T+ S
Sbjct: 58 S-IQGI-EYLTNLEYLNLNGNQITDISPLSNLVKLTNLYIGTNKITDISA 105
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 3e-37
Identities = 62/214 (28%), Positives = 105/214 (49%), Gaps = 16/214 (7%)
Query: 659 NNFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNRE-FVNEIGMISALQHQN 716
++++ IG G V +A+K+++ + Q + + + EI +S H N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 717 LVKLYGCCIEGNQLLLVYEYLENNSLA----RALFGKEGQCLNLDWATRKRICSDIARGL 772
+V Y + ++L LV + L S+ + E + LD +T I ++ GL
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 773 AYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGL-AKLDEDENTHISTR---IAGTVG 828
YLH+ +HRD+KA N+LL +D + +I+DFG+ A L + + GT
Sbjct: 135 EYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 829 YMAPEYAMR--GYLTDKADVYSFGIVALEIVSGK 860
+MAPE + GY KAD++SFGI A+E+ +G
Sbjct: 192 WMAPEVMEQVRGY-DFKADIWSFGITAIELATGA 224
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 4e-37
Identities = 68/214 (31%), Positives = 103/214 (48%), Gaps = 22/214 (10%)
Query: 661 FDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNREFVNEIGMISAL-QHQNLV 718
F+ +G G +G VYKG + G + A+K + E EI M+ H+N+
Sbjct: 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIA 84
Query: 719 KLYGC------CIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDW-ATRKRICSDIARG 771
YG +QL LV E+ S+ + +G L +W A IC +I RG
Sbjct: 85 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY---ICREILRG 141
Query: 772 LAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMA 831
L++LH+ K++HRDIK NVLL ++ K+ DFG++ + +T I GT +MA
Sbjct: 142 LSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMA 197
Query: 832 PEYAMRGYLTD-----KADVYSFGIVALEIVSGK 860
PE D K+D++S GI A+E+ G
Sbjct: 198 PEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 4e-37
Identities = 72/309 (23%), Positives = 122/309 (39%), Gaps = 61/309 (19%)
Query: 659 NNFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQ--LSSKSKQGNREFVNEIGMISALQHQ 715
+++ IG G +G K SDG ++ K+ S ++ + V+E+ ++ L+H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 716 NLVKLYGCCIE--GNQLLLVYEYLENNSLARAL--FGKEGQCLN----LDWATRKRICSD 767
N+V+ Y I+ L +V EY E LA + KE Q L+ L T
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT------Q 119
Query: 768 IARGLAYLHE--ESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAG 825
+ L H + ++HRD+K NV LD N K+ DFGLA++ + + T + G
Sbjct: 120 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-G 178
Query: 826 TVGYMAPE-YAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQ 884
T YM+PE Y +K+D++S G + E+ + P F
Sbjct: 179 TPYYMSPEQMNRMSY-NEKSDIWSLGCLLYELCALM-----PP---F-----------TA 218
Query: 885 GNLLELVD-------PSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTA 937
+ EL + +S + + I N RP++ +
Sbjct: 219 FSQKELAGKIREGKFRRIPYRYSDE----LNEIITRMLNLKDYHRPSVEEILEN------ 268
Query: 938 VQAPIIRRN 946
P+I +
Sbjct: 269 ---PLILEH 274
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 8e-37
Identities = 42/278 (15%), Positives = 99/278 (35%), Gaps = 20/278 (7%)
Query: 88 TVILLKGFNLAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSG 147
+ + +L + + ++E+DLS N + A L L + N L
Sbjct: 13 KIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY- 71
Query: 148 SIPLEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNL 207
++ +STL L L +N + + L S+ + ++NN + + S +
Sbjct: 72 ETL-DLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-RVSCS--RGQGK 122
Query: 208 TEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEG-PIPSTISQLKNLTELRISD--LK 264
+ + +T G +++ LDL+ ++ + L L + +
Sbjct: 123 KNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFI- 181
Query: 265 GSSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNL 324
K++ L L + + + + + + L N+L + L+
Sbjct: 182 ---YDVKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVL-IEKALRFS 236
Query: 325 KKIDYIFLTNNSLS-GTLPDWILTSEKNLDLSYNNFTE 361
+ +++ L N GTL D+ +++ ++ +
Sbjct: 237 QNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKK 274
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 8e-36
Identities = 51/267 (19%), Positives = 96/267 (35%), Gaps = 17/267 (6%)
Query: 101 IPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGDISTLE 160
I E N + ++ + +L N+ +L + GN LS ++ + LE
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 161 ELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGR 220
L L N L L L +L +LR + L++N + ++ +N++ R
Sbjct: 62 LLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ-ELL----VGPSIETLHAANNNIS-R 113
Query: 221 IPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISDLKGSSSSFPNL-QDMKKM 279
+ + L + + L + + + +F L +
Sbjct: 114 VS--CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171
Query: 280 ERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSG 339
E L L+ I + + LK LDLS N+L + Q+ + +I L NN L
Sbjct: 172 EHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV- 227
Query: 340 TLPDWI--LTSEKNLDLSYNNFTESSP 364
+ + + ++ DL N F +
Sbjct: 228 LIEKALRFSQNLEHFDLRGNGFHCGTL 254
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-27
Identities = 35/225 (15%), Positives = 73/225 (32%), Gaps = 23/225 (10%)
Query: 148 SIPLEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNL 207
+I + + + + D+ L L + +++ + LS N + L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 208 TEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTEL-----RISD 262
+ + L + + + L LDL + + ++ L IS
Sbjct: 61 ELLNLSSNVLYE-TLDL-ESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNISR 113
Query: 263 LKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTG-PVPGIL 321
+ S S + + L N IT + ++ LDL N++ +
Sbjct: 114 V--SCSRGQGKK------NIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELA 165
Query: 322 QNLKKIDYIFLTNNSLSGTLPDWI-LTSEKNLDLSYNNFTESSPA 365
+ ++++ L N + + + K LDLS N P
Sbjct: 166 ASSDTLEHLNLQYNFIY-DVKGQVVFAKLKTLDLSSNKLAFMGPE 209
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-36
Identities = 55/276 (19%), Positives = 120/276 (43%), Gaps = 15/276 (5%)
Query: 659 NNFDAANKIGEGGFGPVYKGTL-SDGAVIAVKQLSSKSKQG-NREFVNEIGMISALQHQN 716
++F+ +++G G G V+K + G V+A K + + K + + E+ ++
Sbjct: 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 717 LVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLH 776
+V YG ++ + E+++ SL + L K+ + ++ + +GL YL
Sbjct: 93 IVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQIL--GKVSIAVIKGLTYLR 148
Query: 777 EESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAM 836
E+ KI+HRD+K +N+L++ K+ DFG++ + ++ ++ + GT YM+PE
Sbjct: 149 EK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANSFV-GTRSYMSPERLQ 203
Query: 837 RGYLTDKADVYSFGIVALEIVSGK---SNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDP 893
+ + ++D++S G+ +E+ G+ + + E + P
Sbjct: 204 GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 263
Query: 894 SLGSNFSKKEAMTMLNI-ALLCTNPSPTLRPTMSSA 928
+ M + + + P P L + S
Sbjct: 264 LNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSL 299
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 2e-36
Identities = 44/218 (20%), Positives = 82/218 (37%), Gaps = 22/218 (10%)
Query: 658 TNNFDAANKIGEG--GFGPVYKGT-LSDGAVIAVKQ--LSSKSKQGNREFVNEIGMISAL 712
++ IG+G V G + V++ L + S + E+ +
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 713 QHQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDW-ATRKRICSDIARG 771
H N+V I N+L +V ++ S + +N A I + +
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAY---ILQGVLKA 140
Query: 772 LAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFG-LAKLDED---ENTHISTRI--AG 825
L Y+H VHR +KA+++L+ D +S + +
Sbjct: 141 LDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVK 197
Query: 826 TVGYMAPE---YAMRGYLTDKADVYSFGIVALEIVSGK 860
+ +++PE ++GY K+D+YS GI A E+ +G
Sbjct: 198 VLPWLSPEVLQQNLQGY-DAKSDIYSVGITACELANGH 234
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 4e-36
Identities = 56/214 (26%), Positives = 101/214 (47%), Gaps = 21/214 (9%)
Query: 659 NNFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSK-QGNREFVNEIGMI-SALQHQ 715
+ +IG G +G V K G ++AVK++ S + ++ + ++ ++ +
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81
Query: 716 NLVKLYGCCIEGNQLLLVYEYLENNSLARAL---FGKEGQCLNLDWATRKRICSDIARGL 772
+V+ YG + E + + S + + + + +I + L
Sbjct: 82 YIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEIL--GKITLATVKAL 138
Query: 773 AYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGL-AKLDEDENTHISTRIAGTVGYMA 831
+L E LKI+HRDIK +N+LLD+ N K+ DFG+ +L ++ TR AG YMA
Sbjct: 139 NHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV---DSIAKTRDAGCRPYMA 193
Query: 832 PE-----YAMRGYLTDKADVYSFGIVALEIVSGK 860
PE + +GY ++DV+S GI E+ +G+
Sbjct: 194 PERIDPSASRQGY-DVRSDVWSLGITLYELATGR 226
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-35
Identities = 58/337 (17%), Positives = 110/337 (32%), Gaps = 30/337 (8%)
Query: 70 GSNFTCDCTYSNNTV-C--------------HVTVILLKGFNLAGVIPEEFGNLTFLQEV 114
GS C N T C I L L + F N + LQ +
Sbjct: 2 GSLNPCIEVVPNITYQCMDQKLSKVPDDIPSSTKNIDLSFNPLKILKSYSFSNFSELQWL 61
Query: 115 DLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGDISTLEELVLEDNQLVGPLP 174
DLSR K++ L +L+ L++ GN + P +++LE LV + +L
Sbjct: 62 DLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLES 121
Query: 175 ENLGNLKSLRRILLSSNNFTG-SIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLD- 232
+G L +L+++ ++ N +P + NL NL + + + N + +
Sbjct: 122 FPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQ 181
Query: 233 ---RLDLQGTSLEGPIPSTISQLKNLTELRISD-------LKGSSSSFPNLQDMKKMERL 282
LD+ ++ I Q L EL + +K + L + +
Sbjct: 182 VNLSLDMSLNPIDF-IQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGE 240
Query: 283 ILRNCLITGRIPEYIEDMTDLKI--LDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGT 340
+ P +E + D+ I L++ L + + L S+
Sbjct: 241 FKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYL 300
Query: 341 LPDWILTSEKNLDLSYNNFTESSPATCRESRVNILSS 377
++L + + + L+
Sbjct: 301 EDVPKHFKWQSLSIIRCQLKQFPTLDLPFLKSLTLTM 337
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-34
Identities = 60/288 (20%), Positives = 110/288 (38%), Gaps = 19/288 (6%)
Query: 104 EFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLS--GSIPLEIGDISTLEE 161
+L FL+ + L+ N GS+ L +L+ L + N LS G ++L
Sbjct: 323 PTLDLPFLKSLTLTMN--KGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRH 380
Query: 162 LVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESY-GNLKNLTEFRIDGSNLTGR 220
L L N + + N L+ L+ + + S +L+ L I +N
Sbjct: 381 LDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKID 439
Query: 221 IPNFIGNWTKLDRLDLQGTSLEGPIPS-TISQLKNLTELRISD--LKG-SSSSFPNLQDM 276
T L+ L + G S + S + NLT L +S L+ S F L
Sbjct: 440 FDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLH-- 497
Query: 277 KKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNS 336
+++ L + + + + + L LD SFN++ + K + + LTNNS
Sbjct: 498 -RLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNS 556
Query: 337 LSGT-----LPDWILTSEKNLDLSYNNFTESSPATCRESRVNILSSFS 379
++ W+ ++ L ++ T ++P S V ++ +
Sbjct: 557 VACICEHQKFLQWVKEQKQFL-VNVEQMTCATPVEMNTSLVLDFNNST 603
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 1e-25
Identities = 32/170 (18%), Positives = 52/170 (30%), Gaps = 2/170 (1%)
Query: 95 FNLAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKS-FARLQNLTKLLILGNRLSGSIPLEI 153
FN A ++ F L LQ +D + S F L+ L L I
Sbjct: 385 FNGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIF 444
Query: 154 GDISTLEELVLEDNQLVGPLPEN-LGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRI 212
+++L L + N N N +L + LS + L L +
Sbjct: 445 LGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNM 504
Query: 213 DGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISD 262
+NL + L LD +E K+L +++
Sbjct: 505 SHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTN 554
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 2e-13
Identities = 26/120 (21%), Positives = 41/120 (34%), Gaps = 1/120 (0%)
Query: 99 GVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGDIST 158
+ F N T L +DLS+ F L L L + N L + +
Sbjct: 463 NTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYS 522
Query: 159 LEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLT 218
L L N++ KSL L++N+ I E L+ + E + N+
Sbjct: 523 LSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA-CICEHQKFLQWVKEQKQFLVNVE 581
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-35
Identities = 51/212 (24%), Positives = 100/212 (47%), Gaps = 18/212 (8%)
Query: 659 NNFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQL-SSKSKQGNREFVNEIGMI-SALQHQ 715
++ + ++G G +G V K + G ++AVK++ ++ + Q + + ++ + +
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66
Query: 716 NLVKLYGCCIEGNQLLLVYEYLENNSLARAL--FGKEGQCLNLDWATRKRICSDIARGLA 773
V YG + + E + + SL + +GQ + D + I I + L
Sbjct: 67 FTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGK--IAVSIVKALE 123
Query: 774 YLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPE 833
+LH + L ++HRD+K +NVL++ K+ DFG++ + AG YMAPE
Sbjct: 124 HLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISG--YLVDDVAKDIDAGCKPYMAPE 179
Query: 834 -----YAMRGYLTDKADVYSFGIVALEIVSGK 860
+GY + K+D++S GI +E+ +
Sbjct: 180 RINPELNQKGY-SVKSDIWSLGITMIELAILR 210
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 7e-35
Identities = 61/200 (30%), Positives = 92/200 (46%), Gaps = 13/200 (6%)
Query: 666 KIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNREFV----NEIGMISALQHQNLVKL 720
K+G GG VY +A+K + + E + E+ S L HQN+V +
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFI-PPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 721 YGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESR 780
E + LV EY+E +L G L T + I G+ + H
Sbjct: 77 IDVDEEDDCYYLVMEYIEGPTL-SEYIESHGP---LSVDTAINFTNQILDGIKHAH---D 129
Query: 781 LKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRGYL 840
++IVHRDIK N+L+D + KI DFG+AK + + + + GTV Y +PE A
Sbjct: 130 MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEAT 189
Query: 841 TDKADVYSFGIVALEIVSGK 860
+ D+YS GIV E++ G+
Sbjct: 190 DECTDIYSIGIVLYEMLVGE 209
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 8e-35
Identities = 56/234 (23%), Positives = 95/234 (40%), Gaps = 26/234 (11%)
Query: 637 KELRGLDLQTGYFTLRQIKAATNNFDAANKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSK 696
E D +T + +I F + +G G G + + D +AVK++
Sbjct: 7 LEQDDGDEETSVVIVGKIS-----FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRIL---P 58
Query: 697 QGNREFVNEIG-MISALQHQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLN 755
+ E+ + + +H N+++ + + + E +L + K+ L
Sbjct: 59 ECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAA-TLQEYVEQKDFAHLG 117
Query: 756 LDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLL-----DKDLNAKISDFGLAK 810
L+ + GLA+LH L IVHRD+K N+L+ + A ISDFGL K
Sbjct: 118 LE---PITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171
Query: 811 LDEDENTHISTR--IAGTVGYMAPEY---AMRGYLTDKADVYSFGIVALEIVSG 859
S R + GT G++APE + T D++S G V ++S
Sbjct: 172 KLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-34
Identities = 64/262 (24%), Positives = 103/262 (39%), Gaps = 19/262 (7%)
Query: 103 EEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGDISTLEEL 162
NLT L ++ ++ N A L NLT L + N+++ PL +++ L L
Sbjct: 84 TPLKNLTKLVDILMNNNQIAD--ITPLANLTNLTGLTLFNNQITDIDPL--KNLTNLNRL 139
Query: 163 VLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIP 222
L N + L L SL+++ N T P NL L I + ++
Sbjct: 140 ELSSNTISDI--SALSGLTSLQQLSFG-NQVTDLKP--LANLTTLERLDISSNKVSD--I 192
Query: 223 NFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISDLKGSSSSFPNLQDMKKMERL 282
+ + T L+ L + P + L NL EL ++ + L + + L
Sbjct: 193 SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDL 248
Query: 283 ILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGTLP 342
L N I+ P + +T L L L NQ++ P L L + + L N L P
Sbjct: 249 DLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP 304
Query: 343 DWILTSEKNLDLSYNNFTESSP 364
L + L L +NN ++ SP
Sbjct: 305 ISNLKNLTYLTLYFNNISDISP 326
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-33
Identities = 67/279 (24%), Positives = 111/279 (39%), Gaps = 21/279 (7%)
Query: 86 HVTVILLKGFNLAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRL 145
+L N+ + +L + + R L NLT++ N+L
Sbjct: 25 EKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRL--GIKSIDGVEYLNNLTQINFSNNQL 80
Query: 146 SGSIPLEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLK 205
+ PL +++ L ++++ +NQ+ L NL +L + L +N T P NL
Sbjct: 81 TDITPL--KNLTKLVDILMNNNQIAD--ITPLANLTNLTGLTLFNNQITDIDP--LKNLT 134
Query: 206 NLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISDLKG 265
NL + + ++ + + T L +L G + P ++ L L L IS K
Sbjct: 135 NLNRLELSSNTISD--ISALSGLTSLQQLSF-GNQVTDLKP--LANLTTLERLDISSNK- 188
Query: 266 SSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLK 325
S L + +E LI N I+ P + +T+L L L+ NQL L +L
Sbjct: 189 -VSDISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDIGT--LASLT 243
Query: 326 KIDYIFLTNNSLSGTLPDWILTSEKNLDLSYNNFTESSP 364
+ + L NN +S P LT L L N + SP
Sbjct: 244 NLTDLDLANNQISNLAPLSGLTKLTELKLGANQISNISP 282
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 1e-32
Identities = 55/270 (20%), Positives = 102/270 (37%), Gaps = 24/270 (8%)
Query: 102 PEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGDISTLEE 161
LT L+ + + N + P L NL +L + GN+L I + ++ L +
Sbjct: 192 ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLK-DIG-TLASLTNLTD 247
Query: 162 LVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRI 221
L L +NQ+ L L L + L +N + P + L LT ++ + L
Sbjct: 248 LDLANNQISNL--APLSGLTKLTELKLGANQISNISPLA--GLTALTNLELNENQLEDIS 303
Query: 222 PNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISD--LKGSSSSFPNLQDMKKM 279
P I N L L L ++ P +S L L L + + S +L ++ +
Sbjct: 304 P--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKV----SDVSSLANLTNI 355
Query: 280 ERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSG 339
L + I+ P + ++T + L L+ T N+ + + +L
Sbjct: 356 NWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGAL-- 411
Query: 340 TLPDWI--LTSEKNLDLSYNNFTESSPATC 367
P I S D+++N + ++ +
Sbjct: 412 IAPATISDGGSYTEPDITWNLPSYTNEVSY 441
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 5e-32
Identities = 59/258 (22%), Positives = 107/258 (41%), Gaps = 19/258 (7%)
Query: 107 NLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGDISTLEELVLED 166
L + L + ++ L +T L + SI + ++ L ++ +
Sbjct: 22 ALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSN 77
Query: 167 NQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIPNFIG 226
NQL L NL L IL+++N P NL NLT + + +T P +
Sbjct: 78 NQLTD--ITPLKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LK 131
Query: 227 NWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISDLKGSSSSFPNLQDMKKMERLILRN 286
N T L+RL+L ++ +S L +L +L + L ++ +ERL + +
Sbjct: 132 NLTNLNRLELSSNTISDISA--LSGLTSLQQL---SFGNQVTDLKPLANLTTLERLDISS 186
Query: 287 CLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGTLPDWIL 346
++ + +T+L+ L + NQ++ P L L +D + L N L L
Sbjct: 187 NKVSD--ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDIGTLASL 242
Query: 347 TSEKNLDLSYNNFTESSP 364
T+ +LDL+ N + +P
Sbjct: 243 TNLTDLDLANNQISNLAP 260
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-30
Identities = 49/237 (20%), Positives = 95/237 (40%), Gaps = 17/237 (7%)
Query: 128 SFARLQNLTKLLILGNRLSGSIPLEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRIL 187
+ L K ++ ++ ++ D+ + L + + + + L +L +I
Sbjct: 19 TDTALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSI--DGVEYLNNLTQIN 74
Query: 188 LSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPS 247
S+N T P NL L + ++ + + P + N T L L L + P
Sbjct: 75 FSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP- 129
Query: 248 TISQLKNLTELRISDLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILD 307
+ L NL L +S S L + +++L N + + + ++T L+ LD
Sbjct: 130 -LKNLTNLNRLELSSNT--ISDISALSGLTSLQQLSFGNQVTD---LKPLANLTTLERLD 183
Query: 308 LSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGTLPDWILTSEKNLDLSYNNFTESSP 364
+S N+++ L L ++ + TNN +S P ILT+ L L+ N +
Sbjct: 184 ISSNKVSDISV--LAKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKDIGT 238
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 8e-22
Identities = 37/206 (17%), Positives = 83/206 (40%), Gaps = 19/206 (9%)
Query: 161 ELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGR 220
+ +D + L + +L N T ++ ++ +L +T + D +
Sbjct: 6 ATITQDTPINQI--FTDTALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-- 59
Query: 221 IPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISD--LKGSSSSFPNLQDMKK 278
+ + L +++ L P + L L ++ +++ + + L ++
Sbjct: 60 SIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQI----ADITPLANLTN 113
Query: 279 MERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLS 338
+ L L N IT P ++++T+L L+LS N ++ L L + + N ++
Sbjct: 114 LTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISA--LSGLTSLQQLSFGNQ-VT 168
Query: 339 GTLPDWILTSEKNLDLSYNNFTESSP 364
P LT+ + LD+S N ++ S
Sbjct: 169 DLKPLANLTTLERLDISSNKVSDISV 194
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 2e-05
Identities = 14/96 (14%), Positives = 31/96 (32%), Gaps = 3/96 (3%)
Query: 103 EEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGDISTLEEL 162
NLT + ++ L+ + + P ++ ++ + P I D + E
Sbjct: 369 TPLANLTRITQLGLNDQAWT-NAPVNYKANVSIPNTVKNVTGAL-IAPATISDGGSYTEP 426
Query: 163 VLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIP 198
+ N E I + F+G++
Sbjct: 427 DITWNLP-SYTNEVSYTFSQPVTIGKGTTTFSGTVT 461
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 5e-34
Identities = 42/270 (15%), Positives = 97/270 (35%), Gaps = 20/270 (7%)
Query: 96 NLAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGD 155
+L + + ++E+DLS N + A L L + N L ++
Sbjct: 21 SLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY-ETL-DLES 78
Query: 156 ISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGS 215
+STL L L +N + + L S+ + ++NN + + S + + +
Sbjct: 79 LSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-RVSCS--RGQGKKNIYLANN 130
Query: 216 NLTGRIPNFIGNWTKLDRLDLQGTSLEG-PIPSTISQLKNLTELRISD--LKGSSSSFPN 272
+T G +++ LDL+ ++ + L L + +
Sbjct: 131 KITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFI----YDVKG 186
Query: 273 LQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFL 332
K++ L L + + + + + + L N+L + L+ + +++ L
Sbjct: 187 QVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDL 244
Query: 333 TNNSLS-GTLPDWILTSEKNLDLSYNNFTE 361
N GTL D+ +++ ++ +
Sbjct: 245 RGNGFHCGTLRDFFSKNQRVQTVAKQTVKK 274
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 6e-34
Identities = 54/317 (17%), Positives = 111/317 (35%), Gaps = 18/317 (5%)
Query: 101 IPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGDISTLE 160
I E N + ++ + +L N+ +L + GN LS ++ + LE
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 161 ELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGR 220
L L N L L L +L +LR + L++N + ++ +N++ R
Sbjct: 62 LLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ-ELL----VGPSIETLHAANNNIS-R 113
Query: 221 IPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISDLKGSSSSFPNL-QDMKKM 279
+ + L + + L + + + +F L +
Sbjct: 114 VS--CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171
Query: 280 ERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSG 339
E L L+ I + + LK LDLS N+L + Q+ + +I L NN L
Sbjct: 172 EHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV- 227
Query: 340 TLPDWI--LTSEKNLDLSYNNFTESSPATCRESRVNILSSFSSTGSNSVSWCLKKDLPCP 397
+ + + ++ DL N F + S+ + + + ++ +++ P
Sbjct: 228 LIEKALRFSQNLEHFDLRGNGFHCGTLRDFF-SKNQRVQTVAKQTVKKLTGQNEEECTVP 286
Query: 398 KEAKHYSLFINCGGSPT 414
+ + +P
Sbjct: 287 TLGHYGAYCCEDLPAPF 303
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 5e-27
Identities = 35/272 (12%), Positives = 85/272 (31%), Gaps = 15/272 (5%)
Query: 96 NLAGVIPEEFGNLTFLQEVDLSRNYFNG-SLPKSFARLQNLTKLLILGNRLSGSIPLEIG 154
+ + + G + +Q +DL N + + + A L L + N + + ++
Sbjct: 131 KITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVV 189
Query: 155 DISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDG 214
+ L+ L L N+L + + + I L +N I ++ +NL F + G
Sbjct: 190 -FAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRG 246
Query: 215 SNL-TGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISDLKGSSSSFPNL 273
+ G + +F ++ + Q +++ + T P
Sbjct: 247 NGFHCGTLRDFFSKNQRVQTVAKQ--TVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFA 304
Query: 274 QDMKKMERLILRNCLITG----RIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDY 329
+ ++R G R+ E+ + +D Q + + +
Sbjct: 305 DRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKIT 364
Query: 330 IFLTNNSLSGTLPDWILTSEKNLDLSYNNFTE 361
+ +L + + +L
Sbjct: 365 LEQKKKALDEQVS---NGRRAHAELDGTLQQA 393
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-25
Identities = 35/224 (15%), Positives = 72/224 (32%), Gaps = 21/224 (9%)
Query: 148 SIPLEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNL 207
+I + + + + D+ L L + +++ + LS N + L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 208 TEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTEL-----RISD 262
+ + L + + + L LDL + + ++ L IS
Sbjct: 61 ELLNLSSNVLYE-TLDL-ESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNISR 113
Query: 263 LKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTG-PVPGIL 321
+ S S + + L N IT + ++ LDL N++ +
Sbjct: 114 V--SCSRGQGKK------NIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELA 165
Query: 322 QNLKKIDYIFLTNNSLSGTLPDWILTSEKNLDLSYNNFTESSPA 365
+ ++++ L N + + K LDLS N P
Sbjct: 166 ASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLDLSSNKLAFMGPE 209
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 1e-24
Identities = 29/269 (10%), Positives = 79/269 (29%), Gaps = 15/269 (5%)
Query: 103 EEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGDISTLEEL 162
+E ++ + + N + + S R Q + + N+++ L+ G S ++ L
Sbjct: 93 QELLVGPSIETLHAANNNIS-RVSCS--RGQGKKNIYLANNKITMLRDLDEGCRSRVQYL 149
Query: 163 VLEDNQLVG-PLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRI 221
L+ N++ E + +L + L N + L + + L +
Sbjct: 150 DLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQ-VVFAKLKTLDLSSNKLA-FM 206
Query: 222 PNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISDLKGSSSSFPNLQDMKKMER 281
+ + + L+ L I + +NL + + + + +
Sbjct: 207 GPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQ 265
Query: 282 LILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGTL 341
+ + + + E+ T + L + S G+
Sbjct: 266 TVAKQ-TVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSE 324
Query: 342 PDWI------LTSEKNLDLSYNNFTESSP 364
+ + ++ +D +
Sbjct: 325 TERLECERENQARQREIDALKEQYRTVID 353
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 88.0 bits (218), Expect = 3e-18
Identities = 33/177 (18%), Positives = 61/177 (34%), Gaps = 18/177 (10%)
Query: 196 SIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNL 255
+I E N ++ S+L + + + + LDL G L + ++ L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 256 TELRISD--LKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQL 313
L +S L +L+ + + L L N + + ++ L + N +
Sbjct: 61 ELLNLSSNVL----YETLDLESLSTLRTLDLNNNYVQE-----LLVGPSIETLHAANNNI 111
Query: 314 TGPVPGILQNLKKIDYIFLTNNSLSGTLPD---WILTSEKNLDLSYNNFTESSPATC 367
+ Q K I L NN ++ L D + + LDL N + A
Sbjct: 112 SRVSCSRGQGKKNIY---LANNKIT-MLRDLDEGCRSRVQYLDLKLNEIDTVNFAEL 164
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 48.3 bits (115), Expect = 1e-05
Identities = 20/164 (12%), Positives = 46/164 (28%), Gaps = 4/164 (2%)
Query: 96 NLAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGD 155
+ + E N +E+D + + + + R Q L L +
Sbjct: 323 SETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRA 382
Query: 156 ISTLEELVLEDNQLVG--PLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRID 213
+ L+ + + + E L+ LR I+ + + + ++ +
Sbjct: 383 HAELDGTLQQAVGQIELQHATEEQSPLQLLRAIVKRYEE--MYVEQQSVQNNAIRDWDMY 440
Query: 214 GSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTE 257
T DL S + + + +NL
Sbjct: 441 QHKETQLAEENARLKKLNGEADLALASANATLQELVVREQNLAS 484
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 16/189 (8%), Positives = 43/189 (22%), Gaps = 20/189 (10%)
Query: 96 NLAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLT----KLLILGNRLSGSIPL 151
+ + + T RL L LL + +
Sbjct: 271 TVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLEC 330
Query: 152 EIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFR 211
E + + E+ Q + + ++ + + L
Sbjct: 331 ERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTL 390
Query: 212 IDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISDLKGSSSSFP 271
+ +++LQ + E + + E + + ++
Sbjct: 391 QQA----------------VGQIELQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAI 434
Query: 272 NLQDMKKME 280
DM + +
Sbjct: 435 RDWDMYQHK 443
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 5e-34
Identities = 62/228 (27%), Positives = 110/228 (48%), Gaps = 22/228 (9%)
Query: 645 QTGYFTL--RQIKAATNNFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQL-SSKSKQGNR 700
QTGY T+ ++ +A N+ + ++G G G V+K G VIAVKQ+ S +K+ N+
Sbjct: 9 QTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENK 68
Query: 701 EFVNEIG-MISALQHQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWA 759
+ ++ ++ + +V+ +G I + + E + + L + +
Sbjct: 69 RILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEK--LKKRMQGPIPERIL 126
Query: 760 TRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGL-AKLDEDENTH 818
++ I + L YL E+ ++HRD+K +N+LLD+ K+ DFG+ +L +
Sbjct: 127 --GKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRLV---DDK 179
Query: 819 ISTRIAGTVGYMAPE------YAMRGYLTDKADVYSFGIVALEIVSGK 860
R AG YMAPE Y +ADV+S GI +E+ +G+
Sbjct: 180 AKDRSAGCAAYMAPERIDPPDPTKPDY-DIRADVWSLGISLVELATGQ 226
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 6e-34
Identities = 63/286 (22%), Positives = 115/286 (40%), Gaps = 41/286 (14%)
Query: 104 EFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGDISTLEELV 163
E N +FL+ +D+ N LP +L + N+L +P E+ ++ L +
Sbjct: 148 ELQNSSFLKIIDVDNNSLK-KLPDL---PPSLEFIAAGNNQLE-ELP-ELQNLPFLTAIY 201
Query: 164 LEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIPN 223
++N L LP+ +L+S+ +N +PE NL LT D + L +P+
Sbjct: 202 ADNNSLKK-LPDLPLSLESIV---AGNNILE-ELPE-LQNLPFLTTIYADNNLLK-TLPD 254
Query: 224 FIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISDLKGSS--SSFPNLQDMKKMER 281
+ L+ D T L ++LT L +S+ S PNL
Sbjct: 255 LPPSLEALNVRDNYLTDLP-------ELPQSLTFLDVSENIFSGLSELPPNLY------Y 301
Query: 282 LILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGTL 341
L + I + + L+ L++S N+L +P + L+++ + N L+ +
Sbjct: 302 LNASSNEIR-SLC---DLPPSLEELNVSNNKLIE-LPALPPRLERLI---ASFNHLA-EV 352
Query: 342 PDWILTSEKNLDLSYNNFTE--SSPATCRESRV-NILSSFSSTGSN 384
P+ + K L + YN E P + + R+ + L+ N
Sbjct: 353 PELP-QNLKQLHVEYNPLREFPDIPESVEDLRMNSHLAEVPELPQN 397
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 8e-32
Identities = 56/277 (20%), Positives = 98/277 (35%), Gaps = 44/277 (15%)
Query: 101 IPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGD----- 155
I + TFLQE + +P +++ T+ + + P G+
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 156 --------ISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNL 207
EL L + L LPE +L+SL S N+ T +PE +LK+L
Sbjct: 62 VSRLRDCLDRQAHELELNNLGLS-SLPELPPHLESLV---ASCNSLT-ELPELPQSLKSL 116
Query: 208 TEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISD--LKG 265
+ L+ P L+ L + LE +P + L + + + LK
Sbjct: 117 LVDNNNLKALSDLPPL-------LEYLGVSNNQLEK-LPE-LQNSSFLKIIDVDNNSLKK 167
Query: 266 SSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLK 325
P+L+ + N + +PE ++++ L + N L +P + +L+
Sbjct: 168 LPDLPPSLE------FIAAGNNQLE-ELPE-LQNLPFLTAIYADNNSLKK-LPDLPLSLE 218
Query: 326 KIDYIFLTNNSLSGTLPD-WILTSEKNLDLSYNNFTE 361
I NN L LP+ L + N
Sbjct: 219 SIV---AGNNILE-ELPELQNLPFLTTIYADNNLLKT 251
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 5e-29
Identities = 68/297 (22%), Positives = 108/297 (36%), Gaps = 64/297 (21%)
Query: 101 IPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGDISTLE 160
+P+ +L F+ N LP L LT + N L +P +LE
Sbjct: 168 LPDLPPSLEFI---AAGNNQLE-ELP-ELQNLPFLTAIYADNNSLK-KLPDLPL---SLE 218
Query: 161 ELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGR 220
+V +N L LPE L NL L I +N ++P+ +L+ L + + LT
Sbjct: 219 SIVAGNNILEE-LPE-LQNLPFLTTIYADNNLLK-TLPDLPPSLEALN---VRDNYLT-D 271
Query: 221 IPNFIGNWTKLDRLDLQGTSLEG-------------PIPSTISQLKNLTELRISD--LKG 265
+P + T LD + + L I S +L EL +S+ L
Sbjct: 272 LPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKL-- 329
Query: 266 SSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLT----------- 314
P L ++ERLI + +PE +LK L + +N L
Sbjct: 330 --IELPAL--PPRLERLIASFNHLA-EVPELP---QNLKQLHVEYNPLREFPDIPESVED 381
Query: 315 -------GPVPGILQNLKKIDYIFLTNNSLSGTLPDWILTSEKNLDLSYNNFTESSP 364
VP + QNLK++ + N L PD S ++L ++ +
Sbjct: 382 LRMNSHLAEVPELPQNLKQLH---VETNPLR-EFPDIP-ESVEDLRMNSERVVDPYE 433
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-28
Identities = 55/297 (18%), Positives = 108/297 (36%), Gaps = 49/297 (16%)
Query: 80 SNNTVCHVTVILLKGFNLAGVIPEEFGNL-------------TFLQEVDLSRNYFNGSLP 126
V T P G E++L+ + SLP
Sbjct: 29 EAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS-SLP 87
Query: 127 KSFARLQNLTKLLILGNRLSGSIPLEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRI 186
+ +L L+ N L+ +P + +L L + L+ L
Sbjct: 88 EL---PPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKA----LSDLPPLLEYLG-- 137
Query: 187 LLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIP 246
+S+N +PE N L +D ++L ++P+ + L+ + LE +P
Sbjct: 138 -VSNNQLE-KLPEL-QNSSFLKIIDVDNNSLK-KLPDLPPS---LEFIAAGNNQLEE-LP 189
Query: 247 STISQLKNLTELRISD--LKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLK 304
+ L LT + + LK +L+ ++ N ++ +PE ++++ L
Sbjct: 190 E-LQNLPFLTAIYADNNSLKKLPDLPLSLE------SIVAGNNILE-ELPE-LQNLPFLT 240
Query: 305 ILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGTLPDWILTSEKNLDLSYNNFTE 361
+ N L +P + +L+ ++ + +N L+ LP+ S LD+S N F+
Sbjct: 241 TIYADNNLLKT-LPDLPPSLEALN---VRDNYLT-DLPELP-QSLTFLDVSENIFSG 291
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 9e-23
Identities = 38/255 (14%), Positives = 80/255 (31%), Gaps = 47/255 (18%)
Query: 101 IPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGD----- 155
E NL FL + N +LP +L L + N L+ +P
Sbjct: 229 ELPELQNLPFLTTIYADNNLLK-TLPDL---PPSLEALNVRDNYLT-DLPELPQSLTFLD 283
Query: 156 ------------ISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGN 203
L L N++ L + +L+ L +S+N +P
Sbjct: 284 VSENIFSGLSELPPNLYYLNASSNEIRS-LCDLPPSLEELN---VSNNKLI-ELPALPPR 338
Query: 204 LKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISDL 263
L+ L ++L +P N +L P +++L +
Sbjct: 339 LERLI---ASFNHLA-EVPELPQNLKQLHVEYNPLREF----PDIPESVEDL------RM 384
Query: 264 KGSSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQN 323
+ P L + +++L + + P+ E ++ L ++ ++ P +
Sbjct: 385 NSHLAEVPEL--PQNLKQLHVETNPLR-EFPDIPE---SVEDLRMNSERVVDPYEFAHET 438
Query: 324 LKKIDYIFLTNNSLS 338
K++ ++
Sbjct: 439 TDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 1e-05
Identities = 14/78 (17%), Positives = 25/78 (32%), Gaps = 7/78 (8%)
Query: 92 LKGFNLAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPL 151
L+ + +PE NL L + N P +++ L + R+
Sbjct: 382 LRMNSHLAEVPELPQNLKQL---HVETNPLR-EFPDI---PESVEDLRMNSERVVDPYEF 434
Query: 152 EIGDISTLEELVLEDNQL 169
LE+ V E +
Sbjct: 435 AHETTDKLEDDVFEHHHH 452
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 7e-34
Identities = 46/211 (21%), Positives = 87/211 (41%), Gaps = 22/211 (10%)
Query: 666 KIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNRE-FVNEIGMISALQHQNLVKLYGC 723
+G+G V++G G + A+K ++ S + + E ++ L H+N+VKL+
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 724 --CIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRL 781
+L+ E+ SL L + L + + D+ G+ +L E
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLE-EPSNAYGLPESEFLIVLRDVVGGMNHLRE---N 131
Query: 782 KIVHRDIKATNVLL----DKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPE---- 833
IVHR+IK N++ D K++DFG A+ +++ + GT Y+ P+
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE-LEDDEQFVSLY-GTEEYLHPDMYER 189
Query: 834 ----YAMRGYLTDKADVYSFGIVALEIVSGK 860
+ D++S G+ +G
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-33
Identities = 52/201 (25%), Positives = 84/201 (41%), Gaps = 15/201 (7%)
Query: 666 KIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNREFV----NEIGMISALQHQNLVKL 720
+G GG G VY+ ++A+K +S + + F E LQ ++V +
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMSE-TLSSDPVFRTRMQREARTAGRLQEPHVVPI 99
Query: 721 YGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESR 780
+ QL + + LA L + L A I I L H
Sbjct: 100 HDFGEIDGQLYVDMRLINGVDLAAML--RRQGPLAPPRAVA--IVRQIGSALDAAH---A 152
Query: 781 LKIVHRDIKATNVLLDKDLNAKISDFGLAK-LDEDENTHISTRIAGTVGYMAPEYAMRGY 839
HRD+K N+L+ D A + DFG+A +++ T + + GT+ YMAPE +
Sbjct: 153 AGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV-GTLYYMAPERFSESH 211
Query: 840 LTDKADVYSFGIVALEIVSGK 860
T +AD+Y+ V E ++G
Sbjct: 212 ATYRADIYALTCVLYECLTGS 232
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 137 bits (345), Expect = 2e-33
Identities = 84/366 (22%), Positives = 144/366 (39%), Gaps = 38/366 (10%)
Query: 660 NFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNREFV-NEIGMISALQHQNL 717
++ ++G GGFG V + G +A+KQ + NRE EI ++ L H N+
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74
Query: 718 VKLYGCCIE-------GNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIAR 770
V + + LL EY E L R + C L + + SDI+
Sbjct: 75 VSAR-EVPDGLQKLAPNDLPLLAMEYCEGGDL-RKYLNQFENCCGLKEGPIRTLLSDISS 132
Query: 771 GLAYLHEESRLKIVHRDIKATNVLLD---KDLNAKISDFGLAKLDEDENTHISTRIAGTV 827
L YLHE +I+HRD+K N++L + L KI D G AK + D+ + + GT+
Sbjct: 133 ALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK-ELDQGELCTEFV-GTL 187
Query: 828 GYMAPE-YAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGN 886
Y+APE + Y T D +SFG +A E ++G +RP +L +W V
Sbjct: 188 QYLAPELLEQKKY-TVTVDYWSFGTLAFECITG-----FRP-----FLPNWQPVQWHGKV 236
Query: 887 LLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTAVQAPIIRRN 946
+ + + + + P+P + + + + +R
Sbjct: 237 REKSNEHIVVYDDLTGAVKFSSVL------PTPNHLSGILAGKLERWLQCMLMWHQRQRG 290
Query: 947 SDSQDARFRAFEILSQDSQTHVST-LSQESEMQRTMSIDAPWTDSSVSVQIPDETREHSS 1005
+D Q+ F+ L + + ++ S T + ++ + +T
Sbjct: 291 TDPQNPNVGCFQALDSILSLKLLSVMNMVSGRVHTYPVTENENLQNLKSWLQQDTGIPEE 350
Query: 1006 SSLLLQ 1011
LLQ
Sbjct: 351 EQELLQ 356
|
| >2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* Length = 174 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-33
Identities = 38/195 (19%), Positives = 62/195 (31%), Gaps = 31/195 (15%)
Query: 400 AKHYSLFINCGG-SPTEFEENDYEEDLNTQGPSNFGIVSDRWAYSSTGVYVGNESSKYLA 458
A +N GG S + Y +D G V Y + +
Sbjct: 3 ADKVIWAVNAGGESHVDVHGIHYRKD------PLEGRVGRASDYGMKLPILRS------- 49
Query: 459 ANQYGLNVSGAEYYKTARLAPQSLKYYGLCMLKGSYTVKLHFAEIMFTNDQTYKSLGKRM 518
N Y+T R S Y +G Y + L FAE+ F +++
Sbjct: 50 ------NPEDQVLYQTERYNEDSFGYDIPIKEEGEYVLVLKFAEVYFA------QSQQKV 97
Query: 519 FDVSIQGKQVLKDFDIMEEAGGVGIGITREFKDVSVNGSTMEIHL---YWAGKGTNAIPY 575
FDV + G V+KD DI + G +S+ + + + GK +
Sbjct: 98 FDVRVNGHTVVKDLDIFDRVGH-STAHDEII-PISIKKGKLSVQGEVSTFTGKLSVEFVK 155
Query: 576 RGVYGPLISAITVTP 590
P + A+ +
Sbjct: 156 GYYDNPKVCALFIMK 170
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 5e-33
Identities = 75/338 (22%), Positives = 120/338 (35%), Gaps = 53/338 (15%)
Query: 86 HVTVILLKGFNLAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRL 145
H+T +++ NL +P L L ++S N SLP L L+ L
Sbjct: 62 HITTLVIPDNNLT-SLPALPPELRTL---EVSGNQLT-SLPVLPPGLLELSIFSNPLTHL 116
Query: 146 SGSIPLEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLK 205
S L +L + NQL LP L+ L +S N S+P L
Sbjct: 117 PAL-------PSGLCKLWIFGNQLTS-LPVLPPGLQELS---VSDNQLA-SLPALPSELC 164
Query: 206 NLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTEL--RISDL 263
L + LT +P L L + L +P+ S+L L R++ L
Sbjct: 165 KLW---AYNNQLT-SLPMLPSG---LQELSVSDNQLAS-LPTLPSELYKLWAYNNRLTSL 216
Query: 264 KGSSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQN 323
+ L+ LI+ +T +P ++LK L +S N+LT +P +
Sbjct: 217 ---PALPSGLK------ELIVSGNRLT-SLP---VLPSELKELMVSGNRLTS-LPMLPSG 262
Query: 324 LKKIDYIFLTNNSLSGTLPDWI--LTSEKNLDLSYNNFTESSPATCRESRVNILSSFSST 381
L + + N L+ LP+ + L+SE ++L N +E + RE
Sbjct: 263 LLSLS---VYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGY----- 313
Query: 382 GSNSVSWCLKKDLPCPKEAKHYSLFINCGGSPTEFEEN 419
S + P+E + L P E
Sbjct: 314 -SGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEP 350
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-31
Identities = 71/320 (22%), Positives = 110/320 (34%), Gaps = 42/320 (13%)
Query: 101 IPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGDISTLE 160
+P L L LP L KL I GN+L+ S+P+ L+
Sbjct: 96 LPVLPPGLLELSIFSNPLT----HLPAL---PSGLCKLWIFGNQLT-SLPVLPP---GLQ 144
Query: 161 ELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGR 220
EL + DNQL LP L L +N T S+P L+ L+ + + L
Sbjct: 145 ELSVSDNQLAS-LPALPSELCKLW---AYNNQLT-SLPMLPSGLQELS---VSDNQLA-S 195
Query: 221 IPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISDLKGSSSSFPNLQDMKKME 280
+P KL + + TSL P+ S L EL +S + +S P L +++
Sbjct: 196 LPTLPSELYKLWAYNNRLTSL----PALPS---GLKELIVSGNR--LTSLPVL--PSELK 244
Query: 281 RLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGT 340
L++ +T +P + L L + NQLT +P L +L + L N LS
Sbjct: 245 ELMVSGNRLT-SLPMLP---SGLLSLSVYRNQLTR-LPESLIHLSSETTVNLEGNPLS-E 298
Query: 341 LPDWILTSEKNLDLSYNNFTESSPATCRESRVNILSSFSSTGSNSVSWCLKKDLPCPKEA 400
L + A R ++ W + P A
Sbjct: 299 RTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAAD-----WLVPAREGEPAPA 353
Query: 401 KHYSLFINCGGSPTEFEEND 420
+ +F + D
Sbjct: 354 DRWHMFGQEDNADAFSLFLD 373
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 74.2 bits (182), Expect = 1e-13
Identities = 37/217 (17%), Positives = 74/217 (34%), Gaps = 31/217 (14%)
Query: 101 IPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGD----- 155
+P L L N SLP L +L++ GNRL+ S+P+ +
Sbjct: 196 LPTLPSELYKL---WAYNNRLT-SLPAL---PSGLKELIVSGNRLT-SLPVLPSELKELM 247
Query: 156 ------------ISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGN 203
S L L + NQL LPE+L +L S + L N + ++
Sbjct: 248 VSGNRLTSLPMLPSGLLSLSVYRNQLTR-LPESLIHLSSETTVNLEGNPLSERTLQALRE 306
Query: 204 LKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISDL 263
+ + + S R + + R L + + +P+ + +
Sbjct: 307 ITSAPGY----SGPIIRFDMAGASAPRETRA-LHLAAADWLVPAREGEPAPADRWHMFGQ 361
Query: 264 KGSSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDM 300
+ ++ +F D +++ +I ++ +
Sbjct: 362 EDNADAFSLFLDRLSETENFIKDAGFKAQISSWLAQL 398
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 66.1 bits (161), Expect = 4e-11
Identities = 26/135 (19%), Positives = 47/135 (34%), Gaps = 21/135 (15%)
Query: 229 TKLDRLDLQGTSLEGPIPSTISQLKNLTELRISD--LKGSSSSFPNLQDMKKMERLILRN 286
L++ + L +P + ++T L I D L + P L+ L +
Sbjct: 40 NGNAVLNVGESGLTT-LPDCL--PAHITTLVIPDNNLTSLPALPPELR------TLEVSG 90
Query: 287 CLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGTLPDWIL 346
+T +P + +L I L P + L K+ + N L+ +LP
Sbjct: 91 NQLT-SLPVLPPGLLELSIFSNPLTHL----PALPSGLCKLW---IFGNQLT-SLPVLP- 140
Query: 347 TSEKNLDLSYNNFTE 361
+ L +S N
Sbjct: 141 PGLQELSVSDNQLAS 155
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 1e-32
Identities = 70/310 (22%), Positives = 130/310 (41%), Gaps = 31/310 (10%)
Query: 75 CDCTYSNNTV-CH--------------VTVILLKGFNLAGVIPEEFGNLTFLQEVDLSRN 119
C+C+ + V CH ++ L + + +EF + L+E++L+ N
Sbjct: 7 CECSAQDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNEN 66
Query: 120 YFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEI-GDISTLEELVLEDNQLVGPLPENLG 178
+ P +F L NL L + NRL IPL + +S L +L + +N++V L
Sbjct: 67 IVSAVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQ 125
Query: 179 NLKSLRRILLSSNNFTGSIPE-SYGNLKNLTEFRIDGSNLTGRIPN--FIGNWTKLDRLD 235
+L +L+ + + N+ I ++ L +L + ++ NLT IP L L
Sbjct: 126 DLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHL-HGLIVLR 182
Query: 236 LQGTSLEGPIPSTISQLKNLTELRISDLKGSSSSFPNLQDMKKMERLILRNCLITGRIPE 295
L+ ++ + +L L L IS + PN + L + +C +T +P
Sbjct: 183 LRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPY 241
Query: 296 Y-IEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLS----GTLPDWILTSEK 350
+ + L+ L+LS+N ++ +L L ++ I L L+ L +
Sbjct: 242 LAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRG--LNYLR 299
Query: 351 NLDLSYNNFT 360
L++S N T
Sbjct: 300 VLNVSGNQLT 309
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-26
Identities = 55/247 (22%), Positives = 92/247 (37%), Gaps = 15/247 (6%)
Query: 100 VIPEE-FGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEI-GDIS 157
+IP F L+ L ++D+S N L F L NL L + N L I ++
Sbjct: 94 LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLN 152
Query: 158 TLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNL 217
+LE+L LE L E L +L L + L N S+ L L I
Sbjct: 153 SLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPY 212
Query: 218 TGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTEL-----RISDLKGSSSSFPN 272
+ L L + +L + L L L IS + S
Sbjct: 213 LDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTI--EGSMLHE 270
Query: 273 LQDMKKMERLILRNCLITGRIPEYI-EDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIF 331
L +++ + L + + Y + L++L++S NQLT + ++ ++ +
Sbjct: 271 L---LRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLI 326
Query: 332 LTNNSLS 338
L +N L+
Sbjct: 327 LDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 7e-18
Identities = 45/232 (19%), Positives = 85/232 (36%), Gaps = 11/232 (4%)
Query: 142 GNRLSGSIPLEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESY 201
R ++P I + L L N++ + + L + L+ N + P ++
Sbjct: 20 RKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAF 76
Query: 202 GNLKNLTEFRIDGSNLTGRIPN--FIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELR 259
NL NL + + L IP F G + L +LD+ + + L NL L
Sbjct: 77 NNLFNLRTLGLRSNRLK-LIPLGVFTGL-SNLTKLDISENKIVILLDYMFQDLYNLKSLE 134
Query: 260 ISDLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYI-EDMTDLKILDLSFNQLTGPVP 318
+ D S + +E+L L C +T IP + L +L L +
Sbjct: 135 VGDNDLVYISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRD 193
Query: 319 GILQNLKKIDYIFLTNNSLSGTLPDWILT--SEKNLDLSYNNFTESSPATCR 368
+ L ++ + +++ T+ L + +L +++ N T R
Sbjct: 194 YSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVR 245
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 3e-17
Identities = 39/170 (22%), Positives = 57/170 (33%), Gaps = 6/170 (3%)
Query: 96 NLAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGD 155
NL + E +L L + L N SF RL L L I ++
Sbjct: 163 NLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLY 222
Query: 156 ISTLEELVLEDNQLVGPLPEN-LGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDG 214
L L + L +P + +L LR + LS N + L L E ++ G
Sbjct: 223 GLNLTSLSITHCNLTA-VPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVG 281
Query: 215 SNLTGRIPN--FIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISD 262
L + F G L L++ G L S + NL L +
Sbjct: 282 GQLA-VVEPYAFRGL-NYLRVLNVSGNQLTTLEESVFHSVGNLETLILDS 329
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-32
Identities = 46/211 (21%), Positives = 87/211 (41%), Gaps = 22/211 (10%)
Query: 666 KIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNRE-FVNEIGMISALQHQNLVKLYGC 723
+G+G V++G G + A+K ++ S + + E ++ L H+N+VKL+
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 724 --CIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRL 781
+L+ E+ SL L + L + + D+ G+ +L E
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLE-EPSNAYGLPESEFLIVLRDVVGGMNHLRE---N 131
Query: 782 KIVHRDIKATNVLL----DKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPE---- 833
IVHR+IK N++ D K++DFG A+ +++ + GT Y+ P+
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE-LEDDEQFVSLY-GTEEYLHPDMYER 189
Query: 834 ----YAMRGYLTDKADVYSFGIVALEIVSGK 860
+ D++S G+ +G
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-32
Identities = 57/207 (27%), Positives = 96/207 (46%), Gaps = 21/207 (10%)
Query: 666 KIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNREFV----NEIGMISALQHQNLVKL 720
+G GG V+ L D +AVK L + + F E +AL H +V +
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRA-DLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 721 Y--GCCIEGNQLLLVY---EYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYL 775
Y G E L Y EY++ +L R + EG + + +D + L +
Sbjct: 78 YDTGE-AETPAGPLPYIVMEYVDGVTL-RDIVHTEGP---MTPKRAIEVIADACQALNFS 132
Query: 776 HEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAK-LDEDENTHIST-RIAGTVGYMAPE 833
H + I+HRD+K N+++ K+ DFG+A+ + + N+ T + GT Y++PE
Sbjct: 133 H---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 834 YAMRGYLTDKADVYSFGIVALEIVSGK 860
A + ++DVYS G V E+++G+
Sbjct: 190 QARGDSVDARSDVYSLGCVLYEVLTGE 216
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 5e-32
Identities = 44/203 (21%), Positives = 77/203 (37%), Gaps = 24/203 (11%)
Query: 666 KIGEGGFGPVYKG--TLSDGAVIAVKQLSSKSKQGNRE-FVNEIGMISALQHQNLVKLY- 721
I GG G +Y +G + +K L + + E ++ + H ++V+++
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 722 ----GCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHE 777
+V EY+ SL R+ K L A +I L+YLH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK------LPVAEAIAYLLEILPALSYLH- 199
Query: 778 ESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMR 837
+ +V+ D+K N++L ++ K+ D G + GT G+ APE R
Sbjct: 200 --SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGY-----LYGTPGFQAPEIV-R 250
Query: 838 GYLTDKADVYSFGIVALEIVSGK 860
T D+Y+ G +
Sbjct: 251 TGPTVATDIYTVGRTLAALTLDL 273
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-31
Identities = 36/247 (14%), Positives = 73/247 (29%), Gaps = 32/247 (12%)
Query: 652 RQIKAATNNFDAANKIGEGGFGPVYKGTLSD------GAVIAVKQLSSKSKQGNREFVNE 705
+ + + + +GEG F VY+ T D +K +
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQL 117
Query: 706 IGMISALQHQNLVKLYGCCIEGNQLLLVYEYLENNSL-ARALFGKEGQCLNLDWATRKRI 764
+ + +K Y + N +LV E +L K +
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177
Query: 765 CSDIARGLAYLHEESRLKIVHRDIKATNVLL-----------DKDLNAKISDFGLAK--L 811
+ + +H+ +I+H DIK N +L D + D G +
Sbjct: 178 AMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234
Query: 812 DEDENTHISTRIAGTVGYMAPE-YAMRGYLTDKADVYSFGIVALEIVSGK------SNTN 864
+ T + + T G+ E + + + + D + ++ G
Sbjct: 235 LFPKGTIFTAKC-ETSGFQCVEMLSNKPW-NYQIDYFGVAATVYCMLFGTYMKVKNEGGE 292
Query: 865 YRPKEEF 871
+P+ F
Sbjct: 293 CKPEGLF 299
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 3e-31
Identities = 55/229 (24%), Positives = 91/229 (39%), Gaps = 36/229 (15%)
Query: 659 NNFDAANKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGNREFVNEIG-MISALQHQNL 717
N + +G G G V G +AVK++ + EI + + H N+
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRML---IDFCDIALMEIKLLTESDDHPNV 71
Query: 718 VKLYGCCIEGNQLLLVYEY----LENNSLARALFGKEGQCLNLDWATRKRICSDIARGLA 773
++ Y L + E L++ ++ + + + + IA G+A
Sbjct: 72 IRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNP--ISLLRQIASGVA 129
Query: 774 YLHEESRLKIVHRDIKATNVLLD-------------KDLNAKISDFGLAKLDEDENTHIS 820
+LH LKI+HRD+K N+L+ ++L ISDFGL K + +
Sbjct: 130 HLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186
Query: 821 TR---IAGTVGYMAPE-------YAMRGYLTDKADVYSFGIVALEIVSG 859
T +GT G+ APE + LT D++S G V I+S
Sbjct: 187 TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 54/208 (25%), Positives = 99/208 (47%), Gaps = 18/208 (8%)
Query: 659 NNFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLS----SKSKQGNREFVNEIGMISALQ 713
+F+ +G+G FG VY ++A+K L K+ ++ E+ + S L+
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQ-LRREVEIQSHLR 67
Query: 714 HQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLA 773
H N+++LYG + ++ L+ EY ++ R L ++ + +++A L+
Sbjct: 68 HPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRT--ATYITELANALS 123
Query: 774 YLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPE 833
Y H +++HRDIK N+LL KI+DFG + + GT+ Y+ PE
Sbjct: 124 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--D-LCGTLDYLPPE 177
Query: 834 YAM-RGYLTDKADVYSFGIVALEIVSGK 860
R + +K D++S G++ E + GK
Sbjct: 178 MIEGRMH-DEKVDLWSLGVLCYEFLVGK 204
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 58/198 (29%), Positives = 92/198 (46%), Gaps = 12/198 (6%)
Query: 667 IGEGGFGPVYKGT-LSDGAVIAVKQLSSKS--KQGNRE-FVNEIGMISALQHQNLVKLYG 722
+G+GGF ++ + V A K + K RE EI + +L HQ++V +G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 723 CCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLK 782
+ + + +V E SL K + L A + I G YLH R +
Sbjct: 83 FFEDNDFVFVVLELCRRRSLLELH--KRRKALTEPEA--RYYLRQIVLGCQYLH---RNR 135
Query: 783 IVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRGYLTD 842
++HRD+K N+ L++DL KI DFGLA E + + GT Y+APE + +
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGHSF 194
Query: 843 KADVYSFGIVALEIVSGK 860
+ DV+S G + ++ GK
Sbjct: 195 EVDVWSIGCIMYTLLVGK 212
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 3e-30
Identities = 52/263 (19%), Positives = 91/263 (34%), Gaps = 51/263 (19%)
Query: 630 GGKNVEDKELRGLDLQTGYFTLRQIKAATNNFDAANKIGEGGFGPVYKGT-LSDGAVIAV 688
G + + G ++ G LR + + EGGF VY+ + G A+
Sbjct: 9 GASGRDQSDFVGQTVELGELRLRVRR----------VLAEGGFAFVYEAQDVGSGREYAL 58
Query: 689 KQLSSKSKQGNREFVNEIG-MISALQHQNLVKLYGCCIEGNQ--------LLLVYEYLE- 738
K+L S ++ NR + E+ M H N+V+ G + LL+ E +
Sbjct: 59 KRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKG 118
Query: 739 ------NNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATN 792
+R L +I R + ++H + I+HRD+K N
Sbjct: 119 QLVEFLKKMESRGPL-SCDTVL--------KIFYQTCRAVQHMHR-QKPPIIHRDLKVEN 168
Query: 793 VLLDKDLNAKISDFGLAKLDEDENTHISTRIA-----------GTVGYMAPE---YAMRG 838
+LL K+ DFG A + + T Y PE
Sbjct: 169 LLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNF 228
Query: 839 YLTDKADVYSFGIVALEIVSGKS 861
+ +K D+++ G + + +
Sbjct: 229 PIGEKQDIWALGCILYLLCFRQH 251
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 5e-30
Identities = 48/225 (21%), Positives = 91/225 (40%), Gaps = 29/225 (12%)
Query: 659 NNFDAANKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGNREFV--------------- 703
N++ + +G F + D A+K+ + R+F
Sbjct: 31 NDYRIIRTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 704 --NEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYLEN----NSLARALFGKEGQCLNLD 757
NE+ +I+ ++++ + G +++ ++YEY+EN + +
Sbjct: 90 FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149
Query: 758 WATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENT 817
K I + +Y+H + I HRD+K +N+L+DK+ K+SDFG ++ D+
Sbjct: 150 IQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKI 207
Query: 818 HISTRIAGTVGYMAPEYAMR--GYLTDKADVYSFGIVALEIVSGK 860
S GT +M PE+ Y K D++S GI +
Sbjct: 208 KGS---RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 6e-30
Identities = 58/198 (29%), Positives = 92/198 (46%), Gaps = 12/198 (6%)
Query: 667 IGEGGFGPVYKGT-LSDGAVIAVKQLSSKS--KQGNRE-FVNEIGMISALQHQNLVKLYG 722
+G+GGF ++ + V A K + K RE EI + +L HQ++V +G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 723 CCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLK 782
+ + + +V E SL K + L A + I G YLH R +
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELH--KRRKALTEPEA--RYYLRQIVLGCQYLH---RNR 161
Query: 783 IVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRGYLTD 842
++HRD+K N+ L++DL KI DFGLA E + + GT Y+APE + +
Sbjct: 162 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGHSF 220
Query: 843 KADVYSFGIVALEIVSGK 860
+ DV+S G + ++ GK
Sbjct: 221 EVDVWSIGCIMYTLLVGK 238
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 6e-30
Identities = 60/212 (28%), Positives = 103/212 (48%), Gaps = 11/212 (5%)
Query: 653 QIKAATNNFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLSSKS--KQGNRE-FVNEIGM 708
I +F N +G+G F VY+ + G +A+K + K+ K G + NE+ +
Sbjct: 5 CIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKI 64
Query: 709 ISALQHQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDI 768
L+H ++++LY + N + LV E N + R L + + I
Sbjct: 65 HCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKP---FSENEARHFMHQI 121
Query: 769 ARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVG 828
G+ YLH I+HRD+ +N+LL +++N KI+DFGLA + + T + GT
Sbjct: 122 ITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPN 177
Query: 829 YMAPEYAMRGYLTDKADVYSFGIVALEIVSGK 860
Y++PE A R ++DV+S G + ++ G+
Sbjct: 178 YISPEIATRSAHGLESDVWSLGCMFYTLLIGR 209
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 8e-30
Identities = 50/201 (24%), Positives = 86/201 (42%), Gaps = 34/201 (16%)
Query: 666 KIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNREFV-NEIGMISALQHQNLVKLYGC 723
+G G F V+ G + A+K + KS + NEI ++ ++H+N+V L
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIK-KSPAFRDSSLENEIAVLKKIKHENIVTLEDI 74
Query: 724 CIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRK---------RICSDIARGLAY 774
LV + + G E L D + + + + Y
Sbjct: 75 YESTTHYYLVMQLVS---------GGE---L-FDRILERGVYTEKDASLVIQQVLSAVKY 121
Query: 775 LHEESRLKIVHRDIKATNVLL---DKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMA 831
LHE IVHRD+K N+L +++ I+DFGL+K++++ + GT GY+A
Sbjct: 122 LHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM---STACGTPGYVA 175
Query: 832 PEYAMRGYLTDKADVYSFGIV 852
PE + + D +S G++
Sbjct: 176 PEVLAQKPYSKAVDCWSIGVI 196
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 9e-30
Identities = 48/328 (14%), Positives = 111/328 (33%), Gaps = 30/328 (9%)
Query: 71 SNFTCDCTYSN------NTVCHVTVILLKGFNLAGVIPEEFGNLTFLQEVDLSRNYFNGS 124
++ CD + + + L + + + LQ + L + N
Sbjct: 6 ASGVCDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTI 65
Query: 125 LPKSFARLQNLTKLLILGNRLSGSIPLE-IGDISTLEELVLEDNQLVG-PLPENLGNLKS 182
+F L +L L + N LS S+ G +S+L+ L L N + NL +
Sbjct: 66 EGDAFYSLGSLEHLDLSDNHLS-SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTN 124
Query: 183 LRRILLSSNNFTGSIPESY-GNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSL 241
L+ + + + I L +L E I +L + + + L L +
Sbjct: 125 LQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSES 184
Query: 242 EGPIPSTISQLKNLTELRISDLKGSS---SSFPNLQDMKKMERLILRNCLITG------- 291
+ L ++ L + D + S P + M++L R ++T
Sbjct: 185 AFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELL 244
Query: 292 RIPEYIEDMTDLKILDLSFNQLT---GPVPGILQNLKKIDYIFLTNNSLSG----TLPDW 344
++ YI ++++++ D + N L ++ L K++ + + +
Sbjct: 245 KLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLST 304
Query: 345 ILTSEKN---LDLSYNNFTESSPATCRE 369
+ + + + + + + +
Sbjct: 305 VYSLLEKVKRITVENSKVFLVPCSFSQH 332
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-26
Identities = 61/313 (19%), Positives = 123/313 (39%), Gaps = 30/313 (9%)
Query: 34 VQTLQSIFRKLNFRNGQVNQTSCTEGSWNVTIDDSNGSNFTCDCTYSNNTVCHVTVILLK 93
V + S +KL FR + T+ S+N + + + + T+ +
Sbjct: 218 VDEVSSPMKKLAFRGSVL-----TDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPS 272
Query: 94 GFNLAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEI 153
++ + ++ + + + Y L ++ L+ + ++ + +++ +P
Sbjct: 273 ESDVVSELG--KVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSF 329
Query: 154 GD-ISTLEELVLEDNQLVGPLPEN---LGNLKSLRRILLSSNNFTGSIPESYG---NLKN 206
+ +LE L L +N +V +N G SL+ ++LS N+ S+ ++ LKN
Sbjct: 330 SQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLR-SMQKTGEILLTLKN 388
Query: 207 LTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISD--LK 264
LT I + +P+ K+ L+L T + + + I + L L +S+ L
Sbjct: 389 LTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRV-VKTCI--PQTLEVLDVSNNNLD 444
Query: 265 GSSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNL 324
S P LQ L + + +P+ L ++ +S NQL GI L
Sbjct: 445 SFSLFLPRLQ------ELYISRNKLK-TLPDASL-FPVLLVMKISRNQLKSVPDGIFDRL 496
Query: 325 KKIDYIFLTNNSL 337
+ I+L N
Sbjct: 497 TSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-24
Identities = 47/302 (15%), Positives = 97/302 (32%), Gaps = 27/302 (8%)
Query: 86 HVTVILLKGFNLAGVIPEE-FGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNR 144
++ + + I F LT L E+++ +S ++++ L + +
Sbjct: 124 NLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSE 183
Query: 145 LSGSIPLEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFT-------GSI 197
+ + + +S++ L L D L L + + + + +
Sbjct: 184 SAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNEL 243
Query: 198 PESYGNLKNLTEFRIDGSNLTG--RIPNFIGNW---------TKLDRLDLQGTSLEGPIP 246
+ + L+E D L G + + RL + L +
Sbjct: 244 LKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLS 303
Query: 247 STISQLKNLTELRISDLKGSSSSFPNLQDMKKMERLILRNCLITGRI---PEYIEDMTDL 303
+ S L+ + + + + K Q +K +E L L L+ L
Sbjct: 304 TVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSL 363
Query: 304 KILDLSFNQLT--GPVPGILQNLKKIDYIFLTNNSLSGTLPD--WILTSEKNLDLSYNNF 359
+ L LS N L IL LK + + ++ N+ +PD + L+LS
Sbjct: 364 QTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGI 422
Query: 360 TE 361
Sbjct: 423 RV 424
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 1e-29
Identities = 55/298 (18%), Positives = 115/298 (38%), Gaps = 16/298 (5%)
Query: 78 TYSNNTVCHVTVILLKGFNLAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTK 137
T++ V + L + + F L L+ ++L+ N N ++F L NL
Sbjct: 259 TFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQV 318
Query: 138 LLILGNRLSGSIPLEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSI 197
L + N L + + + L+ N + + L+ L+ + L N T +I
Sbjct: 319 LNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-TI 377
Query: 198 PESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEG-PIPSTISQLKNLT 256
+ ++ + + G+ L + + L LE I + ++ +L
Sbjct: 378 H----FIPSIPDIFLSGNKLV----TLPKINLTANLIHLSENRLENLDILYFLLRVPHLQ 429
Query: 257 ELRISDLKGSSSSFPNL-QDMKKMERLILRNCLITGRIPEYI-----EDMTDLKILDLSF 310
L ++ + SS S + +E+L L ++ + E ++ L++L L+
Sbjct: 430 ILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNH 489
Query: 311 NQLTGPVPGILQNLKKIDYIFLTNNSLSGTLPDWILTSEKNLDLSYNNFTESSPATCR 368
N L PG+ +L + + L +N L+ + + + + LD+S N +P
Sbjct: 490 NYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLPANLEILDISRNQLLAPNPDVFV 547
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-28
Identities = 67/308 (21%), Positives = 115/308 (37%), Gaps = 30/308 (9%)
Query: 88 TVILLKGFNLAGVIPEE-FGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLS 146
++ L I +E F NL L+ +DL + P +F L +L +L + LS
Sbjct: 51 QLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLS 110
Query: 147 GSI--PLEIGDISTLEELVLEDNQLVG-PLPENLGNLKSLRRILLSSNNFTGSIPESYGN 203
++ ++ L L L NQ+ L + G L SL+ I SSN
Sbjct: 111 DAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEP 170
Query: 204 L--KNLTEFRIDGSNLTGRIPNFIGNWTK------LDRLDLQGTSLEGPIPST----ISQ 251
L K L+ F + ++L R+ G L+ LD+ G I IS+
Sbjct: 171 LQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISK 230
Query: 252 LKNLTELRISDLKGSSSSFPNLQDMKK----------MERLILRNCLITGRIPEYIEDMT 301
+ + + + G+ F N++D + + L L + + E +
Sbjct: 231 SQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLK 290
Query: 302 DLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGTLPDWI---LTSEKNLDLSYNN 358
DLK+L+L++N++ L + + L+ N L L L +DL N+
Sbjct: 291 DLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLG-ELYSSNFYGLPKVAYIDLQKNH 349
Query: 359 FTESSPAT 366
T
Sbjct: 350 IAIIQDQT 357
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 5e-25
Identities = 56/323 (17%), Positives = 112/323 (34%), Gaps = 42/323 (13%)
Query: 86 HVTVILLKGFNLAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRL 145
+ V+ L + + E F L LQ ++LS N +F L + + + N +
Sbjct: 291 DLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHI 350
Query: 146 SGSIPLEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTG---------- 195
+ + L+ L L DN L + + S+ I LS N
Sbjct: 351 AIIQDQTFKFLEKLQTLDLRDNAL-----TTIHFIPSIPDIFLSGNKLVTLPKINLTANL 405
Query: 196 ---------SIPESY--GNLKNLTEFRIDGSNLTGRIPNFIGNW-TKLDRLDLQGTSLEG 243
++ Y + +L ++ + + + + L++L L L+
Sbjct: 406 IHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQL 465
Query: 244 PIPSTI-----SQLKNLTELRISDLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYIE 298
+ + L +L L ++ +S + + L L + +T +
Sbjct: 466 AWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT-VLSHND- 523
Query: 299 DMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLS-----GTLPDWILTSEKNLD 353
+L+ILD+S NQL P P + +L +D +T+N T +W+ + +
Sbjct: 524 LPANLEILDISRNQLLAPNPDVFVSLSVLD---ITHNKFICECELSTFINWLNHTNVTIA 580
Query: 354 LSYNNFTESSPATCRESRVNILS 376
+ P + + LS
Sbjct: 581 GPPADIYCVYPDSFSGVSLFSLS 603
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-24
Identities = 53/298 (17%), Positives = 103/298 (34%), Gaps = 26/298 (8%)
Query: 102 PEEFGNLTFLQEVDLSRNYFNG-SLPKSFARLQNLTKLLILGNRLSGSIPLEIGDIS--T 158
F NL L +DLS+N L SF +L +L + N++ E+ + T
Sbjct: 116 DGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKT 175
Query: 159 LEELVLEDNQLVGPLPENLGNL------KSLRRILLSSNNFTGSIPESYGN--------- 203
L L N L + + G L + +S N +T I ++ N
Sbjct: 176 LSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFS 235
Query: 204 ---LKNLTEFRIDGSNLTGRIPNFIGNWTK--LDRLDLQGTSLEGPIPSTISQLKNLTEL 258
++ N+ N + + LDL + LK+L L
Sbjct: 236 LILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVL 295
Query: 259 RISDLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVP 318
++ K + + + ++ L L L+ + + +DL N +
Sbjct: 296 NLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQD 355
Query: 319 GILQNLKKIDYIFLTNNSLSGTLPDWILTSEKNLDLSYNNFTESSPATCRESRVNILS 376
+ L+K+ + L +N+L+ T+ + S ++ LS N + +++
Sbjct: 356 QTFKFLEKLQTLDLRDNALT-TIH--FIPSIPDIFLSGNKLVTLPKINLTANLIHLSE 410
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 8e-24
Identities = 49/313 (15%), Positives = 94/313 (30%), Gaps = 38/313 (12%)
Query: 77 CTYSNNTVCHVTVILLKGFNLAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLT 136
C++ + NL V L + + LS NY SF L+ L
Sbjct: 2 CSFDGRIA------FYRFCNLTQV----PQVLNTTERLLLSFNYIRTVTASSFPFLEQLQ 51
Query: 137 KLLILGNRLSGSIPLEI-GDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTG 195
L + +I E ++ L L L +++ P+ L L + L +
Sbjct: 52 LLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSD 111
Query: 196 SI--PESYGNLKNLTEFRIDGSNLTG-RIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQL 252
++ + NLK LT + + + + G L +D + + L
Sbjct: 112 AVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPL 171
Query: 253 --KNLTELRISDLK------GSSSSFPNLQDMKKMERLILRNCLITGRIP---------- 294
K L+ ++ N +E L + T I
Sbjct: 172 QGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKS 231
Query: 295 --EYIEDMTDLKILDLSFNQLTGPVPGILQNLKK--IDYIFLTNNSLSGTLPDWI--LTS 348
+ + F+ + P L + + ++ L++ + L
Sbjct: 232 QAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKD 291
Query: 349 EKNLDLSYNNFTE 361
K L+L+YN +
Sbjct: 292 LKVLNLAYNKINK 304
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 99.1 bits (247), Expect = 2e-21
Identities = 46/321 (14%), Positives = 97/321 (30%), Gaps = 37/321 (11%)
Query: 83 TVCHVTVILLKGFNLAGVIPEEFGNL------TFLQEVDLSRNYFNGSLPKSFAR----- 131
++ L +L + ++G L+ +D+S N + + +F+
Sbjct: 172 QGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKS 231
Query: 132 -------LQNLTKLLILGNRLSGSIP---LEIGDISTLEELVLEDNQLVGPLPENLGNLK 181
++ + + S++ L L + LK
Sbjct: 232 QAFSLILAHHIMGAGFGFHNIK-DPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLK 290
Query: 182 SLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSL 241
L+ + L+ N E++ L NL + + L + K+ +DLQ +
Sbjct: 291 DLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHI 350
Query: 242 EGPIPSTISQLKNLTELRISDLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDMT 301
T L+ L L + D ++ + + + + L + + +
Sbjct: 351 AIIQDQTFKFLEKLQTLDLRD-----NALTTIHFIPSIPDIFLSGNKLV-----TLPKIN 400
Query: 302 -DLKILDLSFNQLTG-PVPGILQNLKKIDYIFLTNNSLSGTLPDWI---LTSEKNLDLSY 356
++ LS N+L + L + + + L N S D S + L L
Sbjct: 401 LTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGE 460
Query: 357 NNFTESSPATCRESRVNILSS 377
N + LS
Sbjct: 461 NMLQLAWETELCWDVFEGLSH 481
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 48.3 bits (115), Expect = 1e-05
Identities = 13/72 (18%), Positives = 25/72 (34%), Gaps = 3/72 (4%)
Query: 298 EDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGTLPDWILTSEKNL---DL 354
+ + + L LSFN + L+++ + L + T+ + NL DL
Sbjct: 21 QVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDL 80
Query: 355 SYNNFTESSPAT 366
+ P
Sbjct: 81 GSSKIYFLHPDA 92
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 2e-29
Identities = 26/233 (11%), Positives = 59/233 (25%), Gaps = 41/233 (17%)
Query: 667 IGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNREF----------------------- 702
+G+ + T G V + +
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 703 --VNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYL-------ENNSLARALFGKEGQC 753
+ I ++ K+ ++ + ++ + + L
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 754 LNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDE 813
+L R ++ + R LA LH +VH ++ +++LD+ ++ F D
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262
Query: 814 DENTHISTRIAGTVGYMAPE-----YAMRGYLTDKADVYSFGIVALEIVSGKS 861
R A +T D ++ G+ I
Sbjct: 263 ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL 315
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 56/192 (29%), Positives = 88/192 (45%), Gaps = 11/192 (5%)
Query: 666 KIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNREFV-NEIGMISALQHQNLVKLYGC 723
K+G G FG V+ S G +K ++ Q E + EI ++ +L H N++K++
Sbjct: 29 KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88
Query: 724 CIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKI 783
+ + + +V E E L + + + L + + LAY H +
Sbjct: 89 FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QHV 145
Query: 784 VHRDIKATNVLL---DKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRGYL 840
VH+D+K N+L KI DFGLA+L + + T AGT YMAPE R
Sbjct: 146 VHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS--TNAAGTALYMAPEVFKRDV- 202
Query: 841 TDKADVYSFGIV 852
T K D++S G+V
Sbjct: 203 TFKCDIWSAGVV 214
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-29
Identities = 61/231 (26%), Positives = 96/231 (41%), Gaps = 28/231 (12%)
Query: 642 LDLQTGYFTLRQIKAATNNFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNR 700
L G F + + + K+G G +G V A+K + K+
Sbjct: 20 LQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIR-KTSVSTS 78
Query: 701 E---FVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYLENNSL-----ARALFGKEGQ 752
+ E+ ++ L H N++KLY + LV E + L R F E
Sbjct: 79 SNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKF-NEVD 137
Query: 753 CLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLL---DKDLNAKISDFGLA 809
I + G+ YLH+ IVHRD+K N+LL +KD KI DFGL+
Sbjct: 138 A--------AVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLS 186
Query: 810 KLDEDENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGK 860
+ E++ GT Y+APE + Y +K DV+S G++ +++G
Sbjct: 187 AVFENQKKM--KERLGTAYYIAPEVLRKKY-DEKCDVWSIGVILFILLAGY 234
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-29
Identities = 52/208 (25%), Positives = 96/208 (46%), Gaps = 18/208 (8%)
Query: 659 NNFDAANKIGEGGFGPVYKG-TLSDGAVIAVKQLSSKSKQGNREFV----NEIGMISALQ 713
++FD +G+G FG VY + ++A+K L KS+ EI + S L+
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLF-KSQLEKEGVEHQLRREIEIQSHLR 72
Query: 714 HQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLA 773
H N++++Y + ++ L+ E+ L + L ++ + + ++A L
Sbjct: 73 HPNILRMYNYFHDRKRIYLMLEFAPRGELYKEL--QKHGRFDEQRS--ATFMEELADALH 128
Query: 774 YLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPE 833
Y H K++HRDIK N+L+ KI+DFG + T + GT+ Y+ PE
Sbjct: 129 YCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR--T-MCGTLDYLPPE 182
Query: 834 YAM-RGYLTDKADVYSFGIVALEIVSGK 860
+ + +K D++ G++ E + G
Sbjct: 183 MIEGKTH-DEKVDLWCAGVLCYEFLVGM 209
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 4e-29
Identities = 31/238 (13%), Positives = 70/238 (29%), Gaps = 52/238 (21%)
Query: 667 IGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNRE------------------------ 701
+G+ + T G V + +
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 702 ----FVNEIGMISALQHQNLVKLYGCC--IEGNQLLLVYEYLENN--SLARALFGKEGQC 753
F+ ++ Q + ++++ + +Y +++N + L
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 754 LNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDE 813
+L R ++ + R LA LH +VH ++ +++LD+ ++ F D
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257
Query: 814 DENTHISTRIAGTVGYMAPEY-----------AMRGYLTDKADVYSFGIVALEIVSGK 860
+ + G+ PE R +T D ++ G+V I
Sbjct: 258 ARVV-----SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-28
Identities = 66/231 (28%), Positives = 96/231 (41%), Gaps = 29/231 (12%)
Query: 642 LDLQTGYFTLRQIKAATNNFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNR 700
L G F ++ + +G+G FG V G AVK +S K + +
Sbjct: 9 LHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVIS-KRQVKQK 67
Query: 701 EFV----NEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYLENNSL-----ARALFGKEG 751
E+ ++ L H N++KLY + LV E L +R F E
Sbjct: 68 TDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRF-SEV 126
Query: 752 QCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLL---DKDLNAKISDFGL 808
RI + G+ Y+H+ KIVHRD+K N+LL KD N +I DFGL
Sbjct: 127 DA--------ARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGL 175
Query: 809 AKLDEDENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSG 859
+ E GT Y+APE Y +K DV+S G++ ++SG
Sbjct: 176 STHFEASKKM--KDKIGTAYYIAPEVLHGTY-DEKCDVWSTGVILYILLSG 223
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 36/211 (17%)
Query: 658 TNNFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNRE---FVNEIGMISALQ 713
++ +G+G FG V K AVK ++ K+ N++ + E+ ++ L
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVIN-KASAKNKDTSTILREVELLKKLD 79
Query: 714 HQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRK---------RI 764
H N++KL+ + + +V E G E L D ++ RI
Sbjct: 80 HPNIMKLFEILEDSSSFYIVGELYT---------GGE---L-FDEIIKRKRFSEHDAARI 126
Query: 765 CSDIARGLAYLHEESRLKIVHRDIKATNVLL---DKDLNAKISDFGLAKLDEDENTHIST 821
+ G+ Y+H+ IVHRD+K N+LL +KD + KI DFGL+ +
Sbjct: 127 IKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--K 181
Query: 822 RIAGTVGYMAPEYAMRGYLTDKADVYSFGIV 852
GT Y+APE Y +K DV+S G++
Sbjct: 182 DRIGTAYYIAPEVLRGTY-DEKCDVWSAGVI 211
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-28
Identities = 54/267 (20%), Positives = 89/267 (33%), Gaps = 56/267 (20%)
Query: 645 QTGYFTLRQIKAATNNFDAANKIGEGGFGPVYKGT-LSDGAVIAVK-----QLSSKSKQG 698
+ YF + + IG+G +G V A+ A+K ++ + +
Sbjct: 12 ENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKD 71
Query: 699 NREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYLENNSL-----ARALFGKEGQC 753
E+ ++ L H N+ +LY + + LV E L
Sbjct: 72 VERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCA 131
Query: 754 LNLDWATR-------------------------------KRICSDIARGLAYLHEESRLK 782
+++ I I L YLH
Sbjct: 132 MDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QG 188
Query: 783 IVHRDIKATNVLLDKDLNA--KISDFGLAKL----DEDENTHISTRIAGTVGYMAPE--- 833
I HRDIK N L + + K+ DFGL+K + E ++T AGT ++APE
Sbjct: 189 ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTT-KAGTPYFVAPEVLN 247
Query: 834 YAMRGYLTDKADVYSFGIVALEIVSGK 860
Y K D +S G++ ++ G
Sbjct: 248 TTNESY-GPKCDAWSAGVLLHLLLMGA 273
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-28
Identities = 61/320 (19%), Positives = 115/320 (35%), Gaps = 37/320 (11%)
Query: 66 DDSNGSNFTCDCTYSNNTVCHVTVILLKGFNLAGVIPEEFGNLTFLQEVDLSRNYFNGSL 125
+ + D N + +V+ L + V + Q ++L F
Sbjct: 263 RLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSY--NFGWQHLELVNCKFG-QF 319
Query: 126 PKSFARLQNLTKLLILGNRLSGSIPLEIGDISTLEELVLEDNQL--VGPLPENLGNLKSL 183
P +L++L +L N+ + D+ +LE L L N L G ++ SL
Sbjct: 320 P--TLKLKSLKRLTFTSNKGGNAFSEV--DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSL 375
Query: 184 RRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIPN--FIGNWTKLDRLDLQGTSL 241
+ + LS N ++ ++ L+ L SNL ++ + L LD+ T
Sbjct: 376 KYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHT 433
Query: 242 EGPIPSTISQLKNLTELRISD--LKGS--SSSFPNLQDMKKMERLILRNCLITGRIPEYI 297
+ L +L L+++ + + F L+ + L L C + ++
Sbjct: 434 RVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELR---NLTFLDLSQCQLE-QLSPTA 489
Query: 298 -EDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGT------LPDWILTSEK 350
++ L++L+++ NQL GI L + I+L N + L W+
Sbjct: 490 FNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWLNK--- 546
Query: 351 NLDLSYNNFTESSPATCRES 370
N+ E A C S
Sbjct: 547 ------NSQKEQGSAKCSGS 560
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 7e-27
Identities = 53/342 (15%), Positives = 112/342 (32%), Gaps = 22/342 (6%)
Query: 69 NGSNFTCDCTYSNNTV------CHVTVILLKGFNLAGVIPEEFGNLTFLQEVDLSRNYFN 122
N T C N + L L + F + LQ +DLSR
Sbjct: 6 VVPNITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ 65
Query: 123 GSLPKSFARLQNLTKLLILGNRLSGSIPLEIGDISTLEELVLEDNQLVGPLPENLGNLKS 182
++ L +L+ L++ GN + +S+L++LV + L +G+LK+
Sbjct: 66 TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKT 125
Query: 183 LRRILLSSNNFT-GSIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLD----RLDLQ 237
L+ + ++ N +PE + NL NL + + + + ++ LDL
Sbjct: 126 LKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLS 185
Query: 238 GTSLEGPIPSTISQLKNLTELRISD-------LKGSSSSFPNLQDMKKMERLILRNCLIT 290
+ I + L +L + + +K L+ + + +
Sbjct: 186 LNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLE 244
Query: 291 GRIPEYIEDMTDLKILDLSFNQLTG---PVPGILQNLKKIDYIFLTNNSLSGTLPDWILT 347
+E + +L I + L + + L + L + ++
Sbjct: 245 KFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNF 304
Query: 348 SEKNLDLSYNNFTESSPATCRESRVNILSSFSSTGSNSVSWC 389
++L+L F + + + +S + S
Sbjct: 305 GWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDL 346
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-22
Identities = 55/289 (19%), Positives = 95/289 (32%), Gaps = 27/289 (9%)
Query: 95 FNLAGVIPEEFGNLTFLQEVDLSRNYFNGS---LPKSFARLQNLTKLLILGNRLSG---- 147
F+ V+ L L+ L F + L+ L L I RL+
Sbjct: 211 FDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYY 270
Query: 148 --SIPLEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLK 205
I ++ + L + ++ + + L + F +LK
Sbjct: 271 LDDIIDLFNCLTNVSSFSLVSVTIERV--KDFSYNFGWQHLELVNCKFGQFPTLKLKSLK 328
Query: 206 NLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLE--GPIPSTISQLKNLTELRISD- 262
LT SN G + + L+ LDL L G + +L L +S
Sbjct: 329 RLT----FTSNKGGNAFSEVDL-PSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFN 383
Query: 263 -LKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYI-EDMTDLKILDLSFNQLTGPVPGI 320
+ SS+F L +++E L ++ + + + +L LD+S GI
Sbjct: 384 GVITMSSNFLGL---EQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGI 440
Query: 321 LQNLKKIDYIFLTNNSLSGTLPDWI---LTSEKNLDLSYNNFTESSPAT 366
L ++ + + NS I L + LDLS + SP
Sbjct: 441 FNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTA 489
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 4e-28
Identities = 23/228 (10%), Positives = 51/228 (22%), Gaps = 41/228 (17%)
Query: 667 IGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNRE---FVNEIGMISALQHQNLVKLYG 722
+ G V+ + A+K + ++ E + L ++ +
Sbjct: 70 LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARD 129
Query: 723 CC--------------------------IEGNQLLLVYEYLENN--SLARALFGKEGQCL 754
LL+ + L L
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRG 189
Query: 755 NLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDED 814
+ + + + R A L +VH N+ + D + D
Sbjct: 190 DEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALW---- 242
Query: 815 ENTHISTRIAGTVGYMAPEYAMRG--YLTDKADVYSFGIVALEIVSGK 860
+ + V Y E+ T + + G+ +
Sbjct: 243 KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-28
Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 28/214 (13%)
Query: 658 TNNFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNRE---FVNEIGMISALQ 713
++ +G+G FG V K AVK ++ K+ N++ + E+ ++ L
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVIN-KASAKNKDTSTILREVELLKKLD 79
Query: 714 HQNLVKLYGCCIEGNQLLLVYEYLENNSL-----ARALFGKEGQCLNLDWATRKRICSDI 768
H N++KL+ + + +V E L R F E RI +
Sbjct: 80 HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRF-SEHDA--------ARIIKQV 130
Query: 769 ARGLAYLHEESRLKIVHRDIKATNVLL---DKDLNAKISDFGLAKLDEDENTHISTRIAG 825
G+ Y+H+ IVHRD+K N+LL +KD + KI DFGL+ + G
Sbjct: 131 FSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--KDRIG 185
Query: 826 TVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSG 859
T Y+APE Y +K DV+S G++ ++SG
Sbjct: 186 TAYYIAPEVLRGTY-DEKCDVWSAGVILYILLSG 218
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 8e-28
Identities = 65/250 (26%), Positives = 106/250 (42%), Gaps = 37/250 (14%)
Query: 632 KNVEDKELRGLDLQTGYFTLRQIKAATNNFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQ 690
E+ +G+ + G + ++ ++ K+G G +G V + + A+K
Sbjct: 9 SGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKV 68
Query: 691 LS------------SKSKQGNREFV-NEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYL 737
+ +K+ + E + NEI ++ +L H N++KL+ + LV E+
Sbjct: 69 IKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFY 128
Query: 738 ENNSL-----ARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATN 792
E L R F E I I G+ YLH+ IVHRDIK N
Sbjct: 129 EGGELFEQIINRHKF-DECDA--------ANIMKQILSGICYLHK---HNIVHRDIKPEN 176
Query: 793 VLL---DKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSF 849
+LL + LN KI DFGL+ + GT Y+APE + Y +K DV+S
Sbjct: 177 ILLENKNSLLNIKIVDFGLSSFFSK--DYKLRDRLGTAYYIAPEVLKKKY-NEKCDVWSC 233
Query: 850 GIVALEIVSG 859
G++ ++ G
Sbjct: 234 GVIMYILLCG 243
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 9e-28
Identities = 49/194 (25%), Positives = 78/194 (40%), Gaps = 20/194 (10%)
Query: 666 KIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNREFV-NEIGMISALQHQNLVKLYGC 723
IG G +G V A K++ K + + EI ++ +L H N+++LY
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIP-KYFVEDVDRFKQEIEIMKSLDHPNIIRLYET 74
Query: 724 CIEGNQLLLVYEYLENNSLARALFGK--EGQCLNLDWATRKRICSDIARGLAYLHEESRL 781
+ + LV E L F + + A RI D+ +AY H+ L
Sbjct: 75 FEDNTDIYLVMELCTGGEL----FERVVHKRVFRESDA--ARIMKDVLSAVAYCHK---L 125
Query: 782 KIVHRDIKATNVLL---DKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRG 838
+ HRD+K N L D K+ DFGLA + GT Y++P+
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM--RTKVGTPYYVSPQVLEGL 183
Query: 839 YLTDKADVYSFGIV 852
Y + D +S G++
Sbjct: 184 Y-GPECDEWSAGVM 196
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-27
Identities = 58/314 (18%), Positives = 120/314 (38%), Gaps = 42/314 (13%)
Query: 71 SNFTCDCTYSNNTVCHVTVILLKGF----------------NLAGVIPEEFGNLTFLQEV 114
SN DC + + + T + GF + + + ++ +
Sbjct: 15 SNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELL 74
Query: 115 DLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEI-GDISTLEELVLEDNQLVGPL 173
+L+ +FA + KL + N + +P + ++ L LVLE N L L
Sbjct: 75 NLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSS-L 132
Query: 174 PENL-GNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLD 232
P + N L + +S+NN +++ +L ++ + LT + + L
Sbjct: 133 PRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLF 189
Query: 233 RLDLQGTSLEGPIPSTISQLKNLTELRISDLKGSS---SSFPNLQDMKKMERLILRNCLI 289
++ L ST++ + EL S + L L L++ +
Sbjct: 190 HANVSYNLL-----STLAIPIAVEELDASHNSINVVRGPVNVELT------ILKLQHNNL 238
Query: 290 TGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGTLPDWI--LT 347
T + + L +DLS+N+L + +++++ ++++NN L L + +
Sbjct: 239 T-DTAW-LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIP 295
Query: 348 SEKNLDLSYNNFTE 361
+ K LDLS+N+
Sbjct: 296 TLKVLDLSHNHLLH 309
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 3e-27
Identities = 49/282 (17%), Positives = 90/282 (31%), Gaps = 35/282 (12%)
Query: 101 IPEE-FGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGDISTL 159
+P F N L + +S N +F +L L + NRL+ +++ I +L
Sbjct: 132 LPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH---VDLSLIPSL 188
Query: 160 EELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTG 219
+ N L L ++ + S N+ + LT ++ +NLT
Sbjct: 189 FHANVSYNLL-----STLAIPIAVEELDASHNSIN-VVRG--PVNVELTILKLQHNNLT- 239
Query: 220 RIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTEL-----RISDLKGSSSSFPNLQ 274
N+ L +DL LE + +++ L L R+ L P L+
Sbjct: 240 DTAWL-LNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTLK 298
Query: 275 DMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTN 334
L L + + + L+ L L N + LK + L++
Sbjct: 299 ------VLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLKLSTHHTLKNLT---LSH 348
Query: 335 NSLSGTLPDWILTSEKNLDLSYNNFTESSPA------TCRES 370
N + + + + C+ES
Sbjct: 349 NDWDCNSLRALFRNVARPAVDDADQHCKIDYQLEHGLCCKES 390
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 8e-24
Identities = 49/284 (17%), Positives = 91/284 (32%), Gaps = 33/284 (11%)
Query: 101 IPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEI-GDISTL 159
I +V + + L N + + + +P + +
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQV 71
Query: 160 EELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTG 219
E L L D Q+ +++++ + N P + N+ LT ++ ++L+
Sbjct: 72 ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS- 130
Query: 220 RIPNFI-GNWTKLDRLDLQGTSLEGPIPSTISQLKNLTEL-----RISDLKGSSSSFPNL 273
+P I N KL L + +LE T +L L R++ + S P+L
Sbjct: 131 SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV--DLSLIPSL 188
Query: 274 Q-------------DMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGI 320
+E L + I + +L IL L N LT
Sbjct: 189 FHANVSYNLLSTLAIPIAVEELDASHNSIN-VVRG--PVNVELTILKLQHNNLTD--TAW 243
Query: 321 LQNLKKIDYIFLTNNSLSGTLPDWI---LTSEKNLDLSYNNFTE 361
L N + + L+ N L + + + L +S N
Sbjct: 244 LLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLVA 286
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 3e-18
Identities = 30/251 (11%), Positives = 82/251 (32%), Gaps = 19/251 (7%)
Query: 118 RNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGDISTLEELVLEDNQLVGPLPENL 177
R + + + I E ++ + + +++ + L
Sbjct: 6 RQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALL 65
Query: 178 GNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQ 237
+ + + + L+ ++ + + + + + P+ N L L L+
Sbjct: 66 DSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLE 125
Query: 238 GTSLEGPIPSTISQLKNLTEL-----RISDLKGSSSSFPNLQDMKKMERLILRNCLITGR 292
L LT L + + +F ++ L L + +T
Sbjct: 126 RNDLSSLPRGIFHNTPKLTTLSMSNNNLERI--EDDTFQAT---TSLQNLQLSSNRLT-H 179
Query: 293 IPEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGTLPDWILTSEKNL 352
+ + + L ++S+N L+ L ++ + ++NS++ + + L
Sbjct: 180 VD--LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPVNVELTIL 231
Query: 353 DLSYNNFTESS 363
L +NN T+++
Sbjct: 232 KLQHNNLTDTA 242
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 3e-17
Identities = 35/228 (15%), Positives = 75/228 (32%), Gaps = 18/228 (7%)
Query: 148 SIPLEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNL 207
I + ++ ++ L + + + ++ + + +
Sbjct: 12 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 71
Query: 208 TEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTEL-----RISD 262
++ + + +L + ++ P + LT L +S
Sbjct: 72 ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSS 131
Query: 263 LKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYI-EDMTDLKILDLSFNQLTGPVPGIL 321
L F N K+ L + N + RI + + T L+ L LS N+LT ++
Sbjct: 132 L--PRGIFHNTP---KLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTHVDLSLI 185
Query: 322 QNLKKIDYIFLTNNSLSGTLPDWILTSEKNLDLSYNNFTESSPATCRE 369
+L + ++ N LS TL + + LD S+N+ E
Sbjct: 186 PSLFHAN---VSYNLLS-TLAI--PIAVEELDASHNSINVVRGPVNVE 227
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 46/246 (18%), Positives = 86/246 (34%), Gaps = 33/246 (13%)
Query: 692 SSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEG 751
S +I + +N V L + + +L + +
Sbjct: 98 PLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWM-NRRC 156
Query: 752 QCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKL 811
+ + I IA + +LH + ++HRD+K +N+ D K+ DFGL
Sbjct: 157 SLEDREHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTA 213
Query: 812 DEDENTHIS-----------TRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGK 860
+ + + T GT YM+PE + K D++S G++ E++
Sbjct: 214 MDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSF 273
Query: 861 SNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPT 920
S R + ++ ++ L P L + +E + +PSPT
Sbjct: 274 STQMERVR-----------IIT---DVRNLKFPLLFTQKYPQEH----MMVQDMLSPSPT 315
Query: 921 LRPTMS 926
RP +
Sbjct: 316 ERPEAT 321
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 18/73 (24%), Positives = 37/73 (50%), Gaps = 2/73 (2%)
Query: 659 NNFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNREFV-NEIGMISALQHQN 716
+F+ +G GGFG V++ D A+K++ +++ RE V E+ ++ L+H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 717 LVKLYGCCIEGNQ 729
+V+ + +E
Sbjct: 66 IVRYFNAWLETPP 78
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-27
Identities = 47/196 (23%), Positives = 76/196 (38%), Gaps = 13/196 (6%)
Query: 666 KIGEGGFGPVYKGT-LSDGAVIAVK-----QLSSKSKQGNREFVNEIGMISALQHQNLVK 719
IG+G F V + G AVK + +S + E + L+H ++V+
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 720 LYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEES 779
L L +V+E+++ L + + A I L Y H+
Sbjct: 91 LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD-- 148
Query: 780 RLKIVHRDIKATNVLL---DKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAM 836
I+HRD+K VLL + K+ FG+A + R+ GT +MAPE
Sbjct: 149 -NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GTPHFMAPEVVK 206
Query: 837 RGYLTDKADVYSFGIV 852
R DV+ G++
Sbjct: 207 REPYGKPVDVWGCGVI 222
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-27
Identities = 55/203 (27%), Positives = 93/203 (45%), Gaps = 23/203 (11%)
Query: 660 NFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLV 718
+G G FG V+K + G +A K + ++ + E NEI +++ L H NL+
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 719 KLYGCCIEGNQLLLVYEYL---ENNSLARALFGK---EGQCLNLDWATRKRICSDIARGL 772
+LY N ++LV EY+ E LF + E L I G+
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGE-------LFDRIIDESYNLTELDTI--LFMKQICEGI 200
Query: 773 AYLHEESRLKIVHRDIKATNVLL-DKDLNA-KISDFGLAKLDEDENTHISTRIAGTVGYM 830
++H+ + I+H D+K N+L ++D KI DFGLA+ + GT ++
Sbjct: 201 RHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARR-YKPREKLKV-NFGTPEFL 255
Query: 831 APEYAMRGYLTDKADVYSFGIVA 853
APE +++ D++S G++A
Sbjct: 256 APEVVNYDFVSFPTDMWSVGVIA 278
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-27
Identities = 51/203 (25%), Positives = 83/203 (40%), Gaps = 36/203 (17%)
Query: 665 NKIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGC 723
IG G + + + AVK + + E EI ++ QH N++ L
Sbjct: 28 EDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE--IEI-LLRYGQHPNIITLKDV 84
Query: 724 CIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRK---------RICSDIARGLAY 774
+G + +V E ++ L LD R+ + I + + Y
Sbjct: 85 YDDGKYVYVVTELMKGGEL-------------LDKILRQKFFSEREASAVLFTITKTVEY 131
Query: 775 LHEESRLKIVHRDIKATNVLL-DKDLNA---KISDFGLAKLDEDENTHISTRIAGTVGYM 830
LH +VHRD+K +N+L D+ N +I DFG AK EN + T T ++
Sbjct: 132 LHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT-PCYTANFV 187
Query: 831 APE-YAMRGYLTDKADVYSFGIV 852
APE +GY D++S G++
Sbjct: 188 APEVLERQGY-DAACDIWSLGVL 209
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 8e-27
Identities = 58/314 (18%), Positives = 120/314 (38%), Gaps = 42/314 (13%)
Query: 71 SNFTCDCTYSNNTVCHVTVILLKGF----------------NLAGVIPEEFGNLTFLQEV 114
SN DC + + + T + GF + + + ++ +
Sbjct: 21 SNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELL 80
Query: 115 DLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEI-GDISTLEELVLEDNQLVGPL 173
+L+ +FA + KL + N + +P + ++ L LVLE N L L
Sbjct: 81 NLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSS-L 138
Query: 174 PENL-GNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLD 232
P + N L + +S+NN +++ +L ++ + LT + + L
Sbjct: 139 PRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLF 195
Query: 233 RLDLQGTSLEGPIPSTISQLKNLTELRISDLKGSS---SSFPNLQDMKKMERLILRNCLI 289
++ L ST++ + EL S + L L L++ +
Sbjct: 196 HANVSYNLL-----STLAIPIAVEELDASHNSINVVRGPVNVELT------ILKLQHNNL 244
Query: 290 TGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGTLPDWI--LT 347
T + + L +DLS+N+L + +++++ ++++NN L L + +
Sbjct: 245 T-DTAW-LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIP 301
Query: 348 SEKNLDLSYNNFTE 361
+ K LDLS+N+
Sbjct: 302 TLKVLDLSHNHLLH 315
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 110 bits (275), Expect = 6e-25
Identities = 45/265 (16%), Positives = 87/265 (32%), Gaps = 22/265 (8%)
Query: 102 PEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGDISTLEE 161
F N L + +S N +F +L L + NRL+ +++ I +L
Sbjct: 140 RGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH---VDLSLIPSLFH 196
Query: 162 LVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRI 221
+ N L L ++ + S N+ + LT ++ +NLT
Sbjct: 197 ANVSYNLL-----STLAIPIAVEELDASHNSIN-VVRG--PVNVELTILKLQHNNLT-DT 247
Query: 222 PNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISD--LKGSSSSFPNLQDMKKM 279
N+ L +DL LE + +++ L L IS+ L + Q + +
Sbjct: 248 AWL-LNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVALNLYG---QPIPTL 303
Query: 280 ERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSG 339
+ L L + + + L+ L L N + LK + L++N
Sbjct: 304 KVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLKLSTHHTLKNLT---LSHNDWDC 359
Query: 340 TLPDWILTSEKNLDLSYNNFTESSP 364
+ + + +
Sbjct: 360 NSLRALFRNVARPAVDDADQHCKID 384
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 4e-22
Identities = 45/269 (16%), Positives = 91/269 (33%), Gaps = 27/269 (10%)
Query: 101 IPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEI-GDISTL 159
I +V + + L N + + + +P + +
Sbjct: 19 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQV 77
Query: 160 EELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTG 219
E L L D Q+ +++++ + N P + N+ LT ++ ++L+
Sbjct: 78 ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS- 136
Query: 220 RIPNFI-GNWTKLDRLDLQGTSLEGPIPSTISQLKNLTEL-----RISDLKGSSSSFPNL 273
+P I N KL L + +LE T +L L R++ + S P+L
Sbjct: 137 SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV--DLSLIPSL 194
Query: 274 QDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLT 333
+ L++ + ++ LD S N + + L + L
Sbjct: 195 F------HANVSYNLLST-----LAIPIAVEELDASHNSINVVRGPVNVELTILK---LQ 240
Query: 334 NNSLSGTLPDWI-LTSEKNLDLSYNNFTE 361
+N+L+ + +DLSYN +
Sbjct: 241 HNNLT-DTAWLLNYPGLVEVDLSYNELEK 268
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 86.1 bits (213), Expect = 2e-17
Identities = 31/251 (12%), Positives = 84/251 (33%), Gaps = 25/251 (9%)
Query: 124 SLPKSFARLQNLTKLLILGN------RLSGSIPLEIGDISTLEELVLEDNQLVGPLPENL 177
P+ NL + + E ++ + + +++ + L
Sbjct: 12 RQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALL 71
Query: 178 GNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQ 237
+ + + + L+ ++ + + + + + P+ N L L L+
Sbjct: 72 DSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLE 131
Query: 238 GTSLEGPIPSTISQLKNLTEL-----RISDLKGSSSSFPNLQDMKKMERLILRNCLITGR 292
L LT L + ++ + Q ++ L L + +T
Sbjct: 132 RNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDT-----FQATTSLQNLQLSSNRLT-H 185
Query: 293 IPEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGTLPDWILTSEKNL 352
+ + + L ++S+N L+ L ++ + ++NS++ + + L
Sbjct: 186 VD--LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPVNVELTIL 237
Query: 353 DLSYNNFTESS 363
L +NN T+++
Sbjct: 238 KLQHNNLTDTA 248
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 66.1 bits (161), Expect = 4e-11
Identities = 30/179 (16%), Positives = 64/179 (35%), Gaps = 6/179 (3%)
Query: 187 LLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIP 246
+ I + + ID + + +++
Sbjct: 9 VKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPA 68
Query: 247 STISQLKNLTELRISDLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYI-EDMTDLKI 305
+ + + + L ++DL+ +++L + I +P ++ +++ L +
Sbjct: 69 ALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTV 127
Query: 306 LDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGTLPDWI---LTSEKNLDLSYNNFTE 361
L L N L+ GI N K+ + ++NN+L + D TS +NL LS N T
Sbjct: 128 LVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTH 185
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 115 bits (288), Expect = 1e-26
Identities = 60/277 (21%), Positives = 95/277 (34%), Gaps = 29/277 (10%)
Query: 96 NLAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGD 155
++ E + E+ L+R + SLP + +T L I N L S+P
Sbjct: 48 EAVSLLKE--CLINQFSELQLNRLNLS-SLPDNL--PPQITVLEITQNALI-SLPELPAS 101
Query: 156 ISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGS 215
LE L DN+L LPE +LK L + +N T +PE L+ + D +
Sbjct: 102 ---LEYLDACDNRLST-LPELPASLKHLD---VDNNQLT-MLPELPALLEYI---NADNN 150
Query: 216 NLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISD--LKGSSSSFPNL 273
LT +P + L + Q T L P ++L L +S L+ +
Sbjct: 151 QLT-MLPELPTSLEVLSVRNNQLTFL----PE---LPESLEALDVSTNLLESLPAVPVRN 202
Query: 274 QDMKKME-RLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFL 332
++ E R IT IPE I + + L N L+ + L
Sbjct: 203 HHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHG 261
Query: 333 TNNSLSGTLPDWILTSEKNLDLSYNNFTESSPATCRE 369
S + D F E+ + +
Sbjct: 262 PRIYFSMSDGQQNTLHRPLADAVTAWFPENKQSDVSQ 298
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-24
Identities = 57/274 (20%), Positives = 101/274 (36%), Gaps = 38/274 (13%)
Query: 108 LTFLQEVDLSRNYFNGSLPKS----FARLQNLTKLLILG---NRLSGSIPLEIGDISTLE 160
L LS+N F ++ + F+ K + G N + + I+
Sbjct: 5 LPINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--INQFS 62
Query: 161 ELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGR 220
EL L L LP+NL + + ++ N S+PE +L+ L + L+
Sbjct: 63 ELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLPELPASLEYL---DACDNRLS-T 114
Query: 221 IPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISDLKGSSSSFPNLQDMKKME 280
+P + LD + Q T L P + L+ + + L +L E
Sbjct: 115 LPELPASLKHLDVDNNQLTML----PELPALLEYI-NADNNQLTMLPELPTSL------E 163
Query: 281 RLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTG--PVPGILQNLKKIDYIF-LTNNSL 337
L +RN +T +P E L+ LD+S N L VP + ++ + F N +
Sbjct: 164 VLSVRNNQLT-FLP---ELPESLEALDVSTNLLESLPAVPVRNHHSEETEIFFRCRENRI 219
Query: 338 SGTLPDWI--LTSEKNLDLSYNNFTESSPATCRE 369
+ +P+ I L + L N + + +
Sbjct: 220 T-HIPENILSLDPTCTIILEDNPLSSRIRESLSQ 252
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 67.7 bits (165), Expect = 1e-11
Identities = 35/180 (19%), Positives = 63/180 (35%), Gaps = 32/180 (17%)
Query: 186 ILLSSNN-FTGSIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGP 244
I+L NN F+ S Y + S + W K
Sbjct: 3 IMLPINNNFSLSQNSFYNTI----------SGTYADYFSAWDKWEKQALPGENRNEAVSL 52
Query: 245 IPSTISQLKNLTELRISDLKGSS---SSFPNLQDMKKMERLILRNCLITGRIPEYIEDMT 301
+ + +EL+++ L SS + P + L + + +PE
Sbjct: 53 LKE--CLINQFSELQLNRLNLSSLPDNLPPQIT------VLEITQNALI-SLPELP---A 100
Query: 302 DLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGTLPDWILTSEKNLDLSYNNFTE 361
L+ LD N+L+ +P + +LK +D + NN L+ LP+ + ++ N T
Sbjct: 101 SLEYLDACDNRLST-LPELPASLKHLD---VDNNQLT-MLPELP-ALLEYINADNNQLTM 154
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-26
Identities = 55/209 (26%), Positives = 83/209 (39%), Gaps = 39/209 (18%)
Query: 666 KIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNREFV---------NEIGMISALQHQ 715
+G G G V +A+K +S K K EI ++ L H
Sbjct: 17 TLGSGACGEVKLAFERKTCKKVAIKIIS-KRKFAIGSAREADPALNVETEIEILKKLNHP 75
Query: 716 NLVKLYGCCIEGNQLLLVYEYLENNSL-----ARALFGKEGQCLNLDWATRKRICSDIAR 770
++K+ + +V E +E L KE C K +
Sbjct: 76 CIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRL-KEATC--------KLYFYQMLL 125
Query: 771 GLAYLHEESRLKIVHRDIKATNVLL---DKDLNAKISDFGLAKLDEDENTHISTRIAGTV 827
+ YLHE I+HRD+K NVLL ++D KI+DFG +K+ E + + T + GT
Sbjct: 126 AVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI-LGETSLMRT-LCGTP 180
Query: 828 GYMAPE----YAMRGYLTDKADVYSFGIV 852
Y+APE GY D +S G++
Sbjct: 181 TYLAPEVLVSVGTAGY-NRAVDCWSLGVI 208
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 57/228 (25%), Positives = 94/228 (41%), Gaps = 61/228 (26%)
Query: 667 IGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNREFVN--------------------- 704
IG+G +G V +D A+K LS K K +
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLS-KKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 705 ------EIGMISALQHQNLVKLYGCCIEG---NQLLLVYEYLENNSLARALFGKEGQCLN 755
EI ++ L H N+VKL ++ + L +V+E + +
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKLV-EVLDDPNEDHLYMVFELVNQGPV------------- 125
Query: 756 LDWATRKRICSDIAR--------GLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFG 807
++ T K + D AR G+ YLH KI+HRDIK +N+L+ +D + KI+DFG
Sbjct: 126 MEVPTLKPLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFG 182
Query: 808 LAKLDEDENTHISTRIAGTVGYMAPE---YAMRGYLTDKADVYSFGIV 852
++ + + +S GT +MAPE + + DV++ G+
Sbjct: 183 VSNEFKGSDALLSNT-VGTPAFMAPESLSETRKIFSGKALDVWAMGVT 229
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-26
Identities = 54/206 (26%), Positives = 84/206 (40%), Gaps = 33/206 (16%)
Query: 666 KIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNREFV---------NEIGMISALQHQ 715
+G G G V +A++ +S K K EI ++ L H
Sbjct: 142 TLGSGACGEVKLAFERKTCKKVAIRIIS-KRKFAIGSAREADPALNVETEIEILKKLNHP 200
Query: 716 NLVKLYGCCIEGNQLLLVYEYLENNSLARALFGK--EGQCLNLDWATRKRICSDIARGLA 773
++K+ + +V E +E L F K + L K + +
Sbjct: 201 CIIKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKRLKEATC--KLYFYQMLLAVQ 253
Query: 774 YLHEESRLKIVHRDIKATNVLL---DKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYM 830
YLHE I+HRD+K NVLL ++D KI+DFG +K+ E + + T + GT Y+
Sbjct: 254 YLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI-LGETSLMRT-LCGTPTYL 308
Query: 831 APE----YAMRGYLTDKADVYSFGIV 852
APE GY D +S G++
Sbjct: 309 APEVLVSVGTAGY-NRAVDCWSLGVI 333
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-26
Identities = 52/248 (20%), Positives = 98/248 (39%), Gaps = 47/248 (18%)
Query: 632 KNVEDKELRGLDLQTGYFTLRQIKAATNNFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQ 690
K E+ + + + K +D + IG G V + + G AVK
Sbjct: 67 KGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKI 126
Query: 691 LSSKSKQGNREFV--------NEIGMISAL-QHQNLVKLYGCCIEGNQLLLVYEYLENNS 741
+ +++ + E + E ++ + H +++ L + + LV++ +
Sbjct: 127 MEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGE 186
Query: 742 LARALFGKEGQCLNLDWATRK---------RICSDIARGLAYLHEESRLKIVHRDIKATN 792
L D+ T K I + +++LH IVHRD+K N
Sbjct: 187 L-------------FDYLTEKVALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPEN 230
Query: 793 VLLDKDLNAKISDFGLAK-LDEDENTHISTRIAGTVGYMAPE-------YAMRGYLTDKA 844
+LLD ++ ++SDFG + L+ E + GT GY+APE GY +
Sbjct: 231 ILLDDNMQIRLSDFGFSCHLEPGEKL---RELCGTPGYLAPEILKCSMDETHPGY-GKEV 286
Query: 845 DVYSFGIV 852
D+++ G++
Sbjct: 287 DLWACGVI 294
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 75/253 (29%), Positives = 107/253 (42%), Gaps = 41/253 (16%)
Query: 667 IGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNREFVN-EIGMISALQHQNLVKLYGCC 724
+GEG +G V +AVK + K E + EI + L H+N+VK YG
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 725 IEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIAR--------GLAYLH 776
EGN L EY L F + + A+ G+ YLH
Sbjct: 75 REGNIQYLFLEYCSGGEL----FDR--------IEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 777 EESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKL--DEDENTHISTRIAGTVGYMAPE- 833
+ I HRDIK N+LLD+ N KISDFGLA + + ++ GT+ Y+APE
Sbjct: 123 ---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM-CGTLPYVAPEL 178
Query: 834 YAMRGYLTDKADVYSFGIVALEIVSGK--------SNTNYRPKEEF-VYLLDWAYVLQEQ 884
R + + DV+S GIV +++G+ S Y +E YL W +
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 238
Query: 885 GNLLE---LVDPS 894
LL + +PS
Sbjct: 239 LALLHKILVENPS 251
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 4e-26
Identities = 54/207 (26%), Positives = 91/207 (43%), Gaps = 27/207 (13%)
Query: 658 TNNFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNREFV-NEIGMISALQHQ 715
+ +D ++G G FG V++ + G V K ++ ++ V NEI +++ L H
Sbjct: 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFIN-TPYPLDKYTVKNEISIMNQLHHP 108
Query: 716 NLVKLYGCCIEGNQLLLVYEYL---ENNSLARALF---GKEGQCLNLDWATRKRICSDIA 769
L+ L+ + +++L+ E+L E LF E ++
Sbjct: 109 KLINLHDAFEDKYEMVLILEFLSGGE-------LFDRIAAEDYKMSEAEVI--NYMRQAC 159
Query: 770 RGLAYLHEESRLKIVHRDIKATNVLL--DKDLNAKISDFGLA-KLDEDENTHISTRIAGT 826
GL ++HE IVH DIK N++ K + KI DFGLA KL+ DE T
Sbjct: 160 EGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV---KVTTAT 213
Query: 827 VGYMAPEYAMRGYLTDKADVYSFGIVA 853
+ APE R + D+++ G++
Sbjct: 214 AEFAAPEIVDREPVGFYTDMWAIGVLG 240
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 5e-26
Identities = 54/209 (25%), Positives = 101/209 (48%), Gaps = 15/209 (7%)
Query: 658 TNNFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNREFV-NEIGMISALQHQ 715
+++D ++G G FG V++ T + G A K + + ++E V EI +S L+H
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVM-TPHESDKETVRKEIQTMSVLRHP 214
Query: 716 NLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYL 775
LV L+ + N+++++YE++ L + + + + + +GL ++
Sbjct: 215 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAV---EYMRQVCKGLCHM 271
Query: 776 HEESRLKIVHRDIKATNVLL-DKDLNA-KISDFGLA-KLDEDENTHISTRIAGTVGYMAP 832
HE VH D+K N++ K N K+ DFGL LD ++ + GT + AP
Sbjct: 272 HE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV---TTGTAEFAAP 325
Query: 833 EYAMRGYLTDKADVYSFGIVALEIVSGKS 861
E A + D++S G+++ ++SG S
Sbjct: 326 EVAEGKPVGYYTDMWSVGVLSYILLSGLS 354
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 6e-26
Identities = 54/287 (18%), Positives = 92/287 (32%), Gaps = 22/287 (7%)
Query: 95 FNLAGVIPEEF--GNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIP-- 150
FN G E G + + + + +L +L + R+ I
Sbjct: 28 FNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFG 87
Query: 151 -LEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGN------ 203
L + IS L+EL LE+ ++ G P L +L+ N + + +++
Sbjct: 88 ALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWL 147
Query: 204 LKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTIS----QLKNLTELR 259
L I ++ + + L LDL G + + L L
Sbjct: 148 KPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLA 207
Query: 260 ISDLKGSSSSFPNLQDMKKMERL----ILRNCLITGRIPEYIEDMTDLKILDLSFNQLTG 315
+ + + S +L + N L + + L L+LSF L
Sbjct: 208 LRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ 267
Query: 316 PVPGILQNLKKIDYIFLTNNSLSGTLPDWILTSEKNLDLSYNNFTES 362
G+ L +D L+ N L L NL L N F +S
Sbjct: 268 VPKGLPAKLSVLD---LSYNRLDRNPSPDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 73.8 bits (181), Expect = 3e-14
Identities = 44/237 (18%), Positives = 78/237 (32%), Gaps = 22/237 (9%)
Query: 175 ENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIPNFIG-----NWT 229
E G +SL +L + + +K+L+ R+ G +
Sbjct: 37 ELYGGGRSLEYLLKRVDTEADLGQFT-DIIKSLSLKRLTVRAARIPSRILFGALRVLGIS 95
Query: 230 KLDRLDLQGTSLEGPIPSTISQL--KNLTELRISDLK--GSSSSFPNLQDMKK--MERLI 283
L L L+ + G P + + +L L + ++ + LQ K ++ L
Sbjct: 96 GLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLS 155
Query: 284 LRNCLITGRIPEYIEDMTDLKILDLSFNQLTGP-------VPGILQNLKKIDYIFLTNNS 336
+ E + L LDLS N G P L+ + +
Sbjct: 156 IAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMET 215
Query: 337 LSGTLPDWI--LTSEKNLDLSYNNFTESSPATCRESRVNILS-SFSSTGSNSVSWCL 390
SG + LDLS+N+ +++ A + + S + S TG V L
Sbjct: 216 PSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGL 272
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 7e-26
Identities = 54/207 (26%), Positives = 89/207 (42%), Gaps = 27/207 (13%)
Query: 658 TNNFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNRE---FVNEIGMISALQ 713
++N+D ++G+G F V + + G A K ++ K R+ E + LQ
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIIN-TKKLSARDFQKLEREARICRKLQ 63
Query: 714 HQNLVKLYGCCIEGNQLLLVYEYLENNSL-----ARALFGKEGQCLNLDWATRKRICSDI 768
H N+V+L+ E + LV++ + L AR + E I
Sbjct: 64 HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFY-SEADA--------SHCIQQI 114
Query: 769 ARGLAYLHEESRLKIVHRDIKATNVLL---DKDLNAKISDFGLAKLDEDENTHISTRIAG 825
+AY H IVHR++K N+LL K K++DFGLA D AG
Sbjct: 115 LESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW--HGFAG 169
Query: 826 TVGYMAPEYAMRGYLTDKADVYSFGIV 852
T GY++PE + + D+++ G++
Sbjct: 170 TPGYLSPEVLKKDPYSKPVDIWACGVI 196
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 8e-26
Identities = 53/228 (23%), Positives = 89/228 (39%), Gaps = 46/228 (20%)
Query: 652 RQIKAATNNFDAANKIGEGGFGPVYKGT-LSDGAVIAVK--------QLSSKSKQGNREF 702
N++ +G G V + AVK S++ Q RE
Sbjct: 10 HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 703 V-NEIGMISAL-QHQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWAT 760
E+ ++ + H N+++L LV++ ++ L D+ T
Sbjct: 70 TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL-------------FDYLT 116
Query: 761 RK---------RICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKL 811
K +I + + LH+ L IVHRD+K N+LLD D+N K++DFG +
Sbjct: 117 EKVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 173
Query: 812 DEDENTHISTRIAGTVGYMAPE-------YAMRGYLTDKADVYSFGIV 852
D + + GT Y+APE GY + D++S G++
Sbjct: 174 -LDPGEKLRE-VCGTPSYLAPEIIECSMNDNHPGY-GKEVDMWSTGVI 218
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 9e-26
Identities = 75/253 (29%), Positives = 107/253 (42%), Gaps = 41/253 (16%)
Query: 667 IGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNREFVN-EIGMISALQHQNLVKLYGCC 724
+GEG +G V +AVK + K E + EI + L H+N+VK YG
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 725 IEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIAR--------GLAYLH 776
EGN L EY L F + + A+ G+ YLH
Sbjct: 75 REGNIQYLFLEYCSGGEL----FDR--------IEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 777 EESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKL--DEDENTHISTRIAGTVGYMAPE- 833
+ I HRDIK N+LLD+ N KISDFGLA + + ++ GT+ Y+APE
Sbjct: 123 ---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM-CGTLPYVAPEL 178
Query: 834 YAMRGYLTDKADVYSFGIVALEIVSGK--------SNTNYRPKEEF-VYLLDWAYVLQEQ 884
R + + DV+S GIV +++G+ S Y +E YL W +
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 238
Query: 885 GNLLE---LVDPS 894
LL + +PS
Sbjct: 239 LALLHKILVENPS 251
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 9e-26
Identities = 64/217 (29%), Positives = 96/217 (44%), Gaps = 30/217 (13%)
Query: 658 TNNFDAANKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNL 717
+ IG G FG V++ L + +A+K++ + NR E+ ++ ++H N+
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNR----ELQIMRIVKHPNV 94
Query: 718 VKLYGCCIEGNQ------LLLVYEYLENNSLARAL--FGKEGQCLNLDWATRKRICSDIA 769
V L L LV EY+ + RA + K Q + + K +
Sbjct: 95 VDLKAFFYSNGDKKDEVFLNLVLEYVPET-VYRASRHYAKLKQTMPMLLI--KLYMYQLL 151
Query: 770 RGLAYLHEESRLKIVHRDIKATNVLLDKDLNA-KISDFGLAK-LDEDE-NTH-ISTRIAG 825
R LAY+H + I HRDIK N+LLD K+ DFG AK L E N I +R
Sbjct: 152 RSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRY-- 206
Query: 826 TVGYMAPE--YAMRGYLTDKADVYSFGIVALEIVSGK 860
Y APE + Y T D++S G V E++ G+
Sbjct: 207 ---YRAPELIFGATNY-TTNIDIWSTGCVMAELMQGQ 239
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 51/207 (24%), Positives = 85/207 (41%), Gaps = 24/207 (11%)
Query: 667 IGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNREFVNEIGMI-----------SALQH 714
+G+GGFG V+ G L+D +A+K + +++ +++ + H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIP-RNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 715 QNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAY 774
+++L +LV E A+ LF + L + + + +
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLP---AQDLFDYITEKGPLGEGPSRCFFGQVVAAIQH 154
Query: 775 LHEESRLKIVHRDIKATNVLLDKD-LNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPE 833
H +VHRDIK N+L+D AK+ DFG L DE GT Y PE
Sbjct: 155 CH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDF---DGTRVYSPPE 208
Query: 834 Y-AMRGYLTDKADVYSFGIVALEIVSG 859
+ + Y A V+S GI+ ++V G
Sbjct: 209 WISRHQYHALPATVWSLGILLYDMVCG 235
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 51/208 (24%), Positives = 87/208 (41%), Gaps = 26/208 (12%)
Query: 667 IGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNREFVN-------EIGMISALQHQ--N 716
+G GGFG VY G +SD +A+K + K + + + E+ ++ +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVE-KDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 717 LVKLYGCCIEGNQLLLVYEYLENNSLARALFGK--EGQCLNLDWATRKRICSDIARGLAY 774
+++L + +L+ E E + LF E L + A + + + +
Sbjct: 110 VIRLLDWFERPDSFVLILERPEP---VQDLFDFITERGALQEELA--RSFFWQVLEAVRH 164
Query: 775 LHEESRLKIVHRDIKATNVLLDKD-LNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPE 833
H ++HRDIK N+L+D + K+ DFG L +D GT Y PE
Sbjct: 165 CH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF---DGTRVYSPPE 218
Query: 834 Y-AMRGYLTDKADVYSFGIVALEIVSGK 860
+ Y A V+S GI+ ++V G
Sbjct: 219 WIRYHRYHGRSAAVWSLGILLYDMVCGD 246
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 3e-25
Identities = 54/221 (24%), Positives = 98/221 (44%), Gaps = 15/221 (6%)
Query: 641 GLDLQTGYFTLRQIKAATNNFDAANK-IGEGGFGPVYKGT-LSDGAVIAVKQLS-SKSKQ 697
G+DL T + ++ N + +K +G G F V + S G A K L + Q
Sbjct: 10 GVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ 69
Query: 698 GNREFV-NEIGMISALQHQ-NLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLN 755
R + +EI ++ + ++ L+ ++++L+ EY + + + ++
Sbjct: 70 DCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVS 129
Query: 756 LDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLL---DKDLNAKISDFGLAKLD 812
+ R + I G+ YLH+ IVH D+K N+LL + KI DFG+++
Sbjct: 130 ENDVIR--LIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK- 183
Query: 813 EDENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVA 853
+ I GT Y+APE +T D+++ GI+A
Sbjct: 184 IGHACELRE-IMGTPEYLAPEILNYDPITTATDMWNIGIIA 223
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-25
Identities = 45/202 (22%), Positives = 84/202 (41%), Gaps = 32/202 (15%)
Query: 666 KIGEGGFGPVYKGT-LSDGAVIAVKQLS-SKSKQGNREFV-NEIGMISALQHQNLVKLYG 722
++G+G F V + + G A ++ K + + + E + L+H N+V+L+
Sbjct: 18 ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 77
Query: 723 CCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRK---------RICSDIARGLA 773
E L+++ + G E L + + I +
Sbjct: 78 SISEEGHHYLIFDLVT---------GGE---L-FEDIVAREYYSEADASHCIQQILEAVL 124
Query: 774 YLHEESRLKIVHRDIKATNVLL---DKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYM 830
+ H+ + +VHR++K N+LL K K++DFGLA E E AGT GY+
Sbjct: 125 HCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG-FAGTPGYL 180
Query: 831 APEYAMRGYLTDKADVYSFGIV 852
+PE + D+++ G++
Sbjct: 181 SPEVLRKDPYGKPVDLWACGVI 202
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 4e-25
Identities = 60/221 (27%), Positives = 96/221 (43%), Gaps = 31/221 (14%)
Query: 658 TNNFDAANKIGEGGFGPVYKGTLSD-GAVIAVKQLSSKSKQGNREFVNEIGMISALQHQN 716
+ F G+G FG V G G +A+K++ + NRE + + ++ L H N
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE-LQIMQDLAVLHHPN 80
Query: 717 LVKLYGCCIEGNQ-------LLLVYEYLENNSLARAL--FGKEGQCLNLDWATRKRICSD 767
+V+L + L +V EY+ + L R + + K
Sbjct: 81 IVQLQSYFYTLGERDRRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPI--LIKVFLFQ 137
Query: 768 IARGLAYLHEESRLKIVHRDIKATNVLLDK---DLNAKISDFGLAK-LDEDE-NTH-IST 821
+ R + LH S + + HRDIK NVL+++ L K+ DFG AK L E N I +
Sbjct: 138 LIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTL--KLCDFGSAKKLSPSEPNVAYICS 194
Query: 822 RIAGTVGYMAPE--YAMRGYLTDKADVYSFGIVALEIVSGK 860
R Y APE + + Y T D++S G + E++ G+
Sbjct: 195 RY-----YRAPELIFGNQHY-TTAVDIWSVGCIFAEMMLGE 229
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 4e-25
Identities = 51/201 (25%), Positives = 84/201 (41%), Gaps = 34/201 (16%)
Query: 666 KIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQ-HQNLVKLYGC 723
+GEG F K AVK +S K + N + EI + + H N+VKL+
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKIIS-KRMEANTQ--KEITALKLCEGHPNIVKLHEV 74
Query: 724 CIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRK---------RICSDIARGLAY 774
+ LV E L L + +K I + +++
Sbjct: 75 FHDQLHTFLVMELLNGGEL-------------FERIKKKKHFSETEASYIMRKLVSAVSH 121
Query: 775 LHEESRLKIVHRDIKATNVLL---DKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMA 831
+H+ + +VHRD+K N+L + +L KI DFG A+L +N + T T+ Y A
Sbjct: 122 MHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT-PCFTLHYAA 177
Query: 832 PEYAMRGYLTDKADVYSFGIV 852
PE + + D++S G++
Sbjct: 178 PELLNQNGYDESCDLWSLGVI 198
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 4e-25
Identities = 54/272 (19%), Positives = 94/272 (34%), Gaps = 26/272 (9%)
Query: 90 ILLKGFNLAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSI 149
+ F + L L +D + + +L LTKL+ N ++
Sbjct: 23 EVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNNITT-- 78
Query: 150 PLEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTE 209
L++ + L L + N+L ++ L L + +N T + S LT
Sbjct: 79 -LDLSQNTNLTYLACDSNKLTNL---DVTPLTKLTYLNCDTNKLT-KLDVS--QNPLLTY 131
Query: 210 FRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISDLKGSSSS 269
+ LT I + + T+L LD + ++ LT L S K +
Sbjct: 132 LNCARNTLT-EID--VSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKITELD 186
Query: 270 FPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDY 329
K + RL IT ++ + L LD S N+LT + + L ++ Y
Sbjct: 187 VSQN---KLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTY 237
Query: 330 IFLTNNSLSGTLPDWILTSEKNLDLSYNNFTE 361
+ N L+ L L+ L + E
Sbjct: 238 FDCSVNPLT-ELDVSTLSKLTTLHCIQTDLLE 268
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-21
Identities = 43/286 (15%), Positives = 88/286 (30%), Gaps = 26/286 (9%)
Query: 104 EFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGDISTLEELV 163
+ L ++ N L + LT L N+L+ +++ ++ L
Sbjct: 186 DVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLTE---IDVTPLTQLTYFD 239
Query: 164 LEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIPN 223
N L L + L L + + I + + L F+ +G +
Sbjct: 240 CSVNPL-TELD--VSTLSKLTTLHCIQTDLL-EIDLT--HNTQLIYFQAEGCRKIKELD- 292
Query: 224 FIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISD--LKGSSSSFPNLQDMKKMER 281
+ + T+L LD Q + + +SQ L L +++ L + + K++
Sbjct: 293 -VTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTEL----TELD-VSHNTKLKS 343
Query: 282 LILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGTL 341
L N I + + L + Q L N + G
Sbjct: 344 LSCVNAHIQD-FSS-VGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQFGNP 401
Query: 342 PDWILTSEKNLDLSYNNFTESSPATCRESRVNILSSFSSTGSNSVS 387
+ D + N T + +T + +S + +V+
Sbjct: 402 MNIEPGDGGVYDQATNTITWENLSTDNPAVTYTFTSENGAIVGTVT 447
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 2e-20
Identities = 45/229 (19%), Positives = 84/229 (36%), Gaps = 20/229 (8%)
Query: 133 QNLTKLLILGNRLSGSIPLEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNN 192
N + + + + ++TL L ++ + + + L L +++ +SNN
Sbjct: 18 DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITD-MTG-IEKLTGLTKLICTSNN 75
Query: 193 FTGSIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQL 252
T ++ S NLT D + LT + + TKL L+ L +SQ
Sbjct: 76 IT-TLDLS--QNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT---KLDVSQN 126
Query: 253 KNLTELRISDLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQ 312
LT L + + + ++ L ++ + T L LD SFN+
Sbjct: 127 PLLTYLNCARNTLTEIDVSHN---TQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNK 181
Query: 313 LTGPVPGILQNLKKIDYIFLTNNSLSGTLPDWILTSEKNLDLSYNNFTE 361
+T + K ++ + N+++ L LD S N TE
Sbjct: 182 ITE---LDVSQNKLLNRLNCDTNNIT-KLDLNQNIQLTFLDCSSNKLTE 226
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 1e-09
Identities = 26/165 (15%), Positives = 52/165 (31%), Gaps = 12/165 (7%)
Query: 227 NWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISDLKGSSSSFPNLQDMKKMERLILRN 286
N+ + + + + QL LT L + + ++ + + +LI +
Sbjct: 19 NFASEVAAAFEMQATD---TISEEQLATLTSLDCHNSSITD--MTGIEKLTGLTKLICTS 73
Query: 287 CLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGTLPDWIL 346
IT + + T+L L N+LT L L ++ N L+ L
Sbjct: 74 NNITT-LD--LSQNTNLTYLACDSNKLTNLDVTPLTKLTYLN---CDTNKLT-KLDVSQN 126
Query: 347 TSEKNLDLSYNNFTESSPATCRESRVNILSSFSSTGSNSVSWCLK 391
L+ + N TE + + V+ +
Sbjct: 127 PLLTYLNCARNTLTEIDVSHNTQLTELDCHLNKKITKLDVTPQTQ 171
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 2e-07
Identities = 22/115 (19%), Positives = 40/115 (34%), Gaps = 6/115 (5%)
Query: 253 KNLTELRISDLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQ 312
N + + ++ + + + + L N IT + IE +T L L + N
Sbjct: 18 DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITD-MTG-IEKLTGLTKLICTSNN 75
Query: 313 LTGPVPGILQNLKKIDYIFLTNNSLSGTLPDWILTSEKNLDLSYNNFTESSPATC 367
+T NL + +N L+ L LT L+ N T+ +
Sbjct: 76 ITTLDLSQNTNLTYLA---CDSNKLT-NLDVTPLTKLTYLNCDTNKLTKLDVSQN 126
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 9e-05
Identities = 19/97 (19%), Positives = 35/97 (36%), Gaps = 3/97 (3%)
Query: 265 GSSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNL 324
G + SF + + + E + L LD + +T + GI + L
Sbjct: 6 GQTQSFNDWFPDDNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITD-MTGI-EKL 63
Query: 325 KKIDYIFLTNNSLSGTLPDWILTSEKNLDLSYNNFTE 361
+ + T+N+++ TL T+ L N T
Sbjct: 64 TGLTKLICTSNNIT-TLDLSQNTNLTYLACDSNKLTN 99
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 5e-25
Identities = 64/215 (29%), Positives = 110/215 (51%), Gaps = 20/215 (9%)
Query: 656 AATNNFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNREFVN-----EIGMI 709
++++ F K+G G + VYKG + G +A+K + K + E EI ++
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALK----EVKLDSEEGTPSTAIREISLM 57
Query: 710 SALQHQNLVKLYGCCIEGNQLLLVYEYLENNSLARAL--FGKEGQCLNLDWATRKRICSD 767
L+H+N+V+LY N+L LV+E+++N+ L + + L+ K
Sbjct: 58 KELKHENIVRLYDVIHTENKLTLVFEFMDND-LKKYMDSRTVGNTPRGLELNLVKYFQWQ 116
Query: 768 IARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTV 827
+ +GLA+ HE KI+HRD+K N+L++K K+ DFGLA+ S+ + T+
Sbjct: 117 LLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TL 172
Query: 828 GYMAPE--YAMRGYLTDKADVYSFGIVALEIVSGK 860
Y AP+ R Y T D++S G + E+++GK
Sbjct: 173 WYRAPDVLMGSRTYST-SIDIWSCGCILAEMITGK 206
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 6e-25
Identities = 50/211 (23%), Positives = 82/211 (38%), Gaps = 20/211 (9%)
Query: 660 NFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNREFVN---------EIGMI 709
+ + +G G FG V+ + VK + K K ++ EI ++
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIK-KEKVLEDCWIEDPKLGKVTLEIAIL 83
Query: 710 SALQHQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIA 769
S ++H N++K+ LV E + LF + LD I +
Sbjct: 84 SRVEHANIIKVLDIFENQGFFQLVMEKHGS---GLDLFAFIDRHPRLDEPLASYIFRQLV 140
Query: 770 RGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGY 829
+ YL I+HRDIK N+++ +D K+ DFG A E T GT+ Y
Sbjct: 141 SAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK-LFYT-FCGTIEY 195
Query: 830 MAPE-YAMRGYLTDKADVYSFGIVALEIVSG 859
APE Y + +++S G+ +V
Sbjct: 196 CAPEVLMGNPYRGPELEMWSLGVTLYTLVFE 226
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 6e-25
Identities = 54/312 (17%), Positives = 108/312 (34%), Gaps = 44/312 (14%)
Query: 71 SNFTCDCTYSNNTV------CHVTVILLKGFNLAGVIPEEFGNLTFLQEVDLSRN--YFN 122
S C T T + L+ L + F LT L ++ LS N F
Sbjct: 8 SGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFK 67
Query: 123 GSLPKSFARLQNLTKLLILGNRLSGSIPLEIGDISTLEELVLEDNQLVGPLPENL-GNLK 181
G +S +L L + N + ++ + LE L + + L ++ +L+
Sbjct: 68 GCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLR 126
Query: 182 SLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRI-PNFIGNWTKLDRLDLQGTS 240
+L + +S + + + L +L ++ G++ P+ L LDL
Sbjct: 127 NLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQ 186
Query: 241 LEGPIPSTISQLKNLTELRISDLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYI-ED 299
LE P+ + L +L L + + + + +
Sbjct: 187 LEQLSPTAFNSLSSLQVLN------------------------MSHNNFF-SLDTFPYKC 221
Query: 300 MTDLKILDLSFNQLTGPVPGILQNL-KKIDYIFLTNNSLSGT-----LPDWILTSEKNLD 353
+ L++LD S N + LQ+ + ++ LT N + T W + ++ L
Sbjct: 222 LNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQW-IKDQRQLL 280
Query: 354 LSYNNFTESSPA 365
+ ++P+
Sbjct: 281 VEVERMECATPS 292
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 27/136 (19%), Positives = 60/136 (44%), Gaps = 14/136 (10%)
Query: 239 TSLEGPIPSTISQLKNLTELRISDLKGSSSSFPNLQDMKKMERLILRNCLITGR--IPEY 296
TS+ IPS+ ++L L ++ L F L ++ +L L + ++ + +
Sbjct: 20 TSVPTGIPSSATRL-ELESNKLQSL--PHGVFDKL---TQLTKLSLSSNGLSFKGCCSQS 73
Query: 297 IEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGTLPDWI----LTSEKNL 352
T LK LDLSFN + + L++++++ +++L + ++ L + L
Sbjct: 74 DFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYL 131
Query: 353 DLSYNNFTESSPATCR 368
D+S+ + +
Sbjct: 132 DISHTHTRVAFNGIFN 147
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 6e-25
Identities = 55/200 (27%), Positives = 90/200 (45%), Gaps = 17/200 (8%)
Query: 667 IGEGGFGPVYKGT-LSDGAVIAVKQLS-SKSKQGNREFVN-EIGMISALQHQNLVKLYGC 723
IG+G F V + G +A+K + ++ + + + E+ ++ L H N+VKL+
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 724 CIEGNQLLLVYEYLENNSLARALFGK--EGQCLNLDWATRKRICSDIARGLAYLHEESRL 781
L L+ EY + F + A + I + Y H +
Sbjct: 83 IETEKTLYLIMEYASGGEV----FDYLVAHGRMKEKEA--RSKFRQIVSAVQYCH---QK 133
Query: 782 KIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPE-YAMRGYL 840
+IVHRD+KA N+LLD D+N KI+DFG + + G Y APE + + Y
Sbjct: 134 RIVHRDLKAENLLLDADMNIKIADFGFSNEFTV-GGKLDAF-CGAPPYAAPELFQGKKYD 191
Query: 841 TDKADVYSFGIVALEIVSGK 860
+ DV+S G++ +VSG
Sbjct: 192 GPEVDVWSLGVILYTLVSGS 211
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 7e-25
Identities = 39/205 (19%), Positives = 77/205 (37%), Gaps = 24/205 (11%)
Query: 658 TNNFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQN 716
+ A +G G FG V++ S K + EI +++ +H+N
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK-VKGTDQVLVKKEISILNIARHRN 62
Query: 717 LVKLYGCCIEGNQLLLVYEYLENNSL-----ARALFGKEGQCLNLDWATRKRICSDIARG 771
++ L+ +L++++E++ + A E + +
Sbjct: 63 ILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREI--------VSYVHQVCEA 114
Query: 772 LAYLHEESRLKIVHRDIKATNVLL--DKDLNAKISDFGLA-KLDEDENTHISTRIAGTVG 828
L +LH I H DI+ N++ + KI +FG A +L +N + +
Sbjct: 115 LQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPE 168
Query: 829 YMAPEYAMRGYLTDKADVYSFGIVA 853
Y APE ++ D++S G +
Sbjct: 169 YYAPEVHQHDVVSTATDMWSLGTLV 193
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 8e-25
Identities = 57/201 (28%), Positives = 83/201 (41%), Gaps = 35/201 (17%)
Query: 666 KIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNREFV-NEIGMISALQHQNLVKLYGC 723
++G G VY+ A+K L K +++ V EIG++ L H N++KL
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLK---KTVDKKIVRTEIGVLLRLSHPNIIKLKEI 116
Query: 724 CIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRK---------RICSDIARGLAY 774
++ LV E + L D K I +AY
Sbjct: 117 FETPTEISLVLELVTGGEL-------------FDRIVEKGYYSERDAADAVKQILEAVAY 163
Query: 775 LHEESRLKIVHRDIKATNVLL---DKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMA 831
LHE IVHRD+K N+L D KI+DFGL+K+ E + + GT GY A
Sbjct: 164 LHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM--KTVCGTPGYCA 218
Query: 832 PEYAMRGYLTDKADVYSFGIV 852
PE + D++S GI+
Sbjct: 219 PEILRGCAYGPEVDMWSVGII 239
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 55/284 (19%), Positives = 100/284 (35%), Gaps = 34/284 (11%)
Query: 86 HVTVILLKGFNLAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRL 145
T++ L+ +++ + ++F L L + L N + K+F+ L+ L KL I N L
Sbjct: 55 DTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHL 114
Query: 146 SGSIPLEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFT-GSIPESYGNL 204
IP + S+L EL + DN++ L+++ I + N +
Sbjct: 115 V-EIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDG 171
Query: 205 KNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTEL-----R 259
L RI + LT IP L+ L L ++ + + L L +
Sbjct: 172 LKLNYLRISEAKLT-GIPK--DLPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQ 228
Query: 260 ISDLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPG 319
I + + S L + L L N ++ R+P + D+ L+++ L N +T
Sbjct: 229 IRMI--ENGSLSFL---PTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT----- 277
Query: 320 ILQNLKKIDYIFLTNNSLSGTLPDWILTSEKNLDLSYNNFTESS 363
+ N + L N
Sbjct: 278 -----------KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWE 310
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 3e-22
Identities = 63/285 (22%), Positives = 102/285 (35%), Gaps = 47/285 (16%)
Query: 85 CHVTVILLKGFNLAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNR 144
CH+ V+ L +P+E +DL N + F LQ+L L+++ N+
Sbjct: 33 CHLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNK 89
Query: 145 LSGSIPLEI-GDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGN 203
+S I + + L++L + N LV +P NL SL + + N +P+ G
Sbjct: 90 IS-KIHEKAFSPLRKLQKLYISKNHLVE-IPPNL--PSSLVELRIHDNRIR-KVPK--GV 142
Query: 204 LKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSL-EGPIPSTISQLKNLTELRISD 262
L ++ +++ G L L LRIS+
Sbjct: 143 FSGLR---------------------NMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISE 181
Query: 263 LKGSS---SSFPNLQDMKKMERLILRNCLITGRIPEYI-EDMTDLKILDLSFNQLTGPVP 318
K + L L L + I I + L L L NQ+
Sbjct: 182 AKLTGIPKDLPETLN------ELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIEN 234
Query: 319 GILQNLKKIDYIFLTNNSLSGTLPDWI--LTSEKNLDLSYNNFTE 361
G L L + + L NN LS +P + L + + L NN T+
Sbjct: 235 GSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITK 278
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 3e-06
Identities = 16/88 (18%), Positives = 35/88 (39%), Gaps = 1/88 (1%)
Query: 279 MERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLS 338
L L+N I+ + + + L L L N+++ L+K+ ++++ N L
Sbjct: 56 TTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV 115
Query: 339 GTLPDWILTSEKNLDLSYNNFTESSPAT 366
+P + +S L + N +
Sbjct: 116 -EIPPNLPSSLVELRIHDNRIRKVPKGV 142
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-24
Identities = 66/281 (23%), Positives = 103/281 (36%), Gaps = 46/281 (16%)
Query: 75 CDCTYSNNTV-CH--------------VTVILLKGFNLAGVIPEEFGNLTFLQEVDLSRN 119
C C+ + V C ++ L + + F +L L+ + LSRN
Sbjct: 39 CSCSNQFSKVICVRKNLREVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRN 98
Query: 120 YFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEI-GDISTLEELVLEDNQLVGPLPENLG 178
+ +F L NL L + NRL+ +IP +S L+EL L +N +
Sbjct: 99 HIRTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFN 157
Query: 179 NLKSLRRILLSSNNFTGSIPE-SYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQ 237
+ SLRR+ L I E ++ L NL + NL IPN KLD LDL
Sbjct: 158 RIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPNLTPL-IKLDELDLS 215
Query: 238 GTSLEGPIPSTISQLKNLTELRISDLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEY- 296
G L P + L +L +L + I I
Sbjct: 216 GNHLSAIRPGSFQGLMHLQKLW------------------------MIQSQIQ-VIERNA 250
Query: 297 IEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSL 337
+++ L ++L+ N LT + L ++ I L +N
Sbjct: 251 FDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPW 291
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 1e-24
Identities = 59/214 (27%), Positives = 103/214 (48%), Gaps = 21/214 (9%)
Query: 655 KAATNNFDAANKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGN-REFVN-----EIGM 708
+ + K+GEG +G VYK S G ++A+K + + E + EI +
Sbjct: 17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALK----RIRLDAEDEGIPSTAIREISL 72
Query: 709 ISALQHQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDI 768
+ L H N+V L L LV+E++E + L + L + L + K +
Sbjct: 73 LKELHHPNIVSLIDVIHSERCLTLVFEFMEKD-LKKVL---DENKTGLQDSQIKIYLYQL 128
Query: 769 ARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVG 828
RG+A+ H+ +I+HRD+K N+L++ D K++DFGLA+ + + T+
Sbjct: 129 LRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLW 184
Query: 829 YMAPE--YAMRGYLTDKADVYSFGIVALEIVSGK 860
Y AP+ + Y T D++S G + E+++GK
Sbjct: 185 YRAPDVLMGSKKYST-SVDIWSIGCIFAEMITGK 217
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-24
Identities = 54/280 (19%), Positives = 96/280 (34%), Gaps = 44/280 (15%)
Query: 75 CDCTYSNNTV-CH--------------VTVILLKGFNLAGVIPEEFGNLTFLQEVDLSRN 119
C C+ + V C + L N+ + + F +L L+ + L RN
Sbjct: 50 CSCSNQFSKVVCTRRGLSEVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRN 109
Query: 120 YFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEI-GDISTLEELVLEDNQLVGPLPENLG 178
+F L +L L + N L+ IP +S L EL L +N +
Sbjct: 110 SIRQIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIESIPSYAFN 168
Query: 179 NLKSLRRILLSSNNFTGSIPE-SYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQ 237
+ SL R+ L I E ++ L NL + N+ +PN L+ L++
Sbjct: 169 RVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPNLTPL-VGLEELEMS 226
Query: 238 GTSLEGPIPSTISQLKNLTELRISDLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYI 297
G P + L +L +L + N ++
Sbjct: 227 GNHFPEIRPGSFHGLSSLKKLW------------------------VMNSQVSLIERNAF 262
Query: 298 EDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSL 337
+ + L L+L+ N L+ + L+ + + L +N
Sbjct: 263 DGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 9e-14
Identities = 40/190 (21%), Positives = 73/190 (38%), Gaps = 22/190 (11%)
Query: 182 SLRRILLSSNNFTGSIPESYGNL-KNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQG-- 238
+++ + + +P+ + N + +N+ + + L+ L L
Sbjct: 55 QFSKVVCTRRGLS-EVPQ---GIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNS 110
Query: 239 -TSLEGPIPSTISQLKNLTELRISD--LKG-SSSSFPNLQDMKKMERLILRNCLITGRIP 294
+E + L +L L + D L S +F L K+ L LRN I IP
Sbjct: 111 IRQIE---VGAFNGLASLNTLELFDNWLTVIPSGAFEYLS---KLRELWLRNNPIE-SIP 163
Query: 295 EYI-EDMTDLKILDLS-FNQLTGPVPGILQNLKKIDYIFLTNNSLSGTLPDWI-LTSEKN 351
Y + L LDL +L G + L + Y+ L ++ +P+ L +
Sbjct: 164 SYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPNLTPLVGLEE 222
Query: 352 LDLSYNNFTE 361
L++S N+F E
Sbjct: 223 LEMSGNHFPE 232
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 4e-05
Identities = 16/89 (17%), Positives = 28/89 (31%), Gaps = 2/89 (2%)
Query: 280 ERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSG 339
L L I + + L++L L N + G L ++ + L +N L+
Sbjct: 78 RYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTV 137
Query: 340 TLPDWI--LTSEKNLDLSYNNFTESSPAT 366
L+ + L L N
Sbjct: 138 IPSGAFEYLSKLRELWLRNNPIESIPSYA 166
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-24
Identities = 52/199 (26%), Positives = 84/199 (42%), Gaps = 27/199 (13%)
Query: 666 KIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNRE---FVNEIGMISALQHQNLVKLY 721
++G+G F V + + G A K ++ K R+ E + LQH N+V+L+
Sbjct: 36 ELGKGAFSVVRRCVHKTTGLEFAAKIIN-TKKLSARDFQKLEREARICRKLQHPNIVRLH 94
Query: 722 GCCIEGNQLLLVYEYLENNSL-----ARALFGKEGQCLNLDWATRKRICSDIARGLAYLH 776
E + LV++ + L AR + E I +AY H
Sbjct: 95 DSIQEESFHYLVFDLVTGGELFEDIVAREFYS-EADA--------SHCIQQILESIAYCH 145
Query: 777 EESRLKIVHRDIKATNVLL---DKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPE 833
IVHR++K N+LL K K++DFGLA D AGT GY++PE
Sbjct: 146 S---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW--HGFAGTPGYLSPE 200
Query: 834 YAMRGYLTDKADVYSFGIV 852
+ + D+++ G++
Sbjct: 201 VLKKDPYSKPVDIWACGVI 219
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 48/212 (22%), Positives = 89/212 (41%), Gaps = 30/212 (14%)
Query: 658 TNNFDAANKIGEGGFGPVYKGT-LSDGAVIAVK-----QLSSKSKQGNREFV-NEIGMIS 710
++++ ++G G F V K G A K +LSS + +RE + E+ ++
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 711 ALQHQNLVKLYGCCIEGNQLLLVYEYLENNSL-----ARALFGKEGQCLNLDWATRKRIC 765
++H N++ L+ ++L+ E + L + E + +
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESL-TEDEA--------TQFL 114
Query: 766 SDIARGLAYLHEESRLKIVHRDIKATNVLL----DKDLNAKISDFGLAKLDEDENTHIST 821
I G+ YLH +I H D+K N++L + K+ DFG+A +
Sbjct: 115 KQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK-IEAGNEFKN 170
Query: 822 RIAGTVGYMAPEYAMRGYLTDKADVYSFGIVA 853
I GT ++APE L +AD++S G++
Sbjct: 171 -IFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 54/206 (26%), Positives = 102/206 (49%), Gaps = 13/206 (6%)
Query: 659 NNFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQG-NREFVNEIGMISALQHQN 716
+ +K+GEG + VYKG ++A+K++ + ++G + E+ ++ L+H N
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 717 LVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLH 776
+V L+ L LV+EYL+ + L + L + ++ K + RGLAY H
Sbjct: 62 IVTLHDIIHTEKSLTLVFEYLDKD-LKQYL---DDCGNIINMHNVKLFLFQLLRGLAYCH 117
Query: 777 EESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPE--Y 834
+ K++HRD+K N+L+++ K++DFGLA+ + T+ Y P+
Sbjct: 118 RQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRPPDILL 173
Query: 835 AMRGYLTDKADVYSFGIVALEIVSGK 860
Y T + D++ G + E+ +G+
Sbjct: 174 GSTDYST-QIDMWGVGCIFYEMATGR 198
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-24
Identities = 52/284 (18%), Positives = 99/284 (34%), Gaps = 19/284 (6%)
Query: 71 SNFTCDCTYSNNTV------CHVTVILLKGFNLAGVIPEEFGNLTFLQEVDLSRNYFNGS 124
N C + + V + L + + + LQ + L+ N N
Sbjct: 32 RNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTI 91
Query: 125 LPKSFARLQNLTKLLILGNRLSGSIPLEI-GDISTLEELVLEDNQLVGPLPENL-GNLKS 182
SF+ L +L L + N LS ++ +S+L L L N +L +L
Sbjct: 92 EEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTK 150
Query: 183 LRRILLSSNNFTGSIPE-SYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSL 241
L+ + + + + I + L L E ID S+L P + + + L L
Sbjct: 151 LQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQH 210
Query: 242 EGPIPSTISQLKNLTELRISDLKG--------SSSSFPNLQDMKKMERLILRNCLITGRI 293
+ + ++ L + D S+ +L + + + + ++
Sbjct: 211 ILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QV 269
Query: 294 PEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSL 337
+ + ++ L L+ S NQL GI L + I+L N
Sbjct: 270 MKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 8e-13
Identities = 39/226 (17%), Positives = 85/226 (37%), Gaps = 37/226 (16%)
Query: 142 GNRLSGSIPLEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPE-S 200
L+ SIP + ++ L L +N++ +L +L+ ++L+SN +I E S
Sbjct: 40 SGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDS 95
Query: 201 YGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRI 260
+ +L +L + + L+ + S L +LT L +
Sbjct: 96 FSSLGSLEHLDLSYNYLS-NLS-----------------------SSWFKPLSSLTFLNL 131
Query: 261 SD--LKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYI-EDMTDLKILDLSFNQLTGPV 317
K + + K++ L + N +I +T L+ L++ + L
Sbjct: 132 LGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYE 190
Query: 318 PGILQNLKKIDYIFLTNNSLSGTLPDWI---LTSEKNLDLSYNNFT 360
P L++++ + ++ L L + +S + L+L +
Sbjct: 191 PKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLD 235
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 52/213 (24%), Positives = 91/213 (42%), Gaps = 32/213 (15%)
Query: 658 TNNFDAANKIGEGGFGPVYKGT-LSDGAVIAVK-----QLSSKSKQGNREFV-NEIGMIS 710
+ +D ++G G F V K S G A K Q + + +RE + E+ ++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 711 ALQHQNLVKLYGCCIEGNQLLLVYEYLENNSL-----ARALFGKEGQCLNLDWATRKRIC 765
+ H N++ L+ ++L+ E + L + E +
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESL-SEEEA--------TSFI 121
Query: 766 SDIARGLAYLHEESRLKIVHRDIKATNVLL-DKDLNA---KISDFGLA-KLDEDENTHIS 820
I G+ YLH KI H D+K N++L DK++ K+ DFGLA ++++
Sbjct: 122 KQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--- 175
Query: 821 TRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVA 853
I GT ++APE L +AD++S G++
Sbjct: 176 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-24
Identities = 68/218 (31%), Positives = 100/218 (45%), Gaps = 31/218 (14%)
Query: 658 TNNFDAANKIGEGGFGPVYKGTLSD-GAVIAVKQLSSKSKQGNREFVNEIGMISALQHQN 716
++ IG G FG VY+ L D G ++A+K++ + NRE + ++ L H N
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCN 108
Query: 717 LVKLYGCCIEGNQ------LLLVYEYLENNSLARAL--FGKEGQCLNLDWATRKRICSDI 768
+V+L + L LV +Y+ + R + + Q L + + K +
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPET-VYRVARHYSRAKQTLPVIYV--KLYMYQL 165
Query: 769 ARGLAYLHEESRLKIVHRDIKATNVLLDKDLNA-KISDFGLAK-LDEDE-NTH-ISTRIA 824
R LAY+H I HRDIK N+LLD D K+ DFG AK L E N I +R
Sbjct: 166 FRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY- 221
Query: 825 GTVGYMAPE--YAMRGYLTDKADVYSFGIVALEIVSGK 860
Y APE + Y T DV+S G V E++ G+
Sbjct: 222 ----YRAPELIFGATDY-TSSIDVWSAGCVLAELLLGQ 254
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 2e-24
Identities = 56/215 (26%), Positives = 105/215 (48%), Gaps = 17/215 (7%)
Query: 654 IKAATNNFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNREFVN-----EIG 707
+K+ ++ + +GEG F VYK + ++A+K++ + ++ +N EI
Sbjct: 5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIK 64
Query: 708 MISALQHQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSD 767
++ L H N++ L + + LV++++E + L + + L L + K
Sbjct: 65 LLQELSHPNIIGLLDAFGHKSNISLVFDFMETD-LEVII---KDNSLVLTPSHIKAYMLM 120
Query: 768 IARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTV 827
+GL YLH+ I+HRD+K N+LLD++ K++DFGLAK N + ++ T
Sbjct: 121 TLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV-TR 176
Query: 828 GYMAPE--YAMRGYLTDKADVYSFGIVALEIVSGK 860
Y APE + R Y D+++ G + E++
Sbjct: 177 WYRAPELLFGARMYGV-GVDMWAVGCILAELLLRV 210
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 62/289 (21%), Positives = 110/289 (38%), Gaps = 43/289 (14%)
Query: 86 HVTVILLKGFNLAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRL 145
++ L+ + + +F NL L + L N + P +FA L L +L + N+L
Sbjct: 53 DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQL 112
Query: 146 SGSIPLEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSI--PESYGN 203
+P ++ TL+EL + +N++ L + + L +N S ++
Sbjct: 113 K-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQG 169
Query: 204 LKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISDL 263
+K L+ RI +N+T IP G L L L G + +++ L NL +L +S
Sbjct: 170 MKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLS-- 224
Query: 264 KGSSSSFPNLQDMKKMERLILRNCLITGRIPEYI-EDMTDLKILDLSFNQLTGPVPGILQ 322
N + + + L+ L L+ N+L VPG L
Sbjct: 225 ---------------------FNSI--SAVDNGSLANTPHLRELHLNNNKLVK-VPGGLA 260
Query: 323 NLKKIDYIFLTNNSLSGTLPDWI--------LTSEKNLDLSYNNFTESS 363
+ K I ++L NN++S + S + L N
Sbjct: 261 DHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWE 309
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 1e-21
Identities = 63/287 (21%), Positives = 107/287 (37%), Gaps = 50/287 (17%)
Query: 85 CHVTVILLKGFNLAGVIPEE-FGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGN 143
CH+ V+ L +P++ + L DL N F L+NL L+++ N
Sbjct: 31 CHLRVVQCSDLGLE-KVPKDLPPDTALL---DLQNNKITEIKDGDFKNLKNLHTLILINN 86
Query: 144 RLSGSIPLEI-GDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYG 202
++S I + LE L L NQL LPE + K+L+ + + N T + +
Sbjct: 87 KIS-KISPGAFAPLVKLERLYLSKNQLKE-LPEKM--PKTLQELRVHENEIT-KVRK--S 139
Query: 203 NLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSL-EGPIPS-TISQLKNLTELRI 260
L ++ ++L L I + +K L+ +RI
Sbjct: 140 VFNGLN---------------------QMIVVELGTNPLKSSGIENGAFQGMKKLSYIRI 178
Query: 261 SD--LKG-SSSSFPNLQDMKKMERLILRNCLITGRIPEYI-EDMTDLKILDLSFNQLTGP 316
+D + P+L L L IT ++ + + +L L LSFN ++
Sbjct: 179 ADTNITTIPQGLPPSLT------ELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAV 231
Query: 317 VPGILQNLKKIDYIFLTNNSLSGTLPD--WILTSEKNLDLSYNNFTE 361
G L N + + L NN L +P + + L NN +
Sbjct: 232 DNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISA 277
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 21/88 (23%), Positives = 41/88 (46%), Gaps = 1/88 (1%)
Query: 279 MERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLS 338
L L+N IT +++ +L L L N+++ PG L K++ ++L+ N L
Sbjct: 54 TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK 113
Query: 339 GTLPDWILTSEKNLDLSYNNFTESSPAT 366
LP+ + + + L + N T+ +
Sbjct: 114 -ELPEKMPKTLQELRVHENEITKVRKSV 140
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-24
Identities = 52/212 (24%), Positives = 88/212 (41%), Gaps = 30/212 (14%)
Query: 658 TNNFDAANKIGEGGFGPVYKGT-LSDGAVIAVK-----QLSSKSKQGNREFV-NEIGMIS 710
+ +D ++G G F V K S G A K Q + + RE + E+ ++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 711 ALQHQNLVKLYGCCIEGNQLLLVYEYLENNSL-----ARALFGKEGQCLNLDWATRKRIC 765
+ H N++ L+ ++L+ E + L + E +
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESL-SEEEA--------TSFI 121
Query: 766 SDIARGLAYLHEESRLKIVHRDIKATNVLL-DKDLNA---KISDFGLAKLDEDENTHIST 821
I G+ YLH KI H D+K N++L DK++ K+ DFGLA ++
Sbjct: 122 KQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE-IEDGVEFKN 177
Query: 822 RIAGTVGYMAPEYAMRGYLTDKADVYSFGIVA 853
I GT ++APE L +AD++S G++
Sbjct: 178 -IFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 55/214 (25%), Positives = 82/214 (38%), Gaps = 36/214 (16%)
Query: 667 IGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNREFVN-----EIGMISALQHQNLVKL 720
+GEG +G V + AVK L K K EI ++ L+H+N+++L
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILK-KKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 721 YG--CCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIAR-------- 770
E ++ +V EY + + D KR A
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCGM--QEML---------DSVPEKRFPVCQAHGYFCQLID 120
Query: 771 GLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDED--ENTHISTRIAGTVG 828
GL YLH IVH+DIK N+LL KIS G+A+ + T G+
Sbjct: 121 GLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS-QGSPA 176
Query: 829 YMAPEYAM--RGYLTDKADVYSFGIVALEIVSGK 860
+ PE A + K D++S G+ I +G
Sbjct: 177 FQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGL 210
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-24
Identities = 63/210 (30%), Positives = 105/210 (50%), Gaps = 21/210 (10%)
Query: 659 NNFDAANKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGN-REFVN-----EIGMISAL 712
+ KIGEG +G VYK + G A+K K + E + EI ++ L
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALK----KIRLEKEDEGIPSTTIREISILKEL 57
Query: 713 QHQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGL 772
+H N+VKLY +L+LV+E+L+ + L + L + L+ T K + G+
Sbjct: 58 KHSNIVKLYDVIHTKKRLVLVFEHLDQD-LKKLL---DVCEGGLESVTAKSFLLQLLNGI 113
Query: 773 AYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAP 832
AY H+ +++HRD+K N+L++++ KI+DFGLA+ + I T+ Y AP
Sbjct: 114 AYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYRAP 169
Query: 833 E--YAMRGYLTDKADVYSFGIVALEIVSGK 860
+ + Y T D++S G + E+V+G
Sbjct: 170 DVLMGSKKYST-TIDIWSVGCIFAEMVNGT 198
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 6e-24
Identities = 49/196 (25%), Positives = 76/196 (38%), Gaps = 22/196 (11%)
Query: 666 KIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCC 724
+G G G V + G A+K L S + +E + A ++V +
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLY-DSPKARQEV--DH-HWQASGGPHIVCILDVY 91
Query: 725 ----IEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESR 780
LL++ E +E L + + Q A I DI + +LH
Sbjct: 92 ENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREA--AEIMRDIGTAIQFLHS--- 146
Query: 781 LKIVHRDIKATNVLL---DKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPE-YAM 836
I HRD+K N+L +KD K++DFG AK + T T Y+APE
Sbjct: 147 HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQT-PCYTPYYVAPEVLGP 203
Query: 837 RGYLTDKADVYSFGIV 852
Y D++S G++
Sbjct: 204 EKY-DKSCDMWSLGVI 218
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 6e-24
Identities = 42/158 (26%), Positives = 69/158 (43%), Gaps = 18/158 (11%)
Query: 659 NNFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGN-REFVN-----EIGMISA 711
++ KIGEG +G V+K G ++A+K K + + EI M+
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIK----KFLESEDDPVIKKIALREIRMLKQ 58
Query: 712 LQHQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARG 771
L+H NLV L +L LV+EY ++ + L + + K I +
Sbjct: 59 LKHPNLVNLLEVFRRKRRLHLVFEYCDHT-VLHEL---DRYQRGVPEHLVKSITWQTLQA 114
Query: 772 LAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLA 809
+ + H+ +HRD+K N+L+ K K+ DFG A
Sbjct: 115 VNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFA 149
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 7e-24
Identities = 43/158 (27%), Positives = 75/158 (47%), Gaps = 18/158 (11%)
Query: 659 NNFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGN-REFVN-----EIGMISA 711
++ +GEG +G V K G ++A+K K + + + V EI ++
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIK----KFLESDDDKMVKKIAMREIKLLKQ 80
Query: 712 LQHQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARG 771
L+H+NLV L C + + LV+E++++ + L E LD+ ++ I G
Sbjct: 81 LRHENLVNLLEVCKKKKRWYLVFEFVDHT-ILDDL---ELFPNGLDYQVVQKYLFQIING 136
Query: 772 LAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLA 809
+ + H I+HRDIK N+L+ + K+ DFG A
Sbjct: 137 IGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFA 171
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 8e-24
Identities = 54/220 (24%), Positives = 91/220 (41%), Gaps = 30/220 (13%)
Query: 650 TLRQIKAATNNFDAANKIGEGGFGPVYKGT-LSDGAVIAVK-----QLSSKSKQGNREFV 703
T+ + + + +D ++G G F V K S G A K + S + +RE +
Sbjct: 2 TVFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDI 61
Query: 704 -NEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYLENNSL-----ARALFGKEGQCLNLD 757
E+ ++ +QH N++ L+ ++L+ E + L + E +
Sbjct: 62 EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESL-TEEEA---- 116
Query: 758 WATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLL----DKDLNAKISDFGLAKLDE 813
I G+ YLH L+I H D+K N++L KI DFGLA +
Sbjct: 117 ----TEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 169
Query: 814 DENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVA 853
N I GT ++APE L +AD++S G++
Sbjct: 170 FGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 51/213 (23%), Positives = 80/213 (37%), Gaps = 45/213 (21%)
Query: 667 IGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNREFV-NEIGMISALQ-HQNLVKLYGC 723
+GEG V L AVK + K R V E+ M+ Q H+N+++L
Sbjct: 21 LGEGAHARVQTCINLITSQEYAVKIIE-KQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 724 CIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRK---------RICSDIARGLAY 774
E ++ LV+E + S+ L ++ + D+A L +
Sbjct: 80 FEEEDRFYLVFEKMRGGSI-------------LSHIHKRRHFNELEASVVVQDVASALDF 126
Query: 775 LHEESRLKIVHRDIKATNVLL---DKDLNAKISDFGLAKL------DEDENTHISTRIAG 825
LH I HRD+K N+L ++ KI DF L +T G
Sbjct: 127 LHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCG 183
Query: 826 TVGYMAPE------YAMRGYLTDKADVYSFGIV 852
+ YMAPE Y + D++S G++
Sbjct: 184 SAEYMAPEVVEAFSEEASIY-DKRCDLWSLGVI 215
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 45/182 (24%), Positives = 88/182 (48%), Gaps = 19/182 (10%)
Query: 659 NNFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGN-REFVN-----EIGMISA 711
++ KIGEG +G V+K ++A+K + + + E V EI ++
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALK----RVRLDDDDEGVPSSALREICLLKE 57
Query: 712 LQHQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARG 771
L+H+N+V+L+ +L LV+E+ + + L + + +LD K + +G
Sbjct: 58 LKHKNIVRLHDVLHSDKKLTLVFEFCDQD-LKKYF---DSCNGDLDPEIVKSFLFQLLKG 113
Query: 772 LAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMA 831
L + H ++HRD+K N+L++++ K+++FGLA+ S + T+ Y
Sbjct: 114 LGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLWYRP 169
Query: 832 PE 833
P+
Sbjct: 170 PD 171
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 4e-23
Identities = 60/200 (30%), Positives = 89/200 (44%), Gaps = 32/200 (16%)
Query: 667 IGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNREFVN----EIGMISALQHQNLVKLY 721
+G G FG V G G +AVK L+ + K + + V EI + +H +++KLY
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILN-RQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77
Query: 722 GCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIAR--------GLA 773
+V EY+ L F R+ AR +
Sbjct: 78 QVISTPTDFFMVMEYVSGGEL----FDY--------ICKHGRVEEMEARRLFQQILSAVD 125
Query: 774 YLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPE 833
Y H R +VHRD+K NVLLD +NAKI+DFGL+ + D + T G+ Y APE
Sbjct: 126 YCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-FLRTS-CGSPNYAAPE 180
Query: 834 -YAMRGYLTDKADVYSFGIV 852
+ R Y + D++S G++
Sbjct: 181 VISGRLYAGPEVDIWSCGVI 200
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 7e-23
Identities = 53/216 (24%), Positives = 96/216 (44%), Gaps = 28/216 (12%)
Query: 659 NNFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGN-REFVN-----EIGMISA 711
+ + K+GEG +G VYK +A+K + + + E V E+ ++
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIK----RIRLEHEEEGVPGTAIREVSLLKE 89
Query: 712 LQHQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARG 771
LQH+N+++L ++L L++EY EN+ L + + + ++ K + G
Sbjct: 90 LQHRNIIELKSVIHHNHRLHLIFEYAEND-LKKYM----DKNPDVSMRVIKSFLYQLING 144
Query: 772 LAYLHEESRLKIVHRDIKATNVLLDKDLNA-----KISDFGLAKLDEDENTHISTRIAGT 826
+ + H + +HRD+K N+LL + KI DFGLA+ + I T
Sbjct: 145 VNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII-T 200
Query: 827 VGYMAPEYAM--RGYLTDKADVYSFGIVALEIVSGK 860
+ Y PE + R Y T D++S + E++
Sbjct: 201 LWYRPPEILLGSRHYST-SVDIWSIACIWAEMLMKT 235
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 2e-22
Identities = 61/228 (26%), Positives = 100/228 (43%), Gaps = 24/228 (10%)
Query: 644 LQTGYFTLRQIKAATNNFDAANKIGEGGFGPVY----KGTLSDGAVIAVKQLSSKS--KQ 697
LQ + K +F +GEG F V T A+K L + K+
Sbjct: 15 LQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELAT---SREYAIKILEKRHIIKE 71
Query: 698 GNREFVN-EIGMISALQHQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNL 756
+V E ++S L H VKLY + +L Y +N L + + K G +
Sbjct: 72 NKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIG-SFDE 129
Query: 757 DWATRKRI-CSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDE 815
R ++I L YLH I+HRD+K N+LL++D++ +I+DFG AK+ E
Sbjct: 130 TCT---RFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 183
Query: 816 NTHISTR-IAGTVGYMAPEYAM-RGYLTDKA-DVYSFGIVALEIVSGK 860
+ GT Y++PE + K+ D+++ G + ++V+G
Sbjct: 184 SKQARANSFVGTAQYVSPELLTEKSA--CKSSDLWALGCIIYQLVAGL 229
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 3e-22
Identities = 52/195 (26%), Positives = 77/195 (39%), Gaps = 19/195 (9%)
Query: 666 KIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYG-- 722
+G G G V + A+K L + RE E+ A Q ++V++
Sbjct: 69 VLGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARREV--EL-HWRASQCPHIVRIVDVY 124
Query: 723 --CCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESR 780
LL+V E L+ L + + Q A I I + YLH
Sbjct: 125 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREA--SEIMKSIGEAIQYLHS--- 179
Query: 781 LKIVHRDIKATNVLL-DKDLNA--KISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMR 837
+ I HRD+K N+L K NA K++DFG AK N+ T T Y+APE
Sbjct: 180 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL--TTPCYTPYYVAPEVLGP 237
Query: 838 GYLTDKADVYSFGIV 852
D++S G++
Sbjct: 238 EKYDKSCDMWSLGVI 252
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 4e-22
Identities = 63/221 (28%), Positives = 98/221 (44%), Gaps = 24/221 (10%)
Query: 652 RQIKAATNNFDAANKIGEGGFGPVY----KGTLSDGAVIAVKQLSSK---SKQGNREFVN 704
I N+F IG GGFG VY T G + A+K L K KQG +N
Sbjct: 182 LNIHLTMNDFSVHRIIGRGGFGEVYGCRKADT---GKMYAMKCLDKKRIKMKQGETLALN 238
Query: 705 E---IGMISALQHQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATR 761
E + ++S +V + ++L + + + L L + G A
Sbjct: 239 ERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS-QHGV---FSEADM 294
Query: 762 KRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHIST 821
+ ++I GL ++H +V+RD+K N+LLD+ + +ISD GLA + H
Sbjct: 295 RFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--A 349
Query: 822 RIAGTVGYMAPEYAMRGYLTDKA-DVYSFGIVALEIVSGKS 861
GT GYMAPE +G D + D +S G + +++ G S
Sbjct: 350 S-VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHS 389
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 6e-22
Identities = 72/273 (26%), Positives = 118/273 (43%), Gaps = 40/273 (14%)
Query: 659 NNFDAANKIGEGGFGPVY----KGTLSDGAVIAVKQLSSKSKQGNREFV----NEIGMIS 710
++F+ IG+G FG V T + A+K ++ K K R V E+ ++
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDT---KKMYAMKYMN-KQKCVERNEVRNVFKELQIMQ 70
Query: 711 ALQHQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIAR 770
L+H LV L+ + + +V + L L R + + K ++
Sbjct: 71 GLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDL-RYHLQQNV-HFKEETV--KLFICELVM 126
Query: 771 GLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYM 830
L YL +I+HRD+K N+LLD+ + I+DF +A + E + +AGT YM
Sbjct: 127 ALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MAGTKPYM 181
Query: 831 APE----YAMRGYLTDKA-DVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQG 885
APE GY A D +S G+ A E++ G RP Y + + +E
Sbjct: 182 APEMFSSRKGAGY--SFAVDWWSLGVTAYELLRG-----RRP-----YHIRSSTSSKEIV 229
Query: 886 NLLELVDPSLGSNFSKKEAMTMLNIALLCTNPS 918
+ E + S +S +E +++L LL NP
Sbjct: 230 HTFETTVVTYPSAWS-QEMVSLLK-KLLEPNPD 260
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 1e-21
Identities = 52/198 (26%), Positives = 79/198 (39%), Gaps = 30/198 (15%)
Query: 667 IGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCI 725
IG G FG ++AVK + + + EI +L+H N+V+ +
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIE-RGAAIDENVQREIINHRSLRHPNIVRFKEVIL 86
Query: 726 EGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIAR--------GLAYLHE 777
L ++ EY L + + R D AR G++Y H
Sbjct: 87 TPTHLAIIMEYASGGEL----YER--------ICNAGRFSEDEARFFFQQLLSGVSYCH- 133
Query: 778 ESRLKIVHRDIKATNVLLDKD--LNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPE-Y 834
++I HRD+K N LLD KI DFG +K + + + GT Y+APE
Sbjct: 134 --SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTV-GTPAYIAPEVL 189
Query: 835 AMRGYLTDKADVYSFGIV 852
+ Y ADV+S G+
Sbjct: 190 LRQEYDGKIADVWSCGVT 207
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 1e-21
Identities = 51/165 (30%), Positives = 84/165 (50%), Gaps = 24/165 (14%)
Query: 659 NNFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLS-SKSKQGNREF----VNEIGMISAL 712
+ ++ KIG+G FG V+K G +A+K++ K+G F + EI ++ L
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEG---FPITALREIKILQLL 73
Query: 713 QHQNLVKLYGCCIE--------GNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRI 764
+H+N+V L C + LV+++ E++ LA L + + KR+
Sbjct: 74 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHD-LAGLL---SNVLVKFTLSEIKRV 129
Query: 765 CSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLA 809
+ GL Y+H KI+HRD+KA NVL+ +D K++DFGLA
Sbjct: 130 MQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLA 171
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 1e-21
Identities = 48/168 (28%), Positives = 77/168 (45%), Gaps = 20/168 (11%)
Query: 657 ATNNFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLS-SKSKQGNREF----VNEIG--- 707
AT+ ++ +IG G +G VYK G +A+K + G V E+
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 708 MISALQHQNLVKLYGCCI-----EGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRK 762
+ A +H N+V+L C ++ LV+E+++ + L L + L T K
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQD-LRTYL--DKAPPPGLPAETIK 123
Query: 763 RICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAK 810
+ RGL +LH IVHRD+K N+L+ K++DFGLA+
Sbjct: 124 DLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLAR 168
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 1e-21
Identities = 64/202 (31%), Positives = 92/202 (45%), Gaps = 37/202 (18%)
Query: 667 IGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNREFVN----EIGMISALQHQNLVKLY 721
+GEG FG V T +A+K +S + + EI + L+H +++KLY
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFIS-RQLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75
Query: 722 GCCIEGNQLLLVYEYL--ENNSLARALFGKEGQCLNLDWATRKRICSDIAR--------G 771
+++V EY E LF +KR+ D R
Sbjct: 76 DVITTPTDIVMVIEYAGGE-------LFDY--------IVEKKRMTEDEGRRFFQQIICA 120
Query: 772 LAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMA 831
+ Y H R KIVHRD+K N+LLD +LN KI+DFGL+ + D N + T G+ Y A
Sbjct: 121 IEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN-FLKTS-CGSPNYAA 175
Query: 832 PE-YAMRGYLTDKADVYSFGIV 852
PE + Y + DV+S GIV
Sbjct: 176 PEVINGKLYAGPEVDVWSCGIV 197
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 2e-21
Identities = 60/200 (30%), Positives = 92/200 (46%), Gaps = 32/200 (16%)
Query: 667 IGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNREFVN----EIGMISALQHQNLVKLY 721
+G G FG V G G +AVK L+ + K + + V EI + +H +++KLY
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILN-RQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82
Query: 722 GCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIAR--------GLA 773
+ + +V EY+ L F R+ +R G+
Sbjct: 83 QVISTPSDIFMVMEYVSGGEL----FDY--------ICKNGRLDEKESRRLFQQILSGVD 130
Query: 774 YLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPE 833
Y H R +VHRD+K NVLLD +NAKI+DFGL+ + D + T G+ Y APE
Sbjct: 131 YCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-FLRTS-CGSPNYAAPE 185
Query: 834 -YAMRGYLTDKADVYSFGIV 852
+ R Y + D++S G++
Sbjct: 186 VISGRLYAGPEVDIWSSGVI 205
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 2e-21
Identities = 62/276 (22%), Positives = 111/276 (40%), Gaps = 38/276 (13%)
Query: 651 LRQIKAATNNFDAANKIGEGGFGPVY----KGTLSDGAVIAVKQLSSKS--KQGNREFVN 704
++Q++ +F+ IG G FG V K V A+K L+ K+
Sbjct: 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNA---DKVFAMKILNKWEMLKRAETACFR 122
Query: 705 -EIGMISALQHQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKR 763
E ++ + + L+ + N L LV +Y L L K L + A +
Sbjct: 123 EERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLL-SKFEDRLPEEMA--RF 179
Query: 764 ICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRI 823
+++ + +H+ L VHRDIK N+L+D + + +++DFG ++ T S+
Sbjct: 180 YLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA 236
Query: 824 AGTVGYMAPE------YAMRGYLTDKADVYSFGIVALEIVSGKS-----NTN--YR---- 866
GT Y++PE Y + D +S G+ E++ G++ + Y
Sbjct: 237 VGTPDYISPEILQAMEGGKGRY-GPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 295
Query: 867 PKEEFVYLLDWAYVLQEQGNLLE--LVDPS--LGSN 898
KE F + V + +L+ + LG N
Sbjct: 296 HKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQN 331
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-21
Identities = 43/233 (18%), Positives = 89/233 (38%), Gaps = 16/233 (6%)
Query: 132 LQNLTKLLILGNRLSGSIPLEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSN 191
L N K+ + ++ ++ D+ + L + E + L +L + L N
Sbjct: 18 LANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTT--IEGVQYLNNLIGLELKDN 73
Query: 192 NFTGSIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQ 251
T + NL +TE + G+ L + + LDL T + P ++
Sbjct: 74 QIT-DLAP-LKNLTKITELELSGNPLK-NVSAI-AGLQSIKTLDLTSTQITDVTP--LAG 127
Query: 252 LKNLTELRISDLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFN 311
L NL L + + ++ L + ++ L + N ++ P + +++ L L N
Sbjct: 128 LSNLQVLYLDLNQI--TNISPLAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDN 183
Query: 312 QLTGPVPGILQNLKKIDYIFLTNNSLSGTLPDWILTSEKNLDLSYNNFTESSP 364
+++ P L +L + + L NN +S P ++ + L+ T
Sbjct: 184 KISDISP--LASLPNLIEVHLKNNQISDVSPLANTSNLFIVTLTNQTITNQPV 234
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 5e-21
Identities = 49/266 (18%), Positives = 100/266 (37%), Gaps = 23/266 (8%)
Query: 102 PEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGDISTLEE 161
+L + + ++ L NL L + N+++ + + +++ + E
Sbjct: 34 TVTQADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQIT-DLA-PLKNLTKITE 89
Query: 162 LVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRI 221
L L N L + L+S++ + L+S T P + L NL +D + +T I
Sbjct: 90 LELSGNPLKNV--SAIAGLQSIKTLDLTSTQITDVTPLA--GLSNLQVLYLDLNQIT-NI 144
Query: 222 PNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISDLKGSS-SSFPNLQDMKKME 280
+ T L L + + S ++ L NL++L + S L + +
Sbjct: 145 SP-LAGLTNLQYLSIGNAQV-----SDLTPLANLSKLTTLKADDNKISDISPLASLPNLI 198
Query: 281 RLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGT 340
+ L+N I+ P + + ++L I+ L+ +T NL + + S +
Sbjct: 199 EVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVV--KGPSGAPI 254
Query: 341 LPDWILTSEKNLDLSYNNFTESSPAT 366
P I N + N T + +
Sbjct: 255 APATISD---NGTYASPNLTWNLTSF 277
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 27/138 (19%), Positives = 57/138 (41%), Gaps = 8/138 (5%)
Query: 227 NWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISDLKGSSSSFPNLQDMKKMERLILRN 286
++ +++ T + L +T L ++ +Q + + L L++
Sbjct: 17 ALANAIKIAAGKSNVTDT--VTQADLDGITTLSAFGTG--VTTIEGVQYLNNLIGLELKD 72
Query: 287 CLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGTLPDWIL 346
IT + ++++T + L+LS N L + L+ I + LT+ ++ P L
Sbjct: 73 NQIT-DLAP-LKNLTKITELELSGNPLKNVSA--IAGLQSIKTLDLTSTQITDVTPLAGL 128
Query: 347 TSEKNLDLSYNNFTESSP 364
++ + L L N T SP
Sbjct: 129 SNLQVLYLDLNQITNISP 146
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 17/93 (18%), Positives = 32/93 (34%), Gaps = 4/93 (4%)
Query: 272 NLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIF 331
+ ++ +T D+ + L +T + G +Q L + +
Sbjct: 14 PDPALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVTT-IEG-VQYLNNLIGLE 69
Query: 332 LTNNSLSGTLPDWILTSEKNLDLSYNNFTESSP 364
L +N ++ P LT L+LS N S
Sbjct: 70 LKDNQITDLAPLKNLTKITELELSGNPLKNVSA 102
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 3e-21
Identities = 59/221 (26%), Positives = 94/221 (42%), Gaps = 36/221 (16%)
Query: 659 NNFDAANKIGEGGFGPVY----KGTLSDGAVIAVKQLSSK---SKQGNREFVNEIGMISA 711
+ F +G GGFG V+ K T G + A K+L+ K ++G + + E +++
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKAT---GKLYACKKLNKKRLKKRKGYQGAMVEKKILAK 241
Query: 712 LQHQNLVKLYGCCIEGNQLLLVYEY---------LENNSLARALFGKEGQCLNLDWATRK 762
+ + +V L L LV + N F + R
Sbjct: 242 VHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEP----------RA 291
Query: 763 RI-CSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHIST 821
+ I GL +LH+ I++RD+K NVLLD D N +ISD GLA + T
Sbjct: 292 IFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG 348
Query: 822 RIAGTVGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGKS 861
AGT G+MAPE + Y D ++ G+ E+++ +
Sbjct: 349 Y-AGTPGFMAPELLLGEEY-DFSVDYFALGVTLYEMIAARG 387
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 5e-21
Identities = 29/206 (14%), Positives = 76/206 (36%), Gaps = 31/206 (15%)
Query: 134 NLTKLLILGNRLSGSIPLEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNF 193
L S + + +++L + L + + + +++ + +++ +
Sbjct: 21 TFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTDL--TGIEYAHNIKDLTINNIHA 78
Query: 194 TGSIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLK 253
T L NL RI G ++T + T L LD+ ++ + I + I+ L
Sbjct: 79 TNY--NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLP 136
Query: 254 NLTELRISDLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQL 313
+ + +S N IT ++ + +LK L++ F+ +
Sbjct: 137 KVNSIDLSY-----------------------NGAITD--IMPLKTLPELKSLNIQFDGV 171
Query: 314 TGPVPGILQNLKKIDYIFLTNNSLSG 339
+++ K++ ++ + ++ G
Sbjct: 172 HDYRG--IEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 4e-18
Identities = 34/182 (18%), Positives = 63/182 (34%), Gaps = 8/182 (4%)
Query: 179 NLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQG 238
K+ LL + T +I E+ + +LT + N+T + I + L +
Sbjct: 21 TFKAYLNGLLG-QSSTANITEA--QMNSLTYITLANINVT-DLTG-IEYAHNIKDLTINN 75
Query: 239 TSLEGPIPSTISQLKNLTELRISDLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYIE 298
+ IS L NL LRI +S PNL + + L + + I I
Sbjct: 76 IHATNY--NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133
Query: 299 DMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGTLPDWILTSEKNLDLSYNN 358
+ + +DLS+N + L+ L ++ + + + + L
Sbjct: 134 TLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVHDYRGIEDFPKLNQLYAFSQT 192
Query: 359 FT 360
Sbjct: 193 IG 194
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 5e-14
Identities = 21/137 (15%), Positives = 47/137 (34%), Gaps = 5/137 (3%)
Query: 103 EEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGDISTLEEL 162
++++ ++ + + L NL +L I+G ++ + +++L L
Sbjct: 60 TGIEYAHNIKDLTINNIHATNY--NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLL 117
Query: 163 VLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIP 222
+ + + + L + I LS N I L L I +
Sbjct: 118 DISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRG 176
Query: 223 NFIGNWTKLDRLDLQGT 239
I ++ KL++L
Sbjct: 177 --IEDFPKLNQLYAFSQ 191
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 2e-08
Identities = 21/114 (18%), Positives = 43/114 (37%), Gaps = 6/114 (5%)
Query: 253 KNLTELRISDLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQ 312
L SS++ M + + L N +T + IE ++K L ++
Sbjct: 20 STFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVT-DL-TGIEYAHNIKDLTINNIH 77
Query: 313 LTGPVPGILQNLKKIDYIFLTNNSLSGTLPDWI--LTSEKNLDLSYNNFTESSP 364
T P + L ++ + + ++ + LTS LD+S++ +S
Sbjct: 78 ATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSIL 129
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 95.0 bits (236), Expect = 5e-21
Identities = 61/223 (27%), Positives = 96/223 (43%), Gaps = 29/223 (13%)
Query: 719 KLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRK---RICSDIARGLAYL 775
K I +Q ++E SL+ + + L D+ T + +A+G+ +L
Sbjct: 150 KRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL 209
Query: 776 HEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGT-VGYMAPEY 834
SR K +HRD+ A N+LL + KI DFGLA+ + ++ A + +MAPE
Sbjct: 210 --ASR-KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPET 266
Query: 835 AMRGYLTDKADVYSFGIVALEIVS-GKSNTNY---RPKEEFVYLLDWAYVLQEQGNLLEL 890
T ++DV+SFG++ EI S G + Y + EEF L ++G +
Sbjct: 267 IFDRVYTIQSDVWSFGVLLWEIFSLGA--SPYPGVKIDEEFCRRL-------KEGTRMR- 316
Query: 891 VDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933
P + M L C + P+ RPT S V L
Sbjct: 317 -APDYTTP-------EMYQTMLDCWHGEPSQRPTFSELVEHLG 351
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 1e-09
Identities = 29/155 (18%), Positives = 56/155 (36%), Gaps = 20/155 (12%)
Query: 665 NKIGEGGFGPVYKGTL------SDGAVIAVKQL-SSKSKQGNREFVNEIG-MISALQHQN 716
+G G FG V + + +AVK L + +R ++E+ +I H N
Sbjct: 28 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87
Query: 717 LVKLYGCCI-EGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYL 775
+V L G C G L+++ E+ + +L + R +G +
Sbjct: 88 VVNLLGACTKPGGPLMVIVEFCKFGNL-----------STYLRSKRNEFVPYKTKGARFR 136
Query: 776 HEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAK 810
+ + + D+K + ++ S F K
Sbjct: 137 QGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 6e-21
Identities = 68/243 (27%), Positives = 104/243 (42%), Gaps = 20/243 (8%)
Query: 628 YLGGKNVED-KELRGLDLQTGYFTLRQIKAATNNFDAANKIGEGGFGPVY----KGTLSD 682
YL D + + + L + N F +G+GGFG V + T
Sbjct: 152 YLSVAPFADYLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRAT--- 208
Query: 683 GAVIAVKQLSSK---SKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYLEN 739
G + A K+L K ++G +NE ++ + + +V L + L LV +
Sbjct: 209 GKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNG 268
Query: 740 NSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDL 799
L ++ A ++I GL LH E +IV+RD+K N+LLD
Sbjct: 269 GDLKFHIYHMGQAGFPEARA--VFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHG 323
Query: 800 NAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMR-GYLTDKADVYSFGIVALEIVS 858
+ +ISD GLA E I R GTVGYMAPE Y T D ++ G + E+++
Sbjct: 324 HIRISDLGLAV-HVPEGQTIKGR-VGTVGYMAPEVVKNERY-TFSPDWWALGCLLYEMIA 380
Query: 859 GKS 861
G+S
Sbjct: 381 GQS 383
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 94.5 bits (235), Expect = 1e-20
Identities = 45/185 (24%), Positives = 78/185 (42%), Gaps = 24/185 (12%)
Query: 666 KIGEGGFGPVYKG---TLSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYG 722
K+G G +G VYK D A+KQ+ + EI ++ L+H N++ L
Sbjct: 28 KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQK 85
Query: 723 CCIE--GNQLLLVYEYLENNSLARAL-----FGKEGQCLNLDWATRKRICSDIARGLAYL 775
+ ++ L+++Y E++ L + + + L K + I G+ YL
Sbjct: 86 VFLSHADRKVWLLFDYAEHD-LWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 144
Query: 776 HEESRLKIVHRDIKATNVLLDKDLNA----KISDFGLAKLDEDEN---THISTRIAGTVG 828
H ++HRD+K N+L+ + KI+D G A+L + + T
Sbjct: 145 HAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFW 200
Query: 829 YMAPE 833
Y APE
Sbjct: 201 YRAPE 205
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 4e-20
Identities = 45/171 (26%), Positives = 82/171 (47%), Gaps = 32/171 (18%)
Query: 659 NNFDAANKIGEGGFGPVYKG--TLSDGAVIAVKQLS-SKSKQGN-----REFVNEIGMIS 710
++ +IGEG +G V+K + G +A+K++ ++G RE ++
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIRE-------VA 63
Query: 711 ALQ------HQNLVKLYGCCI-----EGNQLLLVYEYLENNSLARALFGKEGQCLNLDWA 759
L+ H N+V+L+ C +L LV+E+++ + L L + +
Sbjct: 64 VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQD-LTTYL--DKVPEPGVPTE 120
Query: 760 TRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAK 810
T K + + RGL +LH ++VHRD+K N+L+ K++DFGLA+
Sbjct: 121 TIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR 168
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 4e-20
Identities = 58/227 (25%), Positives = 96/227 (42%), Gaps = 27/227 (11%)
Query: 651 LRQIKAATNNFDAANKIGEGGFGPVY----KGTLSDGAVIAVKQLSSKSKQGNRE----F 702
L++++ ++F+ IG G F V K T G V A+K ++ K R F
Sbjct: 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQT---GQVYAMKIMN-KWDMLKRGEVSCF 108
Query: 703 VNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRK 762
E ++ + + +L+ + N L LV EY L L K G+ + + A
Sbjct: 109 REERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLL-SKFGERIPAEMA--- 164
Query: 763 RI-CSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHIST 821
R ++I + +H L VHRDIK N+LLD+ + +++DFG + T S
Sbjct: 165 RFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSL 221
Query: 822 RIAGTVGYMAPEYAMRGYLTDKADVY-------SFGIVALEIVSGKS 861
GT Y++PE Y + G+ A E+ G++
Sbjct: 222 VAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQT 268
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 93.0 bits (231), Expect = 9e-20
Identities = 56/350 (16%), Positives = 118/350 (33%), Gaps = 57/350 (16%)
Query: 71 SNFTCDCTYSNNTVCHV--------TVILLKGFNLAGVIPEEFGNLTFLQEVDLSRNYFN 122
S F D S N + HV T++ + ++ + + +L+ L+ + +S N
Sbjct: 1 SEFLVDR--SKNGLIHVPKDLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQ 58
Query: 123 GSLPKSFARLQNLTKLLILGNRLSGSIPLEIGDISTLEELVLEDNQL-VGPLPENLGNLK 181
F Q L L + N+L I L+ L L N P+ + GN+
Sbjct: 59 YLDISVFKFNQELEYLDLSHNKLV-KIS--CHPTVNLKHLDLSFNAFDALPICKEFGNMS 115
Query: 182 SLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIP------------------- 222
L+ + LS+ + S +L + G +
Sbjct: 116 QLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTN 175
Query: 223 ---NFIGNWTKLDRLDLQGTSLEG-----------PIPSTISQLKNLTELRISDLKGSSS 268
+FI + + +L+ ++++ I + + L+ L +++++ + +
Sbjct: 176 KEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWN 235
Query: 269 SF---PNLQDMKKMERLILRNCLITGRIPEYIEDMTD-----LKILDLSFNQLTGPVPGI 320
SF L + + N + G++ D + L I + + P I
Sbjct: 236 SFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYI 295
Query: 321 LQNLKKIDYIFLTNNSLSGT--LPDWILTSEKNLDLSYNNFTESSPATCR 368
+ ++ T + L ++ +LD S N T++ C
Sbjct: 296 YEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCG 345
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 91.8 bits (228), Expect = 2e-19
Identities = 51/295 (17%), Positives = 94/295 (31%), Gaps = 35/295 (11%)
Query: 79 YSNNTVCHVTVILLKGFNLAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKL 138
++ ++ + L+G +L L + + F + N+
Sbjct: 246 HTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIK 305
Query: 139 LILGNRLSGSIPLEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIP 198
+ L IS L +N L + EN G+L L ++L N +
Sbjct: 306 NFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELS 364
Query: 199 ESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLE-GPIPSTISQLKNLTE 257
+ + L +LD+ S+ S K+L
Sbjct: 365 KIAEMTTQM---------------------KSLQQLDISQNSVSYDEKKGDCSWTKSLLS 403
Query: 258 LRISDLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPV 317
L +S + + F L +++ L L + I IP+ + + L+ L+++ NQL
Sbjct: 404 LNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVP 460
Query: 318 PGILQNLKKIDYIFLTNNSLSGT------LPDWILTSEKNLDLSYNNFTESSPAT 366
GI L + I+L N + L W+ KN + S
Sbjct: 461 DGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWL---NKNSQKEQGSAKCSGSGK 512
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 4e-10
Identities = 32/203 (15%), Positives = 61/203 (30%), Gaps = 7/203 (3%)
Query: 188 LSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPS 247
S N +P+ + T I + ++ + I + +KL L + ++ S
Sbjct: 7 RSKNGLI-HVPK--DLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDIS 63
Query: 248 TISQLKNLTELRISDLKGSSSSFPNLQDMKKMERLIL-RNCLITGRIPEYIEDMTDLKIL 306
+ L L +S K S ++ L L N I + +M+ LK L
Sbjct: 64 VFKFNQELEYLDLSHNKLVKISCHPT---VNLKHLDLSFNAFDALPICKEFGNMSQLKFL 120
Query: 307 DLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGTLPDWILTSEKNLDLSYNNFTESSPAT 366
LS L + +L + + + L L T
Sbjct: 121 GLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHF 180
Query: 367 CRESRVNILSSFSSTGSNSVSWC 389
+ V +++ + V
Sbjct: 181 ILDVSVKTVANLELSNIKCVLED 203
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 2e-19
Identities = 21/201 (10%), Positives = 47/201 (23%), Gaps = 45/201 (22%)
Query: 666 KIGEGGFGPVYKGTLSD---GAVIAVKQL---SSKSKQGNREFVNEIGMISALQHQNLVK 719
G ++ D +A+ + +E ++ +S + + +
Sbjct: 38 FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 720 LYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEES 779
+ L+V E++ SL + R +A H
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVADT------SPSPVGAIRAMQSLAAAADAAH--- 146
Query: 780 RLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRGY 839
R + + V + D G L M
Sbjct: 147 RAGVALSIDHPSRVRVSID--------GDVVL-------------AYPATMPDA------ 179
Query: 840 LTDKADVYSFGIVALEIVSGK 860
+ D+ G ++ +
Sbjct: 180 -NPQDDIRGIGASLYALLVNR 199
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 92.1 bits (228), Expect = 2e-19
Identities = 57/359 (15%), Positives = 135/359 (37%), Gaps = 27/359 (7%)
Query: 107 NLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGDISTLEELVLED 166
+ +L + + + + L ++ +++ + + S+ I + + +L L
Sbjct: 19 AFAETIKDNLKKK--SVTDAVTQNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNG 74
Query: 167 NQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIPNFIG 226
N+L + L NLK+L + L N + S +LK L ++ + ++ I +
Sbjct: 75 NKLTDI--KPLTNLKNLGWLFLDENKIK-DL-SSLKDLKKLKSLSLEHNGIS-DING-LV 128
Query: 227 NWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISDLKGSS-SSFPNLQDMKKMERLILR 285
+ +L+ L L + + I+ L LT+L L+ + S L + K++ L L
Sbjct: 129 HLPQLESLYLGNNKI-----TDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLS 183
Query: 286 NCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGTLPDWI 345
I+ + + +L +L+L + NL + + T+ SL
Sbjct: 184 KNHIS--DLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISD 241
Query: 346 LTSEKNLDLSYNNFTESSPATCRESRVNILSSFSSTGSNSVSWCLKKDLPCPKEAKHYSL 405
+ ++ ++ ++ + + + + V+ LK + Y++
Sbjct: 242 DGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHGRVTQPLK---------EVYTV 292
Query: 406 FINCGGSPTEFEENDYEEDLNTQGPSNFGIVSDRWAYSSTGVYVGNESSKYLAANQYGL 464
+ G+ + + + P+ G V W G + N ++ Y++ N + L
Sbjct: 293 SYDVDGTVIKTKVEAGTRITAPKPPTKQGYVFKGWYTEKNGGHEWNFNTDYMSGNDFTL 351
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 6e-19
Identities = 58/277 (20%), Positives = 84/277 (30%), Gaps = 61/277 (22%)
Query: 75 CDCTYSNNTV-CHVTVILLKGFNLAGV---IPEEFGNLTFLQEVDLSRNYFNGSLPKSFA 130
C N T C N + +P + +DLS N SF
Sbjct: 3 CVEVVPNITYQCM-------ELNFYKIPDNLP------FSTKNLDLSFNPLRHLGSYSFF 49
Query: 131 RLQNLTKLLILGNRLSGSIPLEIGD-ISTLEELVLEDNQLVGPLPENL-GNLKSLRRILL 188
L L + + +I +S L L+L N + L L SL++++
Sbjct: 50 SFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQS-LALGAFSGLSSLQKLVA 107
Query: 189 SSNNFTGSIPE-SYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQG---TSLEGP 244
N S+ G+LK L E L++ S
Sbjct: 108 VETNLA-SLENFPIGHLKTLKE------------------------LNVAHNLIQSF--K 140
Query: 245 IPSTISQLKNLTEL-----RISDLKGSSSSFPNLQDMKKME-RLILRNCLITGRIPEYIE 298
+P S L NL L +I + + L M + L L + I
Sbjct: 141 LPEYFSNLTNLEHLDLSSNKIQSI--YCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAF 197
Query: 299 DMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNN 335
LK L L NQL GI L + I+L N
Sbjct: 198 KEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 2e-10
Identities = 30/192 (15%), Positives = 63/192 (32%), Gaps = 41/192 (21%)
Query: 182 SLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIPN--FIGNWTKLDRLDLQGT 239
S + + LS N S+ + L + + I + + + L L L G
Sbjct: 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSL-SHLSTLILTGN 86
Query: 240 SLEGPIPSTI-SQLKNLTELRISDLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYI- 297
++ + S L +L +L + + +
Sbjct: 87 PIQS-LALGAFSGLSSLQKLV------------------------AVETNLA-SLENFPI 120
Query: 298 EDMTDLKILDLSFNQLTG-PVPGILQNLKKIDYIFLTNNSLSGTLPDWILTS-------E 349
+ LK L+++ N + +P NL ++++ L++N + ++ L
Sbjct: 121 GHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLN 179
Query: 350 KNLDLSYNNFTE 361
+LDLS N
Sbjct: 180 LSLDLSLNPMNF 191
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 24/121 (19%), Positives = 51/121 (42%), Gaps = 12/121 (9%)
Query: 245 IPSTISQLKNLTELRISDLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYI-EDMTDL 303
+P + L +L+ + L S SF + +++ L L C I I + + ++ L
Sbjct: 26 LPFSTKNL-DLSFNPLRHL--GSYSFFSF---PELQVLDLSRCEIQ-TIEDGAYQSLSHL 78
Query: 304 KILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGTLPDW---ILTSEKNLDLSYNNFT 360
L L+ N + G L + + +L+ +L ++ L + K L++++N
Sbjct: 79 STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQ 137
Query: 361 E 361
Sbjct: 138 S 138
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 2e-05
Identities = 15/69 (21%), Positives = 25/69 (36%), Gaps = 4/69 (5%)
Query: 301 TDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGTLPDWI---LTSEKNLDLSYN 357
K LDLSFN L + ++ + L+ + T+ D L+ L L+ N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGN 86
Query: 358 NFTESSPAT 366
+
Sbjct: 87 PIQSLALGA 95
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 7e-19
Identities = 59/250 (23%), Positives = 98/250 (39%), Gaps = 63/250 (25%)
Query: 658 TNNFDAANKIGEGGFGPVYKGTLSD-GAVIAVKQLSSKSKQGNREFVNEIGMISALQHQN 716
+ + +G G FG V + + G A+K++ + NRE + ++ L H N
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRE----LDIMKVLDHVN 61
Query: 717 LVKLYGC--------------------------------------CIEGNQLLLVYEYLE 738
++KL + L ++ EY+
Sbjct: 62 IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP 121
Query: 739 NNSLARAL--FGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLD 796
+ L + L F + G+ + ++ + R + ++H L I HRDIK N+L++
Sbjct: 122 DT-LHKVLKSFIRSGRSIPMN--LISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVN 175
Query: 797 -KDLNAKISDFGLAK-LDEDE-NTH-ISTRIAGTVGYMAPE--YAMRGYLTDKADVYSFG 850
KD K+ DFG AK L E + I +R Y APE Y T D++S G
Sbjct: 176 SKDNTLKLCDFGSAKKLIPSEPSVAYICSRF-----YRAPELMLGATEY-TPSIDLWSIG 229
Query: 851 IVALEIVSGK 860
V E++ GK
Sbjct: 230 CVFGELILGK 239
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 8e-19
Identities = 47/279 (16%), Positives = 75/279 (26%), Gaps = 59/279 (21%)
Query: 68 SNGSNFTCDCTYSNNTV------CHVTVILLKGFNLAGVIPEEFGNLTFLQEVDLSRNYF 121
N T C I L G ++ V F L + L N
Sbjct: 9 YNEPKVTTSCPQQGLQAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVL 68
Query: 122 NGSLPKSFARLQNLTKLLILGNRLSGSIPLEI-GDISTLEELVLEDNQLVGPLPEN-LGN 179
+F L L +L + N S+ + L L L+ L L
Sbjct: 69 ARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQE-LGPGLFRG 127
Query: 180 LKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGT 239
L +L+ + L N ++P+ ++L L L L G
Sbjct: 128 LAALQYLYLQDNALQ-ALPD--DTFRDLG---------------------NLTHLFLHGN 163
Query: 240 SLEGPIPSTISQLKNLTELRISDLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYI-E 298
+ L +L L L + + +
Sbjct: 164 RISSVPERAFRGLHSLDRLL------------------------LHQNRVA-HVHPHAFR 198
Query: 299 DMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSL 337
D+ L L L N L+ L L+ + Y+ L +N
Sbjct: 199 DLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 5e-17
Identities = 40/201 (19%), Positives = 75/201 (37%), Gaps = 25/201 (12%)
Query: 173 LPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLD 232
+P + + +RI L N + S+ +NLT + + L L+
Sbjct: 26 VPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83
Query: 233 RLDLQG----TSLEGPIPSTISQLKNLTEL-----RISDLKGSSSSFPNLQDMKKMERLI 283
+LDL S++ P+T L L L + +L F L ++ L
Sbjct: 84 QLDLSDNAQLRSVD---PATFHGLGRLHTLHLDRCGLQEL--GPGLFRGL---AALQYLY 135
Query: 284 LRNCLITGRIPEYI-EDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGTLP 342
L++ + +P+ D+ +L L L N+++ + L +D + L N ++ +
Sbjct: 136 LQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA-HVH 193
Query: 343 DWI---LTSEKNLDLSYNNFT 360
L L L NN +
Sbjct: 194 PHAFRDLGRLMTLYLFANNLS 214
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 2e-18
Identities = 54/323 (16%), Positives = 101/323 (31%), Gaps = 51/323 (15%)
Query: 75 CDCTYSNNTV-CHVTVILLKGFNLAGV--IPEEFGNLTFLQEVDLSRNYFNGSLPKSFAR 131
+C+ C L V +P ++ ++ DLS N SF+R
Sbjct: 6 SECSVIGYNAICI-------NRGLHQVPELPA---HVNYV---DLSLNSIAELNETSFSR 52
Query: 132 LQNLTKLLILGNRLSGSIPLEIGD-ISTLEELVLEDNQLVGPLPEN-LGNLKSLRRILLS 189
LQ+L L + I +S+L L L+ NQ + L L +L + L+
Sbjct: 53 LQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQ-LETGAFNGLANLEVLTLT 111
Query: 190 SNNFTGS-IPESY-GNLKNLTEFRIDGSNLTGRIPN-FIGNWTKLDRLDLQG---TSLE- 242
N G+ + ++ L +L + +N+ P F N + LDL S+
Sbjct: 112 QCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICE 171
Query: 243 ------GPIPSTISQLKNLTELRISDLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEY 296
T+ +L ++T +++ N + L L + +
Sbjct: 172 EDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKR 231
Query: 297 IEDMTDL-------------KILDLSFNQLTGPVPGILQNLK--KIDYIFLTNNSLSGTL 341
D P + L+ + L+ + + L
Sbjct: 232 FFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-AL 290
Query: 342 PDWI---LTSEKNLDLSYNNFTE 361
+ T + L L+ N +
Sbjct: 291 LKSVFSHFTDLEQLTLAQNEINK 313
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 2e-17
Identities = 58/312 (18%), Positives = 102/312 (32%), Gaps = 51/312 (16%)
Query: 96 NLAGVIPEE-FGNLTFLQEVDLSRNYFNGSLPKSFARLQ--NLTKLLILGNRLSGSIPLE 152
N+ + P F N+ +DL+ N + Q + T L + L
Sbjct: 140 NIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYW 199
Query: 153 IGDI--------STLEELVLEDNQLVGPLPENLGNLKSLRRIL-------------LSSN 191
+G +++ L L N + + + + +I
Sbjct: 200 LGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHT 259
Query: 192 NFTGSIPESYGNLK--NLTEFRIDGSNLTGRIPNFI-GNWTKLDRLDLQGTSLEGPIPST 248
NF ++ L+ + + S + + + ++T L++L L + +
Sbjct: 260 NFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEINKIDDNA 318
Query: 249 ISQLKNLTELRISD--LKG-SSSSFPNLQDMKKMERLILRNCLITGRIPEYI-EDMTDLK 304
L +L +L +S L S F NL K+E L L I + + + +LK
Sbjct: 319 FWGLTHLLKLNLSQNFLGSIDSRMFENL---DKLEVLDLSYNHIR-ALGDQSFLGLPNLK 374
Query: 305 ILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGT------LPDWILTSEKNLDLSYNN 358
L L NQL GI L + I+L N + L W+ N+
Sbjct: 375 ELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWLNK---------NS 425
Query: 359 FTESSPATCRES 370
E A C S
Sbjct: 426 QKEQGSAKCSGS 437
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 1e-09
Identities = 26/158 (16%), Positives = 58/158 (36%), Gaps = 12/158 (7%)
Query: 214 GSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISDLKGSSSSFPNL 273
L ++P + +DL S+ ++ S+L++L L++ N
Sbjct: 19 NRGLH-QVPE-LPAHVN--YVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNT 74
Query: 274 -QDMKKMERLILRNCLITGRIPEYI-EDMTDLKILDLSFNQLTGPV--PGILQNLKKIDY 329
+ + + L L ++ + +L++L L+ L G V + L ++
Sbjct: 75 FRGLSSLIILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEM 133
Query: 330 IFLTNNSLSGTLPDWI---LTSEKNLDLSYNNFTESSP 364
+ L +N++ P + LDL++N
Sbjct: 134 LVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICE 171
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 1e-08
Identities = 32/143 (22%), Positives = 62/143 (43%), Gaps = 8/143 (5%)
Query: 76 DCTYSNNTVCHVTVILLKGFNLAGVIPEEFGNLTFLQEVDLSRNYFNGSLPK-SFARLQN 134
+ T+ V L + ++ F + T L+++ L++N N + +F L +
Sbjct: 266 NFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTH 324
Query: 135 LTKLLILGNRLSGSIPLEIGD-ISTLEELVLEDNQLVGPLPENL-GNLKSLRRILLSSNN 192
L KL + N L SI + + + LE L L N + L + L +L+ + L +N
Sbjct: 325 LLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHI-RALGDQSFLGLPNLKELALDTNQ 382
Query: 193 FTGSIPES-YGNLKNLTEFRIDG 214
S+P+ + L +L + +
Sbjct: 383 LK-SVPDGIFDRLTSLQKIWLHT 404
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 3e-08
Identities = 30/128 (23%), Positives = 55/128 (42%), Gaps = 11/128 (8%)
Query: 244 PIPSTISQLKNLTELRISDLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYI-EDMTD 302
+P+ ++ + +L+ I++L + +SF L + ++ L + I ++
Sbjct: 27 ELPAHVNYV-DLSLNSIAEL--NETSFSRL---QDLQFLKVEQQTPGLVIRNNTFRGLSS 80
Query: 303 LKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSL-SGTLPDWI---LTSEKNLDLSYNN 358
L IL L +NQ G L ++ + LT +L L LTS + L L NN
Sbjct: 81 LIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNN 140
Query: 359 FTESSPAT 366
+ PA+
Sbjct: 141 IKKIQPAS 148
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 88.8 bits (220), Expect = 2e-18
Identities = 42/240 (17%), Positives = 91/240 (37%), Gaps = 11/240 (4%)
Query: 104 EFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLT----KLLILGNRLSGSIPLEIGDI-ST 158
+F ++ +++ + + + + N++ + + +
Sbjct: 271 QFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAE 330
Query: 159 LEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLT 218
+ +L + + S + + N FT S+ + LK L + + L
Sbjct: 331 MNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK 390
Query: 219 --GRIPNFIGNWTKLDRLDLQGTSLE-GPIPSTISQLKNLTELRISDLKGSSSSFPNLQD 275
++ N + L+ LD+ SL T + +++ L +S + S F L
Sbjct: 391 NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP- 449
Query: 276 MKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNN 335
K++ L L N I IP+ + + L+ L+++ NQL G+ L + YI+L +N
Sbjct: 450 -PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 77.2 bits (190), Expect = 1e-14
Identities = 49/274 (17%), Positives = 88/274 (32%), Gaps = 28/274 (10%)
Query: 105 FGNLTFLQEVDLSRNYFNGSLPKS--FARLQNLTKLLILGNRLSGSIPLEIGDISTLE-- 160
+ L+ +DLS N F+ LP F L LT L + + + L L
Sbjct: 117 CCPMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFR-QLDLLPVAHLHLSCI 174
Query: 161 ELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGR 220
L L + G E+L + L+ N S+ + ++ L ++
Sbjct: 175 LLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVN-MSVNALGHLQL-------- 225
Query: 221 IPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISDLKGSSSSFPNLQDMKKME 280
+ KL+ + Q + L N+T I S + +E
Sbjct: 226 ------SNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVE 279
Query: 281 RLILRNCLITGRIPEYIEDMTD-----LKILDLSFNQLTGPVPGILQNLKKIDYIFLTNN 335
L + N IT RI ++ L I + + +++ L+ +
Sbjct: 280 YLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSIS 339
Query: 336 SLSG--TLPDWILTSEKNLDLSYNNFTESSPATC 367
+ +S L+ + N FT+S C
Sbjct: 340 DTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGC 373
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 1e-13
Identities = 56/326 (17%), Positives = 107/326 (32%), Gaps = 47/326 (14%)
Query: 68 SNGSNFTCDCTYSNNTVCHVTVILLKGFNLAGV---IPEEFGNLTFLQEVDLSRNYFNGS 124
SN D SN NL V +P + + LS+N +
Sbjct: 29 SNELESMVDY--SNR-------------NLTHVPKDLP------PRTKALSLSQNSISEL 67
Query: 125 LPKSFARLQNLTKLLILGNRLSGSIPLEIGDIST-LEELVLEDNQLVGPLPENLGNLKSL 183
+ L L L + NR+ S+ + + LE L + N+L + + SL
Sbjct: 68 RMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRLQN-IS--CCPMASL 123
Query: 184 RRILLSSNNFTGSIPES--YGNLKNLTEFRIDGSNLTGRIP--NFIGNWTKLDRLDLQGT 239
R + LS N+F +P +GNL LT + + ++ LDL
Sbjct: 124 RHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFR-QLDLLPVAHLHLSCILLDLVSY 181
Query: 240 SLEGPIPSTISQLKNLTELRISDLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYIED 299
++G + Q+ N T L + S S + + L L N + + +
Sbjct: 182 HIKG-GETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMT 240
Query: 300 M-----TDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGTLPDWILTSEKNLDL 354
+L+++ + ++ + + ++ LT + +D
Sbjct: 241 FLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYN------LTITERIDR 294
Query: 355 SYNNFTESSPATCRESRVNILSSFSS 380
++E++ + V S
Sbjct: 295 EEFTYSETALKSLMIEHVKNQVFLFS 320
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 69.9 bits (171), Expect = 2e-12
Identities = 44/283 (15%), Positives = 83/283 (29%), Gaps = 25/283 (8%)
Query: 104 EFGNLTFLQEV----DLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGDISTL 159
+ + L DL + G +S N T L ++ + S ++ L
Sbjct: 162 DLLPVAHLHLSCILLDLVSYHIKGGETESLQIP-NTTVLHLVFHPNSLFSVQVNMSVNAL 220
Query: 160 EELVLEDNQLVG--------PLPENLGNLKSLRRILLSSNNFTGSIPE--SYGNLKNLTE 209
L L + +L L E L L + + + +
Sbjct: 221 GHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEY 280
Query: 210 FRIDGSNLTGRIPNFIGNWTK-----LDRLDLQGTSLEGPIPSTISQLKNLTELRISDLK 264
I +T RI +++ L ++ + S + +S
Sbjct: 281 LNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISD 340
Query: 265 GSSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLT--GPVPGILQ 322
L + T + + + L+ L L N L V + +
Sbjct: 341 TPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTK 400
Query: 323 NLKKIDYIFLTNNSLSGTLPD---WILTSEKNLDLSYNNFTES 362
N+ ++ + ++ NSL+ D S L+LS N T S
Sbjct: 401 NMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGS 443
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 48.3 bits (115), Expect = 1e-05
Identities = 26/98 (26%), Positives = 43/98 (43%), Gaps = 7/98 (7%)
Query: 98 AGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARL-QNLTKLLILGNRLSGSIPLEIGDI 156
+ + ++LS N GS+ F L + L + NR+ SIP ++ +
Sbjct: 417 SHAYDRTCAWAESILVLNLSSNMLTGSV---FRCLPPKVKVLDLHNNRIM-SIPKDVTHL 472
Query: 157 STLEELVLEDNQLVGPLPEN-LGNLKSLRRILLSSNNF 193
L+EL + NQL +P+ L SL+ I L N +
Sbjct: 473 QALQELNVASNQLKS-VPDGVFDRLTSLQYIWLHDNPW 509
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 4e-18
Identities = 61/230 (26%), Positives = 102/230 (44%), Gaps = 29/230 (12%)
Query: 643 DLQTGYFTLRQIKAATNNFDAANKIGEGGFGPVY----KGTLSDGAVIAVKQLSSKSKQG 698
D + T Q A + FD +G G FG V K + G A+K L K K
Sbjct: 25 DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKES---GNHYAMKILD-KQKVV 80
Query: 699 NREFV----NEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCL 754
+ + NE ++ A+ LVKL + + L +V EY+ + L +
Sbjct: 81 KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRF 138
Query: 755 NLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDED 814
+ A + + I YLH L +++RD+K N+L+D+ +++DFG AK +
Sbjct: 139 SEPHA--RFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193
Query: 815 E-NTHISTRIAGTVGYMAPEYAM-RGYLTDKA-DVYSFGIVALEIVSGKS 861
T + GT +APE + +GY +KA D ++ G++ E+ +G
Sbjct: 194 RTWT-----LCGTPEALAPEIILSKGY--NKAVDWWALGVLIYEMAAGYP 236
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 4e-18
Identities = 65/223 (29%), Positives = 111/223 (49%), Gaps = 34/223 (15%)
Query: 655 KAATNNFDAANKIGEGGFGPVY---KGTLSD-GAVIAVKQLSSKSKQGNREFVN---EIG 707
KA + F+ +G+G FG V+ K + SD + A+K L K+ R+ V E
Sbjct: 20 KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLK-KATLKVRDRVRTKMERD 78
Query: 708 MISALQHQNLVKLYGCCIEGNQLLLVYEYL---ENNSLARALF---GKEGQCLNLDWATR 761
++ + H +VKL+ +L L+ ++L + LF KE +
Sbjct: 79 ILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGD-------LFTRLSKEV-MFTEEDV-- 128
Query: 762 KRI-CSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHIS 820
+ +++A L +LH L I++RD+K N+LLD++ + K++DFGL+K D
Sbjct: 129 -KFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY 184
Query: 821 TRIAGTVGYMAPEYAMR-GYLTDKA-DVYSFGIVALEIVSGKS 861
+ GTV YMAPE R G+ ++ D +SFG++ E+++G
Sbjct: 185 S-FCGTVEYMAPEVVNRRGH--TQSADWWSFGVLMFEMLTGTL 224
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 6e-18
Identities = 67/253 (26%), Positives = 110/253 (43%), Gaps = 38/253 (15%)
Query: 630 GGKNVEDKELRGLDLQTGYFTLRQIKAATNNFDAANKIGEGGFGPVY---KGTLSD-GAV 685
GG E +L+T T K NF+ +G G +G V+ K + D G +
Sbjct: 25 GGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKL 84
Query: 686 IAVKQLSSKSKQGNREFV----NEIGMISALQHQN-LVKLYGCCIEGNQLLLVYEYL--- 737
A+K L + + E ++ ++ LV L+ +L L+ +Y+
Sbjct: 85 YAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGG 144
Query: 738 ENNSLARALF---GKEGQCLNLDWATRKRI-CSDIARGLAYLHEESRLKIVHRDIKATNV 793
E LF + + +I +I L +LH+ L I++RDIK N+
Sbjct: 145 E-------LFTHLSQRER-FTEHEV---QIYVGEIVLALEHLHK---LGIIYRDIKLENI 190
Query: 794 LLDKDLNAKISDFGLAKLD-EDENTHISTRIAGTVGYMAPE---YAMRGYLTDKA-DVYS 848
LLD + + ++DFGL+K DE GT+ YMAP+ G+ DKA D +S
Sbjct: 191 LLDSNGHVVLTDFGLSKEFVADETERAYD-FCGTIEYMAPDIVRGGDSGH--DKAVDWWS 247
Query: 849 FGIVALEIVSGKS 861
G++ E+++G S
Sbjct: 248 LGVLMYELLTGAS 260
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 6e-18
Identities = 45/260 (17%), Positives = 104/260 (40%), Gaps = 22/260 (8%)
Query: 107 NLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGDISTLEELVLED 166
+ +L + + + + L ++ +++ + + S+ I + + +L L
Sbjct: 22 AFAETIKDNLKKK--SVTDAVTQNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNG 77
Query: 167 NQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIPNFIG 226
N+L + L NLK+L + L N + S +LK L ++ + ++ I +
Sbjct: 78 NKLTDI--KPLANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLSLEHNGIS-DING-LV 131
Query: 227 NWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISDLKGSS-SSFPNLQDMKKMERLILR 285
+ +L+ L L + + I+ L LT+L L+ + S L + K++ L L
Sbjct: 132 HLPQLESLYLGNNKI-----TDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLS 186
Query: 286 NCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGTLPDWI 345
I+ + + +L +L+L + NL + + T+ SL P+ I
Sbjct: 187 KNHISD--LRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL--VTPEII 242
Query: 346 --LTSEKNLDLSYNNFTESS 363
+ ++ ++ ++
Sbjct: 243 SDDGDYEKPNVKWHLPEFTN 262
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 1e-15
Identities = 41/230 (17%), Positives = 95/230 (41%), Gaps = 19/230 (8%)
Query: 130 ARLQNLTKLLILGNRLSGSIPLEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLS 189
K + ++ ++ +++++++++ ++ + + + L ++ ++ L+
Sbjct: 21 DAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFLN 76
Query: 190 SNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTI 249
N T I + NLKNL +D + + + + + KL L L+ + S I
Sbjct: 77 GNKLT-DI-KPLANLKNLGWLFLDENKVK-DLSSL-KDLKKLKSLSLEHNGI-----SDI 127
Query: 250 SQLKNLTELRISDLKGSS-SSFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDL 308
+ L +L +L L + + L + K++ L L + I+ I + +T L+ L L
Sbjct: 128 NGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYL 185
Query: 309 SFNQLTGPVPGILQNLKKIDYIFLTNNSLSGTLPDWILTSEKNLDLSYNN 358
S N ++ L LK +D + L + P ++ + N
Sbjct: 186 SKNHISDLRA--LAGLKNLDVLELFSQECL-NKPINHQSNLVVPNTVKNT 232
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 2e-15
Identities = 43/191 (22%), Positives = 82/191 (42%), Gaps = 14/191 (7%)
Query: 175 ENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRL 234
+ + L + T ++ ++ L ++ + + S++ + I + +L
Sbjct: 18 FSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIK-SVQG-IQYLPNVTKL 73
Query: 235 DLQGTSLEGPIPSTISQLKNLTELRISDLKGSS-SSFPNLQDMKKMERLILRNCLITGRI 293
L G L + I L NL L L + +L+D+KK++ L L + I+ I
Sbjct: 74 FLNGNKL-----TDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGIS-DI 127
Query: 294 PEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGTLPDWILTSEKNLD 353
+ + L+ L L N++T L L K+D + L +N +S +P LT +NL
Sbjct: 128 -NGLVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLY 184
Query: 354 LSYNNFTESSP 364
LS N+ ++
Sbjct: 185 LSKNHISDLRA 195
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 44/238 (18%), Positives = 90/238 (37%), Gaps = 22/238 (9%)
Query: 103 EEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGDISTLEEL 162
+ L + ++ L+ N + K A L+NL L + N++ L+ D+ L+ L
Sbjct: 62 QGIQYLPNVTKLFLNGNKLT-DI-KPLANLKNLGWLFLDENKVKDLSSLK--DLKKLKSL 117
Query: 163 VLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIP 222
LE N + L +L L + L +N T I L L ++ + ++ I
Sbjct: 118 SLEHNGIS--DINGLVHLPQLESLYLGNNKIT-DI-TVLSRLTKLDTLSLEDNQIS-DIV 172
Query: 223 NFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISDLKGSSSSFPNLQDMKKMERL 282
TKL L L + ++ LKNL L + + + + ++ +
Sbjct: 173 PL-AGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTV 229
Query: 283 ILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGT 340
+ + PE I D D + ++ ++ + + ++ +IF ++
Sbjct: 230 KNTDGSLVT--PEIISDDGDYEKPNVKWH--------LPEFTNEVSFIFYQPVTIGKA 277
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 6e-18
Identities = 55/231 (23%), Positives = 91/231 (39%), Gaps = 40/231 (17%)
Query: 651 LRQIKAATNNFDAANKIGEGGFGPVY----KGTLSDGAVIAVKQLSSKSKQGNRE----F 702
+R ++ +++ IG G FG V K T V A+K LS K + R F
Sbjct: 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKST---RKVYAMKLLS-KFEMIKRSDSAFF 116
Query: 703 VNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRK 762
E +++ +V+L+ + L +V EY+ L + +
Sbjct: 117 WEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM-------------SNY 163
Query: 763 RICSDIAR--------GLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDED 814
+ AR L +H + +HRD+K N+LLDK + K++DFG
Sbjct: 164 DVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 220
Query: 815 ENTHISTRIAGTVGYMAPE----YAMRGYLTDKADVYSFGIVALEIVSGKS 861
E GT Y++PE GY + D +S G+ E++ G +
Sbjct: 221 EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT 271
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 85.3 bits (211), Expect = 9e-18
Identities = 50/366 (13%), Positives = 103/366 (28%), Gaps = 72/366 (19%)
Query: 71 SNFTCDCTYSNNTV------CHVTVILLKGFNLAGVIPEEFGNLTFLQEVDLSRNYFNGS 124
SN C S T + + L + F L+++++S+N
Sbjct: 10 SNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEV 69
Query: 125 LPKS-FARLQNLTKLLIL-GNRLSGSIPLEI-GDISTLEELVLEDNQLVGPLPENLGNLK 181
+ F+ L L ++ I N L I E ++ L+ L++ + + + +
Sbjct: 70 IEADVFSNLPKLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSL 128
Query: 182 SLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSL 241
+ + N +I + L+ + L L +
Sbjct: 129 QKVLLDIQDNINIHTIER--NSFVGLS--------------------FESVILWLNKNGI 166
Query: 242 EGPIPSTISQLKNLTELRISDLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYI-EDM 300
+ I ++ L EL + N + +P +
Sbjct: 167 QE-IHNSAFNGTQLDEL-----------------------NLSDNNNLE-ELPNDVFHGA 201
Query: 301 TDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGTLPDWILTSEKNLDLSYNNFT 360
+ ILD+S ++ L+NLKK+ + +L L + L+Y
Sbjct: 202 SGPVILDISRTRIHSLPSYGLENLKKLRA--RSTYNLKKLPTLEKLVALMEASLTYP--- 256
Query: 361 ESSPATCRESRVNILSSFSSTGSNSVSWCLKKDLPCPKEAKHYSLFINCGGSPTEFEEND 420
S +++ S C K L + + +
Sbjct: 257 ---------SHCCAFANWRRQISELHPICNKSILRQEVDYMTQARGQRSSLAEDNESSYS 307
Query: 421 YEEDLN 426
D+
Sbjct: 308 RGFDMT 313
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 1e-17
Identities = 63/216 (29%), Positives = 94/216 (43%), Gaps = 21/216 (9%)
Query: 655 KAATNNFDAANKIGEGGFGPVY----KGTLSDGAVIAVKQLSSKSKQGNREF---VNEIG 707
+ N F+ +G+G FG V K T G A+K L + E + E
Sbjct: 144 RVTMNEFEYLKLLGKGTFGKVILVKEKAT---GRYYAMKILKKEVIVAKDEVAHTLTENR 200
Query: 708 MISALQHQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRI-CS 766
++ +H L L ++L V EY L L +E + D R R +
Sbjct: 201 VLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHL-SRER-VFSED---RARFYGA 255
Query: 767 DIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGT 826
+I L YLH S +V+RD+K N++LDKD + KI+DFGL K + + T GT
Sbjct: 256 EIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGT 312
Query: 827 VGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGKS 861
Y+APE Y D + G+V E++ G+
Sbjct: 313 PEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRL 347
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 84.2 bits (207), Expect = 2e-17
Identities = 46/270 (17%), Positives = 77/270 (28%), Gaps = 64/270 (23%)
Query: 645 QTGYFTLRQIKAATNNFDAANKIGEGGFGPVYKGTLSDGAVIAVKQL--------SSKSK 696
Q G T KIGEG FG V++ V A+K + + +
Sbjct: 7 QKGPVPFSHCLP-TEKLQRCEKIGEGVFGEVFQTIADHTPV-AIKIIAIEGPDLVNGSHQ 64
Query: 697 QGNREFVNEIGMISALQ---------HQNLVKLYGCCI---------------------- 725
+ E + EI + L + + L
Sbjct: 65 KTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGS 124
Query: 726 --------EGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHE 777
+ +QL +V E+ + K AT K I + LA
Sbjct: 125 ANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK-----LSSLATAKSILHQLTASLAVAEA 179
Query: 778 ESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMR 837
L+ HRD+ NVLL K K+ K + + I +Y +
Sbjct: 180 --SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSII--------DYTLS 229
Query: 838 GYLTDKADVYSFGIVALEIVSGKSNTNYRP 867
D V+ + ++ +G + +
Sbjct: 230 RLERDGIVVFCDVSMDEDLFTGDGDYQFDI 259
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 3e-17
Identities = 64/224 (28%), Positives = 107/224 (47%), Gaps = 34/224 (15%)
Query: 655 KAATNNFDAANKIGEGGFGPVY---KGTLSD-GAVIAVKQLSSKSKQGNREFV----NEI 706
K F+ +G+GG+G V+ K T ++ G + A+K L N + E
Sbjct: 13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAER 72
Query: 707 GMISALQHQNLVKLYGCCIEGNQLLLVYEYL---ENNSLARALF---GKEGQCLNLDWAT 760
++ ++H +V L G +L L+ EYL E LF +EG D A
Sbjct: 73 NILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGE-------LFMQLEREGI-FMEDTA- 123
Query: 761 RKRI-CSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHI 819
++I+ L +LH+ I++RD+K N++L+ + K++DFGL K + T
Sbjct: 124 --CFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVT 178
Query: 820 STRIAGTVGYMAPEYAMR-GYLTDKA-DVYSFGIVALEIVSGKS 861
T GT+ YMAPE MR G+ ++A D +S G + ++++G
Sbjct: 179 HT-FCGTIEYMAPEILMRSGH--NRAVDWWSLGALMYDMLTGAP 219
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 6e-17
Identities = 62/223 (27%), Positives = 104/223 (46%), Gaps = 43/223 (19%)
Query: 655 KAATNNFDAANKIGEGGFGPVY----KGTLSDGAVIAVKQLSSKSKQGNREFV----NEI 706
K + +F +G G FG V+ + G A+K L K + V +E
Sbjct: 2 KYSLQDFQILRTLGTGSFGRVHLIRSRHN---GRYYAMKVLK-KEIVVRLKQVEHTNDER 57
Query: 707 GMISALQHQNLVKLYGCCIEGNQLLLVYEYL---ENNSLARALFG---KEGQCLNLDWAT 760
M+S + H +++++G + Q+ ++ +Y+ E LF K + N
Sbjct: 58 LMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGE-------LFSLLRKSQRFPN----P 106
Query: 761 RKRI-CSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDE-NTH 818
+ +++ L YLH I++RD+K N+LLDK+ + KI+DFG AK D T
Sbjct: 107 VAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT- 162
Query: 819 ISTRIAGTVGYMAPEYAMR-GYLTDKA-DVYSFGIVALEIVSG 859
+ GT Y+APE Y +K+ D +SFGI+ E+++G
Sbjct: 163 ----LCGTPDYIAPEVVSTKPY--NKSIDWWSFGILIYEMLAG 199
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 9e-17
Identities = 42/153 (27%), Positives = 61/153 (39%), Gaps = 17/153 (11%)
Query: 666 KIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCC 724
+G G G V + A+K L + RE E+ A Q ++V++
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARREV--EL-HWRASQCPHIVRIVDVY 80
Query: 725 ----IEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESR 780
LL+V E L+ L + + Q A I I + YLH
Sbjct: 81 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREA--SEIMKSIGEAIQYLHS--- 135
Query: 781 LKIVHRDIKATNVLL-DKDLNA--KISDFGLAK 810
+ I HRD+K N+L K NA K++DFG AK
Sbjct: 136 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 2e-16
Identities = 66/224 (29%), Positives = 100/224 (44%), Gaps = 37/224 (16%)
Query: 655 KAATNNFDAANKIGEGGFGPVY----KGTLSDGAVIAVKQLSSKSKQGNREFVNEIG--- 707
A ++F IG+G FG V K AVK L K+ +E + +
Sbjct: 34 HAKPSDFHFLKVIGKGSFGKVLLARHKAE---EVFYAVKVLQKKAILKKKEEKHIMSERN 90
Query: 708 -MISALQHQNLVKLYGCCIEGNQLLLVYEYL---ENNSLARALF---GKEGQCLNLDWAT 760
++ ++H LV L+ ++L V +Y+ E LF +E C A
Sbjct: 91 VLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGE-------LFYHLQRER-CFLEPRA- 141
Query: 761 RKRI-CSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHI 819
R ++IA L YLH L IV+RD+K N+LLD + ++DFGL K + + N+
Sbjct: 142 --RFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTT 196
Query: 820 STRIAGTVGYMAPEYAMR-GYLTDKA-DVYSFGIVALEIVSGKS 861
ST GT Y+APE + Y D+ D + G V E++ G
Sbjct: 197 ST-FCGTPEYLAPEVLHKQPY--DRTVDWWCLGAVLYEMLYGLP 237
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 3e-16
Identities = 53/219 (24%), Positives = 93/219 (42%), Gaps = 40/219 (18%)
Query: 666 KIGEGGFGPVYKGTLSDGAVIAVKQLS--SKSKQGNREFVN---------EIGMISALQH 714
I G +G V G S+G +A+K++ + + EI +++ H
Sbjct: 29 FISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88
Query: 715 QNLVKLYGCCI-----EGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICS--- 766
N++ L + ++L LV E + + LA+ + + + + + I
Sbjct: 89 PNILGLRDIFVHFEEPAMHKLYLVTELMRTD-LAQVI--HDQR----IVISPQHIQYFMY 141
Query: 767 DIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENT---HISTRI 823
I GL LHE +VHRD+ N+LL + + I DF LA+ D + +++ R
Sbjct: 142 HILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRW 198
Query: 824 AGTVGYMAPE--YAMRGYLTDKADVYSFGIVALEIVSGK 860
Y APE +G+ T D++S G V E+ + K
Sbjct: 199 -----YRAPELVMQFKGF-TKLVDMWSAGCVMAEMFNRK 231
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 4e-16
Identities = 67/224 (29%), Positives = 97/224 (43%), Gaps = 38/224 (16%)
Query: 655 KAATNNFDAANKIGEGGFGPV----YKGTLSDGAVIAVKQLSSKSKQGNREFVN----EI 706
K N+FD +G+G FG V K T G A+K L K ++ V E
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKAT---GRYYAMKILR-KEVIIAKDEVAHTVTES 56
Query: 707 GMISALQHQNLVKLYGCCIEGNQLLLVYEYL---ENNSLARALF---GKEGQCLNLDWAT 760
++ +H L L ++L V EY E LF +E + A
Sbjct: 57 RVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGE-------LFFHLSRER-VFTEERA- 107
Query: 761 RKRI-CSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHI 819
R ++I L YLH +V+RDIK N++LDKD + KI+DFGL K + +
Sbjct: 108 --RFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM 162
Query: 820 STRIAGTVGYMAPEYAMR-GYLTDKA-DVYSFGIVALEIVSGKS 861
T GT Y+APE Y +A D + G+V E++ G+
Sbjct: 163 KT-FCGTPEYLAPEVLEDNDY--GRAVDWWGLGVVMYEMMCGRL 203
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 4e-16
Identities = 53/222 (23%), Positives = 96/222 (43%), Gaps = 41/222 (18%)
Query: 658 TNNFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNREFVN---------EIG 707
+ +G G +G V GA +A+K+L R F + E+
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLY-------RPFQSELFAKRAYRELR 76
Query: 708 MISALQHQNLVKLY------GCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATR 761
++ ++H+N++ L + LV ++ + L + + + L
Sbjct: 77 LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTD-LGKLM-----KHEKLGEDRI 130
Query: 762 KRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENT-HIS 820
+ + + +GL Y+H I+HRD+K N+ +++D KI DFGLA+ + E T ++
Sbjct: 131 QFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVV 187
Query: 821 TRIAGTVGYMAPE--YAMRGYLTDKADVYSFGIVALEIVSGK 860
TR Y APE Y T D++S G + E+++GK
Sbjct: 188 TRW-----YRAPEVILNWMRY-TQTVDIWSVGCIMAEMITGK 223
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 82.0 bits (202), Expect = 4e-16
Identities = 56/217 (25%), Positives = 93/217 (42%), Gaps = 23/217 (10%)
Query: 655 KAATNNFDAANKIGEGGFGPV----YKGTLSDGAVIAVKQLSSKSKQGNREFVNEIGM-- 708
+ +F+ +G+G FG V KGT + AVK L K + V +
Sbjct: 337 RMKLTDFNFLMVLGKGSFGKVMLSERKGT---DELYAVKILK-KDVVIQDDDVECTMVEK 392
Query: 709 ---ISALQHQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRIC 765
+ L +L+ C ++L V EY+ L Q
Sbjct: 393 RVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL----MYHIQQVGRFKEPHAVFYA 448
Query: 766 SDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAG 825
++IA GL +L I++RD+K NV+LD + + KI+DFG+ K + + T G
Sbjct: 449 AEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT-FCG 504
Query: 826 TVGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGKS 861
T Y+APE Y D ++FG++ E+++G++
Sbjct: 505 TPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQA 540
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 59/221 (26%), Positives = 98/221 (44%), Gaps = 39/221 (17%)
Query: 659 NNFDAANKIGEGGFGPVY----KGTLSDGAVIAVKQLSSKSKQGNREFVNEIG-----MI 709
+FD IG G + V K T + A+K + K + E ++ +
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKT---DRIYAMKVVK-KELVNDDEDIDWVQTEKHVFE 64
Query: 710 SALQHQNLVKLYGCCIEGNQLLLVYEYL---ENNSLARALF---GKEGQCLNLDWATRKR 763
A H LV L+ C ++L V EY+ + L ++ L + A R
Sbjct: 65 QASNHPFLVGLHSCFQTESRLFFVIEYVNGGD-------LMFHMQRQR-KLPEEHA---R 113
Query: 764 I-CSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTR 822
++I+ L YLHE I++RD+K NVLLD + + K++D+G+ K ST
Sbjct: 114 FYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST- 169
Query: 823 IAGTVGYMAPEYAMR-GYLTDKA-DVYSFGIVALEIVSGKS 861
GT Y+APE Y + D ++ G++ E+++G+S
Sbjct: 170 FCGTPNYIAPEILRGEDY--GFSVDWWALGVLMFEMMAGRS 208
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 3e-15
Identities = 54/225 (24%), Positives = 97/225 (43%), Gaps = 48/225 (21%)
Query: 658 TNNFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNREFVN---------EIG 707
+ + +G G +G V G +A+K+LS R F + E+
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLS-------RPFQSEIFAKRAYRELL 75
Query: 708 MISALQHQNLVKLY------GCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATR 761
++ +QH+N++ L LV +++ + L + + G +
Sbjct: 76 LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTD-LQKIM----GLKF-----SE 125
Query: 762 KRICS---DIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTH 818
++I + +GL Y+H +VHRD+K N+ +++D KI DFGLA+ + E T
Sbjct: 126 EKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTG 182
Query: 819 -ISTRIAGTVGYMAPE--YAMRGYLTDKADVYSFGIVALEIVSGK 860
+ TR Y APE + Y D++S G + E+++GK
Sbjct: 183 YVVTRW-----YRAPEVILSWMHY-NQTVDIWSVGCIMAEMLTGK 221
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 3e-15
Identities = 60/239 (25%), Positives = 101/239 (42%), Gaps = 27/239 (11%)
Query: 635 EDKELRGLDLQTGYFTLRQIKAATNNFDAANKIGEGGFGPVY----KGTLSDGAVIAVKQ 690
E + T +FD IG G + V K T + A++
Sbjct: 28 SGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKT---DRIYAMRV 84
Query: 691 LSSKSKQGNREFVNEIG-----MISALQHQNLVKLYGCCIEGNQLLLVYEYLENNSLARA 745
+ K + E ++ + A H LV L+ C ++L V EY+ L
Sbjct: 85 VK-KELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFH 143
Query: 746 LFGKEGQCLNLDWATRKRI-CSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKIS 804
+ ++ L + A R ++I+ L YLHE I++RD+K NVLLD + + K++
Sbjct: 144 MQ-RQR-KLPEEHA---RFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLT 195
Query: 805 DFGLAKLDEDENTHISTRIAGTVGYMAPEYAMR-GYLTDKA-DVYSFGIVALEIVSGKS 861
D+G+ K ST GT Y+APE Y + D ++ G++ E+++G+S
Sbjct: 196 DYGMCKEGLRPGDTTST-FCGTPNYIAPEILRGEDY--GFSVDWWALGVLMFEMMAGRS 251
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 5e-15
Identities = 51/219 (23%), Positives = 90/219 (41%), Gaps = 35/219 (15%)
Query: 658 TNNFDAANKIGEGGFGPVYKGTLSD-GAVIAVKQLSSKSKQGNREFVN---------EIG 707
+ IG G G V + +A+K+LS R F N E+
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-------RPFQNQTHAKRAYRELV 76
Query: 708 MISALQHQNLVKLY------GCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATR 761
++ + H+N++ L E + +V E ++ N L + + + LD
Sbjct: 77 LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-LCQVIQ------MELDHERM 129
Query: 762 KRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHIST 821
+ + G+ +LH I+HRD+K +N+++ D KI DFGLA+ + + T
Sbjct: 130 SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMT 184
Query: 822 RIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGK 860
T Y APE + + D++S G + E++ G
Sbjct: 185 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 5e-15
Identities = 58/222 (26%), Positives = 100/222 (45%), Gaps = 41/222 (18%)
Query: 658 TNNFDAANKIGEGGFGPVYKGTLSD-GAVIAVKQLSSKSKQGNREFVN---------EIG 707
+ + +G G +G V + G +AVK+LS R F + E+
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-------RPFQSIIHAKRTYRELR 80
Query: 708 MISALQHQNLVKLY------GCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATR 761
++ ++H+N++ L E N + LV + + L + +C L
Sbjct: 81 LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD-LNNIV-----KCQKLTDDHV 134
Query: 762 KRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENT-HIS 820
+ + I RGL Y+H I+HRD+K +N+ +++D KI DFGLA+ DE T +++
Sbjct: 135 QFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVA 191
Query: 821 TRIAGTVGYMAPE--YAMRGYLTDKADVYSFGIVALEIVSGK 860
TR Y APE Y D++S G + E+++G+
Sbjct: 192 TRW-----YRAPEIMLNWMHY-NQTVDIWSVGCIMAELLTGR 227
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 6e-15
Identities = 58/220 (26%), Positives = 94/220 (42%), Gaps = 37/220 (16%)
Query: 659 NNFDAANKIGEGGFGPVY----KGTLSDGAVIAVKQLSSKSKQGNREFVNEIGM-----I 709
+NF+ +G+G FG V K T G + AVK L K + V
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKET---GDLYAVKVLK-KDVILQDDDVECTMTEKRILS 78
Query: 710 SALQHQNLVKLYGCCIEGNQLLLVYEYL---ENNSLARALFG---KEGQCLNLDWATRKR 763
A H L +L+ C ++L V E++ + L K + A +
Sbjct: 79 LARNHPFLTQLFCCFQTPDRLFFVMEFVNGGD-------LMFHIQKSR-RFDEARA--RF 128
Query: 764 ICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRI 823
++I L +LH+ I++RD+K NVLLD + + K++DFG+ K +T
Sbjct: 129 YAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT-F 184
Query: 824 AGTVGYMAPEYAMR-GYLTDKA-DVYSFGIVALEIVSGKS 861
GT Y+APE Y A D ++ G++ E++ G +
Sbjct: 185 CGTPDYIAPEILQEMLY--GPAVDWWAMGVLLYEMLCGHA 222
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 9e-15
Identities = 44/250 (17%), Positives = 90/250 (36%), Gaps = 23/250 (9%)
Query: 132 LQNLTKLLILGNRLSGSIPLEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSN 191
L N K + ++ + + ++S ++ +++ + + +L+ + LS N
Sbjct: 18 LANAVKQNLGKQSVTDLVSQK--ELSGVQNFNGDNSNIQSL--AGMQFFTNLKELHLSHN 73
Query: 192 NFTGSIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQ 251
+ + +L L E ++ + L + L RL L L ++
Sbjct: 74 QIS-DL-SPLKDLTKLEELSVNRNRLK-NLNGI--PSACLSRLFLDNNELRDT--DSLIH 126
Query: 252 LKNLTELRISDLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFN 311
LKNL L I + K S L + K+E L L IT + + + +DL+
Sbjct: 127 LKNLEILSIRNNKLKS--IVMLGFLSKLEVLDLHGNEITN--TGGLTRLKKVNWIDLTGQ 182
Query: 312 QLT------GPVPGILQNLKKIDYIFLTNNSLS--GTLPDWILTSEKNLDLSYNNFTESS 363
+ P I +K D +++ +S G+ D + E + ++ S
Sbjct: 183 KCVNEPVKYQPELYITNTVKDPDGRWISPYYISNGGSYVDGCVLWELPVYTDEVSYKFSE 242
Query: 364 PATCRESRVN 373
E+
Sbjct: 243 YINVGETEAI 252
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 4e-14
Identities = 39/204 (19%), Positives = 75/204 (36%), Gaps = 17/204 (8%)
Query: 161 ELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGR 220
E + + L + + L + T + + L + F D SN+
Sbjct: 1 ESIQRPTPINQV--FPDPGLANAVKQNLGKQSVTDLVSQK--ELSGVQNFNGDNSNIQ-S 55
Query: 221 IPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISDLKGSS-SSFPNLQDMKKM 279
+ + +T L L L + S +S LK+LT+L + + + + +
Sbjct: 56 LAG-MQFFTNLKELHLSHNQI-----SDLSPLKDLTKLEELSVNRNRLKNLNGI-PSACL 108
Query: 280 ERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSG 339
RL L N + + + + +L+IL + N+L V L L K++ + L N ++
Sbjct: 109 SRLFLDNNELRD--TDSLIHLKNLEILSIRNNKLKSIVM--LGFLSKLEVLDLHGNEITN 164
Query: 340 TLPDWILTSEKNLDLSYNNFTESS 363
T L +DL+
Sbjct: 165 TGGLTRLKKVNWIDLTGQKCVNEP 188
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 4e-10
Identities = 48/230 (20%), Positives = 84/230 (36%), Gaps = 25/230 (10%)
Query: 103 EEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGDISTLEEL 162
L+ +Q + + SL NL +L + N++S PL+ D++ LEEL
Sbjct: 35 VSQKELSGVQNFNGDNSNIQ-SL-AGMQFFTNLKELHLSHNQISDLSPLK--DLTKLEEL 90
Query: 163 VLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIP 222
+ N+L + + L R+ L +N +S +LKNL I + L I
Sbjct: 91 SVNRNRLKN--LNGIPSAC-LSRLFLDNNELRD--TDSLIHLKNLEILSIRNNKLK-SIV 144
Query: 223 NFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISDLKGSSSSFPNLQDMKKMERL 282
+G +KL+ LDL G + + L L ++ DL G ++ ++
Sbjct: 145 M-LGFLSKLEVLDLHGNEI-----TNTGGLTRLKKVNWIDLTGQKCVNEPVKYQPELYIT 198
Query: 283 ILRNCLITGRI-PEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIF 331
I P YI + + + ++ Y F
Sbjct: 199 NTVKDPDGRWISPYYISNGGSYVDGCVLWELPV--------YTDEVSYKF 240
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 9e-15
Identities = 64/221 (28%), Positives = 99/221 (44%), Gaps = 25/221 (11%)
Query: 652 RQIKAATNNFDAANKIGEGGFGPV----YKGTLSDGAVIAVKQLSSKSKQGNREFVNEIG 707
QIK +F +G+G FG V +K T A+K L K + V
Sbjct: 10 LQIKLKIEDFILHKMLGKGSFGKVFLAEFKKT---NQFFAIKALK-KDVVLMDDDVECTM 65
Query: 708 M-----ISALQHQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRK 762
+ A +H L ++ L V EYL L + + +L A
Sbjct: 66 VEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI--QSCHKFDLSRA--T 121
Query: 763 RICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTR 822
++I GL +LH IV+RD+K N+LLDKD + KI+DFG+ K + + +T
Sbjct: 122 FYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT- 177
Query: 823 IAGTVGYMAPEYAMR-GYLTDKA-DVYSFGIVALEIVSGKS 861
GT Y+APE + Y + + D +SFG++ E++ G+S
Sbjct: 178 FCGTPDYIAPEILLGQKY--NHSVDWWSFGVLLYEMLIGQS 216
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 1e-14
Identities = 56/223 (25%), Positives = 99/223 (44%), Gaps = 35/223 (15%)
Query: 655 KAATNNFDAANKIGEGGFGPV----YKGTLSDGAVIAVKQLSSKSKQGNREFVNEIG--- 707
+ +F+ +G+G FG V KGT + AVK L + + +
Sbjct: 16 RMKLTDFNFLMVLGKGSFGKVMLSERKGT---DELYAVKILKKDVVIQDDDVECTMVEKR 72
Query: 708 -MISALQHQNLVKLYGCCIEGNQLLLVYEYL---ENNSLARALFG---KEGQCLNLDWAT 760
+ + L +L+ C ++L V EY+ + L + G+ A
Sbjct: 73 VLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGD-------LMYHIQQVGR-FKEPHA- 123
Query: 761 RKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHIS 820
++IA GL +L I++RD+K NV+LD + + KI+DFG+ K + +
Sbjct: 124 -VFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTK 179
Query: 821 TRIAGTVGYMAPEYAMR-GYLTDKA-DVYSFGIVALEIVSGKS 861
T GT Y+APE Y K+ D ++FG++ E+++G++
Sbjct: 180 T-FCGTPDYIAPEIIAYQPY--GKSVDWWAFGVLLYEMLAGQA 219
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 2e-14
Identities = 47/204 (23%), Positives = 94/204 (46%), Gaps = 37/204 (18%)
Query: 658 TNNFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNREFVN---------EIG 707
+N+ + IG G +G VY + +A+K+++ R F + EI
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVN-------RMFEDLIDCKRILREIT 77
Query: 708 MISALQHQNLVKLYGCCI-----EGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRK 762
+++ L+ +++LY I + ++L +V E +++ L + K L T +
Sbjct: 78 ILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSD-LKKLF--KTPIFL-----TEE 129
Query: 763 RICS---DIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLA-KLDEDENTH 818
I + ++ G ++HE I+HRD+K N LL++D + K+ DFGLA ++ +++T+
Sbjct: 130 HIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTN 186
Query: 819 ISTRIAGTVGYMAPEYAMRGYLTD 842
I + ++ LT
Sbjct: 187 IVNDLEENEEPGPHNKNLKKQLTS 210
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 76.0 bits (187), Expect = 2e-14
Identities = 53/222 (23%), Positives = 88/222 (39%), Gaps = 41/222 (18%)
Query: 658 TNNFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNREFVN---------EIG 707
+ IG G G V +A+K+LS R F N E+
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-------RPFQNQTHAKRAYRELV 113
Query: 708 MISALQHQNLVKLY------GCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATR 761
++ + H+N++ L E + LV E ++ N L + + LD
Sbjct: 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVIQM------ELDHERM 166
Query: 762 KRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENT---H 818
+ + G+ +LH I+HRD+K +N+++ D KI DFGLA+ +
Sbjct: 167 SYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY 223
Query: 819 ISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGK 860
+ TR Y APE + + D++S G + E+V K
Sbjct: 224 VVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 2e-14
Identities = 49/214 (22%), Positives = 89/214 (41%), Gaps = 45/214 (21%)
Query: 665 NKIGEGGFGPVYKGT-LSDGAVIAVKQLSS-KSKQGNREFVNEIGMISALQ----HQNLV 718
K+G G + V++ +++ + VK L K K+ RE I L+ N++
Sbjct: 42 RKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKRE-------IKILENLRGGPNII 94
Query: 719 KLYGCCI--EGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICS---DIARGLA 773
L LV+E++ N + Q L I +I + L
Sbjct: 95 TLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDY-----DIRFYMYEILKALD 144
Query: 774 YLHEESRLKIVHRDIKATNVLLDKDLNA-KISDFGLAKL---DEDENTHISTRIAGTVGY 829
Y H S I+HRD+K NV++D + ++ D+GLA+ ++ N +++R +
Sbjct: 145 YCH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY-----F 196
Query: 830 MAPE--YAMRGYLTDKA-DVYSFGIVALEIVSGK 860
PE + Y D + D++S G + ++ K
Sbjct: 197 KGPELLVDYQMY--DYSLDMWSLGCMLASMIFRK 228
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 74.9 bits (184), Expect = 4e-14
Identities = 41/206 (19%), Positives = 85/206 (41%), Gaps = 36/206 (17%)
Query: 658 TNNFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNREFVN---------EIG 707
+ ++ + IG G +G V + + V+A+K++ R F + EI
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKIL-------RVFEDLIDCKRILREIA 104
Query: 708 MISALQHQNLVKLYGCCI-----EGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRK 762
+++ L H ++VK+ I + ++L +V E +++ + + L K
Sbjct: 105 ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSD-FKKLF--RTPVYLTEL--HIK 159
Query: 763 RICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLA------KLDEDEN 816
+ ++ G+ Y+H I+HRD+K N L+++D + K+ DFGLA + +
Sbjct: 160 TLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQL 216
Query: 817 THISTRIAGTVGYMAPEYAMRGYLTD 842
+ ++ LT
Sbjct: 217 PISPREDDMNLVTFPHTKNLKRQLTG 242
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 74.8 bits (183), Expect = 6e-14
Identities = 39/319 (12%), Positives = 95/319 (29%), Gaps = 39/319 (12%)
Query: 40 IFRKLNFRNGQVNQTSCTEGSWNVTIDDSNGSNFTCDCTYSNNTVCHVTVILLKGFNLAG 99
+ + ++ + S+ +C + L
Sbjct: 257 LSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHVWLCDLPAASLNDQLPQH 316
Query: 100 VIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGDISTL 159
+ +E L + A + L + + + + + E+ L
Sbjct: 317 TFRVIWTGSDSQKECVLL-KDRPECWCRDSATDEQLFRCELSVEKST-VLQSELESCKEL 374
Query: 160 EELVLEDN-------------QLVGPLPENLGNLKSLRRI--------LLSSNNFTGSIP 198
+EL E+ + E L +L+ + + F
Sbjct: 375 QELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENS 434
Query: 199 ESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTEL 258
++ + +LT + + + + LDL L +P ++ L+ L L
Sbjct: 435 VLKMEYADVRVLHLAHKDLT-VLCH-LEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVL 491
Query: 259 RISD--LKGSSSSFPNLQDMKKMERLILRNCLITG-RIPEYIEDMTDLKILDLSFNQLTG 315
+ SD L+ + + ++ +++ L+L N + + + L +L+L N L
Sbjct: 492 QASDNALE----NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 547
Query: 316 P------VPGILQNLKKID 328
+ +L ++ I
Sbjct: 548 EEGIQERLAEMLPSVSSIL 566
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 69.4 bits (169), Expect = 3e-12
Identities = 45/239 (18%), Positives = 85/239 (35%), Gaps = 18/239 (7%)
Query: 128 SFARLQNLTKLLILGNRLSGSIPLEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRIL 187
S L +L + + + + +E VL ++ + + L R
Sbjct: 297 SHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPEC-WCRDSATDEQLFRCE 355
Query: 188 LSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPS 247
LS T + + K L E + + I LD L + +L+
Sbjct: 356 LSVEKST-VLQSELESCKELQELEPENKW---CLLTIILLMRALDPLLYEKETLQ----- 406
Query: 248 TISQLKNLTELRISDLKGSSSSF-----PNLQDMKKMERLILRNCLITGRIPEYIEDMTD 302
S LK + +R + L S F + + L L + +T + ++E +
Sbjct: 407 YFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT--VLCHLEQLLL 464
Query: 303 LKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGTLPDWILTSEKNLDLSYNNFTE 361
+ LDLS N+L +P L L+ ++ + ++N+L L + L L N +
Sbjct: 465 VTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALENVDGVANLPRLQELLLCNNRLQQ 522
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 68.2 bits (166), Expect = 7e-12
Identities = 31/164 (18%), Positives = 61/164 (37%), Gaps = 7/164 (4%)
Query: 35 QTLQSIFRKLNFRNGQVNQTSCTEGSWNVTIDDSNGSNFTCDCTYSNNTVCHVTVILLKG 94
T+ + R L+ + V + + N+V + ++
Sbjct: 386 LTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRV 445
Query: 95 FNLAG---VIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPL 151
+LA + L + +DLS N +LP + A L+ L L N L ++
Sbjct: 446 LHLAHKDLTVLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD- 502
Query: 152 EIGDISTLEELVLEDNQLVG-PLPENLGNLKSLRRILLSSNNFT 194
+ ++ L+EL+L +N+L + L + L + L N+
Sbjct: 503 GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC 546
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 7e-14
Identities = 57/223 (25%), Positives = 105/223 (47%), Gaps = 39/223 (17%)
Query: 658 TNNFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLS--SKSKQGNREFVNEIGMISALQH 714
+ + IGEG +G V + +A+K++S R EI ++ +H
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRH 84
Query: 715 QNLVKLYGCCI-----EGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICS--- 766
+N++ + + + +V + +E + L + L + Q L + IC
Sbjct: 85 ENIIGINDIIRAPTIEQMKDVYIVQDLMETD-LYKLL---KTQHL-----SNDHICYFLY 135
Query: 767 DIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTH-------I 819
I RGL Y+H + ++HRD+K +N+LL+ + KI DFGLA++ + ++ H +
Sbjct: 136 QILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 192
Query: 820 STRIAGTVGYMAPEYAM--RGYLTDKADVYSFGIVALEIVSGK 860
+TR Y APE + +GY T D++S G + E++S +
Sbjct: 193 ATR-----WYRAPEIMLNSKGY-TKSIDIWSVGCILAEMLSNR 229
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 51/183 (27%), Positives = 78/183 (42%), Gaps = 20/183 (10%)
Query: 659 NNFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQH-QN 716
N + KIG G FG +Y GT ++ G +A+K K+K E + +Q
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ--LHIESKIYKMMQGGVG 66
Query: 717 LVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLH 776
+ + C EG+ ++V E L SL LF + +L T + + + Y+H
Sbjct: 67 IPTIRWCGAEGDYNVMVMELL-GPSLE-DLFNFCSRKFSL--KTVLLLADQMISRIEYIH 122
Query: 777 EESRLKIVHRDIKATNVLLDKDLNAK---ISDFGLAK--LDEDENTHISTR----IAGTV 827
++ +HRD+K N L+ I DFGLAK D + HI R + GT
Sbjct: 123 SKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 179
Query: 828 GYM 830
Y
Sbjct: 180 RYA 182
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 4e-13
Identities = 50/185 (27%), Positives = 74/185 (40%), Gaps = 22/185 (11%)
Query: 659 NNFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQH-QN 716
NF KIG G FG + G L +A+K KS+ E L
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHL--EYRFYKQLGSGDG 66
Query: 717 LVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLH 776
+ ++Y G +V E L SL LF + +L T I + + Y+H
Sbjct: 67 IPQVYYFGPCGKYNAMVLELL-GPSLE-DLFDLCDRTFSL--KTVLMIAIQLISRMEYVH 122
Query: 777 EESRLKIVHRDIKATNVLLDKDLNAK-----ISDFGLAK--LDEDENTHISTR----IAG 825
++ +++RD+K N L+ + N I DF LAK +D + HI R + G
Sbjct: 123 SKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTG 179
Query: 826 TVGYM 830
T YM
Sbjct: 180 TARYM 184
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 4e-13
Identities = 45/270 (16%), Positives = 86/270 (31%), Gaps = 65/270 (24%)
Query: 75 CDCTYSNNTVCH-------------VTVILLKGFNLAGVIPEEFGNLTFLQEVDLSRNYF 121
C+C + + L +L + F NL + + +S +
Sbjct: 8 CECHQEEDFRVTCKDIQRIPSLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVT 67
Query: 122 NGSLP-KSFARLQNLTKLLILGNRLSGSIPLEI-GDISTLEELVLEDNQLVG-PLPENLG 178
L SF L +T + I R I + ++ L+ L + + L P +
Sbjct: 68 LQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVY 127
Query: 179 NLKSLRRILLSSNNFTGSIPE-SYGNLKNLTEF-RIDGSNLTGRIPNFIGNWTKLDRLDL 236
+ + ++ N + SIP ++ L N T ++ + T + + N TKLD + L
Sbjct: 128 STDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYL 186
Query: 237 QGTSLEGPIPSTISQLKNLTELRISDLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEY 296
K LT + +F +
Sbjct: 187 NKN-------------KYLTVI-------DKDAFGGVY---------------------- 204
Query: 297 IEDMTDLKILDLSFNQLTGPVPGILQNLKK 326
+ +LD+S +T L++LK+
Sbjct: 205 ----SGPSLLDVSQTSVTALPSKGLEHLKE 230
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 1e-10
Identities = 44/238 (18%), Positives = 78/238 (32%), Gaps = 40/238 (16%)
Query: 134 NLTKLLILGNRLSGSIPLEIGDIST-LEELVLEDNQLVGPLPEN-LGNLKSLRRILLSSN 191
+ + IP + + L L + L +P + NL ++ RI +S +
Sbjct: 12 QEEDFRVTCKDIQ-RIP----SLPPSTQTLKLIETHLRT-IPSHAFSNLPNISRIYVSID 65
Query: 192 NFTGSIPE-SYGNLKNLTEFRIDGSNLTGRIPN--FIGNWTKLDRLDLQGTSLEG-PIPS 247
+ S+ NL +T I + I L L + T L+ P +
Sbjct: 66 VTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKEL-PLLKFLGIFNTGLKMFPDLT 124
Query: 248 TISQLKNLTELRISDLKG----SSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDL 303
+ L I+D ++F L + L L N T + Y + T L
Sbjct: 125 KVYSTDIFFILEITDNPYMTSIPVNAFQGLCNET--LTLKLYNNGFT-SVQGYAFNGTKL 181
Query: 304 KILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGTLPDWILTSEKNLDLSYNNFTE 361
+ L+ N+ L ID ++ G + + LD+S + T
Sbjct: 182 DAVYLNKNK----------YLTVID-----KDAFGG-----VYSGPSLLDVSQTSVTA 219
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 5e-13
Identities = 50/225 (22%), Positives = 99/225 (44%), Gaps = 36/225 (16%)
Query: 658 TNNFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLS--SKSKQGNREFVNEIGMISALQH 714
+++F + +GEG +G V T G ++A+K++ K R EI ++ +H
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL-REIKILKHFKH 68
Query: 715 QNLVKLY-----GCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICS--- 766
+N++ ++ N++ ++ E ++ + L R + Q L + I
Sbjct: 69 ENIITIFNIQRPDSFENFNEVYIIQELMQTD-LHRVI---STQML-----SDDHIQYFIY 119
Query: 767 DIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGT 826
R + LH + ++HRD+K +N+L++ + + K+ DFGLA++ ++ S
Sbjct: 120 QTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ 176
Query: 827 VG---------YMAPE--YAMRGYLTDKADVYSFGIVALEIVSGK 860
G Y APE Y + DV+S G + E+ +
Sbjct: 177 SGMVEFVATRWYRAPEVMLTSAKY-SRAMDVWSCGCILAELFLRR 220
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 5e-13
Identities = 58/228 (25%), Positives = 104/228 (45%), Gaps = 40/228 (17%)
Query: 658 TNNFDAANKIGEGGFGPVYKGTLSD-GAVIAVKQLSSKSKQGNREFVNEIGMISALQHQN 716
+ + +G GG G V+ +D +A+K++ Q + + EI +I L H N
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDN 69
Query: 717 LVKLY--------------GCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRK 762
+VK++ G E N + +V EY+E + LA L + L +
Sbjct: 70 IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETD-LANVL-----EQGPLLEEHAR 123
Query: 763 RICSDIARGLAYLHEESRLKIVHRDIKATNVLLD-KDLNAKISDFGLAKLDEDENTH--- 818
+ RGL Y+H + ++HRD+K N+ ++ +DL KI DFGLA++ + +H
Sbjct: 124 LFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGH 180
Query: 819 ----ISTRIAGTVGYMAPE--YAMRGYLTDKADVYSFGIVALEIVSGK 860
+ T+ Y +P + Y T D+++ G + E+++GK
Sbjct: 181 LSEGLVTK-----WYRSPRLLLSPNNY-TKAIDMWAAGCIFAEMLTGK 222
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 9e-13
Identities = 47/185 (25%), Positives = 79/185 (42%), Gaps = 22/185 (11%)
Query: 659 NNFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQH-QN 716
++ +IGEG FG +++GT L + +A+K +S + +E L
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTG 67
Query: 717 LVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLH 776
+ +Y EG +LV + L SL L G+ ++ T + + +H
Sbjct: 68 IPNVYYFGQEGLHNVLVIDLL-GPSLE-DLLDLCGRKFSV--KTVAMAAKQMLARVQSIH 123
Query: 777 EESRLKIVHRDIKATNVLLDKDLNAK-----ISDFGLAK--LDEDENTHISTR----IAG 825
E+S +V+RDIK N L+ + + + DFG+ K D HI R ++G
Sbjct: 124 EKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 180
Query: 826 TVGYM 830
T YM
Sbjct: 181 TARYM 185
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 9e-13
Identities = 45/236 (19%), Positives = 77/236 (32%), Gaps = 41/236 (17%)
Query: 128 SFARLQNLTKLLILGNRLSGSIPLEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRIL 187
+++ + ++ L+ ++P ++ L L +N L L L ++
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 188 LSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQG---TSLEGP 244
L T + G L L + + L +P L LD+ TSL
Sbjct: 62 LDRAELT-KLQV-DGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLP-- 116
Query: 245 IPSTISQLKNLTELRISDLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYI-EDMTDL 303
+ L L EL L+ + +P + L
Sbjct: 117 -LGALRGLGELQELY------------------------LKGNELK-TLPPGLLTPTPKL 150
Query: 304 KILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGTLPD--WILTSEKNLDLSYN 357
+ L L+ N LT G+L L+ +D + L NSL T+P + L N
Sbjct: 151 EKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 33/136 (24%), Positives = 56/136 (41%), Gaps = 7/136 (5%)
Query: 229 TKLDRLDLQGTSLEGPIPSTISQLKNLTELRISDLKGSSSSFPNLQDMKKMERLILRNCL 288
L L L +T+ LT+L + + + + L L +
Sbjct: 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDR--AELTKLQVDGTLPVLGTLDLSHNQ 88
Query: 289 ITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGTLPDWI--- 345
+ +P + + L +LD+SFN+LT G L+ L ++ ++L N L TLP +
Sbjct: 89 LQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK-TLPPGLLTP 146
Query: 346 LTSEKNLDLSYNNFTE 361
+ L L+ NN TE
Sbjct: 147 TPKLEKLSLANNNLTE 162
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 3e-11
Identities = 56/264 (21%), Positives = 86/264 (32%), Gaps = 65/264 (24%)
Query: 74 TCDCTYSNNTV-CHVTVILLKGFNLAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARL 132
S+ V C NL + P+ + T L LS N +
Sbjct: 5 EVSKVASHLEVNCD-------KRNLTALPPDLPKDTTIL---HLSENLLYTFSLATLMPY 54
Query: 133 QNLTKLLILGNRLSGSIPLEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNN 192
LT+L + L+ + ++ G + L L L NQL LP L +L + +S N
Sbjct: 55 TRLTQLNLDRAELT-KLQVD-GTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNR 111
Query: 193 FTGSIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQL 252
T S+P G L+ L E L L L+G L+ P ++
Sbjct: 112 LT-SLPL--GALRGLGE---------------------LQELYLKGNELKTLPPGLLTPT 147
Query: 253 KNLTELRISDLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYI-EDMTDLKILDLSFN 311
L +L L N +T +P + + +L L L N
Sbjct: 148 PKLEKLS------------------------LANNNLT-ELPAGLLNGLENLDTLLLQEN 182
Query: 312 QLTGPVPGILQNLKKIDYIFLTNN 335
L +P + + FL N
Sbjct: 183 SLYT-IPKGFFGSHLLPFAFLHGN 205
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 2e-12
Identities = 52/217 (23%), Positives = 89/217 (41%), Gaps = 32/217 (14%)
Query: 666 KIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSK---QGNRE-----FVNEIGMI--SALQH 714
K+G G F V+ + + +A+K + E VN+ ++
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 85
Query: 715 QNLVKLYGC----CIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIAR 770
+++KL G +++V+E L N L + E + + L + K+I +
Sbjct: 86 NHILKLLDHFNHKGPNGVHVVMVFEVLGEN-LLALIKKYEHRGIPLIYV--KQISKQLLL 142
Query: 771 GLAYLHEESRLKIVHRDIKATNVLLD------KDLNAKISDFGLA-KLDEDENTHISTRI 823
GL Y+H I+H DIK NVL++ + KI+D G A DE I TR
Sbjct: 143 GLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 200
Query: 824 AGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGK 860
Y +PE + AD++S + E+++G
Sbjct: 201 -----YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 69.7 bits (170), Expect = 2e-12
Identities = 54/183 (29%), Positives = 82/183 (44%), Gaps = 20/183 (10%)
Query: 659 NNFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNL 717
N F KIG G FG +Y GT + +A+K + K+K + + + E + LQ
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTG 64
Query: 718 V-KLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLH 776
+ + +EG+ +LV + L SL LF + L+L T + + + ++H
Sbjct: 65 IPNVRWFGVEGDYNVLVMDLL-GPSLE-DLFNFCSRKLSL--KTVLMLADQMINRVEFVH 120
Query: 777 EESRLKIVHRDIKATNVLLDKDLNAK---ISDFGLAKL--DEDENTHISTR----IAGTV 827
+S +HRDIK N L+ A I DFGLAK D + HI R + GT
Sbjct: 121 SKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTA 177
Query: 828 GYM 830
Y
Sbjct: 178 RYA 180
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 3e-12
Identities = 51/203 (25%), Positives = 85/203 (41%), Gaps = 21/203 (10%)
Query: 142 GNRLSGSIPLEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPES- 200
+L+ +IP I + ++L L+ N+L + L LR + L+ N ++P
Sbjct: 25 SKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGI 80
Query: 201 YGNLKNLTEFRIDGSNLTGRIPNFIGNW-TKLDRLDLQGTSLEGPIPSTI-SQLKNLTEL 258
+ LKNL + + L +P + + L L L L+ +P + L LT L
Sbjct: 81 FKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKS-LPPRVFDSLTKLTYL 138
Query: 259 -----RISDLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYI-EDMTDLKILDLSFNQ 312
+ L F L ++ L L N + R+PE + +T+LK L L NQ
Sbjct: 139 SLGYNELQSL--PKGVFDKL---TSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQ 192
Query: 313 LTGPVPGILQNLKKIDYIFLTNN 335
L G +L+K+ + L N
Sbjct: 193 LKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 2e-07
Identities = 39/139 (28%), Positives = 58/139 (41%), Gaps = 12/139 (8%)
Query: 229 TKLDRLDLQGTSLEGPIPSTISQLKNLTELRISDLKGSS---SSFPNLQDMKKMERLILR 285
+LDLQ L +L L L ++D K + F L K +E L +
Sbjct: 37 ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKEL---KNLETLWVT 93
Query: 286 NCLITGRIPEYIED-MTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGTLPDW 344
+ + +P + D + +L L L NQL P + +L K+ Y+ L N L +LP
Sbjct: 94 DNKLQ-ALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQ-SLPKG 151
Query: 345 I---LTSEKNLDLSYNNFT 360
+ LTS K L L N
Sbjct: 152 VFDKLTSLKELRLYNNQLK 170
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 3e-12
Identities = 48/207 (23%), Positives = 87/207 (42%), Gaps = 28/207 (13%)
Query: 667 IGEGGFGPVYKGT-LSDGAVIAVKQLSSKSK---QGNREFVNEIGMISALQHQ------N 716
IG+G FG V K +A+K + ++ + Q EI ++ L+ Q N
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA----AEEIRILEHLRKQDKDNTMN 160
Query: 717 LVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLH 776
++ + N + + +E L N L + K+ + ++ I + L LH
Sbjct: 161 VIHMLENFTFRNHICMTFELLSMN-LYELI--KKNKFQGFSLPLVRKFAHSILQCLDALH 217
Query: 777 EESRLKIVHRDIKATNVLL--DKDLNAKISDFGLA-KLDEDENTHISTRIAGTVGYMAPE 833
+ +I+H D+K N+LL K+ DFG + + T+I +R Y APE
Sbjct: 218 ---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRF-----YRAPE 269
Query: 834 YAMRGYLTDKADVYSFGIVALEIVSGK 860
+ D++S G + E+++G
Sbjct: 270 VILGARYGMPIDMWSLGCILAELLTGY 296
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 37/184 (20%), Positives = 67/184 (36%), Gaps = 25/184 (13%)
Query: 75 CDCTYSNNTV-CH--------------VTVILLKGFNLAGVIPEE-FGNLTFLQEVDLSR 118
C C ++N + C ++ L NL+ + E LT L + LS
Sbjct: 16 CLC--ASNILSCSKQQLPNVPQSLPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSH 73
Query: 119 NYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEI-GDISTLEELVLEDNQLVGPLPENL 177
N+ N ++F + NL L + N L ++ + D+ LE L+L +N +V
Sbjct: 74 NHLNFISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAF 132
Query: 178 GNLKSLRRILLSSNNFTGSIPE----SYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDR 233
++ L+++ LS N + P L L + + L + +
Sbjct: 133 EDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVK 191
Query: 234 LDLQ 237
L
Sbjct: 192 NGLY 195
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 49/284 (17%), Positives = 86/284 (30%), Gaps = 60/284 (21%)
Query: 142 GNRLSGSIPLEIGDISTLEELVLEDNQLVGPLPEN-LGNLKSLRRILLSSNNFTGSIPE- 199
+L ++P + S L L N L E L +L +LLS N+ I
Sbjct: 27 KQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSE 82
Query: 200 SYGNLKNLTEFRIDGSNLTGRIPN--FIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTE 257
++ + NL + ++L + F L+ L L + + + +++ +
Sbjct: 83 AFVPVPNLRYLDLSSNHLH-TLDEFLFSDL-QALEVLLLYNNHIVV-VDR--NAFEDMAQ 137
Query: 258 LRISDLKGSSSSFPNLQDMKKMERLILRNCLITGRIPE----YIEDMTDLKILDLSFNQL 313
L+ +L L I+ R P + L +LDLS N+L
Sbjct: 138 LQ---------------------KLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKL 175
Query: 314 TGPVPGILQNLKKI--DYIFLTNN------SLSGTLPDWILTSEKNLDLSYNNFTESSPA 365
LQ L + ++L NN L W ++ +
Sbjct: 176 KKLPLTDLQKLPAWVKNGLYLHNNPLECDCKLYQLFSHWQYRQLSSVMDFQEDLYCMHSK 235
Query: 366 -----------TCRESRVNILSSFSSTGSNSVSWCLKKDLPCPK 398
C E + + + G C K K
Sbjct: 236 KLHNIFSLDFFNCSEYK--ESAWEAHLGDTLTIRCDTKQQGMTK 277
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 2e-11
Identities = 33/201 (16%), Positives = 63/201 (31%), Gaps = 36/201 (17%)
Query: 659 NNFDAANKIGEGGFGPVYKGT---------LSDGAVIAVKQLSSKSKQGNREFVNEIGMI 709
+ + G +Y+ ++K L +K + E
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAA 100
Query: 710 SALQHQNLVKLYGC---CI---------EGNQLLLVYEYLENNSLARALFGKEGQCLNLD 757
LQ KLY I + LV L SL AL L+
Sbjct: 101 KPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSER 159
Query: 758 WATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKI--SDFGLAKLDEDE 815
+ ++ + L +LHE VH ++ A N+ +D + +++ + +G A
Sbjct: 160 --SVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPS 214
Query: 816 NTHISTR------IAGTVGYM 830
H++ G + ++
Sbjct: 215 GKHVAYVEGSRSPHEGDLEFI 235
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 3e-11
Identities = 52/236 (22%), Positives = 97/236 (41%), Gaps = 32/236 (13%)
Query: 641 GLDLQTGYFTLRQIKAATNNFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSK--- 696
G D + ++ + + ++ + IG+G FG V K + +A+K + +K
Sbjct: 36 GYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLN 95
Query: 697 QGNREFVNEIGMISALQHQ------NLVKLYGCCIEGNQLLLVYEYLENNSLARALFG-- 748
Q E+ ++ + +V L + N L LV+E L N L+
Sbjct: 96 QA----QIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYN-----LYDLL 146
Query: 749 KEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLL--DKDLNAKISDF 806
+ + ++ + L +L L I+H D+K N+LL K KI DF
Sbjct: 147 RNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDF 205
Query: 807 GLA-KLDEDENTHISTRIAGTVGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGK 860
G + +L + +I +R Y +PE + Y D++S G + +E+ +G+
Sbjct: 206 GSSCQLGQRIYQYIQSRF-----YRSPEVLLGMPY-DLAIDMWSLGCILVEMHTGE 255
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 6e-11
Identities = 38/194 (19%), Positives = 71/194 (36%), Gaps = 36/194 (18%)
Query: 666 KIGEGGFGPVYKGT------LSDGAVIAVKQLSSKSKQ-----------GNREFVNEIGM 708
IG+GGFG +Y + A VK S + E + +
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 709 ISALQHQNLVKLYGCCIEGNQLL----LVYEYLENNSLARALFGKEGQCLNLDWATRKRI 764
L++ + K +G + ++ + + L + ++ + + T ++
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQK-IYEANAKRFSR--KTVLQL 157
Query: 765 CSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKI--SDFGLAK--LDEDENTHIS 820
I L Y+HE VH DIKA+N+LL+ ++ D+GLA E + +
Sbjct: 158 SLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYA 214
Query: 821 TR----IAGTVGYM 830
GT+ +
Sbjct: 215 ADPKRCHDGTIEFT 228
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 8e-11
Identities = 45/194 (23%), Positives = 81/194 (41%), Gaps = 35/194 (18%)
Query: 665 NKIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNREFVN---------EIGMISALQ- 713
K+G+G +G V+K G V+AVK++ F N EI +++ L
Sbjct: 15 KKLGKGAYGIVWKSIDRRTGEVVAVKKIF-------DAFQNSTDAQRTFREIMILTELSG 67
Query: 714 HQNLVKLYGCCI--EGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICS---DI 768
H+N+V L + LV++Y+E + L + L +
Sbjct: 68 HENIVNLLNVLRADNDRDVYLVFDYMETD-LHAVI---RANIL-----EPVHKQYVVYQL 118
Query: 769 ARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVG 828
+ + YLH S ++HRD+K +N+LL+ + + K++DFGL++ + +
Sbjct: 119 IKVIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINE 175
Query: 829 YMAPEYAMRGYLTD 842
+ LTD
Sbjct: 176 NTENFDDDQPILTD 189
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 1e-10
Identities = 53/295 (17%), Positives = 104/295 (35%), Gaps = 43/295 (14%)
Query: 111 LQEVDLSRNYFN-GSLPKSFARLQNLTKLLILGNRLS----GSIPLEIGDISTLEELVLE 165
+Q +D+ + + LQ + + L+ I + L EL L
Sbjct: 5 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 64
Query: 166 DNQL----VGPLPENLGNLK-SLRRILLSSNNFT----GSIPESYGNLKNLTEFRIDGSN 216
N+L V + + L ++++ L + T G + + L L E + +
Sbjct: 65 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNL 124
Query: 217 LTGRIPNFIG-----NWTKLDRLDLQGTSL--EG--PIPSTISQLKNLTELRISDLKGSS 267
L + +L++L L+ SL P+ S + + EL +S+ +
Sbjct: 125 LGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINE 184
Query: 268 SSFPNLQDMKK-----MERLILRNCLITGR----IPEYIEDMTDLKILDLSFNQLTGP-- 316
+ L K +E L L +C +T + + L+ L L N+L
Sbjct: 185 AGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGM 244
Query: 317 ---VPGILQNLKKIDYIFLTNNSLS----GTLPDWILTSE--KNLDLSYNNFTES 362
PG+L ++ +++ ++ G L + E K L L+ N +
Sbjct: 245 AELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDE 299
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 2e-08
Identities = 60/339 (17%), Positives = 115/339 (33%), Gaps = 71/339 (20%)
Query: 85 CHVTVILLKGFNL----AGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQ-----NL 135
C + + L+ L GV+ L LQE+ LS N + + L
Sbjct: 85 CKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRL 144
Query: 136 TKLLILGNRLSGSIPLEIGDI----STLEELVLEDNQ--------LVGPLPENLGNLKSL 183
KL + LS + + + +EL + +N L L ++ L++L
Sbjct: 145 EKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEAL 204
Query: 184 RRILLSSNNFT----GSIPESYGNLKNLTEFRIDGSNLTG----------RIPNFIGNWT 229
+ L S T + + +L E + + L P+ +
Sbjct: 205 K---LESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPS-----S 256
Query: 230 KLDRLDLQGTSL--EG--PIPSTISQLKNLTELRISDLKGSSSSFPNLQDM-----KKME 280
+L L + + +G + + ++L EL ++ + L + ++E
Sbjct: 257 RLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLE 316
Query: 281 RLILRNCLITGR----IPEYIEDMTDLKILDLSFNQLTGP-----VPGILQNLKKIDYIF 331
L +++C T + L L +S N+L G+ Q + ++
Sbjct: 317 SLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLW 376
Query: 332 LTNN--------SLSGTLPDWILTSEKNLDLSYNNFTES 362
L + SL+ TL S + LDLS N ++
Sbjct: 377 LADCDVSDSSCSSLAATLLA--NHSLRELDLSNNCLGDA 413
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 2e-05
Identities = 34/183 (18%), Positives = 63/183 (34%), Gaps = 25/183 (13%)
Query: 205 KNLTEFRIDGSNLT-GRIPNFIGNWTKLDRLDLQGTSL--EG--PIPSTISQLKNLTELR 259
++ I L+ R + + + L L I S + L EL
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 260 ISDLKGSSSSFPNLQDM-----KKMERLILRNCLITGR----IPEYIEDMTDLKILDLSF 310
+ + + K+++L L+NC +TG + + + L+ L LS
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122
Query: 311 NQLTGP-----VPGILQNLKKIDYIFLTNNSLSGTLPDWI------LTSEKNLDLSYNNF 359
N L G+L +++ + L SLS + + K L +S N+
Sbjct: 123 NLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDI 182
Query: 360 TES 362
E+
Sbjct: 183 NEA 185
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 2e-04
Identities = 53/323 (16%), Positives = 109/323 (33%), Gaps = 69/323 (21%)
Query: 85 CHVTVILLKGFNL----AGVIPEEFGNLTFLQEVDLSRNYFNGS----LPKSFARLQ-NL 135
C + + L+ +L + +E+ +S N N + L + L
Sbjct: 142 CRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQL 201
Query: 136 TKLLILGNRLS----GSIPLEIGDISTLEELVLEDNQL----VGPLPENLGN-LKSLRRI 186
L + ++ + + ++L EL L N+L + L L + LR +
Sbjct: 202 EALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTL 261
Query: 187 LLSSNNFT----GSIPESYGNLKNLTEFRIDGSNLTG----------RIPNFIGNWTKLD 232
+ T G + ++L E + G+ L P +L+
Sbjct: 262 WIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPG-----CQLE 316
Query: 233 RLDLQGTSL--EG--PIPSTISQLKNLTELRISDLKGSSSSFPNLQDM-----KKMERLI 283
L ++ S S ++Q + L EL+IS+ + + L + L
Sbjct: 317 SLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLW 376
Query: 284 LRNCLIT----GRIPEYIEDMTDLKILDLSFNQLTGP-VPGILQNLKKIDYIFLTNNSLS 338
L +C ++ + + L+ LDLS N L + +++++++
Sbjct: 377 LADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQ------------ 424
Query: 339 GTLPDWILTSEKNLDLSYNNFTE 361
P +L L L ++E
Sbjct: 425 ---PGCLLEQ---LVLYDIYWSE 441
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 54/234 (23%), Positives = 94/234 (40%), Gaps = 50/234 (21%)
Query: 112 QEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGDISTLEELVLEDNQLVG 171
+ +L + + L ++ +++ + + S+ I + + L L N+L
Sbjct: 22 IKANLKKKSVT-DAV-TQNELNSIDQIIANNSDIK-SVQ-GIQYLPNVRYLALGGNKL-- 75
Query: 172 PLPENLG---NLKSLRRILLSSNNFTGSIPES-YGNLKNLTEFRIDGSNLTGRIPNFIGN 227
++ L +L ++L+ N S+P + L NL E + + L +P+ + +
Sbjct: 76 ---HDISALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFD 130
Query: 228 W-TKLDRLDLQG---TSLEGPIPSTISQLKNLTELRISDLKGSSSSFPNLQDMKKMERLI 283
T L L+L SL +L NLTEL +S + LQ
Sbjct: 131 KLTNLTYLNLAHNQLQSLP---KGVFDKLTNLTELDLSYNQ--------LQ--------- 170
Query: 284 LRNCLITGRIPEYIED-MTDLKILDLSFNQLTGPVP-GILQNLKKIDYIFLTNN 335
+PE + D +T LK L L NQL VP G+ L + YI+L +N
Sbjct: 171 --------SLPEGVFDKLTQLKDLRLYQNQLKS-VPDGVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 47/215 (21%), Positives = 89/215 (41%), Gaps = 40/215 (18%)
Query: 148 SIPLEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNL 207
P + + + L+ + + +N L S+ +I+ ++++ S+ L N+
Sbjct: 12 IFPDDAF--AETIKANLKKKSVTDAVTQN--ELNSIDQIIANNSDIK-SVQ-GIQYLPNV 65
Query: 208 TEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTI-SQLKNLTELRISDLKGS 266
+ G+ L I T L L L G L+ +P+ + +L NL EL + +
Sbjct: 66 RYLALGGNKLH-DISAL-KELTNLTYLILTGNQLQS-LPNGVFDKLTNLKELVLVE---- 118
Query: 267 SSSFPNLQDMKKMERLILRNCLITGRIPEYIED-MTDLKILDLSFNQLTGPVPGILQNLK 325
+++ L P+ + D +T+L L+L+ NQL G+ L
Sbjct: 119 ----------NQLQSL-----------PDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLT 157
Query: 326 KIDYIFLTNNSLSGTLPDWI---LTSEKNLDLSYN 357
+ + L+ N L +LP+ + LT K+L L N
Sbjct: 158 NLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQN 191
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 2e-05
Identities = 29/136 (21%), Positives = 54/136 (39%), Gaps = 12/136 (8%)
Query: 229 TKLDRLDLQGTSLEGPIPSTISQLKNLTELRISDLKGSS-SSFPNLQDMKKMERLILRNC 287
+ + +L+ S+ + L + S S +Q + + L L
Sbjct: 19 AETIKANLKKKSV-----TDAVTQNELNSIDQIIANNSDIKSVQGIQYLPNVRYLALGGN 73
Query: 288 LITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGTLPDWI-- 345
+ I +++T+L L L+ NQL G+ L + + L N L +LPD +
Sbjct: 74 KLH-DISAL-KELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFD 130
Query: 346 -LTSEKNLDLSYNNFT 360
LT+ L+L++N
Sbjct: 131 KLTNLTYLNLAHNQLQ 146
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 3e-05
Identities = 36/101 (35%), Positives = 50/101 (49%), Gaps = 13/101 (12%)
Query: 105 FGNLTFLQEVDLSRNYFNGSLP-KSFARLQNLTKLLILGNRLSGSIPLEIGD-ISTLEEL 162
LT L + L+ N SLP F +L NL +L+++ N+L S+P + D ++ L L
Sbjct: 81 LKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYL 138
Query: 163 VLEDNQLVGPLPE----NLGNLKSLRRILLSSNNFTGSIPE 199
L NQL LP+ L NL L LS N S+PE
Sbjct: 139 NLAHNQLQS-LPKGVFDKLTNLTELD---LSYNQLQ-SLPE 174
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 8e-10
Identities = 31/158 (19%), Positives = 62/158 (39%), Gaps = 22/158 (13%)
Query: 75 CDCTYSNNTV-CH-------------VTVILLKGFNLAGVIPEE--FGNLTFLQEVDLSR 118
C C TV C T L N V+ F L L++++ S
Sbjct: 9 CRC--EGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSN 66
Query: 119 NYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGD-ISTLEELVLEDNQLVGPLPENL 177
N +F + ++L+ NRL ++ ++ + +L+ L+L N++ ++
Sbjct: 67 NKITDIEEGAFEGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRITCVGNDSF 125
Query: 178 GNLKSLRRILLSSNNFTGSIPE-SYGNLKNLTEFRIDG 214
L S+R + L N T ++ ++ L +L+ +
Sbjct: 126 IGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLA 162
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 20/115 (17%), Positives = 48/115 (41%), Gaps = 16/115 (13%)
Query: 229 TKLDRLDLQG---TSLEGPIPSTISQLKNLTELRISD--LKGSSSSFPN--LQDMKKMER 281
+L +++ T +E + E+ ++ L+ + + + ++ ++
Sbjct: 57 PQLRKINFSNNKITDIE---EGAFEGASGVNEILLTSNRLE----NVQHKMFKGLESLKT 109
Query: 282 LILRNCLITGRIPEYI-EDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNN 335
L+LR+ IT + ++ +++L L NQ+T PG L + + L N
Sbjct: 110 LMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 23/91 (25%), Positives = 43/91 (47%), Gaps = 4/91 (4%)
Query: 105 FGNLTFLQEVDLSRNYFNGSLPKS-FARLQNLTKLLILGNRLSGSIPLEIGD-ISTLEEL 162
F + + E+ L+ N ++ F L++L L++ NR++ + + +S++ L
Sbjct: 77 FEGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLL 134
Query: 163 VLEDNQLVGPLPENLGNLKSLRRILLSSNNF 193
L DNQ+ P L SL + L +N F
Sbjct: 135 SLYDNQITTVAPGAFDTLHSLSTLNLLANPF 165
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 7e-06
Identities = 25/120 (20%), Positives = 52/120 (43%), Gaps = 11/120 (9%)
Query: 245 IPSTISQLKNLTELRISDLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYI-EDMTDL 303
IP ++L L + L+ ++ F L ++ ++ N IT I E E + +
Sbjct: 30 IPQYTAEL-RLNNNEFTVLE-ATGIFKKL---PQLRKINFSNNKIT-DIEEGAFEGASGV 83
Query: 304 KILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGTLPDWI---LTSEKNLDLSYNNFT 360
+ L+ N+L + + L+ + + L +N ++ + + L+S + L L N T
Sbjct: 84 NEILLTSNRLENVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT 142
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 41/192 (21%), Positives = 65/192 (33%), Gaps = 35/192 (18%)
Query: 666 KIGEGGFGPVYKG----TLSDGAVIAVKQLSSKSKQGNREF-----------VNEIGMIS 710
KIG GGFG +Y A VK ++ E + +
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 711 ALQHQNLVKLYGC----CIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICS 766
L + + YG + +V E L L + + G Q +T ++
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQK-ISG---QNGTFKKSTVLQLGI 158
Query: 767 DIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKI--SDFGLAKLDEDENTHI----- 819
+ L Y+HE VH DIKA N+LL ++ +D+GL+ H
Sbjct: 159 RMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQEN 215
Query: 820 -STRIAGTVGYM 830
GT+ +
Sbjct: 216 PRKGHNGTIEFT 227
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 59.1 bits (142), Expect = 6e-09
Identities = 75/543 (13%), Positives = 150/543 (27%), Gaps = 163/543 (30%)
Query: 506 TNDQTYKSLGKRMFDVSIQGKQVLKDFD---IMEEAGGVGIGIT-REFKDVSVNGSTME- 560
T + Y+ K + V + +FD + + + ++ E + ++ +
Sbjct: 11 TGEHQYQY--KDILSVFED--AFVDNFDCKDVQDMPKSI---LSKEEIDHIIMSKDAVSG 63
Query: 561 -IHLYWA--GKGTNAIPYRGV-------YGPLISAITVTPNFEVDTGGGLSAGAIVGIVA 610
+ L+W K + + V Y L+S I
Sbjct: 64 TLRLFWTLLSKQEEMV-QKFVEEVLRINYKFLMSPIKTEQR---QPSM------------ 107
Query: 611 GSCAVVIILLFILWRLGYLGGKNVEDKELRGLDLQTGYFTLR-----QIKAATNNFDAAN 665
+ ++I R D+ + Y R +++ A A
Sbjct: 108 ------MTRMYIEQR----------DRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAK 151
Query: 666 KI---GEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYG 722
+ G G G K + A+ S Q + +I ++
Sbjct: 152 NVLIDGVLGSG---KTWV------ALDVCLSYKVQ--CKMDFKIFWLN----------LK 190
Query: 723 CCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLK 782
C +L E L+ L + + + RI I L L + +
Sbjct: 191 NCNSPETVL---EMLQK--LLYQIDPNWTSRSDHSSNIKLRI-HSIQAELRRLLKSKPYE 244
Query: 783 ---IVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRGY 839
+V +++ +L+ KI L ++TR
Sbjct: 245 NCLLVLLNVQNAKAWNAFNLSCKI-------L-------LTTRFKQ-------------- 276
Query: 840 LTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYV----LQEQ---GNLLELVD 892
+TD + ++L+ + P E LL + L + N L
Sbjct: 277 VTDFLSAATTTHISLD----HHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRL-- 330
Query: 893 PSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTAVQAPIIRRNSDSQDA 952
S+ + + T N + + L + S++++LE P R
Sbjct: 331 -SIIAESIRDGLATWDNWKHVNCD---KLTTIIESSLNVLE-------PAEYR------K 373
Query: 953 RFRAFEILSQDSQTHVSTLSQESEMQRTMSIDAPWTDSSVSVQIPDETREHSSSSLLLQN 1012
F + H+ T +S+ W D S + + SL+ +
Sbjct: 374 MFDRLSVFPPS--AHIPT--------ILLSL--IWFDVIKSD-VMVVVNKLHKYSLVEKQ 420
Query: 1013 ENN 1015
Sbjct: 421 PKE 423
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 58.7 bits (141), Expect = 9e-09
Identities = 85/638 (13%), Positives = 171/638 (26%), Gaps = 205/638 (32%)
Query: 301 TDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGTLPDW---ILTSEKNLDLSYN 357
+ + + + ++ + D IL+ E+ +
Sbjct: 9 FETGEHQYQYKDI---LSVFEDAFVD-NFDC-------KDVQDMPKSILSKEE-----ID 52
Query: 358 NFTESSPATCRESRVNILSSFSSTGSNSVSWCLKKDLPCPKEAKHYSLFINCGGSPTEFE 417
+ S S L F W L K+ + F+ E
Sbjct: 53 HIIMSKD---AVSGTLRL--F---------WTL-----LSKQEEMVQKFVE------EVL 87
Query: 418 ENDYE---EDLNTQ--GPSNFGIVSDRWAYSSTGVYVGNES-SKYLAANQYGLNVSGAEY 471
+Y+ + T+ PS +++ + +Y N+ +KY NVS +
Sbjct: 88 RINYKFLMSPIKTEQRQPS---MMTRMYIEQRDRLYNDNQVFAKY--------NVSRLQP 136
Query: 472 YKTARLAPQSLKYYGLCMLKGSYTVKLHFAEIMFTNDQTYKSLGKRMFDVSIQGKQVLKD 531
Y R A L+ V + G + GK +
Sbjct: 137 YLKLRQALLELR-------PAKN-VLID---------------G--VLGS---GKTWV-- 166
Query: 532 FDIMEEAGGVGIGITREFKDVSVNGSTMEIHLYWAGKGTNAIPYRGVYGPLIS-AITVTP 590
A V V M+ ++W P V L + P
Sbjct: 167 ------ALDV-------CLSYKVQ-CKMDFKIFWLNLKNCNSP-ETVLEMLQKLLYQIDP 211
Query: 591 NFEVDTGGGLSAGAIVGIVAGSCAVVIIL--------LFILWRLGYLGGKNVEDKE-LRG 641
N+ + S+ + I + + +L L +L NV++ +
Sbjct: 212 NWT--SRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVL--------LNVQNAKAWNA 261
Query: 642 LDLQTGYFTLRQIKAATNNFDAANKIG------------EGGFGPVY-KGTLSDGAVIAV 688
+L +I T + + P K L
Sbjct: 262 FNLSC------KILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRP 315
Query: 689 KQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFG 748
+ L + N + +I+ L + ++++ + L +
Sbjct: 316 QDLPREVLTTN-PRR--LSIIAESIRDGL-----ATWDN------WKHVNCDKLTTII-- 359
Query: 749 KEGQCLN-LDWATRKRICSDIARGLAYLHE-----ESRLKIVHRDIKATNV--------- 793
LN L+ A +++ L+ L ++ D+ ++V
Sbjct: 360 --ESSLNVLEPAEYRKMFDR----LSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHK 413
Query: 794 --LLDKDLN-AKISDFGL-----AKLDEDENTHISTRIAGTVGYMAPE-YAMRGYLTDKA 844
L++K + IS + KL+ + H I Y P+ + +
Sbjct: 414 YSLVEKQPKESTISIPSIYLELKVKLENEYALH--RSIVDH--YNIPKTFDSDDLIPPYL 469
Query: 845 DVYSFGIVA--LEIVSGKSNTNYRPKEEF--VYL-LDW 877
D Y + + L K+ + F V+L +
Sbjct: 470 DQYFYSHIGHHL-----KNIEHPERMTLFRMVFLDFRF 502
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 55.6 bits (133), Expect = 7e-08
Identities = 83/535 (15%), Positives = 146/535 (27%), Gaps = 172/535 (32%)
Query: 1 MGKIVSVFVVLGFLVLNCFANFGSH-----AQRLPDDEVQTLQSIFRKLNFRNGQVNQTS 55
GK V + C +F P+ ++ LQ + +++ N TS
Sbjct: 161 SGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQID-----PNWTS 215
Query: 56 CTEGSWNV--TIDDSNG--SNFTCDCTYSN-----NTVCHVTVILLKGFNL--------- 97
++ S N+ I Y N V + FNL
Sbjct: 216 RSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAW--NAFNLSCKILLTTR 273
Query: 98 -AGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLL-ILGNRLSGSIPLEIGD 155
V +F + + L + + + LL L R +P E+
Sbjct: 274 FKQVT--DFLSAATTTHISLD------HHSMTLTPDEVKSLLLKYLDCRPQ-DLPREVLT 324
Query: 156 ISTLEELVLEDNQLVGPLPENLG------------NLKSLRRILLSS-NNFTGSIPESYG 202
+ + + E++ N L I+ SS N P Y
Sbjct: 325 TNPR---------RLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLE---PAEYR 372
Query: 203 NL-KNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRIS 261
+ L+ F +++ + + I W + + D+ +++L + L
Sbjct: 373 KMFDRLSVFP-PSAHIPTILLSLI--WFDVIKSDVM---------VVVNKLHKYS-LVEK 419
Query: 262 DLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDL--KILDLSFN-----QLT 314
K S+ S P++ K++ +E+ L I+D +N
Sbjct: 420 QPKESTISIPSIYLELKVK----------------LENEYALHRSIVD-HYNIPKTFDSD 462
Query: 315 GPVPGILQNLKKIDYIF------LTNNSLSGTLPDWILTSEKNLDLSYNNFTE------S 362
+P L Y + L N L LD F E S
Sbjct: 463 DLIPPYLDQ-----YFYSHIGHHLKNIEHPE---RMTLFRMVFLDF---RFLEQKIRHDS 511
Query: 363 SPATCRESRVNILSSFSSTGSNSVSWCLKKDLPCPKEAKHYSLFINCGGSPTEFEE--ND 420
+ S +N L L K Y +I C P +E N
Sbjct: 512 TAWNASGSILNTLQ----------------QL------KFYKPYI-CDNDPK-YERLVNA 547
Query: 421 YEEDLNTQGPSNFGIVSDRWAYSSTGVYVGNESSKYLAANQYGLNVSGAEYYKTA 475
+ L + ++ SKY + L ++ A
Sbjct: 548 ILDFLPKIEEN---LIC----------------SKYTDLLRIALMAEDEAIFEEA 583
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 1e-08
Identities = 35/170 (20%), Positives = 66/170 (38%), Gaps = 23/170 (13%)
Query: 75 CDCTYSNNTV-CHVTVILLKGFNLAGV---IPEEFGNLTFLQEVDLSRNYFNGSLPKSFA 130
C C SNN V C G L + +PE + E+ L +N P +F+
Sbjct: 9 CTC--SNNIVDCR-------GKGLTEIPTNLPET------ITEIRLEQNTIKVIPPGAFS 53
Query: 131 RLQNLTKLLILGNRLSGSIPLEIGD-ISTLEELVLEDNQLVGPLPENLGNLKSLRRILLS 189
+ L ++ + N++S + + + +L LVL N++ L SL+ +LL+
Sbjct: 54 PYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLN 112
Query: 190 SNNFTGSIPE-SYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQG 238
+N + ++ +L NL + + L + + L
Sbjct: 113 ANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQ 161
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 37/187 (19%), Positives = 63/187 (33%), Gaps = 33/187 (17%)
Query: 229 TKLDRLDLQGTSLEGPIPSTISQLKNLTELRISD--LKGSSSSFPN--LQDMKKMERLIL 284
KL R+DL + P L++L L + + P + + ++ L+L
Sbjct: 56 KKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT----ELPKSLFEGLFSLQLLLL 111
Query: 285 RNCLITGRIPEYI-EDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGT--- 340
I + +D+ +L +L L N+L G L+ I + L N
Sbjct: 112 NANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICDCHL 170
Query: 341 --LPDWILTSEKNLDLSYNNFTESSPATCRESRVNILSSFSSTGSNSVSWCLKKDLPCPK 398
L D++ T N E+S A C +S + + K C
Sbjct: 171 KWLADYLHT----------NPIETSGARC--------TSPRRLANKRIGQIKSKKFRCSA 212
Query: 399 EAKHYSL 405
A H+
Sbjct: 213 AAHHHHH 219
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 19/64 (29%), Positives = 26/64 (40%), Gaps = 4/64 (6%)
Query: 301 TDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGTLPDWI---LTSEKNLDLSYN 357
+ + L N + PG KK+ I L+NN +S L L S +L L N
Sbjct: 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGN 90
Query: 358 NFTE 361
TE
Sbjct: 91 KITE 94
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 57.1 bits (137), Expect = 1e-08
Identities = 21/108 (19%), Positives = 38/108 (35%), Gaps = 3/108 (2%)
Query: 112 QEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLE-IGDISTLEELVLEDNQLV 170
+ +R+ +NLT+L I + + L + + L L + + L
Sbjct: 11 SGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR 69
Query: 171 GPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLT 218
P+ L R+ LS N S+ +L E + G+ L
Sbjct: 70 FVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 54.7 bits (131), Expect = 6e-08
Identities = 23/122 (18%), Positives = 34/122 (27%), Gaps = 12/122 (9%)
Query: 75 CDCTYSNNTVCHVTVILLKGFNLAGVIPEEFGNLTFLQEVDLSRNYFNGSLPK-SFARLQ 133
C S+ C + A L E+ + L L
Sbjct: 5 CCPHGSSGLRCT--------RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLG 56
Query: 134 NLTKLLILGNRLSGSIPLEI-GDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNN 192
L L I+ + L + + L L L N L L SL+ ++LS N
Sbjct: 57 ELRNLTIVKSGLR-FVAPDAFHFTPRLSRLNLSFNALES-LSWKTVQGLSLQELVLSGNP 114
Query: 193 FT 194
Sbjct: 115 LH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 50.1 bits (119), Expect = 2e-06
Identities = 19/111 (17%), Positives = 41/111 (36%), Gaps = 5/111 (4%)
Query: 253 KNLTELRISDLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEY-IEDMTDLKILDLSFN 311
+ LR + G+ S +L + + L + N + + + +L+ L + +
Sbjct: 8 HGSSGLRCTR-DGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKS 66
Query: 312 QLTGPVPGILQNLKKIDYIFLTNNSLSGTLPDWILTSE--KNLDLSYNNFT 360
L P ++ + L+ N+L +L + + L LS N
Sbjct: 67 GLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 42.0 bits (98), Expect = 7e-04
Identities = 15/86 (17%), Positives = 30/86 (34%), Gaps = 5/86 (5%)
Query: 284 LRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVP-GILQNLKKIDYIFLTNNSLSGTLP 342
R+ + ++ +L L + Q + L+ L ++ + + + L P
Sbjct: 16 TRDGALD--SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAP 73
Query: 343 D--WILTSEKNLDLSYNNFTESSPAT 366
D L+LS+N S T
Sbjct: 74 DAFHFTPRLSRLNLSFNALESLSWKT 99
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 55.7 bits (134), Expect = 4e-08
Identities = 68/361 (18%), Positives = 121/361 (33%), Gaps = 105/361 (29%)
Query: 658 TNNFDAANKIGEGGFGPVYKG-TLSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQ--- 713
+ K+G G F V+ + +A+K + S ++EI ++ +++
Sbjct: 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETA-LDEIRLLKSVRNSD 94
Query: 714 -----HQNLVKLYGC----CIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRI 764
+ +V+L + G + +V+E L + L + + Q L L K+I
Sbjct: 95 PNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCV--KKI 151
Query: 765 CSDIARGLAYLHEESRLKIVHRDIKATNVLL----------------------------- 795
+ +GL YLH ++ +I+H DIK N+LL
Sbjct: 152 IQQVLQGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSA 209
Query: 796 --------------------DKDLNAKISDFGLAKLDEDENTH-ISTRIAGTVGYMAPEY 834
+ L KI+D G A T I TR Y + E
Sbjct: 210 VSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSLEV 264
Query: 835 AMRGYLTDKADVYSFGIVALEIVSGKS-------NTNYRPKE---EFVYLL--------- 875
+ AD++S +A E+ +G R ++ + LL
Sbjct: 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIV 324
Query: 876 DWAYVLQ---EQGNLL---ELVDPSLGS------NFSKKEAMTMLNIALLCTNPSPTLRP 923
Y + ++G+L +L L +S++EA + L P R
Sbjct: 325 AGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRA 384
Query: 924 T 924
T
Sbjct: 385 T 385
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 47/194 (24%), Positives = 68/194 (35%), Gaps = 38/194 (19%)
Query: 148 SIPLEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPES-YGNLKN 206
S+P I + E+L L+ L L L + L N ++ + +L
Sbjct: 28 SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTE 84
Query: 207 LTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQG---TSLEGPIPSTISQLKNLTELRISDL 263
L + + L + T+LD+L L G SL +L L ELR++
Sbjct: 85 LGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLP---SGVFDRLTKLKELRLNT- 140
Query: 264 KGSSSSFPN-LQDMKKMERLILRNCLITGRIPEYIED-MTDLKILDLSFNQLTGPVPGIL 321
N LQ IP D +T+L+ L LS NQL G
Sbjct: 141 --------NQLQ-----------------SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAF 175
Query: 322 QNLKKIDYIFLTNN 335
L K+ I L N
Sbjct: 176 DRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 5e-07
Identities = 32/91 (35%), Positives = 42/91 (46%), Gaps = 4/91 (4%)
Query: 105 FGNLTFLQEVDLSRNYFNGSLPKS-FARLQNLTKLLILGNRLSGSIPLEIGD-ISTLEEL 162
F +LT L ++ L N SLP F RL L +L + N+L SIP D ++ L+ L
Sbjct: 103 FDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTNLQTL 160
Query: 163 VLEDNQLVGPLPENLGNLKSLRRILLSSNNF 193
L NQL L L+ I L N F
Sbjct: 161 SLSTNQLQSVPHGAFDRLGKLQTITLFGNQF 191
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 8e-07
Identities = 50/197 (25%), Positives = 70/197 (35%), Gaps = 33/197 (16%)
Query: 75 CDCTYSNNTV-CHVTVILLKGFNLAGV---IPEEFGNLTFLQEVDLSRNYFNGSLPKSFA 130
C C V C G +L V IP + L DL +F
Sbjct: 10 CTCNEGKKEVDCQ-------GKSLDSVPSGIPADTEKL------DLQSTGLATLSDATFR 56
Query: 131 RLQNLTKLLILGNRLSGSIPLEIGD-ISTLEELVLEDNQLVGPLPE----NLGNLKSLRR 185
L LT L + N+L ++ + D ++ L L L +NQL LP +L L L
Sbjct: 57 GLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLAS-LPLGVFDHLTQLDKLY- 113
Query: 186 ILLSSNNFTGSIPES-YGNLKNLTEFRIDGSNLTGRIPN--FIGNWTKLDRLDLQGTSLE 242
L N S+P + L L E R++ + L IP F T L L L L+
Sbjct: 114 --LGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAF-DKLTNLQTLSLSTNQLQ 168
Query: 243 GPIPSTISQLKNLTELR 259
+L L +
Sbjct: 169 SVPHGAFDRLGKLQTIT 185
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 38/133 (28%), Positives = 58/133 (43%), Gaps = 6/133 (4%)
Query: 232 DRLDLQGTSLEGPIPSTISQLKNLTELRISDLKGSSSSFPNLQDMKKMERLILRNCLITG 291
++LDLQ T L +T L LT L + + + S D+ ++ L L N +
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA- 96
Query: 292 RIPEYIED-MTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGTLPDWI---LT 347
+P + D +T L L L NQL G+ L K+ + L N L ++P LT
Sbjct: 97 SLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLT 155
Query: 348 SEKNLDLSYNNFT 360
+ + L LS N
Sbjct: 156 NLQTLSLSTNQLQ 168
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 2e-07
Identities = 36/132 (27%), Positives = 57/132 (43%), Gaps = 18/132 (13%)
Query: 77 CTYSNNTV-CH-------------VTVILLKGFNLAGVIPEE--FGNLTFLQEVDLSRNY 120
C TV C T LL N G I + FG L L +++L RN
Sbjct: 6 CHCEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQ 65
Query: 121 FNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGD-ISTLEELVLEDNQLVGPLPENLGN 179
G P +F ++ +L + N++ I ++ + L+ L L DNQ+ +P + +
Sbjct: 66 LTGIEPNAFEGASHIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQISCVMPGSFEH 124
Query: 180 LKSLRRILLSSN 191
L SL + L+SN
Sbjct: 125 LNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 6e-04
Identities = 19/82 (23%), Positives = 33/82 (40%), Gaps = 5/82 (6%)
Query: 280 ERLILRNCLITGRIPEYIED-MTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLS 338
L+L + + + + + L L+L NQLTG P + I + L N +
Sbjct: 32 TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK 91
Query: 339 GTLPDWI---LTSEKNLDLSYN 357
+ + + L K L+L N
Sbjct: 92 -EISNKMFLGLHQLKTLNLYDN 112
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 53/297 (17%), Positives = 91/297 (30%), Gaps = 26/297 (8%)
Query: 28 RLPDDEVQTLQSIFRKLNFRNGQVNQTSCTEGSWNVTIDDSN--GSNFTCDCTYSNNTVC 85
LPD+ L IF L C W D + + +
Sbjct: 11 SLPDE---LLLGIFSCLCLPELLKVSGVCK--RWYRLASDESLWQTLDLTGKNLHPDVTG 65
Query: 86 HVTVILLKGFNLAGVIPEE----FGNLTFLQEVDLSRNYFN-GSLPKSFARLQNLTKLLI 140
+ + F ++ + +Q +DLS + +L ++ L L +
Sbjct: 66 RLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSL 125
Query: 141 LGNRLSGSIPLEIGDISTLEELVLED-----NQLVGPLPENLGNLKSLRRILLSSNNFT- 194
G RLS I + S L L L + L + L L L +FT
Sbjct: 126 EGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELN--LSWCFDFTE 183
Query: 195 -GSIPESYGNLKNLTEFRIDG--SNLTGR-IPNFIGNWTKLDRLDLQG-TSLEGPIPSTI 249
+ +T+ + G NL + + L LDL L+
Sbjct: 184 KHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEF 243
Query: 250 SQLKNLTELRISDLKG-SSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKI 305
QL L L +S + L ++ ++ L + + G + E + L+I
Sbjct: 244 FQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQI 300
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 4e-04
Identities = 36/234 (15%), Positives = 74/234 (31%), Gaps = 35/234 (14%)
Query: 172 PLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKL 231
PL E+ + L +S ++ L ++G L+ I N + + L
Sbjct: 85 PLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNL 144
Query: 232 DRLDLQGTSL--EGPIPSTISQLKNLTELRISD---------LKGSSSSFPNLQD----- 275
RL+L G S E + + +S L EL +S + +
Sbjct: 145 VRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSG 204
Query: 276 ----------------MKKMERLILRNC-LITGRIPEYIEDMTDLKILDLSF-NQLTGPV 317
+ L L + ++ + + L+ L LS +
Sbjct: 205 YRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPET 264
Query: 318 PGILQNLKKIDYIFLTNNSLSGTLPDWILTSEKNLDLSYNNFTESSPATCRESR 371
L + + + + GTL + + +L ++ ++FT + T +
Sbjct: 265 LLELGEIPTLKTLQVFGIVPDGTLQL-LKEALPHLQINCSHFTTIARPTIGNKK 317
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 2e-07
Identities = 45/229 (19%), Positives = 78/229 (34%), Gaps = 52/229 (22%)
Query: 666 KIGEGGFGPVYKG--TLSDGAVIAVKQLSSKSK---QGNREFVNEIGMISALQHQ----- 715
+GEG FG V + + +A+K + + K EI ++ ++ +
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA----RLEINVLKKIKEKDKENK 81
Query: 716 -NLVKLYGCCIEGNQLLLVYEYLENNSLARAL--FGKEGQCLNLDWATRKRICSDIARGL 772
V + + + +E L N F KE + + + L
Sbjct: 82 FLCVLMSDWFNFHGHMCIAFELLGKN-----TFEFLKENNFQPYPLPHVRHMAYQLCHAL 136
Query: 773 AYLHEESRLKIVHRDIKATNVLLDKDLNA-------------------KISDFGLA-KLD 812
+LHE ++ H D+K N+L +++DFG A
Sbjct: 137 RFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDH 193
Query: 813 EDENTHISTRIAGTVGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGK 860
E T ++TR Y PE + G+ DV+S G + E G
Sbjct: 194 EHHTTIVATRH-----YRPPEVILELGWAQ-PCDVWSIGCILFEYYRGF 236
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 3e-07
Identities = 24/141 (17%), Positives = 47/141 (33%), Gaps = 16/141 (11%)
Query: 199 ESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQG---TSLEGPIPSTISQLKNL 255
Y N E + G + I N + D +D L+G L+ L
Sbjct: 13 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDG-----FPLLRRL 66
Query: 256 TELRISDLKGSSSSFPNLQDMKKMERLILRNCLITG-RIPEYIEDMTDLKILDLSFNQLT 314
L +++ + Q + + LIL N + + + + L L + N +T
Sbjct: 67 KTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT 126
Query: 315 GP------VPGILQNLKKIDY 329
V + ++ +D+
Sbjct: 127 NKKHYRLYVIYKVPQVRVLDF 147
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 1e-06
Identities = 29/119 (24%), Positives = 48/119 (40%), Gaps = 9/119 (7%)
Query: 249 ISQLKNLTELRISDLKGS-SSSFPNLQD-MKKMERLILRNCLITGRIPEYIEDMTDLKIL 306
+Q N R DL+G NL + + + + + I ++ + + LK L
Sbjct: 12 AAQYTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTL 69
Query: 307 DLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGTLPDWI----LTSEKNLDLSYNNFTE 361
++ N++ G+ Q L + + LTNNSL L D L S L + N T
Sbjct: 70 LVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTN 127
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 5e-04
Identities = 26/91 (28%), Positives = 38/91 (41%), Gaps = 7/91 (7%)
Query: 107 NLTFLQEVDLSRNYFNGSLPK--SFARLQNLTKLLILGNRLSGSIPLEIGDISTLEELVL 164
L +D S N + K F L+ L LL+ NR+ + L EL+L
Sbjct: 40 TLDQFDAIDFSDN----EIRKLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELIL 95
Query: 165 EDNQLVGPLP-ENLGNLKSLRRILLSSNNFT 194
+N LV + L +LKSL + + N T
Sbjct: 96 TNNSLVELGDLDPLASLKSLTYLCILRNPVT 126
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 4e-07
Identities = 56/244 (22%), Positives = 88/244 (36%), Gaps = 82/244 (33%)
Query: 666 KIGEGGFGPVYKG--TLSDGAVIAVKQLSSKSK---QGNREFVNEIGMISALQHQ----- 715
+GEG FG V + + G +AVK + + + +EI ++ L
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA----RSEIQVLEHLNTTDPNST 76
Query: 716 -NLVKLYGC-------CI--EGNQLLL---VYEYLENNSLARALFGKEGQCLNLDWATRK 762
V++ CI E LL Y++++ N G LD RK
Sbjct: 77 FRCVQMLEWFEHHGHICIVFE----LLGLSTYDFIKEN-------GFLP--FRLD-HIRK 122
Query: 763 RICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNA-------------------KI 803
+ I + + +LH K+ H D+K N+L + K+
Sbjct: 123 -MAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKV 178
Query: 804 SDFGLA-KLDEDENTHISTRIAGTVGYMAPE------YAMRGYLTDKADVYSFGIVALEI 856
DFG A DE +T +STR Y APE ++ DV+S G + +E
Sbjct: 179 VDFGSATYDDEHHSTLVSTRH-----YRAPEVILALGWSQ------PCDVWSIGCILIEY 227
Query: 857 VSGK 860
G
Sbjct: 228 YLGF 231
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 4e-07
Identities = 36/144 (25%), Positives = 65/144 (45%), Gaps = 26/144 (18%)
Query: 74 TC--DCTYSNNTV-CHVTVILLKGFNLAGV---IPEEFGNLTFLQEVDLSRNYFNGSLPK 127
C +CT + V C L + IP + + E+ L N F +PK
Sbjct: 3 RCPTECTCLDTVVRCS-------NKGLKVLPKGIPRD------VTELYLDGNQFT-LVPK 48
Query: 128 SFARLQNLTKLLILGNRLSGSIPLEIGD-ISTLEELVLEDNQLVGPLPENL-GNLKSLRR 185
+ ++LT + + NR+S ++ + ++ L L+L N+L +P LKSLR
Sbjct: 49 ELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRL-RCIPPRTFDGLKSLRL 106
Query: 186 ILLSSNNFTGSIPE-SYGNLKNLT 208
+ L N+ + +PE ++ +L L+
Sbjct: 107 LSLHGNDIS-VVPEGAFNDLSALS 129
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 3e-05
Identities = 31/111 (27%), Positives = 50/111 (45%), Gaps = 15/111 (13%)
Query: 232 DRLDLQGTSLEGPIPSTISQLKNLTEL-----RISDLKGSSSSFPNLQDMKKMERLILRN 286
L L G +P +S K+LT + RIS L S+ SF N+ ++ LIL
Sbjct: 34 TELYLDGNQFTL-VPKELSNYKHLTLIDLSNNRISTL--SNQSFSNM---TQLLTLILSY 87
Query: 287 CLITGRIPEYIED-MTDLKILDLSFNQLTGPVP-GILQNLKKIDYIFLTNN 335
+ IP D + L++L L N ++ VP G +L + ++ + N
Sbjct: 88 NRLR-CIPPRTFDGLKSLRLLSLHGNDISV-VPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 4e-05
Identities = 24/63 (38%), Positives = 30/63 (47%), Gaps = 5/63 (7%)
Query: 301 TDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGTLPDWI---LTSEKNLDLSYN 357
D+ L L NQ T VP L N K + I L+NN +S TL + +T L LSYN
Sbjct: 31 RDVTELYLDGNQFTL-VPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYN 88
Query: 358 NFT 360
Sbjct: 89 RLR 91
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 19/81 (23%), Positives = 35/81 (43%), Gaps = 5/81 (6%)
Query: 280 ERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSG 339
L L T +P+ + + L ++DLS N+++ N+ ++ + L+ N L
Sbjct: 34 TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR- 91
Query: 340 TLPDWI---LTSEKNLDLSYN 357
+P L S + L L N
Sbjct: 92 CIPPRTFDGLKSLRLLSLHGN 112
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 9e-07
Identities = 47/158 (29%), Positives = 63/158 (39%), Gaps = 31/158 (19%)
Query: 75 CDCTYSNNTV-CHVTVILLKGFNLAGV---IPEEFGNLTFLQEVDLSRNYFNGSLPKSFA 130
C C S TV C K A V IP T Q + L N P F
Sbjct: 17 CSC--SGTTVDCRS-----KR--HASVPAGIP------TNAQILYLHDNQITKLEPGVFD 61
Query: 131 RLQNLTKLLILGNRLSGSIPLEIGD-ISTLEELVLEDNQLVGPLPE----NLGNLKSLRR 185
L NL +L + N+L ++P+ + D ++ L L L NQL LP L +LK L
Sbjct: 62 SLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLTV-LPSAVFDRLVHLKELF- 118
Query: 186 ILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIPN 223
+ N T +P L +LT +D N IP+
Sbjct: 119 --MCCNKLT-ELPRGIERLTHLTHLALD-QNQLKSIPH 152
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 36/155 (23%), Positives = 53/155 (34%), Gaps = 31/155 (20%)
Query: 184 RRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQG---TS 240
+ + L N T P + +L NL E + + L + T+L LDL T
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTV 102
Query: 241 LEGPIPSTISQLKNLTELRISDLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDM 300
L + +L +L EL + K L +P IE +
Sbjct: 103 LP---SAVFDRLVHLKELFMCCNK--------LT-----------------ELPRGIERL 134
Query: 301 TDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNN 335
T L L L NQL G L + + +L N
Sbjct: 135 THLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 21/60 (35%), Positives = 31/60 (51%), Gaps = 4/60 (6%)
Query: 301 TDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGTLPDWI---LTSEKNLDLSYN 357
T+ +IL L NQ+T PG+ +L + ++L +N L LP + LT LDL N
Sbjct: 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTN 98
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 1e-06
Identities = 48/296 (16%), Positives = 90/296 (30%), Gaps = 44/296 (14%)
Query: 107 NLTFLQEVDLSRNYFN---GSLPKSFARLQNLTKLLILGNRLSGSIPLEIGDISTLEELV 163
T L +++S +L + R NL L + + + LEEL
Sbjct: 182 TYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELG 241
Query: 164 LE------DNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNL 217
+ L L K LR + + +P Y LT + + +
Sbjct: 242 TGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATV 301
Query: 218 TGR-IPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISDLKG-SSSSFPNLQD 275
+ + KL RL + + + S K+L ELR+ + L +
Sbjct: 302 QSYDLVKLLCQCPKLQRLWVLDYIEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTE 361
Query: 276 ---------MKKMERLILRNCLITGRIPEYI-EDMTDLKILDLSFNQLTGP--------- 316
K+E ++ +T I + ++ L + P
Sbjct: 362 QGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLD 421
Query: 317 --VPGILQNLKKIDYIFLTNNSLSGTLPDWIL-------TSEKNLDLSYNNFTESS 363
I+++ K L SLSG L D + + L +++ ++
Sbjct: 422 IGFGAIVEHCKD-----LRRLSLSGLLTDKVFEYIGTYAKKMEMLSVAFAGDSDLG 472
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 43.0 bits (101), Expect = 5e-04
Identities = 45/306 (14%), Positives = 92/306 (30%), Gaps = 30/306 (9%)
Query: 101 IPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLS--GSIPLEIGDIST 158
+ L+ + + LP ++ LT L + + + L +
Sbjct: 257 LSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKL-LCQCPK 315
Query: 159 LEELVLEDN---QLVGPLPENLGNLKSLR------RILLSSNNFTGSIPESYG-NLKNLT 208
L+ L + D + L +L+ LR ++ + T S L
Sbjct: 316 LQRLWVLDYIEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLE 375
Query: 209 EFRIDGSNLTGR-IPNFIGNWTKLDRLDLQGTSLEGPIPSTI-----------SQLKNLT 256
+T + N + R L + P T+ K+L
Sbjct: 376 SVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLR 435
Query: 257 ELRISDLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYI-EDMTDLKILDLSFNQLTG 315
L +S L KKME L + + ++ L+ L++
Sbjct: 436 RLSLSGLLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGD 495
Query: 316 P-VPGILQNLKKIDYIFLTNNSLSGTLPDWILTSEKNLDLSY---NNFTESSPATCRESR 371
+ L+ + +++++ S+S + L++ +S P +C R
Sbjct: 496 KALLANASKLETMRSLWMSSCSVSFGACKLLGQKMPKLNVEVIDERGAPDSRPESCPVER 555
Query: 372 VNILSS 377
V I +
Sbjct: 556 VFIYRT 561
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 43/268 (16%), Positives = 91/268 (33%), Gaps = 51/268 (19%)
Query: 98 AGVIPEEFGNLTFLQEVDLSRNYFN----------GSLPKSFARLQNLTKLLILGNRLS- 146
A + E + L+ + S + L ++ + L + + N
Sbjct: 49 ARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGP 108
Query: 147 -GSIPLE--IGDISTLEELVLEDNQL-------------VGPLPENLGNLKSLRRILLSS 190
PL + + LE L L +N L + + N LR I+
Sbjct: 109 TAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGR 168
Query: 191 NNFTG----SIPESYGNLKNLTEFRIDGSNLTGR-----IPNFIGNWTKLDRLDLQGTSL 241
N +++ + + L ++ + + + + +L LDLQ +
Sbjct: 169 NRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTF 228
Query: 242 --EG--PIPSTISQLKNLTELRISD----LKGSSSSFPNLQDM--KKMERLILRNCLITG 291
G + + NL EL ++D +G+++ + ++ L L+ I
Sbjct: 229 THLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIEL 288
Query: 292 R----IPEYIED-MTDLKILDLSFNQLT 314
+ I++ M DL L+L+ N+ +
Sbjct: 289 DAVRTLKTVIDEKMPDLLFLELNGNRFS 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 3e-05
Identities = 42/262 (16%), Positives = 79/262 (30%), Gaps = 62/262 (23%)
Query: 157 STLEELVLEDNQLVGP-----LPENLGNLKSLRRILLSSNNFTG-----------SIPES 200
+++E+VL N + G L EN+ + K L S + FTG + ++
Sbjct: 32 DSVKEIVLSGNTI-GTEAARWLSENIASKKDLEIAEFS-DIFTGRVKDEIPEALRLLLQA 89
Query: 201 YGNLKNLTEFRIDGSNLTGR----IPNFIGNWTKLDRLDLQGTSL-------------EG 243
L R+ + + +F+ T L+ L L L E
Sbjct: 90 LLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQEL 149
Query: 244 PIPSTISQLKNLTEL-----RISDLKGSSSSFPNLQDMKKMERLILRNCLITGR-----I 293
+ L + R+ + Q + + + + I +
Sbjct: 150 AVNKKAKNAPPLRSIICGRNRLEN-GSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLL 208
Query: 294 PEYIEDMTDLKILDLSFNQLTGPVPGI------LQNLKKIDYIFLTNN--------SLSG 339
E + +LK+LDL N T G L++ + + L + ++
Sbjct: 209 LEGLAYCQELKVLDLQDNTFT--HLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVD 266
Query: 340 TLPDWILTSEKNLDLSYNNFTE 361
+ L L YN
Sbjct: 267 AFSKLENIGLQTLRLQYNEIEL 288
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 50.7 bits (120), Expect = 2e-06
Identities = 33/207 (15%), Positives = 66/207 (31%), Gaps = 43/207 (20%)
Query: 170 VGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIPNFIG--N 227
L L + L + + N + NLK+L I L + I +
Sbjct: 161 QVDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSL---EIISGGLPDSVVEDILGSD 217
Query: 228 WTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISDLKGSSSSFPNLQDMKKMERLILRNC 287
L++L L + ++ + L S FPNL + L + +
Sbjct: 218 LPNLEKLVLYVGVEDYGFDGDMNVFRPLF---------SKDRFPNL------KWLGIVDA 262
Query: 288 LITGRIPEYI---EDMTDLKILDLSFNQLTGP-VPGILQNLKKIDYIFLTNNSLSGTLPD 343
+ E + + L+ +D+S LT +L ++ K
Sbjct: 263 EEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDK----------------- 305
Query: 344 WILTSEKNLDLSYNNFTESSPATCRES 370
+ K +++ YN ++ ++S
Sbjct: 306 --IKHLKFINMKYNYLSDEMKKELQKS 330
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 2e-06
Identities = 54/249 (21%), Positives = 92/249 (36%), Gaps = 88/249 (35%)
Query: 666 KIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSK---QGNREFVNEIGMISALQHQ-----N 716
K+G+G FG V + + AVK + + K E ++ +Q+ N
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA----KIEADILKKIQNDDINNNN 97
Query: 717 LVKLYGC-------CI--EGNQLLL---VYEYLENNSLARALFGKEGQCLNLDWATRKRI 764
+VK +G C+ E L +YE + N G +++ +
Sbjct: 98 IVKYHGKFMYYDHMCLIFE----PLGPSLYEIITRN-------NYNG--FHIE-DIKL-Y 142
Query: 765 CSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNA----------------------- 801
C +I + L YL + + + H D+K N+LLD
Sbjct: 143 CIEILKALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKST 199
Query: 802 --KISDFGLAKLDEDEN--THISTRIAGTVGYMAPE------YAMRGYLTDKADVYSFGI 851
K+ DFG A + + + I+TR Y APE + + +D++SFG
Sbjct: 200 GIKLIDFGCA-TFKSDYHGSIINTRQ-----YRAPEVILNLGWDV------SSDMWSFGC 247
Query: 852 VALEIVSGK 860
V E+ +G
Sbjct: 248 VLAELYTGS 256
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 3e-06
Identities = 25/115 (21%), Positives = 51/115 (44%), Gaps = 8/115 (6%)
Query: 252 LKNLTELRISDLKGSSSSFPNLQD-MKKMERLILRNCLITGRIPEYIEDMTDLKILDLSF 310
++ EL + + + + L D +++E L N +T I + + LK L+LS
Sbjct: 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSD 73
Query: 311 NQLTGPVPGILQNLKKIDYIFLTNNSLSGTLPDWI----LTSEKNLDLSYNNFTE 361
N+++G + + + + ++ L+ N + L L + K+LDL T
Sbjct: 74 NRVSGGLEVLAEKCPNLTHLNLSGNKIK-DLSTIEPLKKLENLKSLDLFNCEVTN 127
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 8e-06
Identities = 33/141 (23%), Positives = 52/141 (36%), Gaps = 23/141 (16%)
Query: 131 RLQNLTKLLILGNRLS-GSIPLEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLS 189
++ +L++ +R + G + + LE L + L NL L L+++ LS
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELS 72
Query: 190 SNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNW---------TKLDRLDLQG-- 238
N +G + NLT NL+G N I + L LDL
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHL-----NLSG---NKIKDLSTIEPLKKLENLKSLDLFNCE 124
Query: 239 -TSLEGPIPSTISQLKNLTEL 258
T+L + L LT L
Sbjct: 125 VTNLNDYRENVFKLLPQLTYL 145
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 2e-05
Identities = 37/163 (22%), Positives = 63/163 (38%), Gaps = 41/163 (25%)
Query: 155 DISTLEELVLEDNQL-VGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRID 213
S ++ELVL++++ G L + L + + T SI NL L
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI----ANLPKLN----- 64
Query: 214 GSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTEL-----RISDLKGSSS 268
KL +L+L + G + + NLT L +I DL S
Sbjct: 65 ----------------KLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDL----S 104
Query: 269 SFPNLQDMKKMERLILRNCLITGRIPEY----IEDMTDLKILD 307
+ L+ ++ ++ L L NC +T + +Y + + L LD
Sbjct: 105 TIEPLKKLENLKSLDLFNCEVT-NLNDYRENVFKLLPQLTYLD 146
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 3e-04
Identities = 21/105 (20%), Positives = 41/105 (39%), Gaps = 3/105 (2%)
Query: 88 TVILLKGFNLAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSG 147
++L + G + L+ + S+ + +L L KL + NR+SG
Sbjct: 21 ELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSDNRVSG 78
Query: 148 SIPLEIGDISTLEELVLEDNQLVGPL-PENLGNLKSLRRILLSSN 191
+ + L L L N++ E L L++L+ + L +
Sbjct: 79 GLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 6e-06
Identities = 19/123 (15%), Positives = 49/123 (39%), Gaps = 12/123 (9%)
Query: 241 LEGPIPSTISQLK-NLTELRISDLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYIED 299
+ + + +++ + I + + S+ + L L I +I +
Sbjct: 17 RKSVVATEAEKVELHGMIPPIEKMDATLSTLKAC------KHLALSTNNIE-KI-SSLSG 68
Query: 300 MTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGTLPDWI-LTSEKNLDLSYNN 358
M +L+IL L N + + + ++ ++++ N ++ +L L + + L +S N
Sbjct: 69 MENLRILSLGRNLIKK-IENLDAVADTLEELWISYNQIA-SLSGIEKLVNLRVLYMSNNK 126
Query: 359 FTE 361
T
Sbjct: 127 ITN 129
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 4e-05
Identities = 34/217 (15%), Positives = 63/217 (29%), Gaps = 73/217 (33%)
Query: 137 KLLILGNRLSG--SIPLEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFT 194
+ + L + + + + + L L N + +L +++LR + L N
Sbjct: 26 EKVELHGMIPPIEKMDATLSTLKACKHLALSTNNI--EKISSLSGMENLRILSLGRNLIK 83
Query: 195 GSIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQG---TSLEGPIPSTISQ 251
+I N L+ L + SL G I +
Sbjct: 84 -------------------------KIENLDAVADTLEELWISYNQIASLSG-----IEK 113
Query: 252 LKNLTELRISDLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFN 311
L NL L +S+ N + + + + L+ L L+ N
Sbjct: 114 LVNLRVLYMSN-----------------------NKITNWGEIDKLAALDKLEDLLLAGN 150
Query: 312 QLTGPVPG-------------ILQNLKKIDYIFLTNN 335
L L NLKK+D + + +
Sbjct: 151 PLYNDYKENNATSEYRIEVVKRLPNLKKLDGMPVDVD 187
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 3e-04
Identities = 33/161 (20%), Positives = 56/161 (34%), Gaps = 24/161 (14%)
Query: 101 IPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLIL---GNRLSGSIPLEIGDIS 157
+ L + + LS N + + L + L IL N + L+
Sbjct: 40 MDATLSTLKACKHLALSTNNI-----EKISSLSGMENLRILSLGRNLIKKIENLD-AVAD 93
Query: 158 TLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNL 217
TLEEL + NQ+ + L +LR + +S+N T ++G + L L
Sbjct: 94 TLEELWISYNQIA--SLSGIEKLVNLRVLYMSNNKIT-----NWGEIDKLAAL----DKL 142
Query: 218 TGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTEL 258
GN L + + + +L NL +L
Sbjct: 143 --EDLLLAGN--PLYNDYKENNATSEYRIEVVKRLPNLKKL 179
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 1e-05
Identities = 25/115 (21%), Positives = 46/115 (40%), Gaps = 8/115 (6%)
Query: 252 LKNLTELRISDLKGSSSSFPNLQD-MKKMERLILRNCLITGRIPEYIEDMTDLKILDLSF 310
+ EL + + K + L +E L L N + + + + LK L+LS
Sbjct: 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELSE 80
Query: 311 NQLTGPVPGILQNLKKIDYIFLTNNSLSGTLPDWI----LTSEKNLDLSYNNFTE 361
N++ G + + + L + ++ L+ N L + L K+LDL T
Sbjct: 81 NRIFGGLDMLAEKLPNLTHLNLSGNKLK-DISTLEPLKKLECLKSLDLFNCEVTN 134
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 2e-05
Identities = 35/141 (24%), Positives = 52/141 (36%), Gaps = 23/141 (16%)
Query: 131 RLQNLTKLLILGNRLS-GSIPLEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLS 189
+ +L++ + + G I + LE L L + L+ NL L L+++ LS
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELS 79
Query: 190 SNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNW---------TKLDRLDLQG-- 238
N G + L NLT NL+G N + + L LDL
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHL-----NLSG---NKLKDISTLEPLKKLECLKSLDLFNCE 131
Query: 239 -TSLEGPIPSTISQLKNLTEL 258
T+L S L LT L
Sbjct: 132 VTNLNDYRESVFKLLPQLTYL 152
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 7e-05
Identities = 23/105 (21%), Positives = 41/105 (39%), Gaps = 3/105 (2%)
Query: 88 TVILLKGFNLAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSG 147
++L + G I L+ + L S+ + +L L KL + NR+ G
Sbjct: 28 ELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELSENRIFG 85
Query: 148 SIPLEIGDISTLEELVLEDNQLVGPLP-ENLGNLKSLRRILLSSN 191
+ + + L L L N+L E L L+ L+ + L +
Sbjct: 86 GLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 3e-04
Identities = 30/141 (21%), Positives = 56/141 (39%), Gaps = 18/141 (12%)
Query: 176 NLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLD 235
++ L +L + + G I NL + L + N KL +L+
Sbjct: 22 TPAAVREL--VLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSNLPKL-PKLKKLE 77
Query: 236 LQGTSLEGPIPSTISQLKNLTEL-----RISDLKGSSSSFPNLQDMKKMERLILRNCLIT 290
L + G + +L NLT L ++ D+ S+ L+ ++ ++ L L NC +T
Sbjct: 78 LSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDI----STLEPLKKLECLKSLDLFNCEVT 133
Query: 291 GRIPEY----IEDMTDLKILD 307
+ +Y + + L LD
Sbjct: 134 -NLNDYRESVFKLLPQLTYLD 153
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 1e-04
Identities = 38/144 (26%), Positives = 57/144 (39%), Gaps = 31/144 (21%)
Query: 75 CDCTYSNNTV-CHVTVILLKGFNLAGV---IPEEFGNLTFLQEVDLSRNYFNGSLPKSFA 130
C C S + C+ KG L V IP + ++L N F
Sbjct: 5 CSC--SGTEIRCNS-----KG--LTSVPTGIP------SSATRLELESNKLQSLPHGVFD 49
Query: 131 RLQNLTKLLILGNRLSGSIPLEIGD-ISTLEELVLEDNQLVGPLPE----NLGNLKSLRR 185
+L LTKL + N++ S+P + D ++ L L L +N+L LP L LK L
Sbjct: 50 KLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENKLQS-LPNGVFDKLTQLKELAL 107
Query: 186 ILLSSNNFTGSIPE-SYGNLKNLT 208
N S+P+ + L +L
Sbjct: 108 ----DTNQLKSVPDGIFDRLTSLQ 127
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 16/60 (26%), Positives = 27/60 (45%), Gaps = 4/60 (6%)
Query: 301 TDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGTLPDWI---LTSEKNLDLSYN 357
+ L+L N+L G+ L ++ + L+ N + +LPD + LT L L N
Sbjct: 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHEN 86
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 41.8 bits (99), Expect = 2e-04
Identities = 20/60 (33%), Positives = 30/60 (50%), Gaps = 4/60 (6%)
Query: 301 TDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGTLPDWI---LTSEKNLDLSYN 357
T ++L L NQ+T PG+ L ++ + L NN L+ LP + LT L L+ N
Sbjct: 30 TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQLTQLSLNDN 88
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 41.8 bits (99), Expect = 3e-04
Identities = 45/125 (36%), Positives = 55/125 (44%), Gaps = 27/125 (21%)
Query: 75 CDCTYSNNTV-CHVTVILLKGFNLAGV---IPEEFGNLTFLQEVDLSRNYFNGSLPKSFA 130
C C S TV C K LA V IP T Q + L N P F
Sbjct: 7 CSC--SGTTVDCSG-----KS--LASVPTGIP------TTTQVLYLYDNQITKLEPGVFD 51
Query: 131 RLQNLTKLLILGNRLSGSIPLEIGDIST-LEELVLEDNQLVGPLPENLG---NLKSLRRI 186
RL LT+L + N+L+ +P + D T L +L L DNQL +P G NLKSL I
Sbjct: 52 RLTQLTRLDLDNNQLT-VLPAGVFDKLTQLTQLSLNDNQLKS-IPR--GAFDNLKSLTHI 107
Query: 187 LLSSN 191
L +N
Sbjct: 108 WLLNN 112
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 3e-04
Identities = 19/60 (31%), Positives = 32/60 (53%), Gaps = 4/60 (6%)
Query: 301 TDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGTLPDWI---LTSEKNLDLSYN 357
TD + L L+ NQ+T PG+ +L + ++ +N L+ +P + LT LDL+ N
Sbjct: 33 TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQLTQLDLNDN 91
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 6e-04
Identities = 41/125 (32%), Positives = 51/125 (40%), Gaps = 27/125 (21%)
Query: 75 CDCTYSNNTV-CHVTVILLKGFNLAGV---IPEEFGNLTFLQEVDLSRNYFNGSLPKSFA 130
C C V C LA V IP T Q + L+ N P F
Sbjct: 10 CSC--DQTLVNCQN-----IR--LASVPAGIP------TDKQRLWLNNNQITKLEPGVFD 54
Query: 131 RLQNLTKLLILGNRLSGSIPLEIGDIST-LEELVLEDNQLVGPLPENLG---NLKSLRRI 186
L NL +L N+L+ +IP + D T L +L L DN L +P G NLKSL I
Sbjct: 55 HLVNLQQLYFNSNKLT-AIPTGVFDKLTQLTQLDLNDNHLKS-IPR--GAFDNLKSLTHI 110
Query: 187 LLSSN 191
L +N
Sbjct: 111 YLYNN 115
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 3e-04
Identities = 37/157 (23%), Positives = 58/157 (36%), Gaps = 34/157 (21%)
Query: 184 RRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQG---TS 240
+ L +N+ + L +LT+ + G+ L T L L+L S
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQS 90
Query: 241 LEGPIPSTISQLKNLTELRISDLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYIED- 299
L +L L EL ++ + LQ +P+ + D
Sbjct: 91 LP---NGVFDKLTQLKELALNTNQ--------LQ-----------------SLPDGVFDK 122
Query: 300 MTDLKILDLSFNQLTGPVP-GILQNLKKIDYIFLTNN 335
+T LK L L NQL VP G+ L + YI+L +N
Sbjct: 123 LTQLKDLRLYQNQLKS-VPDGVFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 6e-04
Identities = 44/159 (27%), Positives = 66/159 (41%), Gaps = 32/159 (20%)
Query: 75 CDCTYSNNTV-CHVTVILLKGFNLAGV---IPEEFGNLTFLQEVDLSRNYFNGSLPKSFA 130
C C S TV C+ V IP + L DL N F
Sbjct: 5 CSC--SGTTVECY-------SQGRTSVPTGIPAQTTYL------DLETNSLKSLPNGVFD 49
Query: 131 RLQNLTKLLILGNRLSGSIPLEIGD-ISTLEELVLEDNQLVGPLPE----NLGNLKSLRR 185
L +LT+L + GN+L S+P + + +++L L L NQL LP L LK L
Sbjct: 50 ELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQS-LPNGVFDKLTQLKELA- 106
Query: 186 ILLSSNNFTGSIPE-SYGNLKNLTEFRIDGSNLTGRIPN 223
L++N S+P+ + L L + R+ + L +P+
Sbjct: 107 --LNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLK-SVPD 141
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 6e-04
Identities = 30/117 (25%), Positives = 50/117 (42%), Gaps = 8/117 (6%)
Query: 245 IPSTISQLKNLTELRISDLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYIED-MTDL 303
+P+ I T L + S ++ + +L L + +P + + +T L
Sbjct: 22 VPTGIPA--QTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSL 78
Query: 304 KILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGTLPDWI---LTSEKNLDLSYN 357
L+LS NQL G+ L ++ + L N L +LPD + LT K+L L N
Sbjct: 79 TYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQN 134
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
No hit with probability above 80.00
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 1016 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-71 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-68 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-67 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-66 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-64 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-64 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-64 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-62 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 7e-62 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-61 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-61 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-61 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-60 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-60 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 8e-60 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-59 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-59 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-59 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 6e-59 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 8e-58 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-57 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-57 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-56 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-56 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 7e-56 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 7e-56 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-55 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 8e-55 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 9e-55 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-53 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-52 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 7e-52 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-51 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 7e-50 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-46 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 8e-46 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-45 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-45 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 9e-45 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-44 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 6e-44 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-43 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-43 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-43 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-43 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 6e-43 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 8e-43 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-42 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 7e-41 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-40 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-40 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-40 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-39 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-39 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-38 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 6e-38 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-36 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 5e-33 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-32 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-32 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-32 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-27 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-23 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-20 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 7e-16 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 8e-10 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-23 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-11 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-23 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 6e-18 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-14 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-17 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-16 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 6e-10 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-08 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-08 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-08 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-06 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-05 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 0.001 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-10 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-08 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 0.004 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-09 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 7e-07 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 7e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 6e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.001 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 1e-07 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 4e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 5e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 5e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 5e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 5e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.002 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.002 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.004 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 1e-06 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 3e-06 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 1e-05 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 4e-05 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 6e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 0.003 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 2e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 5e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.002 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.003 | |
| d1m9la_ | 198 | c.10.3.1 (A:) Outer arm dynein light chain 1 {Gree | 8e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 9e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.001 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.002 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 236 bits (603), Expect = 2e-71
Identities = 72/280 (25%), Positives = 132/280 (47%), Gaps = 24/280 (8%)
Query: 659 NNFDAANKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLV 718
+IG G FG VYKG + + +++ + Q + F NE+G++ +H N++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 719 KLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEE 778
G QL +V ++ E +SL L E + + I A+G+ YLH +
Sbjct: 68 LFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETK---FEMIKLIDIARQTAQGMDYLHAK 123
Query: 779 SRLKIVHRDIKATNVLLDKDLNAKISDFGLAKL-DEDENTHISTRIAGTVGYMAPEYAM- 836
I+HRD+K+ N+ L +DL KI DFGLA + +H +++G++ +MAPE
Sbjct: 124 ---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 180
Query: 837 --RGYLTDKADVYSFGIVALEIVSGKSN-TNYRPKEEFVYLLDWAYVLQEQGNLLELVDP 893
+ + ++DVY+FGIV E+++G+ +N +++ ++++ Y+ +
Sbjct: 181 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPD--------LS 232
Query: 894 SLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933
+ SN K M + C RP ++ +E
Sbjct: 233 KVRSNCPKA----MKRLMAECLKKKRDERPLFPQILASIE 268
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 227 bits (580), Expect = 3e-68
Identities = 82/276 (29%), Positives = 125/276 (45%), Gaps = 24/276 (8%)
Query: 659 NNFDAANKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLV 718
++G G FG V+ G + +AVK L + F+ E ++ LQHQ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 719 KLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEE 778
+LY + + ++ EY+EN SL L G L + + IA G+A++ E
Sbjct: 72 RLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGI--KLTINKLLDMAAQIAEGMAFIEER 128
Query: 779 SRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRG 838
+HRD++A N+L+ L+ KI+DFGLA+L ED + + APE G
Sbjct: 129 ---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG 185
Query: 839 YLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGS 897
T K+DV+SFGI+ EIV+ G+ E + L+ Y +V P
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY---------RMVRP---D 233
Query: 898 NFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933
N ++ + + LC P RPT S+LE
Sbjct: 234 NCPEE----LYQLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 225 bits (574), Expect = 1e-67
Identities = 76/276 (27%), Positives = 122/276 (44%), Gaps = 24/276 (8%)
Query: 659 NNFDAANKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLV 718
+ +IG G FG V+ G + +A+K + + +F+ E ++ L H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 719 KLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEE 778
+LYG C+E + LV+E++E+ L+ L + G T +C D+ G+AYL E
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLF---AAETLLGMCLDVCEGMAYLEEA 120
Query: 779 SRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRG 838
++HRD+ A N L+ ++ K+SDFG+ + D+ ST V + +PE
Sbjct: 121 ---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS 177
Query: 839 YLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGS 897
+ K+DV+SFG++ E+ S GK R E V + + L P L S
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF---------RLYKPRLAS 228
Query: 898 NFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933
+ I C P RP S + L
Sbjct: 229 T-------HVYQIMNHCWKERPEDRPAFSRLLRQLA 257
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (565), Expect = 2e-66
Identities = 64/275 (23%), Positives = 108/275 (39%), Gaps = 22/275 (8%)
Query: 659 NNFDAANKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLV 718
+ ++G G FG V G +A+K + + EF+ E ++ L H+ LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLV 62
Query: 719 KLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEE 778
+LYG C + + ++ EY+ N L L + +C D+ + YL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR---FQTQQLLEMCKDVCEAMEYLE-- 117
Query: 779 SRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRG 838
+ +HRD+ A N L++ K+SDFGL++ D+ S V + PE M
Sbjct: 118 -SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYS 176
Query: 839 YLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGSN 898
+ K+D+++FG++ EI S P E F E + L
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLG----KMPYERF-----------TNSETAEHIAQGLRLY 221
Query: 899 FSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933
+ + I C + RPT +S +
Sbjct: 222 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (555), Expect = 1e-64
Identities = 74/275 (26%), Positives = 123/275 (44%), Gaps = 22/275 (8%)
Query: 659 NNFDAANKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLV 718
+ K+G+G FG V+ GT + +A+K L F+ E ++ L+H+ LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLV 75
Query: 719 KLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEE 778
+LY + +V EY+ SL L G+ G+ L + + IA G+AY+
Sbjct: 76 QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLR--LPQLVDMAAQIASGMAYVE-- 130
Query: 779 SRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRG 838
R+ VHRD++A N+L+ ++L K++DFGLA+L ED + + APE A+ G
Sbjct: 131 -RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 189
Query: 839 YLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGSN 898
T K+DV+SFGI+ E+ + +L+ V+
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---------------EVLDQVERGYRMP 234
Query: 899 FSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933
+ ++ ++ C P RPT + LE
Sbjct: 235 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 269
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (555), Expect = 1e-64
Identities = 75/291 (25%), Positives = 117/291 (40%), Gaps = 30/291 (10%)
Query: 666 KIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCI 725
IG+G FG V++G G +AVK SS+ ++ + EI L+H+N++
Sbjct: 10 SIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADN 67
Query: 726 EGN----QLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEE--- 778
+ N QL LV +Y E+ SL L + ++ A GLA+LH E
Sbjct: 68 KDNGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 779 --SRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHIS---TRIAGTVGYMAPE 833
+ I HRD+K+ N+L+ K+ I+D GLA + I GT YMAPE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182
Query: 834 Y------AMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVY----LLDWAYVLQE 883
+AD+Y+ G+V EI S + Y D +
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242
Query: 884 QGNLLELVDPSLGSNFSKKEAM-TMLNIALLCTNPSPTLRPTMSSAVSMLE 933
+ + + P++ + + EA+ M I C + R T L
Sbjct: 243 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 218 bits (555), Expect = 2e-64
Identities = 75/319 (23%), Positives = 128/319 (40%), Gaps = 47/319 (14%)
Query: 649 FTLRQIKAATNNFDAA---------NKIGEGGFGPVYKGTL----SDGAVIAVKQL-SSK 694
FT A F IG G FG V G L +A+K L S
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 695 SKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCL 754
+++ R+F++E ++ H N++ L G + ++++ E++EN SL L +GQ
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125
Query: 755 NLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDED 814
+ IA G+ YL + VHRD+ A N+L++ +L K+SDFGL++ ED
Sbjct: 126 --TVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180
Query: 815 ENTHISTR----IAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEE 870
+ + + + + APE T +DV+S+GIV E++S RP +
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYG----ERPYWD 236
Query: 871 FVYLLDWAYVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930
+++ ++ + + L C RP V+
Sbjct: 237 -----------MTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVN 285
Query: 931 MLEGKTAVQAPIIRRNSDS 949
L+ + RN +S
Sbjct: 286 TLDK--------MIRNPNS 296
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (543), Expect = 2e-62
Identities = 63/304 (20%), Positives = 121/304 (39%), Gaps = 44/304 (14%)
Query: 657 ATNNFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNRE-FVNEIGMISALQH 714
++F+ +++G G G V+K + G V+A K + + K R + E+ ++
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 715 QNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAY 774
+V YG ++ + E+++ SL + L + ++ + +GL Y
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTY 119
Query: 775 LHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEY 834
L + KI+HRD+K +N+L++ K+ DFG++ D GT YM+PE
Sbjct: 120 LR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA---NSFVGTRSYMSPER 174
Query: 835 AMRGYLTDKADVYSFGIVALEIVSGK-----------------------SNTNYRPKEEF 871
+ + ++D++S G+ +E+ G+ + T RP+
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234
Query: 872 VYLLDWAYVLQEQGNLLELVD-------PSLGSNFSKKEAMTMLNIALLCTNPSPTLRPT 924
L + + + EL+D P L S E +N C +P R
Sbjct: 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVN---KCLIKNPAERAD 291
Query: 925 MSSA 928
+
Sbjct: 292 LKQL 295
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 209 bits (534), Expect = 7e-62
Identities = 58/276 (21%), Positives = 113/276 (40%), Gaps = 22/276 (7%)
Query: 659 NNFDAANKIGEGGFGPVYKGTLSD-GAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNL 717
+ +K+G G +G VY+G +AVK L + + EF+ E ++ ++H NL
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNL 75
Query: 718 VKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHE 777
V+L G C ++ E++ +L L Q + + + I+ + YL
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ--EVSAVVLLYMATQISSAMEYLE- 132
Query: 778 ESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMR 837
+ +HRD+ A N L+ ++ K++DFGL++L + + + APE
Sbjct: 133 --KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 190
Query: 838 GYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGS 897
+ K+DV++FG++ EI + Y + + EL++
Sbjct: 191 NKFSIKSDVWAFGVLLWEIATYGM---------------SPYPGIDLSQVYELLEKDYRM 235
Query: 898 NFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933
+ + + C +P+ RP+ + E
Sbjct: 236 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 271
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 210 bits (534), Expect = 1e-61
Identities = 77/312 (24%), Positives = 130/312 (41%), Gaps = 48/312 (15%)
Query: 651 LRQIKAATNNFDAANKIGEGGFGPVYKGTL------SDGAVIAVKQLSSKSKQGNR-EFV 703
L ++ NN + IGEG FG V++ ++AVK L ++ + +F
Sbjct: 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 64
Query: 704 NEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLN-------- 755
E +++ + N+VKL G C G + L++EY+ L L +
Sbjct: 65 REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124
Query: 756 ------------LDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKI 803
L A + I +A G+AYL E K VHRD+ N L+ +++ KI
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKI 181
Query: 804 SDFGLAK-LDEDENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSN 862
+DFGL++ + + A + +M PE T ++DV+++G+V EI S
Sbjct: 182 ADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241
Query: 863 TNY-RPKEEFVYLLDWAYVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTL 921
Y EE +Y + GN+L + + + N+ LC + P
Sbjct: 242 PYYGMAHEEVIYYV-------RDGNILACPE---------NCPLELYNLMRLCWSKLPAD 285
Query: 922 RPTMSSAVSMLE 933
RP+ S +L+
Sbjct: 286 RPSFCSIHRILQ 297
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (532), Expect = 1e-61
Identities = 66/290 (22%), Positives = 118/290 (40%), Gaps = 31/290 (10%)
Query: 652 RQIKAATNNFDAAN-KIGEGGFGPVYKGTL---SDGAVIAVKQLSSKSKQGNRE-FVNEI 706
+++ +N A+ ++G G FG V +G +A+K L +++ + E + E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 707 GMISALQHQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICS 766
++ L + +V+L G C + L+LV E L + L GK + + + +
Sbjct: 61 QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLH 116
Query: 767 DIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKL--DEDENTHISTRIA 824
++ G+ YL VHRD+ A NVLL AKISDFGL+K +D +
Sbjct: 117 QVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173
Query: 825 GTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWAYVLQE 883
+ + APE + ++DV+S+G+ E +S G+ E + + E
Sbjct: 174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI-------E 226
Query: 884 QGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933
QG +E + + + C RP + +
Sbjct: 227 QGKRMECPP-----ECPPE----LYALMSDCWIYKWEDRPDFLTVEQRMR 267
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 5e-61
Identities = 71/291 (24%), Positives = 130/291 (44%), Gaps = 31/291 (10%)
Query: 659 NNFDAANKIGEGGFGPVYKGTLSDG-----AVIAVKQLSSKSKQGNR-EFVNEIGMISAL 712
+ IG G FG VYKG L +A+K L + + R +F+ E G++
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 713 QHQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGL 772
H N+++L G + ++++ EY+EN +L + L K+G+ + IA G+
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE---FSVLQLVGMLRGIAAGM 123
Query: 773 AYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKL--DEDENTHISTRIAGTVGYM 830
YL + VHRD+ A N+L++ +L K+SDFGL+++ D+ E T+ ++ + +
Sbjct: 124 KYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 180
Query: 831 APEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLEL 890
APE T +DV+SFGIV E+++ + +++
Sbjct: 181 APEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH---------------EVMKA 225
Query: 891 VDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTAVQAP 941
++ + + + C RP + VS+L+ ++AP
Sbjct: 226 INDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK--LIRAP 274
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 2e-60
Identities = 70/276 (25%), Positives = 106/276 (38%), Gaps = 28/276 (10%)
Query: 659 NNFDAANKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLV 718
IG+G FG V G G +AVK + + + + F+ E +++ L+H NLV
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 63
Query: 719 KLYGCCIEG-NQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHE 777
+L G +E L +V EY+ SL L + L + D+ + YL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVL--GGDCLLKFSLDVCEAMEYLEG 121
Query: 778 ESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMR 837
VHRD+ A NVL+ +D AK+SDFGL K V + APE
Sbjct: 122 N---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK----LPVKWTAPEALRE 174
Query: 838 GYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGS 897
+ K+DV+SFGI+ EI S R + V + +
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP-----------RVEKGYKMDAPD 223
Query: 898 NFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933
+ + C + +RP+ LE
Sbjct: 224 GCPPA----VYEVMKNCWHLDAAMRPSFLQLREQLE 255
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (526), Expect = 2e-60
Identities = 74/299 (24%), Positives = 114/299 (38%), Gaps = 40/299 (13%)
Query: 659 NNFDAANKIGEGGFGPVYKGTL------SDGAVIAVKQLSSKSKQGNRE-FVNEIGMISA 711
N +G G FG V + T +AVK L + RE ++E+ ++S
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 712 L-QHQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLN--------------L 756
L H N+V L G C G L++ EY L L K + L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 757 DWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAK-LDEDE 815
D +A+G+A+L + +HRD+ A N+LL KI DFGLA+ + D
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 816 NTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLL 875
N + V +MAPE T ++DV+S+GI E+ S S+
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS------------- 246
Query: 876 DWAYVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEG 934
+ +++ + M +I C + P RPT V ++E
Sbjct: 247 -PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 8e-60
Identities = 66/276 (23%), Positives = 108/276 (39%), Gaps = 30/276 (10%)
Query: 665 NKIGEGGFGPVYKGTLSD---GAVIAVKQLSSKSKQGN--REFVNEIGMISALQHQNLVK 719
++G G FG V KG +AVK L +++ E + E ++ L + +V+
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 720 LYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEES 779
+ G C E +LV E E L + L ++ + ++ G+ YL E
Sbjct: 73 MIGIC-EAESWMLVMEMAELGPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEES- 126
Query: 780 RLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTR--IAGTVGYMAPEYAMR 837
VHRD+ A NVLL AKISDFGL+K + + + V + APE
Sbjct: 127 --NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184
Query: 838 GYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGS 897
+ K+DV+SFG++ E S +P Y + + +++
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYG----QKP-----------YRGMKGSEVTAMLEKGERM 229
Query: 898 NFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933
M ++ LC RP ++ L
Sbjct: 230 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (521), Expect = 2e-59
Identities = 75/303 (24%), Positives = 113/303 (37%), Gaps = 45/303 (14%)
Query: 659 NNFDAANKIGEGGFGPVYKGTLSD------GAVIAVKQLSSKSKQGNRE-FVNEIGMISA 711
N + +G G FG V T +AVK L K+ RE ++E+ M++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 712 L-QHQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLN--------------- 755
L H+N+V L G C + L++EY L L K +
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 756 ----LDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAK- 810
L + +A+G+ +L + VHRD+ A NVL+ KI DFGLA+
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 811 LDEDENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEE 870
+ D N + V +MAPE G T K+DV+S+GI+ EI S P
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLG----VNPYPG 269
Query: 871 FVYLLDWAYVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930
+ N +L+ + + I C RP+ + S
Sbjct: 270 ----------IPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS 319
Query: 931 MLE 933
L
Sbjct: 320 FLG 322
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 3e-59
Identities = 77/283 (27%), Positives = 122/283 (43%), Gaps = 32/283 (11%)
Query: 660 NFDAANKIGEGGFGPVYKGTLSD----GAVIAVKQLSSKSKQGN-REFVNEIGMISALQH 714
+F+ IG G FG VY GTL D AVK L+ + G +F+ E ++ H
Sbjct: 30 HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 715 QNLVKLYGCCIEG-NQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLA 773
N++ L G C+ L+V Y+++ L + + N +A+G+
Sbjct: 88 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMK 144
Query: 774 YLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKL---DEDENTHISTRIAGTVGYM 830
+L K VHRD+ A N +LD+ K++DFGLA+ E ++ H T V +M
Sbjct: 145 FLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 201
Query: 831 APEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLEL 890
A E T K+DV+SFG++ E+++ P V D L + LL
Sbjct: 202 ALESLQTQKFTTKSDVWSFGVLLWELMTRG-----APPYPDVNTFDITVYLLQGRRLL-- 254
Query: 891 VDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933
P + + + L C +P +RP+ S VS +
Sbjct: 255 -QPEYCPD-------PLYEVMLKCWHPKAEMRPSFSELVSRIS 289
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 203 bits (517), Expect = 3e-59
Identities = 81/320 (25%), Positives = 134/320 (41%), Gaps = 43/320 (13%)
Query: 661 FDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGN---REFVNEIGMISALQHQN 716
F +IG G FG VY + + V+A+K++S KQ N ++ + E+ + L+H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 717 LVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLH 776
++ GC + + LV EY ++ K+ L + +GLAYLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP----LQEVEIAAVTHGALQGLAYLH 132
Query: 777 EESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAM 836
++HRD+KA N+LL + K+ DFG A + N+ + GT +MAPE +
Sbjct: 133 SH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEVIL 184
Query: 837 ---RGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDP 893
G K DV+S GI +E+ K +Y ++ + P
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY------------HIAQNESP 232
Query: 894 SLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS----MLEGKTAVQAPIIRRNSDS 949
+L S + N C P RPT + + E V +I+R D+
Sbjct: 233 ALQSGHWSEYF---RNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDA 289
Query: 950 ----QDARFRAF-EILSQDS 964
+ ++R +IL Q++
Sbjct: 290 VRELDNLQYRKMKKILFQEA 309
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 6e-59
Identities = 67/277 (24%), Positives = 118/277 (42%), Gaps = 24/277 (8%)
Query: 660 NFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQL--SSKSKQGNREFVNEIGMISALQHQN 716
+++ IG G +G K SDG ++ K+L S ++ + V+E+ ++ L+H N
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 717 LVKLYGCCIE--GNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAY 774
+V+ Y I+ L +V EY E LA + + LD R+ + + L
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 775 LHEESR--LKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAP 832
H S ++HRD+K NV LD N K+ DFGLA++ + +T + GT YM+P
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI-LNHDTSFAKAFVGTPYYMSP 183
Query: 833 EYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVD 892
E R +K+D++S G + E+ + ++E + E
Sbjct: 184 EQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAG------------KIREGKF 231
Query: 893 PSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAV 929
+ +S + + I N RP++ +
Sbjct: 232 RRIPYRYSDE----LNEIITRMLNLKDYHRPSVEEIL 264
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 8e-58
Identities = 66/274 (24%), Positives = 110/274 (40%), Gaps = 31/274 (11%)
Query: 665 NKIGEGGFGPVYKGTLSD-GAVIAVKQLSSK--SKQGNREFVNEIGMISALQHQNLVKLY 721
+IG G F VYKG ++ +A +L + +K + F E M+ LQH N+V+ Y
Sbjct: 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74
Query: 722 GCCIE----GNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHE 777
++LV E + + +L L + + + C I +GL +LH
Sbjct: 75 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHT 130
Query: 778 ESRLKIVHRDIKATNVLL-DKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAM 836
+ I+HRD+K N+ + + KI D GLA L + GT +MAPE
Sbjct: 131 RTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA---KAVIGTPEFMAPEMYE 186
Query: 837 RGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLG 896
Y + DVY+FG+ LE+ + + P + Q + V P+
Sbjct: 187 EKY-DESVDVYAFGMCMLEMATSE-----YP------YSECQNAAQIYRRVTSGVKPASF 234
Query: 897 SNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930
+ E I C + R ++ ++
Sbjct: 235 DKVAIPEVK---EIIEGCIRQNKDERYSIKDLLN 265
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 1e-57
Identities = 73/276 (26%), Positives = 110/276 (39%), Gaps = 25/276 (9%)
Query: 659 NNFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNRE-FVNEIGMISALQHQN 716
++D +GEG +G V +AVK + K E EI + L H+N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 717 LVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLH 776
+VK YG EGN L EY L + G + +R + G+ YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG----MPEPDAQRFFHQLMAGVVYLH 120
Query: 777 EESRLKIVHRDIKATNVLLDKDLNAKISDFGLAK-LDEDENTHISTRIAGTVGYMAPEYA 835
+ I HRDIK N+LLD+ N KISDFGLA + + ++ GT+ Y+APE
Sbjct: 121 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177
Query: 836 MRG-YLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPS 894
R + + DV+S GIV +++G+ + Y +E+ L
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS-----DWKEKKTYLNPWK-- 230
Query: 895 LGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930
L + +P+ R T+
Sbjct: 231 ---KIDSA----PLALLHKILVENPSARITIPDIKK 259
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 4e-57
Identities = 66/270 (24%), Positives = 114/270 (42%), Gaps = 27/270 (10%)
Query: 665 NKIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGC 723
++G+G FG VYK + A K + +KS++ +++ EI ++++ H N+VKL
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 724 CIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKI 783
N L ++ E+ ++ + E L + + +C L YLH+ KI
Sbjct: 78 FYYENNLWILIEFCAGGAVDAVMLELERP---LTESQIQVVCKQTLDALNYLHD---NKI 131
Query: 784 VHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAM-----RG 838
+HRD+KA N+L D + K++DFG++ + + I GT +MAPE M
Sbjct: 132 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCETSKDR 190
Query: 839 YLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGSN 898
KADV+S GI +E+ + + + + + L P S
Sbjct: 191 PYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI-------AKSEPPTLAQP---SR 240
Query: 899 FSKKEAMTMLNIALLCTNPSPTLRPTMSSA 928
+S + C + R T S
Sbjct: 241 WSSN----FKDFLKKCLEKNVDARWTTSQL 266
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 1e-56
Identities = 60/276 (21%), Positives = 111/276 (40%), Gaps = 31/276 (11%)
Query: 659 NNFDAANKIGEGGFGPVYKGTL-SDGAVIAVKQLSSK---SKQGNREFVNEIGMISALQH 714
+F+ +G+G FG VY ++A+K L + E+ + S L+H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 715 QNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAY 774
N+++LYG + ++ L+ EY ++ R L + D +++A L+Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQ----KLSKFDEQRTATYITELANALSY 121
Query: 775 LHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEY 834
H +++HRDIK N+LL KI+DFG + + GT+ Y+ PE
Sbjct: 122 CHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---TLCGTLDYLPPEM 175
Query: 835 AMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPS 894
+K D++S G++ E + GK P E Y + + + + + V
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGK-----PPFEANTYQETYKRISRVEFTFPDFVTEG 230
Query: 895 LGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930
++ +P+ RP + +
Sbjct: 231 A------------RDLISRLLKHNPSQRPMLREVLE 254
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 1e-56
Identities = 71/292 (24%), Positives = 114/292 (39%), Gaps = 37/292 (12%)
Query: 659 NNFDAANKIGEGGFGPVYKGTLSDGA---VIAVKQLS-SKSKQGNREFVNEIGMISAL-Q 713
N+ + IGEG FG V K + A+K++ SK +R+F E+ ++ L
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 714 HQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLN------------LDWATR 761
H N++ L G C L L EY + +L L + L
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 762 KRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHIST 821
+D+ARG+ YL + + +HRD+ A N+L+ ++ AKI+DFGL++ E T
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK--T 184
Query: 822 RIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVL 881
V +MA E T +DV+S+G++ EIVS Y
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT---------------PYCG 229
Query: 882 QEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933
L E + + ++ C P RP+ + + L
Sbjct: 230 MTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 281
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 7e-56
Identities = 67/280 (23%), Positives = 111/280 (39%), Gaps = 27/280 (9%)
Query: 659 NNFDAANKIGEGGFGPVYKGTLSD----GAVIAVKQLSSKSKQGNRE-FVNEIGMISALQ 713
+ IGEG FG V++G +A+K + + RE F+ E +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 714 HQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLA 773
H ++VKL G E N + ++ E L L ++ +LD A+ ++ LA
Sbjct: 67 HPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKY---SLDLASLILYAYQLSTALA 122
Query: 774 YLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPE 833
YL + VHRDI A NVL+ + K+ DFGL++ ED + +++ + +MAPE
Sbjct: 123 YLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 179
Query: 834 YAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDP 893
T +DV+ FG+ EI+ K V G +
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI-----------GRIENGERL 228
Query: 894 SLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933
+ N + ++ C P+ RP + + L
Sbjct: 229 PMPPNCPPT----LYSLMTKCWAYDPSRRPRFTELKAQLS 264
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 7e-56
Identities = 63/290 (21%), Positives = 120/290 (41%), Gaps = 31/290 (10%)
Query: 651 LRQIKAATNNFDAANKIGEGGFGPVYKGTLSD-----GAVIAVKQLS-SKSKQGNREFVN 704
LR +K F +G G FG VYKG +A+K+L + S + N+E ++
Sbjct: 3 LRILKE--TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD 60
Query: 705 EIGMISALQHQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRI 764
E +++++ + ++ +L G C+ + L+ + + L + +
Sbjct: 61 EAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNI---GSQYLLNW 116
Query: 765 CSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAK-LDEDENTHISTRI 823
C IA+G+ YL + ++VHRD+ A NVL+ + KI+DFGLAK L +E + +
Sbjct: 117 CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 173
Query: 824 AGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQE 883
+ +MA E + T ++DV+S+G+ E+++ S Y
Sbjct: 174 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS---------------KPYDGIP 218
Query: 884 QGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933
+ +++ + + I + C RP +
Sbjct: 219 ASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFS 268
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 2e-55
Identities = 63/284 (22%), Positives = 112/284 (39%), Gaps = 30/284 (10%)
Query: 659 NNFDAANKIGEGGFGPVYKGTL----SDGAVIAVKQLSSK---SKQGNREFVNEIGMISA 711
+ K+G+G FG V +G +AVK L + +F+ E+ + +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 712 LQHQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARG 771
L H+NL++LYG + + +V E SL L +G + T R +A G
Sbjct: 68 LDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQG---HFLLGTLSRYAVQVAEG 123
Query: 772 LAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKL--DEDENTHISTRIAGTVGY 829
+ YL + + +HRD+ A N+LL KI DFGL + D++ + +
Sbjct: 124 MGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180
Query: 830 MAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLE 889
APE + +D + FG+ E+ T + + + + ++G L
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMF-----TYGQEPWIGLNGSQILHKIDKEGERLP 235
Query: 890 LVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933
+ + + + N+ + C P RPT + L
Sbjct: 236 RPE-----DCPQD----IYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 8e-55
Identities = 68/291 (23%), Positives = 122/291 (41%), Gaps = 32/291 (10%)
Query: 659 NNFDAANKIGEGGFGPVYKGTL------SDGAVIAVKQLS-SKSKQGNREFVNEIGMISA 711
+ ++G+G FG VY+G +A+K ++ + S + EF+NE ++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 712 LQHQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLN------LDWATRKRIC 765
++V+L G +G L++ E + L L N + ++
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 766 SDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAK-LDEDENTHISTRIA 824
+IA G+AYL+ K VHRD+ A N ++ +D KI DFG+ + + E + +
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 825 GTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQ 884
V +M+PE G T +DV+SFG+V EI + E +
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE------QVLRFVME 250
Query: 885 GNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGK 935
G LL+ D N + + +C +P +RP+ +S ++ +
Sbjct: 251 GGLLDKPD-----NCPDM----LFELMRMCWQYNPKMRPSFLEIISSIKEE 292
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 9e-55
Identities = 72/307 (23%), Positives = 130/307 (42%), Gaps = 31/307 (10%)
Query: 651 LRQIKAA---TNNFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNREFVNEI 706
LR I + + KIG+G G VY ++ G +A++Q++ + + +NEI
Sbjct: 9 LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI 68
Query: 707 GMISALQHQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICS 766
++ ++ N+V + G++L +V EYL SL + +D +C
Sbjct: 69 LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-----CMDEGQIAAVCR 123
Query: 767 DIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGT 826
+ + L +LH +++HRDIK+ N+LL D + K++DFG E + ST + GT
Sbjct: 124 ECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GT 179
Query: 827 VGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGN 886
+MAPE R K D++S GI+A+E++ G+ +YL+
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI-------ATNG 232
Query: 887 LLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSM----LEGKTAVQAPI 942
EL +P S + C + R + + + + P+
Sbjct: 233 TPELQNP---EKLSAI----FRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTPL 285
Query: 943 IRRNSDS 949
I ++
Sbjct: 286 IAAAKEA 292
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 1e-53
Identities = 70/311 (22%), Positives = 126/311 (40%), Gaps = 46/311 (14%)
Query: 659 NNFDAANKIGEGGFGPVYKGT------LSDGAVIAVKQLSSKSKQG-NREFVNEIGMISA 711
+ +G G FG V + + +AVK L + +R ++E+ ++
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 712 LQHQ-NLVKLYGCCIE-GNQLLLVYEYLENNSLARALFGKEGQCLN------------LD 757
+ H N+V L G C + G L+++ E+ + +L+ L K + + L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 758 WATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAK-LDEDEN 816
+A+G+ +L K +HRD+ A N+LL + KI DFGLA+ + +D +
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 817 THISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLD 876
+ +MAPE T ++DV+SFG++ EI S V + +
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL-----GASPYPGVKIDE 244
Query: 877 WAYVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKT 936
++G + D + + M L C + P+ RPT S V L
Sbjct: 245 EFCRRLKEGTRMRAPD-----YTTPE----MYQTMLDCWHGEPSQRPTFSELVEHLGN-- 293
Query: 937 AVQAPIIRRNS 947
+++ N+
Sbjct: 294 -----LLQANA 299
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 185 bits (471), Expect = 2e-52
Identities = 56/273 (20%), Positives = 111/273 (40%), Gaps = 24/273 (8%)
Query: 659 NNFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNL 717
+++D ++G G FG V++ T + G A K + + + EI +S L+H L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 718 VKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHE 777
V L+ + N+++++YE++ L + + + + + +GL ++HE
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK---MSEDEAVEYMRQVCKGLCHMHE 142
Query: 778 ESRLKIVHRDIKATNVLLDKDLN--AKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYA 835
VH D+K N++ + K+ DFGL + + + T GT + APE A
Sbjct: 143 N---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAAPEVA 197
Query: 836 MRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSL 895
+ D++S G+++ ++SG S +E + V N+ + +
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRN-----VKSCDWNMDDSAFSGI 252
Query: 896 GSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSA 928
+ + P R T+ A
Sbjct: 253 SEDG--------KDFIRKLLLADPNTRMTIHQA 277
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 184 bits (467), Expect = 7e-52
Identities = 63/336 (18%), Positives = 123/336 (36%), Gaps = 27/336 (8%)
Query: 666 KIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCC 724
++G G FG V++ + G V K +++ NEI +++ L H L+ L+
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 725 IEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIV 784
+ +++L+ E+L L + ++ + + A GL ++HE IV
Sbjct: 96 EDKYEMVLILEFLSGGELFDRIAAEDYK---MSEAEVINYMRQACEGLKHMHE---HSIV 149
Query: 785 HRDIKATNVLLD--KDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRGYLTD 842
H DIK N++ + K + KI DFGLA + T T + APE R +
Sbjct: 150 HLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT--ATAEFAAPEIVDREPVGF 207
Query: 843 KADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGSNFSKK 902
D+++ G++ ++SG P L V + E S+
Sbjct: 208 YTDMWAIGVLGYVLLSGL-----SPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEA--- 259
Query: 903 EAMTMLNIALLCTNPSPTLRPTMSSAVS---MLEGKTAVQAPIIRRNSDSQDARFRAFEI 959
+ P R T+ A+ + + + + I + + +
Sbjct: 260 -----KDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYA 314
Query: 960 LSQDSQTHVSTLSQESEMQRTMSIDAPWTDSSVSVQ 995
Q + ++ S +++ + DS +
Sbjct: 315 DWPAPQPAIGRIANFSSLRKHRPQEYQIYDSYFDRK 350
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 1e-51
Identities = 76/299 (25%), Positives = 124/299 (41%), Gaps = 43/299 (14%)
Query: 659 NNFDAANKIGEGGFGPVYKGTL--------SDGAVIAVKQLSSKSKQGN-REFVNEIGMI 709
+ +GEG FG V + +AVK L S + + + + ++E+ M+
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 710 SAL-QHQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLN------------L 756
+ +H+N++ L G C + L ++ EY +L L + L L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 757 DWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDEN 816
+ARG+ YL + K +HRD+ A NVL+ +D KI+DFGLA+ +
Sbjct: 133 SSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 817 THIST-RIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYL 874
+ T V +MAPE T ++DV+SFG++ EI + G S P EE L
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 249
Query: 875 LDWAYVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933
L + SN + + + + C + P+ RPT V L+
Sbjct: 250 LKEGHR------------MDKPSNCTNE----LYMMMRDCWHAVPSQRPTFKQLVEDLD 292
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (446), Expect = 7e-50
Identities = 60/286 (20%), Positives = 108/286 (37%), Gaps = 29/286 (10%)
Query: 655 KAATNNFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLSSK---SKQGNREFVNEIGMIS 710
K +F +GEG F V L+ A+K L + + E ++S
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 711 ALQHQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIAR 770
L H VKLY + +L Y +N L + + + + D + ++I
Sbjct: 64 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIVS 119
Query: 771 GLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKL-DEDENTHISTRIAGTVGY 829
L YLH I+HRD+K N+LL++D++ +I+DFG AK+ + + GT Y
Sbjct: 120 ALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 176
Query: 830 MAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLE 889
++PE +D+++ G + ++V+G P L + +++ + + E
Sbjct: 177 VSPELLTEKSACKSSDLWALGCIIYQLVAGL-----PPFRAGNEYLIFQKIIKLEYDFPE 231
Query: 890 LVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGK 935
P ++ T R K
Sbjct: 232 KFFPKA------------RDLVEKLLVLDATKRLGCEEMEGYGPLK 265
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 168 bits (426), Expect = 2e-46
Identities = 82/382 (21%), Positives = 137/382 (35%), Gaps = 50/382 (13%)
Query: 659 NNFDAANKIGEGGFGPVYKGTLSD-GAVIAVKQLSSK---SKQGNREFVNEIGMISALQ- 713
N+F IG GGFG VY +D G + A+K L K KQG +NE M+S +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 714 --HQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARG 771
+V + ++L + + + L L A + ++I G
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS----EADMRFYAAEIILG 119
Query: 772 LAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMA 831
L ++H +V+RD+K N+LLD+ + +ISD GLA + H S GT GYMA
Sbjct: 120 LEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMA 173
Query: 832 PEYAMRG-YLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLEL 890
PE +G AD +S G + +++ G S ++ + +
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM--------- 224
Query: 891 VDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAV---------------SMLEGK 935
L +FS E ++L LL + + R M+ +
Sbjct: 225 -AVELPDSFS-PELRSLLE-GLLQRDVN--RRLGCLGRGAQEVKESPFFRSLDWQMVFLQ 279
Query: 936 TAVQAPIIRRNSDSQDARFRAFEILSQDSQTHVSTLSQESEMQR--TMSIDAPWTDSSVS 993
P+I + A ++ + L + E+ R ++I W
Sbjct: 280 K-YPPPLIPPRGEVNAADAFDIGSFDEEDTKGIKLLDSDQELYRNFPLTISERWQQEVAE 338
Query: 994 VQIPDETREHSSSSLLLQNENN 1015
E + +N
Sbjct: 339 TVFDTINAETDRLEARKKTKNK 360
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 164 bits (416), Expect = 8e-46
Identities = 56/286 (19%), Positives = 92/286 (32%), Gaps = 29/286 (10%)
Query: 659 NNFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNL 717
N + KIG G FG +Y GT ++ G +A+K K+K + E + +Q
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVG 64
Query: 718 VKLYG-CCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLH 776
+ C EG+ ++V E L + F T + + + Y+H
Sbjct: 65 IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSR----KFSLKTVLLLADQMISRIEYIH 120
Query: 777 EESRLKIVHRDIKATNVL---LDKDLNAKISDFGLAKLDEDENTHI------STRIAGTV 827
+HRD+K N L K I DFGLAK D TH + + GT
Sbjct: 121 S---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 177
Query: 828 GYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNL 887
Y + + + + D+ S G V + G +
Sbjct: 178 RYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT-----KRQKYERISEKK 232
Query: 888 LELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLE 933
+ L + + C + +P S +
Sbjct: 233 MSTPIEVLCKGYPSE----FATYLNFCRSLRFDDKPDYSYLRQLFR 274
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 163 bits (414), Expect = 1e-45
Identities = 64/284 (22%), Positives = 119/284 (41%), Gaps = 21/284 (7%)
Query: 659 NNFDAANKIGEGGFGPVYKGTLSDGAVIAVKQL--SSKSKQGNREFVNEIGMISALQHQN 716
+ KIGEG +G VYK + G A+K++ + + + EI ++ L+H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 717 LVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLH 776
+VKLY +L+LV+E+L+ + + G L+ T K + G+AY H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG----LESVTAKSFLLQLLNGIAYCH 117
Query: 777 EESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAM 836
+ +++HRD+K N+L++++ KI+DFGLA+ + I
Sbjct: 118 D---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMG 174
Query: 837 RGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLL----------DWAYV--LQEQ 884
+ D++S G + E+V+G + + + + +W V L +
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234
Query: 885 GNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSA 928
+ +P +F K + +++ P R T A
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 163 bits (414), Expect = 2e-45
Identities = 64/282 (22%), Positives = 112/282 (39%), Gaps = 27/282 (9%)
Query: 652 RQIKAATNNFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNRE-FVNEIGMI 709
+Q + + +D + +G G F V ++A+K ++ K+ +G NEI ++
Sbjct: 2 KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVL 61
Query: 710 SALQHQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIA 769
++H N+V L G L L+ + + L + K R+ +
Sbjct: 62 HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF----YTERDASRLIFQVL 117
Query: 770 RGLAYLHEESRLKIVHRDIKATNVLL---DKDLNAKISDFGLAKLDEDENTHISTRIAGT 826
+ YLH+ IVHRD+K N+L D+D ISDFGL+K+ ED + +ST GT
Sbjct: 118 DAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM-EDPGSVLSTAC-GT 172
Query: 827 VGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGN 886
GY+APE + + D +S G++A ++ G + +L+ +
Sbjct: 173 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQ-----ILKAEYE 227
Query: 887 LLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSA 928
+ + + P R T A
Sbjct: 228 FDSPYWDDISDSA--------KDFIRHLMEKDPEKRFTCEQA 261
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 9e-45
Identities = 51/346 (14%), Positives = 113/346 (32%), Gaps = 47/346 (13%)
Query: 666 KIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCC 724
+G G FG V++ S K + K EI +++ +H+N++ L+
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESF 70
Query: 725 IEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIV 784
+L++++E++ + + + L+ + L +LH I
Sbjct: 71 ESMEELVMIFEFISGLDIFERINTSAFE---LNEREIVSYVHQVCEALQFLHS---HNIG 124
Query: 785 HRDIKATNVLLDKDLNA--KISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRGYLTD 842
H DI+ N++ ++ KI +FG A+ + + Y APE ++
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF--TAPEYYAPEVHQHDVVST 182
Query: 843 KADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGSNFSKK 902
D++S G + ++SG + ++ + ++ + E +
Sbjct: 183 ATDMWSLGTLVYVLLSGINPFLAETNQQIIEN-----IMNAEYTFDEEAFKEISIEA--- 234
Query: 903 EAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTAVQAPIIRRNSDSQDARFRAFEILSQ 962
++ R T A+Q P +++ + +
Sbjct: 235 -----MDFVDRLLVKERKSRMTA---------SEALQHPWLKQK-------------IER 267
Query: 963 DSQTHVSTLSQESEMQRTMSIDAPWTDSSVSVQIPDETREHSSSSL 1008
S + TL + D S+ + R S+
Sbjct: 268 VSTKVIRTLKHRRYYHTLIKKDLNMVVSAARISCGGAIRSQKGVSV 313
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 3e-44
Identities = 62/284 (21%), Positives = 112/284 (39%), Gaps = 21/284 (7%)
Query: 660 NFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQL--SSKSKQGNREFVNEIGMISALQHQN 716
NF KIGEG +G VYK G V+A+K++ ++++ + EI ++ L H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 717 LVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLH 776
+VKL N+L LV+E+L + F + K + +GLA+ H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLK---KFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 777 EESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAM 836
+++HRD+K N+L++ + K++DFGLA+ + +
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176
Query: 837 RGYLTDKADVYSFGIVALEIVSGKSN-TNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSL 895
Y + D++S G + E+V+ ++ ++ + E P
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 896 GSNFSKKEAMTMLN---------IALL--CTNPSPTLRPTMSSA 928
+F K +LL + P R + +A
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 159 bits (404), Expect = 6e-44
Identities = 55/207 (26%), Positives = 95/207 (45%), Gaps = 15/207 (7%)
Query: 659 NNFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLSSK---SKQGNREFVNEIGMISALQH 714
+F +G G FG V+ +G A+K L + + +E M+S + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 715 QNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAY 774
+++++G + Q+ ++ +Y+E L L + K +++ L Y
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF----PNPVAKFYAAEVCLALEY 119
Query: 775 LHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEY 834
LH I++RD+K N+LLDK+ + KI+DFG AK D + GT Y+APE
Sbjct: 120 LHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT----YTLCGTPDYIAPEV 172
Query: 835 AMRGYLTDKADVYSFGIVALEIVSGKS 861
D +SFGI+ E+++G +
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYT 199
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 157 bits (399), Expect = 1e-43
Identities = 52/286 (18%), Positives = 102/286 (35%), Gaps = 39/286 (13%)
Query: 660 NFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLS---------SKSKQGNREFVNEIGMI 709
N++ +G G V + AVK + + ++ + E+ ++
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 710 SALQ-HQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDI 768
+ H N+++L LV++ ++ L L K L ++I +
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV----TLSEKETRKIMRAL 119
Query: 769 ARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVG 828
+ LH+ L IVHRD+K N+LLD D+N K++DFG + + + GT
Sbjct: 120 LEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL--REVCGTPS 174
Query: 829 YMAPEYAM------RGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQ 882
Y+APE + D++S G++ +++G +R + + + ++
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM-----IMS 229
Query: 883 EQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSA 928
++ P R T A
Sbjct: 230 GNYQFGSPEWDDYSDTV--------KDLVSRFLVVQPQKRYTAEEA 267
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 158 bits (399), Expect = 1e-43
Identities = 55/309 (17%), Positives = 105/309 (33%), Gaps = 38/309 (12%)
Query: 659 NNFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQH-QN 716
++ +IGEG FG +++GT L + +A+K +S + +E L
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 62
Query: 717 LVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLH 776
+ +Y EG +LV + L + L G+ T + + +H
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSL--EDLLDLCGRKF--SVKTVAMAAKQMLARVQSIH 118
Query: 777 EESRLKIVHRDIKATNVLLDKDLN-----AKISDFGLAKLDEDENTHI------STRIAG 825
E +V+RDIK N L+ + + + DFG+ K D T ++G
Sbjct: 119 E---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 175
Query: 826 TVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQG 885
T YM+ + + + D+ + G V + + G + ++
Sbjct: 176 TARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235
Query: 886 NLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTAVQAPIIRR 945
L EL F ++ N + P + ++ R
Sbjct: 236 PLRELCA-----GFPEE----FYKYMHYARNLAFDATPDYDYLQGLFS-------KVLER 279
Query: 946 NSDSQDARF 954
+ ++D F
Sbjct: 280 LNTTEDENF 288
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 2e-43
Identities = 59/291 (20%), Positives = 114/291 (39%), Gaps = 24/291 (8%)
Query: 657 ATNNFDAANKIGEGGFGPVYKGT--LSDGAVIAVKQLSSKSKQGN--REFVNEIGMISAL 712
A ++ +IGEG +G V+K + G +A+K++ ++ + + E+ ++ L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 713 ---QHQNLVKLYGCCIEGNQLLLVYEYLENNSLAR--ALFGKEGQCLNLDWATRKRICSD 767
+H N+V+L+ C L + + + + + T K +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 768 IARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTV 827
+ RGL +LH ++VHRD+K N+L+ K++DFGLA++ + T + T+
Sbjct: 125 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVVTL 179
Query: 828 GYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLL----------DW 877
Y APE ++ D++S G + E+ K + + + DW
Sbjct: 180 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239
Query: 878 AYVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSA 928
+ F ++ L C +P R + SA
Sbjct: 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 2e-43
Identities = 51/208 (24%), Positives = 94/208 (45%), Gaps = 9/208 (4%)
Query: 658 TNNFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNRE-FVNEIGMISALQHQ 715
+ + IGEG +G V + +A+K++S Q + + EI ++ +H+
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 716 NLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYL 775
N++ + + YL + + L+ K + +L I RGL Y+
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLY-KLLKTQHLSNDHICYFLYQILRGLKYI 125
Query: 776 HEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHIS--TRIAGTVGYMAPE 833
H ++HRD+K +N+LL+ + KI DFGLA++ + ++ H T T Y APE
Sbjct: 126 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182
Query: 834 YAMRGYLTD-KADVYSFGIVALEIVSGK 860
+ D++S G + E++S +
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNR 210
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 155 bits (393), Expect = 6e-43
Identities = 56/282 (19%), Positives = 108/282 (38%), Gaps = 30/282 (10%)
Query: 658 TNNFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLS---SKSKQGNREFVNEIGMISALQ 713
++ ++ +G GG V+ L +AVK L ++ F E +AL
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 714 HQNLVKLYGCCIE----GNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIA 769
H +V +Y G +V EY++ +L + + + +D
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADAC 121
Query: 770 RGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHI--STRIAGTV 827
+ L + H+ I+HRD+K N+++ K+ DFG+A+ D + + + GT
Sbjct: 122 QALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 178
Query: 828 GYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNL 887
Y++PE A + ++DVYS G V E+++G+ Y ++E
Sbjct: 179 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQ-----HVREDPIP 233
Query: 888 LELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAV 929
L ++ + L +P R ++ +
Sbjct: 234 PSARHEGLSADLD--------AVVLKALAKNPENRYQTAAEM 267
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 8e-43
Identities = 61/276 (22%), Positives = 109/276 (39%), Gaps = 30/276 (10%)
Query: 659 NNFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNRE---FVNEIGMIS-ALQ 713
+F +G+G FG V+ A+K L + + + E ++S A +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 714 HQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLA 773
H L ++ L V EYL L + D + ++I GL
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK----FDLSRATFYAAEIILGLQ 117
Query: 774 YLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPE 833
+LH IV+RD+K N+LLDKD + KI+DFG+ K + + +T GT Y+APE
Sbjct: 118 FLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT-FCGTPDYIAPE 173
Query: 834 YAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDP 893
+ D +SFG++ E++ G+S + + +EE + + + ++
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL-----FHSIRMDNPFYPRWLEK 228
Query: 894 SLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAV 929
++ + P R + +
Sbjct: 229 EA------------KDLLVKLFVREPEKRLGVRGDI 252
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 3e-42
Identities = 65/286 (22%), Positives = 112/286 (39%), Gaps = 34/286 (11%)
Query: 665 NKIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQG-----NREFVNEIGMISALQHQNLV 718
+ +GEG F VYK + ++A+K++ + NR + EI ++ L H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 719 KLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEE 778
L + + LV++++E + + L L + K +GL YLH+
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLE----VIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH 119
Query: 779 SRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMR- 837
I+HRD+K N+LLD++ K++DFGLAK N T T Y APE
Sbjct: 120 ---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY-THQVVTRWYRAPELLFGA 175
Query: 838 GYLTDKADVYSFGIVALEIVSGK---------------SNTNYRPKEEFVYLLDWAYVLQ 882
D+++ G + E++ T P EE +
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235
Query: 883 EQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSA 928
+ + + S + + ++ L NP R T + A
Sbjct: 236 TFKSFPGIPLHHIFSAAG-DDLLDLIQ-GLFLFNPC--ARITATQA 277
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 7e-41
Identities = 64/281 (22%), Positives = 106/281 (37%), Gaps = 33/281 (11%)
Query: 659 NNFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNR------EFVNEIGMISA 711
+ +D ++G G F V K S G A K + + + +R + E+ ++
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 712 LQHQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARG 771
+QH N++ L+ ++L+ E + L L KE L I G
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES----LTEEEATEFLKQILNG 125
Query: 772 LAYLHEESRLKIVHRDIKATNVLLDKD----LNAKISDFGLAKLDEDENTHISTRIAGTV 827
+ YLH L+I H D+K N++L KI DFGLA + N I GT
Sbjct: 126 VYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTP 180
Query: 828 GYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNL 887
++APE L +AD++S G++ ++SG S K+E A V
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-----TLANVSAVNYEF 235
Query: 888 LELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSA 928
+ + + + P R T+ +
Sbjct: 236 EDEYFSNTSALA--------KDFIRRLLVKDPKKRMTIQDS 268
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 2e-40
Identities = 70/353 (19%), Positives = 126/353 (35%), Gaps = 45/353 (12%)
Query: 667 IGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCC- 724
+G G G V + A+K L + RE E+ A Q ++V++
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARREV--EL-HWRASQCPHIVRIVDVYE 75
Query: 725 ---IEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRL 781
LL+V E L+ L + + Q I I + YLH +
Sbjct: 76 NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF--TEREASEIMKSIGEAIQYLHS---I 130
Query: 782 KIVHRDIKATNVLLDK---DLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRG 838
I HRD+K N+L + K++DFG AK N+ + T Y+APE
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEVLGPE 188
Query: 839 YLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGSN 898
D++S G++ ++ G P + L + ++ + + + P+ +
Sbjct: 189 KYDKSCDMWSLGVIMYILLCG------YPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 242
Query: 899 FSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTAVQAPIIRRNSDSQDARFRAFE 958
+E ++ PT R T+ + P I +++
Sbjct: 243 EVSEEVKMLIR---NLLKTEPTQRMTI---------TEFMNHPWIMQSTKVPQTPLHTSR 290
Query: 959 ILSQDSQTHVSTLSQESEMQRTMSIDAPWTDSSVSVQIPDETREHSSSSLLLQ 1011
+L +D + + + TM +D QI + E +S+ LLL+
Sbjct: 291 VLKEDKERWEDVKEEMTSALATMRVDYE--------QIKIKKIEDASNPLLLK 335
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (373), Expect = 3e-40
Identities = 49/207 (23%), Positives = 81/207 (39%), Gaps = 20/207 (9%)
Query: 666 KIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNRE------FVNEIGMISALQ--HQN 716
+G GGFG VY G +SD +A+K + E E+ ++ +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 717 LVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLH 776
+++L + +L+ E E + G L + + + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA---LQEELARSFFWQVLEAVRHCH 127
Query: 777 EESRLKIVHRDIKATNVLLDKD-LNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYA 835
++HRDIK N+L+D + K+ DFG L +D T GT Y PE+
Sbjct: 128 N---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY---TDFDGTRVYSPPEWI 181
Query: 836 M-RGYLTDKADVYSFGIVALEIVSGKS 861
Y A V+S GI+ ++V G
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDI 208
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 3e-40
Identities = 68/292 (23%), Positives = 106/292 (36%), Gaps = 35/292 (11%)
Query: 660 NFDAANKIGEGGFGPVYKGTL-SDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLV 718
++ IG G FG VY+ L G ++A+K++ + NRE + ++ L H N+V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIV 76
Query: 719 KLYGCCIEGNQ------LLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGL 772
+L + L LV +Y+ A + L K + R L
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ-TLPVIYVKLYMYQLFRSL 135
Query: 773 AYLHEESRLKIVHRDIKATNVLLDKD-LNAKISDFGLAKLDEDENTHISTRIAGTVGYMA 831
AY+H I HRDIK N+LLD D K+ DFG AK + I
Sbjct: 136 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ-LVRGEPNVSYICSRYYRAP 191
Query: 832 PEYAMRGYLTDKADVYSFGIVALEIVSGKS---------------NTNYRPKEEFVYLLD 876
T DV+S G V E++ G+ P E + ++
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251
Query: 877 WAYVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSA 928
Y + + + + EA+ + + LL P+ R T A
Sbjct: 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCS-RLLEYTPT--ARLTPLEA 300
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 2e-39
Identities = 61/300 (20%), Positives = 115/300 (38%), Gaps = 37/300 (12%)
Query: 659 NNFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGN--REFVNEIGMISALQHQ 715
+ ++ KIG+G FG V+K G +A+K++ ++++ + EI ++ L+H+
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 716 NLVKLYGCCIEG--------NQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSD 767
N+V L C + LV+++ E++ + KR+
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV----KFTLSEIKRVMQM 125
Query: 768 IARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAK---LDEDENTHISTRIA 824
+ GL Y+H KI+HRD+KA NVL+ +D K++DFGLA+ L ++ + T
Sbjct: 126 LLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 182
Query: 825 GTVGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGK---------------SNTNYRPK 868
T+ Y PE + D++ G + E+ + S
Sbjct: 183 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 242
Query: 869 EEFVYLLDWAYVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSA 928
E +D + ++ + + L++ P R A
Sbjct: 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 4e-39
Identities = 52/291 (17%), Positives = 105/291 (36%), Gaps = 33/291 (11%)
Query: 659 NNFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQL--SSKSKQGNREFVNEIGMISALQHQ 715
++ KIGEG +G V+K ++A+K++ + + EI ++ L+H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 716 NLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYL 775
N+V+L+ +L LV+E+ + + K + +GL +
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD----PEIVKSFLFQLLKGLGFC 117
Query: 776 HEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYA 835
H ++HRD+K N+L++++ K+++FGLA+ S +
Sbjct: 118 H---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLF 174
Query: 836 MRGYLTDKADVYSFGIVALEIVSGKS----------------NTNYRPKEEFVYLLDWAY 879
+ D++S G + E+ + P EE W
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEE-----QWPS 229
Query: 880 VLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALL--CTNPSPTLRPTMSSA 928
+ + + P+ S + + LL +P R + A
Sbjct: 230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 1e-38
Identities = 66/305 (21%), Positives = 115/305 (37%), Gaps = 35/305 (11%)
Query: 649 FTLRQIKAAT----NNFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQL--SSKSKQGNRE 701
F +++ + +G G +G V GA +A+K+L +S+ +
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 702 FVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATR 761
E+ ++ ++H+N++ L L ++ GK + L
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRI 123
Query: 762 KRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHIST 821
+ + + +GL Y+H I+HRD+K N+ +++D KI DFGLA+ + E T
Sbjct: 124 QFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTG--- 177
Query: 822 RIAGTVGYMAPEYAM-RGYLTDKADVYSFGIVALEIVSGKS---------------NTNY 865
T Y APE + T D++S G + E+++GK+
Sbjct: 178 -YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG 236
Query: 866 RPKEEFVYLLDWAYVLQEQGNLLELVDPSLGSNFSK--KEAMTMLNIALLCTNPSPTLRP 923
P EFV L L EL S + A+ +L +L + R
Sbjct: 237 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLE-KMLVLDAE--QRV 293
Query: 924 TMSSA 928
T A
Sbjct: 294 TAGEA 298
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 6e-38
Identities = 57/206 (27%), Positives = 86/206 (41%), Gaps = 12/206 (5%)
Query: 659 NNFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLSSK---SKQGNREFVNEIGMISALQH 714
N+FD +G+G FG V + G A+K L + +K V E ++ +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 715 QNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAY 774
L L ++L V EY L L + + ++I L Y
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLS----RERVFTEERARFYGAEIVSALEY 120
Query: 775 LHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEY 834
LH +V+RDIK N++LDKD + KI+DFGL K + GT Y+APE
Sbjct: 121 LHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFCGTPEYLAPEV 176
Query: 835 AMRGYLTDKADVYSFGIVALEIVSGK 860
D + G+V E++ G+
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 139 bits (350), Expect = 2e-36
Identities = 66/334 (19%), Positives = 120/334 (35%), Gaps = 45/334 (13%)
Query: 643 DLQTGYFTLRQIKAATNNFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNRE 701
D + T Q A + FD +G G FG V G A+K L + ++
Sbjct: 25 DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQ 84
Query: 702 ---FVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDW 758
+NE ++ A+ LVKL + + L +V EY+ + L
Sbjct: 85 IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG----RFSE 140
Query: 759 ATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTH 818
+ + I YLH L +++RD+K N+L+D+ +++DFG AK +
Sbjct: 141 PHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT 197
Query: 819 ISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWA 878
+ GT +APE + D ++ G++ E+ +G + +
Sbjct: 198 LC----GTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG 253
Query: 879 YVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPS---PTLRPTMSSAVS----- 930
S+FS + +L LL + + L+ ++ +
Sbjct: 254 -------------KVRFPSHFS-SDLKDLLR-NLLQVDLTKRFGNLKNGVNDIKNHKWFA 298
Query: 931 -----MLEGKTAVQAPIIRRNSDSQDAR-FRAFE 958
+ + V+AP I + D F +E
Sbjct: 299 TTDWIAIYQR-KVEAPFIPKFKGPGDTSNFDDYE 331
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 5e-33
Identities = 56/229 (24%), Positives = 97/229 (42%), Gaps = 18/229 (7%)
Query: 643 DLQTGYFTLRQIKAATNNFDAANKIGEGGFGPVYKGTL----SDGAVIAVKQLS----SK 694
+L+T T K NF+ +G G +G V+ G + A+K L +
Sbjct: 8 ELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQ 67
Query: 695 SKQGNREFVNEIGMISALQHQ-NLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQC 753
+ E ++ ++ LV L+ +L L+ +Y+ L L Q
Sbjct: 68 KAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLS----QR 123
Query: 754 LNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDE 813
+ +I L +LH+ L I++RDIK N+LLD + + ++DFGL+K
Sbjct: 124 ERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 180
Query: 814 DENTHISTRIAGTVGYMAPEYAMRG--YLTDKADVYSFGIVALEIVSGK 860
+ T + GT+ YMAP+ G D +S G++ E+++G
Sbjct: 181 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 229
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (321), Expect = 1e-32
Identities = 63/292 (21%), Positives = 115/292 (39%), Gaps = 31/292 (10%)
Query: 658 TNNFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLS--SKSKQGNREFVNEIGMISALQH 714
+ + +G G +G V G +AVK+LS +S + E+ ++ ++H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 715 QNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAY 774
+N++ L L + L A +C L + + I RGL Y
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 775 LHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEY 834
+H I+HRD+K +N+ +++D KI DFGLA+ +DE T T Y APE
Sbjct: 137 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA----TRWYRAPEI 189
Query: 835 AMR-GYLTDKADVYSFGIVALEIVSGKS---------------NTNYRPKEEFVYLLDWA 878
+ + D++S G + E+++G++ P E + +
Sbjct: 190 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 249
Query: 879 YVLQEQGNLLELVDPSLGSNFSK--KEAMTMLNIALLCTNPSPTLRPTMSSA 928
+L ++ + + F A+ +L +L + R T + A
Sbjct: 250 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLE-KMLVLDSD--KRITAAQA 298
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 1e-32
Identities = 49/211 (23%), Positives = 86/211 (40%), Gaps = 21/211 (9%)
Query: 659 NNFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLS--SKSKQGNREFVNEIGMISALQHQ 715
+ IG G G V +A+K+LS +++ + E+ ++ + H+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 716 NLVKLYGCCI------EGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIA 769
N++ L E + LV E ++ N + + LD + +
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLC-------QVIQMELDHERMSYLLYQML 129
Query: 770 RGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHISTRIAGTVGY 829
G+ +LH I+HRD+K +N+++ D KI DFGLA+ T T Y
Sbjct: 130 CGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRYY 184
Query: 830 MAPEYAMRGYLTDKADVYSFGIVALEIVSGK 860
APE + + D++S G + E+V K
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 126 bits (317), Expect = 2e-32
Identities = 40/209 (19%), Positives = 85/209 (40%), Gaps = 21/209 (10%)
Query: 659 NNFDAANKIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQ-HQN 716
+++ K+G G + V++ +++ + VK L K+ + EI ++ L+ N
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGPN 91
Query: 717 LVKLYGCCIE--GNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAY 774
++ L + LV+E++ N + L + +I + L Y
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDY 144
Query: 775 LHEESRLKIVHRDIKATNVLLD-KDLNAKISDFGLAKLDEDENTHISTRIAGTVGYMAPE 833
H + I+HRD+K NV++D + ++ D+GLA+ + + + PE
Sbjct: 145 CHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPE 199
Query: 834 YAMR-GYLTDKADVYSFGIVALEIVSGKS 861
+ D++S G + ++ K
Sbjct: 200 LLVDYQMYDYSLDMWSLGCMLASMIFRKE 228
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 113 bits (283), Expect = 1e-27
Identities = 45/214 (21%), Positives = 80/214 (37%), Gaps = 26/214 (12%)
Query: 666 KIGEGGFGPVYKGT-LSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCC 724
K+G G F V+ + + +A+K + K +EI ++ + + K
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVR-GDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 725 IEGNQLLLVYEY------------LENNSLARALFGKEGQCLNLDWATRKRICSDIARGL 772
LL + E K+ + + K+I + GL
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 773 AYLHEESRLKIVHRDIKATNVLLDKD------LNAKISDFGLAKLDEDENTHISTRIAGT 826
Y+H R I+H DIK NVL++ + KI+D G A ++ T+ T
Sbjct: 139 DYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI----QT 192
Query: 827 VGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGK 860
Y +PE + AD++S + E+++G
Sbjct: 193 REYRSPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 100 bits (249), Expect = 1e-23
Identities = 59/310 (19%), Positives = 115/310 (37%), Gaps = 33/310 (10%)
Query: 74 TCDCTYSNNTV------CHVTVILLKGFNLAGVIPEEFGNLTFLQEVDLSRNYFNGSLPK 127
C+ ++ L+ + + +F NL L + L N + P
Sbjct: 14 VVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPG 73
Query: 128 SFARLQNLTKLLILGNRLSGSIPLEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRIL 187
+FA L L +L + N+L +P ++ EL + +N++ L + +
Sbjct: 74 AFAPLVKLERLYLSKNQLK-ELPEKMPKTLQ--ELRVHENEITKVRKSVFNGLNQMIVVE 130
Query: 188 LSS--NNFTGSIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPI 245
L + +G ++ +K L+ RI +N+T IP G L L L G +
Sbjct: 131 LGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKITKVD 187
Query: 246 PSTISQLKNLTELRISDLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKI 305
+++ L NL +L +S S+ +L + + L L N + ++P + D +++
Sbjct: 188 AASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQV 246
Query: 306 LDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGTLPDWILTSEKNLDLSYN--NFTESS 363
+ L N ++ + +N + S + L N + E
Sbjct: 247 VYLHNNNISA----------------IGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQ 290
Query: 364 PATCRESRVN 373
P+T R V
Sbjct: 291 PSTFRCVYVR 300
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 90.5 bits (223), Expect = 3e-20
Identities = 48/257 (18%), Positives = 90/257 (35%), Gaps = 8/257 (3%)
Query: 111 LQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGDISTLEELVLEDNQLV 170
L+ V S +PK + L + N+++ + ++ L L+L +N++
Sbjct: 12 LRVVQCSDLGLE-KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS 68
Query: 171 GPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTK 230
P L L R+ LS N + L+ L + + + + N +
Sbjct: 69 KISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIV 128
Query: 231 LDRLDLQGTSLEGPIPSTISQLKNLTELRISDLKGSSSSFPNLQDMKKMERLILRNCLIT 290
++ L G +K L+ +RI+D ++ + L L IT
Sbjct: 129 VE-LGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLP---PSLTELHLDGNKIT 184
Query: 291 GRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGTLPD-WILTSE 349
++ + +L L LSFN ++ G L N + + L NN L
Sbjct: 185 KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYI 244
Query: 350 KNLDLSYNNFTESSPAT 366
+ + L NN +
Sbjct: 245 QVVYLHNNNISAIGSND 261
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 77.4 bits (189), Expect = 7e-16
Identities = 41/230 (17%), Positives = 80/230 (34%), Gaps = 9/230 (3%)
Query: 182 SLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSL 241
LR + S +P+ + + + +T N L L L +
Sbjct: 11 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 67
Query: 242 EGPIPSTISQLKNLTELRISDLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDMT 301
P + L L L +S + P + K ++ L + IT +
Sbjct: 68 SKISPGAFAPLVKLERLYLSKNQ--LKELPE-KMPKTLQELRVHENEITKVRKSVFNGLN 124
Query: 302 DLKILDLSFNQL--TGPVPGILQNLKKIDYIFLTNNSLSGTLPDWILTSEKNLDLSYNNF 359
+ +++L N L +G G Q +KK+ YI + + +++ T+P + S L L N
Sbjct: 125 QMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLPPSLTELHLDGNKI 183
Query: 360 TESSPATCRESRVNILSSFSSTGSNSVSWCLKKDLPCPKEAKHYSLFINC 409
T+ A+ + S ++V + P +E + +
Sbjct: 184 TKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK 233
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 58.9 bits (141), Expect = 8e-10
Identities = 30/202 (14%), Positives = 72/202 (35%), Gaps = 12/202 (5%)
Query: 67 DSNGSNFTCDCTYSNNTVCHVTVILLKGFNLAGVIPEEFGNLTFLQEVDLSRNYFNGSLP 126
N ++ V + +G+ F + L + ++ ++P
Sbjct: 108 HENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIP 166
Query: 127 KSFARLQNLTKLLILGNRLSGSIPLEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRI 186
+ +LT+L + GN+++ + ++ L +L L N + +L N LR +
Sbjct: 167 QGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLREL 224
Query: 187 LLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTG------RIPNFIGNWTKLDRLDLQGTS 240
L++N +P + K + + +N++ P + + L
Sbjct: 225 HLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNP 283
Query: 241 LE-GPI-PSTISQLKNLTELRI 260
++ I PST + +++
Sbjct: 284 VQYWEIQPSTFRCVYVRAAVQL 305
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 100 bits (249), Expect = 1e-23
Identities = 80/317 (25%), Positives = 121/317 (38%), Gaps = 18/317 (5%)
Query: 31 DDEVQTLQSIFRKLNFRNGQVNQTSCTEGSWNVTIDDSNGS--NFTCDCTYSNNTVCHVT 88
+ Q L I + L N T+ + SW T D N + CD ++ V
Sbjct: 5 PQDKQALLQIKKDLG------NPTTLS--SWLPTTDCCNRTWLGVLCD---TDTQTYRVN 53
Query: 89 VILLKGFNLAGV--IPEEFGNLTFLQEVDLSRNY-FNGSLPKSFARLQNLTKLLILGNRL 145
+ L G NL IP NL +L + + G +P + A+L L L I +
Sbjct: 54 NLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNV 113
Query: 146 SGSIPLEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLK 205
SG+IP + I TL L N L G LP ++ +L +L I N +G+IP+SYG+
Sbjct: 114 SGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFS 173
Query: 206 NLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISDLKG 265
L N L ++ S + T+
Sbjct: 174 KLFTSMTISRNRLTGKIPPTFANLNLAF-VDLSRNMLEGDASVLFGSDKNTQKIHLAKNS 232
Query: 266 SSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLK 325
+ + K + L LRN I G +P+ + + L L++SFN L G +P NL+
Sbjct: 233 LAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQ 291
Query: 326 KIDYIFLTNNSLSGTLP 342
+ D NN P
Sbjct: 292 RFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 63.2 bits (152), Expect = 4e-11
Identities = 16/80 (20%), Positives = 28/80 (35%), Gaps = 1/80 (1%)
Query: 72 NFTCDCTYSNNTVCHVTVILLKGFNLAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFAR 131
N ++ + L+ + G +P+ L FL +++S N G +P
Sbjct: 231 NSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGN 289
Query: 132 LQNLTKLLILGNRLSGSIPL 151
LQ N+ PL
Sbjct: 290 LQRFDVSAYANNKCLCGSPL 309
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 96.0 bits (238), Expect = 3e-23
Identities = 29/162 (17%), Positives = 49/162 (30%), Gaps = 21/162 (12%)
Query: 665 NKIGEGGFGPVYKGTLSDGAVIAVK----------QLSSKSKQGNREFVNEIGMISALQH 714
+GEG V+ VK ++ K G+ F + +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 715 QNLVKLYGCCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAY 774
+ L KL G + Y + N L + + + I +A
Sbjct: 66 RALQKLQGLAVPKV-----YAWEGNAVLME--LIDAKELYRVRVENPDEVLDMILEEVAK 118
Query: 775 LHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDEN 816
+ IVH D+ NVL+ + I DF + +E
Sbjct: 119 FYHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEG 156
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.3 bits (204), Expect = 6e-18
Identities = 51/289 (17%), Positives = 93/289 (32%), Gaps = 15/289 (5%)
Query: 75 CDCTYSNNTVCHVTVILLKGFNLAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQN 134
C C L +P + Q + L N + SF +N
Sbjct: 6 CVCYNEPKVTTS-----CPQQGLQ-AVPVGIPAAS--QRIFLHGNRISHVPAASFRACRN 57
Query: 135 LTKLLILGNRLSGSIPLEIGDISTLEELVLEDNQLVGPL-PENLGNLKSLRRILLSSNNF 193
LT L + N L+ ++ LE+L L DN + + P L L + L
Sbjct: 58 LTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGL 117
Query: 194 TGSIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLK 253
P + L L + + L + + L L L G + L
Sbjct: 118 QELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLH 177
Query: 254 NLTELRISDLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQL 313
+L L + + + +D+ ++ L L ++ E + + L+ L L+ N
Sbjct: 178 SLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPW 237
Query: 314 TG--PVPGILQNLKKIDYIFLTNNSLSGTLPDWILTSEKNLDLSYNNFT 360
+ L+K +++ + +LP L L+ N+
Sbjct: 238 VCDCRARPLWAWLQKFR---GSSSEVPCSLPQR-LAGRDLKRLAANDLQ 282
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 72.5 bits (176), Expect = 2e-14
Identities = 45/245 (18%), Positives = 68/245 (27%), Gaps = 28/245 (11%)
Query: 71 SNFTCDCTYSNNTVCHVTVILLKGFNLAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFA 130
D + L L V P F L L + L R P F
Sbjct: 67 VLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFR 126
Query: 131 RLQNLTKLLILGNRLSGSIPLEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSS 190
L L L + N L D+ L L L N++ L SL R+LL
Sbjct: 127 GLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQ 186
Query: 191 NNFTGSIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTIS 250
N P ++ +L L + +NL+ + L L L +
Sbjct: 187 NRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RP 245
Query: 251 QLKNLTELRISDLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSF 310
L + R S + + +P + + + L+
Sbjct: 246 LWAWLQKFRGS------------------------SSEVPCSLP---QRLAGRDLKRLAA 278
Query: 311 NQLTG 315
N L G
Sbjct: 279 NDLQG 283
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 83.5 bits (205), Expect = 2e-17
Identities = 41/197 (20%), Positives = 75/197 (38%), Gaps = 14/197 (7%)
Query: 161 ELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGR 220
L+ +NQ+ P L +L + L+ N + +L NLT+ + + ++
Sbjct: 201 SLIATNNQISDITPLG--ILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNL 256
Query: 221 IPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISDLKGSSSSFPNLQDMKKME 280
P + TKL L L + P EL + + ++K +
Sbjct: 257 AP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQ----LEDISPISNLKNLT 310
Query: 281 RLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGT 340
L L I+ P + +T L+ L + N+++ L NL I+++ +N +S
Sbjct: 311 YLTLYFNNISDISP--VSSLTKLQRLFFANNKVSDVSS--LANLTNINWLSAGHNQISDL 366
Query: 341 LPDWILTSEKNLDLSYN 357
P LT L L+
Sbjct: 367 TPLANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 79.7 bits (195), Expect = 3e-16
Identities = 44/188 (23%), Positives = 79/188 (42%), Gaps = 14/188 (7%)
Query: 178 GNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQ 237
L +L ++ ++N + P G L NL E ++G+ L + + T L LDL
Sbjct: 194 AKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLA 249
Query: 238 GTSLEGPIPSTISQLKNLTELRISDLK-GSSSSFPNLQDMKKMERLILRNCLITGRIPEY 296
+ P +S L LTEL++ + + S L + +E +
Sbjct: 250 NNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLE-----DISP 302
Query: 297 IEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGTLPDWILTSEKNLDLSY 356
I ++ +L L L FN ++ P + +L K+ +F NN +S LT+ L +
Sbjct: 303 ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSDVSSLANLTNINWLSAGH 360
Query: 357 NNFTESSP 364
N ++ +P
Sbjct: 361 NQISDLTP 368
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 60.0 bits (144), Expect = 6e-10
Identities = 21/93 (22%), Positives = 42/93 (45%), Gaps = 6/93 (6%)
Query: 75 CDCTYSNNTVCHVTVILLKGFNLAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQN 134
+ + + ++T + L N++ + P +LT LQ + + N + S A L N
Sbjct: 297 LEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTN 352
Query: 135 LTKLLILGNRLSGSIPLEIGDISTLEELVLEDN 167
+ L N++S PL +++ + +L L D
Sbjct: 353 INWLSAGHNQISDLTPL--ANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 55.0 bits (131), Expect = 2e-08
Identities = 57/278 (20%), Positives = 97/278 (34%), Gaps = 29/278 (10%)
Query: 103 EEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGDISTLEEL 162
+ L L +++ S N P L+NLTKL+ + + + T
Sbjct: 60 DGVEYLNNLTQINFSNNQLTDITP-----LKNLTKLVDILMNNNQIADITPLANLTNLTG 114
Query: 163 VLEDNQLVGPLPE---------------NLGNLKSLRRILLSSNNFTGSIPESYGNLKNL 207
+ N + + + ++ +L + G+ L NL
Sbjct: 115 LTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANL 174
Query: 208 T-EFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISDLKGS 266
T R+D S+ + + T L+ L + P I NL EL ++ +
Sbjct: 175 TTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQL- 231
Query: 267 SSSFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLKK 326
L + + L L N I+ P + +T L L L NQ++ P L L
Sbjct: 232 -KDIGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTA 286
Query: 327 IDYIFLTNNSLSGTLPDWILTSEKNLDLSYNNFTESSP 364
+ + L N L P L + L L +NN ++ SP
Sbjct: 287 LTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP 324
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 54.6 bits (130), Expect = 3e-08
Identities = 36/246 (14%), Positives = 80/246 (32%), Gaps = 21/246 (8%)
Query: 132 LQNLTKLLILGNRLSGSIPLEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSN 191
L K ++ ++ ++ D+ + L + + + + L +L +I S+N
Sbjct: 21 LAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNN 76
Query: 192 NFTGSIPESYGNLKNLTEFRIDGSNLTGRIP------NFIGNWTKLDRLDLQGTSLEGPI 245
T P NL L + ++ + + P D+ +
Sbjct: 77 QLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNL 134
Query: 246 PSTISQLKNLTELRISDLKGSSSSFPNLQDMKKMERL-------ILRNCLITGRIPEYIE 298
++++ S + ++ L L +
Sbjct: 135 NRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLA 194
Query: 299 DMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGTLPDWILTSEKNLDLSYNN 358
+T+L+ L + NQ++ P + +D + L N L LT+ +LDL+ N
Sbjct: 195 KLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKDIGTLASLTNLTDLDLANNQ 252
Query: 359 FTESSP 364
+ +P
Sbjct: 253 ISNLAP 258
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 54.2 bits (129), Expect = 4e-08
Identities = 61/270 (22%), Positives = 103/270 (38%), Gaps = 23/270 (8%)
Query: 96 NLAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGD 155
N+ + + +L + + R S+ L NLT++ N+L+ PL +
Sbjct: 33 NVTDTVSQT--DLDQVTTLQADRLGIK-SI-DGVEYLNNLTQINFSNNQLTDITPL--KN 86
Query: 156 ISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGS 215
++ L ++++ +NQ+ P + N TG + +
Sbjct: 87 LTKLVDILMNNNQIADITPLA------------NLTNLTGLTLFNNQITDIDPLKNLTNL 134
Query: 216 NLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISDLKGSSSSFPNLQ- 274
N N I + + L L G + + L NLT L D+ + S ++
Sbjct: 135 NRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLA 194
Query: 275 DMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTN 334
+ +E LI N I+ P I +T+L L L+ NQL G L +L + + L N
Sbjct: 195 KLTNLESLIATNNQISDITPLGI--LTNLDELSLNGNQLKD--IGTLASLTNLTDLDLAN 250
Query: 335 NSLSGTLPDWILTSEKNLDLSYNNFTESSP 364
N +S P LT L L N + SP
Sbjct: 251 NQISNLAPLSGLTKLTELKLGANQISNISP 280
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 48.1 bits (113), Expect = 4e-06
Identities = 13/83 (15%), Positives = 32/83 (38%), Gaps = 6/83 (7%)
Query: 179 NLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQG 238
L + +L N T ++ ++ +L +T + D + I + L +++
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSN 75
Query: 239 TSLEGPIPSTISQLKNLTELRIS 261
L P + L L ++ ++
Sbjct: 76 NQLTDITP--LKNLTKLVDILMN 96
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 45.0 bits (105), Expect = 3e-05
Identities = 23/98 (23%), Positives = 41/98 (41%), Gaps = 6/98 (6%)
Query: 236 LQGTSLEGPIP-STISQLKNLTELRISDL-KGSSSSFPNLQDMKKMERLILRNCLITGRI 293
L ++ P + I L E + L K + + + D+ ++ L I
Sbjct: 1 LGSATITQDTPINQIFTDTALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKS-- 58
Query: 294 PEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIF 331
+ +E + +L ++ S NQLT P L+NL K+ I
Sbjct: 59 IDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDIL 94
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 39.6 bits (91), Expect = 0.001
Identities = 15/90 (16%), Positives = 36/90 (40%), Gaps = 5/90 (5%)
Query: 270 FPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDY 329
F + + + + +L +T + + D+ + L + + G+ + L +
Sbjct: 16 FTD-TALAEKMKTVLGKTNVTDTVSQ--TDLDQVTTLQADRLGIKS-IDGV-EYLNNLTQ 70
Query: 330 IFLTNNSLSGTLPDWILTSEKNLDLSYNNF 359
I +NN L+ P LT ++ ++ N
Sbjct: 71 INFSNNQLTDITPLKNLTKLVDILMNNNQI 100
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.5 bits (145), Expect = 2e-10
Identities = 41/245 (16%), Positives = 69/245 (28%), Gaps = 12/245 (4%)
Query: 86 HVTVILLKGFNLAGVIPEEFGNLTFLQEVDLSRNYFNG-SLPKSFARLQNLTKLLILGNR 144
V + + E F +Q +DLS + +L ++ L L + G R
Sbjct: 24 GVIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLR 82
Query: 145 LSGSIPLEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNL 204
LS I + S L L L R L+ + +
Sbjct: 83 LSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVA 142
Query: 205 KNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGT---------SLEGPIPSTISQLKNL 255
I NL+G N + L+ QL L
Sbjct: 143 VAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYL 202
Query: 256 TELRISDLKG-SSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLT 314
L +S + L ++ ++ L + + G + E + L+I F +
Sbjct: 203 QHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQINCSHFTTIA 262
Query: 315 GPVPG 319
P G
Sbjct: 263 RPTIG 267
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.7 bits (130), Expect = 2e-08
Identities = 38/266 (14%), Positives = 85/266 (31%), Gaps = 38/266 (14%)
Query: 136 TKLLILGNRLSGSIPLEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTG 195
L + G L + + + + + PL E+ + ++ + LS++
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQGVIA-FRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEV 60
Query: 196 -SIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSL--EGPIPSTISQL 252
++ L ++G L+ I N + + L RL+L G S E + + +S
Sbjct: 61 STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSC 120
Query: 253 KNLTELRISDLKGSSSSFPNLQDMKKMER------------------------------- 281
L EL +S + + E
Sbjct: 121 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHL 180
Query: 282 LILRNCLITGRIPEYIEDMTDLKILDLSF-NQLTGPVPGILQNLKKIDYIFLTNNSLSGT 340
+ + ++ + + L+ L LS + L + + + + GT
Sbjct: 181 DLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGT 240
Query: 341 LPDWILTSEKNLDLSYNNFTESSPAT 366
L + + +L ++ ++FT + T
Sbjct: 241 LQ-LLKEALPHLQINCSHFTTIARPT 265
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.2 bits (87), Expect = 0.004
Identities = 21/99 (21%), Positives = 37/99 (37%), Gaps = 10/99 (10%)
Query: 146 SGSIPLEIGDISTLEELVLED-NQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNL 204
E ++ L+ L L ++ LG + +L+ + + G++ L
Sbjct: 189 KNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEAL 248
Query: 205 KNLTEFRIDGSNLTGRIPNFIGN------WTKLDRLDLQ 237
+L +I+ S+ T IGN W RL LQ
Sbjct: 249 PHL---QINCSHFTTIARPTIGNKKNQEIWGIKCRLTLQ 284
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.4 bits (137), Expect = 2e-09
Identities = 42/210 (20%), Positives = 77/210 (36%), Gaps = 9/210 (4%)
Query: 152 EIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFR 211
E+ +++ E+ + L LP +L K + LS N + LT+
Sbjct: 5 EVSKVASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 212 IDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISDLKGSSSSFP 271
+D + + + + +P L LT L +S + +S
Sbjct: 62 LDRAE---LTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLG 118
Query: 272 NLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIF 331
L+ + +++ L L+ + P + L+ L L+ N LT G+L L+ +D +
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178
Query: 332 LTNNSLSGTLPDWI--LTSEKNLDLSYNNF 359
L NSL T+P L N +
Sbjct: 179 LQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.1 bits (131), Expect = 1e-08
Identities = 37/201 (18%), Positives = 69/201 (34%), Gaps = 8/201 (3%)
Query: 178 GNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQ 237
+ S + N T ++P K+ T + + L + +T+L +L+L
Sbjct: 7 SKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63
Query: 238 GTSLEGPIPSTISQLKNLTELRISDLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYI 297
E L L L +S S Q + + L + +T +
Sbjct: 64 RA--ELTKLQVDGTLPVLGTLDLSH-NQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGAL 120
Query: 298 EDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGTLPDWI--LTSEKNLDLS 355
+ +L+ L L N+L PG+L K++ + L NN+L+ + L + L L
Sbjct: 121 RGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQ 180
Query: 356 YNNFTESSPATCRESRVNILS 376
N+ +
Sbjct: 181 ENSLYTIPKGFFGSHLLPFAF 201
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.7 bits (117), Expect = 7e-07
Identities = 38/210 (18%), Positives = 73/210 (34%), Gaps = 7/210 (3%)
Query: 104 EFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGDISTLEELV 163
E + EV+ + +LP + + T L + N L + + L +L
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 164 LEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIPN 223
L+ +L + L L + LS N LT + + LT
Sbjct: 62 LDRAELTKLQVDG--TLPVLGTLDLSHNQLQSLPLLGQTL-PALTVLDVSFNRLTSLPLG 118
Query: 224 FIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISDLKGSSSSFPNLQDMKKMERLI 283
+ +L L L+G L+ P ++ L +L +++ + L ++ ++ L+
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178
Query: 284 LRNCLITGRIPEYIEDMTDLKILDLSFNQL 313
L+ + IP+ L L N
Sbjct: 179 LQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.5 bits (106), Expect = 1e-05
Identities = 36/177 (20%), Positives = 54/177 (30%), Gaps = 4/177 (2%)
Query: 86 HVTVILLKGFNLAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRL 145
T++ L L T L +++L R + L L L + N+L
Sbjct: 32 DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK--LQVDGTLPVLGTLDLSHNQL 89
Query: 146 SGSIPLEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLK 205
+ L L + N+L L L L+ + L N P
Sbjct: 90 QSLPL-LGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTP 148
Query: 206 NLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISD 262
L + + +NLT + LD L LQ SL IP L +
Sbjct: 149 KLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHG 204
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 53.3 bits (126), Expect = 7e-08
Identities = 22/129 (17%), Positives = 43/129 (33%), Gaps = 9/129 (6%)
Query: 56 CTEGSWNVTIDDSNGSNFTCDCTYSNNTVCHVTVILLKGFNLAGVIPEEFGNLTFLQEVD 115
+ + F + + + L + I L+E++
Sbjct: 231 VRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELN 290
Query: 116 LSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGDISTLEELVLEDNQLVGPLPE 175
+S N LP L +L+ N L+ +P L++L +E N L P+
Sbjct: 291 VSNNKLI-ELPAL---PPRLERLIASFNHLA-EVP---ELPQNLKQLHVEYNPLRE-FPD 341
Query: 176 NLGNLKSLR 184
+++ LR
Sbjct: 342 IPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 51.0 bits (120), Expect = 4e-07
Identities = 25/93 (26%), Positives = 40/93 (43%), Gaps = 10/93 (10%)
Query: 143 NRLSGSIPLEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYG 202
N S I +LEEL + +N+L+ LP L+ L S N+ +PE
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRLERLI---ASFNHLA-EVPELPQ 324
Query: 203 NLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLD 235
NLK L ++ + L P+ + L R++
Sbjct: 325 NLKQL---HVEYNPLRE-FPDIPESVEDL-RMN 352
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 50.2 bits (118), Expect = 6e-07
Identities = 19/102 (18%), Positives = 44/102 (43%), Gaps = 8/102 (7%)
Query: 274 QDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLT 333
+ ++ + + I + L+ L++S N+L +P + L+++ +
Sbjct: 257 SGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRLERLI---AS 312
Query: 334 NNSLSGTLPDWILTSEKNLDLSYNNFTE--SSPATCRESRVN 373
N L+ +P+ + + K L + YN E P + + R+N
Sbjct: 313 FNHLA-EVPE-LPQNLKQLHVEYNPLREFPDIPESVEDLRMN 352
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 49.1 bits (115), Expect = 2e-06
Identities = 16/92 (17%), Positives = 31/92 (33%), Gaps = 9/92 (9%)
Query: 164 LEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIPN 223
N + SL + +S+N +P L+ L ++L +P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERL---IASFNHLA-EVPE 321
Query: 224 FIGNWTKLDRLDLQGTSLEGPIPSTISQLKNL 255
N L +L ++ L P +++L
Sbjct: 322 LPQN---LKQLHVEYNPLRE-FPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 45.2 bits (105), Expect = 3e-05
Identities = 22/89 (24%), Positives = 36/89 (40%), Gaps = 14/89 (15%)
Query: 241 LEGPIPSTISQLKNLTELRISD--LKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYIE 298
I S +L EL +S+ L + P L ERLI + +PE
Sbjct: 272 SSNEIRSLCDLPPSLEELNVSNNKLIELPALPPRL------ERLIASFNHLA-EVPE--- 321
Query: 299 DMTDLKILDLSFNQLTG--PVPGILQNLK 325
+LK L + +N L +P +++L+
Sbjct: 322 LPQNLKQLHVEYNPLREFPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 39.8 bits (91), Expect = 0.001
Identities = 17/48 (35%), Positives = 24/48 (50%), Gaps = 5/48 (10%)
Query: 159 LEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKN 206
EL L + L LPE +L+SL S N+ T +PE +LK+
Sbjct: 40 AHELELNNLGLSS-LPELPPHLESLV---ASCNSLT-ELPELPQSLKS 82
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 51.2 bits (121), Expect = 1e-07
Identities = 24/203 (11%), Positives = 70/203 (34%), Gaps = 16/203 (7%)
Query: 132 LQNLTKLLILGNRLSGSIPLEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSN 191
K + ++ ++ +++++++++ ++ + + + L ++ ++ L+ N
Sbjct: 23 FAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFLNGN 78
Query: 192 NFTGSIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQ 251
T L NL + K + + I +
Sbjct: 79 KLTD-----IKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHL 133
Query: 252 LKNLTELRISDLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFN 311
+ + ++ + L + + + I+ +P + +T L+ L LS N
Sbjct: 134 PQLESLYLGNNKITDITVLSRLTKLDTLSL---EDNQISDIVP--LAGLTKLQNLYLSKN 188
Query: 312 QLTGPVPGILQNLKKIDYIFLTN 334
++ L LK +D + L +
Sbjct: 189 HISDLRA--LAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 43.5 bits (101), Expect = 4e-05
Identities = 16/76 (21%), Positives = 33/76 (43%), Gaps = 6/76 (7%)
Query: 244 PIPSTISQL---KNLTELRISDL-KGSSSSFPNLQDMKKMERLILRNCLITGRIPEYIED 299
+P+ I Q+ E +L K S + ++ ++++I N I I+
Sbjct: 9 TVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQG--IQY 66
Query: 300 MTDLKILDLSFNQLTG 315
+ ++ L L+ N+LT
Sbjct: 67 LPNVTKLFLNGNKLTD 82
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 43.1 bits (100), Expect = 5e-05
Identities = 40/224 (17%), Positives = 79/224 (35%), Gaps = 31/224 (13%)
Query: 141 LGNRLSGSIPLEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPES 200
LG+ ++P I I + + + L + T ++ ++
Sbjct: 3 LGSETI-TVPTPIKQIFSDD------------------AFAETIKDNLKKKSVTDAVTQN 43
Query: 201 YGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRI 260
L ++ + + S++ I + +L L G L P ++ LKNL L +
Sbjct: 44 --ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFL 97
Query: 261 SDLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGI 320
+ + + L + + L+ L L N++T
Sbjct: 98 DE----NKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLESLYLGNNKITDITVL- 152
Query: 321 LQNLKKIDYIFLTNNSLSGTLPDWILTSEKNLDLSYNNFTESSP 364
L K+D + L +N +S +P LT +NL LS N+ ++
Sbjct: 153 -SRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISDLRA 195
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 51.2 bits (121), Expect = 1e-07
Identities = 30/224 (13%), Positives = 59/224 (26%), Gaps = 16/224 (7%)
Query: 132 LQNLTKLLILGNRLSGSIPLEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSN 191
L N K+ + ++ ++ D+ + L + E + L +L + L N
Sbjct: 18 LANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDN 73
Query: 192 NFTGSIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQ 251
T P E + I T S +
Sbjct: 74 QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQV 133
Query: 252 LKNLTELRISDLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFN 311
L L + +++ L L N
Sbjct: 134 LYLDLN----------QITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDN 183
Query: 312 QLTGPVPGILQNLKKIDYIFLTNNSLSGTLPDWILTSEKNLDLS 355
+++ P L +L + + L NN +S P ++ + L+
Sbjct: 184 KISDISP--LASLPNLIEVHLKNNQISDVSPLANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 45.8 bits (107), Expect = 1e-05
Identities = 39/228 (17%), Positives = 76/228 (33%), Gaps = 18/228 (7%)
Query: 107 NLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGDISTLEELVLED 166
L ++ ++ ++ + A L +T L G ++ +I + ++ L L L+D
Sbjct: 17 ALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKD 72
Query: 167 NQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIPNFIG 226
NQ+ +L LK+L +I + S + S + G
Sbjct: 73 NQI-----TDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAG 127
Query: 227 NWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISDLKGSSSSFPNLQDMKKMERLILRN 286
I + +S S L ++ K+ L +
Sbjct: 128 LSNLQVLYLDL-----NQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADD 182
Query: 287 CLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTN 334
I+ P + + +L + L NQ++ P L N + + LTN
Sbjct: 183 NKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 43.5 bits (101), Expect = 5e-05
Identities = 33/200 (16%), Positives = 61/200 (30%), Gaps = 18/200 (9%)
Query: 179 NLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQG 238
L + +I +N T ++ ++ +L +T G+ +T I + L L+L+
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTT-IEG-VQYLNNLIGLELKD 72
Query: 239 TSLEGPIPSTISQLKNLTELRISDLKGSSSSFPNLQDMKKMERLILRNCLIT-------- 290
+ P EL + LK S+ +
Sbjct: 73 NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132
Query: 291 ------GRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGTLPDW 344
+I + LS L NL K+ + +N +S P
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISPLA 192
Query: 345 ILTSEKNLDLSYNNFTESSP 364
L + + L N ++ SP
Sbjct: 193 SLPNLIEVHLKNNQISDVSP 212
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 48.2 bits (114), Expect = 3e-07
Identities = 20/108 (18%), Positives = 41/108 (37%), Gaps = 5/108 (4%)
Query: 101 IPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGDISTLE 160
+ L + +DLS N P + A L+ L ++ + + + ++ L+
Sbjct: 12 VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLE--VLQASDNALENVDGVANLPRLQ 68
Query: 161 ELVLEDNQLVG-PLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNL 207
EL+L +N+L + L + L + L N+ L +
Sbjct: 69 ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEM 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 41.6 bits (97), Expect = 5e-05
Identities = 19/122 (15%), Positives = 43/122 (35%), Gaps = 9/122 (7%)
Query: 112 QEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGDISTLEELVLEDNQLVG 171
+ + L+ ++ +L +T L + NRL P ++ L L +
Sbjct: 1 RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP----ALAALRCLEVLQASDNA 54
Query: 172 P-LPENLGNLKSLRRILLSSNNFTG-SIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWT 229
+ + NL L+ +LL +N + + + L + G++L
Sbjct: 55 LENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLA 113
Query: 230 KL 231
++
Sbjct: 114 EM 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 41.6 bits (97), Expect = 5e-05
Identities = 22/104 (21%), Positives = 44/104 (42%), Gaps = 5/104 (4%)
Query: 225 IGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISDLKGSSSSFPNLQDMKKMERLIL 284
+ + LDL L P+ ++ L+ L L+ SD + + ++ +++ L+L
Sbjct: 16 LEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNA--LENVDGVANLPRLQELLL 72
Query: 285 R-NCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKI 327
N L + + L +L+L N L GI + L ++
Sbjct: 73 CNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEM 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 40.9 bits (95), Expect = 1e-04
Identities = 18/85 (21%), Positives = 35/85 (41%), Gaps = 7/85 (8%)
Query: 282 LILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGI--LQNLKKIDYIFLTNNSLSG 339
L L + +T + ++E + + LDLS N+L P + L+ L+ + ++
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVD- 59
Query: 340 TLPDWILTSEKNLDLSYNNFTESSP 364
L + L L N +S+
Sbjct: 60 --GVANLPRLQELLLCNNRLQQSAA 82
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.6 bits (116), Expect = 1e-06
Identities = 19/161 (11%), Positives = 43/161 (26%), Gaps = 5/161 (3%)
Query: 254 NLTELRISDLKGSSSSFPNL-QDMKKMERLILRNCLITGR----IPEYIEDMTDLKILDL 308
++ L I + S + + L +++ + + L +C +T I + L L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 309 SFNQLTGPVPGILQNLKKIDYIFLTNNSLSGTLPDWILTSEKNLDLSYNNFTESSPATCR 368
N+L + + + SL + L + +
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDN 122
Query: 369 ESRVNILSSFSSTGSNSVSWCLKKDLPCPKEAKHYSLFINC 409
L + K L + +
Sbjct: 123 LLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLAS 163
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.4 bits (105), Expect = 3e-05
Identities = 13/93 (13%), Positives = 31/93 (33%), Gaps = 10/93 (10%)
Query: 111 LQEVDLSRNYFNGS-LPKSFARLQNLTKLLILGNRLSGSIPLEIGDI----STLEELVLE 165
+Q +D+ + + + LQ + + L+ + +I L EL L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 166 DNQLVGPLPENLG-----NLKSLRRILLSSNNF 193
N+L + ++++ L +
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCL 96
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.8 bits (101), Expect = 1e-04
Identities = 20/110 (18%), Positives = 32/110 (29%), Gaps = 26/110 (23%)
Query: 157 STLEELVLEDNQL----VGPLPENLGNLKSLRRILLSSNNFTGSIPESYGN-LKNLTEFR 211
S L L L D + L L SLR + LS+N + ++
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQ----- 423
Query: 212 IDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQL-KNLTELRI 260
L++L L + + L K+ LR+
Sbjct: 424 ---------------PGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRV 458
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.4 bits (100), Expect = 1e-04
Identities = 13/76 (17%), Positives = 24/76 (31%), Gaps = 5/76 (6%)
Query: 134 NLTKLLILGNRLSGSIPLEIGD-ISTLEELVLEDNQL----VGPLPENLGNLKSLRRILL 188
++ L I LS + E+ + + + L+D L + L +L + L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 189 SSNNFTGSIPESYGNL 204
SN
Sbjct: 63 RSNELGDVGVHCVLQG 78
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.6 bits (90), Expect = 0.002
Identities = 14/93 (15%), Positives = 36/93 (38%), Gaps = 13/93 (13%)
Query: 227 NWTKLDRLDLQGTSLEG----PIPSTISQLKNLTELRISDLKGSSSSFPNL-----QDMK 277
+ L L L + + +T+ +L EL +S+ + L Q
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 278 KMERLILRNCLITGRIPEYIEDM----TDLKIL 306
+E+L+L + + + + ++ + L+++
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.2 bits (89), Expect = 0.002
Identities = 12/99 (12%), Positives = 32/99 (32%), Gaps = 16/99 (16%)
Query: 294 PEYIEDMTDLKILDLSFNQLTG----PVPGILQNLKKIDYIFLTNNSLSGTLPDWIL--- 346
+ + L++L L+ ++ + L + + L+NN L ++
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421
Query: 347 ----TSEKNLDLSYNNFTESSPATCRESRVN-----ILS 376
+ L L ++E + + ++S
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 460
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (87), Expect = 0.004
Identities = 16/78 (20%), Positives = 26/78 (33%), Gaps = 6/78 (7%)
Query: 254 NLTELRISDLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYIED-----MTDLKILDL 308
L + +SD SS L + L L N + + + L+ L L
Sbjct: 375 WLADCDVSD-SSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVL 433
Query: 309 SFNQLTGPVPGILQNLKK 326
+ + LQ L+K
Sbjct: 434 YDIYWSEEMEDRLQALEK 451
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 47.9 bits (112), Expect = 1e-06
Identities = 35/174 (20%), Positives = 67/174 (38%), Gaps = 8/174 (4%)
Query: 142 GNRLSGSIPLEIGDISTLEELVLEDNQLVGPLPENL-GNLKSLRRILLSSNNFTGSIPES 200
G L IP +I EL+L DN+L + L G L L ++ L N TG P +
Sbjct: 17 GRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNA 73
Query: 201 YGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRI 260
+ ++ E ++ + + +L L+L + +P + L +LT L +
Sbjct: 74 FEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNL 133
Query: 261 SDLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLT 314
+ + + + + + L P + D++I DL ++
Sbjct: 134 AS-NPFNCNCHLAWFAEWLRKKSLNGGAARCGAPS---KVRDVQIKDLPHSEFK 183
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 47.0 bits (110), Expect = 3e-06
Identities = 27/197 (13%), Positives = 67/197 (34%), Gaps = 15/197 (7%)
Query: 132 LQNLTKLLILGNRLSGSIPLEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSN 191
L K ++ ++ ++ D+ + L + + + + L +L +I S+N
Sbjct: 17 LAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNN 72
Query: 192 NFTGSIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQ 251
T P + + N + + +++
Sbjct: 73 QLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNR 132
Query: 252 LKNLTELRISDLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFN 311
L+ + L + +++L + +T P + ++T L+ LD+S N
Sbjct: 133 LELSSNTISD--------ISALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLDISSN 182
Query: 312 QLTG-PVPGILQNLKKI 327
+++ V L NL+ +
Sbjct: 183 KVSDISVLAKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 45.0 bits (105), Expect = 1e-05
Identities = 27/186 (14%), Positives = 60/186 (32%), Gaps = 12/186 (6%)
Query: 179 NLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQG 238
L + +L N T ++ ++ +L +T + D + I + L +++
Sbjct: 16 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSN 71
Query: 239 TSLEGPIPSTISQLKNLTELRISDLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYIE 298
L L L +++ + L +I +
Sbjct: 72 NQLTDIT--------PLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDP 123
Query: 299 DMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGTLPDWILTSEKNLDLSYNN 358
+ L + T L L + + ++N ++ P LT+ + LD+S N
Sbjct: 124 LKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNK 183
Query: 359 FTESSP 364
++ S
Sbjct: 184 VSDISV 189
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.9 bits (100), Expect = 4e-05
Identities = 23/101 (22%), Positives = 40/101 (39%), Gaps = 2/101 (1%)
Query: 89 VILLKGFNLAGVIPEEFGNLTFLQEVDLSRNYFNG--SLPKSFARLQNLTKLLILGNRLS 146
V+L + ++A + N+ L ++LS N + + NL L + GN L
Sbjct: 45 VVLNRRSSMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK 104
Query: 147 GSIPLEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRIL 187
L+ LEEL L+ N L + + ++R
Sbjct: 105 SERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERF 145
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.4 bits (91), Expect = 6e-04
Identities = 29/113 (25%), Positives = 46/113 (40%), Gaps = 9/113 (7%)
Query: 234 LDLQG-TSLEGPIPSTISQLKNLTELRISDLKGSSSSFPNLQDMKKMERLILRNCLITGR 292
LDL+G S + I + N + L+ + P L L L N +
Sbjct: 27 LDLKGLRSDPDLVAQNIDVVLNRRSSMAATLRIIEENIPELL------SLNLSNNRLYRL 80
Query: 293 --IPEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGTLPD 343
+ ++ +LKIL+LS N+L K++ ++L NSLS T D
Sbjct: 81 DDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRD 133
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.1 bits (85), Expect = 0.003
Identities = 24/177 (13%), Positives = 50/177 (28%), Gaps = 34/177 (19%)
Query: 148 SIPLEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNL 207
+ L + + L+ L +L +L ++ ++ N+ L
Sbjct: 11 QLKLIMSKRYDGSQQALDLKGL--RSDPDLVAQNIDV-VLNRRSSMAATLRIIEENIPEL 67
Query: 208 TEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISDLKGSS 267
+ + L + S + + NL L +S + S
Sbjct: 68 LSLNLSNNRLYRL----------------------DDMSSIVQKAPNLKILNLSGNELKS 105
Query: 268 SSFPNLQDMKKMERLILRNCLITGRIPEY-------IEDMTDLKILDLSFNQLTGPV 317
+ K+E L L ++ + E L LD ++L P+
Sbjct: 106 ERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD--GHELPPPI 160
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.8 bits (96), Expect = 2e-04
Identities = 13/58 (22%), Positives = 24/58 (41%), Gaps = 4/58 (6%)
Query: 286 NCLITGRIPEYI-EDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGTLP 342
+ +P + + ILD+S ++ L+NLKK+ + +L LP
Sbjct: 185 DNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRA--RSTYNLK-KLP 239
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 5e-04
Identities = 10/54 (18%), Positives = 17/54 (31%), Gaps = 4/54 (7%)
Query: 221 IPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISDLKGSSSSFPNLQ 274
+ + LD+ T + + LK L +LK P L+
Sbjct: 193 PNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK----KLPTLE 242
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (87), Expect = 0.002
Identities = 18/218 (8%), Positives = 49/218 (22%), Gaps = 32/218 (14%)
Query: 173 LPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLD 232
+P +L ++ + ++ +L + I +++ I + +
Sbjct: 23 IPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKL 80
Query: 233 RLDLQGTSLEGPIPSTISQLKNLTELRISDLKGSSSSFP--------------------- 271
+ + + + P
Sbjct: 81 HEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINI 140
Query: 272 -------NLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNL 324
+ + L L I ++ N L +
Sbjct: 141 HTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGA 200
Query: 325 KKIDYIFLTNNSLSGTLPDWILTSEKNLD-LSYNNFTE 361
+ ++ + +LP + L + K L S N +
Sbjct: 201 SGPVILDISRTRIH-SLPSYGLENLKKLRARSTYNLKK 237
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (87), Expect = 0.003
Identities = 13/51 (25%), Positives = 21/51 (41%), Gaps = 3/51 (5%)
Query: 100 VIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIP 150
+ + F + +D+SR + SLP L+NL KL +P
Sbjct: 192 LPNDVFHGASGPVILDISRTRIH-SLPSYG--LENLKKLRARSTYNLKKLP 239
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 198 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Score = 39.7 bits (91), Expect = 8e-04
Identities = 28/171 (16%), Positives = 52/171 (30%), Gaps = 13/171 (7%)
Query: 221 IPNFIGNWTKLDR---LDLQGTSLEGPIP------STISQLKNLTELRISDLKGSSSSFP 271
I + I + + + + L G IP +T+S LK L +S
Sbjct: 7 IKDAIRIFEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNN--IEKIS 64
Query: 272 NLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIF 331
+L M+ + L L LI T ++ + L NL+ +
Sbjct: 65 SLSGMENLRILSLGRNLIKKIENLDAVADTLEELWISYNQIASLSGIEKLVNLRVLYMSN 124
Query: 332 LTNNSLSGTLPDWILTSEKNLDLSYNNFTESSPATCRES--RVNILSSFSS 380
+ L ++L L+ N S R+ ++ +
Sbjct: 125 NKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPN 175
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.8 bits (89), Expect = 9e-04
Identities = 14/84 (16%), Positives = 31/84 (36%), Gaps = 6/84 (7%)
Query: 261 SDLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGI 320
++L ++ + N + L LR I I + +D S N++ + G
Sbjct: 5 AELIEQAAQYTNA---VRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLDGF 59
Query: 321 LQNLKKIDYIFLTNNSLSGTLPDW 344
L+++ + + NN +
Sbjct: 60 -PLLRRLKTLLVNNNRICRIGEGL 82
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.9 bits (91), Expect = 0.001
Identities = 17/96 (17%), Positives = 32/96 (33%), Gaps = 4/96 (4%)
Query: 137 KLLILGNRLSGSIPLEIGDISTLEELVLEDNQL----VGPLPENLGNLKSLRRILLSSNN 192
KL + S+ + + +++E+VL N + L EN+ + K L S
Sbjct: 11 KLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIF 70
Query: 193 FTGSIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNW 228
E L+ L + + L +
Sbjct: 71 TGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFG 106
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.1 bits (89), Expect = 0.002
Identities = 34/297 (11%), Positives = 77/297 (25%), Gaps = 33/297 (11%)
Query: 101 IPEEFGNLTFLQEVDLSRNYFNG----SLPKSFARLQNLTKLLILGN---RLSGSIPLEI 153
+ ++E+ LS N L ++ A ++L R+ IP +
Sbjct: 23 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEAL 82
Query: 154 GDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRID 213
+ + + + + LS + + L +I
Sbjct: 83 RLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIA 142
Query: 214 GSNLTGRIPNFIGNWTKLDRLDLQGTSLE----GPIPSTISQLKNLTELRISDLKGSSSS 269
+ + N L + LE T + L +++
Sbjct: 143 RALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEG 202
Query: 270 FPNLQDMKKMERLIL---------RNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGI 320
+L L L + + ++ +L+ L L+ L+
Sbjct: 203 IEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAA 262
Query: 321 L------QNLKKIDYIFLTNNSLSGTLPDWI-------LTSEKNLDLSYNNFTESSP 364
+ + + L N + + + L+L+ N F+E
Sbjct: 263 VVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDD 319
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1016 | |||
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 100.0 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 100.0 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 100.0 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 100.0 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 100.0 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.98 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.97 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.96 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.95 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.91 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.9 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.9 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.9 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.89 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.87 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.87 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.87 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.87 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.86 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.86 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.85 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.85 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.82 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.82 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.78 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.77 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.73 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.68 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.65 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.61 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.6 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.56 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.53 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.51 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.5 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 99.19 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.76 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.73 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.51 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 98.1 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 98.05 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.99 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.72 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.48 | |
| d2o14a1 | 146 | Hypothetical protein YxiM {Bacillus subtilis [TaxI | 92.51 |
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=395.63 Aligned_cols=260 Identities=22% Similarity=0.371 Sum_probs=214.2
Q ss_pred HHHHCCCCCCCCCCCCCCEEEEEEECC-CCCEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEE
Q ss_conf 998238432372023797339998907-9959999992577713169999999999843998711002267616256999
Q 001768 655 KAATNNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLV 733 (1016)
Q Consensus 655 ~~a~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV 733 (1016)
+...++|+..+.||+|+||+||+|.+. +++.||||+++... ...+.|.+|+.++++++|||||+++|++.+++..++|
T Consensus 13 ei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (287)
T d1opja_ 13 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 91 (287)
T ss_dssp BCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred EECHHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEEECCCC-CHHHHHHHHHHHHHHCCCCCEECCCCCEEECCEEEEE
T ss_conf 745799398659820888089999999999699999977761-0399999999999867999882677527457854787
Q ss_pred EEECCCCCHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCEEEECCCCCEEEECCCCCCCCC
Q ss_conf 96369994888830276867678978899999999999999772289876839998760998149964661034643368
Q 001768 734 YEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDE 813 (1016)
Q Consensus 734 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 813 (1016)
|||+++|+|.+++..... ..+++..+..++.|+++||+|||++ +|+||||||+|||+++++.+||+|||+|+...
T Consensus 92 ~E~~~~g~l~~~l~~~~~--~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~ 166 (287)
T d1opja_ 92 TEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT 166 (287)
T ss_dssp EECCTTCBHHHHHHHSCT--TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCC
T ss_pred EECCCCCCHHHHHHHCCC--CCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEECCCCCEEECCCCCEEECC
T ss_conf 631467606777530355--4157999999999999978889878---93057604576899899928983244546537
Q ss_pred CCCCCEEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 88850111014686544812111388997220457999999999299999999913357588999999870883201478
Q 001768 814 DENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDP 893 (1016)
Q Consensus 814 ~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~k~DV~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 893 (1016)
...........|++.|+|||++.+..++.++|||||||++|||++|+.|+......... . ... ..+
T Consensus 167 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~--~---~~i-~~~-------- 232 (287)
T d1opja_ 167 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV--Y---ELL-EKD-------- 232 (287)
T ss_dssp SSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH--H---HHH-HTT--------
T ss_pred CCCCEEECCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH--H---HHH-HCC--------
T ss_conf 88722103556654666927872799981043021789999998679988774259999--9---998-558--------
Q ss_pred CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCCC
Q ss_conf 689998999999999999872099999999988999983158
Q 001768 894 SLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGK 935 (1016)
Q Consensus 894 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 935 (1016)
.....+...+..+.+++.+||+.||++||||+++++.|+..
T Consensus 233 -~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~ 273 (287)
T d1opja_ 233 -YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273 (287)
T ss_dssp -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred -CCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf -88888743309999999997577976893999999999999
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=384.64 Aligned_cols=255 Identities=25% Similarity=0.440 Sum_probs=212.3
Q ss_pred CCCCCCCCCCCCCCEEEEEEECC-CCCEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEEC
Q ss_conf 38432372023797339998907-99599999925777131699999999998439987110022676162569999636
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYL 737 (1016)
Q Consensus 659 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~~ 737 (1016)
++|+..+.||+|+||+||+|... +++.||+|++........+.+.+|+.+++.++|||||++++++.+++..++||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CCCEEEEEEECCCCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEEC
T ss_conf 05388789812858299999998999899999984301727999999999998679998805857798899989999703
Q ss_pred CCCCHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCEEEECCCCCEEEECCCCCCCCCCCCC
Q ss_conf 99948888302768676789788999999999999997722898768399987609981499646610346433688885
Q 001768 738 ENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENT 817 (1016)
Q Consensus 738 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 817 (1016)
++|+|.+++... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+.......
T Consensus 100 ~gg~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 171 (293)
T d1yhwa1 100 AGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (293)
T ss_dssp TTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCCCHHHHHHCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEECCCCCEEECCCHHHEEECCCCC
T ss_conf 798089886415-----999999999999999999999987---972267768886887899686425156413213666
Q ss_pred CEEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 01110146865448121113889972204579999999992999999999133575889999998708832014786899
Q 001768 818 HISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGS 897 (1016)
Q Consensus 818 ~~~~~~~Gt~~y~aPE~~~~~~~~~k~DV~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 897 (1016)
.....+||+.|+|||++.+..++.++||||+||++|||++|+.||............ ..... .. .
T Consensus 172 -~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~------~~~~~-~~-------~ 236 (293)
T d1yhwa1 172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI------ATNGT-PE-------L 236 (293)
T ss_dssp -CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH------HHHCS-CC-------C
T ss_pred -CCCCCCCCCCCCCHHHHCCCCCCCHHCEEHHHHHHHHHHHCCCCCCCCCHHHHHHHH------HHCCC-CC-------C
T ss_conf -444444477736826644799880120313729999980488998997999999999------85799-98-------8
Q ss_pred CCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 989999999999998720999999999889999831585776731248
Q 001768 898 NFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTAVQAPIIRR 945 (1016)
Q Consensus 898 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~~~~p~~~~ 945 (1016)
..+......+.+++.+||+.||++|||+.|++ +|||++.
T Consensus 237 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil---------~Hp~~~~ 275 (293)
T d1yhwa1 237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELL---------QHQFLKI 275 (293)
T ss_dssp SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHT---------TCGGGGG
T ss_pred CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHH---------CCHHHCC
T ss_conf 88553799999999998669966890999996---------4996577
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=391.36 Aligned_cols=254 Identities=28% Similarity=0.437 Sum_probs=211.4
Q ss_pred CCCCCCCCCCCCCCEEEEEEECCCCCEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEECC
Q ss_conf 38432372023797339998907995999999257771316999999999984399871100226761625699996369
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYLE 738 (1016)
Q Consensus 659 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~~~ 738 (1016)
++|+..+.||+|+||.||+|.+.+++.||||++.... ...+.|.+|+.++++++|||||+++|++..++..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHCEEEEEEEECCCEEEEEEEECCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCCCCCCCEECCCCCEEEEEEECC
T ss_conf 9958888982088829999998899999999987886-768999999999996689975653524315993379998369
Q ss_pred CCCHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCEEEECCCCCEEEECCCCCCCCCCCCCC
Q ss_conf 99488883027686767897889999999999999977228987683999876099814996466103464336888850
Q 001768 739 NNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTH 818 (1016)
Q Consensus 739 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 818 (1016)
+|+|.+++.... ..+++..+..++.|+|.||+|||+. +|+||||||+|||+++++.+||+|||+|+........
T Consensus 84 ~g~L~~~l~~~~---~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~ 157 (263)
T d1sm2a_ 84 HGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 157 (263)
T ss_dssp TCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred CCCHHHHHHCCC---CCCCHHHHHHHHHHHHHHHHHHHCC---CEEECCCCHHHEEECCCCCEEECCCCHHEECCCCCCE
T ss_conf 991899752013---4788999999999999987765316---4310443153266668877686553210023688733
Q ss_pred EEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHC-CCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 11101468654481211138899722045799999999929-99999999133575889999998708832014786899
Q 001768 819 ISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSG-KSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGS 897 (1016)
Q Consensus 819 ~~~~~~Gt~~y~aPE~~~~~~~~~k~DV~SlGvil~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 897 (1016)
......||+.|+|||++.+..++.++|||||||++|||+|+ ++|+......+....+ ..... +.
T Consensus 158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i------~~~~~------~~--- 222 (263)
T d1sm2a_ 158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI------STGFR------LY--- 222 (263)
T ss_dssp -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHH------HHTCC------CC---
T ss_pred EECCEECCCCCCCHHHHCCCCCCCHHHHCCHHHHHHHHHHCCCCCCCCCCHHHHHHHH------HHCCC------CC---
T ss_conf 5043001766678578607999840332105999999987898887789999999999------80688------89---
Q ss_pred CCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCCC
Q ss_conf 98999999999999872099999999988999983158
Q 001768 898 NFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGK 935 (1016)
Q Consensus 898 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 935 (1016)
.+...+..+.+++.+||+.||++||||++|++.|+..
T Consensus 223 -~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i 259 (263)
T d1sm2a_ 223 -KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259 (263)
T ss_dssp -CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf -9543679999999997657976891999999999999
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=389.66 Aligned_cols=256 Identities=31% Similarity=0.478 Sum_probs=209.5
Q ss_pred HHHCCCCCCCCCCCCCCEEEEEEECCCCCEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEE
Q ss_conf 98238432372023797339998907995999999257771316999999999984399871100226761625699996
Q 001768 656 AATNNFDAANKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYE 735 (1016)
Q Consensus 656 ~a~~~f~~~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 735 (1016)
...++|++.+.||+|+||.||+|.+++++.||||++.... ...+.|.+|+.++++++|||||+++|++.+ +..++|||
T Consensus 10 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~E 87 (272)
T d1qpca_ 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE 87 (272)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred CCHHHEEEEEEEECCCCCEEEEEEECCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCEEEEEEEECC-CCEEEEEE
T ss_conf 3889938867981079828999999999999999986476-888999999999986799988578731045-97699999
Q ss_pred ECCCCCHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCEEEECCCCCEEEECCCCCCCCCCC
Q ss_conf 36999488883027686767897889999999999999977228987683999876099814996466103464336888
Q 001768 736 YLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDE 815 (1016)
Q Consensus 736 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 815 (1016)
|+++|+|.+++.... ...+++..+..|+.||++||+|||+. +|+||||||+|||+++++.+||+|||+|+.....
T Consensus 88 y~~~g~L~~~~~~~~--~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~ 162 (272)
T d1qpca_ 88 YMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (272)
T ss_dssp CCTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred ECCCCCHHHHHHHCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEEECCCCEEECCCCCEEECCCC
T ss_conf 578982888875147--89887889999999999999999748---9546756422515620244042341014773588
Q ss_pred CCCEEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCC-CCCCHHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 8501110146865448121113889972204579999999992999999-999133575889999998708832014786
Q 001768 816 NTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTN-YRPKEEFVYLLDWAYVLQEQGNLLELVDPS 894 (1016)
Q Consensus 816 ~~~~~~~~~Gt~~y~aPE~~~~~~~~~k~DV~SlGvil~elltG~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 894 (1016)
.........||+.|||||++.++.++.++|||||||++|||+||+.|+. .....+....+ ..+ ..+.
T Consensus 163 ~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i-------~~~-----~~~~ 230 (272)
T d1qpca_ 163 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL-------ERG-----YRMV 230 (272)
T ss_dssp CEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH-------HTT-----CCCC
T ss_pred CCCCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH-------HHC-----CCCC
T ss_conf 6442035677444458289837999824564525799999996898888888999999999-------706-----8888
Q ss_pred CCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCC
Q ss_conf 8999899999999999987209999999998899998315
Q 001768 895 LGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEG 934 (1016)
Q Consensus 895 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~ 934 (1016)
.+. ..+..+.+++.+||+.+|++||||++|++.|+.
T Consensus 231 ~p~----~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 231 RPD----NCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp CCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCC----CCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHH
T ss_conf 965----571999999999758897689399999998611
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=386.30 Aligned_cols=258 Identities=29% Similarity=0.389 Sum_probs=209.4
Q ss_pred HCCCCCCCCCCCCCCEEEEEEECC-CCCEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEE
Q ss_conf 238432372023797339998907-99599999925777-1316999999999984399871100226761625699996
Q 001768 658 TNNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS-KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYE 735 (1016)
Q Consensus 658 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 735 (1016)
.++|++.+.||+|+||+||+|+.. +++.||+|++.... ....+.+.+|+.++++++|||||++++++.+++..++|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEEEEEE
T ss_conf 74608998972174809999999999979999998456641279999999999985799888469654046743679886
Q ss_pred ECCCCCHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCEEEECCCCCEEEECCCCCCCCCCC
Q ss_conf 36999488883027686767897889999999999999977228987683999876099814996466103464336888
Q 001768 736 YLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDE 815 (1016)
Q Consensus 736 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 815 (1016)
|+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+|+.....
T Consensus 84 y~~gg~L~~~l~~~~----~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~ 156 (271)
T d1nvra_ 84 YCSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN 156 (271)
T ss_dssp CCTTEEGGGGSBTTT----BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEET
T ss_pred CCCCCCHHHHHHCCC----CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEECCCCCEEECCCHHHEEECCC
T ss_conf 458980899975379----999999999999999999999975---9835754689978878998798323142240468
Q ss_pred C-CCEEEECCCCCCCCCHHHHCCCCC-CCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 8-501110146865448121113889-97220457999999999299999999913357588999999870883201478
Q 001768 816 N-THISTRIAGTVGYMAPEYAMRGYL-TDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDP 893 (1016)
Q Consensus 816 ~-~~~~~~~~Gt~~y~aPE~~~~~~~-~~k~DV~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 893 (1016)
. .......+||+.|||||++.+..+ +.++||||+||++|||++|+.||........... ........
T Consensus 157 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~-----~~~~~~~~------ 225 (271)
T d1nvra_ 157 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS-----DWKEKKTY------ 225 (271)
T ss_dssp TEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHH-----HHHTTCTT------
T ss_pred CCCCCCCCEEECCCCCCHHHHCCCCCCCCCEEEEHHHHHHHHHHHCCCCCCCCCHHHHHHH-----HHHCCCCC------
T ss_conf 8653111325574742872861899999710161737999999829978888985999999-----98638887------
Q ss_pred CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 6899989999999999998720999999999889999831585776731248
Q 001768 894 SLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTAVQAPIIRR 945 (1016)
Q Consensus 894 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~~~~p~~~~ 945 (1016)
..........+.+++.+|++.||++|||++|++ +|||+.+
T Consensus 226 ---~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil---------~hpwf~~ 265 (271)
T d1nvra_ 226 ---LNPWKKIDSAPLALLHKILVENPSARITIPDIK---------KDRWYNK 265 (271)
T ss_dssp ---STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHT---------TCTTTTC
T ss_pred ---CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHH---------CCHHHCC
T ss_conf ---886446999999999997679966890999996---------1984585
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=386.88 Aligned_cols=260 Identities=28% Similarity=0.421 Sum_probs=211.7
Q ss_pred HHCCCCCCCCCCCCCCEEEEEEECCC------CCEEEEEECCCC-CHHHHHHHHHHHHHHHHC-CCCCEEEEEEEEEECC
Q ss_conf 82384323720237973399989079------959999992577-713169999999999843-9987110022676162
Q 001768 657 ATNNFDAANKIGEGGFGPVYKGTLSD------GAVIAVKQLSSK-SKQGNREFVNEIGMISAL-QHQNLVKLYGCCIEGN 728 (1016)
Q Consensus 657 a~~~f~~~~~LG~G~fG~Vy~~~~~~------~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~ 728 (1016)
..++|++.+.||+|+||+||+|++.. ...||+|.+... .......+.+|+.++.++ +|||||++++++.+.+
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 114 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 114 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHEEEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECC
T ss_conf 78993970198307881999999857885542049999996633587899999999999997158996868778886299
Q ss_pred EEEEEEEECCCCCHHHHHCCCCCC-------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCC
Q ss_conf 569999636999488883027686-------------------7678978899999999999999772289876839998
Q 001768 729 QLLLVYEYLENNSLARALFGKEGQ-------------------CLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIK 789 (1016)
Q Consensus 729 ~~~lV~E~~~~gsL~~~l~~~~~~-------------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlk 789 (1016)
..++|||||++|+|.+++..+... ...+++..+..++.|+++||+|||++ +|+|||||
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlK 191 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLA 191 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCS
T ss_pred EEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCC
T ss_conf 589999727999599999862577751022100001222001257789999999999999999999739---90505270
Q ss_pred CCEEEECCCCCEEEECCCCCCCCCCCCCC-EEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHH-CCCCCCCCC
Q ss_conf 76099814996466103464336888850-1110146865448121113889972204579999999992-999999999
Q 001768 790 ATNVLLDKDLNAKISDFGLAKLDEDENTH-ISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRP 867 (1016)
Q Consensus 790 p~NILl~~~~~~kl~DFGla~~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~k~DV~SlGvil~ellt-G~~p~~~~~ 867 (1016)
|+|||++.++.+||+|||+|+........ ......||+.|||||++.++.++.++|||||||++|||+| |+.||...+
T Consensus 192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~ 271 (325)
T d1rjba_ 192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271 (325)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred HHCCCCCCCCEEEEEECCCCCCCCCCCCEEEECCCCCCCCCCCHHHHCCCCCCCCEECCCHHHHHHHHHHCCCCCCCCCC
T ss_conf 32144345982898514222204577861562343578765783887279999633030003999999838999999989
Q ss_pred CHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCC
Q ss_conf 1335758899999987088320147868999899999999999987209999999998899998315
Q 001768 868 KEEFVYLLDWAYVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEG 934 (1016)
Q Consensus 868 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~ 934 (1016)
....... .. ..+ ..+ ..+...+..+.+|+.+||+.+|++||||+||+++|..
T Consensus 272 ~~~~~~~-----~~-~~~-----~~~----~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 272 VDANFYK-----LI-QNG-----FKM----DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp CSHHHHH-----HH-HTT-----CCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHH-----HH-HCC-----CCC----CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHC
T ss_conf 8999999-----98-569-----989----9887678999999999758896689399999999748
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=386.72 Aligned_cols=255 Identities=26% Similarity=0.434 Sum_probs=209.4
Q ss_pred CCCCCCCCCCCCCCEEEEEEECCC-C---CEEEEEECCCC-CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEE
Q ss_conf 384323720237973399989079-9---59999992577-713169999999999843998711002267616256999
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLSD-G---AVIAVKQLSSK-SKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLV 733 (1016)
Q Consensus 659 ~~f~~~~~LG~G~fG~Vy~~~~~~-~---~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV 733 (1016)
++|+..+.||+|+||+||+|.++. + ..||||.+... .....+.|.+|+.++++++|||||+++|++.+++..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred HHCEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEE
T ss_conf 04278569802788299999995799788999999978445989999999999999857998886189999628877999
Q ss_pred EEECCCCCHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCEEEECCCCCEEEECCCCCCCCC
Q ss_conf 96369994888830276867678978899999999999999772289876839998760998149964661034643368
Q 001768 734 YEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDE 813 (1016)
Q Consensus 734 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 813 (1016)
||||++|+|.+++.... ..++|.++..++.|+|+||+|||+. +|+||||||+|||++.++.+||+|||+|+...
T Consensus 106 ~Ey~~~g~L~~~~~~~~---~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQND---GQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp EECCTTEEHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEECCCCCCEEEECCCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEECCCCCEEECCCCCCEECC
T ss_conf 97227985300210456---7999999999999999988988527---98357615044898899919988844315756
Q ss_pred CCCCCE----EEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHH-CCCCCCCCCCHHHHHHHHHHHHHHHHCCCC
Q ss_conf 888501----110146865448121113889972204579999999992-999999999133575889999998708832
Q 001768 814 DENTHI----STRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWAYVLQEQGNLL 888 (1016)
Q Consensus 814 ~~~~~~----~~~~~Gt~~y~aPE~~~~~~~~~k~DV~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 888 (1016)
...... .....||+.|||||++.++.++.++|||||||++|||+| |+.||......+....+ .. +
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i------~~-~--- 249 (299)
T d1jpaa_ 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAI------EQ-D--- 249 (299)
T ss_dssp ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH------HT-T---
T ss_pred CCCCCCEEEECCCCCCCCCCCCHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHH------HC-C---
T ss_conf 7777653650256668830038788836997861214453578999986799999999999999999------73-7---
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCCC
Q ss_conf 01478689998999999999999872099999999988999983158
Q 001768 889 ELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGK 935 (1016)
Q Consensus 889 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 935 (1016)
.....+...+..+.+++.+||+.+|++||||.||++.|+..
T Consensus 250 ------~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~ 290 (299)
T d1jpaa_ 250 ------YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290 (299)
T ss_dssp ------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred ------CCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf ------88999742269999999997587976892999999999998
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=0 Score=380.75 Aligned_cols=252 Identities=22% Similarity=0.316 Sum_probs=210.4
Q ss_pred HCCCCCCCCCCCCCCEEEEEEECC-CCCEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEE
Q ss_conf 238432372023797339998907-9959999992577713169999999999843998711002267616256999963
Q 001768 658 TNNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEY 736 (1016)
Q Consensus 658 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~ 736 (1016)
-++|++.+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++|||||++++++.+++..++||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEEC
T ss_conf 65758988984076819999998899989999998452431699999999999867997999299999989999999985
Q ss_pred CCCCCHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCEEEECC--CCCEEEECCCCCCCCCC
Q ss_conf 6999488883027686767897889999999999999977228987683999876099814--99646610346433688
Q 001768 737 LENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDK--DLNAKISDFGLAKLDED 814 (1016)
Q Consensus 737 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NILl~~--~~~~kl~DFGla~~~~~ 814 (1016)
|++|+|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+|||++. ++.+||+|||+|+....
T Consensus 105 ~~gg~L~~~l~~~~---~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~ 178 (350)
T d1koaa2 105 MSGGELFEKVADEH---NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 178 (350)
T ss_dssp CCSCBHHHHHTCTT---SCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred CCCCCHHHHHHHHC---CCCCHHHHHHHHHHHHHHHHHHHHC---CCEEEEECHHHEEECCCCCCEEEEEECCHHEECCC
T ss_conf 79988999997623---7899999999999999999999756---97600015467364168898699954521044256
Q ss_pred CCCCEEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 88501110146865448121113889972204579999999992999999999133575889999998708832014786
Q 001768 815 ENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPS 894 (1016)
Q Consensus 815 ~~~~~~~~~~Gt~~y~aPE~~~~~~~~~k~DV~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 894 (1016)
.. ......||+.|||||++.+..++.++||||+||++|||++|+.||......+.... +.........
T Consensus 179 ~~--~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~-----i~~~~~~~~~----- 246 (350)
T d1koaa2 179 KQ--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRN-----VKSCDWNMDD----- 246 (350)
T ss_dssp TS--CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-----HHHTCCCSCC-----
T ss_pred CC--CCCEECCCCCCCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH-----HHHCCCCCCC-----
T ss_conf 54--32000686242188997589987267655465999999859899899799999999-----9847889894-----
Q ss_pred CCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 899989999999999998720999999999889999
Q 001768 895 LGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 895 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 930 (1016)
.........+.+++.+|++.||++|||++|+++
T Consensus 247 ---~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 247 ---SAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp ---GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred ---CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf ---223589999999999975689667908999862
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=382.86 Aligned_cols=261 Identities=25% Similarity=0.395 Sum_probs=213.1
Q ss_pred CCCCCCCCCCCCCCEEEEEEECC-CCCEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEEC
Q ss_conf 38432372023797339998907-99599999925777131699999999998439987110022676162569999636
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYL 737 (1016)
Q Consensus 659 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~~ 737 (1016)
+.|++.+.||+|+||+||+|+.. +++.||+|++........+.+.+|++++++++|||||++++++.+++..++|||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CCEEEEEEEEECCCCEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEECC
T ss_conf 37598479930778199999999999399999987289999999999999998679999884988980099589999627
Q ss_pred CCCCHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCEEEECCCCCEEEECCCCCCCCCCCCC
Q ss_conf 99948888302768676789788999999999999997722898768399987609981499646610346433688885
Q 001768 738 ENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENT 817 (1016)
Q Consensus 738 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 817 (1016)
++|+|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+......
T Consensus 92 ~~g~L~~~~~~~~---~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~- 164 (288)
T d2jfla1 92 AGGAVDAVMLELE---RPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI- 164 (288)
T ss_dssp TTEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-
T ss_pred CCCCHHHHHHHCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEEEECCHHHEEECCCCCEEEEECHHHHCCCCCC-
T ss_conf 9981889998628---9999999999999999999999988---98871407003148789998997161230357786-
Q ss_pred CEEEECCCCCCCCCHHHHC-----CCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCC
Q ss_conf 0111014686544812111-----38899722045799999999929999999991335758899999987088320147
Q 001768 818 HISTRIAGTVGYMAPEYAM-----RGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVD 892 (1016)
Q Consensus 818 ~~~~~~~Gt~~y~aPE~~~-----~~~~~~k~DV~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 892 (1016)
.......||+.|||||++. ...++.++||||+||++|||++|+.||......+....+ . ......
T Consensus 165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i-----~--~~~~~~--- 234 (288)
T d2jfla1 165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI-----A--KSEPPT--- 234 (288)
T ss_dssp HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHH-----H--HSCCCC---
T ss_pred CCCCCCCCCCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH-----H--CCCCCC---
T ss_conf 410010256264799998320257888880665787899999982088999998999999999-----7--079987---
Q ss_pred CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCCCCCCCCCCCCCCCCH
Q ss_conf 868999899999999999987209999999998899998315857767312489982
Q 001768 893 PSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTAVQAPIIRRNSDS 949 (1016)
Q Consensus 893 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~~~~p~~~~~~~~ 949 (1016)
...+...+..+.+++.+||+.||++|||+.|++ +|||+......
T Consensus 235 ----~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell---------~hp~~~~~~~~ 278 (288)
T d2jfla1 235 ----LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLL---------QHPFVTVDSNK 278 (288)
T ss_dssp ----CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHT---------TSGGGCCCCCH
T ss_pred ----CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHH---------CCCCCCCCCCC
T ss_conf ----776566999999999997669966891999996---------29231889899
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=386.80 Aligned_cols=269 Identities=21% Similarity=0.377 Sum_probs=211.3
Q ss_pred HHHCCCCCCCCCCCCCCEEEEEEECC-CCCEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEE
Q ss_conf 98238432372023797339998907-99599999925777-13169999999999843998711002267616256999
Q 001768 656 AATNNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS-KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLV 733 (1016)
Q Consensus 656 ~a~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV 733 (1016)
...++|++.+.||+|+||+||+|+.. +++.||+|+++... ......+.+|+.+++.++|||||++++++.++++.++|
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV 82 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 82 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCCCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEE
T ss_conf 87568889789712778099999998999699999987540978999999999999867999999499999989999999
Q ss_pred EEECCCCCHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCEEEECCCCCEEEECCCCCCCCC
Q ss_conf 96369994888830276867678978899999999999999772289876839998760998149964661034643368
Q 001768 734 YEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDE 813 (1016)
Q Consensus 734 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 813 (1016)
|||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ +|+||||||+|||++.++.+||+|||+|+...
T Consensus 83 mEy~~gg~L~~~l~~~~----~l~~~~~~~~~~qil~aL~yLH~~~--~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 156 (322)
T d1s9ja_ 83 MEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 156 (322)
T ss_dssp EECCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred EECCCCCCHHHHHHHCC----CCCHHHHHHHHHHHHHHHHHHHHHC--CEECCCCCHHHEEECCCCCEEEEECCCCCCCC
T ss_conf 97679986899874249----9999999999999999999999859--99714457799468789989995487762567
Q ss_pred CCCCCEEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHH---------
Q ss_conf 88850111014686544812111388997220457999999999299999999913357588999999870---------
Q 001768 814 DENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQ--------- 884 (1016)
Q Consensus 814 ~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~k~DV~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~--------- 884 (1016)
+. .....+||+.|||||++.+..++.++||||+||++|||++|+.||.....................
T Consensus 157 ~~---~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (322)
T d1s9ja_ 157 DS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233 (322)
T ss_dssp HH---TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------
T ss_pred CC---CCCCCCCCCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCC
T ss_conf 88---621113771411946875899894888998999999999888998998878999999887517754577421233
Q ss_pred C--------------C-------CCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCCCCCCCCCCC
Q ss_conf 8--------------8-------320147868999899999999999987209999999998899998315857767312
Q 001768 885 G--------------N-------LLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTAVQAPII 943 (1016)
Q Consensus 885 ~--------------~-------~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~~~~p~~ 943 (1016)
. . ......+.+.. ......+.+++.+|+..||++|||+.|++ +|||+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~s~~~~dli~~~L~~dP~~R~ta~e~L---------~Hpf~ 301 (322)
T d1s9ja_ 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPS---GVFSLEFQDFVNKCLIKNPAERADLKQLM---------VHAFI 301 (322)
T ss_dssp ------------CCCCHHHHHHHHHTSCCCCCCB---TTBCHHHHHHHHHHTCSSTTTSCCHHHHH---------TSHHH
T ss_pred CCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCC---CCCCHHHHHHHHHHCCCCHHHCCCHHHHH---------HCHHH
T ss_conf 3221111222354134778876650268766764---44899999999998689946790899996---------09864
Q ss_pred CC
Q ss_conf 48
Q 001768 944 RR 945 (1016)
Q Consensus 944 ~~ 945 (1016)
.+
T Consensus 302 ~~ 303 (322)
T d1s9ja_ 302 KR 303 (322)
T ss_dssp HH
T ss_pred CC
T ss_conf 76
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=0 Score=378.69 Aligned_cols=258 Identities=22% Similarity=0.322 Sum_probs=213.0
Q ss_pred HCCCCCCCCCCCCCCEEEEEEECC-CCCEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEE
Q ss_conf 238432372023797339998907-9959999992577713169999999999843998711002267616256999963
Q 001768 658 TNNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEY 736 (1016)
Q Consensus 658 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~ 736 (1016)
.++|++.+.||+|+||.||+|... +++.||+|++..........+.+|+.++++++|||||++++++.+++.+++||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEEC
T ss_conf 40359989993177829999999899979999998872646799999999999867997989199999989999999982
Q ss_pred CCCCCHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCEEEEC--CCCCEEEECCCCCCCCCC
Q ss_conf 699948888302768676789788999999999999997722898768399987609981--499646610346433688
Q 001768 737 LENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLD--KDLNAKISDFGLAKLDED 814 (1016)
Q Consensus 737 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NILl~--~~~~~kl~DFGla~~~~~ 814 (1016)
|++|+|.+++.... ..+++..+..|+.||+.||+|||+. +|+||||||+|||++ .++.+||+|||+|+....
T Consensus 108 ~~gg~L~~~~~~~~---~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~ 181 (352)
T d1koba_ 108 LSGGELFDRIAAED---YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 181 (352)
T ss_dssp CCCCBHHHHTTCTT---CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred CCCCHHHHHHHHCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCCCCCCCCCCCEEEEEECCCCEECCC
T ss_conf 89980888898638---9989999999999999999999977---92651314455311346788489952563034378
Q ss_pred CCCCEEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 88501110146865448121113889972204579999999992999999999133575889999998708832014786
Q 001768 815 ENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPS 894 (1016)
Q Consensus 815 ~~~~~~~~~~Gt~~y~aPE~~~~~~~~~k~DV~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 894 (1016)
.. ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+.... .......
T Consensus 182 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~-----i~~~~~~-------- 246 (352)
T d1koba_ 182 DE--IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQN-----VKRCDWE-------- 246 (352)
T ss_dssp TS--CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH-----HHHCCCC--------
T ss_pred CC--CEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHH-----HHHCCCC--------
T ss_conf 87--20100476453489997479989763338989999999968899899799999999-----9847889--------
Q ss_pred CCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 899989999999999998720999999999889999831585776731248
Q 001768 895 LGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTAVQAPIIRR 945 (1016)
Q Consensus 895 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~~~~p~~~~ 945 (1016)
.........+..+.+++.+|++.||++|||+.|++ +|||+..
T Consensus 247 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil---------~Hp~~~~ 288 (352)
T d1koba_ 247 FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDAL---------EHPWLKG 288 (352)
T ss_dssp CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHH---------TSTTTSS
T ss_pred CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHH---------CCHHHCC
T ss_conf 89300247999999999997569966891899996---------0973488
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=384.03 Aligned_cols=251 Identities=24% Similarity=0.417 Sum_probs=210.3
Q ss_pred CCCCCCCCCCCCCCEEEEEEECC-CCCEEEEEECCCCC---HHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
Q ss_conf 38432372023797339998907-99599999925777---131699999999998439987110022676162569999
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS---KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVY 734 (1016)
Q Consensus 659 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 734 (1016)
++|++.+.||+|+||.||+|+.+ +++.||+|++.... ....+.+.+|+.+++.++|||||++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
T ss_conf 37699889851778589999998999499999981688567689999999999998568888885999999899989998
Q ss_pred EECCCCCHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCEEEECCCCCEEEECCCCCCCCCC
Q ss_conf 63699948888302768676789788999999999999997722898768399987609981499646610346433688
Q 001768 735 EYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDED 814 (1016)
Q Consensus 735 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 814 (1016)
||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 86 Ey~~~g~L~~~l~~~~----~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 86 EYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp ECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred EECCCCCHHHHHHHCC----CCCHHHHHHHHHHHHHHHHHHHHC---CEEEEEECCCCCEECCCCCEEECCCCEEEECCC
T ss_conf 5047985898875048----999999999999999999999988---946522023441466899871155563354488
Q ss_pred CCCCEEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 88501110146865448121113889972204579999999992999999999133575889999998708832014786
Q 001768 815 ENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPS 894 (1016)
Q Consensus 815 ~~~~~~~~~~Gt~~y~aPE~~~~~~~~~k~DV~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 894 (1016)
.. .....||+.|||||++.+..++.++||||+||++|||++|+.||......+.... .. .. .+.
T Consensus 159 ~~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~-----i~--~~------~~~ 222 (263)
T d2j4za1 159 SR---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR-----IS--RV------EFT 222 (263)
T ss_dssp CC---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH-----HH--TT------CCC
T ss_pred CC---CCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH-----HH--CC------CCC
T ss_conf 85---2355788763499997589989314404675999998329999888999999999-----97--18------999
Q ss_pred CCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 899989999999999998720999999999889999831585776731248
Q 001768 895 LGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTAVQAPIIRR 945 (1016)
Q Consensus 895 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~~~~p~~~~ 945 (1016)
.+ ...+..+.+++.+|++.||++|||+.|++ +|||+..
T Consensus 223 ~p----~~~s~~~~~li~~~L~~dp~~R~t~~eil---------~hp~~~~ 260 (263)
T d2j4za1 223 FP----DFVTEGARDLISRLLKHNPSQRPMLREVL---------EHPWITA 260 (263)
T ss_dssp CC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHH---------TCHHHHH
T ss_pred CC----CCCCHHHHHHHHHHCCCCHHHCCCHHHHH---------CCCCCCC
T ss_conf 98----66899999999997647976890999997---------1907078
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=382.79 Aligned_cols=259 Identities=29% Similarity=0.495 Sum_probs=207.9
Q ss_pred HHCCCCCCCCCCCCCCEEEEEEECCCCCEEEEEECCCC--CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
Q ss_conf 82384323720237973399989079959999992577--7131699999999998439987110022676162569999
Q 001768 657 ATNNFDAANKIGEGGFGPVYKGTLSDGAVIAVKQLSSK--SKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVY 734 (1016)
Q Consensus 657 a~~~f~~~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 734 (1016)
..++|++.+.||+|+||.||+|+++. .||||+++.. .....+.|.+|+.++++++|||||+++|++.+ +..++||
T Consensus 6 ~~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~ 82 (276)
T d1uwha_ 6 PDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVT 82 (276)
T ss_dssp CTTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred CCCCEEEEEEEEECCCCEEEEEEECC--EEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CEEEEEE
T ss_conf 54518998898307885899999999--89999997346998999999999999984799878645679715-5899999
Q ss_pred EECCCCCHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCEEEECCCCCEEEECCCCCCCCCC
Q ss_conf 63699948888302768676789788999999999999997722898768399987609981499646610346433688
Q 001768 735 EYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDED 814 (1016)
Q Consensus 735 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 814 (1016)
||+++|+|.+++..... .+++..+..++.|+|+||+|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 83 Ey~~~g~L~~~l~~~~~---~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~ 156 (276)
T d1uwha_ 83 QWCEGSSLYHHLHIIET---KFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR 156 (276)
T ss_dssp ECCCEEEHHHHHHTSCC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred ECCCCCCHHHHHHHCCC---CCCHHHHHHHHHHHHHHHHHHHCC---CEECCCCCHHHEEECCCCCEEECCCCCEEECCC
T ss_conf 65899888999852357---899999999999999998887509---995161478997981899788750022133355
Q ss_pred CC-CCEEEECCCCCCCCCHHHHCC---CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCC
Q ss_conf 88-501110146865448121113---88997220457999999999299999999913357588999999870883201
Q 001768 815 EN-THISTRIAGTVGYMAPEYAMR---GYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLEL 890 (1016)
Q Consensus 815 ~~-~~~~~~~~Gt~~y~aPE~~~~---~~~~~k~DV~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 890 (1016)
.. ........||+.|||||++.+ ..++.++|||||||++|||+||+.||............ ...+..
T Consensus 157 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~------~~~~~~--- 227 (276)
T d1uwha_ 157 WSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFM------VGRGYL--- 227 (276)
T ss_dssp ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHH------HHHTSC---
T ss_pred CCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH------HHCCCC---
T ss_conf 67763125665574317999995056899995315163599999999788998998969999999------965888---
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCCC
Q ss_conf 478689998999999999999872099999999988999983158
Q 001768 891 VDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGK 935 (1016)
Q Consensus 891 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 935 (1016)
.|.. ...+...+..+.+++.+||+.+|++||||.++++.|+..
T Consensus 228 -~p~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l 270 (276)
T d1uwha_ 228 -SPDL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELL 270 (276)
T ss_dssp -CCCG-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCCC-HHCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf -9860-003655549999999997588976892999999999999
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=385.92 Aligned_cols=256 Identities=25% Similarity=0.408 Sum_probs=208.9
Q ss_pred HCCCCCCCCCCCCCCEEEEEEECC-CCCEEEEEECCCC--CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE--CCEEEE
Q ss_conf 238432372023797339998907-9959999992577--71316999999999984399871100226761--625699
Q 001768 658 TNNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSK--SKQGNREFVNEIGMISALQHQNLVKLYGCCIE--GNQLLL 732 (1016)
Q Consensus 658 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~--~~~~~l 732 (1016)
.++|++.+.||+|+||+||+|+.. +++.||+|++... .....+.+.+|+.++++++|||||++++++.+ ++.+++
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred CHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEE
T ss_conf 33379967983088919999999999979999998746579799999999999999778999824899999178998999
Q ss_pred EEEECCCCCHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCEEECCCCCCEEEECCCCCEEEECCCCCC
Q ss_conf 99636999488883027686767897889999999999999977228--9876839998760998149964661034643
Q 001768 733 VYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEES--RLKIVHRDIKATNVLLDKDLNAKISDFGLAK 810 (1016)
Q Consensus 733 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~--~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 810 (1016)
|||||++|+|.+++.........+++..++.++.|++.||+|||+.+ ..+|+||||||+|||++.++.+||+|||+|+
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCHHHCCCCCCCCEEEEECCCEE
T ss_conf 99568999389999851545789999999999999999999999716778878858676542574788857980010003
Q ss_pred CCCCCCCCEEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCC
Q ss_conf 36888850111014686544812111388997220457999999999299999999913357588999999870883201
Q 001768 811 LDEDENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLEL 890 (1016)
Q Consensus 811 ~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~k~DV~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 890 (1016)
...... .......||+.|||||++.+..++.++|||||||++|||++|+.||......+....+ .....
T Consensus 163 ~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i-------~~~~~--- 231 (269)
T d2java1 163 ILNHDT-SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI-------REGKF--- 231 (269)
T ss_dssp HC------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH-------HHTCC---
T ss_pred ECCCCC-CCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHHHHHH-------HCCCC---
T ss_conf 224577-7556677882327999983999993898875278999980188998998999999999-------71899---
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 4786899989999999999998720999999999889999
Q 001768 891 VDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 891 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 930 (1016)
+.++..+ +..+.+++.+||+.||++|||++|+++
T Consensus 232 --~~~~~~~----s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 232 --RRIPYRY----SDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp --CCCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --CCCCCCC----CHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf --8897435----999999999976799557918999972
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=381.82 Aligned_cols=261 Identities=29% Similarity=0.467 Sum_probs=212.8
Q ss_pred HCCCCCCCCCCCCCCEEEEEEECCCCCEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEEC
Q ss_conf 23843237202379733999890799599999925777131699999999998439987110022676162569999636
Q 001768 658 TNNFDAANKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYL 737 (1016)
Q Consensus 658 ~~~f~~~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~~ 737 (1016)
.++|++.+.||+|+||.||+|.+++++.||||++... ....+.|.+|+.++++++|||||+++|++.+ +..++||||+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~ 93 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 93 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred HHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEECCC-CCCHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CCEEEEEEEC
T ss_conf 7997984699307980999999999999999998804-4888999999999986666788689999823-9759999944
Q ss_pred CCCCHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCEEEECCCCCEEEECCCCCCCCCCCCC
Q ss_conf 99948888302768676789788999999999999997722898768399987609981499646610346433688885
Q 001768 738 ENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENT 817 (1016)
Q Consensus 738 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 817 (1016)
++|+|..++..... ..++|..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.......
T Consensus 94 ~~g~l~~~~~~~~~--~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~ 168 (285)
T d1fmka3 94 SKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 168 (285)
T ss_dssp TTCBHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred CCCCHHHHHHHCCC--CCCHHHHHHHHHHHHHHHHHHHHHH---HEECCCCCCEEEEECCCCCEEECCCCHHHHCCCCCC
T ss_conf 79943542000035--5305999999999999999987541---143353123079998999299844255542568873
Q ss_pred CEEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCC-CCCHHHHHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 011101468654481211138899722045799999999929999999-9913357588999999870883201478689
Q 001768 818 HISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNY-RPKEEFVYLLDWAYVLQEQGNLLELVDPSLG 896 (1016)
Q Consensus 818 ~~~~~~~Gt~~y~aPE~~~~~~~~~k~DV~SlGvil~elltG~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 896 (1016)
.......||+.|+|||++..+.++.++|||||||++|||++|+.|+.. ....+....+ ..+ ..+..
T Consensus 169 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i-------~~~-----~~~~~- 235 (285)
T d1fmka3 169 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV-------ERG-----YRMPC- 235 (285)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH-------HTT-----CCCCC-
T ss_pred EEECCCCCCCCCCCHHHHHCCCCCCHHHHHCCHHHHHHHHHCCCCCCCCCCHHHHHHHH-------HHC-----CCCCC-
T ss_conf 35245455665458089837998917741323589999986899999888899999999-------826-----89999-
Q ss_pred CCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCCCCCCCCC
Q ss_conf 998999999999999872099999999988999983158577673
Q 001768 897 SNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTAVQAP 941 (1016)
Q Consensus 897 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~~~~p 941 (1016)
+...+..+.+++.+||+.||++||+|++|+++|+.......|
T Consensus 236 ---~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p 277 (285)
T d1fmka3 236 ---PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 277 (285)
T ss_dssp ---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred ---CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCCCCC
T ss_conf ---832379999999997566975891999999987666238999
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=379.26 Aligned_cols=253 Identities=26% Similarity=0.423 Sum_probs=214.6
Q ss_pred CCCCCCCCCCCCCCEEEEEEECCCCCEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEECC
Q ss_conf 38432372023797339998907995999999257771316999999999984399871100226761625699996369
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYLE 738 (1016)
Q Consensus 659 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~~~ 738 (1016)
++|+..++||+|+||+||+|++++++.||||+++.... ..+.|.+|+.++++++||||++++|++.+++..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCEEEEEEECCCCC-CHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEECCC
T ss_conf 99799689820788399999988998999999874757-78999999999996689860158899850781699997048
Q ss_pred CCCHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCEEEECCCCCEEEECCCCCCCCCCCCCC
Q ss_conf 99488883027686767897889999999999999977228987683999876099814996466103464336888850
Q 001768 739 NNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTH 818 (1016)
Q Consensus 739 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 818 (1016)
+|+|.+++..... .+++..+++++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+|+........
T Consensus 83 ~g~l~~~~~~~~~---~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 156 (258)
T d1k2pa_ 83 NGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 156 (258)
T ss_dssp TEEHHHHHHSGGG---CCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred CCCHHHHHHCCCC---CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCEEEEECCCCCEEECCCHHHEECCCCCCE
T ss_conf 9938886410246---776899999999999999987546---8434665413588769984798861442023578722
Q ss_pred EEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHH-CCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 1110146865448121113889972204579999999992-999999999133575889999998708832014786899
Q 001768 819 ISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGS 897 (1016)
Q Consensus 819 ~~~~~~Gt~~y~aPE~~~~~~~~~k~DV~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 897 (1016)
......||+.|+|||++.+..++.++|||||||++|||+| |+.||......+....+ ..+. . +
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i-------~~~~--~---~---- 220 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI-------AQGL--R---L---- 220 (258)
T ss_dssp CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHH-------HTTC--C---C----
T ss_pred EECCCCCCCCCCCCHHHCCCCCCCCEEECCCCHHHHHHHHCCCCCCCCCCHHHHHHHH-------HHCC--C---C----
T ss_conf 5246578877578078637998852103364324673975599998899999999999-------8079--7---8----
Q ss_pred CCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCC
Q ss_conf 9899999999999987209999999998899998315
Q 001768 898 NFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEG 934 (1016)
Q Consensus 898 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~ 934 (1016)
..+...+..+.+++.+||+.+|++|||++++++.|..
T Consensus 221 ~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 221 YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHC
T ss_conf 9965465999999999766897689399999987418
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=379.16 Aligned_cols=254 Identities=26% Similarity=0.393 Sum_probs=207.2
Q ss_pred HCCCCCCC-CCCCCCCEEEEEEECC---CCCEEEEEECCCC-CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEE
Q ss_conf 23843237-2023797339998907---9959999992577-71316999999999984399871100226761625699
Q 001768 658 TNNFDAAN-KIGEGGFGPVYKGTLS---DGAVIAVKQLSSK-SKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLL 732 (1016)
Q Consensus 658 ~~~f~~~~-~LG~G~fG~Vy~~~~~---~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~l 732 (1016)
.++|...+ +||+|+||.||+|.++ ++..||||+++.. .....+.|.+|+.++++++|||||+++|++.. +..++
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred CCCEEECCCEEECCCCEEEEEEEEECCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC-CEEEE
T ss_conf 44718878487306080999999960897689999998820397899999999999986799888068656036-80799
Q ss_pred EEEECCCCCHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCEEEECCCCCEEEECCCCCCCC
Q ss_conf 99636999488883027686767897889999999999999977228987683999876099814996466103464336
Q 001768 733 VYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLD 812 (1016)
Q Consensus 733 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 812 (1016)
||||+++|+|.+++.... ..+++..+..++.|+|.||+|||++ +|+||||||+|||++.++.+||+|||+|+..
T Consensus 86 vmE~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~ 159 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKAL 159 (285)
T ss_dssp EEECCTTEEHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEECCCCCHHHHHHCCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEECCCCCEEECCCHHHHCC
T ss_conf 998078996899752125---6999999999999999987899868---8105767646604546885420331342115
Q ss_pred CCCCCCE--EEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHH-CCCCCCCCCCHHHHHHHHHHHHHHHHCCCCC
Q ss_conf 8888501--110146865448121113889972204579999999992-9999999991335758899999987088320
Q 001768 813 EDENTHI--STRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWAYVLQEQGNLLE 889 (1016)
Q Consensus 813 ~~~~~~~--~~~~~Gt~~y~aPE~~~~~~~~~k~DV~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 889 (1016)
....... .....||+.|+|||++.++.++.++|||||||++|||+| |+.||......+....+ ..+..
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i-------~~~~~-- 230 (285)
T d1u59a_ 160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI-------EQGKR-- 230 (285)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHH-------HTTCC--
T ss_pred CCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCCHHHHHHHH-------HCCCC--
T ss_conf 543432113562113743358688727999954123220178999993899999997999999999-------81899--
Q ss_pred CCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCC
Q ss_conf 147868999899999999999987209999999998899998315
Q 001768 890 LVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEG 934 (1016)
Q Consensus 890 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~ 934 (1016)
+.. +...+..+.+++.+||+.+|++||||.+|++.|+.
T Consensus 231 ---~~~----p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~ 268 (285)
T d1u59a_ 231 ---MEC----PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 268 (285)
T ss_dssp ---CCC----CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred ---CCC----CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHH
T ss_conf ---999----97678999999999757797689099999999999
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=378.55 Aligned_cols=256 Identities=26% Similarity=0.449 Sum_probs=208.2
Q ss_pred HCCCCCCCCCCCCCCEEEEEEECCCC-----CEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEE
Q ss_conf 23843237202379733999890799-----599999925777-131699999999998439987110022676162569
Q 001768 658 TNNFDAANKIGEGGFGPVYKGTLSDG-----AVIAVKQLSSKS-KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLL 731 (1016)
Q Consensus 658 ~~~f~~~~~LG~G~fG~Vy~~~~~~~-----~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~ 731 (1016)
.+.|+..+.||+|+||.||+|.++.. ..||||++.... ......|.+|+.++++++|||||+++|++.+.+..+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHEEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCEE
T ss_conf 89968615981177909999999689987879999999884459689999999999998568987832367783388038
Q ss_pred EEEEECCCCCHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCEEEECCCCCEEEECCCCCCC
Q ss_conf 99963699948888302768676789788999999999999997722898768399987609981499646610346433
Q 001768 732 LVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKL 811 (1016)
Q Consensus 732 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 811 (1016)
+||||+.+|++.+.+.... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+|+.
T Consensus 86 ~v~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 86 IITEYMENGALDKFLREKD---GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp EEEECCTTEEHHHHHHHTT---TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEEECCCCCCHHHHHCCC---CCCCHHHHHHHHHHHHHHHHHCCCC---CCCCCCCCCCEEEECCCCEEEECCCCHHHC
T ss_conf 9997213574022210234---5420899999999999854121212---342576564427888998499845510300
Q ss_pred CCCCCC--CEEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCC-CCCHHHHHHHHHHHHHHHHCCCC
Q ss_conf 688885--011101468654481211138899722045799999999929999999-99133575889999998708832
Q 001768 812 DEDENT--HISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNY-RPKEEFVYLLDWAYVLQEQGNLL 888 (1016)
Q Consensus 812 ~~~~~~--~~~~~~~Gt~~y~aPE~~~~~~~~~k~DV~SlGvil~elltG~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~ 888 (1016)
...... .......||+.|||||++.++.++.++|||||||++|||++|+.|+.. ....+.... .. .
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~------i~-~---- 228 (283)
T d1mqba_ 160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKA------IN-D---- 228 (283)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH------HH-T----
T ss_pred CCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHH------HH-C----
T ss_conf 357876526742677773434888870499997355634489899999679886556899999999------86-3----
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCCC
Q ss_conf 01478689998999999999999872099999999988999983158
Q 001768 889 ELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGK 935 (1016)
Q Consensus 889 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 935 (1016)
......+...+..+.+++.+||+.+|++||||.+|++.|+..
T Consensus 229 -----~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l 270 (283)
T d1mqba_ 229 -----GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270 (283)
T ss_dssp -----TCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred -----CCCCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf -----578998504579999999997767976893999999999998
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=377.44 Aligned_cols=258 Identities=23% Similarity=0.369 Sum_probs=210.4
Q ss_pred HHCCCCCCCCCCCCCCEEEEEEECC-CCCEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
Q ss_conf 8238432372023797339998907-99599999925777-131699999999998439987110022676162569999
Q 001768 657 ATNNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS-KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVY 734 (1016)
Q Consensus 657 a~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 734 (1016)
..+.|++.+.||+|+||+||+|... +++.||+|++.... ......+.+|+.+++.++|||||++++++.+++..++||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEE
T ss_conf 76666998899406583999999999998999999815773128999999999998679989991989999899888988
Q ss_pred EECCCCCHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCEEEEC---CCCCEEEECCCCCCC
Q ss_conf 63699948888302768676789788999999999999997722898768399987609981---499646610346433
Q 001768 735 EYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLD---KDLNAKISDFGLAKL 811 (1016)
Q Consensus 735 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NILl~---~~~~~kl~DFGla~~ 811 (1016)
|||++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||+. +++.+||+|||+|+.
T Consensus 87 E~~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~ 159 (307)
T d1a06a_ 87 QLVSGGELFDRIVEKG----FYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM 159 (307)
T ss_dssp CCCCSCBHHHHHHTCS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC-----
T ss_pred ECCCCCCHHHHHHCCC----CCCHHHHHHHHHHHHHHHHHHHHC---EEEEEEECCCCEEECCCCCCCEEEEECCCEEEE
T ss_conf 5268984888653036----788789999999999998752413---055687046300110468882499831543587
Q ss_pred CCCCCCCEEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCC
Q ss_conf 68888501110146865448121113889972204579999999992999999999133575889999998708832014
Q 001768 812 DEDENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELV 891 (1016)
Q Consensus 812 ~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~k~DV~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 891 (1016)
..... .....+||+.|||||++.+..++.++||||+||++|||++|+.||......+... ........
T Consensus 160 ~~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~-----~i~~~~~~----- 227 (307)
T d1a06a_ 160 EDPGS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFE-----QILKAEYE----- 227 (307)
T ss_dssp ---------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH-----HHHTTCCC-----
T ss_pred CCCCC--EEEEEEECCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH-----HHHCCCCC-----
T ss_conf 25897--0440032842259188737999807873451599999985979999989999999-----98616877-----
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 786899989999999999998720999999999889999831585776731248
Q 001768 892 DPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTAVQAPIIRR 945 (1016)
Q Consensus 892 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~~~~p~~~~ 945 (1016)
.........+..+.+++.+|++.||++|||++|+++ |||+..
T Consensus 228 ---~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~---------hp~~~~ 269 (307)
T d1a06a_ 228 ---FDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ---------HPWIAG 269 (307)
T ss_dssp ---CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH---------STTTTS
T ss_pred ---CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC---------CHHHCC
T ss_conf ---787666678999999999976089757918999862---------984479
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=379.03 Aligned_cols=254 Identities=27% Similarity=0.412 Sum_probs=206.1
Q ss_pred CCCCCCCCCCCCCCEEEEEEECC-CCCEEEEEECCCCC---HHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
Q ss_conf 38432372023797339998907-99599999925777---131699999999998439987110022676162569999
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS---KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVY 734 (1016)
Q Consensus 659 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 734 (1016)
+.|+..+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|+.++++++|||||++++++.+++..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf 85676279701888099999998999399999984444358899999999999999778999823899999899889999
Q ss_pred EECCCCCHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCEEEECCCCCEEEECCCCCCCCCC
Q ss_conf 63699948888302768676789788999999999999997722898768399987609981499646610346433688
Q 001768 735 EYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDED 814 (1016)
Q Consensus 735 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 814 (1016)
|||++|+|..++..+ ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 95 E~~~~g~l~~~~~~~----~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp ECCSEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EECCCCCHHHHHHHC----CCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCCCEEEECCCCCEEEEECCCCCCCCC
T ss_conf 806999457899737----9999999999999999999999868---976667884217987999789844365334677
Q ss_pred CCCCEEEECCCCCCCCCHHHHCC---CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCC
Q ss_conf 88501110146865448121113---889972204579999999992999999999133575889999998708832014
Q 001768 815 ENTHISTRIAGTVGYMAPEYAMR---GYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELV 891 (1016)
Q Consensus 815 ~~~~~~~~~~Gt~~y~aPE~~~~---~~~~~k~DV~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 891 (1016)
. ....||+.|||||++.+ +.++.++|||||||++|||++|+.||......+... ... .......
T Consensus 168 ~-----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~-----~i~--~~~~~~~- 234 (309)
T d1u5ra_ 168 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-----HIA--QNESPAL- 234 (309)
T ss_dssp B-----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-----HHH--HSCCCCC-
T ss_pred C-----CCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH-----HHH--HCCCCCC-
T ss_conf 8-----73134766368899834678886721454558999999987889999979999999-----998--2899988-
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCCCCCCCCCCCCCCCC
Q ss_conf 786899989999999999998720999999999889999831585776731248998
Q 001768 892 DPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTAVQAPIIRRNSD 948 (1016)
Q Consensus 892 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~~~~p~~~~~~~ 948 (1016)
.... .+..+.+++.+||+.||++|||++|++ +|||+.+...
T Consensus 235 ---~~~~----~s~~~~~li~~~L~~dP~~Rpt~~ell---------~Hp~~~~~~~ 275 (309)
T d1u5ra_ 235 ---QSGH----WSEYFRNFVDSCLQKIPQDRPTSEVLL---------KHRFVLRERP 275 (309)
T ss_dssp ---SCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHT---------TCHHHHSCCC
T ss_pred ---CCCC----CCHHHHHHHHHHCCCCHHHCCCHHHHH---------HCHHHCCCCC
T ss_conf ---8788----899999999997737965791899997---------1997537899
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=376.42 Aligned_cols=246 Identities=28% Similarity=0.391 Sum_probs=201.9
Q ss_pred CCCCCCCCEEEEEEECCC---CCEEEEEECCCC--CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEECCC
Q ss_conf 720237973399989079---959999992577--713169999999999843998711002267616256999963699
Q 001768 665 NKIGEGGFGPVYKGTLSD---GAVIAVKQLSSK--SKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEYLEN 739 (1016)
Q Consensus 665 ~~LG~G~fG~Vy~~~~~~---~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~~~~ 739 (1016)
++||+|+||.||+|.+++ ++.||||+++.. .....+.|.+|+.++++++|||||+++|+|.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCCCCCCCEEEEEEEECCCCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEECC-CCEEEEEECCCC
T ss_conf 7834587829999998169738599999988010898999999999999986799898527777505-977999974788
Q ss_pred CCHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCEEEECCCCCEEEECCCCCCCCCCCCCCE
Q ss_conf 94888830276867678978899999999999999772289876839998760998149964661034643368888501
Q 001768 740 NSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENTHI 819 (1016)
Q Consensus 740 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 819 (1016)
|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+|++|||+|+.........
T Consensus 92 g~L~~~l~~~~----~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 92 GPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp EEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CCHHHHHHHCC----CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCHHHCCCCCCCCCCCCHHHHHHCCCCCCCC
T ss_conf 96899975225----789999999999999997668747---95567776113102356751234134533134323443
Q ss_pred --EEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHH-CCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf --110146865448121113889972204579999999992-99999999913357588999999870883201478689
Q 001768 820 --STRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLG 896 (1016)
Q Consensus 820 --~~~~~Gt~~y~aPE~~~~~~~~~k~DV~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 896 (1016)
.....||+.|||||++.+..++.++|||||||++|||+| |+.||......+....+ ..+.. +
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i-------~~~~~-----~--- 229 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML-------EKGER-----M--- 229 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH-------HTTCC-----C---
T ss_pred CCCCCCCCCCEECCCHHHCCCCCCCHHHHCCCHHHHHHHHHCCCCCCCCCCHHHHHHHH-------HCCCC-----C---
T ss_conf 22445677842039166537999843443034031328965899999998999999999-------82899-----9---
Q ss_pred CCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCC
Q ss_conf 99899999999999987209999999998899998315
Q 001768 897 SNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEG 934 (1016)
Q Consensus 897 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~ 934 (1016)
..+...+..+.+++.+||+.||++||||++|++.|+.
T Consensus 230 -~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 230 -GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp -CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred -CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHC
T ss_conf -9986567999999999758897689098999998528
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=379.34 Aligned_cols=260 Identities=21% Similarity=0.298 Sum_probs=213.0
Q ss_pred CCCCCCCCCCCCCCEEEEEEECC-CCCEEEEEECCCCC---HHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
Q ss_conf 38432372023797339998907-99599999925777---131699999999998439987110022676162569999
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS---KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVY 734 (1016)
Q Consensus 659 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 734 (1016)
++|++.+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|+.++++++|||||++++++.+++..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf 87789889850879099999998999799999986577557778999999999998768888617999999899889999
Q ss_pred EECCCCCHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCEEEECCCCCEEEECCCCCCCCCC
Q ss_conf 63699948888302768676789788999999999999997722898768399987609981499646610346433688
Q 001768 735 EYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDED 814 (1016)
Q Consensus 735 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 814 (1016)
||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+|+....
T Consensus 88 Ey~~gg~L~~~~~~~~----~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIG----SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp CCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred ECCCCCCHHHHHHCCC----CCCHHHHHHHHHHHHHHHHHHCCC---CEECCCCCCCCCCCCCCCEEEECCCCCCEECCC
T ss_conf 7048987777653159----999999999999999999762165---088476774123668885388603210242256
Q ss_pred CC-CCEEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 88-50111014686544812111388997220457999999999299999999913357588999999870883201478
Q 001768 815 EN-THISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDP 893 (1016)
Q Consensus 815 ~~-~~~~~~~~Gt~~y~aPE~~~~~~~~~k~DV~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 893 (1016)
.. .......+||+.|||||++.+..++.++||||+||++|||++|+.||......+.... +. ... .
T Consensus 161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~-----i~--~~~------~ 227 (288)
T d1uu3a_ 161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK-----II--KLE------Y 227 (288)
T ss_dssp ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-----HH--TTC------C
T ss_pred CCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCEEHHHHHHHHHHHCCCCCCCCCHHHHHHH-----HH--CCC------C
T ss_conf 7764333555677552584400268989666230456999998038899899599999999-----97--189------9
Q ss_pred CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 6899989999999999998720999999999889999831585776731248
Q 001768 894 SLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTAVQAPIIRR 945 (1016)
Q Consensus 894 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~~~~p~~~~ 945 (1016)
..+.. ....+.+++.+|++.||++|||+.|+.+.- ...+|||+..
T Consensus 228 ~~p~~----~s~~~~~li~~~L~~dP~~R~t~~e~~~~~---~i~~Hpff~~ 272 (288)
T d1uu3a_ 228 DFPEK----FFPKARDLVEKLLVLDATKRLGCEEMEGYG---PLKAHPFFES 272 (288)
T ss_dssp CCCTT----CCHHHHHHHHTTSCSSGGGSTTSGGGTCHH---HHHTSGGGTT
T ss_pred CCCCC----CCHHHHHHHHHHCCCCHHHCCCHHHHCCCH---HHHCCCCCCC
T ss_conf 99854----799999999998557976891978973778---9876976478
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=371.05 Aligned_cols=251 Identities=25% Similarity=0.418 Sum_probs=198.9
Q ss_pred CCCCCCCCCCCEEEEEEECC-CCCEEEEEECCCC--CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE----CCEEEEEE
Q ss_conf 32372023797339998907-9959999992577--71316999999999984399871100226761----62569999
Q 001768 662 DAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSK--SKQGNREFVNEIGMISALQHQNLVKLYGCCIE----GNQLLLVY 734 (1016)
Q Consensus 662 ~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~----~~~~~lV~ 734 (1016)
+..++||+|+||+||+|... +++.||+|++... .....+.+.+|++++++++|||||++++++.. +..+++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EEEEEEECCCCCEEEEEEECCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCEEEEEE
T ss_conf 85169700828499999999999599999985122798999999999999985799985069999840334588899999
Q ss_pred EECCCCCHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCEEEECC-CCCEEEECCCCCCCCC
Q ss_conf 636999488883027686767897889999999999999977228987683999876099814-9964661034643368
Q 001768 735 EYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDK-DLNAKISDFGLAKLDE 813 (1016)
Q Consensus 735 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NILl~~-~~~~kl~DFGla~~~~ 813 (1016)
||+++|+|.+++.... .+++..+..++.||+.||+|||++. ++|+||||||+|||++. ++.+||+|||+|+...
T Consensus 92 E~~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp ECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred ECCCCCCHHHHHHCCC----CCCHHHHHHHHHHHHHHHHHHHHCC-CCEEECCCCHHHCEEECCCCCEEEEECCCCEECC
T ss_conf 5789894899975135----5469999999999999999999789-9799687674351166799988980057654236
Q ss_pred CCCCCEEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 88850111014686544812111388997220457999999999299999999913357588999999870883201478
Q 001768 814 DENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDP 893 (1016)
Q Consensus 814 ~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~k~DV~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 893 (1016)
.. .....+||+.|||||++.+ .++.++||||+||++|||++|+.||.......... ... ..+... +
T Consensus 167 ~~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~-----~~i-~~~~~~----~ 232 (270)
T d1t4ha_ 167 AS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY-----RRV-TSGVKP----A 232 (270)
T ss_dssp TT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHH-----HHH-TTTCCC----G
T ss_pred CC---CCCCCCCCCCCCCHHHHCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHH-----HHH-HCCCCC----C
T ss_conf 87---6677553813008988478-99986711007999999987889998765599999-----999-738998----6
Q ss_pred CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCCCCCCCCCCCC
Q ss_conf 689998999999999999872099999999988999983158577673124
Q 001768 894 SLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTAVQAPIIR 944 (1016)
Q Consensus 894 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~~~~p~~~ 944 (1016)
.. +......+.+++.+||+.||++|||+.|++ +|||++
T Consensus 233 ~~----~~~~~~~~~~li~~~l~~dp~~R~s~~ell---------~Hp~fk 270 (270)
T d1t4ha_ 233 SF----DKVAIPEVKEIIEGCIRQNKDERYSIKDLL---------NHAFFQ 270 (270)
T ss_dssp GG----GGCCCHHHHHHHHHHSCSSGGGSCCHHHHH---------TSGGGC
T ss_pred CC----CCCCCHHHHHHHHHHCCCCHHHCCCHHHHH---------CCCCCC
T ss_conf 56----755789999999997637975892999996---------775409
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=370.55 Aligned_cols=254 Identities=24% Similarity=0.305 Sum_probs=210.4
Q ss_pred HCCCCCCCCCCCCCCEEEEEEECC-CCCEEEEEECCCCC---HHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEE
Q ss_conf 238432372023797339998907-99599999925777---13169999999999843998711002267616256999
Q 001768 658 TNNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS---KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLV 733 (1016)
Q Consensus 658 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV 733 (1016)
-++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++++++|||||++++++.+++.+++|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCC
T ss_conf 47428988983176849999999899989999998156544979999999999999867999887787640356421110
Q ss_pred EEECCCCCHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCEEEECCCCCEEEECCCCCCCCC
Q ss_conf 96369994888830276867678978899999999999999772289876839998760998149964661034643368
Q 001768 734 YEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDE 813 (1016)
Q Consensus 734 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 813 (1016)
||||++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+|+...
T Consensus 84 ~ey~~gg~L~~~~~~~~----~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~ 156 (337)
T d1o6la_ 84 MEYANGGELFFHLSRER----VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EECCCCCCHHHHHHCCC----CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEECCCCCEEEEECCCCCCCC
T ss_conf 00357986055553256----775999999999996521134315---96224647778476589988882056520035
Q ss_pred CCCCCEEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 88850111014686544812111388997220457999999999299999999913357588999999870883201478
Q 001768 814 DENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDP 893 (1016)
Q Consensus 814 ~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~k~DV~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 893 (1016)
.... .....+||+.|+|||++.+..++.++||||+||++|||++|+.||......+..... .... .
T Consensus 157 ~~~~-~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i-------~~~~------~ 222 (337)
T d1o6la_ 157 SDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI-------LMEE------I 222 (337)
T ss_dssp CTTC-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-------HHCC------C
T ss_pred CCCC-CCCCCEECHHHHHHHHCCCCCCCHHHCCCCHHHHHHHHHHCCCCCCCCCHHHHHHHH-------HCCC------C
T ss_conf 6786-205510088996666504898883331022306788998789999996999999998-------5289------9
Q ss_pred CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCC-----HHHHHHHHCCCCCCCCCCCCC
Q ss_conf 6899989999999999998720999999999-----889999831585776731248
Q 001768 894 SLGSNFSKKEAMTMLNIALLCTNPSPTLRPT-----MSSAVSMLEGKTAVQAPIIRR 945 (1016)
Q Consensus 894 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~ev~~~L~~~~~~~~p~~~~ 945 (1016)
..+.. ....+.+++.+|++.||++||+ +.+++ +|||+..
T Consensus 223 ~~p~~----~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil---------~Hp~f~~ 266 (337)
T d1o6la_ 223 RFPRT----LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVM---------EHRFFLS 266 (337)
T ss_dssp CCCTT----SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHH---------TSGGGTT
T ss_pred CCCCC----CCHHHHHHHHHHCCCCCHHHCCCCCCCHHHHH---------CCCCCCC
T ss_conf 89866----89999999986663893442256523499997---------2915036
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=376.46 Aligned_cols=266 Identities=28% Similarity=0.464 Sum_probs=217.1
Q ss_pred HHHHHHHHCCCCCCCCCCCCCCEEEEEEECC------CCCEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCCCEEEEEEE
Q ss_conf 8999998238432372023797339998907------99599999925777-1316999999999984399871100226
Q 001768 651 LRQIKAATNNFDAANKIGEGGFGPVYKGTLS------DGAVIAVKQLSSKS-KQGNREFVNEIGMISALQHQNLVKLYGC 723 (1016)
Q Consensus 651 ~~~~~~a~~~f~~~~~LG~G~fG~Vy~~~~~------~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~l~~~ 723 (1016)
+.+++...++|++.+.||+|+||+||+|+++ +++.||||++.... ....+.|.+|+.++++++||||++++++
T Consensus 5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred HHHCCCCHHHCEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCCCCCEEE
T ss_conf 33113898893886798207883999999888765778829999998821085799999999999996689976552466
Q ss_pred EEECCEEEEEEEECCCCCHHHHHCCCCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCE
Q ss_conf 7616256999963699948888302768--------------------67678978899999999999999772289876
Q 001768 724 CIEGNQLLLVYEYLENNSLARALFGKEG--------------------QCLNLDWATRKRICSDIARGLAYLHEESRLKI 783 (1016)
Q Consensus 724 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~i 783 (1016)
+...+..++||||+++|+|.+++..... ....+++..+..|+.|++.||+|||+. +|
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~i 161 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KF 161 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TC
T ss_pred ECCCCCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCC---CE
T ss_conf 605980389998158992999998527554210000111001210346788989999999999999985541357---86
Q ss_pred EECCCCCCEEEECCCCCEEEECCCCCCCCCCCC-CCEEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCC-C
Q ss_conf 839998760998149964661034643368888-50111014686544812111388997220457999999999299-9
Q 001768 784 VHRDIKATNVLLDKDLNAKISDFGLAKLDEDEN-THISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGK-S 861 (1016)
Q Consensus 784 iHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~-~~~~~~~~Gt~~y~aPE~~~~~~~~~k~DV~SlGvil~elltG~-~ 861 (1016)
+||||||+|||++.++.+||+|||+|+...... ....+...||+.|+|||.+.+..++.++|||||||++|||++|. +
T Consensus 162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~ 241 (301)
T d1lufa_ 162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241 (301)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred EEEEECCCCEEECCCCCEEECCCHHHEECCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCHHHHHCCCHHHHHHHHCCCCC
T ss_conf 85488401168989992898331442113677641115777767676798997268898056302523629999806899
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCCC
Q ss_conf 99999913357588999999870883201478689998999999999999872099999999988999983158
Q 001768 862 NTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGK 935 (1016)
Q Consensus 862 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 935 (1016)
||......+....+ ..+.. +..+. ..+..+.+|+.+||+.+|++||||.||+++|+..
T Consensus 242 p~~~~~~~e~~~~v-------~~~~~-----~~~p~----~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 242 PYYGMAHEEVIYYV-------RDGNI-----LACPE----NCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299 (301)
T ss_dssp TTTTSCHHHHHHHH-------HTTCC-----CCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CCCCCCHHHHHHHH-------HCCCC-----CCCCC----CCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf 99998999999999-------73997-----88873----2529999999997488965793999999999984
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=369.64 Aligned_cols=257 Identities=25% Similarity=0.315 Sum_probs=209.9
Q ss_pred HCCCCCCCCCCCCCCEEEEEEECC-CCCEEEEEECCCCC------HHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEE
Q ss_conf 238432372023797339998907-99599999925777------13169999999999843998711002267616256
Q 001768 658 TNNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS------KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQL 730 (1016)
Q Consensus 658 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~------~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~ 730 (1016)
.++|++.+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+.++++++|||||++++++.+++..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEE
T ss_conf 56779827981178959999999999989999998756632134068999999999999867998999388999979989
Q ss_pred EEEEEECCCCCHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCEEEECCCC----CEEEECC
Q ss_conf 999963699948888302768676789788999999999999997722898768399987609981499----6466103
Q 001768 731 LLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDL----NAKISDF 806 (1016)
Q Consensus 731 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~----~~kl~DF 806 (1016)
++|||||++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++ .+|++||
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~----~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~Df 161 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKE----SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDF 161 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEECCCCCCCCCHHCCCC----CCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCEEEEECCCCCCCCEEECCH
T ss_conf 99998677864310010356----421557899999999998766625---42211333012798258986664696433
Q ss_pred CCCCCCCCCCCCEEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHCC
Q ss_conf 46433688885011101468654481211138899722045799999999929999999991335758899999987088
Q 001768 807 GLAKLDEDENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGN 886 (1016)
Q Consensus 807 Gla~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~k~DV~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 886 (1016)
|+|+...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||......+.... .......
T Consensus 162 G~a~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~-----i~~~~~~ 234 (293)
T d1jksa_ 162 GLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN-----VSAVNYE 234 (293)
T ss_dssp TTCEECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-----HHTTCCC
T ss_pred HHHHHCCCCC--CCCCCCCCCCCCCHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHH-----HHHCCCC
T ss_conf 4421057776--31224777743099998189999766522140999999708899889999999999-----9816888
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 32014786899989999999999998720999999999889999831585776731248
Q 001768 887 LLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTAVQAPIIRR 945 (1016)
Q Consensus 887 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~~~~p~~~~ 945 (1016)
..... ....+..+.+++.+||+.||++|||++|++ +|||++.
T Consensus 235 ~~~~~--------~~~~s~~~~~li~~~L~~dP~~R~s~~eil---------~hp~~~~ 276 (293)
T d1jksa_ 235 FEDEY--------FSNTSALAKDFIRRLLVKDPKKRMTIQDSL---------QHPWIKP 276 (293)
T ss_dssp CCHHH--------HTTSCHHHHHHHHTTSCSSGGGSCCHHHHH---------HSTTTCC
T ss_pred CCCHH--------CCCCCHHHHHHHHHHCCCCHHHCCCHHHHH---------CCCCCCC
T ss_conf 87010--------478899999999998638966891999996---------1904188
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=0 Score=366.67 Aligned_cols=254 Identities=24% Similarity=0.312 Sum_probs=201.7
Q ss_pred CCCCCCCCCCCCCCEEEEEEECC-CCCEEEEEECCCCC---HHHHHHHHH---HHHHHHHCCCCCEEEEEEEEEECCEEE
Q ss_conf 38432372023797339998907-99599999925777---131699999---999998439987110022676162569
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS---KQGNREFVN---EIGMISALQHQNLVKLYGCCIEGNQLL 731 (1016)
Q Consensus 659 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~---E~~~l~~l~Hpniv~l~~~~~~~~~~~ 731 (1016)
++|++.+.||+|+||.||+|+.. +|+.||+|++.... ......+.+ ++.+++.++|||||++++++.+++..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEE
T ss_conf 76851018842889099999999999799999984587542667999999999999985089985889999999899889
Q ss_pred EEEEECCCCCHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCEEEECCCCCEEEECCCCCCC
Q ss_conf 99963699948888302768676789788999999999999997722898768399987609981499646610346433
Q 001768 732 LVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKL 811 (1016)
Q Consensus 732 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 811 (1016)
+||||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+|+.
T Consensus 84 ivmE~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp EEECCCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEEEECCCCCHHHHHHHCC----CCCHHHHHHHHHHHHHHHHHHHHC---CCCCEEECCCEEEECCCCCEEEEEECEEEE
T ss_conf 9999148983899987325----532789999999999999999977---962204442216785889679822010233
Q ss_pred CCCCCCCEEEECCCCCCCCCHHHHCC-CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCC
Q ss_conf 68888501110146865448121113-88997220457999999999299999999913357588999999870883201
Q 001768 812 DEDENTHISTRIAGTVGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLEL 890 (1016)
Q Consensus 812 ~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~k~DV~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 890 (1016)
..... .....||+.|+|||++.. ..++.++||||+||++|||++|+.||............. ....
T Consensus 157 ~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~------~~~~---- 223 (364)
T d1omwa3 157 FSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR------MTLT---- 223 (364)
T ss_dssp CSSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHH------HSSS----
T ss_pred CCCCC---CCCCCCCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH------HCCC----
T ss_conf 37886---4331134554216876038999844104677899999985999888899899999998------6046----
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCC-----HHHHHHHHCCCCCCCCCCCCC
Q ss_conf 4786899989999999999998720999999999-----889999831585776731248
Q 001768 891 VDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPT-----MSSAVSMLEGKTAVQAPIIRR 945 (1016)
Q Consensus 891 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~ev~~~L~~~~~~~~p~~~~ 945 (1016)
..+..+.. .+..+.+++.+|++.||++||| +++++ +|||++.
T Consensus 224 ~~~~~~~~----~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil---------~Hp~f~~ 270 (364)
T d1omwa3 224 MAVELPDS----FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVK---------ESPFFRS 270 (364)
T ss_dssp CCCCCCSS----SCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHH---------TSGGGTT
T ss_pred CCCCCCCC----CCHHHHHHHHHHCCCCHHHHCCCCCCCHHHHH---------CCCCCCC
T ss_conf 88878877----89999999999856698880887435799997---------4910237
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=367.25 Aligned_cols=251 Identities=23% Similarity=0.348 Sum_probs=209.2
Q ss_pred CCCCCCCCCCCCCCEEEEEEECC-CCCEEEEEECCCCC---HHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
Q ss_conf 38432372023797339998907-99599999925777---131699999999998439987110022676162569999
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS---KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVY 734 (1016)
Q Consensus 659 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 734 (1016)
++|++.+.||+|+||+||+|+.+ +|+.||+|++.... ....+.+.+|+.+++.++|||||++++++.+++..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCHHHEEEEEEECCEEEEEE
T ss_conf 47088889720768089999998999799999984577548899999999999998636967533035685288005676
Q ss_pred EECCCCCHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCEEEECCCCCEEEECCCCCCCCCC
Q ss_conf 63699948888302768676789788999999999999997722898768399987609981499646610346433688
Q 001768 735 EYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDED 814 (1016)
Q Consensus 735 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 814 (1016)
||+++|+|..++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 84 E~~~gg~l~~~~~~~~----~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQ----RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp CCCCSCBHHHHHHHTS----SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred EECCCCCCCCCCCCCC----CCCCCHHHHHHHHHHHHHHHHCCC---CEECCCCCCHHEEECCCCCEEEECCCCCEEECC
T ss_conf 5037863223432222----111007999999998765541247---677055681050386899889831752167124
Q ss_pred CCCCEEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 88501110146865448121113889972204579999999992999999999133575889999998708832014786
Q 001768 815 ENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPS 894 (1016)
Q Consensus 815 ~~~~~~~~~~Gt~~y~aPE~~~~~~~~~k~DV~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 894 (1016)
. ....+||+.|||||++.+..++.++||||+||++|||++|+.||......+....+ .. .. ..
T Consensus 157 ~----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i-----~~--~~------~~ 219 (316)
T d1fota_ 157 V----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI-----LN--AE------LR 219 (316)
T ss_dssp C----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH-----HH--CC------CC
T ss_pred C----CCCCCCCCCCCCHHHHCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCHHHHHHHH-----HC--CC------CC
T ss_conf 5----64345763435999983899980430465333689997598999996999999999-----70--89------88
Q ss_pred CCCCCCHHHHHHHHHHHHHCCCCCCCCCC-----CHHHHHHHHCCCCCCCCCCCCCC
Q ss_conf 89998999999999999872099999999-----98899998315857767312489
Q 001768 895 LGSNFSKKEAMTMLNIALLCTNPSPTLRP-----TMSSAVSMLEGKTAVQAPIIRRN 946 (1016)
Q Consensus 895 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~ev~~~L~~~~~~~~p~~~~~ 946 (1016)
.+.. ....+.+++.+|+..||.+|| |+++++ +|||++..
T Consensus 220 ~p~~----~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il---------~Hp~f~~i 263 (316)
T d1fota_ 220 FPPF----FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVK---------NHPWFKEV 263 (316)
T ss_dssp CCTT----SCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHH---------TSGGGSSC
T ss_pred CCCC----CCHHHHHHHHHHHHHCHHHCCCCCHHHHHHHH---------CCCCCCCC
T ss_conf 9977----89999999999954499766643102199998---------19351467
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=369.35 Aligned_cols=254 Identities=25% Similarity=0.439 Sum_probs=208.2
Q ss_pred CCCCCCCCCCCCCCEEEEEEECC-CCC----EEEEEECCCC-CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEE
Q ss_conf 38432372023797339998907-995----9999992577-71316999999999984399871100226761625699
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLS-DGA----VIAVKQLSSK-SKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLL 732 (1016)
Q Consensus 659 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~----~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~l 732 (1016)
.+|++.+.||+|+||+||+|.+. +++ .||+|++... .....+.|.+|+.++++++|||||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC-CEEE
T ss_conf 999783198208992999999958998898999999965134979999999999999867998881589999619-8369
Q ss_pred EEEECCCCCHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCEEEECCCCCEEEECCCCCCCC
Q ss_conf 99636999488883027686767897889999999999999977228987683999876099814996466103464336
Q 001768 733 VYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLD 812 (1016)
Q Consensus 733 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 812 (1016)
++||+.+|+|.+.+.... ..+++..+..++.|||.||+|||++ +|+||||||+|||++.++.+||+|||+|+..
T Consensus 88 v~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp EEECCTTCBHHHHHHHTS---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred EEEECCCCCCCCCCCCCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCHHHCCEECCCCCEEEECCCCCEEC
T ss_conf 998426874010111334---5799999999999999999999876---9504762120311679987586025522233
Q ss_pred CCCCCC-EEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHH-CCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCC
Q ss_conf 888850-1110146865448121113889972204579999999992-99999999913357588999999870883201
Q 001768 813 EDENTH-ISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWAYVLQEQGNLLEL 890 (1016)
Q Consensus 813 ~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~k~DV~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 890 (1016)
...... ......||+.|+|||++.++.++.++|||||||++|||+| |+.||......+....+. ....
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~------~~~~---- 231 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE------KGER---- 231 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHH------HTCC----
T ss_pred CCCCCCCCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH------CCCC----
T ss_conf 544453223651058644670887469998356544079999999977999999999899999997------5998----
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCCC
Q ss_conf 478689998999999999999872099999999988999983158
Q 001768 891 VDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGK 935 (1016)
Q Consensus 891 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 935 (1016)
+ ..+...+..+.+++.+||+.+|++|||+.++++.|+..
T Consensus 232 --~----~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 232 --L----PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp --C----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --C----CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf --9----99855689999999984789934691999999999998
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=365.22 Aligned_cols=251 Identities=20% Similarity=0.277 Sum_probs=208.9
Q ss_pred CCCCCCCCCCCCCCEEEEEEECC-CCCEEEEEECCCCC---HHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
Q ss_conf 38432372023797339998907-99599999925777---131699999999998439987110022676162569999
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS---KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVY 734 (1016)
Q Consensus 659 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 734 (1016)
++|++.+.||+|+||.||+|+.+ +|+.||+|++.... ....+.+.+|+.+++.++|||||++++++.+.+..++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCC
T ss_conf 37089889611768089999998999899999982677458899999999999999748772740344443222223222
Q ss_pred EECCCCCHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCEEEECCCCCEEEECCCCCCCCCC
Q ss_conf 63699948888302768676789788999999999999997722898768399987609981499646610346433688
Q 001768 735 EYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDED 814 (1016)
Q Consensus 735 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 814 (1016)
||+.+|+|..++.... .+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+|+....
T Consensus 121 e~~~~g~l~~~l~~~~----~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred CCCCCCCHHHHHHHCC----CCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHCCCCCCCCEEEEECEEEEECCC
T ss_conf 2334662266675158----989999999999999989999859---986176799993607789788610103332256
Q ss_pred CCCCEEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 88501110146865448121113889972204579999999992999999999133575889999998708832014786
Q 001768 815 ENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPS 894 (1016)
Q Consensus 815 ~~~~~~~~~~Gt~~y~aPE~~~~~~~~~k~DV~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 894 (1016)
. .....||+.|||||++.+..++.++||||+||++|||++|+.||...........+ . ... +.
T Consensus 194 ~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i-----~--~~~------~~ 256 (350)
T d1rdqe_ 194 R----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI-----V--SGK------VR 256 (350)
T ss_dssp C----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-----H--HCC------CC
T ss_pred C----CCCCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHHHHHHHH-----H--CCC------CC
T ss_conf 6----64336763567889971799885331145007899997588998995999999998-----6--179------88
Q ss_pred CCCCCCHHHHHHHHHHHHHCCCCCCCCCC-----CHHHHHHHHCCCCCCCCCCCCCC
Q ss_conf 89998999999999999872099999999-----98899998315857767312489
Q 001768 895 LGSNFSKKEAMTMLNIALLCTNPSPTLRP-----TMSSAVSMLEGKTAVQAPIIRRN 946 (1016)
Q Consensus 895 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~ev~~~L~~~~~~~~p~~~~~ 946 (1016)
.+.. ....+.+++.+|+..||.+|+ |+++++ +|||+...
T Consensus 257 ~p~~----~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell---------~Hp~f~~~ 300 (350)
T d1rdqe_ 257 FPSH----FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIK---------NHKWFATT 300 (350)
T ss_dssp CCTT----CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHH---------TSGGGTTC
T ss_pred CCCC----CCHHHHHHHHHHHHHCHHHCCCCCCCCHHHHH---------CCCCCCCC
T ss_conf 9766----89999999999834099860655345499997---------19051589
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=367.54 Aligned_cols=255 Identities=25% Similarity=0.379 Sum_probs=211.2
Q ss_pred HHCCCCCCCCCCCCCCEEEEEEECCC----CCEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEE
Q ss_conf 82384323720237973399989079----9599999925777-131699999999998439987110022676162569
Q 001768 657 ATNNFDAANKIGEGGFGPVYKGTLSD----GAVIAVKQLSSKS-KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLL 731 (1016)
Q Consensus 657 a~~~f~~~~~LG~G~fG~Vy~~~~~~----~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~ 731 (1016)
..++|++.+.||+|+||.||+|.+.. +..||+|.+.... ....+.+.+|+.++++++|||||+++|++. ++..+
T Consensus 5 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 83 (273)
T d1mp8a_ 5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 83 (273)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred CHHHEEEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE-CCEEE
T ss_conf 88996987799307882999999936996449999999365668799999999999998689999856988995-37479
Q ss_pred EEEEECCCCCHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCEEEECCCCCEEEECCCCCCC
Q ss_conf 99963699948888302768676789788999999999999997722898768399987609981499646610346433
Q 001768 732 LVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKL 811 (1016)
Q Consensus 732 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 811 (1016)
+||||+++|+|.+++.... ..+++..+..++.|+++||.|||+. +|+||||||+||+++.++.+||+|||+|+.
T Consensus 84 iv~E~~~~g~l~~~~~~~~---~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~ 157 (273)
T d1mp8a_ 84 IIMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRY 157 (273)
T ss_dssp EEEECCTTEEHHHHHHHTT---TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC------
T ss_pred EEEEECCCCCHHHHHHCCC---CCCCHHHHHHHHHHHHHHHHHHCCC---CEECCCCCHHHEEECCCCCEEECCCHHHEE
T ss_conf 9998406980776542247---8999999999999998775230226---744141026553206789678765034213
Q ss_pred CCCCCCCEEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHH-CCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCC
Q ss_conf 68888501110146865448121113889972204579999999992-99999999913357588999999870883201
Q 001768 812 DEDENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWAYVLQEQGNLLEL 890 (1016)
Q Consensus 812 ~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~k~DV~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 890 (1016)
.............||+.|+|||++.+..++.++|||||||++|||++ |++||......+....+ ..+.
T Consensus 158 ~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i-------~~~~---- 226 (273)
T d1mp8a_ 158 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI-------ENGE---- 226 (273)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH-------HTTC----
T ss_pred CCCCCCEECCCEECCCCCCHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHH-------HCCC----
T ss_conf 36776233054005831032667516998874524442478999982699998889999999999-------8189----
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCC
Q ss_conf 47868999899999999999987209999999998899998315
Q 001768 891 VDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEG 934 (1016)
Q Consensus 891 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~ 934 (1016)
.+.. +...+..+.+++.+||+.||++|||+.||++.|+.
T Consensus 227 -~~~~----~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~ 265 (273)
T d1mp8a_ 227 -RLPM----PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 265 (273)
T ss_dssp -CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -CCCC----CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHH
T ss_conf -9989----87779999999999768797689299999999999
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=369.72 Aligned_cols=267 Identities=25% Similarity=0.354 Sum_probs=209.7
Q ss_pred HHHHHHHHCCCCCCCCCCCCCCEEEEEEECC------CCCEEEEEECCCC-CHHHHHHHHHHHHHHHHC-CCCCEEEEEE
Q ss_conf 8999998238432372023797339998907------9959999992577-713169999999999843-9987110022
Q 001768 651 LRQIKAATNNFDAANKIGEGGFGPVYKGTLS------DGAVIAVKQLSSK-SKQGNREFVNEIGMISAL-QHQNLVKLYG 722 (1016)
Q Consensus 651 ~~~~~~a~~~f~~~~~LG~G~fG~Vy~~~~~------~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~Hpniv~l~~ 722 (1016)
...++...++|++.+.||+|+||.||+|.+. +++.||||++... .....+.+..|...+.++ +|+||+.+++
T Consensus 5 ~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~ 84 (299)
T d1ywna1 5 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 84 (299)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CCCCCCCHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCEEEEEEE
T ss_conf 82526167997984498416783999999867775557839999998600171789999999999886149984997411
Q ss_pred EEEEC-CEEEEEEEECCCCCHHHHHCCCCCC------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCC
Q ss_conf 67616-2569999636999488883027686------------7678978899999999999999772289876839998
Q 001768 723 CCIEG-NQLLLVYEYLENNSLARALFGKEGQ------------CLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIK 789 (1016)
Q Consensus 723 ~~~~~-~~~~lV~E~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlk 789 (1016)
++.++ ...++|||||++|+|.+++...... ...+++..+..++.|+++||+|||++ +|+|||||
T Consensus 85 ~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlK 161 (299)
T d1ywna1 85 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLA 161 (299)
T ss_dssp EECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCC
T ss_pred EECCCCCEEEEEEEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCC
T ss_conf 540479757999984589929999985366666532220233214689999999999999999988737---97178677
Q ss_pred CCEEEECCCCCEEEECCCCCCCCCCCCC-CEEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCC-CCCCCCC
Q ss_conf 7609981499646610346433688885-0111014686544812111388997220457999999999299-9999999
Q 001768 790 ATNVLLDKDLNAKISDFGLAKLDEDENT-HISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGK-SNTNYRP 867 (1016)
Q Consensus 790 p~NILl~~~~~~kl~DFGla~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~~~~~~k~DV~SlGvil~elltG~-~p~~~~~ 867 (1016)
|+|||+++++.+||+|||+|+....... .......||+.|||||++.+..++.++|||||||++|||++|. +||....
T Consensus 162 p~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~ 241 (299)
T d1ywna1 162 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 241 (299)
T ss_dssp GGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred CCCEEECCCCCEEECCCCCHHHCCCCCCCCCCCCEEECCCCCCHHHHHCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCC
T ss_conf 31065779982898457520011356652224751667210203686468899663221367899999868899998999
Q ss_pred CHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCCC
Q ss_conf 13357588999999870883201478689998999999999999872099999999988999983158
Q 001768 868 KEEFVYLLDWAYVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGK 935 (1016)
Q Consensus 868 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 935 (1016)
..+... ... ..+. .+..+. ..+..+.+++.+||+.||++|||+.|++++|+..
T Consensus 242 ~~~~~~-----~~~-~~~~-----~~~~~~----~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i 294 (299)
T d1ywna1 242 IDEEFC-----RRL-KEGT-----RMRAPD----YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294 (299)
T ss_dssp CSHHHH-----HHH-HHTC-----CCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHH-----HHH-HCCC-----CCCCCC----CCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf 899999-----999-6389-----888886----5789999999997677966791999999999799
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=360.45 Aligned_cols=251 Identities=17% Similarity=0.258 Sum_probs=206.5
Q ss_pred HCCCCCCCCCCCCCCEEEEEEECC-CCCEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEE
Q ss_conf 238432372023797339998907-9959999992577713169999999999843998711002267616256999963
Q 001768 658 TNNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEY 736 (1016)
Q Consensus 658 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~ 736 (1016)
.++|++.+.||+|+||+||+|... +++.||+|.+..... ....+.+|+.+++.++|||||++++++.+++.+++||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCC-CHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEEC
T ss_conf 0105887898317783999999989996999999757866-599999999999857997989098999889988999953
Q ss_pred CCCCCHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCEEEECCC--CCEEEECCCCCCCCCC
Q ss_conf 69994888830276867678978899999999999999772289876839998760998149--9646610346433688
Q 001768 737 LENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKD--LNAKISDFGLAKLDED 814 (1016)
Q Consensus 737 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NILl~~~--~~~kl~DFGla~~~~~ 814 (1016)
|++|+|.+++.... ..+++.++..++.||+.||+|||+. +|+||||||+|||++.+ ..+|++|||+++....
T Consensus 83 ~~gg~L~~~i~~~~---~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~ 156 (321)
T d1tkia_ 83 ISGLDIFERINTSA---FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCBHHHHHTSSS---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred CCCCCHHHHHHHCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCEEECCCCCEEEEECCCCHHHCCCC
T ss_conf 89980889987538---9999999999999999999999876---99751355444344378851899764411100346
Q ss_pred CCCCEEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 88501110146865448121113889972204579999999992999999999133575889999998708832014786
Q 001768 815 ENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPS 894 (1016)
Q Consensus 815 ~~~~~~~~~~Gt~~y~aPE~~~~~~~~~k~DV~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 894 (1016)
.. ......||+.|+|||...+..++.++||||+||++|||++|+.||......+.... +......+.+...+
T Consensus 157 ~~--~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~-----i~~~~~~~~~~~~~- 228 (321)
T d1tkia_ 157 GD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIEN-----IMNAEYTFDEEAFK- 228 (321)
T ss_dssp TC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH-----HHHTCCCCCHHHHT-
T ss_pred CC--CCCCCCCCCCCCCCHHCCCCCCCCHHHCCCHHHHHHHHHHCCCCCCCCCHHHHHHH-----HHHCCCCCCHHHCC-
T ss_conf 77--53212233222340210487778401130279999999828999999899999999-----98389998802236-
Q ss_pred CCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 899989999999999998720999999999889999
Q 001768 895 LGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 895 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 930 (1016)
.....+.+++.+|+..||++|||++|+++
T Consensus 229 -------~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 229 -------EISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp -------TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -------CCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf -------78999999999986699668909999963
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=366.10 Aligned_cols=256 Identities=28% Similarity=0.395 Sum_probs=208.5
Q ss_pred CCCCCCCCCCCCCCEEEEEEECCC-CC--EEEEEECCCC-CHHHHHHHHHHHHHHHHC-CCCCEEEEEEEEEECCEEEEE
Q ss_conf 384323720237973399989079-95--9999992577-713169999999999843-998711002267616256999
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLSD-GA--VIAVKQLSSK-SKQGNREFVNEIGMISAL-QHQNLVKLYGCCIEGNQLLLV 733 (1016)
Q Consensus 659 ~~f~~~~~LG~G~fG~Vy~~~~~~-~~--~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~lV 733 (1016)
++|+..++||+|+||.||+|.+++ +. .||||++... .....+.|.+|+.+++++ +|||||+++|++.+++.+++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHCEEEEEEEECCCCEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEE
T ss_conf 99688779820788289999998999699999999782338579999999999998622899883678888418736999
Q ss_pred EEECCCCCHHHHHCCCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCEEEECCCCCE
Q ss_conf 96369994888830276------------867678978899999999999999772289876839998760998149964
Q 001768 734 YEYLENNSLARALFGKE------------GQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNA 801 (1016)
Q Consensus 734 ~E~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~ 801 (1016)
|||+++|+|.++++... .....+++..+..++.|||.||.|||+. +|+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EEECCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEEECCCCCE
T ss_conf 980289869999864035555512310123457899999999999999998766308---95455505204898688763
Q ss_pred EEECCCCCCCCCCCCCCEEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCC-CCCCCCCHHHHHHHHHHHH
Q ss_conf 661034643368888501110146865448121113889972204579999999992999-9999991335758899999
Q 001768 802 KISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKS-NTNYRPKEEFVYLLDWAYV 880 (1016)
Q Consensus 802 kl~DFGla~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~k~DV~SlGvil~elltG~~-p~~~~~~~~~~~~~~~~~~ 880 (1016)
||+|||+|+...... ......||..|+|||.+.++.++.++|||||||++|||++|.. ||......+....+
T Consensus 167 kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i----- 239 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL----- 239 (309)
T ss_dssp EECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG-----
T ss_pred EECCCCCCCCCCCCC--CCCCEECCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHHCCCCCCCCCCHHHHHHHH-----
T ss_conf 874344322444223--4553013775555387526999962215313889999983689999999999999999-----
Q ss_pred HHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCCC
Q ss_conf 9870883201478689998999999999999872099999999988999983158
Q 001768 881 LQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGK 935 (1016)
Q Consensus 881 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 935 (1016)
.+...+.. +...+..+.+++.+||+.||++||||.+|++.|+..
T Consensus 240 -------~~~~~~~~----~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i 283 (309)
T d1fvra_ 240 -------PQGYRLEK----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 283 (309)
T ss_dssp -------GGTCCCCC----CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------HHCCCCCC----CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf -------82688888----766789999999997678966894999999999999
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=364.52 Aligned_cols=262 Identities=29% Similarity=0.447 Sum_probs=211.8
Q ss_pred HHHCCCCCCCCCCCCCCEEEEEEECC------CCCEEEEEECCCCC-HHHHHHHHHHHHHHHHC-CCCCEEEEEEEEEEC
Q ss_conf 98238432372023797339998907------99599999925777-13169999999999843-998711002267616
Q 001768 656 AATNNFDAANKIGEGGFGPVYKGTLS------DGAVIAVKQLSSKS-KQGNREFVNEIGMISAL-QHQNLVKLYGCCIEG 727 (1016)
Q Consensus 656 ~a~~~f~~~~~LG~G~fG~Vy~~~~~------~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~ 727 (1016)
...++|+..++||+|+||.||+|++. .++.||||+++... ......+.+|+.++.++ +|||||+++|++.++
T Consensus 20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~ 99 (311)
T d1t46a_ 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (311)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHEEEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEEC
T ss_conf 77899698549820688299999980664477886999999874248779999999999987626999887899898319
Q ss_pred CEEEEEEEECCCCCHHHHHCCCCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCEE
Q ss_conf 256999963699948888302768--------------676789788999999999999997722898768399987609
Q 001768 728 NQLLLVYEYLENNSLARALFGKEG--------------QCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNV 793 (1016)
Q Consensus 728 ~~~~lV~E~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NI 793 (1016)
+..++|||||++|+|.++++.... ....+++..+..++.||++||+|||++ +|+||||||+||
T Consensus 100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NI 176 (311)
T d1t46a_ 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNI 176 (311)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred CEEEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCCC
T ss_conf 97899997379987999998535665444445332223345889999999999999999988757---926662410210
Q ss_pred EECCCCCEEEECCCCCCCCCCCCC-CEEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHH-CCCCCCCCCCHHH
Q ss_conf 981499646610346433688885-01110146865448121113889972204579999999992-9999999991335
Q 001768 794 LLDKDLNAKISDFGLAKLDEDENT-HISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEF 871 (1016)
Q Consensus 794 Ll~~~~~~kl~DFGla~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~~~~~~k~DV~SlGvil~ellt-G~~p~~~~~~~~~ 871 (1016)
|++.++.+|++|||.++....... .......||+.|+|||++.++.++.++|||||||++|||+| |.+|+......+.
T Consensus 177 l~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~ 256 (311)
T d1t46a_ 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256 (311)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred CCCCCCCCCCCCCCHHEECCCCCCCEEEEECCCCHHHCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHH
T ss_conf 00025752102340102336788615862013596876778861799997400102589999998589988778998999
Q ss_pred HHHHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCCC
Q ss_conf 7588999999870883201478689998999999999999872099999999988999983158
Q 001768 872 VYLLDWAYVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGK 935 (1016)
Q Consensus 872 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 935 (1016)
... .. ..+ ..+..+. ..+..+.+|+.+||+.||++||||++++++|+..
T Consensus 257 ~~~-----~i-~~~-----~~~~~~~----~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 257 FYK-----MI-KEG-----FRMLSPE----HAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (311)
T ss_dssp HHH-----HH-HHT-----CCCCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHH-----HH-HCC-----CCCCCCC----CCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf 999-----98-668-----9889854----3659999999997577965792999999999876
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=362.24 Aligned_cols=255 Identities=25% Similarity=0.380 Sum_probs=207.6
Q ss_pred CCCCCCCCCCCCCCEEEEEEECC-CCCEEEEEECCCCC---HHHHHHHHHHHHHHH-HCCCCCEEEEEEEEEECCEEEEE
Q ss_conf 38432372023797339998907-99599999925777---131699999999998-43998711002267616256999
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS---KQGNREFVNEIGMIS-ALQHQNLVKLYGCCIEGNQLLLV 733 (1016)
Q Consensus 659 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~-~l~Hpniv~l~~~~~~~~~~~lV 733 (1016)
++|++.+.||+|+||+||+|+.. +++.||||++.... ....+.+..|..++. .++|||||++++++.+++..++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEE
T ss_conf 97188658940878289999999999899999980555338489999999999999847999687898897049831677
Q ss_pred EEECCCCCHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCEEEECCCCCEEEECCCCCCCCC
Q ss_conf 96369994888830276867678978899999999999999772289876839998760998149964661034643368
Q 001768 734 YEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDE 813 (1016)
Q Consensus 734 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 813 (1016)
|||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+...
T Consensus 82 mEy~~~g~L~~~i~~~~----~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH----KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENM 154 (320)
T ss_dssp EECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEECCCCCHHHHHHCCC----CCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCCEEECCCCCEECCCCCHHHHCC
T ss_conf 75037980899864047----899999999999999999999868---93403476540444489963015553023235
Q ss_pred CCCCCEEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 88850111014686544812111388997220457999999999299999999913357588999999870883201478
Q 001768 814 DENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDP 893 (1016)
Q Consensus 814 ~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~k~DV~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 893 (1016)
.... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+....+ . .. .+
T Consensus 155 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i-----~--~~------~~ 220 (320)
T d1xjda_ 155 LGDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI-----R--MD------NP 220 (320)
T ss_dssp CTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-----H--HC------CC
T ss_pred CCCC-CCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH-----H--CC------CC
T ss_conf 6653-345457877768999982799883232011227898987388999998999999999-----7--18------99
Q ss_pred CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCCCCCCCCCCCCCC
Q ss_conf 68999899999999999987209999999998899998315857767312489
Q 001768 894 SLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTAVQAPIIRRN 946 (1016)
Q Consensus 894 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~~~~p~~~~~ 946 (1016)
..+. ..+..+.+++.+|+..||++||++. .+..+|||+...
T Consensus 221 ~~p~----~~s~~~~dli~~~L~~dP~~R~s~~--------~~l~~hpff~~~ 261 (320)
T d1xjda_ 221 FYPR----WLEKEAKDLLVKLFVREPEKRLGVR--------GDIRQHPLFREI 261 (320)
T ss_dssp CCCT----TSCHHHHHHHHHHSCSSGGGSBTTB--------SCGGGSGGGTTC
T ss_pred CCCC----CCCHHHHHHHHHHCCCCCCCCCCHH--------HHHHHCCHHCCC
T ss_conf 8975----6799999999996544898783889--------999809013158
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=360.55 Aligned_cols=251 Identities=27% Similarity=0.401 Sum_probs=201.6
Q ss_pred CCCCCCCCCEEEEEEECCCC----CEEEEEECCCC-CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE-CCEEEEEEEEC
Q ss_conf 37202379733999890799----59999992577-71316999999999984399871100226761-62569999636
Q 001768 664 ANKIGEGGFGPVYKGTLSDG----AVIAVKQLSSK-SKQGNREFVNEIGMISALQHQNLVKLYGCCIE-GNQLLLVYEYL 737 (1016)
Q Consensus 664 ~~~LG~G~fG~Vy~~~~~~~----~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~-~~~~~lV~E~~ 737 (1016)
.++||+|+||+||+|.+.+. ..||||+++.. .....+.|.+|++++++++|||||+++|++.+ ++..++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred CEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEEEE
T ss_conf 66981368809999999779987999999998843697899999999999986789998678678980699438999874
Q ss_pred CCCCHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCEEEECCCCCEEEECCCCCCCCCCCCC
Q ss_conf 99948888302768676789788999999999999997722898768399987609981499646610346433688885
Q 001768 738 ENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDENT 817 (1016)
Q Consensus 738 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 817 (1016)
++|+|.+++.... ...++..+.+++.|++.||.|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 112 ~~g~l~~~~~~~~---~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 112 KHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp TTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred ECCCHHHHHCCCC---CCCHHHHHHHHHHHHHHHHHHHCCC---CCCCCCCCHHHEEECCCCCEEEECCCCHHHCCCCCC
T ss_conf 0674144210134---5404899999999988765200336---762577668757677999889910652322556655
Q ss_pred C---EEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 0---1110146865448121113889972204579999999992999999999133575889999998708832014786
Q 001768 818 H---ISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPS 894 (1016)
Q Consensus 818 ~---~~~~~~Gt~~y~aPE~~~~~~~~~k~DV~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 894 (1016)
. ......||+.|+|||++.+..++.++||||||+++|||++|+.||....... +.......... +.
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~-----~~~~~i~~g~~------~~ 254 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-----DITVYLLQGRR------LL 254 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-----------CHHHHHTTCC------CC
T ss_pred CCCEECCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHH-----HHHHHHHCCCC------CC
T ss_conf 53100256555645567688743799974574661999999997899998889999-----99999980898------89
Q ss_pred CCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCCC
Q ss_conf 89998999999999999872099999999988999983158
Q 001768 895 LGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGK 935 (1016)
Q Consensus 895 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 935 (1016)
. +...+..+.+++.+||+.||++||+|.||++.|+..
T Consensus 255 ~----p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i 291 (311)
T d1r0pa_ 255 Q----PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 291 (311)
T ss_dssp C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C----CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf 9----644759999999997688976893999999999999
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=364.82 Aligned_cols=256 Identities=24% Similarity=0.413 Sum_probs=207.6
Q ss_pred HCCCCCCCCCCCCCCEEEEEEECCC--C--CEEEEEECCCC---CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEE
Q ss_conf 2384323720237973399989079--9--59999992577---713169999999999843998711002267616256
Q 001768 658 TNNFDAANKIGEGGFGPVYKGTLSD--G--AVIAVKQLSSK---SKQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQL 730 (1016)
Q Consensus 658 ~~~f~~~~~LG~G~fG~Vy~~~~~~--~--~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~ 730 (1016)
.++|++.+.||+|+||.||+|++.. + ..||||++... .....+.|.+|+.++++++|||||+++|++.+ +..
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred HHHEEEEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE-CCH
T ss_conf 4891997898038883999999988999079999999983555798999999999999986899998789877740-100
Q ss_pred EEEEEECCCCCHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCEEEECCCCCEEEECCCCCC
Q ss_conf 99996369994888830276867678978899999999999999772289876839998760998149964661034643
Q 001768 731 LLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAK 810 (1016)
Q Consensus 731 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 810 (1016)
++||||+++|++.+++..+. ..+++..+..++.|+|+||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~---~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~ 159 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQ---GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMR 159 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHG---GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred HEEEEEECCCCHHHHHHCCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEEEEECHHHHCCCCCCCEEECCCHHHH
T ss_conf 11465423861254442126---8999999999999999999875217---87520566888156556543325611555
Q ss_pred CCCCCCCC--EEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHH-CCCCCCCCCCHHHHHHHHHHHHHHHHCCC
Q ss_conf 36888850--1110146865448121113889972204579999999992-99999999913357588999999870883
Q 001768 811 LDEDENTH--ISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWAYVLQEQGNL 887 (1016)
Q Consensus 811 ~~~~~~~~--~~~~~~Gt~~y~aPE~~~~~~~~~k~DV~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 887 (1016)
........ ......|++.|+|||++.+..++.++|||||||++|||+| |+.||......+....+ ...+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i------~~~~-- 231 (273)
T d1u46a_ 160 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI------DKEG-- 231 (273)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH------HTSC--
T ss_pred HCCCCCCCCEECCCCCCCCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH------HHCC--
T ss_conf 30358875265476325731079999837999942156614899999996899999996999999999------8479--
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCCC
Q ss_conf 201478689998999999999999872099999999988999983158
Q 001768 888 LELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGK 935 (1016)
Q Consensus 888 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 935 (1016)
..+.... ..+..+.+++.+||+.||++||||++|.+.|+..
T Consensus 232 ---~~~~~~~----~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 232 ---ERLPRPE----DCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp ---CCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCCCCCC----CCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHC
T ss_conf ---9999854----4539999999997688966792999999999964
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=360.33 Aligned_cols=252 Identities=19% Similarity=0.234 Sum_probs=198.7
Q ss_pred HCCCCCCC-CCCCCCCEEEEEEEC-CCCCEEEEEECCCCCHHHHHHHHHHHHHHHHC-CCCCEEEEEEEEEE----CCEE
Q ss_conf 23843237-202379733999890-79959999992577713169999999999843-99871100226761----6256
Q 001768 658 TNNFDAAN-KIGEGGFGPVYKGTL-SDGAVIAVKQLSSKSKQGNREFVNEIGMISAL-QHQNLVKLYGCCIE----GNQL 730 (1016)
Q Consensus 658 ~~~f~~~~-~LG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~----~~~~ 730 (1016)
.++|++.. .||+|+||+||+|.. .+++.||+|++... ..+.+|+.++.++ +|||||++++++.+ +..+
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred CCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCC-----HHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCCEE
T ss_conf 148798107965454869999998899989999998974-----779999999998669999782989995034689789
Q ss_pred EEEEEECCCCCHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCEEEECC---CCCEEEECCC
Q ss_conf 9999636999488883027686767897889999999999999977228987683999876099814---9964661034
Q 001768 731 LLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDK---DLNAKISDFG 807 (1016)
Q Consensus 731 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NILl~~---~~~~kl~DFG 807 (1016)
++|||||++|+|.+++..+.. ..+++..+..++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~--~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG 159 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG 159 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSC--CCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEECCCCCCHHHHHHHCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 999977899849999986278--7757999999999999999999976---98644410022011355556631135455
Q ss_pred CCCCCCCCCCCEEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHCCC
Q ss_conf 64336888850111014686544812111388997220457999999999299999999913357588999999870883
Q 001768 808 LAKLDEDENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNL 887 (1016)
Q Consensus 808 la~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~k~DV~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 887 (1016)
+|+....... .....||+.|||||++.+..++.++||||+||++|+|++|+.||............ .. .
T Consensus 160 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~------~~--~- 228 (335)
T d2ozaa1 160 FAKETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM------KT--R- 228 (335)
T ss_dssp TCEECCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----------------C-
T ss_pred EEEECCCCCC--CCCCCCCCCCCCCHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHHHHHH------HH--H-
T ss_conf 1233368886--43226775637927774898888888876451677886588998898877889999------99--9-
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 2014786899989999999999998720999999999889999
Q 001768 888 LELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVS 930 (1016)
Q Consensus 888 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 930 (1016)
........+..........+.+++.+|++.||++|||+.|+++
T Consensus 229 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 229 IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp CCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 8538888898543469999999999975699657909999970
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=363.08 Aligned_cols=262 Identities=29% Similarity=0.430 Sum_probs=212.7
Q ss_pred HHCCCCCCCCCCCCCCEEEEEEECCC--------CCEEEEEECCCCCH-HHHHHHHHHHHHHHHC-CCCCEEEEEEEEEE
Q ss_conf 82384323720237973399989079--------95999999257771-3169999999999843-99871100226761
Q 001768 657 ATNNFDAANKIGEGGFGPVYKGTLSD--------GAVIAVKQLSSKSK-QGNREFVNEIGMISAL-QHQNLVKLYGCCIE 726 (1016)
Q Consensus 657 a~~~f~~~~~LG~G~fG~Vy~~~~~~--------~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~ 726 (1016)
..++|++.+.||+|+||.||+|+... +..||||+++.... .....+.+|+..+.++ +|||||+++++|.+
T Consensus 11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~ 90 (299)
T d1fgka_ 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 90 (299)
T ss_dssp CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHHHEEEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCC
T ss_conf 58996970098516782899999857875556675499999988112868899999999999981399969734652201
Q ss_pred CCEEEEEEEECCCCCHHHHHCCCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCEEE
Q ss_conf 6256999963699948888302768------------6767897889999999999999977228987683999876099
Q 001768 727 GNQLLLVYEYLENNSLARALFGKEG------------QCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVL 794 (1016)
Q Consensus 727 ~~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIL 794 (1016)
++..++||||+++|+|.+++..+.. ....+++.++..++.|++.||+|||+. +|+||||||+|||
T Consensus 91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiL 167 (299)
T d1fgka_ 91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVL 167 (299)
T ss_dssp SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred CCEEEEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEEEECCCCEE
T ss_conf 8868999973699909999986067764322233457434679999999999999999876637---9786302210224
Q ss_pred ECCCCCEEEECCCCCCCCCCCCC-CEEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHH-CCCCCCCCCCHHHH
Q ss_conf 81499646610346433688885-01110146865448121113889972204579999999992-99999999913357
Q 001768 795 LDKDLNAKISDFGLAKLDEDENT-HISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFV 872 (1016)
Q Consensus 795 l~~~~~~kl~DFGla~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~~~~~~k~DV~SlGvil~ellt-G~~p~~~~~~~~~~ 872 (1016)
++.++.+||+|||+++....... .......||+.|+|||.+.++.++.++|||||||++|||++ |+.||.........
T Consensus 168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~ 247 (299)
T d1fgka_ 168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 247 (299)
T ss_dssp ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred ECCCCCEEECCCHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHH
T ss_conf 54789767622111011355555431466788846632667517988825554775888887401798989999999999
Q ss_pred HHHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCCCCC
Q ss_conf 58899999987088320147868999899999999999987209999999998899998315857
Q 001768 873 YLLDWAYVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTA 937 (1016)
Q Consensus 873 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~ 937 (1016)
.. ...+. .+..+.. .+..+.+++.+||+.+|++|||+.||++.|+...+
T Consensus 248 ~~-------i~~~~-----~~~~p~~----~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 248 KL-------LKEGH-----RMDKPSN----CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp HH-------HHTTC-----CCCCCSS----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HH-------HHCCC-----CCCCCCC----CHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 99-------97288-----8898743----52999999999766797679399999999988860
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=0 Score=355.22 Aligned_cols=257 Identities=21% Similarity=0.324 Sum_probs=208.9
Q ss_pred HCCCCCCCCCCCCCCEEEEEEECC-CCCEEEEEECCCCCH---------HHHHHHHHHHHHHHHCC-CCCEEEEEEEEEE
Q ss_conf 238432372023797339998907-995999999257771---------31699999999998439-9871100226761
Q 001768 658 TNNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSK---------QGNREFVNEIGMISALQ-HQNLVKLYGCCIE 726 (1016)
Q Consensus 658 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~---------~~~~~~~~E~~~l~~l~-Hpniv~l~~~~~~ 726 (1016)
.++|++.+.||+|+||+||+|+.. +++.||||++..... ...+.+.+|+.++++++ |||||++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred CCCCEECEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEECCC
T ss_conf 66388852884176849999999999989999999624464114788899999999999999985079974799762146
Q ss_pred CCEEEEEEEECCCCCHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCEEEECCCCCEEEECC
Q ss_conf 62569999636999488883027686767897889999999999999977228987683999876099814996466103
Q 001768 727 GNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDF 806 (1016)
Q Consensus 727 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 806 (1016)
++..++|||||++|+|.+++..+. .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~----~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DF 154 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKV----TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDF 154 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred CCCEEEEEECCCCCHHHHHHHHCC----CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEECCCCCEEECCC
T ss_conf 760599997689866899998659----999999999999999999999875---9943234625489868998387124
Q ss_pred CCCCCCCCCCCCEEEECCCCCCCCCHHHHCC------CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 4643368888501110146865448121113------8899722045799999999929999999991335758899999
Q 001768 807 GLAKLDEDENTHISTRIAGTVGYMAPEYAMR------GYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYV 880 (1016)
Q Consensus 807 Gla~~~~~~~~~~~~~~~Gt~~y~aPE~~~~------~~~~~k~DV~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~ 880 (1016)
|+|+...... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||......+.... .
T Consensus 155 G~a~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~-----i 227 (277)
T d1phka_ 155 GFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM-----I 227 (277)
T ss_dssp TTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-----H
T ss_pred HHEEECCCCC--CEEEEECCCCCCCHHHHHCCCCCCCCCCCCHHEECCCCHHHHHHCCCCCCCCCCCHHHHHHH-----H
T ss_conf 0316726887--21345246788898886053445678899233185656023103228889889999999999-----9
Q ss_pred HHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 98708832014786899989999999999998720999999999889999831585776731248
Q 001768 881 LQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTAVQAPIIRR 945 (1016)
Q Consensus 881 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~~~~p~~~~ 945 (1016)
....... ........+..+.+++.+|++.+|++|||+.|++ +|||+++
T Consensus 228 ~~~~~~~--------~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil---------~h~~~~~ 275 (277)
T d1phka_ 228 MSGNYQF--------GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEAL---------AHPFFQQ 275 (277)
T ss_dssp HHTCCCC--------CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHT---------TSGGGCT
T ss_pred HHCCCCC--------CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHH---------CCHHHHH
T ss_conf 8189888--------9854346899999999997658966891999997---------3978797
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=364.58 Aligned_cols=263 Identities=24% Similarity=0.422 Sum_probs=213.0
Q ss_pred HHHHHCCCCCCCCCCCCCCEEEEEEECC------CCCEEEEEECCCC-CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE
Q ss_conf 9998238432372023797339998907------9959999992577-71316999999999984399871100226761
Q 001768 654 IKAATNNFDAANKIGEGGFGPVYKGTLS------DGAVIAVKQLSSK-SKQGNREFVNEIGMISALQHQNLVKLYGCCIE 726 (1016)
Q Consensus 654 ~~~a~~~f~~~~~LG~G~fG~Vy~~~~~------~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~ 726 (1016)
++...++|+..++||+|+||.||+|.+. +++.||||+++.. .......|.+|+.++++++|||||+++|++..
T Consensus 15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~ 94 (308)
T d1p4oa_ 15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 94 (308)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred EEECHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC
T ss_conf 04268991883598207881899999878644778968999998701286899999999999997699988412547842
Q ss_pred CCEEEEEEEECCCCCHHHHHCCCC------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCEEEECCCCC
Q ss_conf 625699996369994888830276------86767897889999999999999977228987683999876099814996
Q 001768 727 GNQLLLVYEYLENNSLARALFGKE------GQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLN 800 (1016)
Q Consensus 727 ~~~~~lV~E~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~ 800 (1016)
++..++||||+++|+|.+++.... .....+++..+.+++.|+|+||.|||++ +|+||||||+|||+++++.
T Consensus 95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~ 171 (308)
T d1p4oa_ 95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFT 171 (308)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCC
T ss_pred CCCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECEECCCCEEECCCCE
T ss_conf 8810677760489988999875033211344468879999999999999999987647---9654328677540359964
Q ss_pred EEEECCCCCCCCCCCCCC-EEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCC-CCCCCCCCHHHHHHHHHH
Q ss_conf 466103464336888850-111014686544812111388997220457999999999299-999999913357588999
Q 001768 801 AKISDFGLAKLDEDENTH-ISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGK-SNTNYRPKEEFVYLLDWA 878 (1016)
Q Consensus 801 ~kl~DFGla~~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~k~DV~SlGvil~elltG~-~p~~~~~~~~~~~~~~~~ 878 (1016)
+||+|||+|+........ ......||+.|+|||.+.+..++.++||||||+++|||+||+ +|+......+....+
T Consensus 172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i--- 248 (308)
T d1p4oa_ 172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV--- 248 (308)
T ss_dssp EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH---
T ss_pred EEEEECCCCEECCCCCCEEECCCEECCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHH---
T ss_conf 99942454202357763031340231632378888736998833344437899999996899999998999999999---
Q ss_pred HHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCCC
Q ss_conf 999870883201478689998999999999999872099999999988999983158
Q 001768 879 YVLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGK 935 (1016)
Q Consensus 879 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 935 (1016)
..+.. +.. +...+..+.+++.+||+.+|++||||.+|+++|+..
T Consensus 249 ----~~~~~-----~~~----p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 249 ----MEGGL-----LDK----PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp ----HTTCC-----CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred ----HHCCC-----CCC----CCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf ----80888-----888----633539999999997577965893999999997876
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=362.70 Aligned_cols=250 Identities=29% Similarity=0.418 Sum_probs=206.3
Q ss_pred HCCCCCCCCCCCCCCEEEEEEECCCCCEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE-CCEEEEEEEE
Q ss_conf 238432372023797339998907995999999257771316999999999984399871100226761-6256999963
Q 001768 658 TNNFDAANKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIE-GNQLLLVYEY 736 (1016)
Q Consensus 658 ~~~f~~~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~-~~~~~lV~E~ 736 (1016)
-++|+..+.||+|+||.||+|.++ ++.||||+++... ..+.+.+|+.++++++||||++++|++.+ .+.+++||||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred HHHEEEEEEEECCCCEEEEEEEEC-CEEEEEEEECCHH--HHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEEC
T ss_conf 899488579820798089999999-9099999988577--7999999999998678989854987887238928999963
Q ss_pred CCCCCHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCEEEECCCCCEEEECCCCCCCCCCCC
Q ss_conf 69994888830276867678978899999999999999772289876839998760998149964661034643368888
Q 001768 737 LENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDEN 816 (1016)
Q Consensus 737 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 816 (1016)
+++|+|.+++..+. ...++|..+++|+.|++.||.|||+. +|+||||||+|||++.++.+|++|||+++......
T Consensus 83 ~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~ 157 (262)
T d1byga_ 83 MAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 157 (262)
T ss_dssp CTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred CCCCCHHHHHHHCC--CCCCCHHHHHHHHHHHHHHCCCCCCC---CEECCCCCHHHHEECCCCCEEECCCCCCEECCCCC
T ss_conf 69998999987457--88889999999999998523211337---65536665676014689977632456003447877
Q ss_pred CCEEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHH-CCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf 501110146865448121113889972204579999999992-9999999991335758899999987088320147868
Q 001768 817 THISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDPSL 895 (1016)
Q Consensus 817 ~~~~~~~~Gt~~y~aPE~~~~~~~~~k~DV~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 895 (1016)
....+|+.|+|||++.++.++.++|||||||++|||+| |+.|+......+....+ .. ...+..
T Consensus 158 ----~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i-------~~-----~~~~~~ 221 (262)
T d1byga_ 158 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV-------EK-----GYKMDA 221 (262)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHH-------TT-----TCCCCC
T ss_pred ----CCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH-------HC-----CCCCCC
T ss_conf ----65566646778178727988858877757999999997899999999999999999-------80-----899999
Q ss_pred CCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCCC
Q ss_conf 9998999999999999872099999999988999983158
Q 001768 896 GSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGK 935 (1016)
Q Consensus 896 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 935 (1016)
+...+..+.+++.+||+.||++||||.+++++|+..
T Consensus 222 ----~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 222 ----PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp ----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf ----765799999999997566976893999999999999
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=356.17 Aligned_cols=266 Identities=22% Similarity=0.263 Sum_probs=202.0
Q ss_pred CCCCCCCCCCEEEEEEECC-CCCEEEEEECCCCCHH-----HHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEE
Q ss_conf 2372023797339998907-9959999992577713-----169999999999843998711002267616256999963
Q 001768 663 AANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSKQ-----GNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEY 736 (1016)
Q Consensus 663 ~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~-----~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~ 736 (1016)
..+.||+|+||+||+|+.. +++.||||++...... ..+.+.+|+.+++.++|||||++++++..++..++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred CCEEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEHHHH
T ss_conf 56385127282999999999996999999842021245679999999999999867999986898542258740220455
Q ss_pred CCCCCHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCEEEECCCCCEEEECCCCCCCCCCCC
Q ss_conf 69994888830276867678978899999999999999772289876839998760998149964661034643368888
Q 001768 737 LENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDEN 816 (1016)
Q Consensus 737 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 816 (1016)
++++.+....... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+......
T Consensus 82 ~~~~~~~~~~~~~----~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~ 154 (299)
T d1ua2a_ 82 METDLEVIIKDNS----LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 154 (299)
T ss_dssp CSEEHHHHHTTCC----SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred HCCHHHHHHHHCC----CCCCHHHHHHHHHHHHHHHHHHHCC---CEECCCCCCCEEEECCCCCCCCCCCCCCCCCCCCC
T ss_conf 3450776554126----6778999999999999999886316---35503577625885377841146576100057875
Q ss_pred CCEEEECCCCCCCCCHHHHCCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCC---
Q ss_conf 5011101468654481211138-899722045799999999929999999991335758899999987088320147---
Q 001768 817 THISTRIAGTVGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVD--- 892 (1016)
Q Consensus 817 ~~~~~~~~Gt~~y~aPE~~~~~-~~~~k~DV~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d--- 892 (1016)
. .....+||+.|+|||++... .++.++||||+||++|||++|+.||......+....+.................
T Consensus 155 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~ 233 (299)
T d1ua2a_ 155 R-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 233 (299)
T ss_dssp C-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred C-CCCCEECCHHHCCHHHHCCCCCCCHHHHHHHCCHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHCCCHHCCCH
T ss_conf 5-433020473336399972677888056436304289999859699999999999999998518997254521000213
Q ss_pred C---CCCCCCC-----HHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 8---6899989-----999999999998720999999999889999831585776731248
Q 001768 893 P---SLGSNFS-----KKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTAVQAPIIRR 945 (1016)
Q Consensus 893 ~---~l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~~~~p~~~~ 945 (1016)
. ......+ ......+.+++.+|+..||++|||++|++ +|||+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L---------~Hp~f~~ 285 (299)
T d1ua2a_ 234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL---------KMKYFSN 285 (299)
T ss_dssp CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHH---------TSGGGTS
T ss_pred HHHHCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHH---------CCHHHCC
T ss_conf 443034789886785656899999999997638945690899996---------7996578
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=359.00 Aligned_cols=266 Identities=27% Similarity=0.337 Sum_probs=199.8
Q ss_pred CCCCCCCCCCCCCCEEEEEEECCCCCEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECC----EEEEEE
Q ss_conf 3843237202379733999890799599999925777131699999999998439987110022676162----569999
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIEGN----QLLLVY 734 (1016)
Q Consensus 659 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~----~~~lV~ 734 (1016)
+.|...+.||+|+||.||+|++ +|+.||||++...... ......|+..+..++|||||++++++.+++ .+++||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred CEEEEEEEEEECCCEEEEEEEE-CCEEEEEEEECCCCHH-HHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCEEEEEEE
T ss_conf 6899988982078819999999-9989999998720046-7999999999962799868326889983798604899999
Q ss_pred EECCCCCHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-----CCCEEECCCCCCEEEECCCCCEEEECCCCC
Q ss_conf 636999488883027686767897889999999999999977228-----987683999876099814996466103464
Q 001768 735 EYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEES-----RLKIVHRDIKATNVLLDKDLNAKISDFGLA 809 (1016)
Q Consensus 735 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~-----~~~iiHrDlkp~NILl~~~~~~kl~DFGla 809 (1016)
|||++|+|.+++... .++|..+++++.|+|.||+|||+.. .++|+||||||+|||++.++.+||+|||++
T Consensus 81 Ey~~~g~L~~~l~~~-----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 81 DYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp ECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred ECCCCCCHHHHHHCC-----CCCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCCEEECCCCCEEEEECCCC
T ss_conf 646698989998658-----999899999999999999998876652046898661531731357868877688763866
Q ss_pred CCCCCCCCC---EEEECCCCCCCCCHHHHCCCC------CCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHH-------
Q ss_conf 336888850---111014686544812111388------9972204579999999992999999999133575-------
Q 001768 810 KLDEDENTH---ISTRIAGTVGYMAPEYAMRGY------LTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVY------- 873 (1016)
Q Consensus 810 ~~~~~~~~~---~~~~~~Gt~~y~aPE~~~~~~------~~~k~DV~SlGvil~elltG~~p~~~~~~~~~~~------- 873 (1016)
+........ ......||+.|+|||++.... ++.++|||||||++|||+||..|+...+......
T Consensus 156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T d1vjya_ 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred CCCCCCCCCEECCCCCEECCCCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHCCCCC
T ss_conf 23467776200135525035476782210565454677767501220159999999628998876631124101225564
Q ss_pred -HHHHHHHHHHHCCCCCCCCCCCCCCC-CHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCCC
Q ss_conf -88999999870883201478689998-999999999999872099999999988999983158
Q 001768 874 -LLDWAYVLQEQGNLLELVDPSLGSNF-SKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGK 935 (1016)
Q Consensus 874 -~~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 935 (1016)
......... ..+...|.++..+ ..+....+.+++.+||+.||++||||.||++.|+..
T Consensus 236 ~~~~~~~~~~----~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i 295 (303)
T d1vjya_ 236 PSVEEMRKVV----CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp CCHHHHHHHH----TTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred CHHHHHHHHH----HCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf 3099999987----50246888776557768999999999997606985895999999999988
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=0 Score=353.92 Aligned_cols=257 Identities=21% Similarity=0.305 Sum_probs=208.0
Q ss_pred HCCCCCCCCCCCCCCEEEEEEEC-CCCCEEEEEECCCCC---HHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECC----E
Q ss_conf 23843237202379733999890-799599999925777---131699999999998439987110022676162----5
Q 001768 658 TNNFDAANKIGEGGFGPVYKGTL-SDGAVIAVKQLSSKS---KQGNREFVNEIGMISALQHQNLVKLYGCCIEGN----Q 729 (1016)
Q Consensus 658 ~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~----~ 729 (1016)
.++|++.+.||+|+||.||+|+. .+++.||+|++.... ......+.+|+.+++.++|||||++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCCE
T ss_conf 62069868996089929999999999989999998556646989999999999999856999887311435432688766
Q ss_pred EEEEEEECCCCCHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCEEEECCCCCEEEECCCCC
Q ss_conf 69999636999488883027686767897889999999999999977228987683999876099814996466103464
Q 001768 730 LLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLA 809 (1016)
Q Consensus 730 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 809 (1016)
.++||||+++|+|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+|||++.++..+++|||.+
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~----~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~ 158 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA 158 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred EEEEEECCCCCEEHHHHCCCC----CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCCCCCCCCCCEEEHHHHH
T ss_conf 999997788987101120358----999999999999999999999857---9527634675566575432010034443
Q ss_pred CCCCCCC--CCEEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHCCC
Q ss_conf 3368888--50111014686544812111388997220457999999999299999999913357588999999870883
Q 001768 810 KLDEDEN--THISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNL 887 (1016)
Q Consensus 810 ~~~~~~~--~~~~~~~~Gt~~y~aPE~~~~~~~~~k~DV~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 887 (1016)
+...... .......+||+.|+|||++.+..++.++||||+||++|||+||+.||......+.... ........
T Consensus 159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~-----~~~~~~~~ 233 (277)
T d1o6ya_ 159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQ-----HVREDPIP 233 (277)
T ss_dssp EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH-----HHHCCCCC
T ss_pred HHHCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCEECCCCHHHHHHHHHCCCCCCCCCHHHHHHH-----HHHCCCCC
T ss_conf 2212354433334642576243699998399999663202652899999769799899699999999-----98469999
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCC-CHHHHHHHHCC
Q ss_conf 201478689998999999999999872099999999-98899998315
Q 001768 888 LELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRP-TMSSAVSMLEG 934 (1016)
Q Consensus 888 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-t~~ev~~~L~~ 934 (1016)
... ... ..+..+.+++.+|++.||++|| |++++.+.|..
T Consensus 234 ~~~----~~~----~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 234 PSA----RHE----GLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp GGG----TSS----SCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred CCH----HCC----CCCHHHHHHHHHHCCCCHHHCHHHHHHHHHHHHH
T ss_conf 710----034----7899999999998667976777399999999999
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=349.74 Aligned_cols=266 Identities=25% Similarity=0.379 Sum_probs=204.9
Q ss_pred CCCCCCCCCCCCCCEEEEEEEC-CCCCEEEEEECCCCC--HHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEE
Q ss_conf 3843237202379733999890-799599999925777--1316999999999984399871100226761625699996
Q 001768 659 NNFDAANKIGEGGFGPVYKGTL-SDGAVIAVKQLSSKS--KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYE 735 (1016)
Q Consensus 659 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 735 (1016)
++|++.+.||+|+||+||+|+. .+++.||+|++.... ......+.+|+.++++++|||||++++++.+++..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEECCEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEE
T ss_conf 99776517723768099999999999799999980222575899999999999986799838874453322432037886
Q ss_pred ECCCCCHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCEEEECCCCCEEEECCCCCCCCCCC
Q ss_conf 36999488883027686767897889999999999999977228987683999876099814996466103464336888
Q 001768 736 YLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDE 815 (1016)
Q Consensus 736 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 815 (1016)
|+.++ +.+++.... ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||.|+.....
T Consensus 82 ~~~~~-~~~~~~~~~--~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 82 FLHQD-LKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp CCSEE-HHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred ECCCC-HHHHHHHHC--CCCCCHHHHHHHHHHHHHHHHHHHCC---CEECCCCCCHHEEECCCCCCEECCCCCCEECCCC
T ss_conf 23774-455544202--56888899999999999999986528---8992135711401134676210357861343688
Q ss_pred CCCEEEECCCCCCCCCHHHHCCCC-CCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCC-
Q ss_conf 850111014686544812111388-997220457999999999299999999913357588999999870883201478-
Q 001768 816 NTHISTRIAGTVGYMAPEYAMRGY-LTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLLELVDP- 893 (1016)
Q Consensus 816 ~~~~~~~~~Gt~~y~aPE~~~~~~-~~~k~DV~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~- 893 (1016)
.. ......||+.|+|||++.... ++.++||||+||++|+|++|+.||............ ....+...+...+
T Consensus 156 ~~-~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i-----~~~~~~~~~~~~~~ 229 (298)
T d1gz8a_ 156 VR-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI-----FRTLGTPDEVVWPG 229 (298)
T ss_dssp SB-CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH-----HHHHCCCCTTTSTT
T ss_pred CC-CCEEECCCCEEEEHHHHCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCHHHHHHHH-----HHHCCCCCHHHCCC
T ss_conf 64-1001036521541122136657774221033331342796687998988999999999-----98328983331444
Q ss_pred -----CCCCC------CC-----HHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCCCCCCCCCCCCC
Q ss_conf -----68999------89-----999999999998720999999999889999831585776731248
Q 001768 894 -----SLGSN------FS-----KKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTAVQAPIIRR 945 (1016)
Q Consensus 894 -----~l~~~------~~-----~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~~~~p~~~~ 945 (1016)
..... .. ......+.+++.+|++.||++|||++|++ +|||++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell---------~H~ff~~ 288 (298)
T d1gz8a_ 230 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAAL---------AHPFFQD 288 (298)
T ss_dssp GGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHH---------TSGGGTT
T ss_pred CCCCCCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHH---------CCHHHCC
T ss_conf 2224212434543222204441667899999999997639955791899996---------7870146
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=351.41 Aligned_cols=273 Identities=23% Similarity=0.344 Sum_probs=202.5
Q ss_pred HHCCCCCCCCCCCCCCEEEEEEECC-C-CCEEEEEECCCCC--HHHHHHHHHHHHHHHHC---CCCCEEEEEEEEEE---
Q ss_conf 8238432372023797339998907-9-9599999925777--13169999999999843---99871100226761---
Q 001768 657 ATNNFDAANKIGEGGFGPVYKGTLS-D-GAVIAVKQLSSKS--KQGNREFVNEIGMISAL---QHQNLVKLYGCCIE--- 726 (1016)
Q Consensus 657 a~~~f~~~~~LG~G~fG~Vy~~~~~-~-~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l---~Hpniv~l~~~~~~--- 726 (1016)
..++|++.++||+|+||+||+|+.. + ++.||||++.... ......+.+|+.+++.+ +||||+++++++..
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred CCCCEEEEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCC
T ss_conf 75897988899215586999999988899899999980232451679999999999998742589880236632214666
Q ss_pred --CCEEEEEEEECCCCCHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCEEEECCCCCEEEE
Q ss_conf --625699996369994888830276867678978899999999999999772289876839998760998149964661
Q 001768 727 --GNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKIS 804 (1016)
Q Consensus 727 --~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~ 804 (1016)
....+++|||++++.+........ ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~ 158 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVPE---PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLA 158 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCT---TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCCEEEEEEEECCCCCHHHHHHCCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCEEEECCCCCEEEC
T ss_conf 66746999997405871444443037---8999899999999999999999758---89835798627898589975421
Q ss_pred CCCCCCCCCCCCCCEEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHH
Q ss_conf 03464336888850111014686544812111388997220457999999999299999999913357588999999870
Q 001768 805 DFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQ 884 (1016)
Q Consensus 805 DFGla~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~k~DV~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 884 (1016)
|||.++...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||......+....+.........
T Consensus 159 dfg~~~~~~~~~--~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 236 (305)
T d1blxa_ 159 DFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 236 (305)
T ss_dssp SCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCG
T ss_pred CHHHHHHHCCCC--CCCCCCCCHHHCCCCHHCCCCCCHHEHHHCHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCH
T ss_conf 000101100234--577765485114831001798881110003289999998787998998989999999984079961
Q ss_pred CCC------CC-CCC---CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCCCCCCCCCCCCCC
Q ss_conf 883------20-147---868999899999999999987209999999998899998315857767312489
Q 001768 885 GNL------LE-LVD---PSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTAVQAPIIRRN 946 (1016)
Q Consensus 885 ~~~------~~-~~d---~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~~~~p~~~~~ 946 (1016)
... .. ... +.....+.......+.+|+.+|++.||++|||+.|++ +|||++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L---------~Hpff~~i 299 (305)
T d1blxa_ 237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL---------SHPYFQDL 299 (305)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHH---------TSGGGTTC
T ss_pred HCCCCCCCCHHHHHCCCCCCCHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHH---------CCHHHCCC
T ss_conf 1053211110333022345645440445899999999998748966791899996---------69634075
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=0 Score=349.35 Aligned_cols=269 Identities=25% Similarity=0.349 Sum_probs=208.0
Q ss_pred CCCCCCCCCCCCCCEEEEEEECCCCCEEEEEECCCCC--HHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEE
Q ss_conf 3843237202379733999890799599999925777--13169999999999843998711002267616256999963
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLSDGAVIAVKQLSSKS--KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYEY 736 (1016)
Q Consensus 659 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~ 736 (1016)
++|++.++||+|+||+||+|+.++++.||||++.... ....+.+.+|+.++++++|||||++++++..++..++++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCCEECCEEECCCCCEEEEEEECCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCCCCEEEEEEE
T ss_conf 99634318722778189999968999999999812326858999999999999867998687660120467731589974
Q ss_pred CCCCCHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCEEEECCCCCEEEECCCCCCCCCCCC
Q ss_conf 69994888830276867678978899999999999999772289876839998760998149964661034643368888
Q 001768 737 LENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDEN 816 (1016)
Q Consensus 737 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 816 (1016)
+.++.+..+.... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+|++|||.|.......
T Consensus 82 ~~~~~~~~~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~ 154 (286)
T d1ob3a_ 82 LDQDLKKLLDVCE----GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (286)
T ss_dssp CSEEHHHHHHTST----TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred EHHHHHHHHHHHC----CCCCHHHHHHHHHHHHHHHHHHCCC---CEEECCCCCCEEEECCCCCEEECCCCCCEECCCCC
T ss_conf 0045678998604----7751445689999999999986057---48826787750568689978732366430114676
Q ss_pred CCEEEECCCCCCCCCHHHHCC-CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHCC---CCC---
Q ss_conf 501110146865448121113-8899722045799999999929999999991335758899999987088---320---
Q 001768 817 THISTRIAGTVGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGN---LLE--- 889 (1016)
Q Consensus 817 ~~~~~~~~Gt~~y~aPE~~~~-~~~~~k~DV~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~--- 889 (1016)
. ......|++.|+|||.+.+ ..++.++||||+||++|||++|+.||......+................ ..+
T Consensus 155 ~-~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (286)
T d1ob3a_ 155 R-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred C-CCCEECCCCHHHHHHHHHCCCCCCCCEEEHHCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf 5-410102431101378871788888410021117589999779799898898999999998638997110421233322
Q ss_pred ---CC---CCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCCCCCCCCCCCC
Q ss_conf ---14---78689998999999999999872099999999988999983158577673124
Q 001768 890 ---LV---DPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTAVQAPIIR 944 (1016)
Q Consensus 890 ---~~---d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~~~~p~~~ 944 (1016)
.. .+.............+.+++.+|++.||++|||++|++ +|||++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell---------~Hp~f~ 285 (286)
T d1ob3a_ 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL---------EHAYFK 285 (286)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHH---------TSGGGG
T ss_pred CCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHH---------CCCCCC
T ss_conf 1433333567646665125899999999998668966890999985---------692207
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=336.88 Aligned_cols=272 Identities=21% Similarity=0.273 Sum_probs=203.6
Q ss_pred HCCCCCCCCCCCCCCEEEEEEEC-CCCCEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECC----EEE
Q ss_conf 23843237202379733999890-799599999925777-131699999999998439987110022676162----569
Q 001768 658 TNNFDAANKIGEGGFGPVYKGTL-SDGAVIAVKQLSSKS-KQGNREFVNEIGMISALQHQNLVKLYGCCIEGN----QLL 731 (1016)
Q Consensus 658 ~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~----~~~ 731 (1016)
+++|++.+.||+|+||+||+|.. .+++.||||++.... ....+.+.+|+.+++.++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEE
T ss_conf 89859978994064809999999999949999998031095899999999999997689898858889950564554149
Q ss_pred EEEEECCCCCHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCEEEECCCCCEEEECCCCCCC
Q ss_conf 99963699948888302768676789788999999999999997722898768399987609981499646610346433
Q 001768 732 LVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKL 811 (1016)
Q Consensus 732 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 811 (1016)
++++|+.+|+|.+++..+ .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+.
T Consensus 87 ~l~~~~~~g~L~~~l~~~-----~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~ 158 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARV 158 (345)
T ss_dssp EEEEECCCEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEECCCCHHHHHHCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEECCCCCEEECCCCCEEE
T ss_conf 999962598656644058-----999999999999999999999978---986777876437887999778754570565
Q ss_pred CCCCCCC--EEEECCCCCCCCCHHHHC-CCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHH-----HH
Q ss_conf 6888850--111014686544812111-388997220457999999999299999999913357588999999-----87
Q 001768 812 DEDENTH--ISTRIAGTVGYMAPEYAM-RGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVL-----QE 883 (1016)
Q Consensus 812 ~~~~~~~--~~~~~~Gt~~y~aPE~~~-~~~~~~k~DV~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~-----~~ 883 (1016)
....... .....+||+.|+|||++. ...++.++||||+||++|||++|+.||.................. ..
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (345)
T d1pmea_ 159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238 (345)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred CCCCCCCCEEECCCCCCCEECHHHHHHCCCCCCCHHHHHCCCCEEHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHHH
T ss_conf 04777641010110265200038786047888741010046701337766979978888899999876520699756642
Q ss_pred HC------CCCCCCCCCCCCCC---CHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCCCCCCCCCCCCCC
Q ss_conf 08------83201478689998---99999999999987209999999998899998315857767312489
Q 001768 884 QG------NLLELVDPSLGSNF---SKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTAVQAPIIRRN 946 (1016)
Q Consensus 884 ~~------~~~~~~d~~l~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~~~~p~~~~~ 946 (1016)
.. .............+ ......++.+++.+|+..||++|||++|++ +|||+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L---------~hpf~~~~ 301 (345)
T d1pmea_ 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL---------AHPYLEQY 301 (345)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHH---------TSGGGTTT
T ss_pred HHHHHHHHCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHH---------CCHHHCCC
T ss_conf 3433222202446775577877783789999999999997648956790899986---------19865558
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=335.62 Aligned_cols=263 Identities=22% Similarity=0.315 Sum_probs=203.3
Q ss_pred HCCCCCCCCCCCCCCEEEEEEECC-CCCEEEEEECCCC--CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECC------
Q ss_conf 238432372023797339998907-9959999992577--7131699999999998439987110022676162------
Q 001768 658 TNNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSK--SKQGNREFVNEIGMISALQHQNLVKLYGCCIEGN------ 728 (1016)
Q Consensus 658 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~------ 728 (1016)
.++|++.++||+|+||+||+|... +++.||||++... .....+.+.+|+.+++.++|||||++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCCC
T ss_conf 77189988980177819999999999989999998522259699999999999998668987547999863576555541
Q ss_pred EEEEEEEECCCCCHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCEEEECCCCCEEEECCCC
Q ss_conf 56999963699948888302768676789788999999999999997722898768399987609981499646610346
Q 001768 729 QLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGL 808 (1016)
Q Consensus 729 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 808 (1016)
++++||||+ +.+|....... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+|++|||+
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKHE-----KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEEEECC-CCCHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCHHHCCCCCCCCCCCCCC
T ss_conf 599998405-52189998740-----226999999999999999998737---876456685111121001221134310
Q ss_pred CCCCCCCCCCEEEECCCCCCCCCHHHHCC-CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHH--------
Q ss_conf 43368888501110146865448121113-889972204579999999992999999999133575889999--------
Q 001768 809 AKLDEDENTHISTRIAGTVGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAY-------- 879 (1016)
Q Consensus 809 a~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~k~DV~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~-------- 879 (1016)
|+...... +...||+.|+|||++.+ ..++.++||||+||++|||++|+.||................
T Consensus 168 a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (346)
T d1cm8a_ 168 ARQADSEM----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 243 (346)
T ss_dssp CEECCSSC----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred EECCCCCC----CCCCCCCCCCCHHHHCCCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCHHHH
T ss_conf 22068763----10245533358899817878996501030038999999786998889768999999850378848888
Q ss_pred ----------HHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCCCCCCCCCCCCCC
Q ss_conf ----------9987088320147868999899999999999987209999999998899998315857767312489
Q 001768 880 ----------VLQEQGNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTAVQAPIIRRN 946 (1016)
Q Consensus 880 ----------~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~~~~p~~~~~ 946 (1016)
.............+.. .......+.+|+.+|+..||++|||+.|+++ |||+...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~---------Hp~f~~~ 307 (346)
T d1cm8a_ 244 QRLQSDEAKNYMKGLPELEKKDFASI----LTNASPLAVNLLEKMLVLDAEQRVTAGEALA---------HPYFESL 307 (346)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGGGT----CTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH---------SGGGTTT
T ss_pred HHHCCHHHHHHHCCCCCCCCCCHHHH----CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC---------CHHHCCC
T ss_conf 65300034433115786665566775----5689999999999977299557929999963---------9623758
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=340.13 Aligned_cols=266 Identities=24% Similarity=0.332 Sum_probs=203.7
Q ss_pred CCCCCCCCCCCCCCEEEEEEECC-CCCEEEEEECCCC--CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE--------C
Q ss_conf 38432372023797339998907-9959999992577--71316999999999984399871100226761--------6
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSK--SKQGNREFVNEIGMISALQHQNLVKLYGCCIE--------G 727 (1016)
Q Consensus 659 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~--------~ 727 (1016)
++|++.++||+|+||+||+|+.. +++.||||++... .......+.+|+.++++++|||++++++++.. +
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCCCCCC
T ss_conf 79889999722748299999998999799999984222463789999999999998359996606765402465444457
Q ss_pred CEEEEEEEECCCCCHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCEEEECCCCCEEEECCC
Q ss_conf 25699996369994888830276867678978899999999999999772289876839998760998149964661034
Q 001768 728 NQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFG 807 (1016)
Q Consensus 728 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 807 (1016)
+..++||||++++.+....... ..++...+..++.|++.||.|||+. +|+||||||+|||++.++.+|++|||
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~~----~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNVL----VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEECCCCCCCCHHHHCC----CCCCCHHHHHHHHHHHHHHHHHCCC---CEEECCCCCHHEEECCCCCEEEEECC
T ss_conf 6389998535787410122203----4433089999999999999885229---98856767222036689968763135
Q ss_pred CCCCCCCCCCC---EEEECCCCCCCCCHHHHCCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf 64336888850---11101468654481211138-899722045799999999929999999991335758899999987
Q 001768 808 LAKLDEDENTH---ISTRIAGTVGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQE 883 (1016)
Q Consensus 808 la~~~~~~~~~---~~~~~~Gt~~y~aPE~~~~~-~~~~k~DV~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 883 (1016)
+|+........ .....+||+.|+|||++.+. .++.++||||+||++|||++|+.||...............
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~----- 237 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL----- 237 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH-----
T ss_pred EEEECCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCHHHCCCCCCEEEEHHHCCCCCCCCCHHHHHHHHHHH-----
T ss_conf 002235544432113566024978742899707999891787006786466174487998998999999999984-----
Q ss_pred HCCCCCCCCCC-------------CCCCCCHH-------HHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCCCCCCCCCCC
Q ss_conf 08832014786-------------89998999-------99999999987209999999998899998315857767312
Q 001768 884 QGNLLELVDPS-------------LGSNFSKK-------EAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTAVQAPII 943 (1016)
Q Consensus 884 ~~~~~~~~d~~-------------l~~~~~~~-------~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~~~~p~~ 943 (1016)
.+......... ........ ....+.+|+.+|+..||++|||+.|++ +|||+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL---------~Hpff 308 (318)
T d3blha1 238 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL---------NHDFF 308 (318)
T ss_dssp HCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHH---------HSGGG
T ss_pred CCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHH---------CCHHH
T ss_conf 189982553443203444332013344555033404445998999999998738965890999997---------49501
Q ss_pred CC
Q ss_conf 48
Q 001768 944 RR 945 (1016)
Q Consensus 944 ~~ 945 (1016)
..
T Consensus 309 ~~ 310 (318)
T d3blha1 309 WS 310 (318)
T ss_dssp SS
T ss_pred CC
T ss_conf 56
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=347.73 Aligned_cols=248 Identities=22% Similarity=0.366 Sum_probs=199.4
Q ss_pred HCCCCCCCCCCCCCCEEEEEEECC-CCCEEEEEECCCCCH------HHHHHHHHHHHHHHHCC--CCCEEEEEEEEEECC
Q ss_conf 238432372023797339998907-995999999257771------31699999999998439--987110022676162
Q 001768 658 TNNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSK------QGNREFVNEIGMISALQ--HQNLVKLYGCCIEGN 728 (1016)
Q Consensus 658 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~------~~~~~~~~E~~~l~~l~--Hpniv~l~~~~~~~~ 728 (1016)
.++|++.+.||+|+||+||+|+.. +++.||||++..... .....+.+|+.++++++ |||||++++++.+++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECC
T ss_conf 88379967984087839999999999979999998568844334556799999999999974358988127999983099
Q ss_pred EEEEEEEECCC-CCHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCEEEECCC-CCEEEECC
Q ss_conf 56999963699-94888830276867678978899999999999999772289876839998760998149-96466103
Q 001768 729 QLLLVYEYLEN-NSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKD-LNAKISDF 806 (1016)
Q Consensus 729 ~~~lV~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NILl~~~-~~~kl~DF 806 (1016)
..++||||+.+ +++.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.+ +.+||+||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~----~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DF 155 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERG----ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDF 155 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCC
T ss_pred EEEEEEEECCCCCHHHHHHHCCC----CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCEEEECCCCEEEECCC
T ss_conf 68999983368622899986158----999999999999999999999877---97556676111477447884897754
Q ss_pred CCCCCCCCCCCCEEEECCCCCCCCCHHHHCCCCC-CCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHC
Q ss_conf 4643368888501110146865448121113889-972204579999999992999999999133575889999998708
Q 001768 807 GLAKLDEDENTHISTRIAGTVGYMAPEYAMRGYL-TDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQG 885 (1016)
Q Consensus 807 Gla~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~-~~k~DV~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 885 (1016)
|+|+..... ..+...||+.|+|||++.+..+ +.++||||+||++|||++|+.||.... . .. ..
T Consensus 156 G~a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--~---------i~--~~ 219 (273)
T d1xwsa_ 156 GSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--E---------II--RG 219 (273)
T ss_dssp TTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--H---------HH--HC
T ss_pred CCCEECCCC---CCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCEEEEHHHHHCCCCCCCCH--H---------HH--HC
T ss_conf 653532444---55665658774799998489978865332554034536756889988736--7---------76--15
Q ss_pred CCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCCCCCCCCCCCCCCC
Q ss_conf 83201478689998999999999999872099999999988999983158577673124899
Q 001768 886 NLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTAVQAPIIRRNS 947 (1016)
Q Consensus 886 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~~~~p~~~~~~ 947 (1016)
. ...+..+ +..+.+++.+|++.||++|||+.|++ +|||++...
T Consensus 220 ~------~~~~~~~----s~~~~~li~~~L~~dp~~R~s~~eil---------~hp~~~~~~ 262 (273)
T d1xwsa_ 220 Q------VFFRQRV----SSECQHLIRWCLALRPSDRPTFEEIQ---------NHPWMQDVL 262 (273)
T ss_dssp C------CCCSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHH---------TSGGGSSCC
T ss_pred C------CCCCCCC----CHHHHHHHHHHCCCCHHHCCCHHHHH---------CCHHHCCCC
T ss_conf 4------4778779----99999999997608975893999985---------398667887
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=340.96 Aligned_cols=266 Identities=25% Similarity=0.299 Sum_probs=196.6
Q ss_pred CCCCCCCCCCCCCEEEEEEECC-CCCEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEC------CEEEE
Q ss_conf 8432372023797339998907-9959999992577713169999999999843998711002267616------25699
Q 001768 660 NFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKLYGCCIEG------NQLLL 732 (1016)
Q Consensus 660 ~f~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~------~~~~l 732 (1016)
+|+..++||+|+||+||+|+.. +++.||||++...... ..+|+.++++++||||+++++++... .++++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CCEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCCCHH----HHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEEEEE
T ss_conf 767516982176839999999999979999998816068----9999999986689898738789974476577318999
Q ss_pred EEEECCCCCHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCEEEECCCC-CEEEECCCCCCC
Q ss_conf 9963699948888302768676789788999999999999997722898768399987609981499-646610346433
Q 001768 733 VYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDL-NAKISDFGLAKL 811 (1016)
Q Consensus 733 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~-~~kl~DFGla~~ 811 (1016)
|||||+++.+..... .......+++..+..++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||+|+.
T Consensus 97 v~Ey~~~~~~~~l~~-~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 97 VLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEECCSEEHHHHHHH-HHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEECCCCCCHHHHHH-HHHCCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEEECCCCCEEEECCCCHHH
T ss_conf 984168860788886-310368999999999999999999999866---8764578860378735897116733660544
Q ss_pred CCCCCCCEEEECCCCCCCCCHHHHCC-CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHH-------HHHHH
Q ss_conf 68888501110146865448121113-88997220457999999999299999999913357588999-------99987
Q 001768 812 DEDENTHISTRIAGTVGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWA-------YVLQE 883 (1016)
Q Consensus 812 ~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~k~DV~SlGvil~elltG~~p~~~~~~~~~~~~~~~~-------~~~~~ 883 (1016)
...... .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||......+....+... .....
T Consensus 173 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~ 250 (350)
T d1q5ka_ 173 LVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250 (350)
T ss_dssp CCTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred CCCCCC--CCCCCCCCCCCCHHHHHCCCCCCCCEEECCCCEEEEEHHHCCCCCCCCCHHHHHHHHHHHHCCCHHHHHHHH
T ss_conf 047765--320025555568277640468882100024652778550287998987999999999997489817765430
Q ss_pred HCCCCCCCCCCCC-----CCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCCCCCCCCCCCC
Q ss_conf 0883201478689-----998999999999999872099999999988999983158577673124
Q 001768 884 QGNLLELVDPSLG-----SNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTAVQAPIIR 944 (1016)
Q Consensus 884 ~~~~~~~~d~~l~-----~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~~~~p~~~ 944 (1016)
.....+..-+... ..........+.+|+.+|+..||++|||+.|++ +|||+.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L---------~Hp~f~ 307 (350)
T d1q5ka_ 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC---------AHSFFD 307 (350)
T ss_dssp CC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHH---------TSGGGG
T ss_pred CCCHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHH---------CCHHHC
T ss_conf 621011035544567444431568999999999997658955792999996---------698452
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=332.15 Aligned_cols=259 Identities=22% Similarity=0.246 Sum_probs=198.0
Q ss_pred HCCCCCCCCCCCCCCEEEEEEECC-CCCEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEE-EEEEEECCEEEEEEE
Q ss_conf 238432372023797339998907-995999999257771316999999999984399871100-226761625699996
Q 001768 658 TNNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNLVKL-YGCCIEGNQLLLVYE 735 (1016)
Q Consensus 658 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l-~~~~~~~~~~~lV~E 735 (1016)
+++|++.+.||+|+||.||+|++. +++.||||++..... ...+..|+++++.++|++++.. .++..+++..++|||
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCEEEEEEEEEECCCCEEEEEEECCCCCEEEEEEECHHCC--CHHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEEEEEE
T ss_conf 8889996898507880999999988998999999721005--88899999999970389960179999951987789998
Q ss_pred ECCCCCHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCEEEECC---CCCEEEECCCCCCCC
Q ss_conf 36999488883027686767897889999999999999977228987683999876099814---996466103464336
Q 001768 736 YLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDK---DLNAKISDFGLAKLD 812 (1016)
Q Consensus 736 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NILl~~---~~~~kl~DFGla~~~ 812 (1016)
|++ +++.+.+.... ..+++..+..++.|++.||+|||++ +|+||||||+|||++. +..+|++|||+|+..
T Consensus 84 ~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~ 156 (299)
T d1ckia_ 84 LLG-PSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156 (299)
T ss_dssp CCC-CBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred ECC-CCHHHHHHHCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCHHHCCCCCCCCCCEEEEECCCCCEEC
T ss_conf 738-71333244306---8876899999999999999999979---9442667876606433577761565046751342
Q ss_pred CCCCCC------EEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHCC
Q ss_conf 888850------11101468654481211138899722045799999999929999999991335758899999987088
Q 001768 813 EDENTH------ISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGN 886 (1016)
Q Consensus 813 ~~~~~~------~~~~~~Gt~~y~aPE~~~~~~~~~k~DV~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 886 (1016)
...... ......||+.|||||++.+..++.++|||||||++|||++|+.||.......................
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 236 (299)
T d1ckia_ 157 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 236 (299)
T ss_dssp BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC
T ss_pred CCCCCCCCEECCCCCCCCCCCCCCCHHHHHCCCCCCHHHEEECCHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCCC
T ss_conf 55445541000135776787353299999189989832188617789999849876655305779999998523567898
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCC
Q ss_conf 320147868999899999999999987209999999998899998315
Q 001768 887 LLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEG 934 (1016)
Q Consensus 887 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~ 934 (1016)
..+ .... .+..+.+++..||+.+|++||+++++.+.|+.
T Consensus 237 ~~~-----~~~~----~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 275 (299)
T d1ckia_ 237 IEV-----LCKG----YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 275 (299)
T ss_dssp HHH-----HTTT----SCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHH
T ss_pred HHH-----HCCC----CCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHH
T ss_conf 357-----5347----88999999999843995579199999999999
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=337.68 Aligned_cols=258 Identities=21% Similarity=0.318 Sum_probs=207.6
Q ss_pred CCCCCCCCCCCCCCEEEEEEECC----CCCEEEEEECCCCC----HHHHHHHHHHHHHHHHCCC-CCEEEEEEEEEECCE
Q ss_conf 38432372023797339998907----99599999925777----1316999999999984399-871100226761625
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLS----DGAVIAVKQLSSKS----KQGNREFVNEIGMISALQH-QNLVKLYGCCIEGNQ 729 (1016)
Q Consensus 659 ~~f~~~~~LG~G~fG~Vy~~~~~----~~~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l~H-pniv~l~~~~~~~~~ 729 (1016)
++|++.+.||+|+||+||+|+.. +|+.||+|.+.... ....+.+.+|+.++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred HCEEEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCC
T ss_conf 02599989832878399999987658879489999983677210168999999999999864679839996200024873
Q ss_pred EEEEEEECCCCCHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCEEEECCCCCEEEECCCCC
Q ss_conf 69999636999488883027686767897889999999999999977228987683999876099814996466103464
Q 001768 730 LLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLA 809 (1016)
Q Consensus 730 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 809 (1016)
.++||||+++|+|.+++.... .+.+..+..++.|++.||+|+|+. +|+||||||+|||++.++.+||+|||+|
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~----~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE----RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred EEEEEECCCCCHHHHHHHHCC----CCCHHHHHHHHHHHHHHHHHHHCC---CEEECCCCCCCEEECCCCCEEEEECCCH
T ss_conf 001231234117999987304----543788888899999999885149---9896547732012469998887413202
Q ss_pred CCCCCCCCCEEEECCCCCCCCCHHHHCCC--CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHCCC
Q ss_conf 33688885011101468654481211138--8997220457999999999299999999913357588999999870883
Q 001768 810 KLDEDENTHISTRIAGTVGYMAPEYAMRG--YLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNL 887 (1016)
Q Consensus 810 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~--~~~~k~DV~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 887 (1016)
+..............|++.|+|||.+.+. .++.++||||+||++|||++|+.||...........+..... ..
T Consensus 177 ~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~---~~-- 251 (322)
T d1vzoa_ 177 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL---KS-- 251 (322)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH---HC--
T ss_pred HHHCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHCC---CC--
T ss_conf 2203444432212223333310687605776887132517777999999768999888877779999998335---68--
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCC-----HHHHHHHHCCCCCCCCCCCCC
Q ss_conf 2014786899989999999999998720999999999-----889999831585776731248
Q 001768 888 LELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPT-----MSSAVSMLEGKTAVQAPIIRR 945 (1016)
Q Consensus 888 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~ev~~~L~~~~~~~~p~~~~ 945 (1016)
.+.. +......+.+++.+|++.||++||+ ++|++ +|||++.
T Consensus 252 ----~~~~----~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil---------~Hpff~~ 297 (322)
T d1vzoa_ 252 ----EPPY----PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIK---------EHLFFQK 297 (322)
T ss_dssp ----CCCC----CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHH---------TSGGGTT
T ss_pred ----CCCC----CCCCCHHHHHHHHHHCCCCHHHCCCCCCCCHHHHH---------CCHHHCC
T ss_conf ----9988----65479999999999744589881999745099997---------4972348
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=0 Score=328.58 Aligned_cols=263 Identities=18% Similarity=0.254 Sum_probs=200.1
Q ss_pred CCCCCCCCCCCCCCEEEEEEECC-CCCEEEEEECCCCCHHHHHHHHHHHHHHHHCC-CCCEEEEEEEEEE--CCEEEEEE
Q ss_conf 38432372023797339998907-99599999925777131699999999998439-9871100226761--62569999
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSKQGNREFVNEIGMISALQ-HQNLVKLYGCCIE--GNQLLLVY 734 (1016)
Q Consensus 659 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-Hpniv~l~~~~~~--~~~~~lV~ 734 (1016)
++|++.++||+|+||+||+|+.. +++.||+|+++... .+.+.+|+.++..+. ||||+++++++.. ....++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHHCCCCCCCCEEEEEEEECCCCCEEEEE
T ss_conf 67189789831748199999988999799999988899---999999999998515799876799999816877126888
Q ss_pred EECCCCCHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCEEEECCCC-CEEEECCCCCCCCC
Q ss_conf 63699948888302768676789788999999999999997722898768399987609981499-64661034643368
Q 001768 735 EYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDL-NAKISDFGLAKLDE 813 (1016)
Q Consensus 735 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~-~~kl~DFGla~~~~ 813 (1016)
||+++++|.... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+|++|||+|+...
T Consensus 112 e~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~ 181 (328)
T d3bqca1 112 EHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181 (328)
T ss_dssp ECCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred EECCCCCHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCEEECCCCCEEEECCCCCCEECC
T ss_conf 631798589974-------6899999999999999999887643---344345644123774899836641565426646
Q ss_pred CCCCCEEEECCCCCCCCCHHHHCCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHH-HHH------HHHHHHHC
Q ss_conf 8885011101468654481211138-899722045799999999929999999991335758-899------99998708
Q 001768 814 DENTHISTRIAGTVGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYL-LDW------AYVLQEQG 885 (1016)
Q Consensus 814 ~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~~k~DV~SlGvil~elltG~~p~~~~~~~~~~~~-~~~------~~~~~~~~ 885 (1016)
.... .....||+.|+|||.+.+. .++.++||||+||++|||++|+.||........... ... ........
T Consensus 182 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 259 (328)
T d3bqca1 182 PGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 259 (328)
T ss_dssp TTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred CCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCHHHHHHHHC
T ss_conf 8874--44322486424761026888888452323354555876048899988760189999999987884155555422
Q ss_pred CCC------CCCCC--------CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 832------01478--------6899989999999999998720999999999889999831585776731248
Q 001768 886 NLL------ELVDP--------SLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTAVQAPIIRR 945 (1016)
Q Consensus 886 ~~~------~~~d~--------~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~~~~p~~~~ 945 (1016)
... ..... .............+.+|+.+|+..||++|||++|++ +|||+..
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L---------~Hp~F~~ 324 (328)
T d3bqca1 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM---------EHPYFYT 324 (328)
T ss_dssp TCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHH---------TSGGGTT
T ss_pred CCCCCCCCCHHCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHH---------CCCCCCC
T ss_conf 5444743000003334331121155211244899999999998669956890899996---------4935588
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=330.11 Aligned_cols=267 Identities=23% Similarity=0.276 Sum_probs=204.9
Q ss_pred CCCCCCCCCCCCCCEEEEEEECC-CCCEEEEEECCCC--CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE------CCE
Q ss_conf 38432372023797339998907-9959999992577--71316999999999984399871100226761------625
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSK--SKQGNREFVNEIGMISALQHQNLVKLYGCCIE------GNQ 729 (1016)
Q Consensus 659 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~------~~~ 729 (1016)
++|++.++||+|+||+||+|... +++.||||++... .......+.+|+.++++++|||||++++++.. ..+
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCCCCCE
T ss_conf 77599889621758599999999999899999988233697999999999999986489876489989702564345762
Q ss_pred EEEEEEECCCCCHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCEEEECCCCCEEEECCCCC
Q ss_conf 69999636999488883027686767897889999999999999977228987683999876099814996466103464
Q 001768 730 LLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLA 809 (1016)
Q Consensus 730 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 809 (1016)
.|+||||+.++.+ +.+.. .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+|++|||++
T Consensus 97 ~~iv~Ey~~~~l~-~~~~~------~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 97 VYLVMELMDANLC-QVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEEEECCSEEHH-HHHTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred EEEEEECCCHHHH-HHHHC------CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCCCCCCCCCEEEECHHHH
T ss_conf 6999841446778-76503------899999999999999999886522---1124567763211365443132010232
Q ss_pred CCCCCCCCCEEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH----------H--
Q ss_conf 3368888501110146865448121113889972204579999999992999999999133575889----------9--
Q 001768 810 KLDEDENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLD----------W-- 877 (1016)
Q Consensus 810 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~k~DV~SlGvil~elltG~~p~~~~~~~~~~~~~~----------~-- 877 (1016)
+...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||............. |
T Consensus 167 ~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 244 (355)
T d2b1pa1 167 RTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred HCCCCCC--CCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHH
T ss_conf 1146665--53322146555581331477778774333566257898659899888977889999997205898799987
Q ss_pred ----HH-HHHHHCCC-----CCCCCCCC-C--CCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCCCCCCCCCCCC
Q ss_conf ----99-99870883-----20147868-9--998999999999999872099999999988999983158577673124
Q 001768 878 ----AY-VLQEQGNL-----LELVDPSL-G--SNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTAVQAPIIR 944 (1016)
Q Consensus 878 ----~~-~~~~~~~~-----~~~~d~~l-~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~~~~p~~~ 944 (1016)
.. ........ ........ . ..........+.+|+.+|+..||++|||++|++ +|||+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL---------~Hpw~~ 315 (355)
T d2b1pa1 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL---------QHPYIN 315 (355)
T ss_dssp SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHH---------TSTTTG
T ss_pred HHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHH---------CCCCCC
T ss_conf 65667777641754356664212643335432101333799999999998769945790899996---------694208
Q ss_pred CC
Q ss_conf 89
Q 001768 945 RN 946 (1016)
Q Consensus 945 ~~ 946 (1016)
..
T Consensus 316 ~~ 317 (355)
T d2b1pa1 316 VW 317 (355)
T ss_dssp GG
T ss_pred CC
T ss_conf 78
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=326.95 Aligned_cols=270 Identities=20% Similarity=0.276 Sum_probs=206.1
Q ss_pred CCCCCCCCCCCCCCEEEEEEECC-CCCEEEEEECCCCC--HHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEE
Q ss_conf 38432372023797339998907-99599999925777--1316999999999984399871100226761625699996
Q 001768 659 NNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKS--KQGNREFVNEIGMISALQHQNLVKLYGCCIEGNQLLLVYE 735 (1016)
Q Consensus 659 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 735 (1016)
++|++.++||+|+||+||+|+.. +++.||||+++... ......+.+|+.+++.++||||+++++++.+.+..++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEE
T ss_conf 99786269712868199999999999699999980321786899999999999985675788821354444431158863
Q ss_pred ECCCCCHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCEEEECCCCCEEEECCCCCCCCCCC
Q ss_conf 36999488883027686767897889999999999999977228987683999876099814996466103464336888
Q 001768 736 YLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEDE 815 (1016)
Q Consensus 736 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 815 (1016)
++.++++..++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+|++|||.|+.....
T Consensus 82 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 82 FCDQDLKKYFDSCN----GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSEEHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred ECCCCCCCCCCCCC----CCCCHHHHHHHHHHHHHHHHHHHCC---CEEEECCCCCCCCCCCCCCEEEEECCHHHCCCCC
T ss_conf 02332221121235----6540367899999999998774339---9860014676121133782665204601104688
Q ss_pred CCCEEEECCCCCCCCCHHHHCCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCC-HHHHHHHHHHHHHHHHCCC---CCC
Q ss_conf 85011101468654481211138-899722045799999999929999999991-3357588999999870883---201
Q 001768 816 NTHISTRIAGTVGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGKSNTNYRPK-EEFVYLLDWAYVLQEQGNL---LEL 890 (1016)
Q Consensus 816 ~~~~~~~~~Gt~~y~aPE~~~~~-~~~~k~DV~SlGvil~elltG~~p~~~~~~-~~~~~~~~~~~~~~~~~~~---~~~ 890 (1016)
.. ......+++.|+|||++... .++.++||||+||++|||++|+.||..... .+................. ...
T Consensus 155 ~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (292)
T d1unla_ 155 VR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233 (292)
T ss_dssp CS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred CC-CCEEECCCCCHHHHHHHCCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHHHHHC
T ss_conf 75-10010344310146675069888804440265418899851899998899999999999861189973551344322
Q ss_pred C---------CCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 4---------786899989999999999998720999999999889999831585776731248
Q 001768 891 V---------DPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTAVQAPIIRR 945 (1016)
Q Consensus 891 ~---------d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~~~~p~~~~ 945 (1016)
. ...............+.+++.+|++.||++|||++|++ +|||+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L---------~Hp~f~~ 288 (292)
T d1unla_ 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEAL---------QHPYFSD 288 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHT---------TSGGGSS
T ss_pred CCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHH---------CCHHHCC
T ss_conf 211334445443104330656899999999998649966890999996---------4953407
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=0 Score=326.68 Aligned_cols=259 Identities=20% Similarity=0.245 Sum_probs=203.7
Q ss_pred HCCCCCCCCCCCCCCEEEEEEECC-CCCEEEEEECCCCCHHHHHHHHHHHHHHHHCCC-CCEEEEEEEEEECCEEEEEEE
Q ss_conf 238432372023797339998907-995999999257771316999999999984399-871100226761625699996
Q 001768 658 TNNFDAANKIGEGGFGPVYKGTLS-DGAVIAVKQLSSKSKQGNREFVNEIGMISALQH-QNLVKLYGCCIEGNQLLLVYE 735 (1016)
Q Consensus 658 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H-pniv~l~~~~~~~~~~~lV~E 735 (1016)
+++|++.+.||+|+||+||+|+.. +++.||||++..... ...+.+|++.+..+.| +|++.+++++..+...++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCC--CHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEEE
T ss_conf 9806997998417882999999988997999999750258--29999999999996489998779999601881179999
Q ss_pred ECCCCCHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCEEEECC-----CCCEEEECCCCCC
Q ss_conf 36999488883027686767897889999999999999977228987683999876099814-----9964661034643
Q 001768 736 YLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDK-----DLNAKISDFGLAK 810 (1016)
Q Consensus 736 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NILl~~-----~~~~kl~DFGla~ 810 (1016)
|+ +++|.+++.... ..+++.++..++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+|+
T Consensus 82 ~~-~~~l~~~~~~~~---~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~ 154 (293)
T d1csna_ 82 LL-GPSLEDLLDLCG---RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154 (293)
T ss_dssp CC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred EC-CCCHHHHHHHHC---CCHHHHHHHHHHHHHHHHHHHHHHC---CCEECCCCCCCEEECCCCCCCCCCEEECCCCEEE
T ss_conf 64-888799997520---3110689999999999999999977---9662667713152347543447956872366057
Q ss_pred CCCCCCC------CEEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHH
Q ss_conf 3688885------0111014686544812111388997220457999999999299999999913357588999999870
Q 001768 811 LDEDENT------HISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQ 884 (1016)
Q Consensus 811 ~~~~~~~------~~~~~~~Gt~~y~aPE~~~~~~~~~k~DV~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 884 (1016)
...+... .......||+.|||||++.+..++.++|||||||++|||++|+.||.....................
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (293)
T d1csna_ 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 234 (293)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred ECCCCCCCCCEEECCCCCEEECHHHCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHCCCC
T ss_conf 71467665411102467627751026798964888886999898319999998698767885302199999999705679
Q ss_pred CCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCC
Q ss_conf 88320147868999899999999999987209999999998899998315
Q 001768 885 GNLLELVDPSLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEG 934 (1016)
Q Consensus 885 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~ 934 (1016)
....+ +.... +..+.+++..|+..+|++||+++.+.+.|+.
T Consensus 235 ~~~~~-----l~~~~----p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~ 275 (293)
T d1csna_ 235 TPLRE-----LCAGF----PEEFYKYMHYARNLAFDATPDYDYLQGLFSK 275 (293)
T ss_dssp SCHHH-----HTTTS----CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred CCHHH-----HCCCC----CHHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
T ss_conf 99589-----65799----8999999999843993008599999999999
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=332.62 Aligned_cols=263 Identities=22% Similarity=0.291 Sum_probs=202.6
Q ss_pred HCCCCCCCCCCCCCCEEEEEEEC-CCCCEEEEEECCCCC--HHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE-----CCE
Q ss_conf 23843237202379733999890-799599999925777--1316999999999984399871100226761-----625
Q 001768 658 TNNFDAANKIGEGGFGPVYKGTL-SDGAVIAVKQLSSKS--KQGNREFVNEIGMISALQHQNLVKLYGCCIE-----GNQ 729 (1016)
Q Consensus 658 ~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~-----~~~ 729 (1016)
.++|++.++||+|+||+||+|+. .+++.||||++.... ....+.+.+|+.+++.++|||+|++++++.. +..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCCC
T ss_conf 98718888983178839999999999979999998820028689999999999998668987425999996346456686
Q ss_pred EEEEEEECCCCCHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCEEEECCCCCEEEECCCCC
Q ss_conf 69999636999488883027686767897889999999999999977228987683999876099814996466103464
Q 001768 730 LLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLA 809 (1016)
Q Consensus 730 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 809 (1016)
.+++++|+.+|+|.+++..+ .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+|++|||.|
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~-----~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred EEEEEEEECCCCHHHHCCCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCCCCCCCCCCCCCCCCHH
T ss_conf 49999962588623200224-----530999999999999999999738---8765166776334554322001321000
Q ss_pred CCCCCCCCCEEEECCCCCCCCCHHHHCCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHCCCC
Q ss_conf 33688885011101468654481211138-89972204579999999992999999999133575889999998708832
Q 001768 810 KLDEDENTHISTRIAGTVGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGNLL 888 (1016)
Q Consensus 810 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~~k~DV~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 888 (1016)
...... .....||+.|+|||...+. .++.++||||+||++|+|++|+.||.+.........+... .....
T Consensus 169 ~~~~~~----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~-----~~~~~ 239 (348)
T d2gfsa1 169 RHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-----VGTPG 239 (348)
T ss_dssp -CCTGG----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH-----HCCCC
T ss_pred CCCCCC----CCCCCCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHH-----CCCCC
T ss_conf 125754----444345435558355337756785512432058999997688997889889999999973-----07997
Q ss_pred CC-------------C--CCCCC-CCC---CHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCCCCCCCCCCCCCC
Q ss_conf 01-------------4--78689-998---99999999999987209999999998899998315857767312489
Q 001768 889 EL-------------V--DPSLG-SNF---SKKEAMTMLNIALLCTNPSPTLRPTMSSAVSMLEGKTAVQAPIIRRN 946 (1016)
Q Consensus 889 ~~-------------~--d~~l~-~~~---~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~~~~p~~~~~ 946 (1016)
.. . .+... ..+ .......+.+|+.+|+..||++|||+.|++ +|||+.+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL---------~Hp~f~~~ 307 (348)
T d2gfsa1 240 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL---------AHAYFAQY 307 (348)
T ss_dssp HHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHH---------TSGGGTTT
T ss_pred HHHHHHCCCHHHHHHHHHCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHH---------CCHHHCCC
T ss_conf 577320010244544430355787555662678999999999997758834593899985---------59954879
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=0 Score=308.57 Aligned_cols=304 Identities=29% Similarity=0.404 Sum_probs=234.6
Q ss_pred CCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCC--CCCCEECCCCCCCCEEEEEEEEECCCCCCC--CCC
Q ss_conf 7899447999999999718778974589988888766678999--998100137999922239999936996576--694
Q 001768 27 QRLPDDEVQTLQSIFRKLNFRNGQVNQTSCTEGSWNVTIDDSN--GSNFTCDCTYSNNTVCHVTVILLKGFNLAG--VIP 102 (1016)
Q Consensus 27 ~~~~~~~~~aL~~~~~~l~~~~~~~~~~~~~~~sw~~~~d~c~--~~~v~C~~~~~~~~~~~v~~L~L~~~~l~~--~~~ 102 (1016)
+-|.|+|++||++||+.+.. +..+++|..+.|||. |.||+|+.. ....||+.|+|.++++++ .+|
T Consensus 1 ~~c~~~e~~aLl~~k~~~~~--------~~~l~sW~~~~d~C~~~w~gv~C~~~---~~~~~v~~L~L~~~~l~g~~~lp 69 (313)
T d1ogqa_ 1 ELCNPQDKQALLQIKKDLGN--------PTTLSSWLPTTDCCNRTWLGVLCDTD---TQTYRVNNLDLSGLNLPKPYPIP 69 (313)
T ss_dssp CCSCHHHHHHHHHHHHHTTC--------CGGGTTCCTTSCTTTTCSTTEEECCS---SSCCCEEEEEEECCCCSSCEECC
T ss_pred CCCCHHHHHHHHHHHHHCCC--------CCCCCCCCCCCCCCCCCCCCEEEECC---CCCEEEEEEECCCCCCCCCCCCC
T ss_conf 99898999999999997799--------98677889999998894889697489---99479889989899888888798
Q ss_pred CCCCCCCCCCEEECCC-CCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCC
Q ss_conf 0027999887998438-879998854333034764001236624798885447867746899005778899887888874
Q 001768 103 EEFGNLTFLQEVDLSR-NYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGDISTLEELVLEDNQLVGPLPENLGNLK 181 (1016)
Q Consensus 103 ~~l~~l~~L~~L~L~~-n~i~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~ 181 (1016)
+.+++|++|++|+|++ |++.|.+|.+|+++++|++|+|++|++.+..+..+..+..|+.+++++|.+.+.+|..+..++
T Consensus 70 ~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~ 149 (313)
T d1ogqa_ 70 SSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLP 149 (313)
T ss_dssp GGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCT
T ss_pred HHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHCCCC
T ss_conf 47846753352020265433300243114542001102035643443322222011100111122455556851220674
Q ss_pred CCHHHHCCCCCCCCCCCCCCCCCCCC-CEEEECCCCCCCCCCHHHHCCCCCCEEEECCCCCCCCCCHHHCCCCCCCEEEC
Q ss_conf 10332025776679887654889986-48981588578877032205898787962488689989021208999989985
Q 001768 182 SLRRILLSSNNFTGSIPESYGNLKNL-TEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRI 260 (1016)
Q Consensus 182 ~L~~L~Ls~N~l~~~~~~~l~~l~~L-~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L 260 (1016)
+|+.+++++|.+.+.+|..+..+..+ +.+.+++|++++..+..+..+.. ..+++..+...+.++..+..+++++.|
T Consensus 150 ~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~-~~l~l~~~~~~~~~~~~~~~~~~l~~l-- 226 (313)
T d1ogqa_ 150 NLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNL-AFVDLSRNMLEGDASVLFGSDKNTQKI-- 226 (313)
T ss_dssp TCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCC-SEEECCSSEEEECCGGGCCTTSCCSEE--
T ss_pred CCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCC--
T ss_conf 00000023553356203121443112323102246435332433222222-233333343322222222222221112--
Q ss_pred CCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCC
Q ss_conf 78879899975611243335332245335445711002999986696469899999761028999887898138969899
Q 001768 261 SDLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGT 340 (1016)
Q Consensus 261 ~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~L~~~~p~~l~~l~~L~~L~L~~N~l~g~ 340 (1016)
++++|.+.+.++ .+..+++|+.|+|++|+++|.+|..|+++++|++|+|++|+++|.
T Consensus 227 ----------------------~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~ 283 (313)
T d1ogqa_ 227 ----------------------HLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGE 283 (313)
T ss_dssp ----------------------ECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEE
T ss_pred ----------------------CCCCCCCCCCCC-CCCCCCCCCCCCCCCCEECCCCCHHHHCCCCCCEEECCCCCCCCC
T ss_conf ----------------------222222222222-222455444444765706660876884799999897958835166
Q ss_pred CCHHH-HCCCCCCCCCCCC-CCCCCCCCC
Q ss_conf 97365-4047830377885-889999532
Q 001768 341 LPDWI-LTSEKNLDLSYNN-FTESSPATC 367 (1016)
Q Consensus 341 ~p~~~-~~~L~~LdLs~N~-l~~~~p~~~ 367 (1016)
+|... +.+|+.+++++|+ ++|.+.+.|
T Consensus 284 iP~~~~L~~L~~l~l~~N~~l~g~plp~c 312 (313)
T d1ogqa_ 284 IPQGGNLQRFDVSAYANNKCLCGSPLPAC 312 (313)
T ss_dssp CCCSTTGGGSCGGGTCSSSEEESTTSSCC
T ss_pred CCCCCCCCCCCHHHHCCCCCCCCCCCCCC
T ss_conf 89866679989788688950019898898
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=293.97 Aligned_cols=270 Identities=21% Similarity=0.273 Sum_probs=195.8
Q ss_pred CCCCCCCCCCCCCCEEEEEEEC-CCCCEEEEEECCCCCHHHHHHHHHHHHHHHHCC-----------CCCEEEEEEEEEE
Q ss_conf 3843237202379733999890-799599999925777131699999999998439-----------9871100226761
Q 001768 659 NNFDAANKIGEGGFGPVYKGTL-SDGAVIAVKQLSSKSKQGNREFVNEIGMISALQ-----------HQNLVKLYGCCIE 726 (1016)
Q Consensus 659 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-----------Hpniv~l~~~~~~ 726 (1016)
.+|+++++||+|+||+||+|+. .+|+.||||++.... ...+.+.+|+.+++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCC-CCHHHHHHHHHHHHHHCCHHHHHHHHCCCCCEEEEEEEEEE
T ss_conf 85799899750778189999999999799999983431-33689999999999840145555542276764789987631
Q ss_pred C--CEEEEEEEECCCCCHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCEEEECCCC-----
Q ss_conf 6--256999963699948888302768676789788999999999999997722898768399987609981499-----
Q 001768 727 G--NQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDL----- 799 (1016)
Q Consensus 727 ~--~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~----- 799 (1016)
. ...+++++++..+......... .....+++..+..++.|++.||+|||+.. +|+||||||+|||++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~i~~qil~al~~lh~~~--~IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKK-YEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHH-TTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTTE
T ss_pred CCCCCEEEEEEECCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHHHHHHHHHHC--CCCCCCCCHHHEEEECCCCCCCC
T ss_conf 2565202343200035420000012-23467868999999999999988876405--86465677057056305765644
Q ss_pred -CEEEECCCCCCCCCCCCCCEEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHH----HH
Q ss_conf -6466103464336888850111014686544812111388997220457999999999299999999913357----58
Q 001768 800 -NAKISDFGLAKLDEDENTHISTRIAGTVGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFV----YL 874 (1016)
Q Consensus 800 -~~kl~DFGla~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~k~DV~SlGvil~elltG~~p~~~~~~~~~~----~~ 874 (1016)
.++++|||.|...... ....+||+.|+|||++....++.++||||+||+++||++|+.||......... .+
T Consensus 169 ~~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~ 244 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244 (362)
T ss_dssp EEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred CEEEEEECCCCCCCCCC----CCCCCCCCCCCCHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCHHHHH
T ss_conf 30567531442123445----42236652105713214667776432012378999998788998987554321026899
Q ss_pred HHHHHHH-------HHHCC----------CCCCCCC----------CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHH
Q ss_conf 8999999-------87088----------3201478----------6899989999999999998720999999999889
Q 001768 875 LDWAYVL-------QEQGN----------LLELVDP----------SLGSNFSKKEAMTMLNIALLCTNPSPTLRPTMSS 927 (1016)
Q Consensus 875 ~~~~~~~-------~~~~~----------~~~~~d~----------~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~e 927 (1016)
....... ..... ....+.. .............+.+|+.+|+..||.+|||++|
T Consensus 245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e 324 (362)
T d1q8ya_ 245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 324 (362)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHHHCCCCHHHHHCCCCCCCCCCCCHHHHCCCCCCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHH
T ss_conf 99999837998788624532200013201220243235776444210001567435899999999987799457908999
Q ss_pred HHHHHCCCCCCCCCCCCC
Q ss_conf 999831585776731248
Q 001768 928 AVSMLEGKTAVQAPIIRR 945 (1016)
Q Consensus 928 v~~~L~~~~~~~~p~~~~ 945 (1016)
++ +|||++.
T Consensus 325 ~L---------~Hp~f~~ 333 (362)
T d1q8ya_ 325 LV---------NHPWLKD 333 (362)
T ss_dssp HH---------TCGGGTT
T ss_pred HH---------CCCCCCC
T ss_conf 96---------6934078
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=4.2e-37 Score=225.60 Aligned_cols=257 Identities=26% Similarity=0.414 Sum_probs=206.4
Q ss_pred CCCCEEECCCCCCCCC--CCHHHHCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCHH
Q ss_conf 9887998438879998--854333034764001236-6247988854478677468990057788998878888741033
Q 001768 109 TFLQEVDLSRNYFNGS--LPKSFARLQNLTKLLILG-NRLSGSIPLEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRR 185 (1016)
Q Consensus 109 ~~L~~L~L~~n~i~~~--~p~~l~~l~~L~~L~Ls~-N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~ 185 (1016)
.++++|+|+++.+.+. +|.++++|++|++|+|++ |+++|.+|..|+++++|++|+|++|++.+..+..+..+.+|+.
T Consensus 50 ~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~ 129 (313)
T d1ogqa_ 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred EEEEEEECCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHHCC
T ss_conf 79889989899888888798478467533520202654333002431145420011020356434433222220111001
Q ss_pred HHCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCHHHHCCCCC-CEEEECCCCCCCCCCHHHCCCCCCCEEECCCCC
Q ss_conf 2025776679887654889986489815885788770322058987-879624886899890212089999899857887
Q 001768 186 ILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKL-DRLDLQGTSLEGPIPSTISQLKNLTELRISDLK 264 (1016)
Q Consensus 186 L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L-~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~n~ 264 (1016)
+++++|++.+.+|..+..++.|+.+++++|.+.+.+|..+..+.++ +.++++.|++++..+..+..+
T Consensus 130 l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l------------ 197 (313)
T d1ogqa_ 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL------------ 197 (313)
T ss_dssp EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGC------------
T ss_pred CCCCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC------------
T ss_conf 11122455556851220674000000235533562031214431123231022464353324332222------------
Q ss_pred CCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHH
Q ss_conf 98999756112433353322453354457110029999866964698999997610289998878981389698999736
Q 001768 265 GSSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGTLPDW 344 (1016)
Q Consensus 265 l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~L~~~~p~~l~~l~~L~~L~L~~N~l~g~~p~~ 344 (1016)
. +..++++++.+.+.+|..+..+++|+.+++++|.+.+.+| .+..+++|+.|+|++|+++|.+|..
T Consensus 198 ------------~-~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~ 263 (313)
T d1ogqa_ 198 ------------N-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQG 263 (313)
T ss_dssp ------------C-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGG
T ss_pred ------------C-CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCEECCCCCHH
T ss_conf ------------2-2233333343322222222222221112222222222222-2224554444447657066608768
Q ss_pred H--HCCCCCCCCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCC
Q ss_conf 5--404783037788588999953234443031012346999853243689999
Q 001768 345 I--LTSEKNLDLSYNNFTESSPATCRESRVNILSSFSSTGSNSVSWCLKKDLPC 396 (1016)
Q Consensus 345 ~--~~~L~~LdLs~N~l~~~~p~~~~~~~~~~l~~~~~~~~~~~~~c~~~~~~c 396 (1016)
+ +++|+.|||++|+++|.+|+.... ..+..+.+.++ ...|+.|..+|
T Consensus 264 l~~L~~L~~L~Ls~N~l~g~iP~~~~L---~~L~~l~l~~N--~~l~g~plp~c 312 (313)
T d1ogqa_ 264 LTQLKFLHSLNVSFNNLCGEIPQGGNL---QRFDVSAYANN--KCLCGSPLPAC 312 (313)
T ss_dssp GGGCTTCCEEECCSSEEEEECCCSTTG---GGSCGGGTCSS--SEEESTTSSCC
T ss_pred HHCCCCCCEEECCCCCCCCCCCCCCCC---CCCCHHHHCCC--CCCCCCCCCCC
T ss_conf 847999998979588351668986667---99897886889--50019898898
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.8e-33 Score=203.77 Aligned_cols=264 Identities=24% Similarity=0.338 Sum_probs=218.2
Q ss_pred EEEEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECC
Q ss_conf 39999936996576694002799988799843887999885433303476400123662479888544786774689900
Q 001768 86 HVTVILLKGFNLAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGDISTLEELVLE 165 (1016)
Q Consensus 86 ~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~ 165 (1016)
..+.++.++.+++. +|..+. +.+++|+|++|+|+...+.+|.++++|++|++++|.+....|..|.+++.|+.|+++
T Consensus 11 ~~~~~~C~~~~L~~-lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~ 87 (305)
T d1xkua_ 11 HLRVVQCSDLGLEK-VPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 87 (305)
T ss_dssp ETTEEECTTSCCCS-CCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CCCEEEECCCCCCC-CCCCCC--CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCEECCC
T ss_conf 59999855999885-198889--997989784991898696576046565231123443445235665279855783156
Q ss_pred CCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCEEEECCCCCC--CCCCHHHHCCCCCCEEEECCCCCCC
Q ss_conf 57788998878888741033202577667988765488998648981588578--8770322058987879624886899
Q 001768 166 DNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLT--GRIPNFIGNWTKLDRLDLQGTSLEG 243 (1016)
Q Consensus 166 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~--~~~p~~l~~l~~L~~L~L~~N~l~~ 243 (1016)
+|+++ .+|..+ ...+..|.+.+|.+....+..+.....+..+....|... ...+..+..+++|+.+++++|.+..
T Consensus 88 ~n~l~-~l~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~ 164 (305)
T d1xkua_ 88 KNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT 164 (305)
T ss_dssp SSCCS-BCCSSC--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS
T ss_pred CCCCC-CCCCCH--HHHHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 87567-676400--111323210246102344445401331100001233333467776422345656712034677451
Q ss_pred CCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCC
Q ss_conf 89021208999989985788798999756112433353322453354457110029999866964698999997610289
Q 001768 244 PIPSTISQLKNLTELRISDLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQN 323 (1016)
Q Consensus 244 ~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~L~~~~p~~l~~ 323 (1016)
++.. .+++|+.|++++|.........+..++.++.|++++|.+.+..+..+..+++|+.|+|++|+|+ .+|..|..
T Consensus 165 -l~~~--~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~ 240 (305)
T d1xkua_ 165 -IPQG--LPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLAD 240 (305)
T ss_dssp -CCSS--CCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTT
T ss_pred -CCCC--CCCCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCC-CCCCCCCC
T ss_conf -6710--1776678989788677888267641341330154455332223454334433224302554002-46311033
Q ss_pred CCCCCEEECCCCCCCCCCCH-HH--------HCCCCCCCCCCCCCC
Q ss_conf 99887898138969899973-65--------404783037788588
Q 001768 324 LKKIDYIFLTNNSLSGTLPD-WI--------LTSEKNLDLSYNNFT 360 (1016)
Q Consensus 324 l~~L~~L~L~~N~l~g~~p~-~~--------~~~L~~LdLs~N~l~ 360 (1016)
+++|+.|+|++|+++. ++. .+ ..+|+.|+|++|++.
T Consensus 241 l~~L~~L~Ls~N~i~~-i~~~~f~~~~~~~~~~~L~~L~L~~N~~~ 285 (305)
T d1xkua_ 241 HKYIQVVYLHNNNISA-IGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285 (305)
T ss_dssp CSSCCEEECCSSCCCC-CCTTSSSCSSCCTTSCCCSEEECCSSSSC
T ss_pred CCCCCEEECCCCCCCC-CCHHHCCCCCHHCCCCCCCEEECCCCCCC
T ss_conf 4678989898986576-38100267210021588897889899576
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-33 Score=205.70 Aligned_cols=261 Identities=21% Similarity=0.212 Sum_probs=177.1
Q ss_pred EEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECC-CCC
Q ss_conf 9936996576694002799988799843887999885433303476400123662479888544786774689900-577
Q 001768 90 ILLKGFNLAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGDISTLEELVLE-DNQ 168 (1016)
Q Consensus 90 L~L~~~~l~~~~~~~l~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~-~N~ 168 (1016)
+.+++.+++ .+|..+. +.+++|+|++|+|+...+.+|..+++|++|++++|.+....+..+..+..+..+... .|.
T Consensus 16 v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~ 92 (284)
T d1ozna_ 16 TSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQ 92 (284)
T ss_dssp EECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTT
T ss_pred EECCCCCCC-CCCCCCC--CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 984799989-4497889--9988897748817987977864142130000134454332111212222222222221022
Q ss_pred CCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCHHHHCCCCCCEEEECCCCCCCCCCHH
Q ss_conf 88998878888741033202577667988765488998648981588578877032205898787962488689989021
Q 001768 169 LVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPST 248 (1016)
Q Consensus 169 l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~ 248 (1016)
+....+..+.++++|+.|++++|.+....+ ..+....+|+.+++++|.+++..+..
T Consensus 93 ~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~------------------------~~~~~~~~L~~l~l~~N~l~~i~~~~ 148 (284)
T d1ozna_ 93 LRSVDPATFHGLGRLHTLHLDRCGLQELGP------------------------GLFRGLAALQYLYLQDNALQALPDDT 148 (284)
T ss_dssp CCCCCTTTTTTCTTCCEEECTTSCCCCCCT------------------------TTTTTCTTCCEEECCSSCCCCCCTTT
T ss_pred CCCCCCHHHCCCCCCCEEECCCCCCCCCCC------------------------CCCCHHCCCCHHHHCCCCCCCCCHHH
T ss_conf 354462010101027787568854432013------------------------53320001211020014314458057
Q ss_pred HCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCC
Q ss_conf 20899998998578879899975611243335332245335445711002999986696469899999761028999887
Q 001768 249 ISQLKNLTELRISDLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKID 328 (1016)
Q Consensus 249 l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~L~~~~p~~l~~l~~L~ 328 (1016)
|..+++|+.|++++|.+..+....+..+++|+.+++++|++.+..|..|..+++|++|++++|.+.+..+..|..+++|+
T Consensus 149 f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~ 228 (284)
T d1ozna_ 149 FRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQ 228 (284)
T ss_dssp TTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCC
T ss_pred HCCCCCHHHCCCCCCCCCCCCHHHHCCCCCCCHHHHHHCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 40434050223141765662566654656341314211434662816766532000233333522100000235546568
Q ss_pred EEECCCCCCCCCCCH-HHHCCCCCCCCCCCCCCCCCCCCCCCCCCCEECC
Q ss_conf 898138969899973-6540478303778858899995323444303101
Q 001768 329 YIFLTNNSLSGTLPD-WILTSEKNLDLSYNNFTESSPATCRESRVNILSS 377 (1016)
Q Consensus 329 ~L~L~~N~l~g~~p~-~~~~~L~~LdLs~N~l~~~~p~~~~~~~~~~l~~ 377 (1016)
+|++++|++.+..+. ++...++.+....+++.+..|...+...+..++.
T Consensus 229 ~L~l~~N~l~C~C~~~~l~~~l~~~~~~~~~~~C~~p~~l~g~~l~~l~~ 278 (284)
T d1ozna_ 229 YLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLPQRLAGRDLKRLAA 278 (284)
T ss_dssp EEECCSSCEECSGGGHHHHHHHHHCCSEECCCBEEESGGGTTCBGGGSCG
T ss_pred EEEECCCCCCCCCCCHHHHHHHHHCCCCCCCEEECCCHHHCCCCCCCCCH
T ss_conf 89811998878756469999998673888866747966984985341898
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-33 Score=203.44 Aligned_cols=204 Identities=18% Similarity=0.226 Sum_probs=96.8
Q ss_pred CCEEECCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCEEEEC-CCCCCCCCCHHHHCCCCCCEEEEC
Q ss_conf 4689900577889988788887410332025776679887654889986489815-885788770322058987879624
Q 001768 159 LEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRID-GSNLTGRIPNFIGNWTKLDRLDLQ 237 (1016)
Q Consensus 159 L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~-~N~l~~~~p~~l~~l~~L~~L~L~ 237 (1016)
+++|+|++|+++...+..|.++++|++|++++|++....+..+..+..++.+... .+.++...+..|.++++|+.|+++
T Consensus 34 ~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~ 113 (284)
T d1ozna_ 34 SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLD 113 (284)
T ss_dssp CSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECT
T ss_pred CCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHCCCCCCCEEECC
T ss_conf 88897748817987977864142130000134454332111212222222222221022354462010101027787568
Q ss_pred CCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCC
Q ss_conf 88689989021208999989985788798999756112433353322453354457110029999866964698999997
Q 001768 238 GTSLEGPIPSTISQLKNLTELRISDLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPV 317 (1016)
Q Consensus 238 ~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~L~~~~ 317 (1016)
+|.+....+..+....+|+.+++++|.++.+....|..+++|+.|++++|.+....+..|..+++|+.+++++|++.+..
T Consensus 114 ~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~ 193 (284)
T d1ozna_ 114 RCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVH 193 (284)
T ss_dssp TSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEEC
T ss_pred CCCCCCCCCCCCCHHCCCCHHHHCCCCCCCCCHHHHCCCCCHHHCCCCCCCCCCCCHHHHCCCCCCCHHHHHHCCCCCCC
T ss_conf 85443201353320001211020014314458057404340502231417656625666546563413142114346628
Q ss_pred CCCCCCCCCCCEEECCCCCCCCCCCHHH--HCCCCCCCCCCCCCCCC
Q ss_conf 6102899988789813896989997365--40478303778858899
Q 001768 318 PGILQNLKKIDYIFLTNNSLSGTLPDWI--LTSEKNLDLSYNNFTES 362 (1016)
Q Consensus 318 p~~l~~l~~L~~L~L~~N~l~g~~p~~~--~~~L~~LdLs~N~l~~~ 362 (1016)
|..|..+++|++|++++|++.+..+..+ +++|+.|++++|++.|.
T Consensus 194 ~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~ 240 (284)
T d1ozna_ 194 PHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCD 240 (284)
T ss_dssp TTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECS
T ss_pred HHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCC
T ss_conf 16766532000233333522100000235546568898119988787
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=4.1e-32 Score=197.12 Aligned_cols=271 Identities=20% Similarity=0.267 Sum_probs=221.3
Q ss_pred CCCCCCEECCC----CCCCCEEEEEEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCCCCCCC
Q ss_conf 99998100137----99992223999993699657669400279998879984388799988543330347640012366
Q 001768 68 SNGSNFTCDCT----YSNNTVCHVTVILLKGFNLAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGN 143 (1016)
Q Consensus 68 c~~~~v~C~~~----~~~~~~~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~Ls~N 143 (1016)
|.|..+.|... .+.+.+..++.|++++|.++.+.+..|.++++|++|++++|.+....|..|..+++|+.|++++|
T Consensus 10 c~~~~~~C~~~~L~~lP~~l~~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n 89 (305)
T d1xkua_ 10 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKN 89 (305)
T ss_dssp EETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSS
T ss_pred ECCCEEEECCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCEECCCCC
T ss_conf 55999985599988519888999798978499189869657604656523112344344523566527985578315687
Q ss_pred CCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCHHHHCCCCCCC--CCCCCCCCCCCCCCEEEECCCCCCCCC
Q ss_conf 247988854478677468990057788998878888741033202577667--988765488998648981588578877
Q 001768 144 RLSGSIPLEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFT--GSIPESYGNLKNLTEFRIDGSNLTGRI 221 (1016)
Q Consensus 144 ~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~--~~~~~~l~~l~~L~~L~L~~N~l~~~~ 221 (1016)
+++ .+|..+ ...|..|++.+|.+....+..+.....+..+....|... ...+..+..+++|+.+++++|.+.. +
T Consensus 90 ~l~-~l~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~-l 165 (305)
T d1xkua_ 90 QLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-I 165 (305)
T ss_dssp CCS-BCCSSC--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS-C
T ss_pred CCC-CCCCCH--HHHHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-C
T ss_conf 567-676400--111323210246102344445401331100001233333467776422345656712034677451-6
Q ss_pred CHHHHCCCCCCEEEECCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHCCCC
Q ss_conf 03220589878796248868998902120899998998578879899975611243335332245335445711002999
Q 001768 222 PNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISDLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDMT 301 (1016)
Q Consensus 222 p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~ 301 (1016)
+..+ +++|+.|++++|......+..|..++.++.|++++|.+.......+..+++|+.|+|++|.|+ .+|..+..++
T Consensus 166 ~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~ 242 (305)
T d1xkua_ 166 PQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHK 242 (305)
T ss_dssp CSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCS
T ss_pred CCCC--CCCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCC-CCCCCCCCCC
T ss_conf 7101--776678989788677888267641341330154455332223454334433224302554002-4631103346
Q ss_pred CCCEEECCCCCCCCCCCCCC------CCCCCCCEEECCCCCCC-CCCCHHH
Q ss_conf 98669646989999976102------89998878981389698-9997365
Q 001768 302 DLKILDLSFNQLTGPVPGIL------QNLKKIDYIFLTNNSLS-GTLPDWI 345 (1016)
Q Consensus 302 ~L~~L~Ls~N~L~~~~p~~l------~~l~~L~~L~L~~N~l~-g~~p~~~ 345 (1016)
+|+.|+|++|+|+......| ..+++|+.|+|++|++. ..++...
T Consensus 243 ~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~~~~~~~ 293 (305)
T d1xkua_ 243 YIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPST 293 (305)
T ss_dssp SCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGG
T ss_pred CCCEEECCCCCCCCCCHHHCCCCCHHCCCCCCCEEECCCCCCCCCCCCHHH
T ss_conf 789898989865763810026721002158889788989957667689768
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=100.00 E-value=2.1e-31 Score=193.04 Aligned_cols=260 Identities=25% Similarity=0.410 Sum_probs=173.9
Q ss_pred EEEEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECC
Q ss_conf 39999936996576694002799988799843887999885433303476400123662479888544786774689900
Q 001768 86 HVTVILLKGFNLAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGDISTLEELVLE 165 (1016)
Q Consensus 86 ~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~ 165 (1016)
+++.|++.+++++.. +.+..+++|++|+|++|+|++..+ +.++++|++|++++|.+.+.. .++.+++|+.|+++
T Consensus 45 ~l~~L~l~~~~I~~l--~gl~~L~nL~~L~Ls~N~l~~l~~--l~~L~~L~~L~L~~n~i~~i~--~l~~l~~L~~L~~~ 118 (384)
T d2omza2 45 QVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADIT--PLANLTNLTGLTLF 118 (384)
T ss_dssp TCCEEECCSSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECC
T ss_pred CCCEEECCCCCCCCC--CCCCCCCCCCEEECCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCC
T ss_conf 878998999898776--242458999989681881798863--347711010301343332222--11123343334433
Q ss_pred CCCCCCCCCC---------------------------------------------------------------CCCCCCC
Q ss_conf 5778899887---------------------------------------------------------------8888741
Q 001768 166 DNQLVGPLPE---------------------------------------------------------------NLGNLKS 182 (1016)
Q Consensus 166 ~N~l~~~~p~---------------------------------------------------------------~l~~l~~ 182 (1016)
+|.+++..+. ....+++
T Consensus 119 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 198 (384)
T d2omza2 119 NNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTN 198 (384)
T ss_dssp SSCCCCCGGGTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCCGGGGGCTT
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 22222222222222221121346631310023222211222221232201111245421101122243332110022353
Q ss_pred CHHHHCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCHHHHCCCCCCEEEECCCCCCCCCCHHHCCCCCCCEEECCC
Q ss_conf 03320257766798876548899864898158857887703220589878796248868998902120899998998578
Q 001768 183 LRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISD 262 (1016)
Q Consensus 183 L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~ 262 (1016)
++.+++++|.+++..+ +..+++|+.|++++|.++.. ..+..+++|+.|++++|.+++..+ +..+++|+.|+++.
T Consensus 199 ~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~ 272 (384)
T d2omza2 199 LESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGA 272 (384)
T ss_dssp CSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCS
T ss_pred CCEEECCCCCCCCCCC--CCCCCCCCEEECCCCCCCCC--CHHHCCCCCCHHCCCCCCCCCCCC--CCCCCCCCEEECCC
T ss_conf 2333035774478786--44457787888877777896--134325653410044674478775--35546687754567
Q ss_pred CCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCC
Q ss_conf 87989997561124333533224533544571100299998669646989999976102899988789813896989997
Q 001768 263 LKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGTLP 342 (1016)
Q Consensus 263 n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~L~~~~p~~l~~l~~L~~L~L~~N~l~g~~p 342 (1016)
+.+.... .+..++.++.+.++.|.+.+. ..+..+++++.|++++|++++..+ +..+++|+.|++++|++++ ++
T Consensus 273 ~~l~~~~--~~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l~~--l~~l~~L~~L~L~~n~l~~-l~ 345 (384)
T d2omza2 273 NQISNIS--PLAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD-VS 345 (384)
T ss_dssp SCCCCCG--GGTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCC-CG
T ss_pred CCCCCCC--CCCCCCCCCCCCCCCCCCCCC--CCCCHHCCCCEEECCCCCCCCCCC--CCCCCCCCEEECCCCCCCC-CH
T ss_conf 4457877--323565222233232333332--210000246767777887789845--3668988989898998999-74
Q ss_pred H-HHHCCCCCCCCCCCCCCCCCC
Q ss_conf 3-654047830377885889999
Q 001768 343 D-WILTSEKNLDLSYNNFTESSP 364 (1016)
Q Consensus 343 ~-~~~~~L~~LdLs~N~l~~~~p 364 (1016)
. .-+++|+.|++++|++++.+|
T Consensus 346 ~l~~l~~L~~L~l~~N~l~~l~~ 368 (384)
T d2omza2 346 SLANLTNINWLSAGHNQISDLTP 368 (384)
T ss_dssp GGGGCTTCCEEECCSSCCCBCGG
T ss_pred HHCCCCCCCEEECCCCCCCCCHH
T ss_conf 67089999989897995899800
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.98 E-value=1.2e-30 Score=188.78 Aligned_cols=256 Identities=25% Similarity=0.370 Sum_probs=192.7
Q ss_pred EEEEEEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCC--------------
Q ss_conf 223999993699657669400279998879984388799988543330347640012366247988--------------
Q 001768 84 VCHVTVILLKGFNLAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSI-------------- 149 (1016)
Q Consensus 84 ~~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~Ls~N~l~~~~-------------- 149 (1016)
..+++.|++++|.+++..+ +.++++|++|++++|.+.+..+ +..+++|+.|++++|.+++..
T Consensus 65 L~nL~~L~Ls~N~l~~l~~--l~~L~~L~~L~L~~n~i~~i~~--l~~l~~L~~L~~~~~~~~~~~~~~~~~~~~~~~~~ 140 (384)
T d2omza2 65 LNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELS 140 (384)
T ss_dssp CTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGGGTTCTTCSEEEEE
T ss_pred CCCCCEEECCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 8999989681881798863--3477110103013433322221--11233433344332222222222222222112134
Q ss_pred -------------------------------------------------CCCCCCCCCCCEEECCCCCCCCCCCCCCCCC
Q ss_conf -------------------------------------------------8544786774689900577889988788887
Q 001768 150 -------------------------------------------------PLEIGDISTLEELVLEDNQLVGPLPENLGNL 180 (1016)
Q Consensus 150 -------------------------------------------------p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l 180 (1016)
...+..+++++.+++++|.+++..| ....
T Consensus 141 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~ 218 (384)
T d2omza2 141 SNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITP--LGIL 218 (384)
T ss_dssp EEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCCCGG--GGGC
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCC--CCCC
T ss_conf 66313100232222112222212322011112454211011222433321100223532333035774478786--4445
Q ss_pred CCCHHHHCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCHHHHCCCCCCEEEECCCCCCCCCCHHHCCCCCCCEEEC
Q ss_conf 41033202577667988765488998648981588578877032205898787962488689989021208999989985
Q 001768 181 KSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRI 260 (1016)
Q Consensus 181 ~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L 260 (1016)
++|+.|++++|+++.. +.+..+++|+.|++.+|.+++..+ +..+++|+.|+++.|++++.. .+..++.++.+.+
T Consensus 219 ~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~ 292 (384)
T d2omza2 219 TNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNIS--PLAGLTALTNLEL 292 (384)
T ss_dssp TTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEEC
T ss_pred CCCCEEECCCCCCCCC--CHHHCCCCCCHHCCCCCCCCCCCC--CCCCCCCCEEECCCCCCCCCC--CCCCCCCCCCCCC
T ss_conf 7787888877777896--134325653410044674478775--355466877545674457877--3235652222332
Q ss_pred CCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCC
Q ss_conf 78879899975611243335332245335445711002999986696469899999761028999887898138969899
Q 001768 261 SDLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGT 340 (1016)
Q Consensus 261 ~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~L~~~~p~~l~~l~~L~~L~L~~N~l~g~ 340 (1016)
..|.+... ..+..+++++.|++++|++++..+ +..+++|+.|++++|++++ ++ .+.++++|++|++++|++++.
T Consensus 293 ~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l~~--l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l 366 (384)
T d2omza2 293 NENQLEDI--SPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDL 366 (384)
T ss_dssp CSSCCSCC--GGGGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBC
T ss_pred CCCCCCCC--CCCCHHCCCCEEECCCCCCCCCCC--CCCCCCCCEEECCCCCCCC-CH-HHCCCCCCCEEECCCCCCCCC
T ss_conf 32333332--210000246767777887789845--3668988989898998999-74-670899999898979958998
Q ss_pred CCHHHHCCCCCCCCCCC
Q ss_conf 97365404783037788
Q 001768 341 LPDWILTSEKNLDLSYN 357 (1016)
Q Consensus 341 ~p~~~~~~L~~LdLs~N 357 (1016)
.|-.-+++|+.|+|++|
T Consensus 367 ~~l~~l~~L~~L~L~~N 383 (384)
T d2omza2 367 TPLANLTRITQLGLNDQ 383 (384)
T ss_dssp GGGTTCTTCSEEECCCE
T ss_pred HHHCCCCCCCEEECCCC
T ss_conf 00003999999639789
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.5e-29 Score=181.25 Aligned_cols=196 Identities=22% Similarity=0.208 Sum_probs=98.3
Q ss_pred EEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCC
Q ss_conf 99369965766940027999887998438879998854333034764001236624798885447867746899005778
Q 001768 90 ILLKGFNLAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGDISTLEELVLEDNQL 169 (1016)
Q Consensus 90 L~L~~~~l~~~~~~~l~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l 169 (1016)
+++++++++. +|+.+. +.+++|+|++|.|++..+.+|..+++|++|+|++|+|+ .++ .++.+++|+.|+|++|++
T Consensus 15 v~C~~~~L~~-iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~-~~~~l~~L~~L~Ls~N~l 89 (266)
T d1p9ag_ 15 VNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDLSHNQL 89 (266)
T ss_dssp EECTTSCCSS-CCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEE-CCSCCTTCCEEECCSSCC
T ss_pred EECCCCCCCE-ECCCCC--CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCC-CCC-CCCCCCCCCCCCCCCCCC
T ss_conf 9806999886-196757--68898988499289859778634565522135665444-431-111122321111122222
Q ss_pred CCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCHHHHCCCCCCEEEECCCCCCCCCCHHH
Q ss_conf 89988788887410332025776679887654889986489815885788770322058987879624886899890212
Q 001768 170 VGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTI 249 (1016)
Q Consensus 170 ~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l 249 (1016)
+ .. +..+..+++|+.|++++|.+....+.. +
T Consensus 90 ~-~~------------------------~~~~~~l~~L~~L~l~~~~~~~~~~~~------------------------~ 120 (266)
T d1p9ag_ 90 Q-SL------------------------PLLGQTLPALTVLDVSFNRLTSLPLGA------------------------L 120 (266)
T ss_dssp S-SC------------------------CCCTTTCTTCCEEECCSSCCCCCCSST------------------------T
T ss_pred C-CC------------------------CCCCCCCCCCCCCCCCCCCCCEEECCC------------------------C
T ss_conf 1-11------------------------112122222222222223110110011------------------------2
Q ss_pred CCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCE
Q ss_conf 08999989985788798999756112433353322453354457110029999866964698999997610289998878
Q 001768 250 SQLKNLTELRISDLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDY 329 (1016)
Q Consensus 250 ~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~L~~~~p~~l~~l~~L~~ 329 (1016)
..+.++..|++++|.+..+....+..+++|+.|++++|++++..+..|..+++|++|+|++|+|+ .+|..+..+++|+.
T Consensus 121 ~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~ 199 (266)
T d1p9ag_ 121 RGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPF 199 (266)
T ss_dssp TTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSE
T ss_pred CCCCCCCCCCCCCCCCCEECCCCCCCCCCCHHCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCC-CCCHHHCCCCCCCE
T ss_conf 22211112212434210221233322111000000015652237200134212423430139785-56866777888999
Q ss_pred EECCCCCCCCC
Q ss_conf 98138969899
Q 001768 330 IFLTNNSLSGT 340 (1016)
Q Consensus 330 L~L~~N~l~g~ 340 (1016)
|+|++|+|.+.
T Consensus 200 L~L~~Np~~Cd 210 (266)
T d1p9ag_ 200 AFLHGNPWLCN 210 (266)
T ss_dssp EECCSCCBCCS
T ss_pred EEECCCCCCCC
T ss_conf 98369998788
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=4.9e-29 Score=179.52 Aligned_cols=202 Identities=24% Similarity=0.281 Sum_probs=167.8
Q ss_pred CCCCCCCEEECCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCHHHHCCCCCCE
Q ss_conf 78677468990057788998878888741033202577667988765488998648981588578877032205898787
Q 001768 154 GDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDR 233 (1016)
Q Consensus 154 ~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~ 233 (1016)
.....+.+++.+++.++ .+|..+. ++|++|+|++|+|++..+..|..+++|++|+|++|+++. ++ .++.+++|+.
T Consensus 7 ~~~~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~-l~-~~~~l~~L~~ 81 (266)
T d1p9ag_ 7 SKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQ-VDGTLPVLGT 81 (266)
T ss_dssp ECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EE-CCSCCTTCCE
T ss_pred CCCCCCEEEECCCCCCC-EECCCCC--CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCC-CC-CCCCCCCCCC
T ss_conf 42689869980699988-6196757--688989884992898597786345655221356654444-31-1111223211
Q ss_pred EEECCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHCCCCCCCEEECCCCCC
Q ss_conf 96248868998902120899998998578879899975611243335332245335445711002999986696469899
Q 001768 234 LDLQGTSLEGPIPSTISQLKNLTELRISDLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQL 313 (1016)
Q Consensus 234 L~L~~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~L 313 (1016)
|++++|+++. .+..+..+++|+.|++++|.+.......+..+.+++.|++++|.+....+..+..+++|+.|++++|++
T Consensus 82 L~Ls~N~l~~-~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l 160 (266)
T d1p9ag_ 82 LDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNL 160 (266)
T ss_dssp EECCSSCCSS-CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCC
T ss_pred CCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCHHCCCCCCCC
T ss_conf 1112222211-111212222222222222311011001122221111221243421022123332211100000001565
Q ss_pred CCCCCCCCCCCCCCCEEECCCCCCCCCCCHHH--HCCCCCCCCCCCCCCCC
Q ss_conf 99976102899988789813896989997365--40478303778858899
Q 001768 314 TGPVPGILQNLKKIDYIFLTNNSLSGTLPDWI--LTSEKNLDLSYNNFTES 362 (1016)
Q Consensus 314 ~~~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~--~~~L~~LdLs~N~l~~~ 362 (1016)
++..+..|..+++|++|+|++|+|+ .+|..+ +++|+.|+|++|+|.|.
T Consensus 161 ~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~Cd 210 (266)
T d1p9ag_ 161 TELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCN 210 (266)
T ss_dssp SCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCS
T ss_pred CCCCCCCCCCCCCCCEEECCCCCCC-CCCHHHCCCCCCCEEEECCCCCCCC
T ss_conf 2237200134212423430139785-5686677788899998369998788
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.95 E-value=4.2e-28 Score=174.20 Aligned_cols=165 Identities=19% Similarity=0.155 Sum_probs=121.3
Q ss_pred CCCCCCCCCCCCEEEEEEECCCCCEEEEEECCCCCH------------------HHHHHHHHHHHHHHHCCCCCEEEEEE
Q ss_conf 432372023797339998907995999999257771------------------31699999999998439987110022
Q 001768 661 FDAANKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSK------------------QGNREFVNEIGMISALQHQNLVKLYG 722 (1016)
Q Consensus 661 f~~~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~------------------~~~~~~~~E~~~l~~l~Hpniv~l~~ 722 (1016)
+.++++||+|+||.||+|...+|+.||||+++.... ........|...+.++.|++++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred CHHCCEEEECCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEE
T ss_conf 02277802485659999997999999999986044346665565630008889999997789999999816999144998
Q ss_pred EEEECCEEEEEEEECCCCCHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCEEEECCCCCEE
Q ss_conf 67616256999963699948888302768676789788999999999999997722898768399987609981499646
Q 001768 723 CCIEGNQLLLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAK 802 (1016)
Q Consensus 723 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~k 802 (1016)
+. ..+++|||+++..+. .++......++.|++.+++|||+. +|+||||||+|||++++ .++
T Consensus 82 ~~----~~~lvme~~~~~~~~-----------~l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~ 142 (191)
T d1zara2 82 WE----GNAVLMELIDAKELY-----------RVRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIW 142 (191)
T ss_dssp EE----TTEEEEECCCCEEGG-----------GCCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEE
T ss_pred EC----CCEEEEEEECCCCCC-----------CHHHHHHHHHHHHHHHHHHHHHHC---CEEECCCCHHHEEEECC-CEE
T ss_conf 62----888999950456542-----------001578999999999999998268---88983689036114289-899
Q ss_pred EECCCCCCCCCCCCCCEEEECCCCCCCCC------HHHHCCCCCCCCCCHHHHHHHHH
Q ss_conf 61034643368888501110146865448------12111388997220457999999
Q 001768 803 ISDFGLAKLDEDENTHISTRIAGTVGYMA------PEYAMRGYLTDKADVYSFGIVAL 854 (1016)
Q Consensus 803 l~DFGla~~~~~~~~~~~~~~~Gt~~y~a------PE~~~~~~~~~k~DV~SlGvil~ 854 (1016)
|+|||+|......... .|.. .+.+ .+.+..++|+||..--++
T Consensus 143 liDFG~a~~~~~~~~~---------~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 143 IIDFPQSVEVGEEGWR---------EILERDVRNIITYF-SRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp ECCCTTCEETTSTTHH---------HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHHH
T ss_pred EEECCCCCCCCCCCCH---------HHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHH
T ss_conf 9877884308998709---------99987799999997-578998446899999874
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.91 E-value=7.8e-22 Score=138.39 Aligned_cols=249 Identities=24% Similarity=0.266 Sum_probs=136.1
Q ss_pred EEEEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECC
Q ss_conf 39999936996576694002799988799843887999885433303476400123662479888544786774689900
Q 001768 86 HVTVILLKGFNLAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGDISTLEELVLE 165 (1016)
Q Consensus 86 ~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~ 165 (1016)
+++.|+|++++++. +|+. +++|++|+|++|+|+ .+|.. +.+|+.|++++|.++ .++.. .+.|++|+++
T Consensus 39 ~l~~LdLs~~~L~~-lp~~---~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L~ 106 (353)
T d1jl5a_ 39 QAHELELNNLGLSS-LPEL---PPHLESLVASCNSLT-ELPEL---PQSLKSLLVDNNNLK-ALSDL---PPLLEYLGVS 106 (353)
T ss_dssp TCSEEECTTSCCSC-CCSC---CTTCSEEECCSSCCS-SCCCC---CTTCCEEECCSSCCS-CCCSC---CTTCCEEECC
T ss_pred CCCEEEECCCCCCC-CCCC---CCCCCEEECCCCCCC-CCCCC---HHHHHHHHHHHCCCC-HHHHH---CCCCCCCCCC
T ss_conf 99899937999887-8898---789888989999796-33620---332033266551432-03210---2211111334
Q ss_pred CCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCC------------------CCCCCCCCCCCEEEECCCCCCCCCC-----
Q ss_conf 57788998878888741033202577667988------------------7654889986489815885788770-----
Q 001768 166 DNQLVGPLPENLGNLKSLRRILLSSNNFTGSI------------------PESYGNLKNLTEFRIDGSNLTGRIP----- 222 (1016)
Q Consensus 166 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~------------------~~~l~~l~~L~~L~L~~N~l~~~~p----- 222 (1016)
+|.+. .+|. +..+++|+.|++++|.+.... ...+..++.++.+.+.+|.......
T Consensus 107 ~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~l~~l~~l~~L~l~~n~~~~~~~~~~~~ 184 (353)
T d1jl5a_ 107 NNQLE-KLPE-LQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSL 184 (353)
T ss_dssp SSCCS-SCCC-CTTCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSSCCCCCTTC
T ss_pred CCCCC-CCCC-HHHHCCCEEECCCCCCCCCCCCCCCCCCCHHHCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCC
T ss_conf 55432-2210-011013123113565100132233332100001222223332000122200111233443222212222
Q ss_pred -------------HHHHCCCCCCEEEECCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCC
Q ss_conf -------------3220589878796248868998902120899998998578879899975611243335332245335
Q 001768 223 -------------NFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISDLKGSSSSFPNLQDMKKMERLILRNCLI 289 (1016)
Q Consensus 223 -------------~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l 289 (1016)
..+..++.|+.++++.|.... .+ ....++..+.+.++.+..... ....+..+++..+.+
T Consensus 185 ~~l~~~~~~~~~~~~~~~l~~L~~l~l~~n~~~~-~~---~~~~~l~~~~~~~~~~~~~~~----~~~~l~~~~~~~~~~ 256 (353)
T d1jl5a_ 185 ESIVAGNNILEELPELQNLPFLTTIYADNNLLKT-LP---DLPPSLEALNVRDNYLTDLPE----LPQSLTFLDVSENIF 256 (353)
T ss_dssp CEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSS-CC---SCCTTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCC
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CC---CCCCCCCCCCCCCCCCCCCCC----CCCCCCCCCCCCCCC
T ss_conf 2233444322221223455533312225422234-55---323343332223333344433----344322222222333
Q ss_pred CC----------------CCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCC
Q ss_conf 44----------------57110029999866964698999997610289998878981389698999736540478303
Q 001768 290 TG----------------RIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGTLPDWILTSEKNLD 353 (1016)
Q Consensus 290 ~~----------------~~p~~l~~l~~L~~L~Ls~N~L~~~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~~L~~Ld 353 (1016)
.+ .++.....+++|++|++++|+|+ .+|. .+++|+.|+|++|+++ .+|.. +++|+.|+
T Consensus 257 ~~l~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~-~lp~---~~~~L~~L~L~~N~L~-~l~~~-~~~L~~L~ 330 (353)
T d1jl5a_ 257 SGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPA---LPPRLERLIASFNHLA-EVPEL-PQNLKQLH 330 (353)
T ss_dssp SEESCCCTTCCEEECCSSCCSEECCCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCS-CCCCC-CTTCCEEE
T ss_pred CCCCCCCCHHCCCCCCCCCCCCCCCCCCCCCEEECCCCCCC-CCCC---CCCCCCEEECCCCCCC-CCCCC-CCCCCEEE
T ss_conf 22234530001233335753234566898898979799168-3566---5487998989999687-54532-28889898
Q ss_pred CCCCCCCCC
Q ss_conf 778858899
Q 001768 354 LSYNNFTES 362 (1016)
Q Consensus 354 Ls~N~l~~~ 362 (1016)
+++|+++..
T Consensus 331 L~~N~L~~l 339 (353)
T d1jl5a_ 331 VEYNPLREF 339 (353)
T ss_dssp CCSSCCSSC
T ss_pred CCCCCCCCC
T ss_conf 769918977
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.90 E-value=8.4e-23 Score=143.93 Aligned_cols=189 Identities=23% Similarity=0.322 Sum_probs=81.7
Q ss_pred HHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 33034764001236624798885447867746899005778899887888874103320257766798876548899864
Q 001768 129 FARLQNLTKLLILGNRLSGSIPLEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLT 208 (1016)
Q Consensus 129 l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~ 208 (1016)
+..+.+|+.|++.+|.++. ++ .+..+++|++|++++|++++..+ +..+++|+.+++++|.++. + ..+..+++|+
T Consensus 37 ~~~l~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~~-i-~~l~~l~~L~ 110 (227)
T d1h6ua2 37 QADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN-V-SAIAGLQSIK 110 (227)
T ss_dssp HHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSC-C-GGGTTCTTCC
T ss_pred HHHCCCCCEEECCCCCCCC-CH-HHHCCCCCCEEECCCCEEECCCC--CCCCCCCCCCCCCCCCCCC-C-CCCCCCCCCC
T ss_conf 8784886899777999976-64-57448888376357853202543--1123343201211122222-2-2222222221
Q ss_pred EEEECCCCCCCCCCHHHHCCCCCCEEEECCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCC
Q ss_conf 89815885788770322058987879624886899890212089999899857887989997561124333533224533
Q 001768 209 EFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISDLKGSSSSFPNLQDMKKMERLILRNCL 288 (1016)
Q Consensus 209 ~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~ 288 (1016)
.+.++++...+. ..+...+.+..+.++.+.+.... .+...++|+.|++++|.+... ..+..+++|+.|+|++|+
T Consensus 111 ~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~n~~~~~--~~l~~l~~L~~L~Ls~n~ 184 (227)
T d1h6ua2 111 TLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNIS--PLAGLTNLQYLSIGNAQVSDL--TPLANLSKLTTLKADDNK 184 (227)
T ss_dssp EEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSC
T ss_pred CCCCCCCCCCCC--CHHCCCCCHHHHHCHHHHHCHHH--HHCCCCCCCCCCCCCCCCCCC--HHHCCCCCCEECCCCCCC
T ss_conf 221222443311--00000230122200000000000--001021110023333333310--010564633564458884
Q ss_pred CCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECC
Q ss_conf 544571100299998669646989999976102899988789813
Q 001768 289 ITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLT 333 (1016)
Q Consensus 289 l~~~~p~~l~~l~~L~~L~Ls~N~L~~~~p~~l~~l~~L~~L~L~ 333 (1016)
+++. + .+..+++|++|+|++|++++..| +.++++|+.|+++
T Consensus 185 l~~l-~-~l~~l~~L~~L~Ls~N~lt~i~~--l~~l~~L~~L~ls 225 (227)
T d1h6ua2 185 ISDI-S-PLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225 (227)
T ss_dssp CCCC-G-GGGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEE
T ss_pred CCCC-H-HHCCCCCCCEEECCCCCCCCCCC--CCCCCCCCEEEEE
T ss_conf 1778-5-34479999989795996899802--0369998989712
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.90 E-value=2.9e-23 Score=146.56 Aligned_cols=207 Identities=20% Similarity=0.289 Sum_probs=91.3
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCEEEE
Q ss_conf 47640012366247988854478677468990057788998878888741033202577667988765488998648981
Q 001768 133 QNLTKLLILGNRLSGSIPLEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRI 212 (1016)
Q Consensus 133 ~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L 212 (1016)
.++..++++.+.+++.. .+..+.+|+.|++.+|.++. + ..+..+++|+.|++++|++++..+ +..+++|+.+++
T Consensus 19 ~~~~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~-l-~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~ 92 (227)
T d1h6ua2 19 ANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-I-EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELEL 92 (227)
T ss_dssp HHHHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEEC
T ss_pred HHHHHHHHCCCCCCCCC--CHHHCCCCCEEECCCCCCCC-C-HHHHCCCCCCEEECCCCEEECCCC--CCCCCCCCCCCC
T ss_conf 99999984888767757--98784886899777999976-6-457448888376357853202543--112334320121
Q ss_pred CCCCCCCCCCHHHHCCCCCCEEEECCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCC
Q ss_conf 58857887703220589878796248868998902120899998998578879899975611243335332245335445
Q 001768 213 DGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISDLKGSSSSFPNLQDMKKMERLILRNCLITGR 292 (1016)
Q Consensus 213 ~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ 292 (1016)
++|.++. + ..+..+++|+.+.++.+...+. ..+...+.+..+.++.+.+... ..+..+++|+.|++++|.+...
T Consensus 93 ~~n~~~~-i-~~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~ 166 (227)
T d1h6ua2 93 SGNPLKN-V-SAIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDL 166 (227)
T ss_dssp CSCCCSC-C-GGGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCC
T ss_pred CCCCCCC-C-CCCCCCCCCCCCCCCCCCCCCC--CHHCCCCCHHHHHCHHHHHCHH--HHHCCCCCCCCCCCCCCCCCCC
T ss_conf 1122222-2-2222222221221222443311--0000023012220000000000--0001021110023333333310
Q ss_pred CCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCCC
Q ss_conf 711002999986696469899999761028999887898138969899973654047830377
Q 001768 293 IPEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNNSLSGTLPDWILTSEKNLDLS 355 (1016)
Q Consensus 293 ~p~~l~~l~~L~~L~Ls~N~L~~~~p~~l~~l~~L~~L~L~~N~l~g~~p~~~~~~L~~LdLs 355 (1016)
.+ +..+++|+.|+|++|++++. + .++++++|++|+|++|++++..|-..+++|+.|+++
T Consensus 167 ~~--l~~l~~L~~L~Ls~n~l~~l-~-~l~~l~~L~~L~Ls~N~lt~i~~l~~l~~L~~L~ls 225 (227)
T d1h6ua2 167 TP--LANLSKLTTLKADDNKISDI-S-PLASLPNLIEVHLKNNQISDVSPLANTSNLFIVTLT 225 (227)
T ss_dssp GG--GTTCTTCCEEECCSSCCCCC-G-GGGGCTTCCEEECTTSCCCBCGGGTTCTTCCEEEEE
T ss_pred HH--HCCCCCCEECCCCCCCCCCC-H-HHCCCCCCCEEECCCCCCCCCCCCCCCCCCCEEEEE
T ss_conf 01--05646335644588841778-5-344799999897959968998020369998989712
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=6.4e-24 Score=150.30 Aligned_cols=220 Identities=19% Similarity=0.134 Sum_probs=133.3
Q ss_pred EEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCEEECCC
Q ss_conf 99993699657669400279998879984388799988543330347640012366247988-85447867746899005
Q 001768 88 TVILLKGFNLAGVIPEEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSI-PLEIGDISTLEELVLED 166 (1016)
Q Consensus 88 ~~L~L~~~~l~~~~~~~l~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~Ls~N~l~~~~-p~~l~~l~~L~~L~L~~ 166 (1016)
..+++.+.+++ .+|+.+. +++++|+|++|.|+...+..|.++++|++|+|++|.+...+ +..|..++.+++|.+..
T Consensus 11 ~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~ 87 (242)
T d1xwdc1 11 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 87 (242)
T ss_dssp SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred CEEEEECCCCC-CCCCCCC--CCCCEEECCCCCCCCCCHHHHHCCCHHHHHHHCCCCCCCEEECCCCCCCCCCCCCCCCC
T ss_conf 99998189988-7688889--98899987699189649668614643232110221124201001122222222211111
Q ss_pred -CCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCC-CCCCCCCCCEEEECCCCCCCCCCHHHHCCC-CCCEEEECCCCCCC
Q ss_conf -778899887888874103320257766798876-548899864898158857887703220589-87879624886899
Q 001768 167 -NQLVGPLPENLGNLKSLRRILLSSNNFTGSIPE-SYGNLKNLTEFRIDGSNLTGRIPNFIGNWT-KLDRLDLQGTSLEG 243 (1016)
Q Consensus 167 -N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~-~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~-~L~~L~L~~N~l~~ 243 (1016)
|.+....+..+..+++|+.+++++|++....+. .+..+..+..+...++.+....+..+..++ .+..|++.+|+++.
T Consensus 88 ~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~ 167 (242)
T d1xwdc1 88 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE 167 (242)
T ss_dssp CTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCE
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCC
T ss_conf 23432222221222222222234211112554333222111122222221211122222222223310012200123333
Q ss_pred CCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCC
Q ss_conf 89021208999989985788798999756112433353322453354457110029999866964698999997610289
Q 001768 244 PIPSTISQLKNLTELRISDLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQN 323 (1016)
Q Consensus 244 ~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~L~~~~p~~l~~ 323 (1016)
+....+.....++.+++.+|.++...+..|..+++|+.|++++|+++...+..|.+
T Consensus 168 ------------------------i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~ 223 (242)
T d1xwdc1 168 ------------------------IHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLEN 223 (242)
T ss_dssp ------------------------ECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTT
T ss_pred ------------------------CCCCCCCCHHHHCCCCCCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCHHHHCC
T ss_conf ------------------------22222220111012123543246424788668999998989799289459779737
Q ss_pred CCCCCEEECCC
Q ss_conf 99887898138
Q 001768 324 LKKIDYIFLTN 334 (1016)
Q Consensus 324 l~~L~~L~L~~ 334 (1016)
++.|+.+++.+
T Consensus 224 l~~L~~l~~~~ 234 (242)
T d1xwdc1 224 LKKLRARSTYN 234 (242)
T ss_dssp CCEEESSSEES
T ss_pred CCCCCCCCCCC
T ss_conf 71341476788
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.89 E-value=3.4e-23 Score=146.16 Aligned_cols=185 Identities=18% Similarity=0.144 Sum_probs=75.7
Q ss_pred CCCEEECCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCC-CCCCCCCCCCCEEEEC-CCCCCCCCCHHHHCCCCCCEEE
Q ss_conf 7468990057788998878888741033202577667988-7654889986489815-8857887703220589878796
Q 001768 158 TLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSI-PESYGNLKNLTEFRID-GSNLTGRIPNFIGNWTKLDRLD 235 (1016)
Q Consensus 158 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~-~~~l~~l~~L~~L~L~-~N~l~~~~p~~l~~l~~L~~L~ 235 (1016)
++++|+|++|+++...+..|.++++|++|++++|.+...+ +..|..+++++++.+. .|++....+..|..+++|+.++
T Consensus 30 ~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~ 109 (242)
T d1xwdc1 30 NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLL 109 (242)
T ss_dssp CCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEE
T ss_pred CCCEEECCCCCCCCCCHHHHHCCCHHHHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 88999876991896496686146432321102211242010011222222222111112343222222122222222223
Q ss_pred ECCCCCCCCCC-HHHCCCCCCCEEECCCCCCCCCCCCCCCCC-CCCCEEECCCCCCCCCCCHHHCCCCCCCEE-ECCCCC
Q ss_conf 24886899890-212089999899857887989997561124-333533224533544571100299998669-646989
Q 001768 236 LQGTSLEGPIP-STISQLKNLTELRISDLKGSSSSFPNLQDM-KKMERLILRNCLITGRIPEYIEDMTDLKIL-DLSFNQ 312 (1016)
Q Consensus 236 L~~N~l~~~~p-~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l-~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L-~Ls~N~ 312 (1016)
+++|.+....+ ..+..+..+..+...++.+..+....+..+ ..+..|++++|+++...+..+. .++++.+ .+++|.
T Consensus 110 l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~~-~~~l~~~~~l~~n~ 188 (242)
T d1xwdc1 110 ISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFN-GTQLDELNLSDNNN 188 (242)
T ss_dssp EESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTTTT-TCCEEEEECTTCTT
T ss_pred CCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCC-CHHHHCCCCCCCCC
T ss_conf 42111125543332221111222222212111222222222233100122001233332222222-01110121235432
Q ss_pred CCCCCCCCCCCCCCCCEEECCCCCCCCCCCHH
Q ss_conf 99997610289998878981389698999736
Q 001768 313 LTGPVPGILQNLKKIDYIFLTNNSLSGTLPDW 344 (1016)
Q Consensus 313 L~~~~p~~l~~l~~L~~L~L~~N~l~g~~p~~ 344 (1016)
++...+..|.++++|++|++++|++. .+|..
T Consensus 189 l~~l~~~~f~~l~~L~~L~Ls~N~l~-~l~~~ 219 (242)
T d1xwdc1 189 LEELPNDVFHGASGPVILDISRTRIH-SLPSY 219 (242)
T ss_dssp CCCCCTTTTTTSCCCSEEECTTSCCC-CCCSS
T ss_pred CCCCCHHHHCCCCCCCEEECCCCCCC-CCCHH
T ss_conf 46424788668999998989799289-45977
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.87 E-value=1.3e-21 Score=137.12 Aligned_cols=184 Identities=20% Similarity=0.351 Sum_probs=103.3
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCEEEECC
Q ss_conf 64001236624798885447867746899005778899887888874103320257766798876548899864898158
Q 001768 135 LTKLLILGNRLSGSIPLEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDG 214 (1016)
Q Consensus 135 L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~ 214 (1016)
+....+..+.+++.++. ..+.+|++|++++|.++.. + .+..+++|++|+|++|++++.. .++.+++|+.|++++
T Consensus 26 ~i~~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l-~-~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~ 99 (210)
T d1h6ta2 26 TIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDE 99 (210)
T ss_dssp HHHHHTTCSCTTSEECH--HHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCS
T ss_pred HHHHHHCCCCCCCCCCH--HHHCCCCEEECCCCCCCCC-H-HHHHCCCCCEEECCCCCCCCCC--CCCCCCCCCCCCCCC
T ss_conf 99998575765775188--7954845897827988874-4-4764899898769896025860--113586212014333
Q ss_pred CCCCCCCCHHHHCCCCCCEEEECCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCC
Q ss_conf 85788770322058987879624886899890212089999899857887989997561124333533224533544571
Q 001768 215 SNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISDLKGSSSSFPNLQDMKKMERLILRNCLITGRIP 294 (1016)
Q Consensus 215 N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p 294 (1016)
|+++. ++ .+..+++|+.|++++|.+.. + ..+..++.++.++++.|.++.. ..+..+++|+.+++++|++.+..+
T Consensus 100 n~i~~-l~-~l~~l~~L~~L~l~~~~~~~-~-~~l~~l~~l~~l~~~~n~l~~~--~~~~~l~~L~~l~l~~n~l~~i~~ 173 (210)
T d1h6ta2 100 NKVKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP 173 (210)
T ss_dssp SCCCC-GG-GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG
T ss_pred CCCCC-CC-CCCCCCCCCCCCCCCCCCCC-C-CCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 33212-22-12122211122345653221-1-2201111122211222333454--310001332100134643025645
Q ss_pred HHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCC
Q ss_conf 1002999986696469899999761028999887898138
Q 001768 295 EYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTN 334 (1016)
Q Consensus 295 ~~l~~l~~L~~L~Ls~N~L~~~~p~~l~~l~~L~~L~L~~ 334 (1016)
+..+++|+.|+|++|+++ .++ .+.++++|++|+|++
T Consensus 174 --l~~l~~L~~L~Ls~N~i~-~l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 174 --LAGLTKLQNLYLSKNHIS-DLR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp --GTTCTTCCEEECCSSCCC-BCG-GGTTCTTCSEEEEEE
T ss_pred --CCCCCCCCEEECCCCCCC-CCH-HHCCCCCCCEEECCC
T ss_conf --367898999989799899-872-116999989997118
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.87 E-value=2.1e-22 Score=141.64 Aligned_cols=102 Identities=25% Similarity=0.311 Sum_probs=35.9
Q ss_pred EEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCC-CHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCC
Q ss_conf 993699657669400279998879984388799988-5433303476400123662479888544786774689900577
Q 001768 90 ILLKGFNLAGVIPEEFGNLTFLQEVDLSRNYFNGSL-PKSFARLQNLTKLLILGNRLSGSIPLEIGDISTLEELVLEDNQ 168 (1016)
Q Consensus 90 L~L~~~~l~~~~~~~l~~l~~L~~L~L~~n~i~~~~-p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~ 168 (1016)
+++++++++. +|..+. +.+++|+|++|.|+..+ +..|..+++|+.|+|++|.+....+..+..+++|++|+|++|+
T Consensus 13 v~Cs~~~L~~-iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~ 89 (192)
T d1w8aa_ 13 VDCTGRGLKE-IPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENK 89 (192)
T ss_dssp EECTTSCCSS-CCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCC
T ss_pred EEEECCCCCC-CCCCCC--CCCCEEEECCCCCCCCCCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCEEEECCCC
T ss_conf 9970899670-298989--7878898489877553020025787627213013632212121222112222101003553
Q ss_pred CCCCCCCCCCCCCCCHHHHCCCCCCC
Q ss_conf 88998878888741033202577667
Q 001768 169 LVGPLPENLGNLKSLRRILLSSNNFT 194 (1016)
Q Consensus 169 l~~~~p~~l~~l~~L~~L~Ls~N~l~ 194 (1016)
+....+..|.++++|+.|+|++|+|+
T Consensus 90 l~~l~~~~F~~l~~L~~L~L~~N~l~ 115 (192)
T d1w8aa_ 90 IKEISNKMFLGLHQLKTLNLYDNQIS 115 (192)
T ss_dssp CCEECSSSSTTCTTCCEEECCSSCCC
T ss_pred CCCCCHHHHHCCCCCCCCCCCCCCCC
T ss_conf 44349799807974655245774535
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.87 E-value=1.1e-21 Score=137.65 Aligned_cols=141 Identities=17% Similarity=0.222 Sum_probs=70.4
Q ss_pred CCCEEEECCCCCCC-CCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHCCCCCCCEEEC
Q ss_conf 87879624886899-89021208999989985788798999756112433353322453354457110029999866964
Q 001768 230 KLDRLDLQGTSLEG-PIPSTISQLKNLTELRISDLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDL 308 (1016)
Q Consensus 230 ~L~~L~L~~N~l~~-~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 308 (1016)
+++.|+|++|+|+. ..+..|..+++|+.|++++|.+.......+..+++|+.|+|++|+|....+..|..+++|++|+|
T Consensus 30 ~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L 109 (192)
T d1w8aa_ 30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNL 109 (192)
T ss_dssp TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEEC
T ss_pred CCCEEEECCCCCCCCCCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCHHHHHCCCCCCCCCC
T ss_conf 87889848987755302002578762721301363221212122211222210100355344349799807974655245
Q ss_pred CCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCH-HHHCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 69899999761028999887898138969899973-654047830377885889999532344
Q 001768 309 SFNQLTGPVPGILQNLKKIDYIFLTNNSLSGTLPD-WILTSEKNLDLSYNNFTESSPATCRES 370 (1016)
Q Consensus 309 s~N~L~~~~p~~l~~l~~L~~L~L~~N~l~g~~p~-~~~~~L~~LdLs~N~l~~~~p~~~~~~ 370 (1016)
++|+|++..+..|..+++|++|+|++|++.+..+. ++...++.+.+..|.+++..|...+..
T Consensus 110 ~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~~~~l~~~~l~~~~~~c~~p~~l~~~ 172 (192)
T d1w8aa_ 110 YDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSKVRDV 172 (192)
T ss_dssp CSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSSTTTTTS
T ss_pred CCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCEEECCCHHHCCC
T ss_conf 774535359778568753342000364434353027776423540356898276898433698
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.87 E-value=4.5e-21 Score=134.02 Aligned_cols=180 Identities=20% Similarity=0.340 Sum_probs=100.5
Q ss_pred ECCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCHHHHCCCCCCC
Q ss_conf 84388799988543330347640012366247988854478677468990057788998878888741033202577667
Q 001768 115 DLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFT 194 (1016)
Q Consensus 115 ~L~~n~i~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 194 (1016)
.+..+.+++.++ ...+.+|+.|++++|.+... + .+..+++|++|+|++|++++. + .+..+++|+.|++++|+++
T Consensus 30 ~l~~~~~~~~~~--~~~L~~L~~L~l~~~~i~~l-~-~l~~l~~L~~L~L~~n~i~~l-~-~~~~l~~L~~L~l~~n~i~ 103 (210)
T d1h6ta2 30 NLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDI-K-PLANLKNLGWLFLDENKVK 103 (210)
T ss_dssp HTTCSCTTSEEC--HHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCC
T ss_pred HHCCCCCCCCCC--HHHHCCCCEEECCCCCCCCC-H-HHHHCCCCCEEECCCCCCCCC-C-CCCCCCCCCCCCCCCCCCC
T ss_conf 857576577518--87954845897827988874-4-476489989876989602586-0-1135862120143333321
Q ss_pred CCCCCCCCCCCCCCEEEECCCCCCCCCCHHHHCCCCCCEEEECCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCC
Q ss_conf 98876548899864898158857887703220589878796248868998902120899998998578879899975611
Q 001768 195 GSIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISDLKGSSSSFPNLQ 274 (1016)
Q Consensus 195 ~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~ 274 (1016)
+ ++ .+..+++|+.|++++|.+.. ...+..+++++.++++.|.+++. ..+..+++|+.+++++|.+..+. .+.
T Consensus 104 ~-l~-~l~~l~~L~~L~l~~~~~~~--~~~l~~l~~l~~l~~~~n~l~~~--~~~~~l~~L~~l~l~~n~l~~i~--~l~ 175 (210)
T d1h6ta2 104 D-LS-SLKDLKKLKSLSLEHNGISD--INGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIV--PLA 175 (210)
T ss_dssp C-GG-GGTTCTTCCEEECTTSCCCC--CGGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCG--GGT
T ss_pred C-CC-CCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCC--CCC
T ss_conf 2-22-12122211122345653221--12201111122211222333454--31000133210013464302564--536
Q ss_pred CCCCCCEEECCCCCCCCCCCHHHCCCCCCCEEECCC
Q ss_conf 243335332245335445711002999986696469
Q 001768 275 DMKKMERLILRNCLITGRIPEYIEDMTDLKILDLSF 310 (1016)
Q Consensus 275 ~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~ 310 (1016)
.+++|+.|+|++|+++. ++ .+..+++|++|+|++
T Consensus 176 ~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 176 GLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp TCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEE
T ss_pred CCCCCCEEECCCCCCCC-CH-HHCCCCCCCEEECCC
T ss_conf 78989999897998998-72-116999989997118
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.86 E-value=2.8e-21 Score=135.20 Aligned_cols=183 Identities=20% Similarity=0.332 Sum_probs=95.1
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCEEE
Q ss_conf 34764001236624798885447867746899005778899887888874103320257766798876548899864898
Q 001768 132 LQNLTKLLILGNRLSGSIPLEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFR 211 (1016)
Q Consensus 132 l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ 211 (1016)
+.++..+.++.+.+++.+. ...+.+|++|++++|.++. + ..+..+++|++|++++|++++..+ +..+++|+.|+
T Consensus 17 l~~~i~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~-l-~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~ 90 (199)
T d2omxa2 17 LAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDIL 90 (199)
T ss_dssp HHHHHHHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEE
T ss_pred HHHHHHHHHCCCCCCCCCC--HHHHCCCCEEECCCCCCCC-C-CCCCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCC
T ss_conf 9999999967787788559--8794687899899999977-5-202137886757545655667640--16775223111
Q ss_pred ECCCCCCCCCCHHHHCCCCCCEEEECCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCC
Q ss_conf 15885788770322058987879624886899890212089999899857887989997561124333533224533544
Q 001768 212 IDGSNLTGRIPNFIGNWTKLDRLDLQGTSLEGPIPSTISQLKNLTELRISDLKGSSSSFPNLQDMKKMERLILRNCLITG 291 (1016)
Q Consensus 212 L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~ 291 (1016)
+++|.+... + .+.++++|+.|++++|.+... ..+..+++|+.|++++|.+... +.+..+++|+.|++.+|++++
T Consensus 91 l~~n~~~~~-~-~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~~--~~l~~~~~L~~L~l~~n~l~~ 164 (199)
T d2omxa2 91 MNNNQIADI-T-PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISDI--SALSGLTSLQQLNFSSNQVTD 164 (199)
T ss_dssp CCSSCCCCC-G-GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCC
T ss_pred CCCCCCCCC-C-CCCCCCCCCCCCCCCCCCCCC--CCCCHHHHHHHHHHHHHHHCCC--CCCCCCCCCCCCCCCCCCCCC
T ss_conf 122222222-1-111122322211122222232--1000122367764311110023--433321111112234555567
Q ss_pred CCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEE
Q ss_conf 571100299998669646989999976102899988789
Q 001768 292 RIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYI 330 (1016)
Q Consensus 292 ~~p~~l~~l~~L~~L~Ls~N~L~~~~p~~l~~l~~L~~L 330 (1016)
.. .+..+++|+.|++++|++++ ++ .++.+++|+.|
T Consensus 165 l~--~l~~l~~L~~L~ls~N~i~~-i~-~l~~L~~L~~L 199 (199)
T d2omxa2 165 LK--PLANLTTLERLDISSNKVSD-IS-VLAKLTNLESL 199 (199)
T ss_dssp CG--GGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEE
T ss_pred CC--CCCCCCCCCEEECCCCCCCC-CC-CCCCCCCCCCC
T ss_conf 70--11679989999787997998-81-01278998949
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.86 E-value=3.3e-19 Score=123.41 Aligned_cols=95 Identities=25% Similarity=0.355 Sum_probs=38.9
Q ss_pred CCCEEECCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCHHHHCC
Q ss_conf 88799843887999885433303476400123662479888544786774689900577889988788887410332025
Q 001768 110 FLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLS 189 (1016)
Q Consensus 110 ~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls 189 (1016)
++++|+|+++.++ .+|.. +++|++|+|++|+|+ .+|.. +.+|+.|++.+|.++ .++.. .+.|++|+++
T Consensus 39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L~ 106 (353)
T d1jl5a_ 39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPEL---PQSLKSLLVDNNNLK-ALSDL---PPLLEYLGVS 106 (353)
T ss_dssp TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCC---CTTCCEEECCSSCCS-CCCSC---CTTCCEEECC
T ss_pred CCCEEEECCCCCC-CCCCC---CCCCCEEECCCCCCC-CCCCC---HHHHHHHHHHHCCCC-HHHHH---CCCCCCCCCC
T ss_conf 9989993799988-78898---789888989999796-33620---332033266551432-03210---2211111334
Q ss_pred CCCCCCCCCCCCCCCCCCCEEEECCCCCC
Q ss_conf 77667988765488998648981588578
Q 001768 190 SNNFTGSIPESYGNLKNLTEFRIDGSNLT 218 (1016)
Q Consensus 190 ~N~l~~~~~~~l~~l~~L~~L~L~~N~l~ 218 (1016)
+|.+. .+|. ++.+++|+.|++++|.+.
T Consensus 107 ~n~l~-~lp~-~~~l~~L~~L~l~~~~~~ 133 (353)
T d1jl5a_ 107 NNQLE-KLPE-LQNSSFLKIIDVDNNSLK 133 (353)
T ss_dssp SSCCS-SCCC-CTTCTTCCEEECCSSCCS
T ss_pred CCCCC-CCCC-HHHHCCCEEECCCCCCCC
T ss_conf 55432-2210-011013123113565100
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.85 E-value=1.5e-24 Score=153.93 Aligned_cols=110 Identities=19% Similarity=0.218 Sum_probs=66.7
Q ss_pred EEEEEEEECCCCCCCCC-CCCCCCCCCCCEEECCCCCCCCC----CCHHHHCCCCCCCCCCCCCCCCCC----CCCCCC-
Q ss_conf 23999993699657669-40027999887998438879998----854333034764001236624798----885447-
Q 001768 85 CHVTVILLKGFNLAGVI-PEEFGNLTFLQEVDLSRNYFNGS----LPKSFARLQNLTKLLILGNRLSGS----IPLEIG- 154 (1016)
Q Consensus 85 ~~v~~L~L~~~~l~~~~-~~~l~~l~~L~~L~L~~n~i~~~----~p~~l~~l~~L~~L~Ls~N~l~~~----~p~~l~- 154 (1016)
.+++.|+++++++++.. ...+..+++++.|+|++|.++.. +...+..+++|++|+|++|.++.. +...+.
T Consensus 2 ~~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~ 81 (460)
T d1z7xw1 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 81 (460)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred CCCCEEEEECCCCCHHHHHHHHHHCCCCCEEEECCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCCHHHHHHHHHHHHC
T ss_conf 98777982089588689999997677999998289999889999999998539998889795985972899999999843
Q ss_pred CCCCCCEEECCCCCCCCC----CCCCCCCCCCCHHHHCCCCCCC
Q ss_conf 867746899005778899----8878888741033202577667
Q 001768 155 DISTLEELVLEDNQLVGP----LPENLGNLKSLRRILLSSNNFT 194 (1016)
Q Consensus 155 ~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~ 194 (1016)
...+|+.|+|++|+++.. ++..+..+++|++|+|++|+++
T Consensus 82 ~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~ 125 (460)
T d1z7xw1 82 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLG 125 (460)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCH
T ss_pred CCCCCCEEECCCCCCCCCCCCCCCCHHHCCCCCCCCCCCCCCCH
T ss_conf 78877887788877543221012110000343200244433202
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.85 E-value=2.4e-20 Score=129.87 Aligned_cols=141 Identities=28% Similarity=0.446 Sum_probs=53.7
Q ss_pred CCCCCCCEEECCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCHHHHCCCCCCE
Q ss_conf 78677468990057788998878888741033202577667988765488998648981588578877032205898787
Q 001768 154 GDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDR 233 (1016)
Q Consensus 154 ~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~ 233 (1016)
..+++|++|+|++|++++..+ +.++++|+.|++++|.+.. ++ .+..+++|+.|++++|.+... ..+..+++|+.
T Consensus 59 ~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~-~~-~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~ 132 (199)
T d2omxa2 59 EYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD-IT-PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNR 132 (199)
T ss_dssp GGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSE
T ss_pred CCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCC-CC-CCCCCCCCCCCCCCCCCCCCC--CCCCHHHHHHH
T ss_conf 137886757545655667640--1677522311112222222-21-111122322211122222232--10001223677
Q ss_pred EEECCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHCCCCCCCEE
Q ss_conf 9624886899890212089999899857887989997561124333533224533544571100299998669
Q 001768 234 LDLQGTSLEGPIPSTISQLKNLTELRISDLKGSSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKIL 306 (1016)
Q Consensus 234 L~L~~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L 306 (1016)
|++++|++.. + ..+..+++|+.|++.+|.++... .+..+++|+.|++++|++++ ++ .+..+++|+.|
T Consensus 133 L~l~~n~l~~-~-~~l~~~~~L~~L~l~~n~l~~l~--~l~~l~~L~~L~ls~N~i~~-i~-~l~~L~~L~~L 199 (199)
T d2omxa2 133 LELSSNTISD-I-SALSGLTSLQQLNFSSNQVTDLK--PLANLTTLERLDISSNKVSD-IS-VLAKLTNLESL 199 (199)
T ss_dssp EECCSSCCCC-C-GGGTTCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEE
T ss_pred HHHHHHHHCC-C-CCCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCEEECCCCCCCC-CC-CCCCCCCCCCC
T ss_conf 6431111002-3-43332111111223455556770--11679989999787997998-81-01278998949
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.82 E-value=1.8e-21 Score=136.28 Aligned_cols=249 Identities=14% Similarity=0.212 Sum_probs=158.7
Q ss_pred CEEECCCCCCCCCCCHHHHCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCC-CCCCCCCCCCCHHHHC
Q ss_conf 799843887999885433303--4764001236624798885447867746899005778899-8878888741033202
Q 001768 112 QEVDLSRNYFNGSLPKSFARL--QNLTKLLILGNRLSGSIPLEIGDISTLEELVLEDNQLVGP-LPENLGNLKSLRRILL 188 (1016)
Q Consensus 112 ~~L~L~~n~i~~~~p~~l~~l--~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~-~p~~l~~l~~L~~L~L 188 (1016)
+.|||+++.+. |..+..+ ..+..+.++...+..... ......+|++|+|+++.++.. +...+.++++|++|+|
T Consensus 3 ~~lDLs~~~l~---~~~l~~l~~~~~~~lrl~~~~~~~~~~-~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L 78 (284)
T d2astb2 3 QTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSL 78 (284)
T ss_dssp SEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCC-SCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEEC
T ss_pred CEEECCCCCCC---CHHHHHHHHCCCEEEECCCCCCCCCHH-HHCCCCCCCEEECCCCCCCHHHHHHHHHHCCCCCCCCC
T ss_conf 77978999788---147999874554274652333455224-42567878878898984577799999974877651452
Q ss_pred CCCCCCCCCCCCCCCCCCCCEEEECCC-CCCCC-CCHHHHCCCCCCEEEECCC-CCCCC-CCHHHCC-CCCCCEEECCCC
Q ss_conf 577667988765488998648981588-57887-7032205898787962488-68998-9021208-999989985788
Q 001768 189 SSNNFTGSIPESYGNLKNLTEFRIDGS-NLTGR-IPNFIGNWTKLDRLDLQGT-SLEGP-IPSTISQ-LKNLTELRISDL 263 (1016)
Q Consensus 189 s~N~l~~~~~~~l~~l~~L~~L~L~~N-~l~~~-~p~~l~~l~~L~~L~L~~N-~l~~~-~p~~l~~-l~~L~~L~L~~n 263 (1016)
+++.+++..+..++.+++|+.|+++++ .++.. +......+++|+.|+++++ .++.. ....+.. .++|+.|+++++
T Consensus 79 ~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~ 158 (284)
T d2astb2 79 EGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGY 158 (284)
T ss_dssp TTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSC
T ss_pred CCCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCHHHHCCCCCCCCHHHHCCC
T ss_conf 34679867899985189975715100134123554036578874356522453323332200010001111101221355
Q ss_pred C--CCCCCCCC-CCCCCCCCEEECCCC-CCCCCCCHHHCCCCCCCEEECCC-CCCCCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf 7--98999756-112433353322453-35445711002999986696469-8999997610289998878981389698
Q 001768 264 K--GSSSSFPN-LQDMKKMERLILRNC-LITGRIPEYIEDMTDLKILDLSF-NQLTGPVPGILQNLKKIDYIFLTNNSLS 338 (1016)
Q Consensus 264 ~--l~~~~~~~-l~~l~~L~~L~Ls~N-~l~~~~p~~l~~l~~L~~L~Ls~-N~L~~~~p~~l~~l~~L~~L~L~~N~l~ 338 (1016)
. ++...... +..+++|+.|++++| .+++.....+..+++|++|++++ +.+++.....++.+++|+.|++.++ +.
T Consensus 159 ~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~-~~ 237 (284)
T d2astb2 159 RKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VP 237 (284)
T ss_dssp GGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SC
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCCEEECCCCCCCCHHHHHHHHCCCCCCEEEEECC-CC
T ss_conf 42444443434232322212355322347783033332135768779899999787378999726999898964488-89
Q ss_pred CCCCHHHHCCCCCCCCCCCCCCCCCCC
Q ss_conf 999736540478303778858899995
Q 001768 339 GTLPDWILTSEKNLDLSYNNFTESSPA 365 (1016)
Q Consensus 339 g~~p~~~~~~L~~LdLs~N~l~~~~p~ 365 (1016)
...-..+...+..|++..++++...++
T Consensus 238 d~~l~~l~~~lp~L~i~~~~ls~~~~~ 264 (284)
T d2astb2 238 DGTLQLLKEALPHLQINCSHFTTIARP 264 (284)
T ss_dssp TTCHHHHHHHSTTSEESCCCSCCTTCS
T ss_pred HHHHHHHHHHCCCCCCCCCCCCCCCCC
T ss_conf 899999997684366168658777788
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.82 E-value=4.3e-23 Score=145.58 Aligned_cols=276 Identities=19% Similarity=0.204 Sum_probs=127.5
Q ss_pred EEEEEEECCCCCCC----CCCCCCCCCCCCCEEECCCCCCCCCCCHHHHC-----CCCCCCCCCCCCCCCCC----CCCC
Q ss_conf 39999936996576----69400279998879984388799988543330-----34764001236624798----8854
Q 001768 86 HVTVILLKGFNLAG----VIPEEFGNLTFLQEVDLSRNYFNGSLPKSFAR-----LQNLTKLLILGNRLSGS----IPLE 152 (1016)
Q Consensus 86 ~v~~L~L~~~~l~~----~~~~~l~~l~~L~~L~L~~n~i~~~~p~~l~~-----l~~L~~L~Ls~N~l~~~----~p~~ 152 (1016)
+.++|+|.+|+++. .+...+...++|++|+|++|.|+......+.. ..+|+.|+|++|+++.. ++..
T Consensus 28 ~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~it~~~~~~l~~~ 107 (460)
T d1z7xw1 28 QCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSST 107 (460)
T ss_dssp TCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHH
T ss_pred CCCEEEECCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCCHHHHHHHHHHHHCCCCCCCEEECCCCCCCCCCCCCCCCH
T ss_conf 99999828999988999999999853999888979598597289999999984378877887788877543221012110
Q ss_pred CCCCCCCCEEECCCCCCCCCCCCC---------------------------------CCCCCCCHHHHCCCCCCC-----
Q ss_conf 478677468990057788998878---------------------------------888741033202577667-----
Q 001768 153 IGDISTLEELVLEDNQLVGPLPEN---------------------------------LGNLKSLRRILLSSNNFT----- 194 (1016)
Q Consensus 153 l~~l~~L~~L~L~~N~l~~~~p~~---------------------------------l~~l~~L~~L~Ls~N~l~----- 194 (1016)
+..+++|++|+|++|.+....... +...+.++.+.++.+.+.
T Consensus 108 l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ls~~~~~~~~~~ 187 (460)
T d1z7xw1 108 LRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVR 187 (460)
T ss_dssp TTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHH
T ss_pred HHCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 00034320024443320234555544301355433322222232220011001122233332222233222212455554
Q ss_pred ------------------------CC----CCCCCCCCCCCCEEEECCCCCCC-----CCCHHHHCCCCCCEEEECCCCC
Q ss_conf ------------------------98----87654889986489815885788-----7703220589878796248868
Q 001768 195 ------------------------GS----IPESYGNLKNLTEFRIDGSNLTG-----RIPNFIGNWTKLDRLDLQGTSL 241 (1016)
Q Consensus 195 ------------------------~~----~~~~l~~l~~L~~L~L~~N~l~~-----~~p~~l~~l~~L~~L~L~~N~l 241 (1016)
.. ....+...+.++.+.+.+|.+.. ...........++.+++++|.+
T Consensus 188 ~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i 267 (460)
T d1z7xw1 188 VLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGI 267 (460)
T ss_dssp HHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCC
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCHHHCCCCCCCCCHHHCCCCCCCCCCCCCCCCCCCC
T ss_conf 32343321122100124112454210110122332222221001002112233442011000111111100001345433
Q ss_pred CCCC----CHHHCCCCCCCEEECCCCCCCCCCCCCC-----CCCCCCCEEECCCCCCCCCCCH----HHCCCCCCCEEEC
Q ss_conf 9989----0212089999899857887989997561-----1243335332245335445711----0029999866964
Q 001768 242 EGPI----PSTISQLKNLTELRISDLKGSSSSFPNL-----QDMKKMERLILRNCLITGRIPE----YIEDMTDLKILDL 308 (1016)
Q Consensus 242 ~~~~----p~~l~~l~~L~~L~L~~n~l~~~~~~~l-----~~l~~L~~L~Ls~N~l~~~~p~----~l~~l~~L~~L~L 308 (1016)
.... ...+...+.+..+++++|.++......+ .....|+.+++++|.+...... .+...++|+.|+|
T Consensus 268 ~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~L 347 (460)
T d1z7xw1 268 TAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQI 347 (460)
T ss_dssp CHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEEC
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHCCCCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCCHHHHHE
T ss_conf 21233433221112343334444433322456421110123334443333233341023344321332211011113201
Q ss_pred CCCCCCCCC----CCCC-CCCCCCCEEECCCCCCCCC----CCHHH--HCCCCCCCCCCCCCCC
Q ss_conf 698999997----6102-8999887898138969899----97365--4047830377885889
Q 001768 309 SFNQLTGPV----PGIL-QNLKKIDYIFLTNNSLSGT----LPDWI--LTSEKNLDLSYNNFTE 361 (1016)
Q Consensus 309 s~N~L~~~~----p~~l-~~l~~L~~L~L~~N~l~g~----~p~~~--~~~L~~LdLs~N~l~~ 361 (1016)
++|.+++.. +..+ ...+.|+.|+|++|.++.. ++..+ .++|+.|||++|+++.
T Consensus 348 s~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~ 411 (460)
T d1z7xw1 348 SNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGD 411 (460)
T ss_dssp CSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCH
T ss_pred EEECCCCCCCCHHHHHHHCCCCCCCEEECCCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCCH
T ss_conf 2101357664001112204567778898979979759999999999629988989899996987
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.78 E-value=5.8e-21 Score=133.40 Aligned_cols=240 Identities=15% Similarity=0.093 Sum_probs=107.3
Q ss_pred CCCCCCCCCCEEECCCCCCCCCC----CHHHHCCCCCCCCCCCCCCCCCC----------CCCCCCCCCCCCEEECCCCC
Q ss_conf 00279998879984388799988----54333034764001236624798----------88544786774689900577
Q 001768 103 EEFGNLTFLQEVDLSRNYFNGSL----PKSFARLQNLTKLLILGNRLSGS----------IPLEIGDISTLEELVLEDNQ 168 (1016)
Q Consensus 103 ~~l~~l~~L~~L~L~~n~i~~~~----p~~l~~l~~L~~L~Ls~N~l~~~----------~p~~l~~l~~L~~L~L~~N~ 168 (1016)
..+.....|++|+|++|.+.... ...+...++|+.|+++.+..... +...+...++|++|+|++|.
T Consensus 25 ~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~ 104 (344)
T d2ca6a1 25 AVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNA 104 (344)
T ss_dssp HHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCC
T ss_pred HHHHHCCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCC
T ss_conf 99963899788978498377899999999998589988888877754334542106787999887547775633000013
Q ss_pred CCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCC-------------HHHHCCCCCCEEE
Q ss_conf 889988788887410332025776679887654889986489815885788770-------------3220589878796
Q 001768 169 LVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIP-------------NFIGNWTKLDRLD 235 (1016)
Q Consensus 169 l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p-------------~~l~~l~~L~~L~ 235 (1016)
+.......+ ...+...++|+.|++++|.+..... ......+.|+.+.
T Consensus 105 i~~~~~~~l--------------------~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~ 164 (344)
T d2ca6a1 105 FGPTAQEPL--------------------IDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSII 164 (344)
T ss_dssp CCTTTHHHH--------------------HHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEE
T ss_pred CCCCCCCCH--------------------HHHHCCCCCCHHEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEE
T ss_conf 455433310--------------------111002343210000024666654311112122221100014676421110
Q ss_pred ECCCCCCCC----CCHHHCCCCCCCEEECCCCCCCCCC-----CCCCCCCCCCCEEECCCCCCCCC----CCHHHCCCCC
Q ss_conf 248868998----9021208999989985788798999-----75611243335332245335445----7110029999
Q 001768 236 LQGTSLEGP----IPSTISQLKNLTELRISDLKGSSSS-----FPNLQDMKKMERLILRNCLITGR----IPEYIEDMTD 302 (1016)
Q Consensus 236 L~~N~l~~~----~p~~l~~l~~L~~L~L~~n~l~~~~-----~~~l~~l~~L~~L~Ls~N~l~~~----~p~~l~~l~~ 302 (1016)
+++|.++.. +...+...+.|+.|+++.|.+.... ...+...++|+.|+|++|.+... +...+..+++
T Consensus 165 l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~ 244 (344)
T d2ca6a1 165 CGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPN 244 (344)
T ss_dssp CCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTT
T ss_pred CCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 13650135543322111123332133543332222222320024332110121122233332222222234443323221
Q ss_pred CCEEECCCCCCCCCCCCCC----C--CCCCCCEEECCCCCCCCCCCHHH-------HCCCCCCCCCCCCCCCC
Q ss_conf 8669646989999976102----8--99988789813896989997365-------40478303778858899
Q 001768 303 LKILDLSFNQLTGPVPGIL----Q--NLKKIDYIFLTNNSLSGTLPDWI-------LTSEKNLDLSYNNFTES 362 (1016)
Q Consensus 303 L~~L~Ls~N~L~~~~p~~l----~--~l~~L~~L~L~~N~l~g~~p~~~-------~~~L~~LdLs~N~l~~~ 362 (1016)
|+.|+|++|.+++.....+ . ..+.|+.|++++|.+.......+ .+.|+.|+|++|++...
T Consensus 245 L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~~ 317 (344)
T d2ca6a1 245 LRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEE 317 (344)
T ss_dssp CCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTT
T ss_pred CHHHHHHCCCCCCHHHHHHHHHHHHCCCCCCCEEECCCCCCCHHHHHHHHHHHHCCCCCCCEEECCCCCCCCC
T ss_conf 1110300475671566788877631568888989898986980899999999970389999897879808986
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.77 E-value=2.8e-21 Score=135.18 Aligned_cols=243 Identities=15% Similarity=0.217 Sum_probs=152.8
Q ss_pred EEEEEEECCCCCCC----CCCCCCCCCCCCCEEECCCCCCCCC---C-------CHHHHCCCCCCCCCCCCCCCCCCCC-
Q ss_conf 39999936996576----6940027999887998438879998---8-------5433303476400123662479888-
Q 001768 86 HVTVILLKGFNLAG----VIPEEFGNLTFLQEVDLSRNYFNGS---L-------PKSFARLQNLTKLLILGNRLSGSIP- 150 (1016)
Q Consensus 86 ~v~~L~L~~~~l~~----~~~~~l~~l~~L~~L~L~~n~i~~~---~-------p~~l~~l~~L~~L~Ls~N~l~~~~p- 150 (1016)
.++.|+|++|.+.. .+...+...+.|+.|+++++..... . ...+...++|+.|+|++|.++....
T Consensus 32 ~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~ 111 (344)
T d2ca6a1 32 SVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQE 111 (344)
T ss_dssp CCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTHH
T ss_pred CCCEEECCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCC
T ss_conf 97889784983778999999999985899888888777543345421067879998875477756330000134554333
Q ss_pred ---CCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCC----CCH
Q ss_conf ---5447867746899005778899887888874103320257766798876548899864898158857887----703
Q 001768 151 ---LEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGR----IPN 223 (1016)
Q Consensus 151 ---~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~----~p~ 223 (1016)
..+...++|++|++++|.+.......+. ..|..+..... ....+.|+.+.+++|.+... +..
T Consensus 112 ~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~--~~l~~~~~~~~---------~~~~~~L~~l~l~~n~i~~~~~~~l~~ 180 (344)
T d2ca6a1 112 PLIDFLSKHTPLEHLYLHNNGLGPQAGAKIA--RALQELAVNKK---------AKNAPPLRSIICGRNRLENGSMKEWAK 180 (344)
T ss_dssp HHHHHHHHCTTCCEEECCSSCCHHHHHHHHH--HHHHHHHHHHH---------HHTCCCCCEEECCSSCCTGGGHHHHHH
T ss_pred CHHHHHCCCCCCHHEECCCCCCCCCCCCCCC--CCCCCCCCCCC---------CCCCCCCCEEECCCCCCCCCCCCCCCC
T ss_conf 1011100234321000002466665431111--21222211000---------146764211101365013554332211
Q ss_pred HHHCCCCCCEEEECCCCCCCC-----CCHHHCCCCCCCEEECCCCCCCCCCC----CCCCCCCCCCEEECCCCCCCCCCC
Q ss_conf 220589878796248868998-----90212089999899857887989997----561124333533224533544571
Q 001768 224 FIGNWTKLDRLDLQGTSLEGP-----IPSTISQLKNLTELRISDLKGSSSSF----PNLQDMKKMERLILRNCLITGRIP 294 (1016)
Q Consensus 224 ~l~~l~~L~~L~L~~N~l~~~-----~p~~l~~l~~L~~L~L~~n~l~~~~~----~~l~~l~~L~~L~Ls~N~l~~~~p 294 (1016)
.+...+.|+.|+|++|.++.. +...+...++|+.|++++|.++.... ..+...++|++|+|++|.|.+...
T Consensus 181 ~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~ 260 (344)
T d2ca6a1 181 TFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGA 260 (344)
T ss_dssp HHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHH
T ss_pred HHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCHHH
T ss_conf 11233321335433322222223200243321101211222333322222222344433232211110300475671566
Q ss_pred H----HHCC--CCCCCEEECCCCCCCCCC----CCCCC-CCCCCCEEECCCCCCCC
Q ss_conf 1----0029--999866964698999997----61028-99988789813896989
Q 001768 295 E----YIED--MTDLKILDLSFNQLTGPV----PGILQ-NLKKIDYIFLTNNSLSG 339 (1016)
Q Consensus 295 ~----~l~~--l~~L~~L~Ls~N~L~~~~----p~~l~-~l~~L~~L~L~~N~l~g 339 (1016)
. .+.. .+.|+.|++++|.++... ...+. .++.|+.|+|++|++..
T Consensus 261 ~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~ 316 (344)
T d2ca6a1 261 AAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 316 (344)
T ss_dssp HHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred HHHHHHHHHCCCCCCCEEECCCCCCCHHHHHHHHHHHHCCCCCCCEEECCCCCCCC
T ss_conf 78887763156888898989898698089999999997038999989787980898
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.73 E-value=3.1e-19 Score=123.54 Aligned_cols=206 Identities=20% Similarity=0.248 Sum_probs=84.4
Q ss_pred CCCCCCEEECCCCCCCCC-CCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCC-CCCCC-CCCCCCCCCCC
Q ss_conf 999887998438879998-8543330347640012366247988854478677468990057-78899-88788887410
Q 001768 107 NLTFLQEVDLSRNYFNGS-LPKSFARLQNLTKLLILGNRLSGSIPLEIGDISTLEELVLEDN-QLVGP-LPENLGNLKSL 183 (1016)
Q Consensus 107 ~l~~L~~L~L~~n~i~~~-~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N-~l~~~-~p~~l~~l~~L 183 (1016)
....|++|||+++.++.. +...+.++++|++|+|+++.++...+..++.+++|++|+|+++ .++.. +...+
T Consensus 44 ~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~------ 117 (284)
T d2astb2 44 SPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLL------ 117 (284)
T ss_dssp CCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHH------
T ss_pred CCCCCCEEECCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCHHH------
T ss_conf 67878878898984577799999974877651452346798678999851899757151001341235540365------
Q ss_pred HHHHCCCCCCCCCCCCCCCCCCCCCEEEECCCC-CCCC-CCHHHHC-CCCCCEEEECCC--CCCCC-CCHHHCCCCCCCE
Q ss_conf 332025776679887654889986489815885-7887-7032205-898787962488--68998-9021208999989
Q 001768 184 RRILLSSNNFTGSIPESYGNLKNLTEFRIDGSN-LTGR-IPNFIGN-WTKLDRLDLQGT--SLEGP-IPSTISQLKNLTE 257 (1016)
Q Consensus 184 ~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~-l~~~-~p~~l~~-l~~L~~L~L~~N--~l~~~-~p~~l~~l~~L~~ 257 (1016)
.++++|++|+++++. ++.. ....+.. .++|+.|++++. .++.. +...+..+++|+.
T Consensus 118 ------------------~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~ 179 (284)
T d2astb2 118 ------------------SSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVH 179 (284)
T ss_dssp ------------------HHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSE
T ss_pred ------------------HHHHHCCCCCCCCCCCCCCCCCHHHHCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf ------------------78874356522453323332200010001111101221355424444434342323222123
Q ss_pred EECCCCC-CCCCCCCCCCCCCCCCEEECCCC-CCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCC
Q ss_conf 9857887-98999756112433353322453-354457110029999866964698999997610289998878981389
Q 001768 258 LRISDLK-GSSSSFPNLQDMKKMERLILRNC-LITGRIPEYIEDMTDLKILDLSFNQLTGPVPGILQNLKKIDYIFLTNN 335 (1016)
Q Consensus 258 L~L~~n~-l~~~~~~~l~~l~~L~~L~Ls~N-~l~~~~p~~l~~l~~L~~L~Ls~N~L~~~~p~~l~~l~~L~~L~L~~N 335 (1016)
|++++|. ++......+..+++|++|+|++| .+++.....+..+++|+.|+++++.-.+.++.....+|+|+ +..+
T Consensus 180 L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~~~d~~l~~l~~~lp~L~---i~~~ 256 (284)
T d2astb2 180 LDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQ---INCS 256 (284)
T ss_dssp EECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTSSCTTCHHHHHHHSTTSE---ESCC
T ss_pred CCCCCCCCCCCHHHHHHCCCCCCCEEECCCCCCCCHHHHHHHHCCCCCCEEEEECCCCHHHHHHHHHHCCCCC---CCCC
T ss_conf 5532234778303333213576877989999978737899972699989896448889899999997684366---1686
Q ss_pred CCCC
Q ss_conf 6989
Q 001768 336 SLSG 339 (1016)
Q Consensus 336 ~l~g 339 (1016)
+++.
T Consensus 257 ~ls~ 260 (284)
T d2astb2 257 HFTT 260 (284)
T ss_dssp CSCC
T ss_pred CCCC
T ss_conf 5877
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.68 E-value=2.1e-17 Score=113.03 Aligned_cols=14 Identities=21% Similarity=0.093 Sum_probs=4.8
Q ss_pred CCCCEEECCCCCCC
Q ss_conf 98879984388799
Q 001768 109 TFLQEVDLSRNYFN 122 (1016)
Q Consensus 109 ~~L~~L~L~~n~i~ 122 (1016)
..+++|+|++|+|+
T Consensus 18 ~~lr~L~L~~n~I~ 31 (162)
T d1a9na_ 18 VRDRELDLRGYKIP 31 (162)
T ss_dssp TSCEEEECTTSCCC
T ss_pred CCCCEEECCCCCCC
T ss_conf 74848978899788
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.65 E-value=5.2e-17 Score=110.80 Aligned_cols=86 Identities=16% Similarity=0.175 Sum_probs=35.6
Q ss_pred CCCCCCCEEECCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCHHHHCCCCCCE
Q ss_conf 78677468990057788998878888741033202577667988765488998648981588578877032205898787
Q 001768 154 GDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGRIPNFIGNWTKLDR 233 (1016)
Q Consensus 154 ~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~ 233 (1016)
.+...|++|+|++|+++ .++..+..+++|+.|+|++|+++. + +.+..+++|+.|++++|+++...+..+..+++|+.
T Consensus 15 ~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~-l-~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~ 91 (162)
T d1a9na_ 15 TNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRK-L-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTE 91 (162)
T ss_dssp ECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCE-E-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCE
T ss_pred CCCCCCCEEECCCCCCC-CCCCCCCCCCCCCEEECCCCCCCC-C-CCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 68574848978899788-657620041459989897997876-4-77445761306431021345777632233453443
Q ss_pred EEECCCCCC
Q ss_conf 962488689
Q 001768 234 LDLQGTSLE 242 (1016)
Q Consensus 234 L~L~~N~l~ 242 (1016)
|++++|+++
T Consensus 92 L~L~~N~i~ 100 (162)
T d1a9na_ 92 LILTNNSLV 100 (162)
T ss_dssp EECCSCCCC
T ss_pred CEECCCCCC
T ss_conf 420300016
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.61 E-value=1.6e-15 Score=102.32 Aligned_cols=41 Identities=32% Similarity=0.418 Sum_probs=14.1
Q ss_pred HHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf 330347640012366247988854478677468990057788
Q 001768 129 FARLQNLTKLLILGNRLSGSIPLEIGDISTLEELVLEDNQLV 170 (1016)
Q Consensus 129 l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~ 170 (1016)
+..+++|++|++++|.++ .+|..++.+++|+.|++++|+++
T Consensus 16 l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~ 56 (124)
T d1dcea3 16 LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE 56 (124)
T ss_dssp GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC
T ss_pred CCCCCCCCEEECCCCCCC-CCHHHHHHHHCCCCCCCCCCCCC
T ss_conf 105898898979787168-65215655431354532432112
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.60 E-value=2.7e-15 Score=100.99 Aligned_cols=41 Identities=27% Similarity=0.408 Sum_probs=13.9
Q ss_pred CCCCCCCCEEECCCCCCCCCCCCCCCCCCCCHHHHCCCCCCC
Q ss_conf 478677468990057788998878888741033202577667
Q 001768 153 IGDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFT 194 (1016)
Q Consensus 153 l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 194 (1016)
+..+++|++|++++|+++ .+|..+..+++|+.|++++|+++
T Consensus 16 l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~ 56 (124)
T d1dcea3 16 LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE 56 (124)
T ss_dssp GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC
T ss_pred CCCCCCCCEEECCCCCCC-CCHHHHHHHHCCCCCCCCCCCCC
T ss_conf 105898898979787168-65215655431354532432112
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.56 E-value=1.4e-17 Score=114.16 Aligned_cols=87 Identities=28% Similarity=0.337 Sum_probs=35.3
Q ss_pred CCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCC
Q ss_conf 00279998879984388799988543330347640012366247988854478677468990057788998878888741
Q 001768 103 EEFGNLTFLQEVDLSRNYFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGDISTLEELVLEDNQLVGPLPENLGNLKS 182 (1016)
Q Consensus 103 ~~l~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~ 182 (1016)
.++..+++|++|+|++|.|+. ++ .|..+++|+.|+|++|.++ .++..+..+++|+.|++++|+++. ++ .+..+++
T Consensus 42 ~sl~~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l~-~~~~l~~ 116 (198)
T d1m9la_ 42 ATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVN 116 (198)
T ss_dssp HHHHHTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-HH-HHHHHHH
T ss_pred HHHHCCCCCCEEECCCCCCCC-CC-CCCCCCCCCCHHHCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCC-CC-CCCCCCC
T ss_conf 677626046151994468998-64-4247825357341353432-100003322123333333322222-22-2222223
Q ss_pred CHHHHCCCCCCC
Q ss_conf 033202577667
Q 001768 183 LRRILLSSNNFT 194 (1016)
Q Consensus 183 L~~L~Ls~N~l~ 194 (1016)
|+.|++++|+++
T Consensus 117 L~~L~L~~N~i~ 128 (198)
T d1m9la_ 117 LRVLYMSNNKIT 128 (198)
T ss_dssp SSEEEESEEECC
T ss_pred CCCCCCCCCHHC
T ss_conf 411123410212
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.53 E-value=1e-13 Score=91.95 Aligned_cols=107 Identities=20% Similarity=0.188 Sum_probs=67.4
Q ss_pred CCEEEECCCCCCCCCCHHHCCCCCCCEEECCCC-CCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHCCCCCCCEEECC
Q ss_conf 787962488689989021208999989985788-7989997561124333533224533544571100299998669646
Q 001768 231 LDRLDLQGTSLEGPIPSTISQLKNLTELRISDL-KGSSSSFPNLQDMKKMERLILRNCLITGRIPEYIEDMTDLKILDLS 309 (1016)
Q Consensus 231 L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~n-~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls 309 (1016)
...+++.++.+. ..|..+..+++|++|++++| .++.+....|..+++|+.|+|++|+|+.+.+.+|..+++|+.|+|+
T Consensus 10 ~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls 88 (156)
T d2ifga3 10 SSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (156)
T ss_dssp SSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred CCEEEECCCCCC-CCCCCCCCCCCCCEEECCCCCCCCCCCCHHHCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEECC
T ss_conf 996985289976-5860025765657431689866443692122566666721620212477420111245543333226
Q ss_pred CCCCCCCCCCCCCCCCCCCEEECCCCCCCC
Q ss_conf 989999976102899988789813896989
Q 001768 310 FNQLTGPVPGILQNLKKIDYIFLTNNSLSG 339 (1016)
Q Consensus 310 ~N~L~~~~p~~l~~l~~L~~L~L~~N~l~g 339 (1016)
+|+|+...+..|.. .+|+.|+|++|++..
T Consensus 89 ~N~l~~l~~~~~~~-~~l~~L~L~~Np~~C 117 (156)
T d2ifga3 89 FNALESLSWKTVQG-LSLQELVLSGNPLHC 117 (156)
T ss_dssp SSCCSCCCSTTTCS-CCCCEEECCSSCCCC
T ss_pred CCCCCCCCHHHHCC-CCCCCCCCCCCCCCC
T ss_conf 78785157456335-321243357986338
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.51 E-value=3.1e-17 Score=112.13 Aligned_cols=114 Identities=18% Similarity=0.270 Sum_probs=61.3
Q ss_pred CCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCC
Q ss_conf 88543330347640012366247988854478677468990057788998878888741033202577667988765488
Q 001768 124 SLPKSFARLQNLTKLLILGNRLSGSIPLEIGDISTLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGN 203 (1016)
Q Consensus 124 ~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~ 203 (1016)
.++.++..+++|++|+|++|+|+ .++ .+..+++|+.|+|++|.++ .++.....+++|+.|++++|+++. + ..+..
T Consensus 39 ~l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l-~~~~~ 113 (198)
T d1m9la_ 39 KMDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-L-SGIEK 113 (198)
T ss_dssp CCHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-H-HHHHH
T ss_pred HHHHHHHCCCCCCEEECCCCCCC-CCC-CCCCCCCCCCHHHCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCC-C-CCCCC
T ss_conf 02467762604615199446899-864-4247825357341353432-100003322123333333322222-2-22222
Q ss_pred CCCCCEEEECCCCCCCCCC-HHHHCCCCCCEEEECCCCCC
Q ss_conf 9986489815885788770-32205898787962488689
Q 001768 204 LKNLTEFRIDGSNLTGRIP-NFIGNWTKLDRLDLQGTSLE 242 (1016)
Q Consensus 204 l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~L~~N~l~ 242 (1016)
+++|+.|++++|+++.... ..+..+++|+.|++++|.+.
T Consensus 114 l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~ 153 (198)
T d1m9la_ 114 LVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLY 153 (198)
T ss_dssp HHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHH
T ss_pred CCCCCCCCCCCCHHCCCCCCCCCCCCCCCCEEECCCCCCC
T ss_conf 2234111234102125542212367776302342798434
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.50 E-value=7.2e-14 Score=92.86 Aligned_cols=69 Identities=19% Similarity=0.117 Sum_probs=28.4
Q ss_pred CCCCCCCCCCCEEECCCC-CCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf 400279998879984388-799988543330347640012366247988854478677468990057788
Q 001768 102 PEEFGNLTFLQEVDLSRN-YFNGSLPKSFARLQNLTKLLILGNRLSGSIPLEIGDISTLEELVLEDNQLV 170 (1016)
Q Consensus 102 ~~~l~~l~~L~~L~L~~n-~i~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~ 170 (1016)
|..+..+++|++|++++| .++.+.+.+|..+++|+.|+|++|+|+...+..|..+++|++|+|++|+++
T Consensus 24 p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~ 93 (156)
T d2ifga3 24 LHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE 93 (156)
T ss_dssp TTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCS
T ss_pred CCCCCCCCCCCEEECCCCCCCCCCCCHHHCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEECCCCCCC
T ss_conf 6002576565743168986644369212256666672162021247742011124554333322678785
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=99.19 E-value=4.1e-10 Score=71.43 Aligned_cols=150 Identities=14% Similarity=0.108 Sum_probs=102.5
Q ss_pred HHHHHHHCCCCCCCCCCCCCCEEEEEEECCCCCEEEEEECCCCCHHHHHHHHHHHHHHHHCC-CCCEEEEEEEEEECCEE
Q ss_conf 99999823843237202379733999890799599999925777131699999999998439-98711002267616256
Q 001768 652 RQIKAATNNFDAANKIGEGGFGPVYKGTLSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQ-HQNLVKLYGCCIEGNQL 730 (1016)
Q Consensus 652 ~~~~~a~~~f~~~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-Hpniv~l~~~~~~~~~~ 730 (1016)
.++...-+.|+..+..+.++...||+.... ++.+.+|+...........+.+|...+..+. +--+.+++.+...++..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHHHHHCEEEEECCCCCCCCCEEEEEEC-CCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCE
T ss_conf 999975135279976789987718999908-9869999848876532556999999999876069987289997508964
Q ss_pred EEEEEECCCCCHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-------------------------------
Q ss_conf 9999636999488883027686767897889999999999999977228-------------------------------
Q 001768 731 LLVYEYLENNSLARALFGKEGQCLNLDWATRKRICSDIARGLAYLHEES------------------------------- 779 (1016)
Q Consensus 731 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~------------------------------- 779 (1016)
++||+++++.++.+.... ......++.++++.++.||+..
T Consensus 86 ~lv~~~l~G~~~~~~~~~---------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE 156 (263)
T ss_dssp EEEEECCSSEEHHHHTTT---------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGG
T ss_pred EEEEEECCCCCCCCCCCC---------CCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHH
T ss_conf 999986043343543344---------02699999989999999855684214357644656555778998776555543
Q ss_pred -------------------------CCCEEECCCCCCEEEECCCCCEEEECCCCCCC
Q ss_conf -------------------------98768399987609981499646610346433
Q 001768 780 -------------------------RLKIVHRDIKATNVLLDKDLNAKISDFGLAKL 811 (1016)
Q Consensus 780 -------------------------~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 811 (1016)
...++|+|+.|.|||++++...-+.||+.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp GGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred CCCCCCCCHHHHHHHHHHHHCCCCCCCEEEEEECCCCCEEECCCCEEEEEECHHCCC
T ss_conf 033232005799999999844986781789860047642364996599960231441
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.76 E-value=8.8e-08 Score=58.10 Aligned_cols=131 Identities=18% Similarity=0.179 Sum_probs=84.5
Q ss_pred CCCCCCC-EEEEEEECCCCCEEEEEECCCCCHHHHHHHHHHHHHHHHCC--CCCEEEEEEEEEECCEEEEEEEECCCCCH
Q ss_conf 2023797-33999890799599999925777131699999999998439--98711002267616256999963699948
Q 001768 666 KIGEGGF-GPVYKGTLSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQ--HQNLVKLYGCCIEGNQLLLVYEYLENNSL 742 (1016)
Q Consensus 666 ~LG~G~f-G~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~--Hpniv~l~~~~~~~~~~~lV~E~~~~gsL 742 (1016)
.+..|.. +.||+....++..+.+|........ .+..|...++.+. .-.+.+++++..+++..++||+++++.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~---~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALN---ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTTS---CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred ECCCCCCCCEEEEEEECCCCEEEEEECCCCCHH---HHHHHHHHHHHHHHCCCCCCCEEEECCCCCCEEEEEEEEECCCC
T ss_conf 767865477589999389878999958966776---89999999999986599988613222456615999874413554
Q ss_pred HHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---------------------------------------------
Q ss_conf 88830276867678978899999999999999772---------------------------------------------
Q 001768 743 ARALFGKEGQCLNLDWATRKRICSDIARGLAYLHE--------------------------------------------- 777 (1016)
Q Consensus 743 ~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~--------------------------------------------- 777 (1016)
.+.. .. ....+.++++.|.-||+
T Consensus 94 ~~~~---------~~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (255)
T d1nd4a_ 94 LSSH---------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL 161 (255)
T ss_dssp TTSC---------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred CCCC---------CC---HHHHHHHHHHHHHHHCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHH
T ss_conf 3221---------26---89999999999998736885448875541246889999998754110113401121379999
Q ss_pred ------C----CCCCEEECCCCCCEEEECCCCCEEEECCCCCCC
Q ss_conf ------2----898768399987609981499646610346433
Q 001768 778 ------E----SRLKIVHRDIKATNVLLDKDLNAKISDFGLAKL 811 (1016)
Q Consensus 778 ------~----~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 811 (1016)
. .++.++|+|+.|.|||++.+..+-+.||+.+..
T Consensus 162 ~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 162 FARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHCCCCCCCEEEECCCCCCCEEEECCCEEEEEECHHCCC
T ss_conf 99998718765795678678887635773796589998533265
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.73 E-value=4.3e-10 Score=71.32 Aligned_cols=122 Identities=16% Similarity=0.086 Sum_probs=0.0
Q ss_pred CCCCEEECCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCC--CCHHHHCCCCCCEE
Q ss_conf 7746899005778899887888874103320257766798876548899864898158857887--70322058987879
Q 001768 157 STLEELVLEDNQLVGPLPENLGNLKSLRRILLSSNNFTGSIPESYGNLKNLTEFRIDGSNLTGR--IPNFIGNWTKLDRL 234 (1016)
Q Consensus 157 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~--~p~~l~~l~~L~~L 234 (1016)
...+.|+++++... ..+..+..+..++...+... .+...+..+++|++|+|++|+++.. ++..+..+++|+.|
T Consensus 22 ~~~~~Ldls~l~~~----~~l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L 96 (162)
T d1koha1 22 GSQQALDLKGLRSD----PDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKIL 96 (162)
T ss_dssp SSSCCBCCCCCSSC----TTTTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCC
T ss_pred HHHCEEECCCCCCC----CHHHHCCCHHHCCHHHHHHH-HHHHHHHHCCCCCEEECCCCCCCCCCHHHHHHHHCCCCCCC
T ss_conf 33086534359898----21554664011225556766-60788974878788637776666773158898658856100
Q ss_pred EECCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCC-------CCCCCCCCEEE
Q ss_conf 62488689989021208999989985788798999756-------11243335332
Q 001768 235 DLQGTSLEGPIPSTISQLKNLTELRISDLKGSSSSFPN-------LQDMKKMERLI 283 (1016)
Q Consensus 235 ~L~~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~-------l~~l~~L~~L~ 283 (1016)
++++|.++......+....+|+.|++++|.+....... +..+|+|+.||
T Consensus 97 ~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD 152 (162)
T d1koha1 97 NLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD 152 (162)
T ss_dssp CCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET
T ss_pred CCCCCCCCCCHHHHHHHCCCCCEEECCCCCCCCCCCCCHHHHHHHHHHCCCCCEEC
T ss_conf 04357213423442220331042664899767676661569999999889978799
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.51 E-value=1.4e-06 Score=51.32 Aligned_cols=77 Identities=14% Similarity=0.132 Sum_probs=49.3
Q ss_pred CCCCCCCCCEEEEEEECCC-CCEEEEEECCCC-------CHHHHHHHHHHHHHHHHC-CC--CCEEEEEEEEEECCEEEE
Q ss_conf 3720237973399989079-959999992577-------713169999999999843-99--871100226761625699
Q 001768 664 ANKIGEGGFGPVYKGTLSD-GAVIAVKQLSSK-------SKQGNREFVNEIGMISAL-QH--QNLVKLYGCCIEGNQLLL 732 (1016)
Q Consensus 664 ~~~LG~G~fG~Vy~~~~~~-~~~vAvK~~~~~-------~~~~~~~~~~E~~~l~~l-~H--pniv~l~~~~~~~~~~~l 732 (1016)
.+.||.|....||+....+ ++.+.+|.-... ......+...|...+..+ .+ ..+++++.+. ++..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred EEEECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCEEEEEC--CCCCEE
T ss_conf 998079852768999957998489996177130346777888778999999999986505798855289985--988779
Q ss_pred EEEECCCCCH
Q ss_conf 9963699948
Q 001768 733 VYEYLENNSL 742 (1016)
Q Consensus 733 V~E~~~~gsL 742 (1016)
|||++++..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEECCCCCCC
T ss_conf 8713577653
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=98.10 E-value=5.8e-06 Score=47.70 Aligned_cols=136 Identities=12% Similarity=0.066 Sum_probs=67.6
Q ss_pred EEEEEEECCCCCEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCE--EEEE-----EEEEECCEEEEEEEECCCCCHHH-
Q ss_conf 339998907995999999257771316999999999984399871--1002-----26761625699996369994888-
Q 001768 673 GPVYKGTLSDGAVIAVKQLSSKSKQGNREFVNEIGMISALQHQNL--VKLY-----GCCIEGNQLLLVYEYLENNSLAR- 744 (1016)
Q Consensus 673 G~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpni--v~l~-----~~~~~~~~~~lV~E~~~~gsL~~- 744 (1016)
-.||++..++|+.+++|...... ....++..|...+..+...++ +..+ .....++..+.++++++|..+..
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred CEEEEEECCCCCEEEEEEECCCC-CCHHHHHHHHHHHHHHHHCCCCCCCCEECCCCEEEEEEEEEEEEEEECCCCCCCCC
T ss_conf 02699983899979999847877-88999999999999998559987875206898056653479999865277688999
Q ss_pred -------------HHCC----CC-CCCC-------------------CCCHHHHHHHHHHHHHHHHHHHH----CCCCCE
Q ss_conf -------------8302----76-8676-------------------78978899999999999999772----289876
Q 001768 745 -------------ALFG----KE-GQCL-------------------NLDWATRKRICSDIARGLAYLHE----ESRLKI 783 (1016)
Q Consensus 745 -------------~l~~----~~-~~~~-------------------~l~~~~~~~i~~qia~aL~yLH~----~~~~~i 783 (1016)
.++. .. .... .++...+..+...+...++.+.. ..+.++
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCCEE
T ss_conf 99999998999999886303578655677897887665689998747699889899999999999999984545687120
Q ss_pred EECCCCCCEEEECCCCCEEEECCCCCCC
Q ss_conf 8399987609981499646610346433
Q 001768 784 VHRDIKATNVLLDKDLNAKISDFGLAKL 811 (1016)
Q Consensus 784 iHrDlkp~NILl~~~~~~kl~DFGla~~ 811 (1016)
+|+|+.+.|||++++ ..+.||+-+..
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ECCCCCCCCEEEECC--CEEEECHHCCC
T ss_conf 247888042878389--35886520146
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=98.05 E-value=2.9e-05 Score=43.70 Aligned_cols=73 Identities=19% Similarity=0.215 Sum_probs=46.9
Q ss_pred CCCCCCCCCEEEEEEECCC--------CCEEEEEECCCCCHHHHHHHHHHHHHHHHCC-CCCEEEEEEEEEECCEEEEEE
Q ss_conf 3720237973399989079--------9599999925777131699999999998439-987110022676162569999
Q 001768 664 ANKIGEGGFGPVYKGTLSD--------GAVIAVKQLSSKSKQGNREFVNEIGMISALQ-HQNLVKLYGCCIEGNQLLLVY 734 (1016)
Q Consensus 664 ~~~LG~G~fG~Vy~~~~~~--------~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-Hpniv~l~~~~~~~~~~~lV~ 734 (1016)
.+.|+.|-.-.+|+....+ .+.|.+++..... ......+|..+++.+. +.-..++++++.+ ++|+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~--~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECCCCC--HHHHHHHHHHHHHHHHHCCCCCEEEEECCC----CEEE
T ss_conf 9991785334348999688775445789817999659961--165899999999999757999808998189----5699
Q ss_pred EECCCCCH
Q ss_conf 63699948
Q 001768 735 EYLENNSL 742 (1016)
Q Consensus 735 E~~~~gsL 742 (1016)
||+++..+
T Consensus 121 efi~g~~l 128 (395)
T d1nw1a_ 121 EYIPSRPL 128 (395)
T ss_dssp CCCCEEEC
T ss_pred EEECCCCC
T ss_conf 97345548
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.99 E-value=2.2e-06 Score=50.11 Aligned_cols=114 Identities=8% Similarity=0.069 Sum_probs=0.0
Q ss_pred HHHHCCCCCCEEEECC-CCCCCC----CCHHHCCCCCCCEEECCCCCCCCCCCCC----CCCCCCCCEEECCCCCCCC--
Q ss_conf 3220589878796248-868998----9021208999989985788798999756----1124333533224533544--
Q 001768 223 NFIGNWTKLDRLDLQG-TSLEGP----IPSTISQLKNLTELRISDLKGSSSSFPN----LQDMKKMERLILRNCLITG-- 291 (1016)
Q Consensus 223 ~~l~~l~~L~~L~L~~-N~l~~~----~p~~l~~l~~L~~L~L~~n~l~~~~~~~----l~~l~~L~~L~Ls~N~l~~-- 291 (1016)
....+.++|+.|+|++ +.++.. +...+...++|+.|++++|.+....... +...+.|+.|+|++|.+..
T Consensus 9 ~l~~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g 88 (167)
T d1pgva_ 9 RLREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPEL 88 (167)
T ss_dssp HHHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHH
T ss_pred HHHHCCCCCCEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCCCEEEEHHHCCHHH
T ss_conf 99828999819782799998989999999997637764540120156215679887531000234330033010214599
Q ss_pred --CCCHHHCCCCCCCEEECCCCCCCCC-------CCCCCCCCCCCCEEECCCCC
Q ss_conf --5711002999986696469899999-------76102899988789813896
Q 001768 292 --RIPEYIEDMTDLKILDLSFNQLTGP-------VPGILQNLKKIDYIFLTNNS 336 (1016)
Q Consensus 292 --~~p~~l~~l~~L~~L~Ls~N~L~~~-------~p~~l~~l~~L~~L~L~~N~ 336 (1016)
.+...+...+.|++|++++|.+... +...+...++|+.|+++.+.
T Consensus 89 ~~~l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~ 142 (167)
T d1pgva_ 89 LARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS 142 (167)
T ss_dssp HHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred HHHHHHHHHHCCCCCEEECCCCCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCC
T ss_conf 999999998489389877887768886579999999999729985386486888
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.72 E-value=7.1e-06 Score=47.20 Aligned_cols=13 Identities=23% Similarity=0.411 Sum_probs=4.3
Q ss_pred CCCCEEEECCCCC
Q ss_conf 9878796248868
Q 001768 229 TKLDRLDLQGTSL 241 (1016)
Q Consensus 229 ~~L~~L~L~~N~l 241 (1016)
++|+.|++++|.+
T Consensus 46 ~~L~~L~Ls~n~l 58 (166)
T d1io0a_ 46 TYVKKFSIVGTRS 58 (166)
T ss_dssp CSCCEEECTTSCC
T ss_pred CCCCEEECCCCCC
T ss_conf 8257430158961
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.48 E-value=0.0015 Score=33.84 Aligned_cols=32 Identities=25% Similarity=0.268 Sum_probs=27.8
Q ss_pred CCCCEEECCCCCCEEEECCCCCEEEECCCCCC
Q ss_conf 89876839998760998149964661034643
Q 001768 779 SRLKIVHRDIKATNVLLDKDLNAKISDFGLAK 810 (1016)
Q Consensus 779 ~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 810 (1016)
-+.++||+|+.+.||+++.+...-+.||+.+.
T Consensus 181 L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 181 LPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp SCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred CCCCCCCCCCCHHHHHCCCCCCEEEECCCCCC
T ss_conf 54503337863656402045412674222123
|
| >d2o14a1 b.18.1.32 (A:14-159) Hypothetical protein YxiM {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Galactose-binding domain-like superfamily: Galactose-binding domain-like family: YxiM N-terminal domain-like domain: Hypothetical protein YxiM species: Bacillus subtilis [TaxId: 1423]
Probab=92.51 E-value=0.14 Score=22.62 Aligned_cols=67 Identities=18% Similarity=0.316 Sum_probs=46.2
Q ss_pred CCCEEEECCCCEEEEEEEEEEEECCCCCCCCCCCEEEEEEECCEEECCCCCCEECCCCCCCEEEEEEEEEEEECCEEEEE
Q ss_conf 20100102662279997788883178541234630148873556412445353050786826998544457508646999
Q 001768 483 KYYGLCMLKGSYTVKLHFAEIMFTNDQTYKSLGKRMFDVSIQGKQVLKDFDIMEEAGGVGIGITREFKDVSVNGSTMEIH 562 (1016)
Q Consensus 483 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 562 (1016)
.+|-+-+.||+|.|++.|.+... .++.+.|..+..++ .+....+.| .+.|++..|.|+
T Consensus 65 ~~f~v~vPnG~Y~Vtv~~Gd~~~-------------~~~~~eg~~~~~~~--------~g~~~~~~~-~V~VtDG~L~l~ 122 (146)
T d2o14a1 65 NTFNVDLPNGLYEVKVTLGNTAR-------------ASVAAEGVFQVINM--------TGDGAEDTF-QIPVTDGQLNLL 122 (146)
T ss_dssp CCEEEECCSEEEEEEEEESSCSE-------------EEEEETTEEEEEEE--------ESTTCEEEE-EEEECSSEEEEE
T ss_pred CEEEEECCCCEEEEEEEEECCCC-------------CCEEEEEEEECCCC--------CCCCEEEEE-EEEEECCEEEEE
T ss_conf 66999889971899999936777-------------62778517800266--------873177899-999879948799
Q ss_pred EEECCCCCC
Q ss_conf 997598763
Q 001768 563 LYWAGKGTN 571 (1016)
Q Consensus 563 ~~~~g~~~~ 571 (1016)
+.-+..|.+
T Consensus 123 ft~~~~G~~ 131 (146)
T d2o14a1 123 VTEGKAGTA 131 (146)
T ss_dssp EEESSTTSC
T ss_pred EECCCCCCC
T ss_conf 843778986
|